PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Davidich, MI; Bornholdt, S				Davidich, Maria I.; Bornholdt, Stefan			Boolean Network Model Predicts Cell Cycle Sequence of Fission Yeast	PLOS ONE			English	Article								A Boolean network model of the cell-cycle regulatory network of fission yeast (Schizosaccharomyces Pombe) is constructed solely on the basis of the known biochemical interaction topology. Simulating the model in the computer faithfully reproduces the known activity sequence of regulatory proteins along the cell cycle of the living cell. Contrary to existing differential equation models, no parameters enter the model except the structure of the regulatory circuitry. The dynamical properties of the model indicate that the biological dynamical sequence is robustly implemented in the regulatory network, with the biological stationary state G1 corresponding to the dominant attractor in state space, and with the biological regulatory sequence being a strongly attractive trajectory. Comparing the fission yeast cell-cycle model to a similar model of the corresponding network in S. cerevisiae, a remarkable difference in circuitry, as well as dynamics is observed. While the latter operates in a strongly damped mode, driven by external excitation, the S. pombe network represents an auto-excited system with external damping.	[Davidich, Maria I.; Bornholdt, Stefan] Univ Bremen, Inst Theoret Phys, Bremen, Germany	University of Bremen	Davidich, MI (corresponding author), Univ Bremen, Inst Theoret Phys, Bremen, Germany.	bornholdt@itp.uni-bremen.de						Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Buck V, 2003, J CELL SCI, V116, P4263; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Forsburg SL, 1999, TRENDS GENET, V15, P340, DOI 10.1016/S0168-9525(99)01798-9; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MARTINCASTELLAN.C, 1996, J EMBO, V15, P839; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; Simanis V, 2003, J CELL SCI, V116, P4263, DOI 10.1242/jcs.00807; Smolen P, 2000, NEURON, V26, P567, DOI 10.1016/S0896-6273(00)81194-0; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Thum KE, 2003, PLANT PHYSIOL, V132, P440, DOI 10.1104/pp.103.022780; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yamaguchi S, 2000, EMBO J, V19, P3968, DOI 10.1093/emboj/19.15.3968	38	333	341	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1672	10.1371/journal.pone.0001672	http://dx.doi.org/10.1371/journal.pone.0001672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301750	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500017
J	Michalski, CW; Maier, M; Erkan, M; Sauliunaite, D; Bergmann, F; Pacher, P; Batkai, S; Giese, NA; Giese, T; Friess, H; Kleeff, J				Michalski, Christoph W.; Maier, Milena; Erkan, Mert; Sauliunaite, Danguole; Bergmann, Frank; Pacher, Pal; Batkai, Sandor; Giese, Nathalia A.; Giese, Thomas; Friess, Helmut; Kleeff, Joerg			Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells	PLOS ONE			English	Article							MATRIX SYNTHESIS; POTENTIAL ROLE; PAIN; IDENTIFICATION; MECHANISMS; EXPRESSION; RECEPTORS; CYTOKINES; SYSTEM; CANCER	Background: While cannabinoids have been shown to ameliorate liver fibrosis, their effects in chronic pancreatitis and on pancreatic stellate cells (PSC) are unknown. Methodology/Principal Findings: The activity of the endocannabinoid system was evaluated in human chronic pancreatitis (CP) tissues. In vitro, effects of blockade and activation of cannabinoid receptors on pancreatic stellate cells were characterized. In CP, cannabinoid receptors were detected predominantly in areas with inflammatory changes, stellate cells and nerves. Levels of endocannabinoids were decreased compared with normal pancreas. Cannabinoid-receptor-1 antagonism effectuated a small PSC phenotype and a trend toward increased invasiveness. Activation of cannabinoid receptors, however, induced de-activation of PSC and dose-dependently inhibited growth and decreased IL-6 and MCP-1 secretion as well as fibronectin, collagen1 and alphaSMA levels. De-activation of PSC was partially reversible using a combination of cannabinoid-receptor-1 and -2 antagonists. Concomitantly, cannabinoid receptor activation specifically decreased invasiveness of PSC, MMP-2 secretion and led to changes in PSC phenotype accompanied by a reduction of intracellular stress fibres. Conclusions/Significance: Augmentation of the endocannabinoid system via exogenously administered cannabinoid receptor agonists specifically induces a functionally and metabolically quiescent pancreatic stellate cell phenotype and may thus constitute an option to treat inflammation and fibrosis in chronic pancreatitis.	[Michalski, Christoph W.; Erkan, Mert; Sauliunaite, Danguole; Friess, Helmut; Kleeff, Joerg] Tech Univ Munich, Dept Surg, Munich, Germany; [Michalski, Christoph W.; Maier, Milena; Giese, Nathalia A.] Heidelberg Univ, Dept General Surg, Heidelberg, Germany; [Bergmann, Frank] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Pacher, Pal; Batkai, Sandor] NIH, NIAAA, Lab Physiol Stud, Sect Oxidative Stress Tissue Injury, Bethesda, MD USA; [Giese, Thomas] Heidelberg Univ, Inst Immunol, Heidelberg, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Ruprecht Karls University Heidelberg	Michalski, CW (corresponding author), Tech Univ Munich, Dept Surg, Munich, Germany.	christoph.michalski@gmx.de	Kleeff, Jorg/B-2124-2009; Batkai, Sandor/G-3889-2010; Michalski, Christoph/U-9167-2019; Batkai, Sandor/H-7983-2014; Pacher, Pal/B-6378-2008	Kleeff, Jorg/0000-0003-3432-6669; Pacher, Pal/0000-0001-7036-8108	Postdoctoral Research Program, Heidelberg University; Intramural Research Program of the NIH/NIAAA [1Z01AA000375-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000375] Funding Source: NIH RePORTER	Postdoctoral Research Program, Heidelberg University; Intramural Research Program of the NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a Postdoctoral Research Program grant of Heidelberg University (to C.W.M) and in part by the Intramural Research Program of the NIH/NIAAA (#1Z01AA000375-01) to P.P. The funders had no role in the design and conduct of the study; neither did they influence collection, analysis and interpretation of the data or preparation, review or approval of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Apte MV, 2003, PANCREAS, V27, P316, DOI 10.1097/00006676-200311000-00008; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; BOCKMAN DE, 1988, GASTROENTEROLOGY, V94, P1459; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Ceyhan GO, 2007, GUT, V56, P534, DOI 10.1136/gut.2006.105528; Correa F, 2005, MINI-REV MED CHEM, V5, P671, DOI 10.2174/1389557054368790; Di Marzo V, 2007, CHEM BIOL, V14, P741, DOI 10.1016/j.chembiol.2007.05.014; Di Sebastiano P, 2004, DIGEST DIS, V22, P267, DOI 10.1159/000082798; DiMagno MJ, 2006, CURR OPIN GASTROEN, V22, P487; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Esposito I, 2001, ZBL CHIR, V126, P867, DOI 10.1055/s-2001-19158; Friess H, 2003, J GASTROINTEST SURG, V7, P943, DOI 10.1016/j.gassur.2003.10.002; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hartel M, 2003, LANGENBECK ARCH SURG, V388, P132, DOI 10.1007/s00423-003-0361-y; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Luttenberger T, 2000, LAB INVEST, V80, P47, DOI 10.1038/labinvest.3780007; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Meng ID, 1998, NATURE, V395, P381, DOI 10.1038/26481; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Michalski CW, 2008, AM J PHYSIOL-GASTR L, V294, pG50, DOI 10.1152/ajpgi.00058.2007; Michalski CW, 2007, ANN SURG, V246, P786, DOI 10.1097/SLA.0b013e318070d56e; Michalski CW, 2007, GASTROENTEROLOGY, V132, P1968, DOI 10.1053/j.gastro.2007.02.035; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; PACHER P, 2006, PHARMACOL REV, V58, P1; Pacifici R, 2003, JAMA-J AM MED ASSOC, V289, P1929, DOI 10.1001/jama.289.15.1929-b; Pertwee RG, 2005, AAPS J, V7, pE625, DOI 10.1208/aapsj070364; Phillips PA, 2003, GUT, V52, P677, DOI 10.1136/gut.52.5.677; Phillips PA, 2003, GUT, V52, P275, DOI 10.1136/gut.52.2.275; Popow A, 2006, J PHYSIOL PHARMACOL, V57, P111; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Schwabe RF, 2005, HEPATOLOGY, V42, P975, DOI 10.1002/hep.20895; Shek FWT, 2002, AM J PATHOL, V160, P1787, DOI 10.1016/S0002-9440(10)61125-X; Shimizu K, 2005, GASTROENTEROLOGY, V128, P2105, DOI 10.1053/j.gastro.2005.03.025; SHIVERS SC, 1994, LIFE SCI, V54, P1281, DOI 10.1016/0024-3205(94)00856-6; Siegmund SV, 2005, HEPATOLOGY, V41, P1085, DOI 10.1002/hep.20667; Talukdar R, 2006, PANCREATOLOGY, V6, P440, DOI 10.1159/000094561; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; van Esch AAJ, 2006, DIGEST LIVER DIS, V38, P518, DOI 10.1016/j.dld.2006.02.002; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Whitcomb DC, 2004, NAT CLIN PRACT GASTR, V1, P46, DOI 10.1038/ncpgasthep0025	51	42	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1701	10.1371/journal.pone.0001701	http://dx.doi.org/10.1371/journal.pone.0001701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301776	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500045
J	Nackerdien, ZE; Keynan, A; Bassler, BL; Lederberg, J; Thaler, DS				Nackerdien, Zeena E.; Keynan, Alexander; Bassler, Bonnie L.; Lederberg, Joshua; Thaler, David S.			Quorum Sensing Influences Vibrio harveyi Growth Rates in a Manner Not Fully Accounted For by the Marker Effect of Bioluminescence	PLOS ONE			English	Article								Background: The light-emitting Vibrios provide excellent material for studying the interaction of cellular communication with growth rate because bioluminescence is a convenient marker for quorum sensing. However, the use of bioluminescence as a marker is complicated because bioluminescence itself may affect growth rate, e. g. by diverting energy. Methodology/Principal Findings: The marker effect was explored via growth rate studies in isogenic Vibrio harveyi (Vh) strains altered in quorum sensing on the one hand, and bioluminescence on the other. By hypothesis, growth rate is energy limited: mutants deficient in quorum sensing grow faster because wild type quorum sensing unleashes bioluminescence and bioluminescence diverts energy. Findings reported here confirm a role for bioluminescence in limiting Vh growth rate, at least under the conditions tested. However, the results argue that the bioluminescence is insufficient to explain the relationship of growth rate and quorum sensing in Vh. A Vh mutant null for all genes encoding the bioluminescence pathway grew faster than wild type but not as fast as null mutants in quorum sensing. Vh quorum sensing mutants showed altered growth rates that do not always rank with their relative increase or decrease in bioluminescence. In addition, the cell-free culture fluids of a rapidly growing Vibrio parahaemolyticus (Vp) strain increased the growth rate of wild type Vh without significantly altering Vh's bioluminescence. The same cell-free culture fluid increased the bioluminescence of Vh quorum mutants. Conclusions/Significance: The effect of quorum sensing on Vh growth rate can be either positive or negative and includes both bioluminescence-dependent and independent components. Bioluminescence tends to slow growth rate but not enough to account for the effects of quorum sensing on growth rate.	[Nackerdien, Zeena E.; Lederberg, Joshua; Thaler, David S.] Rockefeller Univ, Raymond & Beverly Sackler Lab Mol Genet & Informa, New York, NY 10021 USA; [Keynan, Alexander] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, Jerusalem, Israel; [Bassler, Bonnie L.] Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ USA	Rockefeller University; Hebrew University of Jerusalem; Howard Hughes Medical Institute; Princeton University	Nackerdien, ZE (corresponding author), Rockefeller Univ, Raymond & Beverly Sackler Lab Mol Genet & Informa, 1230 York Ave, New York, NY 10021 USA.	thalerd@rockefeller.edu		Bassler, Bonnie/0000-0002-0043-746X	ARO [46938-LS]; Sloan Foundation; HHMI NIH [R01 GM 065859]; NSF [MCB-0343821]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065859] Funding Source: NIH RePORTER	ARO; Sloan Foundation(Alfred P. Sloan Foundation); HHMI NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by ARO project grant 46938-LS to JL and Sloan Foundation support to JL and DST. BLB acknowledges HHMI, NIH grants R01 GM 065859, and NSF grant MCB-0343821. We are grateful to Jack Rudin for his support of AK in New York.	Aiyar SE, 2002, J BACTERIOL, V184, P1349, DOI 10.1128/JB.184.5.1349-1358.2002; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Beste DJV, 2007, J BACTERIOL, V189, P3969, DOI 10.1128/JB.01787-06; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; BLOT M, 1994, MOL GEN GENET, V242, P595, DOI 10.1007/BF00285283; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Carbonell X, 2002, MICROBIOL RES, V157, P257, DOI 10.1078/0944-5013-00167; Chatterjee J, 2002, MOL MICROBIOL, V46, P101, DOI 10.1046/j.1365-2958.2002.03128.x; Colwell RR, 2000, NONCULTURABLE MICROO; Czyz A, 2003, LUMINESCENCE, V18, P140, DOI 10.1002/bio.715; DAVIS K, 2005, APPL ENV MICROBIOL, V71; Diggle SP, 2007, PHILOS T R SOC B, V362, P1241, DOI 10.1098/rstb.2007.2049; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; HASTINGS JW, 1977, ANNU REV MICROBIOL, V31, P549, DOI 10.1146/annurev.mi.31.100177.003001; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Ingraham J. L., 1983, GROWTH BACTERIAL CEL; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jaques S, 2006, J BACTERIOL, V188, P2625, DOI 10.1128/JB.188.7.2625-2635.2006; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; KAPRELYANTS AS, 1993, APPL ENVIRON MICROB, V59, P3187, DOI 10.1128/AEM.59.10.3187-3196.1993; Karlin S, 2001, J BACTERIOL, V183, P5025, DOI 10.1128/JB.183.17.5025-5040.2001; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; LEDERBERG J, 1957, J BACTERIOL, V73, P144, DOI 10.1128/JB.73.1.144-144.1957; LEDERBERG J, 1958, J BACTERIOL, V75, P143, DOI 10.1128/JB.75.2.143-160.1958; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Lupp C, 2004, J BACTERIOL, V186, P3873, DOI 10.1128/JB.186.12.3873-3881.2004; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Neidhardt FC, 1999, J BACTERIOL, V181, P7405, DOI 10.1128/JB.181.24.7405-7408.1999; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Sambrook J., 2002, MOL CLONING LAB MANU; Shapiro JA, 1997, BACTERIA MULTICELLUL; SIMIDU U, 1985, APPL ENVIRON MICROB, V50, P781, DOI 10.1128/AEM.50.4.781-790.1985; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Stabb EV, 2005, ASM NEWS, V71, P223; Stabb EV, 2004, J BACTERIOL, V186, P2906, DOI 10.1128/JB.186.9.2906-2908.2004; STABB EV, 2004, JBACTERIOL, V186, P1205; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Swift S, 1996, TRENDS BIOCHEM SCI, V21, P214; Tannock GW, 2005, APPL ENVIRON MICROB, V71, P8419, DOI 10.1128/AEM.71.12.8419-8425.2005; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Turovskiy Y, 2007, ADV APPL MICROBIOL, V62, P191, DOI 10.1016/S0065-2164(07)62007-3; Vasil ML, 2003, J BACTERIOL, V185, P2061, DOI 10.1128/JB.185.7.2061-2065.2003; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	58	27	32	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1671	10.1371/journal.pone.0001671	http://dx.doi.org/10.1371/journal.pone.0001671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301749	Green Published, gold			2022-12-27	WOS:000260586500016
J	Vinod, PK; Sengupta, N; Bhat, PJ; Venkatesh, KV				Vinod, P. K.; Sengupta, Neelanjan; Bhat, P. J.; Venkatesh, K. V.			Integration of Global Signaling Pathways, cAMP-PKA, MAPK and TOR in the Regulation of FLO11	PLOS ONE			English	Article							PROTEIN-KINASE-A; YEAST SACCHAROMYCES-CEREVISIAE; RAS/CYCLIC AMP PATHWAY; KELCH-REPEAT PROTEINS; G-ALPHA SUBUNIT; FILAMENTOUS GROWTH; PSEUDOHYPHAL DIFFERENTIATION; TRANSLATION INITIATION; G(1) ARREST; NITROGEN	The budding yeast, Saccharomyces cerevisiae, responds to various environmental cues by invoking specific adaptive mechanisms for their survival. Under nitrogen limitation, S. cerevisiae undergoes a dimorphic filamentous transition called pseudohyphae, which helps the cell to forage for nutrients and reach an environment conducive for growth. This transition is governed by a complex network of signaling pathways, namely cAMP-PKA, MAPK and TOR, which controls the transcriptional activation of FLO11, a flocculin gene that encodes a cell wall protein. However, little is known about how these pathways co-ordinate to govern the conversion of nutritional availability into gene expression. Here, we have analyzed an integrative network comprised of cAMP-PKA, MAPK and TOR pathways with respect to the availability of nitrogen source using experimental and steady state modeling approach. Our experiments demonstrate that the steady state expression of FLO11 was bistable over a range of inducing ammonium sulphate concentration based on the preculturing condition. We also show that yeast switched from FLO11 expression to accumulation of trehalose, a STRE response controlled by a transcriptional activator Msn2/4, with decrease in the inducing concentration to complete starvation. Steady state analysis of the integrative network revealed the relationship between the environment, signaling cascades and the expression of FLO11. We demonstrate that the double negative feedback loop in TOR pathway can elicit a bistable response, to differentiate between vegetative growth, filamentous growth and STRE response. Negative feedback on TOR pathway function to restrict the expression of FLO11 under nitrogen starved condition and also with re-addition of nitrogen to starved cells. In general, we show that these global signaling pathways respond with specific sensitivity to regulate the expression of FLO11 under nitrogen limitation. The holistic steady state modeling approach of the integrative network revealed how the global signaling pathways could differentiate between multiple phenotypes.	[Vinod, P. K.; Bhat, P. J.; Venkatesh, K. V.] Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Sengupta, Neelanjan; Venkatesh, K. V.] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Vinod, PK (corresponding author), Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India.	venks@che.iitb.ac.in		Venkatesh, Kareenhalli V./0000-0001-7397-5472; Vinod, P K/0000-0003-2968-498X; Sengupta, Neelanjan/0000-0003-4381-9588	Department of Science and Technology, India [Swarnajayanti fellowship]	Department of Science and Technology, India(Department of Science & Technology (India))	. V. Venkatesh acknowledges the financial support from the Swarnajayanti fellowship, Department of Science and Technology, India.	Adams A, 1997, METHODS YEAST GENETI; Ahn SH, 1999, MOL BIOL CELL, V10, P3301, DOI 10.1091/mbc.10.10.3301; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Batlle M, 2003, J CELL SCI, V116, P701, DOI 10.1242/jcs.00266; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gagiano M, 2002, FEMS YEAST RES, V2, P433, DOI 10.1016/S1567-1356(02)00133-2; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Harashima T, 2002, MOL CELL, V10, P163, DOI 10.1016/S1097-2765(02)00569-5; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HOJEONG KEH, 2003, COMMUN SOIL SCI PLAN, V34, P2193; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; HUBLER L, 1993, MOL CELL BIOL, V13, P6274, DOI 10.1128/MCB.13.10.6274; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; Liu CB, 1998, BIOTECHNOL TECH, V12, P941, DOI 10.1023/A:1008881915907; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Loeb JDJ, 1999, GENETICS, V153, P1535; Lorenz MC, 2000, GENETICS, V154, P609; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; MARKWARDT DD, 1995, J BACTERIOL, V177, P6761, DOI 10.1128/jb.177.23.6761-6765.1995; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Oehlen LJWM, 1998, J BIOL CHEM, V273, P25089, DOI 10.1074/jbc.273.39.25089; Pan XW, 2000, MOL CELL BIOL, V20, P8364, DOI 10.1128/MCB.20.22.8364-8372.2000; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Rohde JR, 2003, CURR TOP MICROBIOL, V279, P53; Rua D, 2001, CURR OPIN MICROBIOL, V4, P720, DOI 10.1016/S1369-5274(01)00274-0; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sengupta N, 2007, BIOPHYS CHEM, V125, P59, DOI 10.1016/j.bpc.2006.06.012; Stanhill A, 1999, MOL CELL BIOL, V19, P7529; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Zurita-Martinez SA, 2005, EUKARYOT CELL, V4, P63, DOI 10.1128/EC.4.1.63-71.2005	59	49	49	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1663	10.1371/journal.pone.0001663	http://dx.doi.org/10.1371/journal.pone.0001663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301741	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586500008
J	Ramakrishna, BS; Subramanian, V; Mohan, V; Sebastian, BK; Young, GP; Farthing, MJ; Binder, HJ				Ramakrishna, Balakrishnan S.; Subramanian, Venkataraman; Mohan, Vivek; Sebastian, Bendon K.; Young, Graeme P.; Farthing, Michael J.; Binder, Henry J.			A Randomized Controlled Trial of Glucose versus Amylase Resistant Starch Hypo-Osmolar Oral Rehydration Solution for Adult Acute Dehydrating Diarrhea	PLOS ONE			English	Article							EFFICACY; THERAPY; CHOLERA; ADJUNCT	Background: Reduction of gross diarrhea rate in excess of that seen over time with intravenous therapy and appropriate antibiotics is not usually achieved by oral glucose-electrolyte rehydration therapy for cholera and cholera-like diarrheas. Methodology and Principal Findings: This prospective randomized clinical trial at a tertiary referral hospital in southern India was undertaken to determine whether amylase resistant starch, substituting for glucose in hypo-osmolar oral rehydration solution, would reduce diarrhea duration and weight in adults with acute severe dehydrating diarrhea. 50 adult males with severe watery diarrhea of less than three days' duration and moderate to severe dehydration were randomized to receive hypo-osmolar ORS (HO-ORS) or HO-ORS in which amylase resistant high amylose maize starch 50g/L substituted for glucose (HAMS-ORS). All remaining therapy followed standard protocol. Duration of diarrhea (ORS commencement to first formed stool) in hours was significantly shorter with HAMS-ORS (median 19, IQR 10-28) compared to HO-ORS (median 42, IQR 24-50) (Bonferroni adjusted P, P-adj < 0.001). Survival analysis (Kaplan-Meier) showed faster recovery from diarrhea in the HAMS-ORS group (P < 0.001, log rank test). Total diarrhea fecal weight in grams (median, IQR) was not significantly lower in the HAMS-ORS group (2190, 1160-5635) compared to HO-ORS (5210, 2095-12190) (P-adj = 0.08). However, stool weight at 13-24 hours (280, 0-965 vs. 1360, 405-2985) and 25-48 hours (0, 0-360 vs. 1080, 55-3485) were significantly lower in HAMS-ORS compared to HO-ORS group (Padj = 0.048 and P = 0.012, respectively). ORS intake after first 24 hours was lower in the HAMS-ORS group. Subgroup analysis of patients with culture isolates of Vibrio cholerae indicated similar significant differences between the treatment groups. Conclusions: Compared to HO-ORS, HAMS-ORS reduced diarrhea duration by 55% and significantly reduced fecal weight after the first 12 hours of ORS therapy in adults with cholera-like diarrhea.	[Ramakrishna, Balakrishnan S.; Subramanian, Venkataraman; Mohan, Vivek; Sebastian, Bendon K.] Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India; [Young, Graeme P.] Flinders Univ S Australia, Dept Med, Adelaide, SA, Australia; [Farthing, Michael J.] Univ London, St Georges, London, England; [Binder, Henry J.] Yale Univ, Sch Med, Dept Intern Med, New Haven, CT USA	Christian Medical College & Hospital (CMCH) Vellore; Flinders University South Australia; University of London; Yale University	Ramakrishna, BS (corresponding author), Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India.	rama@cmcvellore.ac.in	Subramanian, Venkataraman/B-8274-2011; Ramakrishna, Balakrishnan/D-6808-2015	Subramanian, Venkataraman/0000-0003-3603-0861; Ramakrishna, Balakrishnan/0000-0001-5090-9501; Young, Graeme/0000-0001-9458-8383	International Trilateral Collaborative Research [063150/A/00/Z]; Wellcome Trust, London, UK	International Trilateral Collaborative Research; Wellcome Trust, London, UK(Wellcome Trust)	The study was funded by International Trilateral Collaborative Research Grant No. 063150/A/00/Z from the Wellcome Trust, London, UK. The funding source had no involvement in the authors' work.	Alam NH, 2000, J PEDIATR GASTR NUTR, V31, P503, DOI 10.1097/00005176-200011000-00010; Alam NH, 1999, LANCET, V354, P296, DOI 10.1016/S0140-6736(98)09332-5; Alam Seema, 2006, Indian Journal of Pediatrics, V73, P693, DOI 10.1007/BF02898447; Binder HJ, 1998, GASTROENTEROLOGY, V115, P512, DOI 10.1016/S0016-5085(98)70237-9; BINDER HJ, 1991, LARGE INTESTINE PHYS, P1164; Brown IL, 2004, J AOAC INT, V87, P727; Desjeux JF, 1997, BAILLIERE CLIN GASTR, V11, P509, DOI 10.1016/S0950-3528(97)90029-4; Duggan C, 2004, JAMA-J AM MED ASSOC, V291, P2628, DOI 10.1001/jama.291.21.2628; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; GREENOUGH WB, 1993, J DIARRHOEAL DIS RES, V11, P1; Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Hahn S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002847; HEIMDAHL A, 1983, SCAND J INFECT DIS, V15, P293, DOI 10.3109/inf.1983.15.issue-3.10; Hoekstra JH, 2004, J PEDIATR GASTR NUTR, V39, P239, DOI 10.1097/00005176-200409000-00003; HUNT JB, 1992, GUT, V33, P1652, DOI 10.1136/gut.33.12.1652; Le Leu RK, 2003, CARCINOGENESIS, V24, P1347, DOI 10.1093/carcin/bgg098; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; LINDENBA.J, 1965, LANCET, V1, P1081; Murphy C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003754.PUB2; NALIN DR, 2004, JAMA-J AM MED ASSOC, V21, P2632; NATH SK, 1989, AM J PHYSIOL, V256, pG335, DOI 10.1152/ajpgi.1989.256.2.G335; PHILLIPS J, 1995, AM J CLIN NUTR, V62, P121; Raghupathy P, 2006, J PEDIATR GASTR NUTR, V42, P362, DOI 10.1097/01.mpg.0000214163.83316.41; RAMAKRISHNA BS, 1993, GUT, V34, P1215, DOI 10.1136/gut.34.9.1215; Ramakrishna BS, 2000, NEW ENGL J MED, V342, P308, DOI 10.1056/NEJM200002033420502; Sanchez JL, 1997, LANCET, V349, P1825, DOI 10.1016/S0140-6736(97)04486-3; Thillainayagam AV, 1998, GASTROENTEROLOGY, V114, P197, DOI 10.1016/S0016-5085(98)70647-X; UNICEF, 2006, OR REH SALTS PROD NE; WHO, 1995, WHOCDR953	29	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1587	10.1371/journal.pone.0001587	http://dx.doi.org/10.1371/journal.pone.0001587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270575	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000260535900021
J	Rowley, AH; Baker, SC; Shulman, ST; Garcia, FL; Fox, LM; Kos, IM; Crawford, SE; Russo, PA; Hammadeh, R; Takahashi, K; Orenstein, JM				Rowley, Anne H.; Baker, Susan C.; Shulman, Stanford T.; Garcia, Francesca L.; Fox, Linda M.; Kos, Ian M.; Crawford, Susan E.; Russo, Pierre A.; Hammadeh, Rashid; Takahashi, Kei; Orenstein, Jan M.			RNA-Containing Cytoplasmic Inclusion Bodies in Ciliated Bronchial Epithelium Months to Years after Acute Kawasaki Disease	PLOS ONE			English	Article								Background: Kawasaki Disease (KD) is the most common cause of acquired heart disease in children in developed nations. The KD etiologic agent is unknown but likely to be a ubiquitous microbe that usually causes asymptomatic childhood infection, resulting in KD only in genetically susceptible individuals. KD synthetic antibodies made from prevalent IgA gene sequences in KD arterial tissue detect intracytoplasmic inclusion bodies (ICI) resembling viral ICI in acute KD but not control infant ciliated bronchial epithelium. The prevalence of ICI in late-stage KD fatalities and in older individuals with non-KD illness should be low, unless persistent infection is common. Methods and Principal Findings: Lung tissue from late-stage KD fatalities and non-infant controls was examined by light microscopy for the presence of ICI. Nucleic acid stains and transmission electron microscopy (TEM) were performed on tissues that were strongly positive for ICI. ICI were present in ciliated bronchial epithelium in 6/7 (86%) late-stage KD fatalities and 7/27 (26%) controls ages 9-84 years (p=0.01). Nucleic acid stains revealed RNA but not DNA within the ICI. ICI were also identified in lung macrophages in some KD cases. TEM of bronchial epithelium and macrophages from KD cases revealed finely granular homogeneous ICI. Significance: These findings are consistent with a previously unidentified, ubiquitous RNA virus that forms ICI and can result in persistent infection in bronchial epithelium and macrophages as the etiologic agent of KD.	[Rowley, Anne H.; Shulman, Stanford T.; Garcia, Francesca L.; Kos, Ian M.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Childrens Mem Hosp,Ctr Kawasaki Dis, Chicago, IL 60611 USA; [Rowley, Anne H.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL USA; [Crawford, Susan E.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL USA; [Baker, Susan C.] Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Fox, Linda M.; Hammadeh, Rashid] Loyola Univ, Stritch Sch Med, Dept Pathol, Maywood, IL USA; [Russo, Pierre A.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA USA; [Orenstein, Jan M.] George Washington Univ, Sch Med, Dept Pathol, Washington, DC USA; [Takahashi, Kei] Toho Univ, Sch Med, Dept Pathol, Tokyo, Japan	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Loyola University Chicago; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; George Washington University; Toho University	Rowley, AH (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Childrens Mem Hosp,Ctr Kawasaki Dis, Chicago, IL 60611 USA.	a-rowley@northwestern.edu		Rowley, Anne/0000-0003-4695-6676	NIH [HL63771]; Kawasaki Disease Fund of Children's Memorial Hospital; Research Funding Committee of Loyola University Stritch School of Medicine [109703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kawasaki Disease Fund of Children's Memorial Hospital; Research Funding Committee of Loyola University Stritch School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH HL63771 (to AHR), the Kawasaki Disease Fund of Children's Memorial Hospital, and the Research Funding Committee of Loyola University Stritch School of Medicine, LU#109703 (to SCB). Sponsors/funders did not have any role in the design and conduct of the study, data collection analysis, and interpretation, or in preparation, review or approval of the manuscript.	AMANO S, 1980, ACTA PATHOL JAPON, V30, P681; Carlos TS, 2005, J VIROL, V79, P14112, DOI 10.1128/JVI.79.22.14112-14121.2005; Chatziandreou N, 2002, VIROLOGY, V293, P234, DOI 10.1006/viro.2001.1302; Debiaggi M, 2006, J INFECT DIS, V194, P474, DOI 10.1086/505881; FEARNS R, 1994, J GEN VIROL, V75, P3525, DOI 10.1099/0022-1317-75-12-3525; Johnson RM, 2001, CLIN INFECT DIS, V32, P1628, DOI 10.1086/320523; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; MUCHMORE HG, 1981, NATURE, V289, P187, DOI 10.1038/289187a0; NARANG HK, 1982, INFECT IMMUN, V36, P310, DOI 10.1128/IAI.36.1.310-319.1982; Roweley AH, 2007, NELSON TXB PEDIAT, P1036; Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832; Rowley AH, 2005, J IMMUNOL, V175, P8386, DOI 10.4049/jimmunol.175.12.8386; Rowley AH, 2005, J INFECT DIS, V192, P1757, DOI 10.1086/497171; Rowley AH, 2004, J INFECT DIS, V190, P856, DOI 10.1086/422648; Rowley AH, 1997, J IMMUNOL, V159, P5946; Rowley AH, 2001, J IMMUNOL, V166, P1334, DOI 10.4049/jimmunol.166.2.1334; Rowley AH, 2007, CURR OPIN PEDIATR, V19, P71, DOI 10.1097/MOP.0b013e328012720f; Stankovic K, 2007, J INFECTION, V55, P488, DOI 10.1016/j.jinf.2007.09.005	18	68	69	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1582	10.1371/journal.pone.0001582	http://dx.doi.org/10.1371/journal.pone.0001582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270572	Green Submitted, Green Published, gold			2022-12-27	WOS:000260535900018
J	Knowles, TG; Kestin, SC; Haslam, SM; Brown, SN; Green, LE; Butterworth, A; Pope, SJ; Pfeiffer, D; Nicol, CJ				Knowles, Toby G.; Kestin, Steve C.; Haslam, Susan M.; Brown, Steven N.; Green, Laura E.; Butterworth, Andrew; Pope, Stuart J.; Pfeiffer, Dirk; Nicol, Christine J.			Leg Disorders in Broiler Chickens: Prevalence, Risk Factors and Prevention	PLOS ONE			English	Article								Broiler (meat) chickens have been subjected to intense genetic selection. In the past 50 years, broiler growth rates have increased by over 300% (from 25 g per day to 100 g per day). There is growing societal concern that many broiler chickens have impaired locomotion or are even unable to walk. Here we present the results of a comprehensive survey of commercial flocks which quantifies the risk factors for poor locomotion in broiler chickens. We assessed the walking ability of 51,000 birds, representing 4.8 million birds within 176 flocks. We also obtained information on approximately 150 different management factors associated with each flock. At a mean age of 40 days, over 27.6% of birds in our study showed poor locomotion and 3.3% were almost unable to walk. The high prevalence of poor locomotion occurred despite culling policies designed to remove severely lame birds from flocks. We show that the primary risk factors associated with impaired locomotion and poor leg health are those specifically associated with rate of growth. Factors significantly associated with high gait score included the age of the bird (older birds), visit (second visit to same flock), bird genotype, not feeding whole wheat, a shorter dark period during the day, higher stocking density at the time of assessment, no use of antibiotic, and the use of intact feed pellets. The welfare implications are profound. Worldwide approximately 2 x 10(10) broilers are reared within similar husbandry systems. We identify a range of management factors that could be altered to reduce leg health problems, but implementation of these changes would be likely to reduce growth rate and production. A debate on the sustainability of current practice in the production of this important food source is required.	[Knowles, Toby G.; Kestin, Steve C.; Haslam, Susan M.; Brown, Steven N.; Butterworth, Andrew; Pope, Stuart J.; Nicol, Christine J.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Green, Laura E.] Univ Warwick, Biol Sci, Ecol & Epidemiol Grp, Coventry, W Midlands, England; [Pfeiffer, Dirk] Royal Veterinary Coll, Royal Coll St, London, England	University of Bristol; University of Warwick; University of London; University of London Royal Veterinary College	Knowles, TG (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	Toby.Knowles@bristol.ac.uk	Green, Laura/G-8345-2011; Nicol, Christine J/B-4841-2011; Pfeiffer, Dirk U/C-5002-2009; Knowles, Toby G/A-2026-2008	Green, Laura/0000-0003-2957-8773; Nicol, Christine J/0000-0001-6734-2177; Pfeiffer, Dirk U/0000-0001-7000-0530; Knowles, Toby G/0000-0002-3845-0942; Butterworth, Andrew/0000-0002-5904-8397	UK Department of Environment, Food and Rural Affairs [AW0230]	UK Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This study was carried out with funding from the UK Department of Environment, Food and Rural Affairs (Grant AW0230) with whom the design and execution were agreed. When reviewing the paper Defra have suggested modifications to the terminology used to describe broiler lameness within the paper which the authors have accepted.	Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Bradshaw RH, 2002, AVIAN POULT BIOL REV, V13, P45, DOI 10.3184/147020602783698421; Brickett KE, 2007, POULTRY SCI, V86, P2117, DOI 10.1093/ps/86.10.2117; Butterworth A, 2002, ANIM WELFARE, V11, P89; CLASSEN HL, 1989, POULTRY SCI, V68, P873, DOI 10.3382/ps.0680873; Danbury TC, 2000, VET REC, V146, P307, DOI 10.1136/vr.146.11.307; Dawkins MS, 2004, NATURE, V427, P342, DOI 10.1038/nature02226; *FARM AN WELF COUN, 1992, 0910 FAWC; Hall C, 2007, ANIM WELFARE, V16, P499; Kestin SC, 1999, POULTRY SCI, V78, P1085, DOI 10.1093/ps/78.8.1085; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kestin SC, 2001, VET REC, V148, P195, DOI 10.1136/vr.148.7.195; Laster CP, 1999, POULTRY SCI, V78, P197, DOI 10.1093/ps/78.2.197; Mc Geown D, 1999, VET REC, V144, P668, DOI 10.1136/vr.144.24.668; Moller AP, 1999, APPL ANIM BEHAV SCI, V62, P57, DOI 10.1016/S0168-1591(98)00213-5; Reiter K, 2006, ARCH GEFLUGELKD, V70, P208; Reiter K, 2001, ARCH GEFLUGELKD, V65, P137; Sanotra GS, 2003, ANIM WELFARE, V12, P677; Sanotra GS, 2001, WORLD POULTRY SCI J, V57, P55, DOI 10.1079/WPS20010006; Scientific Committee on Animal Health and Animal Welfare, 2000, WELF CHICK KEPT MEAT; Su G, 1999, POULTRY SCI, V78, P949, DOI 10.1093/ps/78.7.949; Weeks CA, 2002, VET REC, V151, P762; Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1; 2007, IND LIVESTOCK PRODUC; [No title captured]; 2005, COMPASSION WORLD FAR	26	248	252	4	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1545	10.1371/journal.pone.0001545	http://dx.doi.org/10.1371/journal.pone.0001545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253493	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535700017
J	Lees, F; Baillie, M; Gettinby, G; Revie, CW				Lees, Fiona; Baillie, Mark; Gettinby, George; Revie, Crawford W.			The Efficacy of Emamectin Benzoate against Infestations of Lepeophtheirus salmonis on Farmed Atlantic Salmon (Salmo salar L) in Scotland, 2002-2006	PLOS ONE			English	Article							CALIGUS-ELONGATUS NORDMANN; SEA LICE INFESTATIONS; ORAL TREATMENT; PARASITIC COPEPODS; BRITISH-COLUMBIA; FIELD TRIALS; KROYER; MANAGEMENT; INFECTION; ABUNDANCE	Background: Infestations of the parasitic copepod Lepeophtheirus salmonis, commonly referred to as sea lice, represent a major challenge to commercial salmon aquaculture. Dependence on a limited number of theraputants to control such infestations has led to concerns of reduced sensitivity in some sea lice populations. This study investigates trends in the efficacy of the in-feed treatment emamectin benzoate in Scotland, the active ingredient most widely used across all salmon producing regions. Methodology/Principal Findings: Study data were drawn from over 50 commercial Atlantic salmon farms on the west coast of Scotland between 2002 and 2006. An epi-informatics approach was adopted whereby available farm records, descriptive epidemiological summaries and statistical linear modelling methods were used to identify factors that significantly affect sea lice abundance following treatment with emamectin benzoate (SLICE (R), Schering Plough Animal Health). The results show that although sea lice infestations are reduced following the application of emamectin benzoate, not all treatments are effective. Specifically there is evidence of variation across geographical regions and a reduction in efficacy over time. Conclusions/Significance: Reduced sensitivity and potential resistance to currently available medicines are constant threats to maintaining control of sea lice populations on Atlantic salmon farms. There is a need for on-going monitoring of emamectin benzoate treatment efficacy together with reasons for any apparent reduction in performance. In addition, strategic rotation of medicines should be encouraged and empirical evidence for the benefit of such strategies more fully evaluated.	[Lees, Fiona; Baillie, Mark; Revie, Crawford W.] Univ Strathclyde, Dept Comp & Inform Sci, Glasgow, Lanark, Scotland; [Lees, Fiona; Gettinby, George] Univ Strathclyde, Dept Stat & Modelling Sci, Glasgow, Lanark, Scotland	University of Strathclyde; University of Strathclyde	Lees, F (corresponding author), Univ Strathclyde, Dept Comp & Inform Sci, Glasgow, Lanark, Scotland.	crawford.revie@cis.strath.ac.uk	Revie, Crawford/B-5002-2011	Revie, Crawford/0000-0002-5018-0340; Baillie, Mark/0000-0002-5618-0667				Armstrong R, 2000, CAN VET J, V41, P607; Bjorn PA, 2002, ICES J MAR SCI, V59, P131, DOI 10.1006/jmsc.2001.1143; Bron J. E., 1993, Pathogens of wild and farmed fish: sea lice., P263; BRON JE, 1993, J FISH DIS, V16, P487, DOI 10.1111/j.1365-2761.1993.tb00882.x; Butler JRA, 2002, PEST MANAG SCI, V58, P595, DOI 10.1002/ps.490; *COGP WORK GROUP, 2005, COD GOOD PRACT SCOTT; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Grant A. N., 1993, Pathogens of wild and farmed fish: sea lice., P255; Gustafson L, 2006, J FISH DIS, V29, P621, DOI 10.1111/j.1365-2761.2006.00761.x; Heuch PA, 2005, AQUACULTURE, V246, P79, DOI 10.1016/j.aquaculture.2004.12.027; *INT COUNC EXPL SE, 2007, 2007ACFM13 WGNAS ICE; Johnson SC, 2004, ZOOL STUD, V43, P229; Kabata Z., 1979, PARASITIC COPEPODA B; LEES F, 2008, J FISH DIS IN PRESS; McKibben MA, 2004, AQUAC RES, V35, P742, DOI 10.1111/j.1365-2109.2004.01096.x; Morton A, 2004, CAN J FISH AQUAT SCI, V61, P147, DOI 10.1139/F04-016; Pike AW, 2000, ADV PARASIT, V44, P233; Rae GH, 2002, PEST MANAG SCI, V58, P515, DOI 10.1002/ps.491; Ramstad A, 2002, DIS AQUAT ORGAN, V50, P29, DOI 10.3354/dao050029; Revie CW, 2007, PREV VET MED, V81, P135, DOI 10.1016/j.prevetmed.2007.04.004; Revie CW, 2003, DIS AQUAT ORGAN, V57, P85, DOI 10.3354/dao057085; Revie CW, 2002, VET REC, V151, P753; Revie CW, 2002, PEST MANAG SCI, V58, P576, DOI 10.1002/ps.476; Revie CW, 2002, J FISH DIS, V25, P391, DOI 10.1046/j.1365-2761.2002.00388.x; Saksida S, 2007, AQUAC RES, V38, P219, DOI 10.1111/j.1365-2109.2007.01651.x; SEARCH Consortium, 2006, SEA LIC RES CHEM HDB; Stone J, 2000, DIS AQUAT ORGAN, V41, P141, DOI 10.3354/dao041141; Stone J, 2000, AQUACULTURE, V186, P205, DOI 10.1016/S0044-8486(99)00374-9; Stone J, 1999, J FISH DIS, V22, P261, DOI 10.1046/j.1365-2761.1999.00176.x; Stone J, 2000, J FISH DIS, V23, P185, DOI 10.1046/j.1365-2761.2000.00233.x; Treasurer J., 1994, Fish Farmer, V17, P46; Treasurer JW, 2000, AQUACULTURE, V187, P247, DOI 10.1016/S0044-8486(00)00309-4; Treasurer JW, 2002, BULL EUR ASSN FISH P, V22, P375; Westcott JD, 2004, AQUAC RES, V35, P784, DOI 10.1111/j.1365-2109.2004.01101.x; WOOTTEN R, 1982, P ROY SOC EDINB B, V81, P185, DOI 10.1017/S0269727000003389	35	139	140	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1549	10.1371/journal.pone.0001549	http://dx.doi.org/10.1371/journal.pone.0001549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253496	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000260535700020
J	Kim, RS; Seitz, AR; Shams, L				Kim, Robyn S.; Seitz, Aaron R.; Shams, Ladan			Benefits of Stimulus Congruency for Multisensory Facilitation of Visual Learning	PLOS ONE			English	Article							AUDITORY-CORTEX; MOTION; DISCRIMINATION; SOUND; ORIENTATION; PLASTICITY; PERCEPTION; MODULATION; ACTIVATION; TACTILE	Studies of perceptual learning have largely focused on unisensory stimuli. However, multisensory interactions are ubiquitous in perception, even at early processing stages, and thus can potentially play a role in learning. Here, we examine the effect of auditory-visual congruency on visual learning. Methodology/Principle Findings. Subjects were trained over five days on a visual motion coherence detection task with either congruent audiovisual, or incongruent audiovisual stimuli. Comparing performance on visual-only trials, we find that training with congruent audiovisual stimuli produces significantly better learning than training with incongruent audiovisual stimuli or with only visual stimuli. Conclusions/Significance. This advantage from stimulus congruency during training suggests that the benefits of multisensory training may result from audiovisual interactions at a perceptual rather than cognitive level.	[Kim, Robyn S.; Shams, Ladan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Seitz, Aaron R.] Boston Univ, Dept Psychol, Boston, MA USA	University of California System; University of California Los Angeles; Boston University	Shams, L (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	ladan@psych.ucla.edu			NSF [predoctoral fellowship]; UCLA [Academic Senate, Career Development]; Naval Research Laboratory	NSF(National Science Foundation (NSF)); UCLA(University of California System); Naval Research Laboratory(United States Department of Defense)	RK was supported by an NSF predoctoral fellowship. This project was partially supported by a UCLA Academic Senate grant and Career Development grant and Naval Research Laboratory grant to LS. The funders had no role in the design and conduct of the study, nor in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Bahrick LE, 2002, DEV PSYCHOBIOL, V41, P352, DOI 10.1002/dev.10049; BALL K, 1981, J EXP PSYCHOL HUMAN, V7, P780, DOI 10.1037/0096-1523.7.4.780; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Carlsen R, 1999, DEV PSYCHOBIOL, V35, P215, DOI 10.1002/(SICI)1098-2302(199911)35:3<215::AID-DEV6>3.3.CO;2-F; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Falchier A, 2002, J NEUROSCI, V22, P5749; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; LEVINSON E, 1975, NATURE, V254, P692, DOI 10.1038/254692a0; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; MOORE C, 2006, INT MULT RES FOR DUB, P18; QIAN N, 1994, J NEUROSCI, V14, P7357; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Seitzt AR, 2005, P NATL ACAD SCI USA, V102, P14895, DOI 10.1073/pnas.0505765102; Shams L, 2005, NEUROSCI LETT, V378, P76, DOI 10.1016/j.neulet.2004.12.035; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	26	79	80	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1532	10.1371/journal.pone.0001532	http://dx.doi.org/10.1371/journal.pone.0001532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SR	18231612	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200039
J	Karam, F; Mbow, F; Fletcher, H; Senghor, CS; Coulibaly, KD; LeFevre, AM; Gueye, NFN; Dieye, T; Sow, PS; Mboup, S; Lienhardt, C				Karam, Farba; Mbow, Fatou; Fletcher, Helen; Senghor, Cheikh S.; Coulibaly, Koura D.; LeFevre, Andrea M.; Gueye, Ndeye F. Ngom; Dieye, Tandakha; Sow, Papa S.; Mboup, Souleymane; Lienhardt, Christian			Sensitivity of IFN-gamma Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; DIAGNOSIS; INDIVIDUALS; ENUMERATION; PREVALENCE; REACTIVITY; RESPONSES; CHILDREN; ANTIGENS	Background. Detection and treatment of latent TB infection (LTBI) in HIV infected individuals is strongly recommended to decrease morbidity and mortality in countries with high levels of HIV. Objective. To assess the validity of a newly developed in-house ELISPOT interferon-c release assay (IGRA) for the detection of LTBI amongst HIV infected individuals, in comparison with the Tuberculin Skin Test (TST). Methodology/Principal Findings. ESAT6/CFP10 (EC) ELISPOT assays were performed, together with a TST, in 285 HIV infected individuals recruited in HIV clinics in Dakar, Senegal, who had no signs of active TB at time of enrolment. Thirty eight of the subjects (13.3%) failed to respond to PHA stimulation and were excluded from the analysis. In the 247 remaining patients, response to PHA did not vary according to CD4 cell count categories (p = 0.51). EC ELISPOT was positive in 125 (50.6%) subjects, while 53 (21.5%) had a positive TST. Concordance between EC ELISPOT and TST was observed in 151 patients (61.1%) (kappa = 0.23). The proportion of subjects with a positive response to the EC ELISPOT assay decreased with declining CD4 counts (p trend = 0.001), but were consistently higher than the proportion of TST responders. In multivariate analysis, the risk of being EC-ELISPOT positive in HIV infected individuals was associated with age, CD4 count and HIV-1 strain. Conclusion. Our study indicates that IGRAs using M. tuberculosis specific antigens are likely to retain their validity for the diagnosis of LTBI among HIV positive individuals, but may be impaired by T-cell anergy in severely immuno-suppressed individuals.	[Mbow, Fatou; Lienhardt, Christian] Inst Rech Dev Programme TB, Dakar, Senegal; [Fletcher, Helen] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol Trop Med, Oxford, England; [Senghor, Cheikh S.; Coulibaly, Koura D.; Sow, Papa S.] Hosp Fann, Clin Maladies Infect, Dakar, Senegal; [LeFevre, Andrea M.] London Sch Hygiene & Trop Med, Infect Dis Epidemiol Unit, London, England; [Gueye, Ndeye F. Ngom] Hosp Fann, Ctr Trait Ambul, Dakar, Senegal; [Karam, Farba; Dieye, Tandakha; Mboup, Souleymane] Hosp Aristide Le Dantec, Lab Bacteriol, Dakar, Senegal; [Lienhardt, Christian] Int Union Against TB & Lung Dis, Clin Trial Div, Paris, France	Institut de Recherche pour le Developpement (IRD); University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Lienhardt, C (corresponding author), Inst Rech Dev Programme TB, Dakar, Senegal.	clienhardt@iuatld.org	Fletcher, Helen/D-1470-2011; Rehman, Andrea/AAP-3172-2020; Lienhardt, Christian/AAU-4969-2021; Rehman, Andrea M/H-1351-2015	Rehman, Andrea/0000-0001-9967-5822; Lienhardt, Christian/0000-0003-0233-893X; Rehman, Andrea M/0000-0001-9967-5822; Fletcher, Helen/0000-0002-0435-1006	European Commission, Framework Programme 5 [QOL 2001-01613]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	European Commission, Framework Programme 5(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study has been conducted under funding from the European Commission, Framework Programme 5, Project QOL 2001-01613.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2001, CLIN DIAGN LAB IMMUN, V8, P1089, DOI 10.1128/CDLI.8.6.1089-1096.2001; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Chapman ALN, 2002, AIDS, V16, P2285, DOI 10.1097/00002030-200211220-00008; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dheda K, 2005, AIDS, V19, P2038, DOI 10.1097/01.aids.0000191923.08938.5b; Dieye TN, 2005, JAIDS-J ACQ IMM DEF, V39, P32, DOI 10.1097/01.qai.0000160515.20581.ad; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Garcia-Garcia MD, 2000, INT J EPIDEMIOL, V29, P369; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hoffmann M, 2007, AIDS, V21, P390, DOI 10.1097/QAD.0b013e328012164b; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Madhi SA, 1999, PEDIATR INFECT DIS J, V18, P800, DOI 10.1097/00006454-199909000-00011; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; *MIN SANT PREV SEN, 2002, B EP MIN SANT PREV S, V9; PAI M, 2007, LANCET INFECT DIS; Palme IB, 2002, PEDIATR INFECT DIS J, V21, P1053, DOI 10.1097/00006454-200211000-00016; Shafer RW, 1996, CLIN INFECT DIS, V22, P683, DOI 10.1093/clinids/22.4.683; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Thiam S, 2005, Med Trop (Mars), V65, P43; Ulrichs T, 2000, INFECT IMMUN, V68, P6073, DOI 10.1128/IAI.68.10.6073-6076.2000; WHALEN C, 1995, AM J RESP CRIT CARE, V151, P129, DOI 10.1164/ajrccm.151.1.7812542; *WHO, 2000, WHOHTMTB2004330	33	67	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1441	10.1371/journal.pone.0001441	http://dx.doi.org/10.1371/journal.pone.0001441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197251	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000260503800012
J	Woltering, JM; Durston, AJ				Woltering, Joost M.; Durston, Antony J.			MiR-10 Represses HoxB1a and HoxB3a in Zebrafish	PLOS ONE			English	Article							GENE CLUSTERS; MICRORNA EXPRESSION; RESPONSE ELEMENTS; MESSENGER-RNA; HINDBRAIN; MOUSE; BOUNDARIES; EVOLUTION; PATTERNS; EMBRYOS	Background. The Hox genes are involved in patterning the anterior-posterior axis. In addition to the protein coding Hox genes, the miR-10, miR-196 and miR-615 families of microRNA genes are conserved within the vertebrate Hox clusters. The members of the miR-10 family are located at positions associated with Hox-4 paralogues. No function is yet known for this microRNA family but the genomic positions of its members suggest a role in anterior-posterior patterning. Methodology/Principal Findings. Using sensor constructs, overexpression and morpholino knockdown, we show in Zebrafish that miR-10 targets HoxB1a and HoxB3a and synergizes with HoxB4 in the repression of these target genes. Overexpression of miR-10 also induces specific phenotypes related to the loss of function of these targets. HoxB1a and HoxB3a have a dominant hindbrain expression domain anterior to that of miR-10 but overlap in a weaker expression domain in the spinal cord. In this latter domain, miR-10 knockdown results in upregulation of the target genes. In the case of a HoxB3a splice variant that includes miR-10c within its primary transcript, we show that the microRNA acts in an autoregulatory fashion. Conclusions/Significance. We find that miR-10 acts to repress HoxB1a and HoxB3a within the spinal cord and show that this repression works cooperatively with HoxB4. As with the previously described interactions between miR-196 and HoxA7 and Hox-8 paralogues, the target genes are located in close proximity to the microRNA. We present a model in which we postulate a link between the clustering of Hox genes and post-transcriptional gene regulation. We speculate that the high density of transcription units and enhancers within the Hox clusters places constraints on the precision of the transcriptional control that can be achieved within these clusters and requires the involvement of post-transcriptional gene silencing to define functional domains of genes appropriately.	[Woltering, Joost M.; Durston, Antony J.] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Woltering, JM (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	jmwoltering@hotmail.com		Woltering, Joost/0000-0002-2630-6572	NWO ALW [811.38.006]; EU [LSHM-CT-2003-504468]	NWO ALW(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	JMW and AJD have been supported by NWO ALW grant 811.38.006 and by the EU network of excellence grant LSHM-CT-2003-504468: Cells Into Organs. Neither organization had influence on the design and conduct of the study, on the collection, analysis, and interpretation of the data, or on the preparation, review, or approval of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BONCINELLI E, 1994, GENETICA, V94, P127, DOI 10.1007/BF01443427; Corredor-Adamez M, 2005, EVOL DEV, V7, P362, DOI 10.1111/j.1525-142X.2005.05042.x; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Godsave SF, 1998, DEV DYNAM, V213, P39, DOI 10.1002/(SICI)1097-0177(199809)213:1<39::AID-AJA4>3.0.CO;2-Z; Hadrys T, 2004, J EXP ZOOL PART B, V302B, P147, DOI 10.1002/jez.b.20012; Hadrys T, 2006, DEV BIOL, V297, P26, DOI 10.1016/j.ydbio.2006.04.446; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoegg S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-317; Hogan BM, 2004, DEV BIOL, V276, P508, DOI 10.1016/j.ydbio.2004.09.018; Hooiveld MHW, 1999, INT J DEV BIOL, V43, P665; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Huang DY, 2002, DEV DYNAM, V223, P353, DOI 10.1002/dvdy.10057; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kwan CT, 2001, DEV BIOL, V232, P176, DOI 10.1006/dbio.2001.0157; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Mainguy G, 2003, TRENDS GENET, V19, P476, DOI 10.1016/S0168-9525(03)00202-6; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Studer M, 1998, DEVELOPMENT, V125, P1025; Tanzer A, 2005, J EXP ZOOL PART B, V304B, P75, DOI 10.1002/jez.b.21021; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	55	133	145	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1396	10.1371/journal.pone.0001396	http://dx.doi.org/10.1371/journal.pone.0001396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167555	gold, Green Published, Green Submitted			2022-12-27	WOS:000260468900024
J	Gruner, AC; Mauduit, M; Tewari, R; Romero, JF; Depinay, N; Kayibanda, M; Lallemand, E; Chavatte, JM; Crisanti, A; Sinnis, P; Mazier, D; Corradin, G; Snounou, G; Renia, L				Gruener, Anne Charlotte; Mauduit, Marjorie; Tewari, Rita; Romero, Jackeline F.; Depinay, Nadya; Kayibanda, Michele; Lallemand, Eliette; Chavatte, Jean-Marc; Crisanti, Andrea; Sinnis, Photini; Mazier, Dominique; Corradin, Giampietro; Snounou, Georges; Renia, Laurent			Sterile Protection against Malaria Is Independent of Immune Responses to the Circumsporozoite Protein	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; T-CELL-CLONES; IRRADIATED SPOROZOITES; VACCINE CANDIDATE; LIFE-CYCLE; BERGHEI; EFFICACY; ANTIGEN; YOELII; PARASITES	Background. Research aimed at developing vaccines against infectious diseases generally seeks to induce robust immune responses to immunodominant antigens. This approach has led to a number of efficient bacterial and viral vaccines, but it has yet to do so for parasitic pathogens. For malaria, a disease of global importance due to infection by Plasmodium protozoa, immunization with radiation-attenuated sporozoites uniquely leads to long lasting sterile immunity against infection. The circumsporozoite protein (CSP), an important component of the sporozoite's surface, remains the leading candidate antigen for vaccines targeting the parasite's pre-erythrocytic stages. Difficulties in developing CSP-based vaccines that reproduce the levels of protection afforded by radiation-attenuated sporozoites have led us to question the role of CSP in the acquisition of sterile immunity. We have used a parasite transgenic for the CSP because it allowed us to test whether a major immunodominant Plasmodium antigen is indeed needed for the induction of sterile protective immunity against infection. Methodology/Main Findings. We employed a P. berghei parasite line that expresses a heterologous CSP from P. falciparum in order to assess the role of the CSP in the protection conferred by vaccination with radiation-attenuated P. berghei parasites. Our data demonstrated that sterile immunity could be obtained despite the absence of immune responses specific to the CSP expressed by the parasite used for challenge. Conclusions. We conclude that other pre-erythrocytic parasite antigens, possibly hitherto uncharacterised, can be targeted to induce sterile immunity against malaria. From a broader perspective, our results raise the question as to whether immunodominant parasite antigens should be the favoured targets for vaccine development.	[Gruener, Anne Charlotte; Mauduit, Marjorie; Depinay, Nadya; Kayibanda, Michele; Lallemand, Eliette; Renia, Laurent] Univ Paris 05, Inst Cochin, Dept Immunol, CNRS,UMR 8104, Paris, France; [Gruener, Anne Charlotte; Mauduit, Marjorie; Depinay, Nadya; Kayibanda, Michele; Lallemand, Eliette; Renia, Laurent] INSERM, U567, Paris, France; [Tewari, Rita; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Fac Nat Sci, London, England; [Romero, Jackeline F.; Corradin, Giampietro] Univ Lausanne, Inst Biochim, Lausanne, Switzerland; [Chavatte, Jean-Marc; Snounou, Georges] Museum Natl Hist Nat, CNRS, Equipe Parasitol Comparee & Modeles Expt, USM0307,IFR101, Paris, France; [Sinnis, Photini] NYU, Sch Med, Dept Med Parasitol, New York, NY USA; [Mazier, Dominique] Univ Paris 06, UMR S511, Paris, France; [Mazier, Dominique] INSERM, U511, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Renia, Laurent] ASTAR, Singapore Immunol Network, Agcy Sci, Biopolis, Singapore, Singapore	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); New York University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Renia, L (corresponding author), Univ Paris 05, Inst Cochin, Dept Immunol, CNRS,UMR 8104, Paris, France.	renia_laurent@immunol.a-star.edu.sg	Tewari, Rita/M-5698-2014; Renia, Laurent/E-2117-2011; Gruner, Anne Charlotte/C-1841-2012; Snounou, Georges/F-3352-2011	Renia, Laurent/0000-0003-0349-1557; Snounou, Georges/0000-0002-6133-6398; Tewari, Rita/0000-0003-3943-1847; Crisanti, Andrea/0000-0002-2406-4426; Chavatte, Jean-Marc/0000-0002-0003-541X	Institut National de la Sante et de a Recherche Medicale (INSERM); A*STAR; European community [LSH-CT-2005-01299]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056840] Funding Source: NIH RePORTER	Institut National de la Sante et de a Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); A*STAR(Agency for Science Technology & Research (A*STAR)); European community(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a core grant from the Institut National de la Sante et de a Recherche Medicale (INSERM), a core grant from A*STAR to the Singapore Immunology Network (LR) and by the European community (MALINV contract n degrees LSH-CT-2005-01299) (LR). The sponsors had no role in the design, conduct, and analysis of the study.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; DRUILHE P, MALARIA PARASITE BIO, V34, P513; Eberl G, 1999, MOL IMMUNOL, V36, P103, DOI 10.1016/S0161-5890(99)00023-1; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; GRILLOT D, 1990, EUR J IMMUNOL, V20, P1215, DOI 10.1002/eji.1830200604; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Hoffman SL, 1998, NAT MED, V4, P1351, DOI 10.1038/3934; Hoffman SL, 2006, NATURE, V444, P824, DOI 10.1038/nature05409; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; LOCKYER MJ, 1987, MOL BIOCHEM PARASIT, V22, P101, DOI 10.1016/0166-6851(87)90073-9; Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Nussenzweig RS, 1997, NEW ENGL J MED, V336, P128, DOI 10.1056/NEJM199701093360210; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; RENIA L, 1993, J IMMUNOL, V150, P1471; Renia L, 2006, EXPERT REV VACCINES, V5, P473, DOI 10.1586/14760584.5.4.473; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; Roggero MA, 2000, EUR J IMMUNOL, V30, P2679, DOI 10.1002/1521-4141(200009)30:9&lt;2679::AID-IMMU2679&gt;3.0.CO;2-#; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; ROMERO PJ, 1988, EUR J IMMUNOL, V18, P1951, DOI 10.1002/eji.1830181213; Snounou G, 2005, TRENDS PARASITOL, V21, P456, DOI 10.1016/j.pt.2005.08.002; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001	35	72	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1371	10.1371/journal.pone.0001371	http://dx.doi.org/10.1371/journal.pone.0001371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159254	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700028
J	Kanakry, CG; Li, Z; Nakai, Y; Sei, Y; Weinberger, DR				Kanakry, Christopher G.; Li, Zhen; Nakai, Yoko; Sei, Yoshitatsu; Weinberger, Daniel R.			Neuregulin-1 Regulates Cell Adhesion via an ErbB2/Phosphoinositide-3 Kinase/Akt-Dependent Pathway: Potential Implications for Schizophrenia and Cancer	PLOS ONE			English	Article								Background. Neuregulin-1 (NRG1) is a putative schizophrenia susceptibility gene involved extensively in central nervous system development as well as cancer invasion and metastasis. Using a B lymphoblast cell model, we previously demonstrated impairment in NRG1 alpha-mediated migration in cells derived from patients with schizophrenia as well as effects of risk alleles in NRG1 and catechol-O-methyltransferase (COMT), a second gene implicated both in schizophrenia susceptibility and in cancer. Methodology/Principal Findings. Here, we examine cell adhesion, an essential component process of cell motility, using an integrin-mediated cell adhesion assay based on an interaction between ICAM-1 and the CD11a/CD18 integrin heterodimer expressed on lymphoblasts. In our assay, NRG1 alpha induces lymphoblasts to assume varying levels of adhesion characterized by time-dependent fluctuations in the firmness of attachment. The maximum range of variation in adhesion over sixty minutes correlates strongly with NRG1a alpha-induced migration (r(2) = 0.61). NRG1 alpha-induced adhesion variation is blocked by erbB2, P13K, and Akt inhibitors, but not by PLC, ROCK, MLCK, or MEK inhibitors, implicating the erbB2/P13K/Akt1 signaling pathway in NRG1-stimulated, integrin-mediated cell adhesion. In cell lines from 20 patients with schizophrenia and 20 normal controls, cells from patients show a significant deficiency in the range of NRG1 alpha-induced adhesion (p = 0.0002). In contrast, the response of patient-derived cells to phorbol myristate acetate is unimpaired. The COMT Val108/158Met genotype demonstrates a strong trend towards predicting the range of the NRG1 alpha-induced adhesion response with risk homozygotes having decreased variation in cell adhesion even in normal subjects (p = 0.063). Conclusion/Significance. Our findings suggest that a mechanism of the NRG1 genetic association with schizophrenia may involve the molecular biology of cell adhesion.	[Kanakry, Christopher G.; Li, Zhen; Nakai, Yoko; Sei, Yoshitatsu; Weinberger, Daniel R.] NIMH, Genes Cognit & Psychosis Program, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Kanakry, Christopher G.] NIH, Howard Hughes Med Inst, Res Scholars Program, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Weinberger, DR (corresponding author), NIMH, Genes Cognit & Psychosis Program, Intramural Res Program, NIH, Bethesda, MD 20892 USA.	weinberd@mail.nih.gov			National Institute of Mental Health; NIH; The Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002907, ZIAMH002904, ZIAMH002907, Z01MH002904] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Intramural Research Program of the National Institute of Mental Health, NIH, provided the majority of the funding as well as the laboratory space in which these experiments were conducted. The Howard Hughes Medical Institute-NIH Research Scholars Program also provided funding that supported this research project. Neither sponsor was involved in the design or conducting of the research itself, the collection, analysis, or interpretation of data, or in the preparation or review of the resulting manuscript.	Atlas E, 2003, MOL CANCER RES, V1, P165; Bahr BA, 1997, J NEUROSCI, V17, P1320; Chan ASH, 1997, J IMMUNOL, V159, P934; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cherry LK, 2004, NAT IMMUNOL, V5, P961, DOI 10.1038/ni1103; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Dedrick RL, 2003, EXPERT OPIN BIOL TH, V3, P85, DOI 10.1517/eobt.3.1.85.20954; Driessens MHE, 1997, EXP CELL RES, V231, P242, DOI 10.1006/excr.1996.3463; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Giannone G, 2002, J BIOL CHEM, V277, P26364, DOI 10.1074/jbc.M203952200; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; GOMPERTS BD, 2003, SIGNAL TRANSDUCTION, pR14; Grabham PW, 2000, J CELL SCI, V113, P3003; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; KOOPMAN G, 1990, J IMMUNOL, V145, P3589; Kumar R, 2001, SEMIN ONCOL, V28, P27, DOI 10.1016/S0093-7754(01)90279-9; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Matsui A, 2000, CANCER LETT, V150, P23, DOI 10.1016/S0304-3835(99)00368-7; NESHER G, 1991, ANN RHEUM DIS, V50, P637, DOI 10.1136/ard.50.9.637; Nielsen M, 1996, J IMMUNOL, V157, P5350; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PATARROYO M, 1985, SCAND J IMMUNOL, V22, P171, DOI 10.1111/j.1365-3083.1985.tb01869.x; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Pietri T, 2004, DEVELOPMENT, V131, P3871, DOI 10.1242/dev.01264; PIKE MC, 1981, J IMMUNOL, V127, P1444; PRESSMAN S, 1991, AM J HUM GENET, V49, P467; Richard PT, 2004, INT J BIOCHEM CELL B, V36, P1135, DOI 10.1016/j.biocel.2004.01.010; Rodriguez-Fernandez JL, 2001, J BIOL CHEM, V276, P40518, DOI 10.1074/jbc.M102896200; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; SEI Y, 2007, MOL PSYCHIAT; Shimizu Y, 1995, J CELL BIOL, V131, P1867, DOI 10.1083/jcb.131.6.1867; Shu S, 2006, P NATL ACAD SCI USA, V103, P19788, DOI 10.1073/pnas.0609385103; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; SOMANATH PR, 2007, J BIOL CHEM; Staubli U, 1998, J NEUROSCI, V18, P3460; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tan M, 1999, CANCER RES, V59, P1620; TAN W, 2007, J BIOL CHEM; Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.mcn.2004.05.001; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Verploegen S, 2005, BLOOD, V106, P1076, DOI 10.1182/blood-2004-09-3755; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu C, 2006, AM J MED GENET B, V141B, P36, DOI 10.1002/ajmg.b.30239; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Zell T, 1996, J IMMUNOL, V156, P883; Zhang ZQ, 1998, J NEUROSCI, V18, P6928; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	69	51	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1369	10.1371/journal.pone.0001369	http://dx.doi.org/10.1371/journal.pone.0001369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159252	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459700026
J	Harrison, BJ; Pujol, J; Ortiz, H; Fornito, A; Pantelis, C; Yucel, M				Harrison, Ben J.; Pujol, Jesus; Ortiz, Hector; Fornito, Alex; Pantelis, Christos; Yucel, Murat			Modulation of Brain Resting-State Networks by Sad Mood Induction	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; FMRI DATA; ALZHEIMERS-DISEASE; NEURAL MECHANISMS; BLIND SEPARATION; LOW-FREQUENCY; MOTOR CORTEX; FLUCTUATIONS	Background: There is growing interest in the nature of slow variations of the blood oxygen level-dependent (BOLD) signal observed in functional MRI resting-state studies. In humans, these slow BOLD variations are thought to reflect an underlying or intrinsic form of brain functional connectivity in discrete neuroanatomical systems. While these 'resting-state networks' may be relatively enduring phenomena, other evidence suggest that dynamic changes in their functional connectivity may also emerge depending on the brain state of subjects during scanning. Methodology/Principal Findings: In this study, we examined healthy subjects (n = 24) with a mood induction paradigm during two continuous fMRI recordings to assess the effects of a change in self-generated mood state (neutral to sad) on the functional connectivity of these resting-state networks (n = 24). Using independent component analysis, we identified five networks that were common to both experimental states, each showing dominant signal fluctuations in the very low frequency domain (similar to 0.04 Hz). Between the two states, we observed apparent increases and decreases in the overall functional connectivity of these networks. Primary findings included increased connectivity strength of a paralimbic network involving the dorsal anterior cingulate and anterior insula cortices with subjects' increasing sadness and decreased functional connectivity of the 'default mode network'. Conclusions/Significance: These findings support recent studies that suggest the functional connectivity of certain resting-state networks may, in part, reflect a dynamic image of the current brain state. In our study, this was linked to changes in subjective mood.	[Harrison, Ben J.; Fornito, Alex; Pantelis, Christos; Yucel, Murat] Univ Melbourne & Melbourne Hlth, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Harrison, Ben J.; Pujol, Jesus; Ortiz, Hector] CRC Corporacio Sanitaria, Inst Alta Tecnol PRBB, Barcelona, Spain; [Yucel, Murat] ORYGEN Res Ctr, Melbourne, Vic, Australia; [Pantelis, Christos] Univ Melbourne, Howard Florey Inst, Melbourne, Vic, Australia	University of Melbourne; Pompeu Fabra University; Orygen, The National Centre of Excellence in Youth Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Harrison, BJ (corresponding author), Univ Melbourne & Melbourne Hlth, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia.	habj@unimelb.edu.au	Pantelis, Christos/H-7722-2014; Harrison, Ben J/I-2940-2014; Yucel, Murat/I-3004-2014; Yücel, Murat/AAY-8124-2020; Alex, Fornito/N-8214-2013	Pantelis, Christos/0000-0002-9565-0238; Yucel, Murat/0000-0002-4705-452X; Yücel, Murat/0000-0002-4705-452X; Alex, Fornito/0000-0001-9134-480X; Harrison, Ben/0000-0002-2226-2074	National Health and Medical Research Council (NHMRC) of Australia [236175, 400420, 350241]; Ian Potter Foundation; Clive and Vera Ramaciotti foundations [RA44/07]; Spanish Ministry of Education [AP2006-02869]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ian Potter Foundation; Clive and Vera Ramaciotti foundations; Spanish Ministry of Education(Spanish Government)	This research was supported by a grant from the National Health and Medical Research Council (NHMRC) of Australia (I.D. 236175) and the Ian Potter Foundation. Dr. Harrison is supported by a National Health and Medical Research Council of Australia (NHMRC) Training Award (I.D. 400420) and an establishment grant from the Clive and Vera Ramaciotti foundations (Reference: RA44/07). Dr Yucel is supported by a NHMRC Program Grant (I.D. 350241). Mr. Ortiz is supported by an FPU grant from the Spanish Ministry of Education (AP2006-02869).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2006, IEEE ENG MED BIOL, V25, P79, DOI 10.1109/MEMB.2006.1607672; Calhoun VD, 2004, NEUROPSYCHOPHARMACOL, V29, P2097, DOI 10.1038/sj.npp.1300543; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; CLARK DM, 1985, J PERS SOC PSYCHOL, V48, P1595, DOI 10.1037/0022-3514.48.6.1595; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DAMOISEAUX JS, 2007, CEREB CORTEX; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius M, 2007, BIOL PSYCHIAT; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Harrison BJ, 2007, SCHIZOPHR RES, V91, P82, DOI 10.1016/j.schres.2006.12.027; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kiviniemi V, 2004, MAGN RESON IMAGING, V22, P197, DOI 10.1016/j.mri.2003.09.007; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Lewis PA, 2005, NEUROIMAGE, V25, P1214, DOI 10.1016/j.neuroimage.2004.11.053; LI YO, 2007, HUM BRAIN MAPP; Liotti M, 2000, BIOL PSYCHIAT, V48, P30, DOI 10.1016/S0006-3223(00)00874-X; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Newton AT, 2007, HUM BRAIN MAPP, V28, P663, DOI 10.1002/hbm.20294; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; PUJOL J, HUMAN BRAIN IN PRESS; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajapakse JC, 2006, IEEE ENG MED BIOL, V25, P102, DOI 10.1109/MEMB.2006.1607674; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Sabatinelli D, 2006, PROG BRAIN RES, V156, P93, DOI 10.1016/S0079-6123(06)56005-4; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yucel M, 2007, ARCH GEN PSYCHIAT, V64, P946, DOI 10.1001/archpsyc.64.8.946; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	73	159	163	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1794	10.1371/journal.pone.0001794	http://dx.doi.org/10.1371/journal.pone.0001794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350136	Green Published, gold			2022-12-27	WOS:000260762300002
J	Kelley, DJ; Oakes, TR; Greischar, LL; Chung, MK; Ollinger, JM; Alexander, AL; Shelton, SE; Kalin, NH; Davidson, RJ				Kelley, Daniel J.; Oakes, Terrence R.; Greischar, Larry L.; Chung, Moo K.; Ollinger, John M.; Alexander, Andrew L.; Shelton, Steven E.; Kalin, Ned H.; Davidson, Richard J.			Automatic Physiological Waveform Processing for fMRI Noise Correction and Analysis	PLOS ONE			English	Article							FLUCTUATIONS; TIME	Functional MRI resting state and connectivity studies of brain focus on neural fluctuations at low frequencies which share power with physiological fluctuations originating from lung and heart. Due to the lack of automated software to process physiological signals collected at high magnetic fields, a gap exists in the processing pathway between the acquisition of physiological data and its use in fMRI software for both physiological noise correction and functional analyses of brain activation and connectivity. To fill this gap, we developed an open source, physiological signal processing program, called PhysioNoise, in the python language. We tested its automated processing algorithms and dynamic signal visualization on resting monkey cardiac and respiratory waveforms. PhysioNoise consistently identifies physiological fluctuations for fMRI noise correction and also generates covariates for subsequent analyses of brain activation and connectivity.	[Kelley, Daniel J.; Oakes, Terrence R.; Greischar, Larry L.; Chung, Moo K.; Ollinger, John M.; Alexander, Andrew L.; Davidson, Richard J.] Univ Wisconsin, Waisman Ctr, Waisman Lab Brain Imaging & Behav, Madison, WI 53705 USA; [Kelley, Daniel J.] Univ Wisconsin, Sch Med & Public Hlth, Ctr Neurosci, Neurosci Training Program, Madison, WI USA; [Kelley, Daniel J.] Univ Wisconsin, Sch Med & Public Hlth, Med Scientist Training Program, Madison, WI USA; [Shelton, Steven E.; Kalin, Ned H.; Davidson, Richard J.] Univ Wisconsin, Dept Psychiat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kelley, DJ (corresponding author), Univ Wisconsin, Waisman Ctr, Waisman Lab Brain Imaging & Behav, Madison, WI 53705 USA.	djkelley@wisc.edu		Chung, Moo/0000-0003-2852-9670; Kalin, Ned/0000-0003-1184-0868; Davidson, Richard/0000-0002-8506-4964	HealthEmotions Research Institute [MH46729, MH69315]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046729, P50MH069315] Funding Source: NIH RePORTER	HealthEmotions Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by MH46729, MH69315, and the HealthEmotions Research Institute.	Ascher D., 2001, NUMERICAL PYTHON LAW; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Billauer E, 2007, PEAKDET PEAK DETECTI; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Chan GSH, 2007, PHYSIOL MEAS, V28, P439, DOI 10.1088/0967-3334/28/4/009; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Drake F., 2001, PYTHON REFERENCE MAN; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones E., 2001, SCIPY OPEN SOURCE SC; Purdon PL, 1998, HUM BRAIN MAPP, V6, P239, DOI 10.1002/(SICI)1097-0193(1998)6:4<239::AID-HBM4>3.3.CO;2-0; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037	16	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1751	10.1371/journal.pone.0001751	http://dx.doi.org/10.1371/journal.pone.0001751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18347739	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000005
J	Ruiz, MIG; Floor, K; Roepman, P; Rodriguez, JA; Meijer, GA; Mooi, WJ; Jassem, E; Niklinski, J; Muley, T; van Zandwijk, N; Smit, EF; Beebe, K; Neckers, L; Ylstra, B; Giaccone, G				Ruiz, Marielle I. Gallegos; Floor, Karijn; Roepman, Paul; Rodriguez, Jose A.; Meijer, Gerrit A.; Mooi, Wolter J.; Jassem, Ewa; Niklinski, Jacek; Muley, Thomas; van Zandwijk, Nico; Smit, Egbert F.; Beebe, Kristin; Neckers, Len; Ylstra, Bauke; Giaccone, Giuseppe			Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER ALTERATION; MICROARRAY ANALYSIS; HEAT-SHOCK-PROTEIN-90; ABERRATIONS; REVEALS; GLIOBLASTOMA; ASSOCIATION; MUTATIONS; SIGNATURE	Background: Lung cancer causes approximately 1.2 million deaths per year worldwide, and non-small cell lung cancer (NSCLC) represents 85% of all lung cancers. Understanding the molecular events in non-small cell lung cancer (NSCLC) is essential to improve early diagnosis and treatment for this disease. Methodology and Principal Findings: In an attempt to identify novel NSCLC related genes, we performed a genome-wide screening of chromosomal copy number changes affecting gene expression using microarray based comparative genomic hybridization and gene expression arrays on 32 radically resected tumor samples from stage I and II NSCLC patients. An integrative analysis tool was applied to determine whether chromosomal copy number affects gene expression. We identified a deletion on 14q32.2-33 as a common alteration in NSCLC (44%), which significantly influenced gene expression for HSP90, residing on 14q32. This deletion was correlated with better overall survival (P = 0.008), survival was also longer in patients whose tumors had low expression levels of HSP90. We extended the analysis to three independent validation sets of NSCLC patients, and confirmed low HSP90 expression to be related with longer overall survival (P = 0.003, P = 0.07 and P = 0.04). Furthermore, in vitro treatment with an HSP90 inhibitor had potent antiproliferative activity in NSCLC cell lines. Conclusions: We suggest that targeting HSP90 will have clinical impact for NSCLC patients.	[Ruiz, Marielle I. Gallegos; Floor, Karijn; Rodriguez, Jose A.; Giaccone, Giuseppe] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Roepman, Paul] Agendia BV, Amsterdam, Netherlands; [Meijer, Gerrit A.; Mooi, Wolter J.; Ylstra, Bauke] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Jassem, Ewa] Univ Gdansk, Gdansk, Poland; [Niklinski, Jacek] Univ Bialystok, Bialystok, Poland; [Muley, Thomas] Heidelberg Univ, Thoraxklinik Heidelberg, Heidelberg, Germany; [van Zandwijk, Nico] Netherlands Canc Inst, Amsterdam, Netherlands; [Smit, Egbert F.] Vrije Univ Amsterdam, Med Ctr, Dept Pulmonary Dis, Amsterdam, Netherlands; [Beebe, Kristin; Neckers, Len] NCI, Ctr Canc Res, Urol Oncol Branch, Bethesda, MD USA	Vrije Universiteit Amsterdam; Agendia; Vrije Universiteit Amsterdam; Fahrenheit Universities; University of Gdansk; University of Bialystok; Ruprecht Karls University Heidelberg; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ruiz, MIG (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	giacconeg@mail.nih.gov	Giaccone, Giuseppe/E-8297-2017; van Zandwijk, Nico/E-4177-2012; Rodriguez, Jose Antonio/AAA-1125-2019; Ylstra, Bauke/D-2906-2012; Muley, Thomas/AAY-9200-2020	Giaccone, Giuseppe/0000-0002-5023-7562; van Zandwijk, Nico/0000-0002-8405-9688; Rodriguez, Jose Antonio/0000-0002-2823-3733; Ylstra, Bauke/0000-0001-9479-3010; Meijer, Gerrit/0000-0003-0330-3130; Smit, Egbert/0000-0002-7329-6995; Jassem, Ewa/0000-0003-4239-4776	NATIONAL CANCER INSTITUTE [Z01BC011032, Z01SC010074, ZIASC010074, ZIABC011032, Z01BC011051, Z01BC010854, ZIABC010854] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balsara BR, 1997, CANCER RES, V57, P2116; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Braga-Basaria M, 2004, J CLIN ENDOCR METAB, V89, P2982, DOI 10.1210/jc.2003-031767; Burrows F, 2004, CELL CYCLE, V3, P1530, DOI 10.4161/cc.3.12.1277; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Choi JS, 2006, LUNG, V184, P355, DOI 10.1007/s00408-006-0009-0; Cullman SB, 2006, SEMIN ONCOL, V33, P457, DOI 10.1053/j.seminoncol.2006.04.001; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Redon R, 2001, CANCER RES, V61, P4122; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Slamon D, 2001, SEMIN ONCOL, V28, P13, DOI 10.1053/sonc.2001.22812; Tay ST, 2003, CANCER RES, V63, P3309; Thomas CY, 2003, CLIN CANCER RES, V9, p6098S; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; van den IJssel P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni191; van Wieringen WN, 2006, BIOINFORMATICS, V22, P1919, DOI 10.1093/bioinformatics/btl269; Wigle DA, 2002, CANCER RES, V62, P3005; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yang J, 2001, CANCER RES, V61, P4010; Yang SC, 2006, CANCER RES, V66, P6990, DOI 10.1158/0008-5472.CAN-06-1042; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zsebik B, 2006, IMMUNOL LETT, V104, P146, DOI 10.1016/j.imlet.2005.11.018	36	88	94	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e0001722	10.1371/journal.pone.0001722	http://dx.doi.org/10.1371/journal.pone.0001722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320023	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600018
J	Zhou, YY; Ramachandran, V; Kumar, KA; Westenberger, S; Refour, P; Zhou, B; Li, FW; Young, JA; Chen, KS; Plouffe, D; Henson, K; Nussenzweig, V; Carlton, J; Vinetz, JM; Duraisingh, MT; Winzeler, EA				Zhou, Yingyao; Ramachandran, Vandana; Kumar, Kota Arun; Westenberger, Scott; Refour, Phillippe; Zhou, Bin; Li, Fengwu; Young, Jason A.; Chen, Kaisheng; Plouffe, David; Henson, Kerstin; Nussenzweig, Victor; Carlton, Jane; Vinetz, Joseph M.; Duraisingh, Manoj T.; Winzeler, Elizabeth A.			Evidence-Based Annotation of the Malaria Parasite's Genome Using Comparative Expression Profiling	PLOS ONE			English	Article							PLASMODIUM-BERGHEI SPOROZOITES; FALCIPARUM LIFE-CYCLE; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; IN-VITRO; FUNCTION PREDICTION; SEXUAL DEVELOPMENT; MEMBRANE-PROTEINS; HOST ERYTHROCYTE; STAGE	A fundamental problem in systems biology and whole genome sequence analysis is how to infer functions for the many uncharacterized proteins that are identified, whether they are conserved across organisms of different phyla or are phylum-specific. This problem is especially acute in pathogens, such as malaria parasites, where genetic and biochemical investigations are likely to be more difficult. Here we perform comparative expression analysis on Plasmodium parasite life cycle data derived from P. falciparum blood, sporozoite, zygote and ookinete stages, and P. yoelii mosquito oocyst and salivary gland sporozoites, blood and liver stages and show that type II fatty acid biosynthesis genes are upregulated in liver and insect stages relative to asexual blood stages. We also show that some universally uncharacterized genes with orthologs in Plasmodium species, Saccharomyces cerevisiae and humans show coordinated transcription patterns in large collections of human and yeast expression data and that the function of the uncharacterized genes can sometimes be predicted based on the expression patterns across these diverse organisms. We also use a comprehensive and unbiased literature mining method to predict which uncharacterized parasite-specific genes are likely to have roles in processes such as gliding motility, host-cell interactions, sporozoite stage, or rhoptry function. These analyses, together with protein-protein interaction data, provide probabilistic models that predict the function of 926 uncharacterized malaria genes and also suggest that malaria parasites may provide a simple model system for the study of some human processes. These data also provide a foundation for further studies of transcriptional regulation in malaria parasites.	[Zhou, Yingyao; Zhou, Bin; Chen, Kaisheng; Plouffe, David; Henson, Kerstin; Winzeler, Elizabeth A.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Ramachandran, Vandana; Westenberger, Scott; Young, Jason A.; Henson, Kerstin; Winzeler, Elizabeth A.] Scripps Res Inst, Dept Cell Biol, ICND202, La Jolla, CA USA; [Kumar, Kota Arun; Nussenzweig, Victor; Carlton, Jane] NYU, Dept Path, New York, NY USA; [Refour, Phillippe; Duraisingh, Manoj T.] Harvard Sch Publ Hlth, Dept Infect Dis & Immunol, Boston, MA USA; [Li, Fengwu; Vinetz, Joseph M.] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA USA	Novartis; Scripps Research Institute; New York University; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego	Zhou, YY (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA USA.	winzeler@scripps.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113; Vinetz, Joseph/0000-0001-8344-2004	Keck Foundation; Ellison Foundation; NIH; Wellcome Trust; Medicines for Malaria Venture; National Science Foundation [pre-doctoral fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI068903, R01AI059472] Funding Source: NIH RePORTER	Keck Foundation(W.M. Keck Foundation); Ellison Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Medicines for Malaria Venture; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by grants to EAW from the Keck Foundation, the Ellison Foundation, NIH, the Wellcome Trust and the Medicines for Malaria Venture, and in part by grants to JMV from the NIH. JAY was supported by a pre-doctoral fellowship from the National Science Foundation.	Al-Olayan EM, 2002, SCIENCE, V295, P677, DOI 10.1126/science.1067159; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Beetsma AL, 1998, EXP PARASITOL, V88, P69, DOI 10.1006/expr.1998.4203; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Camerer E, 2000, J BIOL CHEM, V275, P6580, DOI 10.1074/jbc.275.9.6580; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DINGLASAN RR, 2007, P NATL ACAD SCI US; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Douradinha B, 2007, INT J PARASITOL, V37, P1511, DOI 10.1016/j.ijpara.2007.05.005; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; GULLI MP, 1995, NUCLEIC ACIDS RES, V23, P1912, DOI 10.1093/nar/23.11.1912; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kappe SHI, 2004, ANNU REV CELL DEV BI, V20, P29, DOI 10.1146/annurev.cellbio.20.011603.150935; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Kariuki MM, 1998, AM J TROP MED HYG, V59, P505, DOI 10.4269/ajtmh.1998.59.505; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kumar KA, 2007, MOL BIOCHEM PARASIT, V156, P32, DOI 10.1016/j.molbiopara.2007.07.004; KUMAR MKB, 2004, METHODS MALARIA RES, P93; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; MACK SR, 1978, J PARASITOL, V64, P166, DOI 10.2307/3279638; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Murali TM, 2006, NAT BIOTECHNOL, V24, P1474, DOI 10.1038/nbt1206-1474; OCKENHOUSE CF, 1991, P NATL ACAD SCI USA, V88, P3175, DOI 10.1073/pnas.88.8.3175; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Raibaud A, 2006, MOL BIOCHEM PARASIT, V150, P107, DOI 10.1016/j.molbiopara.2006.07.001; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sacci JB, 2002, MOL BIOCHEM PARASIT, V119, P285, DOI 10.1016/S0166-6851(01)00411-X; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surolia A, 2004, BIOCHEM J, V383, P401, DOI 10.1042/BJ20041051; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Trottein F, 1995, MOL BIOCHEM PARASIT, V74, P129, DOI 10.1016/0166-6851(95)02489-1; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Vinetz JM, 2000, J BIOL CHEM, V275, P10331, DOI 10.1074/jbc.275.14.10331; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhou XHJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-232; ZHOU Y, 2004, BIOINFORMATICS	70	75	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1570	10.1371/journal.pone.0001570	http://dx.doi.org/10.1371/journal.pone.0001570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270564	Green Published, gold			2022-12-27	WOS:000260535900009
J	Pages, D; Rose, J; Conrod, S; Cuine, S; Carrier, P; Heulin, T; Achouak, W				Pages, Delphine; Rose, Jerome; Conrod, Sandrine; Cuine, Stephane; Carrier, Patrick; Heulin, Thierry; Achouak, Wafa			Heavy Metal Tolerance in Stenotrophomonas maltophilia	PLOS ONE			English	Article								Stenotrophomonas maltophilia is an aerobic, non-fermentative Gram-negative bacterium widespread in the environment. S. maltophilia Sm777 exhibits innate resistance to multiple antimicrobial agents. Furthermore, this bacterium tolerates high levels (0.1 to 50 mM) of various toxic metals, such as Cd, Pb, Co, Zn, Hg, Ag, selenite, tellurite and uranyl. S. maltophilia Sm777 was able to grow in the presence of 50 mM selenite and 25 mM tellurite and to reduce them to elemental selenium (Se-0) and tellurium (Te-0) respectively. Transmission electron microscopy and energy dispersive X-ray analysis showed cytoplasmic nanometer-sized electron-dense Se-0 granules and Te-0 crystals. Moreover, this bacterium can withstand up to 2 mM CdCl2 and accumulate this metal up to 4% of its biomass. The analysis of soluble thiols in response to ten different metals showed eightfold increase of the intracellular pool of cysteine only in response to cadmium. Measurements by Cd K-edge EXAFS spectroscopy indicated the formation of Cd-S clusters in strain Sm777. Cysteine is likely to be involved in Cd tolerance and in CdS-clusters formation. Our data suggest that besides high tolerance to antibiotics by efflux mechanisms, S. maltophilia Sm777 has developed at least two different mechanisms to overcome metal toxicity, reduction of oxyanions to non-toxic elemental ions and detoxification of Cd into CdS.	[Pages, Delphine; Conrod, Sandrine; Heulin, Thierry; Achouak, Wafa] CEA, DSV, IBEB, LEMiRE, St Paul Les Durance, France; [Pages, Delphine; Conrod, Sandrine; Heulin, Thierry; Achouak, Wafa] CNRS, UMR Biol Veget & Microbiol Environm, Saint Paul lez Durance, France; [Pages, Delphine; Conrod, Sandrine; Heulin, Thierry; Achouak, Wafa] Aix Marseille Univ, Saint Paul lez Durance, France; [Rose, Jerome] Univ Aix Marseille, UMR 6635 CNRS, CEREGE, IFR 112 PMSE Europole lArbois, Aix En Provence, France; [Cuine, Stephane; Carrier, Patrick] LB3M, SBVME, IBEB, DSV, CEA, Saint Paul lez Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); CEA	Achouak, W (corresponding author), CEA, DSV, IBEB, LEMiRE, St Paul Les Durance, France.	wafa.achouak@cea.fr	, HEULIN/C-1689-2010; ROSE, Jerome/J-5063-2017; Achouak, Wafa/AAX-8916-2021; BM30, Beamline FAME/G-9313-2012	ROSE, Jerome/0000-0003-3071-8147; Achouak, Wafa/0000-0003-4297-6661; 	French Toxicologie Nucleaire Environnementale program	French Toxicologie Nucleaire Environnementale program	This work was supported by the French Toxicologie Nucleaire Environnementale program 2001 06. The funder did not contribute to the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P3079, DOI 10.1128/AAC.44.11.3079-3086.2000; Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P1778, DOI 10.1128/AAC.44.7.1778-1782.2000; Berg G., 1994, Archives of Phytopathology and Plant Protection, V29, P249, DOI 10.1080/03235409409383116; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; BINKS PR, 1995, APPL ENVIRON MICROB, V61, P1318, DOI 10.1128/AEM.61.4.1318-1322.1995; DEBETTE J, 1980, CAN J MICROBIOL, V26, P460, DOI 10.1139/m80-076; Dignani MC, 2003, SEMIN RESP CRIT CARE, V24, P89, DOI 10.1055/s-2003-37920; Dungan RS, 2003, ENVIRON MICROBIOL, V5, P287, DOI 10.1046/j.1462-2920.2003.00410.x; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Heuer H, 1999, FEMS MICROBIOL ECOL, V28, P357, DOI 10.1111/j.1574-6941.1999.tb00590.x; Holmes JD, 1997, MICROBIOL-UK, V143, P2521, DOI 10.1099/00221287-143-8-2521; Juhasz AL, 2000, LETT APPL MICROBIOL, V30, P396, DOI 10.1046/j.1472-765x.2000.00733.x; KNUDSEN GR, 1988, APPL ENVIRON MICROB, V54, P343, DOI 10.1128/AEM.54.2.343-347.1988; KREDICH NM, 1973, J BIOL CHEM, V248, P6187; LAMBERT B, 1989, TRENDS BIOTECHNOL, V7, P215, DOI 10.1016/0167-7799(89)90107-8; Lee EY, 2002, J AIR WASTE MANAGE, V52, P400, DOI 10.1080/10473289.2002.10470796; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Michalovicz A., 1991, LOGICIELS CHIMIE, P102; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Quinn JP, 1998, CLIN INFECT DIS, V27, pS117, DOI 10.1086/514912; REHR JJ, 1990, PHYS REV B, V41, P8139, DOI 10.1103/PhysRevB.41.8139; Rijstenbil JW, 1996, MAR BIOL, V127, P45, DOI 10.1007/BF00993642; Sauge-Merle S, 2003, APPL ENVIRON MICROB, V69, P490, DOI 10.1128/AEM.69.1.490-494.2003; Sharma PK, 2000, APPL ENVIRON MICROB, V66, P3083, DOI 10.1128/AEM.66.7.3083-3087.2000; Teo B.K., 1986, INORGANIC CHEM CONCE; Valdezate S, 2001, ANTIMICROB AGENTS CH, V45, P1581, DOI 10.1128/AAC.45.5.1581-1584.2001; Wang CL, 2001, APPL MICROBIOL BIOT, V56, P425, DOI 10.1007/s002530100660; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; YAMAZAKI E, 1989, FEMS MICROBIOL LETT, V60, P85, DOI 10.1016/0378-1097(89)90082-7; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zhang L, 2001, ANTIMICROB AGENTS CH, V45, P3497, DOI 10.1128/AAC.45.12.3497-3503.2001	32	88	94	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1539	10.1371/journal.pone.0001539	http://dx.doi.org/10.1371/journal.pone.0001539			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253487	Green Published, gold			2022-12-27	WOS:000260535700011
J	Rosenberg, M; Straussman, R; Ben-Ya'acov, A; Ronen, D; Ravid, S				Rosenberg, Michael; Straussman, Ravid; Ben-Ya'acov, Ami; Ronen, Daniel; Ravid, Shoshana			MHC-IIB Filament Assembly and Cellular Localization Are Governed by the Rod Net Charge	PLOS ONE			English	Article							NONMUSCLE MYOSIN-II; COILED-COIL ROD; STRESS FIBERS; SMOOTH-MUSCLE; PHOSPHORYLATION; REGIONS; TAIL; ORGANIZATION; MECHANISM; RESIDUES	Background. Actin-dependent myosin II molecular motors form an integral part of the cell cytoskeleton. Myosin II molecules contain a long coiled-coil rod that mediates filament assembly required for myosin II to exert its full activity. The exact mechanisms orchestrating filament assembly are not fully understood. Methodology/Principal Findings. Here we examine mechanisms controlling filament assembly of non-muscle myosin IIB heavy chain (MHC-IIB). We show that in vitro the entire C-terminus region of net positive charge, found in myosin II rods, is important for self-assembly of MHC-IIB fragments. In contrast, no particular sequences in the rod region with net negative charge were identified as important for self-assembly, yet a minimal area from this region is necessary. Proper paracrystal formation by MHC-IIB fragments requires the 196aa charge periodicity along the entire coiled-coil region. In vivo, in contrast to self-assembly in vitro, negatively-charged regions of the coiled-coil were found to play an important role by controlling the intracellular localization of native MHC-IIB. The entire positively-charged region is also important for intracellular localization of native MHC-IIB. Conclusions/Significance. A correct distribution of positive and negative charges along myosin II rod is a necessary component in proper filament assembly and intracellular localization of MHC-IIB.	[Rosenberg, Michael; Straussman, Ravid; Ben-Ya'acov, Ami; Ronen, Daniel; Ravid, Shoshana] Hebrew Univ Jerusalem, Fac Med, Dept Biochem, Jerusalem, Israel	Hebrew University of Jerusalem	Ravid, S (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Biochem, Jerusalem, Israel.	ravid@cc.huji.ac.il			Israel Cancer Research Foundation; Israel Ministry of Health; Israel Cancer Association	Israel Cancer Research Foundation; Israel Ministry of Health; Israel Cancer Association	This work was supported by grants from Israel Cancer Research Foundation, Israel Ministry of Health, and Israel Cancer Association.	ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; ATKINSON SJ, 1991, J CELL SCI, V99, P823; BENNETT PM, 1981, J MOL BIOL, V146, P201, DOI 10.1016/0022-2836(81)90432-0; CHOWRASHI PK, 1977, J CELL BIOL, V74, P136, DOI 10.1083/jcb.74.1.136; Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; EILERTSEN KJ, 1994, J CELL BIOL, V126, P1201, DOI 10.1083/jcb.126.5.1201; Even-Faitelson L, 2005, CELL SIGNAL, V17, P1137, DOI 10.1016/j.cellsig.2004.12.015; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Hoppe PE, 1996, J CELL BIOL, V135, P371, DOI 10.1083/jcb.135.2.371; Hostetter D, 2004, PLOS BIOL, V2, P1880, DOI 10.1371/journal.pbio.0020356; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kolega J, 1999, CELL MOTIL CYTOSKEL, V43, P255, DOI 10.1002/(SICI)1097-0169(1999)43:3<255::AID-CM8>3.0.CO;2-T; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; LANGANGER G, 1986, J CELL BIOL, V102, P200, DOI 10.1083/jcb.102.1.200; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Olney JJ, 1996, J BIOL CHEM, V271, P20375, DOI 10.1074/jbc.271.34.20375; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Shoffner JD, 1996, BIOCHEM BIOPH RES CO, V218, P860, DOI 10.1006/bbrc.1996.0153; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; SVITKINA TM, 1989, CELL MOTIL CYTOSKEL, V12, P150, DOI 10.1002/cm.970120304; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Trybus KM, 1991, CURR OPIN CELL BIOL, V3, P105, DOI 10.1016/0955-0674(91)90172-U; Tsunashima Y, 2004, BIOPOLYMERS, V75, P264, DOI 10.1002/bip.20114; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; VERKHOVSKY AB, 1993, J CELL BIOL, V123, P637, DOI 10.1083/jcb.123.3.637	39	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1496	10.1371/journal.pone.0001496	http://dx.doi.org/10.1371/journal.pone.0001496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231583	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200009
J	Wiesner, M; Zentz, C; Mayr, C; Wimmer, R; Hammerschmidt, W; Zeidler, R; Moosmann, A				Wiesner, Martina; Zentz, Caroline; Mayr, Christine; Wimmer, Rainer; Hammerschmidt, Wolfgang; Zeidler, Reinhard; Moosmann, Andreas			Conditional Immortalization of Human B Cells by CD40 Ligation	PLOS ONE			English	Article								It is generally assumed that human differentiated cells have a limited life-span and proliferation capacity in vivo, and that genetic modifications are a prerequisite for their immortalization in vitro. Here we readdress this issue, studying the long-term proliferation potential of human B cells. It was shown earlier that human B cells from peripheral blood of healthy donors can be efficiently induced to proliferate for up to ten weeks in vitro by stimulating their receptor CD40 in the presence of interleukin-4. When we applied the same stimuli under conditions of modified cell number and culture size, we were surprised to find that our treatment induced B cells to proliferate throughout an observation period of presently up to 1650 days, representing more than 370 population doublings, which suggested that these B cells were immortalized in vitro. Long-term CD40-stimulated B cell cultures could be established from most healthy adult human donors. These B cells had a constant phenotype, were free from Epstein-Barr virus, and remained dependent on CD40 ligation. They had constitutive telomerase activity and stabilized telomere length. Moreover, they were susceptible to activation by Toll-like receptor 9 ligands, and could be used to expand antigen-specific cytotoxic T cells in vitro. Our results indicate that human somatic cells can evade senescence and be conditionally immortalized by external stimulation only, without a requirement for genetic manipulation or oncoviral infection. Conditionally immortalized human B cells are a new tool for immunotherapy and studies of B cell oncogenesis, activation, and function.	[Wiesner, Martina; Zentz, Caroline; Moosmann, Andreas] GSF, Natl Res Ctr, Clin Cooperat Grp Mol Oncol, Munich, Germany; [Mayr, Christine] Tech Univ, Inst Human Genet, Munich, Germany; [Wimmer, Rainer] Univ Munich, Inst Human Genet, Munich, Germany; [Hammerschmidt, Wolfgang] GSF, Natl Res Ctr Env & Hlth, Dept Gene Vectors, Munich, Germany; [Zeidler, Reinhard] Univ Munich, Dept Otorhinolaryn, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Moosmann, A (corresponding author), GSF, Natl Res Ctr, Clin Cooperat Grp Mol Oncol, Munich, Germany.	moosmann@gsf.de	Zeidler, Reinhard/M-9837-2014; Hammerschmidt, Wolfgang/ABG-3921-2021	Zeidler, Reinhard/0000-0002-3357-4954; Hammerschmidt, Wolfgang/0000-0002-4659-0427; Moosmann, Andreas/0000-0001-8044-5146	HW & J Hector-Stiftung; Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft;  [SFB 455];  [FB-Transregio 36]	HW & J Hector-Stiftung; Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	This study was supported by HW & J Hector-Stiftung, Wilhelm Sander-Stiftung, and Deutsche Forschungsgemeinschaft (SFB 455 and SFB-Transregio 36).	ARPIN C, 1995, SCIENCE, V268, P720, DOI 10.1126/science.7537388; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Bartz H, 2004, VACCINE, V23, P148, DOI 10.1016/j.vaccine.2004.05.020; Berger R, 2004, CANCER GENET CYTOGEN, V153, P86, DOI 10.1016/j.cancergencyto.2003.12.015; Bergwelt-Baildon von M., 2004, CANCER RES, V64, P4056; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BURDIN N, 1995, J IMMUNOL, V154, P2533; Busson-Le Coniat M, 2002, ANN GENET-PARIS, V45, P193, DOI 10.1016/S0003-3995(02)01138-3; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; Forsyth NR, 2004, NEOPLASIA, V6, P258, DOI 10.1593/neo.04103; Galibert L, 1996, J EXP MED, V183, P77, DOI 10.1084/jem.183.1.77; GALIBERT L, 1995, EUR J IMMUNOL, V25, P733, DOI 10.1002/eji.1830250316; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Gudgeon NH, 2005, J VIROL, V79, P5477, DOI 10.1128/JVI.79.9.5477-5488.2005; Hammer MH, 2005, EUR J IMMUNOL, V35, P2250, DOI 10.1002/eji.200526230; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hathcock KS, 2005, IMMUNOL REV, V205, P104, DOI 10.1111/j.0105-2896.2005.00267.x; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hooijberg E, 2000, J IMMUNOL, V165, P4239, DOI 10.4049/jimmunol.165.8.4239; Hu BT, 1997, J IMMUNOL, V159, P1068; Igarashi H, 1997, BLOOD, V89, P1299, DOI 10.1182/blood.V89.4.1299; Jung D, 2001, IMMUNOL INVEST, V30, P157, DOI 10.1081/IMM-100104023; Kansal R, 2005, MODERN PATHOL, V18, P235, DOI 10.1038/modpathol.3800299; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kondo E, 2002, J IMMUNOL, V169, P2164, DOI 10.4049/jimmunol.169.4.2164; Lapointe R, 2003, CANCER RES, V63, P2836; Martens UM, 2002, BRIT J HAEMATOL, V119, P810, DOI 10.1046/j.1365-2141.2002.03910.x; Mayr C, 2006, BLOOD, V107, P742, DOI 10.1182/blood-2005-05-2093; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Moosmann A, 2002, BLOOD, V100, P1755, DOI 10.1182/blood.V100.5.1755.h81702001755_1755_1764; Norrback KF, 1996, BLOOD, V88, P222; O'Nions J, 2004, J GEN VIROL, V85, P881, DOI 10.1099/vir.0.19704-0; Okubo M, 2001, CANCER GENET CYTOGEN, V129, P30, DOI 10.1016/S0165-4608(01)00420-4; POPE JH, 1968, INT J CANCER, V3, P857, DOI 10.1002/ijc.2910030619; RIVOLTINI L, 1995, CANCER RES, V55, P3149; ROUSSET F, 1995, INT IMMUNOL, V7, P1243, DOI 10.1093/intimm/7.8.1243; Rufer N, 2001, BLOOD, V98, P597, DOI 10.1182/blood.V98.3.597; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Siwicki JK, 2004, GENE CHROMOSOME CANC, V41, P133, DOI 10.1002/gcc.20059; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; Vollmer J, 2004, IMMUNOLOGY, V113, P212, DOI 10.1111/j.1365-2567.2004.01962.x; von Bergwelt-Baildon M, 2004, CANCER RES, V64, P4055, DOI 10.1158/0008-5472.CAN-03-3606; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319; VONBERGWELTBAIL.M, 2004, CANCER RES, V63, P2836; Wagner M, 2004, J IMMUNOL, V172, P954, DOI 10.4049/jimmunol.172.2.954; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Zentz C, 2007, HUM IMMUNOL, V68, P75, DOI 10.1016/j.humimm.2006.12.004; Zippelius A, 2002, J EXP MED, V195, P485, DOI 10.1084/jem.20011658	55	64	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1464	10.1371/journal.pone.0001464	http://dx.doi.org/10.1371/journal.pone.0001464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213373	Green Submitted, Green Published, gold			2022-12-27	WOS:000260503900010
J	van Wassenhove, V; Buonomano, DV; Shimojo, S; Shams, L				van Wassenhove, Virginie; Buonomano, Dean V.; Shimojo, Shinsuke; Shams, Ladan			Distortions of Subjective Time Perception Within and Across Senses	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; INTERVAL DISCRIMINATION; DURATION JUDGMENTS; AUDITORY SENSATION; VISUAL FLICKER; RHESUS-MONKEYS; INTERNAL CLOCK; MODEL; BRAIN; INFORMATION	Background. The ability to estimate the passage of time is of fundamental importance for perceptual and cognitive processes. One experience of time is the perception of duration, which is not isomorphic to physical duration and can be distorted by a number of factors. Yet, the critical features generating these perceptual shifts in subjective duration are not understood. Methodology/Findings. We used prospective duration judgments within and across sensory modalities to examine the effect of stimulus predictability and feature change on the perception of duration. First, we found robust distortions of perceived duration in auditory, visual and auditory-visual presentations despite the predictability of the feature changes in the stimuli. For example, a looming disc embedded in a series of steady discs led to time dilation, whereas a steady disc embedded in a series of looming discs led to time compression. Second, we addressed whether visual (auditory) inputs could alter the perception of duration of auditory (visual) inputs. When participants were presented with incongruent audio-visual stimuli, the perceived duration of auditory events could be shortened or lengthened by the presence of conflicting visual information; however, the perceived duration of visual events was seldom distorted by the presence of auditory information and was never perceived shorter than their actual durations. Conclusions/Significance. These results support the existence of multisensory interactions in the perception of duration and, importantly, suggest that vision can modify auditory temporal perception in a pure timing task. Insofar as distortions in subjective duration can neither be accounted for by the unpredictability of an auditory, visual or auditory-visual event, we propose that it is the intrinsic features of the stimulus that critically affect subjective time distortions.	[Shimojo, Shinsuke] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Buonomano, Dean V.; Shams, Ladan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Buonomano, Dean V.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	van Wassenhove, V (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	vvw@caltech.edu	van Wassenhove, Virginie/F-4129-2010	van Wassenhove, Virginie/0000-0002-2569-5502	HFSP [RGP70/2003]; JST.ERATO Shimojo Implicit Brain Function Project	HFSP(Human Frontier Science Program); JST.ERATO Shimojo Implicit Brain Function Project(Japan Science & Technology Agency (JST))	HFSP grant (RGP70/2003) to LS and SS. JST.ERATO Shimojo Implicit Brain Function Project to WW.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bendixen A, 2005, NEUROSCI LETT, V383, P284, DOI 10.1016/j.neulet.2005.04.034; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Dhamala M, 2007, NEUROIMAGE, V34, P764, DOI 10.1016/j.neuroimage.2006.07.044; Droit-Volet S, 2004, COGNITION EMOTION, V18, P849, DOI 10.1080/02699930341000194; DROITVOLET S, 2006, BEHAV PROCESSES; Eagleman DM, 2004, NATURE, V428, P854, DOI 10.1038/nature02467; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P57, DOI 10.1016/0028-3932(70)90025-4; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; FRANCONERI SL, 2005, PSYCHOL RES, V16; GEBHARD JW, 1959, AM J PSYCHOL, V72, P521, DOI 10.2307/1419493; GOLDSTONE S, 1963, PERCEPT MOTOR SKILL, V17, P763, DOI 10.2466/pms.1963.17.3.763; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hodinott-Hill I, 2002, CURR BIOL, V12, P1779, DOI 10.1016/S0960-9822(02)01219-8; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R., 2006, J VISION, P1; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; KORDING KP, 2007, CAUSAL INFEREN UNPUB; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Massaro D.W., 1998, PERCEIVING TALKING F; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; N'Diaye K, 2004, COGNITIVE BRAIN RES, V21, P250, DOI 10.1016/j.cogbrainres.2004.04.006; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Oleron G, 1952, ANN PSYCHOL, V52, P383; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PENNER MJ, 1977, J ACOUST SOC AM, V61, P552, DOI 10.1121/1.381297; Penney T.B., 2005, PSYCHOL FRANCA, V50, P131, DOI [10.1016/j.psfr.2004.10.011, DOI 10.1016/J.PSFR.2004.10.011]; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; POPPEL E, 1978, PERCEPTION; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; ROSACLOT M, 2002, INT J THEOR APPL FIN, V5, P123, DOI DOI 10.1142/S0219024902001377; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Wassenhove V, 2007, J NEUROSCI, V27, P2663, DOI 10.1523/JNEUROSCI.4844-06.2007; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Westheimer G, 1999, EXP BRAIN RES, V129, P121, DOI 10.1007/s002210050942; Wittmann M, 1999, CHRONOBIOL INT, V16, P17, DOI 10.3109/07420529908998709; Wright BA, 1997, J NEUROSCI, V17, P3956; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; YARROW K, 2001, ILLUSORY PERCEPTIONS, P302; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; [No title captured]	74	134	138	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1437	10.1371/journal.pone.0001437	http://dx.doi.org/10.1371/journal.pone.0001437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SN	18197248	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000260503800009
J	Freed, WJ; Chen, J; Baeckman, CM; Schwartz, CM; Vazin, T; Cai, JL; Spivak, CE; Lupica, CR; Rao, MS; Zeng, XM				Freed, William J.; Chen, Jia; Baeckman, Cristina M.; Schwartz, Catherine M.; Vazin, Tandis; Cai, Jingli; Spivak, Charles E.; Lupica, Carl R.; Rao, Mahendra S.; Zeng, Xianmin			Gene Expression Profile of Neuronal Progenitor Cells Derived from hESCs: Activation of Chromosome 11p15.5 and Comparison to Human Dopaminergic Neurons	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BECKWITH-WIEDEMANN-SYNDROME; SIGNATURE SEQUENCING MPSS; IN-VITRO; CONGENITAL HYPERINSULINISM; REGULATABLE LENTIVIRUS; BEHAVIORAL-CHANGES; IMPRINTED GENES; NONCODING RNA; H19 GENE	Background. We initiated differentiation of human embryonic stem cells (hESCs) into dopamine neurons, obtained a purified population of neuronal precursor cells by cell sorting, and determined patterns of gene transcription. Methodology. Dopaminergic differentiation of hESCs was initiated by culturing hESCs with a feeder layer of PA6 cells. Differentiating cells were then sorted to obtain a pure population of PSA-NCAM-expressing neuronal precursors, which were then analyzed for gene expression using Massive Parallel Signature Sequencing (MPSS). Individual genes as well as regions of the genome which were activated were determined. Principal Findings. A number of genes known to be involved in the specification of dopaminergic neurons, including MSX1, CDKN1C, Pitx1 and Pitx2, as well as several novel genes not previously associated with dopaminergic differentiation, were expressed. Notably, we found that a specific region of the genome located on chromosome 11p15.5 was highly activated. This region contains several genes which have previously been associated with the function of dopaminergic neurons, including the gene for tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis, IGF2, and CDKN1C, which cooperates with Nurr1 in directing the differentiation of dopaminergic neurons. Other genes in this region not previously recognized as being involved in the functions of dopaminergic neurons were also activated, including H19, TSSC4, and HBG2. IGF2 and CDKN1C were also found to be highly expressed in mature human TH-positive dopamine neurons isolated from human brain samples by laser capture. Conclusions. The present data suggest that the H19-IGF2 imprinting region on chromosome 11p15.5 is involved in the process through which undifferentiated cells are specified to become neuronal precursors and/or dopaminergic neurons.	[Freed, William J.; Chen, Jia; Baeckman, Cristina M.; Vazin, Tandis; Spivak, Charles E.; Lupica, Carl R.; Zeng, Xianmin] NIDA, Cellular Neurobiol Res Branch, IRP, NIH,US Dept HHS, Baltimore, MD USA; [Schwartz, Catherine M.; Rao, Mahendra S.] NIH, Natl Inst Aging, Dept Hlth & Human Serv DHHS, Lab Neurosci, Intramural Res Prog, Baltimore, MD USA; [Cai, Jingli] Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Jefferson University	Freed, WJ (corresponding author), NIDA, Cellular Neurobiol Res Branch, IRP, NIH,US Dept HHS, Baltimore, MD USA.	wfreed@mail.nih.gov	Lupica, Carl/AAY-3193-2021; backman, cristina/C-1276-2013	Lupica, Carl/0000-0002-5375-3263; 	NIDA; NIA; DHHS; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000472, Z01DA000472] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DHHS; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research was supported by the IRPs of NIDA and NIA, NIDA, DHHS.	Alonso G, 2001, GLIA, V34, P253, DOI 10.1002/glia.1059; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Baer K, 2007, EXP NEUROL, V204, P828, DOI 10.1016/j.expneurol.2006.12.008; Bahi A, 2004, EUR J NEUROSCI, V20, P3473, DOI 10.1111/j.1460-9568.2004.03771.x; Bahi A, 2004, EUR J NEUROSCI, V19, P1621, DOI 10.1111/j.1460-9568.2004.03260.x; Barrett T, 2001, NEUROBIOL DIS, V8, P822, DOI 10.1006/nbdi.2001.0423; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; BLASSKAMPMANN S, 1994, J NEUROSCI RES, V37, P359, DOI 10.1002/jnr.490370308; Brenner S, 2000, P NATL ACAD SCI USA, V97, P1665, DOI 10.1073/pnas.97.4.1665; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Buytaert-Hoefen KA, 2004, STEM CELLS, V22, P669, DOI 10.1634/stemcells.22-5-669; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chung S, 2005, MOL CELL NEUROSCI, V28, P241, DOI 10.1016/j.mcn.2004.09.008; Cichon S, 1996, AM J MED GENET, V67, P229, DOI 10.1002/(SICI)1096-8628(19960409)67:2<229::AID-AJMG17>3.0.CO;2-L; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Donarum EA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-22; Fournet JC, 2000, HORM RES, V53, P2, DOI 10.1159/000053197; Fournet JC, 2001, AM J PATHOL, V158, P2177, DOI 10.1016/S0002-9440(10)64689-5; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Jorgensen JR, 2006, EXP NEUROL, V198, P427, DOI 10.1016/j.expneurol.2005.12.023; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lee MP, 1999, HUM MOL GENET, V8, P683, DOI 10.1093/hmg/8.4.683; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Li H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-103; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LUSTIG O, 1994, MOL REPROD DEV, V38, P239, DOI 10.1002/mrd.1080380302; Marinelli M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P79, DOI 10.2174/187152706784111542; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Micha AE, 1999, DIGESTION, V60, P477, DOI 10.1159/000007694; Michna L, 2001, MOL BRAIN RES, V90, P68, DOI 10.1016/S0169-328X(01)00092-4; Miura T, 2004, STEM CELLS DEV, V13, P694, DOI 10.1089/scd.2004.13.694; Nass R, 2003, ANNU REV PHARMACOL, V43, P521, DOI 10.1146/annurev.pharmtox.43.100901.135934; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; Patton SJ, 1998, MOL BIOL EVOL, V15, P1373, DOI 10.1093/oxfordjournals.molbev.a025865; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; Redmond DE, 2003, DEV BRAIN RES, V146, P99, DOI 10.1016/j.devbrainres.2003.10.001; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; Riddle R, 2003, DEV BRAIN RES, V147, P3, DOI 10.1016/j.devbrainres.2003.09.010; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; Scott RE, 2005, DIFFERENTIATION, V73, P294; Seutin V, 2005, BRIT J PHARMACOL, V146, P167, DOI 10.1038/sj.bjp.0706328; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; TAYLOR ER, 1991, J MOL ENDOCRINOL, V7, P145, DOI 10.1677/jme.0.0070145; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yokomine T, 2005, GENOME RES, V15, P154, DOI 10.1101/gr.2609605; Zeng XM, 2004, STEM CELLS, V22, P292, DOI 10.1634/stemcells.22-3-292; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zeng XM, 2003, STEM CELLS, V21, P647, DOI 10.1634/stemcells.21-6-647; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	66	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1422	10.1371/journal.pone.0001422	http://dx.doi.org/10.1371/journal.pone.0001422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183302	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400018
J	van Vliet-Ostaptchouk, JV; Onland-Moret, NC; Shiri-Sverdlov, R; van Gorp, PJJ; Custers, A; Peeters, PHM; Wijmenga, C; Hofker, MH; van der Schouw, YT				van Vliet-Ostaptchouk, Jana V.; Onland-Moret, N. Charlotte; Shiri-Sverdlov, Ronit; van Gorp, Patrick J. J.; Custers, Anne; Peeters, Petra H. M.; Wijmenga, Cisca; Hofker, Marten H.; van der Schouw, Yvonne T.			Polymorphisms of the TUB Gene Are Associated with Body Composition and Eating Behavior in Middle-Aged Women	PLOS ONE			English	Article							GLYCEMIC LOAD; FOOD-INTAKE; MESSENGER-RNA; NORMAL-WEIGHT; OBESE; PROTEIN; FAT; EXPRESSION; MOUSE; IDENTIFICATION	Background. The TUB gene, encoding an evolutionary conserved protein, is highly expressed in the hypothalamus and might act as a transcription factor. Mutations in TUB cause late-onset obesity, insulin-resistance and neurosensory deficits in mice. An association of common variants in the TUB gene with body weight in humans has been reported. Methods/Findings. The aim was to investigate the relationship of single nucleotide polymorphisms (SNPs) of the TUB gene (rs2272382, rs2272383 and rs1528133) with both anthropometry and self-reported macronutrient intake from a validated food frequency questionnaire. These associations were studied in a population-based, cross-sectional study of 1680 middle-aged Dutch women, using linear regression analysis. The minor allele C of the rs1528133 SNP was significantly associated with increased weight (+1.88 kg, P=0.022) and BMI (+0.56 units, P=0.05). Compared with non-carriers, both AG heterozygotes and AA homozygotes of the rs2272382 SNP derived less energy from fat (AG: -0.55 +/- 0.28%, P=0.05, AA: -0.95 +/- 0.48%, P=0.047). However, both genotypes were associated with an increased energy intake from carbohydrates (0.69 +/- 0.33%, P=0.04 and 1.68 +/- 0.56%, P=0.003, respectively), mainly because of a higher consumption of mono- and disaccharides. Both these SNPs, rs2272382 and rs1528133, were also associated with a higher glycemic load in the diet. The glycemic load was higher among those with AG and AA genotypes for the variant rs2272382 than among the wild types (+1.49 (95% CI: -0.27-3.24) and +3.89 (95% CI: 0.94-6.85) units, respectively). Carriers of the minor allele C of rs1528133 were associated with an increased glycemic load of 1.85 units compared with non-carriers. Conclusions. Genetic variation of the TUB gene was associated with both body composition and macronutrient intake, suggesting that TUB might influence eating behavior.	[van Vliet-Ostaptchouk, Jana V.; Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, Groningen, Netherlands; [van Vliet-Ostaptchouk, Jana V.; Shiri-Sverdlov, Ronit; van Gorp, Patrick J. J.; Custers, Anne; Hofker, Marten H.] Maastricht Univ, Dept Mol Genet, Maastricht, Netherlands; [Onland-Moret, N. Charlotte; Wijmenga, Cisca] Univ Med Ctr Utrecht, DBG Dept Med Genet, Utrecht, Netherlands; [Onland-Moret, N. Charlotte; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen; Maastricht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen	van der Schouw, YT (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	Y.T.vanderSchouw@umcutrecht.nl	van Gorp, Patrick/S-3892-2019; Shiri-Sverdlov, Ronit/X-2642-2019; van Gorp, Patrick/L-9580-2018; van der Schouw, Yvonne T./F-8327-2014; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019; Shiri-Sverdlov, Ronit/E-5571-2017; Onland-Moret, N. Charlotte/G-9185-2011	van Gorp, Patrick/0000-0002-0355-5349; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; van Gorp, Patrick/0000-0002-0355-5349; van der Schouw, Yvonne T./0000-0002-4605-435X; Wijmenga, Cisca/0000-0002-5635-1614; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Onland-Moret, N. Charlotte/0000-0002-2360-913X; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153	Dutch Diabetes Foundation; European Vascular Genomics Network; SenterNovem; IOP Genomics [IGE05012]; European Commission-Europe Against Cancer [WHO AEP/90/05]; Dutch Ministry of Health; Dutch Prevention Fund; LK Research Fund; World Cancer Research Fund [98A04, 2000/30]	Dutch Diabetes Foundation; European Vascular Genomics Network; SenterNovem; IOP Genomics; European Commission-Europe Against Cancer; Dutch Ministry of Health; Dutch Prevention Fund; LK Research Fund; World Cancer Research Fund(World Cancer Research Fund International (WCRF))	We thank the Dutch Diabetes Foundation, the European Vascular Genomics Network, and SenterNovem (IOP Genomics IGE05012) for financial support. The Prospect-EPIC study was financed by the European Commission-Europe Against Cancer (WHO AEP/90/05), the Dutch Ministry of Health, the Dutch Prevention Fund, the LK Research Fund, and the World Cancer Research Fund (WCRF 98A04 and WCRF 2000/30).	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Aubert R, 2000, INT J OBESITY, V24, P920, DOI 10.1038/sj.ijo.0801253; Backberg M, 2004, MOL BRAIN RES, V125, P129, DOI 10.1016/j.molbrainres.2004.03.012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Boker LK, 2001, EUR J EPIDEMIOL, V17, P1047, DOI 10.1023/A:1020009325797; BRAY GA, 1992, AM J CLIN NUTR, V55, P265; Castillo M, 2006, J MOL NEUROSCI, V30, P153, DOI 10.1385/JMN:30:1:153; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P777, DOI 10.1016/0031-9384(93)90188-L; Giannaccini G, 2007, CLIN BIOCHEM, V40, P806, DOI 10.1016/j.clinbiochem.2007.03.020; Gorwood P, 2003, EUR J PHARMACOL, V480, P163, DOI 10.1016/j.ejphar.2003.08.103; Guan XM, 1998, MOL BRAIN RES, V59, P273, DOI 10.1016/S0169-328X(98)00150-8; Hagan MM, 2001, AM J PHYSIOL-REG I, V280, pR814, DOI 10.1152/ajpregu.2001.280.3.R814; HARE B, 2006, AM J CLIN NUTR, V84, P952; Hare-Bruun H, 2006, AM J CLIN NUTR, V84, P871, DOI 10.1093/ajcn/84.4.871; Ikeda A, 2002, J CELL SCI, V115, P9; Kapeller R, 1999, J BIOL CHEM, V274, P24980, DOI 10.1074/jbc.274.35.24980; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Koegler FH, 1999, PHYSIOL BEHAV, V67, P809, DOI 10.1016/S0031-9384(99)00104-3; Kretsch MJ, 1999, J AM DIET ASSOC, V99, P300, DOI 10.1016/S0002-8223(99)00078-4; Lau C, 2006, AM J CLIN NUTR, V84, P641, DOI 10.1093/ajcn/84.3.641; Leibowitz SF, 2004, PEPTIDES, V25, P473, DOI 10.1016/j.peptides.2004.02.006; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Livesey G, 2005, P NUTR SOC, V64, P105, DOI 10.1079/PNS2004400; Loos RJF, 2005, AM J CLIN NUTR, V82, P1097, DOI 10.1093/ajcn/82.5.1097; Ma YS, 2005, AM J EPIDEMIOL, V161, P359, DOI 10.1093/aje/kwi051; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; MORTON GJ, 2006, CENTRAL NERVOUS SYST, V443, P289; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; PRENTICE AM, 1986, BRIT MED J, V292, P983, DOI 10.1136/bmj.292.6526.983; Rankinen T, 2006, ANNU REV NUTR, V26, P413, DOI 10.1146/annurev.nutr.26.061505.111218; Reed DR, 1997, BEHAV GENET, V27, P373, DOI 10.1023/A:1025692031673; Rodgers RJ, 2002, NEUROPEPTIDES, V36, P303, DOI 10.1016/S0143-4179(02)00085-9; Sahly I, 1998, HUM MOL GENET, V7, P1437, DOI 10.1093/hmg/7.9.1437; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Shiri-Sverdlov R, 2006, DIABETES, V55, P385, DOI 10.2337/diabetes.55.02.06.db05-0997; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stubdal H, 2000, MOL CELL BIOL, V20, P878, DOI 10.1128/MCB.20.3.878-882.2000; Wang Y, 2006, PHYSL GENOMICS; Willett W, 2001, EAT DRINK BE HLTH HA; Williams G, 2000, P NUTR SOC, V59, P385, DOI 10.1017/S0029665100000434; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866	48	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1405	10.1371/journal.pone.0001405	http://dx.doi.org/10.1371/journal.pone.0001405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183286	Green Submitted, Green Published, gold			2022-12-27	WOS:000260469400002
J	Tailleux, L; Waddell, SJ; Pelizzola, M; Mortellaro, A; Withers, M; Tanne, A; Castagnoli, PR; Gicquel, B; Stoker, NG; Butcher, PD; Foti, M; Neyrolles, O				Tailleux, Ludovic; Waddell, Simon J.; Pelizzola, Mattia; Mortellaro, Alessandra; Withers, Michael; Tanne, Antoine; Castagnoli, Paola Ricciardi; Gicquel, Brigitte; Stoker, Neil G.; Butcher, Philip D.; Foti, Maria; Neyrolles, Olivier			Probing Host Pathogen Cross-Talk by Transcriptional Profiling of Both Mycobacterium tuberculosis and Infected Human Dendritic Cells and Macrophages	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; GENE-EXPRESSION; NITRIC-OXIDE; REACTIVE OXYGEN; LISTERIA-MONOCYTOGENES; HYPOXIC RESPONSE; UP-REGULATION; IN-VIVO; SURVIVAL; DORMANCY	Background. Transcriptional profiling using microarrays provides a unique opportunity to decipher host pathogen cross-talk on the global level. Here, for the first time, we have been able to investigate gene expression changes in both Mycobacterium tuberculosis, a major human pathogen, and its human host cells, macrophages and dendritic cells. Methodology/Principal Findings. In addition to common responses, we could identify eukaryotic and microbial transcriptional signatures that are specific to the cell type involved in the infection process. In particular M. tuberculosis shows a marked stress response when inside dendritic cells, which is in accordance with the low permissivity of these specialized phagocytes to the tubercle bacillus and to other pathogens. In contrast, the mycobacterial transcriptome inside macrophages reflects that of replicating bacteria. On the host cell side, differential responses to infection in macrophages and dendritic cells were identified in genes involved in oxidative stress, intracellular vesicle trafficking and phagosome acidification. Conclusions/Significance. This study provides the proof of principle that probing the host and the microbe transcriptomes simultaneously is a valuable means to accessing unique information on host pathogen interactions. Our results also underline the extraordinary plasticity of host cell and pathogen responses to infection, and provide a solid framework to further understand the complex mechanisms involved in immunity to M. tuberculosis and in mycobacterial adaptation to different intracellular environments.			Stoker, NG (corresponding author), Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England.	neil.stoker@rvc.ac.uk; butcherp@sgul.ac.uk; maria.foti@unimib.it; olivier.neyrolles@ipbs.fr	Stoker, Neil G/L-8812-2016; Waddell, Simon J/A-9170-2013; Neyrolles, Olivier/AAG-3692-2019; Mortellaro, Alessandra/AAN-4678-2020; Neyrolles, Olivier B/A-3184-2011; Foti, Maria/AAB-9961-2022	Stoker, Neil G/0000-0001-7055-6184; Waddell, Simon J/0000-0002-3684-9116; Neyrolles, Olivier/0000-0003-0047-5885; Mortellaro, Alessandra/0000-0003-1744-2430; Pelizzola, Mattia/0000-0001-6672-9636; FOTI, MARIA/0000-0002-4481-1900; Butcher, Philip/0000-0003-1223-9097; Tailleux, Ludovic/0000-0003-3931-1052	European Community [LSHP-CT-2004-012187]; Wellcome Trust's Functional Genomics Resources Initiative [062511]; EU M.Curie Chair Award	European Community(European Commission); Wellcome Trust's Functional Genomics Resources Initiative(Wellcome Trust); EU M.Curie Chair Award	This work was supported by a 6th Framework Programme Priority [1] grant (Molecular Markers of M. tuberculosis Early Interactions with Host Phagocytes, MM-TB, number LSHP-CT-2004-012187) from the European Community. The whole genome M. tuberculosis microarray was constructed and analysed at St George's University of London as part of the multi-collaborative microbial pathogen microarray facility BuGS, for which funding from The Wellcome Trust's Functional Genomics Resources Initiative is acknowledged (grant number 062511). P.Ricciardi-Castagnoli is a recipient of a EU M.Curie Chair Award.	Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Barker LP, 1997, INFECT IMMUN, V65, P1497, DOI 10.1128/IAI.65.4.1497-1504.1997; Beste DJV, 2007, J BACTERIOL, V189, P3969, DOI 10.1128/JB.01787-06; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cappelli G, 2006, RES MICROBIOL, V157, P445, DOI 10.1016/j.resmic.2005.10.007; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harth G, 2005, MOL MICROBIOL, V58, P1157, DOI 10.1111/j.1365-2958.2005.04899.x; Henderson RA, 1997, J IMMUNOL, V159, P635; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Hutter B, 1998, FEMS MICROBIOL LETT, V167, P7, DOI 10.1111/j.1574-6968.1998.tb13200.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kolb-Maurer A, 2000, INFECT IMMUN, V68, P3680, DOI 10.1128/IAI.68.6.3680-3688.2000; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mangan JA, 2002, METHOD MICROBIOL, V33, P137; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mohagheghpour N, 2000, INFECT IMMUN, V68, P5824, DOI 10.1128/IAI.68.10.5824-5829.2000; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Parish T, 2000, J BACTERIOL, V182, P5715, DOI 10.1128/JB.182.20.5715-5720.2000; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pelizzola M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-335; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ricciardi-Castagnoli P, 2002, NAT REV IMMUNOL, V2, P881, DOI 10.1038/nri936; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schnappinger D, 2006, MICROBES INFECT, V8, P1132, DOI 10.1016/j.micinf.2005.10.027; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Stenger S, 1998, J IMMUNOL, V161, P3582; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Wang CH, 1998, EUR RESPIR J, V11, P809, DOI 10.1183/09031936.98.11040809; Wang JP, 2003, FEMS IMMUNOL MED MIC, V39, P163, DOI 10.1016/S0928-8244(03)00223-2; Werling D, 2004, IMMUNOLOGY, V111, P41, DOI 10.1111/j.1365-2567.2004.01781.x; Werner E, 2004, J CELL SCI, V117, P143, DOI 10.1242/jcs.00937; Westcott MM, 2007, CELL MICROBIOL, V9, P1397, DOI 10.1111/j.1462-5822.2006.00880.x; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	74	148	156	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1403	10.1371/journal.pone.0001403	http://dx.doi.org/10.1371/journal.pone.0001403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167562	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000260468900031
J	Wohr, M; Schwarting, RKW				Woehr, Markus; Schwarting, Rainer K. W.			Ultrasonic Communication in Rats: Can Playback of 50-kHz Calls Induce Approach Behavior?	PLOS ONE			English	Article							INDUCED DEFENSE BEHAVIOR; C-FOS EXPRESSION; 22 KHZ CALLS; LABORATORY RATS; SOCIAL-BEHAVIOR; NUCLEUS-ACCUMBENS; MOUSE MODELS; FEMALE MICE; VOCALIZATIONS; REWARD	Rats emit distinct types of ultrasonic vocalizations, which differ depending on age, the subject's current state and environmental factors. Since it was shown that 50-kHz calls can serve as indices of the animal's positive subjective state, they have received increasing experimental attention, and have successfully been used to study neurobiological mechanisms of positive affect. However, it is likely that such calls do not only reflect a positive affective state, but that they also serve a communicative purpose. Actually, rats emit the highest rates of 50-kHz calls typically during social interactions, like reproductive behavior, juvenile play and tickling. Furthermore, it was recently shown that rats emit 50-kHz calls after separation from conspecifics. The aim of the present study was to test the communicative value of such 50-kHz calls. In a first experiment, conducted in juvenile rats situated singly on a radial maze apparatus, we showed that 50-kHz calls can induce behavioral activation and approach responses, which were selective to 50-kHz signals, since presentation of 22-kHz calls, considered to be aversive or threat signals, led to behavioral inhibition. In two other experiments, we used either natural 50-kHz calls, which had been previously recorded from other rats, or artificial sine wave stimuli, which were identical to these calls with respect to peak frequency, call length and temporal appearance. These signals were presented to either juvenile (Exp. 2) or adult (Exp. 3) male rats. Our data clearly show that 50-kHz signals can induce approach behavior, an effect, which was more pronounced in juvenile rats and which was not selective to natural calls, especially in adult rats. The recipient rats also emitted some 50-kHz calls in response to call presentation, but this effect was observed only in adult subjects. Together, our data show that 50-kHz calls can serve communicative purposes, namely as a social signal, which increases the likelihood of approach in the recipient conspecific.	[Woehr, Markus; Schwarting, Rainer K. W.] Univ Marburg, Marburg, Germany	Philipps University Marburg	Wohr, M (corresponding author), Univ Marburg, Marburg, Germany.	markus.woehr@staff.uni-marburg.de	Wöhr, Markus/AAA-2316-2021; Schwarting, RAINER/AAJ-1516-2021	Wöhr, Markus/0000-0001-6986-5684; Schwarting, Rainer/0000-0002-4686-3974	Deutsche Forschungsgemeinschaft [Schw 559/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Schw 559/8-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; BARFIELD RJ, 1979, AM ZOOL, V19, P469; Barros HMT, 1996, PSYCHOPHARMACOLOGY, V125, P379; Beckett SRG, 1996, PSYCHOPHARMACOLOGY, V127, P384, DOI 10.1007/s002130050102; Beckett SRG, 1997, BRAIN RES BULL, V42, P421, DOI 10.1016/S0361-9230(96)00332-2; Bialy M, 2000, BEHAV NEUROSCI, V114, P983, DOI 10.1037//0735-7044.114.5.983; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; Borta A, 2006, BEHAV BRAIN RES, V166, P271, DOI 10.1016/j.bbr.2005.08.009; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; BRUDZYNSKI SM, 1995, PHYSIOL BEHAV, V57, P1039, DOI 10.1016/0031-9384(95)00003-2; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brunelli SA, 2006, PHYSIOL BEHAV, V87, P527, DOI 10.1016/j.physbeh.2005.11.020; Burgdorf J, 2006, NEUROSCI BIOBEHAV R, V30, P173, DOI 10.1016/j.neubiorev.2005.06.001; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2001, PSYCHOPHARMACOLOGY, V155, P35, DOI 10.1007/s002130100685; BURGDORF J, J COMP PSYC IN PRESS; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Commissaris RL, 2000, PHYSIOL BEHAV, V68, P521, DOI 10.1016/S0031-9384(99)00218-8; CONSTANTINI F, 2006, ACTA ZOOL SINICA, V52, P619; Covington HE, 2003, EUR J PHARMACOL, V467, P1, DOI 10.1016/S0014-2999(03)01558-9; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; CUOMO V, 1988, LIFE SCI, V43, P485, DOI 10.1016/0024-3205(88)90149-X; Endres T, 2007, BEHAV BRAIN RES, V185, P69, DOI 10.1016/j.bbr.2007.07.012; FRANCIS RL, 1977, NATURE, V265, P236, DOI 10.1038/265236a0; FU XW, 1994, PHARMACOL BIOCHEM BE, V49, P835, DOI 10.1016/0091-3057(94)90231-3; GEYER LA, 1978, J COMP PHYSIOL PSYCH, V92, P438, DOI 10.1037/h0077480; Gorisch J, 2006, NEUROBIOL LEARN MEM, V86, P175, DOI 10.1016/j.nlm.2006.02.004; HAUSER MD, 1984, FOLIA PRIMATOL, V43, P24, DOI 10.1159/000156168; Hofer MA, 1996, PSYCHONEUROENDOCRINO, V21, P203, DOI 10.1016/0306-4530(95)00042-9; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Jelen P, 2003, BEHAV BRAIN RES, V141, P63, DOI 10.1016/S0166-4328(02)00321-2; KALTWASSER MT, 1990, J COMP PSYCHOL, V104, P227, DOI 10.1037/0735-7036.104.3.227; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Knutson B, 1999, PHYSIOL BEHAV, V66, P639, DOI 10.1016/S0031-9384(98)00337-0; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; LATANE B, 1968, J PERS SOC PSYCHOL, V9, P142, DOI 10.1037/h0025843; LATANE B, 1969, J EXP SOC PSYCHOL, V5, P61, DOI 10.1016/0022-1031(69)90006-7; McGinnis MY, 2003, PHYSIOL BEHAV, V80, P81, DOI 10.1016/S0031-9384(03)00227-0; MCINTOSH TK, 1978, NATURE, V272, P163, DOI 10.1038/272163a0; MICZEK KA, 1995, PSYCHOPHARMACOLOGY, V121, P38, DOI 10.1007/BF02245590; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Neophytou SI, 2000, BRAIN RES, V854, P158, DOI 10.1016/S0006-8993(99)02334-3; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Panksepp J, 2002, BEHAV BRAIN SCI, V25, P43, DOI 10.1017/S0140525X0247001X; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Panksepp J., 1999, SCI CONSCIOUSNESS, P231; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; PICQ JL, 1992, FOLIA PRIMATOL, V59, P217, DOI 10.1159/000156664; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Ricceri L, 2007, BEHAV BRAIN RES, V176, P40, DOI 10.1016/j.bbr.2006.08.024; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; SALES G D, 1972, Journal of Zoology (London), V168, P149; SALES GD, 1991, BEHAV PROCESS, V24, P83, DOI 10.1016/0376-6357(91)90001-G; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; Sales GD, 1974, ULTRASONIC COMMUNICA; Sanchez C, 2003, EUR J PHARMACOL, V463, P133, DOI 10.1016/S0014-2999(03)01277-9; SCHLEIDT WM, 1952, NATURWISSENSCHAFTEN, V39, P69, DOI 10.1007/BF00596819; Schwarting RKW, 2007, BEHAV BRAIN RES, V182, P208, DOI 10.1016/j.bbr.2007.01.029; SIVIY SM, 1987, DEV PSYCHOBIOL, V20, P39, DOI 10.1002/dev.420200108; SMITH WJ, 1979, AM ZOOL, V19, P531; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; THOMAS DA, 1982, BEHAV NEURAL BIOL, V36, P403, DOI 10.1016/S0163-1047(82)90802-0; THOMAS DA, 1981, B PSYCHONOMIC SOC, V17, P279; Thompson B, 2006, BEHAV BRAIN RES, V168, P64, DOI 10.1016/j.bbr.2005.10.012; TONOUE T, 1986, PSYCHONEUROENDOCRINO, V11, P177, DOI 10.1016/0306-4530(86)90052-1; TORNATZKY W, 1994, PSYCHOPHARMACOLOGY, V116, P346, DOI 10.1007/BF02245339; TORNATZKY W, 1995, PSYCHOPHARMACOLOGY, V121, P135, DOI 10.1007/BF02245600; Veenema HC, 2001, NEUROBIOL AGING, V22, P273, DOI 10.1016/S0197-4580(00)00204-9; WHITE NR, 1990, J COMP PSYCHOL, V104, P255, DOI 10.1037/0735-7036.104.3.255; WHITE NR, 1987, J COMP PSYCHOL, V101, P73, DOI 10.1037/0735-7036.101.1.73; WHITE NR, 1993, BEHAV NEURAL BIOL, V59, P76, DOI 10.1016/0163-1047(93)91201-W; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8; WHITE NR, 1990, J COMP PSYCHOL, V104, P140, DOI 10.1037/0735-7036.104.2.140; WHITE NR, 1989, PHYSIOL BEHAV, V45, P229, DOI 10.1016/0031-9384(89)90123-6; Wintink AJ, 2001, PHARMACOL BIOCHEM BE, V70, P317, DOI 10.1016/S0091-3057(01)00615-3; Wohr M, 2008, PHYSIOL BEHAV, V93, P766, DOI 10.1016/j.physbeh.2007.11.031; Wohr M, 2005, NEUROBIOL LEARN MEM, V84, P228, DOI 10.1016/j.nlm.2005.07.004; WOHR M, BEHAV NEURO IN PRESS	84	189	191	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1365	10.1371/journal.pone.0001365	http://dx.doi.org/10.1371/journal.pone.0001365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159248	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459700022
J	Chang, WC; Ng, JK; Nguyen, T; Pellissier, L; Claeysen, S; Hsiao, EC; Conklin, BR				Chang, Wei Chun; Ng, Jennifer K.; Nguyen, Trieu; Pellissier, Lucie; Claeysen, Sylvie; Hsiao, Edward C.; Conklin, Bruce R.			Modifying Ligand-Induced and Constitutive Signaling of the Human 5-HT4 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD INTRACELLULAR LOOP; FUNCTIONAL SELECTIVITY; WILD-TYPE; EXPRESSION; AGONISTS; G(S); G(I); CONFORMATIONS; DETERMINANTS	G protein-coupled receptors (GPCRs) signal through a limited number of G-protein pathways and play crucial roles in many biological processes. Studies of their in vivo functions have been hampered by the molecular and functional diversity of GPCRs and the paucity of ligands with specific signaling effects. To better compare the effects of activating different G-protein signaling pathways through ligand-induced or constitutive signaling, we developed a new series of RASSLs (receptors activated solely by synthetic ligands) that activate different G-protein signaling pathways. These RASSLs are based on the human 5-HT4b receptor, a GPCR with high constitutive G(s) signaling and strong ligand-induced G-protein activation of the G(s) and G(s/q) pathways. The first receptor in this series, 5-HT4-D(100)A or Rs1 (RASSL serotonin 1), is not activated by its endogenous agonist, serotonin, but is selectively activated by the small synthetic molecules GR113808, GR125487, and RO110-0235. All agonists potently induced G(s) signaling, but only a few (e.g., zacopride) also induced signaling via the G(q) pathway. Zacopride-induced G(q) signaling was enhanced by replacing the C-terminus of Rs1 with the C-terminus of the human 5-HT2C receptor. Additional point mutations (D(66)A and (DN)-N-66) blocked constitutive G(s) signaling and lowered ligand-induced G(q) signaling. Replacing the third intracellular loop of Rs1 with that of human 5-HT1A conferred ligand-mediated G(i) signaling. This G(i)-coupled RASSL, Rs1.3, exhibited no measurable signaling to the G(s) or G(q) pathway. These findings show that the signaling repertoire of Rs1 can be expanded and controlled by receptor engineering and drug selection.	[Chang, Wei Chun; Ng, Jennifer K.; Nguyen, Trieu; Hsiao, Edward C.; Conklin, Bruce R.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Pellissier, Lucie; Claeysen, Sylvie] Univ Montpellier, Inst Genom Fonctionnelle, CNRS, UMR 5203, F-34059 Montpellier, France; [Pellissier, Lucie; Claeysen, Sylvie] INSERM, U661, Montpellier, France; [Chang, Wei Chun] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogenom, San Francisco, CA 94143 USA; [Hsiao, Edward C.; Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conklin, BR (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA.	bconklin@gladstone.ucsf.edu	Pellissier, Lucie P/L-8239-2014; Claeysen, Sylvie/C-8599-2014; Conklin, Bruce/E-4738-2019	Pellissier, Lucie P/0000-0001-7085-3242; Claeysen, Sylvie/0000-0002-0576-5518; Conklin, Bruce/0000-0003-1463-6061	NIH [HL-60664, 2T32DK07418-26]; American Heart Association Predoctoral Fellowship [0415005Y]; J David Gladstone CIRM Fellowship; Kirschstein NRSA Fellowship [F32A624044-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); J David Gladstone CIRM Fellowship; Kirschstein NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grant HL-60664 and American Heart Association Predoctoral Fellowship 0415005Y (to WCC), NIH Fellowship Training Grant 2T32DK07418-26 (to ECH), J David Gladstone CIRM Fellowship (to ECH), and Kirschstein NRSA Fellowship F32A624044-02 (to JKN).	ARMBRUSTER BN, 2007, P NATL ACAD SCI US; Brink CB, 2004, BRIT J CLIN PHARMACO, V57, P373, DOI 10.1111/j.1365-2125.2003.02046.x; Bruysters M, 2005, J BIOL CHEM, V280, P34741, DOI 10.1074/jbc.M504165200; Claeysen S, 2000, MOL PHARMACOL, V58, P136, DOI 10.1124/mol.58.1.136; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Claeysen S, 2001, EMBO REP, V2, P61, DOI 10.1093/embo-reports/kve003; Compan Valerie, 2004, Journal de la Societe de Biologie, V198, P37; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Crowell MD, 2005, NEUROGASTROENT MOTIL, V17, P738, DOI 10.1111/j.1365-2982.2005.00681.x; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gay EA, 2004, MOL PHARMACOL, V66, P97, DOI 10.1124/mol.66.1.97; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hayataka K, 1998, BIOCHEM CELL BIOL, V76, P657, DOI 10.1139/bcb-76-4-657; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hsiao EC, 2007, J BONE MINER RES, V22, pS6; Joubert L, 2002, J BIOL CHEM, V277, P25502, DOI 10.1074/jbc.M202539200; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Kaumann AJ, 2006, PHARMACOL THERAPEUT, V111, P674, DOI 10.1016/j.pharmthera.2005.12.004; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; Kushwaha N, 2006, MOL PHARMACOL, V69, P1518, DOI 10.1124/mol.105.019844; Lefebvre H, 2002, J CLIN ENDOCR METAB, V87, P1211, DOI 10.1210/jc.87.3.1211; Liu YF, 1999, J BIOL CHEM, V274, P16444, DOI 10.1074/jbc.274.23.16444; Malmberg A, 2000, J NEUROCHEM, V75, P1283, DOI 10.1046/j.1471-4159.2000.751283.x; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Orsetti M, 2003, LEARN MEMORY, V10, P420, DOI 10.1101/lm.67303; Ortiz TC, 2000, PHARMACOLOGY, V60, P195, DOI 10.1159/000028369; Pauwels PJ, 2003, TRENDS PHARMACOL SCI, V24, P504, DOI 10.1016/j.tips.2003.08.007; Peng JT, 2006, J BONE MINER RES, V21, pS99; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Rivail L, 2004, BRIT J PHARMACOL, V143, P361, DOI 10.1038/sj.bjp.0705950; Ryman-Rasmussen JP, 2007, NEUROPHARMACOLOGY, V52, P562, DOI 10.1016/j.neuropharm.2006.08.028; Saidak Z, 2006, BRIT J PHARMACOL, V147, P671, DOI 10.1038/sj.bjp.0706661; Scearce-Levie K, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-3; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Srinivasan S, 2003, ANN NY ACAD SCI, V994, P225, DOI 10.1111/j.1749-6632.2003.tb03184.x; SRINIVASAN S, PLOS ONE IN PRESS; Sweger EJ, 2007, J NEUROSCI, V27, P2309, DOI 10.1523/JNEUROSCI.4565-06.2007; Thiagaraj HV, 2007, NEUROCHEM INT, V50, P109, DOI 10.1016/j.neuint.2006.07.017; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	45	38	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1317	10.1371/journal.pone.0001317	http://dx.doi.org/10.1371/journal.pone.0001317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18338032	Green Published, gold			2022-12-27	WOS:000207459600005
J	Ieronimakis, N; Balasundaram, G; Reyes, M				Ieronimakis, Nicholas; Balasundaram, Gayathri; Reyes, Morayma			Direct Isolation, Culture and Transplant of Mouse Skeletal Muscle Derived Endothelial Cells with Angiogenic Potential	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PROGENITOR CELLS; GROWTH-FACTOR; IN-VIVO; ADHESION MOLECULE-1; ANTIGEN SCA-1; UP-REGULATION; EXPRESSION; DYSFUNCTION; CD34	Background: Although diseases associated with microvascular endothelial dysfunction are among the most prevalent illnesses to date, currently no method exists to isolate pure endothelial cells (EC) from skeletal muscle for in vivo or in vitro study. Methodology: By utilizing multicolor fluorescent-activated cell sorting (FACS), we have isolated a distinct population of Sca-1(+), CD31(+), CD34(dim) and CD45(-) cells from skeletal muscles of C57BL6 mice. Characterization of this population revealed these cells are functional EC that can be expanded several times in culture without losing their phenotype or capabilities to uptake acetylated low-density lipoprotein (ac-LDL), produce nitric oxide (NO) and form vascular tubes. When transplanted subcutaneously or intramuscularly into the tibialis anterior muscle, EC formed microvessels and integrated with existing vasculature. Conclusion: This method, which is highly reproducible, can be used to study the biology and role of EC in diseases such as peripheral vascular disease. In addition this method allows us to isolate large quantities of skeletal muscle derived EC with potential for therapeutic angiogenic applications.	[Ieronimakis, Nicholas; Balasundaram, Gayathri; Reyes, Morayma] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ieronimakis, N (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	morayma@u.washington.edu			Departments of Pathology and Lab Medicine at the University of Washington; NIH [5R03AR054955]; Jain Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054955] Funding Source: NIH RePORTER	Departments of Pathology and Lab Medicine at the University of Washington; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jain Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this research has been generously provided by the Departments of Pathology and Lab Medicine at the University of Washington, NIH 5R03AR054955 and the Jain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Couchman JR, 1999, J CELL SCI, V112, P3415; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; CURCIO F, 1992, IN VITRO CELL DEV-AN, V28A, P787; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DeMeyer GRY, 1997, PROG CARDIOVASC DIS, V39, P325, DOI 10.1016/S0033-0620(97)80031-X; Ding SL, 2003, BLOOD, V101, P4816, DOI 10.1182/blood-2002-06-1731; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Donnini D, 2003, BIOCHIMIE, V85, P701, DOI 10.1016/S0300-9084(03)00116-0; Ellis CG, 2005, CRIT CARE, V9, pS3, DOI 10.1186/cc3751; Figarella-Branger D, 2006, J RHEUMATOL, V33, P1623; Ford JW, 1996, J SURG RES, V62, P23, DOI 10.1006/jsre.1996.0167; GRENIER G, 2007, STEM CELLS; Hannum RS, 2001, MICROVASC RES, V61, P287, DOI 10.1006/mvre.2001.2302; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Houzelstein D, 1999, DEVELOPMENT, V126, P2689; Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X; Hurst T, 2006, AM J MED, V119, P560, DOI 10.1016/j.amjmed.2005.07.009; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Kivela R, 2007, HISTOCHEM CELL BIOL, V127, P31, DOI 10.1007/s00418-006-0226-x; Kotton DN, 2003, AM J PHYSIOL-LUNG C, V284, pL990, DOI 10.1152/ajplung.00415.2002; Kranenburg AR, 2005, THORAX, V60, P106, DOI 10.1136/thx.2004.023986; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Landmesser U, 2007, CURR OPIN CARDIOL, V22, P316, DOI 10.1097/HCO.0b013e3281ca710d; Le Grand F, 2004, EXP CELL RES, V301, P232, DOI 10.1016/j.yexcr.2004.07.028; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Loufrani L, 2004, ARTERIOSCL THROM VAS, V24, P671, DOI 10.1161/01.ATV.0000118683.99628.42; Luna G, 2004, STEM CELLS DEV, V13, P528, DOI 10.1089/scd.2004.13.528; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Muller-Delp JM, 2006, MICROCIRCULATION, V13, P339, DOI 10.1080/10739680600619023; Nguyen F, 2005, NEUROMUSCULAR DISORD, V15, P154, DOI 10.1016/j.nmd.2004.11.002; Nistri Silvia, 2002, Biological Procedures Online, V4, P32, DOI 10.1251/bpo31; Okaji Y, 2004, J IMMUNOL METHODS, V295, P183, DOI 10.1016/j.jim.2004.10.005; PASSANITI A, 1992, LAB INVEST, V67, P519; Payne GW, 2006, MICROCIRCULATION, V13, P275, DOI 10.1080/10739680600618710; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; REDDY KG, 1994, J AM COLL CARDIOL, V23, P833, DOI 10.1016/0735-1097(94)90627-0; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; Rosenkranz AC, 2000, J MOL CELL CARDIOL, V32, P1119, DOI 10.1006/jmcc.2000.1149; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Salomonsson S, 2006, AUTOIMMUNITY, V39, P177, DOI 10.1080/08916930600622256; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Scholz D, 1997, CELL TISSUE RES, V290, P623, DOI 10.1007/s004410050968; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Taichman DB, 2003, EXP LUNG RES, V29, P113, DOI 10.1080/01902140303767; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tavian M, 2005, ANN NY ACAD SCI, V1044, P41, DOI 10.1196/annals.1349.006; Thurston G, 2000, MICROCIRCULATION, V7, P67, DOI 10.1038/sj.mn.7300155; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang ZM, 2001, AM J HUM BIOL, V13, P612; WATT SM, 1995, LEUKEMIA LYMPHOMA, V17, P229, DOI 10.3109/10428199509056827; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita JK, 2007, TRENDS CARDIOVAS MED, V17, P59, DOI 10.1016/j.tcm.2007.01.001; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	71	32	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e0001753	10.1371/journal.pone.0001753	http://dx.doi.org/10.1371/journal.pone.0001753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335025	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000007
J	Ding, F; Li, HH; Zhang, SW; Solomon, NM; Camper, SA; Cohen, P; Francke, U				Ding, Feng; Li, Hong Hua; Zhang, Shengwen; Solomon, Nicola M.; Camper, Sally A.; Cohen, Pinchas; Francke, Uta			SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice	PLOS ONE			English	Article								Prader-Willi syndrome (PWS) is the leading genetic cause of obesity. After initial severe hypotonia, PWS children become hyperphagic and morbidly obese, if intake is not restricted. Short stature with abnormal growth hormone secretion, hypogonadism, cognitive impairment, anxiety and behavior problems are other features. PWS is caused by lack of expression of imprinted genes in a similar to 4 mb region of chromosome band 15q11.2. Our previous translocation studies predicted a major role for the C/D box small nucleolar RNA cluster SNORD116 (PWCR1/HBII-85) in PWS. To test this hypothesis, we created similar to 150 kb deletion of the >40 copies of Snord116 (Pwcr1/MBII-85) in C57BL/6 mice. Snord116del mice with paternally derived deletion lack expression of this snoRNA. They have early-onset postnatal growth deficiency, but normal fertility and lifespan. While pituitary structure and somatotrophs are normal, liver Igf1 mRNA is decreased. In cognitive and behavior tests, Snord116del mice are deficient in motor learning and have increased anxiety. Around three months of age, they develop hyperphagia, but stay lean on regular and high-fat diet. On reduced caloric intake, Snord116del mice maintain their weight better than wild-type littermates, excluding increased energy requirement as a cause of hyperphagia. Normal compensatory feeding after fasting, and ability to maintain body temperature in the cold indicate normal energy homeostasis regulation. Metabolic chamber studies reveal that Snord116del mice maintain energy homeostasis by altered fuel usage. Prolonged mealtime and increased circulating ghrelin indicate a defect in meal termination mechanism. Snord116del mice, the first snoRNA deletion animal model, reveal a novel role for a non-coding RNA in growth and feeding regulation.	[Ding, Feng; Li, Hong Hua; Francke, Uta] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Zhang, Shengwen] Stanford Univ, Dept Psychiat & Behavioral Sci, Stanford, CA USA; [Solomon, Nicola M.; Camper, Sally A.] Univ Michigan Ann Arbor, Dept Human Genet, Ann Arbor, MI USA; [Cohen, Pinchas] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA USA; [Francke, Uta] Stanford Univ, Dept Pediat, Stanford, CA USA	Stanford University; Stanford University; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; Stanford University	Ding, F (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	ufrancke@stanford.edu	Ding, Feng/AAH-7335-2019; Ding, Feng/E-5112-2012	Zhang, Shengwen/0000-0001-7318-3870; Camper, Sally/0000-0001-8556-3379	NIH/NICHD; Foundation for Prader-Willi Research	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Foundation for Prader-Willi Research	This work was supported by research grants (to U.F.) from the NIH/NICHD and the Foundation for Prader-Willi Research.	Angulo MA, 2007, AM J MED GENET A, V143A, P1456, DOI 10.1002/ajmg.a.31824; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; BAUMANN G, 1990, ACTA PAEDIATR SCAND, P72; Baumann G., 1990, ACTA PAEDIATR SC   S, V370; Burman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787; Butler MG, 1998, AM J MED GENET, V75, P7, DOI 10.1002/(SICI)1096-8628(19980106)75:1<7::AID-AJMG3>3.3.CO;2-B; Cassidy S.B., 2005, MANAGEMENT GENETIC S, P429; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chamberlain SJ, 2004, HUM MOL GENET, V13, P2971, DOI 10.1093/hmg/ddh314; Choe YH, 2005, J CLIN ENDOCR METAB, V90, P5441, DOI 10.1210/jc.2004-1935; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Ding F, 2005, MAMM GENOME, V16, P424, DOI 10.1007/s00335-005-2460-2; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; Fieldstone A, 1998, OBES RES, V6, P29, DOI 10.1002/j.1550-8528.1998.tb00311.x; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Goldstone AP, 2003, CLIN ENDOCRINOL, V58, P743, DOI 10.1046/j.1365-2265.2003.01788.x; Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P174, DOI 10.1210/jc.2002-021052; Hinton EC, 2006, INT J OBESITY, V30, P313, DOI 10.1038/sj.ijo.0803128; Holland A, 2003, LANCET, V362, P989, DOI 10.1016/S0140-6736(03)14370-X; HOLLAND AJ, 1993, INT J OBESITY, V17, P527; HOLM VA, 1993, PEDIATRICS, V91, P398; Holsen LM, 2006, OBESITY, V14, P1028, DOI 10.1038/oby.2006.118; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Hwang DL, 2008, GROWTH HORM IGF RES, V18, P65, DOI 10.1016/j.ghir.2007.07.007; I'Allemand D, 2002, HORM RES, V58, P215, DOI 10.1159/000066263; Jordan C, 2006, HUM MOL GENET, V15, P2210, DOI 10.1093/hmg/ddl146; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Le Meur E, 2005, DEV BIOL, V286, P587, DOI 10.1016/j.ydbio.2005.07.030; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Lindgren AC, 2000, J PEDIATR-US, V137, P50, DOI 10.1067/mpd.2000.106563; Meguro M, 2001, HUM MOL GENET, V10, P383, DOI 10.1093/hmg/10.4.383; Miller JL, 2007, J NEUROL NEUROSUR PS, V78, P615, DOI 10.1136/jnnp.2006.099044; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; NICOLOSO M, 1994, MOL CELL BIOL, V14, P5766, DOI 10.1128/MCB.14.9.5766; Pecoraro N, 2006, PROG NEUROBIOL, V79, P247, DOI 10.1016/j.pneurobio.2006.07.004; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Runte M, 2005, HUM GENET, V116, P228, DOI 10.1007/s00439-004-1219-2; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schule B, 2007, AM J HUM GENET, V81, P492, DOI 10.1086/520063; Schule B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-18; Seibler J, 1997, BIOCHEMISTRY-US, V36, P1740, DOI 10.1021/bi962443e; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Silver L.M., 1995, MOUSE GENETICS, p62?75; Stefan M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-157; Stefan M, 2005, ENDOCRINOLOGY, V146, P4377, DOI 10.1210/en.2005-0371; Swaab DF, 1997, ACTA PAEDIATR, V86, P50; Talebizadeh Z, 2004, J AUTISM DEV DISORD, V34, P735, DOI 10.1007/s10803-004-5295-x; Tan TMM, 2004, J CLIN ENDOCR METAB, V89, P4162, DOI 10.1210/jc.2004-0835; TRAYHURN P, 1977, NATURE, V266, P60, DOI 10.1038/266060a0; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Whitman B, 2004, J PEDIATR ENDOCR MET, V17, P591; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; YEN TT, 1974, COMP BIOCHEM PHYSIOL, V49, P377, DOI 10.1016/0300-9629(74)90128-5; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; ZIPF WB, 1987, AM J CLIN NUTR, V46, P277, DOI 10.1093/ajcn/46.2.277	71	203	210	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1709	10.1371/journal.pone.0001709	http://dx.doi.org/10.1371/journal.pone.0001709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320030	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600005
J	Smit, JJ; Lindell, DM; Boon, L; Kool, M; Lambrecht, BN; Lukacs, NW				Smit, Joost J.; Lindell, Dennis M.; Boon, Louis; Kool, Mirjam; Lambrecht, Bart N.; Lukacs, Nicholas W.			The Balance between Plasmacytoid DC versus Conventional DC Determines Pulmonary Immunity to Virus Infections	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; MYELOID DENDRITIC CELLS; FLT3 LIGAND EXPANDS; IN-VIVO; AIRWAY HYPERREACTIVITY; INHALED ANTIGEN; GM-CSF; RESPONSES; INFLAMMATION; INNATE	Background: Respiratory syncytial virus (RSV) infects nearly all infants by age 2 and is a leading cause of bronchiolitis. RSV may employ several mechanisms to induce immune dysregulation, including dendritic cell ( DC) modulation during the immune response to RSV. Methods and Findings: Expansion of cDC and pDC by Flt3L treatment promoted an anti-viral response with reduced pathophysiology characterized by decreased airway hyperreactivity, reduced Th2 cytokines, increased Th1 cytokines, and a reduction in airway inflammation and mucus overexpression. These protective aspects of DC expansion could be completely reversed by depleting pDCs during the RSV infection. Expansion of DCs by Flt3L treatment enhanced in CD8+ T cell responses, which was reversed by depletion of pDC. Conclusions: These results indicate that a balance between cDC and pDC in the lung and its lymph nodes is crucial for the outcome of a pulmonary infection. Increased pDC numbers induced by Flt3L treatment have a protective impact on the nature of the overall immune environment.	[Smit, Joost J.; Lindell, Dennis M.; Lukacs, Nicholas W.] Univ Michigan, Med Sch, Dept Pathol, Ann Arbor, MI USA; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Kool, Mirjam; Lambrecht, Bart N.] Erasmus Univ, Med Ctr, Dept Pulmonary Med, Rotterdam, Netherlands	University of Michigan System; University of Michigan; Bioceros B.V.; Erasmus University Rotterdam; Erasmus MC	Lukacs, NW (corresponding author), Univ Michigan, Med Sch, Dept Pathol, Ann Arbor, MI USA.	nlukacs@umich.edu	Boon, Laurence/HCI-3629-2022; Lambrecht, Bart N/K-2484-2014; Lukacs, Nicholas W/ABH-5583-2020	Lambrecht, Bart N/0000-0003-4376-6834; Boon, Louis/0000-0002-0937-9171; Smit, Joost/0000-0003-4612-4036	NIH [AI036302, AI073876]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI036302, R01AI073876, R01AI036302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by NIH grants AI036302 and AI073876.	Agrawal DK, 2001, INT IMMUNOPHARMACOL, V1, P2081, DOI 10.1016/S1567-5769(01)00122-9; Beacock-Sharp H, 2003, INT IMMUNOL, V15, P711, DOI 10.1093/intimm/dxg067; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Braciale Thomas J, 2005, Proc Am Thorac Soc, V2, P141, DOI 10.1513/pats.200503-022AW; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Chaudhry UI, 2006, FASEB J, V20, P982, DOI 10.1096/fj.05-5411fje; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Daro E, 2002, CYTOKINE, V17, P119, DOI 10.1006/cyto.2001.0995; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; GRAHAM BS, 1995, AM J RESP CRIT CARE, V152, pS63, DOI 10.1164/ajrccm/152.4_Pt_2.S63; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kaisho T, 2003, CURR MOL MED, V3, P373, DOI 10.2174/1566524033479726; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lambrecht BN, 1999, AM J RESP CELL MOL, V20, P1165, DOI 10.1165/ajrcmb.20.6.3484; Liu YQ, 2003, J GENE MED, V5, P668, DOI 10.1002/jgm.387; Lou YY, 2007, J IMMUNOL, V178, P1534, DOI 10.4049/jimmunol.178.3.1534; Lukacs NW, 2001, J IMMUNOL, V167, P1060, DOI 10.4049/jimmunol.167.2.1060; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Masten BJ, 2004, J IMMUNOL, V172, P4077, DOI 10.4049/jimmunol.172.7.4077; Miller AL, 2003, J IMMUNOL, V170, P3348, DOI 10.4049/jimmunol.170.6.3348; Miller G, 2003, J IMMUNOL, V170, P3554, DOI 10.4049/jimmunol.170.7.3554; Mosca PJ, 2002, J LEUKOCYTE BIOL, V72, P546; Openshaw PJM, 2003, PEDIATR INFECT DIS J, V22, pS58, DOI 10.1097/00006454-200302001-00009; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Rudd BD, 2007, J IMMUNOL, V178, P5820, DOI 10.4049/jimmunol.178.9.5820; SAPOZNIKOV A, 2007, J EXP MED; Sinigaglia F, 1999, DEV COMP IMMUNOL, V23, P657, DOI 10.1016/S0145-305X(99)00039-7; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Swanson KA, 2004, J IMMUNOL, V173, P4875, DOI 10.4049/jimmunol.173.8.4875; Tekkanat KK, 2001, AM J PATHOL, V159, P631, DOI 10.1016/S0002-9440(10)61734-8; Tekkanat KK, 2001, J IMMUNOL, V166, P3542, DOI 10.4049/jimmunol.166.5.3542; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wang HW, 2006, J IMMUNOL, V177, P6263, DOI 10.4049/jimmunol.177.9.6263; Webb TJ, 2005, CRIT REV IMMUNOL, V25, P465, DOI 10.1615/CritRevImmunol.v25.i6.20; Weigel BJ, 2002, BLOOD, V100, P4169, DOI 10.1182/blood-2002-04-1063; Welliver RC, 2003, PEDIATR INFECT DIS J, V22, pS6, DOI 10.1097/00006454-200302001-00002; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093	42	74	77	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1720	10.1371/journal.pone.0001720	http://dx.doi.org/10.1371/journal.pone.0001720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320041	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600016
J	Sanderson, LM; de Groot, PJ; Hooiveld, GJEJ; Koppen, A; Kalkhoven, E; Muller, M; Kersten, S				Sanderson, Linda M.; de Groot, Philip J.; Hooiveld, Guido J. E. J.; Koppen, Arjen; Kalkhoven, Eric; Mueller, Michael; Kersten, Sander			Effect of Synthetic Dietary Triglycerides: A Novel Research Paradigm for Nutrigenomics	PLOS ONE			English	Article								Background: The effect of dietary fats on human health and disease are likely mediated by changes in gene expression. Several transcription factors have been shown to respond to fatty acids, including SREBP-1c, NF-kappa B, RXRs, LXRs, FXR, HNF4 alpha, and PPARs. However, it is unclear to what extent these transcription factors play a role in gene regulation by dietary fatty acids in vivo. Methodology/Principal Findings: Here, we take advantage of a unique experimental design using synthetic triglycerides composed of one single fatty acid in combination with gene expression profiling to examine the effects of various individual dietary fatty acids on hepatic gene expression in mice. We observed that the number of significantly changed genes and the fold-induction of genes increased with increasing fatty acid chain length and degree of unsaturation. Importantly, almost every single gene regulated by dietary unsaturated fatty acids remained unaltered in mice lacking PPAR alpha. In addition, the majority of genes regulated by unsaturated fatty acids, especially docosahexaenoic acid, were also regulated by the specific PPARa agonist WY14643. Excellent agreement was found between the effects of unsaturated fatty acids on mouse liver versus cultured rat hepatoma cells. Interestingly, using Nuclear Receptor PamChip (R) Arrays, fatty acid-and WY14643-induced interactions between PPARa and coregulators were found to be highly similar, although several PPAR alpha-coactivator interactions specific for WY14643 were identified. Conclusions/Significance: We conclude that the effects of dietary unsaturated fatty acids on hepatic gene expression are almost entirely mediated by PPAR alpha and mimic those of synthetic PPAR alpha agonists in terms of regulation of target genes and molecular mechanism. Use of synthetic dietary triglycerides may provide a novel paradigm for nutrigenomics research.	[Sanderson, Linda M.; de Groot, Philip J.; Hooiveld, Guido J. E. J.; Mueller, Michael; Kersten, Sander] Top Inst Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands; [Sanderson, Linda M.; de Groot, Philip J.; Hooiveld, Guido J. E. J.; Mueller, Michael; Kersten, Sander] Wageningen Univ, Div Human Nutrition, Nutrition, Metabolism & Genom Grp, Wageningen, Netherlands; [Koppen, Arjen; Kalkhoven, Eric] Univ Med Ctr UMC Utrecht, Dept Metabolic & Endocrine Dis, Utrecht, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	Sanderson, LM (corresponding author), Top Inst Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands.	sander.kersten@wur.nl	Kersten, Sander/A-1116-2011; Muller, Michael/B-5795-2008; Hooiveld, Guido JEJ/F-4912-2010; Muller, Michael/M-5724-2019; Koppen, Arjen/GLV-6743-2022	Kersten, Sander/0000-0003-4488-7734; Muller, Michael/0000-0002-5930-9905; Hooiveld, Guido JEJ/0000-0003-1954-3542; Muller, Michael/0000-0002-5930-9905; 				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cheatham CL, 2006, AM J CLIN NUTR, V83, p1458S, DOI 10.1093/ajcn/83.6.1458S; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Duez H, 2005, ARTERIOSCL THROM VAS, V25, P585, DOI 10.1161/01.ATV.0000154140.73570.00; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Fan YY, 2003, CARCINOGENESIS, V24, P1541, DOI 10.1093/carcin/bgg110; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldstein JT, 2003, ARCH BIOCHEM BIOPHYS, V420, P185, DOI 10.1016/j.abb.2003.09.034; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris WS, 2006, CURR OPIN LIPIDOL, V17, P387, DOI 10.1097/01.mol.0000236363.63840.16; Heneweer M, 2007, TOXICOL SCI, V99, P303, DOI 10.1093/toxsci/kfm151; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; KATAN MB, 1995, CAN J CARDIOL, V11, pG36; KATAN MB, 1994, AM J CLIN NUTR, V60, p1017S, DOI 10.1093/ajcn/60.6.1017S; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lambert MS, 1998, BRIT J NUTR, V79, P203, DOI 10.1079/BJN19980032; Leaf A, 2007, CURR OPIN LIPIDOL, V18, P31, DOI 10.1097/MOL.0b013e328012d61b; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Ouamrane L, 2003, BRIT J PHARMACOL, V138, P845, DOI 10.1038/sj.bjp.0705113; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; PEGORIER JP, 2006, NUCL RECEPTORS CONTR; Pounds S, 2004, BIOINFORMATICS, V20, P1737, DOI 10.1093/bioinformatics/bth160; Radominska-Pandya A, 2002, BIOCHEMISTRY-US, V41, P4883, DOI 10.1021/bi0121151; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stafslien DK, 2007, MOL CELL ENDOCRINOL, V264, P82, DOI 10.1016/j.mce.2006.10.016; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Stuhlmeier KM, 1997, J BIOL CHEM, V272, P24679, DOI 10.1074/jbc.272.39.24679; Vanden Heuvel JP, 2006, TOXICOL SCI, V92, P476, DOI 10.1093/toxsci/kfl014; VONHEYDEBRECK A, 2004, BIOCONDUCTOR PROJECT, V7; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zhang F, 2007, PPAR RES, V2007, DOI 10.1155/2007/32696; Zhao A, 2004, DNA CELL BIOL, V23, P519, DOI 10.1089/1044549041562267	63	81	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1681	10.1371/journal.pone.0001681	http://dx.doi.org/10.1371/journal.pone.0001681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301758	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500025
J	Delaunay, A; Bromberg, KD; Hayashi, Y; Mirabella, M; Burch, D; Kirkwood, B; Serra, C; Malicdan, MC; Mizisin, AP; Morosetti, R; Broccolini, A; Guo, LT; Jones, SN; Lira, SA; Puri, PL; Shelton, GD; Ronai, Z				Delaunay, Agnes; Bromberg, Kenneth D.; Hayashi, Yukiko; Mirabella, Massimiliano; Burch, Denise; Kirkwood, Brian; Serra, Carlo; Malicdan, May C.; Mizisin, Andrew P.; Morosetti, Roberta; Broccolini, Aldobrando; Guo, Ling T.; Jones, Stephen N.; Lira, Sergio A.; Puri, Pier Lorenzo; Shelton, G. Diane; Ronai, Ze'ev			The ER-Bound RING Finger Protein 5 (RNF5/RMA1) Causes Degenerative Myopathy in Transgenic Mice and Is Deregulated in Inclusion Body Myositis	PLOS ONE			English	Article								Growing evidence supports the importance of ubiquitin ligases in the pathogenesis of muscular disorders, although underlying mechanisms remain largely elusive. Here we show that the expression of RNF5 (aka RMA1), an ER-anchored RING finger E3 ligase implicated in muscle organization and in recognition and processing of malfolded proteins, is elevated and mislocalized to cytoplasmic aggregates in biopsies from patients suffering from sporadic-Inclusion Body Myositis (sIBM). Consistent with these findings, an animal model for hereditary IBM (hIBM), but not their control littermates, revealed deregulated expression of RNF5. Further studies for the role of RNF5 in the pathogenesis of s-IBM and more generally in muscle physiology were performed using RNF5 transgenic and KO animals. Transgenic mice carrying inducible expression of RNF5, under control of beta-actin or muscle specific promoter, exhibit an early onset of muscle wasting, muscle degeneration and extensive fiber regeneration. Prolonged expression of RNF5 in the muscle also results in the formation of fibers containing congophilic material, blue-rimmed vacuoles and inclusion bodies. These phenotypes were associated with altered expression and activity of ER chaperones, characteristic of myodegenerative diseases such as s-IBM. Conversely, muscle regeneration and induction of ER stress markers were delayed in RNF5 KO mice subjected to cardiotoxin treatment. While supporting a role for RNF5 Tg mice as model for s-IBM, our study also establishes the importance of RNF5 in muscle physiology and its deregulation in ER stress associated muscular disorders.	[Delaunay, Agnes; Burch, Denise; Kirkwood, Brian; Serra, Carlo; Puri, Pier Lorenzo; Ronai, Ze'ev] Burnham Inst Med Res, La Jolla, CA USA; [Bromberg, Kenneth D.] Mount Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Hayashi, Yukiko; Malicdan, May C.] Natl Inst Neurosci, Tokyo, Japan; [Mirabella, Massimiliano; Morosetti, Roberta; Broccolini, Aldobrando] Catholic Univ, Dept Neurosci, Rome, Italy; [Mizisin, Andrew P.; Guo, Ling T.; Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA USA; [Jones, Stephen N.] Univ Massachusetts, Med Sci, Dept Cell Biol, Worcester, MA USA; [Lira, Sergio A.] Mount Sinai Sch Med, Immunobiol Ctr, New York, NY USA; [Puri, Pier Lorenzo] Fdn European Brain Res Inst, Dulbecco Telethon Inst, Rome, Italy	Sanford Burnham Prebys Medical Discovery Institute; Icahn School of Medicine at Mount Sinai; National Center for Neurology & Psychiatry - Japan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Worcester; Icahn School of Medicine at Mount Sinai; Fondazione Telethon; Dulbecco Telethon Institute (DTI)	Delaunay, A (corresponding author), Burnham Inst Med Res, La Jolla, CA USA.	ronai@burnham.org	MIRABELLA, Massimiliano/AAC-4016-2020; Broccolini, Aldobrando/ABE-1311-2021; MOROSETTI, ROBERTA/ABE-1045-2021; Malicdan, May Christine/AAK-7422-2021; Malicdan, May Christine/F-2806-2013; Delaunay-moisan, Agnes/GRX-7749-2022	MIRABELLA, Massimiliano/0000-0002-7783-114X; MOROSETTI, ROBERTA/0000-0001-5017-4904; Delaunay-moisan, Agnes/0000-0003-3105-221X; Puri, Pier Lorenzo/0000-0003-4964-0095; RONAI, ZEEV/0000-0002-3859-0400	NCI [CA097105]; Fondazione Telethon Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA097105] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support by NCI (CA097105 to ZR) is gratefully acknowledged.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Askanas V, 2006, NEUROLOGY, V66, pS39, DOI 10.1212/01.wnl.0000192128.13875.1e; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boonyarom O, 2006, ACTA PHYSIOL, V188, P77, DOI 10.1111/j.1748-1716.2006.01613.x; Broday L, 2004, J CELL BIOL, V165, P857, DOI 10.1083/jcb.200401133; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; DALBIS A, 1989, DEV BIOL, V135, P320, DOI 10.1016/0012-1606(89)90182-6; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Fielitz J, 2007, P NATL ACAD SCI USA, V104, P4377, DOI 10.1073/pnas.0611726104; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Ghersa P, 1998, GENE THER, V5, P1213, DOI 10.1038/sj.gt.3300713; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Gorza L, 2000, FASEB J, V14, P461, DOI 10.1096/fasebj.14.3.461; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Kyushiki H, 1997, CYTOGENET CELL GENET, V79, P114, DOI 10.1159/000134695; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Matsuda N, 2001, J CELL SCI, V114, P1949; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Reid MB, 2005, AM J PHYSIOL-REG I, V288, pR1423, DOI 10.1152/ajpregu.00545.2004; Schoser BGH, 2005, ANN NEUROL, V57, P591, DOI 10.1002/ana.20441; Tarricone E, 2006, ANN NY ACAD SCI, V1069, P472, DOI 10.1196/annals.1351.046; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; ZENGEL JM, 1980, P NATL ACAD SCI-BIOL, V77, P852, DOI 10.1073/pnas.77.2.852	46	46	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1609	10.1371/journal.pone.0001609	http://dx.doi.org/10.1371/journal.pone.0001609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270596	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900043
J	Dicko, A; Sagara, I; Ellis, RD; Miura, K; Guindo, O; Kamate, B; Sogoba, M; Niambele, MB; Sissoko, M; Baby, M; Dolo, A; Mullen, GED; Fay, MP; Pierce, M; Diallo, DA; Saul, A; Miller, LH; Doumbo, OK				Dicko, Alassane; Sagara, Issaka; Ellis, Ruth D.; Miura, Kazutoyo; Guindo, Ousmane; Kamate, Beh; Sogoba, Moussa; Niambele, Mohamed Balla; Sissoko, Mady; Baby, Mounirou; Dolo, Amagana; Mullen, Gregory E. D.; Fay, Michael P.; Pierce, Mark; Diallo, Dapa A.; Saul, Allan; Miller, Louis H.; Doumbo, Ogobara K.			Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; PLASMODIUM-FALCIPARUM; CANDIDATE; SAFETY; RESPONSES; MONKEYS; TRIAL	Background: Apical Membrane Antigen-1 (AMA1) is one of the leading blood stage malaria vaccine candidates. AMA1-C1/Alhydrogel (R) consists of an equal mixture of recombinant AMA1 from FVO and 3D7 clones of P. falciparum, adsorbed onto Alhydrogel (R). A Phase 1 study in semi-immune adults in Mali showed that the vaccine was safe and immunogenic, with higher antibody responses in those who received the 80 mu g dose. The aim of this study was to assess the safety and immunogenicity of this vaccine in young children in a malaria endemic area. Design: This was a Phase 1 dose escalating study in 36 healthy children aged 2-3 years started in March 2006 in Doneguebougou, Mali. Eighteen children in the first cohort were randomized 2:1 to receive either 20 mg AMA1-C1/Alhydrogel (R) or Haemophilus influenzae type b Hiberix (R) vaccine. Two weeks later 18 children in the second cohort were randomized 2: 1 to receive either 80 mg AMA1-C1/Alhydrogel (R) or Haemophilus influenzae type b Hiberix (R) vaccine. Vaccinations were administered on Days 0 and 28 and participants were examined on Days 1, 2, 3, 7, and 14 after vaccination and then about every two months. Results to Day 154 are reported in this manuscript. Results: Of 36 volunteers enrolled, 33 received both vaccinations. There were 9 adverse events related to the vaccination in subjects who received AMA1-C1 vaccine and 7 in those who received Hiberix (R). All were mild to moderate. No vaccine-related serious or grade 3 adverse events were observed. There was no increase in adverse events with increasing dose of vaccine or number of immunizations. In subjects who received the test vaccine, antibodies to AMA1 increased on Day 14 and peaked at Day 42, with changes from baseline significantly different from subjects who received control vaccine. Conclusion: AMA-C1 vaccine is well tolerated and immunogenic in children in this endemic area although the antibody response was short lived.	[Ellis, Ruth D.; Miura, Kazutoyo; Mullen, Gregory E. D.; Pierce, Mark; Saul, Allan; Miller, Louis H.] Natl Inst Hlth, NIAID, Malaria Vaccine Dev Branch, Bethesda, MD USA; [Dicko, Alassane; Sagara, Issaka; Guindo, Ousmane; Kamate, Beh; Sogoba, Moussa; Niambele, Mohamed Balla; Sissoko, Mady; Baby, Mounirou; Dolo, Amagana; Diallo, Dapa A.; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Fac Med, Dept Epidemiol Parasitic Dis, Bamako, Mali; [Fay, Michael P.] Natl Inst Hlth, NIAID, Biostat Res Branch, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dicko, A (corresponding author), Natl Inst Hlth, NIAID, Malaria Vaccine Dev Branch, Bethesda, MD USA.	lmiller@niaid.nih.gov; okd@mrtcbko.org	Miura, Kazutoyo/AAY-9751-2020; Saul, Allan/ABH-2091-2020; Fay, Michael P/A-2974-2008; Saul, Allan J/I-6968-2013	Miura, Kazutoyo/0000-0003-4455-2432; Saul, Allan/0000-0003-0665-4091; Fay, Michael P/0000-0002-8643-9625; Saul, Allan J/0000-0003-0665-4091	Intramural Program of the National Institute of Allergy and Infectious Diseases/National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001056, Z01AI001001, ZIAAI000241, ZIAAI001001, Z01AI000241, ZIAAI001056] Funding Source: NIH RePORTER	Intramural Program of the National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Program of the National Institute of Allergy and Infectious Diseases/National Institutes of Health.	Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Dicko A, 2007, AM J TROP MED HYG, V77, P1028, DOI 10.4269/ajtmh.2007.77.1028; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Fay MP, 2005, BIOSTATISTICS, V6, P171, DOI 10.1093/biostatistics/kxh027; FRUH K, 1991, INFECT IMMUN, V59, P1319; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Kocken CHM, 2000, MOL BIOCHEM PARASIT, V109, P147, DOI 10.1016/S0166-6851(00)00250-4; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; *WHO, ANN TABL 3 BURD DIS, P192; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032	19	41	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1563	10.1371/journal.pone.0001563	http://dx.doi.org/10.1371/journal.pone.0001563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270560	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900005
J	Hayden, JD; Ades, SE				Hayden, Jennifer D.; Ades, Sarah E.			The Extracytoplasmic Stress Factor, sigma(E), Is Required to Maintain Cell Envelope Integrity in Escherichia coli	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; PENICILLIN-BINDING-PROTEINS; ENZYME IIA(NTR); VESICLE PRODUCTION; SMALL RNA; IDENTIFICATION; RESPONSES; REGULON; COMPLEX; GENES	Extracytoplasmic function or ECF sigma factors are the most abundant class of alternative sigma factors in bacteria. Members of the rpoE subclass of ECF sigma factors are implicated in sensing stress in the cell envelope of Gram-negative bacteria and are required for virulence in many pathogens. The best-studied member of this family is rpoE from Escherichia coli, encoding the sigma(E) protein. sigma(E) has been well studied for its role in combating extracytoplasmic stress, and the members of its regulon have been largely defined. sigma(E) is required for viability of E. coli, yet none of the studies to date explain why sigma(E) is essential in seemingly unstressed cells. In this work we investigate the essential role of sigma(E) in E. coli by analyzing the phenotypes associated with loss of sigma(E) activity and isolating suppressors that allow cells to live in the absence of sigma(E). We demonstrate that when sigma(E) is inhibited, cell envelope stress increases and envelope integrity is lost. Many cells lyse and some develop blebs containing cytoplasmic material along their sides. To better understand the connection between transcription by sigma(E) and cell envelope integrity, we identified two multicopy suppressors of the essentiality of sigma(E), ptsN and yhbW. yhbW is a gene of unknown function, while ptsN is a member of the sigma(E) regulon. Overexpression of ptsN lowers the basal level of multiple envelope stress responses, but not that of a cytoplasmic stress response. Our results are consistent with a model in which overexpression of ptsN reduces stress in the cell envelope, thereby promoting survival in the absence of sigma(E).	[Hayden, Jennifer D.; Ades, Sarah E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hayden, JD (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	ades@psu.edu			National Science Foundation [MCB-0347302]	National Science Foundation(National Science Foundation (NSF))	This work was supported by grant MCB-0347302 from the National Science Foundation. The funding agency did not play any role in this study or in preparation of the manuscript.	Ades SE, 1999, GENE DEV, V13, P2449, DOI 10.1101/gad.13.18.2449; Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Button JE, 2007, J BACTERIOL, V189, P1523, DOI 10.1128/JB.01534-06; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Charlson ES, 2006, J BACTERIOL, V188, P7186, DOI 10.1128/JB.00571-06; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Csonka L. N., 1996, ESCHERICHIA COLI SAL, P1210; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; Flardh K, 1997, MOL MICROBIOL, V24, P927, DOI 10.1046/j.1365-2958.1997.4001762.x; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Gralla JD, 2006, EMBO J, V25, P1515, DOI 10.1038/sj.emboj.7601041; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; KELLENBERGER E, 1996, CELLULAR MOL BIOL, P17; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee CR, 2007, P NATL ACAD SCI USA, V104, P4124, DOI 10.1073/pnas.0609897104; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; McBroom AJ, 2006, J BACTERIOL, V188, P5385, DOI 10.1128/JB.00498-06; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; MECSAS J, 1995, J BACTERIOL, V177, P799, DOI 10.1128/jb.177.3.799-804.1995; Meisel U, 2003, J BACTERIOL, V185, P5342, DOI 10.1128/JB.185.18.5342-5348.2003; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 2000, MOL MICROBIOL, V37, P1186, DOI 10.1046/j.1365-2958.2000.02074.x; Rezuchova B, 2003, FEMS MICROBIOL LETT, V225, P1, DOI 10.1016/S0378-1097(03)00480-4; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Thompson KM, 2007, J BACTERIOL, V189, P4243, DOI 10.1128/JB.00020-07; Udekwu KI, 2007, NUCLEIC ACIDS RES, V35, P1279, DOI 10.1093/nar/gkl1154; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	69	113	113	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1573	10.1371/journal.pone.0001573	http://dx.doi.org/10.1371/journal.pone.0001573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253509	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700033
J	Macqueen, DJ; Johnston, IA				Macqueen, Daniel J.; Johnston, Ian A.			An Update on MyoD Evolution in Teleosts and a Proposed Consensus Nomenclature to Accommodate the Tetraploidization of Different Vertebrate Genomes	PLOS ONE			English	Article							MUSCLE REGULATORY FACTORS; GENE; DUPLICATION; FISH; EXPRESSION; HOMOLOGY	Background: MyoD is a muscle specific transcription factor that is essential for vertebrate myogenesis. In several teleost species, including representatives of the Salmonidae and Acanthopterygii, but not zebrafish, two or more MyoD paralogues are conserved that are thought to have arisen from distinct, possibly lineage-specific duplication events. Additionally, two MyoD paralogues have been characterised in the allotetraploid frog, Xenopus laevis. This has lead to a confusing nomenclature since MyoD paralogues have been named outside of an appropriate phylogenetic framework. Methods and Principal Findings: Here we initially show that directly depicting the evolutionary relationships of teleost MyoD orthologues and paralogues is hindered by the asymmetric evolutionary rate of Acanthopterygian MyoD2 relative to other MyoD proteins. Thus our aim was to confidently position the event from which teleost paralogues arose in different lineages by a comparative investigation of genes neighbouring myod across the vertebrates. To this end, we show that genes on the single myod-containing chromosome of mammals and birds are retained in both zebrafish and Acanthopterygian teleosts in a striking pattern of double conserved synteny. Further, phylogenetic reconstruction of these neighbouring genes using Bayesian and maximum likelihood methods supported a common origin for teleost paralogues following the split of the Actinopterygii and Sarcopterygii. Conclusion: Our results strongly suggest that myod was duplicated during the basal teleost whole genome duplication event, but was subsequently lost in the Ostariophysi ( zebrafish) and Protacanthopterygii lineages. We propose a sensible consensus nomenclature for vertebrate myod genes that accommodates polyploidization events in teleost and tetrapod lineages and is justified from a phylogenetic perspective.	[Macqueen, Daniel J.; Johnston, Ian A.] Univ St Andrews, Gatty Marine Lab, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews	Macqueen, DJ (corresponding author), Univ St Andrews, Gatty Marine Lab, Sch Biol, St Andrews, Fife, Scotland.	iaj@st-andrews.ac.uk	Macqueen, Daniel/A-7456-2013; Johnston, Ian A./AAE-2044-2019; Johnston, Ian A/D-6592-2013	Johnston, Ian A/0000-0002-7796-5754	Natural Environment Research Council [NERC/S/A/2004/12435]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DJM was supported by a Natural Environment Research Council studentship (NERC/S/A/2004/12435).	ATCHLEY WR, 1994, P NATL ACAD SCI USA, V91, P11522, DOI 10.1073/pnas.91.24.11522; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; Fernandes JMO, 2007, GENE, V391, P178, DOI 10.1016/j.gene.2006.12.015; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TE, 2003, J EXP BIOL, V206, P3187, DOI 10.1242/jeb.00535; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Le Comber SC, 2004, BIOL J LINN SOC, V82, P431; LIN H, 1991, MOL CELL BIOL, V11, P267, DOI 10.1128/MCB.11.1.267; Macqueen DJ, 2007, J EXP BIOL, V210, P2781, DOI 10.1242/jeb.006981; Macqueen DJ, 2006, FEBS LETT, V580, P4996, DOI 10.1016/j.febslet.2006.08.016; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rescan PY, 1996, COMP BIOCHEM PHYS B, V113, P711, DOI 10.1016/0305-0491(95)02087-X; SCALES JB, 1990, MOL CELL BIOL, V10, P1516, DOI 10.1128/MCB.10.4.1516; Spring J, 1997, FEBS LETT, V400, P2, DOI 10.1016/S0014-5793(96)01351-8; Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan XG, 2002, DEV GENES EVOL, V212, P207, DOI 10.1007/s00427-002-0224-5; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thisse B, 2004, ZFIN DIRECT DATA SUB; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Van de Peer Y, 2002, GENE, V295, P205, DOI 10.1016/S0378-1119(02)00689-3; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305	30	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1567	10.1371/journal.pone.0001567	http://dx.doi.org/10.1371/journal.pone.0001567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253507	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700031
J	Xiao, H; Xu, LH; Yamada, Y; Liu, DX				Xiao, Han; Xu, Ling Hui; Yamada, Yoshiyuki; Liu, Ding Xiang			Coronavirus Spike Protein Inhibits Host Cell Translation by Interaction with eIF3f	PLOS ONE			English	Article								In response to viral infection, the expression of numerous host genes, including predominantly a number of proinflammatory cytokines and chemokines, is usually up-regulated at both transcriptional and translational levels. It was noted that in cells infected with coronavirus, transcription and translation of some of these genes were differentially induced. Drastic induction of their expression at the transcriptional level was observed in cells infected with coronavirus. However, induction of the same genes at the translational level was usually found to be minimal to moderate. To investigate the underlying mechanisms, yeast two-hybrid screen was carried out using SARS-CoV proteins as baits, revealing that a subunit of the eukaryotic initiation factor 3 (eIF3), eIF3f, may interact with the N-terminal region of the SARS-CoV spike ( S) protein. This interaction was subsequently confirmed by co-immunoprecipitation and immunofluorescent staining. Meanwhile, parallel experiments confirmed that eIF3f could also interact with the S protein of another coronavirus, the avian coronavirus infectious bronchitis virus (IBV). These interactions led to the inhibition of translation of a reporter gene in both in vitro expression system and intact cells. Interestingly, IBV-infected cells stably expressing a Flag-tagged eIF3f showed much higher translation of IL-6 and IL-8, suggesting that the interaction between coronavirus S protein and eIF3f plays a functional role in controlling the expression of host genes, especially genes that are induced during coronavirus infection cycles. This study reveals a novel mechanism exploited by coronavirus to regulate viral pathogenesis.	[Xiao, Han; Xu, Ling Hui; Yamada, Yoshiyuki; Liu, Ding Xiang] Inst Mol & Cell Biol, Proteos, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Liu, DX (corresponding author), Inst Mol & Cell Biol, Proteos, Singapore.	dxliu@imcb.a-star.edu.sg	Liu, Ding Xiang/A-2226-2011		Agency for Science, Technology and Research, Singapore; Biomedical Research Council [BMRC 03/1/22/17/220]	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research, Singapore, and a grant from the Biomedical Research Council (BMRC 03/1/22/17/220), Agency for Science, Technology and Research, Singapore.	Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Ali IK, 2001, EMBO J, V20, P4233, DOI 10.1093/emboj/20.15.4233; BLACK BL, 1992, J VIROL, V66, P4058, DOI 10.1128/JVI.66.7.4058-4064.1992; Bos ECW, 1995, VIROLOGY, V214, P453, DOI 10.1006/viro.1995.0056; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Cebulla CM, 1999, INTERVIROLOGY, V42, P325, DOI 10.1159/000053968; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; de Haan CAM, 2004, J VIROL, V78, P6048, DOI 10.1128/JVI.78.11.6048-6054.2004; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Guidotti LG, 2000, VIROLOGY, V273, P221, DOI 10.1006/viro.2000.0442; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Jones BM, 2004, CLIN EXP IMMUNOL, V135, P467, DOI 10.1111/j.1365-2249.2003.02391.x; KATSURA A, 1997, J BIOL CHEM, V272, P1101; KEITH RJ, 1997, J BIOL CHEM, V272, P7106; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Laurent AM, 1998, J GEN VIROL, V79, P2765, DOI 10.1099/0022-1317-79-11-2765; Law HKW, 2005, BLOOD, V106, P2366, DOI 10.1182/blood-2004-10-4166; Liu DX, 1997, J VIROL, V71, P1814, DOI 10.1128/JVI.71.3.1814-1820.1997; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; NATHALIE M, 1997, J BIOL CHEM, V272, P1110; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; SCHNEIDER RJ, 2000, TRANSLATIONAL CONTRO, P901; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shi JQ, 2003, J BIOL CHEM, V278, P5062, DOI 10.1074/jbc.M206427200; Silverman RH, 1999, NATURE, V397, P208, DOI 10.1038/16586; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tseng CTK, 2005, J IMMUNOL, V174, P7977, DOI 10.4049/jimmunol.174.12.7977; Wang L, 2006, ONCOGENE, V25, P4320, DOI 10.1038/sj.onc.1209458; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; Yuan H, 1998, VIROLOGY, V251, P383, DOI 10.1006/viro.1998.9413; Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004; Ziegler T, 2005, J VIROL, V79, P13800, DOI 10.1128/JVI.79.21.13800-13805.2005	39	54	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1494	10.1371/journal.pone.0001494	http://dx.doi.org/10.1371/journal.pone.0001494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231581	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200007
J	Charvin, G; Cross, FR; Siggia, ED				Charvin, Gilles; Cross, Frederick R.; Siggia, Eric D.			A Microfluidic Device for Temporally Controlled Gene Expression and Long-Term Fluorescent Imaging in Unperturbed Dividing Yeast Cells	PLOS ONE			English	Article								Background. Imaging single cells with fluorescent markers over multiple cell cycles is a powerful tool for unraveling the mechanism and dynamics of the cell cycle. Over the past ten years, microfluidic techniques in cell biology have emerged that allow for good control of growth environment. Yet the control and quantification of transient gene expression in unperturbed dividing cells has received less attention. Methodology/Principal Findings. Here, we describe a microfluidic flow cell to grow Saccharomyces Cerevisiae for more than 8 generations (approximate to 12 hrs) starting with single cells, with controlled flow of the growth medium. This setup provides two important features: first, cells are tightly confined and grow in a remarkably planar array. The pedigree can thus be determined and single-cell fluorescence measured with 3 minutes resolution for all cells, as a founder cell grows to a micro-colony of more than 200 cells. Second, we can trigger and calibrate rapid and transient gene expression using reversible administration of inducers that control the GAL1 or MET3 promoters. We then show that periodic 10-20 minutes gene induction pulses can drive many cell division cycles with complete coherence across the cell cluster, with either a G1/S trigger (cln1 cln2 cln3 MET3-CLN2) or a mitotic trigger (cdc20 GALL-CDC20). Conclusions/Significance. In addition to evident cell cycle applications, this device can be used to directly measure the amount and duration of any fluorescently scorable signal-transduction or gene-induction response over a long time period. The system allows direct correlation of cell history (e.g., hysteresis or epigenetics) or cell cycle position with the measured response.	[Charvin, Gilles; Siggia, Eric D.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; [Cross, Frederick R.] Rockefeller Univ, New York, NY USA	Rockefeller University; Rockefeller University	Charvin, G (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	gilles.charvin@gmail.com		charvin, gilles/0000-0002-6852-6952	National Institute of Health; National Science Foundation [DMR-0517138]; Human Frontier Science Program Organization [cross-disciplinary fellowship]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by the National Institute of Health (EDS, FRC), the National Science Foundation DMR-0517138 (EDS), and a long-term cross-disciplinary fellowship from the Human Frontier Science Program Organization (GC).	AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Battogtokh D, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011910; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Burke D., 2000, METHODS YEAST GENETI; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Cross FR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021910; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; LORD PG, 1981, J CELL SCI, V50, P361; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; Mao XC, 2002, CURR MICROBIOL, V45, P37, DOI 10.1007/s00284-001-0046-0; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Smith AE, 2000, P NATL ACAD SCI USA, V97, P9871, DOI 10.1073/pnas.97.18.9871; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sveiczer A, 1996, J CELL SCI, V109, P2947; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509	28	100	102	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1468	10.1371/journal.pone.0001468	http://dx.doi.org/10.1371/journal.pone.0001468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213377	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503900014
J	Wrage, PC; Tran, T; To, K; Keefer, EW; Ruhn, KA; Hong, J; Hattangadi, S; Trevino, I; Tansey, MG				Wrage, Philip C.; Tran, Thi; To, Khai; Keefer, Edward W.; Ruhn, Kelly A.; Hong, John; Hattangadi, Supriya; Trevino, Isaac; Tansey, Malu G.			The Neuro-Glial Properties of Adipose-Derived Adult Stromal (ADAS) Cells Are Not Regulated by Notch 1 and Are Not Derived from Neural Crest Lineage	PLOS ONE			English	Article								We investigated whether adipose-derived adult stromal ( ADAS) are of neural crest origin and the extent to which Notch 1 regulates their growth and differentiation. Mouse ADAS cells cultured in media formulated for neural stem cells (NSC) displayed limited capacity for self-renewal, clonogenicity, and neurosphere formation compared to NSC from the subventricular zone in the hippocampus. Although ADAS cells expressed Nestin, GFAP, NSE and Tuj1 in vitro, exposure to NSC differentiation supplements did not induce mature neuronal marker expression. In contrast, in mesenchymal stem cell (MSC) media, ADAS cells retained their ability to proliferate and differentiate beyond 20 passages and expressed high levels of Nestin. In neuritizing cocktails, ADAS cells extended processes, downregulated Nestin expression, and displayed depolarization-induced Ca2+ transients but no spontaneous or evoked neural network activity on Multi-Electrode Arrays. Deletion of Notch 1 in ADAS cell cultures grown in NSC proliferation medium did not significantly alter their proliferative potential in vitro or the differentiation-induced downregulation of Nestin. Co-culture of ADAS cells with fibroblasts that stably expressed the Notch ligand Jagged 1 or overexpression of the Notch intracellular domain (NICD) did not alter ADAS cell growth, morphology, or cellular marker expression. ADAS cells did not display robust expression of neural crest transcription factors or genes (Sox, CRABP2, and TH); and lineage tracing analyses using Wnt1-Cre; Rosa26R-lacZ or -EYFP reporter mice confirmed that fewer than 2% of the ADAS cell population derived from a Wnt1-positive population during development. In summary, although media formulations optimized for MSCs or NSCs enable expansion of mouse ADAS cells in vitro, we find no evidence that these cells are of neural crest origin, that they can undergo robust terminal differentiation into functionally mature neurons, and that Notch 1 is likely to be a key regulator of their cellular and molecular characteristics.	[Keefer, Edward W.] Univ Texas SW Med Ctr, Dept Plastic Surg, Dallas, TX USA; [Wrage, Philip C.; Tran, Thi; To, Khai; Ruhn, Kelly A.; Hong, John; Hattangadi, Supriya; Trevino, Isaac] Univ Texas SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tansey, MG (corresponding author), Univ Texas SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	malu.tansey@utsouthwestern.edu		Keefer, Edward/0000-0002-0470-9186	National Parkinson Foundation; National Institutes of Health (NIH) Neurological Disorders and Stroke (NINDS) [NS051526-02]; NIH [GM007062]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051526] Funding Source: NIH RePORTER	National Parkinson Foundation; National Institutes of Health (NIH) Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the National Parkinson Foundation, an Exploratory/Developmental R21 grant NS051526-02 (MGT) from the National Institutes of Health (NIH) Neurological Disorders and Stroke (NINDS), and an NIH Predoctoral Training Grant GM007062 (PCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no financial, personal, or professional interests that could be construed to have influenced the paper.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Croft AP, 2004, STEM CELLS DEV, V13, P409, DOI 10.1089/scd.2004.13.409; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; de Melker AA, 2004, DEV DYNAM, V230, P708, DOI 10.1002/dvdy.20091; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sauka-Spengler T, 2006, CURR OPIN GENET DEV, V16, P360, DOI 10.1016/j.gde.2006.06.006; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmidt C, 2005, ANAT EMBRYOL, V209, P349, DOI 10.1007/s00429-005-0459-9; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811; Weinmaster G, 2006, DEVELOPMENT, V133, P3277, DOI 10.1242/dev.02515; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	44	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1453	10.1371/journal.pone.0001453	http://dx.doi.org/10.1371/journal.pone.0001453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197263	gold, Green Submitted, Green Published			2022-12-27	WOS:000260503800024
J	Buck, M; Chojkier, M				Buck, Martina; Chojkier, Mario			A Ribosomal S-6 Kinase-Mediated Signal to C/EBP-beta Is Critical for the Development of Liver Fibrosis	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; OXIDATIVE STRESS; HEPATIC-FIBROSIS; PHOSPHORYLATION; INHIBITION; INDUCTION; PATHWAY; PROTEIN; LAP; PROLIFERATION	Background. In response to liver injury, hepatic stellate cell (HSC) activation causes excessive liver fibrosis. Here we show that activation of RSK and phosphorylation of C/EBP beta on Thr217 in activated HSC is critical for the progression of liver fibrosis. Methodology/Principal Findings. Chronic treatment with the hepatotoxin CCl4 induced severe liver fibrosis in C/EBP beta(+/+) mice but not in mice expressing C/EBP beta-Ala217, a non-phosphorylatable RSK-inhibitory transgene. C/EBP beta-Ala217 was present within the death receptor complex II, with active caspase 8, and induced apoptosis of activated HSC. The C/EBPb-Ala217 peptides directly stimulated caspase 8 activation in a cell-free system. C/EBP beta (+/+) mice with CCl4-induced severe liver fibrosis, while continuing on CCl4, were treated with a cell permeant RSK-inhibitory peptide for 4 or 8 weeks. The peptide inhibited RSK activation, stimulating apoptosis of HSC, preventing progression and inducing regression of liver fibrosis. We found a similar activation of RSK and phosphorylation of human C/EBP beta on Thr266 (human phosphoacceptor) in activated HSC in patients with severe liver fibrosis but not in normal livers, suggesting that this pathway may also be relevant in human liver fibrosis. Conclusions/Significance. These data indicate that the RSK-C/EBP beta phosphorylation pathway is critical for the development of liver fibrosis and suggest a potential therapeutic target.	[Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Buck, Martina; Chojkier, Mario] Vet Affairs Healthcare Ctr, Dept Med, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Buck, M (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbuck@ucsd.edu	Ramos, Joe W./L-6189-2013	Ramos, Joe W./0000-0002-9708-2115	NIDDK; NCI; Department of Veterans Affairs	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs)	Grants from the NIDDK, NCI, and the Department of Veterans Affairs	ANKOMASEY V, 1998, LIVER GROWTH REPAIR, P512; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; CHOJKIER M, 1985, GASTROENTEROLOGY, V88, P115, DOI 10.1016/S0016-5085(85)80142-6; Chojkier M, 2005, HEPATOLOGY, V41, P237, DOI 10.1002/hep.20567; Chojkier M, 2003, J HEPATOL, V39, P437, DOI 10.1016/S0168-8278(03)00231-9; Chojkier M, 1998, LIVER GROWTH REPAIR, P430; CHUNG R, 2005, HARRISONS PRINCIPLES, P1754; Constandinou C, 2005, METH MOLEC MED, V117, P237; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; JIMENEZ W, 1985, HEPATOLOGY, V5, P815, DOI 10.1002/hep.1840050517; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Leite F, 2002, INFECT IMMUN, V70, P4336, DOI 10.1128/IAI.70.8.4336-4343.2002; Marks BD, 2002, ASSAY DRUG DEV TECHN, V1, P73, DOI 10.1089/154065802761001329; MATSUOKA M, 1990, HEPATOLOGY, V11, P599, DOI 10.1002/hep.1840110412; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; *NIH, 2004, ACT PLAN LIV DIS RES, P1; *NIII, 2004, ACT PLAN LIV DIS RES, P137; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Ranjan P, 2006, APOPTOSIS, V11, P1837, DOI 10.1007/s10495-006-9530-0; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; *WHO, RED RISKS PROM HLTH, P1; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Zhang HZ, 2003, BIOCONJUGATE CHEM, V14, P458, DOI 10.1021/bc0256188	50	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1372	10.1371/journal.pone.0001372	http://dx.doi.org/10.1371/journal.pone.0001372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159255	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700029
J	Liu, SB; He, YY; Zhang, Y; Lee, WH; Qian, JQ; Lai, R; Jin, Y				Liu, Shu-Bai; He, Ying-Ying; Zhang, Yun; Lee, Wen-Hui; Qian, Jin-Qiao; Lai, Ren; Jin, Yang			A Novel Non-Lens beta gamma-Crystallin and Trefoil Factor Complex from Amphibian Skin and Its Functional Implications	PLOS ONE			English	Article								Background: In vertebrates, non-lens beta gamma-crystallins are widely expressed in various tissues, but their functions are unknown. The molecular mechanisms of trefoil factors, initiators of mucosal healing and being greatly involved in tumorigenesis, have remained elusive. Principal Findings: A naturally existing 72-kDa complex of non-lens beta gamma-crystallin (alpha-subunit) and trefoil factor (beta-subunit), named beta gamma-CAT, was identified from frog Bombina maxima skin secretions. Its alpha-subunit and beta-subunit (containing three trefoil factor domains), with a non-covalently linked form of alpha beta(2), show significant sequence homology to ep37 proteins, a group of non-lens beta gamma-crystallins identified in newt Cynops pyrrhogaster and mammalian trefoil factors, respectively. beta gamma-CAT showed potent hemolytic activity on mammalian erythrocytes. The specific antiserum against each subunit was able to neutralize its hemolytic activity, indicating that the two subunits are functionally associated. beta gamma-CAT formed membrane pores with a functional diameter about 2.0 nm, leading to K(+) efflux and colloid-osmotic hemolysis. High molecular weight SDS-stable oligomers (>240-kDa) were detected by antibodies against the alpha-subunit with Western blotting. Furthermore, beta gamma-CAT showed multiple cellular effects on human umbilical vein endothelial cells. Low dosages of beta gamma-CAT (25-50 pM) were able to stimulate cell migration and wound healing. At high concentrations, it induced cell detachment (EC(50) 10 nM) and apoptosis. beta gamma-CAT was rapidly endocytosed via intracellular vacuole formation. Under confocal microscope, some of the vacuoles were translocated to nucleus and partially fused with nuclear membrane. Bafilomycin A1 (a specific inhibitor of the vacuolar-type ATPase) and nocodazole (an agent of microtuble depolymerizing), while inhibited beta gamma-CAT induced vacuole formation, significantly inhibited beta gamma-CAT induced cell detachment, suggesting that beta gamma-CAT endocytosis is important for its activities. Conclusions/Significance: These findings illustrate novel cellular functions of non-lens beta gamma-cyrstallins and action mechanism via association with trefoil factors, serving as clues for investigating the possible occurrence of similar molecules and action mechanisms in mammals.	[Liu, Shu-Bai; He, Ying-Ying; Zhang, Yun; Lee, Wen-Hui; Qian, Jin-Qiao; Lai, Ren; Jin, Yang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China; [Liu, Shu-Bai; He, Ying-Ying; Qian, Jin-Qiao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, SB (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China.	zhangy@mail.kiz.ac.cn	Qian, Jinqiao/Q-7822-2019; liu, tonny/F-1570-2010; Jin, Yang/GXF-7896-2022	Jin, Yang/0000-0002-7996-048X; Zhang, Yun/0000-0002-8636-183X	Chinese National Natural Science Foundation [30630014, 30570359]; Chinese Academy of Sciences [KSCX2-YW-R-088]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from The Chinese National Natural Science Foundation (30630014 and 30570359), and a grant of "Key Research Direction" (KSCX2-YW-R-088) from Chinese Academy of Sciences to Y.Z.	ALLEY MC, 1988, CANCER RES, V48, P589; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2947, DOI 10.1007/s00018-005-5483-7; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Bossenmeyer-Pourie C, 2002, J CELL BIOL, V157, P761, DOI 10.1083/jcb200108056; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; COVER TL, 1991, INFECT IMMUN, V59, P1264, DOI 10.1128/IAI.59.4.1264-1270.1991; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; FOHLMAN J, 1976, EUR J BIOCHEM, V68, P457, DOI 10.1111/j.1432-1033.1976.tb10833.x; FREEDMAN JC, 1979, J GEN PHYSIOL, V74, P157, DOI 10.1085/jgp.74.2.157; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HAUSER F, 1991, J BIOL CHEM, V266, P21306; HAUSER F, 1992, J BIOL CHEM, V267, P14451; HAUSER F, 1993, P NATL ACAD SCI USA, V90, P6961, DOI 10.1073/pnas.90.15.6961; Hoying JB, 1996, J CELL PHYSIOL, V168, P294, DOI 10.1002/(SICI)1097-4652(199608)168:2<294::AID-JCP8>3.0.CO;2-K; HUNTER SEC, 1992, INFECT IMMUN, V60, P102, DOI 10.1128/IAI.60.1.102-110.1992; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jin LT, 2004, ELECTROPHORESIS, V25, P2494, DOI 10.1002/elps.200306002; Koumanov KS, 2005, ARCH BIOCHEM BIOPHYS, V434, P150, DOI 10.1016/j.abb.2004.10.025; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai R, 2003, COMP BIOCHEM PHYS B, V134, P509, DOI 10.1016/S1096-4959(02)00294-4; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Ogawa M, 1998, DEV GROWTH DIFFER, V40, P465; Ogawa M, 1997, DEV GENES EVOL, V206, P417, DOI 10.1007/s004270050071; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Ray ME, 1996, ONCOGENE, V12, P2527; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; SABIROV RZ, 1993, GEN PHYSIOL BIOPHYS, V12, P95; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SCHERRER R, 1971, J BACTERIOL, V107, P718, DOI 10.1128/JB.107.3.718-735.1971; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; TAKABATAKE T, 1992, DEV GROWTH DIFFER, V34, P277; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Teichmann U, 1998, MAMM GENOME, V9, P715, DOI 10.1007/s003359900852; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; TOMASETTO C, 1990, EMBO J, V9, P407, DOI 10.1002/j.1460-2075.1990.tb08125.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UMATA T, 1990, J BIOL CHEM, V265, P21940; Wang TC, 2002, NAT MED, V8, P1080, DOI 10.1038/nm1002-1080; WISTOW G, 1995, EXP EYE RES, V61, P637, DOI 10.1016/S0014-4835(05)80058-2; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang J, 2005, BIOCHEM BIOPH RES CO, V330, P1027, DOI 10.1016/j.bbrc.2005.03.077	54	45	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1770	10.1371/journal.pone.0001770	http://dx.doi.org/10.1371/journal.pone.0001770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335045	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000024
J	Meczes, EL; Gilroy, KL; West, KL; Austin, CA				Meczes, Emma L.; Gilroy, Kathryn L.; West, Katherine L.; Austin, Caroline A.			The Impact of the Human DNA Topoisomerase II C-Terminal Domain on Activity	PLOS ONE			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; MITOTIC PHOSPHORYLATION; NUCLEAR-LOCALIZATION; THREONINE 1342; ALPHA; BETA; MUTATION; SITE; COMPLEMENTATION	Background: Type II DNA topoisomerases (topos) are essential enzymes needed for the resolution of topological problems that occur during DNA metabolic processes. Topos carry out an ATP-dependent strand passage reaction whereby one double helix is passed through a transient break in another. Humans have two topoII isoforms, alpha and beta, which while enzymatically similar are differentially expressed and regulated, and are thought to have different cellular roles. The C-terminal domain (CTD) of the enzyme has the most diversity, and has been implicated in regulation. We sought to investigate the impact of the CTD domain on activity. Methodology/Principle Findings: We have investigated the role of the human topoII C-terminal domain by creating constructs encoding C-terminally truncated recombinant topoII alpha and beta and topoII alpha+beta-tail and topoII beta+alpha-tail chimeric proteins. We then investigated function in vivo in a yeast system, and in vitro in activity assays. We find that the C-terminal domain of human topoII isoforms is needed for in vivo function of the enzyme, but not needed for cleavage activity. C-terminally truncated enzymes had similar strand passage activity to full length enzymes, but the presence of the opposite C-terminal domain had a large effect, with the topoII alpha-CTD increasing activity, and the topoII beta-CTD decreasing activity. Conclusions/Significance: In vivo complementation data show that the topoII alpha C-terminal domain is needed for growth, but the topoII beta isoform is able to support low levels of growth without a C-terminal domain. This may indicate that topoII beta has an additional localisation signal. In vitro data suggest that, while the lack of any C-terminal domain has little effect on activity, the presence of either the topoII alpha or beta C-terminal domain can affect strand passage activity. Data indicates that the topoII beta-CTD may be a negative regulator. This is the first report of in vitro data with chimeric human topoIIs.	[Meczes, Emma L.; Gilroy, Kathryn L.; Austin, Caroline A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [West, Katherine L.] Univ Glasgow, Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland	Newcastle University - UK; University of Glasgow	Meczes, EL (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	caroline.austin@ncl.ac.uk		Austin, Caroline/0000-0002-1921-5947; West, Katherine/0000-0002-5994-8969; Gilroy, Kathryn/0000-0003-4607-194X	North East Cancer Research Campaign (NECRC); Biotechnology and Biological Sciences Research Council (BBSRC); Newcastle University	North East Cancer Research Campaign (NECRC); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University	This work was funded by the North East Cancer Research Campaign (NECRC), the Biotechnology and Biological Sciences Research Council (BBSRC), and Newcastle University.	Adachi N, 1997, NUCLEIC ACIDS RES, V25, P3135, DOI 10.1093/nar/25.15.3135; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Cowell IG, 1998, EXP CELL RES, V243, P232, DOI 10.1006/excr.1998.4150; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; Daum JR, 1998, J BIOL CHEM, V273, P30622, DOI 10.1074/jbc.273.46.30622; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Gilroy KL, 2006, NUCLEIC ACIDS RES, V34, P1597, DOI 10.1093/nar/gkl057; GILROY KL, 2007, THESIS; HECK MMS, 1989, J BIOL CHEM, V264, P15161; Ishida R, 2001, CELL STRUCT FUNCT, V26, P215, DOI 10.1247/csf.26.215; Ishida R, 1996, J BIOL CHEM, V271, P30077, DOI 10.1074/jbc.271.47.30077; Isik S, 2003, FEBS LETT, V546, P374, DOI 10.1016/S0014-5793(03)00637-9; Jensen S, 1996, MOL CELL BIOL, V16, P3866; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Leontiou C, 2004, MOL PHARMACOL, V66, P430; Linka RM, 2007, NUCLEIC ACIDS RES, V35, P3810, DOI 10.1093/nar/gkm102; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; Marsh KL, 1996, BIOCHEM PHARMACOL, V52, P1675, DOI 10.1016/S0006-2952(96)00516-3; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; Meczes EL, 1997, CANCER CHEMOTH PHARM, V39, P367, DOI 10.1007/s002800050585; MECZES EL, 1998, THESIS; Mirski SEL, 2003, BIOCHEM BIOPH RES CO, V306, P905, DOI 10.1016/S0006-291X(03)01077-5; Mirski SEL, 1997, EXP CELL RES, V237, P452, DOI 10.1006/excr.1997.3805; Mirski SEL, 1999, EXP CELL RES, V251, P329, DOI 10.1006/excr.1999.4587; Sakaguchi A, 2001, BIOCHEM BIOPH RES CO, V283, P876, DOI 10.1006/bbrc.2001.4856; Sengupta T, 2005, NUCLEIC ACIDS RES, V33, P2364, DOI 10.1093/nar/gki527; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; Takahashi Y, 2006, GENETICS, V172, P783, DOI 10.1534/genetics.105.047167; Turner JG, 2004, J CELL SCI, V117, P3061, DOI 10.1242/jcs.01147; WASSERMAN RA, 1993, CANCER RES, V53, P3591; WELLS NJ, 1995, J BIOL CHEM, V270, P28357; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Wessel I, 1997, CANCER RES, V57, P4451; West KL, 2002, NUCLEIC ACIDS RES, V30, P5416, DOI 10.1093/nar/gkf677	43	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1754	10.1371/journal.pone.0001754	http://dx.doi.org/10.1371/journal.pone.0001754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335031	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000260723000008
J	Roux, X; Dubuquoy, C; Durand, G; Tran-Tolla, TL; Castagne, N; Bernard, J; Petit-Camurdan, A; Eleouet, JF; Riffault, S				Roux, Xavier; Dubuquoy, Catherine; Durand, Guillaume; Tran-Tolla, Thi-Lan; Castagne, Nathalie; Bernard, Julie; Petit-Camurdan, Agnes; Eleouet, Jean-Francois; Riffault, Sabine			Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus	PLOS ONE			English	Article								Background: Bronchiolitis caused by the respiratory syncytial virus (RSV) in infants less than two years old is a growing public health concern worldwide, and there is currently no safe and effective vaccine. A major component of RSV nucleocapsid, the nucleoprotein (N), has been so far poorly explored as a potential vaccine antigen, even though it is a target of protective anti-viral T cell responses and is remarkably conserved between human RSV A and B serotypes. We recently reported a method to produce recombinant N assembling in homogenous rings composed of 10-11 N subunits enclosing a bacterial RNA. These nanoparticles were named sub-nucleocapsid ring structure (N SRS). Methodology and Principal Findings: The vaccine potential of N SRS was evaluated in a well-characterized and widely acknowledged mouse model of RSV infection. BALB/c adult mice were immunized intranasally with N SRS adjuvanted with the detoxified E. coli enterotoxin LT(R192G). Upon RSV challenge, vaccinated mice were largely protected against virus replication in the lungs, with a mild inflammatory lymphocytic and neutrophilic reaction in their airways. Mucosal immunization with N SRS elicited strong local and systemic immunity characterized by high titers of IgG1, IgG2a and IgA anti-N antibodies, antigen-specific CD8(+) T cells and IFN-gamma-producing CD4(+) T cells. Conclusions/Significance: This is the first report of using nanoparticles formed by the recombinant nucleocapsid protein as an efficient and safe intra-nasal vaccine against RSV.	[Roux, Xavier; Dubuquoy, Catherine; Durand, Guillaume; Tran-Tolla, Thi-Lan; Castagne, Nathalie; Bernard, Julie; Petit-Camurdan, Agnes; Eleouet, Jean-Francois; Riffault, Sabine] INRA, Unite Virol & Immunol Mol UR892, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Roux, X (corresponding author), INRA, Unite Virol & Immunol Mol UR892, Jouy En Josas, France.	sabine.riffault@jouy.inra.fr	Eléouët, Jean-François/AAD-1994-2019		INRA Animal Health division; Medical Research Fund [FRM FDT20060607329]	INRA Animal Health division; Medical Research Fund	Xavier Roux was funded during his thesis by the INRA Animal Health division, by the region "Ile de France" and got a fellowship from the Medical Research Fund (FRM FDT20060607329).	BANGHAM CRM, 1986, J IMMUNOL, V137, P3973; Bartholdy C, 2004, J GEN VIROL, V85, P3017, DOI 10.1099/vir.0.80098-0; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; BOXUS M, 2007, J VIROL; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Collins Peter L, 2005, Proc Am Thorac Soc, V2, P166, DOI 10.1513/pats.200501-011AW; CONNORS M, 1991, J VIROL, V65, P1634, DOI 10.1128/JVI.65.3.1634-1637.1991; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; de Haan L, 1998, IMMUNOL CELL BIOL, V76, P270, DOI 10.1046/j.1440-1711.1998.00745.x; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Etchart N, 2001, J IMMUNOL, V167, P384, DOI 10.4049/jimmunol.167.1.384; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hussell T, 1997, EUR J IMMUNOL, V27, P3341, DOI 10.1002/eji.1830271233; Hussell T, 1998, J IMMUNOL, V161, P6215; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KING AMQ, 1987, J VIROL, V61, P2885, DOI 10.1128/JVI.61.9.2885-2890.1987; Laine D, 2003, J VIROL, V77, P11332, DOI 10.1128/JVI.77.21.11332-11346.2003; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; LOPEZ JA, 1988, VIRUS RES, V10, P249, DOI 10.1016/0168-1702(88)90020-2; Morris CB, 2000, VACCINE, V18, P1944, DOI 10.1016/S0264-410X(99)00447-8; Nicollier-Jamot A, 2004, VACCINE, V22, P1079, DOI 10.1016/j.vaccine.2003.10.004; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Plotnicky-Gilquin H, 2002, J VIROL, V76, P10203, DOI 10.1128/JVI.76.20.10203-10210.2002; Riffault S, 2000, J GEN VIROL, V81, P2365, DOI 10.1099/0022-1317-81-10-2365; SAMAL SK, 1991, J GEN VIROL, V72, P1715, DOI 10.1099/0022-1317-72-7-1715; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Simmons CP, 2001, J IMMUNOL, V166, P1106, DOI 10.4049/jimmunol.166.2.1106; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; TAYLOR G, 1995, J VIROL, V69, P6658, DOI 10.1128/JVI.69.11.6658-6664.1995; Taylor G, 1997, J GEN VIROL, V78, P3195, DOI 10.1099/0022-1317-78-12-3195; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tudor D, 2001, VIROLOGY, V286, P197, DOI 10.1006/viro.2001.0957; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; Vaughan K, 2005, VACCINE, V23, P2928, DOI 10.1016/j.vaccine.2004.10.046; Venter M, 2003, J VIROL, V77, P7319, DOI 10.1128/JVI.77.13.7319-7329.2003; Viuff B, 2002, AM J PATHOL, V161, P2195, DOI 10.1016/S0002-9440(10)64496-3; Williams AE, 2004, J IMMUNOL, V173, P7435, DOI 10.4049/jimmunol.173.12.7435; Yan HM, 2002, J VIROL, V76, P10972, DOI 10.1128/JVI.76.21.10972-10979.2002	52	40	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1766	10.1371/journal.pone.0001766	http://dx.doi.org/10.1371/journal.pone.0001766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335041	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000020
J	Chen, NKF; Wong, JS; Kee, IHC; Lai, SH; Thng, CH; Ng, WH; Ng, RTH; Tan, SY; Lee, SY; Tan, MEH; Sivalingam, J; Chow, PKH; Kon, OL				Chen, Nelson K. F.; Wong, Jen San; Kee, Irene H. C.; Lai, Siang Hui; Thng, Choon Hua; Ng, Wai Har; Ng, Robert T. H.; Tan, Soo Yong; Lee, Shu Yen; Tan, Mark E. H.; Sivalingam, Jaichandran; Chow, Pierce K. H.; Kon, Oi Lian			Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model	PLOS ONE			English	Article								Background: Current gene- and cell-based therapies have significant limitations which impede widespread clinical application. Taking diabetes mellitus as a paradigm, we have sought to overcome these limitations by ex vivo electrotransfer of a nonviral insulin expression vector into primary hepatocytes followed by immediate autologous reimplantation in a preclinical model of diabetes. Methods and Results: In a single 3-hour procedure, hepatocytes were isolated from a surgically resected liver wedge, electroporated with an insulin expression plasmid ex vivo and reimplanted intraparenchymally under ultrasonic guidance into the liver in each of 10 streptozotocin-induced diabetic Yorkshire pigs. The vector was comprised of a bifunctional, glucose-responsive promoter linked to human insulin cDNA. Ambient glucose concentrations appropriately altered human insulin mRNA expression and C-peptide secretion within minutes in vitro and in vivo. Treated swine showed correction of hyperglycemia, glucose intolerance, dyslipidemia and other metabolic abnormalities for >= 47 weeks. Metabolic correction correlated significantly with the number of hepatocytes implanted. Importantly, we observed no hypoglycemia even under fasting conditions. Direct intrahepatic implantation of hepatocytes did not alter biochemical indices of liver function or induce abnormal hepatic lobular architecture. About 70% of implanted hepatocytes functionally engrafted, appeared histologically normal, retained vector DNA and expressed human insulin for >= 47 weeks. Based on structural tissue analyses and transcriptome data, we showed that early correction of diabetes attenuated and even prevented pathological changes in the eye, kidney, liver and aorta. Conclusions: We demonstrate that autologous hepatocytes can be efficiently, simply and safely modified by electroporation of a nonviral vector to express, process and secrete insulin durably. This strategy, which achieved significant and sustained therapeutic efficacy in a large preclinical model without adverse effects, warrants consideration for clinical development especially as it could have broader future applications for the treatment of other acquired and inherited diseases for which systemic reconstitution of a specific protein deficiency is critical.	[Wong, Jen San; Chow, Pierce K. H.] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Chen, Nelson K. F.; Wong, Jen San; Ng, Wai Har; Tan, Mark E. H.; Sivalingam, Jaichandran; Kon, Oi Lian] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Kee, Irene H. C.; Ng, Robert T. H.; Chow, Pierce K. H.] Singapore Gen Hosp, Dept Expt Surg, Singapore, Singapore; [Lai, Siang Hui] Hlth Sci Author, Ctr Forensic Med, Singapore, Singapore; [Thng, Choon Hua] Natl Canc Ctr, Dept Oncol Imag, Singapore, Singapore; [Tan, Soo Yong] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Lee, Shu Yen] Singapore Natl Eye Ctr, Singapore, Singapore	Singapore General Hospital; National Cancer Centre Singapore (NCCS); Singapore General Hospital; Health Sciences Authority (HSA); National Cancer Centre Singapore (NCCS); Singapore General Hospital; Singapore National Eye Center	Chow, PKH (corresponding author), Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore.	gsupc@sgh.com.sg; dmskol@nccs.com.sg		Chow, Pierce/0000-0003-0584-2584; Sivalingam, Jaichandran/0000-0002-3815-1272; Tan, Soo-Yong/0000-0002-6348-2823; Lai, Siang Hui/0000-0001-6811-7377	National Medical Research Council, Singapore; Biomedical Research Council, Singapore; Juvenile Diabetes Research Foundation, USA; National Cancer Centre, Singapore	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Juvenile Diabetes Research Foundation, USA(Juvenile Diabetes Research Foundation); National Cancer Centre, Singapore	National Medical Research Council, Singapore; Biomedical Research Council, Singapore, Juvenile Diabetes Research Foundation, USA and National Cancer Centre, Singapore Funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Balamurugan AN, 2006, PANCREAS, V32, P231, DOI 10.1097/01.mpa.0000203961.16630.2f; BARSOUM J, 1990, DNA CELL BIOL, V9, P293, DOI 10.1089/dna.1990.9.293; Beckers GJM, 2006, TRENDS PLANT SCI, V11, P322, DOI 10.1016/j.tplants.2006.05.010; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen NKF, 2005, GENE THER, V12, P655, DOI 10.1038/sj.gt.3302446; Chow PKH, 1997, J SURG RES, V70, P134, DOI 10.1006/jsre.1997.5120; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Dhawan A, 2004, TRANSPLANTATION, V78, P1812, DOI 10.1097/01.TP.0000146386.77076.47; Dombrowski F, 2006, CANCER RES, V66, P1833, DOI 10.1158/0008-5472.CAN-05-2787; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fodor A, 2007, DIABETOLOGIA, V50, P121, DOI 10.1007/s00125-006-0509-8; Frank Adam M, 2005, Adv Surg, V39, P137, DOI 10.1016/j.yasu.2005.04.010; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Giannoukakis N, 2005, CURR OPIN MOL THER, V7, P467; Grompe M, 2001, J INHERIT METAB DIS, V24, P231, DOI 10.1023/A:1010375203539; Grompe M, 1999, Hum Cell, V12, P171; GROTH CG, 1977, TRANSPLANT P, V9, P313; Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213; HAHN JD, 1993, J ANIM SCI, V71, P3020, DOI 10.2527/1993.71113020x; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; Han J, 2007, MOL THER, V15, P1195, DOI 10.1038/sj.mt.6300117; HIGGINS PJ, 1982, DIABETES, V31, P743, DOI 10.2337/diabetes.31.9.743; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jones Timothy W, 2003, Pediatr Diabetes, V4, P143, DOI 10.1034/j.1399-5448.2003.00025.x; Kachi S, 2006, GENE THER, V13, P798, DOI 10.1038/sj.gt.3302700; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; KINGSTON RE, 1996, CURRENT PROTOCOLS MO; Kjems LL, 2001, DIABETES, V50, P2001, DOI 10.2337/diabetes.50.9.2001; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Korompai FL, 2000, HORM METAB RES, V32, P256, DOI 10.1055/s-2007-978631; MAITRA A, 2005, PATHOLOGIC BASIS DIS, P1155; Meyburg J, 2005, TRANSPLANTATION, V80, pS135, DOI 10.1097/01.tp.0000186905.10088.e5; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; MOSCIONI AD, 1989, GASTROENTEROLOGY, V96, P1546, DOI 10.1016/0016-5085(89)90525-8; Muiesan P, 2007, J HEPATOL, V46, P340, DOI 10.1016/j.jhep.2006.11.006; Muraca M, 2002, TRANSPLANTATION, V73, P890, DOI 10.1097/00007890-200203270-00010; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; Picardo A, 1996, J SURG RES, V63, P452, DOI 10.1006/jsre.1996.0291; ROH S, 2004, OPHTHALMOLOGY, P779; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; SCHUTTE JE, 1981, J APPL PHYSIOL, V51, P762, DOI 10.1152/jappl.1981.51.3.762; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Serup P, 2006, DIABETOLOGIA, V49, P2537, DOI 10.1007/s00125-006-0434-x; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Strom SC, 1997, TRANSPLANT P, V29, P2103, DOI 10.1016/S0041-1345(97)00252-2; Tabiin Muhammad T, 2004, J Autoimmune Dis, V1, P3, DOI 10.1186/1740-2557-1-3; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Torbenson M, 2006, AM J SURG PATHOL, V30, P508, DOI 10.1097/00000478-200604000-00012; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Yechoor V, 2005, GENE THER, V12, P101, DOI 10.1038/sj.gt.3302412; ZHANG H, 1992, J PEDIATR SURG, V27, P312, DOI 10.1016/0022-3468(92)90853-Y	58	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1734	10.1371/journal.pone.0001734	http://dx.doi.org/10.1371/journal.pone.0001734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320053	gold, Green Submitted, Green Published			2022-12-27	WOS:000260586600029
J	Lang, P; van Harmelen, V; Ryden, M; Kaaman, M; Parini, P; Carneheim, C; Cassady, AI; Hume, DA; Andersson, G; Arner, P				Lang, Pernilla; van Harmelen, Vanessa; Ryden, Mikael; Kaaman, Maria; Parini, Paolo; Carneheim, Claes; Cassady, A. Ian; Hume, David A.; Andersson, Goran; Arner, Peter			Monomeric Tartrate Resistant Acid Phosphatase Induces Insulin Sensitive Obesity	PLOS ONE			English	Article							ADIPOSE-CELL-SIZE; CATHEPSIN-K; STEM-CELLS; FAT-CELLS; TRANSCRIPTION FACTORS; TNF-ALPHA; ACP 5; TISSUE; EXPRESSION; ADIPOCYTE	Background: Obesity is associated with macrophage infiltration of adipose tissue, which may link adipose inflammation to insulin resistance. However, the impact of inflammatory cells in the pathophysiology of obesity remains unclear. Tartrate resistant acid phosphatase ( TRAP) is an enzyme expressed by subsets of macrophages and osteoclasts that exists either as an enzymatically inactive monomer or as an active, proteolytically processed dimer. Principal Findings: Using mice over expressing TRAP, we show that over-expression of monomeric, but not the dimeric form in adipose tissue leads to early onset spontaneous hyperplastic obesity i.e. many small fat cells. In vitro, recombinant monomeric, but not proteolytically processed TRAP induced proliferation and differentiation of mouse and human adipocyte precursor cells. In humans, monomeric TRAP was highly expressed in the adipose tissue of obese individuals. In both the mouse model and in the obese humans the source of TRAP in adipose tissue was macrophages. In addition, the obese TRAP over expressing mice exhibited signs of a low-grade inflammatory reaction in adipose tissue without evidence of abnormal adipocyte lipolysis, lipogenesis or insulin sensitivity. Conclusion: Monomeric TRAP, most likely secreted from adipose tissue macrophages, induces hyperplastic obesity with normal adipocyte lipid metabolism and insulin sensitivity.	[Lang, Pernilla; Andersson, Goran] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Pathol, Huddinge, Sweden; [van Harmelen, Vanessa; Ryden, Mikael; Kaaman, Maria; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden; [Parini, Paolo] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Chem, Huddinge, Sweden; [Carneheim, Claes] Biovitrum AB, Integrative Pharmacol, Stockholm, Sweden; [Cassady, A. Ian; Hume, David A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Hume, David A.] Univ Edinburgh, Sch Vet Stud, Roslin Inst, Roslin, Midlothian, Scotland	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Swedish Orphan Biovitrum; University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Lang, P (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Pathol, Huddinge, Sweden.	goran.andersson@ki.se; peter.arner@ki.se	Hume, David A/C-7695-2013; Lång, Pernilla/AAA-6660-2019; Cassady, Alan/AAY-2962-2021	Lång, Pernilla/0000-0002-3605-4014; Cassady, Alan/0000-0001-8585-5427; Arner, Peter/0000-0002-6208-6220; Hume, David/0000-0002-2615-1478; van Harmelen, Vanessa/0000-0003-0111-9858	Swedish Research Council; Swedish Heart and Lung Foundation; Novo Nordic Foundation; wedish Diabetes Association; King Gustaf V; Queen Victoria Foundation; European Union [CT-2005-018734]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordic Foundation(Novo Nordisk Foundation); wedish Diabetes Association; King Gustaf V; Queen Victoria Foundation; European Union(European Commission)	This study was supported by grants from Swedish Research Council, Swedish Heart and Lung Foundation, Novo Nordic Foundation, Swedish Diabetes Association and King Gustaf V, Queen Victoria Foundation and the European Union (HEPADIP, LSHM,-CT-2005-018734).	Andersson G, 2003, J BONE MINER RES, V18, P1912, DOI 10.1359/jbmr.2003.18.10.1912; Angel NZ, 2000, J BONE MINER RES, V15, P103, DOI 10.1359/jbmr.2000.15.1.103; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; BAZER FW, 1991, EXP HEMATOL, V19, P910; BONNET FP, 1979, ACTA PAEDIATR BELG, V32, P17; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; BROOK CGD, 1972, BMJ-BRIT MED J, V2, P25, DOI 10.1136/bmj.2.5804.25; BROOK CGD, 1973, ARCH DIS CHILD, V48, P301, DOI 10.1136/adc.48.4.301; Chiellini C, 2003, J CELL PHYSIOL, V195, P309, DOI 10.1002/jcp.10253; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Constant VA, 2006, DIABETOLOGIA, V49, P1402, DOI 10.1007/s00125-006-0253-0; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; EkRylander B, 1997, BIOCHEM J, V321, P305, DOI 10.1042/bj3210305; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Funicello M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000683; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219, DOI 10.1177/002215540004800207; Hayman AR, 2003, J BONE MINER RES, V18, P1905, DOI 10.1359/jbmr.2003.18.10.1905; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; HIRSCH J, 1989, MED CLIN N AM, V73, P83, DOI 10.1016/S0025-7125(16)30693-9; Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458; Hollberg K, 2005, J BONE MINER METAB, V23, P441, DOI 10.1007/s00774-005-0626-3; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Justesen J, 2004, TISSUE ENG, V10, P381, DOI 10.1089/107632704323061744; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lang P, 2005, CELL MOL LIFE SCI, V62, P905, DOI 10.1007/s00018-005-4550-4; Lang P, 2001, J HISTOCHEM CYTOCHEM, V49, P379, DOI 10.1177/002215540104900312; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Ljusberg J, 1999, BIOCHEM J, V343, P63, DOI 10.1042/0264-6021:3430063; Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Partington GA, 2004, BONE, V34, P237, DOI 10.1016/j.bone.2003.11.010; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Raisanen SR, 2001, BIOCHEM BIOPH RES CO, V288, P142, DOI 10.1006/bbrc.2001.5715; REINHOLT FP, 1990, J BONE MINER RES, V5, P1055; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; SALANS LB, 1973, J CLIN INVEST, V52, P929, DOI 10.1172/JCI107258; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; STERN JS, 1972, LANCET, V2, P948; Suzuki K, 1998, J DIABETES COMPLICAT, V12, P176, DOI 10.1016/S1056-8727(97)00107-4; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Vaaraniemi J, 2004, J BONE MINER RES, V19, P1432, DOI 10.1359/JBMR.040603; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; VALET P, 1993, J CLIN INVEST, V91, P2049, DOI 10.1172/JCI116427; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Wang YL, 2005, ARCH BIOCHEM BIOPHYS, V435, P147, DOI 10.1016/j.abb.2004.11.029; Wang YL, 2007, ARCH BIOCHEM BIOPHYS, V461, P85, DOI 10.1016/j.abb.2007.01.025; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010	74	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1713	10.1371/journal.pone.0001713	http://dx.doi.org/10.1371/journal.pone.0001713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320034	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600009
J	Stewart, JP; Kipar, A; Cox, H; Payne, C; Vasiliou, S; Quinn, JP				Stewart, James P.; Kipar, Anja; Cox, Helen; Payne, Catherine; Vasiliou, Sylvia; Quinn, John P.			Induction of Tachykinin Production in Airway Epithelia in Response to Viral Infection	PLOS ONE			English	Article							SUBSTANCE-P RECEPTOR; SYNCYTIAL VIRUS-INFECTION; MARKER-GENE-EXPRESSION; INFLAMMATORY CYTOKINES; IMMUNE-RESPONSE; NEUROPEPTIDES; LYMPHOCYTES; MACROPHAGES; HEMOKININ; CANCER	Background: The tachykinins are implicated in neurogenic inflammation and the neuropeptide substance P in particular has been shown to be a proinflammatory mediator. A role for the tachykinins in host response to lung challenge has been previously demonstrated but has been focused predominantly on the release of the tachykinins from nerves innervating the lung. We have previously demonstrated the most dramatic phenotype described for the substance P encoding gene preprotachykinin-A (PPT-A) to date in controlling the host immune response to the murine gammaherpesvirus 68, in the lung. Methodology/ Principal Findings: In this study we have utilised transgenic mice engineered to co-ordinately express the beta-galactosidase marker gene along with PPT-A to facilitate the tracking of PPT-A expression. Using a combination of these mice and conventional immunohistology we now demonstrate that PPT-A gene expression and substance P peptide are induced in cells of the respiratory tract including tracheal, bronchiolar and alveolar epithelial cells and macrophages after viral infection. This induction was observed 24h post infection, prior to observable inflammation and the expression of pro-inflammatory chemokines in this model. Induced expression of the PPT-A gene and peptide persisted in the lower respiratory tract through day 7 post infection. Conclusions/ Significance: Non-neuronal PPT-A expression early after infection may have important clinical implications for the progression or management of lung disease or infection aside from the well characterised later involvement of the tachykinins during the inflammatory response.	[Stewart, James P.; Cox, Helen] Univ Liverpool, Dept Med Microbiol, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja] Univ Liverpool, Dept Veterinary Pathol, Liverpool, Merseyside, England; [Vasiliou, Sylvia; Quinn, John P.] Univ Liverpool, Div Physiol & Human Anat Cell Biol, Liverpool, Merseyside, England; [Payne, Catherine] Univ Edinburgh, Scottish Ctr Regenerative Med, Edinburgh, Midlothian, Scotland	University of Liverpool; University of Liverpool; University of Liverpool; University of Edinburgh	Stewart, JP (corresponding author), Univ Liverpool, Dept Med Microbiol, POB 147, Liverpool L69 3BX, Merseyside, England.	j.p.stewart@liv.ac.uk; jquinn@liv.ac.uk	Quinn, John P/A-2972-2010; Kipar, Anja/L-7214-2014; Stewart, James/A-6034-2012	Quinn, John P/0000-0003-3551-7803; Kipar, Anja/0000-0001-7289-3459; Stewart, James/0000-0002-8928-2037	BBSRC [NEU15439]; Royal Society (London) University Research Fellowship; Medical Research Council [G0701003] Funding Source: researchfish; MRC [G0701003] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society (London) University Research Fellowship(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by BBSRC grant NEU15439. JPS was supported by a Royal Society (London) University Research Fellowship.	Blum AM, 1999, J IMMUNOL, V162, P6080; Cohen AJ, 1996, CANCER RES, V56, P831; Crimi N, 2003, J ALLERGY CLIN IMMUN, V111, P833, DOI 10.1067/mai.2003.161; D'Agostino B, 2002, CLIN EXP ALLERGY, V32, P472, DOI 10.1046/j.1365-2222.2002.01328.x; Germonpre PR, 1999, EUR RESPIR J, V14, P776, DOI 10.1034/j.1399-3003.1999.14d08.x; GOETZL EJ, 1992, FASEB J, V6, P2646, DOI 10.1096/fasebj.6.9.1612288; Haynes LM, 2002, J VIROL, V76, P6873, DOI 10.1128/JVI.76.14.6873-6881.2002; Ho WZ, 1997, J IMMUNOL, V159, P5654; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Kamijo Y, 2001, LIFE SCI, V70, P1, DOI 10.1016/S0024-3205(01)01361-3; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Lambrecht BN, 1999, EUR J IMMUNOL, V29, P3815, DOI 10.1002/(SICI)1521-4141(199912)29:12<3815::AID-IMMU3815>3.0.CO;2-#; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; MacKenzie A, 2000, MOL CELL NEUROSCI, V16, P620, DOI 10.1006/mcne.2000.0902; MacKenzie A, 2002, MOL CELL NEUROSCI, V19, P72, DOI 10.1006/mcne.2001.1052; Maggi CA, 1997, REGUL PEPTIDES, V70, P75, DOI 10.1016/S0167-0115(97)00029-3; MCGREGOR GP, 1995, ENDOCRINOLOGY, V136, P2538, DOI 10.1210/en.136.6.2538; Millward-Sadler SJ, 2003, ARTHRITIS RHEUM, V48, P146, DOI 10.1002/art.10711; Morteau O, 2001, NAT IMMUNOL, V2, P1088, DOI 10.1038/ni1201-1088; NOVERAL JP, 1995, AM J PHYSIOL-LUNG C, V269, pL339, DOI 10.1152/ajplung.1995.269.3.L339; Palma C, 1998, J NEUROIMMUNOL, V81, P127, DOI 10.1016/S0165-5728(97)00167-7; Payne CM, 2001, J VIROL, V75, P10467, DOI 10.1128/JVI.75.21.10467-10471.2001; Piedimonte G, 1999, AM J PHYSIOL-LUNG C, V277, pL831, DOI 10.1152/ajplung.1999.277.4.L831; Piedimonte G, 2004, PEDIATR RES, V55, P657, DOI 10.1203/01.PDR.0000112244.72924.26; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Sarawar SR, 1996, J VIROL, V70, P3264, DOI 10.1128/JVI.70.5.3264-3268.1996; Sarawar SR, 2002, VIROLOGY, V293, P54, DOI 10.1006/viro.2001.1221; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Tripp RA, 2002, J NEUROIMMUNOL, V129, P141, DOI 10.1016/S0165-5728(02)00169-8; Tripp RA, 2000, J VIROL, V74, P1614, DOI 10.1128/JVI.74.4.1614-1622.2000; Veronesi B, 1999, NEUROPEPTIDES, V33, P447, DOI 10.1054/npep.1999.0761; Weinberg JB, 2004, VIRAL IMMUNOL, V17, P69, DOI 10.1089/088282404322875467; Weinberg JB, 2002, J VIROL, V76, P10518, DOI 10.1128/JVI.76.20.10518-10523.2002; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826; Zhang Y, 2003, BLOOD, V102, P2165, DOI 10.1182/blood-2002-11-3572	36	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1673	10.1371/journal.pone.0001673	http://dx.doi.org/10.1371/journal.pone.0001673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320026	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600001
J	Frund, I; Busch, NA; Schadow, J; Gruber, T; Korner, U; Herrmann, CS				Fruend, Ingo; Busch, Niko A.; Schadow, Jeanette; Gruber, Thomas; Koerner, Ursula; Herrmann, Christoph S.			Time Pressure Modulates Electrophysiological Correlates of Early Visual Processing	PLOS ONE			English	Article							OSCILLATORY BRAIN ACTIVITY; TOP-DOWN FACILITATION; GAMMA-BAND ACTIVITY; EVOKED GAMMA; RESPONSES; STATISTICS; VISION; TASK; EEG	Background: Reactions to sensory events sometimes require quick responses whereas at other times they require a high degree of accuracy-usually resulting in slower responses. It is important to understand whether visual processing under different response speed requirements employs different neural mechanisms. Methodology/Principal Findings: We asked participants to classify visual patterns with different levels of detail as real-world or non-sense objects. In one condition, participants were to respond immediately, whereas in the other they responded after a delay of 1 second. As expected, participants performed more accurately in delayed response trials. This effect was pronounced for stimuli with a high level of detail. These behavioral effects were accompanied by modulations of stimulus related EEG gamma oscillations which are an electrophysiological correlate of early visual processing. In trials requiring speeded responses, early stimulus-locked oscillations discriminated real-world and non-sense objects irrespective of the level of detail. For stimuli with a higher level of detail, oscillatory power in a later time window discriminated real-world and non-sense objects irrespective of response speed requirements. Conclusions/Significance: Thus, it seems plausible to assume that different response speed requirements trigger different dynamics of processing.	[Fruend, Ingo; Busch, Niko A.; Schadow, Jeanette; Herrmann, Christoph S.] Otto Von Guericke Univ, Dept Biol Psychol, Inst Psychol, Magdeburg, Germany; [Fruend, Ingo; Herrmann, Christoph S.] Bernstein Grp Computat Neurosci, Magdeburg, Germany; [Fruend, Ingo] Leibniz Inst Neurobiol, Magdeburg, Germany; [Busch, Niko A.] Univ Paul Sabatier, CNRS, Ctr Rech Cerveau Cognit, Toulouse, France; [Gruber, Thomas] Univ Leipzig, Inst Psychol 1, Leipzig, Germany; [Koerner, Ursula] Honda Res Inst, Offenbach, Germany; [Herrmann, Christoph S.] Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Leipzig University; Honda Motor Company	Frund, I (corresponding author), Otto Von Guericke Univ, Dept Biol Psychol, Inst Psychol, Magdeburg, Germany.	christoph.herrmann@ovgu.de		Herrmann, Christoph/0000-0003-0323-2272; Busch, Niko/0000-0003-4837-0345	German Research Foundation [HE3353/2-2]; BMBF Bernstein Group Magdeburg	German Research Foundation(German Research Foundation (DFG)); BMBF Bernstein Group Magdeburg	JS was supported by the German Research Foundation (DFG, grant HE3353/2-2). IF was supported by the national network on computational neuroscience (BMBF Bernstein Group Magdeburg).	Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Basar E., 1980, EEG BRAIN DYNAMICS; BasarEroglu C, 1996, INT J PSYCHOPHYSIOL, V24, P101, DOI 10.1016/S0167-8760(96)00051-7; Busch NA, 2006, NEUROIMAGE, V29, P1106, DOI 10.1016/j.neuroimage.2005.09.009; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Busch NA, 2006, NEUROIMAGE, V33, P1169, DOI 10.1016/j.neuroimage.2006.07.034; Cariani PA, 2004, IEEE T NEURAL NETWOR, V15, P1100, DOI 10.1109/TNN.2004.833305; Doniger GM, 2000, J COGNITIVE NEUROSCI, V12, P615, DOI 10.1162/089892900562372; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Field DJ, 1999, PHILOS T R SOC A, V357, P2527, DOI 10.1098/rsta.1999.0446; Fisher NI, 1995, STAT ANAL CIRCULAR D; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Frund I, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-27; Frund I, 2007, CLIN NEUROPHYSIOL, V118, P221, DOI 10.1016/j.clinph.2006.09.013; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; Gruber T, 2006, BRAIN RES, V1097, P194, DOI 10.1016/j.brainres.2006.04.069; Herrmann C. S., 2005, EVENT RELATED POTENT, P229; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Herrmann CS, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-13; Herrmann CS, 2000, INT J PSYCHOPHYSIOL, V38, P265, DOI 10.1016/S0167-8760(00)00170-7; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Keselman HJ, 1998, PSYCHOPHYSIOLOGY, V35, P470, DOI 10.1111/1469-8986.3540470; Kording KP, 2000, NEURAL NETWORKS, V13, P1, DOI 10.1016/S0893-6080(99)00088-X; Korner E, 1999, NEURAL NETWORKS, V12, P989, DOI 10.1016/S0893-6080(99)00049-0; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Rodemann T, 2003, NEUROCOMPUTING, V52-4, P901, DOI 10.1016/S0925-2312(02)00827-5; Rodemann T, 2001, NEUROCOMPUTING, V38, P1541, DOI 10.1016/S0925-2312(01)00554-9; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; VanRullen R, 2002, VISION RES, V42, P2593, DOI 10.1016/S0042-6989(02)00298-5	40	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1675	10.1371/journal.pone.0001675	http://dx.doi.org/10.1371/journal.pone.0001675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301752	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500019
J	Janson, PCJ; Winerdal, ME; Marits, P; Thorn, M; Ohlsson, R; Winqvist, O				Janson, Peter C. J.; Winerdal, Malin E.; Marits, Per; Thorn, Magnus; Ohlsson, Rolf; Winqvist, Ola			FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans	PLOS ONE			English	Article								Background: Naturally occurring thymus derived regulatory T cells (Tregs) are central in the maintenance of self-tolerance. The transcription factor FOXP3 is crucial for the suppressive activity of Tregs and is considered the most specific marker for this population. However, human non regulatory T cells upregulate FOXP3 transiently upon activation which calls for other means to identify the Treg population. Since epigenetic mechanisms are involved in the establishment of stable gene expression patterns during cell differentiation, we hypothesized that the methylation profile of the FOXP3 promoter would allow the distinction of truly committed Tregs. Methodology/Principal Findings: Human CD4(+) CD25(hi) Tregs displayed a demethylated FOXP3 promoter (1.4%+/-0.95% SEM methylated) in contrast to CD4(+) CD25(lo) T cells which were partially methylated (27.9%+/-7.1%). Furthermore, stimulated CD4(+)CD25(lo) T cells transiently expressed FOXP3 but remained partially methylated, suggesting promoter methylation as a mechanism for regulation of stable FOXP3 expression and Treg commitment. In addition, transient FOXP3 expressing cells exhibited suppressive abilities that correlate to the methylation status of the FOXP3 promoter. As an alternative to bisulphite sequencing, we present a restriction enzyme based screening method for the identification of committed Tregs and apply this method to evaluate the effect of various culturing conditions. We show that a partial demethylation occurs in long-term cultures after activation, whereas the addition of TGF-beta and/or IL-10 does not induce any additional change in methylation level. Conclusions/Significance: The unique FOXP3 promoter methylation profile in Tregs suggests that a demethylated pattern is a prerequisite for stable FOXP3 expression and suppressive phenotype. Presently, FOXP3 is used to identify Tregs in several human diseases and there are future implications for adoptive Treg transfer in immunotherapy. In these settings there is a need to distinguish true Tregs from transiently FOXP3(+) activated T cells. The screening method we present allows this distinction and enables the identification of cells suitable for in vitro expansions and clinical use.	[Janson, Peter C. J.; Winerdal, Malin E.; Marits, Per; Winqvist, Ola] Karolinska Inst, Dept Med, Clin Allergy Res Unit, Stockholm, Sweden; [Thorn, Magnus] South Stockholm Gen Hosp, Dept Surg, Stockholm, Sweden; [Ohlsson, Rolf] Uppsala Univ, Evol Biol Ctr, Dept Dev & Genet, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Janson, PCJ (corresponding author), Karolinska Inst, Dept Med, Clin Allergy Res Unit, Stockholm, Sweden.	ola.winqvist@karolinska.se		winqvist, Ola/0000-0003-0842-4441	Swedish cancer society; Cancer and Allergy society; Hedlunds foundation; Lundberg foundation; Gustav V. foundation; Selander foundation; Soderbergs foundation	Swedish cancer society(Swedish Cancer Society); Cancer and Allergy society; Hedlunds foundation; Lundberg foundation(European Commission); Gustav V. foundation; Selander foundation; Soderbergs foundation	This work was supported by the Swedish cancer society, the Cancer and Allergy society, the Hedlunds foundation, the Lundberg foundation, Gustav V. foundation, the Selander foundation and the Soderbergs foundation.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clark LB, 1999, J IMMUNOL, V162, P2546; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2006, IMMUNOL REV, V212, P86, DOI 10.1111/j.0105-2896.2006.00426.x; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kriegel MA, 2004, J EXP MED, V199, P1285, DOI 10.1084/jem.20032158; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Taams LS, 2002, EUR J IMMUNOL, V32, P1621, DOI 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; TRAN DQ, 2007, BLOOD; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Wu B, 2007, J IMMUNOL, V178, P3688, DOI 10.4049/jimmunol.178.6.3688; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	42	178	192	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1612	10.1371/journal.pone.0001612	http://dx.doi.org/10.1371/journal.pone.0001612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286169	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400005
J	Guest, CB; Deszo, EL; Hartman, ME; York, JM; Kelley, KW; Freund, GG				Guest, Christopher B.; Deszo, Eric L.; Hartman, Matthew E.; York, Jason M.; Kelley, Keith W.; Freund, Gregory G.			Ca2+/Calmodulin-Dependent Kinase Kinase alpha Is Expressed by Monocytic Cells and Regulates the Activation Profile	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MURINE PERITONEAL-MACROPHAGES; ADENYLATE-CYCLASE ACTIVITY; PHORBOL ESTERS; INTRACELLULAR CALCIUM; TYROSINE PHOSPHORYLATION; TRYPANOSOMA-CRUZI; MOLECULAR-CLONING; INTERFERON-GAMMA; C ACTIVATION	Macrophages are capable of assuming numerous phenotypes in order to adapt to endogenous and exogenous challenges but many of the factors that regulate this process are still unknown. We report that Ca2+/calmodulin-dependent kinase kinase a (CaMKK alpha) is expressed in human monocytic cells and demonstrate that its inhibition blocks type-II monocytic cell activation and promotes classical activation. Affinity chromatography with paramagnetic beads isolated an approximately 50 kDa protein from nuclear lysates of U937 human monocytic cells activated with phorbol-12-myristate-13-acetate (PMA). This protein was identified as CaMKK alpha by mass spectrometry and Western analysis. The function of CaMKK alpha in monocyte activation was examined using the CaMKK alpha inhibitors (STO-609 and forskolin) and siRNA knockdown. Inhibition of CaMKKa, enhanced PMA-dependent CD86 expression and reduced CD11b expression. In addition, inhibition was associated with decreased translocation of CaMKK alpha to the nucleus. Finally, to further examine monocyte activation profiles, TNF alpha and IL-10 secretion were studied. CaMKK alpha inhibition attenuated PMA-dependent IL-10 production and enhanced TNFa production indicating a shift from type-II to classical monocyte activation. Taken together, these findings indicate an important new role for CaMKK alpha in the differentiation of monocytic cells.	[Guest, Christopher B.; Freund, Gregory G.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Deszo, Eric L.; Hartman, Matthew E.; York, Jason M.; Kelley, Keith W.; Freund, Gregory G.] Univ Illinois, Dept Animal Sci, Urbana, IL USA; [Freund, Gregory G.] Univ Illinois, Dept Pathol, Urbana, IL USA; [Guest, Christopher B.; Hartman, Matthew E.; Freund, Gregory G.] Univ Illinois, Dept Coll Med, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Guest, CB (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	freun@uiuc.edu		Kelley, Keith W./0000-0002-6837-8793; Hartman, Matt/0000-0002-6238-1887	National Institutes of Health [DK064862, NS046227]; Ruth Kirschstein Institutional National Research Service Award [5T32 DK59802]; Division of Nutritional Sciences; University of Illinois Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK059802, R01DK064862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS046227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Nutritional Sciences; University of Illinois Agricultural Experiment Station; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Institutes of Health (DK064862 to G.G.F, NS046227 to M.E.H., Ruth Kirschstein Institutional National Research Service Award 5T32 DK59802 to the Division of Nutritional Sciences and Predoctoral Fellowship to C.B.G.), University of Illinois Agricultural Experiment Station (to G.G.F.).	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; BUYS SS, 1984, CELL, V38, P569, DOI 10.1016/0092-8674(84)90511-7; CELADA A, 1986, J IMMUNOL, V137, P2373; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; Chin D, 2002, BIOCHEMISTRY-US, V41, P14001, DOI 10.1021/bi025640o; Deszo EL, 2004, CELL SIGNAL, V16, P271, DOI 10.1016/S0898-6568(03)00137-2; Deszo EL, 2001, J BIOL CHEM, V276, P10212, DOI 10.1074/jbc.M010589200; Engels FHC, 1999, P NATL ACAD SCI USA, V96, P10332, DOI 10.1073/pnas.96.18.10332; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Eto K, 1999, J BIOL CHEM, V274, P22556, DOI 10.1074/jbc.274.32.22556; FUKUDA N, 1989, JPN CIRC J, V53, P270, DOI 10.1253/jcj.53.270; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x; HAMILTON TA, 1985, J IMMUNOL, V134, P2631; HAMILTON TA, 1985, J BIOL CHEM, V260, P1378; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; HUANG FL, 1989, J BIOL CHEM, V264, P4238; Iribarren Pablo, 2002, BMC Immunol, V3, P6, DOI 10.1186/1471-2172-3-6; JOHNSON HM, 1985, P NATL ACAD SCI USA, V82, P5959, DOI 10.1073/pnas.82.17.5959; KARIMI K, 1995, J IMMUNOL, V155, P5786; Keenan C, 1997, IMMUNOLOGY, V90, P557, DOI 10.1046/j.1365-2567.1997.00198.x; KLEIN JB, 1990, J IMMUNOL, V144, P4305; Lin WW, 1998, BRIT J PHARMACOL, V125, P1601, DOI 10.1038/sj.bjp.0702219; MACNEIL S, 1985, CELL CALCIUM, V6, P213; MACNICOL M, 1992, J BIOL CHEM, V267, P12197; MALNOE A, 1985, J NEUROCHEM, V45, P1163, DOI 10.1111/j.1471-4159.1985.tb05537.x; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOON SO, 1984, P NATL ACAD SCI-BIOL, V81, P2298, DOI 10.1073/pnas.81.8.2298; MOSES RM, 1995, DEV BIOL, V171, P111, DOI 10.1006/dbio.1995.1264; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; Nakamura Y, 1996, NEUROSCI LETT, V204, P61, DOI 10.1016/0304-3940(96)12317-X; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; PACE JL, 1983, J IMMUNOL, V130, P2011; Planelles L, 2003, CLIN EXP IMMUNOL, V131, P41, DOI 10.1046/j.1365-2249.2003.02022.x; Rousseau G, 2001, EUR J PHARMACOL, V422, P53, DOI 10.1016/S0014-2999(01)01073-1; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; SAHYOUN N, 1991, P NATL ACAD SCI USA, V88, P2643, DOI 10.1073/pnas.88.7.2643; Sakagami H, 2000, EUR J NEUROSCI, V12, P89, DOI 10.1046/j.1460-9568.2000.00883.x; Schebesch C, 1997, IMMUNOLOGY, V92, P478, DOI 10.1046/j.1365-2567.1997.00371.x; SEBALDT RJ, 1990, J IMMUNOL, V145, P684; Skelton L, 2003, J IMMUNOL, V171, P1941, DOI 10.4049/jimmunol.171.4.1941; SMITH BM, 1983, CANCER RES, V43, P3385; SMITH BM, 1982, CELL CALCIUM, V3, P503, DOI 10.1016/0143-4160(82)90041-0; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SOMERS SD, 1986, J IMMUNOL, V136, P4199; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; TOKUMITSU H, 2002, BIOL CHEM, P277; Tzachanis D, 2002, BLOOD, V99, P1465, DOI 10.1182/blood.V99.4.1465; Uchi H, 2003, J INVEST DERMATOL, V120, P983, DOI 10.1046/j.1523-1747.2003.12250.x; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; WEIEL JE, 1985, J IMMUNOL, V134, P293; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	66	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1606	10.1371/journal.pone.0001606	http://dx.doi.org/10.1371/journal.pone.0001606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270593	Green Submitted, gold, Green Published			2022-12-27	WOS:000260535900040
J	Turner, EC; Snaddon, JL; Fayle, TM; Foster, WA				Turner, Edgar C.; Snaddon, Jake L.; Fayle, Tom M.; Foster, William A.			Oil Palm Research in Context: Identifying the Need for Biodiversity Assessment	PLOS ONE			English	Article							HABITAT; PLANTATIONS; DIVERSITY; FOREST; SABAH	Oil palm cultivation is frequently cited as a major threat to tropical biodiversity as it is centered on some of the world's most biodiverse regions. In this report, Web of Science was used to find papers on oil palm published since 1970, which were assigned to different subject categories to visualize their research focus. Recent years have seen a broadening in the scope of research, with a slight growth in publications on the environment and a dramatic increase in those on biofuel. Despite this, less than 1% of publications are related to biodiversity and species conservation. In the context of global vegetable oil markets, palm oil and soyabean account for over 60% of production but are the subject of less than 10% of research. Much more work must be done to establish the impacts of habitat conversion to oil palm plantation on biodiversity. Results from such studies are crucial for informing conservation strategies and ensuring sustainable management of plantations.	[Turner, Edgar C.; Snaddon, Jake L.; Fayle, Tom M.; Foster, William A.] Univ Museum Zool, Insect Ecol Grp, Cambridge, England	University of Cambridge	Turner, EC (corresponding author), Univ Museum Zool, Insect Ecol Grp, Cambridge, England.	ect23@cam.ac.uk	Fayle, Tom Maurice/A-2721-2009; Snaddon, Jake Lanion/C-8800-2011	Fayle, Tom Maurice/0000-0002-1667-1189; Snaddon, Jake Lanion/0000-0003-3549-5472; Turner, Edgar/0000-0003-2715-2234				Aratrakorn S, 2006, BIRD CONSERV INT, V16, P71, DOI 10.1017/S0959270906000062; Azlan JM, 2006, ORYX, V40, P36, DOI 10.1017/S0030605306000147; Balmford A, 2002, SCIENCE, V295, P2367; Basiron Y, 2007, EUR J LIPID SCI TECH, V109, P289, DOI 10.1002/ejlt.200600223; Chang MS, 1997, T ROY SOC TROP MED H, V91, P382, DOI 10.1016/S0035-9203(97)90248-0; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chung AYC, 2000, B ENTOMOL RES, V90, P475, DOI 10.1017/S0007485300000602; Davis ALV, 2005, ENVIRON ENTOMOL, V34, P1081, DOI 10.1603/0046-225X(2005)034[1081:EODOAS]2.0.CO;2; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Greathead D.J., 1983, Antenna, V7, P105; Hassall M, 2006, EUR J SOIL BIOL, V42, pS197, DOI 10.1016/j.ejsobi.2006.07.002; Henderson J, 2000, ENDEAVOUR, V24, P63, DOI 10.1016/S0160-9327(00)01293-X; Howard F.W., 2001, INSECTS PALMS, V131, DOI [10.1079/9780851993263.0000, DOI 10.1079/9780851993263.0000]; Koh LP, 2007, NATURE, V448, P993, DOI 10.1038/448993a; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Linkie M, 2003, ORYX, V37, P41, DOI 10.1017/S0030605303000103; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; Mariau D., 2001, FAUNA OIL PALM COCON; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Peh KSH, 2006, DIVERS DISTRIB, V12, P572, DOI 10.1111/j.1366-9516.2006.00257.x; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Samways M.J., 2005, INSECT DIVERSITY CON; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stone R, 2007, SCIENCE, V317, P1491, DOI 10.1126/science.317.5844.1491; 2008, WEB SCI ISI WEB SCI	25	51	54	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1572	10.1371/journal.pone.0001572	http://dx.doi.org/10.1371/journal.pone.0001572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270566	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900011
J	Ling, DI; Flores, LL; Riley, LW; Pai, M				Ling, Daphne I.; Flores, Laura L.; Riley, Lee W.; Pai, Madhukar			Commercial Nucleic-Acid Amplification Tests for Diagnosis of Pulmonary Tuberculosis in Respiratory Specimens: Meta-Analysis and Meta-Regression	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; COBAS AMPLICOR SYSTEM; AMPLIFIED DIRECT TEST; MYCOBACTERIUM-TUBERCULOSIS; GEN-PROBE; CLINICAL-EVALUATION; RAPID DIAGNOSIS; ABBOTT LCX; SPUTUM SPECIMENS; NONRESPIRATORY SPECIMENS	Background. Hundreds of studies have evaluated the diagnostic accuracy of nucleic-acid amplification tests (NAATs) for tuberculosis (TB). Commercial tests have been shown to give more consistent results than in-house assays. Previous meta-analyses have found high specificity but low and highly variable estimates of sensitivity. However, reasons for variability in study results have not been adequately explored. We performed a meta-analysis on the accuracy of commercial NAATs to diagnose pulmonary TB and meta-regression to identify factors that are associated with higher accuracy. Methodology/Principal Findings. We identified 2948 citations from searching the literature. We found 402 articles that met our eligibility criteria. In the final analysis, 125 separate studies from 105 articles that reported NAAT results from respiratory specimens were included. The pooled sensitivity was 0.85 (range 0.36-1.00) and the pooled specificity was 0.97 (range 0.54-1.00). However, both measures were significantly heterogeneous (p<.001). We performed subgroup and meta-regression analyses to identify sources of heterogeneity. Even after stratifying by type of commercial test, we could not account for the variability. In the meta-regression, the threshold effect was significant (p=.01) and the use of other respiratory specimens besides sputum was associated with higher accuracy. Conclusions/Significance. The sensitivity and specificity estimates for commercial NAATs in respiratory specimens were highly variable, with sensitivity lower and more inconsistent than specificity. Thus, summary measures of diagnostic accuracy are not clinically meaningful. The use of different cut-off values and the use of specimens other than sputum could explain some of the observed heterogeneity. Based on these observations, commercial NAATs alone cannot be recommended to replace conventional tests for diagnosing pulmonary TB. Improvements in diagnostic accuracy, particularly sensitivity, need to be made in order for this expensive technology to be worthwhile and beneficial in low-resource countries.	[Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Ling, Daphne I.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA USA; [Flores, Laura L.] San Francisco Gen Hosp, Div Pulmonary & Critical Care Med, San Francisco, CA USA; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA USA	McGill University; University of California System; University of California Berkeley; San Francisco General Hospital Medical Center; University of California System; University of California Berkeley	Pai, M (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Flores, Laura L/0000-0002-3574-2499				ABE C, 1993, J CLIN MICROBIOL, V31, P3270, DOI 10.1128/JCM.31.12.3270-3274.1993; Abu-Amero Khaled Khader, 2002, Molecular Biology Today, V3, P39; Al Zahrani K, 2001, INT J TUBERC LUNG D, V5, P855; Alcala L, 2001, DIAGN MICR INFEC DIS, V41, P51, DOI 10.1016/S0732-8893(01)00279-6; Artiles F, 2001, ENFERM INFEC MICR CL, V19, P53, DOI 10.1016/S0213-005X(01)72560-8; Ausina V, 1997, J CLIN MICROBIOL, V35, P1996, DOI 10.1128/JCM.35.8.1996-2002.1997; Barrett A, 2002, J MED MICROBIOL, V51, P895, DOI 10.1099/0022-1317-51-10-895; Basta PC, 2006, MEM I OSWALDO CRUZ, V101, P581, DOI 10.1590/S0074-02762006000600001; BEAVIS KG, 1995, J CLIN MICROBIOL, V33, P2582, DOI 10.1128/JCM.33.10.2582-2586.1995; Bennedsen J, 1996, J CLIN MICROBIOL, V34, P1407, DOI 10.1128/JCM.34.6.1407-1411.1996; Bergmann JS, 1998, J CLIN MICROBIOL, V36, P2766, DOI 10.1128/JCM.36.9.2766-2768.1998; Bergmann JS, 1996, J CLIN MICROBIOL, V34, P1083, DOI 10.1128/JCM.34.5.1083-1085.1996; Bergmann JS, 1999, J CLIN MICROBIOL, V37, P1419, DOI 10.1128/JCM.37.5.1419-1425.1999; Bergmann JS, 2000, J CLIN MICROBIOL, V38, P863, DOI 10.1128/JCM.38.2.863-865.2000; BODMER T, 1994, J CLIN MICROBIOL, V32, P1483, DOI 10.1128/JCM.32.6.1483-1487.1994; Bodmer T, 1996, J CLIN MICROBIOL, V34, P222, DOI 10.1128/JCM.34.1.222-223.1996; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Bogard M, 2001, EUR J CLIN MICROBIOL, V20, P724, DOI 10.1007/s100960100565; Bradley SP, 1996, AM J RESP CRIT CARE, V153, P1606, DOI 10.1164/ajrccm.153.5.8630609; CARPENTIER E, 1995, J CLIN MICROBIOL, V33, P3106, DOI 10.1128/JCM.33.12.3106-3110.1995; Cartuyvels R, 1996, J CLIN MICROBIOL, V34, P2001, DOI 10.1128/JCM.34.8.2001-2003.1996; Catanzaro A, 2000, JAMA-J AM MED ASSOC, V283, P639, DOI 10.1001/jama.283.5.639; *CDCP, 2001, CDC M TUB NUCL AC AM; Chedore P, 1999, DIAGN MICR INFEC DIS, V35, P185, DOI 10.1016/S0732-8893(99)00086-3; CHIN DP, 1995, AM J RESP CRIT CARE, V151, P1872, DOI 10.1164/ajrccm.151.6.7767534; Clarke M, 2003, COCHRANE REV HDB 4 2; Cohen RA, 1998, AM J RESP CRIT CARE, V157, P156, DOI 10.1164/ajrccm.157.1.97-06043; *COLL C, 1996, COCHR METH GROUP SYS; Coll P, 2003, INT J TUBERC LUNG D, V7, P886; DALEY PTS, 2007, INT J TUBERC LUNG D, V11, P1; DAMATO RF, 1995, J CLIN MICROBIOL, V33, P1832, DOI 10.1128/JCM.33.7.1832-1834.1995; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Della-Latta P, 1998, AM J CLIN PATHOL, V110, P301, DOI 10.1093/ajcp/110.3.301; Denis O, 1998, ZBL BAKT-INT J MED M, V288, P59; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; EGGER M, 2001, SYSTEMATIC REV HLTH, P347; EHLERS S, 1994, EUR J CLIN MICROBIOL, V13, P827, DOI 10.1007/BF02111344; Ehlers S, 1996, J CLIN MICROBIOL, V34, P2275, DOI 10.1128/JCM.34.9.2275-2279.1996; Fegou E, 2005, CLIN MICROBIOL INFEC, V11, P593, DOI 10.1111/j.1469-0691.2005.01185.x; Flores LL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-55; Gallina M, 2000, CHEST, V118, P28, DOI 10.1378/chest.118.1.28; Gamboa F, 1998, EUR J CLIN MICROBIOL, V17, P151, DOI 10.1007/s100960050039; Gamboa F, 1998, J CLIN MICROBIOL, V36, P684, DOI 10.1128/JCM.36.3.684-689.1998; Garrino MG, 1999, J CLIN MICROBIOL, V37, P229, DOI 10.1128/JCM.37.1.229-232.1999; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Goessens WHF, 2005, J CLIN MICROBIOL, V43, P2563, DOI 10.1128/JCM.43.6.2563-2566.2005; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; Gurkan O, 2002, INT J TUBERC LUNG D, V6, P538; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; HENGSTLER MKP, 1996, CLIN LAB, V42, P387; Hoffner SE, 1996, SCAND J INFECT DIS, V28, P59, DOI 10.3109/00365549609027151; Hoffner SE, 1996, TUBERCLE LUNG DIS, V77, P67, DOI 10.1016/S0962-8479(96)90078-7; Ichiyama S, 1996, J CLIN MICROBIOL, V34, P130, DOI 10.1128/JCM.34.1.130-133.1996; Ichiyama S, 1997, J CLIN MICROBIOL, V35, P3082, DOI 10.1128/JCM.35.12.3082-3085.1997; Iinuma Y, 1998, MICROBIOL IMMUNOL, V42, P281, DOI 10.1111/j.1348-0421.1998.tb02284.x; Iinuma Y, 2003, EUR J CLIN MICROBIOL, V22, P368, DOI 10.1007/s10096-003-0913-7; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; Jackson KM, 1996, PATHOLOGY, V28, P65, DOI 10.1080/00313029600169553; Jan IS, 1998, J FORMOS MED ASSOC, V97, P204; JONAS V, 1993, J CLIN MICROBIOL, V31, P2410, DOI 10.1128/JCM.31.9.2410-2416.1993; Jonsson B, 2003, SCAND J INFECT DIS, V35, P372, DOI 10.1080/00365540310012244; Jungkind D, 1996, J CLIN MICROBIOL, V34, P2778, DOI 10.1128/JCM.34.11.2778-2783.1996; Kim SY, 2004, DIAGN MICR INFEC DIS, V49, P13, DOI 10.1016/j.diagmicrobio.2003.11.008; Kivihya-Ndugga L, 2004, J CLIN MICROBIOL, V42, P1012, DOI 10.1128/JCM.42.3.1012-1015.2004; LAROCCO MT, 1994, EUR J CLIN MICROBIOL, V13, P726, DOI 10.1007/BF02276055; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Levidiotou S, 2003, EUR J CLIN MICROBIOL, V22, P349, DOI 10.1007/s10096-003-0931-5; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Lim TK, 2003, CHEST, V124, P902, DOI 10.1378/chest.124.3.902; Lim TK, 2000, CHEST, V118, P641, DOI 10.1378/chest.118.3.641; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; Lumb R, 1999, J CLIN MICROBIOL, V37, P3102, DOI 10.1128/JCM.37.10.3102-3107.1999; Maugein J, 2002, DIAGN MICR INFEC DIS, V44, P151, DOI 10.1016/S0732-8893(02)00427-3; McHugh TD, 2004, J MED MICROBIOL, V53, P1215, DOI 10.1099/jmm.0.45780-0; Michos AG, 2006, DIAGN MICR INFEC DIS, V54, P121, DOI 10.1016/j.diagmicrobio.2005.09.002; MILLER N, 1994, J CLIN MICROBIOL, V32, P393, DOI 10.1128/JCM.32.2.393-397.1994; Miragliotta G, 2005, MICROBIOLOGICA, V28, P67; Mitarai S, 2001, J MICROBIOL METH, V47, P339, DOI 10.1016/S0167-7012(01)00341-4; Moore DF, 1998, J CLIN MICROBIOL, V36, P1028, DOI 10.1128/JCM.36.4.1028-1031.1998; MOORE DF, 1995, J CLIN MICROBIOL, V33, P2686, DOI 10.1128/JCM.33.10.2686-2691.1995; Ni Riain U, 1998, IRISH J MED SCI, V167, P79; O'Sullivan CE, 2002, J CLIN MICROBIOL, V40, P1723, DOI 10.1128/JCM.40.5.1723-1727.2002; Oh EJ, 2001, J MICROBIOL METH, V46, P29, DOI 10.1016/S0167-7012(01)00254-8; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Pai M, 2004, NATL MED J INDIA, V17, P86; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P509, DOI 10.1586/14737159.6.4.509; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pai MMM, 2004, EVID BASED MED, V141, pA11, DOI DOI 10.1136/EBM.9.4.101; PAIM, 2004, NATL MED J INDIA, V17, P233; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; PFYFFER GE, 1994, J CLIN MICROBIOL, V32, P918, DOI 10.1128/JCM.32.4.918-923.1994; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P137, DOI 10.1128/JCM.37.1.137-140.1999; Pfyffer GE, 1996, J CLIN MICROBIOL, V34, P834, DOI 10.1128/JCM.34.4.834-841.1996; Piersimoni C, 2002, J CLIN MICROBIOL, V40, P4138, DOI 10.1128/JCM.40.11.4138-4142.2002; Piersimoni C, 2006, J CLIN MICROBIOL, V44, P20, DOI 10.1128/JCM.44.1.20-28.2006; Piersimoni C, 2003, J CLIN MICROBIOL, V41, P5355, DOI 10.1128/JCM.41.12.5355-5365.2003; Piersimoni C, 1998, J CLIN MICROBIOL, V36, P3601, DOI 10.1128/JCM.36.12.3601-3604.1998; Pounder JI, 2006, DIAGN MICR INFEC DIS, V54, P217, DOI 10.1016/j.diagmicrobio.2005.05.018; Putova I, 1996, Cent Eur J Public Health, V4, P91; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rajalahti I, 1998, J CLIN MICROBIOL, V36, P975, DOI 10.1128/JCM.36.4.975-978.1998; Rantakokko-Jalava K, 2001, ANN MED, V33, P55, DOI 10.3109/07853890109002060; Ribeiro Fabíola Karla Corrêa, 2004, Rev. Soc. Bras. Med. Trop., V37, P431, DOI 10.1590/S0037-86822004000600001; Rohner P, 1998, J CLIN MICROBIOL, V36, P3046, DOI 10.1128/JCM.36.10.3046-3047.1998; Roos BR, 1998, INT J TUBERC LUNG D, V2, P235; Ruiz-Serrano MJ, 1998, DIAGN MICR INFEC DIS, V32, P259, DOI 10.1016/S0732-8893(98)00079-0; Rusch-Gerdes S, 2004, DIAGN MICR INFEC DIS, V48, P265, DOI 10.1016/j.diagmicrobio.2003.10.015; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Salajka F, 2000, Monaldi Arch Chest Dis, V55, P9; Sarmiento OL, 2003, J CLIN MICROBIOL, V41, P3233, DOI 10.1128/JCM.41.7.3233-3240.2003; Scarparo C, 2000, J CLIN MICROBIOL, V38, P1559, DOI 10.1128/JCM.38.4.1559-1562.2000; SHEEHAN S, 1997, CLIN LAB, V43, P769; Shetty N, 2000, J CLIN PATHOL, V53, P924, DOI 10.1136/jcp.53.12.924; Shim TS, 2002, CHEST, V121, P774, DOI 10.1378/chest.121.3.774; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; Smith MB, 1999, ARCH PATHOL LAB MED, V123, P1101; Smith MB, 1997, DIAGN MICR INFEC DIS, V27, P113, DOI 10.1016/S0732-8893(97)00029-1; Soini H, 1996, J CLIN MICROBIOL, V34, P1829, DOI 10.1128/JCM.34.7.1829-1830.1996; Stauffer F, 1995, EUR J CLIN MICROBIOL, V14, P1046, DOI 10.1007/BF01590937; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Takakura S, 2005, J CLIN MICROBIOL, V43, P5435, DOI 10.1128/JCM.43.11.5435-5439.2005; Thomsen VO, 1998, APMIS, V106, P699, DOI 10.1111/j.1699-0463.1998.tb00214.x; Tonjum Tone, 1996, Clin Microbiol Infect, V2, P127, DOI 10.1111/j.1469-0691.1996.tb00218.x; Tortoli E, 1997, J CLIN MICROBIOL, V35, P2424, DOI 10.1128/JCM.35.9.2424-2426.1997; Tortoli E, 1999, DIAGN MICR INFEC DIS, V33, P173, DOI 10.1016/S0732-8893(98)00097-2; Viinanen AH, 2000, ANN MED, V32, P279, DOI 10.3109/07853890009011773; Viveiros M, 1999, INT J TUBERC LUNG D, V3, P508; VUORINEN P, 1995, J CLIN MICROBIOL, V33, P1856, DOI 10.1128/JCM.33.7.1856-1859.1995; Walsh A, 2004, INT J TUBERC LUNG D, V8, P609; Walter SD, 1999, J CLIN EPIDEMIOL, V52, P943, DOI 10.1016/S0895-4356(99)00086-4; Wang JY, 2006, J CLIN MICROBIOL, V44, P716, DOI 10.1128/JCM.44.3.716-719.2006; Wang JY, 2004, J CLIN MICROBIOL, V42, P4599, DOI 10.1128/JCM.42.10.4599-4603.2004; Wang SX, 1999, J CLIN MICROBIOL, V37, P1932, DOI 10.1128/JCM.37.6.1932-1934.1999; WELCH K, 1995, DIAGN MICR INFEC DIS, V22, P297, DOI 10.1016/0732-8893(95)00065-I; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; Wobeser WL, 1996, J CLIN MICROBIOL, V34, P134, DOI 10.1128/JCM.34.1.134-139.1996; Woods GL, 2001, ARCH PATHOL LAB MED, V125, P122; Yee Y. C., 2002, SMJ Singapore Medical Journal, V43, P415; ZAMORA JAV, 2006, BMC MED RES METHODOL, P6; ZOLNIRDOVC M, 1995, INFECTION, V23, P216, DOI 10.1007/BF01781200; AM J RESP CRIT CARE, V155, P1804; MMWR MORB MORTAL WKL, V49, P593	147	151	158	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1536	10.1371/journal.pone.0001536	http://dx.doi.org/10.1371/journal.pone.0001536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253484	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700008
J	Krol, HA; Krawczyk, PM; Bosch, KS; Aten, JA; Hol, EM; Reits, EA				Krol, Hilde A.; Krawczyk, Przemek M.; Bosch, Klazien S.; Aten, Jacob A.; Hol, Elly M.; Reits, Eric A.			Polyglutamine Expansion Accelerates the Dynamics of Ataxin-1 and Does Not Result in Aggregate Formation	PLOS ONE			English	Article								Background. Polyglutamine expansion disorders are caused by an expansion of the polyglutamine (polyQ) tract in the disease related protein, leading to severe neurodegeneration. All polyQ disorders are hallmarked by the presence of intracellular aggregates containing the expanded protein in affected neurons. The polyQ disorder SpinoCerebellar Ataxia 1 (SCA1) is caused by a polyQ-expansion in the ataxin-1 protein, which is thought to lead to nuclear aggregates. Methodology/Principal Findings. Using advanced live cell fluorescence microscopy and a filter retardation assay we show that nuclear accumulations formed by polyQ-expanded ataxin-1 do not resemble aggregates of other polyQ-expanded proteins. Instead of being static, insoluble aggregates, nuclear accumulations formed by the polyQ-expanded ataxin-1 showed enhanced intracellular kinetics as compared to wild-type ataxin-1. During mitosis, ataxin-1 accumulations redistributed equally among daughter cells, in contrast to polyQ aggregates. Interestingly, polyQ expansion did not affect the nuclear-cytoplasmic shuttling of ataxin-1 as proposed before. Conclusions/Significance. These results indicate that polyQ expansion does not necessarily lead to aggregate formation, and that the enhanced kinetics may affect the nuclear function of ataxin-1. The unexpected findings for a polyQ-expanded protein and their consequences for ongoing SCA1 research are discussed.	[Krol, Hilde A.; Krawczyk, Przemek M.; Bosch, Klazien S.; Aten, Jacob A.; Reits, Eric A.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Hol, Elly M.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Reits, EA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.a.reits@amc.uva.nl	Hol, Elly/J-2025-2019; Hol, Elly M/F-1891-2013	Hol, Elly/0000-0001-5604-2603; Hol, Elly M/0000-0001-5604-2603	NWO [Veni Grant]	NWO(Netherlands Organization for Scientific Research (NWO))	Supported by NWO-Veni grant	BEENA T, 1998, CLUES PATHOGENESIS S, P241; Burright EN, 1997, HUM MOL GENET, V6, P513, DOI 10.1093/hmg/6.4.513; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Hobdy-Henderson KC, 2003, TRAFFIC, V4, P681, DOI 10.1034/j.1600-0854.2003.00124.x; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Llorian M, 2005, J BIOL CHEM, V280, P38862, DOI 10.1074/jbc.M509185200; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATILLADUENAS A, 2007, CLIN GENETIC MOL PAT, P1; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; ROBITAILLE Y, 1995, ACTA NEUROPATHOL, V90, P572; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25	30	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1503	10.1371/journal.pone.0001503	http://dx.doi.org/10.1371/journal.pone.0001503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231590	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200016
J	Lohse, MB; Johnson, AD				Lohse, Matthew B.; Johnson, Alexander D.			Differential Phagocytosis of White versus Opaque Candida albicans by Drosophila and Mouse Phagocytes	PLOS ONE			English	Article								The human fungal pathogen Candida albicans resides asymptomatically in the gut of most healthy people but causes serious invasive diseases in immunocompromised patients. Many C. albicans strains have the ability to stochastically switch between distinct white and opaque cell types, but it is not known with certainty what role this switching plays in the physiology of the organism. Here, we report a previously undescribed difference between white and opaque cells, namely their interaction with host phagocytic cells. We show that both Drosophila hemocyte- derived S2 cells and mouse macrophage-derived RAW264.7 cells preferentially phagocytose white cells over opaque cells. This difference is seen both in the overall percentage of cultured cells that phagocytose white versus opaque C. albicans and in the average number of C. albicans taken up by each phagocytic cell. We conclude that susceptibility to phagocytosis by cells of the innate immune system is an important distinction between white and opaque C. albicans, and propose that one role of switching from the prevalent white form into the rarer opaque form may be to allow C. albicans to escape phagocytosis.	[Lohse, Matthew B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ajohnson@cgl.ucsf.edu			Ellison Medical Foundation [ID-SS-0628-04]; National Institutes of Health [A149187]; NSF [graduate research fellowship]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049187] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Ellison Medical Foundation grant ID-SS-0628-04 and National Institutes of Health RO1 grant A149187. MBL was supported by a NSF graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Geiger J, 2004, INFECT IMMUN, V72, P667, DOI 10.1128/IAI.72.2.667-677.2004; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Johnson A, 2003, NAT REV MICROBIOL, V1, P106, DOI 10.1038/nrmicro752; KOLOTILA MP, 1990, INFECT IMMUN, V58, P1174, DOI 10.1128/IAI.58.5.1174-1179.1990; Kvaal C, 1999, INFECT IMMUN, V67, P6652; Kvaal CA, 1997, INFECT IMMUN, V65, P4468, DOI 10.1128/IAI.65.11.4468-4475.1997; Lachke SA, 2003, INFECT IMMUN, V71, P4970, DOI 10.1128/IAI.71.9.4970-4976.2003; Lan CY, 2002, P NATL ACAD SCI USA, V99, P14907, DOI 10.1073/pnas.232566499; Lockhart SR, 2003, EUKARYOT CELL, V2, P49, DOI 10.1128/EC.2.1.49-61.2003; Marcil A, 2002, INFECT IMMUN, V70, P6319, DOI 10.1128/IAI.70.11.6319-6329.2002; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; RIKKERINK EHA, 1988, J BACTERIOL, V170, P895, DOI 10.1128/jb.170.2.895-899.1988; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; SOLL DR, 1993, TRENDS GENET, V9, P61, DOI 10.1016/0168-9525(93)90189-O; Soll DR, 2004, BIOESSAYS, V26, P10, DOI 10.1002/bies.10379; Srikantha T, 2006, EUKARYOT CELL, V5, P1674, DOI 10.1128/EC.00252-06; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	27	99	102	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1473	10.1371/journal.pone.0001473	http://dx.doi.org/10.1371/journal.pone.0001473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213381	Green Published, Green Submitted, gold			2022-12-27	WOS:000260503900018
J	Wang, Y; Werz, C; Xu, DB; Chen, ZH; Li, Y; Hafen, E; Bergmann, A				Wang, Yuan; Werz, Christian; Xu, Dongbin; Chen, Zhihong; Li, Ying; Hafen, Ernst; Bergmann, Andreas			Drosophila cbl Is Essential for Control of Cell Death and Cell Differentiation during Eye Development	PLOS ONE			English	Article								Background. Activation of cell surface receptors transduces extracellular signals into cellular responses such as proliferation, differentiation and survival. However, as important as the activation of these receptors is their appropriate spatial and temporal down-regulation for normal development and tissue homeostasis. The Cbl family of E3-ubiquitin ligases plays a major role for the ligand-dependent inactivation of receptor tyrosine kinases (RTKs), most notably the Epidermal Growth Factor Receptor (EGFR) through ubiquitin-mediated endocytosis and lysosomal degradation. Methodology/Principal Findings. Here, we report the mutant phenotypes of Drosophila cbl (D-cbl) during eye development. D-cbl mutants display overgrowth, inhibition of apoptosis, differentiation defects and increased ommatidial spacing. Using genetic interaction and molecular markers, we show that most of these phenotypes are caused by increased activity of the Drosophila EGFR. Our genetic data also indicate a critical role of ubiquitination for D-cbl function, consistent with biochemical models. Conclusions/Significance. These data may provide a mechanistic model for the understanding of the oncogenic activity of mammalian cbl genes.	[Werz, Christian; Hafen, Ernst] Eidgenoss Tech Hochschule Zurich, Inst Mol Syst Biol, Zurich, Switzerland; [Wang, Yuan; Xu, Dongbin; Chen, Zhihong; Li, Ying] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bergmann, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	abergman@mdanderson.org	Xu, Dongbin/C-1469-2012		National Institutes of Health (NIH) [GM068016]; MD Anderson DNA Analysis Core Facility [CA16672]; NIH Cancer Center; Robert A. Welch Foundation [G-1496]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068016] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson DNA Analysis Core Facility; NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) grant GM068016 to AB. Sequencing by the MD Anderson DNA Analysis Core Facility was supported by the NIH Cancer Center support grant CA16672. We gratefully acknowledge support by the Robert A. Welch Foundation (G-1496).	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BASLER K, 1991, CELL, V64, P1069, DOI 10.1016/0092-8674(91)90262-W; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Cordero J, 2004, MECH DEVELOP, V121, P1523, DOI 10.1016/j.mod.2004.07.004; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Karim FD, 1996, GENETICS, V143, P315; Kramer S, 1999, DEVELOPMENT, V126, P2515; KRETZSCHMAR D, 1992, EMBO J, V11, P2531, DOI 10.1002/j.1460-2075.1992.tb05318.x; Krieser RJ, 2007, DEVELOPMENT, V134, P2407, DOI 10.1242/dev.02860; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; Kwak EL, 2006, CLIN CANCER RES, V12, P4283, DOI 10.1158/1078-0432.CCR-06-0189; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; LEBOVITZ RM, 1986, DEV BIOL, V117, P663, DOI 10.1016/0012-1606(86)90335-0; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Newsome TP, 2000, DEVELOPMENT, V127, P851; OKANO H, 1992, DIFFERENTIATION, V52, P1, DOI 10.1111/j.1432-0436.1992.tb00494.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Robertson H, 2000, ONCOGENE, V19, P3299, DOI 10.1038/sj.onc.1203624; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tio M, 1997, DEVELOPMENT, V124, P343; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Werz C, 2005, DEVELOPMENT, V132, P5343, DOI 10.1242/dev.02150; Xu D, 2006, CELL DEATH DIFFER, V13, P1697, DOI 10.1038/sj.cdd.4401920; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; XU T, 1993, DEVELOPMENT, V117, P1223; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Yu SY, 2002, DEVELOPMENT, V129, P3269	65	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1447	10.1371/journal.pone.0001447	http://dx.doi.org/10.1371/journal.pone.0001447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197257	Green Submitted, gold, Green Published			2022-12-27	WOS:000260503800018
J	Zhu, QJ; Liu, C; Ge, Z; Fang, XL; Zhang, X; Straat, K; Bjorkholm, M; Xu, DW				Zhu, Qingjun; Liu, Cheng; Ge, Zheng; Fang, Xiaolei; Zhang, Xi; Straat, Klas; Bjorkholm, Magnus; Xu, Dawei			Lysine-Specific Demethylase 1 (LSD1) Is Required for the Transcriptional Repression of the Telomerase Reverse Transcriptase (hTERT) Gene	PLOS ONE			English	Article								Background. Lysine-specific demethylase 1 (LSD1), catalysing demethylation of mono- and di-methylated histone H3-K4 or K9, exhibits diverse transcriptional activities by mediating chromatin reconfiguration. The telomerase reverse transcriptase (hTERT) gene, encoding an essential component for telomerase activity that is involved in cellular immortalization and transformation, is silent in most normal human cells while activated in up to 90% of human cancers. It remains to be defined how exactly the transcriptional activation of the hTERT gene occurs during the oncogenic process. Methodology/Principal Findings. In the present study, we determined the effect of LSD1 on hTERT transcription. In normal human fibroblasts with a tight hTERT repression, a pharmacological inhibition of LSD1 led to a weak hTERT expression, and a robust induction of hTERT mRNA was observed when LSD1 and histone deacetylases (HDACs) were both inhibited. Small interference RNA-mediated depletion of both LSD1 and CoREST, a co-repressor in HDAC-containing complexes, synergistically activated hTERT transcription. In cancer cells, inhibition of LSD1 activity or knocking-down of its expression led to significant increases in levels of hTERT mRNA and telomerase activity. Chromatin immunoprecipitation assay showed that LSD1 occupied the hTERT proximal promoter, and its depletion resulted in elevated di-methylation of histone H3-K4 accompanied by increased H3 acetylation locally in cancer cells. Moreover, during the differentiation of leukemic HL60 cells, the decreased hTERT expression was accompanied by the LSD1 recruitment to the hTERT promoter. Conclusions/Significance. LSD1 represses hTERT transcription via demethylating H3-K4 in normal and cancerous cells, and together with HDACs, participates in the establishment of a stable repression state of the hTERT gene in normal or differentiated malignant cells. The findings contribute to better understandings of hTERT/telomerase regulation, which may be implicated in the development of therapeutic strategies for telomerase dysregulation-associated human diseases including cancers.	[Zhu, Qingjun] Shandong Univ Traditional Chinese Med, Coll Basic Med Sci, Jinan, Peoples R China; [Fang, Xiaolei] Shandong Univ, Second Hosp, Inst Urol, Jinan, Peoples R China; [Zhang, Xi] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Peoples R China; [Zhu, Qingjun; Liu, Cheng; Ge, Zheng; Straat, Klas; Bjorkholm, Magnus; Xu, Dawei] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Div Hematol, Stockholm, Sweden	Shandong University of Traditional Chinese Medicine; Shandong University; Shandong University; Karolinska Institutet; Karolinska University Hospital	Xu, DW (corresponding author), Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Div Hematol, Stockholm, Sweden.	Dawei.Xu@ki.se		Xu, Dawei/0000-0003-3141-4524	Swedish Cancer Society; Cancer Society in Stockholm; Swedish Research Council; Swedish Society of Medicine; Stockholm County Council; Karolinsks Institute Foundation	Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Stockholm County Council(Stockholm County Council); Karolinsks Institute Foundation	This study was supported by grants from The Swedish Cancer Society, the Cancer Society in Stockholm, the Swedish Research Council, Swedish Society of Medicine, Stockholm County Council and the Karolinsks Institute Foundation (D Xu). The funders played no part in the work related to this manuscript.	Albanell J, 1996, CANCER RES, V56, P1503; Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Holt SE, 1996, MOL CELL BIOL, V16, P2932; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Horikawa I, 1999, CANCER RES, V59, P826; Hou M, 2002, EXP CELL RES, V274, P25, DOI 10.1006/excr.2001.5462; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kumakura S, 2005, CANCER RES, V65, P2778, DOI 10.1158/0008-5472.CAN-04-1819; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Liu C, 2007, CANCER RES, V67, P2626, DOI 10.1158/0008-5472.CAN-06-4126; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Sharma HW, 1995, P NATL ACAD SCI USA, V92, P12343, DOI 10.1073/pnas.92.26.12343; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang SW, 2004, J BIOL CHEM, V279, P55401, DOI 10.1074/jbc.M411352200; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Xu D, 1996, LEUKEMIA, V10, P1354; Xu DW, 1998, BRIT J HAEMATOL, V102, P1367, DOI 10.1046/j.1365-2141.1998.00969.x; Xu DW, 2001, P NATL ACAD SCI USA, V98, P3826, DOI 10.1073/pnas.071043198; Zhang W, 1996, CLIN CANCER RES, V2, P799	46	24	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1446	10.1371/journal.pone.0001446	http://dx.doi.org/10.1371/journal.pone.0001446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197256	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503800017
J	Gaulin, E; Madoui, MA; Bottin, A; Jacquet, C; Mathe, C; Couloux, A; Wincker, P; Dumas, B				Gaulin, Elodie; Madoui, Mohammed-Amine; Bottin, Arnaud; Jacquet, Christophe; Mathe, Catherine; Couloux, Arnaud; Wincker, Patrick; Dumas, Bernard			Transcriptome of Aphanomyces euteiches: New Oomycete Putative Pathogenicity Factors and Metabolic Pathways	PLOS ONE			English	Article							PARASITICA VAR.-NICOTIANAE; FACTORS AFFECTING GROWTH; PHYTOPHTHORA-PARASITICA; TRYPANOTHIONE REDUCTASE; EFFECTOR PROTEINS; GENE DISCOVERY; PLANT; REVEALS; RESISTANCE; VIRULENCE	Aphanomyces euteiches is an oomycete pathogen that causes seedling blight and root rot of legumes, such as alfalfa and pea. The genus Aphanomyces is phylogenically distinct from well-studied oomycetes such as Phytophthora sp., and contains species pathogenic on plants and aquatic animals. To provide the first foray into gene diversity of A. euteiches, two cDNA libraries were constructed using mRNA extracted from mycelium grown in an artificial liquid medium or in contact to plant roots. A unigene set of 7,977 sequences was obtained from 18,864 high-quality expressed sequenced tags (ESTs) and characterized for potential functions. Comparisons with oomycete proteomes revealed major differences between the gene content of A. euteiches and those of Phytophthora species, leading to the identification of biosynthetic pathways absent in Phytophthora, of new putative pathogenicity genes and of expansion of gene families encoding extracellular proteins, notably different classes of proteases. Among the genes specific of A. euteiches are members of a new family of extracellular proteins putatively involved in adhesion, containing up to four protein domains similar to fungal cellulose binding domains. Comparison of A. euteiches sequences with proteomes of fully sequenced eukaryotic pathogens, including fungi, apicomplexa and trypanosomatids, allowed the identification of A. euteiches genes with close orthologs in these microorganisms but absent in other oomycetes sequenced so far, notably transporters and non-ribosomal peptide synthetases, and suggests the presence of a defense mechanism against oxidative stress which was initially characterized in the pathogenic trypanosomatids.	[Gaulin, Elodie; Madoui, Mohammed-Amine; Bottin, Arnaud; Jacquet, Christophe; Mathe, Catherine; Dumas, Bernard] Univ Toulouse, Univ Toulouse 3, CNRS, UMR 5546, Castanet Tolosan, France; [Couloux, Arnaud; Wincker, Patrick] Genoscope CEA, Evry, France; [Couloux, Arnaud; Wincker, Patrick] CNRS, UMR 8030, Evry, France; [Couloux, Arnaud; Wincker, Patrick] Univ Evry, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Gaulin, E (corresponding author), Univ Toulouse, Univ Toulouse 3, CNRS, UMR 5546, Castanet Tolosan, France.	gaulin@scsv.ups-tlse.fr; dumas@scsv.ups-tlse.fr	Dumas, Bernard/D-1751-2009; Madoui, Mohammed-Amin/AAF-3374-2021; jacquet, Christophe/B-2563-2009; Madoui, Mohammed-Amin/ABC-1017-2020; Bottin, Arnaud/A-9436-2010; Mathé, Catherine/A-9205-2012; Madoui, Mohammed-Amin/GYD-9411-2022; BOTTIN, Arnaud/ABF-6872-2020	Dumas, Bernard/0000-0002-4138-3533; Madoui, Mohammed-Amin/0000-0003-4809-2971; jacquet, Christophe/0000-0002-7377-5638; Bottin, Arnaud/0000-0003-1466-1558; Couloux, Arnaud/0000-0003-2356-0062; Gaulin, Elodie/0000-0003-0572-8749	CNRS; University of Toulouse; Genoscope	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse; Genoscope	This work was funded by CNRS, University of Toulouse (Toulouse III) and Genoscope.	Akamatsu HO, 2007, J MICROBIOL METH, V71, P82, DOI 10.1016/j.mimet.2007.08.001; Alphey MS, 1999, J BIOL CHEM, V274, P25613, DOI 10.1074/jbc.274.36.25613; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2007, INT REV CYTOL, V262, P1, DOI 10.1016/S0074-7696(07)62001-4; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazer VS, 2002, J AQUAT ANIM HEALTH, V14, P1, DOI 10.1577/1548-8667(2002)014&lt;0001:AIIAMA&gt;2.0.CO;2; BOLLINGER JM, 1995, J BIOL CHEM, V270, P14031, DOI 10.1074/jbc.270.23.14031; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Costanzo S, 2006, FUNGAL GENET BIOL, V43, P707, DOI 10.1016/j.fgb.2006.04.006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELWICHE PA, 1987, PLANT DIS, V71, P155, DOI 10.1094/PD-71-0155; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Gajendran K, 2006, NUCLEIC ACIDS RES, V34, pD465, DOI 10.1093/nar/gkj119; Gaulin E, 2002, J CELL SCI, V115, P4565, DOI 10.1242/jcs.00138; Gaulin E, 2007, MOL PLANT PATHOL, V8, P539, DOI [10.1111/j.1364-3703.2007.00413.x, 10.1111/j.1364-3703.2007.00413.X]; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Gornhardt B, 2000, MOL PLANT MICROBE IN, V13, P32, DOI 10.1094/MPMI.2000.13.1.32; Gotesson A, 2002, MOL PLANT MICROBE IN, V15, P907, DOI 10.1094/MPMI.2002.15.9.907; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; Hauser M, 2001, MOL MEMBR BIOL, V18, P105, DOI 10.1080/713816114; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Jiang RHY, 2006, MOL BIOL EVOL, V23, P338, DOI 10.1093/molbev/msj039; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; Judelson HS, 2006, MOL PLANT PATHOL, V7, P17, DOI [10.1111/J.1364-3703.2005.00313.X, 10.1111/j.1364-3703.2004.00256.x-i1]; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; LARSSON M, 1994, MYCOL RES, V98, P231, DOI 10.1016/S0953-7562(09)80191-3; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; LEBERRE JY, 2007, NEW PHYTOL, P1; Lee BN, 2005, EUKARYOT CELL, V4, P545, DOI 10.1128/EC.4.3.545-555.2005; Levenfors JP, 2003, EUR J PLANT PATHOL, V109, P535, DOI 10.1023/A:1024711428760; Madoui MA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-471; Martin HL, 2003, AUST J EXP AGR, V43, P1281, DOI 10.1071/EA02150; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; MITCHELL JE, 1966, PHYTOPATHOLOGY, V56, P917; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Panabieres F, 2005, FUNGAL GENET BIOL, V42, P611, DOI 10.1016/j.fgb.2005.03.002; PAPAVIZAS GC, 1960, AM J BOT, V47, P758, DOI 10.2307/2439112; Pilet-Nayel ML, 2005, PHYTOPATHOLOGY, V95, P1287, DOI 10.1094/PHYTO-95-1287; Ponchet M, 1999, CELL MOL LIFE SCI, V56, P1020, DOI 10.1007/s000180050491; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robold AV, 2005, CURR GENET, V47, P307, DOI 10.1007/s00294-004-0559-8; SejalonDelmas N, 1997, PHYTOPATHOLOGY, V87, P899, DOI 10.1094/PHYTO.1997.87.9.899; Soderhall Kenneth, 1999, Freshwater Crayfish, V12, P11; Stacey G, 2002, TRENDS PLANT SCI, V7, P257, DOI 10.1016/S1360-1385(02)02249-5; Susko E, 2004, BIOINFORMATICS, V20, P2279, DOI 10.1093/bioinformatics/bth239; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Torto-Alalibo TA, 2007, MOL PLANT MICROBE IN, V20, P781, DOI 10.1094/MPMI-20-7-0781; Tovar J, 1998, MOL MICROBIOL, V29, P653, DOI 10.1046/j.1365-2958.1998.00968.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Waugh M, 2000, NUCLEIC ACIDS RES, V28, P87, DOI 10.1093/nar/28.1.87; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wicker E, 2001, EUR J PLANT PATHOL, V107, P919, DOI 10.1023/A:1013171217610; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Yan HZ, 2005, FUNGAL GENET BIOL, V42, P339, DOI 10.1016/j.fgb.2005.01.003; Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881	74	77	79	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1723	10.1371/journal.pone.0001723	http://dx.doi.org/10.1371/journal.pone.0001723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320043	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600019
J	Jin, QM; Wei, GB; Lin, Z; Sugai, JV; Lynch, SE; Ma, PX; Giannobile, WV				Jin, Qiming; Wei, Guobao; Lin, Zhao; Sugai, James V.; Lynch, Samuel E.; Ma, Peter X.; Giannobile, William V.			Nanofibrous Scaffolds Incorporating PDGF-BB Microspheres Induce Chemokine Expression and Tissue Neogenesis In Vivo	PLOS ONE			English	Article								Platelet-derived growth factor (PDGF) exerts multiple cellular effects that stimulate wound repair in multiple tissues. However, a major obstacle for its successful clinical application is the delivery system, which ultimately controls the in vivo release rate of PDGF. Polylactic-co-glycolic acid (PLGA) microspheres (MS) in nanofibrous scaffolds (NFS) have been shown to control the release of rhPDGF-BB in vitro. In order to investigate the effects of rhPDGF-BB release from MS in NFS on gene expression and enhancement of soft tissue engineering, rhPDGF-BB was incorporated into differing molecular weight (MW) polymeric MS. By controlling the MW of the MS over a range of 6.5 KDa-64 KDa, release rates of PDGF can be regulated over periods of weeks to months in vitro. The NFS-MS scaffolds were divided into multiple groups based on MS release characteristics and PDGF concentration ranging from 2.5-25.0 mg and evaluated in vivo in a soft tissue wound repair model in the dorsa of rats. At 3, 7, 14 and 21 days post-implantation, the scaffold implants were harvested followed by assessments of cell penetration, vasculogenesis and tissue neogenesis. Gene expression profiles using cDNA microarrays were performed on the PDGF-releasing NFS. The percentage of tissue invasion into MS-containing NFS at 7 days was higher in the PDGF groups when compared to controls. Blood vessel number in the HMW groups containing either 2.5 or 25 mg PDGF was increased above those of other groups at 7d (p<0.01). Results from cDNA array showed that PDGF strongly enhanced in vivo gene expression of the CXC chemokine family members such as CXCL1, CXCL2 and CXCL5. Thus, sustained release of rhPDGF-BB, controlled by slow-releasing MS associated with the NFS delivery system, enhanced cell migration and angiogenesis in vivo, and may be related to an induced expression of chemokine-related genes. This approach offers a technology to accurately control growth factor release to promote soft tissue engineering in vivo.	[Jin, Qiming; Lin, Zhao; Sugai, James V.; Giannobile, William V.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Wei, Guobao; Ma, Peter X.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI USA; [Lynch, Samuel E.] Biomimetic Therapeutics Inc, Franklin, TN USA; [Ma, Peter X.] Univ Michigan, Sch Dent, Dept Biol & Material Sci, Ann Arbor, MI USA; [Giannobile, William V.] Univ Michigan, Sch Dent, Michigan Ctr Oral Hlth Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jin, QM (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	wgiannob@umich.edu	X, Peter/E-4895-2011	Giannobile, William/0000-0002-7102-9746	National Institutes of Health [DE15384, DE14755, DE13397]; AO Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015384, R21DE014755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the National Institutes of Health DE15384 and DE14755 (MPX), and DE13397 and AO Foundation (WVG).	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Chin A, 2006, EXP GERONTOL, V41, P63, DOI 10.1016/j.exger.2005.10.012; Cooke JW, 2006, TISSUE ENG, V12, P1441, DOI 10.1089/ten.2006.12.1441; Faisant N, 2002, EUR J PHARM SCI, V15, P355, DOI 10.1016/S0928-0987(02)00023-4; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Issa R, 2006, AM J PHYSIOL-LUNG C, V291, pL66, DOI 10.1152/ajplung.00384.2005; Jin QM, 2003, J BIOMED MATER RES A, V67A, P54, DOI 10.1002/jbm.a.10058; Kaigler Darnell, 2006, Expert Opin Drug Deliv, V3, P647, DOI 10.1517/17425247.3.5.647; Kaminski WE, 2001, BLOOD, V97, P1990, DOI 10.1182/blood.V97.7.1990; KAPLAN DR, 1979, BLOOD, V53, P1043; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee S, 2006, J MICROENCAPSUL, V23, P741, DOI 10.1080/09687860600945552; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Nirodi CS, 2000, WOUND REPAIR REGEN, V8, P371, DOI 10.1046/j.1524-475x.2000.00371.x; Ostman A, 2001, ADV CANCER RES, V80, P1, DOI 10.1016/S0065-230X(01)80010-5; Ramseier CA, 2006, DENT CLIN N AM, V50, pix; Ramseier Christoph A, 2006, Dent Clin North Am, V50, P245, DOI 10.1016/j.cden.2005.12.001; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; RYSECK RP, 1989, EXP CELL RES, V180, P266, DOI 10.1016/0014-4827(89)90230-9; Sarment DP, 2006, J CLIN PERIODONTOL, V33, P135, DOI 10.1111/j.1600-051X.2005.00870.x; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Steed DL, 2006, PLAST RECONSTR SURG, V117, p143S, DOI 10.1097/01.prs.0000222526.21512.4c; Taba M Jr, 2005, Orthod Craniofac Res, V8, P292; Wang WZ, 2006, PLAST RECONSTR SURG, V117, P138, DOI 10.1097/01.prs.0000185610.36051.67; Wang XT, 2006, PLAST RECONSTR SURG, V117, P129, DOI 10.1097/01.prs.0000185609.07293.3e; Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011; Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; Zolnik BS, 2006, J CONTROL RELEASE, V112, P293, DOI 10.1016/j.jconrel.2006.02.015; Zymek P, 2006, J AM COLL CARDIOL, V48, P2315, DOI 10.1016/j.jacc.2006.07.060	41	65	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1729	10.1371/journal.pone.0001729	http://dx.doi.org/10.1371/journal.pone.0001729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320048	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586600024
J	Wickramarachchi, T; Devi, YS; Mohmmed, A; Chauhan, VS				Wickramarachchi, Thilan; Devi, Yengkhom S.; Mohmmed, Asif; Chauhan, Virander S.			Identification and Characterization of a Novel Plasmodium falciparum Merozoite Apical Protein Involved in Erythrocyte Binding and Invasion	PLOS ONE			English	Article							MALARIA PARASITES; RHOPTRY PROTEIN; MOVING JUNCTION; ANTIGEN; VIVAX; EXPRESSION; DOMAINS; STAGE; LOCALIZATION; TRANSFECTION	Proteins that coat Plasmodium falciparum merozoite surface and those secreted from its apical secretory organelles are considered promising candidates for the vaccine against malaria. In the present study, we have identified an asparagine rich parasite protein (PfAARP; Gene ID PFD1105w), that harbors a predicted signal sequence, a C-terminal transmembrane region and whose transcription and translation patterns are similar to some well characterized merozoite surface/apical proteins. PfAARP was localized to the apical end of the merozoites by GFP-targeting approach using an inducible, schizont-stage expression system, by immunofluorescence assays using anti-PfAARP antibodies. Immuno-electron microsopic studies showed that PfAARP is localized in the apical ends of the rhoptries in the merozoites. RBC binding assays with PfAARP expressed on COS cells surface showed that it binds to RBCs through its N-terminal region with a receptor on the RBC surface that is sensitive to trypsin and neuraminidase treatments. Sequencing of PfAARP from different P. falciparum strains as well as field isolates showed that the N-terminal region is highly conserved. Recombinant protein corresponding to the N-terminal region of PfAARP (PfAARP-N) was produced in its functional form in E. coli. PfAARP-N showed reactivity with immune sera from individuals residing in P. falciparum endemic area. The anti-PfAARP-N rabbit antibodies significantly inhibited parasite invasion in vitro. Our data on localization, functional assays and invasion inhibition, suggest a role of PfAARP in erythrocyte binding and invasion by the merozoite.	[Wickramarachchi, Thilan; Devi, Yengkhom S.; Mohmmed, Asif; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Wickramarachchi, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India.	amohd@icgeb.res.in; virander@icgeb.res.in	Chauhan, Virander S./K-5276-2019		International Post-doctoral research fellowship from ICGEB	International Post-doctoral research fellowship from ICGEB	TW was supported by International Post-doctoral research fellowship from ICGEB.	Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; [Anonymous], 2000, METHODS MALARIA RES; Barale JC, 1997, INFECT IMMUN, V65, P3003, DOI 10.1128/IAI.65.8.3003-3010.1997; Blair PL, 2002, NUCLEIC ACIDS RES, V30, P2224, DOI 10.1093/nar/30.10.2224; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; CLARK JT, 1987, PARASITOL RES, V73, P425, DOI 10.1007/BF00538200; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 2004, METH MOL B, V270, P263; CREWTHER PE, 1990, EXP PARASITOL, V70, P193, DOI 10.1016/0014-4894(90)90100-Q; Dasaradhi PVN, 2005, BIOCHEM BIOPH RES CO, V336, P1062, DOI 10.1016/j.bbrc.2005.08.213; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Ghoneim A, 2007, PARASITOL INT, V56, P31, DOI 10.1016/j.parint.2006.11.001; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hiller NL, 2003, J BIOL CHEM, V278, P48413, DOI 10.1074/jbc.M307266200; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howard RF, 1995, MOL BIOCHEM PARASIT, V74, P43, DOI 10.1016/0166-6851(95)02481-6; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Mohmmed A, 2005, PARASITE IMMUNOL, V27, P197, DOI 10.1111/j.1365-3024.2005.00759.x; OEUVRAY C, 1994, BLOOD, V84, P1594; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; PROELLOCKS NI, 2007, INT J PARAS IN PRESS; RAJAGOPALAN PK, 1990, INDIAN J MED RES-A, V91, P44; Ramasamy G, 2007, MOL BIOCHEM PARASIT, V152, P139, DOI 10.1016/j.molbiopara.2007.01.002; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rich SM, 2000, PARASITOL TODAY, V16, P390, DOI 10.1016/S0169-4758(00)01741-5; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Sachdeva S, 2006, VACCINE, V24, P2007, DOI 10.1016/j.vaccine.2005.11.041; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Wickramarachchi T, 2006, INFECT IMMUN, V74, P798, DOI 10.1128/IAI.74.1.798-801.2006; Zhang KY, 1999, PARASITOL RES, V85, P956, DOI 10.1007/s004360050666	60	51	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1732	10.1371/journal.pone.0001732	http://dx.doi.org/10.1371/journal.pone.0001732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320051	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600027
J	Esposito, CL; D'Alessio, A; De Franciscis, V; Cerchia, L				Esposito, Carla Lucia; D'Alessio, Amelia; De Franciscis, Vittorio; Cerchia, Laura			RETRACTED: A Cross-Talk between TrkB and Ret Tyrosine Kinases Receptors Mediates Neuroblastoma Cells Differentiation (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							NEUROTROPHIC FACTOR; EXPRESSION; HETERODIMERIZATION; ACTIVATION; MECHANISM; TRANSACTIVATION; PATHWAYS; INSIGHTS; ALPHA; BDNF	Understanding the interplay between intracellular signals initiated by multiple receptor tyrosine kinases (RTKs) to give the final cell phenotype is a major pharmacological challenge. Retinoic acid (RA)-treatment of neuroblastoma (NB) cells implicates activation of Ret and TrkB RTKs as critical step to induce cell differentiation. By studying the signaling interplay between TrkB and Ret as paradigmatic example, here we demonstrate the existence of a cross-talk mechanism between the two unrelated receptors that is needed to induce the cell differentiation. Indeed, we show that TrkB receptor promotes Ret phosphorylation by a mechanism that does not require GDNF. This reveals to be a key mechanism, since blocking either TrkB or Ret by small interfering RNA causes a failure in NB biochemical and morphological differentiation. Our results provide the first evidence that a functional transactivation between distinct tyrosine kinases receptors is required for an important physiological process.	[Esposito, Carla Lucia; De Franciscis, Vittorio; Cerchia, Laura] CNR, Ist Endocrinol & Oncol Sperimentale G Salvatore, I-80125 Naples, Italy; [D'Alessio, Amelia] INT Fdn Pascale, Cell Biol & Preclin Models Unit, Naples, Italy; [Esposito, Carla Lucia] Univ Naples Federico II, Dept Biol Patol Cell Mol, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Fondazione Pascale; University of Naples Federico II	Esposito, CL (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale G Salvatore, I-80125 Naples, Italy.	cerchia@unina.it	Esposito, Carla L/K-5246-2016	Esposito, Carla L/0000-0003-0624-6821	European Molecular Imaging Laboratory (EMIL) Network [LSH-2004-503569]; MIUR-FIRB [RBIN04J4J7]; Associazione Italiana per la Ricerca sul Cancro (AIRC)	European Molecular Imaging Laboratory (EMIL) Network; MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the European Molecular Imaging Laboratory (EMIL) Network (LSH-2004-503569), by the MIUR-FIRB grant (#RBIN04J4J7), and by the Associazione Italiana per la Ricerca sul Cancro (AIRC) grant to LC.	Amoresano A, 2005, CELL SIGNAL, V17, P717, DOI 10.1016/j.cellsig.2004.10.012; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; BUNONE G, 1995, EXP CELL RES, V217, P92, DOI 10.1006/excr.1995.1067; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cerchia L, 2003, BIOCHEM J, V372, P897, DOI 10.1042/BJ20021530; Cerchia L, 2006, MOL CANCER RES, V4, P481, DOI 10.1158/1541-7786.MCR-06-0050; DIMITROULAKOS J, 1994, CELL GROWTH DIFFER, V5, P373; Edwin Francis, 2006, V327, P1; Eide FF, 1996, J NEUROSCI, V16, P3123; Faraone D, 2006, BLOOD, V107, P1896, DOI 10.1182/blood-2005-04-1524; Fischer Oliver M., 2006, V327, P85; Graves Lee M, 2002, Mol Interv, V2, P208, DOI 10.1124/mi.2.4.208; Hecht M, 2005, CARCINOGENESIS, V26, P2105, DOI 10.1093/carcin/bgi192; Hunter T, 1998, Harvey Lect, V94, P81; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; MATSUMOTO K, 1995, CANCER RES, V55, P1798; MATSUSHIMA H, 1993, MOL CELL BIOL, V13, P7447, DOI 10.1128/MCB.13.12.7447; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Peluso G, 2001, FASEB J, V15, P1604, DOI 10.1096/fj.00-0727fje; Peterson S, 2004, ONCOGENE, V23, P213, DOI 10.1038/sj.onc.1206980; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; ROSSI A, 1992, INT J DEV NEUROSCI, V10, P527, DOI 10.1016/0736-5748(92)90053-3; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sawai H, 2005, CANCER RES, V65, P11536, DOI 10.1158/0008-5472.CAN-05-2843; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tsui-Pierchala B, 2002, NEURON, V33, P261, DOI 10.1016/S0896-6273(01)00585-2; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6	35	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1643	10.1371/journal.pone.0001643	http://dx.doi.org/10.1371/journal.pone.0001643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286198	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400036
J	Fajardo, A; Martinez-Martin, N; Mercadillo, M; Galan, JC; Ghysels, B; Matthijs, S; Cornelis, P; Wiehlmann, L; Tummler, B; Baquero, F; Martinez, JL				Fajardo, Alicia; Martinez-Martin, Nadia; Mercadillo, Maria; Galan, Juan C.; Ghysels, Bart; Matthijs, Sandra; Cornelis, Pierre; Wiehlmann, Lutz; Tuemmler, Burkhard; Baquero, Fernando; Martinez, Jose L.			The Neglected Intrinsic Resistome of Bacterial Pathogens	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; CAENORHABDITIS-ELEGANS; MECHANISMS; MYCOBACTERIUM; INFECTIONS; SELECTION	Bacteria with intrinsic resistance to antibiotics are a worrisome health problem. It is widely believed that intrinsic antibiotic resistance of bacterial pathogens is mainly the consequence of cellular impermeability and activity of efflux pumps. However, the analysis of transposon-tagged Pseudomonas aeruginosa mutants presented in this article shows that this phenotype emerges from the action of numerous proteins from all functional categories. Mutations in some genes make P. aeruginosa more susceptible to antibiotics and thereby represent new targets. Mutations in other genes make P. aeruginosa more resistant and therefore define novel mechanisms for mutation-driven acquisition of antibiotic resistance, opening a new research field based in the prediction of resistance before it emerges in clinical environments. Antibiotics are not just weapons against bacterial competitors, but also natural signalling molecules. Our results demonstrate that antibiotic resistance genes are not merely protective shields and offer a more comprehensive view of the role of antibiotic resistance genes in the clinic and in nature.	[Fajardo, Alicia; Martinez-Martin, Nadia; Martinez, Jose L.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain; [Mercadillo, Maria; Galan, Juan C.; Baquero, Fernando; Martinez, Jose L.] Hosp Ramon & Cajal, CSIC, Unidad Asoc Ctr Nacl Biotecnol, Madrid, Spain; [Galan, Juan C.; Baquero, Fernando; Martinez, Jose L.] Hosp Ramon & Cajal, CIBERESP, Madrid, Spain; [Galan, Juan C.; Baquero, Fernando] Hosp Ramon & Cajal, Dept Microbiol, Madrid, Spain; [Ghysels, Bart; Matthijs, Sandra; Cornelis, Pierre] Free Univ Brussels, Flanders Interuniver, Inst Biotechnol, Dept Mol & Cell Interact, Lab Microb Interact, Brussels, Belgium; [Wiehlmann, Lutz; Tuemmler, Burkhard] Hannover Med Sch, Klin Forschergruppe, Hannover, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hannover Medical School	Fajardo, A (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain.	jlmtnez@cnb.uam.es	Garcia-Armisen, Tamara/A-6173-2008; Cornelis, Pierre/H-3058-2019; Martinez, Jose L/C-4100-2008; Martinez, Jose L/A-4725-2013	Martinez, Jose L/0000-0001-8813-7607; Fajardo Lubian, Alicia/0000-0002-9537-4878	Spanish Ministerio de Educacion y Ciencia [fellowship];  [BIO2005-04278];  [LSHM-CT-2005-518152];  [LSHM-CT-2005-018705]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); ; ; 	This work was supported by grants BIO2005-04278, LSHM-CT-2005-518152 and LSHM-CT-2005-018705. AF is the recipient of a fellowship from the Spanish Ministerio de Educacion y Ciencia. The funders did not play any role in this study, including those described above.	Ainsa JA, 1997, MOL MICROBIOL, V24, P431, DOI 10.1046/j.1365-2958.1997.3471717.x; Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Alonso A, 1999, MICROBIOL-SGM, V145, P2857, DOI 10.1099/00221287-145-10-2857; Atlas R. M., 1993, HDB MICROBIOLOGICAL; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Davies JE, 1997, CIBA F SYMP, V207, P15; de Chial M, 2003, MICROBIOL-SGM, V149, P821, DOI 10.1099/mic.0.26136-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gales AC, 2001, CLIN INFECT DIS, V32, pS146, DOI 10.1086/320186; Gatell J M, 1996, Semin Respir Infect, V11, P119; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Gould SJ, 1999, P NATL ACAD SCI USA, V96, P11904, DOI 10.1073/pnas.96.21.11904; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; Hogan D, 2002, CURR OPIN MICROBIOL, V5, P472, DOI 10.1016/S1369-5274(02)00357-0; Lee N, 2003, DRUGS, V63, P1511, DOI 10.2165/00003495-200363140-00006; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Levy SB, 1998, NEW ENGL J MED, V338, P1376, DOI 10.1056/NEJM199805073381909; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; LURIA SE, 1957, J BACTERIOL, V74, P461, DOI 10.1002/path.1700740226; Macinga David R., 1999, Frontiers in Bioscience, V4, pD132, DOI 10.2741/Macinga; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MARTINEZ JL, 1994, EUR J CLIN MICROBIOL, V13, P1015, DOI 10.1007/BF02111820; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Morales G, 2004, J BACTERIOL, V186, P4228, DOI 10.1128/JB.186.13.4228-4237.2004; Navas A, 2007, P NATL ACAD SCI USA, V104, P13728, DOI 10.1073/pnas.0704497104; Navon-Venezia S, 2005, CURR OPIN INFECT DIS, V18, P306, DOI 10.1097/01.qco.0000171920.44809.f0; Nikaido H, 2001, SEMIN CELL DEV BIOL, V12, P215, DOI 10.1006/scdb.2000.0247; PANG Y, 1994, ANTIMICROB AGENTS CH, V38, P1408, DOI 10.1128/AAC.38.6.1408; Quinn JP, 1998, CLIN INFECT DIS, V27, pS117, DOI 10.1086/514912; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Sambrook J., 2001, MOL CLONING LAB MANU; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Smith DL, 2004, P NATL ACAD SCI USA, V101, P3709, DOI 10.1073/pnas.0400456101; Spiers AJ, 2000, MICROBIOL-SGM, V146, P2345, DOI 10.1099/00221287-146-10-2345; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; WHO, 2000, OV ANT RES; WIEHLMANN L, 2002, GENOME LETT, V1, P1; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044	48	204	210	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1619	10.1371/journal.pone.0001619	http://dx.doi.org/10.1371/journal.pone.0001619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286176	Green Published, gold			2022-12-27	WOS:000260586400012
J	Patthey, C; Gunhaga, L; Edlund, T				Patthey, Cedric; Gunhaga, Lena; Edlund, Thomas			Early Development of the Central and Peripheral Nervous Systems Is Coordinated by Wnt and BMP Signals	PLOS ONE			English	Article							NEURAL CREST; EXPRESSION PATTERNS; GENE-EXPRESSION; INDUCTION; SPECIFICATION; CHARACTER; CELLS; LENS; DIFFERENTIATION; MESODERM	The formation of functional neural circuits that process sensory information requires coordinated development of the central and peripheral nervous systems derived from neural plate and neural plate border cells, respectively. Neural plate, neural crest and rostral placodal cells are all specified at the late gastrula stage. How the early development of the central and peripheral nervous systems are coordinated remains, however, poorly understood. Previous results have provided evidence that at the late gastrula stage, graded Wnt signals impose rostrocaudal character on neural plate cells, and Bone Morphogenetic Protein (BMP) signals specify olfactory and lens placodal cells at rostral forebrain levels. By using in vitro assays of neural crest and placodal cell differentiation, we now provide evidence that Wnt signals impose caudal character on neural plate border cells at the late gastrula stage, and that under these conditions, BMP signals induce neural crest instead of rostral placodal cells. We also provide evidence that both caudal neural and caudal neural plate border cells become independent of further exposure to Wnt signals at the head fold stage. Thus, the status of Wnt signaling in ectodermal cells at the late gastrula stage regulates the rostrocaudal patterning of both neural plate and neural plate border, providing a coordinated spatial and temporal control of the early development of the central and peripheral nervous systems.	[Patthey, Cedric; Gunhaga, Lena; Edlund, Thomas] Umea Univ, Umea Ctr Mol Med, Umea, Sweden	Umea University	Patthey, C (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	thomas.edlund@ucmm.umu.se		Patthey, Cedric/0000-0002-2627-9578	Swedish Medical Research Council; Foundation for Strategic Research; European Union	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Foundation for Strategic Research; European Union(European Commission)	TE is supported by the Swedish Medical Research Council, the Foundation for Strategic Research and European Union research programs.	Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; BEEBE DC, 1981, DEV BIOL, V84, P96, DOI 10.1016/0012-1606(81)90374-2; Bhattacharyya S, 2004, DEV BIOL, V271, P403, DOI 10.1016/j.ydbio.2004.04.010; Carmona-Fontaine C, 2007, DEV BIOL, V309, P208, DOI 10.1016/j.ydbio.2007.07.006; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641; Comte I, 2004, DEV BRAIN RES, V148, P1, DOI 10.1016/j.devbrainres.2003.08.011; COULY GF, 1985, DEV BIOL, V110, P422, DOI 10.1016/0012-1606(85)90101-0; COULY GF, 1993, DEVELOPMENT, V117, P409; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Del Barrio MG, 2004, DEV DYNAM, V229, P136, DOI 10.1002/dvdy.10456; Endo Y, 2002, DEVELOPMENT, V129, P863; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Faure S, 2002, DEV BIOL, V244, P44, DOI 10.1006/dbio.2002.0579; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Gunhaga L, 2003, NAT NEUROSCI, V6, P701, DOI 10.1038/nn1068; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hidalgo-Sanchez M, 1999, MECH DEVELOP, V81, P175, DOI 10.1016/S0925-4773(98)00224-X; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kos R, 2001, DEVELOPMENT, V128, P1467; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Liu JP, 1998, DEVELOPMENT, V125, P5055; Marklund M, 2004, DEVELOPMENT, V131, P4323, DOI 10.1242/dev.01308; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Olander S, 2006, MECH DEVELOP, V123, P166, DOI 10.1016/j.mod.2005.11.001; Raible DW, 2005, SEMIN CELL DEV BIOL, V16, P673, DOI 10.1016/j.semcdb.2005.06.008; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Sjodal M, 2007, DEV CELL, V13, P141, DOI 10.1016/j.devcel.2007.04.020; Taneyhill LA, 2005, MOL BIOL CELL, V16, P5283, DOI 10.1091/mbc.e05-03-0210; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Wilson SI, 2001, NATURE, V411, P325, DOI 10.1038/35077115; Wu JL, 2005, DEV BIOL, V279, P220, DOI 10.1016/j.ydbio.2004.12.016	42	51	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1625	10.1371/journal.pone.0001625	http://dx.doi.org/10.1371/journal.pone.0001625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286182	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586400018
J	Phillipson, M; Kaur, J; Colarusso, P; Ballantyne, CM; Kubes, P				Phillipson, Mia; Kaur, Jaswinder; Colarusso, Pina; Ballantyne, Christie M.; Kubes, Paul			Endothelial Domes Encapsulate Adherent Neutrophils and Minimize Increases in Vascular Permeability in Paracellular and Transcellular Emigration	PLOS ONE			English	Article								Local edema, a cardinal sign of inflammation associates closely with neutrophil emigration. Neutrophil emigration has been described to occur primarily through endothelial junctions (paracellular) and more rarely directly through endothelial cells (transcellular). Recently, we reported that unlike in wild-type (wt) mice, Mac-1-/- (CD11b) neutrophils predominantly emigrated transcellularly and was significantly delayed taking 20-30 min longer than the paracellular emigration (wt). In the present study we noted significant anatomical disruption of the endothelium and hypothesized that transcellular emigration would greatly increase vascular permeability. Surprisingly, despite profound disruption of the endothelial barrier as the neutrophils moved through the cells, the changes in vascular permeability during transcellular emigration (Mac-1-/-) were not increased more than in wt mice. Instead increased vascular permeability completely tracked the number of emigrated cells and as such, permeability changes were delayed in Mac-1-/- mice. However, by 60 min neutrophils from both sets of mice were emigrating in large numbers. Electron-microscopy and spinning disk multichannel fluorescence confocal microscopy revealed endothelial docking structures that progressed to dome-like structures completely covering wt and Mac-1-/- neutrophils. These domes completely enveloped the emigrating neutrophils in both wt and Mac-1-/- mice making the mode of emigration underneath these structures extraneous to barrier function. In conclusion, predominantly paracellular versus predominantly transcellular emigration does not affect vascular barrier integrity as endothelial dome-like structures retain barrier function.	[Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Kaur, Jaswinder; Colarusso, Pina; Kubes, Paul] Univ Calgary, Dept Physiol & Biophys, Immunol Res Grp, Calgary, AB, Canada; [Ballantyne, Christie M.] Baylor Coll Med, Methodist DeBakey Heart Ctr, Ctr Cardiovascular Dis Prevent, Houston, TX USA	Uppsala University; University of Calgary; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Phillipson, M (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	pkubes@ucalgary.ca	Ballantyne, Christie/A-6599-2008	Ballantyne, Christie/0000-0002-6432-1730; Phillipson, Mia/0000-0002-2387-0266	Canadian Institute of Health Research (CIHR); Swedish Research Council [57X-20675-01-4, 57P-20680-01-4]; Swedish Society for Medical Research; Canadian Association of Gastroenterology [Postdoctoral fellow]; Alberta Heritage Foundation for Medical Research	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; Canadian Association of Gastroenterology; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by the Canadian Institute of Health Research (CIHR), CIHR group grant and the CIHR training grant, Swedish Research Council (57X-20675-01-4, 57P-20680-01-4) and Swedish Society for Medical Research (SSMF). M. Phillipson is a Canadian Association of Gastroenterology Postdoctoral fellow. P.K. is an Alberta Heritage Foundation for Medical Research Scientist and a holder of a Canada Research Chair and the Phoebe, Calvin and Joan Snyder Chair in Critical Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARFORS KE, 1987, BLOOD, V69, P338; Bonnardel-Phu E, 2000, J VASC RES, V37, P32, DOI 10.1159/000025711; Burns AR, 1997, J IMMUNOL, V159, P2893; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Cook-Mills JM, 2005, J LEUKOCYTE BIOL, V77, P487, DOI 10.1189/jlb.0904554; Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Hordijk PL, 2006, FEBS J, V273, P4408, DOI 10.1111/j.1742-4658.2006.05440.x; Kanwar S, 1997, J EXP MED, V185, P1077, DOI 10.1084/jem.185.6.1077; KUROSE I, 1993, CIRC RES, V73, P164, DOI 10.1161/01.RES.73.1.164; LEWIS RE, 1989, MICROVASC RES, V37, P53, DOI 10.1016/0026-2862(89)90072-1; LEWIS RE, 1988, MICROVASC RES, V35, P27, DOI 10.1016/0026-2862(88)90048-9; LEY K, 1986, MICROVASC RES, V31, P84, DOI 10.1016/0026-2862(86)90009-9; Lister KJ, 2007, MICROCIRCULATION, V14, P709, DOI 10.1080/10739680701404879; Liu LX, 2005, J EXP MED, V201, P409, DOI 10.1084/jem.20040830; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Petri B, 2006, FEBS J, V273, P4399, DOI 10.1111/j.1742-4658.2006.05439.x; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; ROSENGREN S, 1991, J APPL PHYSIOL, V71, P1322, DOI 10.1152/jappl.1991.71.4.1322; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	28	79	81	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1649	10.1371/journal.pone.0001649	http://dx.doi.org/10.1371/journal.pone.0001649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18297135	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400042
J	Neres, R; Marinho, CRF; Goncalves, LA; Catarino, MB; Penha-Goncalves, C				Neres, Rita; Marinho, Claudio R. F.; Goncalves, Ligia A.; Catarino, Manuela Beirao; Penha-Goncalves, Carlos			Pregnancy Outcome and Placenta Pathology in Plasmodium berghei ANKA Infected Mice Reproduce the Pathogenesis of Severe Malaria in Pregnant Women	PLOS ONE			English	Article								Pregnancy-associated malaria (PAM) is expressed in a range of clinical complications that include increased disease severity in pregnant women, decreased fetal viability, intra-uterine growth retardation, low birth weight and infant mortality. The physiopathology of malaria in pregnancy is difficult to scrutinize and attempts were made in the past to use animal models for pregnancy malaria studies. Here, we describe a comprehensive mouse experimental model that recapitulates many of the pathological and clinical features typical of human severe malaria in pregnancy. We used P. berghei ANKA-GFP infection during pregnancy to evoke a prominent inflammatory response in the placenta that entails CD11b mononuclear infiltration, up-regulation of MIP-1 alpha chemokine and is associated with marked reduction of placental vascular spaces. Placenta pathology was associated with decreased fetal viability, intra-uterine growth retardation, gross post-natal growth impairment and increased disease severity in pregnant females. Moreover, we provide evidence that CSA and HA, known to mediate P. falciparum adhesion to human placenta, are also involved in mouse placental malaria infection. We propose that reduction of maternal blood flow in the placenta is a key pathogenic factor in murine pregnancy malaria and we hypothesize that exacerbated innate inflammatory responses to Plasmodium infected red blood cells trigger severe placenta pathology. This experimental model provides an opportunity to identify cell and molecular components of severe PAM pathogenesis and to investigate the inflammatory response that leads to the observed fetal and placental blood circulation abnormalities.	[Neres, Rita; Marinho, Claudio R. F.; Goncalves, Ligia A.; Penha-Goncalves, Carlos] Gulbenkian Inst Sci, Oeiras, Portugal; [Catarino, Manuela Beirao] Univ Lisbon, Fac Farm, Lisbon, Portugal	Universidade de Lisboa	Neres, R (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	cpenha@igc.gulbenkian.pt	Penha-Goncalves, Carlos/F-4640-2012; Gonçalves, Lígia Antunes/F-6242-2014; Marinho, Claudio Romero Farias/F-7507-2012	Gonçalves, Lígia Antunes/0000-0001-9804-6899; Marinho, Claudio Romero Farias/0000-0002-1227-3845; Penha-Goncalves, Carlos/0000-0001-7225-1907; Neres, Rita/0000-0003-1794-4377	Fundacao para a Ciencia e Tecnologia, Portugal	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work, RN and CRFM were supported by the Fundacao para a Ciencia e Tecnologia, Portugal. Fundacao para a Ciencia e Tecnologia had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript	Adachi M, 2000, J PARASITOL, V86, P1030, DOI 10.1645/0022-3395(2000)086[1030:SPIBCM]2.0.CO;2; Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; AKINGBADE OA, 1992, J REPROD MED, V37, P273; Albieri A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-34; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214; Beeson JG, 2004, J INFECT DIS, V189, P169, DOI 10.1086/380975; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Benirschke K, 1998, CLIN ANAT, V11, P194, DOI 10.1002/(SICI)1098-2353(1998)11:3<194::AID-CA8>3.0.CO;2-T; Brabin BJ, 2004, ANN TROP PAEDIATR, V24, P311, DOI 10.1179/027249304225019136; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; CHAOUAT G, 1983, IMMUNOL REV, V75, P31, DOI 10.1111/j.1600-065X.1983.tb01090.x; Cot M, 1998, ANN TROP MED PARASIT, V92, P37, DOI 10.1080/00034989860157; Cross JC, 2002, MOL CELL ENDOCRINOL, V187, P207, DOI 10.1016/S0303-7207(01)00703-1; CURRIE GA, 1967, LANCET, V1, P708; Davison BB, 2000, AM J TROP MED HYG, V63, P158, DOI 10.4269/ajtmh.2000.63.158; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DESOWITZ RS, 1989, AM J TROP MED HYG, V41, P630, DOI 10.4269/ajtmh.1989.41.630; Desowitz RS, 1999, ANN TROP MED PARASIT, V93, P415, DOI 10.1080/00034989958429; DESOWITZ RS, 2001, MALARIA PREGNANCY; Diouf I, 2004, J INFECT DIS, V189, P2235, DOI 10.1086/420791; Engwerda CR, 2005, TRENDS PARASITOL, V21, P75, DOI 10.1016/j.pt.2004.11.008; Fievet N, 1995, AM J TROP MED HYG, V53, P612; Freyre A, 2006, EXP PARASITOL, V113, P154, DOI 10.1016/j.exppara.2005.12.019; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fusai T, 2000, MOL BIOCHEM PARASIT, V108, P25, DOI 10.1016/S0166-6851(00)00199-7; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; GREENWOOD AM, 1992, T ROY SOC TROP MED H, V86, P483, DOI 10.1016/0035-9203(92)90078-Q; GUILBERT L, 1993, IMMUNOL CELL BIOL, V71, P49, DOI 10.1038/icb.1993.5; Guleria I, 2000, NAT MED, V6, P589, DOI 10.1038/75074; HIOKI A, 1990, J PROTOZOOL, V37, P163, DOI 10.1111/j.1550-7408.1990.tb01121.x; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; HVIID L, 2007, AM J PATHOL, V6, P6; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Krishnan L, 1996, J IMMUNOL, V156, P644; le Cessie S, 2002, ARCH DIS CHILD-FETAL, V86, P182, DOI 10.1136/fn.86.3.F182; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Muthusamy A, 2004, AM J PATHOL, V164, P2013, DOI 10.1016/S0002-9440(10)63761-3; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; ODUOLA AMJ, 1982, J PROTOZOOL, V29, P77, DOI 10.1111/j.1550-7408.1982.tb02883.x; ODUOLA AMJ, 1986, EXP PARASITOL, V62, P181, DOI 10.1016/0014-4894(86)90022-6; PATHAK G, 1990, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V34, P139; PAVIA CS, 1991, AM J TROP MED HYG, V44, P176, DOI 10.4269/ajtmh.1991.44.176; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; Pouvelle B, 1998, INFECT IMMUN, V66, P4950, DOI 10.1128/IAI.66.10.4950-4956.1998; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; RILEY EM, 1989, AM J TROP MED HYG, V40, P141, DOI 10.4269/ajtmh.1989.40.141; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1058, DOI 10.1016/0002-9378(95)91326-2; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schwarzer E, 2001, PARASITOLOGY, V123, P125, DOI 10.1017/S0031182001008216; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Smith NC, 1996, PARASITOL TODAY, V12, P4, DOI 10.1016/0169-4758(96)80637-5; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Sullivan AD, 2000, PLACENTA, V21, P417, DOI 10.1053/plac.1999.0479; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; TEGOSHI T, 1992, AM J TROP MED HYG, V47, P643, DOI 10.4269/ajtmh.1992.47.643; VANZON AAJC, 1980, TROPENMED PARASITOL, V31, P402; VANZON AAJC, 1980, INFECT IMMUN, V28, P630; WALTER PR, 1982, AM J PATHOL, V109, P330	73	81	83	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1608	10.1371/journal.pone.0001608	http://dx.doi.org/10.1371/journal.pone.0001608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270595	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900042
J	Opiyo, N; Were, F; Govedi, F; Fegan, G; Wasunna, A; English, M				Opiyo, Newton; Were, Fred; Govedi, Fridah; Fegan, Greg; Wasunna, Aggrey; English, Mike			Effect of Newborn Resuscitation Training on Health Worker Practices in Pumwani Hospital, Kenya	PLOS ONE			English	Article							NEONATAL RESUSCITATION; DELIVERY; MULTICENTER	Background: Birth asphyxia kills 0.7 to 1.6 million newborns a year globally with 99% of deaths in developing countries. Effective newborn resuscitation could reduce this burden of disease but the training of health-care providers in low income settings is often outdated. Our aim was to determine if a simple one day newborn resuscitation training (NRT) alters health worker resuscitation practices in a public hospital setting in Kenya. Methods/Principal Findings: We conducted a randomised, controlled trial with health workers receiving early training with NRT (n = 28) or late training (the control group, n = 55). The training was adapted locally from the approach of the UK Resuscitation Council. The primary outcome was the proportion of appropriate initial resuscitation steps with the frequency of inappropriate practices as a secondary outcome. Data were collected on 97 and 115 resuscitation episodes over 7 weeks after early training in the intervention and control groups respectively. Trained providers demonstrated a higher proportion of adequate initial resuscitation steps compared to the control group (trained 66% vs control 27%; risk ratio 2.45, [95% CI 1.75-3.42], p<0.001, adjusted for clustering). In addition, there was a statistically significant reduction in the frequency of inappropriate and potentially harmful practices per resuscitation in the trained group (trained 0.53 vs control 0.92; mean difference 0.40, [95% CI 0.13-0.66], p = 0.004). Conclusions/Significance: Implementation of a simple, one day newborn resuscitation training can be followed immediately by significant improvement in health workers' practices. However, evidence of the effects on long term performance or clinical outcomes can only be established by larger cluster randomised trials.	[Opiyo, Newton; Fegan, Greg; English, Mike] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya; [Were, Fred; Wasunna, Aggrey] Univ Nairobi, Coll Hlth Sci, Dept Paediat & Child Hlth, Nairobi, Kenya; [Govedi, Fridah] Pumwani Maternity Hosp, Nairobi, Kenya; [Fegan, Greg] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [English, Mike] Univ Oxford, Dept Paediat, Oxford, England	Kenya Medical Research Institute; University of Nairobi; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Opiyo, N (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya.	nopiyo@nairobi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018	Fegan, Greg W/0000-0002-2663-2765; English, Michael/0000-0002-7427-0826	Laerdal Foundation of Acute Medicine, Norway; Wellcome Trust [076827]	Laerdal Foundation of Acute Medicine, Norway; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported in part by a grant from the Laerdal Foundation of Acute Medicine, Norway and in part by a Wellcome Trust Senior Research Fellowship awarded to Mike English (#076827). The Laerdal foundation had no role in the design or conduct of the study, made no contribution to the data analysis nor report writing and their permission to publish the results was not sought.	Baskett PJF, 2005, RESUSCITATION, V67, pS181, DOI 10.1016/j.resuscitation.2005.10.006; BERDEN H, 1983, BRIT MED J, V306, P1576; Carbine DN, 2000, PEDIATRICS, V106, P654, DOI 10.1542/peds.106.4.654; Durojaiye L, 2002, J PAEDIATR CHILD H, V38, P241, DOI 10.1046/j.1440-1754.2002.00773.x; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; HALLIDAY HL, 2001, COCHRANE DATABASE SY, V2; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; *INT LIA COMM RES, 2005, RESUSCITATION, V67; Jabbour M, 1996, ANN EMERG MED, V28, P690, DOI 10.1016/S0196-0644(96)70095-1; Jewkes F, 2003, ARCH DIS CHILD, V88, P118, DOI 10.1136/adc.88.2.118; Kamenir SA, 1997, J TROP PEDIATRICS, V43, P170, DOI 10.1093/tropej/43.3.170; MCKENNA SP, 1985, J OCCUP PSYCHOL, V58, P109, DOI 10.1111/j.2044-8325.1985.tb00186.x; O'Hare BA, 2006, J TROP PEDIATRICS, V52, P376, DOI 10.1093/tropej/fml027; OPIYO N, 2006, T R SOC TROP MED HYG, V100, P899; Quan L, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e110; Rowe AK, 2002, INT J QUAL HEALTH C, V14, P521, DOI 10.1093/intqhc/14.6.521; TAN A, 2004, COCHRANE DATABASE SY; Vain NE, 2004, LANCET, V364, P597, DOI 10.1016/S0140-6736(04)16852-9; *WHO, 1997, BAS NEWB RES PRACT G; Wiswell TE, 2000, PEDIATRICS, V105, P1, DOI 10.1542/peds.105.1.1; World Health Organization, 2005, WORLD HLTH REP 2005	21	48	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1599	10.1371/journal.pone.0001599	http://dx.doi.org/10.1371/journal.pone.0001599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270586	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000260535900033
J	Cook, MA; Chan, CK; Jorgensen, P; Ketela, T; So, D; Tyers, M; Ho, CY				Cook, Michael A.; Chan, Chi-Kin; Jorgensen, Paul; Ketela, Troy; So, Daniel; Tyers, Mike; Ho, Chi-Yip			Systematic Validation and Atomic Force Microscopy of Non-Covalent Short Oligonucleotide Barcode Microarrays	PLOS ONE			English	Article							GENOME-WIDE SCREEN; DNA MICROARRAYS; SACCHAROMYCES-CEREVISIAE; SYNTHETIC DNA; GENES; GLASS; SPECIFICITY; SENSITIVITY; FABRICATION; TECHNOLOGY	Background: Molecular barcode arrays provide a powerful means to analyze cellular phenotypes in parallel through detection of short (20-60 base) unique sequence tags, or "barcodes'', associated with each strain or clone in a collection. However, costs of current methods for microarray construction, whether by in situ oligonucleotide synthesis or ex situ coupling of modified oligonucleotides to the slide surface are often prohibitive to large-scale analyses. Methodology/Principal Findings: Here we demonstrate that unmodified 20mer oligonucleotide probes printed on conventional surfaces show comparable hybridization signals to covalently linked 5'-amino-modified probes. As a test case, we undertook systematic cell size analysis of the budding yeast Saccharomyces cerevisiae genome-wide deletion collection by size separation of the deletion pool followed by determination of strain abundance in size fractions by barcode arrays. We demonstrate that the properties of a 13K unique feature spotted 20 mer oligonucleotide barcode microarray compare favorably with an analogous covalently-linked oligonucleotide array. Further, cell size profiles obtained with the size selection/barcode array approach recapitulate previous cell size measurements of individual deletion strains. Finally, through atomic force microscopy (AFM), we characterize the mechanism of hybridization to unmodified barcode probes on the slide surface. Conclusions/Significance: These studies push the lower limit of probe size in genome-scale unmodified oligonucleotide microarray construction and demonstrate a versatile, cost-effective and reliable method for molecular barcode analysis.	[Cook, Michael A.; Jorgensen, Paul; Tyers, Mike; Ho, Chi-Yip] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Cook, Michael A.; Jorgensen, Paul; Tyers, Mike] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Chan, Chi-Kin; Ho, Chi-Yip] Mount Sinai Hosp, Samuel Lunenfeld Res Inst, Microarray Lab, Toronto, ON, Canada; [Ketela, Troy] Univ Toronto, Terrence Donnelly Ctr Cell & Biomol Res, Toronto, ON, Canada; [So, Daniel] Scenterra Inc, Bowie, MD USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Cook, MA (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	tyers@mshri.on.ca; cyho@mshri.on.ca	Tyers, Michael/ABE-3194-2021		Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation; CIHR Doctoral Training Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR Doctoral Training Award(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to Michael Tyers from the Canadian Institutes of Health Research (CIHR) and the Canada Foundation for Innovation. Mike Cook is the recipient of CIHR Doctoral Training Award and Michael Tyers holds a Canada Research Chair in Bioinformatics and Functional Genomics.	Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Call DR, 2001, BIOTECHNIQUES, V30, P368, DOI 10.2144/01302tt06; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Chrisey LA, 1996, NUCLEIC ACIDS RES, V24, P3031, DOI 10.1093/nar/24.15.3031; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Ehrenreich A, 2006, APPL MICROBIOL BIOT, V73, P255, DOI 10.1007/s00253-006-0584-2; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Hansma HG, 1996, NUCLEIC ACIDS RES, V24, P713, DOI 10.1093/nar/24.4.713; Hesse J, 2006, GENOME RES, V16, P1041, DOI 10.1101/gr.4999906; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Hoheisel JD, 2006, NAT REV GENET, V7, P200, DOI 10.1038/nrg1809; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Kimura N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni046; Kimura N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh057; Kucho K, 2004, GENES GENET SYST, V79, P319, DOI 10.1266/ggs.79.319; Kucho KI, 2004, GENES GENET SYST, V79, P189, DOI 10.1266/ggs.79.189; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; McGall G H, 2001, Methods Mol Biol, V170, P71; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Peyser BD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni138; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rogers YH, 1999, ANAL BIOCHEM, V266, P23, DOI 10.1006/abio.1998.2857; Saito I, 1981, Nucleic Acids Symp Ser, P61; Shivaswamy S, 2007, METHODS, V41, P304, DOI 10.1016/j.ymeth.2006.11.002; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Wang HY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r5; Wu JJ, 2006, CANCER RES, V66, P6899, DOI 10.1158/0008-5472.CAN-06-0276; Zhang J, 2002, CURR BIOL, V12, P1992, DOI 10.1016/S0960-9822(02)01305-2; Zhou XC, 2004, LANGMUIR, V20, P8877, DOI 10.1021/la048950b	43	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1546	10.1371/journal.pone.0001546	http://dx.doi.org/10.1371/journal.pone.0001546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253494	gold, Green Submitted, Green Published			2022-12-27	WOS:000260535700018
J	Hay, PJ; Mond, J; Buttner, P; Darby, A				Hay, Phillipa J.; Mond, Jonathan; Buttner, Petra; Darby, Anita			Eating Disorder Behaviors Are Increasing: Findings from Two Sequential Community Surveys in South Australia	PLOS ONE			English	Article							DSM-IV DISORDERS; BULIMIA-NERVOSA; TIME TRENDS; ANOREXIA-NERVOSA; PREVALENCE; ROCHESTER; LIFE	Background. Evidence for an increase in the prevalence of eating disorders is inconsistent. Our aim was to determine change in the population point prevalence of eating disorder behaviors over a 10-year period. Methodology/Principal Findings. Eating disorder behaviors were assessed in consecutive general population surveys of men and women conducted in 1995 (n = 3001, 72% respondents) and 2005 (n = 3047, 63.1% respondents). Participants were randomly sampled from households in rural and metropolitan South Australia. There was a significant (all p < 0.01) and over two-fold increase in the prevalence of binge eating, purging (self-induced vomiting and/or laxative or diuretic misuse) and strict dieting or fasting for weight or shape control among both genders. The most common diagnosis in 2005 was either binge eating disorder or other "eating disorders not otherwise specified'' (EDNOS; n = 119, 4.2%). Conclusions/Significance. In this population sample the point prevalence of eating disorder behaviors increased over the past decade. Cases of anorexia nervosa and bulimia nervosa, as currently defined, remain uncommon.	[Hay, Phillipa J.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Mond, Jonathan] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Buttner, Petra] James Cook Univ, Trop Med & Rehabilitat Sci, Sch Publ Hlth, Townsville, QLD, Australia; [Darby, Anita] James Cook Univ, Sch Med, Discipline Psych, Townsville, QLD, Australia	Western Sydney University; La Trobe University; James Cook University; James Cook University	Hay, PJ (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.	p.hay@uws.edu.au		Mond, Jonathan/0000-0002-0410-091X; Hay, Phillipa/0000-0003-0296-6856	Office of the Vice-Chancellor James Cook University	Office of the Vice-Chancellor James Cook University	The study was supported by an establishment grant to Professor Hay from the Office of the Vice-Chancellor James Cook University.	Aalto-Setala T, 2001, PSYCHOL MED, V31, P791, DOI 10.1017/S0033291701004081; [Anonymous], 2006, EATING WEIGHT DISORD; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; *AUSTR BEUR STAT, 2007, AUSTR BEUR STAT CENS; Brandsma L, 2007, J WOMEN AGING, V19, P155, DOI 10.1300/J074v19n01_10; BUSHNELL JA, 1990, PSYCHOL MED, V20, P671, DOI 10.1017/S0033291700017190; Currin L, 2005, BRIT J PSYCHIAT, V186, P132, DOI 10.1192/bjp.186.2.132; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fairburn CG, 2003, BEHAV RES THER, V41, P509, DOI 10.1016/S0005-7967(02)00088-8; Fairburn Christopher G., 1993, P317; Fichter MM, 2005, INT J EAT DISORDER, V38, P310, DOI 10.1002/eat.20187; FICHTER MM, 1980, ARCH PSYCHIAT NERVEN, V228, P67, DOI 10.1007/BF00365746; *GOV S AUSTR DEP H, 2005, HLTH OMN SURV 2005; Gull W., 1874, CLIN SOC T, V7, P22; HALL A, 1991, PSYCHOL MED, V21, P697, DOI 10.1017/S0033291700022339; Hay P, 1998, INT J EAT DISORDER, V23, P371, DOI 10.1002/(SICI)1098-108X(199805)23:4&lt;371::AID-EAT4&gt;3.0.CO;2-F; Hoek HW, 1998, NEW ENGL J MED, V338, P1231, DOI 10.1056/NEJM199804233381717; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Joiner TE, 1997, AM J PSYCHIAT, V154, P1133; Keel PK, 2006, PSYCHOL MED, V36, P119, DOI 10.1017/S0033291705006148; Lasegue E., 1873, ARCH GEN MED, V1, P385, DOI DOI 10.3917/JFP.032.0003; LUCAS AR, 1991, AM J PSYCHIAT, V148, P917; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mond JM, 2004, INT J EAT DISORDER, V36, P89, DOI 10.1002/eat.20007; MOND JM, INT J EAT D IN PRESS; MYERS JK, 1984, ARCH GEN PSYCHIAT, V41, P959; Park J, 2007, EUR EAT DISORD REV, V15, P311, DOI 10.1002/erv.741; RUSSELL G, 1979, PSYCHOL MED, V9, P429, DOI 10.1017/S0033291700031974; SOUNDY TJ, 1995, PSYCHOL MED, V25, P1065, DOI 10.1017/S0033291700037557; van Son GE, 2006, INT J EAT DISORDER, V39, P565, DOI 10.1002/eat.20316; Wells JE, 2006, AUST NZ J PSYCHIAT, V40, P845, DOI 10.1111/j.1440-1614.2006.01903.x; Westenhoefer J, 2001, INT J EAT DISORDER, V29, P477, DOI 10.1002/eat.1045	33	222	225	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1541	10.1371/journal.pone.0001541	http://dx.doi.org/10.1371/journal.pone.0001541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367EQ	18253489	gold, Green Published, Green Accepted			2022-12-27	WOS:000260535700013
J	Koerner-Rettberg, C; Doths, S; Stroet, A; Schwarze, J				Koerner-Rettberg, Cordula; Doths, Sandra; Stroet, Anke; Schwarze, Juergen			Reduced Lung Function in a Chronic Asthma Model Is Associated with Prolonged Inflammation, but Independent of Peribronchial Fibrosis	PLOS ONE			English	Article								Background: In asthma, mechanisms contributing to chronicity remain to be determined. Recent models of sensitisation with prolonged airway allergen challenges reproduce typical features of chronic asthma. However, the interplay between inflammation, structural changes and lung function is poorly understood. This study was performed to delineate functional, structural and immunological airway changes after cessation of long term challenges to elucidate factors contributing to the development of prolonged lung function changes. Methodology/Principal Findings: Mice sensitised systemically were consecutively challenged intranasally with ovalbumin for two or eight weeks. After the end of challenges, lung function, airway inflammation, features of airway remodelling, local T-cell cytokines and systemic ovalbumin-specific antibodies were monitored. Long term challenges resulted in airway hyperresponsiveness lasting 2 weeks and reduced baseline lung function for 6 weeks after their cessation. In contrast, these changes resolved within one week after short term challenges. Prolonged transforming growth factor beta (TGF-beta)1 production and marked peribronchial fibrosis were only induced by long term challenges. Importantly, fibrosis became apparent only after the onset of lung function changes and outlasted them. Further, long term challenges led to prolonged and intense airway inflammation with marked lymphocytosis, but moderate eosinophilia, sustained IL-5 production and ovalbumin-specific IgG2a antibodies, the latter suggesting a Th1 component to the immune response. In contrast, following short term challenges airway inflammation was dominated by eosinophils and associated with a strong, but transient IL-13 response. Conclusions: Prolonged lung function changes after long term allergen challenges seem to develop and resolve independently of the persistent peribronchial fibrosis. They are more closely associated with intense airway inflammation, marked lymphocytosis, prolonged IL-5 and TGF-beta 1 production in the airways and a Th1 immune response.	[Koerner-Rettberg, Cordula; Doths, Sandra; Stroet, Anke; Schwarze, Juergen] Ruhr Univ Bochum, Childrens Hosp, Bochum, Germany; [Schwarze, Juergen] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammation Res, Edinburgh, Midlothian, Scotland	Ruhr University Bochum; University of Edinburgh	Koerner-Rettberg, C (corresponding author), Ruhr Univ Bochum, Childrens Hosp, Bochum, Germany.	jurgen.schwarze@ed.ac.uk	Schwarze, Jürgen/F-7396-2011; Salmen, Anke/S-9681-2018; Koerner-Rettberg, Cordula/AGI-3532-2022	Salmen, Anke/0000-0002-4751-299X; Koerner-Rettberg, Cordula/0000-0003-0946-1009; Schwarze, Jurgen/0000-0002-6899-748X	Deutsche Forschungsgemeinschaft [Schw 597/2-1]; Bundesministerium fur Bildung und Forschung [01GC9802]; Wellcome Trust [067454]; Medical Research Council [G9900991B] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were supported by the following grants to JS: Schw 597/2-1 from Deutsche Forschungsgemeinschaft, 01GC9802 from Bundesministerium fur Bildung und Forschung and 067454 from the Wellcome Trust.	[Anonymous], 1998, LANCET, V351, P1225; Bento AM, 1998, ALLERGY ASTHMA PROC, V19, P353, DOI 10.2500/108854198778612672; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; BRUSASCO V, 1990, J APPL PHYSIOL, V69, P2209, DOI 10.1152/jappl.1990.69.6.2209; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Cieslewicz G, 1999, J CLIN INVEST, V104, P301, DOI 10.1172/JCI7010; Corbel M, 2003, CLIN EXP ALLERGY, V33, P696, DOI 10.1046/j.1365-2222.2003.01581.x; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamelmann E, 1999, INT ARCH ALLERGY IMM, V118, P90, DOI 10.1159/000024037; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hamelmann E, 2001, IMMUNOL REV, V179, P182, DOI 10.1034/j.1600-065X.2001.790118.x; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hansen G, 2000, J CLIN INVEST, V105, P61, DOI 10.1172/JCI7589; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Jain VV, 2002, J ALLERGY CLIN IMMUN, V110, P867, DOI 10.1067/mai.2002.129371; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; KOVACS EJ, 1994, FASEB J, V8, P854, DOI 10.1096/fasebj.8.11.7520879; Kumar RK, 2004, AM J RESP CRIT CARE, V170, P1043, DOI 10.1164/rccm.200405-681OC; Kumar RK, 2002, CLIN EXP ALLERGY, V32, P1104, DOI 10.1046/j.1365-2222.2002.01420.x; Kumar RK, 2002, AM J RESP CELL MOL, V27, P267, DOI 10.1165/rcmb.F248; Leigh R, 2004, J APPL PHYSIOL, V97, P2258, DOI 10.1152/japplphysiol.00597.2004; Leigh R, 2004, AM J RESP CRIT CARE, V170, P851, DOI 10.1164/rccm.200311-1488OC; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Richter A, 2001, AM J RESP CELL MOL, V25, P385, DOI 10.1165/ajrcmb.25.3.4437; ROCHE WR, 1989, LANCET, V1, P520; Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; Wegmann M, 2005, CLIN EXP ALLERGY, V35, P1263, DOI 10.1111/j.1365-2222.2005.02306.x; Werfel T, 1996, J INVEST DERMATOL, V107, P871, DOI 10.1111/1523-1747.ep12331164	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1575	10.1371/journal.pone.0001575	http://dx.doi.org/10.1371/journal.pone.0001575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253511	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700035
J	Santillan, M; Mackey, MC				Santillan, Moises; Mackey, Michael C.			A Proposed Mechanism for the Interaction of the Segmentation Clock and the Determination Front in Somitogenesis	PLOS ONE			English	Article							VERTEBRATE SEGMENTATION; PRESOMITIC MESODERM; GENE-EXPRESSION; WNT; HES1	Background: Recent discoveries in the field of somitogenesis have confirmed, for the most part, the feasibility of the clock and wavefront model. There are good candidates for both the clock (various genes expressed cyclically in the tail bud of vertebrate embryos have been discovered) and the wavefront (there are at least three different substances, whose expression levels vary along the presomitic mesoderm [PSM], that have important effects on the formation of somites). Nevertheless, the mechanisms through which the wavefront interacts with the clock to arrest the oscillations and induce somite formation have not yet been fully elucidated. Principal Findings: In this work, we propose a gene regulatory network which is consistent with all known experimental facts in embryonic mice, and whose dynamic behaviour provides a potential explanation for the periodic aggregation of PSM cells into blocks: the first step leading to the formation of somites. Significance: To our knowledge, this is the first proposed mechanism that fully explains how a block of PSM cells can stop oscillating simultaneously, and how this process is repeated periodically, via the interaction of the segmentation clock and the determination front.	[Santillan, Moises; Mackey, Michael C.] IPN, Ctr Invest & Estudios Avanzados, Apodaca, Nuevo Leon, Mexico; [Santillan, Moises] McGill Univ, Ctr Nonlinear Dynam, Montreal, PQ, Canada	Instituto Politecnico Nacional - Mexico; McGill University	Santillan, M (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Campus Monterrey, Apodaca, Nuevo Leon, Mexico.	moises.santillan@mac.com	Santillan, Moises/A-2942-2008	Santillan, Moises/0000-0001-8605-7451; Mackey, Michael/0000-0002-8524-2396	Consejo Nacional de Ciencia y Tecnologia (CONACyT, MEXICO); National Science Foundation (USA) [PHY05-51164]; Mathematics of Information Technology and Complex Systems (MITACS) Canada; Natural Sciences and Engineering Research Council (NSERC) Canada	Consejo Nacional de Ciencia y Tecnologia (CONACyT, MEXICO)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation (USA)(National Science Foundation (NSF)); Mathematics of Information Technology and Complex Systems (MITACS) Canada; Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was partially supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT, MEXICO), the National Science Foundation (USA) under Grant No. PHY05-51164, the Mathematics of Information Technology and Complex Systems (MITACS) Canada, and the Natural Sciences and Engineering Research Council (NSERC) Canada.	Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2006, ANAT EMBRYOL, V211, pS3, DOI 10.1007/s00429-006-0124-y; Bernard S, 2006, PHILOS T R SOC A, V364, P1155, DOI 10.1098/rsta.2006.1761; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; Ishikawa A, 2004, MECH DEVELOP, V121, P1443, DOI 10.1016/j.mod.2004.08.003; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; Rodriguez-Gonzalez JG, 2007, J THEOR BIOL, V248, P37, DOI 10.1016/j.jtbi.2007.05.003; Tiedemann HB, 2007, J THEOR BIOL, V248, P120, DOI 10.1016/j.jtbi.2007.05.014	19	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1561	10.1371/journal.pone.0001561	http://dx.doi.org/10.1371/journal.pone.0001561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253505	gold, Green Submitted, Green Published			2022-12-27	WOS:000260535700029
J	Saar, S; Mitra, PP				Saar, Sigal; Mitra, Partha P.			A Technique for Characterizing the Development of Rhythms in Bird Song	PLOS ONE			English	Article								The developmental trajectory of nervous system dynamics shows hierarchical structure on time scales spanning ten orders of magnitude from milliseconds to years. Analyzing and characterizing this structure poses significant signal processing challenges. In the context of birdsong development, we have previously proposed that an effective way to do this is to use the dynamic spectrum or spectrogram, a classical signal processing tool, computed at multiple time scales in a nested fashion. Temporal structure on the millisecond timescale is normally captured using a short time Fourier analysis, and structure on the second timescale using song spectrograms. Here we use the dynamic spectrum on time series of song features to study the development of rhythm in juvenile zebra finch. The method is able to detect rhythmic structure in juvenile song in contrast to previous characterizations of such song as unstructured. We show that the method can be used to examine song development, the accuracy with which rhythm is imitated, and the variability of rhythms across different renditions of a song. We hope that this technique will provide a standard, automated method for measuring and characterizing song rhythm.	[Saar, Sigal] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Saar, Sigal; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); Cold Spring Harbor Laboratory	Saar, S (corresponding author), CUNY City Coll, Dept Biol, New York, NY 10031 USA.	plosone@sigalsaar.com		Mitra, Partha/0000-0001-8818-6804	NIH [5R01MH071744-03]; US Public Health Services (PHS) [DC04722-07, NS050436]; NIH RCMI [G12RR-03060]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004722] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Services (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); NIH RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by Crick-Clay professorship, NIH grant 5R01MH071744-03, US Public Health Services (PHS) grants DC04722-07, NS050436 and by a NIH RCMI grant G12RR-03060 to CCNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Deregnaucourt S, 2004, ANN NY ACAD SCI, V1016, P364, DOI 10.1196/annals.1298.036; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; SAAR S, 2005, DEV RHYTHM SYNTAX ZE; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; THERNICHOVSKI O, 2000, ANIM BEHAV, V59, P1167; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Wild JM, 1998, J NEUROBIOL, V36, P441, DOI 10.1002/(SICI)1097-4695(19980905)36:3<441::AID-NEU11>3.0.CO;2-E	11	47	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1461	10.1371/journal.pone.0001461	http://dx.doi.org/10.1371/journal.pone.0001461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213370	Green Accepted, gold, Green Published			2022-12-27	WOS:000260503900007
J	Gladieux, P; Zhang, XG; Afoufa-Bastien, D; Sanhueza, RMV; Sbaghi, M; Le Cam, B				Gladieux, Pierre; Zhang, Xiu-Guo; Afoufa-Bastien, Damien; Sanhueza, Rosa-Maria Valdebenito; Sbaghi, Mohamed; Le Cam, Bruno			On the Origin and Spread of the Scab Disease of Apple: Out of Central Asia	PLOS ONE			English	Article							PATHOGEN MYCOSPHAERELLA-GRAMINICOLA; POPULATION-STRUCTURE; VENTURIA-INAEQUALIS; GENETIC-STRUCTURE; FUNGAL PATHOGEN; MICROSATELLITE MARKERS; MULTILOCUS STRUCTURE; MIGRATION PATTERNS; ASSIGNMENT METHODS; ALLELIC RICHNESS	Venturia inaequalis is an ascomycete fungus responsible for apple scab, a disease that has invaded almost all apple growing regions worldwide, with the corresponding adverse effects on apple production. Monitoring and predicting the effectiveness of intervention strategies require knowledge of the origin, introduction pathways, and population biology of pathogen populations. Analysis of the variation of genetic markers using the inferential framework of population genetics offers the potential to retrieve this information. Methodology/Principal Findings. Here, we present a population genetic analysis of microsatellite variation in 1,273 strains of V. inaequalis representing 28 orchard samples from seven regions in five continents. Analysis of molecular variance revealed that most of the variation (88%) was distributed within localities, which is consistent with extensive historical migrations of the fungus among and within regions. Despite this shallow population structure, clustering analyses partitioned the data set into separate groups corresponding roughly to geography, indicating that each region hosts a distinct population of the fungus. Comparison of the levels of variability among populations, along with coalescent analyses of migration models and estimates of genetic distances, was consistent with a scenario in which the fungus emerged in Central Asia, where apple was domesticated, before its introduction into Europe and, more recently, into other continents with the expansion of apple growing. Across the novel range, levels of variability pointed to multiple introductions and all populations displayed signatures of significant post-introduction increases in population size. Most populations exhibited high genotypic diversity and random association of alleles across loci, indicating recombination both in native and introduced areas. Conclusions/Significance. Venturia inaequalis is a model of invasive phytopathogenic fungus that has now reached the ultimate stage of the invasion process with a broad geographic distribution and well-established populations displaying high genetic variability, regular sexual reproduction, and demographic expansion.	[Gladieux, Pierre; Afoufa-Bastien, Damien; Le Cam, Bruno] INRA, UMR077 1, Angers, France; [Zhang, Xiu-Guo] Shandong Agr Univ, Dept Plant Pathol, Tai An, Shandong, Peoples R China; [Sanhueza, Rosa-Maria Valdebenito] Natl Res Ctr Grap & Wine, Bento Goncalves, Brazil; [Sbaghi, Mohamed] INRA, Ctr Region Rech Agronom Kenitra, Kenitra, Morocco	INRAE; Shandong Agricultural University	Zhang, XG (corresponding author), Shandong Agr Univ, Dept Plant Pathol, Tai An, Shandong, Peoples R China.	zhxg@sdau.edu.cn; lecam@angers.inra.fr	Gladieux, Pierre/D-1014-2014	Gladieux, Pierre/0000-0003-1929-1576	Microsoft Corporation	Microsoft Corporation(Microsoft)	Part of this work was carried out by using the resources of the Computational Biology Service Unit from Cornell University which is partially funded by Microsoft Corporation.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Bandyopadhyay R, 1998, PLANT DIS, V82, P356, DOI 10.1094/PDIS.1998.82.4.356; Banke S, 2005, MOL ECOL, V14, P1881, DOI 10.1111/j.1365-294X.2005.02536.x; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Berry O, 2004, MOL ECOL, V13, P551, DOI 10.1046/j.1365-294X.2004.2081.x; Boehm EWA, 2003, PHYTOPARASITICA, V31, P236, DOI 10.1007/BF02980833; BROWN AHD, 1980, GENETICS, V96, P523; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Brown James K. M., 1994, Trends in Microbiology, V2, P470, DOI 10.1016/0966-842X(94)90124-4; BRUNNER PC, 2007, J EVOLUTION BIOL, V20, P1; Burgess T, 2001, MYCOL RES, V105, P1331, DOI 10.1017/S0953756201005056; Campbell FT, 2001, BIOSCIENCE, V51, P148, DOI 10.1641/0006-3568(2001)051[0148:TSORAF]2.0.CO;2; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen RS, 1996, GENETICS, V142, P1119; Corander J, 2003, GENETICS, V163, P367; Cornuet JM, 1996, GENETICS, V144, P2001; Couch BC, 2005, GENETICS, V170, P613, DOI 10.1534/genetics.105.041780; Cui LW, 2003, TRENDS PARASITOL, V19, P220, DOI 10.1016/S1471-4922(03)00085-0; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Donnelly MJ, 2002, TRENDS PARASITOL, V18, P75, DOI 10.1016/S1471-4922(01)02198-5; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Engelbrecht CJB, 2004, MOL ECOL, V13, P2995, DOI 10.1111/j.1365-294X.2004.02312.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Falush D, 2003, GENETICS, V164, P1567; Fisher MC, 2002, P NATL ACAD SCI USA, V99, P9067, DOI 10.1073/pnas.132178099; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Garrison VH, 2003, BIOSCIENCE, V53, P469, DOI 10.1641/0006-3568(2003)053[0469:AAADFD]2.0.CO;2; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Guerin F, 2004, MOL ECOL NOTES, V4, P268, DOI 10.1111/j.1471-8286.2004.00637.x; Guerin F, 2004, PHYTOPATHOLOGY, V94, P364, DOI 10.1094/PHYTO.2004.94.4.364; Guerin F, 2007, FUNGAL GENET BIOL, V44, P284, DOI 10.1016/j.fgb.2006.10.005; Hancock J.F., 2004, PLANT EVOLUTION ORIG; Harris SA, 2002, TRENDS GENET, V18, P426, DOI 10.1016/S0168-9525(02)02689-6; Hume JCC, 2003, TRENDS PARASITOL, V19, P144, DOI 10.1016/S1471-4922(03)00008-4; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kauer M, 2003, MOL BIOL EVOL, V20, P1329, DOI 10.1093/molbev/msg148; Kimmel M, 1998, GENETICS, V148, P1921; King JP, 2000, MOL BIOL EVOL, V17, P1859, DOI 10.1093/oxfordjournals.molbev.a026287; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Mabberley, 2006, STORY APPLE; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MCHARDY W, 1996, APPL SCAB BIOL EPIDE; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; MORGAN J, 1993, BOOK APPLES; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palm ME, 2001, BIOSCIENCE, V51, P141, DOI 10.1641/0006-3568(2001)051[0141:SATIOI]2.0.CO;2; Parker IM, 2004, ANNU REV ECOL EVOL S, V35, P675, DOI 10.1146/annurev.ecolsys.34.011802.132339; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrings C, 2002, CONSERV ECOL, V6; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Raboin LM, 2007, FUNGAL GENET BIOL, V44, P64, DOI 10.1016/j.fgb.2006.07.004; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Reich DE, 1999, MOL BIOL EVOL, V16, P453, DOI 10.1093/oxfordjournals.molbev.a026127; Rivas GG, 2004, MOL ECOL, V13, P471, DOI 10.1046/j.1365-294X.2003.02043.x; RIZZO DM, 2005, FUNGAL COMMUNITY, P857; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schofl G, 2006, MOL ECOL, V15, P3895, DOI 10.1111/j.1365-294X.2006.03065.x; Smart C. D., 2001, Biological Invasions, V3, P235, DOI 10.1023/A:1015200920772; Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398; Stukenbrock EH, 2006, MOL ECOL, V15, P2895, DOI 10.1111/j.1365-294X.2006.02986.x; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Taylor JW, 2003, CURR OPIN MICROBIOL, V6, P351, DOI 10.1016/S1369-5274(03)00088-2; Tenzer I, 1999, PHYTOPATHOLOGY, V89, P748, DOI 10.1094/PHYTO.1999.89.9.748; Tenzer I, 1997, EUR J PLANT PATHOL, V103, P565, DOI 10.1023/A:1008636913211; Tenzer I, 1999, EUR J PLANT PATHOL, V105, P545, DOI 10.1023/A:1008775900736; Wikler K, 2000, CAN J BOT, V78, P709, DOI 10.1139/cjb-78-6-709; Wilson EE, 1928, PHYTOPATHOLOGY, V18, P375; Wingfield MJ, 2001, BIOSCIENCE, V51, P134, DOI 10.1641/0006-3568(2001)051[0134:WMOEFF]2.0.CO;2; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; WOOD F, 2003, SILK ROAD; YARWOOD CE, 1970, SCIENCE, V168, P218, DOI 10.1126/science.168.3928.218; Zaffarano PL, 2006, PHYTOPATHOLOGY, V96, P941, DOI 10.1094/PHYTO-96-0941; Zeigler RS, 1998, ANNU REV PHYTOPATHOL, V36, P249, DOI 10.1146/annurev.phyto.36.1.249; Zhan J, 2003, FUNGAL GENET BIOL, V38, P286, DOI 10.1016/S1087-1845(02)00538-8	96	96	100	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1455	10.1371/journal.pone.0001455	http://dx.doi.org/10.1371/journal.pone.0001455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197265	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503800026
J	Liu, CC; Lee, SC; Butler, M; Wu, SC				Liu, Chia-Chyi; Lee, Shiang-Chi; Butler, Michael; Wu, Suh-Chin			High Genetic Stability of Dengue Virus Propagated in MRC-5 Cells as Compared to the Virus Propagated in Vero Cells	PLOS ONE			English	Article								This work investigated the replication kinetics of the four dengue virus serotypes (DEN-1 to DEN-4), including dengue virus type 4 (DEN-4) recovered from an infectious cDNA clone, in Vero cells and in MRC-5 cells grown on Cytodex 1 microcarriers. DEN-1 strain Hawaii, DEN-2 strain NGC, DEN-3 strain H-87, and DEN-4 strain H-241, and DEN-4 strain 814669 derived from cloned DNA, were used to infect Vero cells and MRC-5 cells grown in serum-free or serum-containing microcarrier cultures. Serum-free and serum-containing cultures were found to yield comparable titers of these viruses. The cloned DNA-derived DEN-4 started genetically more homogeneous was used to investigate the genetic stability of the virus propagated in Vero cells and MRC-5 cells. Sequence analysis revealed that the DEN-4 propagated in MRC-5 cells maintained a high genetic stability, compared to the virus propagated in Vero cells. Amino acid substitutions of Gly(104)Cys and Phe(108)Ile were detected at 70%, 60%, respectively, in the envelope (E) protein of DEN-4 propagated in Vero cells, whereas a single mutation of Glu(345)Lys was detected at 50% in E of the virus propagated in MRC-5 cells. Sequencing of multiple clones of three separate DNA fragments spanning 40% of the genome also indicated that DEN-4 propagated in Vero cells contained a higher number of mutations than the virus growing in MRC-5 cells. Although Vero cells yielded a peak virus titer approximately 1 to 17 folds higher than MRC-5 cells, cloned DEN-4 from MRC-5 cells maintained a greater stability than the virus from Vero cells. Serum-free microcarrier cultures of MRC-5 cells offer a potentially valuable system for the large-scale production of live-attenuated DEN vaccines.	[Liu, Chia-Chyi; Lee, Shiang-Chi; Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Life Sci, Inst Biotechnol, Hsinchu, Taiwan; [Butler, Michael] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada	National Tsing Hua University; University of Manitoba	Liu, CC (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Inst Biotechnol, Hsinchu, Taiwan.	scwu@life.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021; Butler, Michael/I-8167-2012; Liu, Chia-Chyi/A-8215-2012	Butler, Michael/0000-0002-4907-3652; Liu, Chia-Chyi/0000-0002-6257-0389	National Health Research Institutes [NHRI-EX95-9534SI]; National Science Council, Taiwan [NSC94-2214-E-007-014, NSC95-2311-B-007-024-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes (NHRI-EX95-9534SI) and the National Science Council (NSC94-2214-E-007-014; NSC95-2311-B-007-024-MY3), Taiwan.	Aunins JG, 2000, ENCY CELL TECHNOLOGY, V2, P1182; Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2; Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528; Blaney JE, 2003, VACCINE, V21, P4317, DOI 10.1016/S0264-410X(03)00487-0; Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Chao DY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-72; Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405; Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462; Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003; Kanesa-Thasan N, 2003, AM J TROP MED HYG, V69, P17, DOI 10.4269/ajtmh.2003.69.17; KAWANO H, 1993, J VIROL, V67, P6567, DOI 10.1128/JVI.67.11.6567-6575.1993; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Lai CJ, 1998, CLIN DIAGN VIROL, V10, P173, DOI 10.1016/S0928-0197(98)00035-X; LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139; Liu CC, 2004, BIOTECHNOL BIOENG, V85, P482, DOI 10.1002/bit.10918; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27; Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264; Stinchcomb DT, 2007, 3 AS REG DENG RES NE; Sun W, 2003, AM J TROP MED HYG, V69, P24; Tang WF, 2005, MICROBIOL IMMUNOL, V49, P285, DOI 10.1111/j.1348-0421.2005.tb03719.x; Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002; Whitehead SS, 2003, VACCINE, V21, P4307, DOI 10.1016/S0264-410X(03)00488-2; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Wu SC, 2002, BIOTECHNOL PROGR, V18, P124, DOI 10.1021/bp010120q; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	35	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1810	10.1371/journal.pone.0001810	http://dx.doi.org/10.1371/journal.pone.0001810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350148	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300014
J	Nagashima, T; Suzuki, T; Kondo, S; Kuroki, Y; Takahashi, K; Ide, K; Yumoto, N; Hasegawa, A; Toyoda, T; Kojima, T; Konagaya, A; Suzuki, H; Hayashizaki, Y; Sakaki, Y; Hatakeyama, M				Nagashima, Takeshi; Suzuki, Takahiro; Kondo, Shinji; Kuroki, Yoko; Takahashi, Kaoru; Ide, Kaori; Yumoto, Noriko; Hasegawa, Aki; Toyoda, Tetsuro; Kojima, Toshio; Konagaya, Akihiko; Suzuki, Harukazu; Hayashizaki, Yoshihide; Sakaki, Yoshiyuki; Hatakeyama, Mariko			Integrative Genome-Wide Expression Analysis Bears Evidence of Estrogen Receptor-Independent Transcription in Heregulin-Stimulated MCF-7 Cells	PLOS ONE			English	Article								Heregulin beta-1 (HRG) is an extracellular ligand that activates mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI3K)/Akt signaling pathways through ErbB receptors. MAPK and Akt have been shown to phosphorylate the estrogen receptor (ER) at Ser-118 and Ser-167, respectively, thereby mimicking the effects of estrogenic activity such as estrogen responsive element (ERE)-dependent transcription. In the current study, integrative analysis was performed using two tiling array platforms, comprising histone H3 lysine 9 (H3K9) acetylation and RNA mapping, together with array comparative genomic hybridization (CGH) analysis in an effort to identify HRG-regulated genes in ER-positive MCF-7 breast cancer cells. Through application of various threshold settings, 333 (326 up-regulated and 7 down-regulated) HRG-regulated genes were detected. Prediction of upstream transcription factors (TFs) and pathway analysis indicated that 21% of HRG-induced gene regulation may be controlled by the MAPK cascade, while only 0.6% of the gene expression is controlled by ERE. A comparison with previously reported estrogen (E2)-regulated gene expression data revealed that only 12 common genes were identified between the 333 HRG-regulated (3.6%) and 239 E2-regulated (5.0%) gene groups. However, with respect to enriched upstream TFs, 4 common TFs were identified in the 14 HRG-regulated (28.6%) and 13 E2-regulated (30.8%) gene groups. These results indicated that while E2 and HRG may induce common TFs, the regulatory mechanisms that govern HRG- and E2-induced gene expression differ.	[Nagashima, Takeshi; Kuroki, Yoko; Takahashi, Kaoru; Ide, Kaori; Yumoto, Noriko; Toyoda, Tetsuro; Kojima, Toshio; Sakaki, Yoshiyuki; Hatakeyama, Mariko] RIKEN Yokohama Inst, Genom Sci Ctr, Computat & Expt Syst Biol Grp, Yokohama, Kanagawa, Japan; [Suzuki, Takahiro; Kondo, Shinji; Suzuki, Harukazu; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, Genomic Sci Ctr, Genome Explorat Res Grp, Yokohama, Kanagawa, Japan; [Hasegawa, Aki; Konagaya, Akihiko] RIKEN Yokohama Inst, Genomic Sci Ctr, Advanced Genome Informat Technol Res Grp, Yokohama, Kanagawa, Japan; [Suzuki, Takahiro; Hayashizaki, Yoshihide] Yokohama City Univ, Internatl Grad Sch Arts & Sci, Div Genomic Informat Resources, Yokohama, Kanagawa, Japan; [Hayashizaki, Yoshihide] Discovery & Res Inst, Genome Sci Lab, RIKEN Wako Main Campus, Saitama, Japan; [Hayashizaki, Yoshihide] RIKEN Frontier Res Syst, Function RNA Res Program, Saitama, Japan	RIKEN; RIKEN; RIKEN; Yokohama City University; RIKEN; RIKEN	Nagashima, T (corresponding author), RIKEN Yokohama Inst, Genom Sci Ctr, Computat & Expt Syst Biol Grp, Yokohama, Kanagawa, Japan.	marikoh@gsc.riken.jp	Suzuki, Takahiro/AAW-8509-2020; Hayashizaki, Yoshihide/N-6590-2015; Konagaya, Akihiko/F-9302-2014; Okada, Mariko/N-6933-2015; Suzuki, Harukazu/N-9553-2015	Suzuki, Takahiro/0000-0002-0972-6911; Suzuki, Harukazu/0000-0002-8087-0836	RIKEN	RIKEN	All funding for this study was supported by current research expenses in RIKEN.	ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; ARNOLD SF, 1995, J STEROID BIOCHEM, V55, P163, DOI 10.1016/0960-0760(95)00177-2; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; Fann M, 2006, BLOOD, V108, P3363, DOI 10.1182/blood-2006-02-005520; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; GRUNT TW, 1995, INT J CANCER, V63, P560, DOI 10.1002/ijc.2910630417; Hasegawa Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl497; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kojima T, 2006, BIOCHEM BIOPH RES CO, V341, P792, DOI 10.1016/j.bbrc.2006.01.032; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Maass N, 2002, CANCER LETT, V185, P219, DOI 10.1016/S0304-3835(02)00286-0; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Proia DA, 2006, J BIOL CHEM, V281, P7089, DOI 10.1074/jbc.M511839200; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Tan M, 1999, CANCER RES, V59, P1620; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Toyoda T, 2007, BIOINFORMATICS, V23, P524, DOI 10.1093/bioinformatics/btl523; Weiss FU, 1997, J CELL PHYSIOL, V173, P187, DOI 10.1002/(SICI)1097-4652(199711)173:2<187::AID-JCP19>3.0.CO;2-D; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1803	10.1371/journal.pone.0001803	http://dx.doi.org/10.1371/journal.pone.0001803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350142	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300008
J	Raoof, M; Nawaz, H; Nusrat, R; Pabaney, AH; Randhawa, AR; Rehman, R; Rizvi, NB; Naqvi, H				Raoof, Mustafa; Nawaz, Haq; Nusrat, Rabeeya; Pabaney, Aqueel Hussain; Randhawa, Ali Raza; Rehman, Rabeea; Rizvi, Nida Butool; Naqvi, Haider			Awareness and Use of Benzodiazepines in Healthy Volunteers and Ambulatory Patients Visiting a Tertiary Care Hospital: A Cross Sectional Survey	PLOS ONE			English	Article							GENERAL-POPULATION; PREVALENCE; PRESCRIPTION; ISSUES; BRAZIL; TERM	Background: Indiscriminate prescription of Benzodiazepines in Pakistan and subsequent availability over-the-counter without prescription is a major public health problem, requiring systematic inquiry through research. Additionally, there is limited data on the awareness and use of Benzodiazepines from developing countries making it impossible to devise meaningful health policies. Methodology/Principal Findings: This was an Observational, Cross-Sectional study. conducted at Aga Khan University. A total of 475 (58.5% males, 41.5% females) people visiting a tertiary care hospital were interviewed by means of a structured questionnaire. The results showed that majority of population was aware of one or more Benzodiazepines (80.4%) and 30.4% had used them at some point in life. 42.4% of the users had been using it for more than a year. Commonest reason for use was sleep disturbance. Frequency of usage was higher for females, married individuals, educated (>Grade12), high socioeconomic status and housewives. More (59%) were prescribed than not and of them most by GP (58.5%). Only 36.5% of them were particularly told about the long-term addiction potential by the use of these drugs. Conclusion: Easy availability, access to re-fills without prescription and self prescription compounded with the lack of understanding of abuse potential of benzodiazepines constitutes a significant problem demanding serious consideration from health policy makers.	[Raoof, Mustafa; Nawaz, Haq; Nusrat, Rabeeya; Pabaney, Aqueel Hussain; Randhawa, Ali Raza; Rehman, Rabeea; Rizvi, Nida Butool] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Naqvi, Haider] Aga Khan Univ, Med Coll, Dept Psychiat, Karachi, Pakistan	Aga Khan University; Aga Khan University	Raoof, M (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	mustafaraoof@yahoo.com	Raoof, Mustafa/D-1664-2012					Ahmad K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-51; Ali B S, 2002, J Pak Med Assoc, V52, P513; de las Cuevas C, 2004, MED SCI MONITOR, V10, pCR288; FUENTEALBA R, 2000, REV PANAM SALUD PUBL, V7, P79; Galduroz JCF, 2005, ADDICT BEHAV, V30, P545, DOI 10.1016/j.addbeh.2004.08.004; Huang BJ, 2006, J CLIN PSYCHIAT, V67, P1062, DOI 10.4088/JCP.v67n0708; Kapczinski F, 2001, SUBST USE MISUSE, V36, P1053, DOI 10.1081/JA-100104489; Khan M M, 1998, J Pak Med Assoc, V48, P293; Khawaja Muhammad Rizwamillah, 2005, JPMA Journal of the Pakistan Medical Association, V55, P259; LADER M, 1984, CURR MED RES OPIN, V8, P120, DOI 10.1185/03007998409109550; LADER M, 1984, PROG NEURO-PSYCHOPH, V8, P85, DOI 10.1016/0278-5846(84)90139-8; LYNDON RW, 1988, AUST NZ J PSYCHIAT, V22, P293, DOI 10.3109/00048678809161210; Magrini N, 1996, EUR J CLIN PHARMACOL, V50, P19, DOI 10.1007/s002280050063; Neutel C Ineke, 2003, Can J Clin Pharmacol, V10, P202; Neutel CI, 2005, INT REV PSYCHIATR, V17, P189, DOI 10.1080/09540260500071863; Ohayon MM, 2002, J CLIN PSYCHIAT, V63, P817, DOI 10.4088/JCP.v63n0912; ROTH T, 1992, J CLIN PSYCHIAT, V53, P14; SWARTZ M, 1991, AM J PUBLIC HEALTH, V81, P592, DOI 10.2105/AJPH.81.5.592; Uchibayashi M, 2007, YAKUGAKU ZASSHI, V127, P217, DOI 10.1248/yakushi.127.217; VOGEL G, 1992, J CLIN PSYCHIAT, V53, P19	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1804	10.1371/journal.pone.0001804	http://dx.doi.org/10.1371/journal.pone.0001804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350143	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300009
J	Liew, CG; Shah, NN; Briston, SJ; Shepherd, RM; Khoo, CP; Dunne, MJ; Moore, HD; Cosgrove, KE; Andrews, PW				Liew, Chee Gee; Shah, Nadia N.; Briston, Sarah J.; Shepherd, Ruth M.; Khoo, Cheen Peen; Dunne, Mark J.; Moore, Harry D.; Cosgrove, Karen E.; Andrews, Peter W.			PAX4 Enhances Beta-Cell Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							PANCREATIC MESENCHYME; SURFACE-ANTIGENS; INSULIN; EXPRESSION; GROWTH; GENE; REQUIREMENT; GENERATION; PROGENITOR; RELEASE	Background: Human embryonic stem cells (HESC) readily differentiate into an apparently haphazard array of cell types, corresponding to all three germ layers, when their culture conditions are altered, for example by growth in suspension as aggregates known as embryoid bodies (EBs). However, this diversity of differentiation means that the efficiency of producing any one particular cell type is inevitably low. Although pancreatic differentiation has been reported from HESC, practicable applications for the use of beta-cells derived from HESC to treat diabetes will only be possible once techniques are developed to promote efficient differentiation along the pancreatic lineages. Methods and Findings: Here, we have tested whether the transcription factor, Pax4 can be used to drive the differentiation of HESC to a beta-cell fate in vitro. We constitutively over-expressed Pax4 in HESCs by stable transfection, and used Q-PCR analysis, immunocytochemistry, ELISA, Ca2+ microfluorimetry and cell imaging to assess the role of Pax4 in the differentiation and intracellular Ca2+ homeostasis of beta-cells developing in embryoid bodies produced from such HESC. Cells expressing key beta-cell markers were isolated by fluorescence-activated cell sorting after staining for high zinc content using the vital dye, Newport Green. Conclusion: Constitutive expression of Pax4 in HESC substantially enhances their propensity to form putative beta-cells. Our findings provide a novel foundation to study the mechanism of pancreatic beta-cells differentiation during early human development and to help evaluate strategies for the generation of purified beta-cells for future clinical applications.	[Liew, Chee Gee; Moore, Harry D.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctrr Stem Cell Biol, Sheffield, S Yorkshire, England; [Liew, Chee Gee; Moore, Harry D.; Andrews, Peter W.] Univ Sheffield, Ctr Stem Cell Biol, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England; [Shah, Nadia N.; Briston, Sarah J.; Shepherd, Ruth M.; Khoo, Cheen Peen; Dunne, Mark J.; Cosgrove, Karen E.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Sheffield; University of Sheffield; University of Manchester	Liew, CG (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctrr Stem Cell Biol, Sheffield, S Yorkshire, England.	karen.e.cosgrove@manchester.ac.uk; p.w.andrews@sheffield.ac.uk		Cosgrove, Karen/0000-0002-5162-0985; BRISTON, SARAH/0000-0001-9772-2007; Andrews, Peter/0000-0001-7215-4410	Juvenile Diabetes Research Foundation; Medical Research Council (UK); Biological and Biotechnical Research Council (UK); Novo Nordisk Research Foundation; Joint MRC/JDRF Career Development Fellowship; MRC [G0300273, G0801059, G113/29, G0700785] Funding Source: UKRI; Medical Research Council [G0700785, G113/29, G0300273, G0801059] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological and Biotechnical Research Council (UK); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Joint MRC/JDRF Career Development Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Juvenile Diabetes Research Foundation (HDM, KEC, MJD, PWA), the Medical Research Council (UK) (KEC, HDM, MJD), the Biological and Biotechnical Research Council (UK) (HDM, PWA) and Novo Nordisk Research Foundation (KEC). KEC is supported by a Joint MRC/JDRF Career Development Fellowship in Stem Cell Research. The authors are grateful to Mark Jones for cell sorting.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P323, DOI 10.1111/j.1440-169x.2006.00867.x; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Greenwood AL, 2007, MECH DEVELOP, V124, P97, DOI 10.1016/j.mod.2006.11.002; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; Jonasson P, 1996, EUR J BIOCHEM, V236, P656, DOI 10.1111/j.1432-1033.1996.00656.x; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jung CY, 1996, EXP MOL MED, V28, P153, DOI 10.1038/emm.1996.24; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Khoo MLM, 2005, BIOL REPROD, V73, P1147, DOI 10.1095/biolreprod.104.036673; Lavon N, 2006, STEM CELLS, V24, P1923, DOI 10.1634/stemcells.2005-0397; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Mfopou JK, 2007, STEM CELLS, V25, P1156, DOI 10.1634/stemcells.2006-0720; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rajagopal J, 2003, SCIENCE, V299, P363; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Smith SB, 2000, J BIOL CHEM, V275, P36910, DOI 10.1074/jbc.M005202200; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Straub SG, 2001, DIABETES, V50, P329, DOI 10.2337/diabetes.50.2.329; STURGESS NC, 1986, J ENDOCRINOL, V109, P201, DOI 10.1677/joe.0.1090201; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Zhang F, 2006, AM J PHYSIOL-CELL PH, V291, pC466, DOI 10.1152/ajpcell.00418.2005	44	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1783	10.1371/journal.pone.0001783	http://dx.doi.org/10.1371/journal.pone.0001783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335054	Green Published, gold, Green Accepted			2022-12-27	WOS:000260723000035
J	Mandel, JT; Ratcliffe, JM; Cerasale, DJ; Winkler, DW				Mandel, James T.; Ratcliffe, John M.; Cerasale, David J.; Winkler, David W.			Laterality and Flight: Concurrent Tests of Side-Bias and Optimality in Flying Tree Swallows	PLOS ONE			English	Article								Behavioural side-bias occurs in many vertebrates, including birds as a result of hemispheric specialization and can be advantageous by improving response times to sudden stimuli and efficiency in multi-tasking. However, behavioural side-bias can lead to morphological asymmetries resulting in reduced performance for specific activities. For flying animals, wing asymmetry is particularly costly and it is unclear if behavioural side-biases will be expressed in flight; the benefits of quick response time afforded by side-biases must be balanced against the costs of less efficient flight due to the morphological asymmetry side-biases may incur. Thus, competing constraints could lead to context-dependent expression or suppression of side-bias in flight. In repeated flight trials through an outdoor tunnel with obstacles, tree swallows (Tachycineta bicolor) preferred larger openings, but we did not detect either individual or population-level side-biases. Thus, while observed behavioural side-biases during substrate-foraging and copulation are common in birds, we did not see such side-bias expressed in obstacle avoidance behaviour in flight. This finding highlights the importance of behavioural context for investigations of side-bias and hemispheric laterality and suggests both proximate and ultimate trade-offs between species-specific cognitive ecology and flight biomechanics.	[Mandel, James T.; Cerasale, David J.; Winkler, David W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Ratcliffe, John M.] Cornell Univ, Dept Neurobiol & Behavior, Ithaca, NY USA	Cornell University; Cornell University	Mandel, JT (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	jtm39@cornell.edu			NSF [IBN-013437]	NSF(National Science Foundation (NSF))	This project was supported by NSF grant IBN-013437 to DWW. The funders had no role in any aspect of the study.	Adam A, 1998, J NEUROPHYSIOL, V80, P1373, DOI 10.1152/jn.1998.80.3.1373; BALMFORD A, 1993, P ROY SOC B-BIOL SCI, V252, P245, DOI 10.1098/rspb.1993.0072; Bisazza A, 1997, ANIM BEHAV, V54, P1273, DOI 10.1006/anbe.1997.0522; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bowlin MS, 2004, AUK, V121, P345, DOI 10.1642/0004-8038(2004)121[0345:NVIFPI]2.0.CO;2; Brown CR, 1998, EVOLUTION, V52, P1461, DOI 10.1111/j.1558-5646.1998.tb02027.x; Buschmann JUF, 2006, BEHAV PROCESS, V73, P62, DOI 10.1016/j.beproc.2006.03.012; Deng C, 1997, BEHAV BRAIN RES, V87, P173, DOI 10.1016/S0166-4328(97)02276-6; Dharmaretnam A, 2005, BEHAV BRAIN RES, V162, P62, DOI 10.1016/j.bbr.2005.03.012; Dukas R, 2004, ANNU REV ECOL EVOL S, V35, P347, DOI 10.1146/annurev.ecolsys.35.112202.130152; GUNTURKUN O, 1987, BEHAV NEUROSCI, V101, P433; Hambly C, 2004, J EXP BIOL, V207, P3977, DOI 10.1242/jeb.01235; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; Malashichev Y. B, 2006, BEHAV MORPHOLOGICAL; Moller AP, 1997, ANIM BEHAV, V54, P1545, DOI 10.1006/anbe.1997.9998; Moller AP, 1997, ASYMMETRY DEV STABIL; Norberg U., 1990, VERTEBRATE FLIGHT ME; Petersen AD, 2001, ANIM BEHAV, V62, P739, DOI 10.1006/anbe.2001.1791; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Prior H, 2002, J EXP BIOL, V205, P1795; Pyle P., 1987, IDENTIFICATION GUIDE; ROBERTSON RJ, 1992, BIRDS N AM ONLINE; Robins A, 2006, ANIM BEHAV, V72, P843, DOI 10.1016/j.anbehav.2006.01.022; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Swaddle JP, 1997, CAN J ZOOL, V75, P948, DOI 10.1139/z97-114; Teather K, 1996, J AVIAN BIOL, V27, P302, DOI 10.2307/3677261; THOMAS ALR, 1993, P ROY SOC B-BIOL SCI, V254, P181, DOI 10.1098/rspb.1993.0144; Vallortigara G, 1996, BEHAV BRAIN RES, V74, P135, DOI 10.1016/0166-4328(95)00037-2; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Ventolini N, 2005, ANIM BEHAV, V69, P1077, DOI 10.1016/j.anbehav.2004.09.003; Winkler David W., 2006, Hornero, V21, P85; [No title captured]	36	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1748	10.1371/journal.pone.0001748	http://dx.doi.org/10.1371/journal.pone.0001748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335028	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000002
J	Dedek, K; Pandarinath, C; Alam, NM; Wellershaus, K; Schubert, T; Willecke, K; Prusky, GT; Weiler, R; Nirenberg, S				Dedek, Karin; Pandarinath, Chethan; Alam, Nazia M.; Wellershaus, Kerstin; Schubert, Timm; Willecke, Klaus; Prusky, Glen T.; Weiler, Reto; Nirenberg, Sheila			Ganglion Cell Adaptability: Does the Coupling of Horizontal Cells Play a Role?	PLOS ONE			English	Article								Background: The visual system can adjust itself to different visual environments. One of the most well known examples of this is the shift in spatial tuning that occurs in retinal ganglion cells with the change from night to day vision. This shift is thought to be produced by a change in the ganglion cell receptive field surround, mediated by a decrease in the coupling of horizontal cells. Methodology/Principal Findings: To test this hypothesis, we used a transgenic mouse line, a connexin57-deficient line, in which horizontal cell coupling was abolished. Measurements, both at the ganglion cell level and the level of behavioral performance, showed no differences between wild-type retinas and retinas with decoupled horizontal cells from connexin57-deficient mice. Conclusion/Significance: This analysis showed that the coupling and uncoupling of horizontal cells does not play a dominant role in spatial tuning and its adjustability to night and day light conditions. Instead, our data suggest that another mechanism, likely arising in the inner retina, must be responsible.	[Dedek, Karin; Schubert, Timm; Weiler, Reto] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany; [Pandarinath, Chethan; Nirenberg, Sheila] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY USA; [Alam, Nazia M.; Prusky, Glen T.] Univ Lethbridge, Canadian Ctr Behavioural Neurosci, Lethbridge, AB, Canada; [Wellershaus, Kerstin; Willecke, Klaus] Univ Bonn, Inst Genet, Bonn, Germany	Carl von Ossietzky Universitat Oldenburg; Cornell University; University of Lethbridge; University of Bonn	Dedek, K (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany.	shn2010@med.cornell.edu	Dedek, Karin/R-6948-2018	Dedek, Karin/0000-0003-1490-0141; Pandarinath, Chethan/0000-0003-1241-1432	National Eye Institute; Deutsche Forschungsgemeinschaft [We 849/14-1, Wi 270/22-5/6]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the National Eye Institute to S.N. and from the Deutsche Forschungsgemeinschaft to R.W. (We 849/14-1) and K.W. (Wi 270/22-5/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; BALDRIDGE WH, 1991, VISUAL NEUROSCI, V7, P441, DOI 10.1017/S0952523800009731; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; Benedek G, 2003, DOC OPHTHALMOL, V106, P201, DOI 10.1023/A:1022548013313; Bieda MC, 1999, J NEUROPHYSIOL, V81, P3092, DOI 10.1152/jn.1999.81.6.3092; BISTI S, 1977, EXP BRAIN RES, V27, P335; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; CAVONIUS CR, 1973, J PHYSIOL-LONDON, V232, P239, DOI 10.1113/jphysiol.1973.sp010267; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; DeValois RL, 1990, SPATIAL VISION; Dodd R. J., 1998, Technical Digest. Summaries of Papers Presented at the International Quantum Electronics Conference. Conference Edition. 1998 Technical Digest Series, Vol.7 (IEEE Cat. No.98CH36236), P153, DOI 10.1109/IQEC.1998.682738; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fahey PK, 2003, VISUAL NEUROSCI, V20, P1, DOI 10.1017/S0952523803201012; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; HAMPSON ECGM, 1994, P ROY SOC B-BIOL SCI, V255, P67, DOI 10.1098/rspb.1994.0010; He SG, 2000, J COMP NEUROL, V418, P33, DOI 10.1002/(SICI)1096-9861(20000228)418:1<33::AID-CNE3>3.0.CO;2-J; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; JENSEN RJ, 1984, J NEUROSCI, V4, P2972; JENSEN RJ, 1986, NEUROSCIENCE, V17, P837, DOI 10.1016/0306-4522(86)90049-7; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; MAFFEI L, 1971, J NEUROPHYSIOL, V34, P579, DOI 10.1152/jn.1971.34.4.579; MANGEL SC, 1985, SCIENCE, V229, P1107, DOI 10.1126/science.4035351; MANGEL SC, 1991, J PHYSIOL-LONDON, V442, P211, DOI 10.1113/jphysiol.1991.sp018790; McMahon MJ, 2004, J NEUROSCI, V24, P3736, DOI 10.1523/JNEUROSCI.5252-03.2004; Muller JF, 1997, VISUAL NEUROSCI, V14, P395, DOI 10.1017/S0952523800011512; NAKA K, 1972, J PHYSIOL-LONDON, V223, P449, DOI 10.1113/jphysiol.1972.sp009857; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Packer OS, 2002, J VISION, V2, DOI 10.1167/2.4.1; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; RODIECK RW, 1965, J NEUROPHYSIOL, V28, P833, DOI 10.1152/jn.1965.28.5.833; Roska B, 2000, J NEUROSCI, V20, P1941; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; SHAPLEY R, 1985, ANNU REV NEUROSCI, V8, P547, DOI 10.1146/annurev.ne.08.030185.002555; SHELLEY J, COMMUNICATION; Shelley J, 2006, EUR J NEUROSCI, V23, P3176, DOI 10.1111/j.1460-9568.2006.04848.x; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; SMITH RA, 1973, J PHYSIOL-LONDON, V230, P115, DOI 10.1113/jphysiol.1973.sp010178; SMITH RG, 1995, VISUAL NEUROSCI, V12, P545, DOI 10.1017/S0952523800008440; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; TERANISHI T, 1983, NATURE, V301, P243, DOI 10.1038/301243a0; TORNQVIST K, 1988, J NEUROSCI, V8, P2279; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANHATEREN JH, 1992, BIOL CYBERN, V68, P23, DOI 10.1007/BF00203134; Vigh J, 1999, VISUAL NEUROSCI, V16, P159, DOI 10.1017/S095252389916111X; Wang Y, 1996, P NATL ACAD SCI USA, V93, P4655, DOI 10.1073/pnas.93.10.4655; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V; Xia YQ, 2003, VISUAL NEUROSCI, V20, P429, DOI 10.1017/S0952523803204089; Xin DY, 1999, J COMP NEUROL, V405, P75, DOI 10.1002/(SICI)1096-9861(19990301)405:1<75::AID-CNE6>3.0.CO;2-D; YANG XL, 1991, P NATL ACAD SCI USA, V88, P3310, DOI 10.1073/pnas.88.8.3310	69	51	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1714	10.1371/journal.pone.0001714	http://dx.doi.org/10.1371/journal.pone.0001714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320035	gold, Green Published			2022-12-27	WOS:000260586600010
J	Rozen, DE; Habets, MGJL; Handel, A; de Visser, JAGM				Rozen, Daniel E.; Habets, Michelle G. J. L.; Handel, Andreas; de Visser, J. Arjan G. M.			Heterogeneous Adaptive Trajectories of Small Populations on Complex Fitness Landscapes	PLOS ONE			English	Article								Background: Small populations are thought to be adaptively handicapped, not only because they suffer more from deleterious mutations but also because they have limited access to new beneficial mutations, particularly those conferring large benefits. Methodology/Principal Findings: Here, we test this widely held conjecture using both simulations and experiments with small and large bacterial populations evolving in either a simple or a complex nutrient environment. Consistent with expectations, we find that small populations are adaptively constrained in the simple environment; however, in the complex environment small populations not only follow more heterogeneous adaptive trajectories, but can also attain higher fitness than the large populations. Large populations are constrained to near deterministic fixation of rare large-benefit mutations. While such determinism speeds adaptation on the smooth adaptive landscape represented by the simple environment, it can limit the ability of large populations from effectively exploring the underlying topography of rugged adaptive landscapes characterized by complex environments. Conclusions: Our results show that adaptive constraints often faced by small populations can be circumvented during evolution on rugged adaptive landscapes.	[Rozen, Daniel E.; Habets, Michelle G. J. L.; de Visser, J. Arjan G. M.] Wageningen Univ, Dept Genet, Wageningen, Netherlands; [Handel, Andreas] Emory Univ, Dept Biol, Atlanta, GA USA; [Rozen, Daniel E.] Univ Manchester, Manchester, Lancs, England	Wageningen University & Research; Emory University; University of Manchester	Rozen, DE (corresponding author), Wageningen Univ, Dept Genet, Wageningen, Netherlands.	daniel.rozen@manchester.ac.uk	Handel, Andreas/F-6056-2012; Rozen, Daniel/M-9896-2014; de Visser, Arjan/GLU-3870-2022	Handel, Andreas/0000-0002-4622-1146; Rozen, Daniel/0000-0002-7772-0239; 	NWO; US NSF postdoctoral fellowship	NWO(Netherlands Organization for Scientific Research (NWO)); US NSF postdoctoral fellowship	This work was supported by grants to J.A.G.M. de V from NWO and a US NSF postdoctoral fellowship in Microbial Biology to D.E.R. There are no competing interests that would influence conclusions of the authors.	Barrett RDH, 2006, BIOL LETTERS, V2, P236, DOI 10.1098/rsbl.2006.0439; Bergstrom CT, 1999, P NATL ACAD SCI USA, V96, P5095, DOI 10.1073/pnas.96.9.5095; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brockhurst MA, 2004, P ROY SOC B-BIOL SCI, V271, P107, DOI 10.1098/rspb.2003.2556; Burch CL, 1999, GENETICS, V151, P921; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Colegrave N, 2005, BIOESSAYS, V27, P1167, DOI 10.1002/bies.20292; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cowperthwaite MC, 2006, PLOS COMPUT BIOL, V2, P1292, DOI 10.1371/journal.pcbi.0020141; Coyne JA, 1997, EVOLUTION, V51, P643, DOI [10.2307/2411143, 10.1111/j.1558-5646.1997.tb03650.x]; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; Fisher R. A., 1958, GENETIC THEORY NATUR; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goodnight CJ, 2006, HEREDITY, V96, P5, DOI 10.1038/sj.hdy.6800746; Habets MGJL, 2006, ECOL LETT, V9, P1041, DOI 10.1111/j.1461-0248.2006.00955.x; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; Jain K, 2007, GENETICS, V175, P1275, DOI 10.1534/genetics.106.067165; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; Korona R, 1996, P ROY SOC B-BIOL SCI, V263, P1665, DOI 10.1098/rspb.1996.0243; Lande R, 1998, GENETICA, V102-3, P21, DOI 10.1023/A:1017018405648; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MACKEN CA, 1989, P NATL ACAD SCI USA, V86, P6191, DOI 10.1073/pnas.86.16.6191; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; MULLER HJ, 1932, AM NAT, V66; Orr HA, 2006, EVOLUTION, V60, P1113; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; PERELSON AS, 1995, P NATL ACAD SCI USA, V92, P9657, DOI 10.1073/pnas.92.21.9657; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Reed DH, 2005, CONSERV BIOL, V19, P563, DOI 10.1111/j.1523-1739.2005.00444.x; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; RUBIN LG, 1987, REV INFECT DIS, V9, P488; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1175; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wilke CO, 2004, GENETICS, V167, P2045, DOI 10.1534/genetics.104.027136; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Wright S, 1932, P 6 INT C GEN, P355; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	53	69	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1715	10.1371/journal.pone.0001715	http://dx.doi.org/10.1371/journal.pone.0001715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320036	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600011
J	Wolf, DM; Fontaine-Bodin, L; Bischofs, I; Price, G; Keasling, J; Arkin, AP				Wolf, Denise M.; Fontaine-Bodin, Lisa; Bischofs, Ilka; Price, Gavin; Keasling, Jay; Arkin, Adam P.			Memory in Microbes: Quantifying History-Dependent Behavior in a Bacterium	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; TIT-FOR-TAT; TRANSCRIPTION FACTOR; BACILLUS-SUBTILIS; POSITIVE FEEDBACK; GENE-EXPRESSION; CELL-CYCLE; IN-VITRO; INFORMATION; SPORULATION	Memory is usually associated with higher organisms rather than bacteria. However, evidence is mounting that many regulatory networks within bacteria are capable of complex dynamics and multi-stable behaviors that have been linked to memory in other systems. Moreover, it is recognized that bacteria that have experienced different environmental histories may respond differently to current conditions. These "memory'' effects may be more than incidental to the regulatory mechanisms controlling acclimation or to the status of the metabolic stores. Rather, they may be regulated by the cell and confer fitness to the organism in the evolutionary game it participates in. Here, we propose that history-dependent behavior is a potentially important manifestation of memory, worth classifying and quantifying. To this end, we develop an information-theory based conceptual framework for measuring both the persistence of memory in microbes and the amount of information about the past encoded in history-dependent dynamics. This method produces a phenomenological measure of cellular memory without regard to the specific cellular mechanisms encoding it. We then apply this framework to a strain of Bacillus subtilis engineered to report on commitment to sporulation and degradative enzyme (AprE) synthesis and estimate the capacity of these systems and growth dynamics to 'remember' 10 distinct cell histories prior to application of a common stressor. The analysis suggests that B. subtilis remembers, both in short and long term, aspects of its cell history, and that this memory is distributed differently among the observables. While this study does not examine the mechanistic bases for memory, it presents a framework for quantifying memory in cellular behaviors and is thus a starting point for studying new questions about cellular regulation and evolutionary strategy.	[Wolf, Denise M.; Fontaine-Bodin, Lisa; Bischofs, Ilka; Price, Gavin; Keasling, Jay; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Fontaine-Bodin, Lisa; Bischofs, Ilka; Price, Gavin; Keasling, Jay; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA USA; [Keasling, Jay] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wolf, DM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	dmwolf@lbl.gov; aparkin@lbl.gov	Keasling, Jay D/J-9162-2012; Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Keasling, Jay D/0000-0003-4170-6088; Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Bischofs, Ilka/0000-0001-5905-7106	National Institutes of Health [R01 GM073010-01]; Department of Energy and the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy and the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge the National Institutes of Health (R01 GM073010-01), the Department of Energy and the Howard Hughes Medical Institute for support during the period of this project.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Arkin A, 1998, GENETICS, V149, P1633; Ash R.B., 1990, INFORM THEORY; Aumann R J, 1995, REPEATED GAMES INCOM; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Basar T., 1995, DYNAMIC NONCOOPERATI, V2nd ed.; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BENGTSSON G, 1977, AUTOMATICA, V13, P333, DOI 10.1016/0005-1098(77)90016-4; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Casadesus J, 2002, BIOESSAYS, V24, P512, DOI 10.1002/bies.10102; Chen I, 2003, FRONT BIOSCI, V8, pS544; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DeWeese MR, 1999, NETWORK-COMP NEURAL, V10, P325, DOI 10.1088/0954-898X/10/4/303; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Entian KD, 1996, ANTON LEEUW INT J G, V69, P109, DOI 10.1007/BF00399416; EWING JA, 1881, P ROY SOC LONDON, V32, P399; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fujita M, 2002, MOL MICROBIOL, V43, P27, DOI 10.1046/j.1365-2958.2002.02732.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Gawande PV, 2005, J FOOD PROTECT, V68, P1154, DOI 10.4315/0362-028X-68.6.1154; Gazzaniga M. S., 2004, COGNITIVE NEUROSCIEN; Greber D, 2007, J BIOTECHNOL, V130, P329, DOI 10.1016/j.jbiotec.2007.05.014; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hellingwerf KJ, 2005, TRENDS MICROBIOL, V13, P152, DOI 10.1016/j.tim.2005.02.001; Hoffer SM, 2001, J BACTERIOL, V183, P4914, DOI 10.1128/JB.183.16.4914-4917.2001; Holden NJ, 2004, J MED MICROBIOL, V53, P585, DOI 10.1099/jmm.0.05491-0; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; Jan J, 2001, APPL MICROBIOL BIOT, V55, P69, DOI 10.1007/s002530000448; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; KOSHLAND DE, 1977, SCIENCE, V196, P1055, DOI 10.1126/science.870969; Krasnoselskij M. A., 1989, SYSTEMS HYSTERESIS; Kreuzer-Martin HW, 2004, J FORENSIC SCI, V49, P961; Kreuzer-Martin HW, 2004, J FORENSIC SCI, V49, P954; KUNST F, 1994, RES MICROBIOL, V145, P393, DOI 10.1016/0923-2508(94)90087-6; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LANDAUER TK, 1986, COGNITIVE SCI, V10, P477, DOI 10.1207/s15516709cog1004_4; LANDE R, 1988, P NATL ACAD SCI USA, V85, P7418, DOI 10.1073/pnas.85.19.7418; Lim HN, 2007, NAT GENET, V39, P269, DOI 10.1038/ng1956; MARAHIEL MA, 1993, MOL MICROBIOL, V7, P631, DOI 10.1111/j.1365-2958.1993.tb01154.x; Maynard Smith J., 1982, pi; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; MORIMOTO BH, 1991, FASEB J, V5, P2061, DOI 10.1096/fasebj.5.7.2010059; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; Novak B, 1998, BIOPHYS CHEM, V72, P185, DOI 10.1016/S0301-4622(98)00133-1; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Robinson TP, 1998, INT J FOOD MICROBIOL, V44, P83, DOI 10.1016/S0168-1605(98)00120-2; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rozen Y, 2001, FEMS MICROBIOL REV, V25, P513, DOI 10.1016/S0168-6445(01)00065-1; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samoilov M, 2001, CHAOS, V11, P108, DOI 10.1063/1.1336499; Sanchez A, 2004, BIOTECHNOL LETT, V26, P403, DOI 10.1023/B:BILE.0000018259.66762.ed; Segel LA, 1998, BIOPHYS CHEM, V72, P223, DOI 10.1016/S0301-4622(98)00136-7; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SHANNON CE, 1948, BELL SYSTEMS TECHNIC, V27; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Song H, 2006, BIOPHYS J, V90, P2309, DOI 10.1529/biophysj.105.074500; STAHL ML, 1984, J BACTERIOL, V158, P411, DOI 10.1128/JB.158.2.411-418.1984; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; VASTANO JA, 1988, PHYS REV LETT, V60, P1773, DOI 10.1103/PhysRevLett.60.1773; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; VOIGT CA, 2004, B SUBTILIS SIN OPERO; Willeboordse FH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026207; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; WOLF DM, 2005, J THEOR BIO IN PRESS	81	81	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1700	10.1371/journal.pone.0001700	http://dx.doi.org/10.1371/journal.pone.0001700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18324309	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586500044
J	Daadi, MM; Maag, AL; Steinberg, GK				Daadi, Marcel M.; Maag, Anne-Lise; Steinberg, Gary K.			Adherent Self-Renewable Human Embryonic Stem Cell-Derived Neural Stem Cell Line: Functional Engraftment in Experimental Stroke Model	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; DOPAMINERGIC-NEURONS; PRECURSOR CELLS; GROWTH-FACTOR; TRANSPLANTATION; PROGENITORS; NICHE; NEUROGENESIS; POPULATION; EXPRESSION	Background: Human embryonic stem cells (hESCs) offer a virtually unlimited source of neural cells for structural repair in neurological disorders, such as stroke. Neural cells can be derived from hESCs either by direct enrichment, or by isolating specific growth factor-responsive and expandable populations of human neural stem cells (hNSCs). Studies have indicated that the direct enrichment method generates a heterogeneous population of cells that may contain residual undifferentiated stem cells that could lead to tumor formation in vivo. Methods/Principal Findings: We isolated an expandable and homogenous population of hNSCs (named SD56) from hESCs using a defined media supplemented with epidermal growth factor (EGF), basic fibroblast growth factor (bFGF) and leukemia inhibitory growth factor (LIF). These hNSCs grew as an adherent monolayer culture. They were fully neuralized and uniformly expressed molecular features of NSCs, including nestin, vimentin and radial glial markers. These hNSCs did not express the pluripotency markers Oct4 or Nanog, nor did they express markers for the mesoderm or endoderm lineages. The self-renewal property of the hNSCs was characterized by a predominant symmetrical mode of cell division. The SD56 hNSCs differentiated into neurons, astrocytes and oligodendrocytes throughout multiple passages in vitro, as well as after transplantation. Together, these criteria confirm the definitive NSC identity of the SD56 cell line. Importantly, they exhibited no chromosome abnormalities and did not form tumors after implantation into rat ischemic brains and into naive nude rat brains and flanks. Furthermore, hNSCs isolated under these conditions migrated toward the ischemia-injured adult brain parenchyma and improved the independent use of the stroke-impaired forelimb two months post-transplantation. Conclusions/Significance: The SD56 human neural stem cells derived under the reported conditions are stable, do not form tumors in vivo and enable functional recovery after stroke. These properties indicate that this hNSC line may offer a renewable, homogenous source of neural cells that will be valuable for basic and translational research.	[Daadi, Marcel M.; Maag, Anne-Lise; Steinberg, Gary K.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University	Daadi, MM (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.	mdaadi@stanford.edu		Steinberg, Gary/0000-0001-6374-1058	William Randolph Hearst Foundation; Edward E. Hills Fund; NIH NINDS [RO1 NS27292, P01 NS37520]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037520, R01NS027292] Funding Source: NIH RePORTER	William Randolph Hearst Foundation; Edward E. Hills Fund; NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Russell and Elizabeth Siegelman, Bernard and Ronni Lacroute, the William Randolph Hearst Foundation, John and Dodie Rosekrans, the Edward E. Hills Fund, Gerald and Marjorie Burnett, and NIH NINDS grants RO1 NS27292 and P01 NS37520.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Carson CT, 2006, NAT MED, V12, P1237, DOI 10.1038/nm1106-1237; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Daadi M, 1998, NEUROSCIENCE, V86, P867, DOI 10.1016/S0306-4522(98)00102-X; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guillaume DJ, 2006, J NEUROSCI RES, V84, P1165, DOI 10.1002/jnr.21022; Hayashi J, 2006, J CEREBR BLOOD F MET, V26, P906, DOI 10.1038/sj.jcbfm.9600247; Ikeda R, 2005, NEUROBIOL DIS, V20, P38, DOI 10.1016/j.nbd.2005.01.031; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Ostenfeld T, 2004, STEM CELLS, V22, P798, DOI 10.1634/stemcells.22-5-798; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Savitz Sean I, 2004, NeuroRx, V1, P406; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; Thomson JA, 1998, SCIENCE, V282, P1827; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	52	146	163	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1644	10.1371/journal.pone.0001644	http://dx.doi.org/10.1371/journal.pone.0001644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286199	gold, Green Submitted, Green Published			2022-12-27	WOS:000260586400037
J	Fehrmann, RSN; de Jonge, HJM; ter Elst, A; de Vries, A; Crijns, AGP; Weidenaar, AC; Gerbens, F; de Jong, S; van der Zee, AGJ; de Vries, EGE; Kamps, WA; Hofstra, RMW; Meerman, GJT; de Bont, ESJM				Fehrmann, Rudolf S. N.; de Jonge, Hendrik J. M.; ter Elst, Arja; de Vries, Andre; Crijns, Anne G. P.; Weidenaar, Alida C.; Gerbens, Frans; de Jong, Steven; van der Zee, Ate G. J.; de Vries, Elisabeth G. E.; Kamps, Willem A.; Hofstra, Robert M. W.; Meerman, Gerard J. te; de Bont, Eveline S. J. M.			A New Perspective on Transcriptional System Regulation (TSR): Towards TSR Profiling	PLOS ONE			English	Article							GENE-EXPRESSION; ORGANIZATION; REPLICATION; BIOLOGY	It has been hypothesized that the net expression of a gene is determined by the combined effects of various transcriptional system regulators (TSRs). However, characterizing the complexity of regulation of the transcriptome is a major challenge. Principal component analysis on 17,550 heterogeneous human microarray experiments revealed that 50 orthogonal factors (hereafter called TSRs) are able to capture 64% of the variability in expression in a wide range of experimental conditions and tissues. We identified gene clusters controlled in the same direction and show that gene expression can be conceptualized as a process influenced by a fairly limited set of TSRs. Furthermore, TSRs can be linked to biological functions, as we demonstrate a strong relation between TSR-related gene clusters and biological functionality as well as cellular localization, i.e. gene products of similarly regulated genes by a specific TSR are located in identical parts of a cell. Using 3,934 diverse mouse microarray experiments we found striking similarities in transcriptional system regulation between human and mouse. Our results give biological insights into regulation of the cellular transcriptome and provide a tool to characterize expression profiles with highly reliable TSRs instead of thousands of individual genes, leading to a >500-fold reduction of complexity with just 50 TSRs. This might open new avenues for those performing gene expression profiling studies.	[Fehrmann, Rudolf S. N.; de Vries, Andre; Gerbens, Frans; Hofstra, Robert M. W.; Meerman, Gerard J. te] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [de Jonge, Hendrik J. M.; ter Elst, Arja; Weidenaar, Alida C.; Kamps, Willem A.; de Bont, Eveline S. J. M.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, Div Pediat Oncol, Groningen, Netherlands; [Fehrmann, Rudolf S. N.; Crijns, Anne G. P.; van der Zee, Ate G. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol, Groningen, Netherlands; [Fehrmann, Rudolf S. N.; de Jong, Steven; de Vries, Elisabeth G. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Fehrmann, RSN (corresponding author), Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands.	e.de.bont@bkk.umcg.nl	Fehrmann, Rudolf/E-2551-2011	Fehrmann, Rudolf/0000-0002-7516-315X; Hofstra, Robert/0000-0001-7498-3829; de Vries, Elisabeth/0000-0002-8949-7425	Foundation for Pediatric Oncology Groningen; Dutch Cancer Society [3661]	Foundation for Pediatric Oncology Groningen; Dutch Cancer Society(KWF Kankerbestrijding)	H.J.M. de J is partially supported by the Foundation for Pediatric Oncology Groningen and E.S.J.M. de B is supported by a grant from the Dutch Cancer Society (grant number 3661). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript. An european patent application has been filed concerning diagnostic use of TSR's by the University of Groningen and the University Medical Center Groningen. The first and the last two authors could receive partial benefits of patent revenu in the future.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes C, 2007, NUCL ACIDS RES; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Gasch AP, 2002, GENOME BIOL, V3; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; L.I. Smith, 2002, TUTORIAL PRINCIPAL C; LORD FM, 1968, STATISTICAL THEORIES, P129; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Rencher A.C., 1998, MULTIVARIATE STAT IN; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102	26	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1656	10.1371/journal.pone.0001656	http://dx.doi.org/10.1371/journal.pone.0001656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18297136	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400046
J	Lee, JY; Muenzberg, H; Gavrilova, O; Reed, JA; Berryman, D; Villanueva, EC; Louis, GW; Leinninger, GM; Bertuzzi, S; Seeley, RJ; Robinson, GW; Myers, MG; Hennighausen, L				Lee, Ji-Yeon; Muenzberg, Heike; Gavrilova, Oksana; Reed, Jacquelyn A.; Berryman, Darlene; Villanueva, Eneida C.; Louis, Gwendolyn W.; Leinninger, Gina M.; Bertuzzi, Stefano; Seeley, Randy J.; Robinson, Gertraud W.; Myers, Martin G., Jr.; Hennighausen, Lothar			Loss of Cytokine-STAT5 Signaling in the CNS and Pituitary Gland Alters Energy Balance and Leads to Obesity	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; HYPOTHALAMIC ARCUATE NUCLEUS; TRANSCRIPTION 5B; NERVOUS-SYSTEM; FOOD-INTAKE; LEPTIN; PROLIFERATION; TRANSDUCER; ACTIVATOR; RECEPTOR	Signal transducers and activators of transcription (STATs) are critical components of cytokine signaling pathways. STAT5A and STAT5B (STAT5), the most promiscuous members of this family, are highly expressed in specific populations of hypothalamic neurons in regions known to mediate the actions of cytokines in the regulation of energy balance. To test the hypothesis that STAT5 signaling is essential to energy homeostasis, we used Cre-mediated recombination to delete the Stat5 locus in the CNS. Mutant males and females developed severe obesity with hyperphagia, impaired thermal regulation in response to cold, hyperleptinemia and insulin resistance. Furthermore, central administration of GM-CSF mediated the nuclear accumulation of STAT5 in hypothalamic neurons and reduced food intake in control but not in mutant mice. These results demonstrate that STAT5 mediates energy homeostasis in response to endogenous cytokines such as GM-CSF.	[Lee, Ji-Yeon; Robinson, Gertraud W.; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, Natl Inst Hlth, Bethesda, MD 20892 USA; [Muenzberg, Heike; Villanueva, Eneida C.; Louis, Gwendolyn W.; Leinninger, Gina M.; Myers, Martin G., Jr.] Univ Michigan, Dept Med & Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Gavrilova, Oksana] NIDDK, Mouse Metab Core Facil, Natl Inst Hlth, Bethesda, MD USA; [Reed, Jacquelyn A.; Seeley, Randy J.] Univ Cincinnati, Cincinnati, OH USA; [Berryman, Darlene] Ohio Univ, Athens, OH 45701 USA; [Bertuzzi, Stefano] Natl Inst Neurol Disorders & Stroke, Mammalian Dev Sect, Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; University of Cincinnati; University System of Ohio; Ohio University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Lee, JY (corresponding author), NIDDK, Lab Genet & Physiol, Natl Inst Hlth, Bethesda, MD 20892 USA.	hennighausen@nih.gov	Muenzberg-Gruening, Heike/N-1978-2017; Robinson, Gertraud/I-2136-2012	Seeley, Randy/0000-0002-3721-5625; Hennighausen, Lothar/0000-0001-8319-9841	Federal Government of the USA; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK061005, ZIADK061005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002790, Z01NS002790] Funding Source: NIH RePORTER	Federal Government of the USA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Federal Government of the USA (intramural and extramural programs of the National Institutes of Health).	Anderson GM, 2006, ENDOCRINOLOGY, V147, P4996, DOI 10.1210/en.2005-0755; Anderson KD, 2003, J NEUROENDOCRINOL, V15, P649, DOI 10.1046/j.1365-2826.2003.01043.x; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Bennett E, 2005, J NEUROENDOCRINOL, V17, P186, DOI 10.1111/j.1365-2826.2005.01296.x; Cave BJ, 2005, NEUROREPORT, V16, P1423, DOI 10.1097/01.wnr.0000176516.19347.6f; Chen HC, 2002, J LIPID RES, V43, P986; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Davey HW, 1999, MOL CELL ENDOCRINOL, V158, P111, DOI 10.1016/S0303-7207(99)00175-6; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; GONG Y, 2007, J BIOL CHEM; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Ma FY, 2005, ENDOCRINOLOGY, V146, P5112, DOI 10.1210/en.2005-0770; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Sleeman MW, 2003, P NATL ACAD SCI USA, V100, P14297, DOI 10.1073/pnas.2335926100; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; XU AW, 2006, ENDOCRINOLOGY	27	70	76	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1639	10.1371/journal.pone.0001639	http://dx.doi.org/10.1371/journal.pone.0001639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286195	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400032
J	Muller, A; Glattard, E; Taleb, O; Kemmel, V; Laux, A; Delalande, F; Roussel, G; Van Dorsselaer, A; Metz-Boutigue, MH; Aunis, D; Goumon, Y				Muller, Arnaud; Glattard, Elise; Taleb, Omar; Kemmel, Veronique; Laux, Alexis; Delalande, Francois; Roussel, Guy; Van Dorsselaer, Alain; Metz-Boutigue, Marie-Helene; Aunis, Dominique; Goumon, Yannick			Endogenous Morphine in SH-SY5Y Cells and the Mouse Cerebellum	PLOS ONE			English	Article								Background: Morphine, the principal active agent in opium, is not restricted to plants, but is also present in different animal tissues and cell types, including the mammalian brain. In fact, its biosynthetic pathway has been elucidated in a human neural cell line. These data suggest a role for morphine in brain physiology (e. g., neurotransmission), but this hypothesis remains a matter of debate. Recently, using the adrenal neuroendocrine chromaffin cell model, we have shown the presence of morphine-6-glucuronide (M6G) in secretory granules and their secretion products, leading us to propose that these endogenous alkaloids might represent new neuroendocrine factors. Here, we investigate the potential function of endogenous alkaloids in the central nervous system. Methodology and Principal Findings: Microscopy, molecular biology, electrophysiology, and proteomic tools were applied to human neuroblastoma SH-SY5Y cells (i) to characterize morphine and M6G, and (ii) to demonstrate the presence of the UDP-glucuronyltransferase 2B7 enzyme, which is responsible for the formation of M6G from morphine. We show that morphine is secreted in response to nicotine stimulation via a Ca2+-dependent mechanism involving specific storage and release mechanisms. We also show that morphine and M6G at concentrations as low as 10 210 M are able to evoke specific naloxone-reversible membrane currents, indicating possible autocrine/paracrine regulation in SH-SY5Y cells. Microscopy and proteomic approaches were employed to detect and quantify endogenous morphine in the mouse brain. Morphine is present in the hippocampus, cortex, olfactory bulb, and cerebellum at concentration ranging from 1.45 to 7.5 pmol/g. In the cerebellum, morphine immunoreactivity is localized to GABA basket cells and their termini, which form close contacts on Purkinje cell bodies. Conclusions/Significance: The presence of morphine in the brain and its localization in particular areas lead us to conclude that it has a specific function in neuromodulation and/or neurotransmission. Furthermore, its presence in cerebellar basket cell termini suggests that morphine has signaling functions in Purkinje cells that remain to be discovered.	[Muller, Arnaud; Glattard, Elise; Taleb, Omar; Kemmel, Veronique; Laux, Alexis; Delalande, Francois; Roussel, Guy; Metz-Boutigue, Marie-Helene; Aunis, Dominique; Goumon, Yannick] INSERM, U575, Physiopathol Syst Nerveux, Strasbourg, France; [Kemmel, Veronique; Roussel, Guy] Inst Chim Biol, Fac Med, Strasbourg, France; [Van Dorsselaer, Alain] Univ Louis Pasteur, LC4 UMR7178, ECPM, CNRS, Lab Spectrom Masse Bio Organ, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Muller, A (corresponding author), INSERM, U575, Physiopathol Syst Nerveux, Strasbourg, France.	yannick.goumon@inserm.u-strasbg.fr	Kemmel, Veronique/O-9018-2015; Taleb, Omar/K-1457-2016; Dominique, Aunis/W-1419-2019; Kemmel, Véronique/V-2590-2019	Kemmel, Veronique/0000-0003-4680-4293; Taleb, Omar/0000-0003-2407-0380; Kemmel, Véronique/0000-0003-4680-4293; Goumon, Yannick/0000-0003-4336-3437; Delalande, Francois/0000-0003-3590-9874; , Elise/0000-0002-4501-9675; Laux-Biehlmann, Alexis/0000-0003-0508-3047	Inserm; University Louis-Pasteur at Strasbourg; Fondation de France; French Ministere delegue a la Recherche et a l'Enseignement Superieur [fellowships]; Fondation Transplantation	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Louis-Pasteur at Strasbourg; Fondation de France(Fondation de France); French Ministere delegue a la Recherche et a l'Enseignement Superieur; Fondation Transplantation	This study was funded by Inserm, the University Louis-Pasteur at Strasbourg, the Fondation de France (to Y.G.), the French Ministere delegue a la Recherche et a l'Enseignement Superieur (Ph.D fellowships to E.G. and A.M.) and the Fondation Transplantation (to Y.G. and D.A.).	Agis-Torres A, 2002, NEUROSCI LETT, V331, P167, DOI 10.1016/S0304-3940(02)00881-9; Aunis D, 1998, INT REV CYTOL, V181, P213, DOI 10.1016/S0074-7696(08)60419-2; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Brailoiu E, 2004, NEUROSCI LETT, V365, P10, DOI 10.1016/j.neulet.2004.03.092; Brands A, 2000, BIOCHEM PHARMACOL, V59, P1441, DOI 10.1016/S0006-2952(00)00274-4; Bushell T, 2002, BRIT J PHARMACOL, V135, P705, DOI 10.1038/sj.bjp.0704518; Cadet P, 2003, J IMMUNOL, V170, P5118, DOI 10.4049/jimmunol.170.10.5118; Cadet P, 2007, J IMMUNOL, V179, P5839, DOI 10.4049/jimmunol.179.9.5839; Doyle GA, 2007, GENE, V395, P98, DOI 10.1016/j.gene.2007.02.004; Figlewicz DP, 1999, EPILEPSY RES, V37, P203, DOI 10.1016/S0920-1211(99)00072-8; Gasnier C, 2004, PROTEOMICS, V4, P1789, DOI 10.1002/pmic.200300693; GINTZLER AR, 1978, SCIENCE, V199, P447, DOI 10.1126/science.339350; GIUDICI AM, 1992, EUR J CELL BIOL, V58, P383; GOLDSTEIN A, 1985, P NATL ACAD SCI USA, V82, P5203, DOI 10.1073/pnas.82.15.5203; Goodall AR, 1997, J NEUROCHEM, V68, P1542; Goumon Y, 2000, NEUROSCI LETT, V293, P135, DOI 10.1016/S0304-3940(00)01507-X; Goumon Y, 2006, J BIOL CHEM, V281, P8082, DOI 10.1074/jbc.M502298200; Goumon Y, 2004, J BIOL CHEM, V279, P13054, DOI 10.1074/jbc.M308533200; GRANDY DK, 1990, MOL ENDOCRINOL, V4, P1370, DOI 10.1210/mend-4-9-1370; Guarna M, 1998, J NEUROCHEM, V70, P147; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; HAZUM E, 1981, SCIENCE, V213, P1010, DOI 10.1126/science.6267691; Hedou G, 2000, J COMP NEUROL, V426, P549, DOI 10.1002/1096-9861(20001030)426:4<549::AID-CNE4>3.0.CO;2-Y; Herbert RB, 2000, NAT PROD REP, V17, P317, DOI 10.1039/a809409h; Heurtaux T, 2006, NEUROPHARMACOLOGY, V50, P317, DOI 10.1016/j.neuropharm.2005.09.007; Horner KA, 2004, BRAIN RES, V1028, P121, DOI 10.1016/j.brainres.2004.07.055; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Kream RM, 2006, MED SCI MONITOR, V12, pRA207; LEE CS, 1991, J PHARMACOL EXP THER, V257, P647; Liu AMF, 2005, NEUROSIGNALS, V14, P136, DOI 10.1159/000086296; Lotsch J, 2005, J PAIN SYMPTOM MANAG, V29, pS10, DOI 10.1016/j.jpainsymman.2005.01.004; Lotsch J, 2001, CLIN PHARMACOKINET, V40, P485; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Martinasevic MK, 1998, DRUG METAB DISPOS, V26, P1039; Meijerink WJHJ, 1999, SHOCK, V12, P165, DOI 10.1097/00024382-199909000-00001; MINAMI M, 1994, NEUROSCI RES, V18, P315, DOI 10.1016/0168-0102(94)90167-8; MOLINA PE, 1995, BIOCHEM BIOPH RES CO, V207, P312, DOI 10.1006/bbrc.1995.1189; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Mrkusich EM, 2004, DEV BRAIN RES, V148, P213, DOI 10.1016/j.devbrainres.2003.10.013; Nagano E, 2000, LIFE SCI, V67, P2453, DOI 10.1016/S0024-3205(00)00825-0; Ou XM, 1998, INT J MOL MED, V1, P105; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pan YX, 2005, MOL PHARMACOL, V68, P866, DOI 10.1124/mol.105.011858; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; ROSS RA, 1983, J NATL CANCER I, V71, P741; ROZENFELD R, 2007, FASEB J; Stefano GB, 2000, TRENDS NEUROSCI, V23, P436, DOI 10.1016/S0166-2236(00)01611-8; STEFANO GB, 1994, ADV NEUROIMMUNOL, V4, P57, DOI 10.1016/S0960-5428(05)80001-4; Suleman FG, 1998, ARCH BIOCHEM BIOPHYS, V358, P63, DOI 10.1006/abbi.1998.0842; TAGUCHI K, 1989, NEUROPHARMACOLOGY, V28, P235, DOI 10.1016/0028-3908(89)90098-1; Taguchi K, 2000, ACTA PHARMACOL SIN, V21, P877; Tenconi B, 1996, DEV BRAIN RES, V94, P175, DOI 10.1016/0165-3806(96)00047-8; van Dorp ELA, 2006, ANESTH ANALG, V102, P1789, DOI 10.1213/01.ane.0000217197.96784.c3; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; WEITZ CJ, 1986, P NATL ACAD SCI USA, V83, P9784, DOI 10.1073/pnas.83.24.9784; Wu DF, 1997, DRUG METAB DISPOS, V25, P768; Yamada Hideyuki, 2003, J Toxicol Sci, V28, P395, DOI 10.2131/jts.28.395; Yu X, 2003, J PHARMACOL EXP THER, V306, P447, DOI 10.1124/jpet.103.048694; ZADINA JE, 1993, J PHARMACOL EXP THER, V265, P254; Zelcer N, 2005, P NATL ACAD SCI USA, V102, P7274, DOI 10.1073/pnas.0502530102; Zeng YS, 2007, BRAIN RES, V1130, P108, DOI 10.1016/j.brainres.2006.10.079; Zhang YH, 2006, BRAIN RES, V1099, P33, DOI 10.1016/j.brainres.2006.04.133; Zhu W, 2007, INT J IMMUNOPATH PH, V20, P229, DOI 10.1177/039463200702000203; Zhu W, 2006, MED SCI MONITOR, V12, pBR350; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	70	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1641	10.1371/journal.pone.0001641	http://dx.doi.org/10.1371/journal.pone.0001641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18327293	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400034
J	Onaivi, ES; Ishiguro, H; Gong, JP; Patel, S; Meozzi, PA; Myers, L; Perchuk, A; Mora, Z; Tagliaferro, PA; Gardner, E; Brusco, A; Akinshola, BE; Hope, B; Lujilde, J; Inada, T; Iwasaki, S; Macharia, D; Teasenfitz, L; Arinami, T; Uhl, GR				Onaivi, Emmanuel S.; Ishiguro, Hiroki; Gong, Jian-Ping; Patel, Sejal; Meozzi, Paul A.; Myers, Lester; Perchuk, Alex; Mora, Zoila; Tagliaferro, Patricia A.; Gardner, Eileen; Brusco, Alicia; Akinshola, B. Emmanuel; Hope, Bruce; Lujilde, Javier; Inada, Toshiya; Iwasaki, Shinya; Macharia, David; Teasenfitz, Lindsey; Arinami, Tadao; Uhl, George R.			Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; EXPRESSION; GENE; DISORDERS; ALCOHOL; ANXIETY; CELLS; RISK; PAIN	Background: Addiction and major depression are mental health problems associated with stressful events in life with high relapse and reoccurrence even after treatment. Many laboratories were not able to detect the presence of cannabinoid CB2 receptors (CB2-Rs) in healthy brains, but there has been demonstration of CB2-R expression in rat microglial cells and other brain associated cells during inflammation. Therefore, neuronal expression of CB2-Rs had been ambiguous and controversial and its role in depression and substance abuse is unknown. Methodology/Principal Findings: In this study we tested the hypothesis that genetic variants of CB2 gene might be associated with depression in a human population and that alteration in CB2 gene expression may be involved in the effects of abused substances including opiates, cocaine and ethanol in rodents. Here we demonstrate that a high incidence of (Q63R) but not (H316Y) polymorphism in the CB2 gene was found in Japanese depressed subjects. CB2-Rs and their gene transcripts are expressed in the brains of naive mice and are modulated following exposure to stressors and administration of abused drugs. Mice that developed alcohol preference had reduced CB2 gene expression and chronic treatment with JWH015 a putative CB2-R agonist, enhanced alcohol consumption in stressed but not in control mice. The direct intracerebroventricular microinjection of CB2 anti-sense oligonucleotide into the mouse brain reduced mouse aversions in the plus-maze test, indicating the functional presence of CB2-Rs in the brain that modifies behavior. We report for the using electron microscopy the sub cellular localization of CB2-Rs that are mainly on post-synaptic elements in rodent brain. Conclusions/Significance: Our data demonstrate the functional expression of CB2-Rs in brain that may provide novel targets for the effects of cannabinoids in depression and substance abuse disorders beyond neuro-immunocannabinoid activity.	[Onaivi, Emmanuel S.; Patel, Sejal; Meozzi, Paul A.; Myers, Lester; Perchuk, Alex; Mora, Zoila; Gardner, Eileen; Macharia, David; Teasenfitz, Lindsey] William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA; [Onaivi, Emmanuel S.; Ishiguro, Hiroki; Gong, Jian-Ping; Iwasaki, Shinya; Arinami, Tadao; Uhl, George R.] Natl Inst Drug Abuse, Mol Neurobiol Branch, Intramural Res Program, Natl Inst Hlth, Bethesda, MD USA; [Ishiguro, Hiroki] Univ Tsukuba, Dept Med Genet, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan; [Tagliaferro, Patricia A.; Brusco, Alicia; Lujilde, Javier] Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina; [Akinshola, B. Emmanuel] Howard Univ, Dept Pharmacol, Washington, DC 20059 USA; [Hope, Bruce] Natl Inst Drug Abuse, Behav Neurosci Branch, Intramural Res Program, Natl Inst Hlth, Bethesda, MD USA; [Inada, Toshiya] Teikyo Univ, Chiba Med Ctr, Chiba, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Tsukuba; University of Buenos Aires; Howard University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Teikyo University	Onaivi, ES (corresponding author), William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA.	OnaiviE@wpunj.edu	Hope, Bruce T/A-9223-2010; Ishiguro, Hiroki/Q-7532-2019; Onaivi, Emmanuel/Q-9679-2019	Hope, Bruce T/0000-0001-5804-7061; Inada, Toshiya/0000-0002-8427-5639	NIDA/IRP; William Paterson University center for research; Public interest trust; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000401, ZIADA000467, ZIADA000492, ZIADA000401, Z01DA000492, Z01DA000165, ZIADA000165, Z01DA000467] Funding Source: NIH RePORTER	NIDA/IRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); William Paterson University center for research; Public interest trust; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by NIDA/IRP and ESO acknowledges financial support from William Paterson University center for research and the Dean, Dr. DeYoung, student worker fund. HI and TA acknowledge Public interest trust, Research aid fund for stress related diseases with commemoration of Imaikimi. The sponsors or funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ashton JC, 2006, NEUROSCI LETT, V396, P113, DOI 10.1016/j.neulet.2005.11.038; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Benito C, 2005, J NEUROSCI, V25, P2530, DOI 10.1523/JNEUROSCI.3923-04.2005; Benito C, 2003, J NEUROSCI, V23, P11136; Bovasso GB, 2001, AM J PSYCHIAT, V158, P2033, DOI 10.1176/appi.ajp.158.12.2033; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Degenhardt L, 2001, ADDICTION, V96, P1603, DOI 10.1046/j.1360-0443.2001.961116037.x; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Griffin G, 1999, EUR J PHARMACOL, V377, P117, DOI 10.1016/S0014-2999(99)00402-1; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; ISHIGURO H, 2006, PHARMACOGENOMICS J; Karsak M, 2005, HUM MOL GENET, V14, P3389, DOI 10.1093/hmg/ddi370; Manzanares J, 2004, NEUROTOX RES, V6, P213, DOI 10.1007/BF03033223; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nieri P, 2003, N-S ARCH PHARMACOL, V368, P352, DOI 10.1007/s00210-003-0831-3; Nunez E, 2004, SYNAPSE, V53, P208, DOI 10.1002/syn.20050; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Onaivi ES, 2006, METH MOLEC MED, V123, P291; ONAIVI ES, 1990, J PHARMACOL EXP THER, V253, P1002; Onaivi ES, 2005, ENDOCANNABINOIDS BRA; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Paxinos G., 2005, RAT BRAIN STEREOTAXI, Vxliii; Pickel VM, 2006, J COMP NEUROL, V495, P299, DOI 10.1002/cne.20881; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Volkow ND, 2005, PHARMACOL THERAPEUT, V108, P3, DOI 10.1016/j.pharmthera.2005.06.021; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zhong LC, 2005, INVEST OPHTH VIS SCI, V46, P1988, DOI 10.1167/iovs.04-0651	36	199	204	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1640	10.1371/journal.pone.0001640	http://dx.doi.org/10.1371/journal.pone.0001640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XR	18286196	gold, Green Submitted, Green Published			2022-12-27	WOS:000260586400033
J	Salvaing, J; Nagel, AC; Mouchel-Vielh, E; Bloyer, S; Maier, D; Preiss, A; Peronnet, F				Salvaing, Juliette; Nagel, Anja C.; Mouchel-Vielh, Emmanuele; Bloyer, Sebastien; Maier, Dieter; Preiss, Anette; Peronnet, Frederique			The Enhancer of Trithorax and Polycomb Corto Interacts with Cyclin G in Drosophila	PLOS ONE			English	Article							CONVEYS EPIGENETIC INHERITANCE; PROTEIN-INTERACTION MAP; BITHORAX COMPLEX; CELLULAR MEMORY; DNA-DAMAGE; TRANSCRIPTIONAL REGULATION; CHROMATIN-ASSOCIATION; GENE-EXPRESSION; A REPRESSION; PC-G	Background: Polycomb (PcG) and trithorax (trxG) genes encode proteins involved in the maintenance of gene expression patterns, notably Hox genes, throughout development. PcG proteins are required for long-term gene repression whereas TrxG proteins are positive regulators that counteract PcG action. PcG and TrxG proteins form large complexes that bind chromatin at overlapping sites called Polycomb and Trithorax Response Elements (PRE/TRE). A third class of proteins, so-called "Enhancers of Trithorax and Polycomb'' (ETP), interacts with either complexes, behaving sometimes as repressors and sometimes as activators. The role of ETP proteins is largely unknown. Methodology/Principal Findings: In a two-hybrid screen, we identified Cyclin G (CycG) as a partner of the Drosophila ETP Corto. Inactivation of CycG by RNA interference highlights its essential role during development. We show here that Corto and CycG directly interact and bind to each other in embryos and S2 cells. Moreover, CycG is targeted to polytene chromosomes where it co-localizes at multiple sites with Corto and with the PcG factor Polyhomeotic (PH). We observed that corto is involved in maintaining Abd-B repression outside its normal expression domain in embryos. This could be achieved by association between Corto and CycG since both proteins bind the regulatory element iab-7 PRE and the promoter of the Abd-B gene. Conclusions/Significance: Our results suggest that CycG could regulate the activity of Corto at chromatin and thus be involved in changing Corto from an Enhancer of TrxG into an Enhancer of PcG.	[Salvaing, Juliette; Mouchel-Vielh, Emmanuele; Bloyer, Sebastien; Peronnet, Frederique] Univ Paris 06, Dev Biol Lab, UMR 7622, CNRS, Paris, France; [Nagel, Anja C.; Maier, Dieter; Preiss, Anette] Univ Hohenheim, Inst Genetik 240, Stuttgart, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University Hohenheim	Salvaing, J (corresponding author), Univ Paris 06, Dev Biol Lab, UMR 7622, CNRS, Paris, France.	Frederique.Peronnet@snv.jussieu.fr	Peronnet, Frederique/J-7101-2015; Nagel, Anja/AAA-4254-2022	Peronnet, Frederique/0000-0003-1354-240X; Nagel, Anja/0000-0002-2733-3249	CNRS; UPMC; ARC [4492]	CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; ARC(Australian Research Council)	This work was supported by CNRS and UPMC and by grant 4492 from ARC to F.P. J.S. was partly supported by a scholarship from ARC	Baek WK, 2003, AM J OBSTET GYNECOL, V188, P634, DOI 10.1067/mob.2003.140; Bates S, 1996, ONCOGENE, V13, P1103; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bhat KM, 1996, DEVELOPMENT, V122, P1113; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; Brumby AM, 2002, EMBO J, V21, P3377, DOI 10.1093/emboj/cdf334; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, PRACT APPROACH SER, P20; CELNIKER SE, 1989, GENE DEV, V3, P1424, DOI 10.1101/gad.3.9.1424; Chun TH, 2005, FEBS LETT, V579, P5275, DOI 10.1016/j.febslet.2005.08.050; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Decoville M, 2001, GENETICS, V157, P237; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dejardin J, 2004, EMBO J, V23, P857, DOI 10.1038/sj.emboj.7600108; DELORENZI M, 1990, DEVELOPMENT, V108, P323; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Gildea JJ, 2000, GENETICS, V156, P645; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Huynh CQ, 1999, J MOL BIOL, V288, P13, DOI 10.1006/jmbi.1999.2674; INGHAM PW, 1985, J EMBRYOL EXP MORPH, V89, P349; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Kodjabachian L, 1998, EMBO J, V17, P1063, DOI 10.1093/emboj/17.4.1063; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; MOEHRLE A, 1994, DEV GENET, V15, P478, DOI 10.1002/dvg.1020150606; Nagel AC, 2002, DEV GENES EVOL, V212, P93, DOI 10.1007/s00427-002-0210-y; Narbonne K, 2004, DEVELOPMENT, V131, P1389, DOI 10.1242/dev.01003; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Okamoto K, 1999, ONCOGENE, V18, P4606, DOI 10.1038/sj.onc.1202821; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Reimers L, 1999, J BIOL CHEM, V274, P11022, DOI 10.1074/jbc.274.16.11022; Remillieux-Leschelle N, 2002, GENETICS, V162, P1259; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Salamov AA, 1998, BIOINFORMATICS, V14, P384, DOI 10.1093/bioinformatics/14.5.384; Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; TAMURA K, 1993, ONCOGENE, V8, P2113; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Tonini T, 2004, ONCOGENE, V23, P4930, DOI 10.1038/sj.onc.1207608; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200	66	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1658	10.1371/journal.pone.0001658	http://dx.doi.org/10.1371/journal.pone.0001658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286205	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400047
J	Folgiero, V; Avetrani, P; Bon, G; Di Carlo, SE; Fabi, A; Nistico, C; Vici, P; Melucci, E; Buglioni, S; Perracchio, L; Sperduti, I; Rosano, L; Sacchi, A; Mottolese, M; Falcioni, R				Folgiero, Valentina; Avetrani, Paolo; Bon, Giulia; Di Carlo, Selene E.; Fabi, Alessandra; Nistico, Cecilia; Vici, Patrizia; Melucci, Elisa; Buglioni, Simonetta; Perracchio, Letizia; Sperduti, Isabella; Rosano, Laura; Sacchi, Ada; Mottolese, Marcella; Falcioni, Rita			Induction of ErbB-3 Expression by alpha 6 beta 4 Integrin Contributes to Tamoxifen Resistance in ER beta 1-Negative Breast Carcinomas (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							ESTROGEN-RECEPTOR-BETA; PHOSPHOINOSITIDE 3-OH KINASE; ALPHA(6)BETA(4) INTEGRIN; CELL-LINE; ER-BETA; CANCER; SURVIVAL; THERAPY; ALPHA; ACTIVATION	Background: Tamoxifen is still the most widely used drug in hormone therapy for the treatment of breast cancer. Its benefits in adjuvant treatment are well documented in controlled and randomized clinical studies, which have demonstrated an increase in disease-free intervals of patients with positive hormonal receptors. However, the mechanisms involved in endocrine resistance are not clear. Laboratory and clinical data now indicate that bi-directional molecular crosstalk between nuclear or membrane ER and growth factor receptor pathways may be involved in endocrine resistance. We recently found a functional interaction between alpha 6 beta 4 integrin and ErbB-3 receptor to maintain the PI3K/Akt survival pathway of mammary tumour cells. We sought to improve understanding of this process in order to provide the involvement of both receptors insight into mechanism of Tamoxifen resistance. Methods and Findings: Using human breast cancer cell lines displaying different levels of alpha 6 beta 4 and ErbB-3 receptors and a series of 232 breast cancer biopsies from patients submitted to adjuvant Tamoxifen monotherapy for five years, we evaluated the functional interaction between both receptors in relationship to Tamoxifen responsiveness. In mammary carcinoma cells, we evidenced that the a6b4 integrin strongly influence Akt phosphorylation through ErbB-3 protein regulation. Moreover, the ErbB-3 inactivation inhibits Akt phosphorylation, induces apoptosis and inhibits in vitro invasion favouring Tamoxifen responsiveness. The analysis of human tumors revealed a significant relationship between a6b4 and ErbB-3 in P-Akt-positive and ER beta 1-negative breast cancers derived from patients with lower disease free survival. Conclusions: We provided evidence that a strong relationship occurs between alpha 6 beta 4 and ErbB-3 positivity in ER beta 1-negative breast cancers. We also found that the association between ErbB-3 and P-Akt positivity mainly occurs in ER beta 1-negative breast cancer derived from patients with lower DFS indicating that both receptors are clinically relevant in predicting the response to Tamoxifen.	[Folgiero, Valentina; Avetrani, Paolo; Bon, Giulia; Di Carlo, Selene E.; Rosano, Laura; Sacchi, Ada; Falcioni, Rita] Regina Elena Inst Canc Res, Dept Expt Oncol, Rome, Italy; [Fabi, Alessandra; Nistico, Cecilia; Vici, Patrizia] Regina Elena Inst Canc Res, Dept Med Oncol, Rome, Italy; [Melucci, Elisa; Buglioni, Simonetta; Perracchio, Letizia; Mottolese, Marcella] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Sperduti, Isabella] Regina Elena Inst Canc Res, Sci Direct, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Folgiero, V (corresponding author), Regina Elena Inst Canc Res, Dept Expt Oncol, Rome, Italy.	falcioni@ifo.it	Rosanò, Laura/I-9266-2012; Falcioni, Rita/H-8869-2017; Rosanò, Laura/B-2863-2018; Fabi, Alessandra/AAC-1021-2019; Melucci, Elisa/K-5860-2016; Rosanò, Laura/AAB-7821-2019; ROSANO', Laura/AAK-1424-2020; Sperduti, Isabella/K-8902-2016; Bon, Giulia/ABH-6498-2020	Falcioni, Rita/0000-0002-3745-4327; Rosanò, Laura/0000-0002-9962-6411; Melucci, Elisa/0000-0003-4908-5271; Rosanò, Laura/0000-0002-3981-8593; ROSANO', Laura/0000-0002-9962-6411; Sperduti, Isabella/0000-0001-5115-3099; Bon, Giulia/0000-0002-5409-5864; Vici, Patrizia/0000-0001-7528-9783; buglioni, simonetta/0000-0002-5066-1523; di carlo, selene/0000-0001-5315-102X; Folgiero, Valentina/0000-0002-9838-1520; Fabi, Alessandra/0000-0002-0758-8033; Nistico, Cecilia/0000-0002-2379-5550	Italian Association for Cancer Research; Ministero della Salute; Alleanza contro il Cancro; Federazione Italiana Ricerca sul Cancro (FIRC) [fellowship]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Alleanza contro il Cancro; Federazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by Grant: Italian Association for Cancer Research and Ministero della Salute (R. Falcioni, M. Mottolese); Alleanza contro il Cancro (M. Mottolese); G. Bon is recipient of a fellowship from Federazione Italiana Ricerca sul Cancro (FIRC).	Bachelder RE, 1999, J CELL BIOL, V147, P1063, DOI 10.1083/jcb.147.5.1063; Barnes DM, 2004, ENDOCR-RELAT CANCER, V11, P85, DOI 10.1677/erc.0.0110085; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bon G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1651; Bon G, 2006, CLIN CANCER RES, V12, P3280, DOI 10.1158/1078-0432.CCR-05-2223; Campbell-Thompson M, 2001, CANCER RES, V61, P632; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Folgiero V, 2007, CANCER RES, V67, P1645, DOI 10.1158/0008-5472.CAN-06-2980; FRIEDRICHS K, 1995, CANCER RES, V55, P901; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; GRUNT TW, 1995, INT J CANCER, V63, P560, DOI 10.1002/ijc.2910630417; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; LANGHOFER M, 1993, J CELL SCI, V105, P753; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Miller WR, 2006, BRIT J CANCER, V94, P1333, DOI 10.1038/sj.bjc.6603082; MILLER WR, 1996, ESTROGEN BREAST CANC, P151; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; Nicholson RI, 2004, ENDOCR-RELAT CANCER, V11, P623, DOI 10.1677/erc.1.00778; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; PASLEAU F, 1993, ONCOGENE, V8, P849; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ryden L, 2005, EUR J CANCER, V41, P256, DOI 10.1016/j.ejca.2004.06.030; Schiff R, 2005, BREAST CANCER RES, V7, P205, DOI 10.1186/bcr1287; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; TRAVASOLI FA, 2005, NATURE CLIN PRACTICE, V2, P116; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	41	44	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1592	10.1371/journal.pone.0001592	http://dx.doi.org/10.1371/journal.pone.0001592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270579	gold, Green Published, Green Submitted			2022-12-27	WOS:000260535900026
J	Lindqvist, L; Oberer, M; Reibarkh, M; Cencic, R; Bordeleau, ME; Vogt, E; Marintchev, A; Tanaka, J; Fagotto, F; Altmann, M; Wagner, G; Pelletier, J				Lindqvist, Lisa; Oberer, Monika; Reibarkh, Mikhail; Cencic, Regina; Bordeleau, Marie-Eve; Vogt, Emily; Marintchev, Assen; Tanaka, Junichi; Fagotto, Francois; Altmann, Michael; Wagner, Gerhard; Pelletier, Jerry			Selective Pharmacological Targeting of a DEAD Box RNA Helicase	PLOS ONE			English	Article								RNA helicases represent a large family of proteins implicated in many biological processes including ribosome biogenesis, splicing, translation and mRNA degradation. However, these proteins have little substrate specificity, making inhibition of selected helicases a challenging problem. The prototypical DEAD box RNA helicase, eIF4A, works in conjunction with other translation factors to prepare mRNA templates for ribosome recruitment during translation initiation. Herein, we provide insight into the selectivity of a small molecule inhibitor of eIF4A, hippuristanol. This coral-derived natural product binds to amino acids adjacent to, and overlapping with, two conserved motifs present in the carboxy-terminal domain of eIF4A. Mutagenesis of amino acids within this region allowed us to alter the hippuristanol-sensitivity of eIF4A and undertake structure/function studies. Our results provide an understanding into how selective targeting of RNA helicases for pharmacological intervention can be achieved.	[Lindqvist, Lisa; Cencic, Regina; Bordeleau, Marie-Eve; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Oberer, Monika; Reibarkh, Mikhail; Marintchev, Assen; Wagner, Gerhard] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Vogt, Emily; Fagotto, Francois] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Tanaka, Junichi] Univ Ryukyus, Dept Chem, Biol, & Marine Sci, Nishihara, Okinawa, Japan; [Altmann, Michael] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Pelletier, Jerry] McGill Univ, McGill Canc Ctr, Montreal, PQ, Canada	McGill University; Harvard University; Harvard Medical School; McGill University; University of the Ryukyus; University of Bern; McGill University	Lindqvist, L (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca	Fagotto, Francois/AAA-9983-2021	Fagotto, Francois/0000-0002-1495-2112; Oberer, Monika/0000-0003-2525-9513; Tanaka, Junichi/0000-0002-8672-7379; Reibarkh, Mikhail/0000-0002-6589-707X; Marintchev, Assen/0000-0002-9901-3500	CIHR [fellowship, Post-doctoral Training Grant]; NSERC CGSM [fellowship]; Max Kade Foundation [post-doctoral fellowship]; NCIC [017099]; NIH [CA 68262]; NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC CGSM(Natural Sciences and Engineering Research Council of Canada (NSERC)); Max Kade Foundation; NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LL was supported by a CIHR Chemical Biology and an NSERC CGSM fellowship. RC was supported by a CIHR Cancer Consortium Post-doctoral Training Grant Award. MO was supported by a post-doctoral fellowship from the Max Kade Foundation. This work was supported by a grant from NCIC (#017099) to JP and an NIH grant (#CA 68262) to GW.	ALTMANN M, 2002, CELL FREE TRANSLATIO; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Cencic R, 2007, COMB CHEM HIGH T SCR, V10, P181, DOI 10.2174/138620707780126688; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; CONROY SC, 1990, ARCH BIOCHEM BIOPHYS, V282, P363, DOI 10.1016/0003-9861(90)90130-Q; COPPOLECCHIA R, 1993, EMBO J, V12, P4005, DOI 10.1002/j.1460-2075.1993.tb06078.x; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; EDERY I, 1983, J BIOL CHEM, V258, P1398; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Low WK, 2007, CHEM BIOL, V14, P715, DOI 10.1016/j.chembiol.2007.05.012; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Oguro A, 2003, RNA, V9, P394, DOI 10.1261/rna.2161303; Otero LJ, 2001, RNA, V7, P1753; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; RAY BK, 1985, J BIOL CHEM, V260, P7651; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shibuya T, 2006, RNA, V12, P360, DOI 10.1261/rna.2190706; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; SONENBERG N, 1981, NUCLEIC ACIDS RES, V9, P1643, DOI 10.1093/nar/9.7.1643; Svitkin YV, 2001, RNA, V7, P1743; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; YODERHILL J, 1993, J BIOL CHEM, V268, P5566	41	97	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1583	10.1371/journal.pone.0001583	http://dx.doi.org/10.1371/journal.pone.0001583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270573	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900019
J	Martinelli, N; Trabetti, E; Pinotti, M; Olivieri, O; Sandri, M; Friso, S; Pizzolo, F; Bozzini, C; Caruso, PP; Cavallari, U; Cheng, S; Pignatti, PF; Bernardi, F; Corrocher, R; Girelli, D				Martinelli, Nicola; Trabetti, Elisabetta; Pinotti, Mirko; Olivieri, Oliviero; Sandri, Marco; Friso, Simonetta; Pizzolo, Francesca; Bozzini, Claudia; Caruso, Pier Paolo; Cavallari, Ugo; Cheng, Suzanne; Pignatti, Pier Franco; Bernardi, Francesco; Corrocher, Roberto; Girelli, Domenico			Combined Effect of Hemostatic Gene Polymorphisms and the Risk of Myocardial Infarction in Patients with Advanced Coronary Atherosclerosis	PLOS ONE			English	Article								Background. Relative little attention has been devoted until now to the combined effects of gene polymorphisms of the hemostatic pathway as risk factors for Myocardial Infarction (MI), the main thrombotic complication of Coronary Artery Disease (CAD). The aim of this study was to evaluate the combined effect of ten common prothrombotic polymorphisms as a determinant of MI. Methodology/Principal Findings. We studied a total of 804 subjects, 489 of whom with angiographically proven severe CAD, with or without MI (n=307; n=182; respectively). An additive model considering ten common polymorphisms [Prothrombin 20210G > A, PAI-1 4G/5G, Fibrinogen beta-455G > A, FV Leiden and "R2'', FVII-402G > A and -323 del/ins, Platelet ADP Receptor P2Y12-744T > C, Platelet Glycoproteins Ia (873G > A), and IIIa (1565T > C)] was tested. The prevalence of MI increased linearly with an increasing number of unfavorable alleles (chi(2) for trend=10.68; P=0.001). In a multiple logistic regression model, the number of unfavorable alleles remained significantly associated with MI after adjustment for classical risk factors. As compared to subjects with 3-7 alleles, those with few (<= 2) alleles had a decreased MI risk (OR 0.34, 95%CIs 0.13-0.93), while those with more (>= 8) alleles had an increased MI risk (OR 2.49, 95%CIs 1.03-6.01). The number of procoagulant alleles correlated directly (r=0.49, P=0.006) with endogenous thrombin potential. Conclusions. The combination of prothrombotic polymorphisms may help to predict MI in patients with advanced CAD.	[Martinelli, Nicola; Olivieri, Oliviero; Sandri, Marco; Friso, Simonetta; Pizzolo, Francesca; Bozzini, Claudia; Corrocher, Roberto; Girelli, Domenico] Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy; [Trabetti, Elisabetta; Cavallari, Ugo; Pignatti, Pier Franco] Univ Verona, Dept Mother & Child & Biol Genet, Sect Biol & Genet, Verona, Italy; [Pinotti, Mirko; Caruso, Pier Paolo; Bernardi, Francesco] Univ Ferrara, Dept Biochem & Mol Biol, Ferrara, Italy; [Cheng, Suzanne] Roche Molecular Systems Inc, Dept Human Genet, Alameda, CA USA	University of Verona; University of Verona; University of Ferrara; Roche Holding	Martinelli, N (corresponding author), Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy.		Martinelli, Nicola/J-5622-2016; Olivieri, Oliviero/A-9126-2008; Girelli, Domenico/B-1183-2008; bernardi, francesco/F-5443-2013; Friso, Simonetta/K-4715-2016; Sandri, Marco/L-2875-2013; Pizzolo, Francesca/AAF-6581-2020	Martinelli, Nicola/0000-0001-6465-5119; Olivieri, Oliviero/0000-0001-8209-9056; Girelli, Domenico/0000-0001-9684-1899; Sandri, Marco/0000-0002-1422-5695; Pizzolo, Francesca/0000-0003-4419-3994; Cavallari, Ugo/0000-0002-3395-4033; Pinotti, Mirko/0000-0002-4114-7055	Italian Ministry of University and Research [2005/065152]; Veneto Region; Cariverona Foundation, Verona, Italy	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Veneto Region(Regione Veneto); Cariverona Foundation, Verona, Italy(Fondazione Cariverona)	Supported by grants from the Italian Ministry of University and Research (grant no. 2005/065152), the Veneto Region, and the Cariverona Foundation, Verona, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2006, ATHEROSCLEROSIS, V186, P240, DOI 10.1016/j.atherosclerosis.2005.10.042; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bozzini C, 2004, THROMB HAEMOSTASIS, V92, P541, DOI 10.1160/Th04-02-0130; Brummel-Ziedins KE, 2005, J THROMB HAEMOST, V3, P2497, DOI 10.1111/j.1538-7836.2005.01584.x; Castoldi E, 2000, THROMB HAEMOSTASIS, V83, P362, DOI 10.1055/s-0037-1613821; Cheng S, 1999, GENOME RES, V9, P936, DOI 10.1101/gr.9.10.936; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins A, 1996, P NATL ACAD SCI USA, V93, P9177, DOI 10.1073/pnas.93.17.9177; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; Eitzman DT, 2005, CIRCULATION, V111, P1822, DOI 10.1161/01.CIR.0000160854.75779.E8; Fontana P, 2003, CIRCULATION, V108, P2971, DOI 10.1161/01.CIR.0000106904.80795.35; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Girelli D, 2000, NEW ENGL J MED, V343, P774, DOI 10.1056/NEJM200009143431104; Hemker HC, 2000, THROMB HAEMOSTASIS, V83, P589; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Janssens ACJW, 2004, AM J HUM GENET, V74, P585, DOI 10.1086/382052; Lane DA, 2000, BLOOD, V95, P1517, DOI 10.1182/blood.V95.5.1517.005k48_1517_1532; Lentz SR, 2005, CIRCULATION, V111, P1733, DOI 10.1161/01.CIR.0000162489.34887.FA; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MORANGE PE, 2006, J THROMB HAEMOS 0104; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; MORTON NE, 1974, AM J HUM GENET, V26, P318; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pinotti M, 2000, BLOOD, V95, P3423, DOI 10.1182/blood.V95.11.3423.011k04_3423_3428; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Regnault W, 2003, PATHOPHYSIOL HAEMO T, V33, P23, DOI 10.1159/000071638; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Santoso S, 1999, BLOOD, V93, P2449, DOI 10.1182/blood.V93.8.2449.408k34_2449_2453; Scanavini D, 2004, ARTERIOSCL THROM VAS, V24, P200, DOI 10.1161/01.ATV.0000109750.34073.f6; Schettert IT, 2006, THROMB RES, V118, P679, DOI 10.1016/j.thromres.2005.11.009; Smith A, 2005, CIRCULATION, V112, P3080, DOI 10.1161/CIRCULATIONAHA.105.557132; van't Hooft FM, 1999, ARTERIOSCL THROM VAS, V19, P3063, DOI 10.1161/01.ATV.19.12.3063; van't Hooft FM, 1999, BLOOD, V93, P3432, DOI 10.1182/blood.V93.10.3432.410k16_3432_3441; Voetsch B, 2004, ARTERIOSCL THROM VAS, V24, P216, DOI 10.1161/01.ATV.0000107402.79771.fc; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; Zee RYL, 2004, HUM MOL GENET, V13, P389, DOI 10.1093/hmg/ddh039	44	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1523	10.1371/journal.pone.0001523	http://dx.doi.org/10.1371/journal.pone.0001523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253477	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700001
J	Rustad, TR; Harrell, MI; Liao, RL; Sherman, DR				Rustad, Tige R.; Harrell, Maria I.; Liao, Reiling; Sherman, David R.			The Enduring Hypoxic Response of Mycobacterium tuberculosis	PLOS ONE			English	Article							STATIONARY-PHASE; GENE-EXPRESSION; LUNG GRANULOMAS; PERSISTENCE; MECHANISMS; PROTEIN; LATENCY; MODEL; DEVR; ACR	Background. A significant body of evidence accumulated over the last century suggests a link between hypoxic microenvironments within the infected host and the latent phase of tuberculosis. Studies to test this correlation have identified the M. tuberculosis initial hypoxic response, controlled by the two-component response regulator DosR. The initial hypoxic response is completely blocked in a dosR deletion mutant. Methodology/Principal Findings. We show here that a dosR deletion mutant enters bacteriostasis in response to in vitro hypoxia with only a relatively mild decrease in viability. In the murine infection model, the phenotype of the mutant was indistinguishable from that of the parent strain. These results suggested that additional genes may be essential for entry into and maintenance of bacteriostasis. Detailed microarray analysis of oxygen starved cultures revealed that DosR regulon induction is transient, with induction of nearly half the genes returning to baseline within 24 hours. In addition, a larger, sustained wave of gene expression follows the DosR-mediated initial hypoxic response. This Enduring Hypoxic Response (EHR) consists of 230 genes significantly induced at four and seven days of hypoxia but not at initial time points. These genes include a surprising number of transcriptional regulators that could control the program of bacteriostasis. We found that the EHR is independent of the DosR-mediated initial hypoxic response, as EHR expression is virtually unaltered in the dosR mutant. Conclusions/Significance. Our results suggest a reassessment of the role of DosR and the initial hypoxic response in MTB physiology. Instead of a primary role in survival of hypoxia induced bacteriostasis, DosR may regulate a response that is largely optional in vitro and in mouse infections. Analysis of the EHR should help elucidate the key regulatory factors and enzymatic machinery exploited by M. tuberculosis for long-term bacteriostasis in the face of oxygen deprivation.	[Rustad, Tige R.; Liao, Reiling; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Rustad, Tige R.; Harrell, Maria I.; Sherman, David R.] Univ Washington, Dept Pathobiol, Seattle, WA USA; [Harrell, Maria I.] Fred Hutchinson Canc Res Ctr, Seattle, WA USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Sherman, DR (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@sbri.org			Akibene Foundation TIGR/NIAID [N01-AI-15447 DRS R01]; NIH [AI 47704 TRR F32, AI 638772]	Akibene Foundation TIGR/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Pilot work: Akibene Foundation TIGR/NIAID grant providing arrays: N01-AI-15447 DRS R01 grant: NIH AI 47704 TRR F32 fellowship: NIH AI 638772	Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; CORPER H. J., 1933, AMER REV TUBERC, V28, P856; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Florczyk MA, 2003, INFECT IMMUN, V71, P5332, DOI 10.1128/IAI.71.9.5332-5343.2003; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Herbert D, 1996, ANTIMICROB AGENTS CH, V40, P2296, DOI 10.1128/AAC.40.10.2296; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lillebaek T, 2002, J INFECT DIS, V185, P401, DOI 10.1086/338342; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MEDLAR EM, 1952, AM REV TUBERC PULM, V66, P36; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Peh HL, 2001, ANTIMICROB AGENTS CH, V45, P2403, DOI 10.1128/AAC.45.8.2403-2404.2001; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Raviglione MC, 2001, ANN NY ACAD SCI, V953, P88, DOI 10.1111/j.1749-6632.2001.tb11364.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; SCHNAPPINGER DES, 2003, J EXP MED, V198; SCHOOLNIK GK, 2001, METHODS ENZ IN PRESS; Sharma D, 2006, FEMS IMMUNOL MED MIC, V48, P329, DOI 10.1111/j.1574-695X.2006.00160.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Sweany HC, 1931, AM REV TUBERC, V24, P558; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; WAYNE LG, 1977, INFECT IMMUN, V17, P528, DOI 10.1128/IAI.17.3.528-530.1977; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	50	353	369	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1502	10.1371/journal.pone.0001502	http://dx.doi.org/10.1371/journal.pone.0001502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231589	gold, Green Published, Green Submitted			2022-12-27	WOS:000260504200015
J	Somel, M; Creely, H; Franz, H; Mueller, U; Lachmann, M; Khaitovich, P; Paabo, S				Somel, Mehmet; Creely, Hilliary; Franz, Henriette; Mueller, Uwe; Lachmann, Michael; Khaitovich, Philipp; Paeaebo, Svante			Human and Chimpanzee Gene Expression Differences Replicated in Mice Fed Different Diets	PLOS ONE			English	Article							POSITIVE SELECTION; EVOLUTION; BRAIN; NUTRITION; SIZE; HOMO	Although the human diet is markedly different from the diets of closely related primate species, the influence of diet on phenotypic and genetic differences between humans and other primates is unknown. In this study, we analyzed gene expression in laboratory mice fed diets typical of humans and of chimpanzees. The effects of human diets were found to be significantly different from that of a chimpanzee diet in the mouse liver, but not in the brain. Importantly, 10% of the genes that differ in their expression between humans and chimpanzee livers differed also between the livers of mice fed the human and chimpanzee diets. Furthermore, both the promoter sequences and the amino acid sequences of these diet-related genes carry more differences between humans and chimpanzees than random genes. Our results suggest that the mouse can be used to study at least some aspects of human-specific traits.	[Somel, Mehmet; Khaitovich, Philipp] Chinese Acad Sci, Shanghai Inst Biol Sci, Partner Inst Computat Biol, Shanghai, Peoples R China; [Somel, Mehmet; Creely, Hilliary; Franz, Henriette; Lachmann, Michael; Khaitovich, Philipp; Paeaebo, Svante] Max Planck Inst Evol Anthropol, Leipzig, Germany; [Mueller, Uwe] Univ Leipzig, Ctr Biotechnol & Biomed, Leipzig, Germany	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Leipzig University	Somel, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Partner Inst Computat Biol, Shanghai, Peoples R China.	somel@eva.mpg.de; khaitovich@eva.mpg.de	Khaitovich, Philipp/HGC-8520-2022; Somel, Mehmet/B-1471-2016	Somel, Mehmet/0000-0002-3138-1307; Muller, Uwe/0000-0003-1502-9271; Franz, Henriette/0000-0001-9358-7442	Chinese Academy of Sciences; Max Planck Society; Bundesministerium fur Bildung und Forschung of Germany; German-American Fullbright Commission [fellowship]	Chinese Academy of Sciences(Chinese Academy of Sciences); Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung of Germany(Federal Ministry of Education & Research (BMBF)); German-American Fullbright Commission	The study was financially supported by the Chinese Academy of Sciences, the Max Planck Society and the Bundesministerium fur Bildung und Forschung of Germany. Author HC was supported by a German-American Fullbright Commission fellowship. None of these institutions played any direct or indirect role in in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; ANDREWS P, 1991, PHILOS T R SOC B, V334, P199, DOI 10.1098/rstb.1991.0109; ANDREWS P, 1991, PHILOS T R SOC LON B, V334, P209; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; BRACE CL, 1987, EVOLUTION, V41, P705, DOI 10.1111/j.1558-5646.1987.tb05847.x; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2006, CURR BIOL, V16, pR356, DOI 10.1016/j.cub.2006.03.082; Kitajka K, 2004, P NATL ACAD SCI USA, V101, P10931, DOI 10.1073/pnas.0402342101; LEONARD WR, 1994, AM J HUM BIOL, V6, P77, DOI 10.1002/ajhb.1310060111; Milton K, 2003, J NUTR, V133, p3886S, DOI 10.1093/jn/133.11.3886S; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Ulijaszek SJ, 2002, P NUTR SOC, V61, P517, DOI 10.1079/PNS2002180; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5	25	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1504	10.1371/journal.pone.0001504	http://dx.doi.org/10.1371/journal.pone.0001504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231591	Green Published, gold			2022-12-27	WOS:000260504200017
J	Cui, J; Chen, C; Lu, HZ; Sun, TZ; Shen, PP				Cui, Jun; Chen, Chun; Lu, Haizhu; Sun, Tingzhe; Shen, Pingping			Two Independent Positive Feedbacks and Bistability in the Bcl-2 Apoptotic Switch	PLOS ONE			English	Article							MITOCHONDRIAL APOPTOSIS; PHARMACOLOGICAL MANIPULATION; CELL-DEATH; BAX; ACTIVATION; PROTEINS; MODEL; MCL-1; PERMEABILITY; DEGRADATION	Background. The complex interplay between B-cell lymphoma 2 (Bcl-2) family proteins constitutes a crucial checkpoint in apoptosis. Its detailed molecular mechanism remains controversial. Our former modeling studies have selected the 'Direct Activation Model' as a better explanation for experimental observations. In this paper, we continue to extend this model by adding interactions according to updating experimental findings. Methodology/Principal Findings. Through mathematical simulation we found bistability, a kind of switch, can arise from a positive (double negative) feedback in the Bcl-2 interaction network established by anti-apoptotic group of Bcl-2 family proteins. Moreover, Bax/Bak auto-activation as an independent positive feedback can enforce the bistability, and make it more robust to parameter variations. By ensemble stochastic modeling, we also elucidated how intrinsic noise can change ultrasensitive switches into gradual responses. Our modeling result agrees well with recent experimental data where bimodal Bax activation distributions in cell population were found. Conclusions/Significance. Along with the growing experimental evidences, our studies successfully elucidate the switch mechanism embedded in the Bcl-2 interaction network and provide insights into pharmacological manipulation of Bcl-2 apoptotic switch as further cancer therapies.	[Cui, Jun; Chen, Chun; Lu, Haizhu; Sun, Tingzhe; Shen, Pingping] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China	Nanjing University	Shen, PP (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.	ppshen@nju.edu.cn	Chen, Chun/D-7835-2013	Chen, Chun/0000-0002-3608-6972; Sun, Tingzhe/0000-0002-9575-4993	National Natural Science Foundation of China [30571538]; Program for New Century Excellent Talents in University [NCET-06-0445]; Key Project of Chinese Ministry of Education [NO107049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (Project No. 30571538), the Program for New Century Excellent Talents in University (NCET-06-0445) and the Key Project of Chinese Ministry of Education (NO107049).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Chen C, 2007, BIOPHYS J, V92, P4304, DOI 10.1529/biophysj.106.099606; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eissing T, 2005, IEE P SYST BIOL, V152, P221, DOI 10.1049/ip-syb:20050046; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Eissing T, 2007, BIOPHYS J, V92, P3332, DOI 10.1529/biophysj.106.100362; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gomez-Benito M, 2005, MOL PHARMACOL, V67, P1991, DOI 10.1124/mol.104.007021; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Nair VD, 2004, J BIOL CHEM, V279, P27494, DOI 10.1074/jbc.M312135200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Saikumar P, 1999, AM J MED, V107, P489, DOI 10.1016/S0002-9343(99)00259-4; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Valentijn AJ, 2003, J CELL BIOL, V162, P599, DOI 10.1083/jcb.200302154; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009	40	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1469	10.1371/journal.pone.0001469	http://dx.doi.org/10.1371/journal.pone.0001469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213378	Green Submitted, gold, Green Published			2022-12-27	WOS:000260503900015
J	Wiggins, P				Wiggins, Philippa			Life Depends upon Two Kinds of Water	PLOS ONE			English	Article							LOW-DENSITY WATER; POSSIBLE MECHANISM; LIQUID; GELS	Background. Many well-documented biochemical processes lack a molecular mechanism. Examples are: how ATP hydrolysis and an enzyme contrive to perform work, such as active transport; how peptides are formed from amino acids and DNA from nucleotides; how proteases cleave peptide bonds, how bone mineralises; how enzymes distinguish between sodium and potassium; how chirality of biopolymers was established prebiotically. Methodology/Principal Findings. It is shown that involvement of water in all these processes is mandatory, but the water must be of the simplified configuration in which there are only two strengths of water-water hydrogen bonds, and in which these two types of water coexist as microdomains throughout the liquid temperature range. Since they have different strengths of hydrogen bonds, the microdomains differ in all their physical and chemical properties. Solutes partition asymmetrically, generating osmotic pressure gradients which must be compensated for or abolished. Displacement of the equilibrium between high and low density waters incurs a thermodynamic cost which limits solubility, depresses ionisation of water, drives protein folding and prevents high density water from boiling at its intrinsic boiling point which appears to be below 0 degrees C. Active processes in biochemistry take place in sequential partial reactions, most of which release small amounts of free energy as heat. This ensures that the system is never far from equilibrium so that efficiency is extremely high. Energy transduction is neither possible and nor necessary. Chirality was probably established in prebiotic clays which must have carried stable populations of high density and low density water domains. Bioactive enantiomorphs partition into low density water in which they polymerise spontaneously. Conclusions/Significance. The simplified model of water has great explanatory power.			Wiggins, P (corresponding author), Mairangi Bay, Auckland, New Zealand.	p.wiggins@paradise.net.nz						[Anonymous], 1973, WATER COMPREHENSIVE; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363; Chaplin MF, 2000, BIOPHYS CHEM, V83, P211, DOI 10.1016/S0301-4622(99)00142-8; Cho CH, 1997, J CHEM PHYS, V107, P7979, DOI 10.1063/1.475060; Drost-Hansen W, 2001, CELL MOL BIOL, V47, P865; EISENBERG D, 1969, W STRUCTURE PROPERTI; GEORGE P, 1970, BIOCHIM BIOPHYS ACTA, V223, P1, DOI 10.1016/0005-2728(70)90126-X; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HASSELBACH W, 1982, ANN NY ACAD SCI, V402, P459, DOI 10.1111/j.1749-6632.1982.tb25768.x; HENDERSON LJ, 1913, FITNESS ENV, P111; HOFFMAN M, 1992, SCIENCE, V256, P1758, DOI 10.1126/science.1615319; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Ling G.N., 1962, PHYS THEORY LIVING S; Mathews C.K., 1990, BIOCHEMISTRY-US, V3d; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; Rees Martin., 1999, JUST 6 NUMBERS; Robinson GW, 1999, BIOPHYS J, V77, P3311, DOI 10.1016/S0006-3495(99)77162-6; ROBINSON JD, 1979, BIOCHIM BIOPHYS ACTA, V549, P145, DOI 10.1016/0304-4173(79)90013-2; Scala A, 2000, NATURE, V406, P166, DOI 10.1038/35018034; STANLEY HE, 1994, PHYSICA A, V205, P122, DOI 10.1016/0378-4371(94)90495-2; VEDAMUTHU M, 1994, J PHYS CHEM-US, V98, P2222, DOI 10.1021/j100060a002; WIGGINS P, 2001, WATER SCI FOOD HLTH, V8; Wiggins Philippa M., 2002, Journal of Biological Physics and Chemistry, V2, P25, DOI 10.4024/12020205.jbpc.02.01; WIGGINS PM, 1990, MICROBIOL REV, V54, P432, DOI 10.1128/MMBR.54.4.432-449.1990; WIGGINS PM, 1982, J THEOR BIOL, V99, P665, DOI 10.1016/0022-5193(82)90193-X; WIGGINS PM, 1982, J THEOR BIOL, V99, P645, DOI 10.1016/0022-5193(82)90192-8; Wiggins PM, 1999, AM J PHYSIOL-CELL PH, V276, pC291, DOI 10.1152/ajpcell.1999.276.2.C291; Wiggins PM, 2002, PHYSICA A, V314, P485, DOI 10.1016/S0378-4371(02)01086-5; WIGGINS PM, 1990, BIOPHYS J, V58, P585, DOI 10.1016/S0006-3495(90)82402-4; WIGGINS PM, 1995, LANGMUIR, V11, P1984, DOI 10.1021/la00006a026; WIGGINS PM, 1995, CELL BIOCHEM FUNCT, V13, P165, DOI 10.1002/cbf.290130305; Wiggins PM, 2001, CELL MOL BIOL, V47, P735; WIGGINS PM, 1991, BIOPHYS J, V60, P8, DOI 10.1016/S0006-3495(91)82026-4; WIGGINS PM, 1995, PROG POLYM SCI, V20, P1121, DOI 10.1016/0079-6700(95)00015-8; Wiggins PM, 1996, CELL BIOL INT, V20, P429, DOI 10.1006/cbir.1996.0054; WIGGINS PM, 1987, INT REV CYTOL, V108, P249, DOI 10.1016/S0074-7696(08)61440-0	38	49	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1406	10.1371/journal.pone.0001406	http://dx.doi.org/10.1371/journal.pone.0001406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183287	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400003
J	Giles, SS; Zaas, AK; Reidy, MF; Perfect, JR; Wright, JR				Giles, Steven S.; Zaas, Aimee K.; Reidy, Mike F.; Perfect, John R.; Wright, Jo Rae			Cryptococcus neoformans Is Resistant to Surfactant Protein A Mediated Host Defense Mechanisms	PLOS ONE			English	Article								Initiation of a protective immune response to infection by the pathogenic fungus Cryptococcus neoformans is mediated in part by host factors that promote interactions between immune cells and C. neoformans yeast. Surfactant protein A (SP-A) contributes positively to pulmonary host defenses against a variety of bacteria, viruses, and fungi in part by promoting the recognition and phagocytosis of these pathogens by alveolar macrophages. In the present study we investigated the role of SP-A as a mediator of host defense against the pulmonary pathogen, C. neoformans. Previous studies have shown that SP-A binds to acapsular and minimally encapsulated strains of C. neoformans. Using in vitro binding assays we confirmed that SP-A does not directly bind to a fully encapsulated strain of C. neoformans (H99). However, we observed that when C. neoformans was incubated in bronchoalveolar fluid, SP-A binding was detected, suggesting that another alveolar host factor may enable SP-A binding. Indeed, we discovered that SP-A binds encapsulated C. neoformans via a previously unknown IgG dependent mechanism. The consequence of this interaction was the inhibition of IgG-mediated phagocytosis of C. neoformans by alveolar macrophages. Therefore, to assess the contribution of SP-A to the pulmonary host defenses we compared in vivo infections using SP-A null mice (SP-A-/-) and wild-type mice in an intranasal infection model. We found that the immune response assessed by cellular counts, TNF alpha cytokine production, and fungal burden in lungs and bronchoalveolar lavage fluids during early stages of infection were equivalent. Furthermore, the survival outcome of C. neoformans infection was equivalent in SP-A-/- and wild-type mice. Our results suggest that unlike a variety of bacteria, viruses, and other fungi, progression of disease with an inhalational challenge of C. neoformans does not appear to be negatively or positively affected by SP-A mediated mechanisms of pulmonary host defense.	[Giles, Steven S.; Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Zaas, Aimee K.; Reidy, Mike F.; Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Wright, JR (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	j.wright@cellbio.duke.edu			National Institutes of Health RSUM [HL-51134, HL-30923, AI-051445]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051134, R01HL030923, R23HL030923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051445] Funding Source: NIH RePORTER	National Institutes of Health RSUM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (HL-51134 and HL-30923). SSG was supported by a National Institutes of Health RSUM (HL-51134). The Duke Human Vaccine Institute Flow Cytometry Core Facility is supported by a National Institutes of Health grant (AI-051445). These funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alcorn JF, 2004, AM J PHYSIOL-LUNG C, V286, pL129, DOI 10.1152/ajplung.00427.2002; Allen MJ, 2001, INFECT IMMUN, V69, P2037, DOI 10.1128/IAI.69.4.2037-2044.2001; Atochina EN, 2004, INFECT IMMUN, V72, P6002, DOI 10.1128/IAI.72.10.6002-6011.2004; Awasthi S, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-28; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crowther JE, 2004, J IMMUNOL, V172, P6866, DOI 10.4049/jimmunol.172.11.6866; CRUICKSHANK JG, 1973, APPL MICROBIOL, V25, P309, DOI 10.1128/AEM.25.2.309-312.1973; Ghildyal R, 1999, J INFECT DIS, V180, P2009, DOI 10.1086/315134; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Giles SS, 2005, FUNGAL GENET BIOL, V42, P20, DOI 10.1016/j.fgb.2004.09.003; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; GRANGER DL, 1985, J CLIN INVEST, V76, P508, DOI 10.1172/JCI112000; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HAURUM JS, 1993, BIOCHEM J, V293, P873, DOI 10.1042/bj2930873; Kishore U, 2002, IMMUNOBIOLOGY, V205, P610, DOI 10.1078/0171-2985-00158; Lin PM, 2006, AM J PHYSIOL-LUNG C, V291, pL1199, DOI 10.1152/ajplung.00188.2006; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; McCormack FX, 1997, BIOCHEMISTRY-US, V36, P8092, DOI 10.1021/bi970313f; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; SCHELENZ S, 1995, INFECT IMMUN, V63, P3360, DOI 10.1128/IAI.63.9.3360-3366.1995; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; Walenkamp AME, 1999, EUR J CLIN INVEST, V29, P83, DOI 10.1046/j.1365-2362.1999.00429.x; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Zaragoza O, 2006, CELL MICROBIOL, V8, P1862, DOI 10.1111/j.1462-5822.2006.00753.x; ZIMMERMAN PE, 1992, J CLIN INVEST, V89, P143, DOI 10.1172/JCI115554	28	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1370	10.1371/journal.pone.0001370	http://dx.doi.org/10.1371/journal.pone.0001370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159253	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459700027
J	Pillai, A				Pillai, Anilkumar			Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; INCREASES CELL-PROLIFERATION; SIGNAL-REGULATED KINASE; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; ATYPICAL ANTIPSYCHOTICS; CHOLINERGIC MARKERS; ABNORMAL EXPRESSION; RECEPTOR; SERUM	Background: Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats. Methods and Findings: Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats. Conclusion: These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders.	Med Coll Georgia, Dept Psychiat & Hlth Behav, Vet Affairs Med Ctr, Med Res Serv Line, Augusta, GA 30912 USA	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pillai, A (corresponding author), Med Coll Georgia, Dept Psychiat & Hlth Behav, Vet Affairs Med Ctr, Med Res Serv Line, Augusta, GA 30912 USA.	apillai@mail.mcg.edu	PILLAI, ANILKUMAR/N-4809-2017					Angelucci F, 2000, INT J NEUROPSYCHOPH, V3, P13, DOI 10.1017/S1461145700001759; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Browning JL, 2005, BIOL PSYCHIAT, V57, P617, DOI 10.1016/j.biopsych.2004.12.002; Buckley PF, 2007, SCHIZOPHR RES, V94, P1, DOI 10.1016/j.schres.2007.01.025; Buckley PF, 2007, SCHIZOPHR RES, V91, P1, DOI 10.1016/j.schres.2006.12.026; Bunney WE, 2000, BRAIN RES REV, V31, P138, DOI 10.1016/S0165-0173(99)00031-4; Bymaster FP, 1996, PSYCHOPHARMACOLOGY, V124, P87, DOI 10.1007/BF02245608; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; De Luca V, 2005, PSYCHOPHARMACOLOGY, V183, P378, DOI 10.1007/s00213-005-0191-4; DIDRIKSEN M, 1995, EUR J PHARMACOL, V281, P241, DOI 10.1016/0014-2999(95)00242-D; Ding W, 2007, J CELL PHYSIOL, V212, P796, DOI 10.1002/jcp.21078; Durany N, 2001, SCHIZOPHR RES, V52, P79, DOI 10.1016/S0920-9964(00)00084-0; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; Green W, 2006, BRAIN RES, V1070, P242, DOI 10.1016/j.brainres.2005.11.047; Grillo RW, 2007, J PSYCHIAT RES, V41, P31, DOI 10.1016/j.jpsychires.2006.01.005; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hashimoto K, 2005, PSYCHIAT RES, V135, P257, DOI 10.1016/j.psychres.2003.11.006; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Iritani S, 2003, PROG NEURO-PSYCHOPH, V27, P801, DOI 10.1016/S0278-5846(03)00112-X; Jarskog LF, 2007, NEUROPSYCHOPHARMACOL, V32, P95, DOI 10.1038/sj.npp.1301074; Jockers-Scherubl MC, 2004, NEUROSCI LETT, V371, P79, DOI 10.1016/j.neulet.2004.08.045; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kinon BJ, 1996, PSYCHOPHARMACOLOGY, V124, P2, DOI 10.1007/BF02245602; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Kyosseva SV, 2004, CEREBELLUM, V3, P94, DOI 10.1080/14734220410029164; Manji Husseini K, 2003, Sci STKE, V2003, ppe49; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Mueller HT, 2004, SCHIZOPHR RES, V71, P361, DOI 10.1016/j.schres.2004.02.016; Pillai A, 2006, SCHIZOPHR RES, V82, P95, DOI 10.1016/j.schres.2005.11.021; PILLAI A, 2007, NEUROPSYCHOPHAR 0905; Pizzorusso T, 1996, CURR OPIN NEUROL, V9, P122, DOI 10.1097/00019052-199604000-00012; Pozzi L, 2003, J NEUROCHEM, V86, P451, DOI 10.1046/j.1471-4159.2003.01851.x; RYLETT RJ, 1994, TRENDS NEUROSCI, V17, P486, DOI 10.1016/0166-2236(94)90138-4; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shimizu E, 2003, NEUROSCI LETT, V351, P111, DOI 10.1016/j.neulet.2003.08.004; Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005; Skarsfeldt T, 1996, PSYCHOPHARMACOLOGY, V124, P126, DOI 10.1007/BF02245612; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Tan YL, 2005, SCHIZOPHR RES, V74, P263, DOI 10.1016/j.schres.2004.08.004; Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001; Terry AV, 2002, PSYCHOPHARMACOLOGY, V164, P360, DOI 10.1007/s00213-002-1230-z; Terry AV, 2003, NEUROPSYCHOPHARMACOL, V28, P300, DOI 10.1038/sj.npp.1300039; Torrey EF, 2001, SCHIZOPHR RES, V49, P295, DOI 10.1016/S0920-9964(00)00081-5; Toyooka K, 2002, PSYCHIAT RES, V110, P249, DOI 10.1016/S0165-1781(02)00127-0; Weickert CS, 2003, MOL PSYCHIATR, V8, P592, DOI 10.1038/sj.mp.4001308; Weickert CS, 2005, MOL PSYCHIATR, V10, P637, DOI 10.1038/sj.mp.4001678; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xu B, 2005, PLOS MED, V2, P999, DOI 10.1371/journal.pmed.0020263; Yang BH, 2004, PSYCHIAT CLIN NEUROS, V58, P262, DOI 10.1111/j.1440-1819.2004.01229.x; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1784	10.1371/journal.pone.0001784	http://dx.doi.org/10.1371/journal.pone.0001784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18335055	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000036
J	Sureka, K; Ghosh, B; Dasgupta, A; Basu, J; Kundu, M; Bose, I				Sureka, Kamakshi; Ghosh, Bhaswar; Dasgupta, Arunava; Basu, Joyoti; Kundu, Manikuntala; Bose, Indrani			Positive Feedback and Noise Activate the Stringent Response Regulator Rel in Mycobacteria	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; STATIONARY-PHASE; TUBERCULOSIS; PERSISTENCE; POLYPHOSPHATE; BISTABILITY; SMEGMATIS; PATHOGEN; STOCHASTICITY	Phenotypic heterogeneity in an isogenic, microbial population enables a subset of the population to persist under stress. In mycobacteria, stresses like nutrient and oxygen deprivation activate the stress response pathway involving the two-component system MprAB and the sigma factor, SigE. SigE in turn activates the expression of the stringent response regulator, rel. The enzyme polyphosphate kinase 1 (PPK1) regulates this pathway by synthesizing polyphosphate required for the activation of MprB. The precise manner in which only a subpopulation of bacterial cells develops persistence, remains unknown. Rel is required for mycobacterial persistence. Here we show that the distribution of rel expression levels in a growing population of mycobacteria is bimodal with two distinct peaks corresponding to low (L) and high (H) expression states, and further establish that a positive feedback loop involving the mprAB operon along with stochastic gene expression are responsible for the phenotypic heterogeneity. Combining single cell analysis by flow cytometry with theoretical modeling, we observe that during growth, noise-driven transitions take a subpopulation of cells from the L to the H state within a "window of opportunity'' in time preceding the stationary phase. It is these cells which adapt to nutrient depletion in the stationary phase via the stringent response. We find evidence of hysteresis in the expression of rel in response to changing concentrations of PPK1. Hysteresis promotes robustness in the maintenance of the induced state. Our results provide, for the first time, evidence that bistability and stochastic gene expression could be important for the development of "heterogeneity with an advantage'' in mycobacteria and suggest strategies for tackling tuberculosis like targeting transitions from the low to the high rel expression state.	[Sureka, Kamakshi; Dasgupta, Arunava; Basu, Joyoti; Kundu, Manikuntala] Bose Inst, Dept Chem, Kolkata, India; [Ghosh, Bhaswar; Bose, Indrani] Bose Inst, Dept Phys, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Sureka, K (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	manikuntala@vsnl.net	Sureka, Kamakshi/ABE-4125-2021	Sureka, Kamakshi/0000-0003-3093-5299	Council of Scientific and Industrial Research, Government of India [fellowship]; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	B.G. was supported by a fellowship from the Council of Scientific and Industrial Research, Government of India. This work was supported in part by a grant from the Department of Biotechnology, Government of India.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bishai W, 2000, NATURE, V406, P683, DOI 10.1038/35021159; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Choudhuri BS, 2002, BIOCHEM J, V367, P279, DOI 10.1042/BJ20020615; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; De Voss JJ, 1999, J BACTERIOL, V181, P4443, DOI 10.1128/JB.181.15.4443-4451.1999; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; He HJ, 2005, J BACTERIOL, V187, P202, DOI 10.1128/JB.187.1.202-212.2005; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Manganelli R, 2007, MOL MICROBIOL, V65, P258, DOI 10.1111/j.1365-2958.2007.05819.x; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; WU Q, 2005, J BACTERIOL, V179, P2922; Zahrt TC, 2003, INFECT IMMUN, V71, P6962, DOI 10.1128/IAI.71.12.6962-6970.2003	35	83	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1771	10.1371/journal.pone.0001771	http://dx.doi.org/10.1371/journal.pone.0001771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335046	Green Submitted, gold, Green Published			2022-12-27	WOS:000260723000025
J	Wijers, SLJ; Schrauwen, P; Saris, WHM; Lichtenbelt, WDV				Wijers, Sander L. J.; Schrauwen, Patrick; Saris, Wim H. M.; Lichtenbelt, Wouter D. van Marken			Human Skeletal Muscle Mitochondrial Uncoupling Is Associated with Cold Induced Adaptive Thermogenesis	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; ENERGY-EXPENDITURE; PROTEIN-3 CONTENT; MILD COLD; TEMPERATURE; PREVALENCE; OVERWEIGHT; EXPRESSION; RESPONSES; OBESITY	Background: Mild cold exposure and overfeeding are known to elevate energy expenditure in mammals, including humans. This process is called adaptive thermogenesis. In small animals, adaptive thermogenesis is mainly caused by mitochondrial uncoupling in brown adipose tissue and regulated via the sympathetic nervous system. In humans, skeletal muscle is a candidate tissue, known to account for a large part of the epinephrine-induced increase in energy expenditure. However, mitochondrial uncoupling in skeletal muscle has not extensively been studied in relation to adaptive thermogenesis in humans. Therefore we hypothesized that cold-induced adaptive thermogenesis in humans is accompanied by an increase in mitochondrial uncoupling in skeletal muscle. Methodology/Principal Findings: The metabolic response to mild cold exposure in 11 lean, male subjects was measured in a respiration chamber at baseline and mild cold exposure. Skeletal muscle mitochondrial uncoupling (state 4) was measured in muscle biopsies taken at the end of the respiration chamber stays. Mild cold exposure caused a significant increase in 24h energy expenditure of 2.8% (0.32 MJ/day, range of -0.21 to 1.66 MJ/day, p<0.05). The individual increases in energy expenditure correlated to state 4 respiration (p<0.02, R-2 = 0.50). Conclusions/Significance: This study for the first time shows that in humans, skeletal muscle has the intrinsic capacity for cold induced adaptive thermogenesis via mitochondrial uncoupling under physiological conditions. This opens possibilities for mitochondrial uncoupling as an alternative therapeutic target in the treatment of obesity.	[Wijers, Sander L. J.; Schrauwen, Patrick; Saris, Wim H. M.; Lichtenbelt, Wouter D. van Marken] Maastricht Univ, NUTRIM, Dept Human Biol, Maastricht, Netherlands	Maastricht University	Wijers, SLJ (corresponding author), Maastricht Univ, NUTRIM, Dept Human Biol, Maastricht, Netherlands.	S.Wijers@hb.unimaas.nl		Wijers, Sander/0000-0002-2944-4356; schrauwen, patrick/0000-0002-0973-847X				[Anonymous], 2000, WHO TECH REP SER, V894, pi; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; DAVIS TRA, 1960, AM J PHYSIOL, V198, P471, DOI 10.1152/ajplegacy.1960.198.3.471; Harris AM, 2006, J THERM BIOL, V31, P634, DOI 10.1016/j.jtherbio.2006.08.007; Hesselink MKC, 2003, J CLIN INVEST, V111, P479, DOI 10.1172/JCI16653; Himms-Hagen J, 2001, Rev Endocr Metab Disord, V2, P395, DOI 10.1023/A:1011856617047; JEQUIER E, 1983, AM J CLIN NUTR, V38, P989, DOI 10.1093/ajcn/38.6.989; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; Lichtenbelt WDV, 2002, AM J PHYSIOL-ENDOC M, V282, pE1077, DOI 10.1152/ajpendo.00020.2001; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Miranda EJ, 2006, J ANAL TOXICOL, V30, P219, DOI 10.1093/jat/30.3.219; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064; Schokker DF, 2007, OBES REV, V8, P101, DOI 10.1111/j.1467-789X.2006.00273.x; Schrauwen P, 2000, DIABETOLOGIA, V43, P1408, DOI 10.1007/s001250051547; Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001; Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; SIMONSEN L, 1992, AM J PHYSIOL, V263, pE850, DOI 10.1152/ajpendo.1992.263.5.E850; van Ooijen AMJ, 2004, PHYSIOL BEHAV, V82, P545, DOI 10.1016/j.physbeh.2004.05.001; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; WARWICK PM, 1990, BRIT J NUTR, V63, P481, DOI 10.1079/BJN19900135; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wijers SLJ, 2007, J CLIN ENDOCR METAB, V92, P4299, DOI 10.1210/jc.2007-1065; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	31	91	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1777	10.1371/journal.pone.0001777	http://dx.doi.org/10.1371/journal.pone.0001777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335051	Green Published, Green Submitted, gold			2022-12-27	WOS:000260723000030
J	Vicario, CM; Pecoraro, P; Turriziani, P; Koch, G; Caltagirone, C; Oliveri, M				Vicario, Carmelo Mario; Pecoraro, Patrizia; Turriziani, Patrizia; Koch, Giacomo; Caltagirone, Carlo; Oliveri, Massimiliano			Relativistic Compression and Expansion of Experiential Time in the Left and Right Space	PLOS ONE			English	Article							MENTAL REPRESENTATION; NEURAL MECHANISMS; NUMBER; DURATION	Time, space and numbers are closely linked in the physical world. However, the relativistic-like effects on time perception of spatial and magnitude factors remain poorly investigated. Here we wanted to investigate whether duration judgments of digit visual stimuli are biased depending on the side of space where the stimuli are presented and on the magnitude of the stimulus itself. Different groups of healthy subjects performed duration judgment tasks on various types of visual stimuli. In the first two experiments visual stimuli were constituted by digit pairs ( 1 and 9), presented in the centre of the screen or in the right and left space. In a third experiment visual stimuli were constituted by black circles. The duration of the reference stimulus was fixed at 300 ms. Subjects had to indicate the relative duration of the test stimulus compared with the reference one. The main results showed that, regardless of digit magnitude, duration of stimuli presented in the left hemispace is underestimated and that of stimuli presented in the right hemispace is overestimated. On the other hand, in midline position, duration judgments are affected by the numerical magnitude of the presented stimulus, with time underestimation of stimuli of low magnitude and time overestimation of stimuli of high magnitude. These results argue for the presence of strict interactions between space, time and magnitude representation on the human brain.	[Vicario, Carmelo Mario] Univ Roma La Sapienza, Dipartimento Psicol, Rome, Italy; [Pecoraro, Patrizia; Turriziani, Patrizia; Oliveri, Massimiliano] Univ Palermo, Dipartimento Psicol, Palermo, Italy; [Koch, Giacomo; Caltagirone, Carlo; Oliveri, Massimiliano] IRCCS, Rome, Italy	Sapienza University Rome; University of Palermo	Vicario, CM (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, Rome, Italy.	maxoliveri@unipa.it	Caltagirone, Carlo/B-4930-2013; Koch, Giacomo/G-3155-2012; VICARIO, CARMELO/AAR-2521-2021; Oliveri, Massimiliano/HDO-5602-2022	Turriziani, Patrizia/0000-0003-4802-280X; KOch, Giacomo/0000-0001-6155-9439				Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DELONG AJ, 1981, SCIENCE, V213, P681, DOI 10.1126/science.7256273; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; MECK WH, 1985, J EXP PSYCHOL ANIM B, V11, P591, DOI 10.1037/0097-7403.11.4.591; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; ROBERTS WA, 1994, J EXP PSYCHOL ANIM B, V20, P66, DOI 10.1037/0097-7403.20.1.66; ROBERTS WA, 1995, CURR DIR PSYCHOL SCI, V4, P47, DOI 10.1111/1467-8721.ep10771008; Roitman JD, 2007, ACTA PSYCHOL, V124, P296, DOI 10.1016/j.actpsy.2006.03.008; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Vicario C. M., 2007, BRAIN COGNITION, V39, P1317; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002	20	122	126	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1716	10.1371/journal.pone.0001716	http://dx.doi.org/10.1371/journal.pone.0001716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XT	18320037	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586600012
J	Johansson, BP; Shannon, O; Bjorck, L				Johansson, Bjorn P.; Shannon, Oonagh; Bjorck, Lars			IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential	PLOS ONE			English	Article								Background: IdeS, a proteinase from Streptococcus pyogenes, cleaves immunoglobulin (Ig) G antibodies with a unique degree of specificity. Pathogenic IgG antibodies constitute an important clinical problem contributing to the pathogenesis of a number of autoimmune conditions and acute transplant rejection. To be able to effectively remove such antibodies is therefore an important clinical challenge. Methodology/Principal Findings: IdeS was found to specifically and efficiently cleave IgG in human blood in vitro (20 mg of IdeS caused a complete degradation of IgG in one ml of human whole blood in 15 minutes) and to clear IgG from the blood stream of rabbits in vivo (no IgG was detected six hours following an intravenous injection of 5 mg of IdeS) without any side effects. In a mouse model of immune thrombocytopenic purpura (ITP), polyclonal IgG antibodies against platelet surface antigens were used to induce a lethal disease. These profoundly thrombocytopenic animals were treated and cured by a single injection of IdeS. Conclusions/Significance: Novel information is provided concerning the IgG-cleaving activity of IdeS in vitro and in vivo. The highly specific and rapid elimination of IgG in vivo, the dramatic effect in a mouse model of ITP, and the lack of side effects in the treated animals, indicate that IdeS could also be used to treat IgG-driven diseases in humans.	[Johansson, Bjorn P.; Shannon, Oonagh; Bjorck, Lars] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden	Lund University	Johansson, BP (corresponding author), Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden.	lars.bjorck@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189	Swedish Research Council [project 7480]; Swedish Government Funds for Clinical Research; Foundations of Greta and Johan Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical Research; Foundations of Greta and Johan Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg; Hansa Medical AB	This work was supported by the Swedish Research Council (project 7480), the Swedish Government Funds for Clinical Research (ALF), the Foundations of Greta and Johan Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg, and by Hansa Medical AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson P, 2006, INFECT IMMUN, V74, P497, DOI 10.1128/IAI.74.1.497-503.2006; Akesson P, 2004, J INFECT DIS, V189, P797, DOI 10.1086/381982; BERTA E, 1994, INT J ARTIF ORGANS, V17, P603, DOI 10.1177/039139889401701109; BYGREN P, 1985, LANCET, V2, P1295; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; COLLIN M, 2007, P NATL ACAD IN PRESS; Dominguez V, 2003, HAEMATOLOGICA, V88, P679; Eming R, 2006, AUTOIMMUNITY, V39, P609, DOI 10.1080/08916930600972040; Fujimi S, 2006, BLOOD, V107, P4399, DOI 10.1182/blood-2005-09-3776; Lei BF, 2001, NAT MED, V7, P1298, DOI 10.1038/nm1201-1298; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; PALMER A, 1989, LANCET, V1, P10; PALMER A, 1988, LANCET, V2, P272; Stummvoll GH, 2005, ANN RHEUM DIS, V64, P1015, DOI 10.1136/ard.2004.029660; Tomer A, 2005, J THROMB HAEMOST, V3, P74, DOI 10.1111/j.1538-7836.2004.01052.x; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101	19	71	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1692	10.1371/journal.pone.0001692	http://dx.doi.org/10.1371/journal.pone.0001692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301769	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500036
J	Blanco, S; Sanz-Garcia, M; Santos, CR; Lazo, PA				Blanco, Sandra; Sanz-Garcia, Marta; Santos, Claudio R.; Lazo, Pedro A.			Modulation of Interleukin-1 Transcriptional Response by the Interaction between VRK2 and the JIP1 Scaffold Protein	PLOS ONE			English	Article								Background: Cellular biological responses to specific stimulation are determined by a balance among signaling pathways. Protein interactions are likely to modulate these pathways. Vaccinia-related kinase-2 (VRK2) is a novel human kinase that can modulate different signaling pathways. Principal Findings: We report that in vivo, the activity of JIP1-JNK complexes is downregulated by VRK2 in response to interleukin-1 beta. Also the reduction of endogenous VRK2 with shRNA increases the transcriptional response to IL-1 beta. The JIP1 scaffold protein assembles three consecutive members of a given MAPK pathway forming signaling complexes and their signal can be modulated by interactions with regulatory proteins that remain to be identified. Knocking-down JIP1 with siRNA resulted in elimination of the AP1 transcriptional response to IL-1 beta. VRK2, a member of novel Ser-Thr kinase family, is able to stably interact with JIP1, TAK1 and MKK7, but not JNK, and can be isolated forming oligomeric complexes with different proportions of TAK1, MKK7 beta 1 and JNK. JIP1 assembles all these proteins in an oligomeric signalosome. VRK2 binding to the JIP1 signalosome prevents the association of JNK and results in a reduction in its phosphorylation and downregulation of AP1-dependent transcription. Conclusions/Significance: This work suggests that the intracellular level of VRK2 protein can modulate the flow through a signaling pathway and alter the response from a receptor that can be distributed by more than one pathway, and thus contribute to the cellular specificity of the response by forming alternative signaling complexes. Furthermore, the effect might be more general and affect other signaling routes assembled on the JIP1 scaffold protein for which a model is proposed.	[Blanco, Sandra; Sanz-Garcia, Marta; Santos, Claudio R.; Lazo, Pedro A.] Univ Salamanca, Program Oncol Traslac, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Blanco, S (corresponding author), Univ Salamanca, Program Oncol Traslac, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain.	plazozbi@usal.es	2008, Ibsal/A-1268-2012; Blanco, Sandra/B-2070-2017; Lazo, Pedro A./M-6435-2014	Blanco, Sandra/0000-0001-7352-9392; Lazo, Pedro A./0000-0001-8997-3025	Ministerio de Educacion y Ciencia, CSIC (Spain) [predoctoral fellowships, SAF2004-02900, SAF2007-60242, CSD-2007-0017]; Fundacao para a Ciencia e a Tecnologia (Portugal) [predoctoral fellowships]; Fundacion de Investigacion Medica; Federacion de Cajas de Ahorro de Castilla y Leon	Ministerio de Educacion y Ciencia, CSIC (Spain)(Spanish Government); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundacion de Investigacion Medica; Federacion de Cajas de Ahorro de Castilla y Leon	S.B., M.S-G, and C.R.S. have predoctoral fellowships from Ministerio de Educacion y Ciencia, CSIC (Spain) and Fundacao para a Ciencia e a Tecnologia (Portugal) respectively. This work was funded by grants from Ministerio de Educacion y Ciencia (SAF2004-02900, SAF2007-60242 and Consolider CSD-2007-0017), Fundacion de Investigacion Medica MM and Federacion de Cajas de Ahorro de Castilla y Leon to P.A.L.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dong ZH, 2005, MOL BRAIN RES, V134, P282, DOI 10.1016/j.molbrainres.2004.10.039; Dunn C, 2002, CELL SIGNAL, V14, P585, DOI 10.1016/S0898-6568(01)00275-3; Eminel S, 2004, J BIOL CHEM, V279, P55385, DOI 10.1074/jbc.M405858200; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Haefliger JA, 2003, J CELL SCI, V116, P1463, DOI 10.1242/jcs.00356; Hammaker DR, 2004, J IMMUNOL, V172, P1612, DOI 10.4049/jimmunol.172.3.1612; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Helbecque N, 2003, MOL PSYCHIATR, V8, P413, DOI 10.1038/sj.mp.4001344; Holtmann H, 2001, J BIOL CHEM, V276, P3508, DOI 10.1074/jbc.M004376200; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Jensen LE, 2003, FEBS LETT, V545, P199, DOI 10.1016/S0014-5793(03)00533-7; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kim JW, 2005, P NATL ACAD SCI USA, V102, P14308, DOI 10.1073/pnas.0501600102; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; KOLCH W, 2005, NAT REV MOL CELL BIO; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; LAZO PA, 2005, AFCS NATURE MOL PAGE, DOI DOI 10.1038/:MP.A003025.003001; Li CH, 2005, J NEUROCHEM, V93, P290, DOI 10.1111/j.1471-4159.2005.03086.x; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Ling ZD, 2003, DIABETES, V52, P2497, DOI 10.2337/diabetes.52.10.2497; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Nakahira M, 2007, IMMUNITY, V26, P163, DOI 10.1016/j.immuni.2007.01.010; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Whitmarsh AJ, 2001, METHOD ENZYMOL, V332, P319; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; WHITMARSH AJ, 1999, SCI STKE, pPE1, DOI DOI 10.1126/STKE.1999.1.PE1; Willoughby EA, 2003, J BIOL CHEM, V278, P10731, DOI 10.1074/jbc.M207324200; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Yamano S, 1999, J VIROL, V73, P10095, DOI 10.1128/JVI.73.12.10095-10103.1999; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	69	50	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1660	10.1371/journal.pone.0001660	http://dx.doi.org/10.1371/journal.pone.0001660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286207	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586400049
J	Page, TJ; Humphreys, WF; Hughes, JM				Page, Timothy J.; Humphreys, William F.; Hughes, Jane M.			Shrimps Down Under: Evolutionary Relationships of Subterranean Crustaceans from Western Australia (Decapoda: Atyidae: Stygiocaris)	PLOS ONE			English	Article								Background: We investigated the large and small scale evolutionary relationships of the endemic Western Australian subterranean shrimp genus Stygiocaris (Atyidae) using nuclear and mitochondrial genes. Stygiocaris is part of the unique cave biota of the coastal, anchialine, limestones of the Cape Range and Barrow Island, most of whose nearest evolutionary relations are found in coastal caves of the distant North Atlantic. The dominance of atyids in tropical waters and their food resources suggest they are pivotal in understanding these groundwater ecosystems. Methodology/Principle Findings: Our nuclear and mitochondrial analyses all recovered the Mexican cave genus Typhlatya as the sister taxon of Stygiocaris, rather than any of the numerous surface and cave atyids from Australia or the Indo-Pacific region. The two described Stygiocaris species were recovered as monophyletic, and a third, cryptic, species was discovered at a single site, which has very different physiochemical properties from the sites hosting the two described species. Conclusions/Significance: Our findings suggest that Stygiocaris and Typhlatya may descend from a common ancestor that lived in the coastal marine habitat of the ancient Tethys Sea, and were subsequently separated by plate tectonic movements. This vicariant process is commonly thought to explain the many disjunct anchialine faunas, but has rarely been demonstrated using phylogenetic techniques. The Cape Range's geological dynamism, which is probably responsible for the speciation of the various Stygiocaris species, has also led to geographic population structure within species. In particular, Stygiocaris lancifera is split into northern and southern groups, which correspond to population splits within other sympatric subterranean taxa.	[Page, Timothy J.; Hughes, Jane M.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Humphreys, William F.] Western Australian Museum, Western Australia, Australia	Griffith University; Western Australian Museum	Page, TJ (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia.	t.page@griffith.edu.au	Page, Timothy/B-9000-2008; hughes, jane m/C-5321-2008	Page, Timothy/0000-0002-3521-3503; Humphreys, William/0000-0002-8998-9323	Butler Trust (WA Museum); Western Australian Museum; National Estate Grants Scheme; Australian National Parks and Wildlife Service; West Australian Petroleum Pty Ltd; Department of Defence; Waterhouse Club, South Australian Museum; Australian Rivers Institute, Griffith University	Butler Trust (WA Museum); Western Australian Museum; National Estate Grants Scheme; Australian National Parks and Wildlife Service; West Australian Petroleum Pty Ltd; Department of Defence; Waterhouse Club, South Australian Museum; Australian Rivers Institute, Griffith University(Griffith University)	Collections of Stygiocaris were made under funding from the Butler Trust (WA Museum), Western Australian Museum, National Estate Grants Scheme, Australian National Parks and Wildlife Service, West Australian Petroleum Pty Ltd and the Department of Defence. Field work in the Gibson Desert was supported by the Waterhouse Club, South Australian Museum. Lab work was funded by the Australian Rivers Institute, Griffith University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M., 1993, Records of the Western Australian Museum Supplement, V45, P145; Avise John C., 1994, pi; Boulton A. J., 2003, Aquatic Ecosystem Health & Management, V6, P41, DOI 10.1080/14634980301475; Burns A, 2000, HYDROBIOLOGIA, V437, P83, DOI 10.1023/A:1026555501638; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Choy Satish C., 1996, Records of the Western Australian Museum, V18, P103; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins LB, 2006, SEDIMENT GEOL, V185, P1, DOI 10.1016/j.sedgeo.2005.10.005; Cook BD, 2008, MOL ECOL, V17, P1066, DOI 10.1111/j.1365-294X.2007.03637.x; Cooper SJB, 2007, MOL ECOL, V16, P1533, DOI 10.1111/j.1365-294X.2007.03261.x; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; CULVER DC, FRESHWATER IN PRESS, DOI DOI 10.1111/J.1365-2427.2007.01856.X; Danielopol DL, 2000, ZOOL SCR, V29, P1, DOI 10.1046/j.1463-6409.2000.00027.x; Danielopol DL, 2000, TRENDS ECOL EVOL, V15, P223, DOI 10.1016/S0169-5347(00)01868-1; Darwin C, 1859, ORIGIN SPECIES MEANS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUZIK MT, INVERTEBRAT IN PRESS; Hamilton-Smith E., 1967, Journal of the Australian Entomological Society, V6, P103; Hamilton-Smith Elery, 2001, Records of the Western Australian Museum Supplement, V64, P85; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; HOLTHUIS L. B., 1960, CRUSTACEANA, V1, P47, DOI 10.1163/156854060X00069; Holthuis LB, 1993, RECENT GENERA CARIDE; Hrbek T, 2003, J EVOLUTION BIOL, V16, P17, DOI 10.1046/j.1420-9101.2003.00475.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys W.F., 1993, Records of the Western Australian Museum Supplement, V45, P165; Humphreys W.F., 2001, Records of the Western Australian Museum Supplement, V64, P15; Humphreys WF, 2005, CRUSTACEANA, V78, P1339, DOI 10.1163/156854005776759861; Humphreys W.F., 2001, Records of the Western Australian Museum Supplement, V64, P63; Humphreys W.F., 1991, Records of the Western Australian Museum, V15, P383; Humphreys W. F., 1999, Journal of the Royal Society of Western Australia, V82, P89; Humphreys W.F., 1993, REC AUST MUS S, P25; Humphreys W. F, 1994, SUBTERRANEAN FAUNA C; Humphreys WF, 2006, AUST J BOT, V54, P115, DOI 10.1071/BT04151; Humphreys WF, 2000, ECOSY WORLD, V30, P581; Humphreys WF, 2001, ENVIRON BIOL FISH, V62, P297, DOI 10.1023/A:1011880726946; Humphreys WF., 2001, MEMOIRES BIOSPEOLOGI, V28, P107; HUMPHREYS WF, INVERTEBRAT IN PRESS; Hunter RL, 2008, J BIOGEOGR, V35, P65, DOI 10.1111/j.1365-2699.2007.01767.x; ILIFFE TM, 1984, MAR ENVIRON RES, V12, P173, DOI 10.1016/0141-1136(84)90002-3; Iliffe TM, 2000, ECOSY WORLD, V30, P59; Jaume D, 2001, ZOOL J LINN SOC-LOND, V133, P1, DOI 10.1006/zjls.2000.0288; Kano Y, 2004, ZOOL SCR, V33, P423, DOI 10.1111/j.0300-3256.2004.00159.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; Knott Brenton, 1993, Records of the Western Australian Museum Supplement, V45, P109; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; MACIOLEK JA, 1983, B MAR SCI, V33, P606; McQuarrie N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017992; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Page TJ, 2007, MOL PHYLOGENET EVOL, V43, P645, DOI 10.1016/j.ympev.2006.08.007; Page TJ, 2007, INVERTEBR SYST, V21, P137, DOI 10.1071/IS06023; Page TJ, 2005, J BIOGEOGR, V32, P581, DOI 10.1111/j.1365-2699.2004.01226.x; Pohlman JW, 2000, ECOSY WORLD, V30, P345; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Proudlove G, 2003, TRENDS ECOL EVOL, V18, P272, DOI 10.1016/S0169-5347(03)00095-8; Rambaut A., 2007, TRACE 1 4; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Santos SR, 2006, MOL ECOL, V15, P2699, DOI 10.1111/j.1365-294X.2006.02965.x; SANZ S, 1995, CONTRIB ZOOL, V65, P79; Schubart CD, 2000, MOL PHYLOGENET EVOL, V15, P179, DOI 10.1006/mpev.1999.0754; Seymour JR, 2007, AQUAT MICROB ECOL, V50, P11, DOI 10.3354/ame01153; SKET B, 1986, STYGOLOGIA, V2, P317; Sket B, 1996, TRENDS ECOL EVOL, V11, P221, DOI 10.1016/0169-5347(96)20031-X; SMITH MJ, 1981, HYDROBIOLOGIA, V85, P49, DOI 10.1007/BF00011344; STOCK JH, 1986, CRUSTACEAN BIOGEOGRA, P195; Sturmbauer C, 1996, P NATL ACAD SCI USA, V93, P10855, DOI 10.1073/pnas.93.20.10855; SWOFFORD DL, 2002, PAUP VERSION 4 0B5 P; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRONTELJ P, FRESHWATER IN PRESS, DOI DOI 10.1111/J.1365-2427.2007.01877.X; Trontelj P, 2007, MOL ECOL, V16, P2841, DOI 10.1111/j.1365-294X.2007.03345.x; Trontelj P, 2007, ACTA CARSOLOGICA, V36, P183; von Rintelen K, 2007, BIOLOGY LETT, V3, P262, DOI 10.1098/rsbl.2006.0613; WEBB MS, 2003, THESIS TEXAS A M U C; WILLIAMS W. D., 1964, AUSTRALIAN J MAR FRESHWATER RES, V15, P93; Wyrwoll K-H, 1993, RECORDS W AUSTR MU S, V45, P1; Yam RSW, 2006, J N AM BENTHOL SOC, V25, P406, DOI 10.1899/0887-3593(2006)25[406:PDAGOA]2.0.CO;2; Zaksek V, 2007, MOL PHYLOGENET EVOL, V42, P223, DOI 10.1016/j.ympev.2006.07.009	88	68	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1618	10.1371/journal.pone.0001618	http://dx.doi.org/10.1371/journal.pone.0001618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286175	Green Published, gold			2022-12-27	WOS:000260586400011
J	Scholz, B; Svensson, M; Alm, H; Skold, K; Falth, M; Kultima, K; Guigoni, C; Doudnikoff, E; Li, Q; Crossman, AR; Bezard, E; Andren, PE				Scholz, Birger; Svensson, Marcus; Alm, Henrik; Skold, Karl; Falth, Maria; Kultima, Kim; Guigoni, Celine; Doudnikoff, Evelyne; Li, Qin; Crossman, Alan R.; Bezard, Erwan; Andren, Per E.			Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; PLASMA HOMOCYSTEINE LEVELS; LONG-TERM POTENTIATION; PARKINSONS-DISEASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; PROTEIN-SYNTHESIS; MODEL; BRAIN; ACID	L-3,4-dihydroxypheylalanine (L-dopa)-induced dyskinesia represent a debilitating complication of therapy for Parkinson's disease (PD) that result from a progressive sensitization through repeated L-dopa exposures. The MPTP macaque model was used to study the proteome in dopamine-depleted striatum with and without subsequent acute and chronic L-dopa treatment using two-dimensional difference in-gel electrophoresis (2D-DIGE) and mass spectrometry. The present data suggest that the dopamine-depleted striatum is so sensitive to de novo L-dopa treatment that the first ever administration alone would be able (i) to induce rapid post-translational modification-based proteomic changes that are specific to this first exposure and (ii), possibly, lead to irreversible protein level changes that would be not further modified by chronic L-dopa treatment. The apparent equivalence between first and chronic L-dopa administration suggests that priming would be the direct consequence of dopamine loss, the first L-dopa administrations only exacerbating the sensitization process but not inducing it.	[Scholz, Birger; Svensson, Marcus; Alm, Henrik; Skold, Karl; Falth, Maria; Kultima, Kim; Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala Biomed Ctr BMC, Uppsala, Sweden; [Guigoni, Celine; Doudnikoff, Evelyne; Bezard, Erwan] Univ Victor Segalen Bordeaux 2, Ctr Natl Rech Scient, Bordeaux Inst Neurosci, UMR 5227, Bordeaux, France; [Li, Qin] China Acad Med Sci, Inst Lab Animal Sci, Beijing, Peoples R China; [Crossman, Alan R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Uppsala University; UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; University of Manchester	Scholz, B (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala Biomed Ctr BMC, Uppsala, Sweden.	erwan.bezard@u-bordeaux2.fr	Söderquist, Marcus/B-5202-2012; Bezard, Erwan/ABD-5153-2021; Bezard, Erwan/A-8173-2008	Söderquist, Marcus/0000-0001-7068-5429; Doudnikoff, Evelyne/0000-0002-3770-8585; Andren, Per/0000-0002-4062-7743; Kultima, Kim/0000-0002-0680-1410; Bezard, Erwan/0000-0002-0410-4638; Alm, Henrik/0000-0003-0287-8071	Michael J. Fox Foundation for Parkinson Research; Swedish Research Council [2002-6116, 2004-3417]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); K&A Wallenberg Foundation; Karolinska Institutet	Michael J. Fox Foundation for Parkinson Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet)	We want to acknowledge the work (2D-DIGE separations) done by the Proteomic Resource Centre at Uppsala university, which was established with funding from Wallenberg Consortium North (WCN). This study was sponsored by the Michael J. Fox Foundation for Parkinson Research (ARC,EB), Swedish Research Council (VR) Grants 2002-6116 and 2004-3417 (PEA), the Swedish Foundation for International Cooperation in Research and Higher Education (STINT) Institutional grant (PEA), the K&A Wallenberg Foundation (PEA), Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at the Centre for Medical Innovations (CMI) at Karolinska Institutet (PEA).	Alm H, 2006, ENVIRON HEALTH PERSP, V114, P254, DOI 10.1289/ehp.8419; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Aubert I, 2007, BIOL PSYCHIAT, V61, P836, DOI 10.1016/j.biopsych.2006.06.038; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bezard E, 2000, SYNAPSE, V38, P363, DOI 10.1002/1098-2396(20001201)38:3<363::AID-SYN16>3.3.CO;2-1; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 2001, NAT REV NEUROSCI, V2, P577, DOI 10.1038/35086062; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; BOLAM JP, 1992, EXPT NEUROANATOMY PR, P1; BOUNDY VA, 1993, MOL PHARMACOL, V43, P666; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Brotchie JA, 2005, MOVEMENT DISORD, V20, P919, DOI 10.1002/mds.20612; Brown AM, 2005, EUR J NEUROSCI, V22, P247, DOI 10.1111/j.1460-9568.2005.04190.x; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; CEPEDA C, 2006, SCI STKE; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; FRAUSCHER G, 1995, LIFE SCI, V57, P813, DOI 10.1016/0024-3205(95)02009-8; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gracy KN, 1999, NEUROSCIENCE, V90, P107, DOI 10.1016/S0306-4522(98)00440-0; Guigoni C, 2005, EUR J NEUROSCI, V22, P283, DOI 10.1111/j.1460-9568.2005.04196.x; Guigoni C, 2007, NEUROBIOL DIS, V26, P452, DOI 10.1016/j.nbd.2007.02.001; Guilloteau D, 1998, NUCL MED BIOL, V25, P331, DOI 10.1016/S0969-8051(97)00224-2; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hallett PJ, 2005, NEUROPHARMACOLOGY, V48, P503, DOI 10.1016/j.neuropharm.2004.11.008; HERSCH SM, 1995, J NEUROSCI, V15, P5222; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Julien C, 2006, NEUROCHEM INT, V48, P404, DOI 10.1016/j.neuint.2005.12.002; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Kocher T, 2006, J PROTEOME RES, V5, P659, DOI 10.1021/pr0503836; Kultima K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-475; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Marsden C.D., 1982, MOVEMENT DISORD, P96; NADJAR A, 2007, PROG NEUROBIOL UNPUB; Nadjar A, 2006, J NEUROSCI, V26, P8653, DOI 10.1523/JNEUROSCI.2582-06.2006; Picconi B, 2005, NEUROTOXICOLOGY, V26, P779, DOI 10.1016/j.neuro.2005.02.002; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Samadi P, 2006, ANN NEUROL, V59, P282, DOI 10.1002/ana.20738; Schneider JS, 2003, BRAIN RES, V990, P38, DOI 10.1016/S0006-8993(03)03382-1; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Siniscalchi A, 2006, NUTR NEUROSCI, V9, P11, DOI 10.1080/10284150600583446; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Waagepetersen HS, 1998, DEV NEUROSCI-BASEL, V20, P310, DOI 10.1159/000017326; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Zoccolella S, 2006, CLIN CHEM LAB MED, V44, P863, DOI 10.1515/CCLM.2006.143	60	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1589	10.1371/journal.pone.0001589	http://dx.doi.org/10.1371/journal.pone.0001589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270577	gold, Green Published			2022-12-27	WOS:000260535900023
J	Lemus, JA; Blanco, G; Grande, J; Arroyo, B; Garcia-Montijano, M; Martinez, F				Lemus, Jesus A.; Blanco, Guillermo; Grande, Javier; Arroyo, Bernardo; Garcia-Montijano, Marino; Martinez, Felix			Antibiotics Threaten Wildlife: Circulating Quinolone Residues and Disease in Avian Scavengers	PLOS ONE			English	Article							ANTIMICROBIAL USE; RESISTANCE; MICROFLORA; PHARMACEUTICALS; TETRACYCLINES; BACTERIA	Antibiotic residues that may be present in carcasses of medicated livestock could pass to and greatly reduce scavenger wildlife populations. We surveyed residues of the quinolones enrofloxacin and its metabolite ciprofloxacin and other antibiotics (amoxicillin and oxytetracycline) in nestling griffon Gyps fulvus, cinereous Aegypius monachus and Egyptian Neophron percnopterus vultures in central Spain. We found high concentrations of antibiotics in the plasma of many nestling cinereous (57%) and Egyptian (40%) vultures. Enrofloxacin and ciprofloxacin were also found in liver samples of all dead cinereous vultures. This is the first report of antibiotic residues in wildlife. We also provide evidence of a direct association between antibiotic residues, primarily quinolones, and severe disease due to bacterial and fungal pathogens. Our results indicate that, by damaging the liver and kidney and through the acquisition and proliferation of pathogens associated with the depletion of lymphoid organs, continuous exposure to antibiotics could increase mortality rates, at least in cinereous vultures. If antibiotics ingested with livestock carrion are clearly implicated in the decline of the vultures in central Spain then it should be considered a primary concern for conservation of their populations.	[Lemus, Jesus A.] CSIC, Museo Ciencias Nat, Dept Ecol Evol, Madrid, Spain; [Garcia-Montijano, Marino] GIR Diagnostics SL, Madrid, Spain; [Grande, Javier; Arroyo, Bernardo; Martinez, Felix] JCCM, UCLM, CSIC, IREC, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Museu de Ciencies Naturals de Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Blanco, G (corresponding author), JCCM, UCLM, CSIC, IREC, Ciudad Real, Spain.	gublanco2@yahoo.es	Blanco, Guillermo/L-3170-2014	Blanco, Guillermo/0000-0001-5742-4929				Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Ainsa J.A., 2002, INT MICROBIOL, V5, P155, DOI [10.1007/s10123-002-0082-z, DOI 10.1007/S10123-002-0082-Z]; Anadon A, 1996, AVIAN PATHOL, V25, P449, DOI 10.1080/03079459608419154; Aranaz A, 1997, SEMIN AVIAN EXOT PET, V6, P9, DOI 10.1016/S1055-937X(97)80036-9; Bataille L, 2002, J HEPATOL, V37, P696, DOI 10.1016/S0168-8278(02)00268-4; Blanco G., 2007, ENV RES TRENDS, P153; Blanco G, 2007, ENVIRON MICROBIOL, V9, P1738, DOI 10.1111/j.1462-2920.2007.01291.x; Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x; Brown SA, 1996, J VET PHARMACOL THER, V19, P1, DOI 10.1111/j.1365-2885.1996.tb00001.x; Cole RA, 1999, FIELD MANUAL WILDLIF, P48; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; de Carvalho LR, 2003, BRAZ J MICROBIOL, V34, P218, DOI 10.1590/S1517-83822003000300007; Donazar JA, 1993, BUITRES IBERICOS; Garcia-Rey C, 2006, CLIN MICROBIOL INFEC, V12, P55, DOI 10.1111/j.1469-0691.2006.01397.x; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; GRASSMICK BK, 1992, ANN PHARMACOTHER, V26, P636, DOI 10.1177/106002809202600504; Harrenstien LA, 2000, J AVIAN MED SURG, V14, P228, DOI 10.1647/1082-6742(2000)014[0228:DOEIRT]2.0.CO;2; HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Langelier K.M., 1993, P231; Lathers CM, 2002, J CLIN PHARMACOL, V42, P587, DOI 10.1177/00970002042006001; MARTINEZ F, 2004, QUERCUS, V227, P69; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Montagnac Richard, 2005, Nephrol Ther, V1, P44, DOI 10.1016/j.nephro.2005.02.005; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Okerman L, 2001, FOOD ADDIT CONTAM, V18, P385, DOI 10.1080/02652030010024320; Prescott J. F., 2000, ANTIMICROBIAL THERAP; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; SHARMA JP, 1978, J CHROMATOGR, V166, P213, DOI 10.1016/S0021-9673(00)92264-7; Tell LA, 2001, REV SCI TECH OIE, V20, P180, DOI 10.20506/rst.20.1.1273; Tella JL, 2001, NATURE, V410, P408, DOI 10.1038/35068717; THOMAS NJ, 1999, FIELD MANUAL WILDLIF, P349; Van Bambeke F, 2005, CLIN MICROBIOL INFEC, V11, P256, DOI 10.1111/j.1469-0691.2005.01131.x; *VET MED EV UN, MRL SUMM REP; WINSOR DK, 1981, APPL ENVIRON MICROB, V42, P1123, DOI 10.1128/AEM.42.6.1123-1124.1981; Zimpfer A, 2004, VIRCHOWS ARCH, V444, P87, DOI 10.1007/s00428-003-0917-9	36	43	46	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1444	10.1371/journal.pone.0001444	http://dx.doi.org/10.1371/journal.pone.0001444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197254	Green Published, gold			2022-12-27	WOS:000260503800015
J	Tubaldi, F; Ansuini, C; Tirindelli, R; Castiello, U				Tubaldi, Federico; Ansuini, Caterina; Tirindelli, Roberto; Castiello, Umberto			The Grasping Side of Odours	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ORBITOFRONTAL CORTEX; RHESUS-MONKEY; HUMAN BRAIN; HAND; PERCEPTION; OBJECTS; VISION; GRIP; EYE	Background: Research on multisensory integration during natural tasks such as reach-to-grasp is still in its infancy. Crossmodal links between vision, proprioception and audition have been identified, but how olfaction contributes to plan and control reach-to-grasp movements has not been decisively shown. We used kinematics to explicitly test the influence of olfactory stimuli on reach-to-grasp movements. Methodology/Principal Findings: Subjects were requested to reach towards and grasp a small or a large visual target (i.e., precision grip, involving the opposition of index finger and thumb for a small size target and a power grip, involving the flexion of all digits around the object for a large target) in the absence or in the presence of an odour evoking either a small or a large object that if grasped would require a precision grip and a whole hand grasp, respectively. When the type of grasp evoked by the odour did not coincide with that for the visual target, interference effects were evident on the kinematics of hand shaping and the level of synergies amongst fingers decreased. When the visual target and the object evoked by the odour required the same type of grasp, facilitation emerged and the intrinsic relations amongst individual fingers were maintained. Conclusions/Significance: This study demonstrates that olfactory information contains highly detailed information able to elicit the planning for a reach-to-grasp movement suited to interact with the evoked object. The findings offer a substantial contribution to the current debate about the multisensory nature of the sensorimotor transformations underlying grasping.	[Tubaldi, Federico; Ansuini, Caterina; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Tirindelli, Roberto] Univ Parma, Dept Neurosci, Parma, Italy; [Castiello, Umberto] Univ London, Royal Holloway, Dept Psychol, Egham, Surrey, England	University of Padua; University of Parma; University of London; Royal Holloway University London	Tubaldi, F (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it		Castiello, Umberto/0000-0003-0629-1286	University of Padova	University of Padova	This work was supported by a project grant from the University of Padova to UC.	Ansuini C, 2007, EXP BRAIN RES, V180, P85, DOI 10.1007/s00221-006-0840-9; ARBIB MA, 1985, HUM NEUROBIOL, V4, P63; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; BEGLIOMINI C, 2007, PLOS ONE, V10, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bock O, 1999, EXP BRAIN RES, V125, P61, DOI 10.1007/s002210050658; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Castiello U, 1999, TRENDS COGN SCI, V3, P264, DOI 10.1016/S1364-6613(99)01346-7; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; CASTIELLO U, J PSYCHOPHY IN PRESS; Castiello U, 2006, CHEM SENSES, V31, P665, DOI 10.1093/chemse/bjl007; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; COLEBATCH JG, 1989, BRAIN, V112, P749, DOI 10.1093/brain/112.3.749; DIFRANCO DW, 1997, DSC, V61, P17; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Frak V, 2001, EXP BRAIN RES, V136, P120, DOI 10.1007/s002210000583; Furr RM, 2003, PSYCHOL METHODS, V8, P275, DOI 10.1037/1082-989X.8.3.275; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Goodwin AW, 1998, J NEUROSCI, V18, P10724; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Grigor J, 1999, CHEM SENSES, V24, P137, DOI 10.1093/chemse/24.2.137; GRIGOR JA, 1995, CHEM SENSES, V20, P163; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Hummel T, 1996, BRAIN RES, V717, P160, DOI 10.1016/0006-8993(96)00094-7; Jenmalm P, 2000, J NEUROPHYSIOL, V84, P2984, DOI 10.1152/jn.2000.84.6.2984; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Klatzky RL, 2000, PRESENCE-TELEOP VIRT, V9, P399, DOI 10.1162/105474600566907; KLATZKY RL, 1987, PSYCHOL LEARN MOTIV, V21, P121; KLATZKY RL, 1987, J EXP PSYCHOL GEN, V116, P356; Lalanne C, 2004, J PHYSIOL-PARIS, V98, P265, DOI 10.1016/j.jphysparis.2004.06.001; Lederman SJ, 2003, 11TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS - HAPTICS 2003, PROCEEDINGS, P151, DOI 10.1109/HAPTIC.2003.1191261; Lederman SJ, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P97, DOI 10.1109/HAPTIC.2002.998946; MacKenzie C. L., 1994, THE GRASPING HAND; MORECRAFT RJ, 1993, J COMP NEUROL, V337, P669, DOI 10.1002/cne.903370411; Osterbauer RA, 2005, J NEUROPHYSIOL, V93, P3434, DOI 10.1152/jn.00555.2004; Patchay S, 2003, PSYCHON B REV, V10, P924, DOI 10.3758/BF03196553; PATCHAY S, 2006, EXP BRAIN RES, V23, P1; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; ROLLS ET, 1994, J NEUROSCI, V14, P5437; ROSSI S, PLOS ONE IN PRESS; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Sarfarazi M, 1999, CHEM SENSES, V24, P145, DOI 10.1093/chemse/24.2.145; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Stein Barry E., 1995, P683; STEIN BE, 1990, ANN NY ACAD SCI, V608, P51, DOI 10.1111/j.1749-6632.1990.tb48891.x; THOMPSON B, 1985, J EXP EDUC, V54, P50, DOI 10.1080/00220973.1985.10806398; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Wing A.M., 1996, HAND BRAIN NEUROPHYS; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Zahariev MA, 2007, EXP BRAIN RES, V180, P69, DOI 10.1007/s00221-006-0845-4	55	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1795	10.1371/journal.pone.0001795	http://dx.doi.org/10.1371/journal.pone.0001795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350137	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762300003
J	Achilli, A; Perego, UA; Bravi, CM; Coble, MD; Kong, QP; Woodward, SR; Salas, A; Torroni, A; Bandelt, HJ				Achilli, Alessandro; Perego, Ugo A.; Bravi, Claudio M.; Coble, Michael D.; Kong, Qing-Peng; Woodward, Scott R.; Salas, Antonio; Torroni, Antonio; Bandelt, Hans-Juergen			The Phylogeny of the Four Pan-American MtDNA Haplogroups: Implications for Evolutionary and Disease Studies	PLOS ONE			English	Article								Only a limited number of complete mitochondrial genome sequences belonging to Native American haplogroups were available until recently, which left America as the continent with the least amount of information about sequence variation of entire mitochondrial DNAs. In this study, a comprehensive overview of all available complete mitochondrial DNA (mtDNA) genomes of the four pan-American haplogroups A2, B2, C1, and D1 is provided by revising the information scattered throughout GenBank and the literature, and adding 14 novel mtDNA sequences. The phylogenies of haplogroups A2, B2, C1, and D1 reveal a large number of sub-haplogroups but suggest that the ancestral Beringian population(s) contributed only six (successful) founder haplotypes to these haplogroups. The derived clades are overall starlike with coalescence times ranging from 18,000 to 21,000 years (with one exception) using the conventional calibration. The average of about 19,000 years somewhat contrasts with the corresponding lower age of about 13,500 years that was recently proposed by employing a different calibration and estimation approach. Our estimate indicates a human entry and spread of the pan-American haplogroups into the Americas right after the peak of the Last Glacial Maximum and comfortably agrees with the undisputed ages of the earliest Paleoindians in South America. In addition, the phylogenetic approach also indicates that the pathogenic status proposed for various mtDNA mutations, which actually define branches of Native American haplogroups, was based on insufficient grounds.	[Achilli, Alessandro; Perego, Ugo A.; Torroni, Antonio] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ degli Studi Perugia, Dipartimento Biol Cell Ambientale, Perugia, Italy; [Perego, Ugo A.; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Bravi, Claudio M.] Inst Multidisciplin Biol Celular, Lab Genet Mol Poblac, La Plata, Argentina; [Coble, Michael D.] Armed Forces Inst Pathol, Armed Forces DNA Identificat Lab, Rockville, MD USA; [Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, Lab Cell & Mol Evolut, & Mol Biol Domestic Animals, Kunming, Peoples R China; [Kong, Qing-Peng] Yunnan Univ, Laboratory for Conservat & Utilizat Bio resource, Kunming, Peoples R China; [Salas, Antonio] Univ Santiago Compostela, Hosp Clin Univ, Inst Med Legal, Grupo Med Xenomica, Unidade Xenetica, Galicia, Spain; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany	University of Pavia; United States Department of Defense; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Universidade de Santiago de Compostela; University of Hamburg	Achilli, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	Achilli, Alessandro/I-9236-2012; Salas, Antonio/E-3977-2012; Torroni, Antonio/E-1557-2011; Salas, Antonio/U-2029-2019; Perego, Ugo/AAG-9327-2019; Coble, Michael D/E-7540-2010	Achilli, Alessandro/0000-0001-6871-3451; Salas, Antonio/0000-0002-2336-702X; Torroni, Antonio/0000-0002-4163-4478; Salas, Antonio/0000-0002-2336-702X; Coble, Michael/0000-0003-3687-0342	Progetti Ricerca Interesse Nazionale; Fondazione Cariplo	Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Cariplo(Fondazione Cariplo)	This research received support from Progetti Ricerca Interesse Nazionale 2005 (Italian Ministry of the University) (to AT) and Fondazione Cariplo (to AT). Funding agencies had no role in the design and conduct of the study.	Accetturo M, 2006, HUM MUTAT, V27, P965, DOI 10.1002/humu.20365; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Crispim D, 2005, DIABETIC MED, V22, P1683, DOI 10.1111/j.1464-5491.2005.01702.x; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Forster P, 1996, AM J HUM GENET, V59, P935; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MITOMAP, HUM MIT GEN DAT; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Monson K.L., 2002, FORENSIC SCI COMMUN, V4, P2; MOSQUERAMIGUEL A, 2008, CANC RES IN PRESS; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; PARSONS TJ, UNPUB; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rocha H, 1999, AM J HUM GENET, V65, P1457, DOI 10.1086/302641; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Scozzari R, 1997, AM J HUM GENET, V60, P241; Simon DK, 2001, J MED GENET, V38, P58, DOI 10.1136/jmg.38.1.58; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9	50	196	204	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1764	10.1371/journal.pone.0001764	http://dx.doi.org/10.1371/journal.pone.0001764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335039	Green Published, gold			2022-12-27	WOS:000260723000018
J	Fearnside, JF; Dumas, ME; Rothwell, AR; Wilder, SP; Cloarec, O; Toye, A; Blancher, C; Holmes, E; Tatoud, R; Barton, RH; Scott, J; Nicholson, JK; Gauguier, D				Fearnside, Jane F.; Dumas, Marc-Emmanuel; Rothwell, Alice R.; Wilder, Steven P.; Cloarec, Olivier; Toye, Ayo; Blancher, Christine; Holmes, Elaine; Tatoud, Roger; Barton, Richard H.; Scott, James; Nicholson, Jeremy K.; Gauguier, Dominique			Phylometabonomic Patterns of Adaptation to High Fat Diet Feeding in Inbred Mice	PLOS ONE			English	Article								Insulin resistance plays a central role in type 2 diabetes and obesity, which develop as a consequence of genetic and environmental factors. Dietary changes including high fat diet (HFD) feeding promotes insulin resistance in rodent models which present useful systems for studying interactions between genetic background and environmental influences contributing to disease susceptibility and progression. We applied a combination of classical physiological, biochemical and hormonal studies and plasma H-1 NMR spectroscopy-based metabonomics to characterize the phenotypic and metabotypic consequences of HFD (40%) feeding in inbred mouse strains (C57BL/6, 129S6, BALB/c, DBA/2, C3H) frequently used in genetic studies. We showed the wide range of phenotypic and metabonomic adaptations to HFD across the five strains and the increased nutrigenomic predisposition of 129S6 and C57BL/6 to insulin resistance and obesity relative to the other strains. In contrast mice of the BALB/c and DBA/2 strains showed relative resistance to HFD-induced glucose intolerance and obesity. Hierarchical metabonomic clustering derived from H-1 NMR spectral data of the strains provided a phylometabonomic classification of strain-specific metabolic features and differential responses to HFD which closely match SNP-based phylogenetic relationships between strains. Our results support the concept of genomic clustering of functionally related genes and provide important information for defining biological markers predicting spontaneous susceptibility to insulin resistance and pathological adaptations to fat feeding.	[Fearnside, Jane F.; Rothwell, Alice R.; Wilder, Steven P.; Toye, Ayo; Blancher, Christine; Gauguier, Dominique] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dumas, Marc-Emmanuel; Cloarec, Olivier; Holmes, Elaine; Barton, Richard H.; Nicholson, Jeremy K.] Imperial Coll London, Dept Biomol Med, Div Surg, Oncol, Reproduct Biol & Anaesthetics, Fac Med, London, England; [Dumas, Marc-Emmanuel] Ecole Normale Superieure Lyon, CRMN Lyon FRE 3008, Lab Chem UMR 5185, Lyon, France; [Tatoud, Roger; Scott, James] Imperial Coll London, Fac Med, London, England	University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Ecole Normale Superieure de Lyon (ENS de LYON); Imperial College London	Fearnside, JF (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	gdomi@well.ox.ac.uk; gdomi@well.ox.ac.uk	Dumas, Marc-Emmanuel/C-1736-2008; Nicholson, Jeremy K/B-3395-2012; Holmes, Elaine/A-2189-2015; Gauguier, Dominique/G-2190-2016; Holmes, Elaine/ABE-6606-2020	Dumas, Marc-Emmanuel/0000-0001-9523-7024; Nicholson, Jeremy K/0000-0002-8123-8349; Gauguier, Dominique/0000-0001-6156-9530; Holmes, Elaine/0000-0002-0556-8389; TATOUD, Roger/0000-0002-3999-8264; Barton, Richard H./0000-0001-7469-2845; Wilder, Steven/0000-0001-8049-2559; Tatoud, Roger/0000-0002-2394-6435	Wellcome Functional Genomics Initiative BAIR [066786]; Wellcome Prize Studentship; Wellcome Senior Fellowship in Basic Biomedical Science [057733]	Wellcome Functional Genomics Initiative BAIR; Wellcome Prize Studentship; Wellcome Senior Fellowship in Basic Biomedical Science	This work is supported by the Wellcome Functional Genomics Initiative BAIR (Biological Atlas of Insulin Resistance) (066786). Steven P. Wilder is the recipient of a Wellcome Prize Studentship in Bioinformatics and Statistical Genetics. Dominique Gauguier holds a Wellcome Senior Fellowship in Basic Biomedical Science (057733).	Albers JJ, 1999, J LIPID RES, V40, P295; Argmann CA, 2005, CELL METAB, V2, P349, DOI 10.1016/j.cmet.2005.11.002; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bogue M, 2003, J APPL PHYSIOL, V95, P1335, DOI 10.1152/japplphysiol.00562.2003; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; FERRANNINI E, 2007, J CLIN ENDOCRINOL ME; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Perusse L, 2000, AM J CLIN NUTR, V72, p1285S, DOI 10.1093/ajcn/72.5.1285s; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; West DB, 1998, AM J CLIN NUTR, V67, p505S, DOI 10.1093/ajcn/67.3.505S; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Zhang JH, 2005, GENOME RES, V15, P241, DOI 10.1101/gr.2901705	39	82	82	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1668	10.1371/journal.pone.0001668	http://dx.doi.org/10.1371/journal.pone.0001668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301746	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500013
J	Sodhi, NS; Bickford, D; Diesmos, AC; Lee, TM; Koh, LP; Brook, BW; Sekercioglu, CH; Bradshaw, CJA				Sodhi, Navjot S.; Bickford, David; Diesmos, Arvin C.; Lee, Tien Ming; Koh, Lian Pin; Brook, Barry W.; Sekercioglu, Cagan H.; Bradshaw, Corey J. A.			Measuring the Meltdown: Drivers of Global Amphibian Extinction and Decline	PLOS ONE			English	Article								Habitat loss, climate change, over-exploitation, disease and other factors have been hypothesised in the global decline of amphibian biodiversity. However, the relative importance of and synergies among different drivers are still poorly understood. We present the largest global analysis of roughly 45% of known amphibians (2,583 species) to quantify the influences of life history, climate, human density and habitat loss on declines and extinction risk. Multi-model Bayesian inference reveals that large amphibian species with small geographic range and pronounced seasonality in temperature and precipitation are most likely to be Red-Listed by IUCN. Elevated habitat loss and human densities are also correlated with high threat risk. Range size, habitat loss and more extreme seasonality in precipitation contributed to decline risk in the 2,454 species that declined between 1980 and 2004, compared to species that were stable (n = 1,545) or had increased (n = 28). These empirical results show that amphibian species with restricted ranges should be urgently targeted for conservation.	[Sodhi, Navjot S.; Bickford, David; Diesmos, Arvin C.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Diesmos, Arvin C.] Natl Museum Philippines, Herpetol Sect, Div Zool, Manila, Philippines; [Lee, Tien Ming] Univ Calif San Diego, Div Biol Sci, Ecol Behav & Evolut Sect, La Jolla, CA 92093 USA; [Koh, Lian Pin] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Brook, Barry W.; Bradshaw, Corey J. A.] Univ Adelaide, Res Inst Climate Change & Sustainabil, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Sekercioglu, Cagan H.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Bradshaw, Corey J. A.] Charles Darwin Univ, Sch Environm Res, Inst Adv Studies, Darwin, NT 0909, Australia	National University of Singapore; National Museum of the Philippines; University of California System; University of California San Diego; Princeton University; University of Adelaide; Stanford University; Charles Darwin University	Sodhi, NS (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsbdp@nus.edu.sg; dbsns@nus.edu.sg	Bickford, David P/A-5306-2011; Diesmos, Arvin C./AGG-8542-2022; Koh, Lian Pin/A-5794-2010; Sekercioglu, Cagan H/A-2331-2013; Bradshaw, Corey J.A./A-1311-2008; Brook, Barry W./G-2686-2011	Bickford, David P/0000-0003-1478-3387; Koh, Lian Pin/0000-0001-8152-3871; Sekercioglu, Cagan H/0000-0001-9639-294X; Bradshaw, Corey J.A./0000-0002-5328-7741; Brook, Barry W./0000-0002-2491-1517; Sekercioglu, Cagan H./0000-0003-3193-0377	National University of Singapore [R-154-000-264-112]; Singapore Ministry of Education [R-154-000-270-112]	National University of Singapore(National University of Singapore); Singapore Ministry of Education(Ministry of Education, Singapore)	The research was supported by the National University of Singapore (R-154-000-264-112) and the Singapore Ministry of Education (R-154-000-270-112).	Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Bickford DP, 2005, Ecology & Evolution in the Tropics: A Herpetological Perspective, P260; Bielby J, 2006, ANIM CONSERV, V9, P135, DOI 10.1111/j.1469-1795.2005.00013.x; Brook BW, 2006, ECOL LETT, V9, P375, DOI 10.1111/j.1461-0248.2006.00883.x; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Crawley M. J, 2002, STAT COMPUTING INTRO; Elliott LP, 2007, BIOSCIENCE, V57, P608, DOI 10.1641/B570708; *EUR COMM JRC IES, 2002, GLC 2000 GLOB LAND C; FELSENSTEIN J, 1985, AM NAT, V70, P1; Hero JM, 2005, J ZOOL, V267, P221, DOI 10.1017/S0952836905007296; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; *IUCN CI NATURESER, 2006, GLOB AMPH ASS; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Linberger P., 2008, J BUS FINANCE LIBRAR, V5; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Lips KR, 2005, BIOTROPICA, V37, P163, DOI 10.1111/j.1744-7429.2005.00023.x; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lukacs PM, 2007, J APPL ECOL, V44, P456, DOI 10.1111/j.1365-2664.2006.01267.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Murray BR, 2005, AUSTRAL ECOL, V30, P564, DOI 10.1111/j.1442-9993.2005.01471.x; Murray BR, 1998, J ANIM ECOL, V67, P567, DOI 10.1046/j.1365-2656.1998.00217.x; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Payne JL, 2007, P NATL ACAD SCI USA, V104, P10506, DOI 10.1073/pnas.0701257104; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Williams SE, 1998, P ROY SOC B-BIOL SCI, V265, P597, DOI 10.1098/rspb.1998.0336	39	320	343	2	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1636	10.1371/journal.pone.0001636	http://dx.doi.org/10.1371/journal.pone.0001636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286193	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400029
J	Bell, DJ; Nyirongo, SK; Mukaka, M; Zijlstra, EE; Plowe, CV; Molyneux, ME; Ward, SA; Winstanley, PA				Bell, David J.; Nyirongo, Suzgo K.; Mukaka, Mavuto; Zijlstra, Ed E.; Plowe, Christopher V.; Molyneux, Malcolm E.; Ward, Steve A.; Winstanley, Peter A.			Sulfadoxine-Pyrimethamine-Based Combinations for Malaria: A Randomised Blinded Trial to Compare Efficacy, Safety and Selection of Resistance in Malawi	PLOS ONE			English	Article								Background: In Malawi, there has been a return of Plasmodium falciparum sensitivity to chloroquine (CQ) since sulfadoxine-pyrimethamine (SP) replaced CQ as first line treatment for uncomplicated malaria. When used for prophylaxis, Amodiaquine (AQ) was associated with agranulocytosis but is considered safe for treatment and is increasingly being used in Africa. Here we compare the efficacy, safety and selection of resistance using SP or CQ+SP or artesunate (ART)+SP or AQ+SP for the treatment of uncomplicated falciparum malaria. Methodology and Findings: 455 children aged 1-5 years were recruited into a double-blinded randomised trial comparing SP to the three combination therapies. Using intention to treat analysis with missing outcomes treated as successes, and without adjustment to distinguish recrudescence from new infections, the day 28 adequate clinical and parasitological response (ACPR) rate for SP was 25%, inferior to each of the three combination therapies (p < 0.001). AQ+SP had an ACPR rate of 97%, higher than CQ+ SP (81%) and ART+SP (70%), p < 0.001. Nineteen children developed a neutropenia of # 0.5 x 10(3) cells/ml by day 14, more commonly after AQ+SP (p=0.03). The mutation pfcrt 76T, associated with CQ resistance, was detected in none of the pre-treatment or post-treatment parasites. The prevalence of the pfmdr1 86Y mutation was higher after treatment with AQ+SP than after SP, p=0.002. Conclusions: The combination AQ+SP was highly efficacious, despite the low efficacy of SP alone; however, we found evidence that AQ may exert selective pressure for resistance associated mutations many weeks after treatment. This study confirms the return of CQ sensitivity in Malawi and importantly, shows no evidence of the re-emergence of pfcrt 76T after treatment with CQ or AQ. Given the safety record of AQ when used as a prophylaxis, our observations of marked falls in neutrophil counts in the AQ+SP group requires further scrutiny.	[Bell, David J.; Ward, Steve A.] Univ Liverpool, Liverpool Sch Trop Med, Dept Mol & Biochem Parasitol, Liverpool L3 5QA, Merseyside, England; [Nyirongo, Suzgo K.; Mukaka, Mavuto; Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Prog, Blantyre, Malawi; [Zijlstra, Ed E.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Plowe, Christopher V.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD USA; [Bell, David J.; Winstanley, Peter A.] Univ Liverpool, Sch Clin Sci, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University System of Maryland; University of Maryland Baltimore; University of Liverpool	Bell, DJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Mol & Biochem Parasitol, Liverpool L3 5QA, Merseyside, England.	belldavidj@gmail.com	Ward, Steve/G-6003-2015	Ward, Steve/0000-0003-2331-3192	Wellcome Trust [066681]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust Training Fellowship in Clinical Tropical Medicine awarded to David Bell (grant number 066681). The funders had no role in the study design or execution, or in the analysis and presentation of the data.	Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Alker AP, 2005, ANTIMICROB AGENTS CH, V49, P3919, DOI 10.1128/AAC.49.9.3919-3921.2005; [Anonymous], 2003, ASS MON ANT DRUG EFF; Brasseur P, 1999, T ROY SOC TROP MED H, V93, P645, DOI 10.1016/S0035-9203(99)90083-4; CARR R, 1986, LANCET, V1, P556; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; Djimde AA, 2004, J INFECT DIS, V190, P853, DOI 10.1086/422758; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; DOUER D, 1985, ISRAEL J MED SCI, V21, P331; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; ELLIS ME, 1987, J INFECTION, V15, P147, DOI 10.1016/S0163-4453(87)93130-6; Gasasira AF, 2003, AM J TROP MED HYG, V68, P127, DOI 10.4269/ajtmh.2003.68.127; Happi CT, 2006, AM J TROP MED HYG, V75, P155, DOI 10.4269/ajtmh.2006.75.155; HATTON CSR, 1986, LANCET, V1, P411; Hawley SR, 1996, MOL BIOCHEM PARASIT, V80, P15, DOI 10.1016/0166-6851(96)02655-2; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; NEFTEL KA, 1986, BRIT MED J, V292, P721, DOI 10.1136/bmj.292.6522.721; Nsobya SL, 2007, ANTIMICROB AGENTS CH, V51, P3023, DOI 10.1128/AAC.00012-07; Obonyo CO, 2007, T ROY SOC TROP MED H, V101, P117, DOI 10.1016/j.trstmh.2006.07.001; Olliaro P., 2003, COCHRANE DB SYST REV, V2, pCD000016; OLUMESE P, 2007, ANTIMALARIAL TREATME; PHILLIPSHOWARD PA, 1990, J ROY SOC MED, V83, P82, DOI 10.1177/014107689008300208; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; RHODES EGH, 1986, BRIT MED J, V292, P717, DOI 10.1136/bmj.292.6522.717; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; WATKINS WM, 1993, T ROY SOC TROP MED H, V87, P75, DOI 10.1016/0035-9203(93)90431-O; WHO, 2006, GUID TREATM MAL; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	34	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1578	10.1371/journal.pone.0001578	http://dx.doi.org/10.1371/journal.pone.0001578			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270569	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000260535900014
J	Bochdanovits, Z; Sondervan, D; Perillous, S; van Beijsterveldt, T; Boomsma, D; Heutink, P				Bochdanovits, Zoltan; Sondervan, David; Perillous, Sophie; van Beijsterveldt, Toos; Boomsma, Dorret; Heutink, Peter			Genome-Wide Prediction of Functional Gene-Gene Interactions Inferred from Patterns of Genetic Differentiation in Mice and Men	PLOS ONE			English	Article								The human genome encodes a limited number of genes yet contributes to individual differences in a vast array of heritable traits. A possible explanation for the capacity our genome to generate this virtually unlimited range of phenotypic variation in complex traits is to assume functional interactions between genes. Therefore we searched two mammalian genomes to identify potential epistatic interactions by looking for co-adapted genes marked by excess two-locus genetic differentiation between populations/lineages using publicly available SNP genotype data. The practical motivation for this effort is to reduce the number of pair-wise tests that need to be performed in genome-wide association studies aimed at detecting GxG interactions, by focusing on pairs predicted to be more likely to jointly affect variation in complex traits. Hence, this approach generates a list of candidate interactions that can be empirically tested. In both the mouse and human data we observed two-locus genetic differentiation in excess of what can be expected from chance alone based on simulations. In an attempt to validate our hypothesis that pairs of genes showing excess genetic divergence represent potential functional interactions, we selected a small set of gene combinations postulated to be interacting based on our analyses and looked for a combined effect of the selected genes on variation in complex traits in both mice and man. In both cases the individual effect of the genes were not significant, instead we observed marginally significant interaction effects. These results show that genome wide searches for gene-gene interactions based on population genetic data are feasible and can generate interesting candidate gene pairs to be further tested for their contribution to phenotypic variation in complex traits.	[Bochdanovits, Zoltan; Sondervan, David; Perillous, Sophie; Boomsma, Dorret; Heutink, Peter] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Med Genom, Amsterdam, Netherlands; [Bochdanovits, Zoltan; Sondervan, David; Boomsma, Dorret; Heutink, Peter] Vrije Univ Amsterdam, Vrije Univ Amsterdam Med Ctr, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [van Beijsterveldt, Toos; Boomsma, Dorret; Heutink, Peter] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam	Bochdanovits, Z (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Med Genom, Amsterdam, Netherlands.	z.bochdanovits@vumc.nl	Boomsma, Dorret I/AAX-4470-2020	van Beijsterveldt, Toos/0000-0002-6617-4201; Heutink, Peter/0000-0001-5218-1737	Centre for Medical Systems Biology (CMSB); NWO [575-25-012, 575-25-006, 904-57-94, 051.02.060, 668.772, 480-04-004, 400-05-717]; NWO/SPI [56-464-14192]; NIMH [RO1 MH58799-03]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058799] Funding Source: NIH RePORTER	Centre for Medical Systems Biology (CMSB); NWO(Netherlands Organization for Scientific Research (NWO)); NWO/SPI(Netherlands Organization for Scientific Research (NWO)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Centre for Medical Systems Biology (CMSB), a centre of excellence approved by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO). D.B. was supported by NWO grants NWO 575-25-012; NWO 575-25-006; NWO 904-57-94; NWO 051.02.060, 668.772; NWO/SPI 56-464-14192; NWO 480-04-004; NWO 400-05-717 and by NIMH RO1 MH58799-03.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Boomsma DI, 2005, GENES BRAIN BEHAV, V4, P466, DOI 10.1111/j.1601-183X.2005.00141.x; CARLBORG O, 2006, EPISTASIS RELEASE GE, V38, P418; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Meyer DK, 2000, J NEUROSCI, V20, P6743, DOI 10.1523/JNEUROSCI.20-18-06743.2000; Okada M, 2004, HIPPOCAMPUS, V14, P337, DOI 10.1002/hipo.10185; Okubo T, 2003, ALCOHOL CLIN EXP RES, V27, p68S, DOI 10.1097/01.ALC.0000078616.63296.41; Payseur BA, 2005, GENETICS, V171, P1905, DOI 10.1534/genetics.105.046193; Payseur BA, 2007, J HERED, V98, P115, DOI 10.1093/jhered/esl064; POLLAK E, 1979, BIOMETRICS, V35, P119, DOI 10.2307/2529940; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Wade MJ, 1998, EVOLUTION, V52, P1537, DOI 10.1111/j.1558-5646.1998.tb02235.x; WADE MJ, 1991, SCIENCE, V253, P1015, DOI 10.1126/science.1887214; Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WEIR BS, 1996, GENETIC DATA ANAL, V2, P161; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1920, P NATL ACAD SCI USA, V6, P320, DOI 10.1073/pnas.6.6.320; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Xie F, 2004, J NEUROCHEM, V90, P1521, DOI 10.1111/j.1471-4159.2004.02685.x	33	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1593	10.1371/journal.pone.0001593	http://dx.doi.org/10.1371/journal.pone.0001593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270580	Green Submitted, gold, Green Published			2022-12-27	WOS:000260535900027
J	Chao, KC; Chao, KF; Fu, YS; Liu, SH				Chao, Kuo Ching; Chao, Kuo Fang; Fu, Yu Show; Liu, Shing Hwa			Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 Diabetes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BONE-MARROW; IN-VITRO; GLUCOSE-METABOLISM; ENDOCRINE-CELLS; BLOOD-CELLS; NEURONS; DIFFERENTIATION; EXPRESSION; FUSION	Background. There is a widespread interest in developing renewable sources of islet-replacement tissue for type I diabetes mellitus. Human mesenchymal cells isolated from the Wharton's jelly of the umbilical cord (HUMSCs), which can be easily obtained and processed compared with embryonic and bone marrow stem cells, possess stem cell properties. HUMSCs may be a valuable source for the generation of islets. Methodology and Principal Findings. HUMSCs were induced to transform into islet-like cell clusters in vitro through stepwise culturing in neuron-conditioned medium. To assess the functional stability of the islet-like cell clusters in vivo, these cell clusters were transplanted into the liver of streptozotocin-induced diabetic rats via laparotomy. Glucose tolerance was measured on week 12 after transplantation accompanied with immunohistochemistry and electron microscopy analysis. These islet-like cell clusters were shown to contain human C-peptide and release human insulin in response to physiological glucose levels. Real-time RT-PCR detected the expressions of insulin and other pancreatic beta-cell-related genes (Pdx1, Hlxb9, Nkx2.2, Nkx6.1, and Glut-2) in these islet-like cell clusters. The hyperglycemia and glucose intolerance in streptozotocin-induced diabetic rats was significantly alleviated after xenotransplantation of islet-like cell clusters, without the use of immunosuppressants. In addition to the existence of islet-like cell clusters in the liver, some special fused liver cells were also found, which characterized by human insulin and nuclei-positive staining and possessing secretory granules. Conclusions and Significance. In this study, we successfully differentiate HUMSCs into mature islet-like cell clusters, and these islet-like cell clusters possess insulin-producing ability in vitro and in vivo. HUMSCs in Wharton's Jelly of the umbilical cord seem to be the preferential source of stem cells to convert into insulin-producing cells, because of the large potential donor pool, its rapid availability, no risk of discomfort for the donor, and low risk of rejection.	[Fu, Yu Show] Natl Yang Ming Univ, Sch Med, Dept Anat, Taipei, Taiwan; [Chao, Kuo Ching; Chao, Kuo Fang] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University	Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan.	shliu@ha.mc.ntu.edu.tw		LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC95-2323-B-0002-007]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC95-2323-B-0002-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Delacour A, 2004, MECH DEVELOP, V121, P3, DOI 10.1016/j.mod.2003.11.004; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ende N, 2004, BIOCHEM BIOPH RES CO, V325, P665, DOI 10.1016/j.bbrc.2004.10.091; Ende N, 2004, BIOCHEM BIOPH RES CO, V321, P168, DOI 10.1016/j.bbrc.2004.06.121; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fu YS, 2004, J BIOMED SCI, V11, P652, DOI 10.1159/000079678; GUNNARSSON R, 1983, LANCET, V2, P571; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hori Y, 2005, PLOS MED, V2, P347, DOI 10.1371/journal.pmed.0020103; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Medvinsky A, 2003, NATURE, V422, P823, DOI 10.1038/422823a; Mfopou JK, 2007, STEM CELLS, V25, P1156, DOI 10.1634/stemcells.2006-0720; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Naftanel MA, 2004, PLOS MED, V1, P198, DOI 10.1371/journal.pmed.0010058; Nanji SA, 2006, DIABETES OBES METAB, V8, P15, DOI 10.1111/j.1463-1326.2005.00476.x; Oh SH, 2004, LAB INVEST, V84, P607, DOI 10.1038/labinvest.3700074; OHGAWARA H, 1993, TOHOKU J EXP MED, V169, P159, DOI 10.1620/tjem.169.159; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Pileggi A, 2006, CURR OPIN ORGAN TRAN, V11, P7, DOI 10.1097/01.mot.0000203878.00901.26; Ramiya VK, 2000, NAT MED, V6, P278; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; ROBERTSON RP, 1992, J CLIN INVEST, V90, P320, DOI 10.1172/JCI115865; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Treutelaar MK, 2003, DIABETES, V52, P2503, DOI 10.2337/diabetes.52.10.2503; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Waki A, 2001, BRAIN RES, V894, P88, DOI 10.1016/S0006-8993(01)01983-7; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699	44	242	287	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1451	10.1371/journal.pone.0001451	http://dx.doi.org/10.1371/journal.pone.0001451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197261	Green Published, Green Submitted, gold			2022-12-27	WOS:000260503800023
J	Mangal, TD; Paterson, S; Fenton, A				Mangal, Tara D.; Paterson, Steve; Fenton, Andrew			Predicting the Impact of Long-Term Temperature Changes on the Epidemiology and Control of Schistosomiasis: A Mechanistic Model	PLOS ONE			English	Article								Background. Many parasites of medical and veterinary importance are transmitted by cold-blooded intermediate hosts or vectors, the abundance of which will vary with ambient temperatures, potentially altering disease prevalence. In particular, if global climate change will increase mean ambient temperature in a region endemic with a human pathogen then it is possible that the incidence of disease will similarly increase. Here we examine this possibility by using a mathematical model to explore the effects of increasing long-term mean ambient temperature on the prevalence and abundance of the parasite Schistosoma mansoni, the causative agent of schistosomiasis in humans. Principal Findings. The model showed that the impact of temperature on disease prevalence and abundance is not straightforward; the mean infection burden in humans increases up to 30 degrees C, but then crashes at 35 degrees C, primarily due to increased mortalities of the snail intermediate host. In addition, increased temperatures changed the dynamics of disease from stable, endemic infection to unstable, epidemic cycles at 35 degrees C. However, the prevalence of infection was largely unchanged by increasing temperatures. Temperature increases also affected the response of the model to changes in each parameter, indicating certain control strategies may become less effective with local temperature changes. At lower temperatures, the most effective single control strategy is to target the adult parasites through chemotherapy. However, as temperatures increase, targeting the snail intermediate hosts, for example through molluscicide use, becomes more effective. Conclusions. These results show that S. mansoni will not respond to increased temperatures in a linear fashion, and the optimal control strategy is likely to change as temperatures change. It is only through a mechanistic approach, incorporating the combined effects of temperature on all stages of the life-cycle, that we can begin to predict the consequences of climate change on the incidence and severity of such diseases.	[Paterson, Steve; Fenton, Andrew] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Mangal, TD (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	d.mangal@liverpool.ac.uk	Paterson, Steve/D-2154-2009; Fenton, Andy/B-5972-2009	Paterson, Steve/0000-0002-1307-2981; Fenton, Andy/0000-0002-7676-917X	University of Liverpool studentship	University of Liverpool studentship	TM was funded by a University of Liverpool studentship.	Allen EJ, 2003, ACTA TROP, V87, P251, DOI 10.1016/S0001-706X(03)00065-2; ANDERSON RM, 1979, PARASITOLOGY, V79, P63, DOI 10.1017/S0031182000051982; CHEEVER AW, 1968, AM J TROP MED HYG, V17, P38, DOI 10.4269/ajtmh.1968.17.38; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; COHEN JE, 1977, ANNU REV ECOL SYST, V8, P209, DOI 10.1146/annurev.es.08.110177.001233; Feng ZL, 2002, MATH BIOSCI, V177, P271, DOI 10.1016/S0025-5564(01)00115-8; Gryseels B, 1996, PARASITOL TODAY, V12, P115, DOI 10.1016/0169-4758(96)80671-5; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; MACDONAL.G, 1965, T ROY SOC TROP MED H, V59, P489, DOI 10.1016/0035-9203(65)90152-5; Malone JB, 2001, ACTA TROP, V79, P59, DOI 10.1016/S0001-706X(01)00103-6; Malone JB, 2001, ACTA TROP, V79, P7, DOI 10.1016/S0001-706X(01)00133-4; Malone JB, 1997, PARASITOL TODAY, V13, P112, DOI 10.1016/S0169-4758(97)01009-0; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; STURROCK RF, 1994, PARASITOLOGY, V109, P443, DOI 10.1017/S0031182000080690; WHO, 2003, CLIM CHANG HUM HLTH; Williams GM, 2002, ACTA TROP, V82, P253, DOI 10.1016/S0001-706X(02)00017-7; WOOLHOUSE MEJ, 1991, ACTA TROP, V49, P241, DOI 10.1016/0001-706X(91)90077-W; WOOLHOUSE MEJ, 1992, ACTA TROP, V50, P189, DOI 10.1016/0001-706X(92)90076-A; WOOLHOUSE MEJ, 1994, EPIDEMIOLOGY HUMAN S, P197; Yang HM, 1998, MEM I OSWALDO CRUZ, V93, P63	27	78	79	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1438	10.1371/journal.pone.0001438	http://dx.doi.org/10.1371/journal.pone.0001438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197249	Green Submitted, gold, Green Published			2022-12-27	WOS:000260503800010
J	Ji, F; Liu, ZJ; Cao, JP; Li, N; Liu, ZJ; Zuo, JX; Chen, Y; Wang, XZ; Sun, J				Ji, Fang; Liu, Zhanjie; Cao, Jianping; Li, Na; Liu, Zhijian; Zuo, Jinxin; Chen, Yan; Wang, Xinzhi; Sun, Jian			B Cell Response Is Required for Granuloma Formation in the Early Infection of Schistosoma japonicum	PLOS ONE			English	Article								Schistosoma egg-induced liver granuloma is a dynamic inflammatory reaction that results from complex immune responses to the infection. However, the role of B cells in inflammatory granuloma development is not yet fully understood. We report here that B cell function is required for S. japonicum egg-induced granuloma pathology in early infection. Both OBF-1 knockout mice and mu MT mice develop severely reduced hepatic granulomas at five weeks post-infection compared to their wild-type counterparts. In contrast, they display no significant difference in granuloma pathology at eight weeks postinfection. Moreover, we find that B cells and antibodies accumulate in the granulomas of wild-type mice early in the infection, indicating a contribution of the B cell response to the granulomatous inflammation. Furthermore, defects in B cell function markedly reduce liver egg burden. These results suggest an important role for B cells in early granuloma pathology. Surprisingly, we found that the S. japonicum infection destroys the structure of the lymphoid follicles. This disruptive effect is correlated with a severely impaired T cell-dependent antibody response upon challenge with ovalbumin. Thus, these findings reveal a novel aspect of the interaction between Schistosoma and the host immune system.	[Ji, Fang; Li, Na; Chen, Yan; Sun, Jian] Shanghai Jiao Tong Univ, Inst Med Sci, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Liu, Zhanjie; Liu, Zhijian; Zuo, Jinxin; Wang, Xinzhi; Sun, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci, Hlth Sci Inst, Shanghai, Peoples R China; [Cao, Jianping] Natl Inst Parasitic Dis, Chinese Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention	Sun, J (corresponding author), Shanghai Jiao Tong Univ, Inst Med Sci, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	jsun@sibs.ac.cn	Cao, Jianping/AFL-5468-2022	Cao, Jianping/0000-0002-1974-0047	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX1-YW-R-45]; Shanghai Science and Technology Committee [074319112]; Shanghai Leading Academic Discipline Project [T0206]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was partly supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-45), Shanghai Science and Technology Committee (074319112), and the Shanghai Leading Academic Discipline Project (T0206).	Bishop GA, 2003, CRIT REV IMMUNOL, V23, P149, DOI 10.1615/CritRevImmunol.v23.i3.10; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; EPSTEIN MM, 1995, J EXP MED, V182, P915, DOI 10.1084/jem.182.4.915; Fehr T, 2000, INT IMMUNOL, V12, P1275, DOI 10.1093/intimm/12.9.1275; Ferru I, 1998, SCAND J IMMUNOL, V48, P233; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; GARB KS, 1981, J IMMUNOL, V127, P115; Hernandez HJ, 1997, J IMMUNOL, V158, P4832; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Jankovic D, 1999, J IMMUNOL, V163, P337; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; Jenkins SJ, 2005, PARASITE IMMUNOL, V27, P385, DOI 10.1111/j.1365-3024.2005.00789.x; Ju ZL, 2007, IMMUNOLOGY, V120, P281, DOI 10.1111/j.1365-2567.2006.02500.x; Kamel OW, 1999, AM J PATHOL, V155, P681, DOI 10.1016/S0002-9440(10)65165-6; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; King CL, 2001, PARASITE IMMUNOL, V23, P607, DOI 10.1046/j.1365-3024.2001.00420.x; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Peng SL, 2006, CELL MOL IMMUNOL, V3, P87; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Stadecker MJ, 2004, IMMUNOL REV, V201, P168, DOI 10.1111/j.0105-2896.2004.00197.x; Stavitsky AB, 2004, INFECT IMMUN, V72, P1, DOI 10.1128/IAI.72.1.1-12.2004; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wolniak KL, 2004, CRIT REV IMMUNOL, V24, P39, DOI 10.1615/CritRevImmunol.v24.20; Zuo JX, 2007, J AUTOIMMUN, V29, P87, DOI 10.1016/j.jaut.2007.05.001	39	20	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1724	10.1371/journal.pone.0001724	http://dx.doi.org/10.1371/journal.pone.0001724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320044	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600020
J	de Candia, P; Blekhman, R; Chabot, AE; Oshlack, A; Gilad, Y				de Candia, Paola; Blekhman, Ran; Chabot, Adrien E.; Oshlack, Alicia; Gilad, Yoav			A Combination of Genomic Approaches Reveals the Role of FOXO1a in Regulating an Oxidative Stress Response Pathway	PLOS ONE			English	Article								Background: While many of the phenotypic differences between human and chimpanzee may result from changes in gene regulation, only a handful of functionally important regulatory differences are currently known. As a first step towards identifying transcriptional pathways that have been remodeled in the human lineage, we focused on a transcription factor, FOXO1a, which we had previously found to be up-regulated in the human liver compared to that of three other primate species. We concentrated on this gene because of its known role in the regulation of metabolism and in longevity. Methodology: Using a combination of expression profiling following siRNA knockdown and chromatin immunoprecipitation in a human liver cell line, we identified eight novel direct transcriptional targets of FOXO1a. This set includes the gene for thioredoxin-interacting protein (TXNIP), the expression of which is directly repressed by FOXO1a. The thioredoxin-interacting protein is known to inhibit the reducing activity of thioredoxin (TRX), thereby hindering the cellular response to oxidative stress and affecting life span. Conclusions: Our results provide an explanation for the repeated observations that differences in the regulation of FOXO transcription factors affect longevity. Moreover, we found that TXNIP is down-regulated in human compared to chimpanzee, consistent with the up-regulation of its direct repressor FOXO1a in humans, and with differences in longevity between the two species.	[de Candia, Paola; Blekhman, Ran; Chabot, Adrien E.; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Oshlack, Alicia] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia	University of Chicago; Walter & Eliza Hall Institute	de Candia, P (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	pdecandi@bsd.uchicago.edu; gilad@uchicago.edu	de Candia, Paola/HGC-8826-2022; Oshlack, Alicia/P-6139-2014; de Candia, Paola/Z-1498-2019	de Candia, Paola/0000-0003-4767-446X; Oshlack, Alicia/0000-0001-9788-5690; de Candia, Paola/0000-0003-4767-446X; Blekhman, Ran/0000-0003-3218-613X	NIH [GM077959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grant GM077959.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Cutler RG, 2005, ANN NY ACAD SCI, V1055, P93, DOI 10.1196/annals.1323.027; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Huby T, 2001, J BIOL CHEM, V276, P22209, DOI 10.1074/jbc.M102204200; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Jee C, 2005, GENES CELLS, V10, P1203, DOI 10.1111/j.1365-2443.2005.00913.x; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; OSHLACK A, 2007, BIOINFORMATICS; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shimokawa I, 2002, AM J PATHOL, V160, P2259, DOI 10.1016/S0002-9440(10)61173-X; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Vavouri T, 2005, CURR OPIN GENET DEV, V15, P395, DOI 10.1016/j.gde.2005.05.002; Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211; Yoshida T, 2006, BIOFACTORS, V27, P47, DOI 10.1002/biof.5520270105; YU M, 2007, MAMM GENOME	48	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1670	10.1371/journal.pone.0001670	http://dx.doi.org/10.1371/journal.pone.0001670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301748	Green Published, gold			2022-12-27	WOS:000260586500015
J	Limb, CJ; Braun, AR				Limb, Charles J.; Braun, Allen R.			Neural Substrates of Spontaneous Musical Performance: An fMRI Study of Jazz Improvisation	PLOS ONE			English	Article							ANTERIOR PREFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; COGNITIVE NEUROSCIENCE; BRAIN; ORGANIZATION; RESPONSES; CORRELATE; ANATOMY; IMAGERY	To investigate the neural substrates that underlie spontaneous musical performance, we examined improvisation in professional jazz pianists using functional MRI. By employing two paradigms that differed widely in musical complexity, we found that improvisation (compared to production of over-learned musical sequences) was consistently characterized by a dissociated pattern of activity in the prefrontal cortex: extensive deactivation of dorsolateral prefrontal and lateral orbital regions with focal activation of the medial prefrontal (frontal polar) cortex. Such a pattern may reflect a combination of psychological processes required for spontaneous improvisation, in which internally motivated, stimulus-independent behaviors unfold in the absence of central processes that typically mediate self-monitoring and conscious volitional control of ongoing performance. Changes in prefrontal activity during improvisation were accompanied by widespread activation of neocortical sensorimotor areas (that mediate the organization and execution of musical performance) as well as deactivation of limbic structures (that regulate motivation and emotional tone). This distributed neural pattern may provide a cognitive context that enables the emergence of spontaneous creative activity.	[Limb, Charles J.; Braun, Allen R.] Natl Inst Deafness & Other Commun Disorders, Language Sect, Voice Speech & Language Branch, NIH, Bethesda, MD USA; Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Peabody Conservatory Music, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Johns Hopkins University	Limb, CJ (corresponding author), Natl Inst Deafness & Other Commun Disorders, Language Sect, Voice Speech & Language Branch, NIH, Bethesda, MD USA.	climb@jhmi.edu			Division of Intramural Research; National Institute on Deafness and Other Communication Disorders; National Institutes of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000031, ZIADC000031] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded solely by the Division of Intramural Research, National Institute on Deafness and Other Communication Disorders, National Institutes of Health.	Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; BERLINER P, 1994, THINKING JAZZ INFINI, pR19; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BRANSFORD J, 1993, IDEAL PROBLEM SOLVER, pR13; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Braun AR, 2001, BRAIN, V124, P2028, DOI 10.1093/brain/124.10.2028; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Carlsson ML, 2000, ACTA PSYCHIAT SCAND, V102, P401, DOI 10.1034/j.1600-0447.2000.102006401.x; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dietrich A, 2004, PSYCHON B REV, V11, P1011, DOI 10.3758/BF03196731; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; HENTOFF N, 2004, AM MUSIC IS, pR19; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P793, DOI 10.1017/S0140525X00003976; Hobson JA, 2000, BEHAV BRAIN SCI, V23, P951, DOI 10.1017/S0140525X00494021; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, NEUROIMAGE, V25, P1068, DOI 10.1016/j.neuroimage.2004.12.050; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Nisenson E., 1995, ASCENSION J COLTRANE; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Parsons LM, 2001, ANN NY ACAD SCI, V930, P211, DOI 10.1111/j.1749-6632.2001.tb05735.x; Passingham D, 2004, CURR OPIN NEUROBIOL, V14, P163, DOI 10.1016/j.conb.2004.03.003; Perry DW, 1999, NEUROREPORT, V10, P3453, DOI 10.1097/00001756-199911080-00035; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Schooler J.W., 1997, CREATIVE COGNITION A, P97; Shirley DA, 1996, PSYCHOL REP, V79, P563, DOI 10.2466/pr0.1996.79.2.563; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	43	368	375	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1679	10.1371/journal.pone.0001679	http://dx.doi.org/10.1371/journal.pone.0001679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301756	Green Published, gold			2022-12-27	WOS:000260586500023
J	Minnhagen, P; Bernhardsson, S				Minnhagen, Petter; Bernhardsson, Sebastian			The Blind Watchmaker Network: Scale-Freeness and Evolution	PLOS ONE			English	Article							CONNECTIVITY	It is suggested that the degree distribution for networks of the cell-metabolism for simple organisms reflects a ubiquitous randomness. This implies that natural selection has exerted no or very little pressure on the network degree distribution during evolution. The corresponding random network, here termed the blind watchmaker network has a power-law degree distribution with an exponent gamma >= 2. It is random with respect to a complete set of network states characterized by a description of which links are attached to a node as well as a time-ordering of these links. No a priory assumption of any growth mechanism or evolution process is made. It is found that the degree distribution of the blind watchmaker network agrees very precisely with that of the metabolic networks. This implies that the evolutionary pathway of the cell-metabolism, when projected onto a metabolic network representation, has remained statistically random with respect to a complete set of network states. This suggests that even a biological system, which due to natural selection has developed an enormous specificity like the cellular metabolism, nevertheless can, at the same time, display well defined characteristics emanating from the ubiquitous inherent random element of Darwinian evolution. The fact that also completely random networks may have scale-free node distributions gives a new perspective on the origin of scale-free networks in general.	[Minnhagen, Petter; Bernhardsson, Sebastian] Umea Univ, Dept Theoret Phys, S-90187 Umea, Sweden; [Minnhagen, Petter; Bernhardsson, Sebastian] Ctr Models Life, Copenhagen, Denmark	Umea University	Minnhagen, P (corresponding author), Umea Univ, Dept Theoret Phys, S-90187 Umea, Sweden.	sebbeb@tp.umu.se			Swedish Research Council [50412501]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council through contract 50412501.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dawkins R., 1985, BLIND WATCHMAKER WHY; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Gleiss PM, 2001, ADV COMPLEX SYST, V04, P207, DOI [10.1142/S0219525901000140, DOI 10.1142/S0219525901000140]; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; MINNHAGEN P, 2007, EPL, V78; Minnhagen P, 2007, CHAOS, V17, DOI 10.1063/1.2720101; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Pfeiffer T, 2005, PLOS BIOL, V3, P1269, DOI 10.1371/journal.pbio.0030228; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; WAGNER A, 2003, SCI STKE, V41; Wagner A., 2005, ROBUSTNESS EVOLVABIL	21	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1690	10.1371/journal.pone.0001690	http://dx.doi.org/10.1371/journal.pone.0001690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301767	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500034
J	Mangel, M; Bonsall, MB				Mangel, Marc; Bonsall, Michael B.			Phenotypic Evolutionary Models in Stem Cell Biology: Replacement, Quiescence, and Variability	PLOS ONE			English	Article							STOCHASTIC SIMULATION; SELECTION; MATHEMATICS; RADIATION; DYNAMICS; ECOLOGY; HISTORY; FITNESS; SYSTEMS	Phenotypic evolutionary models have been used with great success in many areas of biology, but thus far have not been applied to the study of stem cells except for investigations of cancer. We develop a framework that allows such modeling techniques to be applied to stem cells more generally. The fundamental modeling structure is the stochastic kinetics of stem cells in their niche and of transit amplifying and fully differentiated cells elsewhere in the organism, with positive and negative feedback. This formulation allows graded signals to be turned into all or nothing responses, and shows the importance of looking beyond the niche for understanding how stem cells behave. Using the deterministic version of this framework, we show how competition between different stem cell lines can be analyzed, and under what circumstances stem cells in a niche will be replaced by other stem cells with different phenotypic characteristics. Using the stochastic version of our framework and state dependent life history theory, we show that the optimal behavior of a focal stem cell will involve long periods of quiescence and that a population of identical stem cells will show great variability in the times at which activity occurs; we compare our results with classic ones on quiescence and variability in the hematopoietic system.	[Mangel, Marc] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; [Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford, England	University of California System; University of California Santa Cruz; University of Oxford	Mangel, M (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA.	msmangel@ucsc.edu		Bonsall, Michael/0000-0003-0250-0423	NSF; Royal Society; Astor Travel Fund; University of Oxford	NSF(National Science Foundation (NSF)); Royal Society(Royal Society of London); Astor Travel Fund; University of Oxford	This work was supported by the NSF, Royal Society, and the Astor Travel Fund, University of Oxford.	Alon U, 2007, INTRO SYSTEMS BIOL D; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; ANVERSA P, 2006, ESSENTIALS STEM CELL, P425; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Barbour A., 1974, ADV APPL PROBAB, V6, P21, DOI [DOI 10.2307/1426205, 10.2307/1426205]; BARBOUR AD, 1980, ADV APPL PROBAB, V12, P591, DOI 10.2307/1426422; Bonsall MB, 2004, P ROY SOC B-BIOL SCI, V271, P1143, DOI 10.1098/rspb.2004.2722; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Clark CW, 2000, OX ECOL EV; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Dieckmann U, 1997, TRENDS ECOL EVOL, V12, P128, DOI 10.1016/S0169-5347(97)01004-5; DOBZHANSKY T, 1964, AM ZOOL, V4, P443; Fisher RA, 1930, GENETICAL THEORY NAT; Frank S. A., 2007, DYNAMICS CANC INCIDE; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; Grant P.R., 2007, WHY SPECIES MULTIPLY; Houston AI, 1999, MODELS ADAPTIVE BEHA; Kingsland S. E., 1985, MODELING NATURE EPIS; Kirouac DC, 2006, CURR OPIN BIOTECH, V17, P538, DOI 10.1016/j.copbio.2006.07.003; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; KURTZ TG, 1971, J APPL PROBAB, V8, P344, DOI 10.2307/3211904; KURTZ TG, 1970, J APPL PROBAB, V7, P49, DOI 10.2307/3212147; Lanza R., 2006, ESSENTIALS STEM CELL; LeGrand EK, 1997, Q REV BIOL, V72, P135, DOI 10.1086/419763; MacDonald N., 1989, BIOL DELAY SYSTEMS L; MADHAVI A, 2007, PLOS COMPUT BIOL, V3, P1; MANGEL M, 1994, THEOR POPUL BIOL, V45, P16, DOI 10.1006/tpbi.1994.1002; Mangel M, 2004, THEOR POPUL BIOL, V65, P353, DOI 10.1016/j.tpb.2003.07.005; Mangel M, 2006, THEORETICAL BIOLOGIST'S TOOLBOX: QUANTITATIVE METHODS FOR ECOLOGY AND EVOLUTIONARY BIOLOGY, P1, DOI 10.2277/ 0521537487; MANGEL M, 1992, ANNU REV ECOL SYST, V23, P507; Mangel M., 1988, DYNAMIC MODELING BEH; Mangel M, 2007, OIKOS, V116, P1779, DOI 10.1111/j.2007.0030-1299.16248.x; Mangel M, 2007, EVOLUTION, V61, P1208, DOI 10.1111/j.1558-5646.2007.00094.x; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; MAY RM, 2007, USES ABUSES MATH BIO; Mayr E., 1982, GROWTH BIOL THOUGHT; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; Murray JD, 2003, MATH BIOL, V3; Neff T, 2006, BLOOD, V107, P1751, DOI 10.1182/blood-2005-06-2335; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; PAINTER PR, 1968, ANNU REV MICROBIOL, V22, P519, DOI 10.1146/annurev.mi.22.100168.002511; PIELOU E C, 1969, P286; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTEN CS, 2006, ESSENTIALS STEM CELL, P11; Puterman ML., 2014, MARKOV DECISION PROC; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Robert JS, 2004, BIOESSAYS, V26, P1005, DOI 10.1002/bies.20100; Shostak S, 2006, BIOESSAYS, V28, P301, DOI 10.1002/bies.20376; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Venner S, 2006, J THEOR BIOL, V241, P725, DOI 10.1016/j.jtbi.2006.01.008; Vincent T. L., 2005, EVOLUTIONARY GAME TH; Viswanathan S, 2005, BIOTECHNOL APPL BIOC, V42, P119, DOI 10.1042/BA20040207; VOGEL H, 1969, J THEOR BIOL, V22, P249, DOI 10.1016/0022-5193(69)90004-6; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wodarz D, 2005, LECT NOTES MATH MODE; Zandstra PW, 2001, ANNU REV BIOMED ENG, V3, P275, DOI 10.1146/annurev.bioeng.3.1.275	63	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1591	10.1371/journal.pone.0001591	http://dx.doi.org/10.1371/journal.pone.0001591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270578	Green Published, gold			2022-12-27	WOS:000260535900025
J	Pezer, Z; Ugarkovic, D				Pezer, Zeljka; Ugarkovic, Durdica			RNA Pol II Promotes Transcription of Centromeric Satellite DNA in Beetles	PLOS ONE			English	Article								Transcripts of centromeric satellite DNAs are known to play a role in heterochromatin formation as well as in establishment of the kinetochore. However, little is known about basic mechanisms of satellite DNA expression within constitutive heterochromatin and its regulation. Here we present comprehensive analysis of transcription of abundant centromeric satellite DNA, PRAT from beetle Palorus ratzeburgii ( Coleoptera). This satellite is characterized by preservation and extreme sequence conservation among evolutionarily distant insect species. PRAT is expressed in all three developmental stages: larvae, pupae and adults at similar level. Transcripts are abundant comprising 0.033% of total RNA and are heterogeneous in size ranging from 0.5 kb up to more than 5 kb. Transcription proceeds from both strands but with 10 fold different expression intensity and transcripts are not processed into siRNAs. Most of the transcripts (80%) are not polyadenylated and remain in the nucleus while a small portion is exported to the cytoplasm. Multiple, irregularly distributed transcription initiation sites as well as termination sites have been mapped within the PRAT sequence using primer extension and RLM-RACE. The presence of cap structure as well as poly( A) tails in a portion of the transcripts indicate RNA polymerase II dependent transcription and a putative polymerase II promoter site overlaps the most conserved part of the PRAT sequence. The treatment of larvae with alpha-amanitin decreases the level of PRAT transcripts at concentrations that selectively inhibit pol II activity. In conclusion, stable, RNA polymerase II dependant transcripts of abundant centromeric satellite DNA, not regulated by RNAi, have been identified and characterized. This study offers a basic understanding of expression of highly abundant heterochromatic DNA which in beetle species constitutes up to 50% of the genome.	[Pezer, Zeljka; Ugarkovic, Durdica] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia	Rudjer Boskovic Institute	Pezer, Z (corresponding author), Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia.	ugarkov@.irb.hr			Croatian Ministry of Science [00982604]; EU FP6 Marie Curie Transfer of Knowledge [MTKD-CT-2006-042248]	Croatian Ministry of Science(Ministry of Science, Education and Sports, Republic of Croatia); EU FP6 Marie Curie Transfer of Knowledge(European Commission)	Grants 00982604 from the Croatian Ministry of Science and EU FP6 Marie Curie Transfer of Knowledge Grant MTKD-CT-2006-042248	Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; BONACCORSI S, 1990, CHROMOSOMA, V99, P260, DOI 10.1007/BF01731701; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Chiodi I, 2004, NUCLEIC ACIDS RES, V32, P4127, DOI 10.1093/nar/gkh759; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COATS SR, 1994, NUCLEIC ACIDS RES, V22, P4697, DOI 10.1093/nar/22.22.4697; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Lee HR, 2006, MOL BIOL EVOL, V23, P2505, DOI 10.1093/molbev/msl127; Lorite P, 2002, GENOME, V45, P609, DOI 10.1139/G02-022; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; May BP, 2005, PLOS GENET, V1, P705, DOI 10.1371/journal.pgen.0010079; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; Mravinac B, 2005, J MOL EVOL, V61, P542, DOI 10.1007/s00239-004-0342-y; Mravinac B, 2002, J MOL EVOL, V54, P774, DOI 10.1007/s0023901-0079-9; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Renault S, 1999, INSECT BIOCHEM MOLEC, V29, P103, DOI 10.1016/S0965-1748(98)00113-1; RouleuxBonnin F, 1996, EUR J BIOCHEM, V238, P752, DOI 10.1111/j.1432-1033.1996.0752w.x; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; SKINNER DM, 1977, BIOSCIENCE, V27, P790, DOI 10.2307/1297755; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; TRAPITZ P, 1988, CHROMOSOMA, V96, P159, DOI 10.1007/BF00331048; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; UGARKOVIC DL, 1992, BIOCHIMIE, V74, P1075, DOI 10.1016/0300-9084(92)90005-Y; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang FW, 2006, MOL CELL BIOL, V26, P4028, DOI 10.1128/MCB.02189-05; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Yasuhara JC, 2005, P NATL ACAD SCI USA, V102, P10958, DOI 10.1073/pnas.0503424102	35	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1594	10.1371/journal.pone.0001594	http://dx.doi.org/10.1371/journal.pone.0001594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270581	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900028
J	Yang, DC; Tsay, HJ; Lin, SY; Chiou, SH; Li, MJ; Chang, TJ; Hung, SC				Yang, Der-Chih; Tsay, Huey-Jen; Lin, Shan-Yang; Chiou, Shih-Hwa; Li, Mei-Jane; Chang, Tai-Jay; Hung, Shih-Chieh			cAMP/PKA Regulates Osteogenesis, Adipogenesis and Ratio of RANKL/OPG mRNA Expression in Mesenchymal Stem Cells by Suppressing Leptin	PLOS ONE			English	Article								Background: Mesenchymal stem cells (MSCs) are a pluripotent cell type that can differentiate into adipocytes, osteoblasts and other cells. The reciprocal relationship between adipogenesis and osteogenesis was previously demonstrated; however, the mechanisms remain largely unknown. Methods and Findings: We report that activation of PKA by 3-isobutyl-1 methyl xanthine ( IBMX) and forskolin enhances adipogenesis, the gene expression of PPAR gamma 2 and LPL, and downregulates the gene expression of Runx2 and osteopontin, markers of osteogenesis. PKA activation also decreases the ratio of Receptor Activator of the NF-kappa B Ligand to Osteoprotegerin (RANKL/OPG) gene expression-the key factors of osteoclastogenesis. All these effects are mediated by the cAMP/PKA/CREB pathway by suppressing leptin, and may contribute to PKA stimulators-induced in vivo bone loss in developing zebrafish. Conclusions: Using MSCs, the center of a newly proposed bone metabolic unit, we identified cAMP/PKA signaling, one of the many signaling pathways that regulate bone homeostasis via controlling cyto-differentiation of MSCs and altering RANKL/OPG gene expression.	[Yang, Der-Chih; Chiou, Shih-Hwa; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Tsay, Huey-Jen] Natl Yang Ming Univ, Inst Neurosci, Taipei, Taiwan; [Yang, Der-Chih; Lin, Shan-Yang; Chiou, Shih-Hwa; Li, Mei-Jane; Hung, Shih-Chieh] Natl Yang Ming Univ, Veterans Gen Hosp Taipei, Dept Med Res & Educ, Taipei, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Veterans Gen Hosp Taipei, Dept Orthopaed & Traumatol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, DC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	hungsc@vghtpe.gov.tw			National Scientific Council [NSC-95-2314-B-075-047-MY3, NSC-95-2627-B-010-009-, NSC-96-2627-B-010-009-]; National Yang-Ming University; Ministry of Education; Aim for the Top University Plan; Veterans General Hospital-Taipei [V95E1-002, V95E1-003]	National Scientific Council; National Yang-Ming University; Ministry of Education; Aim for the Top University Plan(Ministry of Education, Taiwan); Veterans General Hospital-Taipei(Taipei Veterans General Hospital)	National Scientific Council (NSC-95-2314-B-075-047-MY3, NSC-95-2627-B-010-009-, NSC-96-2627-B-010-009-) and grants from National Yang-Ming University, Ministry of Education, Aim for the Top University Plan, and Veterans General Hospital-Taipei (V95E1-002 & V95E1-003).	Barr VA, 1997, ENDOCRINOLOGY, V138, P4463, DOI 10.1210/en.138.10.4463; BERESFORD JN, 1992, J CELL SCI, V102, P341; Burguera B, 2001, ENDOCRINOLOGY, V142, P3546, DOI 10.1210/en.142.8.3546; Chang YJ, 2006, STEM CELLS, V24, P679, DOI 10.1634/stemcells.2004-0308; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Deng H, 1999, BIOPOLYMERS, V50, P656, DOI 10.1002/(SICI)1097-0282(199911)50:6<656::AID-BIP10>3.0.CO;2-9; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Felix R, 1996, EUR J ENDOCRINOL, V134, P143, DOI 10.1530/eje.0.1340143; FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3; Glasow A, 2001, J CLIN ENDOCR METAB, V86, P4472, DOI 10.1210/jc.86.9.4472; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Johnson RM, 2000, J EXP ZOOL, V286, P718, DOI 10.1002/(SICI)1097-010X(20000601)286:7&lt;718::AID-JEZ6&gt;3.0.CO;2-I; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kvissel AK, 2004, CELL SIGNAL, V16, P577, DOI 10.1016/j.cellsig.2003.08.014; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Laharrague P, 1998, FASEB J, V12, P747, DOI 10.1096/fasebj.12.9.747; Lin SY, 2004, J BIOMED MATER RES B, V70B, P203, DOI 10.1002/jbm.b.30067; Martin A, 2005, ENDOCRINOLOGY, V146, P3652, DOI 10.1210/en.2004-1509; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H; NEELON FA, 1973, LANCET, V1, P631; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Szkudelski T, 2005, PHYSIOL RES, V54, P79, DOI 10.33549/physiolres.930570; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Watanabe M, 2003, BIOCHEM BIOPH RES CO, V300, P429, DOI 10.1016/S0006-291X(02)02860-7; Weisenhorn DMV, 2001, EXP NEUROL, V169, P44, DOI 10.1006/exnr.2001.7651; Yamauchi M, 2001, CLIN ENDOCRINOL, V55, P341, DOI 10.1046/j.1365-2265.2001.01361.x; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104; Zoico E, 2003, CLIN ENDOCRINOL, V59, P97, DOI 10.1046/j.1365-2265.2003.01808.x	47	111	115	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1540	10.1371/journal.pone.0001540	http://dx.doi.org/10.1371/journal.pone.0001540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253488	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535700012
J	Amisten, S; Braun, OO; Johansson, L; Ridderstrale, M; Melander, O; Erlinge, D				Amisten, Stefan; Braun, Oscar Oe.; Johansson, Lovisa; Ridderstrale, Martin; Melander, Olle; Erlinge, David			The P2Y(13) Met-158-Thr Polymorphism, Which Is in Linkage Disequilibrium with the P2Y(12) Locus, Is Not Associated with Acute Myocardial Infarction	PLOS ONE			English	Article								Background and Aims. The aims of this study were to investigate (1) if P2Y(12) polymorphisms defining the P2Y(12) H2 allele are associated with any other SNPs that may explain the previously reported association with increased ADP induced platelet activation and association with peripheral arterial disease and coronary artery disease and (2) if such variants are associated with acute myocardial infarction (AMI) or classical risk factors for AMI. Methods and Results. The P2Y(13) Met-158-Thr polymorphism was found to be in linkage disequilibrium (LD) with the P2Y(12) H2 haplotype (all examined SNPs: D' = 1.0, r(2) = 0.936-1.0), defining a novel P2Y(12) H2/P2Y(13) Thr-158 haplotype. Genotyping of an AMI case control population (n = 1244 cases, 2488 controls) revealed no association of the P2Y(13) Thr-158 allele with AMI (OR = 0.96, 95% C.I. 0.82-1.12, P = 0.63). Also, no differences between the genotype frequencies of P2Y(13) Met-158-Met and Met-158-Thr/Thr-158-Thr were seen in AMI case-control subpopulations (early onset AMI OR = 1.06, 95% C.I. 0.85-1.31, P = 0.62); family history of AMI (OR = 0.98, 95% C.I. 0.78-1.22, P = 0.83) nor in early onset AMIs with family history of AMI (OR = 1.0, 95% C.I. 0.74-1.36, P = 1.0). Genotyping of the P2Y(13) Met-158-Thr polymorphism in a population based sample (n = 6055) revealed no association with cardiovascular risk factors. In addition, the P2Y(13) Met-158-Thr polymorphism was genotyped in a diabetes case-control population, and associations were found neither with DM nor with any examined DM risk factors. Conclusion Genotyping. The P2Y(13) Met-158-Thr polymorphism is in tight LD with the P2Y(12) locus but is not associated with AMI or classical cardiovascular risk factors.	[Amisten, Stefan; Braun, Oscar Oe.; Erlinge, David] Univ Lund Hosp, Dept Cardiol, S-22185 Lund, Sweden; [Johansson, Lovisa; Ridderstrale, Martin; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University; Skane University Hospital; Lund University	Erlinge, D (corresponding author), Univ Lund Hosp, Dept Cardiol, S-22185 Lund, Sweden.	david.erlinge@med.lu.se	Ridderstråle, Martin/F-7678-2012; Reinius, Lovisa/C-4555-2014	Reinius, Lovisa/0000-0001-5029-0120; O. Braun, Oscar/0000-0003-3263-2718; Melander, Olle/0000-0002-2581-484X	Swedish Scientific Research Council; Swedish Heart and Lung Foundation Lund University Hospital; Vascular Wall program (Lund Medical faculty)	Swedish Scientific Research Council(Swedish Research Council); Swedish Heart and Lung Foundation Lund University Hospital; Vascular Wall program (Lund Medical faculty)	The study has been supported by the Swedish Scientific Research Council, the Swedish Heart and Lung Foundation Lund University Hospital funds and the Vascular Wall program (Lund Medical faculty).	AMISTEN S, 2006, EUR HEART J; Angiolillo DJ, 2005, THROMB RES, V116, P491, DOI 10.1016/j.thromres.2005.03.001; Ayyanathan K, 1996, BIOCHEM BIOPH RES CO, V218, P783, DOI 10.1006/bbrc.1996.0139; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Cattaneo M, 2003, P NATL ACAD SCI USA, V100, P1978, DOI 10.1073/pnas.0437879100; Cavallari U, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-59; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; CUISSET T, 2007, THROMB RES; Fontana P, 2003, CIRCULATION, V108, P2971, DOI 10.1161/01.CIR.0000106904.80795.35; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Hetherington SL, 2005, ARTERIOSCL THROM VAS, V25, P252, DOI 10.1161/01.ATV.0000148708.44691.27; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; McCullough PA, 2007, CLIN J AM SOC NEPHRO, V2, P611, DOI 10.2215/CJN.03871106; Murugappan S, 2006, FRONT BIOSCI-LANDMRK, V11, P1977, DOI 10.2741/1939; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Remijn JA, 2007, CLIN CHEM LAB MED, V45, P187, DOI 10.1515/CCLM.2007.036; Schettert IT, 2006, THROMB RES, V118, P679, DOI 10.1016/j.thromres.2005.11.009; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; von Beckerath N, 2005, BLOOD COAGUL FIBRIN, V16, P199, DOI 10.1097/01.mbc.0000164429.21040.0a; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Wiviott SD, 2007, N ENGL J MED; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200; Ziegler S, 2005, STROKE, V36, P1394, DOI 10.1161/01.STR.0000169922.79281.a5	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1462	10.1371/journal.pone.0001462	http://dx.doi.org/10.1371/journal.pone.0001462			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213371	gold, Green Submitted, Green Published			2022-12-27	WOS:000260503900008
J	Boucrot, E; Kirchhausen, T				Boucrot, Emmanuel; Kirchhausen, Tomas			Mammalian Cells Change Volume during Mitosis	PLOS ONE			English	Article								Using single cell-imaging methods we have found that the volume of adherent cells grown in culture decreases as the cells rounds when it enters mitosis. A minimal volume is reached at metaphase. Rapid volume recovery initiates before abscission as cells make the transition from metaphase to cytokinesis. These volume changes are simultaneous with the rapid surface area decrease and recovery observed in mitotic cells [1].	[Boucrot, Emmanuel; Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	kirchhausen@crystal.harvard.edu			NIH [GM075252, GM62566]; International Human Frontier Science Program Organization (HFSPO) [fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252, P01GM062566] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH GM075252 and GM62566 (TK). EB was supported by a fellowship from the International Human Frontier Science Program Organization (HFSPO).	Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Chen LX, 2007, CELL PROLIFERAT, V40, P253, DOI 10.1111/j.1365-2184.2007.00432.x; Coupin GT, 1999, J CELL SCI, V112, P2431; Habela CW, 2007, CELL CYCLE, V6, P1613, DOI 10.4161/cc.6.13.4357; Rouzaire-Dubois B, 1998, J PHYSIOL-LONDON, V510, P93, DOI 10.1111/j.1469-7793.1998.093bz.x; SCHNEIDER EL, 1976, EXP CELL RES, V98, P298, DOI 10.1016/0014-4827(76)90441-9; Wondergem N, 2001, J PHYSIOL-LONDON, V532, P661, DOI 10.1111/j.1469-7793.2001.0661e.x; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200	8	67	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1477	10.1371/journal.pone.0001477	http://dx.doi.org/10.1371/journal.pone.0001477			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213385	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503900022
J	Biddick, RK; Law, GL; Young, ET				Biddick, Rhiannon K.; Law, G. Lynn; Young, Elton T.			Adr1 and Cat8 Mediate Coactivator Recruitment and Chromatin Remodeling at Glucose-Regulated Genes	PLOS ONE			English	Article								Background. Adr1 and Cat8 co-regulate numerous glucose-repressed genes in S. cerevisiae, presenting a unique opportunity to explore their individual roles in coactivator recruitment, chromatin remodeling, and transcription. Methodology/Principal Findings. We determined the individual contributions of Cat8 and Adr1 on the expression of a cohort of glucose-repressed genes and found three broad categories: genes that need both activators for full derepression, genes that rely mostly on Cat8 and genes that require only Adr1. Through combined expression and recruitment data, along with analysis of chromatin remodeling at two of these genes, ADH2 and FBP1, we clarified how these activators achieve this wide range of co-regulation. We find that Adr1 and Cat8 are not intrinsically different in their abilities to recruit coactivators but rather, promoter context appears to dictate which activator is responsible for recruitment to specific genes. These promoter-specific contributions are also apparent in the chromatin remodeling that accompanies derepression: ADH2 requires both Adr1 and Cat8, whereas, at FBP1, significant remodeling occurs with Cat8 alone. Although over-expression of Adr1 can compensate for loss of Cat8 at many genes in terms of both activation and chromatin remodeling, this over-expression cannot complement all of the cat8D phenotypes. Conclusions/Significance. Thus, at many of the glucose-repressed genes, Cat8 and Adr1 appear to have interchangeable roles and promoter architecture may dictate the roles of these activators.	[Biddick, Rhiannon K.; Law, G. Lynn] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	ety@u.washington.edu			NIGMS [PHS MRSA T32 GM07270]; National Institutes of Health [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079, T32GM007270] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R. Biddick was supported in part by PHS MRSA T32 GM07270 from NIGMS. The research was supported by a grant from the National Institutes of Health GM26079 to ETY.	Agricola E, 2004, BIOCHEMISTRY-US, V43, P8878, DOI 10.1021/bi049577+; Agricola E, 2006, MOL MICROBIOL, V62, P1433, DOI 10.1111/j.1365-2958.2006.05451.x; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; COLLART MAO, 2005, CURRENT PROTOCOLS MO; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Di Mauro E, 2002, J BIOL CHEM, V277, P7002, DOI 10.1074/jbc.M106719200; Di Mauro E, 2000, J BIOL CHEM, V275, P7612, DOI 10.1074/jbc.275.11.7612; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DONOVIEL MS, 1995, MOL CELL BIOL, V15, P3442; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Komarnitsky PB, 1998, MOL CELL BIOL, V18, P5861, DOI 10.1128/MCB.18.10.5861; Kratzer S, 1997, MOL MICROBIOL, V26, P631, DOI 10.1046/j.1365-2958.1997.5611937.x; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Roth S, 2004, CURR GENET, V45, P121, DOI 10.1007/s00294-003-0476-2; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; TAGUCHI AKW, 1987, GENETICS, V116, P531; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	39	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1436	10.1371/journal.pone.0001436	http://dx.doi.org/10.1371/journal.pone.0001436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197247	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503800008
J	Hampl, V; Silberman, JD; Stechmann, A; Diaz-Trivino, S; Johnson, PJ; Roger, AJ				Hampl, Vladimir; Silberman, Jeffrey D.; Stechmann, Alexandra; Diaz-Trivino, Sara; Johnson, Patricia J.; Roger, Andrew J.			Genetic Evidence for a Mitochondriate Ancestry in the 'Amitochondriate' Flagellate Trimastix pyriformis	PLOS ONE			English	Article							PARASITE ENTAMOEBA-HISTOLYTICA; TRICHOMONAS-VAGINALIS; PROCESSING PEPTIDASE; HYDROGENOSOMES CONTAIN; CRYPTOSPORIDIUM-PARVUM; PRIMITIVE EUKARYOTES; PROTEIN IMPORT; CARRIER FAMILY; FE-HYDROGENASE; SECONDARY LOSS	Most modern eukaryotes diverged from a common ancestor that contained the alpha-proteobacterial endosymbiont that gave rise to mitochondria. The 'amitochondriate' anaerobic protist parasites that have been studied to date, such as Giardia and Trichomonas harbor mitochondrion-related organelles, such as mitosomes or hydrogenosomes. Yet there is one remaining group of mitochondrion-lacking flagellates known as the Preaxostyla that could represent a primitive 'pre-mitochondrial' lineage of eukaryotes. To test this hypothesis, we conducted an expressed sequence tag (EST) survey on the preaxostylid flagellate Trimastix pyriformis, a poorly-studied free-living anaerobe. Among the ESTs we detected 19 proteins that, in other eukaryotes, typically function in mitochondria, hydrogenosomes or mitosomes, 12 of which are found exclusively within these organelles. Interestingly, one of the proteins, aconitase, functions in the tricarboxylic acid cycle typical of aerobic mitochondria, whereas others, such as pyruvate: ferredoxin oxidoreductase and [FeFe] hydrogenase, are characteristic of anaerobic hydrogenosomes. Since Trimastix retains genetic evidence of a mitochondriate ancestry, we can now say definitively that all known living eukaryote lineages descend from a common ancestor that had mitochondria.	[Hampl, Vladimir; Silberman, Jeffrey D.; Stechmann, Alexandra; Diaz-Trivino, Sara; Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Silberman, Jeffrey D.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR USA; [Johnson, Patricia J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	Dalhousie University; University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California Los Angeles	Roger, AJ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	Andrew.Roger@Dal.Ca	Silberman, Jeffrey D/AAK-8220-2020; Hampl, Vladimir/A-4339-2008	Silberman, Jeffrey D/0000-0002-2965-9197; Hampl, Vladimir/0000-0002-5430-7564	Canadian Institutes for Health Research (CIHR) [MOP-62809, postdoctoral fellowship]; Canadian Institute for Advanced Research (CIFAR) [fellowship, Steacie Memorial Fellowship]; Natural Sciences and Engineering Research Council of Canada [Steacie Memorial Fellowship]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Trimastix pyriformis EST data were generated as part of AJRs involvement in the Genome Atlantic/Genome Canada sponsored Protist EST Program Project. This work and partial salary support for VH, JDS and SDT came from an operating grant MOP-62809 from the Canadian Institutes for Health Research (CIHR) awarded to AJR. VH was also supported by a fellowship from the Canadian Institute for Advanced Research (CIFAR). AS was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). AJR is supported by the E.W.R. Steacie Memorial Fellowship from the Natural Sciences and Engineering Research Council of Canada and the CIFAR Program in Integrated Microbial Diversity.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BLOODGOO.RA, 1974, J MORPHOL, V143, P77, DOI 10.1002/jmor.1051430104; Bozner P, 1997, J PARASITOL, V83, P224, DOI 10.2307/3284444; Braun HP, 1997, INT J BIOCHEM CELL B, V29, P1043, DOI 10.1016/S1357-2725(97)00032-0; Brown MT, 2007, MOL MICROBIOL, V64, P1154, DOI 10.1111/j.1365-2958.2007.05719.x; Brugerolle G, 1997, EUR J PROTISTOL, V33, P121, DOI 10.1016/S0932-4739(97)80029-6; Bui ETN, 1996, P NATL ACAD SCI USA, V93, P9651, DOI 10.1073/pnas.93.18.9651; CAROTHERS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P409, DOI 10.1016/0003-9861(89)90309-3; CARPENTER KJ, 2007, PROTIST IN PRESS, DOI DOI 10.1016/J.PROTIS.2007.09.002; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; CAVALIERSMITH T, 1983, ENDOCYTOBIOLOGY, V2, P265; Chan KW, 2005, CURR BIOL, V15, P737, DOI 10.1016/j.cub.2005.02.068; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Dacks JB, 2001, MOL BIOL EVOL, V18, P1034, DOI 10.1093/oxfordjournals.molbev.a003875; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Germot A, 1996, P NATL ACAD SCI USA, V93, P14614, DOI 10.1073/pnas.93.25.14614; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampl V, 2005, MOL BIOL EVOL, V22, P2508, DOI 10.1093/molbev/msi245; Hirt RP, 1997, CURR BIOL, V7, P995, DOI 10.1016/S0960-9822(06)00420-9; Horner DS, 1996, P ROY SOC B-BIOL SCI, V263, P1053, DOI 10.1098/rspb.1996.0155; Horner DS, 2001, MOL BIOL EVOL, V18, P1970, DOI 10.1093/oxfordjournals.molbev.a003737; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Karlin S, 1999, P NATL ACAD SCI USA, V96, P9190, DOI 10.1073/pnas.96.16.9190; KRUGER N, 1994, J BACTERIOL, V176, P3614; Kulda J., 1978, P1; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; LaGier MJ, 2003, MICROBIOL-SGM, V149, P3519, DOI 10.1099/mic.0.26365-0; Leander BS, 2004, J EUKARYOT MICROBIOL, V51, P291, DOI 10.1111/j.1550-7408.2004.tb00569.x; Luciano P, 1997, J MOL BIOL, V272, P213, DOI 10.1006/jmbi.1997.1231; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Margulis L, 2000, P NATL ACAD SCI USA, V97, P6954, DOI 10.1073/pnas.97.13.6954; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Mukherjee M, 2006, EUKARYOT CELL, V5, P2062, DOI 10.1128/EC.00205-06; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Nagao Y, 2000, J BIOL CHEM, V275, P34552, DOI 10.1074/jbc.M003110200; O'Kelly CJ, 1999, PROTIST, V150, P149, DOI 10.1016/S1434-4610(99)70018-0; OLAUSSON T, 1995, BBA-BIOENERGETICS, V1231, P1, DOI 10.1016/0005-2728(95)00058-Q; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; REEVES RE, 1977, J BIOL CHEM, V252, P726; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Riordan CE, 2003, CURR GENET, V44, P138, DOI 10.1007/s00294-003-0432-1; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Roger AJ, 1996, P NATL ACAD SCI USA, V93, P14618, DOI 10.1073/pnas.93.25.14618; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satre M, 2007, BIOCHIMIE, V89, P1058, DOI 10.1016/j.biochi.2007.03.004; Simpson AGB, 2002, J EUKARYOT MICROBIOL, V49, P239, DOI 10.1111/j.1550-7408.2002.tb00529.x; Simpson AGB, 2000, EUR J PROTISTOL, V36, P229, DOI 10.1016/S0932-4739(00)80001-2; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Townson SM, 1996, MOL BIOCHEM PARASIT, V79, P183, DOI 10.1016/0166-6851(96)02661-8; van der Giezen M, 2003, MOL BIOL EVOL, V20, P1051, DOI 10.1093/molbev/msg103; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949	72	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1383	10.1371/journal.pone.0001383	http://dx.doi.org/10.1371/journal.pone.0001383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167542	gold, Green Published, Green Submitted			2022-12-27	WOS:000260468900011
J	Gill, MB; Edgar, R; May, JS; Stevenson, PG				Gill, Michael B.; Edgar, Rachel; May, Janet S.; Stevenson, Philip G.			A Gamma-Herpesvirus Glycoprotein Complex Manipulates Actin to Promote Viral Spread	PLOS ONE			English	Article								Viruses lack self-propulsion. To move in multi-cellular hosts they must therefore manipulate infected cells. Herpesviruses provide an archetype for many aspects of host manipulation, but only for alpha-herpesviruses in is there much information about they move. Other herpesviruses are not necessarily the same. Here we show that Murine gamma-herpesvirus-68 (MHV-68) induces the outgrowth of long, branched plasma membrane fronds to create an intercellular network for virion traffic. The fronds were actin-based and RhoA-dependent. Time-lapse imaging showed that the infected cell surface became highly motile and that virions moved on the fronds. This plasma membrane remodelling was driven by the cytoplasmic tail of gp48, a MHV-68 glycoprotein previously implicated in intercellular viral spread. The MHV-68 ORF58 was also required, but its role was simply transporting gp48 to the plasma membrane, since a gp48 mutant exported without ORF58 did not require ORF58 to form membrane fronds either. Together, gp48/ORF58 were sufficient to induce fronds in transfected cells, as were the homologous BDLF2/BMRF2 of Epstein-Barr virus. Gp48/ORF58 therefore represents a conserved module by which gamma-herpesviruses rearrange cellular actin to increase intercellular contacts and thereby promote their spread.	[Gill, Michael B.; Edgar, Rachel; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Gill, MB (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Edgar, Rachel/0000-0002-3348-0851	Medical Research Council [G0400427, G9800903]; CR-UK [C19612/A6189]; Wellcome Trust Senior Clinical Fellow [GR076956MA]; MRC [G0400427, G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); Wellcome Trust Senior Clinical Fellow(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council grants G0400427 and G9800903, and by CR-UK grant C19612/A6189. PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Smith CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001048; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; THORLEY L, 2001, NAT REV IMMUNOL, V1, P75; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997	32	34	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1808	10.1371/journal.pone.0001808	http://dx.doi.org/10.1371/journal.pone.0001808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350146	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762300012
J	Powell, H; Smart, J; Wood, LG; Grissell, T; Shafren, DR; Hensley, MJ; Gibson, PG				Powell, Heather; Smart, Joanne; Wood, Lisa G.; Grissell, Terry; Shafren, Darren R.; Hensley, Michael J.; Gibson, Peter G.			Validity of the Common Cold Questionnaire (CCQ) in Asthma Exacerbations	PLOS ONE			English	Article							ACUTE RESPIRATORY ILLNESS; PCR ASSAY; RHINOVIRUS; INFECTIONS; DIAGNOSIS; SEVERITY; SPUTUM	Background: The common cold questionnaire (CCQ) is used to discriminate those with and without a viral infection. Its usefulness in people with acute asthma is unknown. Our aim was to assess the ability of the CCQ to detect viral infection and to monitor recovery during a viral induced asthma exacerbation and confirmed by virological testing. Methodology/Principal Findings: We studied subjects (>= 7 yrs) admitted to hospital with acute asthma and diagnosed as positive (n = 63), or negative to viral infection (n = 27) according to molecular and virological testing from respiratory samples. CCQ, asthma history and asthma control questionnaires were completed and repeated 4-6 weeks later. Sensitivity, specificity, and response to change of the CCQ were assessed by receiver operator curve (ROC) analysis and effect size calculation respectively. The CCQ did not discriminate between viral and non-viral infection for subjects with asthma (sensitivity = 76.2%; specificity = 29.6%). ROC analysis could not differentiate between positive or negative virus in subjects with asthma. The CCQ had a large response to change following recovery (effect size = 1.01). 39% of subjects recovering from viral exacerbation remained positive to virological testing at follow-up despite improvement in clinical symptoms. The CCQ reflected clinical improvement in these subjects, thus providing additional information to complement virological testing. Conclusions/Significance: The CCQ is a useful instrument for monitoring response to viral infection in people with asthma. Reliable differentiation between viral and non-viral asthma exacerbations was not achieved with the CCQ and requires specific virological testing. When combined with virological testing, the CCQ should be a useful outcome measure for evaluating therapies in viral-induced asthma.	[Powell, Heather; Smart, Joanne; Wood, Lisa G.; Grissell, Terry; Hensley, Michael J.; Gibson, Peter G.] John Hunter Hosp, Dept Resp & Sleep Med, Hunter Med Res Inst, New Lambton, NSW, Australia; [Wood, Lisa G.; Grissell, Terry; Shafren, Darren R.; Hensley, Michael J.; Gibson, Peter G.] Univ Newcastle, Sch Med Practice & Populat Hlth, Callaghan, NSW, Australia; [Shafren, Darren R.] Royal Newcastle Hosp, Picornaviral Res Unit, Newcastle, NSW, Australia	Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Newcastle	Powell, H (corresponding author), John Hunter Hosp, Dept Resp & Sleep Med, Hunter Med Res Inst, New Lambton, NSW, Australia.	Peter.Gibson@hnehealth.nsw.gov.au	Wood, Lisa G/G-7068-2013; gibson, peter/G-6194-2014	Wood, Lisa/0000-0002-0941-9225; gibson, peter/0000-0001-5865-489X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett B, 2005, J CLIN EPIDEMIOL, V58, P609, DOI 10.1016/j.jclinepi.2004.11.019; Barrett Bruce, 2002, J Fam Pract, V51, P265; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Deffernez C, 2004, J CLIN MICROBIOL, V42, P3212, DOI 10.1128/JCM.42.7.3212-3218.2004; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Jacobs B, 2000, J CLIN EPIDEMIOL, V53, P793, DOI 10.1016/S0895-4356(99)00238-3; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kawakita K, 2004, COMPLEMENT THER MED, V12, P181, DOI 10.1016/j.ctim.2004.10.004; KIRSHNER B, 1985, J CHRON DIS, V38, P27, DOI 10.1016/0021-9681(85)90005-0; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Murray Clare S, 2004, Proc Am Thorac Soc, V1, P99, DOI 10.1513/pats.2306027; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Shepperd S, 2004, J CLIN EPIDEMIOL, V57, P809, DOI 10.1016/j.jclinepi.2003.12.016; Simpson JL, 2003, J CLIN VIROL, V26, P339, DOI 10.1016/S1386-6532(02)00084-7; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2001, CLIN EXP ALLERGY, V31, P1745, DOI 10.1046/j.1365-2222.2001.01230.x; WISELKA MJ, 1991, THORAX, V46, P706, DOI 10.1136/thx.46.10.706	25	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1802	10.1371/journal.pone.0001802	http://dx.doi.org/10.1371/journal.pone.0001802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350141	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762300007
J	degli Atti, MLC; Merler, S; Rizzo, C; Ajelli, M; Massari, M; Manfredi, P; Furlanello, C; Tomba, GS; Iannelli, M				degli Atti, Marta Luisa Ciofi; Merler, Stefano; Rizzo, Caterina; Ajelli, Marco; Massari, Marco; Manfredi, Piero; Furlanello, Cesare; Tomba, Gianpaolo Scalia; Iannelli, Mimmo			Mitigation Measures for Pandemic Influenza in Italy: An Individual Based Model Considering Different Scenarios	PLOS ONE			English	Article							SPREAD; STRATEGIES; TRAVEL	Background: Individual-based models can provide the most reliable estimates of the spread of infectious diseases. In the present study, we evaluated the diffusion of pandemic influenza in Italy and the impact of various control measures, coupling a global SEIR model for importation of cases with an individual based model (IBM) describing the Italian epidemic. Methodology/Principal Findings: We co-located the Italian population (57 million inhabitants) to households, schools and workplaces and we assigned travel destinations to match the 2001 census data. We considered different R-0 values (1.4; 1.7; 2), evaluating the impact of control measures (vaccination, antiviral prophylaxis -AVP-, international air travel restrictions and increased social distancing). The administration of two vaccine doses was considered, assuming that first dose would be administered 1-6 months after the first world case, and different values for vaccine effectiveness (VE). With no interventions, importation would occur 37-77 days after the first world case. Air travel restrictions would delay the importation of the pandemic by 7-37 days. With an R-0 of 1.4 or 1.7, the use of combined measures would reduce clinical attack rates (AR) from 21-31% to 0.3-4%. Assuming an R-0 of 2, the AR would decrease from 38% to 8%, yet only if vaccination were started within 2 months of the first world case, in combination with a 90% reduction in international air traffic, closure of schools/workplaces for 4 weeks and AVP of household and school/work close contacts of clinical cases. Varying VE would not substantially affect the results. Conclusions: This IBM, which is based on country-specific demographic data, could be suitable for the real-time evaluation of measures to be undertaken in the event of the emergence of a new pandemic influenza virus. All preventive measures considered should be implemented to mitigate the pandemic.	[degli Atti, Marta Luisa Ciofi; Rizzo, Caterina; Massari, Marco] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Merler, Stefano; Ajelli, Marco; Furlanello, Cesare] Fondazione Bruno Kessler, Trento, Italy; [Rizzo, Caterina] Univ Bari, Dept Pharm Biol, Bari, Italy; [Ajelli, Marco] Univ Trento, Department of Informat Engn & Comp Sci, Trento, Italy; [Manfredi, Piero] Univ Pisa, Dept Stat & Math Appl Ec, Pisa, Italy; [Tomba, Gianpaolo Scalia] Univ Tor Vergata, Dept Math, Rome, Italy; [Iannelli, Mimmo] Univ Trento, Dept Math, Trento, Italy	Istituto Superiore di Sanita (ISS); Fondazione Bruno Kessler; Universita degli Studi di Bari Aldo Moro; University of Trento; University of Pisa; University of Rome Tor Vergata; University of Trento	degli Atti, MLC (corresponding author), Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.	marta.ciofi@iss.it	merler, stefano/I-3557-2017; Rizzo, Caterina/H-4092-2012; Ajelli, Marco/AAX-1113-2020; degli Atti, Marta Ciofi/K-4650-2018	merler, stefano/0000-0002-5117-0611; Rizzo, Caterina/0000-0002-5583-7508; Ajelli, Marco/0000-0003-1753-4749; degli Atti, Marta Ciofi/0000-0001-6492-4497; Furlanello, Cesare/0000-0002-5384-3605; Iannelli, Mimmo/0000-0002-1637-2234	EPICO Project of the Provincia Autonoma di Trento, Italy	EPICO Project of the Provincia Autonoma di Trento, Italy	This work has been partially funded by the EPICO Project of the Provincia Autonoma di Trento, Italy.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Demicheli V, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001269.PUB2, 10.1002/14651858.CD001269]; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glezen WP, 2006, INT J EPIDEMIOL, V35, P352, DOI 10.1093/ije/dyi293; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; *I NAZ STAT, 2006, STAT TRASP AER ANN; *I NAZ STAT, 2004, 8 CENS IND ART; *I NAZ STAT, 2005, IND MULT FAM STIL VI, P122; *I NAZ STAT, 2006, STRUTT FAM OP FAM FI; *INFL TEAM ECDPAC, 2007, EUR SURVEILL, V12; Istituto Nazionale di Statistica, 2001, 14 CENS GEN POP AB; Jefferson T, 2005, LANCET, V365, P773, DOI 10.1016/S0140-6736(05)17984-7; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; *MIN SAL, 2005, INFL VACC COV; Smith S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub2; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; *SWISS INF, 2007, SWITZ ANN STOCKP BIR; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503; *WHO, 2006, EMERG INFECT DIS, V81, P42	33	124	125	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1790	10.1371/journal.pone.0001790	http://dx.doi.org/10.1371/journal.pone.0001790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335060	Green Submitted, Green Published, gold			2022-12-27	WOS:000260723000041
J	Fukuda, T; Kondo, Y; Nakagama, H				Fukuda, Tomokazu; Kondo, Yasuyuki; Nakagama, Hitoshi			The Anti-Proliferative Effects of the CHFR Depend on the Forkhead Associated Domain, but not E3 Ligase Activity Mediated by Ring Finger Domain	PLOS ONE			English	Article								The CHFR protein comprises fork head associated- (FHA) and RING-finger (RF) domain and is frequently downregulated in human colon and gastric cancers up to 50%. The loss of CHFR mRNA expression is a consequence of promoter methylation, suggesting a tumor suppressor role for this gene in gastrointestinal carcinogenesis. In terms of the biological functions of CHFR, it has been shown to activate cell cycle checkpoint when cells are treated with microtubule depolymerizing agents. Furthermore, CHFR was reported to have E3 ligase activity and promote ubiquitination and degradation of oncogenic proteins such as Aurora A and polo-like kinase 1. However, molecular pathways involved in the tumor suppressive function of CHFR are not yet clear since the two established roles of this protein are likely to inhibit cell growth. In this study, we have identified that the FHA domain of CHFR protein is critical for growth suppressive properties, whereas the RF and cysteine rich domains (Cys) are not required for this function. In contrast, the RF and Cys domains are essential for E3 ligase activity of CHFR. By the use of a cell cycle checkpoint assay, we also confirmed that the FHA domain of CHFR plays an important role in initiating a cell cycle arrest at G2/M, indicating a functional link exists between the anti-proliferative effects and checkpoint function of this tumor suppressor protein via this domain. Collectively, our data show that the checkpoint function of the FHA domain of CHFR is a core component of anti-proliferative properties against the gastrointestinal carcinogenesis.	[Fukuda, Tomokazu; Kondo, Yasuyuki; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Biochem, Tokyo 104, Japan	National Cancer Center - Japan	Fukuda, T (corresponding author), Natl Canc Ctr, Res Inst, Div Biochem, Tokyo 104, Japan.	hnakagam@gan2.res.ncc.go.jp	Fukuda, Tomokazu/O-1257-2018	Fukuda, Tomokazu/0000-0001-8456-0483	Ministry of Health, Labour and Welfare of Japan [Grant-in-Aid]; Sankyo Foundation of Life Science [06-016]; Foundation for the Promotion of Cancer Research in Japan [Research Resident Fellowship]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Sankyo Foundation of Life Science; Foundation for the Promotion of Cancer Research in Japan	This work was supported in part by a Grant-in-Aid for Cancer Research for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan, and by a Research Grant of the Sankyo Foundation of Life Science (06-016). Y.K. is a recipient of a Research Resident Fellowship from the Foundation for the Promotion of Cancer Research in Japan.	Bertholon J, 2003, ONCOGENE, V22, P8956, DOI 10.1038/sj.onc.1207078; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Chaturvedi P, 2002, CANCER RES, V62, P1797; Corn PG, 2003, CARCINOGENESIS, V24, P47, DOI 10.1093/carcin/24.1.47; Crane R, 2004, J CELL SCI, V117, P5975, DOI 10.1242/jcs.01418; Daniels MJ, 2004, NAT STRUCT MOL BIOL, V11, P1114, DOI 10.1038/nsmb837; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Fukuda T, 2005, MOL CELL BIOL, V25, P5270, DOI 10.1128/MCB.25.12.5270-5281.2005; Hamilton JP, 2006, CLIN GASTROENTEROL H, V4, P701, DOI 10.1016/j.cgh.2006.03.007; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Homma N, 2005, VIRCHOWS ARCH, V446, P120, DOI 10.1007/s00428-004-1146-6; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Koga Y, 2006, J GASTROENTEROL, V41, P133, DOI 10.1007/s00535-005-1732-7; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; MARTINEZ R, 2007, CARCINOGENESIS; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2001, J CELL SCI, V114, P1949; Morioka Y, 2006, ANTICANCER RES, V26, P4267; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ogi K, 2005, CANCER BIOL THER, V4, P773, DOI 10.4161/cbt.4.7.1896; Privette LM, 2007, CANCER RES, V67, P6064, DOI 10.1158/0008-5472.CAN-06-4109; Satoh A, 2003, CANCER RES, V63, P8606; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Tokunaga E, 2006, BREAST CANCER RES TR, V97, P199, DOI 10.1007/s10549-005-9112-9; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Vahteristo P, 2001, CANCER RES, V61, P5718; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Yanokura M, 2007, ONCOL REP, V17, P41; Yoshida K, 2006, ANTICANCER RES, V26, P49; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	44	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1776	10.1371/journal.pone.0001776	http://dx.doi.org/10.1371/journal.pone.0001776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335050	Green Submitted, gold, Green Published			2022-12-27	WOS:000260723000029
J	Santos, AFA; Lengruber, RB; Soares, EA; Jere, A; Sprinz, E; Martinez, AMB; Silveira, J; Sion, FS; Pathak, VK; Soares, MA				Santos, Andre F. A.; Lengruber, Renan B.; Soares, Esmeralda A.; Jere, Abhay; Sprinz, Eduardo; Martinez, Ana M. B.; Silveira, Jussara; Sion, Fernando S.; Pathak, Vinay K.; Soares, Marcelo A.			Conservation Patterns of HIV-1 RT Connection and RNase H Domains: Identification of New Mutations in NRTI-Treated Patients	PLOS ONE			English	Article								Background: Although extensive HIV drug resistance information is available for the first 400 amino acids of its reverse transcriptase, the impact of antiretroviral treatment in C-terminal domains of Pol (thumb, connection and RNase H) is poorly understood. Methods and Findings: We wanted to characterize conserved regions in RT C-terminal domains among HIV-1 group M subtypes and CRF. Additionally, we wished to identify NRTI-related mutations in HIV-1 RT C-terminal domains. We sequenced 118 RNase H domains from clinical viral isolates in Brazil, and analyzed 510 thumb and connection domain and 450 RNase H domain sequences collected from public HIV sequence databases, together with their treatment status and histories. Drug-naive and NRTI-treated datasets were compared for intra- and inter-group conservation, and differences were determined using Fisher's exact tests. One third of RT C-terminal residues were found to be conserved among group M variants. Three mutations were found exclusively in NRTI-treated isolates. Nine mutations in the connection and 6 mutations in the RNase H were associated with NRTI treatment in subtype B. Some of them lay in or close to amino acid residues which contact nucleic acid or near the RNase H active site. Several of the residues pointed out herein have been recently associated to NRTI exposure or increase drug resistance to NRTI. Conclusions: This is the first comprehensive genotypic analysis of a large sequence dataset that describes NRTI-related mutations in HIV-1 RT C-terminal domains in vivo. The findings into the conservation of RT C-terminal domains may pave the way to more rational drug design initiatives targeting those regions.	[Santos, Andre F. A.; Lengruber, Renan B.; Soares, Esmeralda A.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Humana, Rio De Janeiro, Brazil; [Jere, Abhay; Pathak, Vinay K.] Natl Canc Inst Frederick, HIV Drug Resistance Program, Frederick, MD USA; [Sprinz, Eduardo] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Martinez, Ana M. B.; Silveira, Jussara] Fundacao Univ Rio Grande, Rio Grande, Brazil; [Sion, Fernando S.] Hosp Univ Gaffree Guinle, Rio De Janeiro, Brazil; [Soares, Marcelo A.] Inst Nacl Canc, Unidade Genet, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal do Rio Grande; National Cancer Institute (Inca)	Santos, AFA (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Humana, Rio De Janeiro, Brazil.	masoares@biologia.ufrj.br	sprinz, eduardo/V-7961-2019; Santos, Andre FA/I-5734-2016; Soares, Marcelo A/G-5662-2010	sprinz, eduardo/0000-0003-4343-8304; Pathak, Vinay/0000-0003-2441-8412; Sion, Fernando Samuel/0000-0001-6315-139X	Brazilian Ministry of Science and Technology [403589/2004-5]; Rio de Janeiro State Science Foundation [E-26/171.337/2002]; Brazilian Ministry of Health [322/2005]; NATIONAL CANCER INSTITUTE [ZIABC010532, Z01BC010532] Funding Source: NIH RePORTER	Brazilian Ministry of Science and Technology; Rio de Janeiro State Science Foundation; Brazilian Ministry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this study was from the Brazilian Ministry of Science and Technology (CNPq) grant no. 403589/2004-5, Rio de Janeiro State Science Foundation (FAPERJ) grant no. E-26/171.337/2002 and the Brazilian Ministry of Health (PN-DST/AIDS) grant no. 322/2005. The sponsors had no role in any step of the study design, data analysis or manuscript preparation.	Abram ME, 2005, J VIROL, V79, P11952, DOI 10.1128/JVI.79.18.11952-11961.2005; Arion D, 2002, J BIOL CHEM, V277, P1370, DOI 10.1074/jbc.M110254200; Cane PA, 2007, AIDS, V21, P447, DOI 10.1097/QAD.0b013e3280129964; Ceccherini-Silberstein F, 2005, J VIROL, V79, P10718, DOI 10.1128/JVI.79.16.10718-10729.2005; Ceccherini-Silberstein F, 2004, AIDS, V18, pF11, DOI 10.1097/01.aids.0000131394.76221.02; Coffin J, 1997, RETROVIRUSES; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DELVIKSFRANKENB.KA, J VIROL, V81, P6837; GOOBARLARSSON L, 1993, VIROLOGY, V196, P731, DOI 10.1006/viro.1993.1530; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Julias JG, 2003, J VIROL, V77, P8548, DOI 10.1128/JVI.77.15.8548-8554.2003; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; Kane CT, 2001, AIDS RES HUM RETROV, V17, P1211, DOI 10.1089/088922201316912817; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Rhee SY, 2005, J INFECT DIS, V192, P456, DOI 10.1086/431601; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SMITH JS, 1992, J BIOL CHEM, V267, P15071; Stuyver L, 1997, ANTIMICROB AGENTS CH, V41, P284, DOI 10.1128/AAC.41.2.284; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tippmann HF, 2004, BRIEF BIOINFORM, V5, P82, DOI 10.1093/bib/5.1.82; VOLKMANN S, 1993, BIOCHIMIE, V75, P71, DOI 10.1016/0300-9084(93)90027-P; WOHRL BM, 1990, BIOCHEMISTRY-US, V29, P10141, DOI 10.1021/bi00496a001	32	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1781	10.1371/journal.pone.0001781	http://dx.doi.org/10.1371/journal.pone.0001781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335052	Green Submitted, Green Published, gold			2022-12-27	WOS:000260723000033
J	Yang, N; Huang, J; Greshock, J; Liang, S; Barchetti, A; Hasegawa, K; Kim, S; Giannakakis, A; Li, CS; O'Brien-Jenkins, A; Katsaros, D; Butzow, R; Coukos, G; Zhang, L				Yang, Nuo; Huang, Jia; Greshock, Joel; Liang, Shun; Barchetti, Andrea; Hasegawa, Kosei; Kim, Sarah; Giannakakis, Antonis; Li, Chunsheng; O'Brien-Jenkins, Anne; Katsaros, Dionyssios; Butzow, Ralf; Coukos, George; Zhang, Lin			Transcriptional Regulation of PIK3CA Oncogene by NF-kappa B in Ovarian Cancer Microenvironment	PLOS ONE			English	Article								PIK3CA upregulation, amplification and mutation have been widely reported in ovarian cancers and other tumors, which strongly suggests that PIK3CA is a promising therapeutic target. However, to date the mechanisms underlying PIK3CA regulation and activation in vivo is still unclear. During tumorigenesis, host-tumor interactions may play a critical role in editing the tumor. Here, we report a novel mechanism through which the tumor microenvironment activates the PIK3CA oncogene. We show that PIK3CA upregulation occurs in non-proliferating tumor regions in vivo. We identified and characterized the PIK3CA 5' upstream transcriptional regulatory region and confirmed that PIK3CA is transcriptionally regulated through NF-kappa B pathway. These results offer a new mechanism through which the tumor microenvironment directly activates oncogenic pathways in tumor cells.	[Yang, Nuo; Liang, Shun; Barchetti, Andrea; Hasegawa, Kosei; Kim, Sarah; Giannakakis, Antonis; Li, Chunsheng; O'Brien-Jenkins, Anne; Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA USA; [Huang, Jia; Greshock, Joel; Coukos, George] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA USA; [Greshock, Joel] GlaxoSmithKline Inc, Translational Med & Genet, King Of Prussia, PA USA; [Giannakakis, Antonis] Democritus Univ Thrace, Lab Gene Express, Modern Diagnost & Therap Methods, Alexandroupolis, Greece; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, Turin, Italy; [Butzow, Ralf] Univ Helsinki, Dept Obstet, Helsinki, Finland; [Butzow, Ralf] Univ Helsinki, Dept Gynecol, Helsinki, Finland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; GlaxoSmithKline; Democritus University of Thrace; University of Turin; University of Helsinki; University of Helsinki	Zhang, L (corresponding author), Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Giannakakis, Antonis/ABA-2399-2021; Zhang, Lin/K-8478-2012; Li, chunsheng/G-4418-2011; Giannakakis, Antonis/AAN-8329-2021; Coukos, George/ABG-7389-2020	Giannakakis, Antonis/0000-0003-2975-0326; Coukos, George/0000-0001-8813-7367	NCI [P01-CA83638]; Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; American Cancer Society; Hellenic Ministry of Education [predoctoral fellowship]; Italian Association for Cancer Research; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; American Cancer Society(American Cancer Society); Hellenic Ministry of Education; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI P01-CA83638 SPORE in Ovarian Cancer (Career Development Award, LZ); the Ovarian Cancer Research Fund (GC and LZ); Mary Kay Ash Charitable Foundation (LZ) and the American Cancer Society (LZ). AG was supported in part by a predoctoral fellowship from the Hellenic Ministry of Education (Program HERACLITOS, EPEAEK). DK was partly supported by the Italian Association for Cancer Research (AIRC).	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bast Robert C. Jr., 2007, V174, P91; Berchuck A, 2003, GYNECOL ONCOL, V88, pS67, DOI 10.1006/gyno.2002.6687; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu LM, 2002, CANCER RES, V62, P1087; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; KULL FC, 1985, P NATL ACAD SCI USA, V82, P5756, DOI 10.1073/pnas.82.17.5756; Lassus H, 2003, GYNECOL ONCOL, V91, P504, DOI 10.1016/j.ygyno.2003.08.034; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mok SC, 2007, ADV CANCER RES, V96, P1, DOI 10.1016/S0065-230X(06)96001-1; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Ozols RF, 2000, SEMIN ONCOL, V27, P47; Parsons R, 2005, CLIN CANCER RES, V11, P7965, DOI 10.1158/1078-0432.CCR-05-1681; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; SMITH RA, 1986, J BIOL CHEM, V261, P4871; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VERCAMMEN D, 1995, CYTOKINE, V7, P463, DOI 10.1006/cyto.1995.0063; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wenham RM, 2002, BEST PRACT RES CL OB, V16, P483, DOI 10.1053/beog.2002.0298; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Zhang L, 2004, CANCER BIOL THER, V3, P1283, DOI 10.4161/cbt.3.12.1388; Zhang L, 2005, CANCER RES, V65, P925; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2003, CANCER RES, V63, P4225; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1; Zijlstra A, 2006, BLOOD, V107, P317, DOI 10.1182/blood-2005-04-1458	53	31	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1758	10.1371/journal.pone.0001758	http://dx.doi.org/10.1371/journal.pone.0001758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335034	Green Submitted, Green Published, gold			2022-12-27	WOS:000260723000012
J	Horisawa, K; Doi, N; Yanagawa, H				Horisawa, Kenichi; Doi, Nobuhide; Yanagawa, Hiroshi			Use of cDNA Tiling Arrays for Identifying Protein Interactions Selected by In Vitro Display Technologies	PLOS ONE			English	Article								In vitro display technologies such as mRNA display are powerful screening tools for protein interaction analysis, but the final cloning and sequencing processes represent a bottleneck, resulting in many false negatives. Here we describe an application of tiling array technology to identify specifically binding proteins selected with the in vitro virus (IVV) mRNA display technology. We constructed transcription-factor tiling (TFT) arrays containing similar to 1,600 open reading frame sequences of known and predicted mouse transcription-regulatory factors (334,372 oligonucleotides, 50-mer in length) to analyze cDNA fragments from mRNA-display screening for Jun-associated proteins. The use of the TFT arrays greatly increased the coverage of known Jun-interactors to 28% (from 14% with the cloning and sequencing approach), without reducing the accuracy (similar to 75%). This method could detect even targets with extremely low expression levels (less than a single mRNA copy per cell in whole brain tissue). This highly sensitive and reliable method should be useful for high-throughput protein interaction analysis on a genome-wide scale.	[Horisawa, Kenichi; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Fac Sci & Technol, Yokohama, Kanagawa 223, Japan	Keio University	Horisawa, K (corresponding author), Keio Univ, Dept Biosci & Informat, Fac Sci & Technol, Yokohama, Kanagawa 223, Japan.	hyana@bio.keio.ac.jp	Doi, Nobuhide/C-4481-2014	Doi, Nobuhide/0000-0002-2402-6390	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [Grant-in-Aid]; Research for Promoting Technological Seeds Program of the Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research for Promoting Technological Seeds Program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by a Grant-in-Aid for The 21st Century Center of Excellence (COE) Program entitled Understanding and Control of Life's Function via Systems Biology (Keio Univ.) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); The Keio University Global Center of Excellence (G-COE) Program entitled Center for Human Metabolomic Systems Biology of the MEXT; and The Research for Promoting Technological Seeds Program of the Japan Science and Technology Agency (JST).	CAMPBELL N, 1996, BIOLOGY; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; DAVYDOV IV, 1995, GENE, V161, P271, DOI 10.1016/0378-1119(95)00271-7; Doi N, 1999, FEBS LETT, V457, P227, DOI 10.1016/S0014-5793(99)01041-8; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fukuda I, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl618; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gunji W, 2004, BIOCHEM BIOPH RES CO, V325, P265, DOI 10.1016/j.bbrc.2004.10.025; Hammond PW, 2001, J BIOL CHEM, V276, P20898, DOI 10.1074/jbc.M011641200; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; He MY, 1997, NUCLEIC ACIDS RES, V25, P5132, DOI 10.1093/nar/25.24.5132; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Horisawa K, 2005, J BIOCHEM, V137, P121, DOI 10.1093/jb/mvi023; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsumura Nobutaka, 2006, Current Proteomics, V3, P199, DOI 10.2174/157016406779475371; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; McPherson M, 2002, CHEM BIOL, V9, P691, DOI 10.1016/S1074-5521(02)00148-5; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; 't Hoen PAC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng020; Tateyama S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj025	34	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1646	10.1371/journal.pone.0001646	http://dx.doi.org/10.1371/journal.pone.0001646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286201	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400039
J	Mlisana, K; Auld, SC; Grobler, A; van Loggerenberg, F; Williamson, C; Iriogbe, I; Sobieszczyk, ME; Abdool Karim, SS				Mlisana, Koleka; Auld, Sara C.; Grobler, Anneke; van Loggerenberg, Francois; Williamson, Carolyn; Iriogbe, Itua; Sobieszczyk, Magdalena E.; Abdool Karim, Salim Safurdeen		CAPRISA 002 Acute Infection Study Team	Anaemia in Acute HIV-1 Subtype C Infection	PLOS ONE			English	Article								Background: The high prevalence of anaemia and the increased morbidity and mortality associated with anaemia during AIDS has been well described yet there has been little information about anaemia and changes in haemoglobin levels during acute and early HIV-1 infection. Methods: HIV-negative women (n = 245) were enrolled into an observational cohort as part of the Centre for the AIDS Programme of Research in South Africa (CAPRISA) Acute Infection Study. Acute infection was diagnosed following a positive HIV RNA PCR in the absence of antibodies, or detection of HIV-1 antibodies within 3 months of a previously negative antibody test. Haemotologic parameters were assessed before infection and at regular intervals in the first twelve months of HIV infection. Results: Fifty-seven participants with acute HIV infection were identified at a median of 14.5 days post-infection ( range 10-81) and were enrolled in the CAPRISA Acute Infection cohort at a median of 41 days post-infection (range 15-104). Mean haemoglobin prior to HIV-1 infection was 12.7 g/dL, with a mean decline of 0.46 g/dL following infection. The prevalence of anaemia increased from 25.0% prior to HIV-1 infection to 52.6% at 3 months post-infection, 61.1% at 6 months post-infection, and 51.4% at 12 months post-infection. Conclusions: Haematologic derangements and anaemia with a trend towards iron deficiency are common with acute HIV-1 subtype C infection in this small cohort. The negative impact of anaemia concurrent with established HIV infection upon morbidity and mortality has been well documented but the prognostic potential and long-term effects of anaemia during acute HIV-1 infection remain unknown.	[Mlisana, Koleka; Auld, Sara C.; Grobler, Anneke; van Loggerenberg, Francois; Iriogbe, Itua; Abdool Karim, Salim Safurdeen] Univ KwaZulu Natal, CAPRISA, Durban, South Africa; [Auld, Sara C.; Sobieszczyk, Magdalena E.; Abdool Karim, Salim Safurdeen] Columbia Univ, New York, NY USA; [Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa	University of Kwazulu Natal; Columbia University; University of Cape Town	Mlisana, K (corresponding author), Univ KwaZulu Natal, CAPRISA, Durban, South Africa.	mlisanak@ukzn.ac.za	Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Mlisana, Koleka/N-6204-2013	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; Mlisana, Koleka/0000-0002-8436-3268; van Loggerenberg, Francois/0000-0001-5317-7983; Grobler, Anneke/0000-0002-7809-7688; , Carolyn/0000-0003-0125-1226	Centre for the AIDs Programme of Research in South Africa (CAPRISA) [AI51794]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	Centre for the AIDs Programme of Research in South Africa (CAPRISA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Centre for the AIDs Programme of Research in South Africa (CAPRISA). CAPRISA is part of the Comprehensive International Program of Research on AIDS (CIPRA) and is supported by the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS)(grant# AI51794). The funders approved the design of the study and provided monitoring oversight thoughout the conduct of the study. The funders were not involved in the collection, analysis of data or in the preparation, review or approval of the manuscript.	Bahner I, 1997, BLOOD, V90, P1787, DOI 10.1182/blood.V90.5.1787; Berhane K, 2004, JAIDS-J ACQ IMM DEF, V37, P1245, DOI 10.1097/01.qai.0000134759.01684.27; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; Kreuzer KA, 1997, ANN HEMATOL, V75, P179, DOI 10.1007/s002770050340; Kreuzer KA, 1997, BRIT J HAEMATOL, V96, P235, DOI 10.1046/j.1365-2141.1997.d01-2031.x; Lau B, 2005, JAIDS-J ACQ IMM DEF, V39, P620; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Lundgren JD, 2003, CLIN INFECT DIS, V37, pS297, DOI 10.1086/376909; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 1999, CLIN INFECT DIS, V29, P44, DOI 10.1086/520178; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Moses AV, 1996, BLOOD, V87, P919, DOI 10.1182/blood.V87.3.919.bloodjournal873919; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Savarino A, 1999, CELL BIOCHEM FUNCT, V17, P279, DOI 10.1002/(SICI)1099-0844(199912)17:4<279::AID-CBF833>3.0.CO;2-J; Semba RD, 2005, ARCH INTERN MED, V165, P2229, DOI 10.1001/archinte.165.19.2229; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; World Health Organization, 1992, WHOMCHMSM922, V2nd; Zhou J, 2005, HIV MED, V6, P216, DOI 10.1111/j.1468-1293.2005.00292.x	19	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1626	10.1371/journal.pone.0001626	http://dx.doi.org/10.1371/journal.pone.0001626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286183	Green Accepted, Green Published, gold			2022-12-27	WOS:000260586400019
J	Takeuchi, Y; Myers, R; Danos, O				Takeuchi, Yasuhiro; Myers, Richard; Danos, Olivier			Recombination and Population Mosaic of a Multifunctional Viral Gene, Adeno-Associated Virus cap	PLOS ONE			English	Article								Homologous recombination is a dominant force in evolution and results in genetic mosaics. To detect evidence of recombination events and assess the biological significance of genetic mosaics, genome sequences for various viral populations of reasonably large size are now available in the GenBank. We studied a multi-functional viral gene, the adeno-associated virus (AAV) cap gene, which codes for three capsid proteins, VP1, VP2 and VP3. VP1-3 share a common C-terminal domain corresponding to VP3, which forms the viral core structure, while the VP1 unique N-terminal part contains an enzymatic domain with phospholipase A2 activity. Our recombinant detection program (RecI) revealed five novel recombination events, four of which have their cross-over points in the N-terminal, VP1 and VP2 unique region. Comparison of phylogenetic trees for different cap gene regions confirmed discordant phylogenies for the recombinant sequences. Furthermore, differences in the phylogenetic tree structures for the VP1 unique (VP1u) region and the rest of cap highlighted the mosaic nature of cap gene in the AAV population: two dominant forms of VP1u sequences were identified and these forms are linked to diverse sequences in the rest of cap gene. This observation together with the finding of frequent recombination in the VP1 and 2 unique regions suggests that this region is a recombination hot spot. Recombination events in this region preserve protein blocks of distinctive functions and contribute to convergence in VP1u and divergence of the rest of cap. Additionally the possible biological significance of two dominant VP1u forms is inferred.	[Takeuchi, Yasuhiro; Myers, Richard; Danos, Olivier] UCL, MRC, UCL Ctr Med Mol Virol, Div Infect & Immunol, London, England; [Myers, Richard] Hlth Protect Agcy, Ctr Infect, London, England; [Danos, Olivier] Hop Necker Enfants Malad, INSERM, U781, Inst Fed Rech Necker Enfants Malad IFR 94, Paris, France	University of London; University College London; Health Protection Agency; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Takeuchi, Y (corresponding author), UCL, MRC, UCL Ctr Med Mol Virol, Div Infect & Immunol, London, England.	y.takeuchi@ucl.ac.uk	Takeuchi, Yasuhiro/C-1640-2008		UCL Clinical Research and Development Committee	UCL Clinical Research and Development Committee	This work was funded by UCL Clinical Research and Development Committee. This sponsor played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bartosch B, 2004, J VIROL, V78, P13880, DOI 10.1128/JVI.78.24.13880-13890.2004; Chen CL, 2005, J VIROL, V79, P14781, DOI 10.1128/JVI.79.23.14781-14792.2005; deSouza SJ, 1996, P NATL ACAD SCI USA, V93, P14632, DOI 10.1073/pnas.93.25.14632; Erles K, 1999, J MED VIROL, V59, P406, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;406::AID-JMV22&gt;3.0.CO;2-N; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gilbert W, 1997, P NATL ACAD SCI USA, V94, P7698, DOI 10.1073/pnas.94.15.7698; Grieger JC, 2007, J VIROL, V81, P7833, DOI 10.1128/JVI.00580-07; Grieger JC, 2006, J VIROL, V80, P5199, DOI 10.1128/JVI.02723-05; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hueffer K, 2003, CURR OPIN MICROBIOL, V6, P392, DOI 10.1016/S1369-5274(03)00083-3; Kohlbrenner E, 2005, MOL THER, V12, P1217, DOI 10.1016/j.ymthe.2005.08.018; Kronenberg S, 2005, J VIROL, V79, P5296, DOI 10.1128/JVI.79.9.5296-5303.2005; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Sonntag F, 2006, J VIROL, V80, P11040, DOI 10.1128/JVI.01056-06; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Weitzman MD, 1996, J VIROL, V70, P1845, DOI 10.1128/JVI.70.3.1845-1854.1996; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xiao WD, 1999, J VIROL, V73, P3994, DOI 10.1128/JVI.73.5.3994-4003.1999; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; YALKINOGLU AO, 1988, CANCER RES, V48, P3123; Yan ZY, 2005, J VIROL, V79, P364, DOI 10.1128/JVI.79.1.364-379.2005; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001	27	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1634	10.1371/journal.pone.0001634	http://dx.doi.org/10.1371/journal.pone.0001634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286191	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400027
J	Ochsenreiter, T; Cipriano, M; Hajduk, SL				Ochsenreiter, Torsten; Cipriano, Michael; Hajduk, Stephen L.			Alternative mRNA Editing in Trypanosomes Is Extensive and May Contribute to Mitochondrial Protein Diversity	PLOS ONE			English	Article								The editing of trypanosome mitochondrial mRNAs produces transcripts necessary for mitochondrial functions including electron transport and oxidative phosphorylation. Precursor-mRNAs are often extensively edited by specific uridine insertion or deletion that is directed by small guide RNAs (gRNAs). Recently, it has been shown that cytochrome c oxidase subunit III (COXIII) mRNAs can be alternatively edited to encode a novel mitochondrial membrane protein composed of a unique hydrophilic N-terminal sequence of unknown function and the C-terminal hydrophobic segment of COXIII. To extend the analysis of alternative editing in Trypanosoma brucei we have constructed libraries with over 1100 full-length mitochondrial cDNAs and the sequences of over 1200 gRNA genes. Using this data, we show that alternative editing of COXIII, ATPase subunit 6 (A6), and NADH dehydrogenase subunits 7, 8 and 9 (ND7, 8, 9) mRNAs can produce novel open reading frames (ORFs). Several gRNAs potentially responsible for the alternative editing of these mRNAs were also identified. These findings show that alternative editing of mitochondrial mRNAs is common in T. brucei and expands the diversity of mitochondrial proteins in these organisms.	[Ochsenreiter, Torsten; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Cipriano, Michael] Univ Calif Davis, Dept Med Microbiol, Davis, CA USA	University System of Georgia; University of Georgia; University of California System; University of California Davis	Ochsenreiter, T (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	shajduk@bmb.uga.edu	Ochsenreiter, Torsten/E-6040-2010	Cipriano, Michael/0000-0001-8163-8812	National Institutes of Health [AI21401]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021401, R21AI021401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI21401).	ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; ALDRITT SM, 1989, MOL CELL BIOL, V9, P3614, DOI 10.1128/MCB.9.9.3614; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; CORELL RA, 1993, NUCLEIC ACIDS RES, V21, P4313, DOI 10.1093/nar/21.18.4313; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; Edqvist J, 2000, J MOL BIOL, V297, P381, DOI 10.1006/jmbi.2000.3530; Fang J, 2001, EUR J BIOCHEM, V268, P3075, DOI 10.1046/j.1432-1327.2001.02205.x; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; LANDWEBER LF, 1993, NATURE, V363, P179, DOI 10.1038/363179a0; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Madison-Antenucci S, 2002, CELL, V108, P435, DOI 10.1016/S0092-8674(02)00653-0; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; OCHSENREITER T, 2007, NUCL ACIDS MOL BIOL; Ochsenreiter T, 2007, RNA, V13, P1, DOI 10.1261/rna.232907; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; READ LK, 1994, MOL BIOCHEM PARASIT, V68, P297, DOI 10.1016/0166-6851(94)90174-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RILEY GR, 1995, NUCLEIC ACIDS RES, V23, P708, DOI 10.1093/nar/23.4.708; Simpson L, 2003, RNA, V9, P265, DOI 10.1261/rna.2178403; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M	30	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1566	10.1371/journal.pone.0001566	http://dx.doi.org/10.1371/journal.pone.0001566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270563	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900008
J	Zheng, L; Wayper, PJ; Gibbs, AJ; Fourment, M; Rodoni, BC; Gibbs, MJ				Zheng, Linda; Wayper, Paul J.; Gibbs, Adrian J.; Fourment, Mathieu; Rodoni, Brendan C.; Gibbs, Mark J.			Accumulating Variation at Conserved Sites in Potyvirus Genomes Is Driven by Species Discovery and Affects Degenerate Primer Design	PLOS ONE			English	Article								Unknown and foreign viruses can be detected using degenerate primers targeted at conserved sites in the known viral gene sequences. Conserved sites are found by comparing sequences and so the usefulness of a set of primers depends crucially on how well the known sequences represent the target group including unknown sequences. Methodology/Principal Findings: We developed a method for assessing the apparent stability of consensus sequences at sites over time using deposition dates from Genbank. We tested the method using 17 conserved sites in potyvirus genomes. The accumulation of knowledge of sequence variants over 20 years caused 'consensus decay' of the sites. Rates of decay were rapid at all sites but varied widely and as a result, the ranking of the most conserved sites changed. The discovery and reporting of sequences from previously unknown and distinct species, rather than from strains of known species, dominated the decay, indicating it was largely a sampling effect related to the progressive discovery of species, and recent virus mutation was probably only a minor contributing factor. Conclusion/Significance: We showed that in the past, the sampling bias has misled the choice of the most conserved target sites for genus specific degenerate primers. The history of sequence discoveries indicates primer designs should be updated regularly and provides an additional dimension for improving the design of degenerate primers.	[Zheng, Linda; Wayper, Paul J.; Gibbs, Mark J.] Australian Natl Univ, Sch Bot & Zool, Canberra, ACT, Australia; [Fourment, Mathieu] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Rodoni, Brendan C.] Dept Primary Ind, Knoxfield, Victoria, Australia	Australian National University; Macquarie University	Zheng, L (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT, Australia.	linda.zheng@anu.edu.au	Fourment, Mathieu/E-4665-2012	Fourment, Mathieu/0000-0001-8153-9822	Victorian State Government of The Commenwealth of Australia	Victorian State Government of The Commenwealth of Australia	This work is part of my PhD program which was supported by the Department of Primary Industries ("Our Rural Landscape") funded by the Victorian State Government of The Commenwealth of Australia. The funders of this study had no role in the design or conduct of this study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adams MJ, 2005, ARCH VIROL, V150, P459, DOI 10.1007/s00705-004-0440-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, POTYVIRIDAE; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Chen J, 2001, ARCH VIROL, V146, P757, DOI 10.1007/s007050170144; COLINET D, 1993, J VIROL METHODS, V45, P149, DOI 10.1016/0166-0934(93)90099-D; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; French R, 2005, VIROLOGY, V343, P179, DOI 10.1016/j.virol.2005.08.037; Fuji S, 2003, ARCH VIROL, V148, P2249, DOI 10.1007/s00705-003-0169-7; Fuji S, 2003, ARCH VIROL, V148, P613, DOI 10.1007/s00705-002-0961-9; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Gibbs A, 1997, J VIROL METHODS, V63, P9, DOI 10.1016/S0166-0934(96)02103-9; Gibbs A, 1998, J VIROL METHODS, V74, P67, DOI 10.1016/S0166-0934(98)00070-6; Hall JS, 2001, VIROLOGY, V282, P230, DOI 10.1006/viro.2001.0841; Hall JS, 2001, J VIROL, V75, P10231, DOI 10.1128/JVI.75.21.10231-10243.2001; Hall T., 2005, BIOEDIT BIOL SEQUENC; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LANGEVELD SA, 1991, J GEN VIROL, V72, P1531, DOI 10.1099/0022-1317-72-7-1531; NICOLAS O, 1991, J VIROL METHODS, V32, P57, DOI 10.1016/0166-0934(91)90185-3; PAPPU SS, 1993, J VIROL METHODS, V41, P9, DOI 10.1016/0166-0934(93)90158-N; Shannon C., 1949, MATH THEORY COMMUNIC, P379; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996	23	36	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1586	10.1371/journal.pone.0001586	http://dx.doi.org/10.1371/journal.pone.0001586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270574	Green Published, gold			2022-12-27	WOS:000260535900020
J	Engbert, R; Nuthmann, A				Engbert, Ralf; Nuthmann, Antje			Self-Consistent Estimation of Mislocated Fixations during Reading	PLOS ONE			English	Article							EYE-MOVEMENTS; SACCADE GENERATION; DYNAMICAL MODEL; INFORMATION; POSITIONS; TRACKING; WORDS; MIND	During reading, we generate saccadic eye movements to move words into the center of the visual field for word processing. However, due to systematic and random errors in the oculomotor system, distributions of within-word landing positions are rather broad and show overlapping tails, which suggests that a fraction of fixations is mislocated and falls on words to the left or right of the selected target word. Here we propose a new procedure for the self-consistent estimation of the likelihood of mislocated fixations in normal reading. Our approach is based on iterative computation of the proportions of several types of oculomotor errors, the underlying probabilities for word-targeting, and corrected distributions of landing positions. We found that the average fraction of mislocated fixations ranges from about 10% to more than 30% depending on word length. These results show that fixation probabilities are strongly affected by oculomotor errors.	[Engbert, Ralf; Nuthmann, Antje] Univ Potsdam, Dept Psychol, Potsdam, Germany	University of Potsdam	Engbert, R (corresponding author), Univ Potsdam, Dept Psychol, Potsdam, Germany.	Ralf.Engbert@uni-potsdam.de	Engbert, Ralf/AAC-4860-2020	Engbert, Ralf/0000-0002-2909-5811; Nuthmann, Antje/0000-0003-3338-3434	Deutsche Forschungsgemeinschaft [EN 471/2-1, KL 955/6-1, KL 955/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (grants EN 471/2-1, KL 955/6-1, and KL 955/14-1).	Binder KS, 1999, J EXP PSYCHOL HUMAN, V25, P1162, DOI 10.1037/0096-1523.25.4.1162; Brysbaert M., 2005, COGNITIVE PROCESS, V16, P53, DOI DOI 10.1093/ACPROF:OSO/9780198566816.003.0003; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Drieghe D, 2008, Q J EXP PSYCHOL, V61, P1239, DOI 10.1080/17470210701467953; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Engbert R, 2002, VISION RES, V42, P621, DOI 10.1016/S0042-6989(01)00301-7; Engbert Ralf, 2007, P319, DOI 10.1016/B978-008044980-7/50016-1; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Kliegl R, 2004, EUR J COGN PSYCHOL, V16, P262, DOI 10.1080/09541440340000213; Kliegl R, 2007, J EXP PSYCHOL GEN, V136, P530, DOI 10.1037/0096-3445.136.3.530; MCCONKIE GW, 1988, VISION RES, V46, P245; Nuthmann A, 2005, VISION RES, V45, P2201, DOI 10.1016/j.visres.2005.02.014; NUTHMANN A, 2006, THESIS U POTSDAM GER; Nuthmann A, 2007, VISION RES, V47, P990, DOI 10.1016/j.visres.2006.11.005; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; RAYNER K, 2004, LEARN MEM COGN, V6, P1290; Rayner K, 2007, J EXP PSYCHOL GEN, V136, P520, DOI 10.1037/0096-3445.136.3.520; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Trukenbrod HA, 2007, VISION RES, V47, P2426, DOI 10.1016/j.visres.2007.05.010; Vitu F, 2001, VISION RES, V41, P3513, DOI 10.1016/S0042-6989(01)00166-3; White SJ, 2006, Q J EXP PSYCHOL, V59, P760, DOI 10.1080/02724980543000024; White SJ, 2006, VISION RES, V46, P426, DOI 10.1016/j.visres.2005.07.006; White SJ, 2004, EUR J COGN PSYCHOL, V16, P52, DOI 10.1080/09541440340000204	25	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1534	10.1371/journal.pone.0001534	http://dx.doi.org/10.1371/journal.pone.0001534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367EQ	18253482	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535700006
J	Hiss, JA; Przyborski, JM; Schwarte, F; Lingelbach, K; Schneider, G				Hiss, Jan Alexander; Przyborski, Jude Marek; Schwarte, Florian; Lingelbach, Klaus; Schneider, Gisbert			The Plasmodium Export Element Revisited	PLOS ONE			English	Article							MALARIA PARASITE; VARIANT PROTEINS; FALCIPARUM; SIGNAL; TRAFFICKING; FAMILY; SURFACE; CYTOADHERENCE; EXPRESSION; PREDICTION	We performed a bioinformatical analysis of protein export elements (PEXEL) in the putative proteome of the malaria parasite Plasmodium falciparum. A protein family-specific conservation of physicochemical residue profiles was found for PEXEL-flanking sequence regions. We demonstrate that the family members can be clustered based on the flanking regions only and display characteristic hydrophobicity patterns. This raises the possibility that the flanking regions may contain additional information for a family-specific role of PEXEL. We further show that signal peptide cleavage results in a positional alignment of PEXEL from both proteins with, and without, a signal peptide.	[Hiss, Jan Alexander; Schwarte, Florian; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Prote, Frankfurt, Germany; [Przyborski, Jude Marek; Lingelbach, Klaus] Univ Marburg, Fac Biol, Marburg, Germany	Goethe University Frankfurt; Philipps University Marburg	Hiss, JA (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Prote, Frankfurt, Germany.	hiss@bioinformatik.uni-frankfurt.de	Przyborski, Jude/ABC-9498-2021	Przyborski, Jude/0000-0002-3494-7767; Hiss, Jan Alexander/0000-0003-0559-4330; Schneider, Gisbert/0000-0001-6706-1084	Beilstein-Institut zur Forderung der Chemischen Wissenschaften; Centre for Membrane Proteomics at Goethe-University, Frankfurt am Main; DFG priority program [1131]	Beilstein-Institut zur Forderung der Chemischen Wissenschaften; Centre for Membrane Proteomics at Goethe-University, Frankfurt am Main; DFG priority program(German Research Foundation (DFG))	This research was supported by the Beilstein-Institut zur Forderung der Chemischen Wissenschaften, and the Centre for Membrane Proteomics at Goethe-University, Frankfurt am Main. J.M.P is supported by the DFG priority program (SPP) 1131.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baumeister S, 1999, Novartis Found Symp, V226, P145; BAUMEISTER S, 1999, NOVART FDN SYMP, V226, P154; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Cochrane G, 2006, NUCLEIC ACIDS RES, V34, pD10, DOI 10.1093/nar/gkj130; Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; JONES DD, 1975, J THEOR BIOL, V50, P167, DOI 10.1016/0022-5193(75)90031-4; Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; NIELSEN H, 1998, P 6 INT C INT SYST M, P122; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Ralph SA, 2004, MOL BIOL EVOL, V21, P2183, DOI 10.1093/molbev/msh233; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Sargent F, 2006, FEMS MICROBIOL LETT, V254, P198, DOI 10.1111/j.1574-6968.2005.00049.x; Schmuker M, 2007, J MOL MODEL, V13, P225, DOI 10.1007/s00894-006-0140-0; SCHNEIDER G, 1993, J MOL EVOL, V36, P586, DOI 10.1007/BF00556363; Schneider G, 1999, GENE, V237, P113, DOI 10.1016/S0378-1119(99)00310-8; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zuegge J, 2001, J MOL GRAPH MODEL, V19, P304, DOI 10.1016/S1093-3263(00)00074-7	43	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1560	10.1371/journal.pone.0001560	http://dx.doi.org/10.1371/journal.pone.0001560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253504	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535700028
J	Gardiner, A; Barker, D; Butlin, RK; Jordan, WC; Ritchie, MG				Gardiner, Anastasia; Barker, Daniel; Butlin, Roger K.; Jordan, William C.; Ritchie, Michael G.			Evolution of a Complex Locus: Exon Gain, Loss and Divergence at the Gr39a Locus in Drosophila	PLOS ONE			English	Article								Background. Gene families typically evolve by gene duplication followed by the adoption of new or altered gene functions. A different way to evolve new but related functions is alternative splicing of existing exons of a complex gene. The chemosensory gene families of animals are characterised by numerous loci of related function. Alternative splicing has only rarely been reported in chemosensory loci, for example in 5 out of around 120 loci in Drosophila melanogaster. The gustatory receptor gene Gr39a has four large exons that are alternatively spliced with three small conserved exons. Recently the genome sequences of eleven additional species of Drosophila have become available allowing us to examine variation in the structure of the Gr39a locus across a wide phylogenetic range of fly species. Methodology/Principal Findings. We describe a fifth exon and show that the locus has a complex evolutionary history with several duplications, pseudogenisations and losses of exons. PAML analyses suggested that the whole gene has a history of purifying selection, although this was less strong in exons which underwent duplication. Conclusions/Significance. Estimates of functional divergence between exons were similar in magnitude to functional divergence between duplicated genes, suggesting that exon divergence is broadly equivalent to gene duplication.	[Gardiner, Anastasia; Barker, Daniel; Ritchie, Michael G.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Butlin, Roger K.] Univ Sheffield, Dept Animal & Plant Sci, Sheffield, S Yorkshire, England; [Jordan, William C.] Zool Soc London, Inst Zool, London, England	University of St Andrews; University of Sheffield; Zoological Society of London	Gardiner, A (corresponding author), Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland.	ag91@st-andrews.ac.uk	Butlin, Roger K/F-7709-2013; Ritchie, Michael G/F-7055-2013	Butlin, Roger K/0000-0003-4736-0954; Ritchie, Michael G/0000-0001-7913-8675	Natural Environment Research Council UK [NE/C003187/1]; Research Councils UK [Academic Fellowship]; Natural Environment Research Council [NE/C003187/1] Funding Source: researchfish; NERC [NE/C003187/1] Funding Source: UKRI	Natural Environment Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Research Councils UK(UK Research & Innovation (UKRI)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council UK, grant NE/C003187/1. DB was supported by a Research Councils UK Academic Fellowship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amrein H, 2004, CURR OPIN NEUROBIOL, V14, P435, DOI 10.1016/j.conb.2004.07.008; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; COX DR, 1962, J ROY STAT SOC B, V24, P406; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; GARDINER A, 2007, MOL ECOLOGY UNPUB; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2003, GENETICA, V118, P133, DOI 10.1023/A:1024197424306; Gu X, 2001, J COMPUT BIOL, V8, P221, DOI 10.1089/10665270152530827; Guo S, 2007, MOL BIOL EVOL, V24, P1198, DOI 10.1093/molbev/msm038; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Lynch M, 2000, GENETICS, V154, P459; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P7122, DOI 10.1073/pnas.0702133104; Ohno S., 1970, EVOLUTION GENE DUPLI; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Proulx SR, 2006, EVOLUTION, V60, P881; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Talavera D, 2007, PLOS COMPUT BIOL, V3, P375, DOI 10.1371/journal.pcbi.0030033; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	35	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1513	10.1371/journal.pone.0001513	http://dx.doi.org/10.1371/journal.pone.0001513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231599	Green Published, Green Accepted, gold			2022-12-27	WOS:000260504200025
J	Kuhn, L; Sinkala, M; Kankasa, C; Semrau, K; Kasonde, P; Scott, N; Mwiya, M; Vwalika, C; Walter, J; Tsai, WY; Aldrovandi, GM; Thea, DM				Kuhn, Louise; Sinkala, Moses; Kankasa, Chipepo; Semrau, Katherine; Kasonde, Prisca; Scott, Nancy; Mwiya, Mwiya; Vwalika, Cheswa; Walter, Jan; Tsai, Wei-Yann; Aldrovandi, Grace M.; Thea, Donald M.			High Uptake of Exclusive Breastfeeding and Reduced Early Post-Natal HIV Transmission	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; PROSPECTIVE COHORT; RESPIRATORY-INFECTION; SOUTH-AFRICA; MOTHER; INFANT; INTERVENTION; DEATHS; DURBAN	Background. Empirical data showing the clear benefits of exclusive breastfeeding (EBF) for HIV prevention are needed to encourage implementation of lactation support programs for HIV-infected women in low resource settings among whom replacement feeding is unsafe. We conducted a prospective, observational study in Lusaka, Zambia, to test the hypothesis that EBF is associated with a lower risk of postnatal HIV transmission than non-EBF. Methods and Results. As part of a randomized trial of early weaning, 958 HIV-infected women and their infants were recruited and all were encouraged to breastfeed exclusively to 4 months. Single-dose nevirapine was provided to prevent transmission. Regular samples were collected from infants to 24 months of age and tested by PCR. Detailed measurements of actual feeding behaviors were collected to examine, in an observational analysis, associations between feeding practices and postnatal HIV transmission. Uptake of EBF was high with 84% of women reporting only EBF cumulatively to 4 months. Post-natal HIV transmission before 4 months was significantly lower (p = 0.004) among EBF (0.040 95% CI: 0.024-0.055) than non-EBF infants (0.102 95% CI: 0.047-0.157); time-dependent Relative Hazard (RH) of transmission due to non-EBF = 3.48 (95% CI: 1.71-7.08). There were no significant differences in the severity of disease between EBF and non-EBF mothers and the association remained significant (RH = 2.68 95% CI: 1.28-5.62) after adjusting for maternal CD4 count, plasma viral load, syphilis screening results and low birth weight. Conclusions. Non-EBF more than doubles the risk of early postnatal HIV transmission. Programs to support EBF should be expanded universally in low resource settings. EBF is an affordable, feasible, acceptable, safe and sustainable practice that also reduces HIV transmission providing HIV-infected women with a means to protect their children's lives. Trial Registration. ClinicalTrials.gov NCT00310726	[Kuhn, Louise; Walter, Jan] Columbia Univ, Mailman Sch Publ Hlth, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Kuhn, Louise; Walter, Jan] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Sinkala, Moses; Vwalika, Cheswa] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Kankasa, Chipepo; Kasonde, Prisca; Mwiya, Mwiya] Univ Zambia, Univ Teaching Hosp, Lusaka, Zambia; [Semrau, Katherine; Scott, Nancy; Thea, Donald M.] Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA USA; [Tsai, Wei-Yann] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Aldrovandi, Grace M.] Univ So Calif, Childrens Hosp, Dept Pediat, Los Angeles, CA 90027 USA	Columbia University; Columbia University; University of Zambia; Boston University; Columbia University; Children's Hospital Los Angeles; University of Southern California	Kuhn, L (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Gertrude H Sergievsky Ctr, New York, NY 10027 USA.	lk24@columbia.edu		Semrau, Katherine/0000-0002-8360-1391; Walter, Jan/0000-0003-2247-5560; Scott, Nancy/0000-0002-4713-4642; Thea, Donald/0000-0002-6933-1030	National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) [R01 HD 39611, R01 HD 40777]; Centers for Disease Control and Prevention (CDC), Global AIDS Program (GAP); Elizabeth Glaser Pediatric AIDS Foundation (EGPAF); USAID Country Research Activity Award [GHS-A-00-00020-00]	National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention (CDC), Global AIDS Program (GAP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Elizabeth Glaser Pediatric AIDS Foundation (EGPAF); USAID Country Research Activity Award(United States Agency for International Development (USAID))	Funding: The study was supported by grants from the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH) (R01 HD 39611 and R01 HD 40777). Additional funding was received from the Centers for Disease Control and Prevention (CDC), Global AIDS Program (GAP); Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) (GMA is a recipient of the EGPAF Scientist Award); and USAID Country Research Activity Award (GHS-A-00-00020-00). The funders had no role in the design and conduct of the study, in the collection of the data, the interpretation of the data and in the preparation, review and approval of the manuscript.	Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; *CENTR STAT OFF, 2003, ZAMB DEM HLTH SURF 2; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; de Onis M, 2006, ACTA PAEDIATR, V95, P16, DOI 10.1080/08035320500495423; Ekpini ER, 1997, LANCET, V349, P1054, DOI 10.1016/S0140-6736(96)06444-6; Embree JE, 2000, AIDS, V14, P2535, DOI 10.1097/00002030-200011100-00016; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Fewtrell MS, 2007, AM J CLIN NUTR, V85, p635S, DOI 10.1093/ajcn/85.2.635S; Flores M, 2002, ANN TROP PAEDIATR, V22, P85, DOI 10.1179/027249302125000210; Forsyth B, 2001, AIDS, V15, P1326, DOI 10.1097/00002030-200107060-00024; Gaillard P, 2001, STAT MED, V20, P3525, DOI 10.1002/sim.1092; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jelliffe D. B., 1978, HUMAN MILK MODERN WO; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; LAWRENCE RA, 1999, BREASTFEEDING GUIDE; Matchaba PT, 1999, LANCET, V354, P1901, DOI 10.1016/S0140-6736(05)76865-3; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Neville M.C, 1983, LACTATION PHYSL NUTR; NEVILLE MC, 1990, ANN NY ACAD SCI, V586, P1, DOI 10.1111/j.1749-6632.1990.tb17783.x; POPKIN BM, 1990, PEDIATRICS, V86, P874; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Shaffer N, 1999, LANCET, V354, P1901, DOI 10.1016/S0140-6736(99)90207-6; SINKALA M, 2007, NO BENEFIT EARLY CES; Smith MM, 2000, NUTR REV, V58, P333, DOI 10.1111/j.1753-4887.2000.tb01830.x; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Thea DM, 2004, CONTROL CLIN TRIALS, V25, P353, DOI 10.1016/j.cct.2004.06.005; Thea DM, 2006, AIDS, V20, P1539, DOI 10.1097/01.aids.0000237370.49241.dc; VANDEPERRE P, 1991, NEW ENGL J MED, V325, P593, DOI 10.1056/NEJM199108293250901; VICTORA CG, 1987, LANCET, V2, P319; Walter J, 2006, J INFECT DIS, V194, P1510, DOI 10.1086/508996; World Health Organization, 2000, MAST CAUS MAN; 2000, WHOCDR9335	42	80	81	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1363	10.1371/journal.pone.0001363	http://dx.doi.org/10.1371/journal.pone.0001363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159246	Green Submitted, Green Published, gold			2022-12-27	WOS:000207459700020
J	Gaidelyte, A; Vaara, M; Bamford, DH				Gaidelyte, Ausra; Vaara, Martti; Bamford, Dennis H.			Bacteria, Phages and Septicemia	PLOS ONE			English	Article								The use of phages is an attractive option to battle antibiotic resistant bacteria in certain bacterial infections, but the role of phage ecology in bacterial infections is obscure. Here we surveyed the phage ecology in septicemia, the most severe type of bacterial infection. We observed that the majority of the bacterial isolates from septicemia patients spontaneously secreted phages active against other isolates of the same bacterial strain, but not to the strain causing the disease. Such phages were also detected in the initial blood cultures, indicating that phages are circulating in the blood at the onset of sepsis. The fact that most of the septicemic bacterial isolates carry functional prophages suggests an active role of phages in bacterial infections. Apparently, prophages present in sepsis-causing bacterial clones play a role in clonal selection during bacterial invasion.	[Gaidelyte, Ausra; Bamford, Dennis H.] Univ Helsinki, Inst Biotechnol, Dept Biol & Environm Sci, Helsinki, Finland; [Vaara, Martti] Helsinki Univ Hosp, Dept Clin Microbiol, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Bamford, DH (corresponding author), Univ Helsinki, Inst Biotechnol, Dept Biol & Environm Sci, Helsinki, Finland.	dennis.bamford@helsinki.fi	Domanska, Ausra/H-5206-2013; Domanska, Ausra/W-8927-2019; Vaara, Martti S/D-1698-2013	Domanska, Ausra/0000-0002-3772-6003; Bamford, Dennis/0000-0002-6438-8118	Finland Finnish Centre of Excellence Programme [1210253, 1213992, 1213467]	Finland Finnish Centre of Excellence Programme	This work was supported by the Academy of Finland Finnish Centre of Excellence Programme 2006-2011 (grants 1210253, 1213992, 1213467 to DHB).	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2; BAMFORD JKH, 1991, VIROLOGY, V181, P348, DOI 10.1016/0042-6822(91)90501-2; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Boyd EF, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P223; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Goerke C, 2006, ANTIMICROB AGENTS CH, V50, P171, DOI 10.1128/AAC.50.1.171-177.2006; Heymann DL, 2006, CELL, V124, P671, DOI 10.1016/j.cell.2006.02.009; Jikia D, 2005, CLIN EXP DERMATOL, V30, P23, DOI 10.1111/j.1365-2230.2004.01600.x; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Matsushiro A, 1999, J BACTERIOL, V181, P2257, DOI 10.1128/JB.181.7.2257-2260.1999; OLKKONEN VM, 1989, VIROLOGY, V171, P229, DOI 10.1016/0042-6822(89)90530-8; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Sulakvelidze A, 2005, DRUG DISCOV TODAY, V10, P807, DOI 10.1016/S1359-6446(05)03441-0; Teel LD, 2002, INFECT IMMUN, V70, P4282, DOI 10.1128/IAI.70.8.4282-4291.2002; *US FDA, FDA APPR LIST SPEC B; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	23	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1145	10.1371/journal.pone.0001145	http://dx.doi.org/10.1371/journal.pone.0001145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	18188406	gold, Green Published, Green Submitted			2022-12-27	WOS:000207459000028
J	Vallenet, D; Nordmann, P; Barbe, V; Poirel, L; Mangenot, S; Bataille, E; Dossat, C; Gas, S; Kreimeyer, A; Lenoble, P; Oztas, S; Poulain, J; Segurens, B; Robert, C; Abergel, C; Claverie, JM; Raoult, D; Medigue, C; Weissenbach, J; Cruveiller, S				Vallenet, David; Nordmann, Patrice; Barbe, Valerie; Poirel, Laurent; Mangenot, Sophie; Bataille, Elodie; Dossat, Carole; Gas, Shahinaz; Kreimeyer, Annett; Lenoble, Patricia; Oztas, Sophie; Poulain, Julie; Segurens, Beatrice; Robert, Catherine; Abergel, Chantal; Claverie, Jean-Michel; Raoult, Didier; Medigue, Claudine; Weissenbach, Jean; Cruveiller, Stephane			Comparative Analysis of Acinetobacters: Three Genomes for Three Lifestyles	PLOS ONE			English	Article							QUINOPROTEIN GLUCOSE-DEHYDROGENASE; VIBRIO-ANGUILLARUM; ESCHERICHIA-COLI; NATURAL TRANSFORMATION; VIRULENCE PLASMID; BIOFILM FORMATION; BAUMANNII; GENES; IDENTIFICATION; IRON	Acinetobacter baumannii is the source of numerous nosocomial infections in humans and therefore deserves close attention as multidrug or even pandrug resistant strains are increasingly being identified worldwide. Here we report the comparison of two newly sequenced genomes of A. baumannii. The human isolate A. baumannii AYE is multidrug resistant whereas strain SDF, which was isolated from body lice, is antibiotic susceptible. As reference for comparison in this analysis, the genome of the soil-living bacterium A. baylyi strain ADP1 was used. The most interesting dissimilarities we observed were that i) whereas strain AYE and A. baylyi genomes harbored very few Insertion Sequence elements which could promote expression of downstream genes, strain SDF sequence contains several hundred of them that have played a crucial role in its genome reduction (gene disruptions and simple DNA loss); ii) strain SDF has low catabolic capacities compared to strain AYE. Interestingly, the latter has even higher catabolic capacities than A. baylyi which has already been reported as a very nutritionally versatile organism. This metabolic performance could explain the persistence of A. baumannii nosocomial strains in environments where nutrients are scarce; iii) several processes known to play a key role during host infection (biofilm formation, iron uptake, quorum sensing, virulence factors) were either different or absent, the best example of which is iron uptake. Indeed, strain AYE and A. baylyi use siderophore-based systems to scavenge iron from the environment whereas strain SDF uses an alternate system similar to the Haem Acquisition System (HAS). Taken together, all these observations suggest that the genome contents of the 3 Acinetobacters compared are partly shaped by life in distinct ecological niches: human (and more largely hospital environment), louse, soil.	[Vallenet, David; Barbe, Valerie; Mangenot, Sophie; Bataille, Elodie; Dossat, Carole; Gas, Shahinaz; Kreimeyer, Annett; Lenoble, Patricia; Oztas, Sophie; Poulain, Julie; Segurens, Beatrice; Medigue, Claudine; Weissenbach, Jean; Cruveiller, Stephane] CEA, Inst Genom Genoscope, CNRS, UMR8030, Evry, France; [Nordmann, Patrice; Poirel, Laurent] Univ Paris 11, Hop Bicetre, Assistance Publique Hop Paris, Fac Med Paris Sud, Serv Bacteriol Virol, Le Kremlin Bicetre, France; [Robert, Catherine; Raoult, Didier] Univ Mediterranee, CNRS UMR6020, Fac Med, Unite Rickettsies, Marseille, France; [Abergel, Chantal; Claverie, Jean-Michel] IBSM, CNRS UPR2589, Informat Genom Structurale, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Vallenet, D (corresponding author), CEA, Inst Genom Genoscope, CNRS, UMR8030, Evry, France.	vallenet@genoscope.cns.fr; scruveil@genoscope.cns.fr	Claverie, Jean Michel/Z-2183-2019; RAOULT, Didier/A-8434-2008; Poirel, Laurent/ABE-6736-2020; Claverie, Jean-Michel/AAG-4889-2019	RAOULT, Didier/0000-0002-0633-5974; Claverie, Jean-Michel/0000-0003-1424-0315; Poulain, Julie/0000-0002-8744-3116; Abergel, Chantal/0000-0003-1875-4049; Vallenet, David/0000-0001-6648-0332; Poirel, Laurent/0000-0001-5160-5286				Abdel-el-haleem D., 2003, AFR J BIOTECHNOL, V2, P71, DOI 10.5897/AJB2003.000-1014; Achaz G, 2007, BIOINFORMATICS, V23, P119, DOI 10.1093/bioinformatics/btl519; Actis LA, 1999, J MICROBIOL METH, V39, P79, DOI 10.1016/S0167-7012(99)00099-8; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Averhoff B, 2003, ARCH MICROBIOL, V180, P385, DOI 10.1007/s00203-003-0616-6; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; BAUMANN P, 1968, J BACTERIOL, V95, P1520, DOI 10.1128/JB.95.5.1520-1541.1968; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; BOUVET PJM, 1987, ANN INST PASTEUR MIC, V138, P569, DOI 10.1016/0769-2609(87)90042-1; Boyer F, 2005, BIOINFORMATICS, V21, P4209, DOI 10.1093/bioinformatics/bti711; Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLETONJANSEN AM, 1988, NUCLEIC ACIDS RES, V16, P6228, DOI 10.1093/nar/16.13.6228; CLETONJANSEN AM, 1989, MOL GEN GENET, V217, P430, DOI 10.1007/BF02464914; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dal S, 2005, APPL ENVIRON MICROB, V71, P1025, DOI 10.1128/AEM.71.2.1025-1034.2005; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; de Vries J, 2001, FEMS MICROBIOL LETT, V195, P211, DOI 10.1111/j.1574-6968.2001.tb10523.x; Di Lorenzo M, 2003, J BACTERIOL, V185, P5822, DOI 10.1128/JB.185.19.5822-5830.2003; DOLZANI L, 1995, J CLIN MICROBIOL, V33, P1108, DOI 10.1128/JCM.33.5.1108-1113.1995; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FONTECAVE M, 1994, BIOMETALS, V7, P3; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Galan B, 2004, J BACTERIOL, V186, P2215, DOI 10.1128/JB.186.7.2215-2220.2004; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heritier C, 2006, CLIN MICROBIOL INFEC, V12, P123, DOI 10.1111/j.1469-0691.2005.01320.x; Houhamdi L, 2006, AM J TROP MED HYG, V74, P526, DOI 10.4269/ajtmh.2006.74.526; Janssen P, 1997, INT J SYST BACTERIOL, V47, P1179, DOI 10.1099/00207713-47-4-1179; Kang BR, 2004, CAN J MICROBIOL, V50, P935, DOI 10.1139/W04-083; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Maslunka C, 2006, SYST APPL MICROBIOL, V29, P216, DOI 10.1016/j.syapm.2005.07.015; McKean SC, 2007, MICROBIOL-SGM, V153, P2203, DOI 10.1099/mic.0.2007/005926-0; MERINO E, 1992, MOL MICROBIOL, V6, P2175, DOI 10.1111/j.1365-2958.1992.tb01391.x; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; Ofori-Darko E, 2000, INFECT IMMUN, V68, P3657, DOI 10.1128/IAI.68.6.3657-3666.2000; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; PIERSON LS, 1994, J BACTERIOL, V176, P3966, DOI 10.1128/JB.176.13.3966-3974.1994; RUMBAUGH KP, 2006, ANAL BIOANAL CHEM; Segal H, 2005, FEMS MICROBIOL LETT, V243, P425, DOI 10.1016/j.femsle.2005.01.005; Segura A, 1999, J BACTERIOL, V181, P3494, DOI 10.1128/JB.181.11.3494-3504.1999; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; SMITH LT, 1988, J BACTERIOL, V170, P3142, DOI 10.1128/jb.170.7.3142-3149.1988; Smith MA, 2003, APPL ENVIRON MICROB, V69, P524, DOI 10.1128/AEM.69.1.524-532.2003; Smith MG, 2004, MOL CELL BIOL, V24, P3874, DOI 10.1128/MCB.24.9.3874-3884.2004; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Stork M, 2002, PLASMID, V48, P222, DOI 10.1016/S0147-619X(02)00111-7; TAYLOR WH, 1961, J BACTERIOL, V81, P694, DOI 10.1128/JB.81.5.694-703.1961; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; TOLMASKY ME, 1995, MOL MICROBIOL, V15, P87, DOI 10.1111/j.1365-2958.1995.tb02223.x; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; vanderPloeg JR, 1996, J BACTERIOL, V178, P5438, DOI 10.1128/jb.178.18.5438-5446.1996; VANEECHOUTTE M, 1995, J CLIN MICROBIOL, V33, P11; Vidal R, 1996, MICROBIOS, V86, P49; Walzer G, 2006, ENVIRON MICROBIOL, V8, P1026, DOI 10.1111/j.1462-2920.2006.00994.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Welch TJ, 2000, J BACTERIOL, V182, P6762, DOI 10.1128/JB.182.23.6762-6773.2000; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Whitehead NA, 2001, NAT BIOTECHNOL, V19, P735, DOI 10.1038/90780; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0	74	245	872	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1805	10.1371/journal.pone.0001805	http://dx.doi.org/10.1371/journal.pone.0001805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350144	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762300010
J	Desrivieres, S; Krause, K; Dyer, A; Frank, J; Blomeyer, D; Lathrop, M; Mann, K; Banaschewski, T; Laucht, M; Schumann, G				Desrivieres, Sylvane; Krause, Kristina; Dyer, Anne; Frank, Josef; Blomeyer, Dorothea; Lathrop, Mark; Mann, Karl; Banaschewski, Tobias; Laucht, Manfred; Schumann, Gunter			Nucleotide Sequence Variation within the PI3K p85 Alpha Gene Associates with Alcohol Risk Drinking Behaviour in Adolescents	PLOS ONE			English	Article								Background: While the phosphatidylinositol 3-kinase (PI3K)-dependent signaling pathway is typically known to regulate cell growth and survival, emerging evidence suggest a role for this pathway in regulating the behavioural responses to addictive drugs. Methodology/Principal Findings: To investigate whether PI3K contributes to patterns of risky alcohol drinking in human, we investigated genetic variations in PIK3R1, encoding the 85 kD regulatory subunit of PIK, in 145 family trios consisting of 15-16 year old adolescents and their parents. Screening for mutations in exons, exon-intron boundaries and regulatory sequences, we identified 14 single nucleotide polymorphisms (SNPs) in the PIK3R1 gene region from exon 1 to the beginning of the 39 untranslated region (UTR). These SNPs defined haplotypes for the respective PIK3R1 region. Four haplotype tagging (ht)SNPs (rs706713, rs2302975, rs171649 and rs1043526), discriminating all haplotypes with a frequency >= 4.5% were identified. These htSNPs were used to genotype adolescents from the "Mannheim Study of Risk Children'' (MARC). Transmission disequilibrium tests in these adolescents and their parents demonstrated sex-specific association of two SNPs, rs2302975 and rs1043526, with patterns of risky alcohol consumption in male adolescents, including lifetime prevalence of drunkenness (p = 0.0019 and 0.0379, respectively) and elevated maximum amount of drinking (p = 0.0020 and 0.0494, respectively), as a measure for binge drinking pattern. Conclusions/Significance: Our findings highlight a previously unknown relevance of PIK3R1 genotypes for alcohol use disorders and might help discriminate individuals at risk for alcoholism.	[Desrivieres, Sylvane; Krause, Kristina; Schumann, Gunter] Kings Coll London, Sect Addict Biol, Interdisciplinary Res Grp Addict, London WC2R 2LS, England; [Krause, Kristina; Frank, Josef; Mann, Karl; Schumann, Gunter] Central Inst Mental Hlth, Dept Addict Med, Mol Genet Lab, Mannheim, Germany; [Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Blomeyer, Dorothea; Banaschewski, Tobias; Laucht, Manfred] Central Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany; [Dyer, Anne] Central Inst Mental Hlth, Dept Psychosomat Med, Mannheim, Germany; [Laucht, Manfred] Univ Potsdam, Dept Psychol, Div Clin Psychol, Potsdam, Germany	University of London; King's College London; Central Institute of Mental Health; CEA; UDICE-French Research Universities; Universite Paris Saclay; Central Institute of Mental Health; Central Institute of Mental Health; University of Potsdam	Desrivieres, S (corresponding author), Kings Coll London, Sect Addict Biol, Interdisciplinary Res Grp Addict, London WC2R 2LS, England.	manfred.laucht@zi-mannheim.de	Schumann, Gunter/H-1013-2013; Banaschewski, Tobias/ABE-5985-2020; Desrivieres, Sylvane/B-7399-2011; Desrivières, Sylvane/ABC-4336-2021	Banaschewski, Tobias/0000-0003-4595-1144; Desrivieres, Sylvane/0000-0002-9120-7060; Desrivières, Sylvane/0000-0002-9120-7060	German Federal Ministry for Education and Research [FKZ EB 01011300]; German National Genome Research Network [FKZ 01GS0117]; UK Department of Health NIHR-Biomedical Research Centre; European Commission [PL 037286]; Medical Research Council [G9817803B] Funding Source: researchfish	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; UK Department of Health NIHR-Biomedical Research Centre; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the German Federal Ministry for Education and Research as part of the "Baden-Wuerttemberg Consortium for Addiction Research" (FKZ EB 01011300), the German "National Genome Research Network" (FKZ 01GS0117) as well as the UK Department of Health NIHR-Biomedical Research Centre "Mental Health" and the Framework Programme 6 of the European Commission (Project "IMAGEN" PL 037286). Design and conduct of the study, collection, analysis, interpretation of the data, preparation, review and approval of the manuscript were completely independent of the sponsors of this study.	Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Cowen MS, 2005, J PHARMACOL EXP THER, V315, P590, DOI 10.1124/jpet.105.090449; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Dodd PR, 2000, NEUROCHEM INT, V37, P509, DOI 10.1016/S0197-0186(00)00061-9; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fiskerstrand CE, 1999, FEBS LETT, V458, P171, DOI 10.1016/S0014-5793(99)01150-3; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Higuchi S, 2006, CURR OPIN PSYCHIATR, V19, P253, DOI 10.1097/01.yco.0000218595.54054.7a; Hingson R, 2003, J STUD ALCOHOL, V64, P23, DOI 10.15288/jsa.2003.64.23; Hodge CW, 2006, PSYCHOPHARMACOLOGY, V183, P429, DOI 10.1007/s00213-005-0217-y; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang CC, 2004, J NEUROCHEM, V89, P217, DOI 10.1111/j.1471-4159.2003.02307.x; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Laucht M, 2000, J AM ACAD CHILD PSY, V39, P1229, DOI 10.1097/00004583-200010000-00009; Long Fan, 2004, In Silico Biology, V4, P395; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McCarty CA, 2004, PEDIATRICS, V114, P714, DOI 10.1542/peds.2003-0864-L; MULLER R, 1991, CHANGING TRENDS CONS; Nolen-Hoeksema S, 2006, J GEN PSYCHOL, V133, P357, DOI 10.3200/GENP.133.4.357-374; Olive MF, 2005, MOL PHARMACOL, V67, P349, DOI 10.1124/mol.104.003319; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Pincock S, 2003, LANCET, V362, P1126, DOI 10.1016/S0140-6736(03)14502-3; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schroeder JP, 2005, PSYCHOPHARMACOLOGY, V179, P262, DOI 10.1007/s00213-005-2175-9; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Sher KJ, 2005, ANNU REV CLIN PSYCHO, V1, P493, DOI 10.1146/annurev.clinpsy.1.102803.144107; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Tsai GC, 1998, ANNU REV MED, V49, P173; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; Uhl GR, 2008, BIOCHEM PHARMACOL, V75, P98, DOI 10.1016/j.bcp.2007.06.042; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; XU K, 2007, PHARMACOGENOMICS J	49	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1769	10.1371/journal.pone.0001769	http://dx.doi.org/10.1371/journal.pone.0001769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335044	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000023
J	Mohan, S; Ma, PWK; Williams, WP; Luthe, DS				Mohan, Srinidi; Ma, Peter W. K.; Williams, W. Paul; Luthe, Dawn S.			A Naturally Occurring Plant Cysteine Protease Possesses Remarkable Toxicity against Insect Pests and Synergizes Bacillus thuringiensis Toxin	PLOS ONE			English	Article							CORN-BORER LEPIDOPTERA; PERITROPHIC MATRIX; TRANSGENIC PLANTS; INTESTINAL MUCIN; DIAMONDBACK MOTH; RESISTANCE; NOCTUIDAE; PROTEINS; CROPS; DEGRADATION	When caterpillars feed on maize (Zea maize L.) lines with native resistance to several Lepidopteran pests, a defensive cysteine protease, Mir1-CP, rapidly accumulates at the wound site. Mir1-CP has been shown to inhibit caterpillar growth in vivo by attacking and permeabilizing the insect's peritrophic matrix (PM), a structure that surrounds the food bolus, assists in digestion and protects the midgut from microbes and toxins. PM permeabilization weakens the caterpillar defenses by facilitating the movement of other insecticidal proteins in the diet to the midgut microvilli and thereby enhancing their toxicity. To directly determine the toxicity of Mir1-CP, the purified recombinant enzyme was directly tested against four economically significant Lepidopteran pests in bioassays. Mir1-CP LC50 values were 1.8, 3.6, 0.6, and 8.0 ppm for corn earworm, tobacco budworm, fall armyworm and southwestern corn borer, respectively. These values were the same order of magnitude as those determined for the Bacillus thuringiensis toxin Bt-CryIIA. In addition to being directly toxic to the larvae, 60 ppb Mir1-CP synergized sublethal concentrations of Bt-CryIIA in all four species. Permeabilization of the PM by Mir1-CP probably provides ready access to Bt-binding sites on the midgut microvilli and increases its activity. Consequently, Mir1-CP could be used for controlling caterpillar pests in maize using non-transgenic approaches and potentially could be used in other crops either singly or in combination with Bt-toxins.	[Mohan, Srinidi; Ma, Peter W. K.] Mississippi State, Dept Entomol, Starkville, MS USA; [Williams, W. Paul] Mississippi State, USDA ARS, Corn Host Plant Resist Lab, Starkville, MS USA; [Luthe, Dawn S.] Penn State Univ, Dept Crop & Soil Sci, University Pk, PA USA	Mississippi State University; Mississippi State University; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mohan, S (corresponding author), Mississippi State, Dept Entomol, Starkville, MS USA.	DSL14@psu.edu	GUO, Zhaoyu/AAS-5699-2020		National Science Foundation Awards [IBN-0131328, IOS-0641219]	National Science Foundation Awards(National Science Foundation (NSF))	This research was funded by National Science Foundation Awards IBN-0131328 and IOS-0641219.	Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Ali MI, 2006, J ECON ENTOMOL, V99, P164, DOI 10.1603/0022-0493(2006)099[0164:SOHZAH]2.0.CO;2; BOULTER D, 1993, PHYTOCHEMISTRY, V34, P1453, DOI 10.1016/S0031-9422(00)90828-8; Brookes G., 2005, AgBioForum, V8, P187; Chaufaux J, 2001, J ECON ENTOMOL, V94, P1564, DOI 10.1603/0022-0493-94.6.1564; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; DAVIS FM, 1988, MISS AGR EXP STN TEC, V157, P1; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; GATEHOUSE AMR, 1993, PHILOS T R SOC B, V342, P279, DOI 10.1098/rstb.1993.0158; Gould F, 2003, NAT BIOTECHNOL, V21, P1450, DOI 10.1038/nbt1203-1450; HAMA H, 1992, APPL ENTOMOL ZOOL, V27, P355, DOI 10.1303/aez.27.355; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hoffmann WA, 2002, ANN BOT-LONDON, V90, P37, DOI 10.1093/aob/mcf140; HOFMANN C, 1988, EUR J BIOCHEM, V173, P85, DOI 10.1111/j.1432-1033.1988.tb13970.x; HOFTE H, 1989, MICROBIOL REV, V53, P242; Huesing J., 2004, AgBioForum, V7, P84; James C., 2006, PREVIEW GLOBAL STATU; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECADET MM, 1967, J INVERTEBR PATHOL, V9, P310, DOI 10.1016/0022-2011(67)90065-1; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; LUTHY P, 1981, BACILLUS THURINGIENS; Mohan S, 2006, J INSECT PHYSIOL, V52, P21, DOI 10.1016/j.jinsphys.2005.08.011; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899; PECHAN T, 2000, PLANT CELL, V33; RAWLINGS ND, 1992, BIOL CHEM H-S, V373, P1211, DOI 10.1515/bchm3.1992.373.2.1211; ROBERTSON JL, PESTICIDE BIOASSAYS; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; *SAS I INC, 1998, SAS STAT US GUID VER; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; TOJO A, 1983, APPL ENVIRON MICROB, V45, P576, DOI 10.1128/AEM.45.2.576-580.1983; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041; WI FIJ, 1999, J GEN VIROL, V80, P3289; WILLIAMS WP, 1990, J ECON ENTOMOL, V83, P1578, DOI 10.1093/jee/83.4.1578; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	45	47	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1786	10.1371/journal.pone.0001786	http://dx.doi.org/10.1371/journal.pone.0001786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335057	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000038
J	Bouchabke, O; Chang, FQ; Simon, M; Voisin, R; Pelletier, G; Durand-Tardif, M				Bouchabke, Oumaya; Chang, Fengqi; Simon, Matthieu; Voisin, Roger; Pelletier, Georges; Durand-Tardif, Mylene			Natural Variation in Arabidopsis thaliana as a Tool for Highlighting Differential Drought Responses	PLOS ONE			English	Article							CELL-MEMBRANE STABILITY; WATER-USE EFFICIENCY; PLANT-RESPONSES; COMPLEX TRAITS; IDENTIFICATION; EXPRESSION; TOLERANCE; DEFICIT; STRESS; GROWTH	To test whether natural variation in Arabidopsis could be used to dissect out the genetic basis of responses to drought stress, we characterised a number of accessions. Most of the accessions belong to a core collection that was shown to maximise the genetic diversity captured for a given number of individual accessions in Arabidopsis thaliana. We measured total leaf area (TLA), Electrolyte Leakage (EL), Relative Water Content (RWC), and Cut Rosette Water Loss (CRWL) in control and mild water deficit conditions. A Principal Component Analysis revealed which traits explain most of the variation and showed that some accessions behave differently compared to the others in drought conditions, these included Ita-0, Cvi-0 and Shahdara. This study relied on genetic variation found naturally within the species, in which populations are assumed to be adapted to their environment. Overall, Arabidopsis thaliana showed interesting phenotypic variations in response to mild water deficit that can be exploited to identify genes and alleles important for this complex trait.	[Bouchabke, Oumaya; Chang, Fengqi; Simon, Matthieu; Voisin, Roger; Pelletier, Georges; Durand-Tardif, Mylene] INRA, Stn Genet Amelioration plantes, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bouchabke, O (corresponding author), INRA, Stn Genet Amelioration plantes, F-78026 Versailles, France.	durand-t@versailles.inra.fr		Mylene, Durand-Tardif/0000-0003-1568-6941; Bouchabke-Coussa, Oumaya/0000-0003-3311-666X	PRA fellowship [BT02-5]; INRA	PRA fellowship; INRA	Dr. F. Chang has been supported by a PRA fellowship (BT02-5). All the other authors received INRA support.	Aguirrezabal L, 2006, PLANT CELL ENVIRON, V29, P2216, DOI 10.1111/j.1365-3040.2006.01595.x; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Bandurska H, 2001, ACTA PHYSIOL PLANT, V23, P483, DOI 10.1007/s11738-001-0059-0; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Calenge F, 2006, PLANT PHYSIOL, V141, P1630, DOI 10.1104/pp.106.082396; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Jones HG, 2007, J EXP BOT, V58, P119, DOI 10.1093/jxb/erl118; Juenger TE, 2005, PLANT CELL ENVIRON, V28, P697, DOI 10.1111/j.1365-3040.2004.01313.x; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Knight CA, 2006, MOL ECOL, V15, P1229, DOI 10.1111/j.1365-294X.2006.02818.x; KOORNNEEF M, 2004, ANN REV PLANT BIOL, V55; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Liu L, 2004, EUPHYTICA, V138, P149, DOI 10.1023/B:EUPH.0000046801.27042.14; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; LUDLOW MM, 1989, STRUCTURAL AND FUNCTIONAL RESPONSES TO ENVIRONMENTAL STRESSES : WATER SHORTAGE, P269; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mouille G, 2006, PLANT PHYSIOL, V141, P1035, DOI 10.1104/pp.106.079384; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Perchepied L, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000123; Pigliucci M, 1998, TRENDS PLANT SCI, V3, P485, DOI 10.1016/S1360-1385(98)01343-0; PREMACHANDRA GS, 1992, J EXP BOT, V43, P1569, DOI 10.1093/jxb/43.12.1569; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Richards LA, 1941, SOIL SCI, V51, P377, DOI 10.1097/00010694-194105000-00005; Richards RA, 1996, PLANT GROWTH REGUL, V20, P157, DOI 10.1007/BF00024012; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Scott P, 2000, ANN BOT-LONDON, V85, P159, DOI 10.1006/anbo.1999.1006; Sherrard ME, 2006, EVOLUTION, V60, P2478, DOI 10.1111/j.0014-3820.2006.tb01883.x; Shindo C, 2007, ANN BOT-LONDON, V99, P1043, DOI 10.1093/aob/mcl281; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295	44	99	101	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1705	10.1371/journal.pone.0001705	http://dx.doi.org/10.1371/journal.pone.0001705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301780	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586500049
J	Bethune, MT; Borda, JT; Ribka, E; Liu, MX; Phillippi-Falkenstein, K; Jandacek, RJ; Doxiadis, GGM; Gray, GM; Khosla, C; Sestak, K				Bethune, Michael T.; Borda, Juan T.; Ribka, Erin; Liu, Michael-Xun; Phillippi-Falkenstein, Kathrine; Jandacek, Ronald J.; Doxiadis, Gaby G. M.; Gray, Gary M.; Khosla, Chaitan; Sestak, Karol			A Non-Human Primate Model for Gluten Sensitivity	PLOS ONE			English	Article								Background and Aims: Gluten sensitivity is widespread among humans. For example, in celiac disease patients, an inflammatory response to dietary gluten leads to enteropathy, malabsorption, circulating antibodies against gluten and transglutaminase 2, and clinical symptoms such as diarrhea. There is a growing need in fundamental and translational research for animal models that exhibit aspects of human gluten sensitivity. Methods: Using ELISA-based antibody assays, we screened a population of captive rhesus macaques with chronic diarrhea of non-infectious origin to estimate the incidence of gluten sensitivity. A selected animal with elevated anti-gliadin antibodies and a matched control were extensively studied through alternating periods of gluten-free diet and gluten challenge. Blinded clinical and histological evaluations were conducted to seek evidence for gluten sensitivity. Results: When fed with a gluten-containing diet, gluten-sensitive macaques showed signs and symptoms of celiac disease including chronic diarrhea, malabsorptive steatorrhea, intestinal lesions and anti-gliadin antibodies. A gluten-free diet reversed these clinical, histological and serological features, while reintroduction of dietary gluten caused rapid relapse. Conclusions: Gluten-sensitive rhesus macaques may be an attractive resource for investigating both the pathogenesis and the treatment of celiac disease.	[Bethune, Michael T.; Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Borda, Juan T.; Ribka, Erin; Liu, Michael-Xun; Phillippi-Falkenstein, Kathrine; Sestak, Karol] Tulane Natl Primate Res Ctr, Covington, LA USA; [Jandacek, Ronald J.] Univ Cincinnati, Dept Pathol, Lab Med, Cincinnati, OH USA; [Doxiadis, Gaby G. M.] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Gray, Gary M.] Stanford Univ, Dept Med, Stanford, CA USA; [Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA USA; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA USA; [Sestak, Karol] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA USA	Stanford University; Tulane University; University System of Ohio; University of Cincinnati; Stanford University; Stanford University; Stanford University; Tulane University	Bethune, MT (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	ksestak@tulane.edu		Khosla, Chaitan/0000-0001-6529-495X	TNPRC [R21 AI54146, R01 DK063158, P51 RR00164, U24 RR018111]; University of Cincinnati [DK59630]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR018111, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076653, U24DK059630, U2CDK059630, R01DK063158] Funding Source: NIH RePORTER	TNPRC; University of Cincinnati; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support: This research was jointly supported by R21 AI54146 to K.S., R01 DK063158 to C.K., grants P51 RR00164 and U24 RR018111 to the TNPRC, and DK59630 to the University of Cincinnati. M.T.B. was a recipient of an NIH Cellular and Molecular Biology Training Grant through Stanford University at the outset of this work.	Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; BATT RM, 1984, RES VET SCI, V37, P339, DOI 10.1016/S0034-5288(18)31875-7; BATT RM, 1987, DIGEST DIS SCI, V32, P184, DOI 10.1007/BF01297107; BETHUNE MT, 2008, PLOS ONE IN PRESS; Borda JT, 2004, AM J PATHOL, V165, P2111, DOI 10.1016/S0002-9440(10)63261-0; Cerf-Bensussan N, 2007, GUT, V56, P157, DOI 10.1136/gut.2005.090498; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Dassanayake RP, 2005, J CLIN MICROBIOL, V43, P641, DOI 10.1128/JCM.43.2.641-649.2005; DICKE W K, 1953, Acta Paediatr, V42, P34, DOI 10.1111/j.1651-2227.1953.tb05563.x; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Green PHR, 2006, ANNU REV MED, V57, P207, DOI 10.1146/annurev.med.57.051804.122404; HALL EJ, 1992, GUT, V33, P198, DOI 10.1136/gut.33.2.198; HARRIS RL, 1984, LAB ANIM SCI, V34, P610; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Johnston SD, 1998, QJM-MON J ASSOC PHYS, V91, P853, DOI 10.1093/qjmed/91.12.853; MAKI M, 1995, BAILLIERE CLIN GASTR, V9, P231, DOI 10.1016/0950-3528(95)90030-6; March JB, 2003, DIGEST DIS SCI, V48, P608, DOI 10.1023/A:1022565522441; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Polvi A, 1998, TISSUE ANTIGENS, V52, P543, DOI 10.1111/j.1399-0039.1998.tb03085.x; Polvi A, 1997, TISSUE ANTIGENS, V49, P236, DOI 10.1111/j.1399-0039.1997.tb02744.x; Ramesh G, 2005, CLIN DIAGN LAB IMMUN, V12, P192, DOI 10.1128/CDLI.12.1.192-197.2005; Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition, 1990, ARCH DIS CHILD, V65, P909; Rewers M, 2005, GASTROENTEROLOGY, V128, pS47, DOI 10.1053/j.gastro.2005.02.030; Schuppan Detlef, 2005, Nutr Clin Care, V8, P54; Sestak K, 2005, CURR HIV RES, V3, P199, DOI 10.2174/1570162054368084; Sestak K, 2003, INFECT IMMUN, V71, P4079, DOI 10.1128/IAI.71.7.4079-4086.2003; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2005, NAT CLIN PRACT GASTR, V2, P140, DOI 10.1038/ncpgasthep0111; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Spurkland A, 1997, TISSUE ANTIGENS, V49, P29, DOI 10.1111/j.1399-0039.1997.tb02706.x; Stepniak D, 2006, TRENDS BIOTECHNOL, V24, P433, DOI 10.1016/j.tibtech.2006.08.003; WAGNER JD, 1988, LAB ANIM SCI, V38, P592; Wahab PJ, 2002, AM J CLIN PATHOL, V118, P459	36	57	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1614	10.1371/journal.pone.0001614	http://dx.doi.org/10.1371/journal.pone.0001614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286171	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400007
J	Pooggin, MM; Futterer, J; Hohn, T				Pooggin, Mikhail M.; Fuetterer, Johannes; Hohn, Thomas			Cross-Species Functionality of Pararetroviral Elements Driving Ribosome Shunting	PLOS ONE			English	Article								Background: Cauliflower mosaic virus (CaMV) and Rice tungro bacilliform virus (RTBV) belong to distinct genera of pararetroviruses infecting dicot and monocot plants, respectively. In both viruses, polycistronic translation of pregenomic (pg) RNA is initiated by shunting ribosomes that bypass a large region of the pgRNA leader with several short (s) ORFs and a stable stem-loop structure. The shunt requires translation of a 5'-proximal sORF terminating near the stem. In CaMV, mutations knocking out this sORF nearly abolish shunting and virus viability. Methodology/Principal Findings: Here we show that two distant regions of the CaMV leader that form a minimal shunt configuration comprising the sORF, a bottom part of the stem, and a shunt landing sequence can be replaced by heterologous sequences that form a structurally similar configuration in RTBV without any dramatic effect on shunt-mediated translation and CaMV infectivity. The CaMV-RTBV chimeric leader sequence was largely stable over five viral passages in turnip plants: a few alterations that did eventually occur in the virus progenies are indicative of fine tuning of the chimeric sequence during adaptation to a new host. Conclusions/Significance: Our findings demonstrate cross-species functionality of pararetroviral cis-elements driving ribosome shunting and evolutionary conservation of the shunt mechanism. We are grateful to Matthias Muller and Sandra Pauli for technical assistance. This work was initiated at Friedrich Miescher Institute (Basel, Switzerland). We thank Prof. Thomas Boller for hosting the group at the Institute of Botany.	[Pooggin, Mikhail M.; Hohn, Thomas] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Fuetterer, Johannes] ETH Zentrum, Inst Plant Sci, Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pooggin, MM (corresponding author), Univ Basel, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	Mikhail.Pooggin@unibas.ch		Pooggin, Mikhail/0000-0003-2308-393X	FEBS [fellowship]	FEBS	This work was initially supported a FEBS fellowship to MMP.	Babinger K, 2006, DEVELOPMENT, V133, P4045, DOI 10.1242/dev.02582; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; BONNEVILLE JM, 1989, CELL, V59, P1135, DOI 10.1016/0092-8674(89)90769-1; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P9488, DOI 10.1073/pnas.0603597103; de Breyne S, 2003, NUCLEIC ACIDS RES, V31, P608, DOI 10.1093/nar/gkg143; Dominguez DI, 1998, J BIOL CHEM, V273, P3669, DOI 10.1074/jbc.273.6.3669; DRIESEN M, 1993, VIROLOGY, V195, P203, DOI 10.1006/viro.1993.1361; FUTTERER J, 1990, EMBO J, V9, P1697, DOI 10.1002/j.1460-2075.1990.tb08293.x; FUTTERER J, 1991, EMBO J, V10, P3887, DOI 10.1002/j.1460-2075.1991.tb04958.x; FUTTERER J, 1993, CELL, V73, P789, DOI 10.1016/0092-8674(93)90257-Q; Futterer J, 1996, J VIROL, V70, P2999; FUTTERER J, 1994, VIROLOGY, V198, P663, DOI 10.1006/viro.1994.1078; Futterer J, 1997, J VIROL, V71, P7984; Geering ADW, 2005, ARCH VIROL, V150, P787, DOI 10.1007/s00705-004-0471-z; Guerra-Peraza O, 2000, J VIROL, V74, P2067, DOI 10.1128/JVI.74.5.2067-2072.2000; Hemmings-Mieszczak M, 1998, RNA, V4, P101; HemmingsMieszczak M, 1997, J MOL BIOL, V267, P1075, DOI 10.1006/jmbi.1997.0929; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hull R., 1999, ENCYCL VIROL, V65, P1292; Hull R., 2002, MATTHEWS PLANT VIROL; KISSLASZLO Z, 1995, EMBO J, V14, P3552, DOI 10.1002/j.1460-2075.1995.tb07361.x; Lorkovic ZJ, 2000, TRENDS PLANT SCI, V5, P160, DOI 10.1016/S1360-1385(00)01595-8; Mize GJ, 1998, J BIOL CHEM, V273, P32500, DOI 10.1074/jbc.273.49.32500; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; Pauli S, 2004, J VIROL, V78, P12120, DOI 10.1128/JVI.78.22.12120-12128.2004; Pooggin MM, 2002, PLANT VIRUSES AS MOLECULAR PATHOGENS, P317; Pooggin MM, 2006, RNA, V12, P841, DOI 10.1261/rna.2285806; Pooggin MM, 2000, J BIOL CHEM, V275, P17288, DOI 10.1074/jbc.M001143200; Pooggin MM, 1999, J GEN VIROL, V80, P2217, DOI 10.1099/0022-1317-80-8-2217; Pooggin MM, 1998, J VIROL, V72, P4157, DOI 10.1128/JVI.72.5.4157-4169.1998; Pooggin MM, 2001, P NATL ACAD SCI USA, V98, P886, DOI 10.1073/pnas.98.3.886; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; ROTHNIE HM, 1994, EMBO J, V13, P2200, DOI 10.1002/j.1460-2075.1994.tb06497.x; Ryabova LA, 2000, GENE DEV, V14, P817; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; Shababi M, 2006, J VIROL, V80, P3811, DOI 10.1128/JVI.80.8.3811-3822.2006; THIBEAULD O, 2008, ALTERNATIVE IN PRESS; Xi QR, 2005, J VIROL, V79, P5676, DOI 10.1128/JVI.79.9.5676-5683.2005; Yueh A, 2000, GENE DEV, V14, P414	40	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1650	10.1371/journal.pone.0001650	http://dx.doi.org/10.1371/journal.pone.0001650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286203	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400043
J	Popmihajlov, Z; Smith, KA				Popmihajlov, Zoran; Smith, Kendall A.			Negative Feedback Regulation of T Cells via Interleukin-2 and FOXP3 Reciprocity	PLOS ONE			English	Article								As interleukin-2 (IL2) is central to the clonal expansion of antigen-selected T cells, we investigated the relationship between IL2 and the negative regulatory transcription factor FOXP3. We found IL2 to be responsible for T cell antigen receptor (TCR)activated FOXP3 expression by both CD4+ and CD8+ human T cells, and as anticipated, FOXP3 expression restricted TCR-stimulated IL2 expression. However, no evidence could be found that FOXP3+ cells actively suppress IL2 expression by FOXP3-cells. These data are consistent with an IL2/FOXP3- dependent negative feedback loop that normally regulates the T cell immune response. It follows that a defect in this negative feedback loop as a result of a deficiency of either IL2 or FOXP3 will lead to a hyperproliferative autoimmune syndrome, without the necessity of invoking an active suppressive function for FOXP3+ T cells.	[Popmihajlov, Zoran; Smith, Kendall A.] Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA	Cornell University	Popmihajlov, Z (corresponding author), Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA.	kasmith@med.cornell.edu			NIAID/NIH; Belfer Foundation	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Belfer Foundation	NIAID/NIH, Belfer Foundation. Neither funding source participated in the conduct of the study, in the collection, analysis, intrpretation of the data, or in the preparation, review or approval of the manuscript.	Ahmadzadeh M, 2007, J IMMUNOTHER, V30, P294, DOI 10.1097/CJI.0b013e3180336787; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clark LB, 1999, J IMMUNOL, V162, P2546; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; GILLIS S, 1978, J IMMUNOL, V120, P2027; GODFREY VL, 1994, AM J PATHOL, V145, P281; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Horak I, 1995, IMMUNOL REV, V148, P35, DOI 10.1111/j.1600-065X.1995.tb00092.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Klebb G, 1996, CLIN IMMUNOL IMMUNOP, V81, P282, DOI 10.1006/clin.1996.0190; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kuroda K, 1996, J IMMUNOL, V157, P1422; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; MARSON A, 2007, NATURE; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; PANDIYAN P, 2007, NAT IMMUNOL     1104, P1; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; RUSSELL WL, 1959, P NATL ACAD SCI USA, V45, P18, DOI 10.1073/pnas.45.1.18; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x; SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; SuriPayer E, 1996, J IMMUNOL, V157, P1799; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y., 2007, NATURE; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	64	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1581	10.1371/journal.pone.0001581	http://dx.doi.org/10.1371/journal.pone.0001581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18324310	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900017
J	Shindo, A; Yamamoto, TS; Ueno, N				Shindo, Asako; Yamamoto, Takamasa S.; Ueno, Naoto			Coordination of Cell Polarity during Xenopus Gastrulation	PLOS ONE			English	Article								Cell polarity is an essential feature of animal cells contributing to morphogenesis. During Xenopus gastrulation, it is known that chordamesoderm cells are polarized and intercalate each other allowing anterior-posterior elongation of the embryo proper by convergent extension (CE). Although it is well known that the cellular protrusions at both ends of polarized cells exert tractive force for intercalation and that PCP pathway is known to be essential for the cell polarity, little is known about what triggers the cell polarization and what the polarization causes to control intracellular events enabling the intercalation that leads to the CE. In our research, we used EB3 (end-binding 3), a member of + TIPs that bind to the plus end of microtubule (MT), to visualize the intracellular polarity of chordamesoderm cells during CE to investigate the trigger of the establishment of cell polarity. We found that EB3 movement is polarized in chordamesoderm cells and that the notochordsomite tissue boundary plays an essential role in generating the cell polarity. This polarity was generated before the change of cell morphology and the polarized movement of EB3 in chordamesoderm cells was also observed near the boundary between the chordamesoderm tissue and naive ectoderm tissue or lateral mesoderm tissues induced by a low concentration of nodal mRNA. These suggest that definitive tissue separation established by the distinct levels of nodal signaling is essential for the chordamesodermal cells to acquire mediolateral cell polarity.	[Shindo, Asako; Yamamoto, Takamasa S.; Ueno, Naoto] Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Japan; [Shindo, Asako; Ueno, Naoto] Grad Univ Adv Stud SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Shindo, A (corresponding author), Natl Inst Basic Biol, Dept Dev Biol, Div Morphogenesis, Okazaki, Japan.	nueno@nibb.ac.jp		Shindo, Asako/0000-0002-3314-7151; Ueno, Naoto/0000-0002-8375-2317	Ministry of Education, Culture, Sport, Science and Technology, Japan	Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A grant from the Ministry of Education, Culture, Sport, Science and Technology, Japan.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; ARIIZUMI T, 1991, International Journal of Developmental Biology, V35, P407; Chung HA, 2005, DEV BIOL, V282, P95, DOI 10.1016/j.ydbio.2005.02.030; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Hyodo-Miura J, 2006, DEV CELL, V11, P69, DOI 10.1016/j.devcel.2006.04.019; Iioka H, 2004, J CELL BIOL, V164, P169, DOI 10.1083/jcb.200310027; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; JONES CM, 1995, DEVELOPMENT, V121, P3651; KELLER R, 1989, J EXP ZOOL, V251, P134, DOI 10.1002/jez.1402510204; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Lane MC, 1997, DEVELOPMENT, V124, P895; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ninomiya H, 2004, NATURE, V430, P364, DOI 10.1038/nature02620; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Skoglund P, 2006, DEV DYNAM, V235, P1974, DOI 10.1002/dvdy.20818; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; SMITH KJ, 1994, CANCER RES, V54, P3672; Stepanova T, 2003, J NEUROSCI, V23, P2655; Strong CF, 2000, DEV BIOL, V222, P405, DOI 10.1006/dbio.2000.9710; Tamai K, 1999, DEV GROWTH DIFFER, V41, P41; VASILIEV JM, 1991, J CELL SCI, V98, P1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; WANG SX, 1994, NATURE, V369, P400, DOI 10.1038/369400a0; Wittmann T, 2001, J CELL SCI, V114, P3795; Yamamoto TS, 2001, DEVELOPMENT, V128, P2769; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	36	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1600	10.1371/journal.pone.0001600	http://dx.doi.org/10.1371/journal.pone.0001600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270587	Green Submitted, Green Published, gold			2022-12-27	WOS:000260535900034
J	Callister, SJ; Mccue, LA; Turse, JE; Monroe, ME; Auberry, KJ; Smith, RD; Adkins, JN; Lipton, MS				Callister, Stephen J.; McCue, Lee Ann; Turse, Joshua E.; Monroe, Matthew E.; Auberry, Kenneth J.; Smith, Richard D.; Adkins, Joshua N.; Lipton, Mary S.			Comparative Bacterial Proteomics: Analysis of the Core Genome Concept	PLOS ONE			English	Article							CONSERVED HYPOTHETICAL PROTEINS; ACCURATE MASS; ESCHERICHIA-COLI; ESSENTIAL GENES; GEOBACTER-SULFURREDUCENS; NUMERICAL-ANALYSIS; IDENTIFICATION; SALMONELLA; TYPHIMURIUM; EVOLUTION	While comparative bacterial genomic studies commonly predict a set of genes indicative of common ancestry, experimental validation of the existence of this core genome requires extensive measurement and is typically not undertaken. Enabled by an extensive proteome database developed over six years, we have experimentally verified the expression of proteins predicted from genomic ortholog comparisons among 17 environmental and pathogenic bacteria. More exclusive relationships were observed among the expressed protein content of phenotypically related bacteria, which is indicative of the specific lifestyles associated with these organisms. Although genomic studies can establish relative orthologous relationships among a set of bacteria and propose a set of ancestral genes, our proteomics study establishes expressed lifestyle differences among conserved genes and proposes a set of expressed ancestral traits.	[Callister, Stephen J.; Turse, Joshua E.; Monroe, Matthew E.; Smith, Richard D.; Adkins, Joshua N.; Lipton, Mary S.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [McCue, Lee Ann] Pacific NW Natl Lab, Comp Sci & Math Div, Richland, WA USA; [Auberry, Kenneth J.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Adkins, JN (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	Joshua.Adkins@pnl.gov; mary.lipton@pnl.gov	Monroe, Matthew/L-1157-2019; , 0000-0001-7041-1823/B-9144-2014; Adkins, Joshua/B-9881-2013; Lipton, Mary S/H-3913-2012; Smith, Richard D/J-3664-2012	, 0000-0001-7041-1823/0000-0001-7041-1823; Adkins, Joshua/0000-0003-0399-0700; Smith, Richard D/0000-0002-2381-2349; McCue, Lee Ann/0000-0003-4456-517X	Environmental Molecular Sciences Laboratory; Department of Energy's Office of Biological and Environmental Research, Pacific Northwest National Laboratory [ER63232-1018220-0007203]; National Institute of Allergy and Infectious Diseases; NIH/DHHS [Y1-AI-4894-01]; NIH National Center for Research Resources [RR18522]; DOE [DE-AC05-76RLO 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	Environmental Molecular Sciences Laboratory; Department of Energy's Office of Biological and Environmental Research, Pacific Northwest National Laboratory; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The research described in this paper was performed in the Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. Portions of this work were supported by the Department of Energy Office of Biological and Environmental Research at PNNL grant (ER63232-1018220-0007203), the National Institute of Allergy and Infectious Diseases (NIH/DHHS through interagency agreement Y1-AI-4894-01) and the NIH National Center for Research Resources (RR18522). PNNL is a multi-program national laboratory operated by Battelle for the DOE under Contract DE-AC05-76RLO 1830.	Adkins JN, 2006, MOL CELL PROTEOMICS, V5, P1450, DOI 10.1074/mcp.M600139-MCP200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSONG C, 2007, J PROTEOME IN PRESS; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Callister SJ, 2006, J MICROBIOL METH, V67, P424, DOI 10.1016/j.mimet.2006.04.021; Chang HR, 1997, INT J SYST BACTERIOL, V47, P1253, DOI 10.1099/00207713-47-4-1253; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Clark MA, 2001, J BACTERIOL, V183, P1853, DOI 10.1128/JB.183.6.1853-1861.2001; COSTAS M, 1990, ELECTROPHORESIS, V11, P382, DOI 10.1002/elps.1150110507; CRUZ CMV, 1984, J GEN MICROBIOL, V130, P2983; Ding YHR, 2006, BBA-PROTEINS PROTEOM, V1764, P1198, DOI 10.1016/j.bbapap.2006.04.017; Elias DA, 2007, J MICROBIOL METH, V68, P367, DOI 10.1016/j.mimet.2006.09.023; Elias DA, 2006, J MICROBIOL METH, V66, P223, DOI 10.1016/j.mimet.2005.11.009; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; Fang RH, 2006, MOL CELL PROTEOMICS, V5, P714, DOI 10.1074/mcp.M500301-MCP200; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jiang M, 2007, J BACTERIOL, V189, P3434, DOI 10.1128/JB.00090-07; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kiebel GR, 2006, PROTEOMICS, V6, P1783, DOI 10.1002/pmic.200500500; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kyrpides N, 1999, J MOL EVOL, V49, P413, DOI 10.1007/PL00006564; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Luo Q, 2007, J PROTEOME RES, V6, P3042, DOI 10.1021/pr070127o; Manes NP, 2007, MOL CELL PROTEOMICS, V6, P717, DOI 10.1074/mcp.M600282-MCP200; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Mira A, 2005, MOL BIOL EVOL, V22, P2135, DOI 10.1093/molbev/msi209; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Owens RM, 2004, EMBO J, V23, P3375, DOI 10.1038/sj.emboj.7600343; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Reen FJ, 2005, APPL ENVIRON MICROB, V71, P1616, DOI 10.1128/AEM.71.3.1616-1625.2005; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Richter M, 2007, J BACTERIOL, V189, P4899, DOI 10.1128/JB.00119-07; Romine MF, 2004, OMICS, V8, P239, DOI 10.1089/omi.2004.8.239; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schmid AK, 2005, J PROTEOME RES, V4, P709, DOI 10.1021/pr049815n; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Silhavy D, 1998, CURR GENET, V33, P340, DOI 10.1007/s002940050345; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; STONE M, 2007, MICROBE, V2, P474; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; West-Eberhard Mary Jane, 2003, pi; Yang F, 2005, J PROTEOME RES, V4, P846, DOI 10.1021/pr0497475; Zhang WW, 2006, BIOCHEM BIOPH RES CO, V349, P1412, DOI 10.1016/j.bbrc.2006.09.019; Zhang WW, 2006, PROTEOMICS, V6, P4286, DOI 10.1002/pmic.200500930; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	60	54	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1542	10.1371/journal.pone.0001542	http://dx.doi.org/10.1371/journal.pone.0001542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253490	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700014
J	Sun, XJ; Xu, PF; Zhou, T; Hu, M; Fu, CT; Zhang, Y; Jin, Y; Chen, Y; Chen, SJ; Huang, QH; Liu, TX; Chen, Z				Sun, Xiao-Jian; Xu, Peng-Fei; Zhou, Ting; Hu, Ming; Fu, Chun-Tang; Zhang, Yong; Jin, Yi; Chen, Yi; Chen, Sai-Juan; Huang, Qiu-Hua; Liu, Ting Xi; Chen, Zhu			Genome-Wide Survey and Developmental Expression Mapping of Zebrafish SET Domain-Containing Genes	PLOS ONE			English	Article							HISTONE H3; CHROMATIN MODIFICATIONS; METHYLTRANSFERASE; PROTEIN; METHYLATION; IDENTIFICATION; REPRESSION; GENETICS; BLIMP-1; SMYD3	SET domain-containing proteins represent an evolutionarily conserved family of epigenetic regulators, which are responsible for most histone lysine methylation. Since some of these genes have been revealed to be essential for embryonic development, we propose that the zebrafish, a vertebrate model organism possessing many advantages for developmental studies, can be utilized to study the biological functions of these genes and the related epigenetic mechanisms during early development. To this end, we have performed a genome-wide survey of zebrafish SET domain genes. 58 genes total have been identified. Although gene duplication events give rise to several lineage-specific paralogs, clear reciprocal orthologous relationship reveals high conservation between zebrafish and human SET domain genes. These data were further subject to an evolutionary analysis ranging from yeast to human, leading to the identification of putative clusters of orthologous groups (COGs) of this gene family. By means of whole-mount mRNA in situ hybridization strategy, we have also carried out a developmental expression mapping of these genes. A group of maternal SET domain genes, which are implicated in the programming of histone modification states in early development, have been identified and predicted to be responsible for all known sites of SET domain-mediated histone methylation. Furthermore, some genes show specific expression patterns in certain tissues at certain stages, suggesting the involvement of epigenetic mechanisms in the development of these systems. These results provide a global view of zebrafish SET domain histone methyltransferases in evolutionary and developmental dimensions and pave the way for using zebrafish to systematically study the roles of these genes during development.	[Sun, Xiao-Jian; Xu, Peng-Fei; Hu, Ming; Zhang, Yong; Jin, Yi; Chen, Yi; Chen, Sai-Juan; Huang, Qiu-Hua; Liu, Ting Xi; Chen, Zhu] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Sun, Xiao-Jian; Zhou, Ting; Fu, Chun-Tang; Chen, Sai-Juan; Liu, Ting Xi; Chen, Zhu] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Sun, Xiao-Jian; Chen, Zhu] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai, Peoples R China; [Liu, Ting Xi] E Inst Shanghai Univ, Model Organ Div, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, TX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, Shanghai 200030, Peoples R China.	txliu@sibs.ac.cn; zchen@stn.sh.cn	Xu, Pengfei/AAA-3809-2022; Sun, Xiao-Jian/D-1560-2011	Xu, Pengfei/0000-0002-7318-8548; Sun, Xiao-Jian/0000-0001-8826-4614; Zhou, Ting/0000-0002-1880-5371	National Natural Science Foundation of China [30370334, 30525019]; Hundred Talents Program of Chinese Academy of Sciences; Chinese National Key Basic Research Project (973); Samuel Waxman Cancer Research Foundation, New York [co-principal investigator]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National Key Basic Research Project (973)(National Basic Research Program of China); Samuel Waxman Cancer Research Foundation, New York	This work was in part supported by the National Natural Science Foundation of China Grant 30370334 (to QHH), Grant 30525019, Hundred Talents Program of Chinese Academy of Sciences (to TXL), and the Chinese National Key Basic Research Project (973) (to ZC). XJS is a co-principal investigator supported by the Samuel Waxman Cancer Research Foundation, New York.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aravind L, 2003, CELL CYCLE, V2, P369, DOI 10.4161/cc.2.4.419; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Biron VL, 2004, DEV BIOL, V276, P337, DOI 10.1016/j.ydbio.2004.08.038; Bradbury J, 2004, PLOS BIOL, V2, P568, DOI 10.1371/journal.pbio.0020148; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Buonamici S, 2003, BLOOD CELL MOL DIS, V31, P206, DOI 10.1016/S1079-9796(03)00159-1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chou A, 1999, BIOINFORMATICS, V15, P376, DOI 10.1093/bioinformatics/15.5.376; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hernandez-Lagunas L, 2005, DEV BIOL, V278, P347, DOI 10.1016/j.ydbio.2004.11.014; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; HWANG I, 1995, IMMUNOGENETICS, V42, P353, DOI 10.1007/BF00179396; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kim SM, 2006, BIOCHEM BIOPH RES CO, V345, P318, DOI 10.1016/j.bbrc.2006.04.095; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cellbio.8.1.563; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Lin WC, 2006, CURR OPIN GENET DEV, V16, P137, DOI 10.1016/j.gde.2006.02.002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Liu TX, 2002, P NATL ACAD SCI USA, V99, P6136, DOI 10.1073/pnas.072560099; Marino-Ramirez L, 2006, PROTEINS, V62, P838, DOI 10.1002/prot.20814; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pearson W R, 2000, Methods Mol Biol, V132, P185; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Stern HM, 2003, NAT REV CANCER, V3, P533, DOI 10.1038/nrc1126; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Xie M, 1997, J BIOL CHEM, V272, P26360, DOI 10.1074/jbc.272.42.26360; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	83	93	100	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1499	10.1371/journal.pone.0001499	http://dx.doi.org/10.1371/journal.pone.0001499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231586	gold, Green Published			2022-12-27	WOS:000260504200012
J	Underwood, EC; Shaw, MR; Wilson, KA; Kareiva, P; Klausmeyer, KR; McBride, MF; Bode, M; Morrison, SA; Hoekstra, JM; Possingham, HP				Underwood, Emma C.; Shaw, M. Rebecca; Wilson, Kerrie A.; Kareiva, Peter; Klausmeyer, Kirk R.; McBride, Marissa F.; Bode, Michael; Morrison, Scott A.; Hoekstra, Jonathan M.; Possingham, Hugh P.			Protecting Biodiversity when Money Matters: Maximizing Return on Investment	PLOS ONE			English	Article							PLANT DIVERSITY; CONSERVATION; SELECTION; HOTSPOTS; EARTHS; COSTS	Conventional wisdom identifies biodiversity hotspots as priorities for conservation investment because they capture dense concentrations of species. However, density of species does not necessarily imply conservation 'efficiency'. Here we explicitly consider conservation efficiency in terms of species protected per dollar invested. Methodology/Principal Findings. We apply a dynamic return on investment approach to a global biome and compare it with three alternate priority setting approaches and a random allocation of funding. After twenty years of acquiring habitat, the return on investment approach protects between 32% and 69% more species compared to the other priority setting approaches. To correct for potential inefficiencies of protecting the same species multiple times we account for the complementarity of species, protecting up to three times more distinct vertebrate species than alternate approaches. Conclusions/Significance. Incorporating costs in a return on investment framework expands priorities to include areas not traditionally highlighted as priorities based on conventional irreplaceability and vulnerability approaches.	[Underwood, Emma C.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Shaw, M. Rebecca; Klausmeyer, Kirk R.; Morrison, Scott A.] Nature Conservancy, San Francisco, CA USA; [Wilson, Kerrie A.; Bode, Michael; Possingham, Hugh P.] Univ Queensland, Sch Integrat Biol, Ecol Ctr, Brisbane, Qld, Australia; [Kareiva, Peter; Hoekstra, Jonathan M.] Nature Conservancy, Seattle, WA USA; [McBride, Marissa F.] Univ Melbourne, Sch Botany, Environm Sci, Melbourne, Vic, Australia	University of California System; University of California Davis; Nature Conservancy; University of Queensland; Nature Conservancy; University of Melbourne	Underwood, EC (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.	eunderwoodrussell@ucdavis.edu	POSSINGHAM, HUGH/R-8310-2019; Bode, Michael/A-7116-2009; Possingham, Hugh/B-1337-2008; McBride, Marissa FC/D-5573-2009; Bode, Michael/P-1333-2019; Wilson, Kerrie/W-4181-2019; Wilson, Kerrie A/C-8058-2009	POSSINGHAM, HUGH/0000-0001-7755-996X; Bode, Michael/0000-0002-5886-4421; Possingham, Hugh/0000-0001-7755-996X; Bode, Michael/0000-0002-5886-4421; Wilson, Kerrie/0000-0002-0092-935X; Wilson, Kerrie A/0000-0002-0092-935X; McBride, Marissa/0000-0002-7498-292X	Nature Conservancy of California; Rodney Johnson/Katherine Ordway Stewardship Endowment; The Oracle Corporation; University of Queensland; Australian Research Council	Nature Conservancy of California; Rodney Johnson/Katherine Ordway Stewardship Endowment; The Oracle Corporation; University of Queensland(University of Queensland); Australian Research Council(Australian Research Council)	Research was funded by The Nature Conservancy of California, the Rodney Johnson/Katherine Ordway Stewardship Endowment, The Oracle Corporation, the University of Queensland, and the Australian Research Council.	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; *CIESIN IFPRI WRI, 2005, GRIDD POP WORLD GPW; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; De Groot R, 2003, ECOL ECON, V44, P187, DOI 10.1016/S0921-8009(02)00273-2; Drechsler M, 2005, BIOL CONSERV, V122, P253, DOI 10.1016/j.biocon.2004.07.015; Ekins O, 2003, ECOL ECON, V44, P159, DOI 10.1016/S0921-8009(02)00271-9; *EUR COMM JOINT RE, 2004, GLOB LAND COV MAPP; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Houerou H. N. le, 1981, Ecosystems of the world 11. Mediterranean-type shrublands, P479; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; RUNDEL PW, 1998, LANDSCAPE DISTURBANC, P3; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Strange N, 2006, BIOL CONSERV, V131, P33, DOI 10.1016/j.biocon.2006.02.002; WILLIAMS PH, 2001, ENCY BIODIVERSITY, V1, P813; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; *WORLD WILDL FUND, 2006, WILDFINDER ONL DAT S; 2004, C PART CONV BIOL DIV	35	62	62	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1515	10.1371/journal.pone.0001515	http://dx.doi.org/10.1371/journal.pone.0001515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231601	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200027
J	Caviedes-Vidal, E; Karasov, WH; Chediack, JG; Fasulo, V; Cruz-Neto, AP; Otani, L				Caviedes-Vidal, Enrique; Karasov, William H.; Chediack, Juan Gabriel; Fasulo, Veronica; Cruz-Neto, Ariovaldo P.; Otani, Lye			Paracellular Absorption: A Bat Breaks the Mammal Paradigm	PLOS ONE			English	Article							SPARROW PASSER-DOMESTICUS; SMALL-INTESTINE; PASSIVE ABSORPTION; ROUSETTUS-AEGYPTIACUS; LIQUID-CHROMATOGRAPHY; GLUCOSE-ABSORPTION; AMINO-ACIDS; IN-VIVO; RAT; TRANSPORT	Bats tend to have less intestinal tissue than comparably sized nonflying mammals. The corresponding reduction in intestinal volume and hence mass of digesta carried is advantageous because the costs of flight increase with load carried and because take-off and maneuverability are diminished at heavier masses. Water soluble compounds, such as glucose and amino acids, are absorbed in the small intestine mainly via two pathways, the transporter-mediated transcellular and the passive, paracellular pathways. Using the microchiropteran bat Artibeus literatus (mean mass 80.6 +/- 3.7 g), we tested the predictions that absorption of water-soluble compounds that are not actively transported would be extensive as a compensatory mechanism for relatively less intestinal tissue, and would decline with increasing molecular mass in accord with sieve-like paracellular absorption. Using a standard pharmacokinetic technique, we fed, or injected intraperitonealy the metabolically inert carbohydrates L-rhamnose (molecular mass = 164 Da) and cellobiose (molecular mass = 342 Da) which are absorbed only by paracellular transport, and 3-O-methyl-D-glucose (3OMD-glucose) which is absorbed via both mediated (active) and paracellular transport. As predicted, the bioavailability of paracellular probes declined with increasing molecular mass (rhamnose, 90 +/- 11%; cellobiose, 10 +/- 3%, n = 8) and was significantly higher in bats than has been reported for laboratory rats and other mammals. In addition, absorption of 3OMD-glucose was high (96 +/- 11%). We estimated that the bats rely on passive, paracellular absorption for more than 70% of their total glucose absorption, much more than in non-flying mammals. Although possibly compensating for less intestinal tissue, a high intestinal permeability that permits passive absorption might be less selective than a carrier-mediated system for nutrient absorption and might permit toxins to be absorbed from plant and animal material in the intestinal lumen.	[Caviedes-Vidal, Enrique; Chediack, Juan Gabriel; Fasulo, Veronica] Univ Nacl San Luis, CONICET, Fac Ciencias Humanas, Lab Biol Prof E Caviedes Codelia, San Luis, Argentina; [Caviedes-Vidal, Enrique; Chediack, Juan Gabriel] Univ Nacl San Luis, Dept Bioquim & Ciencias Biol, San Luis, Argentina; [Karasov, William H.] Univ Wisconsin Madison, Dept Wildlife Ecol, Madison, WI USA; [Fasulo, Veronica] Univ Nacl San Luis, Fac Ciencias Human, Area Psicobiol, San Luis, Argentina; [Cruz-Neto, Ariovaldo P.; Otani, Lye] Univ Estadual Paulista, Inst Biocien, Dept Zool, Sao Paulo, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis; Universidad Nacional de San Luis; University of Wisconsin System; University of Wisconsin Madison; Universidad Nacional de San Luis; Universidade Estadual Paulista	Caviedes-Vidal, E (corresponding author), Univ Nacl San Luis, CONICET, Fac Ciencias Humanas, Lab Biol Prof E Caviedes Codelia, San Luis, Argentina.	enrique.caviedes@gmail.com	cruz-neto, ariovaldo/Y-7225-2019; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Chediack, Juan Gabriel/ABB-6521-2021; Cruz-Neto, Ariovaldo P/B-2958-2013; Caviedes-Vidal, Enrique/J-9204-2013	cruz-neto, ariovaldo/0000-0001-5270-7276; Cruz-Neto, Ariovaldo P/0000-0001-5270-7276; Caviedes-Vidal, Enrique/0000-0003-4526-4969; Chediack, Juan Gabriel/0000-0002-5049-5860	National Science Foundation (USA) [IBN-0216709, IOS-0615678]; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Universidad Nacional de San Luis (Argentina) [25561, 22Q751]; Max McGraw Wildlife Foundation	National Science Foundation (USA)(National Science Foundation (NSF)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Universidad Nacional de San Luis (Argentina); Max McGraw Wildlife Foundation	Funding was provided by the National Science Foundation (USA) (IBN-0216709 and IOS-0615678 to WHK), the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) and the Universidad Nacional de San Luis (Argentina) (FONCYT 25561 and 22Q751 respectively, to EC-V) and, the Max McGraw Wildlife Foundation.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Afik D, 1997, PHYSIOL ZOOL, V70, P370, DOI 10.1086/639618; ANDERSON JH, 1973, J MORPHOL, V141, P281, DOI 10.1002/jmor.1051410304; ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; BARRY RE, 1976, J MAMMAL, V57, P273, DOI 10.2307/1379688; BIJLSMA PB, 1995, GASTROENTEROLOGY, V108, P687, DOI 10.1016/0016-5085(95)90440-9; BUDDINGTON RK, 1992, AM J PHYSIOL, V263, pG605, DOI 10.1152/ajpgi.1992.263.5.G605; CaviedesVidal E, 1996, AM J PHYSIOL-REG I, V271, pR561, DOI 10.1152/ajpregu.1996.271.3.R561; Chang MH, 2004, J EXP BIOL, V207, P3109, DOI 10.1242/jeb.01154; Chang MH, 2004, J COMP PHYSIOL B, V174, P181, DOI 10.1007/s00360-003-0403-3; CHANG RLS, 1975, BIOPHYS J, V15, P861, DOI 10.1016/S0006-3495(75)85862-0; Chediack JG, 2003, J COMP PHYSIOL B, V173, P187, DOI 10.1007/s00360-002-0314-8; Chediack JG, 2001, J EXP BIOL, V204, P723; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; DELAHUNTY T, 1987, COMP BIOCHEM PHYS A, V86, P565, DOI 10.1016/0300-9629(87)90542-1; Diamond J, 1999, IBIS, V141, P181, DOI 10.1111/j.1474-919X.1999.tb07540.x; DIAMOND J, 1991, NEWS PHYSIOL SCI, V6, P92, DOI 10.1152/physiologyonline.1991.6.2.92; DIAMOND JM, 1984, J PHYSIOL-LONDON, V349, P419, DOI 10.1113/jphysiol.1984.sp015165; Du P., 1998, J BIOMOL TECH, V9, P31; FASULO V, 2004, BIOCELL, V28, P58; FINE KD, 1993, GASTROENTEROLOGY, V105, P1117, DOI 10.1016/0016-5085(93)90957-E; FORMAN GL, 1972, KANS U SCI B, V49, P591; Gibaldi M., 1982, PHARMACOKINETICS, P494; GUILLEMETTE M, 1994, AUK, V111, P900, DOI 10.2307/4088822; IKEDA TS, 1989, J MEMBRANE BIOL, V110, P87, DOI 10.1007/BF01870995; KARASOV WH, 1988, BIOSCIENCE, V38, P602, DOI 10.2307/1310825; KARASOV WH, 1994, AM J PHYSIOL, V267, pG18, DOI 10.1152/ajpgi.1994.267.1.G18; KARASOV WH, 1985, AM J PHYSIOL, V249, pG271, DOI 10.1152/ajpgi.1985.249.2.G271; KEEGAN DJ, 1979, S AFR J ZOOL, V14, P220; Kisielinski K, 2002, CLIN EXP MED, V2, P131, DOI 10.1007/s102380200018; KLITE PD, 1965, J BACTERIOL, V90, P375, DOI 10.1128/JB.90.2.375-379.1965; Lane JS, 1999, AM J PHYSIOL-GASTR L, V276, pG789, DOI 10.1152/ajpgi.1999.276.3.G789; Lavin SR, 2004, INTEGR COMP BIOL, V44, P717; Levey DJ, 1996, COMP BIOCHEM PHYS A, V113, P225, DOI 10.1016/0300-9629(95)02046-2; LOO JCK, 1968, J PHARM SCI, V57, P918, DOI 10.1002/jps.2600570602; MADARA JL, 1988, AM J PHYSIOL, V254, pG416, DOI 10.1152/ajpgi.1988.254.3.G416; MADARA JL, 1988, CELL, V53, P497, DOI 10.1016/0092-8674(88)90562-4; MADARA JL, 1986, J CELL BIOL, V102, P2125, DOI 10.1083/jcb.102.6.2125; MADARA JL, 1987, J MEMBRANE BIOL, V100, P149, DOI 10.1007/BF02209147; Maina JN, 2000, J EXP BIOL, V203, P3045; Makanya AN, 1997, J EXP BIOL, V200, P2415; Makanya AN, 2001, ACTA BIOL HUNG, V52, P75, DOI 10.1556/ABiol.52.2001.1.8; MAYHEW TM, 1985, J ANAT, V141, P1; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NORBERG UM, 1995, FUNCT ECOL, V9, P48, DOI 10.2307/2390089; Nudds RL, 2002, AM J PHYSIOL-REG I, V283, pR249, DOI 10.1152/ajpregu.00409.2001; PAPPENHEIMER IR, 1987, J MEMBRANE BIOL, V100, P137, DOI 10.1007/BF02209146; PAPPENHEIMER JR, 1993, AM J PHYSIOL, V265, pG409, DOI 10.1152/ajpgi.1993.265.3.G409; PAPPENHEIMER JR, 1990, AM J PHYSIOL, V259, pG290, DOI 10.1152/ajpgi.1990.259.2.G290; PAPPENHEIMER JR, 1987, J MEMBRANE BIOL, V100, P123, DOI 10.1007/BF02209145; Pencek RR, 2002, J NUTR, V132, P1929, DOI 10.1093/jn/132.7.1929; Polson C, 2003, J CHROMATOGR B, V785, P263, DOI 10.1016/S1570-0232(02)00914-5; Riviere JE, 1999, COMP PHARMACOKINETIC; SCHWARTZ RM, 1995, GASTROENTEROLOGY, V109, P1206, DOI 10.1016/0016-5085(95)90580-4; Sigalet DL, 1996, J SURG RES, V61, P379, DOI 10.1006/jsre.1996.0133; Sigalet DL, 2000, J PEDIATR SURG, V35, P661, DOI 10.1053/jpsu.2000.5937; SMULDERS AP, 1971, J MEMBRANE BIOL, V5, P297, DOI 10.1007/BF01957348; Snipes RL, 1997, ADV ANAT EMBRYOL CEL, V138, P1; SNIPES RL, 1994, DIGESTIVE SYSTEM IN MAMMALS: FOOD, FORM, AND FUNCTION, P234, DOI 10.1017/CBO9780511661716.016; Tedman R.A., 1985, Australian Mammalogy, V8, P271; Tracy CR, 2007, J EXP BIOL, V210, P1726, DOI 10.1242/jeb.02766; UHING MR, 1995, J CLIN INVEST, V95, P2799, DOI 10.1172/JCI117984; Verzar F., 1936, ABSORPTION INTESTINE; WAGNER JG, 1974, J PHARMACOKINET BIOP, V2, P469, DOI 10.1007/BF01070942; WILKINSON L, 1992, SYSTAT WINDOWS STAT, P750; Wood HO, 1944, J ANAT, V78, P103	67	52	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1425	10.1371/journal.pone.0001425	http://dx.doi.org/10.1371/journal.pone.0001425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183305	Green Submitted, gold, Green Published			2022-12-27	WOS:000260469400021
J	Lee, J; Folley, BS; Gore, J; Park, S				Lee, Junghee; Folley, Bradley S.; Gore, John; Park, Sohee			Origins of Spatial Working Memory Deficits in Schizophrenia: An Event-Related fMRI and Near-Infrared Spectroscopy Study	PLOS ONE			English	Article								Abnormal prefrontal functioning plays a central role in the working memory (WM) deficits of schizophrenic patients, but the nature of the relationship between WM and prefrontal activation remains undetermined. Using two functional neuroimaging methods, we investigated the neural correlates of remembering and forgetting in schizophrenic and healthy participants. We focused on the brain activation during WM maintenance phase with event-related functional magnetic resonance imaging (fMRI). We also examined oxygenated hemoglobin changes in relation to memory performance with the near-infrared spectroscopy (NIRS) using the same spatial WM task. Distinct types of correct and error trials were segregated for analysis. fMRI data indicated that prefrontal activation was increased during WM maintenance on correct trials in both schizophrenic and healthy subjects. However, a significant difference was observed in the functional asymmetry of frontal activation pattern. Healthy subjects showed increased activation in the right frontal, temporal and cingulate regions. Schizophrenic patients showed greater activation compared with control subjects in left frontal, temporal and parietal regions as well as in right frontal regions. We also observed increased 'false memory' errors in schizophrenic patients, associated with increased prefrontal activation and resembling the activation pattern observed on the correct trials. NIRS data replicated the fMRI results. Thus, increased frontal activity was correlated with the accuracy of WM in both healthy control and schizophrenic participants. The major difference between the two groups concerned functional asymmetry; healthy subjects recruited right frontal regions during spatial WM maintenance whereas schizophrenic subjects recruited a wider network in both hemispheres to achieve the same level of memory performance. Increased "false memory'' errors and accompanying bilateral prefrontal activation in schizophrenia suggest that the etiology of memory errors must be considered when comparing group performances. Finally, the concordance of fMRI and NIRS data supports NIRS as an alternative functional neuroimaging method for psychiatric research.	[Lee, Junghee; Folley, Bradley S.; Park, Sohee] Vanderbilt Univ, Ctr Integrat & Cognit Neurosci, Dept Psychol, Nashville, TN 37240 USA; [Folley, Bradley S.; Park, Sohee] Vanderbilt Univ, Kennedy Ctr, Nashville, TN USA; [Gore, John] Vanderbilt Univ, Inst Imaging Sci, Dept Radiol, Nashville, TN USA; [Folley, Bradley S.; Park, Sohee] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lee, J (corresponding author), Vanderbilt Univ, Ctr Integrat & Cognit Neurosci, Dept Psychol, Nashville, TN 37240 USA.	sohee.park@vanderbilt.edu	Lee, Junghee/C-5226-2014; Lee, Junghee/AAX-6124-2021	Lee, Junghee/0000-0001-9567-8700; Lee, Junghee/0000-0001-9567-8700; Park, Sohee/0000-0003-3797-4776	 [MH-073028];  [Discovery Grant]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073028] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by MH-073028 to Sohee Park and the Discovery Grant to Sohee Park and John Gore.	Addington J, 2000, SCHIZOPHR RES, V44, P47, DOI 10.1016/S0920-9964(99)00160-7; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; *AM PSYCH ASS, 1991, DIAGN STAT MAN MENT; Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; BILDER RM, 1994, AM J PSYCHIAT, V151, P1437; Brown DW, 2003, PEDIATR RES, V54, P861, DOI 10.1203/01.PDR.0000090928.93045.BE; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1071, DOI 10.1001/archpsyc.62.10.1071; Carter C, 1996, BIOL PSYCHIAT, V40, P930, DOI 10.1016/S0006-3223(96)00350-2; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; Chey J, 2002, PSYCHIAT RES, V110, P259, DOI 10.1016/S0165-1781(02)00105-1; Conklin HM, 2000, AM J PSYCHIAT, V157, P275, DOI 10.1176/appi.ajp.157.2.275; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Crow TJ, 1996, SCHIZOPHR RES, V22, P181, DOI 10.1016/S0920-9964(96)00068-0; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; DAVID AS, 1994, SCHIZOPHRENIA BULL, V20, P249, DOI 10.1093/schbul/20.2.249; DeLisi LE, 1997, SCHIZOPHRENIA BULL, V23, P255, DOI 10.1093/schbul/23.2.255; Fallgatter AJ, 1998, EUR ARCH PSY CLIN N, V248, P245, DOI 10.1007/s004060050045; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J, 2005, NEUROIMAGE, V26, P215, DOI 10.1016/j.neuroimage.2005.01.055; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Gold JM, 2003, J ABNORM PSYCHOL, V112, P61, DOI 10.1037/0021-843X.112.1.61; GOLDMAN R, 1987, HDB PHYSL NERVOUS SY, V5, P373; Green MF, 1996, AM J PSYCHIAT, V153, P321; Heckers S, 2002, PSYCHIAT RES-NEUROIM, V116, P25, DOI 10.1016/S0925-4927(02)00067-7; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P119, DOI 10.1093/schbul/19.1.119; HOFFMAN RE, 1994, SCHIZOPHRENIA BULL, V20, P257, DOI 10.1093/schbul/20.2.257; JACOBSEN CF, 1935, COMP PSYCHOL MONOGR, V13, P3; Kennan RP, 2002, HUM BRAIN MAPP, V16, P183, DOI 10.1002/hbm.10039; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Krieger S, 2005, AM J PSYCHIAT, V162, P1206, DOI 10.1176/appi.ajp.162.6.1206; Kubota Y, 2005, SCHIZOPHR RES, V77, P65, DOI 10.1016/j.schres.2005.01.007; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Liddle PF, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1111/j.0065-1591.2000.007s021[dash]3.x; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Millikan GA, 1942, REV SCI INSTRUM, V13, P434, DOI 10.1063/1.1769941; Myles-Worsley M, 2002, AM J MED GENET, V114, P609, DOI 10.1002/ajmg.10644; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nicklin SE, 2003, ARCH DIS CHILD-FETAL, V88, P263; NUECHTERLEIN KH, 1994, NEUROPSYCHOLOGY SCHI; Obrig H, 2000, INT J PSYCHOPHYSIOL, V35, P125, DOI 10.1016/S0167-8760(99)00048-3; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Park S, 1999, BIOL PSYCHIAT, V46, P392, DOI 10.1016/S0006-3223(98)00370-9; PARK S, 1995, J ABNORM PSYCHOL, V104, P355, DOI 10.1037/0021-843X.104.2.355; Park S, 1997, SCHIZOPHR RES, V26, P213, DOI 10.1016/S0920-9964(97)00051-0; Park S, 2003, SCHIZOPHR RES, V59, P261, DOI 10.1016/S0920-9964(02)00209-8; PARK S, 1995, ARCH GEN PSYCHIAT, V52, P821; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Park S.J., 2002, PRINCIPLES EXPT PSYC, P83; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Reilly JL, 2006, ARCH GEN PSYCHIAT, V63, P1189, DOI 10.1001/archpsyc.63.11.1189; Roitman SEL, 2000, SCHIZOPHR RES, V41, P447; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Shinba T, 2004, BIOL PSYCHIAT, V55, P154, DOI 10.1016/S0006-3223(03)00547-X; Silver H, 2003, AM J PSYCHIAT, V160, P1809, DOI 10.1176/appi.ajp.160.10.1809; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Talairach J., 1988, COPLANAR STEREOTAXIC; Tallent KA, 1999, PSYCHIAT RES, V89, P161, DOI 10.1016/S0165-1781(99)00101-8; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Walter H, 2003, SCHIZOPHR RES, V61, P175, DOI 10.1016/S0920-9964(02)00225-6; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551	79	79	80	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1760	10.1371/journal.pone.0001760	http://dx.doi.org/10.1371/journal.pone.0001760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335036	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000014
J	Robinson, F; Jackson, RJ; Smith, CWJ				Robinson, Fiona; Jackson, Richard J.; Smith, Christopher W. J.			Expression of Human nPTB Is Limited by Extreme Suboptimal Codon Content	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; HIGH-LEVEL EXPRESSION; TRANSFER-RNA; SECONDARY STRUCTURE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; GENE; OPTIMIZATION; USAGE; PTB	Background: The frequency of synonymous codon usage varies widely between organisms. Suboptimal codon content limits expression of viral, experimental or therapeutic heterologous proteins due to limiting cognate tRNAs. Codon content is therefore often adjusted to match codon bias of the host organism. Codon content also varies between genes within individual mammalian species. However, little attention has been paid to the consequences of codon content upon translation of host proteins. Methodology/Principal Findings: In comparing the splicing repressor activities of transfected human PTB and its two tissue-restricted paralogs-nPTB and ROD1-we found that the three proteins were expressed at widely varying levels. nPTB was expressed at 1-3% the level of PTB despite similar levels of mRNA expression and 74% amino acid identity. The low nPTB expression was due to the high proportion of codons with A or U at the third codon position, which are suboptimal in human mRNAs. Optimization of the nPTB codon content, akin to the "humanization" of foreign ORFs, allowed efficient translation in vivo and in vitro to levels comparable with PTB. We were then able to demonstrate that all three proteins act as splicing repressors. Conclusions/Significance: Our results provide a striking illustration of the importance of mRNA codon content in determining levels of protein expression, even within cells of the natural host species.	[Robinson, Fiona; Jackson, Richard J.; Smith, Christopher W. J.] Univ Cambridge, Dept Biochem, Cambridge, England	University of Cambridge	Robinson, F (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	cwjs1@cam.ac.uk			Wellcome Trust [059879, 077877]; Canadian Cambridge Trust with Merck Frosst Canada Inc [studentship]; Cambridge Commonwealth Trust; Corpus Christi College	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Cambridge Trust with Merck Frosst Canada Inc; Cambridge Commonwealth Trust; Corpus Christi College	This work was supported by Wellcome Trust programme grants (059879 & 077877) to CWJS. F.R. was supported by studentship funds from the Canadian Cambridge Trust with Merck Frosst Canada Inc., an Overseas Research Studentship, Cambridge Commonwealth Trust, and Corpus Christi College. None of the funders or sponsors played any role in the research or preparation of the manuscript.	*ACC INC, 2001, WISC; Ali IK, 2001, EMBO J, V20, P4233, DOI 10.1093/emboj/20.15.4233; AOTA S, 1986, NUCLEIC ACIDS RES, V14, P6345, DOI 10.1093/nar/14.16.6345; Ashiya M, 1997, RNA, V3, P996; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BONEKAMP F, 1988, NUCLEIC ACIDS RES, V16, P3013, DOI 10.1093/nar/16.7.3013; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; CHEVALLIER A, 1979, BIOCHIMIE, V61, P245, DOI 10.1016/S0300-9084(79)80070-X; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; DASSO MC, 1989, NUCLEIC ACIDS RES, V17, P3129, DOI 10.1093/nar/17.8.3129; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gooding C, 2003, J BIOL CHEM, V278, P15201, DOI 10.1074/jbc.M210131200; Gooding C, 1998, RNA, V4, P85; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Guthrie C., 1982, MOL BIOL YEAST SACCH, P487; Hamdan FF, 2002, PARASITOL RES, V88, P583, DOI 10.1007/s00436-001-0585-0; HATFIELD D, 1986, BIOCHEM INT, V13, P835; HOLLER TP, 1993, GENE, V136, P323, DOI 10.1016/0378-1119(93)90488-O; Horvath H, 2000, P NATL ACAD SCI USA, V97, P1914, DOI 10.1073/pnas.030527497; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy JP, 1996, NAT BIOTECHNOL, V14, P610, DOI 10.1038/nbt0596-610; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Massaer M, 2001, INT ARCH ALLERGY IMM, V125, P32, DOI 10.1159/000053794; Narum DL, 2001, INFECT IMMUN, V69, P7250, DOI 10.1128/IAI.69.12.7250-7253.2001; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; OUENZAR B, 1988, BIOCHIM BIOPHYS ACTA, V950, P429, DOI 10.1016/0167-4781(88)90140-6; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Perez I, 1997, RNA, V3, P764; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Robinson F, 2006, J BIOL CHEM, V281, P800, DOI 10.1074/jbc.M510578200; Semon M, 2006, MOL BIOL EVOL, V23, P523, DOI 10.1093/molbev/msj053; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; SPELLMAN RH, 2007, MOL CELL, V27; THOMAS LK, 1988, P NATL ACAD SCI USA, V85, P4242, DOI 10.1073/pnas.85.12.4242; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829; Zhang WQ, 2002, RNA, V8, P671, DOI 10.1017/S1355838202027036; Zhao KN, 2005, MOL CELL BIOL, V25, P8643, DOI 10.1128/MCB.25.19.8643-8655.2005; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	57	22	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1801	10.1371/journal.pone.0001801	http://dx.doi.org/10.1371/journal.pone.0001801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335065	Green Published, Green Submitted, gold			2022-12-27	WOS:000260723000047
J	Blackiston, DJ; Casey, ES; Weiss, MR				Blackiston, Douglas J.; Casey, Elena Silva; Weiss, Martha R.			Retention of Memory through Metamorphosis: Can a Moth Remember What It Learned As a Caterpillar?	PLOS ONE			English	Article								Insects that undergo complete metamorphosis experience enormous changes in both morphology and lifestyle. The current study examines whether larval experience can persist through pupation into adulthood in Lepidoptera, and assesses two possible mechanisms that could underlie such behavior: exposure of emerging adults to chemicals from the larval environment, or associative learning transferred to adulthood via maintenance of intact synaptic connections. Fifth instar Manduca sexta caterpillars received an electrical shock associatively paired with a specific odor in order to create a conditioned odor aversion, and were assayed for learning in a Y choice apparatus as larvae and again as adult moths. We show that larvae learned to avoid the training odor, and that this aversion was still present in the adults. The adult aversion did not result from carryover of chemicals from the larval environment, as neither applying odorants to naive pupae nor washing the pupae of trained caterpillars resulted in a change in behavior. In addition, we report that larvae trained at third instar still showed odor aversion after two molts, as fifth instars, but did not avoid the odor as adults, consistent with the idea that post-metamorphic recall involves regions of the brain that are not produced until later in larval development. The present study, the first to demonstrate conclusively that associative memory survives metamorphosis in Lepidoptera, provokes intriguing new questions about the organization and persistence of the central nervous system during metamorphosis. Our results have both ecological and evolutionary implications, as retention of memory through metamorphosis could influence host choice by polyphagous insects, shape habitat selection, and lead to eventual sympatric speciation.	[Blackiston, Douglas J.; Casey, Elena Silva; Weiss, Martha R.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA	Georgetown University	Blackiston, DJ (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	weissm@georgetown.edu		Blackiston, Douglas/0000-0001-7231-0196				Akhtar Y, 2003, J CHEM ECOL, V29, P1853, DOI 10.1023/A:1024802328458; ALLOWAY TM, 1972, AM ZOOL, V12, P471; Andersson S, 2003, J CHEM ECOL, V29, P2303, DOI 10.1023/A:1026226514968; Barron AB, 1999, ANIM BEHAV, V58, P621, DOI 10.1006/anbe.1999.1169; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; BERENBAUM MR, 1984, AM MIDL NAT, V111, P64, DOI 10.2307/2425543; Bernays EA, 1996, ENTOMOL EXP APPL, V78, P1, DOI 10.1007/BF00304451; Bernays Elizabeth A., 1993, P1; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Carlsson MA, 1999, J CHEM ECOL, V25, P2445, DOI 10.1023/A:1020865922827; Chow JK, 2005, CHEMOECOLOGY, V15, P129, DOI 10.1007/s00049-005-0304-x; CORBET SA, 1985, ECOL ENTOMOL, V10, P143, DOI 10.1111/j.1365-2311.1985.tb00543.x; Daly KC, 2000, J EXP BIOL, V203, P2025; Davis JM, 2004, TRENDS ECOL EVOL, V19, P411, DOI 10.1016/j.tree.2004.04.006; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DEBOER G, 1992, ENTOMOL EXP APPL, V63, P3, DOI 10.1007/BF00350341; DETHIER VG, 1980, PHYSIOL ENTOMOL, V5, P321, DOI 10.1111/j.1365-3032.1980.tb00242.x; Gandolfi M, 2003, P ROY SOC B-BIOL SCI, V270, P2623, DOI 10.1098/rspb.2003.2541; Ghumare SS, 2005, J INSECT BEHAV, V18, P105, DOI 10.1007/s10905-005-9350-z; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Gutierrez-Ibanez C, 2007, NATURWISSENSCHAFTEN, V94, P595, DOI 10.1007/s00114-007-0233-3; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HOPKINS AD, 1916, US DEP AGR PROGRAM W; ISINGRINI M, 1985, P NATL ACAD SCI USA, V82, P8545, DOI 10.1073/pnas.82.24.8545; Kelber A, 1996, J EXP BIOL, V199, P1127; Kelber A, 1997, ISR J PLANT SCI, V45, P235, DOI 10.1080/07929978.1997.10676687; Kerpel SM, 2005, J INSECT BEHAV, V18, P433, DOI 10.1007/s10905-005-3701-7; Kinoshita M, 1999, J EXP BIOL, V202, P95; LEE JC, 1990, ANIM BEHAV, V39, P163, DOI 10.1016/S0003-3472(05)80736-5; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu SS, 2006, ECOL ENTOMOL, V31, P307, DOI 10.1111/j.1365-2311.2006.00777.x; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Matsumoto Y, 2002, J COMP PHYSIOL A, V188, P295, DOI 10.1007/s00359-002-0303-0; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; Neuser K, 2005, ANIM BEHAV, V69, P891, DOI 10.1016/j.anbehav.2004.06.013; Olsson POC, 2006, ANIM BEHAV, V72, P545, DOI 10.1016/j.anbehav.2005.10.023; PHILLIPS WM, 1977, ENTOMOL EXP APPL, V21, P71, DOI 10.1007/BF00300343; Pszczolkowski MA, 2005, PHYSIOL BEHAV, V86, P168, DOI 10.1016/j.physbeh.2005.07.007; RAFFA KF, 1987, ENTOMOL EXP APPL, V44, P221, DOI 10.1007/BF00369182; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2007, J INSECT PHYSIOL, V53, P923, DOI 10.1016/j.jinsphys.2007.03.007; Ray S, 1999, NEUROSCI LETT, V259, P37, DOI 10.1016/S0304-3940(98)00892-1; Rietdorf K, 2002, PHYSIOL ENTOMOL, V27, P223, DOI 10.1046/j.1365-3032.2002.00289.x; Rojas JC, 1999, PHYSIOL ENTOMOL, V24, P83, DOI 10.1046/j.1365-3032.1999.00117.x; SMITH MA, 1979, ANIM BEHAV, V27, P365, DOI 10.1016/0003-3472(79)90170-2; Stamps JA, 2006, ANIM BEHAV, V72, P1279, DOI 10.1016/j.anbehav.2006.03.010; Storeck A, 2000, ENTOMOL EXP APPL, V97, P41, DOI 10.1023/A:1004052717737; TULLY T, 1994, J NEUROSCI, V14, P68; vanEmden HF, 1996, PHYSIOL ENTOMOL, V21, P325, DOI 10.1111/j.1365-3032.1996.tb00873.x; Walters ET, 2001, J EXP BIOL, V204, P457; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357; Weiss MR, 2003, ANIM BEHAV, V65, P425, DOI 10.1006/anbe.2003.2084; Wolf R, 1998, LEARN MEMORY, V5, P166	53	91	93	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1736	10.1371/journal.pone.0001736	http://dx.doi.org/10.1371/journal.pone.0001736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320055	gold, Green Published			2022-12-27	WOS:000260586600031
J	Rakhimova, E; Munder, A; Wiehlmann, L; Bredenbruch, F; Tummler, B				Rakhimova, Elza; Munder, Antje; Wiehlmann, Lutz; Bredenbruch, Florian; Tuemmler, Burkhard			Fitness of Isogenic Colony Morphology Variants of Pseudomonas aeruginosa in Murine Airway Infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS LUNG; BIOFILM FORMATION; ESCHERICHIA-COLI; INTRACLONAL DIVERSITY; FUNCTIONAL GENOMICS; STATIONARY-PHASE; GENETIC-ANALYSIS; HIGHLY ADHERENT; DNA RELEASE; EVOLUTION	Chronic lung infections with Pseudomonas aeruginosa are associated with the diversification of the persisting clone into niche specialists and morphotypes, a phenomenon called 'dissociative behaviour'. To explore the potential of P. aeruginosa to change its morphotype by single step loss-of-function mutagenesis, a signature-tagged mini-Tn5 plasposon library of the cystic fibrosis airway isolate TBCF10839 was screened for colony morphology variants under nine different conditions in vitro. Transposon insertion into 1% of the genome changed colony morphology into eight discernable morphotypes. Half of the 55 targets encode features of primary or secondary metabolism whereby quinolone production was frequently affected. In the other half the transposon had inserted into genes of the functional categories transport, regulation or motility/chemotaxis. To mimic dissociative behaviour of isogenic strains in lungs, pools of 25 colony morphology variants were tested for competitive fitness in an acute murine airway infection model. Six of the 55 mutants either grew better or worse in vivo than in vitro, respectively. Metabolic proficiency of the colony morphology variant was a key determinant for survival in murine airways. The most common morphotype of self-destructive autolysis did unexpectedly not impair fitness. Transposon insertions into homologous genes of strain PAO1 did not reproduce the TBCF10839 mutant morphotypes for 16 of 19 examined loci pointing to an important role of the genetic background on colony morphology. Depending on the chosen P. aeruginosa strain, functional genome scans will explore other areas of the evolutionary landscape. Based on our discordant findings of mutant phenotypes in P. aeruginosa strains PAO1, PA14 and TBCF10839, we conclude that the current focus on few reference strains may miss modes of niche adaptation and dissociative behaviour that are relevant for the microevolution of complex traits in the wild.	[Rakhimova, Elza; Munder, Antje; Wiehlmann, Lutz; Tuemmler, Burkhard] Hannover Med Sch, Clin Res Grp, Hannover, Germany; [Bredenbruch, Florian] Helmholtz Ctr Infect Res, Div Cell Biol & Immunol, Braunschweig, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research	Rakhimova, E (corresponding author), Hannover Med Sch, Clin Res Grp, OE6710, Hannover, Germany.	tuemmler.burkhard@mh-hannover.de		Munder, Antje/0000-0002-3198-8336	Deutsche Forschungsgemeinschaft [SFB587, A9]; DFG-sponsored graduate college, project A3 [GK745]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-sponsored graduate college, project A3	This work was supported by a grant of the Deutsche Forschungsgemeinschaft (SFB587, A9). ER has received a stipend from the DFG-sponsored graduate college GK745, project A3.	ALLEFS JJHM, 1990, NUCLEIC ACIDS RES, V18, P3099, DOI 10.1093/nar/18.10.3099; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Arevalo-Ferro C, 2004, PROTEOMICS, V4, P1241, DOI 10.1002/pmic.200300709; BANERJEE PC, 1983, J BACTERIOL, V155, P238, DOI 10.1128/JB.155.1.238-245.1983; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bredenbruch F, 2005, J BACTERIOL, V187, P3630, DOI 10.1128/JB.187.11.3630-3635.2005; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Bush A., 2006, CYSTIC FIBROSIS 21 C; Chang YST, 2007, FEMS MICROBIOL LETT, V270, P201, DOI 10.1111/j.1574-6968.2007.00664.x; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; CUSKEY SM, 1985, J BACTERIOL, V162, P872, DOI 10.1128/JB.162.3.872-880.1985; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; Denervaud V, 2004, J CLIN MICROBIOL, V42, P554, DOI 10.1128/JCM.42.2.554-562.2004; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Diaz E, 2007, CURR OPIN CRIT CARE, V13, P45, DOI 10.1097/MCC.0b013e3280121816; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Doyle TB, 2004, J BACTERIOL, V186, P6341, DOI 10.1128/JB.186.19.6341-6350.2004; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Enderle PJ, 1998, BIOTECHNIQUES, V25, P954, DOI 10.2144/98256bm05; Farrow JM, 2007, J BACTERIOL, V189, P3425, DOI 10.1128/JB.00209-07; Favre-Bonte S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-33; Foster KR, 2007, CURR BIOL, V17, pR319, DOI 10.1016/j.cub.2007.03.005; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hansen SK, 2007, J BACTERIOL, V189, P4932, DOI 10.1128/JB.00041-07; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009; Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x; Knight CG, 2006, NAT GENET, V38, P1015, DOI 10.1038/ng1867; Kretzschmar U, 2002, MICROBIOL-SGM, V148, P3839, DOI 10.1099/00221287-148-12-3839; Kwon YM, 2000, J MICROBIOL METH, V41, P195, DOI 10.1016/S0167-7012(00)00159-7; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lieberman David, 2003, Am J Respir Med, V2, P459; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Munder A, 2005, MICROBES INFECT, V7, P600, DOI 10.1016/j.micinf.2004.12.021; Munder A, 2002, EXP TOXICOL PATHOL, V54, P127, DOI 10.1078/0940-2993-00240; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OJENIYI B, 1991, APMIS, V99, P925, DOI 10.1111/j.1699-0463.1991.tb01280.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Raleigh E. A., 1997, CURRENT PROTOCOLS MO, V1; Ramos J, 2004, PSEUDOMONAS; Ravel J, 2003, TRENDS MICROBIOL, V11, P195, DOI 10.1016/S0966-842X(03)00076-3; Reva ON, 2006, J BACTERIOL, V188, P4079, DOI 10.1128/JB.00101-06; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; SEIFERT SH, 2006, EVOLUTION MICROBIAL; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Simpson DA, 2000, INFECT IMMUN, V68, P2493, DOI 10.1128/IAI.68.5.2493-2502.2000; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tummler B, 2006, PSEUDOMONAS, VOL 4: MOLECULAR BIOLOGY OF EMERGING ISSUES, P35; TUMMLER B, 1991, J CLIN MICROBIOL, V29, P1265; Vlamakis HC, 2005, NAT CELL BIOL, V7, P933, DOI 10.1038/ncb1005-933; von Gotz F, 2004, J BACTERIOL, V186, P3837, DOI 10.1128/JB.186.12.3837-3847.2004; Vulic M, 2001, GENETICS, V158, P519; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wehmhoner D, 2003, J BACTERIOL, V185, P5807, DOI 10.1128/JB.185.19.5807-5814.2003; Wiehlmann L, 2007, INT J MED MICROBIOL, V297, P615, DOI 10.1016/j.ijmm.2007.03.014; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; ZIERDT CH, 1964, J BACTERIOL, V87, P1003, DOI 10.1128/JB.87.5.1003-1010.1964; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	98	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1685	10.1371/journal.pone.0001685	http://dx.doi.org/10.1371/journal.pone.0001685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301762	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500029
J	Bulwin, GC; Walter, S; Schlawinsky, M; Heinemann, T; Schulze, A; Hohne, W; Krause, G; Kalka-Moll, W; Fraser, P; Volk, HD; Lohler, J; Milford, EL; Utku, N				Bulwin, Grit-Carsta; Waelter, Stephanie; Schlawinsky, Mirko; Heinemann, Thomas; Schulze, Anke; Hoehne, Wolfgang; Krause, Gerd; Kalka-Moll, Wiltrud; Fraser, Patricia; Volk, Hans-Dieter; Loehler, Juergen; Milford, Edgar L.; Utku, Nalan			HLA-DR Alpha 2 Mediates Negative Signalling via Binding to Tirc7 Leading to Anti-Inflammatory and Apoptotic Effects in Lymphocytes In Vitro and In Vivo	PLOS ONE			English	Article								Classically, HLA-DR expressed on antigen presenting cells (APC) initiates lymphocyte activation via presentation of peptides to TCR bearing CD4+ T- Cells. Here we demonstrate that HLA-DR alpha 2 domain (sHLA-DR alpha 2) also induces negative signals by engaging TIRC7 on lymphocytes. This interaction inhibits proliferation and induces apoptosis in CD4+ and CD8+ T-cells via activation of the intrinsic pathway. Proliferation inhibition is associated with SHP-1 recruitment by TIRC7, decreased phosphorylation of STAT4, TCR-zeta chain & ZAP70, and inhibition of IFN-gamma and FasL expression. HLA-DR alpha 2 and TIRC7 co-localize at the APC-T cell interaction site. Triggering HLA-DR - TIRC7 pathway demonstrates that sHLA-DRa2 treatment inhibits proinflammatory-inflammatory cytokine expression in APC & T cells after lipopolysaccaride (LPS) stimulation in vitro and induces apoptosis in vivo. These results suggest a novel antiproliferative role for HLA-DR mediated via TIRC7, revise the notion of an exclusive stimulatory interaction of HLA-DR with CD4+ T cells and highlights a novel physiologically relevant regulatory pathway.	[Bulwin, Grit-Carsta; Waelter, Stephanie; Schlawinsky, Mirko; Schulze, Anke; Loehler, Juergen; Utku, Nalan] CellAct Pharma GmbH, Berlin, Germany; [Heinemann, Thomas] Univ Bonn, Kekule Inst Organ Chem Biochem, Bonn, Germany; [Hoehne, Wolfgang] Charite, Inst Biochem, Campus Mitte, Berlin, Germany; [Krause, Gerd] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Kalka-Moll, Wiltrud] Klinikum Univ Koln, Med Mikrobiol, Cologne, Germany; [Fraser, Patricia] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA USA; [Volk, Hans-Dieter; Utku, Nalan] Humboldt Univ, Inst Med Immunol, Campus Mitte, Berlin, Germany; [Loehler, Juergen] Heinrich Pette Inst, Mol Pathol, Hamburg, Germany; [Milford, Edgar L.] Brigham & Womens Hosp, Dept Med, Renal Div, Boston, MA USA	University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Cologne; Harvard University; Brigham & Women's Hospital; Humboldt University of Berlin; Heinrich Pette Institute; Harvard University; Brigham & Women's Hospital	Bulwin, GC (corresponding author), CellAct Pharma GmbH, Berlin, Germany.	nalan.utku@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668	German government for research and development [Bmbf future grant]	German government for research and development	Bmbf future grant (German government for research and development)	Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Bulwin GC, 2006, J IMMUNOL, V177, P6833, DOI 10.4049/jimmunol.177.10.6833; Dinges MM, 2001, INFECT IMMUN, V69, P1256, DOI 10.1128/IAI.69.3.1256-1264.2001; FREDERICK P, 1996, J IMMUNOL, V157, P4521; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745, DOI 10.1146/annurev.iy.09.040191.003525; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Hsu HC, 2001, J IMMUNOL, V166, P772, DOI 10.4049/jimmunol.166.2.772; IRWIN MJ, 1993, IMMUNOL REV, V131, P61, DOI 10.1111/j.1600-065X.1993.tb01530.x; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; KARP DR, 1990, NATURE, V346, P474, DOI 10.1038/346474a0; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; Kovacs B, 1999, APOPTOSIS, V4, P327, DOI 10.1023/A:1009691120129; Kumamoto Y, 2004, AM J TRANSPLANT, V4, P505, DOI 10.1111/j.1600-6143.2004.00367.x; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Marsh SG, 2000, HLA FACTS BOOK; Parham P, 1999, IMMUNOL REV, V167, P5, DOI 10.1111/j.1600-065X.1999.tb01378.x; Paul W., 1993, FUNDAMENTAL IMMUNOLO, P1211; RATHMELL JC, 2002, CELL S, V109, P97; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Utku N, 2006, CLIN EXP IMMUNOL, V144, P142, DOI 10.1111/j.1365-2249.2006.03044.x; Utku N, 1998, IMMUNITY, V9, P509, DOI 10.1016/S1074-7613(00)80634-2; Wang LH, 1999, J IMMUNOL, V162, P3897; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Zhang Q, 2000, AM J PATHOL, V157, P1137, DOI 10.1016/S0002-9440(10)64629-9	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1576	10.1371/journal.pone.0001576	http://dx.doi.org/10.1371/journal.pone.0001576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270567	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900012
J	Dolinay, T; Wu, W; Kaminski, N; Ifedigbo, E; Kaynar, AM; Szilasi, M; Watkins, SC; Ryter, SW; Hoetzel, A; Choi, AMK				Dolinay, Tamas; Wu, Wei; Kaminski, Naftali; Ifedigbo, Emeka; Kaynar, A. Murat; Szilasi, Maria; Watkins, Simon C.; Ryter, Stefan W.; Hoetzel, Alexander; Choi, Augustine M. K.			Mitogen-Activated Protein Kinases Regulate Susceptibility to Ventilator-Induced Lung Injury	PLOS ONE			English	Article								Background: Mechanical ventilation causes ventilator-induced lung injury in animals and humans. Mitogen-activated protein kinases have been implicated in ventilator-induced lung injury though their functional significance remains incomplete. We characterize the role of p38 mitogen-activated protein kinase/mitogen activated protein kinase kinase-3 and c-Jun-NH(2)-terminal kinase-1 in ventilator-induced lung injury and investigate novel independent mechanisms contributing to lung injury during mechanical ventilation. Methodology and Principle Findings: C57/BL6 wild-type mice and mice genetically deleted for mitogen-activated protein kinase kinase-3 (mkk-3(-/-)) or c-Jun-NH(2)-terminal kinase-1 (jnk1(-/-)) were ventilated, and lung injury parameters were assessed. We demonstrate that mkk3(-/-) or jnk1(-/-) mice displayed significantly reduced inflammatory lung injury and apoptosis relative to wild-type mice. Since jnk1(-/-) mice were highly resistant to ventilator-induced lung injury, we performed comprehensive gene expression profiling of ventilated wild- type or jnk1(-/-) mice to identify novel candidate genes which may play critical roles in the pathogenesis of ventilator-induced lung injury. Microarray analysis revealed many novel genes differentially expressed by ventilation including matrix metalloproteinase-8 (MMP8) and GADD45 alpha. Functional characterization of MMP8 revealed that mmp8(-/-) mice were sensitized to ventilator-induced lung injury with increased lung vascular permeability. Conclusions: We demonstrate that mitogen-activated protein kinase pathways mediate inflammatory lung injury during ventilator-induced lung injury. C-Jun-NH(2)-terminal kinase was also involved in alveolo-capillary leakage and edema formation, whereas MMP8 inhibited alveolo-capillary protein leakage.			Dolinay, T (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	amchoi@rics.bwh.harvard.edu	Kaynar, Ata Murat/ABI-6877-2020; Dolinay, Tamas/ABG-1399-2020; Watkins, Simon/ABG-2590-2021	Kaynar, Ata Murat/0000-0001-8847-0450; Watkins, Simon/0000-0003-4092-1552; Kaminski, Naftali/0000-0001-5917-4601	NIH [R01-HL60234, R01-HL55330, R01-HL079904, P01-HL70807]; American Heart Association [0335035N]; Deutsche Forschungsgemeinschaft [HO 2464/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055330, R01HL079904, P01HL070807, R01HL060234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH grants R01-HL60234, R01-HL55330, R01-HL079904, and P01-HL70807 awarded to A.M.K. Choi, an award from the American Heart Association to S. W. Ryter, (AHA #0335035N) and a grant from the Deutsche Forschungsgemeinschaft to Alexander Hoetzel (DFG HO 2464/1-1).	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Bregeon F, 2002, RESP PHYSIOL NEUROBI, V132, P191, DOI 10.1016/S1569-9048(02)00069-1; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chess PR, 2005, J APPL PHYSIOL, V99, P1226, DOI 10.1152/japplphysiol.01105.2004; Crimi E, 2006, AM J RESP CRIT CARE, V174, P178, DOI 10.1164/rccm.200507-1178OC; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Prost N, 2007, J APPL PHYSIOL, V102, P794, DOI 10.1152/japplphysiol.00742.2006; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Fayolle C, 2008, J INVEST DERMATOL, V128, P196, DOI 10.1038/sj.jid.5700963; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Grasso S, 2002, ANESTHESIOLOGY, V96, P795, DOI 10.1097/00000542-200204000-00005; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hales CA, 2001, RESP PHYSIOL, V124, P159, DOI 10.1016/S0034-5687(00)00193-6; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jones JCR, 2005, J CELL SCI, V118, P2557, DOI 10.1242/jcs.02395; KOHNO K, 2004, AM J PHYSIOL-LUNG C, pL184; Li LF, 2004, AM J RESP CRIT CARE, V169, P518, DOI 10.1164/rccm.200305-660OC; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Ma SF, 2005, AM J PHYSIOL-LUNG C, V289, pL468, DOI 10.1152/ajplung.00109.2005; Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Mayr VD, 2006, CRIT CARE, V10, DOI 10.1186/cc5086; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Morse D, 2003, AM J PHYSIOL-LUNG C, V285, pL250, DOI 10.1152/ajplung.00387.2002; Nakamura M, 2004, AM J PATHOL, V164, P1949, DOI 10.1016/S0002-9440(10)63755-8; Ning W, 2004, PHYSIOL GENOMICS, V18, P70, DOI 10.1152/physiolgenomics.00221.2003; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Oudin S, 2002, AM J RESP CELL MOL, V27, P107, DOI 10.1165/ajrcmb.27.1.4766; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Petrache I, 2003, AM J RESP CELL MOL, V28, P574, DOI 10.1165/rcmb.2002-0075OC; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Shaulian E, 1999, J BIOL CHEM, V274, P29595, DOI 10.1074/jbc.274.42.29595; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tschumperlin DJ, 2000, AM J RESP CRIT CARE, V162, P357, DOI 10.1164/ajrccm.162.2.9807003; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; von Bethmann AN, 1998, AM J RESP CRIT CARE, V157, P263, DOI 10.1164/ajrccm.157.1.9608052; Winkler MK, 2003, AM J PHYSIOL-LUNG C, V284, pL557, DOI 10.1152/ajplung.00195.2002; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101	54	76	81	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1601	10.1371/journal.pone.0001601	http://dx.doi.org/10.1371/journal.pone.0001601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270588	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000260535900035
J	Lemire, J; Mailloux, RJ; Appanna, VD				Lemire, Joseph; Mailloux, Ryan J.; Appanna, Vasu D.			Mitochondrial Lactate Dehydrogenase Is Involved in Oxidative-Energy Metabolism in Human Astrocytoma Cells (CCF-STTG1)	PLOS ONE			English	Article								Lactate has long been regarded as an end product of anaerobic energy production and its fate in cerebral metabolism has not been precisely delineated. In this report, we demonstrate, for the first time, the ability of a human astrocytic cell line (CCF-STTG1) to consume lactate and to generate ATP via oxidative phosphorylation. C-13-NMR and HPLC analyses aided in the identification of tricarboxylic acid (TCA) cyle metabolites and ATP in the astrocytic mitochondria incubated with lactate. Oxamate, an inhibitor of lactate dehydrogenase (LDH), abolished mitochondrial lactate consumption. Electrophoretic and fluorescence microscopic analyses helped localize LDH in the mitochondria. Taken together, this study implicates lactate as an important contributor to ATP metabolism in the brain, a finding that may significantly change our notion of how this important organ manipulates its energy budget.	[Lemire, Joseph; Mailloux, Ryan J.; Appanna, Vasu D.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada	Laurentian University	Lemire, J (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	VAppanna@laurentian.ca		Mailloux, Ryan/0000-0003-3986-9830; Appanna, Vasu/0000-0002-0138-5665	Industry Canada; The Northern Ontario Heritage Fund	Industry Canada; The Northern Ontario Heritage Fund	Industry Canada and The Northern Ontario Heritage Fund	Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; Baumgart E, 1996, J BIOL CHEM, V271, P3846; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684; Beriault R, 2005, ELECTROPHORESIS, V26, P2892, DOI 10.1002/elps.200500040; Berkich DA, 2005, J NEUROSCI RES, V79, P106, DOI 10.1002/jnr.20325; BIGNAMI A, 1991, ADV EXP MED BIOL, V296, P197; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Bouzier-Sore AK, 2006, EUR J NEUROSCI, V24, P1687, DOI 10.1111/j.1460-9568.2006.05056.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; BROOKS GA, 1986, FASEB J, V45, P2924; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Chatham JC, 2001, AM J PHYSIOL-ENDOC M, V281, pE794, DOI 10.1152/ajpendo.2001.281.4.E794; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; GALLINA FG, 1994, ARCH BIOCHEM BIOPHYS, V308, P515, DOI 10.1006/abbi.1994.1072; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Guzman M, 2001, TRENDS ENDOCRIN MET, V12, P169, DOI 10.1016/S1043-2760(00)00370-2; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Hertz L, 2004, J CEREBR BLOOD F MET, V24, P1241, DOI 10.1097/00004647-200411000-00008; Hu YB, 1997, J NEUROCHEM, V69, P1484; HURLEY BF, 1984, J APPL PHYSIOL, V56, P1260, DOI 10.1152/jappl.1984.56.5.1260; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mailloux R, 2007, CELL PHYSIOL BIOCHEM, V20, P627, DOI 10.1159/000107546; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mailloux RJ, 2006, J BIOCHEM MOL TOXIC, V20, P198, DOI 10.1002/jbt.20137; MALMQVIST U, 1991, PFLUG ARCH EUR J PHY, V419, P230, DOI 10.1007/BF00371100; McClelland GB, 2003, BIOCHEM BIOPH RES CO, V304, P130, DOI 10.1016/S0006-291X(03)00550-3; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Mentz S, 1999, J NEUROCHEM, V72, P980, DOI 10.1046/j.1471-4159.1999.0720980.x; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Moyle GJ, 2002, AIDS, V16, P1341, DOI 10.1097/00002030-200207050-00005; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Popanda O, 1998, BBA-GENE STRUCT EXPR, V1397, P102, DOI 10.1016/S0167-4781(97)00229-7; Ramos M, 2003, DEV BRAIN RES, V143, P33, DOI 10.1016/S0165-3806(03)00097-X; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHMITT J, 1975, HUMANGENETIK, V28, P239, DOI 10.1007/BF00278550; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; SHANNON JE, 1978, CRYOBIOLOGY, V15, P239, DOI 10.1016/0011-2240(78)90032-9; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Singh R, 2005, J BIOCHEM BIOPH METH, V64, P189, DOI 10.1016/j.jbbm.2005.07.005; WILKINSON JH, 1972, ENZYME, V13, P170, DOI 10.1159/000459658; Yates SP, 2005, ANAL BIOCHEM, V340, P41, DOI 10.1016/j.ab.2005.01.051	53	62	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1550	10.1371/journal.pone.0001550	http://dx.doi.org/10.1371/journal.pone.0001550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253497	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535700021
J	Pacheco, AG; Tuboi, SH; Faulhaber, JC; Harrison, LH; Schechter, M				Pacheco, Antonio G.; Tuboi, Suely H.; Faulhaber, Jose C.; Harrison, Lee H.; Schechter, Mauro			Increase in Non-AIDS Related Conditions as Causes of Death among HIV-Infected Individuals in the HAART Era in Brazil	PLOS ONE			English	Article								In 1996, Brazil became the first developing country to provide free and universal access to HAART. Although a decrease in overall mortality has been documented, there are no published data on the impact of HAART on causes of death among HIV-infected individuals in Brazil. We assessed temporal trends of mortality due to cardiovascular diseases (CVD), diabetes mellitus (DM) and other conditions generally not associated with HIV-infection among persons with and without HIV infection in Brazil between 1999 and 2004. Methodology/Principal Findings. Odds ratios were used to compare causes of death in individuals who had HIV/AIDS listed on any field of the death certificate with those who did not. Logistic regression models were fitted with generalized estimating equations to account for spatial correlation; co-variables were added to the models to control for potential confounding. Of 5,856,056 deaths reported in Brazil between 1999 and 2004 67,249 (1.15%) had HIV/AIDS listed on the death certificate and non-HIV-related conditions were listed on 16.3% in 1999, increasing to 24.1% by 2004 (p < 0.001). The adjusted average yearly increases were 8% and 0.8% for CVD (p < 0.001), and 12% and 2.8% for DM (p < 0.001), for those who had and did not have HIV/AIDS listed on the death certificate, respectively. Similar results were found for these conditions as underlying causes of death. Conclusions/Significance. In Brazil between 1999 and 2004 conditions usually considered not to be related to HIV-infection appeared to become more likely causes of death over time than reported causes of death among individuals who had HIV/AIDS listed on the death certificate than in those who did not. This observation has important programmatic implications for developing countries that are scaling-up access to antiretroviral therapy.	[Pacheco, Antonio G.] Oswaldo Cruz Fdn FIOCRUZ, Comp Sci Program, Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, Brazil; [Pacheco, Antonio G.; Tuboi, Suely H.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Grad Sch Publ Hlth, Infect Dis Epidemiol Res Unit, Pittsburgh, PA USA; [Tuboi, Suely H.; Faulhaber, Jose C.] Univ Fed Rio de Janeiro, Hosp Escola Sao Francisco de Assis, Proj Praca Onze, Rio De Janeiro, Brazil; [Schechter, Mauro] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, AIDS Res Lab, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Pacheco, AG (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Comp Sci Program, Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, Brazil.	apacheco@fiocruz.br	Pacheco, Antonio Guilherme/E-6378-2013; Schechter, Mauro/AAG-7445-2020	Pacheco, Antonio Guilherme/0000-0003-3095-1774; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI052788] Funding Source: NIH RePORTER; NIAID NIH HHS [K24 AI052788] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brito Ana Maria de, 2005, Braz J Infect Dis, V9, P9, DOI 10.1590/S1413-86702005000100004; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; *CDCP, 2007, HIV MORT 2004; *CDCP, 2007, HIV AIDS SURV REP 20, V17, P16; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Grangeiro A, 2006, REV SAUDE PUBL, V40, P60, DOI 10.1590/S0034-89102006000800009; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Haraki Cristianne Aparecida Costa, 2005, Rev. bras. epidemiol., V8, P19; *I BRAS GEOGR EST, 2006, PROJ POP; Johansson LA, 2002, J EPIDEMIOL COMMUN H, V56, P301, DOI 10.1136/jech.56.4.301; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P197, DOI 10.1590/S1415-790X2002000200007; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; LOHSE N, 2007, J ANTIMICROB CHEMOTH; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; MIETTINEN OS, 1981, AM J EPIDEMIOL, V114, P144, DOI 10.1093/oxfordjournals.aje.a113161; *MIN SAUD, 2007, MORT; *MIN SAUD SECR VIG, 2006, REC TER ANT AD AD IN; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; R Development Core Team, 2006, R LANG ENV STAT COMP; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Schechter M, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000279704.16804.ae; Selik RM, 2002, J ACQ IMMUN DEF SYND, V29, P378, DOI 10.1097/00126334-200204010-00009; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Tuboi SH, 2005, JAIDS-J ACQ IMM DEF, V40, P324, DOI 10.1097/01.qai.0000182627.28595.01; *WHO, 2004, INT STAT CLASS DIS H, V2; *WHO, 2007, HLTH STAT HLHT INF S; World Health Organization, 2006, PROGR GLOB ACC HIV A; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J, 2004, STAT MED, V23, P879, DOI 10.1002/sim.1736	36	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1531	10.1371/journal.pone.0001531	http://dx.doi.org/10.1371/journal.pone.0001531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231611	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200038
J	Kroth, PG; Chiovitti, A; Gruber, A; Martin-Jezequel, V; Mock, T; Parker, MS; Stanley, MS; Kaplan, A; Caron, L; Weber, T; Maheswari, U; Armbrust, EV; Bowler, C				Kroth, Peter G.; Chiovitti, Anthony; Gruber, Ansgar; Martin-Jezequel, Veronique; Mock, Thomas; Parker, Micaela Schnitzler; Stanley, Michele S.; Kaplan, Aaron; Caron, Lise; Weber, Till; Maheswari, Uma; Armbrust, E. Virginia; Bowler, Chris			A Model for Carbohydrate Metabolism in the Diatom Phaeodactylum tricornutum Deduced from Comparative Whole Genome Analysis	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; BETA-CARBONIC ANHYDRASE; SKELETONEMA-COSTATUM; MARINE DIATOMS; THALASSIOSIRA-PSEUDONANA; INORGANIC CARBON; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; MYOINOSITOL DEHYDROGENASE; CYANIDIOSCHYZON-MEROLAE	Background. Diatoms are unicellular algae responsible for approximately 20% of global carbon fixation. Their evolution by secondary endocytobiosis resulted in a complex cellular structure and metabolism compared to algae with primary plastids. Methodology/Principal Findings. The whole genome sequence of the diatom Phaeodactylum tricornutum has recently been completed. We identified and annotated genes for enzymes involved in carbohydrate pathways based on extensive EST support and comparison to the whole genome sequence of a second diatom, Thalassiosira pseudonana. Protein localization to mitochondria was predicted based on identified similarities to mitochondrial localization motifs in other eukaryotes, whereas protein localization to plastids was based on the presence of signal peptide motifs in combination with plastid localization motifs previously shown to be required in diatoms. We identified genes potentially involved in a C4-like photosynthesis in P. tricornutum and, on the basis of sequence-based putative localization of relevant proteins, discuss possible differences in carbon concentrating mechanisms and CO2 fixation between the two diatoms. We also identified genes encoding enzymes involved in photorespiration with one interesting exception: glycerate kinase was not found in either P. tricornutum or T. pseudonana. Various Calvin cycle enzymes were found in up to five different isoforms, distributed between plastids, mitochondria and the cytosol. Diatoms store energy either as lipids or as chrysolaminaran (a beta-1,3-glucan) outside of the plastids. We identified various beta-glucanases and large membrane-bound glucan synthases. Interestingly most of the glucanases appear to contain C-terminal anchor domains that may attach the enzymes to membranes. Conclusions/Significance. Here we present a detailed synthesis of carbohydrate metabolism in diatoms based on the genome sequences of Thalassiosira pseudonana and Phaeodactylum tricornutum. This model provides novel insights into acquisition of dissolved inorganic carbon and primary metabolic pathways of carbon in two different diatoms, which is of significance for an improved understanding of global carbon cycles.	[Kroth, Peter G.; Gruber, Ansgar; Weber, Till] Univ Konstanz, Fachbereich Biol, Constance, Germany; [Chiovitti, Anthony] Univ Melbourne, Sch Botany, Melbourne, Vic, Australia; [Martin-Jezequel, Veronique] Univ Nantes, Fac Sci, EA 2663, Nantes, France; [Mock, Thomas; Parker, Micaela Schnitzler; Armbrust, E. Virginia] Univ Washington, Sch Oceanogr, Seattle, WA USA; [Stanley, Michele S.] Dunstaffnage Marine Lab, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Kaplan, Aaron] Hebrew Univ Jerusalem, Dept Plants & Env Sci, Jerusalem, Israel; [Caron, Lise] Univ Nantes, INSERM, Fac Med, U533, Nantes, France; [Maheswari, Uma; Bowler, Chris] Ecole Normale Super, CNRS, UMR8186, Paris, France; [Maheswari, Uma; Bowler, Chris] Villa Comun, Stazione Zool, Cell Signal Lab, Naples, Italy	University of Konstanz; University of Melbourne; Nantes Universite; University of Washington; University of Washington Seattle; UHI Millennium Institute; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Stazione Zoologica Anton Dohrn di Napoli	Kroth, PG (corresponding author), Univ Konstanz, Fachbereich Biol, Constance, Germany.	Peter.Kroth@unikonstanz.de	Gruber, Ansgar/B-9587-2008; Kaplan, Aaron/GLN-5655-2022; Kroth, Peter G/A-9728-2008; Bowler, Chris/AAC-6256-2019; Stanley, Michele S/D-5859-2013; Mock, Thomas/A-3127-2008	Gruber, Ansgar/0000-0002-5876-4391; Kroth, Peter G/0000-0003-4734-8955; Mock, Thomas/0000-0001-9604-0362; Shunmugam, Uma/0000-0001-7007-9234; Stanley, Michele/0000-0002-2348-3231; martin-jezequel, veronique/0000-0002-6633-1334; Parker, Micaela/0000-0003-1007-4612; Bowler, Chris/0000-0003-3835-6187; Kaplan, Aaron/0000-0002-0815-5731	Deutsche Forschungsgemeinschaft [1661/3-2, 1661/4-1]; University of Konstanz; Australian Research Council [LP0454982]; Defence Science and Technology Organization of the Australian Department of Defence; University of Melbourne; EU Sixth Framework Programme "Diatomics" [LSHG-CT-2004-512035]; University of Nantes; CNRS; German Academic Exchange Service (DAAD). [fellowship]; PNW Center for Human Health and Ocean Studies; NIH/National Institute of Environmental Health [P50 ES012762]; National Science Foundation [OCE-0434087]; Gordon and Betty Moore Foundation; Pacific Northwest Center for Human Health and Ocean Sciences; Marine Microbiology Investigator Award; US Department of Energy; Genoscope; Agence Nationale de la Recherche (ANR France); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012762] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Konstanz; Australian Research Council(Australian Research Council); Defence Science and Technology Organization of the Australian Department of Defence; University of Melbourne(University of Melbourne); EU Sixth Framework Programme "Diatomics"; University of Nantes; CNRS(Centre National de la Recherche Scientifique (CNRS)); German Academic Exchange Service (DAAD).(Deutscher Akademischer Austausch Dienst (DAAD)); PNW Center for Human Health and Ocean Studies; NIH/National Institute of Environmental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Northwest Center for Human Health and Ocean Sciences; Marine Microbiology Investigator Award; US Department of Energy(United States Department of Energy (DOE)); Genoscope; Agence Nationale de la Recherche (ANR France)(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	PGK is supported by the Deutsche Forschungsgemeinschaft (DFG, projects 1661/3-2, 1661/4-1) and the University of Konstanz. AC acknowledges funding from the Australian Research Council and industry partner, Akzo Nobel, Gateshead, UK (Industry Linkage Grant #LP0454982), as well as financial assistance from the Defence Science and Technology Organization of the Australian Department of Defence and the University of Melbourne (MRGS scheme). VMJ was supported by EU Sixth Framework Programme "Diatomics" (LSHG-CT-2004-512035), the University of Nantes and CNRS. TM was supported by a fellowship within the Postdoc program of the German Academic Exchange Service (DAAD). MSP is supported in part by the PNW Center for Human Health and Ocean Studies (NIH/National Institute of Environmental Health: P50 ES012762 and National Science Foundation: OCE-0434087) and by the Gordon and Betty Moore Foundation. MS was supported by the EC Sixth Framework Programme "Diatomics" (LSHG-CT-2004-512035). LC was supported by CNRS. EVA is supported by the Pacific Northwest Center for Human Health and Ocean Sciences (National Institute of Environmental Health: P50 ES012762 and National Science Foundation: OCE-0434087) and a Gordon and Betty Moore Foundation Marine Microbiology Investigator Award. Diatom whole genome sequencing was funded by the US Department of Energy and was performed at the Joint Genome Institute (Walnut Creek, CA, USA).The generation and sequencing of P. tricornutum ESTs was coordinated by CB and was performed at Genoscope (Evry, France) as a part of projects funded by Genoscope, the EU Sixth Framework Programme (Diatomics; LSHG-CT-2004-512035), and the Agence Nationale de la Recherche (ANR; France).	Alekseeva SA, 2005, APPL BIOCHEM MICRO+, V41, P185, DOI 10.1007/s10438-005-0033-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; BEARDALL J, 1990, Marine Microbial Food Webs, V4, P7; BEARDALL J, 1989, AQUAT BOT, V34, P105, DOI 10.1016/0304-3770(89)90052-1; Behrenfeld MJ, 1996, NATURE, V383, P508, DOI 10.1038/383508a0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brett CT, 2000, INT REV CYTOL, V199, P161, DOI 10.1016/S0074-7696(00)99004-1; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; BURNELL JN, 1988, ARCH BIOCHEM BIOPHYS, V260, P187, DOI 10.1016/0003-9861(88)90440-7; Cabello-Pasini A, 2001, BOT MAR, V44, P199, DOI 10.1515/BOT.2001.026; CARDENAS ML, 1998, BIOCHIM BIOPHYS ACTA, V140, P242; Chiovitti A, 2004, EUR J PHYCOL, V39, P117, DOI 10.1080/0967026042000201885; COLMAN B, 1988, J EXP BOT, V39, P1025, DOI 10.1093/jxb/39.8.1025; DRECHSLER Z, 1993, PLANTA, V191, P34; DREW ED, 1984, STORAGE CARBOHYDRATE, P133; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fey V, 2005, J EXP BOT, V56, P1491, DOI 10.1093/jxb/eri180; Fischer H, 1999, J PHYCOL, V35, P113, DOI 10.1046/j.1529-8817.1999.3510113.x; FOGG GE, 1983, BOT MAR, V26, P3, DOI 10.1515/botm.1983.26.1.3; FORD CW, 1965, J CHEM SOC, P7035, DOI 10.1039/jr9650007035; Geigenberger P, 2005, J EXP BOT, V56, P1469, DOI 10.1093/jxb/eri178; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; GIBBS SP, 1981, INT REV CYTOL, V72, P49, DOI DOI 10.1016/S0074-7696(08)61194-8; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Graciet E, 2002, J BIOL CHEM, V277, P12697, DOI 10.1074/jbc.M111121200; Granum E, 2005, CAN J BOT, V83, P898, DOI 10.1139/B05-077; Granum E, 2002, MAR ECOL PROG SER, V242, P83, DOI 10.3354/meps242083; Grauvogel C, 2007, MOL BIOL EVOL, V24, P1611, DOI 10.1093/molbev/msm075; Gross W, 2003, EUR J PHYCOL, V38, P191, DOI 10.1080/1364253031000121705; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; HAMA J, 1992, J EXP MAR BIOL ECOL, V162, P159, DOI 10.1016/0022-0981(92)90199-K; HANDA N, 1969, MAR BIOL, V4, P208, DOI 10.1007/BF00393894; Harada H, 2005, CAN J BOT, V83, P909, DOI 10.1139/B05-078; Harada H, 2005, PLANT PHYSIOL, V139, P1041, DOI 10.1104/pp.105.065185; Harada H, 2006, PLANT PHYSIOL, V142, P1318, DOI 10.1104/pp.106.086561; Harper JT, 2003, MOL BIOL EVOL, V20, P1730, DOI 10.1093/molbev/msg195; HIPPS PP, 1976, BIOCHEM BIOPH RES CO, V68, P1133, DOI 10.1016/0006-291X(76)90314-4; HUPPE HC, 1994, ANNU REV PLANT PHYS, V45, P577, DOI 10.1146/annurev.pp.45.060194.003045; HUSIC DW, 1987, CRIT REV PLANT SCI, V5, P45, DOI 10.1080/07352688709382234; Igamberdiev AU, 2001, PHYSIOL PLANTARUM, V111, P427, DOI 10.1034/j.1399-3054.2001.1110402.x; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; Kanai R., 1999, C4 PLANT BIOL, P49, DOI [10.5860/choice.36-6275, DOI 10.5860/CHOICE.36-6275, DOI 10.1016/B978-012614440-6/50004-5]; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; KAPLAN A, 1981, PLANT PHYSIOL, V67, P229, DOI 10.1104/pp.67.2.229; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; Kroth PG, 2005, CURR GENET, V48, P389, DOI 10.1007/s00294-005-0033-2; Lavaud J, 2007, FUNCT PLANT SCI BIOT, V1, P267; Leboulanger C, 1998, J PHYCOL, V34, P651, DOI 10.1046/j.1529-8817.1998.340651.x; Leboulanger C, 1997, DEEP-SEA RES PT I, V44, P2131, DOI 10.1016/S0967-0637(97)00090-3; Lee RE, 1998, PROTIST, V149, P341, DOI 10.1016/S1434-4610(98)70040-9; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; LONG JJ, 1994, J BIOL CHEM, V269, P2827; Maheswari U, 2005, NUCLEIC ACIDS RES, V33, pD344, DOI 10.1093/nar/gki121; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martin William, 2000, VVolume 9, P9; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; MCCONVILLE MJ, 1986, CARBOHYD RES, V153, P330, DOI 10.1016/S0008-6215(00)90276-3; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MERRETT MJ, 1973, NEW PHYTOL, V72, P751, DOI 10.1111/j.1469-8137.1973.tb02051.x; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michels AK, 2005, PLANT PHYSIOL, V137, P911, DOI 10.1104/pp.104.055285; Mitra M, 2004, PLANT PHYSIOL, V135, P173, DOI 10.1104/pp.103.037283; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; NORMAN EG, 1991, PLANT PHYSIOL, V95, P693, DOI 10.1104/pp.95.3.693; Ogawa T, 2003, PHOTOSYNTH RES, V77, P105, DOI 10.1023/A:1025865500026; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Park H, 2007, ENVIRON MICROBIOL, V9, P403, DOI 10.1111/j.1462-2920.2006.01151.x; Park YI, 1996, PHOTOSYNTH RES, V50, P23, DOI 10.1007/BF00018218; Parker MS, 2005, J PHYCOL, V41, P1142, DOI 10.1111/j.1529-8817.2005.00139.x; Parker MS, 2004, J PHYCOL, V40, P557, DOI 10.1111/j.1529-8817.2004.03184.x; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; PAUL JS, 1976, ARCH MICROBIOL, V110, P247, DOI 10.1007/BF00690234; PAULSEN BS, 1978, CARBOHYD RES, V62, P386, DOI 10.1016/S0008-6215(00)80888-5; PILKIS SJ, 1994, J BIOL CHEM, V269, P21925; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; RAVEN JA, 1981, CAN B FISH AQUAT SCI, P55; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; ROESSLER PG, 1987, J PHYCOL, V23, P494, DOI 10.1111/j.1529-8817.1987.tb02536.x; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; Satoh D, 2001, PLANT PHYSIOL, V126, P1459, DOI 10.1104/pp.126.4.1459; Scheibe R, 2005, J EXP BOT, V56, P1481, DOI 10.1093/jxb/eri181; Stein R, 1997, PHYTOCHEMISTRY, V46, P17, DOI 10.1016/S0031-9422(96)00830-8; Storseth TR, 2005, CARBOHYD RES, V340, P1159, DOI 10.1016/j.carres.2004.12.036; Storseth TR, 2006, CARBOHYD RES, V341, P2108, DOI 10.1016/j.carres.2006.05.005; Sugiyama J, 1999, J MOL BIOL, V286, P247, DOI 10.1006/jmbi.1998.2458; Sun N, 2003, PLANT MOL BIOL, V53, P467, DOI 10.1023/B:PLAN.0000019071.12878.9e; SUZUKI K, 1991, J PHYCOL, V27, P492, DOI 10.1111/j.0022-3646.1991.00492.x; Szabo E, 2007, PHYSIOL PLANTARUM, V129, P484, DOI 10.1111/j.1399-3054.2006.00849.x; Tamoi M, 1996, ARCH BIOCHEM BIOPHYS, V334, P27, DOI 10.1006/abbi.1996.0425; Tanaka Y, 2005, PLANT PHYSIOL, V138, P207, DOI 10.1104/pp.104.058982; Tolbert NE, 1997, ANNU REV PLANT PHYS, V48, P1, DOI 10.1146/annurev.arplant.48.1.1; TOLBERT NE, 1980, BIOCH PLANTS, P2; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744, DOI 10.4319/lo.2000.45.3.0744; Tortell PD, 1997, NATURE, V390, P243, DOI 10.1038/36765; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Van Oijen T, 2004, EUR J PHYCOL, V39, P161, DOI 10.1080/0967026042000202127; VARUM KM, 1984, J EXP MAR BIOL ECOL, V83, P13, DOI 10.1016/0022-0981(84)90114-X; VARUM KM, 1986, J EXP MAR BIOL ECOL, V102, P249, DOI 10.1016/0022-0981(86)90180-2; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; Waterkeyn L., 1987, CELLULE, V74, P198; Weber APM, 2004, PLANT MOL BIOL, V55, P17, DOI 10.1007/s11103-004-0376-y; Weber APM, 2004, J EXP BOT, V55, P1231, DOI 10.1093/jxb/erh091; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; Wiese A, 1999, FEBS LETT, V461, P13, DOI 10.1016/S0014-5793(99)01417-9; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; Wingler A, 2000, PHILOS T R SOC B, V355, P1517, DOI 10.1098/rstb.2000.0712; WINKLER U, 1995, PLANTA, V195, P403; Wittpoth C, 1998, PLANTA, V206, P79, DOI 10.1007/s004250050376; WU J, 1991, BOT ACTA, V104, P283, DOI 10.1111/j.1438-8677.1991.tb00231.x; Yamaguchi K, 2000, PLANT CELL PHYSIOL, V41, P1397, DOI 10.1093/pcp/pcd074; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438	134	324	340	11	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1426	10.1371/journal.pone.0001426	http://dx.doi.org/10.1371/journal.pone.0001426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183306	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400022
J	Connon, CJ; Nakamura, T; Hopkinson, A; Quantock, A; Yagi, N; Doutch, J; Meek, KM				Connon, Che J.; Nakamura, Takahiro; Hopkinson, Andy; Quantock, Andrew; Yagi, Naoto; Doutch, James; Meek, Keith M.			The Biomechanics of Amnion Rupture: An X-Ray Diffraction Study	PLOS ONE			English	Article								Pre-term birth is the leading cause of perinatal and neonatal mortality, 40% of which are attributed to the pre-term premature rupture of amnion. Rupture of amnion is thought to be associated with a corresponding decrease in the extracellular collagen content and/or increase in collagenase activity. However, there is very little information concerning the detailed organisation of fibrillar collagen in amnion and how this might influence rupture. Here we identify a loss of lattice like arrangement in collagen organisation from areas near to the rupture site, and present a 9% increase in fibril spacing and a 50% decrease in fibrillar organisation using quantitative measurements gained by transmission electron microscopy and the novel application of synchrotron X-ray diffraction. These data provide an accurate insight into the biomechanical process of amnion rupture and highlight X-ray diffraction as a new and powerful tool in our understanding of this process.	[Connon, Che J.] Univ Reading, Sch Pharm, Reading, Berks, England; [Nakamura, Takahiro] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Hopkinson, Andy] Univ Nottingham, Dept Ophthalmol, Nottingham NG7 2RD, England; [Quantock, Andrew; Doutch, James; Meek, Keith M.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Yagi, Naoto] Japan Synchrotron Radiat Res Inst, Kobe, Hyogo, Japan	University of Reading; Kyoto Prefectural University of Medicine; University of Nottingham; Cardiff University; Japan Synchrotron Radiation Research Institute	Connon, CJ (corresponding author), Univ Reading, Sch Pharm, Reading, Berks, England.	c.j.connon@reading.ac.uk	Connon, Che/B-3128-2012; Hopkinson, Andrew/A-2287-2011	Connon, Che/0000-0001-8264-6531; Doutch, James/0000-0003-0747-8368	Royal Society; RCUK Fellowship; CCLRC Direct Access [46242]; Spring-8 [2006A1012]; MRC [G0600755] Funding Source: UKRI; Medical Research Council [G0600755] Funding Source: researchfish	Royal Society(Royal Society of London); RCUK Fellowship(UK Research & Innovation (UKRI)); CCLRC Direct Access; Spring-8(SPring-8); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Royal Society (CJC), RCUK Fellowship (CJC), CCLRC Direct Access Grant 46242 ( KM, CJC) and Spring-8 Grant 2006A1012 (AJQ). KM is a Royal Society-Wolfson Research Merit Award holder.	ALZAID NS, 1980, J REPROD FERTIL, V59, P383; APLIN JD, 1985, J CELL SCI, V79, P119; ASPDEN RM, 1981, PROC R SOC SER B-BIO, V212, P299, DOI 10.1098/rspb.1981.0040; BOURESLI MN, 1981, CELL TISSUE RES, V220, P263; BOURNE GL, 1960, AM J OBSTET GYNECOL, V79, P1070, DOI 10.1016/0002-9378(60)90512-3; Clark GL, 1934, AM J PHYSIOL, V108, P74, DOI 10.1152/ajplegacy.1934.108.1.74; Connon CJ, 2000, J REFRACT SURG, V16, P448; FARRELL RA, 1969, B MATH BIOPHYS, V31, P727, DOI 10.1007/BF02477784; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; GOODFELLOW JM, 1978, J MOL BIOL, V119, P237, DOI 10.1016/0022-2836(78)90436-9; HALABURT JT, 1989, EUR J OBSTET GYN R B, V31, P75, DOI 10.1016/0028-2243(89)90028-2; HUKINS DWL, 1985, TRENDS BIOCHEM SCI, V10, P260, DOI 10.1016/0968-0004(85)90077-5; KEIRSE MJNC, 1989, AM J PERINAT, V6, P226, DOI 10.1055/s-2007-999582; Krenchel H., 1964, FIBRE REINFORCEMENT; Lei HQ, 1996, J CLIN INVEST, V98, P1971, DOI 10.1172/JCI119001; Lewis RA, 2000, J SYNCHROTRON RADIAT, V7, P348, DOI 10.1107/S0909049500009973; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; Meek KM, 2003, MATRIX BIOL, V22, P467, DOI 10.1016/S0945-053X(03)00081-7; Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002; PAAVOLA LG, 1995, BIOL REPROD, V53, P321, DOI 10.1095/biolreprod53.2.321; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Stuart EL, 2005, BIOL REPROD, V72, P230, DOI 10.1095/biolreprod.104.033381; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; WORTHINGTON CR, 1984, INT J BIOL MACROMOL, V7, P2	25	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1147	10.1371/journal.pone.0001147	http://dx.doi.org/10.1371/journal.pone.0001147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	18188405	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000207459000030
J	Han, SZ; Guthridge, JM; Harley, ITW; Sestak, AL; Kim-Howard, X; Kaufman, KM; Namjou, B; Deshmukh, H; Bruner, G; Espinoza, LR; Gilkeson, GS; Harley, JB; James, JA; Nath, SK				Han, Shizhong; Guthridge, Joel M.; Harley, Isaac T. W.; Sestak, Andrea L.; Kim-Howard, Xana; Kaufman, Kenneth M.; Namjou, Bahram; Deshmukh, Harshal; Bruner, Gail; Espinoza, Luis R.; Gilkeson, Gary S.; Harley, John B.; James, Judith A.; Nath, Swapan K.			Osteopontin and Systemic Lupus Erythematosus Association: A Probable Gene-Gender Interaction	PLOS ONE			English	Article								Osteopontin (SPP1) is an important bone matrix mediator found to have key roles in inflammation and immunity. SPP1 genetic polymorphisms and increased osteopontin protein levels have been reported to be associated with SLE in small patient collections. The present study evaluates association between SPP1 polymorphisms and SLE in a large cohort of 1141 unrelated SLE patients [707 European-American (EA) and 434 African-American (AA)], and 2009 unrelated controls (1309 EA and 700 AA). Population-based case-control association analyses were performed. To control for potential population stratification, admixture adjusted logistic regression, genomic control (GC), structured association (STRAT), and principal components analysis (PCA) were applied. Combined analysis of 2 ethnic groups, showed the minor allele of 2 SNPs (rs1126616T and rs9138C) significantly associated with higher risk of SLE in males (P = 0.0005, OR = 1.73, 95% CI = 1.28-2.33), but not in females. Indeed, significant gene-gender interactions in the 2 SNPs, rs1126772 and rs9138, were detected (P = 0.001 and P = 0.0006, respectively). Further, haplotype analysis identified rs1126616T-rs1126772A-rs9138C which demonstrated significant association with SLE in general (P = 0.02, OR = 1.30, 95% CI 1.08-1.57), especially in males (P = 0.0003, OR = 2.42, 95% CI 1.51-3.89). Subgroup analysis with single SNPs and haplotypes also identified a similar pattern of gender-specific association in AA and EA. GC, STRAT, and PCA results within each group showed consistent associations. Our data suggest SPP1 is associated with SLE, and this association is especially stronger in males. To our knowledge, this report serves as the first association of a specific autosomal gene with human male lupus.	[Han, Shizhong; Guthridge, Joel M.; Harley, Isaac T. W.; Sestak, Andrea L.; Kim-Howard, Xana; Kaufman, Kenneth M.; Namjou, Bahram; Deshmukh, Harshal; Bruner, Gail; Harley, John B.; James, Judith A.; Nath, Swapan K.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Kaufman, Kenneth M.; Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Kaufman, Kenneth M.; Harley, John B.; James, Judith A.; Nath, Swapan K.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Espinoza, Luis R.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Gilkeson, Gary S.] Med Univ South Carolina, Charleston, SC USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical University of South Carolina	Han, SZ (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	swapan-nath@omrf.ouhsc.edu	Han, Shizhong/E-4084-2010; Han, Shizhong/H-5785-2011	Harley, Isaac/0000-0003-1282-5395; Guthridge, Joel/0000-0002-9308-237X; Han, Shizhong/0000-0002-5114-6742	National Institutes of Health [AR048928, AI063622, RR020143, AR049084, AI24717, AR42460, AR048940, AI053747, AR12253, DE15223, RR01577, RR14467, AI31584]; US Department of Veterans Affairs; The Alliance for Lupus Research; Mary Kirkland Scholar; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR014467, P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053747, R01AI063622, R01AI024717, R01AI031584, R37AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR048928, P50AR048940, R01AR042460, P01AR049084, P30AR053483, N01AR012253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); The Alliance for Lupus Research; Mary Kirkland Scholar; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institutes of Health (AR048928, AI063622, RR020143, AR049084, AI24717, AR42460, AR048940, AI053747, AR12253, DE15223, RR01577, RR14467, and AI31584), the US Department of Veterans Affairs, The Alliance for Lupus Research and a Mary Kirkland Scholar	Arbuckle MR, 2003, LUPUS, V12, P99, DOI 10.1191/0961203303lu334oa; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Chabanon Herve, 2004, Briefings in Functional Genomics & Proteomics, V3, P240; Chiocchetti A, 2004, BLOOD, V103, P1376, DOI 10.1182/blood-2003-05-1748; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Cowley BD, 2001, KIDNEY INT, V60, P2087, DOI 10.1046/j.1523-1755.2001.00065.x; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Forton AC, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9025; Graham DSC, 2006, HUM MOL GENET, V15, P3195, DOI 10.1093/hmg/ddl395; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; KATAGIRI Y, 1995, ANN NY ACAD SCI, V760, P371, DOI 10.1111/j.1749-6632.1995.tb44660.x; Kaufman KM, 2006, ARTHRITIS RHEUM-US, V54, P2533, DOI 10.1002/art.21963; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; MATKOVITS T, 1995, ENDOCRINOLOGY, V136, P3971, DOI 10.1210/en.136.9.3971; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Miyazaki T, 2005, EUR J IMMUNOL, V35, P1510, DOI 10.1002/eji.200425672; Mok CC, 1999, LUPUS, V8, P188, DOI 10.1191/096120399678847605; Molina JF, 1996, MEDICINE, V75, P124, DOI 10.1097/00005792-199605000-00002; Nath SK, 2004, CURR OPIN IMMUNOL, V16, P794, DOI 10.1016/j.coi.2004.09.007; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Stein CM, 2002, ARTHRITIS RHEUM, V46, P428, DOI 10.1002/art.10105; Sun M, 2005, NUCLEIC ACIDS RES, V33, P5533, DOI 10.1093/nar/gki852; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xing C, 2005, HUM GENET, V118, P309, DOI 10.1007/s00439-005-0061-5; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	40	60	66	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e0001757	10.1371/journal.pone.0001757	http://dx.doi.org/10.1371/journal.pone.0001757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335026	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000011
J	Campbell, HA; Fraser, KPP; Bishop, CM; Peck, LS; Egginton, S				Campbell, Hamish A.; Fraser, Keiron P. P.; Bishop, Charles M.; Peck, Lloyd S.; Egginton, Stuart			Hibernation in an Antarctic Fish: On Ice for Winter	PLOS ONE			English	Article								Active metabolic suppression in anticipation of winter conditions has been demonstrated in species of mammals, birds, reptiles and amphibians, but not fish. This is because the reduction in metabolic rate in fish is directly proportional to the decrease in water temperature and they appear to be incapable of further suppressing their metabolic rate independently of temperature. However, the Antarctic fish (Notothenia coriiceps) is unusual because it undergoes winter metabolic suppression irrespective of water temperature. We assessed the seasonal ecological strategy by monitoring swimming activity, growth, feeding and heart rate (f(H)) in N. coriiceps as they free-ranged within sub-zero waters. The metabolic rate of wild fish was extrapolated from f(H) recordings, from oxygen consumption calibrations established in the laboratory prior to fish release. Throughout the summer months N. coriiceps spent a considerable proportion of its time foraging, resulting in a growth rate (G(w)) of 0.18 +/- 0.2% day(-1). In contrast, during winter much of the time was spent sedentary within a refuge and fish showed a net loss in Gw (-0.05 +/- 0.05% day(-1)). Whilst inactive during winter, N. coriiceps displayed a very low fH, reduced sensory and motor capabilities, and standard metabolic rate was one third lower than in summer. In a similar manner to other hibernating species, dormancy was interrupted with periodic arousals. These arousals, which lasted a few hours, occurred every 4-12 days. During arousal activity, f(H) and metabolism increased to summer levels. This endogenous suppression and activation of metabolic processes, independent of body temperature, demonstrates that N. coriiceps were effectively 'putting themselves on ice' during winter months until food resources improved. This study demonstrates that at least some fish species can enter a dormant state similar to hibernation that is not temperature driven and presumably provides seasonal energetic benefits.	[Campbell, Hamish A.; Egginton, Stuart] Univ Birmingham, Dept Physiol, Birmingham, W Midlands, England; [Fraser, Keiron P. P.; Peck, Lloyd S.] Natl Env Res Council, British Antarctic Survey, Cambridge, England; [Bishop, Charles M.] Univ Bangor, Dept Biol Sci, Bangor, Gwynedd, Wales	University of Birmingham; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Bangor University	Campbell, HA (corresponding author), Univ Birmingham, Dept Physiol, Birmingham, W Midlands, England.	dr.hamish.campbell@gmail.com		Campbell, Hamish/0000-0003-1428-1686; Egginton, Stuart/0000-0002-3084-9692	NERC (UK) Antarctic Funding Initiative; British Antarctic Survey; Natural Environment Research Council [dml011000] Funding Source: researchfish; NERC [dml011000] Funding Source: UKRI	NERC (UK) Antarctic Funding Initiative(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Antarctic Survey; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by an NERC (UK) Antarctic Funding Initiative Grant in collaboration with the British Antarctic Survey.	AXELSSON M, 1992, J EXP BIOL, V167, P179; Brett J.R., 1979, FISH PHYSL; Brockington S, 2001, MAR BIOL, V139, P127; CAMPBELL HA, 2005, J FISH BIOL, V66, P1; CASAUX C, 1990, ANTARCTICA POLAR BIO, V11, P63; Choi IH, 1998, PHYSIOL ZOOL, V71, P257, DOI 10.1086/515915; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; Clarke A, 1996, TRENDS ECOL EVOL, V11, P212, DOI 10.1016/0169-5347(96)10029-X; Cliff A, 1973, SPATIAL AUTOCORRELAT; Coggan R, 1997, J EXP MAR BIOL ECOL, V210, P23, DOI 10.1016/S0022-0981(96)02717-7; Coggan R, 1997, J EXP MAR BIOL ECOL, V213, P215, DOI 10.1016/S0022-0981(96)02731-1; Cooke Steven J., 2003, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, V134A, P157, DOI 10.1016/S1095-6433(02)00240-4; Cossins AR, 1996, NATURE, V382, P582, DOI 10.1038/382582a0; CRAWSHAW LI, 1980, ANNU REV PHYSIOL, V42, P473, DOI 10.1146/annurev.ph.42.030180.002353; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Desjardins M, 2006, J EXP MAR BIOL ECOL, V335, P142, DOI 10.1016/j.jembe.2006.03.011; Elvert R, 2005, J EXP BIOL, V208, P1373, DOI 10.1242/jeb.01546; Everson I., 1970, Bull. Br. Antarct. Surv., VNo. 23, P25; FARRELL AP, 1992, FISH PHYSL A, V12; GIESER F, 1996, ADAPTATIONS COLD; Grigg Gordon, 1996, P13; JOHNSTON IA, 1991, MAR BIOL, V109, P191, DOI 10.1007/BF01319386; JOHNSTON IA, 1993, MAR BIOL, V115, P7, DOI 10.1007/BF00349380; Kawaguchi K., 1989, P NIPR S POLAR BIOL, V2, P111; Lyman C.P., 1982, HIBERNATION TORPOR M; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; NORTH AW, 1988, CYBIUM, V12, P91; Sayer MDJ, 1996, J FISH BIOL, V49, P41, DOI 10.1111/j.1095-8649.1996.tb00004.x; Targett T.E., 1990, 2 INT S BIOL ANT FIS, P37; White M.G., 1991, P87; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	31	56	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1743	10.1371/journal.pone.0001743	http://dx.doi.org/10.1371/journal.pone.0001743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320061	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586600038
J	Hayashi, K; Lopes, SMCD; Kaneda, M; Tang, FC; Hajkova, P; Lao, KQ; O'Carroll, D; Das, PP; Tarakhovsky, A; Miska, EA; Surani, MA				Hayashi, Katsuhiko; Lopes, Susana M. Chuva de Sousa; Kaneda, Masahiro; Tang, Fuchou; Hajkova, Petra; Lao, Kaiqin; O'Carroll, Donal; Das, Partha P.; Tarakhovsky, Alexander; Miska, Eric A.; Surani, M. Azim			MicroRNA Biogenesis Is Required for Mouse Primordial Germ Cell Development and Spermatogenesis	PLOS ONE			English	Article							HUMAN LUNG CANCERS; SMALL RNAS; TRYPANOSOMA-BRUCEI; ENZYME DICER; EXPRESSION; GENE; PROTEIN; PIWI; DIFFERENTIATION; RETROTRANSPOSON	Background: MicroRNAs (miRNAs) are critical regulators of transcriptional and post-transcriptional gene silencing, which are involved in multiple developmental processes in many organisms. Apart from miRNAs, mouse germ cells express another type of small RNA, piwi-interacting RNAs (piRNAs). Although it has been clear that piRNAs play a role in repression of retrotransposons during spermatogenesis, the function of miRNA in mouse germ cells has been unclear. Methodology/Principal Findings: In this study, we first revealed the expression pattern of miRNAs by using a real-time PCR-based 220-plex miRNA expression profiling method. During development of germ cells, miR-17-92 cluster, which is thought to promote cell cycling, and the ES cell-specific cluster encoding miR-290 to -295 (miR-290-295 cluster) were highly expressed in primordial germ cells (PGCs) and spermatogonia. A set of miRNAs was developmentally regulated. We next analysed function of miRNA biogenesis in germ cell development by using conditional Dicer-knockout mice in which Dicer gene was deleted specifically in the germ cells. Dicer-deleted PGCs and spermatogonia exhibited poor proliferation. Retrotransposon activity was unexpectedly suppressed in Dicer-deleted PGCs, but not affected in the spermatogonia. In Dicer-deleted testis, spermatogenesis was retarded at an early stage when proliferation and/or early differentiation. Additionally, we analysed spermatogenesis in conditional Argonaute2-deficient mice. In contrast to Dicer-deficient testis, spermatogenesis in Argonaute2-deficient testis was indistinguishable from that in wild type. Conclusion/Significance: These results illustrate that miRNAs are important for the proliferation of PGCs and spermatogonia, but dispensable for the repression of retrotransposons in developing germ cells. Consistently, miRNAs promoting cell cycling are highly expressed in PGCs and spermatogonia. Furthermore, based on normal spermatogenesis in Argonaute2-deficient testis, the critical function of Dicer in spermatogenesis is independent of Argonaute2.	[Hayashi, Katsuhiko; Lopes, Susana M. Chuva de Sousa; Kaneda, Masahiro; Tang, Fuchou; Hajkova, Petra; Das, Partha P.; Miska, Eric A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res United Kingdom Gurdon Ins, Cambridge, England; [Lao, Kaiqin] Appl Biosyst Inc, Advanced Res Technol, Foster City, CA USA; [O'Carroll, Donal; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signal, New York, NY USA	University of Cambridge; Thermo Fisher Scientific; Applied Biosystems; Rockefeller University	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res United Kingdom Gurdon Ins, Cambridge, England.	as10021@mole.bio.cam.ac.uk	Kaneda, Masahiro/E-3117-2010	Kaneda, Masahiro/0000-0003-0660-7156; Das, Partha Pratim/0000-0003-3544-2629; O'Carroll, Donal/0000-0002-8626-2217; Hajkova, Petra/0000-0003-4145-1468; Surani, Azim/0000-0002-8640-4318; Miska, Eric/0000-0002-4450-576X	Wellcome Trust; Japan Society for Promotion of Science; Netherlands Organization for Scientific Research	Wellcome Trust(Wellcome TrustEuropean Commission); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Wellcome Trust, the Japan Society for Promotion of Science, the Netherlands Organization for Scientific Research	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bourc'his D, 2006, CYTOGENET GENOME RES, V113, P36, DOI 10.1159/000090813; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Costa Y, 2006, HUM MOL GENET, V15, P2324, DOI 10.1093/hmg/ddl158; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Djikeng A, 2001, RNA, V7, P1522; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moe-Behrens GHG, 2003, MOL ENDOCRINOL, V17, P2630, DOI 10.1210/me.2003-0006; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nolan T, 2005, NUCLEIC ACIDS RES, V33, P1564, DOI 10.1093/nar/gki300; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	63	371	403	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1738	10.1371/journal.pone.0001738	http://dx.doi.org/10.1371/journal.pone.0001738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320056	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600033
J	Iijima, K; Chiang, HC; Hearn, SA; Hakker, I; Gatt, A; Shenton, C; Granger, L; Leung, A; Iijima-Ando, K; Zhong, Y				Iijima, Koichi; Chiang, Hsueh-Cheng; Hearn, Stephen A.; Hakker, Inessa; Gatt, Anthony; Shenton, Christopher; Granger, Linda; Leung, Amy; Iijima-Ando, Kanae; Zhong, Yi			A beta 42 Mutants with Different Aggregation Profiles Induce Distinct Pathologies in Drosophila	PLOS ONE			English	Article								Aggregation of the amyloid-beta-42 (A beta 42) peptide in the brain parenchyma is a pathological hallmark of Alzheimer's disease (AD), and the prevention of Ab aggregation has been proposed as a therapeutic intervention in AD. However, recent reports indicate that Ab can form several different prefibrillar and fibrillar aggregates and that each aggregate may confer different pathogenic effects, suggesting that manipulation of A beta 42 aggregation may not only quantitatively but also qualitatively modify brain pathology. Here, we compare the pathogenicity of human A beta 42 mutants with differing tendencies to aggregate. We examined the aggregation-prone, EOFAD-related (Arc) under bar tic mutation (A beta 42 (arc) under bar) and an (art) under bar ificial mutation (A beta 42 (art) under bar) that is known to suppress aggregation and toxicity of A beta 42 in vitro. In the Drosophila brain, A beta 42Arc formed more oligomers and deposits than did wild type A beta 42, while A beta 42art formed fewer oligomers and deposits. The severity of locomotor dysfunction and premature death positively correlated with the aggregation tendencies of Ab peptides. Surprisingly, however, A beta 42art caused earlier onset of memory defects than A beta 42. More remarkably, each Ab induced qualitatively different pathologies. A beta 42Arc caused greater neuron loss than did A beta 42, while A beta 42art flies showed the strongest neurite degeneration. This pattern of degeneration coincides with the distribution of Thioflavin S-stained Ab aggregates: A beta 42Arc formed large deposits in the cell body, A beta 42art accumulated preferentially in the neurites, while A beta 42 accumulated in both locations. Our results demonstrate that manipulation of the aggregation propensity of A beta 42 does not simply change the level of toxicity, but can also result in qualitative shifts in the pathology induced in vivo.	[Iijima, Koichi; Chiang, Hsueh-Cheng; Hearn, Stephen A.; Hakker, Inessa; Leung, Amy; Iijima-Ando, Kanae; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Iijima, Koichi; Gatt, Anthony; Granger, Linda] Thomas Jefferson Univ Hosp, Farber Inst Neurosci, Lab Neurodegenerative Dis Gene Discovery, Philadelphia, PA USA; [Shenton, Christopher; Granger, Linda; Iijima-Ando, Kanae] Thomas Jefferson Univ Hosp, Farber Inst Neurosci, Lab Neurogenet & Protein Misfolding Dis, Philadelphia, PA USA; [Iijima, Koichi; Iijima-Ando, Kanae] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA USA; [Chiang, Hsueh-Cheng] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY USA	Cold Spring Harbor Laboratory; Jefferson University; Jefferson University; Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Iijima, K (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	Koichi.Iijima@jefferson.edu; zhongyi@cshl.edu		Zhong, Yi/0000-0001-7810-9899; Hearn, Stephen/0000-0002-2489-2424; Zhong, Yi/0000-0002-7927-5976	Alzheimer's Association; Pilot Research Award from Thomas Jefferson University; Hereditary Disease Foundation; Farber Institute for Neurosciences; National Institutes of Health	Alzheimer's Association(Alzheimer's Association); Pilot Research Award from Thomas Jefferson University; Hereditary Disease Foundation; Farber Institute for Neurosciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Alzheimer's Association (to K.I.), Pilot Research Award from Thomas Jefferson University (to K.I.), the Hereditary Disease Foundation (to K.I.-A.), the start-up funds from Farber Institute for Neurosciences (to K.I. and K. I.-A. ), and the National Institutes of Health (to Y.Z.).	BRAND AH, 1993, DEVELOPMENT, V118, P401; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Cummings JL, 2000, NEUROBIOL AGING, V21, P845, DOI 10.1016/S0197-4580(00)00183-4; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Fay DS, 1998, J NEUROCHEM, V71, P1616; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly JW, 2005, NEW ENGL J MED, V352, P722, DOI 10.1056/NEJMcibr044231; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Ryman Davis, 2006, Current Alzheimer Research, V3, P465, DOI 10.2174/156720506779025198; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Slow EJ, 2006, TRENDS GENET, V22, P408, DOI 10.1016/j.tig.2006.05.008; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; THAL DR, 2006, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2006.6.RE1; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201	43	127	139	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1703	10.1371/journal.pone.0001703	http://dx.doi.org/10.1371/journal.pone.0001703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301778	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586500047
J	Crawford, LW; Ables, ET; Oh, YA; Boone, B; Levy, S; Gannon, M				Crawford, Laura Wilding; Ables, Elizabeth Tweedie; Oh, Young Ah; Boone, Braden; Levy, Shawn; Gannon, Maureen			Gene Expression Profiling of a Mouse Model of Pancreatic Islet Dysmorphogenesis	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; BETA-CELLS; TRANSCRIPTION FACTORS; ENDOCRINE-CELLS; PLASMA-MEMBRANE; DIFFERENTIATION; MICE; GRANULES; GROWTH; PROLIFERATION	Background: In the past decade, several transcription factors critical for pancreas organogenesis have been identified. Despite this success, many of the factors necessary for proper islet morphogenesis and function remain uncharacterized. Previous studies have shown that transgenic over-expression of the transcription factor Hnf6 specifically in the pancreatic endocrine cell lineage resulted in disruptions in islet morphogenesis, including dysfunctional endocrine cell sorting, increased individual islet size, increased number of peripheral endocrine cell types, and failure of islets to migrate away from the ductal epithelium. The mechanisms whereby maintained Hnf6 causes defects in islet morphogenesis have yet to be elucidated. Methodology/Principal Findings: We exploited the dysmorphic islets in Hnf6 transgenic animals as a tool to identify factors important for islet morphogenesis. Genome-wide microarray analysis was used to identify differences in the gene expression profiles of late gestation and early postnatal total pancreas tissue from wild type and Hnf6 transgenic animals. Here we report the identification of genes with an altered expression in Hnf6 transgenic animals and highlight factors with potential importance in islet morphogenesis. Importantly, gene products involved in cell adhesion, cell migration, ECM remodeling and proliferation were found to be altered in Hnf6 transgenic pancreata, revealing specific candidates that can now be analyzed directly for their role in these processes during islet development. Conclusions/Significance: This study provides a unique dataset that can act as a starting point for other investigators to explore the role of the identified genes in pancreatogenesis, islet morphogenesis and mature beta cell function.	[Oh, Young Ah; Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabetes Endocrinol & Metabol, Nashville, TN 37203 USA; [Crawford, Laura Wilding; Ables, Elizabeth Tweedie; Boone, Braden; Levy, Shawn; Gannon, Maureen] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Crawford, LW (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Diabetes Endocrinol & Metabol, Nashville, TN 37203 USA.	maureen.gannon@vanderbilt.edu	Gannon, Maureen A/F-9060-2012	Levy, Shawn/0000-0002-1369-5740; Ables, Elizabeth/0000-0002-6934-9302	NIH [DK065131]; JDRF Career Development Award [2-2002-583]; Vanderbilt Molecular Endocrinology [5-T32-DK07563]; Vanderbilt Training Program in Developmental Biology [5-T32-HD05702]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563, R01DK065131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF Career Development Award(Juvenile Diabetes Research Foundation); Vanderbilt Molecular Endocrinology; Vanderbilt Training Program in Developmental Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: NIH grant DK065131 and JDRF Career Development Award grant #2-2002-583 to M. Gannon; Vanderbilt Molecular Endocrinology Training Grant 5-T32-DK07563 to L. Crawford; Vanderbilt Training Program in Developmental Biology Grant 5-T32-HD05702 to E. Tweedie Ables.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arava Y, 1999, DIABETES, V48, P552, DOI 10.2337/diabetes.48.3.552; Bennett M V, 1978, Neurosci Res Program Bull, V16, P1; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Cirulli V, 2000, J CELL BIOL, V150, P1445, DOI 10.1083/jcb.150.6.1445; Dahl U, 1996, DEVELOPMENT, V122, P2895; DANIEL P, 2006, DEV DYNAM, V235, P1720; De Leon DD, 2006, PHYSIOL GENOMICS, V24, P133, DOI 10.1152/physiolgenomics.00156.2005; Easom RA, 2000, SEMIN CELL DEV BIOL, V11, P253, DOI 10.1006/scdb.2000.0174; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; Gannon M, 2000, DEVELOPMENT, V127, P2883; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; GU DL, 1993, DEVELOPMENT, V118, P33; Gu GQ, 2002, DEVELOPMENT, V129, P2447; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Hald J, 2003, DEV BIOL, V260, P426, DOI 10.1016/S0012-1606(03)00326-9; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Martelli AM, 2000, TRAFFIC, V1, P976, DOI 10.1034/j.1600-0854.2000.011207.x; MEISSNER HP, 1976, NATURE, V262, P502, DOI 10.1038/262502a0; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Offield MF, 1996, DEVELOPMENT, V122, P983; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PICTET RL, 1972, DEV BIOL, V29, P436, DOI 10.1016/0012-1606(72)90083-8; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Qiu LH, 2005, MOL CELL PROTEOMICS, V4, P1311, DOI 10.1074/mcp.M500016-MCP200; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; RHODES CJ, 1987, J BIOL CHEM, V262, P10712; Roche E, 2000, J PHYSIOL BIOCHEM, V56, P119, DOI 10.1007/BF03179907; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; SAMOLS E, 1988, J CLIN INVEST, V82, P350, DOI 10.1172/JCI113593; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Stenmark H, 2001, GENOME BIOL, V2; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Takahashi M, 2002, DEVELOPMENT, V129, P1327; Tan YJ, 2006, GASTROENTEROLOGY, V130, P1283, DOI 10.1053/j.gastro.2006.01.010; TEITELMAN G, 1987, DEV BIOL, V121, P454, DOI 10.1016/0012-1606(87)90182-5; TEITELMAN G, 1987, DEV BIOL, V120, P425, DOI 10.1016/0012-1606(87)90246-6; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tweedie E, 2006, DIABETES, V55, P3264, DOI 10.2337/db06-0090; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	80	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1611	10.1371/journal.pone.0001611	http://dx.doi.org/10.1371/journal.pone.0001611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18297134	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400004
J	Detto, T; Hemmi, JM; Backwell, PRY				Detto, Tanya; Hemmi, Jan M.; Backwell, Patricia R. Y.			Colouration and Colour Changes of the Fiddler Crab, Uca capricornis: A Descriptive Study	PLOS ONE			English	Article								Colour changes in animals may be triggered by a variety of social and environmental factors and may occur over a matter of seconds or months. Crustaceans, like fiddler crabs (genus Uca), are particularly adept at changing their colour and have been the focus of numerous studies. However, few of these studies have attempted to quantitatively describe the individual variation in colour and pattern or their adaptive significance. This paper quantitatively describes the colour patterns of the fiddler crab Uca capricornis and their ability to change on a socially significant timescale. The most dramatic changes in colour pattern are associated with moulting. These ontogenetic changes result in a general reduction of the colour pattern with increasing size, although females are more colourful and variable than similarly-sized males. Uca capricornis are also capable of rapid colour changes in response to stress, but show no endogenous rhythms associated with the semilunar and tidal cycles commonly reported in other fiddler crabs. The extreme colour polymorphism and the relative stability of the colour patterns in Uca capricornis are consistent with their use in visually mediated mate recognition.	[Detto, Tanya; Hemmi, Jan M.] Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia; [Detto, Tanya; Backwell, Patricia R. Y.] Australian Natl Univ, Sch Botany & Zool, Canberra, ACT, Australia; [Hemmi, Jan M.] Australian Natl Univ, Res Sch Biol Sci, ARC Ctr Excellence Vision Sci, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University	Detto, T (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia.	tanya.detto@anu.edu.au	Backwell, Patricia RY/C-8883-2009; Hemmi, Jan M/B-6458-2008	Hemmi, Jan M/0000-0003-4629-9362	Centre for Visual Sciences [ANU PhD Scholarship]; ARC Discovery; ARC Centre of Excellence for Vision Research	Centre for Visual Sciences; ARC Discovery(Australian Research Council); ARC Centre of Excellence for Vision Research(Australian Research Council)	This work was funded by an ANU PhD Scholarship with an additional contribution by the Centre for Visual Sciences (TKD), an ARC Discovery Grant (PRYB), and the ARC Centre of Excellence for Vision Research and Centre for Visual Sciences (JMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 1996, ANIM BEHAV, V52, P73, DOI 10.1006/anbe.1996.0153; BAUER RT, 1981, MAR BIOL, V64, P141, DOI 10.1007/BF00397103; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; BOOTH CL, 1990, BIOL J LINN SOC, V40, P125, DOI 10.1111/j.1095-8312.1990.tb01973.x; BROWN FA, 1953, J EXP ZOOL, V123, P29, DOI 10.1002/jez.1401230103; BROWN FA, 1948, PHYSIOL ZOOL, V21, P361, DOI 10.1086/physzool.21.4.30152015; Crane Jocelyn, 1944, ZOOLOGICA [NEW YORK], V29, P161; Detto T, 2007, P ROY SOC B-BIOL SCI, V274, P2785, DOI 10.1098/rspb.2007.1059; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; FINGERMAN M, 1965, PHYSIOL REV, V45, P296, DOI 10.1152/physrev.1965.45.2.296; George R.W., 1982, Records of the Western Australian Museum Supplement, V14, P1; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; Johnstone RA, 1997, P ROY SOC B-BIOL SCI, V264, P1547, DOI 10.1098/rspb.1997.0215; JORMALAINEN V, 1995, BIOL J LINN SOC, V55, P45, DOI 10.1111/j.1095-8312.1995.tb01049.x; Knowles FGW, 1940, J EXP BIOL, V17, P262; LAND M, 1995, J COMP PHYSIOL A, V177, P81, DOI 10.1007/BF00243400; LEE WL, 1966, ECOLOGY, V47, P930, DOI 10.2307/1935640; Merilaita S, 1997, ANIM BEHAV, V54, P769, DOI 10.1006/anbe.1996.0490; NOBLE G. K., 1939, BULL AMER MUS NAT HIST, V76, P1; O'Connor KI, 1999, ANIM BEHAV, V58, P1269, DOI 10.1006/anbe.1999.1260; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Osorio D, 1997, TRENDS ECOL EVOL, V12, P167, DOI 10.1016/S0169-5347(97)01038-0; RAO KR, 1985, BIOL CRUSTACEA, V9, P395; Rust C. C., 1962, Journal of Mammalogy, V43, P323, DOI 10.2307/1376938; SCHOENER TW, 1976, EVOLUTION, V30, P650, DOI 10.1111/j.1558-5646.1976.tb00946.x; Shih HT, 1999, ZOOL STUD, V38, P164; Thurman C. L, 1990, ADAPTIVE COLORATION, P109; THURMAN CL, 1988, COMP BIOCHEM PHYS C, V91, P171, DOI 10.1016/0742-8413(88)90184-3; Tibbetts EA, 2004, P ROY SOC B-BIOL SCI, V271, P1955, DOI 10.1098/rspb.2004.2784; Todd PA, 2006, MAR BIOL, V148, P1357, DOI 10.1007/s00227-005-0159-2; Todd PA, 2005, ECOL RES, V20, P497, DOI 10.1007/s11284-004-0034-5; Warner GF, 1977, BIOL CRABS; WILKENS JL, 1965, BIOL BULL, V128, P133, DOI 10.2307/1539396; Zeil J, 2001, J EXP BIOL, V204, P2561; Zeil J, 1996, J EXP BIOL, V199, P1569; [No title captured]	36	49	49	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1629	10.1371/journal.pone.0001629	http://dx.doi.org/10.1371/journal.pone.0001629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286186	Green Published, gold			2022-12-27	WOS:000260586400022
J	Palstra, RJ; Simonis, M; Klous, P; Brasset, E; Eijkelkamp, B; de Laat, W				Palstra, Robert-Jan; Simonis, Marieke; Klous, Petra; Brasset, Emilie; Eijkelkamp, Bart; de Laat, Wouter			Maintenance of Long-Range DNA Interactions after Inhibition of Ongoing RNA Polymerase II Transcription	PLOS ONE			English	Article								A relationship exists between nuclear architecture and gene activity and it has been proposed that the activity of ongoing RNA polymerase II transcription determines genome organization in the mammalian cell nucleus. Recently developed 3C and 4C technology allowed us to test the importance of transcription for nuclear architecture. We demonstrate that upon transcription inhibition binding of RNA polymerase II to gene regulatory elements is severely reduced. However, contacts between regulatory DNA elements and genes in the beta-globin locus are unaffected and the locus still interacts with the same genomic regions elsewhere on the chromosome. This is a general phenomenon since the great majority of intra- and interchromosomal interactions with the ubiquitously expressed Rad23a gene are also not affected. Our data demonstrate that without transcription the organization and modification of nucleosomes at active loci and the local binding of specific trans-acting factors is unaltered. We propose that these parameters, more than transcription or RNA polymerase II binding, determine the maintenance of long-range DNA interactions.	[Palstra, Robert-Jan; Simonis, Marieke; Klous, Petra; Brasset, Emilie; Eijkelkamp, Bart; de Laat, Wouter] Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Palstra, RJ (corresponding author), Erasmus MC, Dept Cell Biol & Genet, Rotterdam, Netherlands.	w.delaat@erasmusmc.nl	Eijkelkamp, Bart/G-7109-2015; Brasset, Emilie/J-6684-2015	Eijkelkamp, Bart/0000-0003-0179-8977; de Laat, Wouter/0000-0002-6393-595X; Brasset, Emilie/0000-0003-2479-7969; Palstra, Robert-Jan/0000-0003-4600-2303	Netherlands Organisation for Scientific Research (NWO) [912-04-082, 815-02-013, 825-07-012]; Netherlands Genomics Initiative [050-71-324]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative	This work was supported by grants from the Netherlands Organisation for Scientific Research (NWO) (912-04-082 and 815-02-013), and the Netherlands Genomics Initiative (050-71-324). E.B. was supported by a Rubicon grant from the Netherlands Organisation for Scientific Research (NWO) (825-07-012). The funding organizations didn't have any role in preparation of the manuscript	Bender MA, 2006, BLOOD, V108, P1395, DOI 10.1182/blood-2006-04-014431; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; CHODOSH LA, 1989, J BIOL CHEM, V264, P2250; Cook PR, 2003, J CELL SCI, V116, P4483, DOI 10.1242/jcs.00819; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; COOK PR, 1995, J CELL SCI, V108, P2927; de Laat W, 2007, CURR OPIN GENET DEV, V17, P456, DOI 10.1016/j.gde.2007.07.009; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Englmann A, 2005, CHROMOSOME RES, V13, P183, DOI 10.1007/s10577-005-0845-4; Faro-Trindade I, 2006, BIOCHEM SOC T, V34, P1133, DOI 10.1042/BST0341133; Forsberg EC, 1999, J BIOL CHEM, V274, P26850, DOI 10.1074/jbc.274.38.26850; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gong XQ, 2004, J BIOL CHEM, V279, P27422, DOI 10.1074/jbc.M402163200; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Kooren J, 2007, J BIOL CHEM, V282, P16544, DOI 10.1074/jbc.M701159200; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Marenduzzo D, 2006, BIOPHYS J, V90, P3712, DOI 10.1529/biophysj.105.077685; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; NOORDERMEER D, 2008, PLOS GENET IN PRESS; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Schubeler D, 2000, GENE DEV, V14, P940; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van de Corput MPC, 2001, METHODS, V25, P111, DOI 10.1006/meth.2001.1220; Volpi EV, 2000, J CELL SCI, V113, P1565; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	51	100	105	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1661	10.1371/journal.pone.0001661	http://dx.doi.org/10.1371/journal.pone.0001661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286208	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400050
J	Zoungrana, A; Coulibaly, B; Sie, A; Walter-Sack, I; Mockenhaupt, FP; Kouyate, B; Schirmer, RH; Klose, C; Mansmann, U; Meissner, P; Muller, O				Zoungrana, Augustin; Coulibaly, Boubacar; Sie, Ali; Walter-Sack, Ingeborg; Mockenhaupt, Frank P.; Kouyate, Bocar; Schirmer, R. Heiner; Klose, Christina; Mansmann, Ulrich; Meissner, Peter; Mueller, Olaf			Safety and Efficacy of Methylene Blue Combined with Artesunate or Amodiaquine for Uncomplicated Falciparum Malaria: A Randomized Controlled Trial from Burkina Faso	PLOS ONE			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; COMBINATION THERAPY; ARTEMETHER-LUMEFANTRINE; GAMBIAN CHILDREN; AFRICAN CHILDREN; CHLOROQUINE; ARTEMISININ; RESISTANCE; MORBIDITY; UGANDA	Background: Besides existing artemisinin-based combination therapies, alternative safe, effective and affordable drug combinations against falciparum malaria are needed. Methylene blue (MB) was the first synthetic antimalarial drug ever used, and recent studies have been promising with regard to its revival in malaria therapy. The objective of this study was to assess the safety and efficacy of two MB-based malaria combination therapies, MB-artesunate (AS) and MB-amodiaquine (AQ),compared to the local standard of care, AS-AQ, in Burkina Faso. Methods and Findings: Open-label randomised controlled phase II study in 180 children aged 6-10 years with uncomplicated falciparum malaria in Nouna, north-western Burkina Faso. Follow-up was for 28 days and analysis by intention-to-treat. The treatment groups were similar in baseline characteristics and there was only one loss to follow-up. No drug-related serious adverse events and no deaths occurred. MB-containing regimens were associated with mild vomiting and dysuria. No early treatment failures were observed. Parasite clearance time differed significantly among groups and was the shortest with MB-AS. By day 14, the rates of adequate clinical and parasitological response after PCR-based correction for recrudescence were 87% for MB-AS, 100% for MB-AQ (p = 0.004), and 100% for AS-AQ (p = 0.003). By day 28, the respective figure was lowest for MB-AS (62%), intermediate for the standard treatment AS-AQ (82%; p = 0.015), and highest for MB-AQ (95%; p< 0.001; p = 0.03). Conclusions: MB-AQ is a promising alternative drug combination against malaria in Africa. Moreover, MB has the potential to further accelerate the rapid parasite clearance of artemisinin-based combination therapies. More than a century after the antimalarial properties of MB had been described, its role in malaria control deserves closer attention.	[Zoungrana, Augustin; Coulibaly, Boubacar; Sie, Ali; Kouyate, Bocar] Ctr Rech Sante Nouna, Nouna, Burkina Faso; [Walter-Sack, Ingeborg] Heidelberg Univ, Med Sch, Dept Internal Med 6, Heidelberg, Germany; [Mockenhaupt, Frank P.] Charite Univ Med Berlin, Inst Trop Med & Internat Hlth, Berlin, Germany; [Schirmer, R. Heiner] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany; [Klose, Christina] Heidelberg Univ, Inst Med Biometrics & Informat, Heidelberg, Germany; [Mansmann, Ulrich] Univ Munich, Med Sch, Inst Bioinformat & Epidemiol, Munich, Germany; [Meissner, Peter; Mueller, Olaf] Heidelberg Univ, Med Sch, Dept Trop Hyg & Publ Hlth, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munich; Ruprecht Karls University Heidelberg	Zoungrana, A (corresponding author), Ctr Rech Sante Nouna, Nouna, Burkina Faso.	olaf.mueller@urz.uni-heidelberg.de	Mockenhaupt, Frank P/U-9824-2017	Mockenhaupt, Frank P/0000-0002-8117-5421; SIE, Ali/0000-0002-3959-2520	German Science Foundation [SFB 544]	German Science Foundation(German Research Foundation (DFG))	The study was supported through the German Science Foundation (SFB 544). The funder had no role in the design and conduct of the study, in the collection, analysis, and interpretation, review, or approval of the manuscript.	Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Akoachere M, 2005, ANTIMICROB AGENTS CH, V49, P4592, DOI 10.1128/AAC.49.11.4592-4597.2005; Barennes H, 2004, TROP MED INT HEALTH, V9, P438, DOI 10.1111/j.1365-3156.2004.01224.x; BLOLAND PB, 2000, B WORLD HEALTH ORGAN, V78, P1387; Borrmann S, 2004, J INFECT DIS, V189, P901, DOI 10.1086/381785; Borrmann S, 2003, ANTIMICROB AGENTS CH, V47, P901, DOI 10.1128/AAC.47.3.901-904.2003; BUCHHOLZ K, 2007, ANTIMICR AG IN PRESS; Duffy PE, 2005, LANCET, V366, P1908, DOI 10.1016/S0140-6736(05)67768-9; Garner P, 2005, PLOS MED, V2, P287, DOI 10.1371/journal.pmed.0020105; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Guttmann P., 1891, BERLIN KLIN WOCH, P953; Hastings IM, 2000, PARASITOL TODAY, V16, P340, DOI 10.1016/S0169-4758(00)01707-5; *INT ART STUD GROU, 2002, COCHR LIB; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Kremsner PG, 2005, LANCET, V365, P1441; Mandi G, 2005, TROP MED INT HEALTH, V10, P32, DOI 10.1111/j.1365-3156.2004.01356.x; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Meissner PE, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-45; Meissner PE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-84; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Muller O, 1996, TROP MED INT HEALTH, V1, P124, DOI 10.1046/j.1365-3156.1996.d01-13.x; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Noedl H, 2007, TROP MED INT HEALTH, V12, P69; Nosten F, 2002, DRUGS, V62, P1315, DOI 10.2165/00003495-200262090-00003; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; *SPC, 2005, SUMM PROD CHAR; Staedke SG, 2001, LANCET, V358, P368, DOI 10.1016/S0140-6736(01)05557-X; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Sutherland CJ, 2003, AM J TROP MED HYG, V69, P19, DOI 10.4269/ajtmh.2003.69.19; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2003, ASS MON ANT DRUG EFF; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zongo I, 2005, AM J TROP MED HYG, V73, P826, DOI 10.4269/ajtmh.2005.73.826; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	46	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1630	10.1371/journal.pone.0001630	http://dx.doi.org/10.1371/journal.pone.0001630			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286187	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400023
J	Kitchen, A; Miyamoto, MM; Mulligan, CJ				Kitchen, Andrew; Miyamoto, Michael M.; Mulligan, Connie J.			A Three-Stage Colonization Model for the Peopling of the Americas	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL GENOME; DNA-SEQUENCE DATA; NEW-WORLD; NATIVE-AMERICANS; NORTH-AMERICA; MTDNA VARIATION; REGION SEQUENCES; MODERN HUMANS; EVOLUTIONARY; POPULATIONS	Background: We evaluate the process by which the Americas were originally colonized and propose a three-stage model that integrates current genetic, archaeological, geological, and paleoecological data. Specifically, we analyze mitochondrial and nuclear genetic data by using complementary coalescent models of demographic history and incorporating nongenetic data to enhance the anthropological relevance of the analysis. Methodology/Findings: Bayesian skyline plots, which provide dynamic representations of population size changes over time, indicate that Amerinds went through two stages of growth approximate to 40,000 and approximate to 15,000 years ago separated by a long period of population stability. Isolation-with-migration coalescent analyses, which utilize data from sister populations to estimate a divergence date and founder population sizes, suggest an Amerind population expansion starting approximate to 15,000 years ago. Conclusions/Significance: These results support a model for the peopling of the New World in which Amerind ancestors diverged from the Asian gene pool prior to 40,000 years ago and experienced a gradual population expansion as they moved into Beringia. After a long period of little change in population size in greater Beringia, Amerinds rapidly expanded into the Americas approximate to 15,000 years ago either through an interior ice-free corridor or along the coast. This rapid colonization of the New World was achieved by a founder group with an effective population size of approximate to 1,000-5,400 individuals. Our model presents a detailed scenario for the timing and scale of the initial migration to the Americas, substantially refines the estimate of New World founders, and provides a unified theory for testing with future datasets and analytic methods.	[Kitchen, Andrew; Mulligan, Connie J.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Miyamoto, Michael M.] Univ Florida, Dept Zool, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kitchen, A (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	mulligan@anthro.ufl.edu			National Science Foundation [BSR-0518530]; Department of Zoology, University of Florida	National Science Foundation(National Science Foundation (NSF)); Department of Zoology, University of Florida(University of Florida)	This study was supported by a grant from the National Science Foundation to CJM (BSR-0518530) and by funds from the Department of Zoology, University of Florida to MMM.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Dillehay TomD., 1997, ARCHAEOLOGICAL CONTE; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fix AG, 2005, AM J PHYS ANTHROPOL, V128, P430, DOI 10.1002/ajpa.20230; Forster P, 1996, AM J HUM GENET, V59, P935; Goebel T, 2007, SCIENCE, V315, P194, DOI 10.1126/science.1137564; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P15625, DOI 10.1073/pnas.0704215104; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Hoffecker JF, 2003, EVOL ANTHROPOL, V12, P34, DOI 10.1002/evan.10103; Hopkins D.M., 1982, PALEOECOLOGY BERINGI, P3, DOI DOI 10.1016/B978-0-12-355860-2.50008-9; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JOBLING MA, 2004, HUMAN EVOLUTIONARY G, P339; Joyce DJ, 2006, QUATERN INT, V142, P44, DOI 10.1016/j.quaint.2005.03.004; KITCHEN A, 2007, MOL PHYLOGE IN PRESS; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kolman CJ, 1996, GENETICS, V142, P1321; KOLMAN CJ, 1995, GENETICS, V140, P273; Kuzmin YV, 2005, AM ANTIQUITY, V70, P773, DOI 10.2307/40035874; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; Non AL, 2007, MOL PHYLOGENET EVOL, V44, P1164, DOI 10.1016/j.ympev.2006.12.020; O'Rourke DH, 2000, HUM BIOL, V72, P15; Overstreet David F., 2005, PALEOAMERICAN ORIGIN, P183; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Polanski A, 1998, P NATL ACAD SCI USA, V95, P5456, DOI 10.1073/pnas.95.10.5456; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Silva WA, 2002, AM J HUM GENET, V71, P187, DOI 10.1086/341358; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Zazula GD, 2003, NATURE, V423, P603, DOI 10.1038/423603a	56	125	126	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1596	10.1371/journal.pone.0001596	http://dx.doi.org/10.1371/journal.pone.0001596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367ES	18270583	Green Published, gold			2022-12-27	WOS:000260535900030
J	McDunn, JE; Husain, KD; Polpitiya, AD; Burykin, A; Ruan, J; Li, Q; Schierding, W; Lin, N; Dixon, D; Zhang, W; Coopersmith, CM; Dunne, WM; Colonna, M; Ghosh, BK; Cobb, JP				McDunn, Jonathan E.; Husain, Kareem D.; Polpitiya, Ashoka D.; Burykin, Anton; Ruan, Jianhua; Li, Qing; Schierding, William; Lin, Nan; Dixon, David; Zhang, Weixiong; Coopersmith, Craig M.; Dunne, W. Michael; Colonna, Marco; Ghosh, Bijoy K.; Cobb, J. Perren			Plasticity of the Systemic Inflammatory Response to Acute Infection during Critical Illness: Development of the Riboleukogram	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; GENE-EXPRESSION PATTERNS; SEPSIS; DEFINITIONS; INHIBITION; MACROPHAGE; MODEL	Background: Diagnosis of acute infection in the critically ill remains a challenge. We hypothesized that circulating leukocyte transcriptional profiles can be used to monitor the host response to and recovery from infection complicating critical illness. Methodology/Principal Findings: A translational research approach was employed. Fifteen mice underwent intratracheal injections of live P. aeruginosa, P. aeruginosa endotoxin, live S. pneumoniae, or normal saline. At 24 hours after injury, GeneChip microarray analysis of circulating buffy coat RNA identified 219 genes that distinguished between the pulmonary insults and differences in 7-day mortality. Similarly, buffy coat microarray expression profiles were generated from 27 mechanically ventilated patients every two days for up to three weeks. Significant heterogeneity of VAP microarray profiles was observed secondary to patient ethnicity, age, and gender, yet 85 genes were identified with consistent changes in abundance during the seven days bracketing the diagnosis of VAP. Principal components analysis of these 85 genes appeared to differentiate between the responses of subjects who did versus those who did not develop VAP, as defined by a general trajectory (riboleukogram) for the onset and resolution of VAP. As patients recovered from critical illness complicated by acute infection, the riboleukograms converged, consistent with an immune attractor. Conclusions/Significance: Here we present the culmination of a mouse pneumonia study, demonstrating for the first time that disease trajectories derived from microarray expression profiles can be used to quantitatively track the clinical course of acute disease and identify a state of immune recovery. These data suggest that the onset of an infection-specific transcriptional program may precede the clinical diagnosis of pneumonia in patients. Moreover, riboleukograms may help explain variance in the host response due to differences in ethnic background, gender, and pathogen. Prospective clinical trials are indicated to validate our results and test the clinical utility of riboleukograms.	[McDunn, Jonathan E.; Husain, Kareem D.; Polpitiya, Ashoka D.; Burykin, Anton; Schierding, William; Dixon, David; Coopersmith, Craig M.; Cobb, J. Perren] Washington Univ, Dept Surg, Ctr Crit Illness & Hlth Engn, St Louis, MO 63130 USA; [McDunn, Jonathan E.; Coopersmith, Craig M.] Washington Univ St. Louis, Dept Anesthesiol, St Louis, MO USA; [Ruan, Jianhua; Zhang, Weixiong] Washington Univ St. Louis, Dept Comp Sci & Engn, St Louis, MO USA; [Li, Qing; Lin, Nan] Washington Univ St. Louis, Dept Math, St Louis, MO USA; [Zhang, Weixiong; Cobb, J. Perren] Washington Univ St. Louis, Dept Genet, St Louis, MO USA; [Dunne, W. Michael] Washington Univ St. Louis, Dept Mol Microbiol, St Louis, MO USA; [Colonna, Marco] Washington Univ St. Louis, Dept Pathol & Immunol, St Louis, MO USA; [Ghosh, Bijoy K.] Washington Univ St. Louis, Dept Elect & Syst Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	McDunn, JE (corresponding author), Washington Univ, Dept Surg, Ctr Crit Illness & Hlth Engn, St Louis, MO 63130 USA.	cobb@wustl.edu	Ruan, Jianhua/I-2529-2012	McDunn, Jonathan/0000-0001-8792-828X; Ruan, Jianhua/0000-0002-5622-3137; Zhang, Weixiong/0000-0002-4998-9791; Schierding, William/0000-0001-5659-2701; Colonna, Marco/0000-0001-5222-4987	NIH [GM075023, GM008795]; NSF [IIS-0535257]; American College of Surgeons Clowes Career Development Award; Barnes-Jewish Hospital Foundation Research Award; Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075023] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American College of Surgeons Clowes Career Development Award; Barnes-Jewish Hospital Foundation Research Award; Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH GM075023 (JPC), NIH GM008795 (JEM), NSF IIS-0535257 (WZ), the American College of Surgeons Clowes Career Development Award (JPC), a Barnes-Jewish Hospital Foundation Research Award (JPC), and an institutional grant from Washington University in St. Louis (JEM).	Dominguez AA, 2006, SEMIN RESP CRIT CARE, V27, P104, DOI 10.1055/s-2006-933678; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Ayala A, 2003, CRIT CARE MED, V31, pS558, DOI 10.1097/01.CCM.0000081438.04801.D9; Bagley RJ, 1996, J THEOR BIOL, V183, P269, DOI 10.1006/jtbi.1996.0220; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brownstein BH, 2006, PHYSIOL GENOMICS, V24, P298, DOI 10.1152/physiolgenomics.00213.2005; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chung TP, 2006, J AM COLL SURGEONS, V203, P585, DOI 10.1016/j.jamcollsurg.2006.06.028; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cobb JP, 2004, LANCET, V363, P2076, DOI 10.1016/S0140-6736(04)16460-X; COBB JP, 2007, 4 NIH S UNPUB; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Craven DE, 2006, CHEST, V130, P251, DOI 10.1378/chest.130.1.251; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Giantsou E, 2005, INTENS CARE MED, V31, P1488, DOI 10.1007/s00134-005-2697-y; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Johnson SB, 2007, ANN SURG, V245, P611, DOI 10.1097/01.sla.0000251619.10648.32; Kauffman S. A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kinoshita K, 2007, NEUROL RES, V29, P47, DOI 10.1179/174313206X152500; Knight PR, 2004, SHOCK, V21, P26, DOI 10.1097/01.shk.0000101668.49265.19; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McDunn JE, 2006, SURGERY, V139, P133, DOI 10.1016/j.surg.2005.02.005; Naderi A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-9; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Perl M, 2005, CRIT CARE MED, V33, P1351, DOI 10.1097/01.CCM.0000166352.28018.A9; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; RUAN J, 2006, P RECOMB SAT C SYST; RUAN J, 2007, PHYS REV E IN PRESS; Smith Jason W, 2006, J Intensive Care Med, V21, P160, DOI 10.1177/0885066605284330; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6	40	57	61	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1564	10.1371/journal.pone.0001564	http://dx.doi.org/10.1371/journal.pone.0001564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270561	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900006
J	Prady, SL; Richmond, SJ; Morton, VM; MacPherson, H				Prady, Stephanie L.; Richmond, Stewart J.; Morton, Veronica M.; MacPherson, Hugh			A Systematic Evaluation of the Impact of STRICTA and CONSORT Recommendations on Quality of Reporting for Acupuncture Trials	PLOS ONE			English	Article								Background: We investigated whether there had been an improvement in quality of reporting for randomised controlled trials of acupuncture since the publication of the STRICTA and CONSORT statements. We conducted a before-and-after study, comparing ratings for quality of reporting following the publication of both STRICTA and CONSORT recommendations. Methodology and Principal Findings: Ninety peer reviewed journal articles reporting the results of acupuncture trials were selected at random from a wider sample frame of 266 papers. Papers published in three distinct time periods (1994-1995, 1999-2000 and 2004-2005) were compared. Assessment criteria were developed directly from CONSORT and STRICTA checklists. Papers were independently assessed for quality of reporting by two assessors, one of whom was blind to information which could have introduced systematic bias (e.g. date of publication). We detected a statistically significant increase in the reporting of CONSORT items for papers published in each time period measured. We did not, however, find a difference between the number of STRICTA items reported in journal articles published before and 3 to 4 years following the introduction of STRICTA recommendations. Conclusions and Significance: The results of this study suggest that general standards of reporting for acupuncture trials have significantly improved since the introduction of the CONSORT statement in 1996, but that quality in reporting details specific to acupuncture interventions has yet to change following the more recent introduction of STRICTA recommendations. Wider targeting and revision of the guidelines is recommended.	[Prady, Stephanie L.; Richmond, Stewart J.; Morton, Veronica M.; MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Prady, SL (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	slp505@york.ac.uk		MacPherson, Hugh/0000-0003-4255-4768	Foundation for Traditional Chinese Medicine; Department of Health NCC RCD	Foundation for Traditional Chinese Medicine; Department of Health NCC RCD	Stephanie Prady was funded by the Foundation for Traditional Chinese Medicine to carry out this study. Both Stewart Richmond and Hugh MacPherson are funded by personal awards from the Department of Health NCC RCD. No funder played any part in the design, conduct and analysis of this study, analysing the results or the decision to publish.	Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Devereaux PJ, 2002, CONTROL CLIN TRIALS, V23, P380, DOI 10.1016/S0197-2456(02)00214-3; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Egger M, 2003, HLTH TECHNOL ASSESS, V7; Halpern SH, 2004, INT J OBSTET ANESTH, V13, P207, DOI 10.1016/j.ijoa.2004.03.009; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MacPherson H, 2002, J ALTERN COMPLEM MED, V8, P85, DOI 10.1089/107555302753507212; MacPherson H, 2001, COMPLEMENT THER MED, V9, P246, DOI 10.1054/ctim.2001.0488; MacPherson Hugh, 2002, Acupunct Med, V20, P22; Mills E, 2005, J CLIN EPIDEMIOL, V58, P662, DOI 10.1016/j.jclinepi.2005.01.004; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D., 2002, BMC PEDIATR, V2; Montori VM, 2002, J CLIN EPIDEMIOL, V55, P787, DOI 10.1016/S0895-4356(02)00446-8; Prady SL, 2007, J ALTERN COMPLEM MED, V13, P939, DOI 10.1089/acm.2007.7186; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5	22	116	120	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1577	10.1371/journal.pone.0001577	http://dx.doi.org/10.1371/journal.pone.0001577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270568	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900013
J	Ungrin, MD; Joshi, C; Nica, A; Bauwens, C; Zandstra, PW				Ungrin, Mark D.; Joshi, Chirag; Nica, Andra; Bauwens, Celine; Zandstra, Peter W.			Reproducible, Ultra High-Throughput Formation of Multicellular Organization from Single Cell Suspension-Derived Human Embryonic Stem Cell Aggregates	PLOS ONE			English	Article							VISCERAL ENDODERM; DIFFERENTIATION; BODY; BODIES; EXPRESSION; SURVIVAL; CULTURE; AXIS; CARDIOMYOCYTES; MORPHOGENESIS	Background: Human embryonic stem cells (hESC) should enable novel insights into early human development and provide a renewable source of cells for regenerative medicine. However, because the three-dimensional hESC aggregates [embryoid bodies (hEB)] typically employed to reveal hESC developmental potential are heterogeneous and exhibit disorganized differentiation, progress in hESC technology development has been hindered. Methodology/Principal Findings: Using a centrifugal forced-aggregation strategy in combination with a novel centrifugal-extraction approach as a foundation, we demonstrated that hESC input composition and inductive environment could be manipulated to form large numbers of well-defined aggregates exhibiting multi-lineage differentiation and substantially improved self-organization from single-cell suspensions. These aggregates exhibited coordinated bi-domain structures including contiguous regions of extraembryonic endoderm- and epiblast-like tissue. A silicon wafer-based microfabrication technology was used to generate surfaces that permit the production of hundreds to thousands of hEB per cm(2). Conclusions/Significance:The mechanisms of early human embryogenesis are poorly understood. We report an ultra high throughput (UHTP) approach for generating spatially and temporally synchronised hEB. Aggregates generated in this manner exhibited aspects of peri-implantation tissue-level morphogenesis. These results should advance fundamental studies into early human developmental processes, enable high-throughput screening strategies to identify conditions that specify hESC-derived cells and tissues, and accelerate the pre-clinical evaluation of hESC-derived cells.	[Ungrin, Mark D.; Joshi, Chirag; Nica, Andra; Bauwens, Celine; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Bauwens, Celine; Zandstra, Peter W.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada	University of Toronto; University of Toronto	Ungrin, MD (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	peter.zandstra@utoronto.ca		Ungrin, Mark/0000-0002-7410-1491	Canadian Institutes of Health Research; Stem Cell Research Foundation; Canada Research Chair program; Canadian Microsystems Consortium [in-kind grant]; Canadian Stem Cell Network [in-kind grant]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Research Foundation; Canada Research Chair program(Canada Research Chairs); Canadian Microsystems Consortium; Canadian Stem Cell Network	Funding was provided by the Canadian Institutes of Health Research, the Stem Cell Research Foundation, the Canada Research Chair program, an in-kind grant from the Canadian Microsystems Consortium, and the Canadian Stem Cell Network. Sponsors and funders were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bauwens C, 2005, BIOTECHNOL BIOENG, V90, P452, DOI 10.1002/bit.20445; Blum B, 2007, STEM CELLS, V25, P1924, DOI 10.1634/stemcells.2007-0073; Bruder JM, 2006, LANGMUIR, V22, P8266, DOI 10.1021/la0608563; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Chu JH, 2005, DEVELOPMENT, V132, P5539, DOI 10.1242/dev.02157; Conley BJ, 2004, FETAL DIAGN THER, V19, P218, DOI 10.1159/000076701; Conley BJ, 2007, BIOCHEM CELL BIOL, V85, P121, DOI 10.1139/O06-145; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Eakin GS, 2004, SEMIN CELL DEV BIOL, V15, P619, DOI 10.1016/j.semcdb.2004.04.008; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Gilbert S.F., 2000, DEV BIOL; GOLDFARB M, 1991, ANN NY ACAD SCI, V638, P38, DOI 10.1111/j.1749-6632.1991.tb49016.x; Herzog W, 2004, DEVELOPMENT, V131, P3681, DOI 10.1242/dev.01235; Hirashima M, 2004, BLOOD, V104, P711, DOI 10.1182/blood-2004-01-0254; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Ingber DE, 2007, DEVELOPMENT, V134, P2541, DOI 10.1242/dev.003707; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035; Kimura-Yoshida C, 2007, P NATL ACAD SCI USA, V104, P5919, DOI 10.1073/pnas.0607779104; Koike M, 2005, CYTOTECHNOLOGY, V47, P3, DOI 10.1007/s10616-005-3743-x; Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259; Kurosawa H, 2003, J BIOSCI BIOENG, V96, P409, DOI 10.1263/jbb.96.409; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; Li L, 2004, DEVELOPMENT, V131, P5277, DOI 10.1242/dev.01415; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Perea-Gomez A, 1999, DEVELOPMENT, V126, P4499; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raikwar SP, 2006, PHYSIOLOGY, V21, P19, DOI 10.1152/physiol.00034.2005; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328; Seiler A, 2004, REPROD TOXICOL, V18, P231, DOI 10.1016/j.reprotox.2003.10.015; Sohn SK, 2003, BONE MARROW TRANSPL, V31, P967, DOI 10.1038/sj.bmt.1704042; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; UNGRIN M, 2007, CURR PROTOC STEM CEL, V2; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Walters MJ, 2001, MECH DEVELOP, V100, P263, DOI 10.1016/S0925-4773(00)00535-9; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weitzer G, 2006, HANDB EXP PHARM, V174, P21; Wells JM, 2000, DEVELOPMENT, V127, P1563; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	65	297	346	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1565	10.1371/journal.pone.0001565	http://dx.doi.org/10.1371/journal.pone.0001565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270562	Green Submitted, Green Published, gold			2022-12-27	WOS:000260535900007
J	Berthelot, G; Thibault, V; Tafflet, M; Escolano, S; El Helou, N; Jouven, X; Hermine, O; Toussaint, JF				Berthelot, Geoffroy; Thibault, Valerie; Tafflet, Muriel; Escolano, Sylvie; El Helou, Nour; Jouven, Xavier; Hermine, Olivier; Toussaint, Jean-Francois			The Citius End: World Records Progression Announces the Completion of a Brief Ultra-Physiological Quest	PLOS ONE			English	Article							BLOOD	World records (WR) in sports illustrate the ultimate expression of human integrated muscle biology, through speed or strength performances. Analysis and prediction of man's physiological boundaries in sports and impact of external (historical or environmental) conditions on WR occurrence are subject to scientific controversy. Based on the analysis of 3263 WR established for all quantifiable official contests since the first Olympic Games, we show here that WR progression rate follows a piecewise exponential decaying pattern with very high accuracy (mean adjusted r(2) values = 0.91 +/- 0.08 (s.d.)). Starting at 75% of their estimated asymptotic values in 1896, WR have now reached 99%, and, present conditions prevailing, half of all WR will not be improved by more than 0,05% in 2027. Our model, which may be used to compare future athletic performances or assess the impact of international antidoping policies, forecasts that human species' physiological frontiers will be reached in one generation. This will have an impact on the future conditions of athlete training and on the organization of competitions. It may also alter the Olympic motto and spirit.	[Berthelot, Geoffroy; Thibault, Valerie; Tafflet, Muriel; Escolano, Sylvie; El Helou, Nour; Toussaint, Jean-Francois] IRMES, Paris, France; [Tafflet, Muriel; Escolano, Sylvie; Jouven, Xavier] INSERM, IFR69, U780, Villejuif, France; [Jouven, Xavier; Hermine, Olivier; Toussaint, Jean-Francois] Univ Paris 05, Paris, France; [Hermine, Olivier] Hop Necker Enfants Malad, CNRS, UMR 8147, Paris, France; [Toussaint, Jean-Francois] AP HP, CIMS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Berthelot, G (corresponding author), IRMES, Paris, France.	irmes@insep.fr	Hermine, Olivier/Q-7072-2018; Helou, Nour El/AAH-6490-2021	Helou, Nour El/0000-0002-6012-0042; Berthelot, Geoffroy/0000-0003-4036-6114; escolano, sylvie/0000-0003-0864-4321; Hermine, Olivier/0000-0003-2574-3874	Centre National de Developpement du Sport; Ministry of Health, Youth and Sport	Centre National de Developpement du Sport; Ministry of Health, Youth and Sport	We thank the Centre National de Developpement du Sport and the Ministry of Health, Youth and Sport for financial contribution.	[Anonymous], 2007, Nature, V448, P512; [Anonymous], 2007, REPORT COMMISSIONER; Buckley JG, 2000, CLIN BIOMECH, V15, P352, DOI 10.1016/S0268-0033(99)00094-7; *CHIDL AR LIFT UP, HIST OL WEIGHTL; Dennis C, 2005, NATURE, V434, P260, DOI 10.1038/434260a; Eichner ER, 2007, SPORTS MED, V37, P389, DOI 10.2165/00007256-200737040-00030; GEIPEL I, 2001, J DOPINGPROZESSES; Harbom L, 2005, J PEACE RES, V42, P623, DOI 10.1177/0022343305056238; Kalinski MI, 2003, PERSPECT BIOL MED, V46, P445, DOI 10.1353/pbm.2003.0035; Kayser Bengt, 2007, BMC Med Ethics, V8, P2, DOI 10.1186/1472-6939-8-2; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Lovett RA, 2007, NATURE, V448, P104, DOI 10.1038/448104a; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MILLER PS, 2006, NATURE, V441, P784; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Mosegaard K, 2002, INVERSE PROBL, V18, pR29, DOI 10.1088/0266-5611/18/3/201; Nevill AM, 2007, INT J SPORTS MED, V28, P1012, DOI 10.1055/s-2007-965088; Nevill AM, 2005, MED SCI SPORT EXER, V37, P1785, DOI 10.1249/01.mss.0000181676.62054.79; Norton K, 2001, SPORTS MED, V31, P763, DOI 10.2165/00007256-200131110-00001; Reinboud W, 2004, NATURE, V432, P147, DOI 10.1038/432147a; REINBOUD W, PROGR ATHLETIC; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Tatem AJ, 2004, NATURE, V431, P525, DOI 10.1038/431525a; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; WILLINK R, 2006, METROLOGIA, V43, P39	27	58	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1552	10.1371/journal.pone.0001552	http://dx.doi.org/10.1371/journal.pone.0001552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253499	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535700023
J	Di Ventura, B; Funaya, C; Antony, C; Knop, M; Serrano, L				Di Ventura, Barbara; Funaya, Charlotta; Antony, Claude; Knop, Michael; Serrano, Luis			Reconstitution of Mdm2-Dependent Post-Translational Modifications of p53 in Yeast	PLOS ONE			English	Article								p53 mediates cell cycle arrest or apoptosis in response to DNA damage. Its activity is subject to a tight regulation involving a multitude of post-translational modifications. The plethora of functional protein interactions of p53 at present precludes a clear understanding of regulatory principles in the p53 signaling network. To circumvent this complexity, we studied here the minimal requirements for functionally relevant p53 post-translational modifications by expressing human p53 together with its best characterized modifier Mdm2 in budding yeast. We find that expression of the human p53-Mdm2 module in yeast is sufficient to faithfully recapitulate key aspects of p53 regulation in higher eukaryotes, such as Mdm2-dependent targeting of p53 for degradation, sumoylation at lysine 386 and further regulation of this process by p14(ARF). Interestingly, sumoylation is necessary for the recruitment of p53-Mdm2 complexes to yeast nuclear bodies morphologically akin to human PML bodies. These results suggest a novel role for Mdm2 as well as for p53 sumoylation in the recruitment of p53 to nuclear bodies. The reductionist yeast model that was established and validated in this study will now allow to incrementally study simplified parts of the intricate p53 network, thus helping elucidate the core mechanisms of p53 regulation as well as test novel strategies to counteract p53 malfunctions.	[Di Ventura, Barbara; Funaya, Charlotta; Antony, Claude; Knop, Michael; Serrano, Luis] Univ Heidelberg BZH, Biochem Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Di Ventura, B (corresponding author), Univ Heidelberg BZH, Biochem Ctr, Heidelberg, Germany.	barbara.diventura@bzh.uni-heidelberg.de	antony, claude/K-5342-2013	Fredriksson Funaya, Charlotta/0000-0003-1375-1287	EC [COMBIO]	EC(European CommissionEuropean Commission Joint Research Centre)	This work was partly financed by the EC grant COMBIO.	[Anonymous], 1991, Methods Enzymol, V194, P1; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Cooper B, 2003, VIROLOGY, V306, P87, DOI 10.1016/S0042-6822(02)00012-0; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Lu X, 2005, CURR OPIN GENET DEV, V15, P27, DOI 10.1016/j.gde.2004.12.008; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Riedel CG, 2005, J BIOL CHEM, V280, P37846, DOI 10.1074/jbc.M504244200; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Waddell S, 2001, ONCOGENE, V20, P6001, DOI 10.1038/sj.onc.1204702; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292	25	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1507	10.1371/journal.pone.0001507	http://dx.doi.org/10.1371/journal.pone.0001507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231594	gold, Green Submitted, Green Published			2022-12-27	WOS:000260504200020
J	Monaci, P; Luzzago, A; Santini, C; De Pra, A; Arcuri, M; Magistri, F; Bellini, A; Ansuini, H; Ambrosio, M; Ammendola, V; Bigotti, MG; Cirillo, A; Nuzzo, M; Nasti, AA; Neuner, P; Orsatti, L; Pezzanera, M; Sbardellati, A; Silvestre, G; Uva, P; Viti, V; Barbato, G; Colloca, S; Demartis, A; De Rinaldis, E; Giampaoli, S; Lahm, A; Palombo, F; Talamo, F; Vitelli, A; Nicosia, A; Cortese, R				Monaci, Paolo; Luzzago, Alessandra; Santini, Claudia; De Pra, Alessandra; Arcuri, Mirko; Magistri, Francesca; Bellini, Alessandro; Ansuini, Helenia; Ambrosio, Maria; Ammendola, Virginia; Bigotti, Maria Giulia; Cirillo, Agostino; Nuzzo, Maurizio; Nasti, Annamaria Assunta; Neuner, Philippe; Orsatti, Laura; Pezzanera, Monica; Sbardellati, Andrea; Silvestre, Giuseppe; Uva, Paolo; Viti, Valentina; Barbato, Gaetano; Colloca, Stefano; Demartis, Anna; De Rinaldis, Emanuele; Giampaoli, Saverio; Lahm, Armin; Palombo, Fabio; Talamo, Fabio; Vitelli, Alessandra; Nicosia, Alfredo; Cortese, Riccardo			Differential Screening of Phage-Ab Libraries by Oligonucleotide Microarray Technology	PLOS ONE			English	Article								A novel and efficient tagArray technology was developed that allows rapid identification of antibodies which bind to receptors with a specific expression profile, in the absence of biological information. This method is based on the cloning of a specific, short nucleotide sequence (tag) in the phagemid coding for each phage-displayed antibody fragment (phage-Ab) present in a library. In order to set up and validate the method we identified about 10,000 different phage-Abs binding to receptors expressed in their native form on the cell surface (10 k Membranome collection) and tagged each individual phage-Ab. The frequency of each phage-Ab in a given population can at this point be inferred by measuring the frequency of its associated tag sequence through standard DNA hybridization methods. Using tiny amounts of biological samples we identified phage-Abs binding to receptors preferentially expressed on primary tumor cells rather than on cells obtained from matched normal tissues. These antibodies inhibited cell proliferation in vitro and tumor development in vivo, thus representing therapeutic lead candidates.	[Monaci, Paolo; Luzzago, Alessandra; Santini, Claudia; De Pra, Alessandra; Arcuri, Mirko; Magistri, Francesca; Bellini, Alessandro; Ansuini, Helenia; Bigotti, Maria Giulia; Cirillo, Agostino; Nuzzo, Maurizio; Neuner, Philippe; Orsatti, Laura; Pezzanera, Monica; Sbardellati, Andrea; Silvestre, Giuseppe; Uva, Paolo; Viti, Valentina; Barbato, Gaetano; Colloca, Stefano; Demartis, Anna; De Rinaldis, Emanuele; Giampaoli, Saverio; Lahm, Armin; Palombo, Fabio; Talamo, Fabio; Vitelli, Alessandra; Nicosia, Alfredo; Cortese, Riccardo] Ist Ric Biol Mol P Angeletti, Dept Biotechnol, Rome, Italy; [Ambrosio, Maria; Ammendola, Virginia; Bigotti, Maria Giulia; Nasti, Annamaria Assunta; Silvestre, Giuseppe] CEINGE, Naples, Italy	Merck & Company; CEINGE Biotecnologie Avanzate	Monaci, P (corresponding author), Ist Ric Biol Mol P Angeletti, Dept Biotechnol, Rome, Italy.	paolo_monaci@merck.com	Uva, Paolo/A-2877-2011; Barbato, Gaetano/G-4904-2011	Uva, Paolo/0000-0002-9524-8492; Barbato, Gaetano/0000-0001-9840-6858; ambrosio, maria rosaria/0000-0002-7911-9770; Palombo, Fabio/0000-0003-0473-4901; Bigotti, Giulia/0000-0001-9595-3338				Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Brooks D, 1995, CLIN CANCER RES, V1, P1259; Buckhaults P, 2001, CANCER RES, V61, P6996; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; Fuh G, 2007, EXPERT OPIN BIOL TH, V7, P73, DOI 10.1517/14712598.7.1.73; Gomme PT, 2005, DRUG DISCOV TODAY, V10, P267, DOI 10.1016/S1359-6446(04)03333-1; Hegmans JPJJ, 2002, J IMMUNOL METHODS, V262, P191, DOI 10.1016/S0022-1759(02)00005-4; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Moura IC, 2004, BLOOD, V103, P1838, DOI 10.1182/blood-2003-07-2440; Rainov NG, 2005, CURR OPIN MOL THER, V7, P483; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1508	10.1371/journal.pone.0001508	http://dx.doi.org/10.1371/journal.pone.0001508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231595	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200021
J	Foss, M; Wilcox, BWL; Alsop, GB; Zhang, DH				Foss, Margit; Wilcox, Buck W. L.; Alsop, G. Bradley; Zhang, Dahong			Taxol Crystals Can Masquerade as Stabilized Microtubules	PLOS ONE			English	Article								Taxol is a potent anti-mitotic drug used in chemotherapy, angioplastic stents, and cell biology research. By binding and stabilizing microtubules, Taxol inhibits their dynamics, crucial for cell division, motility, and survival. The drug has also been reported to induce formation of asters and bundles composed of stabilized microtubules. Surprisingly, at commonly used concentrations, Taxol forms crystals that rapidly bind fluorescent tubulin subunits, generating structures with an uncanny resemblance to microtubule asters and bundles. Kinetic and topological considerations suggest that tubulin subunits, rather than microtubules, bind the crystals. This sequestration of tubulin from the subunit pool would be expected to shift the equilibrium of free to polymerized tubulin to disfavor assembly. Our results imply that some previously reported Taxol-induced asters or bundles could include or be composed of tubulin-decorated Taxol crystals. Thus, reevaluation of certain morphological, chemical, and physical properties of Taxol-treated microtubules may be necessary. Moreover, our findings suggest a novel mechanism for chemotherapy-induced cytotoxicity in non-dividing cells, with far-reaching medical implications.	[Foss, Margit; Zhang, Dahong] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Wilcox, Buck W. L.; Alsop, G. Bradley] Oregon State Univ, Mol & Cell Biol Prog, Corvallis, OR USA; [Zhang, Dahong] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR USA	Oregon State University; Oregon State University; Oregon State University	Zhang, DH (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	zhangd@science.oregonstate.edu			B.W.L. Wilcox [HHMI summer research fellowship]; NSF [MCB-0090725, 0424897]	B.W.L. Wilcox; NSF(National Science Foundation (NSF))	This work was supported by an HHMI summer research fellowship to B.W.L. Wilcox, and NSF Grant MCB-0090725, 0424897 to D. Zhang. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Antoine JC, 2007, LANCET NEUROL, V6, P75, DOI 10.1016/S1474-4422(06)70679-2; Cross RA, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P317; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; GLOUSHANKOVA NA, 1994, P NATL ACAD SCI USA, V91, P8597, DOI 10.1073/pnas.91.18.8597; GREEN KJ, 1983, CELL MOTIL CYTOSKEL, V3, P283, DOI 10.1002/cm.970030402; HAMMALVAREZ SF, 1994, P NATL ACAD SCI USA, V91, P7812, DOI 10.1073/pnas.91.16.7812; HARRIS PJ, 1992, J CELL SCI, V102, P557; Honore S, 2004, CANCER RES, V64, P4957, DOI 10.1158/0008-5472.CAN-04-0693; Jiko M, 2007, INT J CLIN ONCOL, V12, P284, DOI 10.1007/s10147-007-0681-y; Jordan MA, 1996, CANCER RES, V56, P816; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Lazareva EM, 2003, CELL BIOL INT, V27, P633, DOI 10.1016/S1065-6995(03)00120-3; Liggins RT, 1997, J PHARM SCI, V86, P1458, DOI 10.1021/js9605226; MATHEW AE, 1992, J MED CHEM, V35, P145, DOI 10.1021/jm00079a019; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Pryor DE, 2002, BIOCHEMISTRY-US, V41, P9109, DOI 10.1021/bi020211b; ROBERTS JR, 1989, J HISTOCHEM CYTOCHEM, V37, P1659, DOI 10.1177/37.11.2572626; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; SANDOVAL IV, 1984, J CELL BIOL, V99, pS113, DOI 10.1083/jcb.99.1.113s; SCHATTEN G, 1982, J CELL BIOL, V94, P455, DOI 10.1083/jcb.94.2.455; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; TURNER PF, 1984, J CELL BIOL, V99, P940, DOI 10.1083/jcb.99.3.940; URRUTIA R, 1991, P NATL ACAD SCI USA, V88, P6701, DOI 10.1073/pnas.88.15.6701; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; WHITE JG, 1982, AM J PATHOL, V108, P184; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yang CM, 2006, ADV DRUG DELIVER REV, V58, P402, DOI 10.1016/j.addr.2006.01.017; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	33	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1476	10.1371/journal.pone.0001476	http://dx.doi.org/10.1371/journal.pone.0001476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213384	Green Submitted, Green Published, gold			2022-12-27	WOS:000260503900021
J	Lesnick, TG; Sorenson, EJ; Ahlskog, JE; Henley, JR; Shehadeh, L; Papapetropoulos, S; Maraganore, DM				Lesnick, Timothy G.; Sorenson, Eric J.; Ahlskog, J. Eric; Henley, John R.; Shehadeh, Lina; Papapetropoulos, Spiridon; Maraganore, Demetrius M.			Beyond Parkinson Disease: Amyotrophic Lateral Sclerosis and the Axon Guidance Pathway	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; CENTRAL-NERVOUS-SYSTEM; ANTERIOR HORN CELLS; MOTOR-NEURONS; EXPRESSION; SEMAPHORIN; ALS; DROSOPHILA; MIGRATION; PROTEIN	Background. We recently described a genomic pathway approach to study complex diseases. We demonstrated that models constructed using single nucleotide polymorphisms (SNPs) within axon guidance pathway genes were highly predictive of Parkinson disease (PD) susceptibility, survival free of PD, and age at onset of PD within two independent whole-genome association datasets. We also demonstrated that several axon guidance pathway genes represented by SNPs within our final models were differentially expressed in PD. Methodology/ Principal Findings. Here we employed our genomic pathway approach to analyze data from a whole-genome association dataset of amyotrophic lateral sclerosis (ALS); and demonstrated that models constructed using SNPs within axon guidance pathway genes were highly predictive of ALS susceptibility (odds ratio = 1739.73, p= 2.92x10(-60)), survival free of ALS (hazards ratio = 149.80, p= 1.25x10(-74)), and age at onset of ALS (R-2= 0.86, p= 5.96x10(-66)). We also extended our analyses of a whole-genome association dataset of PD, which shared 320,202 genomic SNPs in common with the whole-genome association dataset of ALS. We compared for ALS and PD the genes represented by SNPs in the final models for susceptibility, survival free of disease, and age at onset of disease and noted that 52.2%, 37.8%, and 34.9% of the genes were shared respectively. Conclusions/Significance. Our findings for the axon guidance pathway and ALS have prior biological plausibility, overlap partially with PD, and may provide important insight into the causes of these and related neurodegenerative disorders.	[Lesnick, Timothy G.] Mayo Clin, Dept Hlth Sci Res, Div Biostat, Rochester, MN USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Shehadeh, Lina] Univ Miami, Miller Sch Med, Mol & Cell Pharmacol, Miami, FL USA; [Papapetropoulos, Spiridon] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL USA; [Sorenson, Eric J.; Ahlskog, J. Eric] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Miami; University of Miami; Mayo Clinic	Maraganore, DM (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	dmaraganore@mayo.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Henley, John/D-7171-2011	Henley, John/0000-0003-1846-5941	National Institutes of Health [R01 ES10751]; Michael J. Fox Foundation; Linked Efforts to Accelerate Parkinson Solutions award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL083673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; Linked Efforts to Accelerate Parkinson Solutions award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the National Institutes of Health (R01 ES10751 to DMM), and the Michael J. Fox Foundation (Linked Efforts to Accelerate Parkinson Solutions award to DMM). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ABDULLA EM, 1993, ANN NY ACAD SCI, V679, P276, DOI 10.1111/j.1749-6632.1993.tb18308.x; Allan DW, 1998, J COMP NEUROL, V391, P275, DOI 10.1002/(SICI)1096-9861(19980216)391:3<275::AID-CNE1>3.0.CO;2-Z; Bajaj NPS, 1998, NEUROSCI LETT, V245, P45, DOI 10.1016/S0304-3940(98)00176-1; Bajaj NPS, 1999, PROG NEURO-PSYCHOPH, V23, P833, DOI 10.1016/S0278-5846(99)00044-5; Bajaj NPS, 2000, AMYOTROPH LATERAL SC, V1, P319, DOI 10.1080/146608200300079563; Barrett C, 2001, MECH DEVELOP, V106, P163, DOI 10.1016/S0925-4773(01)00415-4; Boulin T, 2006, CURR BIOL, V16, P1871, DOI 10.1016/j.cub.2006.08.056; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Breslow NE, 1980, IARC SCI PUBL, P5; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; Burgess RW, 2006, J NEUROSCI, V26, P5756, DOI 10.1523/JNEUROSCI.0736-06.2006; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Chung YH, 2005, BRAIN RES, V1050, P203, DOI 10.1016/j.brainres.2005.05.060; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043; COX DR, 1972, J R STAT SOC B, V34, P187; De Winter F, 2006, MOL CELL NEUROSCI, V32, P102, DOI 10.1016/j.mcn.2006.03.002; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Franz CK, 2005, J NEUROSCI, V25, P2081, DOI 10.1523/JNEUROSCI.4880-04.2005; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Garruto Ralph M., 2006, Current Alzheimer Research, V3, P397, DOI 10.2174/156720506778249425; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hu JH, 2003, J NEUROCHEM, V85, P422, DOI 10.1046/j.1471-4159.2003.01669.x; Huang X, 2003, DEVELOPMENT, V130, P3147, DOI 10.1242/dev.00518; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Ignacio S, 2005, ANN NY ACAD SCI, V1053, P121, DOI 10.1196/annals.1344.010; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasperaviciute D, 2007, BRAIN, V130, P2292, DOI 10.1093/brain/awm055; Kato S, 2003, ACTA NEUROPATHOL, V106, P112, DOI 10.1007/s00401-003-0708-z; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Lederer CW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-26; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Lindholm T, 2004, NEUROREPORT, V15, P649, DOI 10.1097/00001756-200403220-00015; Lucanic M, 2006, DEVELOPMENT, V133, P4549, DOI 10.1242/dev.02648; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Nakamura S, 1997, NEUROLOGY, V48, P267, DOI 10.1212/WNL.48.1.267; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Parent M, 2006, J NEURAL TRANSM-SUPP, P85; Patel K, 2001, DEVELOPMENT, V128, P5031; Patzke H, 2002, TRENDS NEUROSCI, V25, P8, DOI 10.1016/S0166-2236(00)02000-2; Sato-Maeda M, 2006, DEVELOPMENT, V133, P937, DOI 10.1242/dev.02268; Schneider VA, 2003, DEV BIOL, V263, P1, DOI 10.1016/S0012-1606(03)00329-4; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; VANES MA, 2007, LANCET NEUROL; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Xiao T, 2003, J NEUROSCI, V23, P4190; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	65	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1449	10.1371/journal.pone.0001449	http://dx.doi.org/10.1371/journal.pone.0001449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197259	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503800020
J	Contu, D; Morelli, L; Santoni, F; Foster, JW; Francalacci, P; Cucca, F				Contu, Daniela; Morelli, Laura; Santoni, Federico; Foster, Jamie W.; Francalacci, Paolo; Cucca, Francesco			Y-Chromosome Based Evidence for Pre-Neolithic Origin of the Genetically Homogeneous but Diverse Sardinian Population: Inference for Association Scans	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; LINKAGE DISEQUILIBRIUM; MULTIPLE-SCLEROSIS; MAXIMUM-LIKELIHOOD; IBERIAN PENINSULA; GENE FLOW; EUROPE; PERSPECTIVE; DEMOGRAPHY; HAPLOTYPE	The island of Sardinia shows a unique high incidence of several autoimmune diseases with multifactorial inheritance, particularly type 1 diabetes and multiple sclerosis. The prior knowledge of the genetic structure of this population is fundamental to establish the optimal design for association studies in these diseases. Previous work suggested that the Sardinians are a relatively homogenous population, but some reports were contradictory and data were largely based on variants subject to selection. For an unbiased assessment of genetic structure, we studied a combination of neutral Y-chromosome variants, 21 biallelic and 8 short tandem repeats (STRs) in 930 Sardinian males. We found a high degree of interindividual variation but a homogenous distribution of the detected variability in samples from three separate regions of the island. One haplogroup, I-M26, is rare or absent outside Sardinia and is very common (0.37 frequency) throughout the island, consistent with a founder effect. A Bayesian full likelihood analysis (BATWING) indicated that the time from the most recent common ancestor (TMRCA) of I-M26, was 21.0 (16.0-25.5) thousand years ago (KYA) and that the population began to expand 14.0 (7.8-22.0) KYA. These results suggest a largely pre-Neolithic settlement of the island with little subsequent gene flow from outside populations. Consequently, Sardinia is an especially attractive venue for case-control genome wide association scans in common multifactorial diseases. Concomitantly, the high degree of interindividual variation in the current population facilitates fine mapping efforts to pinpoint the aetiologic polymorphisms.	[Morelli, Laura; Foster, Jamie W.; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Contu, Daniela] Ospedale Microcitemico, Lab Immunogenet, Cagliari, Italy; [Santoni, Federico] Ctr Adv Stud Res & Dev Sardinia, CRS4, Pula, Italy; [Francalacci, Paolo] Univ Sassari, Dept Zool & Genet Evol, Sassari, Italy	University of Sassari; University of Sassari	Cucca, F (corresponding author), Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy.	fcucca@uniss.it		CUCCA, Francesco/0000-0002-7414-1995; FRANCALACCI, Paolo/0000-0001-7912-162X; Santoni, Federico/0000-0002-3258-4747	Telethon-JDRF [GJT030477]; Interreg III	Telethon-JDRF(Juvenile Diabetes Research Foundation); Interreg III(European Commission)	This work was supported by funds from Telethon-JDRF (GJT030477) to FC and Interreg III to PF.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; Bickel DR, 2002, COMPUT STAT DATA AN, V39, P153, DOI 10.1016/S0167-9473(01)00057-3; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Bosch E, 2003, HUM GENET, V112, P353, DOI 10.1007/s00439-003-0913-9; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Contu D, 2002, DIABETES, V51, P3573, DOI 10.2337/diabetes.51.12.3573; CONTU L, 1992, TISSUE ANTIGENS, V40, P165, DOI 10.1111/j.1399-0039.1992.tb02041.x; CUCCA F, 1995, HUM IMMUNOL, V43, P301, DOI 10.1016/0198-8859(95)00042-3; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Fraumene C, 2003, HUM GENET, V114, P1, DOI 10.1007/s00439-003-1008-3; Hedges SB, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-31; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; Lampis R, 2000, HUM MOL GENET, V9, P2959, DOI 10.1093/hmg/9.20.2959; Lange K., 1997, MATH STAT METHODS GE; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; LILLIU G, 1982, CIVILTA NURAGICA; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; Marrosu MG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-25; Martinez L, 2007, EUR J HUM GENET, V15, P485, DOI 10.1038/sj.ejhg.5201769; Nei M., 1987, MOL EVOLUTIONARY GEN; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rosatelli MC, 1998, HUM GENET, V103, P428, DOI 10.1007/s004390050846; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; SLATKIN M, 1995, GENETICS, V139, P457; SONDAAR P, 1995, CR ACAD SCI II, V320, P145; SONDAAR PY, 1998, SARDINIAN AEGEAN CHR, P45; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weale ME, 2002, MOL BIOL EVOL, V19, P1008, DOI 10.1093/oxfordjournals.molbev.a004160; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947; Zei G, 2003, EUR J HUM GENET, V11, P802, DOI 10.1038/sj.ejhg.5201040; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; ZOLEDZIEWSKA M, 2007, DIABETES IN PRESS	57	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1430	10.1371/journal.pone.0001430	http://dx.doi.org/10.1371/journal.pone.0001430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183308	Green Published, Green Submitted, gold			2022-12-27	WOS:000260469400024
J	Scharlemann, JPW; Benz, D; Hay, SI; Purse, BV; Tatem, AJ; Wint, GRW; Rogers, DJ				Scharlemann, Joern P. W.; Benz, David; Hay, Simon I.; Purse, Bethan V.; Tatem, Andrew J.; Wint, G. R. William; Rogers, David J.			Global Data for Ecology and Epidemiology: A Novel Algorithm for Temporal Fourier Processing MODIS Data	PLOS ONE			English	Article							TIME-SERIES; BOVINE TUBERCULOSIS; BORNE DISEASE; EAST-AFRICA; SATELLITE; NDVI; BLUETONGUE; PREDICTION; ACCURACY; EUROPE	Background. Remotely-sensed environmental data from earth-orbiting satellites are increasingly used to model the distribution and abundance of both plant and animal species, especially those of economic or conservation importance. Time series of data from the MODerate-resolution Imaging Spectroradiometer (MODIS) sensors on-board NASA's Terra and Aqua satellites offer the potential to capture environmental thermal and vegetation seasonality, through temporal Fourier analysis, more accurately than was previously possible using the NOAA Advanced Very High Resolution Radiometer (AVHRR) sensor data. MODIS data are composited over 8- or 16-day time intervals that pose unique problems for temporal Fourier analysis. Applying standard techniques to MODIS data can introduce errors of up to 30% in the estimation of the amplitudes and phases of the Fourier harmonics. Methodology/Principal Findings. We present a novel spline-based algorithm that overcomes the processing problems of composited MODIS data. The algorithm is tested on artificial data generated using randomly selected values of both amplitudes and phases, and provides an accurate estimate of the input variables under all conditions. The algorithm was then applied to produce layers that capture the seasonality in MODIS data for the period from 2001 to 2005. Conclusions/Significance. Global temporal Fourier processed images of 1 km MODIS data for Middle Infrared Reflectance, day- and night-time Land Surface Temperature (LST), Normalised Difference Vegetation Index (NDVI), and Enhanced Vegetation Index (EVI) are presented for ecological and epidemiological applications. The finer spatial and temporal resolution, combined with the greater geolocational and spectral accuracy of the MODIS instruments, compared with previous multi-temporal data sets, mean that these data may be used with greater confidence in species' distribution modelling.	[Hay, Simon I.; Tatem, Andrew J.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Scharlemann, Joern P. W.; Benz, David; Hay, Simon I.; Purse, Bethan V.; Tatem, Andrew J.; Wint, G. R. William] Univ Oxford, Wellcome Trust Collaborative Progr, Kenya Med Res Inst, Ctr Geogr Med, Malaria Publ Hlth Epidemiol Grp, Nairobi, Kenya	University of Oxford; Kenya Medical Research Institute	Rogers, DJ (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, S Parks Rd, Oxford OX1 3PS, England.	david.rogers@zoo.ox.ac.uk	Purse, Bethan V/I-6640-2012; Hay, Simon Iain/F-8967-2015; Scharlemann, Jorn/A-4737-2008	Purse, Bethan V/0000-0001-5140-2710; Hay, Simon Iain/0000-0002-0611-7272; Scharlemann, Jorn/0000-0002-2834-6367; Wint, William/0000-0003-0916-0847; Tatem, Andrew/0000-0002-7270-941X	DEFRA [SE3229, SE4105]; Wellcome Trust [079091]; Pro-Poor Livestock Policy Initiative and Environmental Animal Health Management Initiative of the Food and Agriculture Organisation of the United Nations [TF/IGAD/CPA 183295-2006/AGAL, GCP/PHI/050/ITA]; BBSRC/DEFRA [BBS/B/00603, SE4104]; European Union [GOCE-2003-010284]; Biotechnology and Biological Sciences Research Council [BBS/B/00646, BBS/B/00603] Funding Source: researchfish	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome Trust(Wellcome TrustEuropean Commission); Pro-Poor Livestock Policy Initiative and Environmental Animal Health Management Initiative of the Food and Agriculture Organisation of the United Nations; BBSRC/DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was funded by grants from DEFRA (SE3229 to GRWW, SE4105 to Sarah Randolph supporting JPWS), Wellcome Trust (Senior Research Fellowship #079091 to SIH), Pro-Poor Livestock Policy Initiative and Environmental Animal Health Management Initiative of the Food and Agriculture Organisation of the United Nations (TF/IGAD/CPA 183295-2006/AGAL and GCP/PHI/050/ITA to GRWW), BBSRC/DEFRA (BBS/B/00603 to BVP and SE4104 to DJR), European Union (GOCE-2003-010284 EDEN supporting DB, GRWW and DJR). This work forms part of the output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk) principally funded by the Wellcome Trust, UK. This publication is catalogued by the EDEN Steering Committee as EDEN 0047 (http://www.eden-fp6project.net/). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES L, 1994, INT J REMOTE SENS, V15, P1115, DOI 10.1080/01431169408954145; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Baylis M, 2001, VET REC, V149, P639, DOI 10.1136/vr.149.21.639; Boyd D. S., 1998, REMOTE SENSING REV, V16, P293, DOI DOI 10.1080/02757259809532357; Chatfield C, 1980, ANAL TIME SERIES INT; EASTMAN JR, 1993, PHOTOGRAMM ENG REM S, V59, P991; FAO, 2007, GRIDD LIV WORLD; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 1999, TROP MED INT HEALTH, V4, P58, DOI 10.1046/j.1365-3156.1999.00355.x; Hendrickx G, 2000, PARASITOLOGY, V120, P121, DOI 10.1017/S0031182099005338; Hendrickx G, 2001, B ENTOMOL RES, V91, P333, DOI 10.1079/BER2001103; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Johnson DDP, 1998, P ROY SOC B-BIOL SCI, V265, P951, DOI 10.1098/rspb.1998.0383; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Jonsson P, 2002, IEEE T GEOSCI REMOTE, V40, P1824, DOI 10.1109/TGRS.2002.802519; Julien Y, 2006, REMOTE SENS ENVIRON, V103, P43, DOI 10.1016/j.rse.2006.03.011; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; MENENTI M, 1993, ADV SPACE RES-SERIES, V13, P233, DOI 10.1016/0273-1177(93)90550-U; Myneni RB, 1998, J GEOPHYS RES-ATMOS, V103, P6145, DOI 10.1029/97JD03603; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Omumbo JA, 2002, PHOTOGRAMM ENG REM S, V68, P161; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Press W.H, 1996, FORTRAN NUMERICAL RE, V1; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Randolph SE, 2006, ADV PARASIT, V62, P263, DOI 10.1016/S0065-308X(05)62008-8; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; Robinson T, 1997, MED VET ENTOMOL, V11, P235, DOI 10.1111/j.1365-2915.1997.tb00401.x; Roerink GJ, 2000, INT J REMOTE SENS, V21, P1911, DOI 10.1080/014311600209814; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Rogers David J., 1994, P247; Rogers DJ, 2003, NAT REV MICROBIOL, V1, P231, DOI 10.1038/nrmicro776; Rogers DJ, 2002, PHOTOGRAMM ENG REM S, V68, P112; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; ROGERS DJ, 2004, TRYPANOSOMIASES, P129; ROGERS DJ, 2006, 36 PPLPI FAO UN; Salomon, 2004, GEOSC REM SENS S 200, V1, P241, DOI DOI 10.1109/IGARSS.2004.1369005; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Tan B, 2006, REMOTE SENS ENVIRON, V105, P98, DOI 10.1016/j.rse.2006.06.008; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; Verhoef W, 1996, INT J REMOTE SENS, V17, P231, DOI 10.1080/01431169608949001; Wan ZM, 1997, IEEE T GEOSCI REMOTE, V35, P980, DOI 10.1109/36.602541; Wen J, 2004, MT RES DEV, V24, P348, DOI 10.1659/0276-4741(2004)024[0348:ROACVI]2.0.CO;2; Wint GRW, 2002, TRENDS MICROBIOL, V10, P441, DOI 10.1016/S0966-842X(02)02444-7; Wolfe RE, 2002, REMOTE SENS ENVIRON, V83, P31, DOI 10.1016/S0034-4257(02)00085-8	51	196	197	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1408	10.1371/journal.pone.0001408	http://dx.doi.org/10.1371/journal.pone.0001408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183289	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000260469400005
J	Hamblin, MT; Warburton, ML; Buckler, ES				Hamblin, Martha T.; Warburton, Marilyn L.; Buckler, Edward S.			Empirical Comparison of Simple Sequence Repeats and Single Nucleotide Polymorphisms in Assessment of Maize Diversity and Relatedness	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR MARKERS; INBRED LINES; MICROSATELLITES; EVOLUTION; INFERENCE; LOCI; POPULATIONS; HETEROSIS; GERMPLASM	While Simple Sequence Repeats (SSRs) are extremely useful genetic markers, recent advances in technology have produced a shift toward use of single nucleotide polymorphisms (SNPs). The different mutational properties of these two classes of markers result in differences in heterozygosities and allele frequencies that may have implications for their use in assessing relatedness and evaluation of genetic diversity. We compared analyses based on 89 SSRs (primarily dinucleotide repeats) to analyses based on 847 SNPs in individuals from the same 259 inbred maize lines, which had been chosen to represent the diversity available among current and historic lines used in breeding. The SSRs performed better at clustering germplasm into populations than did a set of 847 SNPs or 554 SNP haplotypes, and SSRs provided more resolution in measuring genetic distance based on allele-sharing. Except for closely related pairs of individuals, measures of distance based on SSRs were only weakly correlated with measures of distance based on SNPs. Our results suggest that 1) large numbers of SNP loci will be required to replace highly polymorphic SSRs in studies of diversity and relatedness and 2) relatedness among highly-diverged maize lines is difficult to measure accurately regardless of the marker system.	[Hamblin, Martha T.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Warburton, Marilyn L.] Ctr Int Mejoramiento Maiz y Trigo, Mexico City, DF, Mexico; [Buckler, Edward S.] USDA ARS, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA)	Hamblin, MT (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	mth3@cornell.edu	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Warburton, Marilyn/J-2250-2017	Buckler, Edward/0000-0002-3100-371X; Warburton, Marilyn/0000-0002-9542-9912	NSF [DBI 0321467]; USDA-ARS; Institute for Genomic Diversity	NSF(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Institute for Genomic Diversity	Funding: NSF DBI 0321467, USDA-ARS, Institute for Genomic Diversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Benchimol LL, 2000, PLANT BREEDING, V119, P491, DOI 10.1046/j.1439-0523.2000.00539.x; CHARCOSSET A, 1991, THEOR APPL GENET, V81, P571, DOI 10.1007/BF00226720; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gardiner J, 2004, PLANT PHYSIOL, V134, P1317, DOI 10.1104/pp.103.034538; Grenier C, 2000, THEOR APPL GENET, V101, P190, DOI 10.1007/s001220051468; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Jones ES, 2007, THEOR APPL GENET, V115, P361, DOI 10.1007/s00122-007-0570-9; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Laborda PR, 2005, THEOR APPL GENET, V111, P1288, DOI 10.1007/s00122-005-0055-7; Laval G, 2002, GENET SEL EVOL, V34, P481, DOI [10.1051/gse:2002019, 10.1186/1297-9686-34-4-481]; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; Lockwood DR, 2007, CROP SCI, V47, P861, DOI 10.2135/cropsci2006.04.0262; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Payseur BA, 2006, TRENDS GENET, V22, P424, DOI 10.1016/j.tig.2006.06.009; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Skinner DZ, 1999, CROP SCI, V39, P1237, DOI 10.2135/cropsci1999.0011183X003900040046x; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Warburton ML, 2005, EUPHYTICA, V142, P97, DOI 10.1007/s10681-005-0817-y; Warburton ML, 2002, CROP SCI, V42, P1832, DOI 10.2135/cropsci2002.1832; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; YU J, 2007, THEOR APPL IN PRESS; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	37	172	179	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1367	10.1371/journal.pone.0001367	http://dx.doi.org/10.1371/journal.pone.0001367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159250	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459700024
J	Kuhlicke, J; Frick, JS; Morote-Garcia, JC; Rosenberger, P; Eltzschig, HK				Kuhlicke, Johannes; Frick, Julia S.; Morote-Garcia, Julio C.; Rosenberger, Peter; Eltzschig, Holger K.			Hypoxia Inducible Factor (HIF)-1 Coordinates Induction of Toll-Like Receptors TLR2 and TLR6 during Hypoxia	PLOS ONE			English	Article							ECTO-5'-NUCLEOTIDASE CD73; NEUTROPHIL ACCUMULATION; DENDRITIC CELLS; FACTOR-I; ADENOSINE; RECOGNITION; ACTIVATION; EXPRESSION; HIF-1-ALPHA; COOPERATION	Background. During acute infection and inflammation, dramatic shifts in tissue metabolism are typical, thereby resulting in profound tissue hypoxia. Therefore, we pursued the hypothesis, that tissue hypoxia may influence innate immune responses by transcriptional modulation of Toll-like receptor (TLRs) expression and function. Methodology/Principal Findings. We gained first insight from transcriptional profiling of murine dendritic cells exposed to hypoxia (2% oxygen for 24 h). While transcript levels of other TLRs remained unchanged, we found a robust induction of TLR2 (2.3 +/- 60.7-fold; P<0.05) and TLR6 (3.46 +/- 1.56-fold; P<0.05). Additional studies in different cells types and cell-lines including human dendritic cells, monocytic cells (MM6), endothelia (HMEC-1) or intestinal epithelia (Caco-2) confirmed TLR2 and TLR6 induction of transcript, protein and function during hypoxia. Furthermore, analysis of the putative TLR2 and TLR6 promoters revealed previously unrecognized binding sites for HIF-1, which were shown by chromatin immunoprecipitation to bind the pivotal hypoxia-regulating transcription factor HIF-1alpha. Studies using loss and gain of function of HIF-1 confirmed a critical role of HIF-1alpha in coordinating TLR2 and TLR6 induction. Moreover, studies of murine hypoxia (8% oxygen over 6 h) showed TLR2 and TLR 6 induction in mucosal organs in vivo. In contrast, hypoxia induction of TLR2 and TLR6 was abolished in conditional HIF-1 alpha mutant mice. Conclusions/Significance. Taking together, these studies reveal coordinated induction of TLR2 and TLR6 during hypoxia and suggest tissue hypoxia in transcriptional adaptation of innate immune responses during acute infection or inflammation.	[Kuhlicke, Johannes; Morote-Garcia, Julio C.; Rosenberger, Peter; Eltzschig, Holger K.] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Frick, Julia S.] Univ Tubingen Hosp, Dept Microbiol, Tubingen, Germany; [Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Perioperat Med, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Eltzschig, HK (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	holger.eltzschig@uchsc.edu		Frick, Julia-Stefanie/0000-0002-7662-7956	Deutsche Forschungsgemeinschaft (DFG) Graduate College [685]; German Research Foundation (DFG) [EL274/2-2]; Foundation for Anesthesia Research and Education (FAER)	Deutsche Forschungsgemeinschaft (DFG) Graduate College(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Foundation for Anesthesia Research and Education (FAER)	Funding: This work was supported by Deutsche Forschungsgemeinschaft (DFG) Graduate College 685 to JK, a German Research Foundation (DFG) grant EL274/2-2 and a Foundation for Anesthesia Research and Education (FAER) to HKE.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asikainen TM, 2005, P NATL ACAD SCI USA, V102, P10212, DOI 10.1073/pnas.0504520102; Asikainen TM, 2005, FREE RADICAL BIO MED, V38, P1002, DOI 10.1016/j.freeradbiomed.2004.12.004; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; DHARMSATHAPHORN K, 1990, METHOD ENZYMOL, V192, P354; Dieterich HJ, 2006, CRIT CARE MED, V34, P1775, DOI 10.1097/01.CCM.0000218814.77568.BC; ECKLE T, 2007, BLOOD; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Evans SM, 2000, CANCER RES, V60, P2018; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Haddad JJ, 2003, CRIT CARE, V7, P47, DOI 10.1186/cc1840; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hatoum OA, 2003, GASTROENTEROLOGY, V125, P58, DOI 10.1016/S0016-5085(03)00699-1; HAUSER CJ, 1988, J LAB CLIN MED, V112, P68; Johnson CM, 2007, J BIOL CHEM, V282, P31197, DOI 10.1074/jbc.M705151200; Karhausen J, 2005, CELL CYCLE, V4, P256; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kokura S, 2002, FREE RADICAL BIO MED, V33, P427, DOI 10.1016/S0891-5849(02)00852-3; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Kruschewski M, 2001, DIGEST DIS SCI, V46, P2336, DOI 10.1023/A:1012334727509; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Tamura DY, 2002, SHOCK, V17, P269, DOI 10.1097/00024382-200204000-00005; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yokoyama K, 2001, HEPATO-GASTROENTEROL, V48, P401; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	55	143	148	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1364	10.1371/journal.pone.0001364	http://dx.doi.org/10.1371/journal.pone.0001364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159247	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459700021
J	Bistue, AJCS; Birshan, D; Tomaras, AP; Dandekar, M; Tran, T; Newmark, J; Bui, D; Gupta, N; Hernandez, K; Sarno, R; Zorreguieta, A; Actis, LA; Tolmasky, ME				Bistue, Alfonso J. C. Soler; Birshan, Daniel; Tomaras, Andrew P.; Dandekar, Manisha; Tran, Tung; Newmark, Jason; Bui, Duyen; Gupta, Nisha; Hernandez, Keziah; Sarno, Renee; Zorreguieta, Angeles; Actis, Luis A.; Tolmasky, Marcelo E.			Klebsiella pneumoniae Multiresistance Plasmid pMET1: Similarity with the Yersinia pestis Plasmid pCRY and Integrative Conjugative Elements	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; AMIKACIN RESISTANCE; RECOMBINATION SITES; BACTERIAL PLASMIDS; ESCHERICHIA-COLI; PROTEIN; SYSTEM; SEGREGATION; PARG; BIOSYNTHESIS	Background: Dissemination of antimicrobial resistance genes has become an important public health and biodefense threat. Plasmids are important contributors to the rapid acquisition of antibiotic resistance by pathogenic bacteria. Principal Findings: The nucleotide sequence of the Klebsiella pneumoniae multiresistance plasmid pMET1 comprises 41,723 bp and includes Tn1331.2, a transposon that carries the bla(TEM-1) gene and a perfect duplication of a 3-kbp region including the aac(6')-Ib, aadA1, and bla(OXA-9) genes. The replication region of pMET1 has been identified. Replication is independent of DNA polymerase I, and the replication region is highly related to that of the cryptic Yersinia pestis 91001 plasmid pCRY. The potential partition region has the general organization known as the parFG locus. The self-transmissible pMET1 plasmid includes a type IV secretion system consisting of proteins that make up the mating pair formation complex (Mpf) and the DNA transfer (Dtr) system. The Mpf is highly related to those in the plasmid pCRY, the mobilizable high-pathogenicity island from E. coli ECOR31 (HPIECOR31), which has been proposed to be an integrative conjugative element (ICE) progenitor of high-pathogenicity islands in other Enterobacteriaceae including Yersinia species, and ICEKp1, an ICE found in a K. pneumoniae strain causing primary liver abscess. The Dtr MobB and MobC proteins are highly related to those of pCRY, but the endonuclease is related to that of plasmid pK245 and has no significant homology with the protein of similar function in pCRY. The region upstream of mobB includes the putative oriT and shares 90% identity with the same region in the HPIECOR31. Conclusions: The comparative analyses of pMET1 with pCRY, HPIECOR31, and ICEKp1 show a very active rate of genetic exchanges between Enterobacteriaceae including Yersinia species, which represents a high public health and biodefense threat due to transfer of multiple resistance genes to pathogenic Yersinia strains.	[Bistue, Alfonso J. C. Soler; Birshan, Daniel; Dandekar, Manisha; Tran, Tung; Newmark, Jason; Bui, Duyen; Gupta, Nisha; Hernandez, Keziah; Sarno, Renee; Zorreguieta, Angeles; Tolmasky, Marcelo E.] Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Dept Biol Sci, Coll Nat Sci & Math, Fullerton, CA 92634 USA; [Tomaras, Andrew P.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH USA	California State University System; California State University Fullerton; University System of Ohio; Miami University	Bistue, AJCS (corresponding author), Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Dept Biol Sci, Coll Nat Sci & Math, Fullerton, CA 92634 USA.	mtolmasky@fullerton.edu	Tolmasky, Marcelo/AAC-5316-2020; Soler-Bistué, Alfonso/AAV-3123-2021	Tolmasky, Marcelo/0000-0002-6298-7811; Soler-Bistué, Alfonso/0000-0002-3917-0002	Public Health Service [2R15AI047115]; National Institutes of Health; National Science Foundation [0420479]; LA Basin Minority Health; Health Disparities International Research Training Program (MHIRT) [5T37MD001368-09]; Howell-CSUPERB Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI047115] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001368] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); LA Basin Minority Health; Health Disparities International Research Training Program (MHIRT); Howell-CSUPERB Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by Public Health Service grant 2R15AI047115 (to M.E.T.) from the National Institutes of Health and National Science Foundation grant 0420479 (to L.A.A.). J.N. and D.B. were supported in part by LA Basin Minority Health and Health Disparities International Research Training Program (MHIRT) 5T37MD001368-09 (National Center on Minority Health and Health Disparities). T.T. was the recipient of a Howell-CSUPERB Scholar Award.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avila P, 1996, J MOL BIOL, V261, P135, DOI 10.1006/jmbi.1996.0447; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2003, MOL MICROBIOL, V49, P487, DOI 10.1046/j.1365-2958.2003.03564.x; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Belogurov AA, 2000, J MOL BIOL, V296, P969, DOI 10.1006/jmbi.1999.3493; BHATTACHARJEE M, 1992, J BACTERIOL, V174, P6659, DOI 10.1128/JB.174.20.6659-6665.1992; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bui DY, 2006, J BACTERIOL, V188, P2812, DOI 10.1128/JB.188.8.2812-2820.2006; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Chen YT, 2006, ANTIMICROB AGENTS CH, V50, P3861, DOI 10.1128/AAC.00456-06; COHEN SN, 1993, GENE, V135, P67, DOI 10.1016/0378-1119(93)90050-D; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ding ZY, 2003, TRENDS MICROBIOL, V11, P527, DOI 10.1016/j.tim.2003.09.004; Ebringer A, 2007, CLIN RHEUMATOL, V26, P289, DOI 10.1007/s10067-006-0391-2; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Gupta A, 2002, SEMIN PERINATOL, V26, P340, DOI 10.1053/sper.2002.36267; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; IRIARTE M, 2006, YERSINIA ENTEROCOLIT; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; McGhee GC, 2000, APPL ENVIRON MICROB, V66, P4897, DOI 10.1128/AEM.66.11.4897-4907.2000; Moller-Jensen J, 2000, TRENDS MICROBIOL, V8, P313, DOI 10.1016/S0966-842X(00)01787-X; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Nunez B, 2001, MOL MICROBIOL, V39, P1088, DOI 10.1046/j.1365-2958.2001.02308.x; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; PETERSON BC, 1985, J BACTERIOL, V164, P1359, DOI 10.1128/JB.164.3.1359-1361.1985; PETERSON BC, 1985, J BACTERIOL, V161, P1042, DOI 10.1128/JB.161.3.1042-1048.1985; PETERSON BC, 1983, J BACTERIOL, V156, P177, DOI 10.1128/JB.156.1.177-185.1983; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P2889, DOI 10.1128/AAC.00398-06; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; REISH O, 1993, J HOSP INFECT, V25, P287, DOI 10.1016/0195-6701(93)90115-G; Rice LB, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P271; Sarno R, 2002, ANTIMICROB AGENTS CH, V46, P3422, DOI 10.1128/AAC.46.11.3422-3427.2002; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Strauch E, 2003, MICROBIOL-SGM, V149, P2829, DOI 10.1099/mic.0.26418-0; Taylor DE, 2004, PLASMID BIOLOGY, P473; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolmasky ME, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P35; TOLMASKY ME, 1990, PLASMID, V24, P218, DOI 10.1016/0147-619X(90)90005-W; TOLMASKY ME, 1987, ANTIMICROB AGENTS CH, V31, P1955, DOI 10.1128/AAC.31.12.1955; TOLMASKY ME, 1988, ANTIMICROB AGENTS CH, V32, P1416, DOI 10.1128/AAC.32.9.1416; TOLMASKY ME, 1993, PLASMID, V29, P31, DOI 10.1006/plas.1993.1004; van't Veen A, 2005, J CLIN MICROBIOL, V43, P4961, DOI 10.1128/JCM.43.10.4961-4967.2005; vanHam RCHJ, 1997, J BACTERIOL, V179, P4768, DOI 10.1128/jb.179.15.4768-4777.1997; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Walsh TR, 2006, CURR OPIN MICROBIOL, V9, P476, DOI 10.1016/j.mib.2006.08.009; Waters Virginia L., 2007, P285; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; WOLOJ M, 1986, ANTIMICROB AGENTS CH, V29, P315, DOI 10.1128/AAC.29.2.315	61	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1800	10.1371/journal.pone.0001800	http://dx.doi.org/10.1371/journal.pone.0001800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350140	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762300006
J	Muller, IB; Knockel, J; Groves, MR; Jordanova, R; Ealick, SE; Walter, RD; Wrenger, C				Mueller, Ingrid B.; Knoeckel, Julia; Groves, Matthew R.; Jordanova, Rositsa; Ealick, Steven E.; Walter, Rolf D.; Wrenger, Carsten			The Assembly of the Plasmodial PLP Synthase Complex Follows a Defined Course	PLOS ONE			English	Article								Background: Plants, fungi, bacteria and the apicomplexan parasite Plasmodium falciparum are able to synthesize vitamin B6 de novo, whereas mammals depend upon the uptake of this essential nutrient from their diet. The active form of vitamin B6 is pyridoxal 5-phosphate (PLP). For its synthesis two enzymes, Pdx1 and Pdx2, act together, forming a multimeric complex consisting of 12 Pdx1 and 12 Pdx2 protomers. Methodology/Principal Findings: Here we report amino acid residues responsible for stabilization of the structural and enzymatic integrity of the plasmodial PLP synthase, identified by using distinct mutational analysis and biochemical approaches. Residues R85, H88 and E91 (RHE) are located at the Pdx1: Pdx1 interface and play an important role in Pdx1 complex assembly. Mutation of these residues to alanine impedes both Pdx1 activity and Pdx2 binding. Furthermore, changing D26, K83 and K151 (DKK), amino acids from the active site of Pdx1, to alanine obstructs not only enzyme activity but also formation of the complex. In contrast to the monomeric appearance of the RHE mutant, alteration of the DKK residues results in a hexameric assembly, and does not affect Pdx2 binding or its activity. While the modelled position of K151 is distal to the Pdx1: Pdx1 interface, it affects the assembly of hexameric Pdx1 into a functional dodecamer, which is crucial for PLP synthesis. Conclusions/Significance: Taken together, our data suggest that the assembly of a functional Pdx1: Pdx2 complex follows a defined pathway and that inhibition of this assembly results in an inactive holoenzyme.	[Mueller, Ingrid B.; Knoeckel, Julia; Walter, Rolf D.; Wrenger, Carsten] Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany; [Groves, Matthew R.; Jordanova, Rositsa] European Mol Biol Lab Hamburg Outstation, Hamburg, Germany; [Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA	Bernhard Nocht Institut fur Tropenmedizin; European Molecular Biology Laboratory (EMBL); Cornell University	Muller, IB (corresponding author), Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany.	wrenger@bni-hamburg.de	Wrenger, Carsten/E-4110-2013	Wrenger, Carsten/0000-0001-5987-1749; Vivian, Julia/0000-0001-6688-7714; Groves, Matthew/0000-0001-9859-5177	Deutsche Forschungsgemeinschaft [WA 395/15]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant WA 395/15.	Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Dong YX, 2004, EUR J BIOCHEM, V271, P745, DOI 10.1111/j.1432-1033.2003.03973.x; Ehrenshaft M, 1998, MOL CELL, V1, P603, DOI 10.1016/S1097-2765(00)80060-X; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Geerlof A, 2006, ACTA CRYSTALLOGR D, V62, P1125, DOI 10.1107/S0907444906030307; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; KERRY JA, 1986, EUR J BIOCHEM, V158, P581, DOI 10.1111/j.1432-1033.1986.tb09794.x; Knockel J, 2007, MOL BIOCHEM PARASIT, V152, P108, DOI 10.1016/j.molbiopara.2006.12.005; LAM HM, 1992, J BACTERIOL, V174, P6033, DOI 10.1128/JB.174.19.6033-6045.1992; LAM HM, 1992, J BACTERIOL, V174, P1554, DOI 10.1128/jb.174.5.1554-1567.1992; Newton P, 1999, ANNU REV MED, V50, P179, DOI 10.1146/annurev.med.50.1.179; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; PFLUG W, 1983, H-S Z PHYSIOL CHEM, V364, P1627, DOI 10.1515/bchm2.1983.364.2.1627; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; ROA BB, 1989, J BACTERIOL, V171, P4767, DOI 10.1128/jb.171.9.4767-4777.1989; Sambrook J., 2002, MOL CLONING LAB MANU; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Stolz J, 2003, J BIOL CHEM, V278, P18990, DOI 10.1074/jbc.M300949200; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Wrenger C, 2001, J BIOL CHEM, V276, P29651, DOI 10.1074/jbc.M100578200; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1815	10.1371/journal.pone.0001815	http://dx.doi.org/10.1371/journal.pone.0001815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350152	Green Submitted, Green Published, gold			2022-12-27	WOS:000260762300018
J	Dale, R; Roche, J; Snyder, K; McCall, R				Dale, Rick; Roche, Jennifer; Snyder, Kristy; McCall, Ryan			Exploring Action Dynamics as an Index of Paired-Associate Learning	PLOS ONE			English	Article							MENTAL CHRONOMETRY; FIELD-THEORY; TIME; DECISION; MOVEMENTS; ATTENTION; SELECTION; SYSTEM	Much evidence exists supporting a richer interaction between cognition and action than commonly assumed. Such findings demonstrate that short-timescale processes, such as motor execution, may relate in systematic ways to longer-timescale cognitive processes, such as learning. We further substantiate one direction of this interaction: the flow of cognition into action systems. Two experiments explored match-to-sample paired-associate learning, in which participants learned randomized pairs of unfamiliar symbols. During the experiments, their hand movements were continuously tracked using the Nintendo Wiimote. Across learning, participant arm movements are initiated and completed more quickly, exhibit lower fluctuation, and exert more perturbation on the Wiimote during the button press. A second experiment demonstrated that action dynamics index novel learning scenarios, and not simply acclimatization to the Wiimote interface. Results support a graded and systematic covariation between cognition and action, and recommend ways in which this theoretical perspective may contribute to applied learning contexts.	[Dale, Rick; Roche, Jennifer; Snyder, Kristy; McCall, Ryan] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA	University of Memphis	Dale, R (corresponding author), Univ Memphis, Dept Psychol, Memphis, TN 38152 USA.	radale@memphis.edu	Tapp, Kristy/D-8880-2012; Snyder, Kristy/C-2822-2014; Dale, Rick/F-4660-2010	Snyder, Kristy/0000-0002-0063-3620; Dale, Rick/0000-0001-7865-474X	NSF [BCS-0720322]; Direct For Social, Behav & Economic Scie [1216638] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was partly supported by NSF Grant BCS-0720322 to the first author.	ABRAMS RA, 1991, PSYCHOL SCI, V2, P153, DOI 10.1111/j.1467-9280.1991.tb00123.x; Anderson JR, 2002, COGNITIVE SCI, V26, P85, DOI 10.1207/s15516709cog2601_3; Azevedo R., 2006, HDB ED PSYCHOL, V2, P803; BALOTA DA, 1995, J EXP PSYCHOL LEARN, V21, P1289, DOI 10.1037/0278-7393.21.5.1289; BALOTA DA, 1989, J MEM LANG, V28, P14, DOI 10.1016/0749-596X(89)90026-0; CACIOPPO JT, 1993, J PERS SOC PSYCHOL, V65, P5; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; Davidson PR, 2003, CURR OPIN NEUROBIOL, V13, P232, DOI 10.1016/S0959-4388(03)00038-2; Dixon JA, 2007, CURR DIR PSYCHOL SCI, V16, P111, DOI 10.1111/j.1467-8721.2007.00486.x; Doyle D, 2001, EXP BRAIN RES, V139, P333, DOI 10.1007/s002210100742; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; Erlhagen W, 2002, PSYCHOL REV, V109, P545, DOI 10.1037//0033-295X.109.3.545; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Fodor J. A, 1983, MODULARITY MIND; Fu WT, 2001, BEHAV RES METH INS C, V33, P149, DOI 10.3758/BF03195360; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; GORDON AM, 1984, B PSYCHONOMIC SOC, V22, P214; Jeannerod M., 2006, MOTOR COGNITION; John B. E., 2004, P SIGCHI C HUM FACT, P455, DOI DOI 10.1145/985692.985750; Keith TZ, 2005, MULTIPLE REGRESSION; Magill R. A., 2006, MOTOR LEARNING CONTR; Markman AB, 2005, PSYCHOL SCI, V16, P6, DOI 10.1111/j.0956-7976.2005.00772.x; Mattes S, 2002, VIS COGN, V9, P477, DOI 10.1080/13506280143000548; McKinstry C, 2008, PSYCHOL SCI, V19, P22, DOI 10.1111/j.1467-9280.2008.02041.x; Newell A., 1990, UNIFIED THEORIES COG; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rosenbaum D. A., 2002, STEVENS HDB EXPT PSY, V1, P315; Rosenbaum DA, 2004, J MOTOR BEHAV, V36, P390, DOI 10.1080/00222895.2004.11008003; Rosenbaum DA, 2005, AM PSYCHOL, V60, P308, DOI 10.1037/0003-066X.60.4.308; ROSENBAUM DA, 1991, PSYCHOL SCI, V2, P86, DOI 10.1111/j.1467-9280.1991.tb00106.x; SALVUCCI DD, 1999, THESIS DPT CARN MEL; Schutte AR, 2007, MOTOR CONTROL, V11, P166, DOI 10.1123/mcj.11.2.166; Sheliga BM, 1997, EXP BRAIN RES, V114, P339, DOI 10.1007/PL00005642; Spivey M., 2006, CONTINUITY MIND; Spivey MJ, 2006, CURR DIR PSYCHOL SCI, V15, P207, DOI 10.1111/j.1467-8721.2006.00437.x; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; STEPHEN DG, 2006, DYNAMICS REPRE UNPUB; THOMAS LE, 2006, J VIS, V6, P871; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; Ulrich R, 1999, ACTA PSYCHOL, V102, P43, DOI 10.1016/S0001-6918(99)00019-0; Wells P, 2007, J LANG SOC PSYCHOL, V26, P321, DOI 10.1177/0261927X07306978	52	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1728	10.1371/journal.pone.0001728	http://dx.doi.org/10.1371/journal.pone.0001728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XT	18320047	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600023
J	Oleksyk, TK; Zhao, K; De La Vega, FM; Gilbert, DA; O'Brien, SJ; Smith, MW				Oleksyk, Taras K.; Zhao, Kai; De La Vega, Francisco M.; Gilbert, Dennis A.; O'Brien, Stephen J.; Smith, Michael W.			Identifying Selected Regions from Heterozygosity and Divergence Using a Light-Coverage Genomic Dataset from Two Human Populations	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; HAPLOTYPE MAP; SIGNATURES; DIVERSITY; SCANS	When a selective sweep occurs in the chromosomal region around a target gene in two populations that have recently separated, it produces three dramatic genomic consequences: 1) decreased multi-locus heterozygosity in the region; 2) elevated or diminished genetic divergence (F-ST) of multiple polymorphic variants adjacent to the selected locus between the divergent populations, due to the alternative fixation of alleles; and 3) a consequent regional increase in the variance of FST ((SFST)-F-2) for the same clustered variants, due to the increased alternative fixation of alleles in the loci surrounding the selection target. In the first part of our study, to search for potential targets of directional selection, we developed and validated a resampling-based computational approach; we then scanned an array of 31 different-sized moving windows of SNP variants (5-65 SNPs) across the human genome in a set of European and African American population samples with 183,997 SNP loci after correcting for the recombination rate variation. The analysis revealed 180 regions of recent selection with very strong evidence in either population or both. In the second part of our study, we compared the newly discovered putative regions to those sites previously postulated in the literature, using methods based on inspecting patterns of linkage disequilibrium, population divergence and other methodologies. The newly found regions were cross-validated with those found in nine other studies that have searched for selection signals. Our study was replicated especially well in those regions confirmed by three or more studies. These validated regions were independently verified, using a combination of different methods and different databases in other studies, and should include fewer false positives. The main strength of our analysis method compared to others is that it does not require dense genotyping and therefore can be used with data from population-based genome SNP scans from smaller studies of humans or other species.	[Oleksyk, Taras K.; Zhao, Kai; O'Brien, Stephen J.; Smith, Michael W.] NCI, Lab Genom Div, Frederick, MD 21701 USA; [Oleksyk, Taras K.; Smith, Michael W.] NCI, SAIC Frederick, Inc, Basic Res Prog, Frederick, MD USA; [De La Vega, Francisco M.; Gilbert, Dennis A.] Appl Biosyst Inc, Foster City, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Thermo Fisher Scientific; Applied Biosystems	Oleksyk, TK (corresponding author), NCI, Lab Genom Div, Frederick, MD 21701 USA.	oleksyk@ncifcrf.gov	Smith, Michael/B-5341-2012; Taras, Oleksyk/J-8805-2013; De La Vega, Francisco/H-3832-2011; OBRIEN, STEPHEN/ABD-1346-2020	Taras, Oleksyk/0000-0002-8148-3918; OBRIEN, STEPHEN/0000-0001-7857-0757	National Cancer Institute, National Institutes of Health [N01-CO-12400]; NATIONAL CANCER INSTITUTE [Z01BC005800, Z01BC010270] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; BERRY A, 1993, GENETICS, V134, P869; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Cavalli-Sforza LL., 2000, GENES PEOPLES LANGUA; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; De La Vega FM, 2002, BIOTECHNIQUES, P48; Dove A, 2005, NAT METHODS, V2, P989, DOI 10.1038/nmeth1205-989; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Huttley GA, 1999, GENETICS, V152, P1711; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; LEWONTIN RC, 1973, GENETICS, V74, P175; NEI M, 1974, GENETICS, V76, P379; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Olson S, 2002, SCIENCE, V298, P1324, DOI 10.1126/science.298.5597.1324; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; TAYLOR MFJ, 1995, SCIENCE, V270, P1497, DOI 10.1126/science.270.5241.1497; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323	43	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1712	10.1371/journal.pone.0001712	http://dx.doi.org/10.1371/journal.pone.0001712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320033	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586600008
J	Schneider, H; Wang, HY; Raab, M; Valk, E; Smith, X; Lovatt, M; Wu, ZL; Maqueira-Iglesias, B; Strebhardt, K; Rudd, CE				Schneider, Helga; Wang, Hongyan; Raab, Monika; Valk, Elke; Smith, Xin; Lovatt, Matt; Wu, Zhonglin; Maqueira-Iglesias, Braudel; Strebhardt, Klaus; Rudd, Christopher E.			Adaptor SKAP-55 Binds p21(ras) Activating Exchange Factor RasGRP1 and Negatively Regulates the p21(ras)-ERK Pathway in T-Cells	PLOS ONE			English	Article							ANTIGEN RECEPTOR; RAS ACTIVATION; PROTEIN; SKAP55; STIMULATION; COSTIMULATION; EXPRESSION; ADHESION; P21RAS; DOMAIN	While the adaptor SKAP-55 mediates LFA-1 adhesion on T-cells, it is not known whether the adaptor regulates other aspects of signaling. SKAP-55 could potentially act as a node to coordinate the modulation of adhesion with downstream signaling. In this regard, the GTPase p21(ras) and the extracellular signal-regulated kinase (ERK) pathway play central roles in T-cell function. In this study, we report that SKAP-55 has opposing effects on adhesion and the activation of the p21(ras)-ERK pathway in T-cells. SKAP-55 deficient primary T-cells showed a defect in LFA-1 adhesion concurrent with the hyperactivation of the ERK pathway relative to wild-type cells. RNAi knock down (KD) of SKAP-55 in T-cell lines also showed an increase in p21(ras) activation, while over-expression of SKAP-55 inhibited activation of ERK and its transcriptional target ELK. Three observations implicated the p21(ras) activating exchange factor RasGRP1 in the process. Firstly, SKAP-55 bound to RasGRP1 via its C-terminus, while secondly, the loss of binding abrogated SKAP-55 inhibition of ERK and ELK activation. Thirdly, SKAP-55-/- primary T-cells showed an increased presence of RasGRP1 in the trans-Golgi network (TGN) following TCR activation, the site where p21(ras) becomes activated. Our findings indicate that SKAP-55 has a dual role in regulating p21(ras)-ERK pathway via RasGRP1, as a possible mechanism to restrict activation during T-cell adhesion.	[Schneider, Helga; Valk, Elke; Wu, Zhonglin; Maqueira-Iglesias, Braudel; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signalling Sect, Cambridge CB2 1QP, England; [Schneider, Helga; Wang, Hongyan; Raab, Monika; Valk, Elke; Lovatt, Matt; Wu, Zhonglin; Rudd, Christopher E.] Hammersmith Hosp, Imperial Coll London, Fac Med, Div Investigative Sci, Mol Immunol Sect, London, England; [Wang, Hongyan; Smith, Xin; Rudd, Christopher E.] Cambridge Inst Med Res, Cambridge, England; [Raab, Monika; Strebhardt, Klaus] Goethe Univ Frankfurt, Med Sch, Dept Gynecol & Obstet, Frankfurt, Germany	University of Cambridge; Imperial College London; University of Cambridge; Goethe University Frankfurt	Schneider, H (corresponding author), Univ Cambridge, Dept Pathol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	cer51@cam.ac.uk	Rudd, Christopher E/GOH-2021-2022; Strebhardt, Klaus/E-8765-2011; hongyan, wang/GWQ-6360-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; Strebhardt, Klaus/0000-0003-2173-9763	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Wellcome Trust, BBSRC	Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Duke-Cohan JS, 2006, J BIOL CHEM, V281, P13743, DOI 10.1074/jbc.M508774200; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Guilbault B, 2004, J BIOL CHEM, V279, P19523, DOI 10.1074/jbc.M314273200; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; Marie-Cardine A, 1998, J BIOL CHEM, V273, P25789, DOI 10.1074/jbc.273.40.25789; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; McGilvray ID, 1997, J BIOL CHEM, V272, P10287; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Reedquist KA, 1998, J BIOL CHEM, V273, P4944, DOI 10.1074/jbc.273.9.4944; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Smith JA, 1997, J EXP MED, V185, P1413, DOI 10.1084/jem.185.8.1413; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Valk E, 2006, IMMUNITY, V25, P807, DOI 10.1016/j.immuni.2006.08.024; Wang H, 2007, MOL CELL BIOL, V27, P6863, DOI 10.1128/MCB.00556-07; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wu LT, 2002, MOL CELL BIOL, V22, P2673, DOI 10.1128/MCB.22.8.2673-2686.2002	41	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1718	10.1371/journal.pone.0001718	http://dx.doi.org/10.1371/journal.pone.0001718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320039	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586600014
J	Vacher, C; Piou, D; Desprez-Loustau, ML				Vacher, Corinne; Piou, Dominique; Desprez-Loustau, Marie-Laure			Architecture of an Antagonistic Tree/Fungus Network: The Asymmetric Influence of Past Evolutionary History	PLOS ONE			English	Article							SPECIES ABUNDANCE; PARASITIC FUNGI; PLANT; SPECIALIZATION; COMPARTMENTS; NESTEDNESS; PATHOGENS; ANGIOSPERMS; PATTERNS; TREES	Background: Compartmentalization and nestedness are common patterns in ecological networks. The aim of this study was to elucidate some of the processes shaping these patterns in a well resolved network of host/pathogen interactions. Methology/Principal Findings: Based on a long-term (1972-2005) survey of forest health at the regional scale (all French forests; 15 million ha), we uncovered an almost fully connected network of 51 tree taxa and 157 parasitic fungal species. Our analyses revealed that the compartmentalization of the network maps out the ancient evolutionary history of seed plants, but not the ancient evolutionary history of fungal species. The very early divergence of the major fungal phyla may account for this asymmetric influence of past evolutionary history. Unlike compartmentalization, nestedness did not reflect any consistent phylogenetic signal. Instead, it seemed to reflect the ecological features of the current species, such as the relative abundance of tree species and the life-history strategies of fungal pathogens. We discussed how the evolution of host range in fungal species may account for the observed nested patterns. Conclusion/Significance: Overall, our analyses emphasized how the current complexity of ecological networks results from the diversification of the species and their interactions over evolutionary times. They confirmed that the current architecture of ecological networks is not only dependant on recent ecological processes.	[Vacher, Corinne; Piou, Dominique; Desprez-Loustau, Marie-Laure] INRA, Inst Sci Rech Agron, UMR Biodivers Genes & Communautes 1202, Villenave Dornon, France; [Piou, Dominique] Ministere Agr Peche, Dept Sante Forets, Cenon, France	INRAE	Vacher, C (corresponding author), INRA, Inst Sci Rech Agron, UMR Biodivers Genes & Communautes 1202, Villenave Dornon, France.	cvacher@bordeaux.inra.fr	Vacher, Corinne/ABG-8163-2020; Vacher, Corinne/Q-3182-2019; Vacher, Corinne/J-1777-2012	Vacher, Corinne/0000-0003-3023-6113; Vacher, Corinne/0000-0003-3023-6113	INRA	INRA	This study was funded by the INRA.	ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2006, SFI S SCI C, P143; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Berbee ML, 2001, MYCOTA, V7, P229; Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Brandle M, 2006, OIKOS, V113, P296, DOI 10.1111/j.2006.0030-1299.14418.x; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brandle M, 2003, EVOL ECOL RES, V5, P941; Brasier C. M., 2001, Biological Invasions, V3, P223, DOI 10.1023/A:1015248819864; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Combes Claude., 2001, PARASITISM ECOLOGY E; Csardi G., 2005, IGRAPH ROUTINES NETW; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Fonseca CR, 1996, J ANIM ECOL, V65, P339, DOI 10.2307/5880; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Garcia-Guzman G, 2007, ECOLOGY, V88, P589, DOI 10.1890/05-1174; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Ives AR, 2006, AM NAT, V168, pE1, DOI 10.1086/505157; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Mielke P. W., 2001, PERMUTATION METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paradis E., 2006, APE ANAL PHYLOGENETI; Parker IM, 2004, ANNU REV ECOL EVOL S, V35, P675, DOI 10.1146/annurev.ecolsys.34.011802.132339; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips D.H., 1982, DIS FOREST ORNAMENTA; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Roy BA, 2001, EVOLUTION, V55, P41, DOI 10.1111/j.0014-3820.2001.tb01271.x; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; Stevens P.F., 2006, ANGIOSPERM PHYLOGENY; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; Thomas PA, 2003, J ECOL, V91, P489, DOI 10.1046/j.1365-2745.2003.00783.x; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	55	71	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1740	10.1371/journal.pone.0001740	http://dx.doi.org/10.1371/journal.pone.0001740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320058	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600035
J	Herbeck, JT; Gottlieb, GS; Li, XH; Hu, Z; Detels, R; Phair, J; Rinaldo, C; Jacobson, LP; Margolick, JB; Mullins, JI				Herbeck, Joshua T.; Gottlieb, Geoffrey S.; Li, Xiuhong; Hu, Zheng; Detels, Roger; Phair, John; Rinaldo, Charles; Jacobson, Lisa P.; Margolick, Joseph B.; Mullins, James I.			Lack of Evidence for Changing Virulence of HIV-1 in North America	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4 CELL COUNTS; MULTICENTER AIDS COHORT; REPLICATIVE FITNESS; TEMPORAL TRENDS; NATURAL-HISTORY; ESCAPE MUTATION; VIRAL LOAD; SEROCONVERSION; INFECTION	Background. Several long-term cohort studies and in-vitro fitness assays have resulted in inconsistent reports on changes in HIV-1 virulence, including reports of decreasing, stable, and increasing virulence over the course of the AIDS pandemic. We tested the hypothesis of changing HIV-1 virulence by examining trends in prognostic clinical markers of disease progression from 1984 to 2005 among nearly 400 antiretroviral-naive participants in the United States Multicenter AIDS Cohort Study (MACS), a longitudinal study of HIV infection in men who have sex with men (MSM). Methodology/Principal Findings. Because clinical AIDS endpoints could not be used (due to antiretroviral therapies and prophylaxis), three prognostic markers of disease progression were used as proxies for HIV-1 virulence: plasma viral RNA load and CD4+ T cell count at "set point'' (between similar to 9 and similar to 15 months after seroconversion), and rate of CD4 cell decline within three years after seroconversion. We performed multivariate analyses of the association between these markers and seroconversion year, with covariates including MACS site, race/ethnic group, seroconversion age, and CCR5 Delta 32 status. No statistically significant association was found between year of seroconversion and "set point'' plasma viral load (at similar to 9 months after seroconversion: slope=-0.004 log(10) copies/mL/year, p=0.76; at similar to 15 months: slope=-0.005 log(10) copies/mL/year, p=0.71), CD4 cell count after seroconversion (at similar to 9 months: slope=-0.112 cells/mL/year, p=0.22; at similar to 15 months: slope=-0.047 cells/mL/year, p=0.64), or rate of CD4 cell decline over the first three years after seroconversion (slope=-0.010 cells/mu l/yr(2), p=0.88). Conclusions/Significance. The lack of significant trends from 1984 to 2005 in these prognostic markers of HIV disease progression suggests no major change in HIV-1 virulence over the AIDS pandemic in MSM in the US.	[Herbeck, Joshua T.; Gottlieb, Geoffrey S.; Mullins, James I.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Li, Xiuhong; Hu, Zheng; Jacobson, Lisa P.; Margolick, Joseph B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA USA; [Phair, John] Northwestern Univ, Med Sch, Chicago, IL USA; [Rinaldo, Charles] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gottlieb, GS (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.	gottlieb@u.washington.edu		Jacobson, Lisa P./0000-0003-1722-6826; Gottlieb, Geoffrey/0000-0002-5749-481X	NIH [T32 AI07140]; University of Washington CFAR [STD/HIV Training Grant]; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung and Blood Institute;  [R01 AI058894];  [R37 AI47734];  [P01 AI57005];  [P30 AI27757];  [K08 AI049755];  [UO1-AI-35043];  [UO1-AI-37984];  [UO1-AI-35039];  [UO1-AI-35040];  [UO1-AI-37613];  [UO1-AI-35041]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI049755, R01AI058894, R37AI047734, U01AI037984, P30AI027757, U01AI035040, T32AI007140, P01AI057005, U01AI035039, U01AI035043, U01AI035042, U01AI037613, U01AI035041] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington CFAR; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided to JIM by R01 AI058894, R37 AI47734, P01 AI57005, to JTH and JIM by P30 AI27757, to JTH by NIH T32 AI07140, STD/HIV Training Grant at University of Washington CFAR, and to GSG by K08 AI049755. The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute. UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041.	Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Dorrucci M, 2005, AIDS, V19, P331; Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911; EWALD PW, 1994, PHILOS T R SOC B, V346, P333, DOI 10.1098/rstb.1994.0150; FULTZ PN, 1990, AIDS, V4, P619, DOI 10.1097/00002030-199007000-00002; Galai N, 1996, AM J EPIDEMIOL, V143, P278; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; GIORGI JV, 1990, CLIN IMMUNOL IMMUNOP, V55, P173, DOI 10.1016/0090-1229(90)90096-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta SB, 2007, J INFECT DIS, V195, P546, DOI 10.1086/510909; Harrigan PR, 1998, J VIROL, V72, P3773, DOI 10.1128/JVI.72.5.3773-3778.1998; HOLMBERG SD, 1995, J ACQ IMMUN DEF SYND, V9, P291; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Keet IPM, 1996, AIDS, V10, P1601, DOI 10.1097/00002030-199611000-00025; KESTENS L, 1995, J INFECT DIS, V172, P957, DOI 10.1093/infdis/172.4.957; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MELLORS JW, 2007, J AM MED AS IN PRESS; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; OBRIEN TR, 1995, AM J EPIDEMIOL, V142, P636, DOI 10.1093/oxfordjournals.aje.a117687; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Sinicco A, 1997, BRIT MED J, V314, P1232, DOI 10.1136/bmj.314.7089.1232; Touloumi G, 2003, JAIDS-J ACQ IMM DEF, V34, P76, DOI 10.1097/00126334-200309010-00012; Vanhems P, 1999, J INFECT DIS, V180, P1803, DOI 10.1086/315110	32	34	34	10	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1525	10.1371/journal.pone.0001525	http://dx.doi.org/10.1371/journal.pone.0001525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253479	Green Published, gold, Green Accepted			2022-12-27	WOS:000260535700003
J	White, LF; Pagano, M				White, Laura Forsberg; Pagano, Marcello			Transmissibility of the Influenza Virus in the 1918 Pandemic	PLOS ONE			English	Article							DYNAMICS; INSIGHTS	Background. With a heightened increase in concern for an influenza pandemic we sought to better understand the 1918 Influenza pandemic, the most devastating epidemic of the previous century. Methodology/Principal Findings. We use data from several communities in Maryland, USA as well as two ships that experienced well-documented outbreaks of influenza in 1918. Using a likelihood-based method and a nonparametric method, we estimate the serial interval and reproductive number throughout the course of each outbreak. This analysis shows the basic reproductive number to be slightly lower in the Maryland communities (between 1.34 and 3.21) than for the enclosed populations on the ships (R-0 = 4.97, SE = 3.31). Additionally the effective reproductive number declined to sub epidemic levels more quickly on the ships (within around 10 days) than in the communities (within 30-40 days). The mean serial interval for the ships was consistent (3.33, SE = 5.96 and 3.81, SE = 3.69), while the serial intervals in the communities varied substantially (between 2.83, SE = 0.53 and 8.28, SE = 951.95). Conclusions/Significance. These results illustrate the importance of considering the population dynamics when making statements about the epidemiological parameters of Influenza. The methods that we employ for estimation of the reproductive numbers and the serial interval can be easily replicated in other populations and with other diseases.	[White, Laura Forsberg; Pagano, Marcello] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA	Boston University	White, LF (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	lfwhite@bu.edu		White, Laura F/0000-0002-0588-8235	National Institutes of Health [R01 EB0006195]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Work funded by a grant from the National Institutes of Health, R01 EB0006195.	Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; ANDERSON R M, 1991; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; *CDCP, 2006, PAND INFL PRES FUT W; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; FINNEY DJ, 1976, BIOMETRICS, V32, P721, DOI 10.2307/2529258; FRASER C, 2007, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0000758; Frost W.H., 1919, PUBLIC HLTH REPORTS, V34, P491, DOI [10.2307/4575056, DOI 10.2307/4575056]; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; Halloran ME, 2002, VACCINE, V20, P3254; HEALY MJR, 1972, BIOCHEM J, V130, P207, DOI 10.1042/bj1300207; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; WHITE LF, 2007, STAT MED IN PRESS; FLUWEB HIST INFLUENZ	24	60	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1498	10.1371/journal.pone.0001498	http://dx.doi.org/10.1371/journal.pone.0001498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231585	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200011
J	Naffar-Abu-Amara, S; Shay, T; Galun, M; Cohen, N; Isakoff, SJ; Kam, Z; Geiger, B				Naffar-Abu-Amara, Suha; Shay, Tal; Galun, Meirav; Cohen, Naomi; Isakoff, Steven J.; Kam, Zvi; Geiger, Benjamin			Identification of Novel Pro-Migratory, Cancer-Associated Genes Using Quantitative, Microscopy-Based Screening	PLOS ONE			English	Article								Background. Cell migration is a highly complex process, regulated by multiple genes, signaling pathways and external stimuli. To discover genes or pharmacological agents that can modulate the migratory activity of cells, screening strategies that enable the monitoring of diverse migratory parameters in a large number of samples are necessary. Methodology. In the present study, we describe the development of a quantitative, high-throughput cell migration assay, based on a modified phagokinetic tracks (PKT) procedure, and apply it for identifying novel pro-migratory genes in a cancer-related gene library. In brief, cells are seeded on fibronectin-coated 96-well plates, covered with a monolayer of carboxylated latex beads. Motile cells clear the beads, located along their migratory paths, forming tracks that are visualized using an automated, transmitted-light screening microscope. The tracks are then segmented and characterized by multi-parametric, morphometric analysis, resolving a variety of morphological and kinetic features. Conclusions. In this screen we identified 4 novel genes derived from breast carcinoma related cDNA library, whose over-expression induces major alteration in the migration of the stationary MCF7 cells. This approach can serve for high throughput screening for novel ways to modulate cellular migration in pathological states such as tumor metastasis and invasion.	[Naffar-Abu-Amara, Suha; Cohen, Naomi; Kam, Zvi; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Shay, Tal] Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel; [Galun, Meirav] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Isakoff, Steven J.] Mass Gen Hosp Canc Ctr, Boston, MA USA; [Isakoff, Steven J.] Harvard Med Sch, Dept Cell Biol, Boston, MA USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Harvard University; Harvard Medical School	Geiger, B (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	benny.geiger@weizmann.ac.il	Isakoff, Steven/ABE-3566-2020; Shay, Tal/J-4028-2016	Shay, Tal/0000-0003-0755-1350	Israel Science Foundation; NIGMS; NIH [U54GM64346]; Weizmann Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weizmann Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Israel Science Foundation and an NIGMS grant for the Cell Migration Consortium (NIH Grant U54GM64346), and by the Kahn fund for systems biology at the Weizmann Institute.	ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Ayaki M, 2000, BBA-MOL CELL RES, V1495, P40, DOI 10.1016/S0167-4889(99)00153-6; Baudoux B, 2000, EUR J CELL BIOL, V79, P41, DOI 10.1078/S0171-9335(04)70006-0; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; COOMBER BL, 1990, ARTERIOSCLEROSIS, V10, P215, DOI 10.1161/01.ATV.10.2.215; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; IWASAKI T, 1995, INT J CANCER, V63, P282, DOI 10.1002/ijc.2910630223; Kawa S, 1997, FEBS LETT, V420, P196, DOI 10.1016/S0014-5793(97)01516-0; Libotte T, 2001, EXP CELL RES, V270, P129, DOI 10.1006/excr.2001.5339; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liron Y, 2006, J MICROSC-OXFORD, V221, P145, DOI 10.1111/j.1365-2818.2006.01550.x; Mastyugin V, 2004, J BIOMOL SCREEN, V9, P712, DOI 10.1177/1087057104269495; Mukai M, 2003, INT J ONCOL, V22, P1247; Ogata Riko, 1998, Kurume Medical Journal, V45, P11; Ohmori T, 2001, J BIOL CHEM, V276, P5274, DOI 10.1074/jbc.M005405200; Onishi Y, 2003, CLIN EXP METASTAS, V20, P51, DOI 10.1023/A:1022594503657; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Paran Y, 2007, J STRUCT BIOL, V158, P233, DOI 10.1016/j.jsb.2006.12.013; Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855; Price LS, 2001, SEMIN CANCER BIOL, V11, P167, DOI 10.1006/scbi.2000.0367; SHARON E, 2001, SEGMENTATION BOUNDAR, P469; Takanami I, 2002, ONCOL REP, V9, P125; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395r; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; WONG MKK, 1988, J CELL BIOL, V107, P1777, DOI 10.1083/jcb.107.5.1777; Zahm JM, 1997, CELL MOTIL CYTOSKEL, V37, P33, DOI 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I	28	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1457	10.1371/journal.pone.0001457	http://dx.doi.org/10.1371/journal.pone.0001457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213366	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503900003
J	Rintamaki, R; Grimaldi, S; Englund, A; Haukka, J; Partonen, T; Reunanen, A; Aromaa, A; Lonnqvist, J				Rintamaki, Reeta; Grimaldi, Sharon; Englund, Ani; Haukka, Jari; Partonen, Timo; Reunanen, Antti; Aromaa, Arpo; Lonnqvist, Jouko			Seasonal Changes in Mood and Behavior Are Linked to Metabolic Syndrome	PLOS ONE			English	Article							SERUM URIC-ACID; PATTERN ASSESSMENT QUESTIONNAIRE; CIRCADIAN CLOCK; LIGHT; EXPRESSION; TRANSCRIPTION; DOPAMINE; DISEASE; TIME; TEMPERATURE	Background. Obesity is a major public health problem worldwide. Metabolic syndrome is a risk factor to the cardiovascular diseases. It has been reported that disruptions of the circadian clockwork are associated with and may predispose to metabolic syndrome. Methodology and Principal Findings. 8028 individuals attended a nationwide health examination survey in Finland. Data were collected with a face-to-face interview at home and during an individual health status examination. The waist circumference, height, weight and blood pressure were measured and samples were taken for laboratory tests. Participants were assessed using the ATP-III criteria for metabolic syndrome and with the Seasonal Pattern Assessment Questionnaire for their seasonal changes in mood and behavior. Seasonal changes in weight in particular were a risk factor of metabolic syndrome, after controlling for a number of known risk and potential confounding factors. Conclusions and Significance. Metabolic syndrome is associated with high global scores on the seasonal changes in mood and behavior, and with those in weight in particular. Assessment of these changes may serve as a useful indicator of metabolic syndrome, because of easy assessment. Abnormalities in the circadian clockwork which links seasonal fluctuations to metabolic cycles may predispose to seasonal changes in weight and to metabolic syndrome.	[Rintamaki, Reeta; Grimaldi, Sharon; Englund, Ani; Haukka, Jari; Partonen, Timo; Lonnqvist, Jouko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Reunanen, Antti; Aromaa, Arpo] Natl Publ Hlth Inst, Dept Hlth & Funct Capacity, Helsinki, Finland; [Lonnqvist, Jouko] Helsinki Univ Hosp, Dept Psych, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Partonen, T (corresponding author), Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland.	timo.partonen@ktl.fi	Haukka, Jari/G-1484-2014; Partonen, Timo/G-1105-2012	Haukka, Jari/0000-0003-1450-6208; Partonen, Timo/0000-0003-1951-2455; Rintamaki, Reeta/0000-0003-4678-5555	Academy of Finland [201097, 210262]; The Finnish Medical Foundation	Academy of Finland(Academy of Finland); The Finnish Medical Foundation	The study was supported in part by grants from the Academy of Finland (#201097 and #210262), and a grant from The Finnish Medical Foundation (to Dr. Partonen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2006, TRENDS CELL BIOL, V16, P547, DOI 10.1016/j.tcb.2006.09.005; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; BRAINARD GC, 1987, BRAIN RES, V424, P199, DOI 10.1016/0006-8993(87)91211-X; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Coutinho TD, 2007, AM J HYPERTENS, V20, P83, DOI 10.1016/j.amjhyper.2006.06.015; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Duan W, 2002, J NEUROCHEM, V80, P101, DOI 10.1046/j.0022-3042.2001.00676.x; Foulkes NS, 1996, P NATL ACAD SCI USA, V93, P14140, DOI 10.1073/pnas.93.24.14140; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Holmback U, 2003, EUR J NUTR, V42, P75, DOI 10.1007/s00394-003-0386-6; KASPER S, 1989, ARCH GEN PSYCHIAT, V46, P823; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Kawamoto R, 2006, INTERNAL MED, V45, P605, DOI 10.2169/internalmedicine.45.1661; KAWATO M, 1982, J THEOR BIOL, V98, P369, DOI 10.1016/0022-5193(82)90125-4; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Koskinen S, 2004, HLTH FUNCTIONAL CAPA; LAM RW, 1994, AM J PSYCHIAT, V151, P744; LAPOSKY AD, 2007, FEBS LETT IN PRESS, DOI DOI 10.1016/J.FEBSLET.2007.06.079]; Lincoln GA, 2006, SCIENCE, V314, P1941, DOI 10.1126/science.1132009; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Madden PAF, 1996, ARCH GEN PSYCHIAT, V53, P47; Magnusson A, 1996, J AFFECT DISORDERS, V40, P121, DOI 10.1016/0165-0327(96)00036-5; Magnusson A, 1997, J AFFECT DISORDERS, V42, P113, DOI 10.1016/S0165-0327(96)00104-8; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Meijer JH, 2007, GEN COMP ENDOCR, V152, P159, DOI 10.1016/j.ygcen.2007.01.018; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Onat A, 2006, PREV MED, V43, P136, DOI 10.1016/j.ypmed.2006.04.005; Partonen T, 2004, ACTA PSYCHIAT SCAND, V109, P110, DOI 10.1046/j.0001-690X.2003.00226.x; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Penfield S, 2005, CURR BIOL, V15, P1998, DOI 10.1016/j.cub.2005.11.010; Ptitsyn AA, 2007, PLOS COMPUT BIOL, V3, P1108, DOI 10.1371/journal.pcbi.0030120; Revel FG, 2007, P NATL ACAD SCI USA, V104, P13816, DOI 10.1073/pnas.0704699104; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tarkkonen L., 1987, STAT STUDIES, V7; Thompson C, 2004, J AFFECT DISORDERS, V78, P219, DOI 10.1016/S0165-0327(02)00314-2; Thompson C, 1997, BRIT J PSYCHIAT, V170, P431, DOI 10.1192/bjp.170.5.431; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P11227, DOI 10.1073/pnas.0401882101; van Oort BEH, 2007, NATURWISSENSCHAFTEN, V94, P183, DOI 10.1007/s00114-006-0174-2; Vehkalahti K, 2000, STAT RES REPORTS, V17; Wehr T., 1984, SEASONAL PATTERN ASS; WHO, 2003, DIET NUTR PREVENTION, V916; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206; Young MA, 2003, PSYCHIAT RES, V117, P75, DOI 10.1016/S0165-1781(02)00299-8; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	65	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1482	10.1371/journal.pone.0001482	http://dx.doi.org/10.1371/journal.pone.0001482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SO	18213390	Green Published, Green Submitted, gold			2022-12-27	WOS:000260503900027
J	Schneider, A; Garlick, JA; Egles, C				Schneider, Aurore; Garlick, Jonathan A.; Egles, Christophe			Self-Assembling Peptide Nanofiber Scaffolds Accelerate Wound Healing	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; KERATINOCYTES IN-VITRO; INDUCED MOTILITY; FACTOR RECEPTOR; FACTOR-ALPHA; TISSUE; MIGRATION; REPAIR; MODEL; REEPITHILIALIZATION	Cutaneous wound repair regenerates skin integrity, but a chronic failure to heal results in compromised tissue function and increased morbidity. To address this, we have used an integrated approach, using nanobiotechnology to augment the rate of wound reepithelialization by combining self-assembling peptide (SAP) nanofiber scaffold and Epidermal Growth Factor (EGF). This SAP bioscaffold was tested in a bioengineered Human Skin Equivalent (HSE) tissue model that enabled wound reepithelialization to be monitored in a tissue that recapitulates molecular and cellular mechanisms of repair known to occur in human skin. We found that SAP underwent molecular self-assembly to form unique 3D structures that stably covered the surface of the wound, suggesting that this scaffold may serve as a viable wound dressing. We measured the rates of release of EGF from the SAP scaffold and determined that EGF was only released when the scaffold was in direct contact with the HSE. By measuring the length of the epithelial tongue during wound reepithelialization, we found that SAP scaffolds containing EGF accelerated the rate of wound coverage by 5 fold when compared to controls without scaffolds and by 3.5 fold when compared to the scaffold without EGF. In conclusion, our experiments demonstrated that biomaterials composed of a biofunctionalized peptidic scaffold have many properties that are well-suited for the treatment of cutaneous wounds including wound coverage, functionalization with bioactive molecules, localized growth factor release and activation of wound repair.	[Garlick, Jonathan A.; Egles, Christophe] Tufts Univ, Dept Biomed Engn, Medford, MA USA; [Schneider, Aurore] MIT, Ctr Biomed Engn, Cambridge, MA USA; [Schneider, Aurore; Garlick, Jonathan A.] Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Div Canc Biol & Tissue Engn, Boston, MA 02111 USA	Tufts University; Massachusetts Institute of Technology (MIT); Tufts University	Egles, C (corresponding author), Tufts Univ, Sch Dent Med, Dept Oral & Maxillofacial Pathol, Div Canc Biol & Tissue Engn, Boston, MA 02111 USA.	Christophe.egles@tufts.edu	Taylor, Graham/A-4027-2012	EGLES, Christophe/0000-0003-0982-7752	Center for Integrated Tissue Engineering at School of Dental Medicine at Tufts University; NIH/NIBIB; Fondation pour la Recherche Medicale	Center for Integrated Tissue Engineering at School of Dental Medicine at Tufts University; NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was supported by the Center for Integrated Tissue Engineering at School of Dental Medicine at Tufts University and NIH/NIBIB funds via the P41 Tissue Engineering Resource Center. AS is indebted to the Fondation pour la Recherche Medicale for financial support.	BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BROWN C, 1991, J INVEST DERMATOL, V96, P724, DOI 10.1111/1523-1747.ep12470960; BUCKLEY A, 1985, P NATL ACAD SCI USA, V82, P7340, DOI 10.1073/pnas.82.21.7340; BUCKLEY A, 1987, J SURG RES, V43, P322, DOI 10.1016/0022-4804(87)90088-6; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; FRANKLIN JD, 1979, PLAST RECONSTR SURG, V64, P766, DOI 10.1097/00006534-197912000-00003; Garlick JA, 1996, J DENT RES, V75, P912, DOI 10.1177/00220345960750030801; GARLICK JA, 1994, LAB INVEST, V70, P916; GARLICK JA, 1994, J INVEST DERMATOL, V103, P554, DOI 10.1111/1523-1747.ep12396847; Garlick Jonathan A., 1992, Journal of Dermatology (Tokyo), V19, P797; Garlick JA, 2007, ADV BIOCHEM ENG BIOT, V103, P207; Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033; Gottrup F, 2000, WOUND REPAIR REGEN, V8, P83, DOI 10.1046/j.1524-475x.2000.00083.x; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; Kurten RC, 2005, AM J PHYSIOL-CELL PH, V288, pC109, DOI 10.1152/ajpcell.00024.2003; LAATO M, 1986, ANN SURG, V203, P379; Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MATSUI C, 1995, J INVEST DERMATOL, V105, P648, DOI 10.1111/1523-1747.ep12324108; Mustoe T, 2004, AM J SURG, V187, p65S, DOI 10.1016/S0002-9610(03)00306-4; Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031; Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747; NOGUCHI S, 1991, AM J PHYSIOL, V260, pE620, DOI 10.1152/ajpendo.1991.260.4.E620; OKEEFE E, 1982, J INVEST DERMATOL, V78, P482, DOI 10.1111/1523-1747.ep12510246; ONO I, 1995, J DERMATOL SCI, V10, P241, DOI 10.1016/0923-1811(95)00454-Z; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Rovee D.T., 1972, EPIDERMAL WOUND HEAL, P71; ROVEE DT, 2003, EPIDERMIS WOUND HEAL; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SARRET Y, 1992, J INVEST DERMATOL, V98, P12, DOI 10.1111/1523-1747.ep12493517; SARRET Y, 1992, J INVEST DERMATOL, V99, P656, DOI 10.1111/1523-1747.ep12668151; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tamariz-Dominguez E, 2002, CELL TISSUE RES, V307, P79, DOI 10.1007/s004410100450; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; WOODLEY DT, 1988, J CELL PHYSIOL, V136, P140, DOI 10.1002/jcp.1041360118; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5	44	165	171	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1410	10.1371/journal.pone.0001410	http://dx.doi.org/10.1371/journal.pone.0001410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183291	Green Published, gold			2022-12-27	WOS:000260469400007
J	Tisserant, A; Konig, H				Tisserant, Anne; Koenig, Harald			Signal-Regulated Pre-mRNA Occupancy by the General Splicing Factor U2AF	PLOS ONE			English	Article							MAP-KINASE; TRANSDUCTION	Alternative splicing of transcripts in a signal-dependent manner has emerged as an important concept to ensure appropriate expression of splice variants under different conditions. Binding of the general splicing factor U2AF to splice sites preceding alternatively spliced exons has been suggested to be an important step for splice site recognition. For splicing to proceed, U2AF has to be replaced by other factors. We show here that U2AF interacts with the signal-dependent splice regulator Sam68 and that forced expression of Sam68 results in enhanced binding of the U2AF65 subunit to an alternatively spliced pre-mRNA sequence in vivo. Conversely, the rapid signal-induced and phosphorylation-dependent interference with Sam68 binding to RNA was accompanied by reduced pre-mRNA occupancy of U2AF in vivo. Our data suggest that Sam68 can affect splice site occupancy by U2AF in signal-dependent splicing. We propose that the induced release of U2AF from pre-mRNA provides a regulatory step to control alternative splicing.	[Tisserant, Anne; Koenig, Harald] Forschungszentrum Karlsruhe, Inst Genet & Toxikol, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Konig, H (corresponding author), Forschungszentrum Karlsruhe, Inst Genet & Toxikol, Karlsruhe, Germany.	harald.koenig@itg.fzk.de		Konig, Harald/0000-0002-0117-0939	Deutsche Forschungsgemeinschaft [KO2046]; Forschungszentrum Karlsruhe GmbH [PhD student scholarship]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum Karlsruhe GmbH	The work was funded by a Research grant from the Deutsche Forschungsgemeinschaft (DFG), grant# KO2046. Anne Tisserant was supported by a PhD student scholarship from the Forschungszentrum Karlsruhe GmbH.	Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chiara MD, 1997, EMBO J, V16, P4746, DOI 10.1093/emboj/16.15.4746; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; MULLEN MP, 1991, GENE DEV, V5, P642, DOI 10.1101/gad.5.4.642; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; ZAHALKA MA, 1995, J IMMUNOL, V154, P5345; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	28	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1418	10.1371/journal.pone.0001418	http://dx.doi.org/10.1371/journal.pone.0001418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183298	gold, Green Submitted, Green Published			2022-12-27	WOS:000260469400014
J	Mao, T; O'Connor, DH; Scheuss, V; Nakai, J; Svoboda, K				Mao, Tianyi; O'Connor, Daniel H.; Scheuss, Volker; Nakai, Junichi; Svoboda, Karel			Characterization and Subcellular Targeting of GCaMP-Type Genetically-Encoded Calcium Indicators	PLOS ONE			English	Article								Genetically-encoded calcium indicators (GECIs) hold the promise of monitoring [Ca2+] in selected populations of neurons and in specific cellular compartments. Relating GECI fluorescence to neuronal activity requires quantitative characterization. We have characterized a promising new genetically-encoded calcium indicator-GCaMP2- in mammalian pyramidal neurons. Fluorescence changes in response to single action potentials (17 +/- 10% Delta F/F [mean +/- SD]) could be detected in some, but not all, neurons. Trains of high-frequency action potentials yielded robust responses (302 +/- 50% for trains of 40 action potentials at 83 Hz). Responses were similar in acute brain slices from in utero electroporated mice, indicating that long-term expression did not interfere with GCaMP2 function. Membrane-targeted versions of GCaMP2 did not yield larger signals than their non-targeted counterparts. We further targeted GCaMP2 to dendritic spines to monitor Ca2+ accumulations evoked by activation of synaptic NMDA receptors. We observed robust DF/F responses (range: 37%-264%) to single spine uncaging stimuli that were correlated with NMDA receptor currents measured through a somatic patch pipette. One major drawback of GCaMP2 was its low baseline fluorescence. Our results show that GCaMP2 is improved from the previous versions of GCaMP and may be suited to detect bursts of high-frequency action potentials and synaptic currents in vivo.	[Mao, Tianyi; O'Connor, Daniel H.; Scheuss, Volker; Svoboda, Karel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mao, Tianyi; O'Connor, Daniel H.; Scheuss, Volker; Svoboda, Karel] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA; [Nakai, Junichi] RIKEN Brain Sci Inst, Lab Memory & Learn, Saitama, Japan	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; RIKEN	Mao, T (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	svobodak@janelia.hhmi.org	Nakai, Junichi/GQZ-6415-2022; Volker, Scheuss/G-7846-2015	Scheuss, Volker/0000-0002-0659-3228; Mao, Tianyi/0000-0002-3532-8319	HHMI; NIH	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHMI, NIH. Funders had no role in the design and conduct, analysis or reporting of the study.	CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Diez-Garcia J, 2007, NEUROIMAGE, V34, P859, DOI 10.1016/j.neuroimage.2006.10.021; Emmanouilidou E, 1999, CURR BIOL, V9, P915, DOI 10.1016/S0960-9822(99)80398-4; GRAY NW, 2006, PLOS BIOL, P4; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lee MY, 2006, P NATL ACAD SCI USA, V103, P13232, DOI 10.1073/pnas.0605757103; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MANK M, 2005, BIOPHYS J; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; PALMER AE, 2006, CHEM BIOL IN PRESS; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; SHANER NC, 2004, NAT BIOTECHNOL; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Yuste R, 1999, J NEUROSCI, V19, P1976; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	52	118	124	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1796	10.1371/journal.pone.0001796	http://dx.doi.org/10.1371/journal.pone.0001796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350138	gold, Green Published, Green Accepted			2022-12-27	WOS:000260762300004
J	Yu, JZ; Poulton, J; Huang, YC; Deng, WM				Yu, Jianzhong; Poulton, John; Huang, Yi-Chun; Deng, Wu-Min			The Hippo Pathway Promotes Notch Signaling in Regulation of Cell Differentiation, Proliferation, and Oocyte Polarity	PLOS ONE			English	Article								Specification of the anterior-posterior axis in Drosophila oocytes requires proper communication between the germ-line cells and the somatically derived follicular epithelial cells. Multiple signaling pathways, including Notch, contribute to oocyte polarity formation by controlling the temporal and spatial pattern of follicle cell differentiation and proliferation. Here we show that the newly identified Hippo tumor-suppressor pathway plays a crucial role in the posterior follicle cells in the regulation of oocyte polarity. Disruption of the Hippo pathway, including major components Hippo, Salvador, and Warts, results in aberrant follicle-cell differentiation and proliferation and dramatic disruption of the oocyte anterior-posterior axis. These phenotypes are related to defective Notch signaling in follicle cells, because misexpression of a constitutively active form of Notch alleviates the oocyte polarity defects. We also find that follicle cells defective in Hippo signaling accumulate the Notch receptor and display defects in endocytosis markers. Our findings suggest that the interaction between Hippo and classic developmental pathways such as Notch is critical to spatial and temporal regulation of differentiation and proliferation and is essential for development of the body axes in Drosophila.	[Yu, Jianzhong; Poulton, John; Huang, Yi-Chun; Deng, Wu-Min] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Yu, JZ (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	wumin@bio.fsu.edu	Yu, Jianzhong/F-6050-2010		American Heart Association [Scientist Development Grant]; National Institutes of Health [R01 GM072562]; FSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072562] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WMD is supported by a Scientist Development Grant from the American Heart Association, Florida/Puerto Rico affiliate; National Institutes of Health Grant R01 GM072562; and the FSU College of Arts and Sciences set-up fund.	Beccari S, 2002, MECH DEVELOP, V111, P115, DOI 10.1016/S0925-4773(01)00615-3; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Deng WM, 1998, INT J DEV BIOL, V42, P541; Deng WM, 2001, DEVELOPMENT, V128, P4737; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P2837; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hariharan IK, 2006, CURR BIOL, V16, pR1037, DOI 10.1016/j.cub.2006.11.012; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; MacDougall N, 2001, DEVELOPMENT, V128, P665; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Morimoto AM, 1996, DEVELOPMENT, V122, P3745; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Poulton JS, 2007, DEV BIOL, V311, P1, DOI 10.1016/j.ydbio.2007.08.030; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rawls AS, 2002, CURR BIOL, V12, P1021, DOI 10.1016/S0960-9822(02)00893-X; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun JJ, 2007, DEV CELL, V12, P431, DOI 10.1016/j.devcel.2007.02.003; Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Twombly V, 1996, DEVELOPMENT, V122, P1555; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xi RW, 2003, DEV CELL, V4, P167, DOI 10.1016/S1534-5807(02)00412-4; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	74	87	92	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1761	10.1371/journal.pone.0001761	http://dx.doi.org/10.1371/journal.pone.0001761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335037	Green Published, Green Submitted, gold			2022-12-27	WOS:000260723000015
J	Lesica, NA; Grothe, B				Lesica, Nicholas A.; Grothe, Benedikt			Efficient Temporal Processing of Naturalistic Sounds	PLOS ONE			English	Article								In this study, we investigate the ability of the mammalian auditory pathway to adapt its strategy for temporal processing under natural stimulus conditions. We derive temporal receptive fields from the responses of neurons in the inferior colliculus to vocalization stimuli with and without additional ambient noise. We find that the onset of ambient noise evokes a change in receptive field dynamics that corresponds to a change from bandpass to lowpass temporal filtering. We show that these changes occur within a few hundred milliseconds of the onset of the noise and are evident across a range of overall stimulus intensities. Using a simple model, we illustrate how these changes in temporal processing exploit differences in the statistical properties of vocalizations and ambient noises to increase the information in the neural response in a manner consistent with the principles of efficient coding.	[Lesica, Nicholas A.; Grothe, Benedikt] Univ Munich, Dept Biol 2, Martinsried, Germany; [Lesica, Nicholas A.; Grothe, Benedikt] Bernstein Ctr Comput Neurosci, Munich, Germany	University of Munich	Lesica, NA (corresponding author), Univ Munich, Dept Biol 2, Martinsried, Germany.	lesica@zi.biologie.uni-muenchen.de	Grothe, Benedikt/A-7877-2010	Lesica, Nicholas/0000-0001-5238-4462; Grothe, Benedikt/0000-0001-7317-0615	Bernstein Center for Computational Neuroscience	Bernstein Center for Computational Neuroscience	NAL and BG were supported by the Bernstein Center for Computational Neuroscience.	ATTIAS H, 1997, ADV NEURAL INFORM PR, V9; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Caspary DM, 2002, HEARING RES, V168, P163, DOI 10.1016/S0378-5955(02)00363-5; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Escabi MA, 2005, J NEUROSCI, V25, P9524, DOI 10.1523/JNEUROSCI.1804-05.2005; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; GROTHE B, 1994, J NEUROPHYSIOL, V71, P706, DOI 10.1152/jn.1994.71.2.706; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; LeBeau FEN, 1996, J NEUROPHYSIOL, V75, P902, DOI 10.1152/jn.1996.75.2.902; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Lesica NA, 2006, NETWORK-COMP NEURAL, V17, P43, DOI 10.1080/09548980500328409; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Pollak GD, 2003, TRENDS NEUROSCI, V26, P33, DOI 10.1016/S0166-2236(02)00009-7; REES A, 1987, HEARING RES, V27, P129, DOI 10.1016/0378-5955(87)90014-1; REES A, 1989, J ACOUST SOC AM, V85, P1978, DOI 10.1121/1.397851; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Siveke I, 2006, J NEUROPHYSIOL, V96, P1425, DOI 10.1152/jn.00713.2005; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; VANHATEREN JH, 1992, BIOL CYBERN, V68, P23, DOI 10.1007/BF00203134; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Willmore B, 2003, NETWORK-COMP NEURAL, V14, P553, DOI 10.1088/0954-898X/14/3/309; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005	37	40	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1655	10.1371/journal.pone.0001655	http://dx.doi.org/10.1371/journal.pone.0001655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301738	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500005
J	Mount, AM; Smith, CM; Kupresanin, F; Stoermer, K; Heath, WR; Belz, GT				Mount, Adele M.; Smith, Christopher M.; Kupresanin, Fiona; Stoermer, Kristina; Heath, William R.; Belz, Gabrielle T.			Multiple Dendritic Cell Populations Activate CD4(+) T Cells after Viral Stimulation	PLOS ONE			English	Article								Dendritic cells (DC) are a heterogeneous cell population that bridge the innate and adaptive immune systems. CD8a DC play a prominent, and sometimes exclusive, role in driving amplification of CD8(+) T cells during a viral infection. Whether this reliance on a single subset of DC also applies for CD4(+) T cell activation is unknown. We used a direct ex vivo antigen presentation assay to probe the capacity of flow cytometrically purified DC populations to drive amplification of CD4(+) and CD8(+) T cells following infection with influenza virus by different routes. This study examined the contributions of non-CD8 alpha DC populations in the amplification of CD8(+) and CD4(+) T cells in cutaneous and systemic influenza viral infections. We confirmed that in vivo, effective immune responses for CD8(+) T cells are dominated by presentation of antigen by CD8a DC but can involve non-CD8a DC. In contrast, CD4(+) T cell responses relied more heavily on the contributions of dermal DC migrating from peripheral lymphoid tissues following cutaneous infection, and CD4 DC in the spleen after systemic infection. CD4(+) T cell priming by DC subsets that is dependent upon the route of administration raises the possibility that vaccination approaches could be tailored to prime helper T cell immunity.	[Mount, Adele M.; Smith, Christopher M.; Kupresanin, Fiona; Stoermer, Kristina; Heath, William R.; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Mount, AM (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	belz@wehi.edu.au	Belz, Gabrielle T/C-9350-2013	Belz, Gabrielle T/0000-0002-9660-9587; Heath, William/0000-0001-9670-259X	National Health and Medical Research Council of Australia; University of Melbourne Research Scholarship; NHMRC CJ Martin Fellowship; Wellcome Trust Senior Overseas Fellowship; Viertel Fellowship; Howard Hughes Medical Institute International Fellowships	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Research Scholarship(University of Melbourne); NHMRC CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Senior Overseas Fellowship(Wellcome Trust); Viertel Fellowship; Howard Hughes Medical Institute International Fellowships	This work was funded by the National Health and Medical Research Council of Australia, a University of Melbourne Research Scholarship (A.M.M. and C.M.S.) and an NHMRC CJ Martin Fellowship (C.M.S), a Wellcome Trust Senior Overseas Fellowship (G.T.B.), Viertel Fellowship (G.T.B.) and Howard Hughes Medical Institute International Fellowships (G.T.B. and W.R. H)	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kerksiek KM, 2005, BLOOD, V105, P742, DOI 10.1182/blood-2004-05-1891; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; Morgan DJ, 1996, J IMMUNOL, V157, P978; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Perry JA, 2004, J IMMUNOL, V172, P475, DOI 10.4049/jimmunol.172.1.475; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898; Veeraswamy RK, 2003, J IMMUNOL, V170, P5367, DOI 10.4049/jimmunol.170.11.5367; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	37	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1691	10.1371/journal.pone.0001691	http://dx.doi.org/10.1371/journal.pone.0001691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301768	Green Published, gold			2022-12-27	WOS:000260586500035
J	Spurgeon, SL; Jones, RC; Ramakrishnan, R				Spurgeon, Sandra L.; Jones, Robert C.; Ramakrishnan, Ramesh			High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array	PLOS ONE			English	Article							IN-VITRO; MYOD; EVOLUTION; MYOSTATIN; FAMILY; GROWTH	We describe a high throughput gene expression platform based on microfluidic dynamic arrays. This system allows 2,304 simultaneous real time PCR gene expression measurements in a single chip, while requiring less pipetting than is required to set up a 96 well plate. We show that one can measure the expression of 45 different genes in 18 tissues with replicates in a single chip. The data have excellent concordance with conventional real time PCR and the microfluidic dynamic arrays show better reproducibility than commercial DNA microarrays.	[Spurgeon, Sandra L.; Jones, Robert C.; Ramakrishnan, Ramesh] Fluidigm Corp, San Francisco, CA USA		Spurgeon, SL (corresponding author), Fluidigm Corp, San Francisco, CA USA.	ramesh.ramakrishnan@fluidigm.com	Baird, Cheryl L/F-6569-2011					Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson MJ, 2007, BIOCHEMISTRY-US, V46, P5722, DOI 10.1021/bi700096p; [Anonymous], 2006, NAT BIOTECHNOL, V24, P1039; *ANSI SBS, 22004 ANSISBS; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Delgado I, 2003, GENOMICS, V82, P109, DOI 10.1016/S0888-7543(03)00104-6; DIAS P, 1990, AM J PATHOL, V137, P1283; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; LIANG P, 2007, NAT BIOTECHNOL, V24, P1151; Liang P, 2007, NAT BIOTECHNOL, V25, P27, DOI 10.1038/nbt0107-27; Liu J, 2003, ANAL CHEM, V75, P4718, DOI 10.1021/ac0346407; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Saunders MA, 2006, AM J HUM GENET, V79, P1089, DOI 10.1086/509707; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14; *TAQMAN PREAMQ MAS, APPL BIOSYSTEMS; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warren LA, 2007, DIGITAL ARRAY RESPON; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Zhao P, 2003, CR BIOL, V326, P1049, DOI 10.1016/j.crvi.2003.09.035	32	298	335	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1662	10.1371/journal.pone.0001662	http://dx.doi.org/10.1371/journal.pone.0001662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301740	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500007
J	Steiner, T; Hess, P; Bae, JH; Wiltschi, B; Moroder, L; Budisa, N				Steiner, Thomas; Hess, Petra; Bae, Jae Hyun; Wiltschi, Birgit; Moroder, Luis; Budisa, Nediljko			Synthetic Biology of Proteins: Tuning GFPs Folding and Stability with Fluoroproline	PLOS ONE			English	Article							PROLYL CIS/TRANS-ISOMERASES; CIS-TRANS ISOMERIZATION; PROLINE RESIDUES; FLUORESCENT; CONFORMATIONS; MUTATIONS; EVOLUTION; CATALYSIS; VARIANTS	Background: Proline residues affect protein folding and stability via cis/trans isomerization of peptide bonds and by the C-gamma-exo or -endo puckering of their pyrrolidine rings. Peptide bond conformation as well as puckering propensity can be manipulated by proper choice of ring substituents, e. g. C-gamma-fluorination. Synthetic chemistry has routinely exploited ring-substituted proline analogs in order to change, modulate or control folding and stability of peptides. Methodology/Principal Findings: In order to transmit this synthetic strategy to complex proteins, the ten proline residues of enhanced green fluorescent protein (EGFP) were globally replaced by (4R)- and (4S)-fluoroprolines (FPro). By this approach, we expected to affect the cis/trans peptidyl-proline bond isomerization and pyrrolidine ring puckering, which are responsible for the slow folding of this protein. Expression of both protein variants occurred at levels comparable to the parent protein, but the (4R)-FPro-EGFP resulted in irreversibly unfolded inclusion bodies, whereas the (4S)-FPro-EGFP led to a soluble fluorescent protein. Upon thermal denaturation, refolding of this variant occurs at significantly higher rates than the parent EGFP. Comparative inspection of the X-ray structures of EGFP and (4S)-FPro-EGFP allowed to correlate the significantly improved refolding with the C-gamma-endo puckering of the pyrrolidine rings, which is favored by 4S-fluorination, and to lesser extents with the cis/trans isomerization of the prolines. Conclusions/Significance: We discovered that the folding rates and stability of GFP are affected to a lesser extent by cis/trans isomerization of the proline bonds than by the puckering of pyrrolidine rings. In the C-gamma-endo conformation the fluorine atoms are positioned in the structural context of the GFP such that a network of favorable local interactions is established. From these results the combined use of synthetic amino acids along with detailed structural knowledge and existing protein engineering methods can be envisioned as a promising strategy for the design of complex tailor-made proteins and even cellular structures of superior properties compared to the native forms.	[Steiner, Thomas; Hess, Petra; Bae, Jae Hyun; Wiltschi, Birgit; Moroder, Luis; Budisa, Nediljko] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Steiner, T (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	budisa@biochem.mpg.de	Budisa, Nediljko/AAG-7291-2019; Budisa, Nediljko/AAA-4634-2022; Budisa, Nediljko/T-4812-2017	Budisa, Nediljko/0000-0001-8437-7304; Budisa, Nediljko/0000-0001-8437-7304; Moroder, Luis/0000-0001-9570-5713; Wiltschi, Birgit/0000-0001-5230-0951	BioFuture Program of the Federal Ministry of Education and Research of Germany; Munich Center for Integrated Protein Science (CIPSM)	BioFuture Program of the Federal Ministry of Education and Research of Germany; Munich Center for Integrated Protein Science (CIPSM)	This work was supported by the BioFuture Program of the Federal Ministry of Education and Research of Germany and by the Munich Center for Integrated Protein Science (CIPSM).	Battistutta R, 2000, PROTEINS, V41, P429, DOI 10.1002/1097-0134(20001201)41:4<429::AID-PROT10>3.0.CO;2-D; Boulegue C, 2006, J MOL BIOL, V358, P846, DOI 10.1016/j.jmb.2006.02.031; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budisa N, 2004, BIOL CHEM, V385, P191, DOI 10.1515/BC.2004.038; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Connor RE, 2007, POLYM REV, V47, P9, DOI 10.1080/15583720601109552; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Dunitz JD, 2004, CHEMBIOCHEM, V5, P614, DOI 10.1002/cbic.200300801; Eberhardt ES, 1996, J AM CHEM SOC, V118, P12261, DOI 10.1021/ja9623119; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Eyles SJ, 2000, J MOL BIOL, V301, P737, DOI 10.1006/jmbi.2000.4002; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Fischer G, 2000, CHEM SOC REV, V29, P119, DOI 10.1039/a803742f; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; Golbik R, 2005, BIOCHEMISTRY-US, V44, P16026, DOI 10.1021/bi051442w; Golbik R, 1999, PROTEIN SCI, V8, P1505, DOI 10.1110/ps.8.7.1505; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mayer Marcus, 2004, Methods Mol Med, V94, P239; MILNERWHITE EJ, 1992, J MOL BIOL, V228, P725, DOI 10.1016/0022-2836(92)90859-I; Minks C, 1999, BIOCHEMISTRY-US, V38, P10649, DOI 10.1021/bi990580g; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Palm GJ, 1999, METHOD ENZYMOL, V302, P378, DOI 10.1016/S0076-6879(99)02034-0; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Renner C, 2001, ANGEW CHEM INT EDIT, V40, P923, DOI 10.1002/1521-3773(20010302)40:5<923::AID-ANIE923>3.0.CO;2-#; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Wiltschi B, 2007, APPL MICROBIOL BIOT, V74, P739, DOI 10.1007/s00253-006-0823-6; WUTHRICH K, 1974, FEBS LETT, V43, P337, DOI 10.1016/0014-5793(74)80674-5; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Yoo TH, 2007, P NATL ACAD SCI USA, V104, P13887, DOI 10.1073/pnas.0701904104	38	78	81	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1680	10.1371/journal.pone.0001680	http://dx.doi.org/10.1371/journal.pone.0001680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301757	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500024
J	Muleris, M; Chalastanis, A; Meyer, N; Lae, M; Dutrillaux, B; Sastre-Garau, X; Hamelin, R; Flejou, JF; Duval, A				Muleris, Martine; Chalastanis, Alexandra; Meyer, Nicolas; Lae, Marick; Dutrillaux, Bernard; Sastre-Garau, Xavier; Hamelin, Richard; Flejou, Jean-Francois; Duval, Alex			Chromosomal Instability in Near-Diploid Colorectal Cancer: A Link between Numbers and Structure	PLOS ONE			English	Article								Chromosomal instability (CIN) plays a crucial role in tumor development and occurs mainly as the consequence of either missegregation of normal chromosomes (MSG) or structural rearrangement (SR). However, little is known about the respective chromosomal targets of MSG and SR and the way these processes combined within tumors to generate CIN. To address these questions, we karyotyped a consecutive series of 96 near-diploid colorectal cancers (CRCs) and distinguished chromosomal changes generated by either MSG or SR in tumor cells. Eighty-three tumors (86%) presented with chromosomal abnormalities that contained both MSGs and SRs to varying degrees whereas all 13 others (14%) showed normal karyotype. Using a maximum likelihood statistical method, chromosomes affected by MSG or SR and likely to represent changes that are selected for during tumor progression were found to be different and mostly mutually exclusive. MSGs and SRs were not randomly associated within tumors, delineating two major pathways of chromosome alterations that consisted of either chromosome gains by MSG or chromosomal losses by both MSG and SR. CRCs showing microsatellite instability (MSI) presented with either normal karyotype or chromosome gains whereas MSS (microsatellite stable) CRCs exhibited a combination of the two pathways. Taken together, these data provide new insights into the respective involvement of MSG and SR in near-diploid colorectal cancers, showing how these processes target distinct portions of the genome and result in specific patterns of chromosomal changes according to MSI status.	[Muleris, Martine; Chalastanis, Alexandra; Hamelin, Richard; Flejou, Jean-Francois; Duval, Alex] CDR St Antoine, UMRS 762, INSERM, F-75012 Paris, France; [Muleris, Martine; Chalastanis, Alexandra; Hamelin, Richard; Flejou, Jean-Francois; Duval, Alex] UPMC Univ Paris 06, CDR, UMRS 762, Paris, France; [Meyer, Nicolas] Fac Med, Lab biostat informat med, Strasbourg, France; [Meyer, Nicolas] CHU, Dept Sante Publ, Strasbourg, France; [Lae, Marick; Sastre-Garau, Xavier] Inst Curie, Dept Biol Tumeurs, Serv Pathol, Paris, France; [Dutrillaux, Bernard] Museum Natl dHistoire Naturelle, OSEB, UMR 5202, Paris, France; [Flejou, Jean-Francois] Hop Saint Antoine, Serv dAnatom Pathol, F-75012 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Museum National d'Histoire Naturelle (MNHN); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Muleris, M (corresponding author), CDR St Antoine, UMRS 762, INSERM, F-75012 Paris, France.	martine.muleris@cephb.fr		Sastre-Garau, Xavier/0000-0001-5992-2083	Association pour la Recherche contre le Cancer [3946]; GEFLUC; le Ministere Francais de la Recherche (MRT) [fellowship]	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); GEFLUC; le Ministere Francais de la Recherche (MRT)	This work was partly supported by grants from the Association pour la Recherche contre le Cancer (ARC n 3946) and GEFLUC (groupement des entreprises francaises dans la lutte contre le cancer). AC was recipient of a fellowship from le Ministere Francais de la Recherche (MRT).	BAUER KD, 1993, CYTOMETRY, V14, P486, DOI 10.1002/cyto.990140506; Boardman LA, 2007, CLIN CANCER RES, V13, P2323, DOI 10.1158/1078-0432.CCR-06-2739; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Chan TL, 2001, ONCOGENE, V20, P4871, DOI 10.1038/sj.onc.1204653; Chang SC, 2005, WORLD J GASTROENTERO, V11, P778, DOI 10.3748/wjg.v11.i6.778; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Duval A, 2002, CANCER RES, V62, P1609; Duval A, 2002, CANCER RES, V62, P2447; Georgiades IB, 1999, ONCOGENE, V18, P7933, DOI 10.1038/sj.onc.1203368; Goel A, 2003, CANCER RES, V63, P1608; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Hoglund M, 2002, CANCER RES, V62, P5939; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Jourdan F, 2003, VIRCHOWS ARCH, V443, P115, DOI 10.1007/s00428-003-0833-z; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; MULERIS M, 1988, CANCER GENET CYTOGEN, V32, P43, DOI 10.1016/0165-4608(88)90310-X; MULERIS M, 1990, CANCER GENET CYTOGEN, V46, P143, DOI 10.1016/0165-4608(90)90100-O; MULERIS M, 1990, CANCER GENET CYTOGEN, V44, P107, DOI 10.1016/0165-4608(90)90203-M; REMVIKOS Y, 1995, GENE CHROMOSOME CANC, V12, P272, DOI 10.1002/gcc.2870120406; SCHAFFER LG, 2005, INT SYSTEM HUMAN CYT; Sugai T, 2000, INT J CANCER, V88, P614, DOI 10.1002/1097-0215(20001115)88:4<614::AID-IJC15>3.3.CO;2-S; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Yao J, 1999, INT J CANCER, V80, P667, DOI 10.1002/(SICI)1097-0215(19990301)80:5<667::AID-IJC6>3.0.CO;2-0	29	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1632	10.1371/journal.pone.0001632	http://dx.doi.org/10.1371/journal.pone.0001632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286189	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400025
J	Ohkuni, K; Abdulle, R; Tong, AHY; Boone, C; Kitagawa, K				Ohkuni, Kentaro; Abdulle, Rashid; Tong, Amy Hin Yan; Boone, Charles; Kitagawa, Katsumi			Ybp2 Associates with the Central Kinetochore of Saccharomyces cerevisiae and Mediates Proper Mitotic Progression	PLOS ONE			English	Article								The spindle checkpoint ensures the accurate segregation of chromosomes by monitoring the status of kinetochore attachment to microtubules. Simultaneous mutations in one of several kinetochore and cohesion genes and a spindle checkpoint gene cause a synthetic-lethal or synthetic-sick phenotype. A synthetic genetic array (SGA) analysis using a mad2 Delta query mutant strain of yeast identified YBP2, a gene whose product shares sequence similarity with the product of YBP1, which is required for H2O2-induced oxidation of the transcription factor Yap1. ybp2 Delta was sensitive to benomyl and accumulated at the mitotic stage of the cell cycle. Ybp2 physically associates with proteins of the COMA complex (Ctf19, Okp1, Mcm21, and Ame1) and 3 components of the Ndc80 complex (Ndc80, Nuf2, and Spc25 but not Spc24) in the central kinetochore and with Cse4 (the centromeric histone and CENP-A homolog). Chromatin-immunoprecipitation analyses revealed that Ybp2 associates specifically with CEN DNA. Furthermore, ybp2 Delta showed synthetic-sick interactions with mutants of the genes that encode the COMA complex components. Ybp2 seems to be part of a macromolecular kinetochore complex and appears to contribute to the proper associations among the central kinetochore subcomplexes and the kinetochore-specific nucleosome.	[Ohkuni, Kentaro; Abdulle, Rashid; Kitagawa, Katsumi] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; [Tong, Amy Hin Yan; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Tong, Amy Hin Yan; Boone, Charles] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada	St Jude Children's Research Hospital; University of Toronto; University of Toronto	Ohkuni, K (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, 332 N Lauderdale St, Memphis, TN 38105 USA.	katsumi.kitagawa@stjude.org			National Cancer Institute [CA21765]; NIH [GM68418]; American Lebanese Syrian Association Charities (ALSAC); Canadian Institutes of Health Research (CIHR); Genome Canada; Genome Ontario; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068418] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Association Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Genome Ontario; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KK was supported by the Cancer Center Support Grant CA21765 from the National Cancer Institute, the NIH grant GM68418, and the American Lebanese Syrian Association Charities (ALSAC). CB was supported by grants from the Canadian Institutes of Health Research (CIHR) and Genome Canada and Genome Ontario.	Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Daniel JA, 2006, GENETICS, V172, P53, DOI 10.1534/genetics.105.046441; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gulshan K, 2004, EUKARYOT CELL, V3, P318, DOI 10.1128/EC.3.2.318-330.2004; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kitagawa K, 2003, MOL CELL, V11, P1201, DOI 10.1016/S1097-2765(03)00145-X; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; KOSHLAND D, 1987, METHOD ENZYMOL, V155, P351; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Kroll ES, 1996, GENETICS, V143, P95; Lee MS, 2004, P NATL ACAD SCI USA, V101, P10655, DOI 10.1073/pnas.0404102101; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Measday V, 2004, NAT CELL BIOL, V6, P94, DOI 10.1038/ncb0204-94; Measday V, 2002, METHOD ENZYMOL, V350, P316, DOI 10.1016/S0076-6879(02)50971-X; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Montpetit B, 2005, GENETICS, V171, P489, DOI 10.1534/genetics.105.045799; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pot I, 2005, CELL CYCLE, V4, P1448, DOI 10.4161/cc.4.10.2106; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; Rose MD., 1990, METHODS YEAST GENETI; Sharp JA, 2003, CURR TOP MICROBIOL, V274, P23; SIKORSKI RS, 1989, GENETICS, V122, P19; SPENCER F, 1990, GENETICS, V124, P237; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607	54	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1617	10.1371/journal.pone.0001617	http://dx.doi.org/10.1371/journal.pone.0001617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286174	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400010
J	Vicente-Crespo, M; Pascual, M; Fernandez-Costa, JM; Garcia-Lopez, A; Monferrer, L; Miranda, ME; Zhou, L; Artero, RD				Vicente-Crespo, Marta; Pascual, Maya; Fernandez-Costa, Juan M.; Garcia-Lopez, Amparo; Monferrer, Lidon; Miranda, M. Eugenia; Zhou, Lei; Artero, Ruben D.			Drosophila Muscleblind Is Involved in troponin T Alternative Splicing and Apoptosis	PLOS ONE			English	Article							TRANSLATIONAL REPRESSOR BRUNO; MYOTONIC-DYSTROPHY TYPE-1; NUCLEAR FOCI; REPEAT TRANSCRIPTS; GENE-EXPRESSION; PRONEURAL GENE; RNA; PROTEINS; FAMILY; MODEL	Background: Muscleblind-like proteins (MBNL) have been involved in a developmental switch in the use of defined cassette exons. Such transition fails in the CTG repeat expansion disease myotonic dystrophy due, in part, to sequestration of MBNL proteins by CUG repeat RNA. Four protein isoforms (MblA-D) are coded by the unique Drosophila muscleblind gene. Methodology/Principal Findings: We used evolutionary, genetic and cell culture approaches to study muscleblind (mbl) function in flies. The evolutionary study showed that the MblC protein isoform was readily conserved from nematods to Drosophila, which suggests that it performs the most ancestral muscleblind functions. Overexpression of MblC in the fly eye precursors led to an externally rough eye morphology. This phenotype was used in a genetic screen to identify five dominant suppressors and 13 dominant enhancers including Drosophila CUG-BP1 homolog aret, exon junction complex components tsunagi and Aly, and pro-apoptotic genes Traf1 and reaper. We further investigated Muscleblind implication in apoptosis and splicing regulation. We found missplicing of troponin T in muscleblind mutant pupae and confirmed Muscleblind ability to regulate mouse fast skeletal muscle Troponin T (TnnT3) minigene splicing in human HEK cells. MblC overexpression in the wing imaginal disc activated apoptosis in a spatially restricted manner. Bioinformatics analysis identified a conserved FKRP motif, weakly resembling a sumoylation target site, in the MblC-specific sequence. Site-directed mutagenesis of the motif revealed no change in activity of mutant MblC on TnnT3 minigene splicing or aberrant binding to CUG repeat RNA, but altered the ability of the protein to form perinuclear aggregates and enhanced cell death-inducing activity of MblC overexpression. Conclusions/Significance: Taken together our genetic approach identify cellular processes influenced by Muscleblind function, whereas in vivo and cell culture experiments define Drosophila troponin T as a new Muscleblind target, reveal a potential involvement of MblC in programmed cell death and recognize the FKRP motif as a putative regulator of MblC function and/or subcellular location in the cell.	[Vicente-Crespo, Marta; Pascual, Maya; Fernandez-Costa, Juan M.; Garcia-Lopez, Amparo; Monferrer, Lidon; Miranda, M. Eugenia; Artero, Ruben D.] Univ Valencia, Dept Genet, Valencia, Spain; [Zhou, Lei] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL USA	University of Valencia; State University System of Florida; University of Florida	Vicente-Crespo, M (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	ruben.artero@uv.es	Fernandez-Costa, Juan M/Q-1670-2015; Artero, Ruben/K-6815-2014; MONFERRER, LIDÓN/H-8107-2015; Vicente-Crespo, Marta/AAT-8644-2020	Fernandez-Costa, Juan M/0000-0002-1854-6082; Artero, Ruben/0000-0003-1596-047X; MONFERRER, LIDÓN/0000-0001-8117-6814; Vicente-Crespo, Marta/0000-0002-8381-6747	Generalitat Valenciana [GV04B164, predoctoral fellowship]; Ministerio de Educacion y Ciencia (MEC) [SAF2003-03536, SAF2006-09121, FPU fellowships]; Muscular Dystrophy Association (USA) [3315]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Muscular Dystrophy Association (USA)(Muscular Dystrophy Association)	Work supported by grants GV04B164 from the Generalitat Valenciana, SAF2003-03536 and SAF2006-09121 from the Ministerio de Educacion y Ciencia (MEC), and 3315 from the Muscular Dystrophy Association (USA). M.V.C. and A.G.L were supported by FPU fellowships from the MEC and J.M.F.C. by a predoctoral fellowship from the Generalitat Valenciana.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Begemann G, 1997, DEVELOPMENT, V124, P4321; Benoist P, 1998, J BIOL CHEM, V273, P7538, DOI 10.1074/jbc.273.13.7538; Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; BRAND AH, 1993, DEVELOPMENT, V118, P401; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chaudhuri T, 2005, J MOL BIOL, V352, P58, DOI 10.1016/j.jmb.2005.06.066; Cheah PY, 2000, DEVELOPMENT, V127, P3325; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Dean B, 2007, AUST NZ J PSYCHIAT, V41, P308, DOI 10.1080/00048670701213245; Delaunay J, 2004, NUCLEIC ACIDS RES, V32, P3070, DOI 10.1093/nar/gkh627; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Edgar AJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-1; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Garcia-Casado Z, 2002, GENESIS, V34, P111, DOI 10.1002/gene.10147; GARCIALOPEZ LMA, PLOS ONE IN PRESS; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Grimaldi D.A., 1990, B AM MUSEUM NATURAL; Hay BA, 2004, NAT REV GENET, V5, P911, DOI 10.1038/nrg1491; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; KANIA A, 1995, GENETICS, V139, P1663; Kim HJ, 2007, CELL DEATH DIFFER, V14, P103, DOI 10.1038/sj.cdd.4401935; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; LEE KS, 2007, DIFFERENTIATION; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Machuca-Tzili L, 2006, HUM GENET, V120, P487, DOI 10.1007/s00439-006-0228-8; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Monferrer L, 2006, J HERED, V97, P67, DOI 10.1093/jhered/esj003; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Ran RQ, 2004, CELL STRESS CHAPERON, V9, P229, DOI 10.1379/CSC-19R.1; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shulman JM, 2003, GENETICS, V165, P1233; Squillace RM, 2002, DEV BIOL, V250, P218, DOI 10.1006/dbio.2002.0798; Strodicke M, 2000, MECH DEVELOP, V96, P67, DOI 10.1016/S0925-4773(00)00371-3; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Toba G, 1999, GENETICS, V151, P725; Vicente M, 2007, DIFFERENTIATION, V75, P427, DOI 10.1111/j.1432-0436.2006.00156.x; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yan N, 2004, GENETICS, V168, P1433, DOI 10.1534/genetics.104.033985; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhou L, 2005, EMBO REP, V6, P769, DOI 10.1038/sj.embor.7400473	65	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1613	10.1371/journal.pone.0001613	http://dx.doi.org/10.1371/journal.pone.0001613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286170	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400006
J	Wang, YZ; Wei, JH; Bisel, B; Tang, DM; Seemann, JC				Wang, Yanzhuang; Wei, Jen-Hsuan; Bisel, Blaine; Tang, Danming; Seemann, Joachim			Golgi Cisternal Unstacking Stimulates COPI Vesicle Budding and Protein Transport	PLOS ONE			English	Article								The Golgi apparatus in mammalian cells is composed of flattened cisternae that are densely packed to form stacks. We have used the Golgi stacking protein GRASP65 as a tool to modify the stacking state of Golgi cisternae. We established an assay to measure protein transport to the cell surface in post-mitotic cells in which the Golgi was unstacked. Cells with an unstacked Golgi showed a higher transport rate compared to cells with stacked Golgi membranes. Vesicle budding from unstacked cisternae in vitro was significantly increased compared to stacked membranes. These results suggest that Golgi cisternal stacking can directly regulate vesicle formation and thus the rate of protein transport through the Golgi. The results further suggest that at the onset of mitosis, unstacking of cisternae allows extensive and rapid vesiculation of the Golgi in preparation for its subsequent partitioning.	[Wang, Yanzhuang; Tang, Danming] Univ Michigan, Dept Mol, Cell & Developmental Biol, Ann Arbor, MI USA; [Wei, Jen-Hsuan; Bisel, Blaine; Seemann, Joachim] Univ Texas SW Med Ctr, Dept Cell Biol, Dallas, TX USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, YZ (corresponding author), Univ Michigan, Dept Mol, Cell & Developmental Biol, Ann Arbor, MI USA.	joachim.seemann@utsouthwestern.edu	Wang, Yanzhuang/AAE-5299-2019; Wei, Jen-Hsuan/AAG-2920-2021	Wang, Yanzhuang/0000-0002-1864-7094; Wei, Jen-Hsuan/0000-0001-8958-6455	Pardee Cancer Research Foundation; Virginia Murchison Lithicum Scholar in Medical Research	Pardee Cancer Research Foundation; Virginia Murchison Lithicum Scholar in Medical Research	Y.W. is supported by the Pardee Cancer Research Foundation. J.S. is a Virginia Murchison Lithicum Scholar in Medical Research.	Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; LIN CY, 2000, P NATL ACAD SCI US; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lowe M, 2007, NAT REV MOL CELL BIO, V8, P429, DOI 10.1038/nrm2179; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Martinez-Menarguez JA, 2001, J CELL BIOL, V155, P1213, DOI 10.1083/jcb.200108029; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mironov AA, 2005, BBA-MOL CELL RES, V1744, P340, DOI 10.1016/j.bbamcr.2005.03.005; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rabouille C, 2003, MOL MEMBR BIOL, V20, P117, DOI 10.1080/0968768031000084163; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; TANG D, 2007, J BIOL CHEM; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Xiang Y, 2007, J BIOL CHEM, V282, P21829, DOI 10.1074/jbc.M611716200; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	38	53	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1647	10.1371/journal.pone.0001647	http://dx.doi.org/10.1371/journal.pone.0001647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18297130	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400040
J	Briedis, KM; Starr, A; Bourne, PE				Briedis, Kristine M.; Starr, Ayelet; Bourne, Philip E.			Analysis of the Human Kinome Using Methods Including Fold Recognition Reveals Two Novel Kinases	PLOS ONE			English	Article							CHOLINE PHOSPHOLIPID-METABOLISM; SEQUENCE; PROTEINS; CLASSIFICATION; RESOURCE; HOMOLOGY; DATABASE	Background: Protein sequence similarity is a commonly used criterion for inferring the unknown function of a protein from a protein of known function. However, proteins can diverge significantly over time such that sequence similarity is difficult, if not impossible, to find. In some cases, a structural similarity remains over long evolutionary time scales and once detected can be used to predict function. Methodology/Principal Findings: Here we employed a high-throughput approach to assign structural and functional annotation to the human proteome, focusing on the collection of human protein kinases, the human kinome. We compared human protein sequences to a library of domains from known structures using WU-BLAST, PSI-BLAST, and 123D. This approach utilized both sequence comparison and fold recognition methods. The resulting set of potential protein kinases was cross-checked against previously identified human protein kinases, and analyzed for conserved kinase motifs. Conclusions/Significance: We demonstrate that our structure-based method can be used to identify both typical and atypical human protein kinases. We also identify two potentially novel kinases that contain an interesting combination of kinase and acyl-CoA dehydrogenase domains.	[Briedis, Kristine M.] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Starr, Ayelet] Univ Calif San Diego, Dept Bioengn, La Jolla, CA USA; [Bourne, Philip E.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Briedis, KM (corresponding author), Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA.	kbriedis@ucsd.edu	Bourne, Philip/ABG-8967-2021	Bourne, Philip/0000-0002-7618-7292; Briedis, Kasparas/0000-0003-0338-9544	NIH [GM63208]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM063208] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH GM63208.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Alexandrov N, 2003, BIOINFORMATICS, V19, P429, DOI 10.1093/bioinformatics/btg006; Alexandrov N N, 1996, Pac Symp Biocomput, P53; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Bartlett Gail J, 2003, Methods Biochem Anal, V44, P387; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Daigle DM, 1999, CHEM BIOL, V6, P11, DOI 10.1016/S1074-5521(99)80016-7; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HOLM L, 1995, EMBO J, V14, P1287, DOI 10.1002/j.1460-2075.1995.tb07114.x; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Li WW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r51; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yang AS, 2000, J MOL BIOL, V301, P679, DOI 10.1006/jmbi.2000.3974; Ye X, 2004, MOL BIOL REP, V31, P191, DOI 10.1023/B:MOLE.0000043622.57408.6b; Yuan C, 2004, J BIOL CHEM, V279, P17801, DOI 10.1074/jbc.M401382200	31	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1597	10.1371/journal.pone.0001597	http://dx.doi.org/10.1371/journal.pone.0001597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270584	Green Published, gold			2022-12-27	WOS:000260535900031
J	Jiang, YJ; Xu, DS; Zhao, Y; Zhang, LW				Jiang, Yanjun; Xu, Dongsheng; Zhao, Yong; Zhang, Luwen			Mutual Inhibition between Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Lytic Replication Initiators in Dually-Infected Primary Effusion Lymphoma	PLOS ONE			English	Article								Background: Both Kaposi's sarcoma-associated herpesvirus ( KSHV) and Epstein-Barr virus (EBV) are members of the human gamma herpesvirus family: each is associated with various human cancers. The majority of AIDS-associated primary effusion lymphoma (PEL) are co-infected with both KSHV and EBV. Dually-infected PELs selectively switch from latency to lytic replication of either KSHV or EBV in response to chemical stimuli. KSHV replication and transcription activator (K-RTA) is necessary and sufficient for the switch from KSHV latency to lytic replication, while EBV BZLF1 gene product (EBV-Z) is a critical initiator for induction of EBV lytic replication. Methodology/Principal Findings: We show K-RTA and EBV-Z are co-localized and physically interact with each other in dually-infected PELs. K-RTA inhibits the EBV lytic replication by nullifying EBV-Z-mediated EBV lytic gene activation. EBV-Z inhibits KSHV lytic gene expression by blocking K-RTA-mediated transactivations. The physical interaction between K-RTA and EBV-Z are required for the mutual inhibition of the two molecules. The leucine heptapeptide repeat (LR) region in K-RTA and leucine zipper region in EBV-Z are involved in the physical interactions of the two molecules. Finally, initiation of KSHV lytic gene expression is correlated with the reduction of EBV lytic gene expression in the same PEL cells. Conclusions/Significance: In this report, how the two viruses interact with each other in dually infected PELs is addressed. Our data may provide a possible mechanism for maintaining viral latency and for selective lytic replication in dually infected PELs, i.e., through mutual inhibition of two critical lytic replication initiators. Our data about putative interactions between EBV and KSHV would be applicable to the majority of AIDS-associated PELs and may be relevant to the pathogenesis of PELs.	[Jiang, Yanjun; Xu, Dongsheng; Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Zhao, Yong; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Jiang, YJ (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.	lzhang2@unlnotes.unl.edu			NIH [AI59132, CA108951]; NCRR COBRA [RR15635]; NATIONAL CANCER INSTITUTE [R01CA108951] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR COBRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the NIH AI59132, CA108951, and NCRR COBRA grant RR15635 (LZ).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Arvanitakis L, 1996, BLOOD, V88, P2648, DOI 10.1182/blood.V88.7.2648.bloodjournal8872648; Bell P, 2000, J VIROL, V74, P11800, DOI 10.1128/JVI.74.24.11800-11810.2000; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Bu W, 2007, J VIROL, V81, P5788, DOI 10.1128/JVI.00140-07; Carroll KD, 2006, J VIROL, V80, P9697, DOI 10.1128/JVI.00746-06; Cayrol C, 1996, J BIOL CHEM, V271, P31799, DOI 10.1074/jbc.271.50.31799; Cayrol C, 1996, EMBO J, V15, P2748, DOI 10.1002/j.1460-2075.1996.tb00635.x; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; Chang H, 2005, J VIROL, V79, P4651, DOI 10.1128/JVI.79.8.4651-4663.2005; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, INFECT AGENT DIS, V5, P215; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; COX MA, 1990, J VIROL, V64, P313, DOI 10.1128/JVI.64.1.313-321.1990; Deng HY, 2000, J GEN VIROL, V81, P3043, DOI 10.1099/0022-1317-81-12-3043; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Deng Z, 2001, J VIROL, V75, P10334, DOI 10.1128/JVI.75.21.10334-10347.2001; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Drexler HG, 1998, LEUKEMIA, V12, P1507, DOI 10.1038/sj.leu.2401160; Fan W, 2005, J VIROL, V79, P1244, DOI 10.1128/JVI.79.2.1244-1251.2005; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; FLEMINGTON E, 1990, P NATL ACAD SCI USA, V87, P9459, DOI 10.1073/pnas.87.23.9459; Fujii K, 2000, J VIROL, V74, P2550, DOI 10.1128/JVI.74.6.2550-2557.2000; Gershburg E, 2002, J VIROL, V76, P998, DOI 10.1128/JVI.76.3.998-1003.2002; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Groves AK, 2001, J VIROL, V75, P9446, DOI 10.1128/JVI.75.19.9446-9457.2001; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P6245, DOI 10.1128/JVI.75.13.6245-6248.2001; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Hwang S, 2001, J VIROL, V75, P9509, DOI 10.1128/JVI.75.19.9509-9516.2001; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; KENNEY S, 1988, P NATL ACAD SCI USA, V85, P1652, DOI 10.1073/pnas.85.5.1652; Kieff E, 1996, VIROLOGY, P2343; KOUZARIDES T, 1991, ONCOGENE, V6, P195; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; Lan K, 2005, J VIROL, V79, P7453, DOI 10.1128/JVI.79.12.7453-7465.2005; Liang YY, 2003, P NATL ACAD SCI USA, V100, P8490, DOI 10.1073/pnas.1432843100; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; LIEBERMAN PM, 1990, J VIROL, V64, P2560, DOI 10.1128/JVI.64.6.2560-2568.1990; Liu PF, 2003, VIROLOGY, V310, P199, DOI 10.1016/S0042-6822(03)00145-4; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; MANET E, 1989, EMBO J, V8, P1819, DOI 10.1002/j.1460-2075.1989.tb03576.x; Matsumura S, 2005, J VIROL, V79, P8493, DOI 10.1128/JVI.79.13.8493-8505.2005; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Moore P., 2001, VIROLOGY, P2803; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; PAGANO JS, 1991, TXB INTERNAL MED, V307, P1499; Park J, 2000, J VIROL, V74, P11977, DOI 10.1128/JVI.74.24.11977-11982.2000; RaabTraub N, 1996, SEMIN VIROL, V7, P315, DOI 10.1006/smvy.1996.0039; Rickinson AB, 1996, VIROLOGY, P2397; Sakakibara S, 2001, J VIROL, V75, P6894, DOI 10.1128/JVI.75.15.6894-6900.2001; Saveliev AK, 2002, VIROLOGY, V299, P301, DOI 10.1006/viro.2002.1561; Seaman WT, 1999, VIROLOGY, V263, P436, DOI 10.1006/viro.1999.9963; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Trivedi P, 2004, BLOOD, V103, P313, DOI 10.1182/blood-2003-05-1710; TSURUMI T, 1994, J VIROL, V68, P3354, DOI 10.1128/JVI.68.5.3354-3363.1994; TSURUMI T, 1993, J VIROL, V67, P4651, DOI 10.1128/JVI.67.8.4651-4658.1993; TSURUMI T, 1993, J VIROL, V67, P7648, DOI 10.1128/JVI.67.12.7648-7653.1993; URIER G, 1989, EMBO J, V8, P1447, DOI 10.1002/j.1460-2075.1989.tb03527.x; Wang P, 2005, J VIROL, V79, P13298, DOI 10.1128/JVI.79.21.13298-13309.2005; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wang SZE, 2003, J VIROL, V77, P9590, DOI 10.1128/JVI.77.17.9590-9612.2003; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; Wu FY, 2003, J VIROL, V77, P8893, DOI 10.1128/JVI.77.16.8893-8914.2003; Wu FY, 2002, P NATL ACAD SCI USA, V99, P10683, DOI 10.1073/pnas.162352299; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Ye JJ, 2007, J VIROL, V81, P9279, DOI 10.1128/JVI.00982-07; Zacny VL, 1999, J VIROL, V73, P7271, DOI 10.1128/JVI.73.9.7271-7277.1999; Zerby D, 1999, MOL CELL BIOL, V19, P1617; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; ZHANG L, 2000, J VIROL, V74, P5748; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; ZHANG Q, 1994, MOL CELL BIOL, V14, P1929, DOI 10.1128/MCB.14.3.1929; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	88	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1569	10.1371/journal.pone.0001569	http://dx.doi.org/10.1371/journal.pone.0001569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253508	Green Published, gold			2022-12-27	WOS:000260535700032
J	Viengchareun, S; Servel, N; Feve, B; Freemark, M; Lombes, M; Binart, N				Viengchareun, Say; Servel, Nathalie; Feve, Bruno; Freemark, Michael; Lombes, Marc; Binart, Nadine			Prolactin Receptor Signaling Is Essential for Perinatal Brown Adipocyte Function: A Role for Insulin-like Growth Factor-2	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; ADIPOSE-TISSUE; GENE-EXPRESSION; TRANSGENIC MICE; KNOCKOUT MICE; PRL RECEPTOR; DEFICIENT MICE; PPAR-GAMMA; FACTOR-II; HORMONE	Background. The lactogenic hormones prolactin (PRL) and placental lactogens (PL) play central roles in reproduction and mammary development. Their actions are mediated via binding to PRL receptor (PRLR), highly expressed in brown adipose tissue (BAT), yet their impact on adipocyte function and metabolism remains unclear. Methodology/Principal Findings. PRLR knockout (KO) newborn mice were phenotypically characterized in terms of thermoregulation and their BAT differentiation assayed for gene expression studies. Derived brown preadipocyte cell lines were established to evaluate the molecular mechanisms involved in PRL signaling on BAT function. Here, we report that newborn mice lacking PRLR have hypotrophic BAT depots that express low levels of adipocyte nuclear receptor PPAR gamma 2, its coactivator PGC-1 alpha, uncoupling protein 1 (UCP1) and the beta 3 adrenoceptor, reducing mouse viability during cold challenge. Immortalized PRLR KO preadipocytes fail to undergo differentiation into mature adipocytes, a defect reversed by reintroduction of PRLR. That the effects of the lactogens in BAT are at least partly mediated by Insulin-like Growth Factor-2 (IGF-2) is supported by: i) a striking reduction in BAT IGF-2 expression in PRLR KO mice and in PRLR-deficient preadipocytes; ii) induction of cellular IGF-2 expression by PRL through JAK2/STAT5 pathway activation; and iii) reversal of defective differentiation in PRLR KO cells by exogenous IGF-2. Conclusions. Our findings demonstrate that the lactogens act in concert with IGF-2 to control brown adipocyte differentiation and growth. Given the prominent role of brown adipose tissue during the perinatal period, our results identified prolactin receptor signaling as a major player and a potential therapeutic target in protecting newborn mammals against hypothermia.	[Servel, Nathalie; Freemark, Michael; Binart, Nadine] INSERM, U845, Paris, France; [Viengchareun, Say; Feve, Bruno; Lombes, Marc] Inserm, U693, Le Kremlin Bicetre, France; [Viengchareun, Say; Feve, Bruno; Lombes, Marc] Univ Paris Sud, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Servel, Nathalie; Freemark, Michael; Binart, Nadine] Univ Paris 05, Fac de Med Rene Descartes, UMR S845, Site Necker, Paris, France; [Freemark, Michael] Duke Univ, Med Ctr, Div Pediat Endocrinol & Diabetes, Durham, NC USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Duke University	Binart, N (corresponding author), INSERM, U845, Paris, France.	binart@necker.fr	Viengchareun, Say/GOV-6812-2022; Lombes, Marc/L-5933-2018; Binart, Nadine/F-2949-2013; Viengchareun, Say/M-6612-2017	Lombes, Marc/0000-0003-3189-023X; Binart, Nadine/0000-0002-5606-3866; viengchareun, say/0000-0003-4280-3250; Feve, Bruno/0000-0001-6577-9009; Servel, Nathalie/0000-0001-6925-6256	NICHD NIH HHS [R01 HD024192, HD24192] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024192] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Binart N, 2000, ENDOCRINOLOGY, V141, P2691, DOI 10.1210/en.141.7.2691; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cianfarani S, 2005, J CLIN ENDOCR METAB, V90, P6028, DOI 10.1210/jc.2005-0721; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Flint DJ, 2006, J ENDOCRINOL, V191, P101, DOI 10.1677/joe.1.06939; Flint David J, 2003, Pituitary, V6, P97, DOI 10.1023/B:PITU.0000004800.57449.67; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Freemark M, 1997, J CLIN INVEST, V99, P1107, DOI 10.1172/JCI119239; FREEMARK M, 1993, ENDOCRINOLOGY, V133, P1830, DOI 10.1210/en.133.4.1830; Freemark M, 2002, ENDOCRINOLOGY, V143, P1378, DOI 10.1210/en.143.4.1378; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Golozoubova V, 2004, MOL ENDOCRINOL, V18, P384, DOI 10.1210/me.2003-0267; GRAY SL, 2006, ENDOCRINOLOGY; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Kedzia U, 2005, CANCER RES, V65, P8497, DOI 10.1158/0008-5472.CAN-04-3937; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Laustsen PG, 2002, GENE DEV, V16, P3213, DOI 10.1101/gad.1034802; LeBaron MJ, 2007, ENDOCRINOLOGY, V148, P989, DOI 10.1210/en.2006-1219; Lehr L, 2006, FEBS LETT, V580, P4661, DOI 10.1016/j.febslet.2006.07.037; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; LOMBES M, 1993, BIOCHEM J, V292, P577, DOI 10.1042/bj2920577; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; MOHAN S, 1995, J CLIN ENDOCR METAB, V80, P637, DOI 10.1210/jc.80.2.637; Nanbu-Wakao R, 2000, MOL ENDOCRINOL, V14, P307, DOI 10.1210/me.14.2.307; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Pearce S, 2005, J ENDOCRINOL, V184, P351, DOI 10.1677/joe.1.05732; RICQUIER D, 2000, J PHYSL, V1, P3; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; ROYSTER M, 1995, ENDOCRINOLOGY, V136, P3892, DOI 10.1210/en.136.9.3892; Teixeira M, 2006, J BIOL CHEM, V281, P10496, DOI 10.1074/jbc.M512254200; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Viengchareun S, 2004, J MOL ENDOCRINOL, V33, P679, DOI 10.1677/jme.1.01563; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915	49	47	50	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1535	10.1371/journal.pone.0001535	http://dx.doi.org/10.1371/journal.pone.0001535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253483	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700007
J	Yonehara, K; Shintani, T; Suzuki, R; Sakuta, H; Takeuchi, Y; Nakamura-Yonehara, K; Noda, M				Yonehara, Keisuke; Shintani, Takafumi; Suzuki, Ryoko; Sakuta, Hiraki; Takeuchi, Yasushi; Nakamura-Yonehara, Kayo; Noda, Masaharu			Expression of SPIG1 Reveals Development of a Retinal Ganglion Cell Subtype Projecting to the Medial Terminal Nucleus in the Mouse	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; ACCESSORY OPTIC-SYSTEM; DENDRITIC STRATIFICATION; MORPHOLOGICAL PROPERTIES; DIRECTIONAL SELECTIVITY; TANGENTIAL DISPERSION; IMAGE MOTION; DIFFERENTIATION; DIVERSITY; RECEPTOR	Visual information is transmitted to the brain by roughly a dozen distinct types of retinal ganglion cells (RGCs) defined by a characteristic morphology, physiology, and central projections. However, our understanding about how these parallel pathways develop is still in its infancy, because few molecular markers corresponding to individual RGC types are available. Previously, we reported a secretory protein, SPIG1(clone name; D/Bsp120I #1), preferentially expressed in the dorsal region in the developing chick retina. Here, we generated knock-in mice to visualize SPIG1-expressing cells with green fluorescent protein. We found that the mouse retina is subdivided into two distinct domains for SPIG1 expression and SPIG1 effectively marks a unique subtype of the retinal ganglion cells during the neonatal period. SPIG1-positive RGCs in the dorsotemporal domain project to the dorsal lateral geniculate nucleus (dLGN), superior colliculus, and accessory optic system (AOS). In contrast, in the remaining region, here named the pan-ventronasal domain, SPIG1-positive cells form a regular mosaic and project exclusively to the medial terminal nucleus (MTN) of the AOS that mediates the optokinetic nystagmus as early as P1. Their dendrites costratify with ON cholinergic amacrine strata in the inner plexiform layer as early as P3. These findings suggest that these SPIG1-positive cells are the ON direction selective ganglion cells (DSGCs). Moreover, the MTN-projecting cells in the pan-ventronasal domain are apparently composed of two distinct but interdependent regular mosaics depending on the presence or absence of SPIG1, indicating that they comprise two functionally distinct subtypes of the ON DSGCs. The formation of the regular mosaic appears to be commenced at the end of the prenatal stage and completed through the peak period of the cell death at P6. SPIG1 will thus serve as a useful molecular marker for future studies on the development and function of ON DSGCs.	[Yonehara, Keisuke; Shintani, Takafumi; Suzuki, Ryoko; Sakuta, Hiraki; Takeuchi, Yasushi; Nakamura-Yonehara, Kayo; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan; [Yonehara, Keisuke; Shintani, Takafumi; Sakuta, Hiraki; Noda, Masaharu] Grad Univ Adv Stud, Sch Life Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Sakuta, Hiraki/0000-0003-2375-0528; Yonehara, Keisuke/0000-0001-9541-6671; Shintani, Takafumi/0000-0002-6165-2307	Ministry of Education, Culture, Sports, Science and Technology of Japan; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science for Young Scientists [Research Fellowship]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST). This work was also supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (KY).	Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Bansal A, 2000, J NEUROSCI, V20, P7672; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Bodnarenko SR, 1999, NEUROREPORT, V10, P2955, DOI 10.1097/00001756-199909290-00015; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; Bruhn SL, 1996, J NEUROSCI, V16, P1430; BUHL EH, 1986, J COMP NEUROL, V253, P163, DOI 10.1002/cne.902530204; Cellerino A, 2000, EUR J NEUROSCI, V12, P613, DOI 10.1046/j.1460-9568.2000.00944.x; Cook JE, 2001, VISUAL NEUROSCI, V18, P289, DOI 10.1017/S0952523801182131; Cook JE, 2000, TRENDS NEUROSCI, V23, P26, DOI 10.1016/S0166-2236(99)01487-3; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; DANN JF, 1987, J COMP NEUROL, V262, P141, DOI 10.1002/cne.902620111; DANN JF, 1988, J NEUROSCI, V8, P1485; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Diao L, 2004, J NEUROBIOL, V61, P236, DOI 10.1002/neu.20041; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Eglen SJ, 2006, MATH MED BIOL, V23, P79, DOI 10.1093/imammb/dql003; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; FAMIGLIETTI EV, 1983, VISION RES, V23, P1265, DOI 10.1016/0042-6989(83)90102-5; FAMIGLIETTI EV, 1992, J COMP NEUROL, V324, P322, DOI 10.1002/cne.903240303; FISHER LJ, 1979, J EMBRYOL EXP MORPH, V54, P219; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; GalliResta L, 1997, J NEUROSCI, V17, P7831; Gross JM, 2005, P NATL ACAD SCI USA, V102, P4371, DOI 10.1073/pnas.0501061102; He SG, 1998, VISUAL NEUROSCI, V15, P369, DOI 10.1017/S095252389815215X; HINDS JW, 1974, DEV BIOL, V37, P381, DOI 10.1016/0012-1606(74)90156-0; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Jeyarasasingam G, 1998, J COMP NEUROL, V394, P335; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; Masland RH, 2000, ANNU REV NEUROSCI, V23, P249, DOI 10.1146/annurev.neuro.23.1.249; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; MASLIM J, 1986, J COMP NEUROL, V254, P382, DOI 10.1002/cne.902540310; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; OLNEY JW, 1968, INVEST OPHTH VISUAL, V7, P250; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Peters MA, 2002, DEV BIOL, V251, P59, DOI 10.1006/dbio.2002.0791; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; RAMOA AS, 1988, J NEUROSCI, V8, P4239; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; REESE BE, 1995, P NATL ACAD SCI USA, V92, P2494, DOI 10.1073/pnas.92.7.2494; Reese BE, 2002, PROG RETIN EYE RES, V21, P153, DOI 10.1016/S1350-9462(01)00024-6; Reese BE, 1999, EUR J NEUROSCI, V11, P2965, DOI 10.1046/j.1460-9568.1999.00712.x; Resta V, 2005, DEVELOPMENT, V132, P2873, DOI 10.1242/dev.01855; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Rodieck R.W., 1998, 1 STEPS SEEING; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Sakuta H, 2006, J NEUROSCI, V26, P10868, DOI 10.1523/JNEUROSCI.3027-06.2006; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Shintani T, 2004, J NEUROBIOL, V59, P34, DOI 10.1002/neu.10338; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; VANDERTOGT C, 1993, J COMP NEUROL, V338, P175, DOI 10.1002/cne.903380204; Waid DK, 1998, DEVELOPMENT, V125, P1059; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307	81	73	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1533	10.1371/journal.pone.0001533	http://dx.doi.org/10.1371/journal.pone.0001533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253481	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700005
J	Randriamampita, C; Mouchacca, P; Malissen, B; Marguet, D; Trautmann, A; Lellouch, AC				Randriamampita, Clotilde; Mouchacca, Pierre; Malissen, Bernard; Marguet, Didier; Trautmann, Alain; Lellouch, Annemarie Coffman			A Novel ZAP-70 Dependent FRET Based Biosensor Reveals Kinase Activity at both the Immunological Synapse and the Antisynapse	PLOS ONE			English	Article								Many hypotheses attempting to explain the speed and sensitivity with which a T-cell discriminates the antigens it encounters include a notion of relative spatial and temporal control of particular biochemical steps involved in the process. An essential step in T-cell receptor (TCR) mediated signalling is the activation of the protein tyrosine kinase ZAP-70. ZAP-70 is recruited to the TCR upon receptor engagement and, once activated, is responsible for the phosphorylation of the protein adaptor, Linker for Activation of T-cells, or LAT. LAT phosphorylation results in the recruitment of a signalosome including PLC gamma 1, Grb2/SOS, GADS and SLP-76. In order to examine the real time spatial and temporal evolution of ZAP-70 activity following TCR engagement in the immune synapse, we have developed ROZA, a novel FRET-based biosensor whose function is dependent upon ZAP-70 activity. This new probe not only provides a measurement of the kinetics of ZAP-70 activity, but also reveals the subcellular localization of the activity as well. Unexpectedly, ZAP-70 dependent FRET was observed not only at the T-cell -APC interface, but also at the opposite pole of the cell or "antisynapse''.	[Randriamampita, Clotilde; Trautmann, Alain] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Randriamampita, Clotilde; Trautmann, Alain] Inserm, U567, Paris, France; [Mouchacca, Pierre; Malissen, Bernard; Marguet, Didier; Lellouch, Annemarie Coffman] Univ Aix Marseille 2, Ctr dImmunologie Marseille Luminy, Marseille, France; [Mouchacca, Pierre; Malissen, Bernard; Marguet, Didier; Lellouch, Annemarie Coffman] Inserm, U631, Marseille, France; [Mouchacca, Pierre; Malissen, Bernard; Marguet, Didier; Lellouch, Annemarie Coffman] CNRS, UMR6102, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Randriamampita, C (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	randriamampita@cochin.inserm.fr; lellouch@marseille.inserm.fr	Marguet, Didier/B-9946-2008; Lellouch, Annemarie/E-9905-2014; Marguet, Didier/AGO-5421-2022; Malissen, Bernard/AAK-4659-2020	Marguet, Didier/0000-0003-3198-5095; Randriamampita, Clotilde/0000-0001-8594-7831; Malissen, Bernard/0000-0003-1340-9342	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer; Ministere de la Recherche	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Ligue Nationale Contre le Cancer(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by institutional grants from Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Ligue Nationale Contre le Cancer (AT), Association pour la Recherche sur le Cancer (BM), and Ministere de la Recherche (AT & BM).	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burroughs NJ, 2007, IMMUNOL REV, V216, P69; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Kohler K, 2005, CHEMBIOCHEM, V6, P152, DOI 10.1002/cbic.200400241; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Sato M, 2002, NAT BIOTECHNOL, V20, P287, DOI 10.1038/nbt0302-287; Sloan-Lancaster J, 1998, J CELL BIOL, V143, P613, DOI 10.1083/jcb.143.3.613; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	25	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1521	10.1371/journal.pone.0001521	http://dx.doi.org/10.1371/journal.pone.0001521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231606	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200033
J	Trape, S				Trape, Sebastien			Shark Attacks in Dakar and the Cap Vert Peninsula, Senegal: Low Incidence despite High Occurrence of Potentially Dangerous Species	PLOS ONE			English	Article								Background. The International Shark Attack File mentions only four unprovoked shark attacks on the coast of West Africa during the period 1828-2004, an area where high concentrations of sharks and 17 species potentially dangerous to man have been observed. To investigate if the frequency of shark attacks could be really low and not just under-reported and whether there are potentially sharks that might attack in the area, a study was carried out in Dakar and the Cap Vert peninsula, Senegal. Methodology/Principal Findings. Personnel of health facilities, administrative services, traditional authorities and groups of fishermen from the region of Dakar were interviewed about the occurrence of shark attacks, and visual censuses were conducted along the coastline to investigate shark communities associated with the coasts of Dakar and the Cap Vert peninsula. Six attacks were documented for the period 1947-2005, including two fatal ones attributed to the tiger shark Galeocerdo cuvieri. All attacks concerned fishermen and only one occurred after 1970. Sharks were observed year round along the coastline in waters 3-15 m depth. Two species potentially dangerous for man, the nurse shark Ginglymostoma cirratum and the blacktip shark Carcharhinus limbatus, represented together 94% of 1,071 sharks enumerated during 1,459 hours of observations. Threatening behaviour from sharks was noted in 12 encounters (1.1%), including 8 encounters with C. limbatus, one with Galeocerdo cuvieri and 3 with unidentified sharks. Conclusions/Significance. These findings suggest that the frequency of shark attacks on the coast of West Africa is underestimated. However, they also indicate that the risk is very low despite the abundance of sharks. In Dakar area, most encounters along the coastline with potentially dangerous species do not result in an attack. Compared to other causes of water related deaths, the incidence of shark attack appears negligible, at least one thousand fold lower.	[Trape, Sebastien] IRD, Unite Rech 070, Dakar, Senegal; [Trape, Sebastien] Univ Montpellier, Lab ECOLAG, Unit Mixte Rech 5119, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Trape, S (corresponding author), IRD, Unite Rech 070, Dakar, Senegal.	sebastien_trape@yahoo.fr						BALDRIDGE HD, 1988, CALIF FISH GAME, V74, P208; BALDRIDGE HD, 1974, SHARK ATTACK; BLACHE J, 1970, CLES DETERMINATION P; BURGESS GH, 1990, DISCOVERING SHARKS, P101; Cadenat J., 1950, Bull Inst franc Afr noire, V12, P944; Cadenat J., 1957, Bull Inst franY Afr N, V19B, P274; CADENAT J, 1981, REQUINS MEDITERRANEE; Cadenat J, 1950, POISSONS MER SENEGAL; Caldicott DGE, 2001, INJURY, V32, P445, DOI 10.1016/S0020-1383(01)00041-9; Chauveau JP., 1989, CAHIERS SCI HUMAINES, V25, P237; CHAVANCE P, 2006, COMMISSION EUROPEENN, V1; Compagno L. J. V., 2001, ANNOTATED ILLUSTRATE, V2; COMPAGNO LJV, 1984, FAO FISHERIES SYNO 2, V125; COMPAGNO LJV, 1984, FAO FISHERIES SYNO 1, V125; DEJOU D, 1948, B MED AOF, V5, P23; MANIGUET X, 1991, DENTS MORT; *MIN EC FIN, 2006, DIR PREV STAT; REBERT JP, 1977, ATLAS NATL SENEGAL, P36; Seret B., 1990, POISSONS MER OUEST A; STEVENS JD, 1987, SHARKS	20	7	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1495	10.1371/journal.pone.0001495	http://dx.doi.org/10.1371/journal.pone.0001495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231582	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200008
J	Thera, MA; Doumbo, OK; Coulibaly, D; Diallo, DA; Kone, AK; Guindo, AB; Traore, K; Dicko, A; Sagara, I; Sissoko, MS; Baby, M; Sissoko, M; Diarra, I; Niangaly, A; Dolo, A; Daou, M; Diawara, SI; Heppner, DG; Stewart, VA; Angov, E; Bergmann-Leitner, ES; Lanar, DE; Dutta, S; Soisson, L; Diggs, CL; Leach, A; Owusu, A; Dubois, MC; Cohen, J; Nixon, JN; Gregson, A; Takala, SL; Lyke, KE; Plowe, CV				Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Diallo, Dapa A.; Kone, Abdoulaye K.; Guindo, Ando B.; Traore, Karim; Dicko, Alassane; Sagara, Issaka; Sissoko, Mahamadou S.; Baby, Mounirou; Sissoko, Mady; Diarra, Issa; Niangaly, Amadou; Dolo, Amagana; Daou, Modibo; Diawara, Sory I.; Heppner, D. Gray; Stewart, V. Ann; Angov, Evelina; Bergmann-Leitner, Elke S.; Lanar, David E.; Dutta, Sheetij; Soisson, Lorraine; Diggs, Carter L.; Leach, Amanda; Owusu, Alex; Dubois, Marie-Claude; Cohen, Joe; Nixon, Jason N.; Gregson, Aric; Takala, Shannon L.; Lyke, Kirsten E.; Plowe, Christopher V.			Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial	PLOS ONE			English	Article								Background. The objective was to evaluate the safety, reactogenicity and immunogenicity of the AMA-1-based blood-stage malaria vaccine FMP2.1/AS02A in adults exposed to seasonal malaria. Methodology/Principal Findings. A phase 1 double blind randomized controlled dose escalation trial was conducted in Bandiagara, Mali, West Africa, a rural town with intense seasonal transmission of Plasmodium falciparum malaria. The malaria vaccine FMP2.1/AS02A is a recombinant protein (FMP2.1) based on apical membrane antigen-1 (AMA-1) from the 3D7 clone of P. falciparum, adjuvanted with AS02A. The comparator vaccine was a cell-culture rabies virus vaccine (RabAvert). Sixty healthy, malaria-experienced adults aged 18-55 y were recruited into 2 cohorts and randomized to receive either a half dose or full dose of the malaria vaccine (FMP2.1 25 mu g/AS02A 0.25 mL or FMP2.1 50 mu g/AS02A 0.5 mL) or rabies vaccine given in 3 doses at 0, 1 and 2 mo, and were followed for 1 y. Solicited symptoms were assessed for 7 d and unsolicited symptoms for 30 d after each vaccination. Serious adverse events were assessed throughout the study. Titers of anti-AMA-1 antibodies were measured by ELISA and P. falciparum growth inhibition assays were performed on sera collected at pre- and post-vaccination time points. Transient local pain and swelling were common and more frequent in both malaria vaccine dosage groups than in the comparator group. Anti-AMA-1 antibodies increased significantly in both malaria vaccine groups, peaking at nearly 5-fold and more than 6-fold higher than baseline in the half-dose and full-dose groups, respectively. Conclusion/Significance. The FMP2.1/AS02A vaccine had a good safety profile, was well-tolerated, and was highly immunogenic in malaria-exposed adults. This malaria vaccine is being evaluated in Phase 1 and 2 trials in children at this site. Trial Registration. ClinicalTrials.gov NCT00308061	Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Diallo, Dapa A.; Kone, Abdoulaye K.; Guindo, Ando B.; Traore, Karim; Dicko, Alassane; Sagara, Issaka; Sissoko, Mahamadou S.; Baby, Mounirou; Sissoko, Mady; Diarra, Issa; Niangaly, Amadou; Dolo, Amagana; Daou, Modibo; Diawara, Sory I.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Heppner, D. Gray; Stewart, V. Ann; Angov, Evelina; Bergmann-Leitner, Elke S.; Lanar, David E.; Dutta, Sheetij] Walter Reed Army Inst, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Soisson, Lorraine; Diggs, Carter L.] US Agency Int Dev, Malaria Vaccine Dev Prog, Washington, DC USA; [Leach, Amanda; Owusu, Alex; Dubois, Marie-Claude; Cohen, Joe] GlaxoSmithKline Biologicals, World Wide Clin Dev Malaria Vaccines, Rixensart, Belgium; [Nixon, Jason N.; Gregson, Aric; Takala, Shannon L.; Lyke, Kirsten E.; Plowe, Christopher V.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University of Bamako; Walter Reed Army Institute of Research (WRAIR); GlaxoSmithKline; University System of Maryland; University of Maryland Baltimore	Plowe, CV (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	cplowe@medicine.umaryland.edu	Lanar, David E/B-3560-2011; Leach, Amanda/AAS-1120-2020; Bergmann-Leitner, Elke S./B-3548-2011; Bergmann-Leitner, Elke/I-5431-2019	Leach, Amanda/0000-0002-7114-9967; Bergmann-Leitner, Elke S./0000-0002-8571-8956; Bergmann-Leitner, Elke/0000-0002-8571-8956; Takala-Harrison, Shannon/0000-0003-4674-8500; Traore, Karim/0000-0002-9553-6611; Gregson, Aric/0000-0001-6806-0868; Thera, Mahamadou A/0000-0002-2679-035X	National Institute of Allergy and Infectious Diseases [N01AI85346, U19AI065683]; Fogarty International Center, National Institutes of Health [D43TW001589]; United States Agency for International Development, Washington, D.C.; Military Infectious Diseases Research Program, Fort Detrick, MD; Doris Duke Charitable Foundation [Distinguished Clinical Scientist Award]; FOGARTY INTERNATIONAL CENTER [D43TW001589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085346, U19AI065683] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); United States Agency for International Development, Washington, D.C.(United States Agency for International Development (USAID)); Military Infectious Diseases Research Program, Fort Detrick, MD; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Site development and the conduct of the trial were supported by contract N01AI85346 and cooperative agreement U19AI065683 from the National Institute of Allergy and Infectious Diseases and grant D43TW001589 from the Fogarty International Center, National Institutes of Health. Vaccine production and laboratory assays were supported by the United States Agency for International Development, Washington, D.C. and by the Military Infectious Diseases Research Program, Fort Detrick, MD. Program staff from the National Institute of Allergy and Infectious Diseases contributed to study design discussions but played no role in the collection, analysis or interpretation of data, writing the paper, or the decision to submit it for publication. CVP is supported by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; BERGMANNLEITNER E, 2007, AM J TROP M IN PRESS; Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; Diallo DA, 2005, CLIN INFECT DIS, V41, P255, DOI 10.1086/430707; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Escalante AA, 2001, MOL BIOCHEM PARASIT, V113, P279, DOI 10.1016/S0166-6851(01)00229-8; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Lyke KE, 2004, VACCINE, V22, P3169, DOI 10.1016/j.vaccine.2004.01.054; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; RIPLEY BW, 2007, MICROBES INFECT, V9, P761; SOLTYSIK S, 1993, ANN NY ACAD SCI, V690, P392; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032	33	80	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1465	10.1371/journal.pone.0001465	http://dx.doi.org/10.1371/journal.pone.0001465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213374	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503900011
J	Valles, Y; Halanych, KM; Boore, JL				Valles, Yvonne; Halanych, Kenneth M.; Boore, Jeffrey L.			Group II Introns Break New Boundaries: Presence in a Bilaterian's Genome	PLOS ONE			English	Article								Group II introns are ribozymes, removing themselves from their primary transcripts, as well as mobile genetic elements, transposing via an RNA intermediate, and are thought to be the ancestors of spliceosomal introns. Although common in bacteria and most eukaryotic organelles, they have never been reported in any bilaterian animal genome, organellar or nuclear. Here we report the first group II intron found in the mitochondrial genome of a bilaterian worm. This location is especially surprising, since animal mitochondrial genomes are generally distinct from those of plants, fungi, and protists by being small and compact, and so are viewed as being highly streamlined, perhaps as a result of strong selective pressures for fast replication while establishing germ plasm during early development. This intron is found in the mtDNA of an annelid worm, (an undescribed species of Nephtys), where the complete sequence revealed a 1819 bp group II intron inside the cox1 gene. We infer that this intron is the result of a recent horizontal gene transfer event from a viral or bacterial vector into the mitochondrial genome of Nephtys sp. Our findings hold implications for understanding mechanisms, constraints, and selective pressures that account for patterns of animal mitochondrial genome evolution	[Valles, Yvonne; Boore, Jeffrey L.] Joint Genome Inst, Dept Energy DOE, Walnut Creek, CA USA; [Valles, Yvonne; Boore, Jeffrey L.] Univ Calif Berkley, Dept Integrat Biol, Berkeley, CA USA; [Halanych, Kenneth M.] Auburn Univ, Life Sci Dept, Auburn, AL USA; [Boore, Jeffrey L.] Genome Proj Solution, Hercules, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; Auburn University System; Auburn University	Boore, JL (corresponding author), Joint Genome Inst, Dept Energy DOE, Walnut Creek, CA USA.	JLBoore@Genome-ProjectSolutions.com	Halanych, Ken M/A-9480-2009; Valles, Yvonne/AAC-9380-2019	Halanych, Ken M/0000-0002-8658-9674; Valles, Yvonne/0000-0002-5435-4504	U.S. National Science Foundation [EAR-0120646]; U. S. Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	U.S. National Science Foundation(National Science Foundation (NSF)); U. S. Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory(University of California System)	This study was supported by a grant from the U.S. National Science Foundation EAR-0120646 (to KMH and JLB). Part of this work was performed under the auspices of the U. S. Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under Contract No. DE-AC02-05CH11231.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Beagley CT, 1998, GENETICS, V148, P1091; Belfort M, 2002, MOBILE DNA; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clark M. E., 1962, Zoologische Jahrbuecher (Allgemeine Zoologie), V70, P24; CLARK ME, 1968, J MORPHOL, V124, P483, DOI 10.1002/jmor.1051240406; Dai LX, 2003, NUCLEIC ACIDS RES, V31, P424, DOI 10.1093/nar/gkg049; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Foley S, 2000, J VIROL, V74, P611, DOI 10.1128/JVI.74.2.611-618.2000; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; KNOOP V, 1994, J MOL BIOL, V242, P389, DOI 10.1006/jmbi.1994.1589; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Palmer JD, 1991, CURR OPIN GENET DEV, V1, P470, DOI 10.1016/S0959-437X(05)80194-7; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Robart AR, 2005, CYTOGENET GENOME RES, V110, P589, DOI 10.1159/000084992; Rot C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-71; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Oppen MJH, 1999, P ROY SOC B-BIOL SCI, V266, P179, DOI 10.1098/rspb.1999.0619; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; YAMADA T, 1994, NUCLEIC ACIDS RES, V22, P2532, DOI 10.1093/nar/22.13.2532; Zimmerly S, 2001, NUCLEIC ACIDS RES, V29, P1238, DOI 10.1093/nar/29.5.1238; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1488	10.1371/journal.pone.0001488	http://dx.doi.org/10.1371/journal.pone.0001488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213396	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503900033
J	Kubica, M; Guzik, K; Koziel, J; Zarebski, M; Richter, W; Gajkowska, B; Golda, A; Maciag-Gudowska, A; Brix, K; Shaw, L; Foster, T; Potempa, J				Kubica, Malgorzata; Guzik, Krzysztof; Koziel, Joanna; Zarebski, Miroslaw; Richter, Walter; Gajkowska, Barbara; Golda, Anna; Maciag-Gudowska, Agnieszka; Brix, Klaudia; Shaw, Les; Foster, Timothy; Potempa, Jan			A Potential New Pathway for Staphylococcus aureus Dissemination: The Silent Survival of S. aureus Phagocytosed by Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; TOXIN INDUCES APOPTOSIS; ALPHA-TOXIN; IN-VITRO; LISTERIA-MONOCYTOGENES; ALVEOLAR MACROPHAGES; HUMAN KERATINOCYTES; CELLULAR INVASION; VIRULENCE FACTORS; AGR	Although considered to be an extracellular pathogen, Staphylococcus aureus is able to invade a variety of mammalian, nonprofessional phagocytes and can also survive engulfment by professional phagocytes such as neutrophils and monocytes. In both of these cell types S. aureus promptly escapes from the endosomes/phagosomes and proliferates within the cytoplasm, which quickly leads to host cell death. In this report we show that S. aureus interacted with human monocyte-derived macrophages in a very different way to those of other mammalian cells. Upon phagocytosis by macrophages, S. aureus persisted intracellularly in vacuoles for 3-4 days before escaping into the cytoplasm and causing host cell lysis. Until the point of host cell lysis the infected macrophages showed no signs of apoptosis or necrosis and were functional. They were able to eliminate intracellular staphylococci if prestimulated with interferon-gamma at concentrations equivalent to human therapeutic doses. S. aureus survival was dependent on the alternative sigma factor B as well as the global regulator agr, but not SarA. Furthermore, isogenic mutants deficient in alpha-toxin, the metalloprotease aureolysin, protein A, and sortase A were efficiently killed by macrophages upon phagocytosis, although with different kinetics. In particular alpha-toxin was a key effector molecule that was essential for S. aureus intracellular survival in macrophages. Together, our data indicate that the ability of S. aureus to survive phagocytosis by macrophages is determined by multiple virulence factors in a way that differs considerably from its interactions with other cell types. S. aureus persists inside macrophages for several days without affecting the viability of these mobile cells which may serve as vehicles for the dissemination of infection.	[Guzik, Krzysztof] Jagiellonian Univ, Fac Biochem, Dept Immunol, Krakow, Poland; [Zarebski, Miroslaw] Jagiellonian Univ, Fac Biochem Biophys Biotechnol, Dept Cell Biophys, Krakow, Poland; [Richter, Walter] Friedrich Schiller Univ Jena, Med Fac, Ctr Electron Microscopy, Jena, Germany; [Gajkowska, Barbara] Polish Acad Sci, Med Res Ctr, Dept Cell Ultrastructure, Warsaw, Poland; [Brix, Klaudia] Jacobs Univ Bremen, Sch Engn & Sci, Bremen, Germany; [Shaw, Les] Univ South Forida, Dept Biol, Tampa, FL USA; [Foster, Timothy] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [Koziel, Joanna; Golda, Anna; Maciag-Gudowska, Agnieszka; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland	Jagiellonian University; Jagiellonian University; Friedrich Schiller University of Jena; Polish Academy of Sciences; Jacobs University; State University System of Florida; University of South Florida; Trinity College Dublin; Jagiellonian University	Kubica, M (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland.	staphaureus@gmail.com; kaniajoanna@gmail.com	Shaw, Lindsey/AAI-1741-2020; Potempa, Jan/AAA-6850-2021; Brix, Klaudia/F-5072-2013	Shaw, Lindsey/0000-0002-0629-8990; Brix, Klaudia/0000-0002-4476-0357	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Alexander EH, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-5; Ali F, 2003, J INFECT DIS, V188, P1119, DOI 10.1086/378675; Amer AO, 2002, CURR OPIN MICROBIOL, V5, P56, DOI 10.1016/S1369-5274(02)00286-2; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Baran J, 2001, INFECT IMMUN, V69, P1287, DOI 10.1128/IAI.69.3.1287-1297.2001; BAUGHN RE, 1975, INFECT IMMUN, V12, P346, DOI 10.1128/IAI.12.2.346-352.1975; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; CHEUNG AL, 1994, J CLIN INVEST, V94, P1815, DOI 10.1172/JCI117530; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; da Silva MCA, 2004, AM J PHYSIOL-LUNG C, V287, pL543, DOI 10.1152/ajplung.00256.2003; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Drevets DA, 1999, INFECT IMMUN, V67, P3512, DOI 10.1128/IAI.67.7.3512-3517.1999; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; ELLIOTT GR, 1982, ANTIMICROB AGENTS CH, V22, P781, DOI 10.1128/AAC.22.5.781; Esen M, 2001, APOPTOSIS, V6, P431, DOI 10.1023/A:1012445925628; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Fowler T, 2003, CELL MICROBIOL, V5, P417, DOI 10.1046/j.1462-5822.2003.00290.x; Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Guzik K, 2007, CELL DEATH DIFFER, V14, P171, DOI 10.1038/sj.cdd.4401927; HARMSEN AG, 1985, SCIENCE, V230, P1277, DOI 10.1126/science.4071052; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Haslinger-Loffler B, 2006, KIDNEY INT, V70, P1089, DOI 10.1038/sj.ki.5001710; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; Henry-Stanley MJ, 2003, J SURG RES, V113, P42, DOI 10.1016/S0022-4804(03)00156-2; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; JAKAB GJ, 1976, J CLIN INVEST, V57, P1533, DOI 10.1172/JCI108423; Join-Lambert OF, 2005, CELL MICROBIOL, V7, P167, DOI 10.1111/j.1462-5822.2004.00444.x; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; KAPRAL FA, 1959, J EXP MED, V110, P123, DOI 10.1084/jem.110.1.123; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Koterski JF, 2005, INFECT IMMUN, V73, P504, DOI 10.1128/IAI.73.1.504-513.2005; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; LOWY FD, 1988, J ULTRA MOL STRUCT R, V98, P137, DOI 10.1016/S0889-1605(88)80906-6; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MELLY MA, 1960, J EXP MED, V112, P1121, DOI 10.1084/jem.112.6.1121; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; Menzies BE, 1998, INFECT IMMUN, V66, P5994, DOI 10.1128/IAI.66.12.5994-5998.1998; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Michailova L, 2000, INT J MED MICROBIOL, V290, P259; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Nair SP, 2003, INFECT IMMUN, V71, P4167, DOI 10.1128/IAI.71.7.4167-4170.2003; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Nuzzo I, 2000, FEMS IMMUNOL MED MIC, V27, P235, DOI 10.1111/j.1574-695X.2000.tb01435.x; Peacock SJ, 1999, MICROBIOL-SGM, V145, P3477, DOI 10.1099/00221287-145-12-3477; Petti Cathy A., 2003, Cardiology Clinics, V21, P219, DOI 10.1016/S0733-8651(03)00030-4; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; SAVILL J, 1994, IMMUNOPHARMACOLOGY N, P295; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2006, J BACTERIOL, V188, P6070, DOI 10.1128/JB.00551-06; Shompole S, 2003, MOL MICROBIOL, V49, P919, DOI 10.1046/j.1365-2958.2003.03618.x; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Staali L, 2006, CELL MICROBIOL, V8, P690, DOI 10.1111/j.1462-5822.2005.00662.x; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Weglarczyk K, 2004, INFECT IMMUN, V72, P2590, DOI 10.1128/IAI.72.5.2590-2597.2004; Wesson CA, 1998, INFECT IMMUN, V66, P5238, DOI 10.1128/IAI.66.11.5238-5243.1998; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	87	305	317	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1409	10.1371/journal.pone.0001409	http://dx.doi.org/10.1371/journal.pone.0001409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183290	gold, Green Submitted, Green Published			2022-12-27	WOS:000260469400006
J	Schaefer, M; Steringer, JP; Lyko, F				Schaefer, Matthias; Steringer, Julia P.; Lyko, Frank			The Drosophila Cytosine-5 Methyltransferase Dnmt2 Is Associated with the Nuclear Matrix and Can Access DNA during Mitosis	PLOS ONE			English	Article							ENTAMOEBA-HISTOLYTICA; SPINDLE MATRIX; GAMMA-TUBULIN; NUMB PROTEIN; RNA; METHYLATION; LOCALIZATION; CELLS; EXPRESSION; SKELETOR	Cytosine-5 methyltransferases of the Dnmt2 family are highly conserved in evolution and their biological function is being studied in several organisms. Although all structural DNA methyltransferase motifs are present in Dnmt2, these enzymes show a strong tRNA methyltransferase activity. In line with an enzymatic activity towards substrates other than DNA, Dnmt2 has been described to localize to the cytoplasm. Using molecular and biochemical approaches we show here that Dnmt2 is both a cytoplasmic and a nuclear protein. Sub-cellular fractionation shows that a significant amount of Dnmt2 is bound to the nuclear matrix. Sub-cellular localization analysis reveals that Dnmt2 proteins are enriched in actively dividing cells. Dnmt2 localization is highly dynamic during the cell cycle. Using live imaging we observed that Dnmt2-EGFP enters prophase nuclei and shows a spindle-like localization pattern during mitotic divisions. Additional experiments suggest that this localization is microtubule dependent and that Dnmt2 can access DNA during mitotic cell divisions. Our results represent the first comprehensive characterization of Dnmt2 proteins on the cellular level and have important implications for our understanding of the molecular activities of Dnmt2.	[Schaefer, Matthias; Steringer, Julia P.; Lyko, Frank] Deutsch Krebsforschungszentrum, Div Epigenet, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Lyko, F (corresponding author), Deutsch Krebsforschungszentrum, Div Epigenet, D-6900 Heidelberg, Germany.	f.lyko@dkfz.de	Matthias, Schaefer Ronald/E-9157-2015	Matthias, Schaefer Ronald/0000-0003-1952-8115	Deutsche Forschungsgemeinschaft [SCHA 1267/2-1]; Priority Programme Epigenetics	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Programme Epigenetics	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SCHA 1267/2-1 and Priority Programme Epigenetics).	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Banerjee S, 2005, MOL BIOCHEM PARASIT, V139, P91, DOI 10.1016/j.molbiopara.2004.10.003; Banerjee S, 2003, MOL BIOCHEM PARASIT, V126, P35, DOI 10.1016/S0166-6851(02)00244-X; Belmont AS, 2002, P NATL ACAD SCI USA, V99, P15855, DOI 10.1073/pnas.262672799; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cotter L, 2007, J MOL BIOL, V369, P683, DOI 10.1016/j.jmb.2007.03.051; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Inano K, 2000, J BIOCHEM-TOKYO, V128, P315, DOI 10.1093/oxfordjournals.jbchem.a022755; Jeltsch A, 2006, TRENDS BIOCHEM SCI, V31, P306, DOI 10.1016/j.tibs.2006.04.005; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; LAM YW, 2006, CELL BIOL LAB HDB, P103; LIAU MC, 1975, BIOCHEMISTRY-US, V14, P127, DOI 10.1021/bi00672a022; Lyko F, 2000, MECH DEVELOP, V95, P215, DOI 10.1016/S0925-4773(00)00325-7; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; PATRIOTIS C, 1990, J CELL SCI, V95, P667; RAFF JW, 1993, J CELL BIOL, V121, P823, DOI 10.1083/jcb.121.4.823; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RIEMER D, 1995, J CELL SCI, V108, P3189; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Sakita-Suto S, 2007, MOL BIOL CELL, V18, P1107, DOI 10.1091/mbc.E06-11-1021; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P185, DOI 10.1016/S0091-679X(08)60913-9; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Walker DL, 2000, J CELL BIOL, V151, P1401, DOI 10.1083/jcb.151.7.1401; Wasser M, 2000, NAT CELL BIOL, V2, P268, DOI 10.1038/35010535; Webb C, 1999, COLD SPRING HARB SYM, V64, P109, DOI 10.1101/sqb.1999.64.109; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	44	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1414	10.1371/journal.pone.0001414	http://dx.doi.org/10.1371/journal.pone.0001414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183295	gold, Green Published, Green Submitted			2022-12-27	WOS:000260469400011
J	Benner, EJ; Banerjee, R; Reynolds, AD; Sherman, S; Pisarev, VM; Tsiperson, V; Nemachek, C; Ciborowski, P; Przedborski, S; Mosley, RL; Gendelman, HE				Benner, Eric J.; Banerjee, Rebecca; Reynolds, Ashley D.; Sherman, Simon; Pisarev, Vladimir M.; Tsiperson, Vladislav; Nemachek, Craig; Ciborowski, Pawel; Przedborski, Serge; Mosley, R. Lee; Gendelman, Howard E.			Nitrated alpha-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons	PLOS ONE			English	Article							POSTTRANSLATIONAL PROTEIN MODIFICATIONS; AMYLOID-BETA-PEPTIDE; BLOOD-BRAIN-BARRIER; PARKINSONS-DISEASE; FIBRIL FORMATION; MOUSE MODEL; ALZHEIMER-DISEASE; SUBSTANTIA-NIGRA; T-CELLS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP	Background. The neuropathology of Parkinson's disease (PD) includes loss of dopaminergic neurons in the substantia nigra, nitrated alpha-synuclein (N-alpha-Syn) enriched intraneuronal inclusions or Lewy bodies and neuroinflammation. While the contribution of innate microglial inflammatory activities to disease are known, evidence for how adaptive immune mechanisms may affect the course of PD remains obscure. We reasoned that PD-associated oxidative protein modifications create novel antigenic epitopes capable of peripheral adaptive T cell responses that could affect nigrostriatal degeneration. Methods and Findings. Nitrotyrosine (NT)-modified alpha-Syn was detected readily in cervical lymph nodes (CLN) from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP) intoxicated mice. Antigen-presenting cells within the CLN showed increased surface expression of major histocompatibility complex class II, initiating the molecular machinery necessary for efficient antigen presentation. MPTP-treated mice produced antibodies to native and nitrated alpha-Syn. Mice immunized with the NT-modified C-terminal tail fragment of alpha-Syn, but not native protein, generated robust T cell proliferative and pro-inflammatory secretory responses specific only for the modified antigen. T cells generated against the nitrated epitope do not respond to the unmodified protein. Mice deficient in T and B lymphocytes were resistant to MPTP-induced neurodegeneration. Transfer of T cells from mice immunized with N-alpha-Syn led to a robust neuroinflammatory response with accelerated dopaminergic cell loss. Conclusions. These data show that NT modifications within alpha-Syn, can bypass or break immunological tolerance and activate peripheral leukocytes in draining lymphoid tissue. A novel mechanism for disease is made in that NT modifications in alpha-Syn induce adaptive immune responses that exacerbate PD pathobiology. These results have implications for both the pathogenesis and treatment of this disabling neurodegenerative disease.	[Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Neurol & Cell Biol, New York, NY 10027 USA; [Benner, Eric J.; Banerjee, Rebecca; Reynolds, Ashley D.; Tsiperson, Vladislav; Nemachek, Craig; Ciborowski, Pawel; Mosley, R. Lee; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Ctr Neurovirol & Neurodegen Dis, Dept Pharmacol & Exptl Neurosci, Omaha, NE USA; [Benner, Eric J.; Mosley, R. Lee] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Gendelman, Howard E.] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE USA; [Sherman, Simon; Pisarev, Vladimir M.] Univ Nebraska, Med Ctr, Nebraska Inf Ctr Life Sci, Eppley Canc Inst, Omaha, NE USA; [Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Neurol & Cell Biol, New York, NY 10027 USA.	SP30@Columbia.edu; rlmosley@unmc.edu; hegendel@unmc.edu	Gendelman, Howard E/G-8242-2012; Pisarev, Vladimir M./E-1373-2012	Pisarev, Vladimir M./0000-0002-5729-9846	National Institute of Neurological Disorders and Stroke [NS36136, NS43985, NS007488, NS42269, NS38370, NS11766, NS049264]; National Institute of Mental Health [MH64570]; National Institute of Aging [AG021617]; National Institute of Environmental Health Sciences [ES013177]; U.S. Department of Defense [17-03-1]; Parkinson's Disease Foundation [CU51523606]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766, T32NS007488, P01NS043985, P50NS038370, R21NS049264, R01NS042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the National Institute of Neurological Disorders and Stroke Grants (NS36136, NS43985, NS007488, NS42269, NS38370, NS11766 and NS049264); National Institute of Mental Health (MH64570); National Institute of Aging (AG021617); National Institute of Environmental Health Sciences (ES013177); U.S. Department of Defense Grant (17-03-1); the Parkinson's Disease Foundation (CU51523606) and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoura Z, 1999, ARTHRITIS RHEUM, V42, P833, DOI 10.1002/1529-0131(199905)42:5<833::AID-ANR1>3.3.CO;2-K; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; Burkhardt Harald, 2001, Trends in Immunology, V22, P291, DOI 10.1016/S1471-4906(01)01935-4; CasciolaRosen L, 1997, J EXP MED, V185, P71, DOI 10.1084/jem.185.1.71; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Ciborowski P, 2004, J NEUROIMMUNOL, V157, P11, DOI 10.1016/j.jneuroim.2004.08.033; Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Enose Y, 2005, GLIA, V51, P161, DOI 10.1002/glia.20193; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; FISZER U, 1994, ACTA NEUROL SCAND, V90, P160; Fiszer U, 1996, J NEUROL SCI, V139, P66, DOI 10.1016/S0022-510X(96)00002-0; FISZER U, 1994, J NEUROL SCI, V121, P39, DOI 10.1016/0022-510X(94)90154-6; Gendelman HE, 2002, J NEUROVIROL, V8, P474, DOI 10.1080/13550280290168631; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GLANZER JG, 2007, J NEUROCHEM; Guan Pingping, 2003, Appl Bioinformatics, V2, P63; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hisanaga K, 2001, ARCH NEUROL-CHICAGO, V58, P1580, DOI 10.1001/archneur.58.10.1580; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; KAPLAN HJ, 1977, J IMMUNOL, V118, P809; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Klockgether T, 2004, CELL TISSUE RES, V318, P115, DOI 10.1007/s00441-004-0975-6; Kosiewicz MM, 1996, J IMMUNOL, V157, P1905; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lampe JB, 2003, EUR NEUROL, V50, P64, DOI 10.1159/000072500; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; LE WD, 1995, J NEUROIMMUNOL, V57, P45, DOI 10.1016/0165-5728(94)00160-P; Liberatore GT, 1999, NAT MED, V5, P1403; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Ohmori H, 2005, AUTOIMMUN REV, V4, P224, DOI 10.1016/j.autrev.2004.11.011; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Przedborski S, 2001, J NEUROCHEM, V76, P637, DOI 10.1046/j.1471-4159.2001.00174.x; Ricardo-Dukelow M, 2007, J NEUROIMMUNOL, V185, P37, DOI 10.1016/j.jneuroim.2007.01.004; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shin EC, 2000, MOL CELLS, V10, P65, DOI 10.1007/s100590070011; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TANNER CM, 1992, OCCUP MED, V7, P503; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; Utz PJ, 1998, ARTHRITIS RHEUM, V41, P1152, DOI 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2005, MOL BRAIN RES, V134, P84, DOI 10.1016/j.molbrainres.2004.11.014; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wenkel H, 2000, J IMMUNOL, V164, P5125, DOI 10.4049/jimmunol.164.10.5125; Wersinger C, 2006, CURR MED CHEM, V13, P591, DOI 10.2174/092986706776055760; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	88	249	265	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1376	10.1371/journal.pone.0001376	http://dx.doi.org/10.1371/journal.pone.0001376			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167537	gold, Green Published, Green Submitted			2022-12-27	WOS:000260468900005
J	Gao, P; Xin, ZY; Zheng, ZL				Gao, Peng; Xin, Zeyu; Zheng, Zhi-Liang			The OSU1/QUA2/TSD2-Encoded Putative Methyltransferase Is a Critical Modulator of Carbon and Nitrogen Nutrient Balance Response in Arabidopsis	PLOS ONE			English	Article							LATERAL ROOT INITIATION; ROP10 SMALL GTPASE; ABSCISIC-ACID; GENE-EXPRESSION; AMINO-ACIDS; ASPARAGINE SYNTHETASE; GLUTAMINE-SYNTHETASE; SIGNAL-TRANSDUCTION; PROTEIN; PLANTS	The balance between carbon (C) and nitrogen (N) nutrients must be tightly coordinated so that cells can optimize their opportunity for metabolism, growth and development. However, the C and N nutrient balance perception and signaling mechanism remains poorly understood. Here, we report the isolation and characterization of two allelic oversensitive to sugar1 mutants (osu1-1, osu1-2) in Arabidopsis thaliana. Using the cotyledon anthocyanin accumulation and root growth inhibition assays, we show that the osu1 mutants are more sensitive than wild-type to both of the imbalanced C/N conditions, high C/low N and low C/high N. However, under the balanced C/N conditions (low C/low N or high C/high N), the osu1 mutants have similar anthocyanin levels and root lengths as wild-type. Consistently, the genes encoding two MYB transcription factors (MYB75 and MYB90) and an Asn synthetase isoform (ASN1) are strongly up-regulated by the OSU1 mutation in response to high C/low N and low C/high N, respectively. Furthermore, the enhanced sensitivity of osu1-1 to high C/low N with respect to anthocyanin accumulation but not root growth inhibition can be suppressed by co-suppression of MYB75, indicating that MYB75 acts downstream of OSU1 in the high C/low N imbalance response. Map-based cloning reveals that OSU1 encodes a member of a large family of putative methyltransferases and is allelic to the recently reported QUA2/TSD2 locus identified in genetic screens for cell-adhesion-defective mutants. Accumulation of OSU1/QUA2/TSD2 transcript was not regulated by C and N balance, but the OSU1 promoter was slightly more active in the vascular system. Taken together, our results show that the OSU1/QUA2/TSD2-encoded putative methyltransferase is required for normal C/N nutrient balance response in plants.	[Gao, Peng; Xin, Zeyu; Zheng, Zhi-Liang] CUNY, Dept Biol Sci, Lehman Coll, Bronx, NY USA; [Zheng, Zhi-Liang] CUNY, Grad Sch & Univ Ctr, Plant Sci PhD Subprog, New York, NY USA	City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System	Zheng, ZL (corresponding author), CUNY, Dept Biol Sci, Lehman Coll, Bronx, NY USA.	zhiliang.zheng@lehman.cuny.edu			NIH [S06GM008225]; City University of New York PSC-CUNY program [68436-00-37]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008225] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City University of New York PSC-CUNY program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH-SCORE grant (S06GM008225, Project Number 12 to Z-LZ) and in part by the City University of New York PSC-CUNY program (68436-00-37 to Z-LZ).	Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Dan H, 2007, PLANT MOL BIOL, V63, P221, DOI 10.1007/s11103-006-9084-0; Ferrario-Mery S, 2005, PLANTA, V223, P28, DOI 10.1007/s00425-005-0063-5; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Ishiyama K, 2004, J BIOL CHEM, V279, P16598, DOI 10.1074/jbc.M313710200; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karthikeyan AS, 2007, PLANTA, V225, P907, DOI 10.1007/s00425-006-0408-8; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Krupkova E, 2007, PLANT J, V50, P735, DOI 10.1111/j.1365-313X.2007.03123.x; Lam HM, 1998, PLANT J, V16, P345, DOI 10.1046/j.1365-313x.1998.00302.x; Lam HM, 2003, PLANT PHYSIOL, V132, P926, DOI 10.1104/pp.103.020123; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Lea US, 2007, PLANTA, V225, P1245, DOI 10.1007/s00425-006-0414-x; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Matsui K, 2004, PLANT BIOTECHNOL J, V2, P487, DOI 10.1111/j.1467-7652.2004.00094.x; MeloOliveira R, 1996, P NATL ACAD SCI USA, V93, P4718, DOI 10.1073/pnas.93.10.4718; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moorhead GBG, 2003, PLANT PHYSIOL, V133, P492, DOI 10.1104/pp.103.025627; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Peter GJ, 2006, J BIOL CHEM, V281, P5546, DOI 10.1074/jbc.M513842200; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Sun CW, 1997, PLANT J, V11, P1017, DOI 10.1046/j.1365-313X.1997.11051017.x; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Xin ZY, 2005, PLANT PHYSIOL, V139, P1350, DOI 10.1104/pp.105.068064; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zheng ZL, 2002, PLANT CELL, V14, P2787, DOI 10.1105/tpc.005611	62	35	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1387	10.1371/journal.pone.0001387	http://dx.doi.org/10.1371/journal.pone.0001387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167546	gold, Green Published			2022-12-27	WOS:000260468900015
J	Shaykhiev, R; Behr, J; Bals, R				Shaykhiev, Renat; Behr, Juergen; Bals, Robert			Microbial Patterns Signaling via Toll-Like Receptors 2 and 5 Contribute to Epithelial Repair, Growth and Survival	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; STAPHYLOCOCCUS-AUREUS; CELL-PROLIFERATION; WOUND REPAIR; INNATE IMMUNITY; CUTTING EDGE; HOST-DEFENSE; LIPOPOLYSACCHARIDE; INFLAMMATION; RECOGNITION	Epithelial cells (ECs) continuously interact with microorganisms and detect their presence via different pattern-recognition receptors (PRRs) including Toll-like receptors (TLRs). Ligation of epithelial TLRs by pathogens is usually associated with the induction of pro-inflammatory mediators and antimicrobial factors. In this study, using human airway ECs as a model, we found that detection of microbial patterns via epithelial TLRs directly regulates tissue homeostasis. Staphylococcus aureus(S. aureus) and microbial patterns signaling via TLR2 and TLR5 induce a set of non-immune epithelial responses including cell migration, wound repair, proliferation, and survival of primary and cancerous ECs. Using small interfering RNA (siRNA) gene targeting, receptor-tyrosine kinase microarray and inhibition studies, we determined that TLR and the epidermal growth factor receptor (EGFR) mediate the stimulating effect of microbial patterns on epithelial repair. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. This effect is independent of hematopoietic and other cells as well as inflammatory cytokines suggesting that epithelia are able to regulate their integrity in an autonomous non-inflammatory manner by sensing microbes directly via TLRs.	[Shaykhiev, Renat; Bals, Robert] Univ Marburg, Dept Internal Med, Div Pulm Dis, D-3550 Marburg, Germany; [Behr, Juergen] Univ Munich, Dept Intern Med, Div Pulmonary Dis, Munich, Germany	Philipps University Marburg; University of Munich	Bals, R (corresponding author), Univ Marburg, Dept Internal Med, Div Pulm Dis, D-3550 Marburg, Germany.	bals@staff.uni-marburg.de	Shaykhiev, Renat/D-2855-2011		Deutsche Forschungsgemeinschaft Ba [1641/7, SFB/TR22]; Wilhelm Sander Stiftung	Deutsche Forschungsgemeinschaft Ba(German Research Foundation (DFG)); Wilhelm Sander Stiftung	This study was supported by the Deutsche Forschungsgemeinschaft Ba 1641/7, SFB/TR22 (A8) and the Wilhelm Sander Stiftung to Robert Bals. The sponsors were not involved in collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2000, J ENDOTOXIN RES, V6, P383, DOI 10.1177/09680519000060050901; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Geiser T, 2000, AM J PHYSIOL-LUNG C, V279, pL1184, DOI 10.1152/ajplung.2000.279.6.L1184; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024; Hasan UA, 2007, P NATL ACAD SCI USA, V104, P8047, DOI 10.1073/pnas.0700664104; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hornef MW, 2005, J ENDOTOXIN RES, V11, P124, DOI 10.1179/096805105X35224; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Hou YF, 2006, MOL IMMUNOL, V43, P1982, DOI 10.1016/j.molimm.2005.11.013; Itoh Y, 2005, CYTOKINE, V29, P275, DOI 10.1016/j.cyto.2004.11.005; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KANG YH, 1995, SHOCK, V4, P441; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Kojima M, 2000, ONCOGENE, V19, P1225, DOI 10.1038/sj.onc.1203427; Lambiase A, 2000, INVEST OPHTH VIS SCI, V41, P1063; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; NUSRAT A, 1994, J CLIN INVEST, V93, P2056, DOI 10.1172/JCI117200; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sato A, 2006, J GASTROEN HEPATOL, V21, P521, DOI 10.1111/j.1440-1746.2005.03977.x; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Togbe D, 2006, J LEUKOCYTE BIOL, V80, P451, DOI 10.1189/jlb.0206099; Valverde P, 2004, EXP EYE RES, V78, P27, DOI 10.1016/j.exer.2003.10.002; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Whitsett JA, 2002, J CLIN INVEST, V109, P565, DOI 10.1172/JCI200215209; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yoshimura A, 1999, J IMMUNOL, V163, P1	50	69	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1393	10.1371/journal.pone.0001393	http://dx.doi.org/10.1371/journal.pone.0001393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167552	Green Published, gold, Green Submitted			2022-12-27	WOS:000260468900021
J	Bluteau, J; Coquillart, S; Payan, Y; Gentaz, E				Bluteau, Jeremy; Coquillart, Sabine; Payan, Yohan; Gentaz, Edouard			Haptic Guidance Improves the Visuo-Manual Tracking of Trajectories	PLOS ONE			English	Article							INTERNAL-MODELS; MOVEMENT	Background: Learning to perform new movements is usually achieved by following visual demonstrations. Haptic guidance by a force feedback device is a recent and original technology which provides additional proprioceptive cues during visuo-motor learning tasks. The effects of two types of haptic guidances-control in position (HGP) or in force (HGF)-on visuo-manual tracking ("following") of trajectories are still under debate. Methodology/Principals Findings: Three training techniques of haptic guidance (HGP, HGF or control condition, NHG, without haptic guidance) were evaluated in two experiments. Movements produced by adults were assessed in terms of shapes (dynamic time warping) and kinematics criteria (number of velocity peaks and mean velocity) before and after the training sessions. Trajectories consisted of two Arabic and two Japanese-inspired letters in Experiment 1 and ellipses in Experiment 2. We observed that the use of HGF globally improves the fluency of the visuo-manual tracking of trajectories while no significant improvement was found for HGP or NHG. Conclusion/Significance: These results show that the addition of haptic information, probably encoded in force coordinates, play a crucial role on the visuo-manual tracking of new trajectories.	[Bluteau, Jeremy; Coquillart, Sabine] Inst Natl Rech Informat & Automat, LIG, Grenoble, France; [Bluteau, Jeremy; Payan, Yohan] Univ Joseph Fourier, CNRS, TIMC IMAG, Grenoble, France; [Bluteau, Jeremy; Gentaz, Edouard] Univ Pierre Mendes France, CNRS, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bluteau, J (corresponding author), Inst Natl Rech Informat & Automat, LIG, Grenoble, France.	edouard.gentaz@upmf-grenoble.fr	Payan, Yohan/N-3980-2019; PAYAN, Yohan/E-3993-2013	Payan, Yohan/0000-0002-6012-4123; PAYAN, Yohan/0000-0002-6012-4123; Gentaz, Edouard/0000-0003-0574-5557	Region Rhone-Alpes	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	We thank "Region Rhone-Alpes", especially the Cluster ISLE-II and the PPF "Interactions Multimodales" for the partial funding of this research.	Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; CONTI F, 2003, EUROHAPTICS 03; Feygin D, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P40, DOI 10.1109/HAPTIC.2002.998939; GILLESPIE PTC, 1998, ASME INT MECH ENG C, V64, P171; Henmi K, 1998, IEEE INT CONF ROBOT, P1275, DOI 10.1109/ROBOT.1998.677278; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Liu J, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-20; Morris D, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P21; Niels R., 2004, THESIS RADBOUD U NIJ; PALLUELGERMAIN R, 2007, P IEEE WORLD HAPT 20, V2007, P72; SCHMIDT RA, 1987, MOTOR CONTROL LEARNI; Solis J, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P255, DOI 10.1109/HAPTIC.2002.998966; Srimathveeravalli G, 2005, WORLD HAPTICS CONFERENCE: FIRST JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRUTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P452; Teo CL, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P335, DOI 10.1109/HAPTIC.2002.998977; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; VIVIANI P, 1991, J EXP PSYCHOL HUMAN, V17, P198, DOI 10.1037/0096-1523.17.1.198; Yokokohji Y, 1996, P IEEE VIRT REAL ANN, P46, DOI 10.1109/VRAIS.1996.490509	19	91	91	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1775	10.1371/journal.pone.0001775	http://dx.doi.org/10.1371/journal.pone.0001775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335049	gold, Green Submitted, Green Published			2022-12-27	WOS:000260723000028
J	Chinappen-Horsley, U; Blake, GM; Fogelman, I; Kato, B; Ahmadi, KR; Spector, TD				Chinappen-Horsley, Usha; Blake, Glen M.; Fogelman, Ignac; Kato, Bernet; Ahmadi, Kourosh R.; Spector, Tim D.			Quantitative Trait Loci for Bone Lengths on Chromosome 5 Using Dual Energy X-Ray Absorptiometry Imaging in the Twins UK Cohort	PLOS ONE			English	Article								Human height is a highly heritable and complex trait but finding important genes has proven more difficult than expected. One reason might be the composite measure of height which may add heterogeneity and noise. The aim of this study was to conduct a genome-wide linkage scan to identify quantitative trait loci (QTL) for lengths of spine, femur, tibia, humerus and radius. These were investigated as alternative measures for height in a large, population-based twin sample with the potential to find genes underlying bone size and bone diseases. 3,782 normal Caucasian females, 18-80 years old, with whole body dual energy X-ray absorptiometry (DXA) images were used. A novel and reproducible method, linear pixel count (LPC) was used to measure skeletal sizes on DXA images. Intraclass correlations and heritability estimates were calculated for lengths of spine, femur, tibia, humerus and radius on monozygotic (MZ; n = 1,157) and dizygotic (DZ; n = 2,594) twins. A genome-wide linkage scan was performed on 2000 DZ twin subjects. All skeletal sites excluding spine were highly correlated. Intraclass correlations showed results for MZ twins to be significantly higher than DZ twins for all traits. Heritability results were as follows: spine, 66%; femur, 73%; tibia, 65%; humerus, 57%; radius, 68%. Results showed reliable evidence of highly suggestive linkage on chromosome 5 for spine (LOD score = 3.0) and suggestive linkage for femur (LOD score = 2.19) in the regions of 105cM and 155cM respectively. We have shown strong heritability of all skeletal sizes measured in this study and provide preliminary evidence that spine length is linked to the chromosomal region 5q15-5q23.1. Bone size phenotype appears to be more useful than traditional height measures to uncover novel genes. Replication and further fine mapping of this region is ongoing to determine potential genes influencing bone size and diseases affecting bone.	[Chinappen-Horsley, Usha; Kato, Bernet; Ahmadi, Kourosh R.; Spector, Tim D.] St Thomas Hosp, Kings Coll London Sch Med, Twin Res & Genet Epidemiol Unit, London, England; [Chinappen-Horsley, Usha; Blake, Glen M.; Fogelman, Ignac; Spector, Tim D.] Guys Hosp, Kings Coll London Sch Med, Dept Nuclear Med, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Chinappen-Horsley, U (corresponding author), St Thomas Hosp, Kings Coll London Sch Med, Twin Res & Genet Epidemiol Unit, London, England.	usha.chinappen@kcl.ac.uk	Ahmadi, Kourosh R/B-6379-2012		BBSRC; Wellcome Trust	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	BBSRC and Wellcome Trust for funding.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Antoniades L, 2003, RHEUMATOLOGY, V42, P791, DOI 10.1093/rheumatology/keg227; Arden NK, 1996, J BONE MINER RES, V11, P530; Barber MJ, 2004, GENET EPIDEMIOL, V26, P97, DOI 10.1002/gepi.10299; Beck SR, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S31; Chen Y, 2007, AM J HUM BIOL, V19, P559, DOI 10.1002/ajhb.20619; Chinappen-Horsley U, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-113; Deng HW, 2002, AM J MED GENET, V113, P29, DOI 10.1002/ajmg.10742; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Iturria SJ, 1999, GENET EPIDEMIOL, V17, pS169; Kenchappa RS, 2002, J NEUROSCI, V22, P8402; Krishna J, 1997, CLIN GENET, V51, P48; Martin R. B., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P209; Neale MC, 2006, STAT MODELING; Niwa T, 2007, J CHROMATOGR B, V855, P59, DOI 10.1016/j.jchromb.2006.12.029; Palloni A, 2005, J GERONTOL A-BIOL, V60, P804, DOI 10.1093/gerona/60.6.804; Parker JM, 1996, AM J RESP CRIT CARE, V154, P533, DOI 10.1164/ajrccm.154.2.8756834; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Ritz P, 2004, J Nutr Health Aging, V8, P386; Sale MM, 2005, ANN HUM GENET, V69, P517, DOI 10.1046/j.1529-8817.2005.00176.x; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; SMITH WDF, 1992, J GERONTOL, V47, pM40, DOI 10.1093/geronj/47.2.M40; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Stata Statistical Software (computer software) [program], 2005, STAT STAT SOFTW COMP; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Willemsen G, 2004, EUR J HUM GENET, V12, P820, DOI 10.1038/sj.ejhg.5201229; Wilson SG, 2004, J BONE MINER RES, V19, P270, DOI 10.1359/JBMR.0301224; Wu XD, 2003, EUR J HUM GENET, V11, P271, DOI 10.1038/sj.ejhg.5200952	34	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1752	10.1371/journal.pone.0001752	http://dx.doi.org/10.1371/journal.pone.0001752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335030	Green Submitted, Green Published, gold			2022-12-27	WOS:000260723000006
J	Obermeyer, Z; Abbott-Klafter, J; Murray, CJL				Obermeyer, Ziad; Abbott-Klafter, Jesse; Murray, Christopher J. L.			Has the DOTS Strategy Improved Case Finding or Treatment Success? An Empirical Assessment	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DIRECTLY OBSERVED THERAPY; TUBERCULOSIS-CONTROL; GLOBAL TRENDS; BURDEN; PREVALENCE; COUNTRIES; HIV; VACCINATION; CONVERSION	Background: Nearly fifteen years after the start of WHO's DOTS strategy, tuberculosis remains a major global health problem. Given the lack of empirical evidence that DOTS reduces tuberculosis burden, considerable debate has arisen about its place in the future of global tuberculosis control efforts. An independent evaluation of DOTS, one of the most widely-implemented and longest-running interventions in global health, is a prerequisite for meaningful improvements to tuberculosis control efforts, including WHO's new Stop TB Strategy. We investigate the impact of the expansion of the DOTS strategy on tuberculosis case finding and treatment success, using only empirical data. Methods and Findings: We study the effect of DOTS using time-series cross-sectional methods. We first estimate the impact of DOTS expansion on case detection, using reported case notification data and controlling for other determinants of change in notifications, including HIV prevalence, GDP, and country-specific effects. We then estimate the effect of DOTS expansion on treatment success. DOTS programme variables had no statistically significant impact on case detection in a wide range of models and specifications. DOTS population coverage had a significant effect on overall treatment success rates, such that countries with full DOTS coverage benefit from at least an 18% increase in treatment success (95% CI: 5-31%). Conclusions: The DOTS technical package improved overall treatment success. By contrast, DOTS expansion had no effect on case detection. This finding is less optimistic than previous analyses. Better epidemiological and programme data would facilitate future monitoring and evaluation efforts.	[Obermeyer, Ziad] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Obermeyer, Ziad; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metrics & Eval, Seattle, WA USA; [Abbott-Klafter, Jesse] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Harvard University; Harvard Medical School; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Obermeyer, Z (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	ziad_obermeyer@hms.harvard.edu			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by a grant from the Bill and Melinda Gates Foundation to the Institute for Health Metrics and Evaluation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GLOB TUB CONTR SURV; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; [Anonymous], 2001, WHOCDSTB2001287; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Beck N, 2001, ANNU REV POLIT SCI, V4, P271, DOI 10.1146/annurev.polisci.4.1.271; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; BLEED D, 2000, WHOCDSTB2000275; *CDC, 2007, GLOB HLTH ACT EP; Chen XY, 2004, LANCET, V364, P417; *CHIN CDCP, 2007, CHIN DIS SURV SYST; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Diel R, 2006, EUR RESPIR J, V28, P16, DOI 10.1183/09031936.06.00107005; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; EDWARDS LB, 1969, AM REV RESP DIS S132, V99; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; HERBST K, 2002, S AFRICA HLTH REV 20, P373; Hill AR, 2002, MEDICINE, V81, P179, DOI 10.1097/00005792-200205000-00002; Huong NT, 2006, INT J TUBERC LUNG D, V10, P963; Katz JonathanN., 1996, POLIT ANAL, V6, DOI [10.1093/pan/6.1.1, DOI 10.1093/PAN/6.1.1]; *KOR TUB SURV SYST, 2007, BACKGR KOR TUB SURV; KRISTENSEN IP, 2003, SOC POL METH SUMM ME; Lienhardt C, 2004, TROP MED INT HEALTH, V9, P833, DOI 10.1111/j.1365-3156.2004.01273.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lu CL, 2006, LANCET, V368, P1088, DOI 10.1016/S0140-6736(06)69337-9; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; *MED SAN FRONT CAM, 2004, RUNN OUT BREATH TB C; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; MENZIES R, 1992, AM REV RESPIR DIS, V145, P621, DOI 10.1164/ajrccm/145.3.621; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; NETTO E, 1999, WHOTB99259; NETTO E, 1999, WHOTB98237; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Porco TC, 1998, THEOR POPUL BIOL, V54, P117, DOI 10.1006/tpbi.1998.1366; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; Raviglione MC, 2002, LANCET, V359, P775, DOI 10.1016/S0140-6736(02)07880-7; RAVIGLIONE MC, 1997, WHOTB97225; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; ROELSGAARD E., 1964, BULL WORLD HEALTH ORGAN, V30, P459; Sebhatu M, 2007, B WORLD HEALTH ORGAN, V85, P593, DOI 10.2471/BLT.06.038604; Shafey O, 2003, TOBACCO CONTROL COUN; Squire SB, 2004, LANCET, V364, P391, DOI 10.1016/S0140-6736(04)16777-9; STYBLO K, 1989, REV INFECT DIS, V11, pS339; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; *UN STAT DIV, 2006, UN COMM DAT; *UNAIDS, 2006, EST AD HIV PRE UNPUB; UNAIDS, 2006, REP GLOB AIDS EP; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; van der Werf MJ, 2007, B WORLD HEALTH ORGAN, V85, P370, DOI 10.2471/BLT.06.039941; Volmink J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub2; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; Vranken R, 2002, INT J TUBERC LUNG D, V6, P111; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; *WHO, 2006, EP EXP IND TB PROGR; *WHO, 2004, GLOB TUB CONTR; *WHO, 2006, GLOB TUB CONTR SURV; *WHO, 2005, GLOB TUB CONTR SURV; *WHO, 2003, WHOCDSTB2003316; *WHO UNICEF, 2006, WHO UNICEF VACC COV; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Health Organization, 2002, GLOB TUB CONTR SURV; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	78	61	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1721	10.1371/journal.pone.0001721	http://dx.doi.org/10.1371/journal.pone.0001721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320042	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586600017
J	Mallajosyula, JK; Kaur, D; Chinta, SJ; Rajagopalan, S; Rane, A; Nicholls, DG; Di Monte, DA; Macarthur, H; Andersen, JK				Mallajosyula, Jyothi K.; Kaur, Deepinder; Chinta, Shankar J.; Rajagopalan, Subramanian; Rane, Anand; Nicholls, David G.; Di Monte, Donato A.; Macarthur, Heather; Andersen, Julie K.			MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology	PLOS ONE			English	Article								Age-related increases in monoamine oxidase B (MAO-B) may contribute to neurodegeneration associated with Parkinson's disease (PD). The MAO-B inhibitor deprenyl, a long-standing antiparkinsonian therapy, is currently used clinically in concert with the dopamine precursor L-DOPA. Clinical studies suggesting that deprenyl treatment alone is not protective against PD associated mortality were targeted to symptomatic patients. However, dopamine loss is at least 60% by the time PD is symptomatically detectable, therefore lack of effect of MAO-B inhibition in these patients does not negate a role for MAO-B in pre-symptomatic dopaminergic loss. In order to directly evaluate the role of age-related elevations in astroglial MAO-B in the early initiation or progression of PD, we created genetically engineered transgenic mice in which MAO-B levels could be specifically induced within astroglia in adult animals. Elevated astrocytic MAO-B mimicking age related increase resulted in specific, selective and progressive loss of dopaminergic neurons in the substantia nigra (SN), the same subset of neurons primarily impacted in the human condition. This was accompanied by other PD-related alterations including selective decreases in mitochondrial complex I activity and increased mitochondrial oxidative stress. Along with a global astrogliosis, we observed local microglial activation within the SN. These pathologies correlated with decreased locomotor activity. Importantly, these events occurred even in the absence of the PD-inducing neurotoxin MPTP. Our data demonstrates that elevation of murine astrocytic MAO-B by itself can induce several phenotypes of PD, signifying that MAO-B could be directly involved in multiple aspects of disease neuropathology. Mechanistically this may involve increases in membrane permeant H(2)O(2) which can oxidize dopamine within dopaminergic neurons to dopaminochrome which, via interaction with mitochondrial complex I, can result in increased mitochondrial superoxide. Our inducible astrocytic MAO-B transgenic provides a novel model for exploring pathways involved in initiation and progression of several key features associated with PD pathology and for therapeutic drug testing.	[Mallajosyula, Jyothi K.; Kaur, Deepinder; Chinta, Shankar J.; Rajagopalan, Subramanian; Rane, Anand; Nicholls, David G.; Andersen, Julie K.] Buck Inst Age Res, Novato, CA USA; [Di Monte, Donato A.] Parkinsons Inst, Basic Sci Res, Sunnyvale, CA USA; [Macarthur, Heather] Saint Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO USA	Buck Institute for Research on Aging; Saint Louis University	Mallajosyula, JK (corresponding author), Buck Inst Age Res, Novato, CA USA.	jandersen@buckinstitute.org	NICHOLLS, DAVID G/K-4300-2012; Rane, Anders/L-2675-2013; Zhu, Longjun/C-2938-2012	Di Monte, Donato/0000-0002-8296-836X; Andersen, Julie/0000-0003-1324-4875	National Parkinson's Foundation [R01 NS40057-04]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040057] Funding Source: NIH RePORTER	National Parkinson's Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were funded via R01 NS40057-04 (JKA) and the National Parkinson's Foundation (JKM).	ADAMS JD, 1991, FREE RADICAL BIO MED, V10, P161, DOI 10.1016/0891-5849(91)90009-R; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BUCKMAN TD, 1993, J NEUROCHEM, V60, P2046, DOI 10.1111/j.1471-4159.1993.tb03489.x; BUDD DC, 1995, J NEUROCHEM, V65, P615; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Cohen G, 1983, J Neural Transm Suppl, V19, P89; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; Damier P, 1996, NEUROLOGY, V46, P1262, DOI 10.1212/WNL.46.5.1262; DOCHERTY M, 1991, J NEUROCHEM, V56, P1569, DOI 10.1111/j.1471-4159.1991.tb02053.x; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; FOWLER CJ, 1980, J NEURAL TRANSM, V49, P1, DOI 10.1007/BF01249185; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Gerlach M, 1996, NEUROLOGY, V47, pS137, DOI 10.1212/WNL.47.6_Suppl_3.137S; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; IRWIN I, 1992, BRAIN RES, V572, P224, DOI 10.1016/0006-8993(92)90473-M; Kang YS, 1997, NEUROREPORT, V8, P2053, DOI 10.1097/00001756-199705260-00049; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kumar MJ, 2003, J BIOL CHEM, V278, P46432, DOI 10.1074/jbc.M306378200; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; LEVITT P, 1982, P NATL ACAD SCI-BIOL, V79, P6385, DOI 10.1073/pnas.79.20.6385; LEWITT PA, 1994, J NEURAL TRANSM-SUPP, P171; Magyar K, 2004, NEUROTOXICOLOGY, V25, P233, DOI 10.1016/S0161-813X(03)00102-5; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Mandel S, 2003, CNS DRUGS, V17, P729, DOI 10.2165/00023210-200317100-00004; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Miller J.H., 1972, EXPT MOL GENETICS; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Ochs SD, 2005, J NEUROSCI METH, V142, P201, DOI 10.1016/j.jneumeth.2004.08.010; OLANOW CW, 1993, MOVEMENT DISORD, V8, pS1, DOI 10.1002/mds.870080503; Peng J, 2002, J BIOL CHEM, V277, P44285, DOI 10.1074/jbc.M207407200; Peng J, 2006, J NEUROSCI, V26, P11644, DOI 10.1523/JNEUROSCI.3447-06.2006; PICKEL VM, 1992, DEV BRAIN RES, V70, P75, DOI 10.1016/0165-3806(92)90105-6; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Riederer P, 1987, Adv Neurol, V45, P111; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; SAURA J, 1994, J NEURAL TRANSM-SUPP, P89; Schneider E, 1995, J NEURAL TRANSM-SUPP, P391; SCHNEIDER JS, 1988, J NEUROPATH EXP NEUR, V47, P452, DOI 10.1097/00005072-198807000-00006; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; SHOULSON I, 1992, EUR NEUROL, V32, P46; Shoulson I, 1998, ANN NEUROL, V43, P318; Smith DW, 2004, NEUROREPORT, V15, P1025, DOI 10.1097/00001756-200404290-00018; SOONG NW, 1992, NAT GENET, V2, P318; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Szende B, 2001, J NEURAL TRANSM, V108, P25, DOI 10.1007/s007020170094; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Vindis C, 2001, KIDNEY INT, V59, P76, DOI 10.1046/j.1523-1755.2001.00468.x; Wei Q, 1996, J NEUROSCI RES, V46, P666; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3; WESTLUND KN, 1985, SCIENCE, V230, P181, DOI 10.1126/science.3875898; WHITTEMORE ER, 1994, NEUROREPORT, V5, P1485, DOI 10.1097/00001756-199407000-00019; Wu RM, 1996, ANN NY ACAD SCI, V786, P379, DOI 10.1111/j.1749-6632.1996.tb39078.x; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; Youdim MBH, 2006, BRIT J PHARMACOL, V147, pS287, DOI 10.1038/sj.bjp.0706464; Zoccarato F, 2005, J BIOL CHEM, V280, P15587, DOI 10.1074/jbc.M500657200	62	186	190	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1616	10.1371/journal.pone.0001616	http://dx.doi.org/10.1371/journal.pone.0001616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286173	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586400009
J	Alten, JA; Moran, A; Tsimelzon, AI; Mastrangelo, MAA; Hilsenbeck, SG; Poli, V; Tweardy, DJ				Alten, Jeffrey A.; Moran, Ana; Tsimelzon, Anna I.; Mastrangelo, Mary-Ann A.; Hilsenbeck, Susan G.; Poli, Valeria; Tweardy, David J.			Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3	PLOS ONE			English	Article								Half of trauma deaths are attributable to hypovolemic circulatory collapse (HCC). We established a model of HCC in rats involving minor trauma plus severe hemorrhagic shock (HS). HCC in this model was accompanied by a 50% reduction in peak acceleration of aortic blood flow and cardiomyocyte apoptosis. HCC and apoptosis increased with increasing duration of hypotension. Apoptosis required resuscitation, which provided an opportunity to intervene therapeutically. Administration of IL-6 completely reversed HCC, prevented cardiac dysfunction and cardiomyocyte apoptosis, reduced mortality 5-fold and activated intracardiac signal transducer and activator of transcription (STAT) 3. Pre-treatment of rats with a selective inhibitor of Stat3, T40214, reduced the IL-6-mediated increase in cardiac Stat3 activity, blocked successful resuscitation by IL-6 and reversed IL-6-mediated protection from cardiac apoptosis. The hearts of mice deficient in the naturally occurring dominant negative isoform of Stat3, Stat3 beta, were completely resistant to HS-induced apoptosis. Microarray analysis of hearts focusing on apoptosis related genes revealed that expression of 29% of apoptosis related genes was altered in HS vs. sham rats. IL-6 treatment normalized the expression of these genes, while T40214 pretreatment prevented IL-6-mediated normalization. Thus, cardiac dysfunction, cardiomyocyte apoptosis and induction of apoptosis pathway genes are important components of HCC; IL-6 administration prevented HCC by blocking cardiomyocyte apoptosis and induction of apoptosis pathway genes via Stat3 and warrants further study as a resuscitation adjuvant for prevention of HCC and death in trauma patients.	[Alten, Jeffrey A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Tsimelzon, Anna I.; Hilsenbeck, Susan G.] Baylor Coll Med, Breast Care Ctr, Dept Med, Houston, TX USA; [Moran, Ana; Mastrangelo, Mary-Ann A.; Tweardy, David J.] Baylor Coll Med, Dept Med, Houston, TX USA; [Tweardy, David J.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX USA; [Poli, Valeria] Univ Turin, Dept Genet, Biol & Biochem, Turin, Italy	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Turin	Alten, JA (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	dtweardy@bcm.edu	Poli, Valeria/A-9215-2012; Tweardy, David/L-3929-2019	Poli, Valeria/0000-0002-3739-3966; 	National Heart, Lung and Blood Institute of the NIH [HL076169]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066991, R01HL076169] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grant HL076169 (DJT) from the National Heart, Lung and Blood Institute of the NIH.	Atweh N, 2000, J TRAUMA, V49, P53; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brocheriou V, 2000, J GENE MED, V2, P326, DOI 10.1002/1521-2254(200009/10)2:5<326::AID-JGM133>3.0.CO;2-1; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Deb S, 1999, J TRAUMA, V46, P582, DOI 10.1097/00005373-199904000-00005; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; HARTLEY CJ, 1995, AM J PHYSIOL-HEART C, V268, pH499, DOI 10.1152/ajpheart.1995.268.1.H499; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hirano T, 1998, Int Rev Immunol, V16, P249; Holcroft JW, 1999, J TRAUMA, V46, P588; Hsu Hui-Chen, 2004, Current Drug Targets - Inflammation and Allergy, V3, P413, DOI 10.2174/1568010042634523; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; LAMBERT CR, 1983, AM HEART J, V106, P136, DOI 10.1016/0002-8703(83)90451-9; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Peden M, 2002, INJURY LEADING CAUSE; PEITZMAN AB, 1995, CURR PROB SURG, V32, P930; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sahai H., 2000, ANAL VARIANCE FIXED; Saura M, 2006, J BIOL CHEM, V281, P30057, DOI 10.1074/jbc.M606279200; Shao H, 2006, J IMMUNOL, V176, P2933, DOI 10.4049/jimmunol.176.5.2933; Subrato D, 2000, J TRAUMA, V49, P47, DOI 10.1097/00005373-200007000-00007; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WIGGERS CJ, 1947, AM HEART J, V33, P633, DOI 10.1016/0002-8703(47)90079-3; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhao MM, 2004, PHYSIOL GENOMICS, V19, P93, DOI 10.1152/physiolgenomics.00040.2004	38	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1605	10.1371/journal.pone.0001605	http://dx.doi.org/10.1371/journal.pone.0001605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270592	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900039
J	Wassie, L; Demissie, A; Aseffa, A; Abebe, M; Yamuah, L; Tilahun, H; Petros, B; Rook, G; Zumla, A; Andersen, P; Doherty, TM				Wassie, Liya; Demissie, Abebech; Aseffa, Abraham; Abebe, Markos; Yamuah, Lawrence; Tilahun, Hiwot; Petros, Beyene; Rook, Graham; Zumla, Alimuddin; Andersen, Peter; Doherty, T. Mark		VACSEL Study Grp	Ex Vivo Cytokine mRNA Levels Correlate with Changing Clinical Status of Ethiopian TB Patients and their Contacts Over Time	PLOS ONE			English	Article							INTERFERON-GAMMA PRODUCTION; DECREASED IFN-GAMMA; GROWTH-FACTOR-BETA; MYCOBACTERIUM-TUBERCULOSIS; SPLICE VARIANT; ACTIVE TUBERCULOSIS; ENCODING IL-4; CELLS; INFECTION; INTERLEUKIN-4	There is an increasing body of evidence which suggests that IL-4 plays a role in the pathogenesis of TB, but a general consensus on its role remains elusive. We have previously published data from a cohort of Ethiopian TB patients, their contacts, and community controls suggesting that enhanced IL-4 production is associated with infection with M. tuberculosis, rather than overt disease and that long-term protection in infected community controls is associated with co-production of the IL-4 antagonist IL-4 delta 2, alongside elevated IL-4. Here, for the first time, we compare data on expression of IFN-gamma, IL-4 and IL-4 delta 2 over time in TB patients and their household contacts. During the follow-up period, the TB patients completed therapy and ceased to display TB-like symptoms. This correlated with a decrease in the relative amount of IL- 4 expressed. Over the same period, the clinical status of some of their contacts also changed, with a number developing TB-like symptoms or clinically apparent TB. IL-4 expression was disproportionately increased in this group. The findings support the hypothesis that elevated IL-4 production is generally associated with infection, but that TB disease is associated with a relatively increased expression of IL-4 compared to IFN-gamma and IL-4 delta 2. However, the data also suggest that there are no clear-cut differences between groups: the immune response over time appears to include changes in the expression of IFN-gamma, IL-4 and IL-4 delta 2, and it is the relative, not absolute levels of cytokine expression that are characteristic of clinical status.	[Andersen, Peter; Doherty, T. Mark] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Wassie, Liya; Demissie, Abebech; Aseffa, Abraham; Abebe, Markos; Yamuah, Lawrence; Tilahun, Hiwot] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Petros, Beyene] Addis Ababa Univ, Dept Biol, Addis Ababa, Ethiopia; [Rook, Graham; Zumla, Alimuddin] Royal Free Univ Coll, Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London, England	Statens Serum Institut; Addis Ababa University; University of London; University College London	Doherty, TM (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	TMD@ssi.dk	ZUMLA, Alimuddin/ABA-8208-2020; Aseffa, Abraham/J-3248-2016	ZUMLA, Alimuddin/0000-0002-5111-5735; Aseffa, Abraham/0000-0002-8028-1150; Wassie, Liya/0000-0002-5494-5275; Andersen, Peter/0000-0002-5869-2551; Brookes, Roger/0000-0002-5361-0617; Rook, Graham/0000-0002-8041-8110	EU [ICA4-CT-1999-10005, IC4-2001-10050]	EU(European Commission)	This work was supported by the European commission through EU contracts ICA4-CT-1999-10005 and IC4-2001-10050. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Demissie A, 2006, INFECT IMMUN, V74, P2817, DOI 10.1128/IAI.74.5.2817-2822.2006; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2007, TUBERCULOSIS, V87, P237, DOI 10.1016/j.tube.2006.11.001; Doherty TM, 2005, CLIN MICROBIOL REV, V18, P687, DOI 10.1128/CMR.18.4.687-702.2005; Doherty TM, 2005, J IMMUNOL METHODS, V298, P129, DOI 10.1016/j.jim.2005.01.013; Doherty TM, 2002, CURR OPIN PULM MED, V8, P183, DOI 10.1097/00063198-200205000-00006; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Fletcher HA, 2004, IMMUNOLOGY, V112, P669, DOI 10.1111/j.1365-2567.2004.01922.x; Fletcher HA, 2007, CURR MOL MED, V7, P319, DOI 10.2174/156652407780598520; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Goter-Robinson C, 2006, VACCINE, V24, P3522, DOI 10.1016/j.vaccine.2006.02.005; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Kawahara M, 2002, INFECT IMMUN, V70, P6614, DOI 10.1128/IAI.70.12.6614-6620.2002; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Martinez ON, 2001, AM J GASTROENTEROL, V96, P1665; McCarthy OR, 2001, J ROY SOC MED, V94, P413, DOI 10.1177/014107680109400813; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Rhodes SG, 2007, INFECT IMMUN, V75, P3006, DOI 10.1128/IAI.01932-06; Rieder HL, 2003, INT J TUBERC LUNG D, V7, pS333; Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Seah GT, 2001, AM J RESP CRIT CARE, V164, P1016, DOI 10.1164/ajrccm.164.6.2012138; Seah GT, 2001, SCAND J INFECT DIS, V33, P106, DOI 10.1080/003655401750065472; Seah GT, 1999, J IMMUNOL METHODS, V228, P139, DOI 10.1016/S0022-1759(99)00084-8; Smith SM, 2002, TUBERCULOSIS, V82, P7, DOI 10.1054/tube.2001.0317; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; SURCEL HM, 1994, IMMUNOLOGY, V81, P171; Swaminathan S, 1999, CLIN INFECT DIS, V28, P1290, DOI 10.1086/514794; Tegbaru B, 2006, CLIN VACCINE IMMUNOL, V13, P784, DOI 10.1128/CVI.00098-06; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; van Helden Paul D, 2006, Novartis Found Symp, V279, P17; VANHELDEN PD, 2006, NOVART FDN SYMP, V279, P216; VANHELDEN PD, 2006, NOVART FDN SYMP, V279, P31; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Yoshikai Y, 2006, CRIT REV IMMUNOL, V26, P515, DOI 10.1615/CritRevImmunol.v26.i6.40	52	45	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1522	10.1371/journal.pone.0001522	http://dx.doi.org/10.1371/journal.pone.0001522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231607	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000260504200034
J	Feldblum, PJ; Adeiga, A; Bakare, R; Wevill, S; Lendvay, A; Obadaki, F; Olayemi, MO; Wang, L; Nanda, K; Rountree, W				Feldblum, Paul J.; Adeiga, Adesina; Bakare, Rashidi; Wevill, Silver; Lendvay, Anja; Obadaki, Fatimah; Olayemi, M. Onikepe; Wang, Lily; Nanda, Kavita; Rountree, Wes			SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria	PLOS ONE			English	Article							NONOXYNOL 9; TRANSMISSION; SAFETY	Background. The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk. Methodology/ Principal Findings. This was a Phase 3, double-blind, randomized, placebo-controlled trial. Participants made up to 12 monthly follow-up visits for HIV testing, adverse event reporting, and study product supply. The study was conducted between September 2004 and December 2006 in Lagos and Ibadan, Nigeria, where we enrolled 2153 HIV-negative women at high risk of HIV infection. Participants were randomized 1:1 to SAVVY or placebo. The effectiveness endpoint was incidence of HIV infection as indicated by detection of HIV antibodies in oral mucosal transudate (rapid test) or blood (ELISA), and confirmed by Western blot or PCR testing. We observed 33 seroconversions (21 in the SAVVY group, 12 in the placebo group). The Kaplan-Meier estimates of the cumulative probability of HIV infection at 12 months were 0.028 in the SAVVY group and 0.015 in the placebo group (2-sided p-value for the log-rank test of treatment effect 0.121). The point estimate of the hazard ratio was 1.7 for SAVVY versus placebo (95% confidence interval 0.9, 3.5). Because of lower-than-expected HIV incidence, we did not observe the required number of HIV infections (66) for adequate power to detect an effect of SAVVY. Follow-up frequencies of adverse events, reproductive tract adverse events, abnormal pelvic examination findings, chlamydial infections and vaginal infections were similar in the study arms. No serious adverse event was attributable to SAVVY use. Conclusions/Significance. SAVVY did not reduce the incidence of HIV infection. Although the hazard ratio was higher in the SAVVY than the placebo group, we cannot conclude that there was a harmful treatment effect of SAVVY. Trial Registration. ClinicalTrials.gov NCT00130078	[Feldblum, Paul J.; Wevill, Silver; Lendvay, Anja; Wang, Lily; Nanda, Kavita; Rountree, Wes] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Adeiga, Adesina; Obadaki, Fatimah] Nigerian Inst Med Res, Lagos, Nigeria; [Bakare, Rashidi; Olayemi, M. Onikepe] Univ Ibadan, Coll Med, Ibadan, Nigeria	University of Ibadan	Feldblum, PJ (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	pfeldblum@fhi.org		Nanda, Kavita/0000-0001-7650-2929	United States Agency for International Development (USAID) [CCP-A-00-95-00022-02, GPO-A-00-05-00022-00]; Cellegy Pharmaceuticals; CONRAD (Arlington, VA)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Cellegy Pharmaceuticals; CONRAD (Arlington, VA)	This study was supported by funds from the United States Agency for International Development (USAID) under Cooperative Agreement CCP-A-00-95-00022-02 and GPO-A-00-05-00022-00. Cellegy Pharmaceuticals (formerly BIOSYN, Inc., Huntingdon Valley, PA) and CONRAD (Arlington, VA) donated the investigational product (SAVVY and placebo-gel applicators) evaluated in this study.	Ballagh SA, 2002, CONTRACEPTION, V66, P369, DOI 10.1016/S0010-7824(02)00433-X; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Bax R, 2002, CONTRACEPTION, V66, P365, DOI 10.1016/S0010-7824(02)00389-X; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; FDA, 1998, PROV CLIN EV EFF HUM; *JOINT UN PROGR HI, 2006, REP GLOB AIDS EP; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klebanoff MA, 2007, AM J OBSTET GYNECOL, V197, p10A, DOI 10.1016/j.ajog.2007.02.030; Krebs FC, 2000, ANTIMICROB AGENTS CH, V44, P1954, DOI 10.1128/AAC.44.7.1954-1960.2000; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Mauck CK, 2004, CONTRACEPTION, V70, P221, DOI 10.1016/j.contraception.2003.12.008; Mauck CK, 2004, CONTRACEPTION, V70, P233, DOI 10.1016/j.contraception.2004.04.010; Mauck CK, 2004, CONTRACEPTION, V70, P227, DOI 10.1016/j.contraception.2004.02.001; Mayer KH, 1995, INFECT AGENT DIS, V4, P273; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; PETERSON L, 2007, PLOS IN PRESS; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; RAYMOND EG, 2007, SEX TRANSM IN PRESS; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; SCHWARTZ JL, 2006, MICR 2006 C CAP TOWN; Steiner MJ, 2006, NEW ENGL J MED, V354, P2642, DOI 10.1056/NEJMp068111; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Wilkinson D, 2002, LANCET INFECT DIS, V2, P613, DOI 10.1016/S1473-3099(02)00396-1	27	227	232	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1474	10.1371/journal.pone.0001474	http://dx.doi.org/10.1371/journal.pone.0001474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213382	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503900019
J	Zhu, HS; Casselman, A; Reppert, SM				Zhu, Haisun; Casselman, Amy; Reppert, Steven M.			Chasing Migration Genes: A Brain Expressed Sequence Tag Resource for Summer and Migratory Monarch Butterflies (Danaus plexippus)	PLOS ONE			English	Article							OUABAIN BINDING-SITE; ENDOCRINE REGULATION; SUN COMPASS; GENOME; CLOCK; TIME; INSENSITIVITY; LEPIDOPTERA; MUTAGENESIS; RESIDUES	North American monarch butterflies (Danaus plexippus) undergo a spectacular fall migration. In contrast to summer butterflies, migrants are juvenile hormone (JH) deficient, which leads to reproductive diapause and increased longevity. Migrants also utilize time-compensated sun compass orientation to help them navigate to their overwintering grounds. Here, we describe a brain expressed sequence tag (EST) resource to identify genes involved in migratory behaviors. A brain EST library was constructed from summer and migrating butterflies. Of 9,484 unique sequences, 6068 had positive hits with the non-redundant protein database; the EST database likely represents similar to 52% of the gene-encoding potential of the monarch genome. The brain transcriptome was cataloged using Gene Ontology and compared to Drosophila. Monarch genes were well represented, including those implicated in behavior. Three genes involved in increased JH activity (allatotropin, juvenile hormone acid methyltransfersase, and takeout) were upregulated in summer butterflies, compared to migrants. The locomotion-relevant turtle gene was marginally upregulated in migrants, while the foraging and single-minded genes were not differentially regulated. Many of the genes important for the monarch circadian clock mechanism (involved in sun compass orientation) were in the EST resource, including the newly identified cryptochrome 2. The EST database also revealed a novel Na+/K+ ATPase allele predicted to be more resistant to the toxic effects of milkweed than that reported previously. Potential genetic markers were identified from 3,486 EST contigs and included 1599 double-hit single nucleotide polymorphisms (SNPs) and 98 microsatellite polymorphisms. These data provide a template of the brain transcriptome for the monarch butterfly. Our "snap-shot'' analysis of the differential regulation of candidate genes between summer and migratory butterflies suggests that unbiased, comprehensive transcriptional profiling will inform the molecular basis of migration. The identified SNPs and microsatellite polymorphisms can be used as genetic markers to address questions of population and subspecies structure.	[Zhu, Haisun; Casselman, Amy] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu			NIH [R01 NS047141]; University of Massachusetts Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH R01 NS047141 and funds from the University of Massachusetts Medical School.	ACKERY PR, 1984, MILKWEED BUTTERFLIES, V7; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bodily KD, 2001, J NEUROSCI, V21, P3113, DOI 10.1523/JNEUROSCI.21-09-03113.2001; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Brower AVZ, 2004, ANN ENTOMOL SOC AM, V97, P519, DOI 10.1603/0013-8746(2004)097[0519:GPASON]2.0.CO;2; BROWER AVZ, 1991, EVOLUTION, V45, P1281, DOI 10.1111/j.1558-5646.1991.tb04393.x; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Brower LP, 1996, J EXP BIOL, V199, P93; Collins B, 2007, PFLUG ARCH EUR J PHY, V454, P857, DOI 10.1007/s00424-006-0188-9; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Croyle ML, 1997, EUR J BIOCHEM, V248, P488, DOI 10.1111/j.1432-1033.1997.00488.x; EANES WF, 1978, EVOLUTION, V32, P784, DOI 10.1111/j.1558-5646.1978.tb04633.x; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Herman WS, 2001, P ROY SOC B-BIOL SCI, V268, P2509, DOI 10.1098/rspb.2001.1765; HERMAN WS, 1975, GEN COMP ENDOCR, V26, P534, DOI 10.1016/0016-6480(75)90176-8; HERMAN WS, 1985, MIGRATION MECH ADA S, V27, P799; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HOLZINGER F, 1992, FEBS LETT, V314, P477, DOI 10.1016/0014-5793(92)81530-Y; Holzinger F, 1996, J CHEM ECOL, V22, P1921, DOI 10.1007/BF02028512; Huntley D, 2006, BIOINFORMATICS, V22, P495, DOI 10.1093/bioinformatics/btk006; Johny S, 2006, PARASITOLOGY, V132, P803, DOI 10.1017/S0031182006009863; LESSMAN CA, 1981, EXPERIENTIA, V37, P599, DOI 10.1007/BF01990072; Li S, 2005, PEPTIDES, V26, P63, DOI 10.1016/j.peptides.2004.08.023; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; MALCOLM SB, 1989, EXPERIENTIA, V45, P284, DOI 10.1007/BF01951814; Mebs D, 2000, CHEMOECOLOGY, V10, P201, DOI 10.1007/PL00001823; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; OBERHAUSER KS, 2004, MONARCH BUTTERFLY BI, V8; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; PARSONS JA, 1965, J PHYSIOL-LONDON, V178, P290, DOI 10.1113/jphysiol.1965.sp007628; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Pielage J, 2002, DEV BIOL, V249, P283, DOI 10.1006/dbio.2002.0770; PRICE EM, 1990, J BIOL CHEM, V265, P6638; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; SMITH DS, 1994, BUTTERFLIES W INDIES, V8; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; Urquhart FA., 1960, MONARCH BUTTERFLY; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	54	40	43	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1345	10.1371/journal.pone.0001345	http://dx.doi.org/10.1371/journal.pone.0001345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183285	Green Submitted, Green Published, gold			2022-12-27	WOS:000260469400001
J	Berger, LR; Churchill, SE; De Klerk, B; Quinn, RL				Berger, Lee R.; Churchill, Steven E.; De Klerk, Bonita; Quinn, Rhonda L.			Small-Bodied Humans from Palau, Micronesia	PLOS ONE			English	Article							HOMO-FLORESIENSIS; BODY PROPORTIONS; LATE PLEISTOCENE; SIZE; AUSTRALOPITHECUS; SAPIENS; HOMINID; BRAIN	Newly discovered fossil assemblages of small bodied Homo sapiens from Palau, Micronesia possess characters thought to be taxonomically primitive for the genus Homo. Background: Recent surface collection and test excavation in limestone caves in the rock islands of Palau, Micronesia, has produced a sizeable sample of human skeletal remains dating roughly between 940-2890 cal ybp. Principle Findings: Preliminary analysis indicates that this material is important for two reasons. First, individuals from the older time horizons are small in body size even relative to "pygmoid" populations from Southeast Asia and Indonesia, and thus may represent a marked case of human insular dwarfism. Second, while possessing a number of derived features that align them with Homo sapiens, the human remains from Palau also exhibit several skeletal traits that are considered to be primitive for the genus Homo. Significance: These features may be previously unrecognized developmental correlates of small body size and, if so, they may have important implications for interpreting the taxonomic affinities of fossil specimens of Homo.	[Berger, Lee R.; De Klerk, Bonita] Univ Witwatersrand, Inst Human Evolut, Bernard Price Inst Palaeontol, Sch GeoSci, Johannesburg, South Africa; [Churchill, Steven E.] Duke Univ, Dept Biol Anthropol & Anat, Durham, NC USA; [Quinn, Rhonda L.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	University of Witwatersrand; Duke University; Rutgers State University New Brunswick	Berger, LR (corresponding author), Univ Witwatersrand, Inst Human Evolut, Bernard Price Inst Palaeontol, Sch GeoSci, Johannesburg, South Africa.	Lee.Berger@wits.ac.za	Berger, Lee Rogers/AAC-3484-2020; Churchill, Steven/AAA-9386-2022	Berger, Lee Rogers/0000-0002-0367-7629; Quinn, Rhonda/0000-0003-2580-864X	National Geographic Society Missions Programme; University of the Witwatersrand; BHP Billiton	National Geographic Society Missions Programme(National Geographic Society); University of the Witwatersrand; BHP Billiton	National Geographic Society Missions Programme and University of the Witwatersrand and BHP Billiton	Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; ATHENS JS, 1999, HIST PRESERVATION 2, V4; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Clark GR., 2006, J ISL COAST ARCHAEOL, V1, P215, DOI [10.1080/15564890600831705, DOI 10.1080/15564890600831705]; CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; Conroy GC, 2007, HOMO, V58, P1, DOI 10.1016/j.jchb.2006.11.001; DIAMOND J, 1992, DISCOVER, V13, P70; Dickinson WR., 2007, J ISL COAST ARCHAEOL, V2, P175, DOI [10.1080/15564890701623639, DOI 10.1080/15564890701623639]; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Fitzpatrick S, 2006, J ISLAND COAST ARCHA, V1, P5, DOI [10.1080/15564890600639504, DOI 10.1080/15564890600639504]; Fitzpatrick SM, 2003, ANTIQUITY, V77, P719, DOI 10.1017/S0003598X00061664; Fitzpatrick SM, 2003, J ARCHAEOL SCI, V30, P1175, DOI 10.1016/S0305-4403(03)00014-1; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Hazell LC, 2006, ARCHAEOL OCEAN, V41, P12, DOI 10.1002/j.1834-4453.2006.tb00601.x; Henneberg M., 2004, FARMING, V4, P2; HOWELLS WW, 1989, SKULL SHAPES MAP CAM; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lam YM, 1996, AM J PHYS ANTHROPOL, V100, P545; Liston J, 2005, RADIOCARBON, V47, P295, DOI 10.1017/S0033822200019780; LUCAS PW, 2006, INT C SERIES, V1296, P74; Martin R., 1928, LEHRBUCH ANTHR, V1; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Nelson GC, 2006, ANTHROPOL SCI, V114, P1, DOI 10.1537/ase.040710; Richards GD, 2006, J EVOLUTION BIOL, V19, P1744, DOI 10.1111/j.1420-9101.2006.01179.x; Rosenberg KR, 2006, P NATL ACAD SCI USA, V103, P3552, DOI 10.1073/pnas.0508681103; SCHMID P, 1983, FOLIA PRIMATOL, V40, P283, DOI 10.1159/000156111; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Sokal R. R, 1981, BIOMETRY; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165	34	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1780	10.1371/journal.pone.0001780	http://dx.doi.org/10.1371/journal.pone.0001780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18347737	Green Published, gold			2022-12-27	WOS:000260723000032
J	Boily, G; Seifert, EL; Bevilacqua, L; He, XH; Sabourin, G; Estey, C; Moffat, C; Crawford, S; Saliba, S; Jardine, K; Xuan, J; Evans, M; Harper, ME; McBurney, MW				Boily, Gino; Seifert, Erin L.; Bevilacqua, Lisa; He, Xiao Hong; Sabourin, Guillaume; Estey, Carmen; Moffat, Cynthia; Crawford, Sean; Saliba, Sarah; Jardine, Karen; Xuan, Jian; Evans, Meredith; Harper, Mary-Ellen; McBurney, Michael W.			SirT1 Regulates Energy Metabolism and Response to Caloric Restriction in Mice	PLOS ONE			English	Article								The yeast sir2 gene and its orthologues in Drosophila and C. elegans have well-established roles in lifespan determination and response to caloric restriction. We have studied mice carrying two null alleles for SirT1, the mammalian orthologue of sir2, and found that these animals inefficiently utilize ingested food. These mice are hypermetabolic, contain inefficient liver mitochondria, and have elevated rates of lipid oxidation. When challenged with a 40% reduction in caloric intake, normal mice maintained their metabolic rate and increased their physical activity while the metabolic rate of SirT1-null mice dropped and their activity did not increase. Moreover, CR did not extend lifespan of SirT1-null mice. Thus, SirT1 is an important regulator of energy metabolism and, like its orthologues from simpler eukaryotes, the SirT1 protein appears to be required for a normal response to caloric restriction.	[Boily, Gino; He, Xiao Hong; Sabourin, Guillaume; Moffat, Cynthia; Crawford, Sean; Saliba, Sarah; Jardine, Karen; McBurney, Michael W.] Univ Ottawa, Dept Med, Ctr Canc Therapeut, Hlth Res Inst, Ottawa, ON, Canada; [Seifert, Erin L.; Bevilacqua, Lisa; Estey, Carmen; Xuan, Jian; Evans, Meredith; Harper, Mary-Ellen; McBurney, Michael W.] Univ Ottawa, Dept Biochem, Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Boily, G (corresponding author), Univ Ottawa, Dept Med, Ctr Canc Therapeut, Hlth Res Inst, Ottawa, ON, Canada.	mmcburney@ohri.ca		Harper, Mary-Ellen/0000-0003-3864-5886; Crawford, Sean/0000-0002-0665-4772	Canadian Institutes of Health Research; Fonds de Recherche en Sante du Quebec [fellowship]; Canadian Diabetes Association [fellowship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Diabetes Association	This project was funded by the Canadian Institutes of Health Research (CIHR; MM and MEH). GB and ES are recipients of fellowships from the Fonds de Recherche en Sante du Quebec (FRSQ) and the Canadian Diabetes Association (CDA), respectively.	Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Bezaire V, 2001, AM J PHYSIOL-ENDOC M, V281, pE975, DOI 10.1152/ajpendo.2001.281.5.E975; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200	40	354	365	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1759	10.1371/journal.pone.0001759	http://dx.doi.org/10.1371/journal.pone.0001759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335035	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000013
J	Kola, B; Farkas, I; Christ-Crain, M; Wittmann, G; Lolli, F; Amin, F; Harvey-White, J; Liposits, Z; Kunos, G; Grossman, AB; Fekete, C; Korbonits, M				Kola, Blerina; Farkas, Imre; Christ-Crain, Mirjam; Wittmann, Gabor; Lolli, Francesca; Amin, Faisal; Harvey-White, Judith; Liposits, Zsolt; Kunos, George; Grossman, Ashley B.; Fekete, Csaba; Korbonits, Marta			The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System	PLOS ONE			English	Article							RECEPTOR ANTAGONIST SR141716; CB1 RECEPTOR; FOOD-INTAKE; ENDOCANNABINOID RELEASE; NEUROPEPTIDE-Y; KNOCKOUT MICE; PROTEIN; HYPOTHALAMUS; METABOLISM; NUTRIENT	Introduction: Ghrelin and cannabinoids stimulate appetite, this effect possibly being mediated by the activation of hypothalamic AMP-activated protein kinase (AMPK), a key enzyme in appetite and metabolism regulation. The cannabinoid receptor type 1 (CB1) antagonist rimonabant can block the orexigenic effect of ghrelin. In this study, we have elucidated the mechanism of the putative ghrelin-cannabinoid interaction. Methods: The effects of ghrelin and CB1 antagonist rimonabant in wild-type mice, and the effect of ghrelin in CB1-knockout animals, were studied on food intake, hypothalamic AMPK activity and endogenous cannabinoid content. In patch-clamp electrophysiology experiments the effect of ghrelin was assessed on the synaptic inputs in parvocellular neurons of the hypothalamic paraventricular nucleus, with or without the pre-administration of a CB1 antagonist or of cannabinoid synthesis inhibitors. Results and Conclusions: Ghrelin did not induce an orexigenic effect in CB1-knockout mice. Correspondingly, both the genetic lack of CB1 and the pharmacological blockade of CB1 inhibited the effect of ghrelin on AMPK activity. Ghrelin increased the endocannabinoid content of the hypothalamus in wild-type mice and this effect was abolished by rimonabant pre-treatment, while no effect was observed in CB1-KO animals. Electrophysiology studies showed that ghrelin can inhibit the excitatory inputs on the parvocellular neurons of the paraventricular nucleus, and that this effect is abolished by administration of a CB1 antagonist or an inhibitor of the DAG lipase, the enzyme responsible for 2-AG synthesis. The effect is also lost in the presence of BAPTA, an intracellular calcium chelator, which inhibits endocannabinoid synthesis in the recorded parvocellular neuron and therefore blocks the retrograde signaling exerted by endocannabinoids. In summary, an intact cannabinoid signaling pathway is necessary for the stimulatory effects of ghrelin on AMPK activity and food intake, and for the inhibitory effect of ghrelin on paraventricular neurons.	[Farkas, Imre; Wittmann, Gabor; Liposits, Zsolt; Fekete, Csaba] Hungarian Acad Sci, Inst Expt Med, Dept Endocrine Neurobiol, Budapest, Hungary; [Kola, Blerina; Christ-Crain, Mirjam; Lolli, Francesca; Amin, Faisal; Grossman, Ashley B.; Korbonits, Marta] Univ London, Barts & London Sch Med & Dentist, Dept Endocrinol, London, England; [Harvey-White, Judith; Kunos, George] NIH, NIAAA, Lab Physiol Stud, Bethesda, MD USA; [Fekete, Csaba] Tufts-New England Med Ctr, Dept Med, Tupper Res Inst, Div Endocrinol, Diabetes, Metabol & Mol Med, Boston, MA USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Tufts Medical Center	Fekete, C (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Endocrine Neurobiol, Budapest, Hungary.	Feketecs@koki.hu; m.korbonits@qmul.ac.uk	Liposits, Zsolt/K-8145-2019	Christ-Crain, Mirjam/0000-0002-6336-0965; Liposits, Zsolt/0000-0002-3508-2750; Fekete, Csaba/0000-0002-8206-562X; Korbonits, Marta/0000-0002-4101-9432	Wellcome Trust [319/2006]; ETT; Sixth EU Research Framework Programme [LSHM-CT-2003-503041]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, Z01AA000350] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); ETT; Sixth EU Research Framework Programme(European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by a Wellcome Trust Project Grant, by ETT (319/2006) and the Sixth EU Research Framework Programme (contact LSHM-CT-2003-503041). The funders did not have a role in this manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Batkai S, 2004, AM J PHYSIOL-HEART C, V287, pH595, DOI 10.1152/ajpheart.00184.2004; Bequet F, 2007, EUR J NEUROSCI, V26, P3458, DOI 10.1111/j.1460-9568.2007.05900.x; CRESPO I, 2007, NEUROPHARMACOLOGY; Di Marzo V, 2000, J NEUROCHEM, V75, P2434, DOI 10.1046/j.1471-4159.2000.0752434.x; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di S, 2005, ENDOCRINOLOGY, V146, P4292, DOI 10.1210/en.2005-0610; Di S, 2003, J NEUROSCI, V23, P4850; Fekete C, 2004, ENDOCRINOLOGY, V145, P4816, DOI 10.1210/en.2004-0476; Fride E, 2003, EUR J PHARMACOL, V461, P27, DOI 10.1016/S0014-2999(03)01295-0; Gamber KM, 2005, NEUROPHARMACOLOGY, V49, P646, DOI 10.1016/j.neuropharm.2005.04.017; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Higgins SC, 2007, ANN MED, V39, P116, DOI 10.1080/07853890601149179; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Matias I, 2008, NEUROPHARMACOLOGY, V54, P206, DOI 10.1016/j.neuropharm.2007.06.011; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Poncelet M, 2003, NEUROSCI LETT, V343, P216, DOI 10.1016/S0304-3940(03)00397-5; Rigamonti AE, 2006, EUR J PHARMACOL, V542, P116, DOI 10.1016/j.ejphar.2006.05.028; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217	34	227	232	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1797	10.1371/journal.pone.0001797	http://dx.doi.org/10.1371/journal.pone.0001797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335063	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000260723000045
J	Higuera, PE; Brubaker, LB; Anderson, PM; Brown, TA; Kennedy, AT; Hu, FS				Higuera, Philip E.; Brubaker, Linda B.; Anderson, Patricia M.; Brown, Thomas A.; Kennedy, Alison T.; Hu, Feng Sheng			Frequent Fires in Ancient Shrub Tundra: Implications of Paleorecords for Arctic Environmental Change	PLOS ONE			English	Article							CHARCOAL RECORDS; BOREAL FOREST; VEGETATION HISTORY; ALASKA; LAKE; TERRESTRIAL; TEMPERATURE; FEEDBACKS; EXCHANGE; POLLEN	Understanding feedbacks between terrestrial and atmospheric systems is vital for predicting the consequences of global change, particularly in the rapidly changing Arctic. Fire is a key process in this context, but the consequences of altered fire regimes in tundra ecosystems are rarely considered, largely because tundra fires occur infrequently on the modern landscape. We present paleoecological data that indicate frequent tundra fires in northcentral Alaska between 14,000 and 10,000 years ago. Charcoal and pollen from lake sediments reveal that ancient birch-dominated shrub tundra burned as often as modern boreal forests in the region, every 144 years on average (+/- 90 s.d.; n = 44). Although paleoclimate interpretations and data from modern tundra fires suggest that increased burning was aided by low effective moisture, vegetation cover clearly played a critical role in facilitating the paleofires by creating an abundance of fine fuels. These records suggest that greater fire activity will likely accompany temperature-related increases in shrub-dominated tundra predicted for the 21(st) century and beyond. Increased tundra burning will have broad impacts on physical and biological systems as well as on land-atmosphere interactions in the Arctic, including the potential to release stored organic carbon to the atmosphere.	[Higuera, Philip E.; Brubaker, Linda B.] Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; [Anderson, Patricia M.] Univ Washington, Quaternary Res Ctr, Dept Earth & Space Sci, Seattle, WA USA; [Brown, Thomas A.] Ctr Accelerator Mass Spectrometry, Lawrence Livermore Natl Lab, Livermore, CA USA; [Kennedy, Alison T.] Montana State Univ, Dept Earth Sci, Bozeman, MT USA; [Hu, Feng Sheng] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [Hu, Feng Sheng] Univ Illinois, Dept Geol, Urbana, IL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Montana State University System; Montana State University Bozeman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Higuera, PE (corresponding author), Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA.	philip.higuera@montana.edu	Higuera, Philip Edward/B-1330-2010	Higuera, Philip Edward/0000-0001-5396-9956; Brown, Tom/0000-0001-9984-7647	U.S. National Science Foundation [0112586]; Arctic System Science Program	U.S. National Science Foundation(National Science Foundation (NSF)); Arctic System Science Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the U.S. National Science Foundation through a Graduate Research Fellowship to PEH and award number 0112586 to LBB, PMA, and TAB from the Arctic System Science Program.	Abbott MB, 2000, QUATERNARY RES, V53, P154, DOI 10.1006/qres.1999.2112; *ACIA, 2004, IMP WARM ARCT ARCT C, P1042; Anderson PM, 2004, DEV QUA SCI, V1, P427; ANDERSON PM, 1994, QUATERNARY SCI REV, V13, P71, DOI 10.1016/0277-3791(94)90125-2; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; BRUBAKER LB, 1983, QUATERNARY RES, V20, P194, DOI 10.1016/0033-5894(83)90077-7; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; de Groot WJ, 1999, INT J WILDLAND FIRE, V9, P51, DOI 10.1071/WF99005; DUGLE JR, 1966, CAN J BOTANY, V44, P929, DOI 10.1139/b66-106; Earle CJ, 1996, REV PALAEOBOT PALYNO, V92, P83, DOI 10.1016/0034-6667(95)00095-X; Edwards ME, 2005, ECOLOGY, V86, P1696, DOI 10.1890/03-0787; Eugster W, 2000, GLOBAL CHANGE BIOL, V6, P84, DOI 10.1046/j.1365-2486.2000.06015.x; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Higuera PE, 2007, QUATERNARY SCI REV, V26, P1790, DOI 10.1016/j.quascirev.2007.03.010; JOHNSON EA, 1994, ADV ECOL RES, V25, P239, DOI 10.1016/S0065-2504(08)60216-0; Kasischke ES, 2002, INT J WILDLAND FIRE, V11, P131, DOI 10.1071/WF02023; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Liljedahl A, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000554; Lynch JA, 2004, CAN J FOREST RES, V34, P1642, DOI 10.1139/X04-071; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; McGuire AD, 2006, ANNU REV ENV RESOUR, V31, P61, DOI 10.1146/annurev.energy.31.020105.100253; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; PALE members, 1994, PAGES WORKSHOP REPOR, V1, P53; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Racine C., 2006, NPSAKRARCNNRTR200602; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rhodes AN, 1998, HOLOCENE, V8, P113, DOI 10.1191/095968398671104653; Shaver GR, 2006, J ECOL, V94, P740, DOI 10.1111/j.1365-2745.2006.01139.x; SHIUE WK, 1982, J R STAT SOC C-APPL, V31, P130; Sitch S, 2007, ECOL APPL, V17, P213, DOI 10.1890/1051-0761(2007)017[0213:ATCBOC]2.0.CO;2; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000484; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Telford RJ, 2004, HOLOCENE, V14, P296, DOI 10.1191/0959683604hl707fa; THOMAN DR, 1969, TECHNOMETRICS, V11, P805, DOI 10.2307/1266900; Tinner W, 2006, VEG HIST ARCHAEOBOT, V15, P279, DOI 10.1007/s00334-006-0052-z; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; WRIGHT HE, 1984, ECOLOGY, V65, P657, DOI 10.2307/1941430; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	39	186	187	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e0001744	10.1371/journal.pone.0001744	http://dx.doi.org/10.1371/journal.pone.0001744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320025	gold, Green Submitted, Green Published			2022-12-27	WOS:000260586600039
J	Waibler, Z; Sender, LY; Merten, C; Hartig, R; Kliche, S; Gunzer, M; Reichardt, P; Kalinke, U; Schraven, B				Waibler, Zoe; Sender, Linda Y.; Merten, Camilla; Hartig, Roland; Kliche, Stefanie; Gunzer, Matthias; Reichardt, Peter; Kalinke, Ulrich; Schraven, Burkhart			Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies	PLOS ONE			English	Article								Superagonistic CD28 antibodies (CD28SAs) activate T lymphocytes without concomitant perturbation of the TCR/CD3-complex. In rodents these reagents induce the preferential expansion of regulatory T cells and can be used for the treatment of autoimmune diseases. Unexpectedly, the humanized CD28 superagonist TGN1412 caused severe and life threatening adverse effects during a recently conducted phase I clinical trail. The underlying molecular mechanisms are as yet unclear. We show that TGN1412 as well as the commercially available CD28 superagonist ANC28.1 induce a delayed but extremely sustained calcium response in human naive and memory CD4+ T cells but not in cynomolgus T lymphocytes. The sustained Ca++-signal was associated with the activation of multiple intracellular signaling pathways and together these events culminated in the rapid de novo synthesis of high amounts of pro-inflammatory cytokines, most notably IFN-gamma and TNF-alpha. Importantly, sustained transmembranous calcium flux, activation of Src-kinases as well as activation of PI3K were found to be absolutely required for CD28SA-mediated production of IFN-gamma and IL-2. Collectively, our data suggest a molecular basis for the severe side effects caused by TGN1412 and impinge upon the relevance of non-human primates as preclinical models for reagents that are supposed to modify the function of human T cells.	[Waibler, Zoe; Sender, Linda Y.; Kalinke, Ulrich] Paul Ehrlich Inst, D-6070 Langen, Germany; [Merten, Camilla; Hartig, Roland; Kliche, Stefanie; Gunzer, Matthias; Reichardt, Peter; Schraven, Burkhart] Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany	Paul Ehrlich Institute; Otto von Guericke University	Waibler, Z (corresponding author), Paul Ehrlich Inst, D-6070 Langen, Germany.	kalul@pei.de; Burkhart.Schraven@med.ovgu.de	Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055; Hartig, Roland/0000-0002-3706-7458; Kalinke, Ulrich/0000-0003-0503-9564	German Research Foundation [SFB432, B15]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG) to B.S. and to U.K. (SFB432, B15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE R, 1995, J IMMUNOL, V154, P985; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Beyersdorf N, 2006, AUTOIMMUN REV, V5, P40, DOI 10.1016/j.autrev.2005.06.001; Beyersdorf N, 2005, ANN RHEUM DIS, V64, P91, DOI 10.1136/ard.2005.042564; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Beyersdorf N, 2006, IMMUNOLOGY, V119, P441, DOI 10.1111/j.1365-2567.2006.02455.x; Bischof A, 2000, EUR J IMMUNOL, V30, P876, DOI 10.1002/1521-4141(200003)30:3<876::AID-IMMU876>3.0.CO;2-M; Dennehy KM, 2007, J IMMUNOL, V178, P1363, DOI 10.4049/jimmunol.178.3.1363; Dennehy KM, 2003, INT IMMUNOL, V15, P655, DOI 10.1093/intimm/dxg063; Expert Scientific Group, 2006, EXP SCI GROUP PHAS O; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hanke T, 2006, LANCET, V368, P1569, DOI 10.1016/S0140-6736(06)69651-7; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hunig T, 2005, IMMUNOL LETT, V100, P21, DOI 10.1016/j.imlet.2005.06.012; Ibegbu C, 2001, J MED PRIMATOL, V30, P291, DOI 10.1034/j.1600-0684.2001.300601.x; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Kirchgessner H, 2001, J EXP MED, V193, P1269, DOI 10.1084/jem.193.11.1269; LEDBETTER JA, 1990, BLOOD, V75, P1531; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; NUNES J, 1991, MOL IMMUNOL, V28, P427, DOI 10.1016/0161-5890(91)90156-E; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; PANTALEO G, 1986, EUR J IMMUNOL, V16, P1639, DOI 10.1002/eji.1830161228; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Rodriguez-Palmero M, 2006, J RHEUMATOL, V33, P110; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; ROSS SE, 1994, BIOCHEM BIOPH RES CO, V198, P88, DOI 10.1006/bbrc.1994.1013; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; SAEZRODRIGUEZ J, 2007, COMPREHENSIVE UNPUB; Schmidt J, 2003, J NEUROIMMUNOL, V140, P143, DOI 10.1016/S0165-5728(03)00182-6; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Sester U, 2007, EUR J IMMUNOL, V37, P2881, DOI 10.1002/eji.200737206; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Siefken R, 1998, J IMMUNOL, V161, P1645; Sopper S, 1997, CYTOMETRY, V29, P351; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	46	68	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1708	10.1371/journal.pone.0001708	http://dx.doi.org/10.1371/journal.pone.0001708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320029	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600004
J	Fu, J; Fong, K; Bellacosa, A; Ross, E; Apostolou, S; Bassi, DE; Jin, F; Zhang, J; Cairns, P; Ibanez de Caceres, I; Braunewell, KH; Klein-Szanto, AJ				Fu, Jian; Fong, Kathryn; Bellacosa, Alfonso; Ross, Eric; Apostolou, Sinoula; Bassi, Daniel E.; Jin, Fang; Zhang, Jirong; Cairns, Paul; Ibanez de Caceres, Immaculada; Braunewell, Karl-Heinz; Klein-Szanto, Andres J.			VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival	PLOS ONE			English	Article								VILIP-1, a member of the neuronal Ca++ sensor protein family, acts as a tumor suppressor gene in an experimental animal model by inhibiting cell proliferation, adhesion and invasiveness of squamous cell carcinoma cells. Western Blot analysis of human tumor cells showed that VILIP-1 expression was undetectable in several types of human tumor cells, including 11 out of 12 non-small cell lung carcinoma (NSCLC) cell lines. The down-regulation of VILIP-1 was due to loss of VILIP-1 mRNA transcripts. Rearrangements, large gene deletions or mutations were not found. Hypermethylation of the VILIP-1 promoter played an important role in gene silencing. In most VILIP-1-silent cells the VILIP-1 promoter was methylated. In vitro methylation of the VILIP-1 promoter reduced its activity in a promoter-reporter assay. Transcriptional activity of endogenous VILIP-1 promoter was recovered by treatment with 59-aza-29-deoxycytidine (5'-Aza-dC). Trichostatin A (TSA), a histone deacetylase inhibitor, potently induced VILIP-1 expression, indicating that histone deacetylation is an additional mechanism of VILIP-1 silencing. TSA increased histone H3 and H4 acetylation in the region of the VILIP-1 promoter. Furthermore, statistical analysis of expression and promoter methylation (n = 150 primary NSCLC samples) showed a significant relationship between promoter methylation and protein expression downregulation as well as between survival and decreased or absent VILIP-1 expression in lung cancer tissues (p < 0.0001). VILIP-1 expression is silenced by promoter hypermethylation and histone deacetylation in aggressive NSCLC cell lines and primary tumors and its clinical evaluation could have a role as a predictor of short-term survival in lung cancer patients.	[Fu, Jian; Fong, Kathryn; Bassi, Daniel E.; Jin, Fang; Zhang, Jirong; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Human Genet Program, Philadelphia, PA USA; [Ross, Eric] Fox Chase Canc Ctr, Biomathematics & Biostat, Philadelphia, PA USA; [Apostolou, Sinoula] Fox Chase Canc Ctr, Bioinformat Facility, Philadelphia, PA USA; [Cairns, Paul; Ibanez de Caceres, Immaculada] Fox Chase Canc Ctr, Surg Oncol, Philadelphia, PA USA; [Braunewell, Karl-Heinz] Humboldt Univ, Neurosci Res Ctr Charite, Fac Med, Berlin, Germany	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fu, J (corresponding author), Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA.	aj_klein-szanto@fccc.edu			National Institutes of Health [CA107257, CA06927]; Commonwealth of Pennsylvania; Pennsylvania Department of Health; Deutsche Krebshilfe; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA107257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Pennsylvania Department of Health; Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health CA107257, CA06927, by an appropriation from the Commonwealth of Pennsylvania, and by a grant from the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. K.-H. B was supported by a grant from Deutsche Krebshilfe.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2005, CARCINOGENESIS, V26, P1481, DOI 10.1093/carcin/bgi020; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cairns P, 2001, CLIN CANCER RES, V7, P2727; Chang YS, 2004, ONCOGENE, V23, P6569, DOI 10.1038/sj.onc.1207882; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Deng XY, 2005, ACTA BIOCH BIOPH SIN, V37, P241, DOI 10.1111/j.1745-7270.2005.00034.x; Fan JQ, 2005, P NATL ACAD SCI USA, V102, P17751, DOI 10.1073/pnas.0509175102; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gierke P, 2004, BIOCHEM BIOPH RES CO, V323, P38, DOI 10.1016/j.bbrc.2004.08.055; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Liu T, 2006, CANCER TREAT REV, V32, P157, DOI 10.1016/j.ctrv.2005.12.006; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mahloogi H, 2003, CANCER RES, V63, P4997; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Osada H, 2001, CANCER RES, V61, P8331; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tani M, 2004, GENE CHROMOSOME CANC, V40, P146, DOI 10.1002/gcc.20027; Toyooka S, 2003, CLIN CANCER RES, V9, P3034; Wickborn C, 2006, MOL CARCINOGEN, V45, P572, DOI 10.1002/mc.20201; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041; Zhu WG, 2001, CANCER RES, V61, P1327	37	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1698	10.1371/journal.pone.0001698	http://dx.doi.org/10.1371/journal.pone.0001698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301774	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500042
J	James, KE; Schneider, H; Ansell, SW; Evers, M; Robba, L; Uszynski, G; Pedersen, N; Newton, AE; Russell, SJ; Vogel, JC; Kilian, A				James, Karen E.; Schneider, Harald; Ansell, Stephen W.; Evers, Margaret; Robba, Lavinia; Uszynski, Grzegorz; Pedersen, Niklas; Newton, Angela E.; Russell, Stephen J.; Vogel, Johannes C.; Kilian, Andrzej			Diversity Arrays Technology (DArT) for Pan-Genomic Evolutionary Studies of Non-Model Organisms	PLOS ONE			English	Article							BAYESIAN-INFERENCE; GENETIC-VARIATION; MARKERS; PHYLOGEOGRAPHY; AMPLIFICATION; PHYLOGENY; RELATIVES	Background: High-throughput tools for pan-genomic study, especially the DNA microarray platform, have sparked a remarkable increase in data production and enabled a shift in the scale at which biological investigation is possible. The use of microarrays to examine evolutionary relationships and processes, however, is predominantly restricted to model or near-model organisms. Methodology/Principal Findings: This study explores the utility of Diversity Arrays Technology (DArT) in evolutionary studies of non-model organisms. DArT is a hybridization-based genotyping method that uses microarray technology to identify and type DNA polymorphism. Theoretically applicable to any organism (even one for which no prior genetic data are available), DArT has not yet been explored in exclusively wild sample sets, nor extensively examined in a phylogenetic framework. DArT recovered 1349 markers of largely low copy-number loci in two lineages of seed-free land plants: the diploid fern Asplenium viride and the haploid moss Garovaglia elegans. Direct sequencing of 148 of these DArT markers identified 30 putative loci including four routinely sequenced for evolutionary studies in plants. Phylogenetic analyses of DArT genotypes reveal phylogeographic and substrate specificity patterns in A. viride, a lack of phylogeographic pattern in Australian G. elegans, and additive variation in hybrid or mixed samples. Conclusions/Significance: These results enable methodological recommendations including procedures for detecting and analysing DArT markers tailored specifically to evolutionary investigations and practical factors informing the decision to use DArT, and raise evolutionary hypotheses concerning substrate specificity and biogeographic patterns. Thus DArT is a demonstrably valuable addition to the set of existing molecular approaches used to infer biological phenomena such as adaptive radiations, population dynamics, hybridization, introgression, ecological differentiation and phylogeography.	[James, Karen E.; Schneider, Harald; Ansell, Stephen W.; Robba, Lavinia; Pedersen, Niklas; Newton, Angela E.; Russell, Stephen J.; Vogel, Johannes C.] Nat Hist Museum, Dept Bot, London SW7 5BD, England; [Evers, Margaret; Uszynski, Grzegorz; Kilian, Andrzej] Diversity Arrays Technol PL, Canberra, ACT, Australia	Natural History Museum London	James, KE (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.	k.james@nhm.ac.uk	Robba, Lavinia/J-4667-2012; Schneider, Harald/B-6681-2008	Schneider, Harald/0000-0002-4548-7268; Kilian, Andrzej/0000-0002-2730-7462; James, Karen/0000-0002-8458-3420	Natural History Museum Research Fund, NERC [GR3/12073]; Marie Curie Postdoctoral Fellowship [MEIF-CT-2003-501682]	Natural History Museum Research Fund, NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Marie Curie Postdoctoral Fellowship(European Commission)	This work has been financially supported by The Natural History Museum Research Fund, NERC grant GR3/12073 in support of specimen collection and Marie Curie Postdoctoral Fellowship MEIF-CT-2003-501682 to Niklas Pedersen.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Archibald JK, 2006, TAXON, V55, P747, DOI 10.2307/25065648; Avise J, 2004, MOL MARKERS NATURAL; Bryant D, 2002, LECT NOTES COMPUT SC, V2452, P375; Bussell JD, 2005, PERSPECT PLANT ECOL, V7, P3, DOI 10.1016/j.ppees.2004.07.001; Dane F, 2007, GENET RESOUR CROP EV, V54, P327, DOI 10.1007/s10722-005-4897-2; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Doyle J. J., 1987, PHYTOCHEM B, P11; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Howarth DG, 2005, EVOLUTION, V59, P948, DOI 10.1111/j.0014-3820.2005.tb01034.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; KILIAN A, 2003, WAKE DOUBLE HELIX GR, P443; Koehler-Santos P, 2006, BIOL J LINN SOC, V88, P611, DOI 10.1111/j.1095-8312.2006.00647.x; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Laroche J, 1999, MOL BIOL EVOL, V16, P441, DOI 10.1093/oxfordjournals.molbev.a026126; Lezar S, 2004, THEOR APPL GENET, V109, P1329, DOI 10.1007/s00122-004-1759-9; LOVIS JD, 1968, NATURWISSENSCHAFTEN, V55, P117, DOI 10.1007/BF00624239; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Olsen KM, 2004, PLANT MOL BIOL, V56, P517, DOI 10.1007/s11103-004-5043-9; Pedersen N, 2007, SYST ASSOC SPEC VOL, V71, P367; Pelser PB, 2003, MOL PHYLOGENET EVOL, V29, P613, DOI 10.1016/S1055-7903(03)00139-8; Rambaut A, 2004, TRACER VERSION 1 2; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Schneider H, 2005, P ROY SOC B-BIOL SCI, V272, P455, DOI 10.1098/rspb.2004.2965; Simmons MP, 2007, MOL PHYLOGENET EVOL, V42, P528, DOI 10.1016/j.ympev.2006.08.008; Stefanovic S, 2004, SYST BIOL, V53, P384, DOI 10.1080/10635150490445896; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; VANDEPEER Y, 1993, COMPUT APPL BIOSCI, V9, P177; Vogel JC, 1998, BOT ACTA, V111, P241, DOI 10.1111/j.1438-8677.1998.tb00702.x; VOGEL JC, 1995, THESIS U CAMBRIDGE; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z	44	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1682	10.1371/journal.pone.0001682	http://dx.doi.org/10.1371/journal.pone.0001682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301759	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500026
J	Wallace, RG; Fitch, WM				Wallace, Robert G.; Fitch, Walter M.			Influenza A H5N1 Immigration Is Filtered Out at Some International Borders	PLOS ONE			English	Article							PHYLOGENETIC STRUCTURE; STATISTICAL PHYLOGEOGRAPHY; GEOGRAPHICAL-DISTRIBUTION; CLADISTIC-ANALYSIS; GENE FLOW; EVOLUTION; VIRUS; AFRICA; SPREAD; HAPLOTYPES	Background: Geographic spread of highly pathogenic influenza A H5N1, the bird flu strain, appears a necessary condition for accelerating the evolution of a related human-to-human infection. As H5N1 spreads the virus diversifies in response to the variety of socioecological environments encountered, increasing the chance a human infection emerges. Genetic phylogenies have for the most part provided only qualitative evidence that localities differ in H5N1 diversity. For the first time H5N1 variation is quantified across geographic space. Methodology and Principal Findings: We constructed a statistical phylogeography of 481 H5N1 hemagglutinin genetic sequences from samples collected across 28 Eurasian and African localities through 2006. The MigraPhyla protocol showed southern China was a source of multiple H5N1 strains. Nested clade analysis indicated H5N1 was widely dispersed across southern China by both limited dispersal and long distance colonization. The UniFrac metric, a measure of shared phylogenetic history, grouped H5N1 from Indonesia, Japan, Thailand and Vietnam with those from southeastern Chinese provinces engaged in intensive international trade. Finally, H5N1's accumulative phylogenetic diversity was greatest in southern China and declined beyond. The gradient was interrupted by areas of greater and lesser phylogenetic dispersion, indicating H5N1 migration was restricted at some geopolitical borders. Thailand and Vietnam, just south of China, showed significant phylogenetic clustering, suggesting newly invasive H5N1 strains have been repeatedly filtered out at their northern borders even as both countries suffered recurring outbreaks of endemic strains. In contrast, Japan, while successful in controlling outbreaks, has been subjected to multiple introductions of the virus. Conclusions: The analysis demonstrates phylogenies can provide local health officials with more than hypotheses about relatedness. Pathogen dispersal, the functional relationships among disease ecologies across localities, and the efficacy of control efforts can also be inferred, all from viral genetic sequences alone.	[Wallace, Robert G.; Fitch, Walter M.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Wallace, RG (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	rwallace@uci.edu			National Institutes of Health NIAID [1R21AI063275-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063275] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health NIAID grant 1R21AI063275-01.	Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chutinimitkul S, 2007, EMERG INFECT DIS, V13, P506, DOI 10.3201/eid1303.061103; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CLIFF A, 1986, SPATIAL ASPECTS INFL; CRANDALL KA, 1993, GENETICS, V134, P959; CRANDALL KA, 1999, STAT MOL BIOL GENETI, P186; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Fasina FO, 2007, LANCET INFECT DIS, V7, P696, DOI 10.1016/S1473-3099(07)70244-X; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Flint PL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-132; Gibson CC, 2000, ECOL ECON, V32, P217, DOI 10.1016/S0921-8009(99)00092-0; GILBERT M, 2007, GLOBAL ENV CHANGE IN; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2003, ECOLOGY, V84, P532, DOI 10.1890/0012-9658(2003)084[0532:SAINMA]2.0.CO;2; Gould SJ, 2002, STRUCTURE EVOLUTIONA; HoDac H., 2007, MIGRAPHYLA STAT ANAL; Janies D, 2007, SYST BIOL, V56, P321, DOI 10.1080/10635150701266848; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Keller W, 2007, REV DEV ECON, V11, P107, DOI 10.1111/j.1467-9361.2007.00359.x; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; LEGENDRE P, 2001, CONGRUENCE DISTANCE; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; MADDISON WP, 2006, MESQUITE MODULAR SYS; Mase M, 2005, VIROLOGY, V339, P101, DOI 10.1016/j.virol.2005.05.010; MIYAMOTO MM, 1995, SYST BIOL, V44, P64, DOI 10.2307/2413483; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Oyana TJ, 2006, AVIAN DIS, V50, P508, DOI 10.1637/7597-040506.1; Pennington RT, 2006, NEW PHYTOL, V172, P605, DOI 10.1111/j.1469-8137.2006.01902.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 2006, MOL ECOL NOTES, V6, P590, DOI 10.1111/j.1471-8286.2006.01368.x; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Rweyemamu M, 2000, ANN NY ACAD SCI, V916, P61, DOI 10.1111/j.1749-6632.2000.tb05275.x; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; SLATKIN M, 1989, GENETICS, V123, P603; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TEMPLETON AR, 1995, GENETICS, V140, P767; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; WALLACE R, 1995, ENVIRON PLANN A, V27, P1085, DOI 10.1068/a271085; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Webb CO, 2007, PHYLOCOM SOFTWARE AN; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; Yuen K. Y., 2005, Hong Kong Medical Journal, V11, P189; Zwickl DJ., 2006, THESIS	68	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1697	10.1371/journal.pone.0001697	http://dx.doi.org/10.1371/journal.pone.0001697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301773	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500041
J	Meyer, B; Kuever, J				Meyer, Birte; Kuever, Jan			Homology Modeling of Dissimilatory APS Reductases (AprBA) of Sulfur-Oxidizing and Sulfate-Reducing Prokaryotes	PLOS ONE			English	Article							WOLINELLA-SUCCINOGENES QUINOL; PROTEIN STRUCTURES; WEB SERVER; DESULFOVIBRIO-DESULFURICANS; ADENYLYLSULFATE REDUCTASES; ARCHAEOGLOBUS-FULGIDUS; ISOTOPE FRACTIONATION; ANAEROBIC OXIDATION; FUMARATE REDUCTASE; CRYSTAL-STRUCTURE	The dissimilatory adenosine-5 '-phosphosulfate (APS) reductase (cofactors flavin adenine dinucleotide, FAD, and two [4Fe-4S] centers) catalyzes the transformation of APS to sulfite and AMP in sulfate-reducing prokaryotes (SRP); in sulfur-oxidizing bacteria (SOB) it has been suggested to operate in the reverse direction. Recently, the three-dimensional structure of the Archaeoglobus fulgidus enzyme has been determined in different catalytically relevant states providing insights into its reaction cycle. Methodology/Principal Findings. Full-length AprBA sequences from 20 phylogenetically distinct SRP and SOB species were used for homology modeling. In general, the average accuracy of the calculated models was sufficiently good to allow a structural and functional comparison between the beta- and alpha-subunit structures (78.8-99.3% and 89.5-96.8% of the AprB and AprA main chain atoms, respectively, had root mean square deviations below 1 angstrom with respect to the template structures). Besides their overall conformity, the SRP- and SOB-derived models revealed the existence of individual adaptations at the electron-transferring AprB protein surface presumably resulting from docking to different electron donor/acceptor proteins. These structural alterations correlated with the protein phylogeny (three major phylogenetic lineages: (1) SRP including LGT-affected Archaeoglobi and SOB of Apr lineage II, (2) crenarchaeal SRP Caldivirga and Pyrobaculum, and (3) SOB of the distinct Apr lineage I) and the presence of potential APS reductase-interacting redox complexes. The almost identical protein matrices surrounding both [4Fe-4S] clusters, the FAD cofactor, the active site channel and center within the AprB/A models of SRP and SOB point to a highly similar catalytic process of APS reduction/sulfite oxidation independent of the metabolism type the APS reductase is involved in and the species it has been originated from. Conclusions. Based on the comparative models, there are no significant structural differences between dissimilatory APS reductases from SRP and SOB; this might be indicative for a similar catalytic process of APS reduction/sulfite oxidation.	[Meyer, Birte; Kuever, Jan] Bremen Inst Mat Testing, Bremen, Germany		Kuever, J (corresponding author), Bremen Inst Mat Testing, Bremen, Germany.	kuever@mpa-bremen.de			Max-Planck-Society; German Research Foundation	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG))	This study was funded by the Max-Planck-Society and the German Research Foundation.	Amo Taku, 2002, Archaea, V1, P113, DOI 10.1155/2002/616075; Brune DC, 1995, ANOXYGENIC PHOTOSYNT, P847, DOI 10.1007/0-306-47954-0_39; Bruser T., 2000, ENV TECHNOLOGIES TRE, P47; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Dahl C, 2001, METHOD ENZYMOL, V331, P427; DAHL C, 1994, METHOD ENZYMOL, V243, P400; DEISENHOFER J, 1989, EMBO J, V8, P2149, DOI 10.1002/j.1460-2075.1989.tb08338.x; Fiser A, 2001, COMPUTATIONAL BIOCHEMISTRY AND BIOPHYSICS, P275; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Fritz G, 2000, FEBS LETT, V473, P63, DOI 10.1016/S0014-5793(00)01500-3; Fritz G, 2002, P NATL ACAD SCI USA, V99, P1836, DOI 10.1073/pnas.042664399; Fritz G, 2002, J BIOL CHEM, V277, P26066, DOI 10.1074/jbc.M203397200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Habicht KS, 2005, APPL ENVIRON MICROB, V71, P3770, DOI 10.1128/AEM.71.7.3770-3777.2005; Habicht KS, 2001, GEOLOGY, V29, P555, DOI 10.1130/0091-7613(2001)029<0555:IFBSRN>2.0.CO;2; HANSEN TA, 1994, ANTON LEEUW INT J G, V66, P165, DOI 10.1007/BF00871638; Haveman SA, 2004, J BACTERIOL, V186, P7944, DOI 10.1128/JB.186.23.7944-7950.2004; Hipp WM, 1997, MICROBIOL-UK, V143, P2891, DOI 10.1099/00221287-143-9-2891; Hooft RWW, 1996, J APPL CRYSTALLOGR, V29, P714, DOI 10.1107/S0021889896008631; HUBER H, 2002, PROKARYOTES EVOLVING; Itoh T, 2003, J BIOSCI BIOENG, V96, P203, DOI 10.1263/jbb.96.203; Krieger E., 2003, STRUCTURAL BIOINFORM; LAMPREIA J, 1994, METHOD ENZYMOL, V243, P241; Lancaster CRD, 2003, FEBS LETT, V555, P21, DOI 10.1016/S0014-5793(03)01100-1; Lancaster CRD, 2003, ADV PROTEIN CHEM, V63, P131; Lennon BW, 1999, PROTEIN SCI, V8, P2366; LESK AM, 1986, PHILOS T R SOC A, V317, P345, DOI 10.1098/rsta.1986.0044; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Meyer B, 2007, MICROBIOL-SGM, V153, P2026, DOI 10.1099/mic.0.2006/003152-0; MICHAELS GB, 1970, BIOCHEM BIOPH RES CO, V39, P321, DOI 10.1016/0006-291X(70)90579-6; Mussmann M, 2005, J BACTERIOL, V187, P7126, DOI 10.1128/JB.187.20.7126-7137.2005; PECK HD, 1965, BIOCHIM BIOPHYS ACTA, V96, P429, DOI 10.1016/0005-2787(65)90561-7; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Pires RH, 2003, BBA-BIOENERGETICS, V1605, P67, DOI 10.1016/S0005-2728(03)00065-3; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; RABUS R, 1999, PROKARYOTES EVOLVING, P1; SCHEDEL M, 1980, ARCH MICROBIOL, V124, P205, DOI 10.1007/BF00427728; Schiffer A, 2006, BIOCHEMISTRY-US, V45, P2960, DOI 10.1021/bi0521689; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sperling D, 2001, METHOD ENZYMOL, V331, P419; TAYLOR BF, 1994, METHOD ENZYMOL, V243, P393; TINDALL BJ, 1991, SYST APPL MICROBIOL, V14, P218, DOI 10.1016/S0723-2020(11)80371-1; TRUPER HG, 1982, PHILOS T ROY SOC B, V298, P529, DOI 10.1098/rstb.1982.0095; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT	51	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1514	10.1371/journal.pone.0001514	http://dx.doi.org/10.1371/journal.pone.0001514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231600	gold, Green Published, Green Submitted			2022-12-27	WOS:000260504200026
J	Hegde, A; Qiu, NC; Qiu, XH; Ho, SHK; Tay, KQY; George, J; Ng, FSL; Govindarajan, KR; Gong, ZY; Mathavan, S; Jiang, YJ				Hegde, Ashok; Qiu, Nick Chuanxin; Qiu, Xuehui; Ho, Steven Hao-Kee; Tay, Kenny Qi-Ye; George, Joshy; Ng, Felicia Soo Lee; Govindarajan, Kunde Ramamoorthy; Gong, Zhiyuan; Mathavan, Sinnakaruppan; Jiang, Yun-Jin			Genomewide Expression Analysis in Zebrafish mind bomb Alleles with Pancreas Defects of Different Severity Identifies Putative Notch Responsive Genes	PLOS ONE			English	Article								Background. Notch signaling is an evolutionarily conserved developmental pathway. Zebrafish mind bomb(mib) mutants carry mutations on mib gene, which encodes a RING E3 ligase required for Notch activation via Delta/Jagged ubiquitylation and internalization. Methodology/Principal Findings. We examined the mib mutants for defects in pancreas development using in situ hybridization and GFP expression analysis of pancreas-specific GFP lines, carried out the global gene expression profile analysis of three different mib mutant alleles and validated the microarray data using real-time PCR and fluorescent double in situ hybridization. Our study showed that the mib mutants have diminished exocrine pancreas and this defect was most severe in mib(ta52b) followed by mib(m132) and then mib(tfi91), which is consistent with the compromised Notch activity found in corresponding mib mutant alleles. Global expression profile analysis of mib mutants showed that there is a significant difference in gene expression profile of wt and three mib mutant alleles. There are 91 differentially expressed genes that are common to all three mib alleles. Through detailed analysis of microarray data, we have identified several previously characterized genes and some putative Notch-responsive genes involved in pancreas development. Moreover, results from real-time PCR and fluorescent double in situ hybridization were largely consistent with microarray data. Conclusions/Significance. This study provides, for the first time, a global gene expression profile in mib mutants generating useful genomic resources and providing an opportunity to identify the function of novel genes involved in Notch signaling and Notch-regulated developmental processes.	[Hegde, Ashok; Qiu, Nick Chuanxin; Qiu, Xuehui; Ho, Steven Hao-Kee; Tay, Kenny Qi-Ye; Jiang, Yun-Jin] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Lab Dev Signalling & Patterning, Singapore, Singapore; [George, Joshy; Govindarajan, Kunde Ramamoorthy; Mathavan, Sinnakaruppan] Genome Inst Singapore, Agency Sci Technol & Res, Singapore, Singapore; [Ng, Felicia Soo Lee] Bioinform Inst, Agency Sci Technol & Res, Singapore, Singapore; [Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Jiang, Yun-Jin] Natl Univ Singapore, Dept Biochem, Singapore, Singapore; [Jiang, Yun-Jin] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Jiang, YJ (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Lab Dev Signalling & Patterning, Singapore, Singapore.	yjjiang@imcb.a-star.edu.sg	George, Joshy/K-4841-2019; Jiang, Yun-Jin/E-3995-2010; Gong, Zhiyuan/H-8794-2012	Jiang, Yun-Jin/0000-0003-0499-7306; Gong, Zhiyuan/0000-0002-9660-5260; George, Joshy/0000-0001-8510-8229	Biomedical Research Council of Singapore [04/1/50/22/295]; Juvenile Diabetes Research Foundation International [04/1/50/22/295]	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation)	This work was supported by a joint grant from the Biomedical Research Council of Singapore and Juvenile Diabetes Research Foundation International (BMRC-JDRF, 04/1/50/22/295) and the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Appel B, 1998, DEVELOPMENT, V125, P371; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chiang MK, 2003, DEV CELL, V4, P383, DOI 10.1016/S1534-5807(03)00035-2; Chong SW, 2005, TRENDS CELL BIOL, V15, P453, DOI 10.1016/j.tcb.2005.07.008; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Fortini ME, 2001, CURR OPIN CELL BIOL, V13, P627, DOI 10.1016/S0955-0674(00)00261-1; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hans S, 2004, DEVELOPMENT, V131, P2957, DOI 10.1242/dev.01167; Hill DJ, 1999, J ENDOCRINOL, V160, P305, DOI 10.1677/joe.0.1600305; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Huang HG, 2001, GENESIS, V30, P134, DOI 10.1002/gene.1048; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Irvin DK, 2003, DEV NEUROSCI-BASEL, V25, P162, DOI 10.1159/000072265; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kim HJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-23; Kohyama J, 2005, DEV BIOL, V286, P311, DOI 10.1016/j.ydbio.2005.08.003; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Leake D, 1999, DIFFERENTIATION, V65, P181, DOI 10.1046/j.1432-0436.1999.6540181.x; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Mally MI, 1996, DIABETOLOGIA, V39, P474, DOI 10.1007/s001250050468; Matesic LE, 2006, HUM MOL GENET, V15, P3485, DOI 10.1093/hmg/ddl425; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Oates AC, 2002, DEVELOPMENT, V129, P2929; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pleau JM, 1997, BIOCHEM BIOPH RES CO, V233, P227, DOI 10.1006/bbrc.1997.6432; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Qiu XH, 2004, DEV DYNAM, V231, P621, DOI 10.1002/dvdy.20155; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Riley BB, 2004, DEV DYNAM, V231, P278, DOI 10.1002/dvdy.20133; Schafer M, 2007, DEV BIOL, V301, P117, DOI 10.1016/j.ydbio.2006.09.018; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Shankaran SS, 2007, DEV BIOL, V304, P615, DOI 10.1016/j.ydbio.2007.01.004; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Takamiya M, 2006, DEV DYNAM, V235, P978, DOI 10.1002/dvdy.20720; Takke C, 1999, DEVELOPMENT, V126, P1811; THISSE B, 2001, NIH ZFIN DIRECT DATA; Thisse C., 2005, ZFIN DIRECT DATA SUB; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tsutsumi M, 2007, GENE EXPR PATTERNS, V7, P227, DOI 10.1016/j.modgep.2006.10.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Haeften TW, 2004, EUR J CLIN INVEST, V34, P249, DOI 10.1111/j.1365-2362.2004.01337.x; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Willer GB, 2005, GENETICS, V170, P1827, DOI 10.1534/genetics.105.041608; Xu J, 2006, GENETICS, V174, P735, DOI 10.1534/genetics.106.061523; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yang H, 2003, P NATL ACAD SCI USA, V100, P1122, DOI 10.1073/pnas.0237337100; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	98	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1479	10.1371/journal.pone.0001479	http://dx.doi.org/10.1371/journal.pone.0001479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213387	Green Submitted, Green Published, gold			2022-12-27	WOS:000260503900024
J	Nakagawa, H; Tategu, M; Yamauchi, R; Sasaki, K; Sekimachi, S; Yoshida, K				Nakagawa, Hiroki; Tategu, Moe; Yamauchi, Rieko; Sasaki, Kaori; Sekimachi, Sota; Yoshida, Kenichi			Transcriptional Regulation of an Evolutionary Conserved Intergenic Region of CDT2-INTS7	PLOS ONE			English	Article							BIDIRECTIONAL PROMOTER; NUCLEAR; PROTEIN; E2F; L2DTL/CDT2; COMPLEX; FAMILY; PCNA	Background. In the mammalian genome, a substantial number of gene pairs (approximately 10%) are arranged head-to-head on opposite strands within 1,000 base pairs, and separated by a bidirectional promoter(s) that generally drives the co-expression of both genes and results in functional coupling. The significance of unique genomic configuration remains elusive. Methodology/Principal Findings. Here we report on the identification of an intergenic region of non-homologous genes, CDT2, a regulator of DNA replication, and an integrator complex subunit 7 (INTS7), an interactor of the largest subunit of RNA polymerase II. The CDT2-INTS7 intergenic region is 246 and 245 base pairs long in human and mouse respectively and is evolutionary well-conserved among several mammalian species. By measuring the luciferase activity in A549 cells, the intergenic human sequence was shown to be able to drive the reporter gene expression in either direction and notably, among transcription factors E2F, E2F1 similar to E2F4, but not E2F5 and E2F6, this sequence clearly up-regulated the reporter gene expression exclusively in the direction of the CDT2 gene. In contrast, B-Myb, c-Myb, and p53 down-regulated the reporter gene expression in the transcriptional direction of the INTS7 gene. Overexpression of E2F1 by adenoviral-mediated gene transfer resulted in an increased CDT2, but not INTS7, mRNA level. Real-time polymerase transcription (RT-PCR) analyses of the expression pattern for CDT2 and INTS7 mRNA in human adult and fetal tissues and cell lines revealed that transcription of these two genes are asymmetrically regulated. Moreover, the abundance of mRNA between mouse and rat tissues was similar, but these patterns were quite different from the results obtained from human tissues. Conclusions/Significance. These findings add a unique example and help to understand the mechanistic insights into the regulation of gene expression through an evolutionary conserved intergenic region of the mammalian genome.	[Nakagawa, Hiroki; Tategu, Moe; Yamauchi, Rieko; Sasaki, Kaori; Sekimachi, Sota; Yoshida, Kenichi] Meiji Univ, Sch Agr, Dept Life Sci, Kanagawa, Japan	Meiji University	Yoshida, K (corresponding author), Meiji Univ, Sch Agr, Dept Life Sci, Kanagawa, Japan.	yoshida@isc.meiji.ac.jp			JSPS	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by JSPS.	Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004; Chen PY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-2; GAVALAS A, 1995, J BIOL CHEM, V270, P2403, DOI 10.1074/jbc.270.5.2403; Goto Y, 2006, J CELL PHYSIOL, V209, P923, DOI 10.1002/jcp.20802; Goto Y, 2006, BBA-GENE STRUCT EXPR, V1759, P60, DOI 10.1016/j.bbaexp.2006.02.004; Hayashi R, 2007, DNA CELL BIOL, V26, P91, DOI 10.1089/dna.2006.0515; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Johnson DG, 2006, CURR MOL MED, V6, P731; LI YY, 2006, PLOS COMPUT BIOL, V2; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Segal Y, 2001, J BIOL CHEM, V276, P11791, DOI 10.1074/jbc.M007477200; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488; Yoshida SH, 2003, GENETICS, V164, P881	20	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1484	10.1371/journal.pone.0001484	http://dx.doi.org/10.1371/journal.pone.0001484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213392	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503900029
J	Company, JB; Puig, P; Sarda, F; Palanques, A; Latasa, M; Scharek, R				Company, Joan B.; Puig, Pere; Sarda, Francesc; Palanques, Albert; Latasa, Mikel; Scharek, Renate			Climate Influence on Deep Sea Populations	PLOS ONE			English	Article							SHRIMP ARISTEUS-ANTENNATUS; ECOLOGICAL ASPECTS; 20-1ST CENTURY; DENSE WATER; FISHERIES; WESTERN; RISSO; MANAGEMENT; SIMULATION; CASCADES	Dynamics of biological processes on the deep-sea floor are traditionally thought to be controlled by vertical sinking of particles from the euphotic zone at a seasonal scale. However, little is known about the influence of lateral particle transport from continental margins to deep-sea ecosystems. To address this question, we report here how the formation of dense shelf waters and their subsequent downslope cascade, a climate induced phenomenon, affects the population of the deep-sea shrimp Aristeus antennatus. We found evidence that strong currents associated with intense cascading events correlates with the disappearance of this species from its fishing grounds, producing a temporary fishery collapse. Despite this initial negative effect, landings increase between 3 and 5 years after these major events, preceded by an increase of juveniles. The transport of particulate organic matter associated with cascading appears to enhance the recruitment of this deep-sea living resource, apparently mitigating the general trend of overexploitation. Because cascade of dense water from continental shelves is a global phenomenon, we anticipate that its influence on deep-sea ecosystems and fisheries worldwide should be larger than previously thought.	[Puig, Pere; Sarda, Francesc; Palanques, Albert; Latasa, Mikel] ICM CSIC, Barcelona, Spain; [Scharek, Renate] Inst Espanol Oceanogr (IEO), Ctr Oceanogr Gijon, Gijon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Company, JB (corresponding author), ICM CSIC, Barcelona, Spain.	batista@icm.csic.es	Company, Joan B./K-7274-2014; Latasa, Mikel/D-2202-2011; Scharek, Renate/M-4530-2018; Sarda, Francisco/L-6229-2014; Palanques, Albert/C-2661-2013; Puig, Pere/E-5422-2013	Company, Joan B./0000-0002-5878-7155; Latasa, Mikel/0000-0002-8202-0923; Scharek, Renate/0000-0001-9306-9047; Sarda, Francisco/0000-0001-7905-4148; Puig, Pere/0000-0001-6189-5504; Palanques, Albert/0000-0003-2544-2342	US Office of Naval Research [N00014-1-0379]; Spanish Ministerio de Educacion y Ciencia [REN 2002-04151-C02-01]	US Office of Naval Research(Office of Naval Research); Spanish Ministerio de Educacion y Ciencia(Spanish Government)	Supported by the US Office of Naval Research grant N00014-1-0379 (PP; current meter data) and the Spanish Ministerio de Educacion y Ciencia grant REN 2002-04151-C02-01	Alegret J. L., 2004, HIST CONFRARIA PESCA, P295; Bethoux JP, 2002, J MARINE SYST, V33, P117, DOI 10.1016/S0924-7963(02)00055-6; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; Billett DSM, 2001, PROG OCEANOGR, V50, P13, DOI 10.1016/S0079-6611(01)00046-5; Caddy JF, 1999, REV FISH BIOL FISHER, V9, P1, DOI 10.1023/A:1008829909601; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Carbonell A, 2003, FISH RES, V65, P323, DOI 10.1016/j.fishres.2003.09.023; D'Onghia G, 2005, FISH RES, V76, P22, DOI 10.1016/j.fishres.2005.05.007; D'Onghia G, 2004, SCI MAR, V68, P87, DOI 10.3989/scimar.2004.68s387; de Madron XD, 2005, PROG OCEANOGR, V64, P83, DOI 10.1016/j.pocean.2004.08.004; DEMESTRE M, 1990, THESIS U BARCELONA, P443; Demestre M, 1993, SCI MAR, V57, P183; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; FAO Nations F.a.A.O.o.t.U., 2004, STAT WORLD FISH AQ; Fieux M., 1974, C INTERNAT CNRS FORM, V215, P165; Font J, 2007, SCI MAR, V71, P339, DOI 10.3989/scimar.2007.71n2339; Gage JD, 2003, ECOSY WORLD, V28, P313; Gordon JDM, 2001, CONT SHELF RES, V21, P987, DOI 10.1016/S0278-4343(00)00121-7; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; Herring P., 2002, BIOL DEEP OCEAN, P314; Ivanov VV, 2004, PROG OCEANOGR, V60, P47, DOI 10.1016/j.pocean.2003.12.002; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Lopez-Jurado JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024430; Maynou F, 2006, AQUAT LIVING RESOUR, V19, P161, DOI 10.1051/alr:2006014; MEDOC Group, 1970, NATURE, V227, P1037, DOI [10.1038/2271037a0, DOI 10.1038/2271037A0]; Merino G, 2007, SCI MAR, V71, P537, DOI 10.3989/scimar.2007.71n3537; Merrett N.R., 1997, DEEP SEA DEMERSAL FI, P282; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Roberts CM, 2002, TRENDS ECOL EVOL, V17, P242, DOI 10.1016/S0169-5347(02)02492-8; SALAT J, 2006, UNUSUAL EXTENSION W; SARDA F, 1987, Investigacion Pesquera (Barcelona), V51, P213; Sarda F, 2004, SCI MAR, V68, P117, DOI 10.3989/scimar.2004.68s3117; SARDA F, 1994, FISH B-NOAA, V92, P599; Sarda F, 1997, MAR FRESHWATER RES, V48, P73, DOI 10.1071/MF95043; Sarda Francesc, 2003, Journal of Northwest Atlantic Fishery Science, V31, P127; Schroder K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027121; Smith CR, 2006, DEEP-SEA RES PT II, V53, P875, DOI 10.1016/j.dsr2.2006.02.001; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	42	174	176	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1431	10.1371/journal.pone.0001431	http://dx.doi.org/10.1371/journal.pone.0001431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197243	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503800004
J	Duan, JJ; Marvier, M; Huesing, J; Dively, G; Huang, ZY				Duan, Jian J.; Marvier, Michelle; Huesing, Joseph; Dively, Galen; Huang, Zachary Y.			A Meta-Analysis of Effects of Bt Crops on Honey Bees (Hymenoptera: Apidae)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXIN; APIS-MELLIFERA; TRYPSIN-INHIBITOR; TRANSGENIC COTTON; CORN POLLEN; PROTEIN; EVOLUTION	Background. Honey bees (Apis mellifera L.) are the most important pollinators of many agricultural crops worldwide and are a key test species used in the tiered safety assessment of genetically engineered insect-resistant crops. There is concern that widespread planting of these transgenic crops could harm honey bee populations. Methodology/Principal Findings. We conducted a meta-analysis of 25 studies that independently assessed potential effects of Bt Cry proteins on honey bee survival (or mortality). Our results show that Bt Cry proteins used in genetically modified crops commercialized for control of lepidopteran and coleopteran pests do not negatively affect the survival of either honey bee larvae or adults in laboratory settings. Conclusions/Significance. Although the additional stresses that honey bees face in the field could, in principle, modify their susceptibility to Cry proteins or lead to indirect effects, our findings support safety assessments that have not detected any direct negative effects of Bt crops for this vital insect pollinator.	[Marvier, Michelle] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Duan, Jian J.; Huesing, Joseph] Monsanto Comp, Ecol Technol Ctr, St Louis, MO USA; [Dively, Galen] Univ Maryland, Dept Entomol, College Pk, MD USA; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI USA	Santa Clara University; Monsanto; University System of Maryland; University of Maryland College Park; Michigan State University	Marvier, M (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	mmarvier@scu.edu	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547; Marvier, Michelle/0000-0001-8360-9265	EPA [CR-832147-01]	EPA(United States Environmental Protection Agency)	M. Marvier was supported by EPA grant CR-832147-01.	ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Arpaia S., 1996, Journal of Genetics and Breeding, V50, P315; Council NR., 2007, STATUS POLLINATORS N; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Gurevitch Jessica, 1993, P378; Hanley AV, 2003, J APICULT RES, V42, P77, DOI 10.1080/00218839.2003.11101097; Hunter JE, 2000, INT J SELECT ASSESS, V8, P275, DOI 10.1111/1468-2389.00156; LATSCH G, 2007, SPIEGEL ONLINE INT; Liu B, 2005, BIODIVERS CONSERV, V14, P3487, DOI 10.1007/s10531-004-0824-7; MAGGI VL, 1993, 42932210 US EPA MRID; MAGGI VL, 2000, 45086307 US EPA MRID; MAGGI VL, 1994, 43439203 US EPA MRID; MAGGI VL, 2000, 45337102 US EPA MRID; MAGGI VL, 2002, MSL17762 MONS CO; MAGGI VL, 1999, 45041503 US EPA MRID; MAGGI VL, 2000, 45086308 US EPA MRID; MAGGI VL, 1994, 43439202 US EPA MRID; MAGGI VL, 2002, MSL17761 MONS CO; MAGGI VL, 1993, 43145207 US EPA MRID; MAGGI VL, 1999, 44904311 US EPA MRID; MAGGI VL, 1993, 43145206 US EPA MRID; MAGGI VL, 1999, 44904310 US EPA MRID; MAGGI VL, 1996, 44124702 US EPA MRID; MAGGI VL, 1993, 42932209 US EPA MRID; Malone LA, 2004, APIDOLOGIE, V35, P655, DOI 10.1051/apido:2004063; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; Malone LA, 1999, APIDOLOGIE, V30, P465, DOI 10.1051/apido:19990601; Malone LA, 2001, APIDOLOGIE, V32, P57, DOI 10.1051/apido:2001111; Marvier M, 2002, ECOL APPL, V12, P1119, DOI 10.1890/1051-0761(2002)012[1119:IRAFNS]2.0.CO;2; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; MCDONALD J, 2007, SAN FRANCISCO CHRON, pF4; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; O'Callaghan M, 2005, ANNU REV ENTOMOL, V50, P271, DOI 10.1146/annurev.ento.50.071803.130352; OECD, 1998, 213 OECD; OECD (Organisation of Cooperation and Development), 2007, OECD ENV HLTH SAF PU, V42; PALMER SJ, 1997, 44384302 US EPA MRID; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rose R, 2007, APIDOLOGIE, V38, P368, DOI 10.1051/apido:2007022; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Sims SR, 1997, SOUTHWEST ENTOMOL, V22, P395; Sims SR, 1995, SOUTHWEST ENTOMOL, V20, P493; Sutton AJAK, 2000, METHODS METAANALYSIS; US EPA (United States of America Environmental Protection Agency), 1996, MICR PEST TEST GUID	44	126	142	3	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1415	10.1371/journal.pone.0001415	http://dx.doi.org/10.1371/journal.pone.0001415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183296	Green Published, gold			2022-12-27	WOS:000260469400012
J	Tabor, R; Friedrich, RW				Tabor, Rico; Friedrich, Rainer W.			Pharmacological Analysis of Ionotropic Glutamate Receptor Function in Neuronal Circuits of the Zebrafish Olfactory Bulb	PLOS ONE			English	Article							GRANULE CELLS; MITRAL CELLS; NMDA RECEPTORS; GABA RELEASE; DENDRODENDRITIC INHIBITION; PRESYNAPTIC INHIBITION; RECIPROCAL SYNAPSES; GAMMA-OSCILLATIONS; ODOR STIMULATION; ANTENNAL LOBE	Although synaptic functions of ionotropic glutamate receptors in the olfactory bulb have been studied in vitro, their roles in pattern processing in the intact system remain controversial. We therefore examined the functions of ionotropic glutamate receptors during odor processing in the intact olfactory bulb of zebrafish using pharmacological manipulations. Odor responses of mitral cells and interneurons were recorded by electrophysiology and 2-photon Ca(2+) imaging. The combined blockade of AMPA/kainate and NMDA receptors abolished odor-evoked excitation of mitral cells. The blockade of AMPA/kainate receptors alone, in contrast, increased the mean response of mitral cells and decreased the mean response of interneurons. The blockade of NMDA receptors caused little or no change in the mean responses of mitral cells and interneurons. However, antagonists of both receptor types had diverse effects on the magnitude and time course of individual mitral cell and interneuron responses and, thus, changed spatio-temporal activity patterns across neuronal populations. Oscillatory synchronization was abolished or reduced by AMPA/kainate and NMDA receptor antagonists, respectively. These results indicate that (1) interneuron responses depend mainly on AMPA/kainate receptor input during an odor response, (2) interactions among mitral cells and interneurons regulate the total olfactory bulb output activity, (3) AMPA/kainate receptors participate in the synchronization of odor-dependent neuronal ensembles, and (4) ionotropic glutamate receptor-containing synaptic circuits shape odor-specific patterns of olfactory bulb output activity. These mechanisms are likely to be important for the processing of odor-encoding activity patterns in the olfactory bulb.	[Tabor, Rico; Friedrich, Rainer W.] Max Planck Inst Med Res, Dept Biomed Opt, Heidelberg, Germany; [Friedrich, Rainer W.] Friedrich Miescher Inst, Basel, Switzerland	Max Planck Society; Friedrich Miescher Institute for Biomedical Research	Friedrich, RW (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, Heidelberg, Germany.	Rainer.Friedrich@fmi.ch		Friedrich, Rainer/0000-0001-9107-0482	Max-Planck-Society; Novartis Research Foundation; Deutsche Forschungsgemeinschaft [FOR 643]	Max-Planck-Society(Max Planck Society); Novartis Research Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck-Society, the Novartis Research Foundation and the Deutsche Forschungsgemeinschaft (FOR 643).	ALLISON AC, 1953, BIOL REV, V28, P195, DOI 10.1111/j.1469-185X.1953.tb01376.x; Andres K.H., 1970, CIBA FDN S TASTE SME, P177; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V81, P15, DOI 10.1152/jn.1999.81.1.15; Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; BERKOWICZ DA, 1994, J NEUROPHYSIOL, V71, P2557, DOI 10.1152/jn.1994.71.6.2557; CHAPUT MA, 1985, PHYSIOL BEHAV, V34, P249, DOI 10.1016/0031-9384(85)90113-1; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; DuchampViret P, 1997, PROG NEUROBIOL, V53, P561, DOI 10.1016/S0301-0082(97)00049-X; Edwards JG, 2002, J COMP NEUROL, V454, P294, DOI 10.1002/cne.10445; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; Ennis M, 1996, NEUROREPORT, V7, P989, DOI 10.1097/00001756-199604100-00007; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; FULLER CL, 2006, J COMP NEUR IN PRESS; GRAY CM, 1988, EXP BRAIN RES, V69, P378; Halabisky B, 2000, J NEUROSCI, V20, P5124; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; HASSELMO ME, 1990, COLD SPRING HARB SYM, V55, P599; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 2001, P NATL ACAD SCI USA, V98, P337, DOI 10.1073/pnas.021445798; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Lagier S, 2007, P NATL ACAD SCI USA, V104, P7259, DOI 10.1073/pnas.0701846104; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; NICKELL WT, 1994, BRAIN RES BULL, V35, P119, DOI 10.1016/0361-9230(94)90091-4; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sassoe-Pognetto M, 2000, J NEUROSCI, V20, P2192; Schoppa NE, 2006, J NEUROSCI, V26, P12996, DOI 10.1523/JNEUROSCI.3503-06.2006; Schoppa NE, 2006, NEURON, V49, P271, DOI 10.1016/j.neuron.2005.11.038; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; TROMBLEY PQ, 1990, J NEUROPHYSIOL, V64, P598, DOI 10.1152/jn.1990.64.2.598; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; WACHOWIAK M, 2005, J NEUROPHYSIOL; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; Zelles T, 2006, J NEUROSCI, V26, P30, DOI 10.1523/JNEUROSCI.1419-05.2006	60	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1416	10.1371/journal.pone.0001416	http://dx.doi.org/10.1371/journal.pone.0001416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183297	Green Published, Green Submitted, gold			2022-12-27	WOS:000260469400013
J	Garcia-Gonzalo, FR; Belmonte, JCI				Garcia-Gonzalo, Francesc R.; Izpisua Belmonte, Juan Carlos			Albumin-Associated Lipids Regulate Human Embryonic Stem Cell Self-Renewal	PLOS ONE			English	Article							DEFINED CULTURE-CONDITIONS; FIBROBLAST-GROWTH-FACTOR; PHOSPHATIDIC-ACID; DERIVATION; DIFFERENTIATION; PLURIPOTENCY; PROLIFERATION; MAINTENANCE; PATHWAYS; SURVIVAL	Background. Although human embryonic stem cells (hESCs) hold great promise as a source of differentiated cells to treat several human diseases, many obstacles still need to be surmounted before this can become a reality. First among these, a robust chemically-defined system to expand hESCs in culture is still unavailable despite recent advances in the understanding of factors controlling hESC self-renewal. Methodology/Principal Findings. In this study, we attempted to find new molecules that stimulate long term hESC self-renewal. In order to do this, we started from the observation that a commercially available serum replacement product has a strong positive effect on the expansion of undifferentiated hESCs when added to a previously reported chemically-defined medium. Subsequent experiments demonstrated that the active ingredient within the serum replacement is lipid-rich albumin. Furthermore, we show that this activity is trypsin-resistant, strongly suggesting that lipids and not albumin are responsible for the effect. Consistent with this, lipid-poor albumin shows no detectable activity. Finally, we identified the major lipids bound to the lipid-rich albumin and tested several lipid candidates for the effect. Conclusions/Significance. Our discovery of the role played by albumin-associated lipids in stimulating hESC self-renewal constitutes a significant advance in the knowledge of how hESC pluripotency is maintained by extracellular factors and has important applications in the development of increasingly chemically defined hESC culture systems.	[Garcia-Gonzalo, Francesc R.; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Ctr Regen Med Barcelona, Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Garcia-Gonzalo, Francesc/W-2639-2017	Garcia-Gonzalo, Francesc/0000-0002-9152-2191	Spanish Ministry of Education and Science [postdoctoral fellowship]; National Institutes of Health; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Cellex	Spanish Ministry of Education and Science(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Cellex(Foundation CELLEX)	FRG-G has been supported by a postdoctoral fellowship from the Spanish Ministry of Education and Science. Work in the laboratory of JCIB was supported by grants from the National Institutes of Health, G. Harold and Leila Y. Mathers Charitable Foundation, and Fundacion Cellex.	Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Chase LG, 2007, CURR OPIN CHEM BIOL, V11, P367, DOI 10.1016/j.cbpa.2007.06.421; Christoforou N, 2007, PROG CARDIOVASC DIS, V49, P396, DOI 10.1016/j.pcad.2007.02.006; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Gangaram-Panday ST, 2007, TRENDS MOL MED, V13, P164, DOI 10.1016/j.molmed.2007.02.002; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; HERINGDORF DM, 2006, BIOCHIM BIOPHYS ACTA, V1768, P923; Inniss K, 2006, STEM CELLS DEV, V15, P789, DOI 10.1089/scd.2006.15.789; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; Kim DS, 2007, CELL TRANSPLANT, V16, P117; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; PRICE PJ, 1998, Patent No. 9830679; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Singh AM, 2007, TRENDS CARDIOVAS MED, V17, P96, DOI 10.1016/j.tcm.2007.02.003; Skottman H, 2007, REGEN MED, V2, P265, DOI 10.2217/17460751.2.3.265; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; WANG L, 2007, BLOOD           0829; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu DC, 2007, FRONT BIOSCI-LANDMRK, V12, P4525, DOI 10.2741/2407; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103	47	114	137	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1384	10.1371/journal.pone.0001384	http://dx.doi.org/10.1371/journal.pone.0001384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167543	Green Submitted, Green Published, gold			2022-12-27	WOS:000260468900012
J	Pai, JK; Mukamal, KJ; Rexrode, KM; Rimm, EB				Pai, Jennifer K.; Mukamal, Kenneth J.; Rexrode, Kathryn M.; Rimm, Eric B.			C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PROMOTER REGION; BASE-LINE; INFLAMMATION; ASSOCIATION; MARKERS; PREDICTION; HAPLOTYPES; HEALTH	Background. C-reactive protein (CRP), an acute phase reactant and marker of inflammation, has been shown to predict risk of incident cardiovascular events. However, few studies have comprehensively examined six common single-nucleotide polymorphisms (SNPs) in the CRP gene, haplotypes, and plasma CRP levels with risk of coronary heart disease (CHD). Methods and Findings. We conducted parallel nested case-control studies within two ongoing, prospective cohort studies of U. S. women (Nurses' Health Study) and men (Health Professionals Follow-up Study). Blood samples were available in a subset of 32,826 women and 18,225 men for biomarker and DNA analyses. During 8 and 6 years of follow-up, 249 women and 266 men developed incident nonfatal myocardial infarction or fatal CHD, and controls (498 women, 531 men) were matched 2: 1 on age, smoking, and date of blood draw from participants free of cardiovascular disease at the time the case was diagnosed. Among both women and men, minor alleles were significantly associated with higher CRP levels for SNPs 1919A>T and 4741G>C, but associated with lower CRP levels for SNPs 2667G>C and 3872C>T. SNP 2667G>C was individually associated with increased risk of CHD in both women [OR 1.57 (95% CI 1.01-2.44); p = 0.047] and men [1.93 (95% CI 1.30-2.88); p = 0.001]. Two of the five common haplotypes were associated with lower CRP levels, and Haplotype 4 which included minor alleles for 2667 and 3872 was associated with significantly lower CRP levels and an elevated risk of CHD. The remaining SNPs or haplotypes were not associated with CHD in both populations. Conclusions. Common variation in the CRP gene was significantly associated with plasma CRP levels; however, the association between common SNPs and CRP levels did not correspond to a predicted change in CHD risk. The underlying inflammatory processes which predict coronary events cannot be captured solely by variation in the CRP gene.	[Pai, Jennifer K.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Pai, Jennifer K.; Rimm, Eric B.] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Channing Lab, Boston, MA USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Div Prevent Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pai, JK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	jpai@hsph.harvard.edu	Rexrode, Kathryn M/I-1177-2018; Mukamal, Kenneth/GVR-7978-2022	Rexrode, Kathryn/0000-0003-3387-8429	National Institutes of Health [HL35464, CA55075, HL34594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL035464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants (HL35464, CA55075, and HL34594) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danik JS, 2006, ANN HUM GENET, V70, P705, DOI 10.1111/j.1469-1809.2006.00272.x; de Maat MPM, 2004, CURR OPIN LIPIDOL, V15, P651, DOI 10.1097/00041433-200412000-00005; Dupuis J, 2005, ATHEROSCLEROSIS, V182, P307, DOI 10.1016/j.atherosclerosis.2005.02.015; Ford ES, 2004, CLIN CHEM, V50, P574, DOI 10.1373/clinchem.2003.027359; GABH Rose, 1982, WHO MONOGRAPH SERIES; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Ledue TB, 2003, CLIN CHEM, V49, P1258, DOI 10.1373/49.8.1258; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Obisesan TO, 2004, ARTERIOSCL THROM VAS, V24, P1874, DOI 10.1161/01.ATV.0000140060.13203.22; Pai JK, 2002, CLIN CHEM, V48, P1781; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.2307/2335290; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Szalai AJ, 2002, VASC PHARMACOL, V39, P105, DOI 10.1016/S1537-1891(02)00294-X; Wang QW, 2006, AM J PHYSIOL-HEART C, V291, pH2752, DOI 10.1152/ajpheart.01164.2005; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	37	72	81	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1395	10.1371/journal.pone.0001395	http://dx.doi.org/10.1371/journal.pone.0001395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167554	Green Submitted, Green Published, gold			2022-12-27	WOS:000260468900023
J	Creighton, CJ				Creighton, Chad J.			Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors	PLOS ONE			English	Article							CELLS IN-VITRO; GENE-EXPRESSION; HUMAN BREAST; CANCER; IDENTIFICATION; MICROARRAYS; ACTIVATION; ESTROGEN; RECEPTOR; REVEALS	Background: Gene transcription patterns associated with activation of oncogenes Myc, c-Src, beta-catenin, E2F3, H-Ras, HER2, EGFR, MEK, Raf, MAPK, Akt, and cyclin D1, as well as of the cell cycle and of androgen signaling have been generated in previous studies using experimental models. It was not clear whether genes in these "oncogenic signatures'' would show coordinate expression patterns in human prostate tumors, particularly as most of the signatures were derived from cell types other than prostate. Principal Findings: The above oncogenic pathway signatures were examined in four different gene expression profile datasets of human prostate tumors (representing similar to 250 patients in all), using both Q1-Q2 and one-sided Fisher's exact enrichment analysis methods. A significant fraction (similar to 5%) of genes up-regulated experimentally by Myc, c-Src, HER2, Akt, or androgen were co-expressed in human tumors with the oncogene or biomarker corresponding to the pathway signature. Genes down-regulated experimentally, however, did not show anticipated patterns of anti-enrichment in the human tumors. Conclusions: Significant subsets of the genes in these experimentally-derived oncogenic signatures are relevant to the study of human prostate cancer. Both molecular biologists and clinical researchers could focus attention on the relatively small number of genes identified here as having coordinate patterns that arise from both the experimental system and the human disease system.			Creighton, CJ (corresponding author), Baylor Coll Med, Div Biostat, Dept Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	creighto@bcm.edu			NIH [P30 CA125123]; Dan L. Duncan Cancer Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CJC was supported in part by NIH grant P30 CA125123, and the Dan L. Duncan Cancer Center at Baylor College of Medicine. No funding source played any role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Dehm SM, 2004, BIOCHEM CELL BIOL, V82, P263, DOI 10.1139/o03-077; DePrimo SE, 2002, GENOME BIOL, V3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Paronetto MP, 2004, AM J PATHOL, V164, P1243, DOI 10.1016/S0002-9440(10)63212-9; Rhodes DR, 2002, CANCER RES, V62, P4427; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	27	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1816	10.1371/journal.pone.0001816	http://dx.doi.org/10.1371/journal.pone.0001816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350153	Green Submitted, gold, Green Published			2022-12-27	WOS:000260762300019
J	Deng, JM; Li, T; Wang, GX; Liu, J; Yu, ZL; Zhao, CM; Ji, MF; Zhang, Q; Liu, JQ				Deng, Jian-Ming; Li, Tao; Wang, Gen-Xuan; Liu, Jing; Yu, Ze-Long; Zhao, Chang-Ming; Ji, Ming-Fei; Zhang, Qiang; Liu, Jian-quan			Trade-Offs between the Metabolic Rate and Population Density of Plants	PLOS ONE			English	Article								The energetic equivalence rule, which is based on a combination of metabolic theory and the self-thinning rule, is one of the fundamental laws of nature. However, there is a progressively increasing body of evidence that scaling relationships of metabolic rate vs. body mass and population density vs. body mass are variable and deviate from their respective theoretical values of 3/4 and -3/4 or -2/3. These findings questioned the previous hypotheses of energetic equivalence rule in plants. Here we examined the allometric relationships between photosynthetic mass (M-p) or leaf mass (M-L) vs. body mass (beta); population density vs. body mass (d); and leaf mass vs. population density, for desert shrubs, trees, and herbaceous plants, respectively. As expected, the allometric relationships for both photosynthetic mass (i.e. metabolic rate) and population density varied with the environmental conditions. However, the ratio between the two exponents was -1 (i.e. beta/delta = -1) and followed the trade-off principle when local resources were limited. Our results demonstrate for the first time that the energetic equivalence rule of plants is based on trade-offs between the variable metabolic rate and population density rather than their constant allometric exponents.	[Deng, Jian-Ming; Li, Tao; Yu, Ze-Long; Zhao, Chang-Ming; Ji, Ming-Fei; Zhang, Qiang; Liu, Jian-quan] Lanzhou Univ, MOE Key Lab Arid & Grassland, Sch Life Sci, Lanzhou 730000, Peoples R China; [Wang, Gen-Xuan] Zhejiang Univ, Coll Life Sci, Inst Agroecol & Ecoengn, Hangzhou, Peoples R China; [Liu, Jing] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China	Lanzhou University; Zhejiang University; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Deng, JM (corresponding author), Lanzhou Univ, MOE Key Lab Arid & Grassland, Sch Life Sci, Lanzhou 730000, Peoples R China.	wanggx@zju.edu.cn; Liujq@nwipb.ac.cn			Natural Science Foundation of China [30730020, 30430560]; 863 Program of China [2006AA100202]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China)	This study was supported by the Natural Science Foundation of China (Grant 30730020 and 30430560) and the hi-tech research and development program (863 Program) of China (Grant 2006AA100202).	Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; Begon M., 1996, ECOLOGY; Bi HQ, 2000, ECOLOGY, V81, P1477, DOI 10.1890/0012-9658(2000)081[1477:ETSTBL]2.0.CO;2; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chen BM, 2007, J INTEGR PLANT BIOL, V49, P1537, DOI 10.1111/j.1774-7909.2007.00531.x; CRY H, 2004, ECOLOGY, V85, P1802; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; DENG JM, 2006, ACTA ECOLPGICA SINAC, V26, P2282; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V398, P573, DOI 10.1038/19219; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; ENQUIST BJ, 2003, SCALING MACROECOLOGI; Gong CM, 2006, PAK J BOT, V38, P647; HUTCHINGS M, 1983, NEW SCI, V98, P765; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kleiman D, 2007, J ECOL, V95, P376, DOI 10.1111/j.1365-2745.2006.01205.x; Kozlowski J, 2005, FUNCT ECOL, V19, P739, DOI 10.1111/j.1365-2435.2005.01021.x; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; Li HT, 2006, J INTEGR PLANT BIOL, V48, P268, DOI 10.1111/j.1744-7909.2006.00222.x; Liu J, 2006, J INTEGR PLANT BIOL, V48, P415, DOI 10.1111/j.1744-7909.2006.00240.x; Loeuille N, 2006, ECOL LETT, V9, P171, DOI 10.1111/j.1461-0248.2005.00861.x; LONG JN, 1984, FOREST ECOL MANAG, V7, P191, DOI 10.1016/0378-1127(84)90067-7; LONSDALE WM, 1990, ECOLOGY, V71, P1373, DOI 10.2307/1938275; LUO TX, 1996, PATTERNS BIOL PRODUC, P50; LYSHEDE OB, 1979, BOT J LINN SOC, V78, P85, DOI 10.1111/j.1095-8339.1979.tb02187.x; Morris EC, 2002, ECOL RES, V17, P17, DOI 10.1046/j.1440-1703.2002.00459.x; Niklas KJ, 2003, EVOL ECOL RES, V5, P459; Niklas KJ, 2002, AM J BOT, V89, P812, DOI 10.3732/ajb.89.5.812; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; OSAWA A, 1993, ECOLOGY, V74, P1020, DOI 10.2307/1940472; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pretzsch H, 2006, OECOLOGIA, V146, P572, DOI 10.1007/s00442-005-0126-0; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; Reynolds JH, 2005, J ECOL, V93, P362, DOI 10.1111/j.1365-2745.2005.00976.x; RICHARDS RA, 1991, FIELD CROP RES, V26, P141, DOI 10.1016/0378-4290(91)90033-R; Ricklefs RE, 2003, FUNCT ECOL, V17, P384, DOI 10.1046/j.1365-2435.2003.00745.x; Roderick ML, 2004, FUNCT ECOL, V18, P197, DOI 10.1111/j.0269-8463.2004.00832.x; Wang G, 2004, B MATH BIOL, V66, P1875, DOI 10.1016/j.bulm.2004.04.005; WANG G, 1996, INTRASPECIFIC COMPET, P28; WELLER DE, 1991, ECOLOGY, V72, P747, DOI 10.2307/2937216; WELLER DE, 1987, ECOLOGY, V68, P813, DOI 10.2307/1938352; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; White J., 1980, Demography and evolution in plant populations., P21; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107; Zhang DY, 1999, FIELD CROP RES, V61, P179, DOI 10.1016/S0378-4290(98)00156-7	60	35	44	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1799	10.1371/journal.pone.0001799	http://dx.doi.org/10.1371/journal.pone.0001799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350139	Green Submitted, Green Published, gold			2022-12-27	WOS:000260762300005
J	Yimer, G; Aderaye, G; Amogne, W; Makonnen, E; Aklillu, E; Lindquist, L; Yamuah, L; Feleke, B; Aseffa, A				Yimer, Getnet; Aderaye, Getachew; Amogne, Wondwossen; Makonnen, Eyasu; Aklillu, Eleni; Lindquist, Lars; Yamuah, Lawrence; Feleke, Beniyam; Aseffa, Abraham			Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVALENCE; GENOTYPE; DRUGS	Background: To assess and compare the prevalence, severity and prognosis of anti-TB drug induced hepatotoxicity (DIH) in HIV positive and HIV negative tuberculosis (TB) patients in Ethiopia. Methodology/Principal Findings: In this study, 103 HIV positive and 94 HIV negative TB patients were enrolled. All patients were evaluated for different risk factors and monitored biochemically and clinically for development of DIH. Sub-clinical hepatotoxicity was observed in 17.3% of the patients and 8 out of the 197 (4.1%) developed clinical hepatotoxicity. Seven of the 8 were HIV positive and 2 were positive for HBsAg. Conclusions/Significance: Sub-clinical hepatotoxicity was significantly associated with HIV co-infection (p = 0.002), concomitant drug intake (p = 0.008), and decrease in CD4 count (p = 0.001). Stepwise restarting of anti TB treatment was also successful in almost all the patients who developed clinical DIH. We therefore conclude that anti-TB DIH is a major problem in HIV-associated TB with a decline in immune status and that there is a need for a regular biochemical and clinical follow up for those patients who are at risk.	[Yimer, Getnet; Yamuah, Lawrence; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Yimer, Getnet; Aderaye, Getachew; Amogne, Wondwossen; Makonnen, Eyasu] Addis Ababa Univ, Med Fac, Addis Ababa, Ethiopia; [Aklillu, Eleni] Karolinska Inst, Dept Clin Pharmacol, Stockholm, Sweden; [Lindquist, Lars] Karolinska Inst, Dept Internal Med, Infect Dis Unit, Stockholm, Sweden; [Feleke, Beniyam] St Peters TB Specialized Hosp, Addis Ababa, Ethiopia	Addis Ababa University; Karolinska Institutet; Karolinska Institutet	Yimer, G (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.	getadera@yahoo.com	Aklillu, Eleni/ABG-3461-2021; Aseffa, Abraham/J-3248-2016; Degu, Wondwossen Amogne/GON-3590-2022; Yimer, Getnet/A-9436-2015	Aseffa, Abraham/0000-0002-8028-1150; Aklillu, Eleni/0000-0002-9788-0790; Yimer, Getnet/0000-0002-1469-837X; Makonnen, Eyasu/0000-0002-9259-5288	AHRI; Sida/SAREC [HIV-2006-031]	AHRI; Sida/SAREC	The study done in Ethiopia was fully funded by AHRI, with part of the study done in Sweden funded by Sida/SAREC grant HIV-2006-031.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Ali J, 1996, POSTGRAD MED, V99, P217, DOI 10.1080/00325481.1996.11946128; Anand A C, 2006, Med J Armed Forces India, V62, P45, DOI 10.1016/S0377-1237(06)80155-3; BARNES PF, 1993, ANN INTERN MED, V119, P400, DOI 10.7326/0003-4819-119-5-199309010-00009; Bassey EB, 2005, PUBLIC HEALTH, V119, P405, DOI 10.1016/j.puhe.2004.05.012; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; Bruchfeld J, 2000, T ROY SOC TROP MED H, V94, P677, DOI 10.1016/S0035-9203(00)90230-X; Campos-Franco J, 2004, Eur J Intern Med, V15, P396, DOI 10.1016/j.ejim.2004.07.005; CHEUKMING T, 2002, MONITORING HEPATOTOX; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; *FOC DIS WATCH, 2004, NATURE REV MICROBIOL, V2, P930; GOOZE L, 2003, TUBERCULOSIS HIV; Gross M, 1999, CANCER EPIDEM BIOMAR, V8, P683; HOFFMANN C, 2006, HIV MED, P395; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Kimmoun Elisabeth, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS408, DOI 10.1046/j.1440-1746.17.s3.36.x; KOJU D, 2005, KATHMANDU J SCI ENG, V1; Lee BH, 2005, CHEST, V127, P1304, DOI 10.1378/chest.127.4.1304; Mahmood K, 2007, PAK J MED SCI, V23, P33; OZICK LA, 1995, AM J GASTROENTEROL, V90, P1978; Pan L, 2005, WORLD J GASTROENTERO, V11, P2518, DOI 10.3748/wjg.v11.i16.2518; Pedral-Sampaio Diana B., 2004, Braz J Infect Dis, V8, P211, DOI 10.1590/S1413-86702004000300004; Pol S, 2004, CLIN INFECT DIS, V38, pS65, DOI 10.1086/381499; SHAKYA R, 2006, KATHMANDU U J SCI EN, V2, P1; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Sturgill MG, 1997, CLIN CHEM, V43, P1512; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; World Health Organization, 2004, TB HIV CLIN MAN, V2nd; World Health Organization, 2006, ANT THER HIV INF AD; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yepes JF, 2004, ORAL SURG ORAL MED O, V98, P267, DOI 10.1016/j.tripleo.2004.05.012	31	43	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1809	10.1371/journal.pone.0001809	http://dx.doi.org/10.1371/journal.pone.0001809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350147	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762300013
J	Strom, K; Hansson, O; Lucas, S; Nevsten, P; Fernandez, C; Klint, C; Moverare-Skrtic, S; Sundler, F; Ohlsson, C; Holm, C				Strom, Kristoffer; Hansson, Ola; Lucas, Stephanie; Nevsten, Pernilla; Fernandez, Celine; Klint, Cecilia; Moverare-Skrtic, Sofia; Sundler, Frank; Ohlsson, Claes; Holm, Cecilia			Attainment of Brown Adipocyte Features in White Adipocytes of Hormone-Sensitive Lipase Null Mice	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; RECEPTOR COREPRESSOR RIP140; ADIPOSE-TISSUE; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; RETINOIC ACID; FAT-CELLS; IN-VIVO; DIFFERENTIATION; DEFICIENCY	Background: Hormone-sensitive lipase (HSL) is expressed predominantly in adipose tissue, where it plays an important role in catecholamine-stimulated hydrolysis of stored tri- and diglycerides, thus mobilizing fatty acids. HSL exhibits broad substrate specificity and besides acylglycerides it hydrolyzes cholesteryl esters, retinyl esters and lipoidal esters. Despite its role in fatty acid mobilization, HSL null mice have been shown to be resistant to diet-induced obesity. Methodology/Principal Findings: Following a high-fat diet (HFD) regimen, energy expenditure, measured using indirect calorimetry, was increased in HSL null mice. White adipose tissue of HSL null mice was characterized by reduced mass and reduced protein expression of PPAR gamma, a key transcription factor in adipogenesis, and stearoyl-CoA desaturase 1, the expression of which is known to be positively correlated to the differentiation state of the adipocyte. The protein expression of uncoupling protein-1 (UCP-1), the highly specific marker of brown adipocytes, was increased 7-fold in white adipose tissue of HSL null mice compared to wildtype littermates. Transmission electron microscopy revealed an increase in the size of mitochondria of white adipocytes of HSL null mice. The mRNA expression of pRb and RIP140 was decreased in isolated white adipocytes, while the expression of UCP-1 and CPT1 was increased in HSL null mice compared to wildtype littermates. Basal oxygen consumption was increased almost 3-fold in white adipose tissue of HSL null mice and was accompanied by increased uncoupling activity. Conclusions: These data suggest that HSL is involved in the determination of white versus brown adipocytes during adipocyte differentiation The exact mechanism(s) underlying this novel role of HSL remains to be elucidated, but it seems clear that HSL is required to sustain normal expression levels of pRb and RIP140, which both promote differentiation into the white, rather than the brown, adipocyte lineage.	[Strom, Kristoffer; Hansson, Ola; Lucas, Stephanie; Fernandez, Celine; Klint, Cecilia; Sundler, Frank; Holm, Cecilia] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Nevsten, Pernilla] Lund Univ, Natl Ctr High Resolut Electron Microscopy, Lund, Sweden; [Moverare-Skrtic, Sofia; Ohlsson, Claes] Gothenburg Univ, Sahlgrenska Acad, Res Ctr Endocrinol & Metabolism, Gothenburg, Sweden	Lund University; Lund University; University of Gothenburg	Strom, K (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	kristoffer.strom@med.lu.se	Fernandez, Celine/ABH-9332-2020; Ohlsson, Claes/AGP-3544-2022; Skrtic, Sofia/AAQ-1585-2020; Hansson, Ola/F-1793-2011	Fernandez, Celine/0000-0003-1290-4982; Ohlsson, Claes/0000-0002-9633-2805; Hansson, Ola/0000-0002-7394-7639; LUCAS, Stephanie/0000-0001-7530-7486	Swedish Research Council [11284, 621-2203-300]; Juvenile Diabetes Foundation, USA [Center of Excellence Grant]; Knut and Alice Wallenberg Foundation, Sweden; Swedish Diabetes Association; Novo Nordisk; Swedish Foundation for Strategic Research; Foundation of Tage Blucher for Medical Research; Swedish Research School of Genomics and Bioinformatics	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Foundation, USA; Knut and Alice Wallenberg Foundation, Sweden(Knut & Alice Wallenberg Foundation); Swedish Diabetes Association; Novo Nordisk(Novo Nordisk); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Tage Blucher for Medical Research; Swedish Research School of Genomics and Bioinformatics	Financial support was provided by the Swedish Research Council (project no 11284 to C.H. and project no 621-2203-300 to Reine Wallenberg at HREM), a Center of Excellence Grant from the Juvenile Diabetes Foundation, USA, and Knut and Alice Wallenberg Foundation, Sweden, the Swedish Diabetes Association, and the following foundations: Novo Nordisk, A. Pahlsson, Salubrin/Druvan, and Torsten and Ragnar Soderberg. O.H. was supported by the Cell Factory for Functional Genomics, a program funded by the Swedish Foundation for Strategic Research, S.L was supported by the Foundation of Tage Blucher for Medical Research and C.F. was supported by the Swedish Research School of Genomics and Bioinformatics. The funding agencies did not take any part in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; Brown NF, 1997, BIOCHEM J, V327, P225, DOI 10.1042/bj3270225; Cannon B, 2001, Methods Mol Biol, V155, P295; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Fex M, 2004, ENDOCRINOLOGY, V145, P3746, DOI 10.1210/en.2003-1673; Fortier M, 2004, AM J PHYSIOL-ENDOC M, V287, pE282, DOI 10.1152/ajpendo.00203.2003; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Grober J, 2003, J BIOL CHEM, V278, P6510, DOI 10.1074/jbc.M208513200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hansson O, 2005, J LIPID RES, V46, P2614, DOI 10.1194/jlr.M500028-JLR200; Hansson O, 2006, J PROTEOME RES, V5, P1701, DOI 10.1021/pr060101h; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Park SY, 2005, AM J PHYSIOL-ENDOC M, V289, pE30, DOI 10.1152/ajpendo.00251.2004; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ribot J, 2005, BBA-MOL BASIS DIS, V1740, P249, DOI 10.1016/j.bbadis.2004.10.013; RODBELL M, 1964, J BIOL CHEM, V239, P375; Roduit R, 2001, DIABETES, V50, P1970, DOI 10.2337/diabetes.50.9.1970; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	48	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1793	10.1371/journal.pone.0001793	http://dx.doi.org/10.1371/journal.pone.0001793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335062	gold, Green Submitted, Green Published			2022-12-27	WOS:000260723000044
J	Risueno, RM; Schamel, WWA; Alarcon, B				Risueno, Ruth M.; Schamel, Wolfgang W. A.; Alarcon, Balbino			T Cell Receptor Engagement Triggers Its CD3 epsilon and CD3 zeta Subunits to Adopt a Compact, Locked Conformation	PLOS ONE			English	Article								How the T cell antigen receptor (TCR) discriminates between molecularly related peptide/Major Histocompatibility Complex (pMHC) ligands and converts this information into different possible signaling outcomes is still not understood. One current model proposes that strong pMHC ligands, but not weak ones, induce a conformational change in the TCR. Evidence supporting this comes from a pull-down assay that detects ligand-induced binding of the TCR to the N-terminal SH3 domain of the adapter protein Nck, and also from studies with a neoepitope-specific antibody. Both methods rely on the exposure of a polyproline sequence in the CD3 epsilon subunit of the TCR, and neither indicates whether the conformational change is transmitted to other CD3 subunits. Using a protease-sensitivity assay, we now show that the cytoplasmic tails of CD3 epsilon and CD3 zeta subunits become fully protected from degradation upon TCR triggering. These results suggest that the TCR conformational change is transmitted to the tails of CD3 epsilon and CD3 zeta, and perhaps all CD3 subunits. Furthermore, the resistance to protease digestion suggests that CD3 cytoplasmic tails adopt a compact structure in the triggered TCR. These results are consistent with a model in which transduction of the conformational change induced upon TCR triggering promotes condensation and shielding of the CD3 cytoplasmic tails.	[Risueno, Ruth M.; Alarcon, Balbino] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Schamel, Wolfgang W. A.] Max Planck Inst Immunobiol, Freiburg, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Max Planck Society	Risueno, RM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	balarcon@cbm.uam.es	Risueño, Ruth Muñoz/G-9969-2015; Alarcon, Balbino/N-9648-2016	Risueño, Ruth Muñoz/0000-0003-4048-9536; Alarcon, Balbino/0000-0001-7820-1070	CICYT [SAF2006-01391]; Comunidad de Madrid [SAL-0159/2006]; EU [LSHC-CT-2005-018914]; Emmy Noether Fellowship from DFG [SCHA976/1, SFB620]	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad de Madrid(Comunidad de Madrid); EU(European Commission); Emmy Noether Fellowship from DFG(German Research Foundation (DFG))	This work was supported by grants SAF2006-01391 from CICYT, SAL-0159/2006 from the Comunidad de Madrid, and LSHC-CT-2005-018914 from the EU (to B.A.), and by an Emmy Noether Fellowship from the DFG (SCHA976/1) and SFB620 (to W.W.S). The institutional support of Fundacion Ramon Areces to the CBMSO is also acknowledged.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; Bachmann MF, 1999, IMMUNOL TODAY, V20, P568, DOI 10.1016/S0167-5699(99)01543-1; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; GILBERT JM, 1995, J VIROL, V69, P7410, DOI 10.1128/JVI.69.12.7410-7415.1995; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Huo XW, 1999, BIOCHEMISTRY-US, V38, P16941, DOI 10.1021/bi9919448; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Jose ES, 1998, EUR J IMMUNOL, V28, P12; KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9; KAYE J, 1984, J IMMUNOL, V133, P1339; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Laczko I, 1998, BIOCHEM BIOPH RES CO, V242, P474, DOI 10.1006/bbrc.1997.7989; Lin J, 2001, J CELL SCI, V114, P243; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Pitcher LA, 2003, IMMUNOL REV, V191, P47, DOI 10.1034/j.1600-065X.2003.00003.x; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; Risueno RM, 2006, P NATL ACAD SCI USA, V103, P9625, DOI 10.1073/pnas.0601785103; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Sahuquillo AG, 1998, J EXP MED, V187, P1179, DOI 10.1084/jem.187.8.1179; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Stones JD, 2006, J IMMUNOL, V176, P1498, DOI 10.4049/jimmunol.176.3.1498; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Wess J, 1997, LIFE SCI, V60, P1007, DOI 10.1016/S0024-3205(97)00041-6; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; YOON ST, 1994, IMMUNITY, V1, P563	49	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1747	10.1371/journal.pone.0001747	http://dx.doi.org/10.1371/journal.pone.0001747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320063	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600041
J	Banci, L; Bertini, I; Boca, M; Girotto, S; Martinelli, M; Valentine, JS; Vieru, M				Banci, Lucia; Bertini, Ivano; Boca, Mirela; Girotto, Stefania; Martinelli, Manuele; Valentine, Joan Selverstone; Vieru, Miguela			SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization	PLOS ONE			English	Article								There are about 100 single point mutations of copper, zinc superoxide dismutase 1 (SOD1) which are reported (http://alsod.iop.kcl.ac.uk/Als/index.aspx) to be related to the familial form (fALS) of amyotrophic lateral sclerosis (ALS). These mutations are spread all over the protein. It is well documented that fALS produces protein aggregates in the motor neurons of fALS patients, which have been found to be associated to mitochondria. We selected eleven SOD1 mutants, most of them reported as pathological, and characterized them investigating their propensity to aggregation using different techniques, from circular dichroism spectra to ThT-binding fluorescence, size-exclusion chromatography and light scattering spectroscopy. We show here that these eleven SOD1 mutants, only when they are in the metal-free form, undergo the same general mechanism of oligomerization as found for the WT metal-free protein. The rates of oligomerization are different but eventually they give rise to the same type of soluble oligomeric species. These oligomers are formed through oxidation of the two free cysteines of SOD1 (6 and 111) and stabilized by hydrogen bonds, between beta strands, thus forming amyloid-like structures. SOD1 enters the mitochondria as demetallated and mitochondria are loci where oxidative stress may easily occur. The soluble oligomeric species, formed by the apo form of both WT SOD1 and its mutants through an oxidative process, might represent the precursor toxic species, whose existence would also suggest a common mechanism for ALS and fALS. The mechanism here proposed for SOD1 mutant oligomerization is absolutely general and it provides a common unique picture for the behaviors of the many SOD1 mutants, of different nature and distributed all over the protein.	[Banci, Lucia; Bertini, Ivano; Boca, Mirela; Girotto, Stefania; Martinelli, Manuele; Vieru, Miguela] Univ Florence, Dept Chem, Magnet Resonance Ctr CERM, Florence, Italy; [Banci, Lucia] FiorGen Fdn, Florence, Italy; [Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA USA	University of Florence; University of California System; University of California Los Angeles	Banci, L (corresponding author), Univ Florence, Dept Chem, Magnet Resonance Ctr CERM, Florence, Italy.	bertini@cerm.unifi.it	Girotto, Stefania/F-5997-2012	martinelli, manuele/0000-0002-9371-076X; BANCI, LUCIA/0000-0003-0562-5774	NMR [LSHG-CT-2004-512052]; MIUR PRIN-2005 [2005039878]; Marie Curie Host Fellowship [MEST-CT-2004-504391]; National Institutes of Health [DK46828, NS049134]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	NMR; MIUR PRIN-2005(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Marie Curie Host Fellowship(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the European Community Understanding Protein Misfolding and Aggregation by NMR UPMAN Grant LSHG CT 2004 512052 11-1-04 to 10-31-07 by MIUR PRIN 2005 2005039878 and by Marie Curie Host Fellowship for Early Stage Research Training MEST CT 2004 504391 NMR in Inorganic Structural Biology. It also was supported by National Institutes of Health Grants DK46828 and NS049134 to JSV	Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bertini I, 1998, ADV INORG CHEM, V45, P127, DOI 10.1016/S0898-8838(08)60026-4; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Ohi T, 2004, J NEUROL SCI, V225, P19, DOI 10.1016/j.jns.2004.06.008; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647	30	137	141	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1677	10.1371/journal.pone.0001677	http://dx.doi.org/10.1371/journal.pone.0001677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301754	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500021
J	Barak, JD; Liang, AS				Barak, Jeri D.; Liang, Anita S.			Role of Soil, Crop Debris, and a Plant Pathogen in Salmonella enterica Contamination of Tomato Plants	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM; FRESH FRUITS; SURVIVAL; VEGETABLES; STRAINS	Background: In the U. S., tomatoes have become the most implicated vehicle for produce-associated Salmonellosis with 12 outbreaks since 1998. Although unconfirmed, trace backs suggest pre-harvest contamination with Salmonella enterica. Routes of tomato crop contamination by S. enterica in the absence of direct artificial inoculation have not been investigated. Methodology/Principal Findings: This work examined the role of contaminated soil, the potential for crop debris to act as inoculum from one crop to the next, and any interaction between the seedbourne plant pathogen Xanthomonas campestris pv. vesicatoria and S. enterica on tomato plants. Our results show S. enterica can survive for up to six weeks in fallow soil with the ability to contaminate tomato plants. We found S. enterica can contaminate a subsequent crop via crop debris; however a fallow period between crop incorporation and subsequent seeding can affect contamination patterns. Throughout these studies, populations of S. enterica declined over time and there was no bacterial growth in either the phyllosphere or rhizoplane. The presence of X. campestris pv. vesicatoria on co-colonized tomato plants had no effect on the incidence of S. enterica tomato phyllosphere contamination. However, growth of S. enterica in the tomato phyllosphere occurred on co-colonized plants in the absence of plant disease. Conclusions/Significance: S. enterica contaminated soil can lead to contamination of the tomato phyllosphere. A six week lag period between soil contamination and tomato seeding did not deter subsequent crop contamination. In the absence of plant disease, presence of the bacterial plant pathogen, X. campestris pv. vesicatoria was beneficial to S. enterica allowing multiplication of the human pathogen population. Any event leading to soil contamination with S. enterica could pose a public health risk with subsequent tomato production, especially in areas prone to bacterial spot disease.	[Barak, Jeri D.; Liang, Anita S.] USDA ARS, Western Reg Res Ctr, Produce Safety & Microbiol Res Unit, Albany, CA USA	United States Department of Agriculture (USDA)	Barak, JD (corresponding author), USDA ARS, Western Reg Res Ctr, Produce Safety & Microbiol Res Unit, Albany, CA USA.	jbarak@pw.usda.gov			U.S. Department of Agriculture [5325-42000-044-00D]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the U.S. Department of Agriculture (Agricultural Research Service CRIS project number 5325-42000-044-00D).	Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P325; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2001, PLANT DIS, V85, P169, DOI 10.1094/PDIS.2001.85.2.169; Bidol S. A., 2007, Morbidity and Mortality Weekly Report, V56, P909; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Castillo A, 2004, J FOOD PROTECT, V67, P713, DOI 10.4315/0362-028X-67.4.713; Charkowski AO, 2002, APPL ENVIRON MICROB, V68, P3114, DOI 10.1128/AEM.68.6.3114-3120.2002; Cummings K, 2001, EMERG INFECT DIS, V7, P1046, DOI 10.3201/eid0706.010625; GILBERTSON RL, 1990, PLANT DIS, V74, P322, DOI 10.1094/PD-74-0322; Guo X, 2002, J FOOD PROTECT, V65, P274, DOI 10.4315/0362-028X-65.2.274; Guo X, 2001, APPL ENVIRON MICROB, V67, P4760, DOI 10.1128/AEM.67.10.4760-4764.2001; Guo XA, 2002, APPL ENVIRON MICROB, V68, P3639, DOI 10.1128/AEM.68.7.3639-3643.2002; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Jaeger CH, 1999, APPL ENVIRON MICROB, V65, P2685; Jensen AN, 2006, APPL ENVIRON MICROB, V72, P1833, DOI 10.1128/AEM.72.3.1833-1842.2006; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Natvig EE, 2002, APPL ENVIRON MICROB, V68, P2737, DOI 10.1128/AEM.68.6.2737-2744.2002; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; RUIZ BG, 1987, EPIDEMIOL INFECT, V98, P271, DOI 10.1017/S0950268800062026; Wells JM, 1999, PLANT DIS, V83, P722, DOI 10.1094/PDIS.1999.83.8.722; Wells JM, 1997, PLANT DIS, V81, P867, DOI 10.1094/PDIS.1997.81.8.867	24	110	113	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1657	10.1371/journal.pone.0001657	http://dx.doi.org/10.1371/journal.pone.0001657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301739	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500006
J	Dinsdale, EA; Pantos, O; Smriga, S; Edwards, RA; Angly, F; Wegley, L; Hatay, M; Hall, D; Brown, E; Haynes, M; Krause, L; Sala, E; Sandin, SA; Thurber, RV; Willis, BL; Azam, F; Knowlton, N; Rohwer, F				Dinsdale, Elizabeth A.; Pantos, Olga; Smriga, Steven; Edwards, Robert A.; Angly, Florent; Wegley, Linda; Hatay, Mark; Hall, Dana; Brown, Elysa; Haynes, Matthew; Krause, Lutz; Sala, Enric; Sandin, Stuart A.; Thurber, Rebecca Vega; Willis, Bette L.; Azam, Farooq; Knowlton, Nancy; Rohwer, Forest			Microbial Ecology of Four Coral Atolls in the Northern Line Islands	PLOS ONE			English	Article							WHOLE-GENOME AMPLIFICATION; WHITE-BAND DISEASE; GREAT-BARRIER-REEF; ORGANIC-CARBON; NUTRIENT ENRICHMENT; COMMUNITY STRUCTURE; DIADEMA-ANTILLARUM; HIGH-THROUGHPUT; ELKHORN CORAL; DNA	Microbes are key players in both healthy and degraded coral reefs. A combination of metagenomics, microscopy, culturing, and water chemistry were used to characterize microbial communities on four coral atolls in the Northern Line Islands, central Pacific. Kingman, a small uninhabited atoll which lies most northerly in the chain, had microbial and water chemistry characteristic of an open ocean ecosystem. On this atoll the microbial community was equally divided between autotrophs (mostly Prochlorococcus spp.) and heterotrophs. In contrast, Kiritimati, a large and populated (similar to 5500 people) atoll, which is most southerly in the chain, had microbial and water chemistry characteristic of a near-shore environment. On Kiritimati, there were 10 times more microbial cells and virus-like particles in the water column and these microbes were dominated by heterotrophs, including a large percentage of potential pathogens. Culturable Vibrios were common only on Kiritimati. The benthic community on Kiritimati had the highest prevalence of coral disease and lowest coral cover. The middle atolls, Palmyra and Tabuaeran, had intermediate densities of microbes and viruses and higher percentages of autotrophic microbes than either Kingman or Kiritimati. The differences in microbial communities across atolls could reflect variation in 1) oceaonographic and/or hydrographic conditions or 2) human impacts associated with land-use and fishing. The fact that historically Kingman and Kiritimati did not differ strongly in their fish or benthic communities (both had large numbers of sharks and high coral cover) suggest an anthropogenic component in the differences in the microbial communities. Kingman is one of the world's most pristine coral reefs, and this dataset should serve as a baseline for future studies of coral reef microbes. Obtaining the microbial data set, from atolls is particularly important given the association of microbes in the ongoing degradation of coral reef ecosystems worldwide.	[Dinsdale, Elizabeth A.; Pantos, Olga; Angly, Florent; Wegley, Linda; Hatay, Mark; Hall, Dana; Brown, Elysa; Haynes, Matthew; Thurber, Rebecca Vega; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Dinsdale, Elizabeth A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [Smriga, Steven; Sala, Enric; Sandin, Stuart A.; Azam, Farooq; Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanography, Ctr Marine Biodiv & Conservat, La Jolla, CA USA; [Edwards, Robert A.; Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA USA; [Edwards, Robert A.] Fellowship Interpretation Genomes, Burr Ridge, IL USA; [Krause, Lutz] Bielefeld Univ, CeBiTec, Bielefeld, Germany; [Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Ctr Excellence Coral Reef Stud, ARC, Townsville, Qld, Australia	California State University System; San Diego State University; Flinders University South Australia; University of California System; University of California San Diego; Scripps Institution of Oceanography; California State University System; San Diego State University; University of Bielefeld; James Cook University	Dinsdale, EA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	Elizabeth_dinsdale@hotmail.com; frohwer@gmail.com	chen, qi/C-8585-2011; Krause, Lutz/M-7305-2015; Rohwer, Forest/AAC-5315-2019; Edwards, Robert/Q-1691-2019; Azam, Farooq/A-2306-2012; Krause, Lutz/G-6283-2013; Angly, Florent E/A-7717-2011	Krause, Lutz/0000-0003-3806-0845; Edwards, Robert/0000-0001-8383-8949; Krause, Lutz/0000-0003-3806-0845; Angly, Florent E/0000-0002-8999-0738; Rohwer, Forest/0000-0003-1548-5429; dinsdale, elizabeth/0000-0002-2177-203X	Marine Microbial Initiative of the Gordon and Betty Moore Foundation; Moore Family Foundation; Fairweather Foundation; National Geographic Society; Marine Managed Areas Science Project of Conservation International; Scripps Institution of Oceanography; NSF [Graduate Research Fellowship]	Marine Microbial Initiative of the Gordon and Betty Moore Foundation; Moore Family Foundation; Fairweather Foundation; National Geographic Society(National Geographic Society); Marine Managed Areas Science Project of Conservation International; Scripps Institution of Oceanography(University of California System); NSF(National Science Foundation (NSF))	The research was supported by the Marine Microbial Initiative of the Gordon and Betty Moore Foundation to FLR. Further support came from Moore Family Foundation, the Fairweather Foundation, National Geographic Society, the Marine Managed Areas Science Project of Conservation International, Scripps Institution of Oceanography, E. Scripps, I. Gayler, and several private donors. Additional support came from the Coral Reef Targeted Research Program's Coral Disease Working Group and an NSF Graduate Research Fellowship to SS.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; AYUKAI T, 1995, CORAL REEFS, V14, P141, DOI 10.1007/BF00367231; Bak RPM, 1998, MAR ECOL PROG SER, V175, P285, DOI 10.3354/meps175285; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; BRAINARD R, 2005, STATE CORAL REEF ECO, P338; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cai YYC, 2003, FASEB J, V17, pA987; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; COOK J, 1784, HIS MAJESTYS SHIPS R; Corbett DR, 1999, LIMNOL OCEANOGR, V44, P1045, DOI 10.4319/lo.1999.44.4.1045; Dhulipala PDK, 2003, FASEB J, V17, pA587; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; EDWARDS RA, 2007, OCEANOGR, V20, P26; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; FANNING E, 1833, VOYAGES WORLD SELECT; FARRELL A, 1928, J CAMERONS ODYSSEY; Fasham MJR, 2001, AMBIO, P4; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; FRIEDLANDER A, 1997, ECOLOGICAL SURVEYS C; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Gunn MR, 2007, MOL ECOL NOTES, V7, P393, DOI 10.1111/j.1471-8286.2007.01696.x; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; HODGSON G, 1990, MAR BIOL, V104, P493, DOI 10.1007/BF01314355; Holt J., 1994, BERGEYS MANUAL DETER; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kumar G, 2007, NAT METHODS, pAN30; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; Lessios HA, 2005, CORAL REEFS, V24, P125, DOI 10.1007/s00338-004-0443-5; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; MARAGOS JE, 1997, ECOLOGICAL SURVEYS C; MORIARTY DJW, 1979, MAR BIOL, V53, P193, DOI 10.1007/BF00389189; MORIARTY DJW, 1985, MAR BIOL, V85, P285, DOI 10.1007/BF00393249; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; PAUL JH, 1986, MAR ECOL PROG SER, V33, P29, DOI 10.3354/meps033029; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Ravindran J, 2002, CORAL REEFS, V21, P252, DOI 10.1007/s00338-002-0247-4; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rosenberg E, 2004, ANNU REV MICROBIOL, V58, P143, DOI 10.1146/annurev.micro.58.030603.123610; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; SAENGER C, 2006, SALINE SYS, V2; SANDIN SA, 2008, PLOS ONE IN PRESS; Sato M, 2005, BIOMOL ENG, V22, P129, DOI 10.1016/j.bioeng.2005.05.001; Scanlan DJ, 2002, FEMS MICROBIOL ECOL, V40, P1, DOI 10.1111/j.1574-6941.2002.tb00930.x; Seymour JR, 2005, MAR ECOL PROG SER, V288, P1, DOI 10.3354/meps288001; Shaw DR, 1999, AM J HUM GENET, V65, pA419; SHERR EB, 1993, CURRENT METHODS AQUA, P213; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SOROKIN YI, 1972, OCEANOLOGY-USSR, V12, P169; SOROKIN YI, 1973, NATURE, V242, P415, DOI 10.1038/242415a0; Thacker RW, 2001, CORAL REEFS, V19, P318, DOI 10.1007/s003380000122; Thompson FL, 2005, INT J SYST EVOL MICR, V55, P913, DOI 10.1099/ijs.0.63370-0; TRESILIAN FH, 1838, HAWAIIAN SPECTATOR, V1, P241; Trichet J, 2001, SEDIMENT GEOL, V140, P177, DOI 10.1016/S0037-0738(00)00177-9; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; *UNESCO, 1994, IOC REP MAN GUID, V29; van Duyl FC, 2006, CORAL REEFS, V25, P23, DOI 10.1007/s00338-005-0066-5; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305; Wegley L, 2004, MAR ECOL PROG SER, V273, P89, DOI 10.3354/meps273089; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wilkinson C., 2004, STATUS CORAL REEFS W; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	93	297	304	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1584	10.1371/journal.pone.0001584	http://dx.doi.org/10.1371/journal.pone.0001584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301735	gold, Green Accepted, Green Published			2022-12-27	WOS:000260586500002
J	Hase, T; Niimura, Y; Kaminuma, T; Tanaka, H				Hase, Takeshi; Niimura, Yoshihito; Kaminuma, Tsuguchika; Tanaka, Hiroshi			Non-Uniform Survival Rate of Heterodimerization Links in the Evolution of the Yeast Protein-Protein Interaction Network	PLOS ONE			English	Article							SIMPLE DEPENDENCE; MODULARITY; TOPOLOGY; NUMBER; MAP	Protein-protein interaction networks (PINs) are scale-free networks with a small-world property. In a small-world network, the average cluster coefficient (< C >) is much higher than in a random network, but the average shortest path length (< L >) is similar between the two networks. To understand the evolutionary mechanisms shaping the structure of PINs, simulation studies using various network growth models have been performed. It has been reported that the heterodimerization (HD) model, in which a new link is added between duplicated nodes with a uniform probability, could reproduce scale-freeness and a high < C >. In this paper, however, we show that the HD model is unsatisfactory, because (i) to reproduce the high < C > in the yeast PIN, a much larger number (n(HI)) of HD links (links between duplicated nodes) are required than the estimated number of n(HI) in the yeast PIN and (ii) the spatial distribution of triangles in the yeast PIN is highly skewed but the HD model cannot reproduce the skewed distribution. To resolve these discrepancies, we here propose a new model named the non-uniform heterodimerization (NHD) model. In this model, an HD link is preferentially attached between duplicated nodes when they share many common neighbors. Simulation studies demonstrated that the NHD model can successfully reproduce the high < C >, the low n(HI), and the skewed distribution of triangles in the yeast PIN. These results suggest that the survival rate of HD links is not uniform in the evolution of PINs, and that an HD link between high-degree nodes tends to be evolutionarily conservative. The non-uniform survival rate of HD links can be explained by assuming a low mutation rate for a high-degree node, and thus this model appears to be biologically plausible.	[Hase, Takeshi; Niimura, Yoshihito; Kaminuma, Tsuguchika; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo, Japan; [Tanaka, Hiroshi] Tokyo Med & Dental Univ, Sch Biomed Sci, Dept Bioinformat, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Hase, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo, Japan.	niimura@bioinfo.tmd.ac.jp	Hase, Takeshi/AAB-9085-2022					Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chung F, 2002, P NATL ACAD SCI USA, V99, P15879, DOI 10.1073/pnas.252631999; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Cohen R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.058701; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ispolatov I, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/145; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kim J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055101; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Middendorf M, 2005, P NATL ACAD SCI USA, V102, P3192, DOI 10.1073/pnas.0409515102; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Patil A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-100; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Raval A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066119; Rodriguez-Caso C, 2005, FEBS J, V272, P6423, DOI 10.1111/j.1742-4658.2005.05041.x; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILLIAMS RJ, 2002, SCIENCE, V297, P1551; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	44	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1667	10.1371/journal.pone.0001667	http://dx.doi.org/10.1371/journal.pone.0001667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301745	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586500012
J	Leisner, C; Loeth, N; Lamberth, K; Justesen, S; Sylvester-Hvid, C; Schmidt, EG; Claesson, M; Buus, S; Stryhn, A				Leisner, Christian; Loeth, Nina; Lamberth, Kasper; Justesen, Sune; Sylvester-Hvid, Christina; Schmidt, Esben G.; Claesson, Mogens; Buus, Soren; Stryhn, Anette			One-Pot, Mix-and-Read Peptide-MHC Tetramers	PLOS ONE			English	Article							T-CELLS; IN-VIVO; ELISPOT ASSAY; BLOOD; BIOTINYLATION; PURIFICATION; LYMPHOCYTES; EXPRESSION; GENERATION; RESPONSES	Background: Cytotoxic T Lymphocytes (CTL) recognize complexes of peptide ligands and Major Histocompatibility Complex (MHC) class I molecules presented at the surface of Antigen Presenting Cells (APC). Detection and isolation of CTL's are of importance for research on CTL immunity, and development of vaccines and adoptive immune therapy. Peptide-MHC tetramers have become important reagents for detection and enumeration of specific CTL's. Conventional peptide-MHC-tetramer production involves recombinant MHC production, in vitro refolding, biotinylation and tetramerization; each step followed by various biochemical steps such as chromatographic purification, concentration etc. Such cumbersome production protocols have limited dissemination and restricted availability of peptide-MHC tetramers effectively precluding large-scale screening strategies involving many different peptide-MHC tetramers. Methodology/Principal Findings: We have developed an approach whereby any given tetramer specificity can be produced within 2 days with very limited effort and hands-on time. The strategy is based on the isolation of correctly oxidized, in vivo biotinylated recombinant MHC I heavy chain (HC). Such biotinylated MHC I HC molecules can be refolded in vitro, tetramerized with streptavidin, and used for specific T cell staining-all in a one-pot reaction without any intervening purification steps. Conclusions/Significance: We have developed an efficient "one-pot, mix-and-read'' strategy for peptide-MHC tetramer generation, and demonstrated specific T cell straining comparable to a commercially available MHC-tetramer. Here, seven peptide-MHC tetramers representing four different human MHC (HLA) class I proteins have been generated. The technique should be readily extendable to any binding peptide and pre-biotinylated MHC (at this time we have over 40 different pre-biotinylated HLA proteins). It is simple, robust, and versatile technique with a very broad application potential as it can be adapted both to small- and large-scale production of one or many different peptide-MHC tetramers for T cell isolation, or epitope screening.	[Leisner, Christian; Loeth, Nina; Lamberth, Kasper; Justesen, Sune; Sylvester-Hvid, Christina; Schmidt, Esben G.; Claesson, Mogens; Buus, Soren; Stryhn, Anette] Univ Copenhagen, Lab Experimental Immunol, Copenhagen, Denmark	University of Copenhagen	Leisner, C (corresponding author), Univ Copenhagen, Lab Experimental Immunol, Copenhagen, Denmark.	s.buus@immi.ku.dk	Buus, Soren/F-5446-2010	Stryhn, Anette/0000-0002-4581-3553; Buus, Soren/0000-0001-8363-1999	6FP EU [503231]; NIH [266200400025C]; Danish FTP [274-05-0582]; Danish Cancer Society [DP06015]	6FP EU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish FTP; Danish Cancer Society(Danish Cancer Society)	This work was supported by the 6FP EU grant 503231, the NIH contract 266200400025C, the Danish FTP 274-05-0582 and by the Danish Cancer Society DP06015.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Cull MG, 2000, METHOD ENZYMOL, V326, P430; CZERKINSKY C, 1988, J IMMUNOL METHODS, V115, P31, DOI 10.1016/0022-1759(88)90306-7; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Ferre H, 2003, PROTEIN SCI, V12, P551, DOI 10.1110/ps.0233003; Keenan RD, 2001, BRIT J HAEMATOL, V115, P428, DOI 10.1046/j.1365-2141.2001.03106.x; Markovic SN, 2006, CLIN EXP IMMUNOL, V145, P438, DOI 10.1111/j.1365-2249.2006.03157.x; OSTERBORG A, 1995, BRIT J HAEMATOL, V89, P110; Pedersen LO, 2001, EUR J IMMUNOL, V31, P2986, DOI 10.1002/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Romero P, 1998, MOL MED TODAY, V4, P305, DOI 10.1016/S1357-4310(98)01280-5; Savage P, 2002, BRIT J CANCER, V86, P1336, DOI 10.1038/sj.bjc.6600223; Savage P, 2007, TUMOR BIOL, V28, P70, DOI 10.1159/000099152; Scheibenbogen C, 1997, CLIN CANCER RES, V3, P221; Suni MA, 1998, J IMMUNOL METHODS, V212, P89, DOI 10.1016/S0022-1759(98)00004-0; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Yang JB, 2004, HUM IMMUNOL, V65, P692, DOI 10.1016/j.humimm.2004.04.001	17	85	115	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1678	10.1371/journal.pone.0001678	http://dx.doi.org/10.1371/journal.pone.0001678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301755	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500022
J	Chen, H; Xu, GZ; Zhao, Y; Tian, B; Lu, HM; Yu, XM; Xu, ZJ; Ying, NJ; Hu, SN; Hua, YJ				Chen, Huan; Xu, Guangzhi; Zhao, Ye; Tian, Bing; Lu, Huiming; Yu, Xiaomin; Xu, Zhenjian; Ying, Nanjiao; Hu, Songnian; Hua, Yuejin			A Novel OxyR Sensor and Regulator of Hydrogen Peroxide Stress with One Cysteine Residue in Deinococcus radiodurans	PLOS ONE			English	Article								In bacteria, OxyR is a peroxide sensor and transcription regulator, which can sense the presence of reactive oxygen species and induce antioxidant system. When the cells are exposed to H2O2, OxyR protein is activated via the formation of a disulfide bond between the two conserved cysteine residues (C199 and C208). In Deinococcus radiodurans, a previously unreported special characteristic of DrOxyR (DR0615) is found with only one conserved cysteine. dr0615 gene mutant is hypersensitive to H2O2, but only a little to ionizing radiation. Site-directed mutagenesis and subsequent in vivo functional analyses revealed that the conserved cysteine (C210) is necessary for sensing H2O2, but its mutation did not alter the binding characteristics of OxyR on DNA. Under oxidant stress, DrOxyR is oxidized to sulfenic acid form, which can be reduced by reducing reagents. In addition, quantitative real-time PCR and global transcription profile results showed that OxyR is not only a transcriptional activator (e.g., katE, drb0125), but also a transcriptional repressor (e.g., dps, mntH). Because OxyR regulates Mn and Fe ion transporter genes, Mn/Fe ion ratio is changed in dr0615 mutant, suggesting that the genes involved in Mn/Fe ion homeostasis, and the genes involved in antioxidant mechanism are highly cooperative under extremely oxidant stress. In conclusion, these findings expand the OxyR family, which could be divided into two classes: typical 2-Cys OxyR and 1-Cys OxyR.	[Chen, Huan; Xu, Guangzhi; Zhao, Ye; Tian, Bing; Lu, Huiming; Xu, Zhenjian; Ying, Nanjiao; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Key Lab Chinese Minist Agr Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Chen, Huan; Hu, Songnian] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou, Peoples R China; [Yu, Xiaomin; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Chen, H (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Key Lab Chinese Minist Agr Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China.	husn@big.ac.cn; yjhua@zju.edu.cn	Zhao, Ye/I-2936-2014; Lu, Huiming/ABG-1372-2021; Chen, Huan/CAH-8180-2022; LU, HUIMING/C-1996-2014; Hu, Songnian/C-6509-2013	Zhao, Ye/0000-0002-5455-2586; Lu, Huiming/0000-0002-2743-7419; Hu, Songnian/0000-0003-3966-3111	National Basic Research Program [2004CB19604]; National Hi-Tech Development Program [2007AA021305]; Distinguished Young Scientist [30425038]; National Natural Science Foundation of China [30330020]	National Basic Research Program(National Basic Research Program of China); National Hi-Tech Development Program(National High Technology Research and Development Program of China); Distinguished Young Scientist; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by a grant from the National Basic Research Program (2004CB19604), a grant from the National Hi-Tech Development Program (2007AA021305), a grant for Distinguished Young Scientist (30425038), and a key project from the National Natural Science Foundation of China (30330020) to YJH.	ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Brune I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-21; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; CHEN H, 2007, PROGR NATURAL SCI, V17, P525; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Cuypers MG, 2007, J MOL BIOL, V371, P787, DOI 10.1016/j.jmb.2006.11.032; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Du X, 2007, APPL MICROBIOL BIOT, V75, P1343, DOI 10.1007/s00253-007-0940-x; Earl AM, 2002, J BACTERIOL, V184, P1003, DOI 10.1128/jb.184.4.1003-1009.2002; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Esposito R, 2003, INT ENDOD J, V36, P599, DOI 10.1046/j.1365-2591.2003.00692.x; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Gao GJ, 2005, CHINESE SCI BULL, V50, P311, DOI 10.1360/982004-719; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Harrison A, 2007, J BACTERIOL, V189, P1004, DOI 10.1128/JB.01040-06; HELMANN JD, 2002, SCI STKE, pPE46, DOI DOI 10.1126/STKE.20002.157.PE46; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Huang LF, 2007, DNA REPAIR, V6, P167, DOI 10.1016/j.dnarep.2006.09.006; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kim SG, 2006, J MOL BIOL, V361, P105, DOI 10.1016/j.jmb.2006.06.010; KULLIK I, 1995, J BACTERIOL, V177, P1285, DOI 10.1128/jb.177.5.1285-1291.1995; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; RAAHAVE D, 1974, ANTIMICROB AGENTS CH, V6, P603, DOI 10.1128/AAC.6.5.603; Rocha ER, 2003, ANAEROBE, V9, P165, DOI 10.1016/S1075-9964(03)00118-5; Runyen-Janecky L, 2006, INFECT IMMUN, V74, P4666, DOI 10.1128/IAI.00562-06; Seib KL, 2007, MOL MICROBIOL, V63, P54, DOI 10.1111/j.1365-2958.2006.05478.x; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tanaka M, 2005, J BACTERIOL, V187, P3693, DOI 10.1128/JB.187.11.3693-3697.2005; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Thompson DK, 2002, APPL ENVIRON MICROB, V68, P881, DOI 10.1128/AEM.68.2.881-892.2002; Tian B, 2004, LUMINESCENCE, V19, P78, DOI 10.1002/bio.761; TIMMINS J, 2007, EMBO J; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wallecha A, 2003, J BACTERIOL, V185, P2203, DOI 10.1128/JB.185.7.2203-2209.2003; Wang XD, 2006, J BACTERIOL, V188, P8335, DOI 10.1128/JB.01318-06; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xu ZJ, 2007, MICROBIOL-SGM, V153, P1642, DOI 10.1099/mic.0.2006/002857-0; Zeller T, 2007, J BACTERIOL, V189, P3784, DOI 10.1128/JB.01795-06; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	59	85	88	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1602	10.1371/journal.pone.0001602	http://dx.doi.org/10.1371/journal.pone.0001602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270589	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900036
J	Garcia-Lopez, A; Monferrer, L; Garcia-Alcover, I; Vicente-Crespo, M; Alvarez-Abril, MC; Artero, RD				Garcia-Lopez, Amparo; Monferrer, Lidon; Garcia-Alcover, Irma; Vicente-Crespo, Marta; Carmen Alvarez-Abril, M.; Artero, Ruben D.			Genetic and Chemical Modifiers of a CUG Toxicity Model in Drosophila	PLOS ONE			English	Article								Non-coding CUG repeat expansions interfere with the activity of human Muscleblind-like (MBNL) proteins contributing to myotonic dystrophy 1 (DM1). To understand this toxic RNA gain-of-function mechanism we developed a Drosophila model expressing 60 pure and 480 interrupted CUG repeats in the context of a non-translatable RNA. These flies reproduced aspects of the DM1 pathology, most notably nuclear accumulation of CUG transcripts, muscle degeneration, splicing misregulation, and diminished Muscleblind function in vivo. Reduced Muscleblind activity was evident from the sensitivity of CUG-induced phenotypes to a decrease in muscleblind genetic dosage and rescue by MBNL1 expression, and further supported by the co-localization of Muscleblind and CUG repeat RNA in ribonuclear foci. Targeted expression of CUG repeats to the developing eye and brain mushroom bodies was toxic leading to rough eyes and semilethality, respectively. These phenotypes were utilized to identify genetic and chemical modifiers of the CUG-induced toxicity. 15 genetic modifiers of the rough eye phenotype were isolated. These genes identify putative cellular processes unknown to be altered by CUG repeat RNA, and they include mRNA export factor Aly, apoptosis inhibitor Thread, chromatin remodelling factor Nurf-38, and extracellular matrix structural component Viking. Ten chemical compounds suppressed the semilethal phenotype. These compounds significantly improved viability of CUG expressing flies and included non-steroidal anti-inflammatory agents (ketoprofen), muscarinic, cholinergic and histamine receptor inhibitors (orphenadrine), and drugs that can affect sodium and calcium metabolism such as clenbuterol and spironolactone. These findings provide new insights into the DM1 phenotype, and suggest novel candidates for DM1 treatments.	[Garcia-Lopez, Amparo; Monferrer, Lidon; Garcia-Alcover, Irma; Vicente-Crespo, Marta; Carmen Alvarez-Abril, M.; Artero, Ruben D.] Univ Valencia, Dept Genet, Burjassot, Spain	University of Valencia	Garcia-Lopez, A (corresponding author), Univ Valencia, Dept Genet, Burjassot, Spain.	ruben.artero@uv.es	Artero, Ruben/K-6815-2014; MONFERRER, LIDÓN/H-8107-2015; Vicente-Crespo, Marta/AAT-8644-2020	Artero, Ruben/0000-0003-1596-047X; MONFERRER, LIDÓN/0000-0001-8117-6814; Vicente-Crespo, Marta/0000-0002-8381-6747	Generalitat Valenciana [GV04B164, IIARC0/04/051]; Ministerio de Educacion y Ciencia (MEC) [SAF2003-03536, predoctoral fellowships]; Muscular Dystrophy Association [3315, 4127]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Muscular Dystrophy Association(Muscular Dystrophy Association)	Our work was supported by grants GV04B164 and IIARC0/04/051 from the Generalitat Valenciana, SAF2003-03536 from the Ministerio de Educacion y Ciencia (MEC), and Muscular Dystrophy Association (3315 and 4127). A.G.L and M.V. were recipients of predoctoral fellowships from the MEC.	BATE M, 1993, MESODERM ITS DERIVAT; Begemann G, 1997, DEVELOPMENT, V124, P4321; Bharathi V, 2004, J CELL SCI, V117, P1911, DOI 10.1242/jcs.01034; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Desaphy JF, 2003, MOL PHARMACOL, V63, P659, DOI 10.1124/mol.63.3.659; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fischer W, 2001, N-S ARCH PHARMACOL, V363, P182, DOI 10.1007/s002100000341; Furuya H, 2005, BIOCHEM PHARMACOL, V69, P503, DOI 10.1016/j.bcp.2004.10.005; Garcia-Casado Z, 2002, GENESIS, V34, P111, DOI 10.1002/gene.10147; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Gomes-Pereira M, 2006, MUTAT RES-FUND MOL M, V598, P15, DOI 10.1016/j.mrfmmm.2006.01.011; Gu HY, 2006, J NEUROSCI, V26, P265, DOI 10.1523/JNEUROSCI.4109-05.2006; Guichet A, 2001, DEV BIOL, V237, P93, DOI 10.1006/dbio.2001.0354; HARO MD, 2006, HUM MOL GENET; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kurihara T, 2005, INTERNAL MED, V44, P1027, DOI 10.2169/internalmedicine.44.1027; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Machuca-Tzili L, 2006, HUM GENET, V120, P487, DOI 10.1007/s00439-006-0228-8; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Marek KW, 2000, NEURON, V25, P537, DOI 10.1016/S0896-6273(00)81058-2; Mathews WR, 2006, DEVELOPMENT, V133, P1143, DOI 10.1242/dev.02256; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; MOHLER J, 1995, DEVELOPMENT, V121, P237; Monferrer L, 2006, J HERED, V97, P67, DOI 10.1093/jhered/esj003; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Prokopenko SN, 2000, GENETICS, V156, P1691; Ranum L.P., 2006, ANN REV NEUROSCI; Read RD, 2004, MOL CELL BIOL, V24, P6676, DOI 10.1128/mcb.24.15.6676-6689.2004; Rhodes JD, 2006, HUM MOL GENET, V15, P3559, DOI 10.1093/hmg/ddl432; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VICENTE M, 2007, DIFFERENTIATION; VICENTECRESPO M, PLOS ONE IN PRESS	51	89	93	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1595	10.1371/journal.pone.0001595	http://dx.doi.org/10.1371/journal.pone.0001595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270582	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900029
J	Nakatsuji, T; Liu, YT; Huang, CP; Gallo, RL; Huang, CM				Nakatsuji, Teruaki; Liu, Yu-Tsueng; Huang, Cheng-Po; Gallo, Richard L.; Huang, Chun-Ming			Vaccination Targeting a Surface Sialidase of P. acnes: Implication for New Treatment of Acne Vulgaris	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PROPIONIBACTERIUM-ACNES; STREPTOCOCCUS-PNEUMONIAE; ANTIBODY-RESPONSE; COMPLETE GENOME; HUMAN SKIN; INFECTION; CELLS; TISSUE; MODEL	Background: Acne vulgaris afflicts more than fifty million people in the United State and the severity of this disorder is associated with the immune response to Propionibacterium acnes (P. acnes). Systemic therapies for acne target P. acnes using antibiotics, or target the follicle with retinoids such as isotretinoin. The latter systemic treatment is highly effective but also carries a risk of side effects including immune imbalance, hyperlipidemia, and teratogenicity. Despite substantial research into potential new therapies for this common disease, vaccines against acne vulgaris are not yet available. Methods and Findings: Here we create an acne vaccine targeting a cell wall-anchored sialidase of P. acnes. The importance of sialidase to disease pathogenesis is shown by treatment of a human sebocyte cell line with recombinant sialidase that increased susceptibility to P. acnes cytotoxicity and adhesion. Mice immunized with sialidase elicit a detectable antibody; the anti-sialidase serum effectively neutralized the cytotoxicity of P. acnes in vitro and P. acnes-induced interleukin-8 (IL-8) production in human sebocytes. Furthermore, the sialidase-immunized mice provided protective immunity against P. acnes in vivo as this treatment blocked an increase in ear thickness and release of pro-inflammatory macrophage inflammatory protein (MIP-2) cytokine. Conclusions: Results indicated that acne vaccines open novel therapeutic avenues for acne vulgaris and other P. acnes-associated diseases.	[Nakatsuji, Teruaki; Gallo, Richard L.; Huang, Chun-Ming] Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA; [Nakatsuji, Teruaki; Huang, Cheng-Po; Gallo, Richard L.; Huang, Chun-Ming] VA San Diego Healthcare Ctr, San Diego, CA USA; [Liu, Yu-Tsueng; Huang, Cheng-Po; Huang, Chun-Ming] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA; [Huang, Chun-Ming] La Jolla Inst Mol Med, San Diego, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Nakatsuji, T (corresponding author), Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA.	chunming@ucsd.edu	Zouboulis, Christos C./I-4493-2013; Nakatsuji, Teruaki/O-6794-2014; Gallo, Richard L/A-8931-2009; , Chun-Ming/AAM-1856-2020	Zouboulis, Christos C./0000-0003-1646-2608; Nakatsuji, Teruaki/0000-0002-6187-2991; Gallo, Richard L/0000-0002-1401-7861; , Chun-Ming/0000-0002-3352-5394	National Institutes of Health [R01-AI067395-01, R21-R022754-01, R21-I58002-01, P30-AI36214-12S1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants [R01-AI067395-01, R21-R022754-01, R21-I58002-01 (C-MH) and P30-AI36214-12S1 (Y-TL)].	Basal E, 2004, J MICROBIOL, V42, P117; Bruggemann H, 2005, SEMIN CUTAN MED SURG, V24, P67, DOI 10.1016/j.sder.2005.03.001; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Cooper AJ, 1998, MED J AUSTRALIA, V169, P259, DOI 10.5694/j.1326-5377.1998.tb140250.x; DALEN A, 1980, ARCH DERMATOL RES, V269, P253, DOI 10.1007/BF00406418; El All HSA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-4; Gloor M, 2002, DERMATOLOGY, V205, P260, DOI 10.1159/000065856; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; KOBAYASHI F, 1980, INFECT IMMUN, V27, P391, DOI 10.1128/IAI.27.2.391-396.1980; Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533; Layton AM, 2006, J EUR ACAD DERMATOL, V20, P773, DOI 10.1111/j.1468-3083.2006.01671.x; Loveckova Yvona, 2002, Biomedical Papers (Olomouc), V146, P29; MARCINKIEWICZ J, 1991, Medycyna Doswiadczalna i Mikrobiologia, V43, P167; MARTIN A, 1993, CYTOTECHNOLOGY, V11, P49, DOI 10.1007/BF00749057; Mirshahpanah P, 2007, CUTAN OCUL TOXICOL, V26, P195, DOI 10.1080/15569520701502815; Mochizuki H, 2005, FEMS IMMUNOL MED MIC, V43, P287, DOI 10.1016/j.femsim.2004.09.009; Nakano K, 2007, SKIN PHARMACOL PHYS, V20, P29, DOI 10.1159/000096169; Ochsendorf Falk, 2006, J Dtsch Dermatol Ges, V4, P828, DOI 10.1111/j.1610-0387.2006.06053.x; Oeff MK, 2006, DERMATOLOGY, V213, P266, DOI 10.1159/000095056; Perry AL, 2006, LETT APPL MICROBIOL, V42, P185, DOI 10.1111/j.1472-765X.2006.01866.x; Romics L, 2005, J LEUKOCYTE BIOL, V78, P1255, DOI 10.1189/jlb.0804448; Shi Y, 2007, PROTEOMICS, V7, P4589, DOI 10.1002/pmic.200700425; Sun BY, 2007, MOL CELL PROTEOMICS, V6, P141, DOI 10.1074/mcp.T600046-MCP200; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; TAKAOKI M, 1980, IMMUNOLOGY, V40, P27; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Tong HH, 2005, INFECT IMMUN, V73, P7775, DOI 10.1128/IAI.73.11.7775-7778.2005; WEBSTER GF, 1981, APPL ENVIRON MICROB, V41, P1269, DOI 10.1128/AEM.41.5.1269-1270.1981; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Wolska Katarzyna, 2006, Polish Journal of Microbiology, V55, P43; Zaluga E, 1998, Ann Acad Med Stetin, V44, P65; ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487	34	58	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1551	10.1371/journal.pone.0001551	http://dx.doi.org/10.1371/journal.pone.0001551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253498	gold, Green Published, Green Submitted			2022-12-27	WOS:000260535700022
J	Villar-Garea, A; Imhof, A				Villar-Garea, Ana; Imhof, Axel			Fine Mapping of Posttranslational Modifications of the Linker Histone H1 from Drosophila melanogaster	PLOS ONE			English	Article								The linker histone H1 binds to the DNA in between adjacent nucleosomes and contributes to chromatin organization and transcriptional control. It is known that H1 carries diverse posttranslational modifications (PTMs), including phosphorylation, lysine methylation and ADP-ribosylation. Their biological functions, however, remain largely unclear. This is in part due to the fact that most of the studies have been performed in organisms that have several H1 variants, which complicates the analyses. We have chosen Drosophila melanogaster, a model organism, which has a single H1 variant, to approach the study of the role of H1 PTMs during embryonic development. Mass spectrometry mapping of the entire sequence of the protein showed phosphorylation only in the ten N-terminal amino acids, mostly at S10. For the first time, changes in the PTMs of a linker H1 during the development of a multicellular organism are reported. The abundance of H1 monophosphorylated at S10 decreases as the embryos age, which suggests that this PTM is related to cell cycle progression and/or cell differentiation. Additionally, we have found a polymorphism in the protein sequence that can be mistaken with lysine methylation if the analysis is not rigorous.	[Villar-Garea, Ana; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Histone Modificat Grp, Munich Ctr Integrated Prot Sci, Munich, Germany	University of Munich	Villar-Garea, A (corresponding author), Univ Munich, Adolf Butenandt Inst, Histone Modificat Grp, Munich Ctr Integrated Prot Sci, Marchioninistr 15, Munich, Germany.	Imhof@lmu.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Villar Garea, Ana/0000-0001-8960-1635	European Union [LSHG-CT-2006-037415]; German research council [IM23/4-3]	European Union(European Commission); German research council(German Research Foundation (DFG))	The work was funded by grants from a European Union (LSHG-CT-2006-037415) and the German research council (IM23/4-3).	ANDERSON KV, 1980, CELL, V21, P717, DOI 10.1016/0092-8674(80)90435-3; Arrigoni G, 2006, PROTEOMICS, V6, P757, DOI 10.1002/pmic.200500073; Bharath MMS, 2002, BIOCHEMISTRY-US, V41, P7617, DOI 10.1021/bi025773+; BLUMENFELD M, 1979, BIOCHEM GENET, V17, P163, DOI 10.1007/BF00484482; BRESNICK EH, 1991, BIOCHEMISTRY-US, V30, P3490, DOI 10.1021/bi00228a020; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Dou YL, 2005, MOL CELL BIOL, V25, P3914, DOI 10.1128/MCB.25.10.3914-3922.2005; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; DRAVES PH, 1992, J MOL BIOL, V225, P1105, DOI 10.1016/0022-2836(92)90108-V; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; GIANCOTTI V, 1984, BIOCHEM J, V218, P321, DOI 10.1042/bj2180321; GURLEY LR, 1995, J BIOL CHEM, V270, P27653, DOI 10.1074/jbc.270.46.27653; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HARISANOVA NT, 1986, MOL BIOL REP, V11, P199, DOI 10.1007/BF00419597; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; IZAURRALDE E, 1989, J MOL BIOL, V210, P573, DOI 10.1016/0022-2836(89)90133-2; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Ner SS, 2001, J BIOL CHEM, V276, P37569, DOI 10.1074/jbc.M105635200; Ponte I, 2003, MOL BIOL EVOL, V20, P371, DOI 10.1093/molbev/msg041; Pruss D, 1996, SCIENCE, V274, P614, DOI 10.1126/science.274.5287.614; Sarg B, 2005, FEBS J, V272, P3673, DOI 10.1111/j.1742-4658.2005.04793.x; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Talasz H, 1996, BIOCHEMISTRY-US, V35, P1761, DOI 10.1021/bi951914e; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Talasz H, 2002, CELL DEATH DIFFER, V9, P27, DOI 10.1038/sj.cdd.4400925; TALMAGE DA, 1987, MOL CELL BIOL, V7, P4118, DOI 10.1128/MCB.7.11.4118; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; THOMAS JO, 1992, NUCLEIC ACIDS RES, V20, P187, DOI 10.1093/nar/20.2.187; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vermaak D, 1998, CURR BIOL, V8, P533, DOI 10.1016/S0960-9822(98)70206-4; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zlatanova J, 2000, FASEB J, V14, P1697, DOI 10.1096/fj.99-0869rev	43	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1553	10.1371/journal.pone.0001553	http://dx.doi.org/10.1371/journal.pone.0001553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253500	Green Published, gold			2022-12-27	WOS:000260535700024
J	Gerber, HB; Pikman, Y; Fisher, RP				Gerber, Hilary B.; Pikman, Yana; Fisher, Robert P.			The CDK-Activating Kinase (CAK) Csk1 Is Required for Normal Levels of Homologous Recombination and Resistance to DNA Damage in Fission Yeast	PLOS ONE			English	Article								Background. Cyclin-dependent kinases (CDKs) perform essential roles in cell division and gene expression in all eukaryotes. The requirement for an upstream CDK-activating kinase (CAK) is also universally conserved, but the fission yeast Schizosaccharomyces pombe appears to be unique in having two CAKs with both overlapping and specialized functions that can be dissected genetically. The Mcs6 complex-orthologous to metazoan Cdk7/cyclin H/Mat1-activates the cell-cycle CDK, Cdk1, but its non-redundant essential function appears to be in regulation of gene expression, as part of transcription factor TFIIH. The other CAK is Csk1, an ortholog of budding yeast Cak1, which activates all three essential CDKs in S. pombe Cdk1, Mcs6 and Cdk9, the catalytic subunit of positive transcription elongation factor b (P-TEFb)-but is not itself essential. Methodology/Principal Findings. Cells lacking csk1(+) are viable but hypersensitive to agents that damage DNA or block replication. Csk1 is required for normal levels of homologous recombination (HR), and interacts genetically with components of the HR pathway. Tests of damage sensitivity in csk1, mcs6 and cdk9 mutants indicate that Csk1 acts pleiotropically, through Cdk9 and at least one other target ( but not through Mcs6) to preserve genomic integrity. Conclusions/Significance. The two CAKs in fission yeast, which differ with respect to their substrate range and preferences for monomeric CDKs versus CDK/cyclin complexes as substrates, also support different functions of the CDK network in vivo. Csk1 plays a non-redundant role in safeguarding genomic integrity. We propose that specialized activation pathways dependent on different CAKs might insulate CDK functions important in DNA damage responses from those capable of triggering mitosis.	[Gerber, Hilary B.; Pikman, Yana; Fisher, Robert P.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Gerber, Hilary B.] Cornell Univ, Grad Sch Med Sci, Prog Biochem Cell & Mol Biol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Fisher, RP (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.	r-fisher@ski.mskcc.org		Pikman, Yana/0000-0002-5336-0216	American Cancer Society [RSG-99-043-044-CCG]	American Cancer Society(American Cancer Society)	Work supported in part by American Cancer Society grant RSG-99-043-044-CCG to RPF.	Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Akamatsu Y, 2007, EMBO J, V26, P1352, DOI 10.1038/sj.emboj.7601582; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bamps S, 2004, BIOCHEM BIOPH RES CO, V325, P1424, DOI 10.1016/j.bbrc.2004.10.190; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Buck V, 1995, EMBO J, V14, P6173, DOI 10.1002/j.1460-2075.1995.tb00308.x; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Chen J, 2003, NATURE, V424, P228, DOI 10.1038/nature01746; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Damagnez V, 1995, EMBO J, V14, P6164, DOI 10.1002/j.1460-2075.1995.tb00307.x; DARBON JM, 1994, ONCOGENE, V9, P3127; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P1480, DOI 10.1093/nar/gkh317; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; Espinoza FH, 1996, SCIENCE, V273, P1714, DOI 10.1126/science.273.5282.1714; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hermand D, 1998, EMBO J, V17, P7230, DOI 10.1093/emboj/17.24.7230; Hermand D, 2001, EMBO J, V20, P82, DOI 10.1093/emboj/20.1.82; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kaldis P, 1996, CELL, V86, P553, DOI 10.1016/S0092-8674(00)80129-4; Kaldis P, 1998, J CELL SCI, V111, P3585; Kaldis P, 1998, MOL BIOL CELL, V9, P2545, DOI 10.1091/mbc.9.9.2545; Karagiannis J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000433; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee KM, 1999, CURR BIOL, V9, P441, DOI 10.1016/S0960-9822(99)80194-8; Lee KM, 2005, MOL BIOL CELL, V16, P2734, DOI 10.1091/mbc.E04-11-0982; Lehmann AR, 1996, MUTAT RES-DNA REPAIR, V363, P147, DOI 10.1016/0921-8777(96)00017-1; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Liu J, 2000, MOL BIOL EVOL, V17, P1061, DOI 10.1093/oxfordjournals.molbev.a026387; Maftahi M, 2002, NUCLEIC ACIDS RES, V30, P4781, DOI 10.1093/nar/gkf581; MOLZ L, 1989, GENETICS, V122, P773; MOLZ L, 1993, EMBO J, V12, P1723, DOI 10.1002/j.1460-2075.1993.tb05817.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; Ostapenko D, 2005, MOL CELL BIOL, V25, P3906, DOI 10.1128/MCB.25.10.3906-3913.2005; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Ross KE, 2000, MOL BIOL CELL, V11, P1597, DOI 10.1091/mbc.11.5.1597; Saiz JE, 2002, CURR BIOL, V12, P1100, DOI 10.1016/S0960-9822(02)00903-X; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Thuret JY, 1996, CELL, V86, P565, DOI 10.1016/S0092-8674(00)80130-0; Tsakraklides V, 2002, J BIOL CHEM, V277, P33482, DOI 10.1074/jbc.M205537200; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Walworth NC, 2000, CURR OPIN CELL BIOL, V12, P697, DOI 10.1016/S0955-0674(00)00154-X; WANG ZG, 1994, NATURE, V368, P74, DOI 10.1038/368074a0	61	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1492	10.1371/journal.pone.0001492	http://dx.doi.org/10.1371/journal.pone.0001492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231579	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200005
J	Tcherepanova, I; Harris, J; Starr, A; Cleveland, J; Ketteringham, H; Calderhead, D; Horvatinovich, J; Healey, D; Nicolette, CA				Tcherepanova, Irina; Harris, Jason; Starr, Aijing; Cleveland, Jaclyn; Ketteringham, Helen; Calderhead, David; Horvatinovich, Joe; Healey, Don; Nicolette, Charles A.			Multiplex RT-PCR Amplification of HIV Genes to Create a Completely Autologous DC-Based Immunotherapy for the Treatment of HIV Infection	PLOS ONE			English	Article								Background. Effective therapy for HIV-infected individuals remains an unmet medical need. Promising clinical trials with dendritic cell (DC)-based immunotherapy consisting of autologous DC loaded with autologous virus have been reported, however, these approaches depend on large numbers of HIV virions to generate sufficient doses for even limited treatment regimens. Methodology/Principal Findings. The present study describes a novel approach for RT-PCR amplification of HIV antigens. Previously, RT-PCR amplification of autologous viral sequences has been confounded by the high mutation rate of the virus which results in unreliable primer-template binding. To resolve this problem we developed a multiplex RT-PCR strategy that allows reliable strain-independent amplification of highly polymorphic target antigens from any patient and requires neither viral sequence data nor custom-designed PCR primers for each individual. We demonstrate the application of our RT-PCR process to amplify translationally-competent RNA encoding regions of Gag, Vpr, Rev and Nef. The products amplified using this method represent a complex mixture of autologous antigens encoded by viral quasispecies. We further demonstrate that DCs electroporated with in vitro-transcribed HIV RNAs are capable of stimulating poly-antigen-specific CD8+ T cell responses in vitro. Conclusion/Significance. This study describes a strategy to overcome patient to patient viral diversity enabling strain-independent RT-PCR amplification of RNAs encoding sequence divergent quasispecies of Gag, Vpr, Rev and Nef from small volumes of infectious plasma. The approach allows creation of a completely autologous therapy that does not require advance knowledge of the HIV genomic sequences, does not have yield limitations and has no intact virus in the final product. The simultaneous use of autologous viral antigens and DCs may provoke broad patient-specific immune responses that could potentially induce effective control of viral loads in the absence of conventional antiretroviral drug therapy.	[Tcherepanova, Irina; Harris, Jason; Starr, Aijing; Cleveland, Jaclyn; Ketteringham, Helen; Calderhead, David; Horvatinovich, Joe; Healey, Don; Nicolette, Charles A.] Argos Therapeut Inc, Dept Res & Dev, Durham, NC USA		Tcherepanova, I (corresponding author), Argos Therapeut Inc, Dept Res & Dev, Durham, NC USA.	itcherepanova@argostherapeutics.com			Argos Therapeutics	Argos Therapeutics	All funding was provided by Argos Therapeutics.	Addo MM, 2002, DNA CELL BIOL, V21, P671, DOI 10.1089/104454902760330219; Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Candotti D, 2004, J VIROL METHODS, V118, P39, DOI 10.1016/j.jviromet.2004.01.017; CHANG PS, 1990, CLIN BIOTECHNOL, V2, P23; Christopherson C, 1997, NUCLEIC ACIDS RES, V25, P654, DOI 10.1093/nar/25.3.654; Cohen WM, 2002, J VIROL, V76, P10219, DOI 10.1128/JVI.76.20.10219-10225.2002; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Erali M, 1999, J CLIN MICROBIOL, V37, P792, DOI 10.1128/JCM.37.3.792-795.1999; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Gamberg J, 2004, IMMUNOL CELL BIOL, V82, P38, DOI 10.1111/j.1440-1711.2004.01204.x; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Garber DA, 2004, LANCET INFECT DIS, V4, P397, DOI 10.1016/S1473-3099(04)01056-4; Garcia F, 2005, J INFECT DIS, V191, P1680, DOI 10.1086/429340; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1999, NAT MED, V5, P1233, DOI 10.1038/15184; Harrer T, 1996, J IMMUNOL, V156, P2616; Hel Z, 2006, J IMMUNOL, V176, P85, DOI 10.4049/jimmunol.176.1.85; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Nabel GJ, 2001, NATURE, V410, P1002, DOI 10.1038/35073500; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Scriba TJ, 2005, VACCINE, V23, P1158, DOI 10.1016/j.vaccine.2004.08.026; Singh RAK, 2004, J IMMUNOL, V173, P4387, DOI 10.4049/jimmunol.173.7.4387; Su Z, 2002, CANCER RES, V62, P5041; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x	36	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1489	10.1371/journal.pone.0001489	http://dx.doi.org/10.1371/journal.pone.0001489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231576	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200002
J	Hussain, MA; Naveed, SA; Sechi, LA; Ranjan, S; Alvi, A; Ahmed, I; Ranjan, A; Mukhopadhyay, S; Ahmed, N				Hussain, M. Abid; Naveed, Shaik A.; Sechi, Leonardo A.; Ranjan, Sarita; Alvi, Ayesha; Ahmed, Irshad; Ranjan, Akash; Mukhopadhyay, Sangita; Ahmed, Niyaz			Isocitrate Dehydrogenase of Helicobacter pylori Potentially Induces Humoral Immune Response in Subjects with Peptic Ulcer Disease and Gastritis	PLOS ONE			English	Article								Background. H. pylori causes gastritis and peptic ulcers and is a risk factor for the development of gastric carcinoma. Many of the proteins such as urease, porins, flagellins and toxins such as lipo-polysaccharides have been identified as potential virulence factors which induce proinflammatory reaction. We report immunogenic potentials of isocitrate dehydrogenase (ICD), an important house keeping protein of H. pylori. Methodology/Principal Findings. Amino acid sequences of H. pylori ICD were subjected to in silico analysis for regions with predictably high antigenic indexes. Also, computational modelling of the H. pylori ICD as juxtaposed to the E. coli ICD was carried out to determine levels of structure similarity and the availability of surface exposed motifs, if any. The icd gene was cloned, expressed and purified to a very high homogeneity. Humoral response directed against H. pylori ICD was detected through an enzyme linked immunosorbent assay ( ELISA) in 82 human subjects comprising of 58 patients with H. pylori associated gastritis or ulcer disease and 24 asymptomatic healthy controls. The H. pylori ICD elicited potentially high humoral immune response and revealed high antibody titers in sera corresponding to endoscopically-confirmed gastritis and ulcer disease subjects. However, urea-breath-test negative healthy control samples and asymptomatic control samples did not reveal any detectable immune responses. The ELISA for proinflammatory cytokine IL-8 did not exhibit any significant proinflammatory activity of ICD. Conclusions/Significance. ICD of H. pylori is an immunogen which interacts with the host immune system subsequent to a possible autolytic-release and thereby significantly elicits humoral responses in individuals with invasive H. pylori infection. However, ICD could not significantly stimulate IL8 induction in a cultured macrophage cell line (THP1) and therefore, may not be a notable proinflammatory agent.	[Hussain, M. Abid; Alvi, Ayesha; Ahmed, Niyaz] Ctr DNA Fingerprinting & Diagnost CDFD, Pathogen Evolut Lab, Hyderabad, Andhra Pradesh, India; [Naveed, Shaik A.; Ahmed, Irshad] Deccan Coll Med Sci & Allied Hosp, Ctr Liver Res & Diagnost, Hyderabad, Andhra Pradesh, India; [Sechi, Leonardo A.] Univ Degli Studi Sassari, Fac Med, Sezione Microbiol Speriment Clin, Dipart Sci Biomed, Sassari, Italy; [Ranjan, Sarita; Ranjan, Akash] CDFD, Comp Funct Genom Grp, Hyderabad, Andhra Pradesh, India; [Mukhopadhyay, Sangita] CDFD, Lab Mol Cell Biol, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Sassari; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Ahmed, N (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Pathogen Evolut Lab, Hyderabad, Andhra Pradesh, India.	niyaz@cdfd.org.in	Shaik, Abdul Naveed/I-1018-2019; Ahmed, Niyaz/D-2589-2010; Sechi, Leonardo Antonio/Y-3109-2018	Shaik, Abdul Naveed/0000-0002-3672-2246; Ahmed, Niyaz/0000-0001-6425-7583; Ranjan, Akash/0000-0002-4582-1553; Mukhopadhyay, Sangita/0000-0002-5511-3315; sechi, leonardo antonio/0000-0003-0566-2049	Dept. of Biotechnology, Government of India [CDFD Core]	Dept. of Biotechnology, Government of India	Funding from CDFD Core Grants (Dept. of Biotechnology, Government of India)	AHMED KS, 2004, SINGAP MED J, V47, P291; Akhter Yusuf, 2007, Infect Agent Cancer, V2, P2, DOI 10.1186/1750-9378-2-2; ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; Cao P, 1998, INFECT IMMUN, V66, P2984, DOI 10.1128/IAI.66.6.2984-2986.1998; Carroll IM, 2003, J CLIN MICROBIOL, V41, P5755, DOI 10.1128/JCM.41.12.5755-5759.2003; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; COVER TL, 1995, J CLIN MICROBIOL, V33, P1496, DOI 10.1128/JCM.33.6.1496-1500.1995; COVER TL, 1994, J BIOL CHEM, V269, P10566; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Glupczynski Y, 1998, BRIT MED BULL, V54, P175; GOOSSENS H, 1992, J CLIN MICROBIOL, V30, P176, DOI 10.1128/JCM.30.1.176-180.1992; Hussain MA, 2004, J CLIN MICROBIOL, V42, P2372, DOI 10.1128/JCM.42.6.2372-2378.2004; JOHANSEN HK, 1995, CLIN DIAGN LAB IMMUN, V2, P149, DOI 10.1128/CDLI.2.2.149-155.1995; Kauser F, 2005, J CLIN MICROBIOL, V43, P1538, DOI 10.1128/JCM.43.4.1538-1545.2005; Kauser F, 2004, J CLIN MICROBIOL, V42, P5302, DOI 10.1128/JCM.42.11.5302-5308.2004; Kimmel B, 2000, INFECT IMMUN, V68, P915, DOI 10.1128/IAI.68.2.915-920.2000; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Megraud F, 1996, SCAND J GASTROENTERO, V31, P57, DOI 10.3109/00365529609094536; MITCHELL HM, 1988, MED J AUSTRALIA, V149, P604, DOI 10.5694/j.1326-5377.1988.tb120800.x; NEWELL DG, 1987, J GEN MICROBIOL, V133, P163; Phadnis SH, 1996, INFECT IMMUN, V64, P905, DOI 10.1128/IAI.64.3.905-912.1996; Pitson SM, 1999, EUR J BIOCHEM, V260, P258, DOI 10.1046/j.1432-1327.1999.00153.x; Prouzet-Mauleon V, 2005, J CLIN MICROBIOL, V43, P4237, DOI 10.1128/JCM.43.8.4237-4241.2005; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; van der Ende A, 1998, INFECT IMMUN, V66, P1822, DOI 10.1128/IAI.66.5.1822-1826.1998; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998	30	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1481	10.1371/journal.pone.0001481	http://dx.doi.org/10.1371/journal.pone.0001481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213389	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503900026
J	Palmer, HG; Anjos-Afonso, F; Carmeliet, G; Takeda, H; Watt, FM				Palmer, Hector G.; Anjos-Afonso, Fernando; Carmeliet, Geert; Takeda, Hikaru; Watt, Fiona M.			The Vitamin D Receptor Is a Wnt Effector that Controls Hair Follicle Differentiation and Specifies Tumor Type in Adult Epidermis	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; MOUSE EPIDERMIS; E-CADHERIN; EXPRESSION; GROWTH; MICE; MORPHOGENESIS; ANALOGS; CANCER	We have investigated how Wnt and vitamin D receptor signals regulate epidermal differentiation. Many epidermal genes induced by beta-catenin, including the stem cell marker keratin 15, contain vitamin D response elements (VDREs) and several are induced independently of TCF/Lef. The VDR is required for beta-catenin induced hair follicle formation in adult epidermis, and the vitamin D analog EB1089 synergises with beta-catenin to stimulate hair differentiation. Human trichofolliculomas (hair follicle tumours) are characterized by high nuclear beta-catenin and VDR, whereas infiltrative basal cell carcinomas (BCCs) have high beta-catenin and low VDR levels. In mice, EB1089 prevents beta-catenin induced trichofolliculomas, while in the absence of VDR beta-catenin induces tumours resembling BCCs. We conclude that VDR is a TCF/Lef-independent transcriptional effector of the Wnt pathway and that vitamin D analogues have therapeutic potential in tumors with inappropriate activation of Wnt signalling.	[Palmer, Hector G.; Watt, Fiona M.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Anjos-Afonso, Fernando] Canc Res UK London Res Inst, London, England; [Carmeliet, Geert] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Leuven, Belgium; [Takeda, Hikaru] Yamagata Univ, Sch Med, Dept Dermatol, Yamagata, Japan	Cancer Research UK; CRUK Cambridge Institute; Cancer Research UK; KU Leuven; Yamagata University	Watt, FM (corresponding author), Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England.	fiona.watt@cancer.org.uk	Palmer, Héctor G./AAG-8332-2019; Watt, Fiona/AHB-0226-2022; Seoane, Joan/AAG-9173-2019	Watt, Fiona/0000-0001-9151-5154; Seoane, Joan/0000-0002-6541-5974; Palmer, Hector/0000-0002-9823-5638; Anjos-Afonso, Fernando/0000-0003-4392-488X	European Union Marie Curie [Fellowship]; CR-UK	European Union Marie Curie(European Commission); CR-UK(Cancer Research UK)	HGP is the recipient of a European Union Marie Curie Fellowship. This work was supported by CR-UK.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Bikle DD, 2004, J NUTR, V134, p3472S, DOI 10.1093/jn/134.12.3472S; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; HUGHES MR, 1991, J RECEPTOR RES, V11, P699, DOI 10.3109/10799899109066437; Jaaskelainen T, 2000, J CELL BIOCHEM, V76, P548; Jih DM, 1999, J CUTAN PATHOL, V26, P113, DOI 10.1111/j.1600-0560.1999.tb01814.x; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Niemann C, 2002, DEVELOPMENT, V129, P95; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Pena C, 2005, HUM MOL GENET, V14, P3361, DOI 10.1093/hmg/ddi366; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakai Y, 2001, J CLIN INVEST, V107, P961, DOI 10.1172/JCI11676; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Skorija K, 2005, MOL ENDOCRINOL, V19, P855, DOI 10.1210/me.2004-0415; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Vegesna V, 2002, ENDOCRINOLOGY, V143, P4389, DOI 10.1210/en.2002-220118; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	34	105	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1483	10.1371/journal.pone.0001483	http://dx.doi.org/10.1371/journal.pone.0001483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213391	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000260503900028
J	Chapelsky, S; Batty, S; Frost, M; Mogridge, J				Chapelsky, Sarah; Batty, Sarah; Frost, Mia; Mogridge, Jeremy			Inhibition of Anthrax Lethal Toxin-Induced Cytolysis of RAW264.7 Cells by Celastrol	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; BACILLUS-ANTHRACIS; PROTECTIVE ANTIGEN; DEPENDENT PROCESS; DENDRITIC CELLS; KINASE-KINASE; MACROPHAGES; RECEPTOR; SUSCEPTIBILITY; ACTIVATION	Background. Bacillus anthracis is the bacterium responsible for causing anthrax. The ability of B. anthracis to cause disease is dependent on a secreted virulence factor, lethal toxin, that promotes survival of the bacteria in the host by impairing the immune response. A well-studied effect of lethal toxin is the killing of macrophages, although the molecular mechanisms involved have not been fully characterized. Methodology/Principal Findings. Here, we demonstrate that celastrol, a quinone methide triterpene derived from a plant extract used in herbal medicine, inhibits lethal toxin-induced death of RAW264.7 murine macrophages. Celastrol did not prevent cleavage of mitogen activated protein kinase kinase 1, a cytosolic target of the toxin, indicating that it did not inhibit the uptake or catalytic activity of lethal toxin. Surprisingly, celastrol conferred almost complete protection when it was added up to 1.5 h after intoxication, indicating that it could rescue cells in the late stages of intoxication. Since the activity of the proteasome has been implicated in intoxication using other pharmacological agents, we tested whether celastrol blocked proteasome activity. We found that celastrol inhibited the proteasome-dependent degradation of proteins in RAW264.7 cells, but only slightly inhibited proteasome-mediated cleavage of fluorogenic substrates in vitro. Furthermore, celastrol blocked stimulation of IL-18 processing, indicating that celastrol acted upstream of inflammasome activation. Conclusions/Significance. This work identifies celastrol as an inhibitor of lethal toxin-mediated macrophage lysis and suggests an inhibitory mechanism involving inhibition of the proteasome pathway.	[Chapelsky, Sarah; Batty, Sarah; Frost, Mia; Mogridge, Jeremy] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto	Mogridge, J (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	jeremy.mogridge@utoronto.ca			NIH [RO1 AI067683]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067683] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grant RO1 AI067683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Alileche A, 2006, CELL CYCLE, V5, P100, DOI 10.4161/cc.5.1.2283; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Banks David J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010714; Banks DJ, 2005, CELL MICROBIOL, V7, P1173, DOI 10.1111/j.1462-5822.2005.00545.x; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Crawford MA, 2006, J IMMUNOL, V176, P7557, DOI 10.4049/jimmunol.176.12.7557; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Gimenez AP, 2004, J IMMUNOL, V173, P521, DOI 10.4049/jimmunol.173.1.521; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101	40	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1421	10.1371/journal.pone.0001421	http://dx.doi.org/10.1371/journal.pone.0001421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183301	Green Published, Green Submitted, gold			2022-12-27	WOS:000260469400017
J	Klinke, DJ				Klinke, David J., II			Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-SECRETION; PANCREAS; INTERVENTION; PREVENTION; MOLECULES; PATTERNS; CHILDREN; ANTIBODY; ISLETS	Background. Type 1 diabetes mellitus is characterized by an inability to produce insulin endogenously. Based on a series of histopathology studies of patients with recent onset of the disease, it is commonly stated that the onset of clinical symptoms corresponds to an 80-95% reduction in beta cell mass. Motivated by the clinical importance of the degree of beta cell destruction at onset, a meta-analysis was used to determine the validity of this common wisdom. Methods and Findings. The histopathology results identifying insulin containing islets in patients younger than 20 years of age were extracted from three different studies. The results for 105 patients were stratified by duration of diabetic symptoms and age at onset. Linear regression and a non-parametric bootstrap approach were used to determine the dependence of residual beta cell mass to age at onset. The percentage reduction in beta cell mass was highly correlated (p < 0.001) with the age of onset with the greatest reduction in beta cell mass in the youngest patients. As this trend had not been previously observed, an alternative physiology-based model is proposed that captures this age-dependence. Conclusions. The severity in beta cell reduction at onset decreased with age where, on average, a 40% reduction in beta cell mass was sufficient to precipitate clinical symptoms at 20 years of age. The observed trend was consistent with a physiology-based model where the threshold for onset is based upon a dynamic balance between insulin-production capacity, which is proportional to beta cell mass, and insulin demand, which is proportional to body weight.	[Klinke, David J., II] W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA; [Klinke, David J., II] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV USA	West Virginia University; West Virginia University	Klinke, DJ (corresponding author), W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA.	david.klinke@mail.wvu.edu		Klinke, David/0000-0003-3299-4938	West Virginia University Research Corporation	West Virginia University Research Corporation	This work was supported by the West Virginia University Research Corporation.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ARMITAGE P, 2002, STAT METHODS MED RES, P102; Atkinson MA, 2005, DIABETES, V54, P1253, DOI 10.2337/diabetes.54.5.1253; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Barker JM, 2007, J PEDIATR-US, V150, P31, DOI 10.1016/j.jpeds.2006.09.033; Beers KJ, 2007, NUMERICAL METHODS FOR CHEMICAL ENGINEERING: APPLICATIONS IN MATLAB, P372; CHERNICK MR, 1999, BOOTSTRAP METHODS PR, P150; Daaboul J, 2003, REV ENDOCR METAB DIS, V4, P317, DOI 10.1023/A:1027308310837; DONIACH I, 1973, Clinical Endocrinology, V2, P233, DOI 10.1111/j.1365-2265.1973.tb00425.x; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; FOULIS AK, 1987, DIABETOLOGIA, V30, P333, DOI 10.1007/BF00299027; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Green A, 2000, LANCET, V355, P873; Greenbaum CJ, 2002, DIABETES, V51, P951, DOI 10.2337/diabetes.51.4.951; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Kloppel G, 1984, Behring Inst Mitt, P42; Kolb H, 2001, DIABETOLOGIA, V44, P1349, DOI 10.1007/s001250100636; Komulainen J, 1997, DIABETIC MED, V14, P532, DOI 10.1002/(SICI)1096-9136(199707)14:7<532::AID-DIA403>3.0.CO;2-6; Kuczmarski RJ, 2000, ADV DATA, V314, P1; LERNMARK A, 1995, VIRCHOWS ARCH, V425, P631; Marchetti P, 2000, DIABETES CARE, V23, P701, DOI 10.2337/diacare.23.5.701; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; SCIBILIA J, 1986, ACTA ENDOCRINOL-COP, V113, P326; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; SOCHETT EB, 1987, DIABETOLOGIA, V30, P453, DOI 10.1007/BF00279611; SOMOZA N, 1994, J IMMUNOL, V153, P1360; Sosenko JM, 2006, DIABETES CARE, V29, P643, DOI 10.2337/diacare.29.03.06.dc05-1006; SRIKANTA S, 1984, DIABETES, V33, P717, DOI 10.2337/diabetes.33.8.717; Steele C, 2004, DIABETES, V53, P426, DOI 10.2337/diabetes.53.2.426; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; VARDI P, 1991, DIABETOLOGIA, V34, P93, DOI 10.1007/BF00500379; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; World Health Organization, 1999, REP WHO CONS 1; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	41	64	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1374	10.1371/journal.pone.0001374	http://dx.doi.org/10.1371/journal.pone.0001374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167535	Green Published, gold, Green Submitted			2022-12-27	WOS:000260468900003
J	Li, YF; Maedler, K; Shu, L; Haataja, L				Li, Yunfeng; Maedler, Kathrin; Shu, Luan; Haataja, Leena			UCP-2 and UCP-3 Proteins Are Differentially Regulated in Pancreatic Beta-Cells	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; OXYGEN SPECIES PRODUCTION; TYPE-2 DIABETIC-PATIENTS; FREE FATTY-ACIDS; UNCOUPLING PROTEIN-2; SKELETAL-MUSCLE; HIGH GLUCOSE; PROLONGED EXPOSURE; MESSENGER-RNA; KNOCKOUT MICE	Background. Increased uncoupling protein-2 (UCP-2) expression has been associated with impaired insulin secretion, whereas UCP-3 protein levels are decreased in the skeleton muscle of type-2 diabetic subjects. In the present studies we hypothesize an opposing effect of glucose on the regulation of UCP-2 and UCP-3 in pancreatic islets. Methodology. Dominant negative UCP-2 and wild type UCP-3 adenoviruses were generated, and insulin release by transduced human islets was measured. UCP-2 and UCP-3 mRNA levels were determined using quantitative PCR. UCP-2 and UCP-3 protein expression was investigated in human islets cultured in the presence of different glucose concentrations. Human pancreatic sections were analyzed for subcellular localization of UCP-3 using immunohistochemistry. Principal Findings. Dominant negative UCP-2 expression in human islets increased insulin secretion compared to control islets (p<0.05). UCP-3 mRNA is expressed in human islets, but the relative abundance of UCP-2 mRNA was 8.1-fold higher (p<0.05). Immunohistochemical analysis confirmed co-localization of UCP-3 protein with mitochondria in human beta-cells. UCP-2 protein expression in human islets was increased similar to 2-fold after high glucose exposure, whereas UCP-3 protein expression was decreased by similar to 40% (p<0.05). UCP-3 overexpression improved glucose-stimulated insulin secretion. Conclusions. UCP-2 and UCP-3 may have distinct roles in regulating beta-cell function. Increased expression of UCP-2 and decreased expression of UCP-3 in humans with chronic hyperglycemia may contribute to impaired glucose-stimulated insulin secretion. These data imply that mechanisms that suppress UCP-2 or mechanisms that increase UCP-3 expression and/or function are potential therapeutic targets to offset defects of insulin secretion in humans with type-2 diabetes.	[Li, Yunfeng; Maedler, Kathrin; Shu, Luan; Haataja, Leena] Univ Calif Los Angeles, David Geffen Sch Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Haataja, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA.	lhaataja@mednet.ucla.edu	Maedler, Kathrin/ABE-3022-2021	Maedler, Kathrin/0000-0002-7436-1197	Larry L. Hillblom Foundation [2003/1Mc, 2005/1C]; American Diabetes Association [706JF41]	Larry L. Hillblom Foundation; American Diabetes Association(American Diabetes Association)	Larry L. Hillblom Foundation 2003/1Mc (LH), 2005/1C (KM) and American Diabetes Association 706JF41 (KM)	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Briaud I, 2002, DIABETES, V51, P662, DOI 10.2337/diabetes.51.3.662; Brown JEP, 2002, FEBS LETT, V513, P189, DOI 10.1016/S0014-5793(02)02296-2; Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; EIZIRIK DL, 1992, J CLIN INVEST, V90, P1263, DOI 10.1172/JCI115989; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feeney CJ, 2003, J NEUROSCI METH, V125, P13, DOI 10.1016/S0165-0270(03)00027-X; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hesselink MKC, 2005, HORM METAB RES, V37, P550, DOI 10.1055/s-2005-870421; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Jimenez M, 2002, EUR J BIOCHEM, V269, P2878, DOI 10.1046/j.1432-1033.2002.02953.x; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; Langin D, 2001, NEW ENGL J MED, V345, P1772, DOI 10.1056/NEJM200112133452412; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Li LX, 2002, ENDOCRINOLOGY, V143, P1371, DOI 10.1210/en.143.4.1371; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V204, P85, DOI 10.1016/S0303-7207(03)00124-2; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mattson MP, 2003, BIOCHEM BIOPH RES CO, V304, P539, DOI 10.1016/S0006-291X(03)00627-2; Medvedev AV, 2002, J BIOL CHEM, V277, P42639, DOI 10.1074/jbc.M208645200; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Ritzel RA, 2003, J CLIN ENDOCR METAB, V88, P742, DOI 10.1210/jc.2002-021250; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572; Schrauwen P, 2001, DIABETES, V50, P2870, DOI 10.2337/diabetes.50.12.2870; Son C, 2004, DIABETOLOGIA, V47, P47, DOI 10.1007/s00125-003-1272-8; Song SH, 2002, J CLIN ENDOCR METAB, V87, P213, DOI 10.1210/jc.87.1.213; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	54	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1397	10.1371/journal.pone.0001397	http://dx.doi.org/10.1371/journal.pone.0001397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167556	Green Submitted, Green Published, gold			2022-12-27	WOS:000260468900025
J	Serre, D; Montpetit, A; Pare, G; Engert, JC; Yusuf, S; Keavney, B; Hudson, TJ; Anand, S				Serre, David; Montpetit, Alexandre; Pare, Guillaume; Engert, James C.; Yusuf, Salim; Keavney, Bernard; Hudson, Thomas J.; Anand, Sonia			Correction of Population Stratification in Large Multi-Ethnic Association Studies	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; GENETIC ASSOCIATION; 52 COUNTRIES; RISK-FACTORS; HUMAN GENOME; REVEALS; POLYMORPHISMS; RELATEDNESS; INTERHEART; DIVERSITY	Background. The vast majority of genetic risk factors for complex diseases have, taken individually, a small effect on the end phenotype. Population-based association studies therefore need very large sample sizes to detect significant differences between affected and non-affected individuals. Including thousands of affected individuals in a study requires recruitment in numerous centers, possibly from different geographic regions. Unfortunately such a recruitment strategy is likely to complicate the study design and to generate concerns regarding population stratification. Methodology/Principal Findings. We analyzed 9,751 individuals representing three main ethnic groups - Europeans, Arabs and South Asians - that had been enrolled from 154 centers involving 52 countries for a global case/control study of acute myocardial infarction. All individuals were genotyped at 103 candidate genes using 1,536 SNPs selected with a tagging strategy that captures most of the genetic diversity in different populations. We show that relying solely on self-reported ethnicity is not sufficient to exclude population stratification and we present additional methods to identify and correct for stratification. Conclusions/Significance. Our results highlight the importance of carefully addressing population stratification and of carefully "cleaning'' the sample prior to analyses to obtain stronger signals of association and to avoid spurious results.	[Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Serre, David; Montpetit, Alexandre; Pare, Guillaume] McGill Univ, Genome Quebec Innovation Ctr, Montreal, PQ, Canada; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Anand, Sonia] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Yusuf, Salim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Keavney, Bernard] Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; McGill University; McGill University; McGill University; McMaster University; Newcastle University - UK	Hudson, TJ (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	tom.hudson@oicr.on.ca		Yusuf, Salim/0000-0003-4776-5601; Keavney, Bernard/0000-0001-9573-0812; Engert, James/0000-0001-8411-4790	Canadian Institutes of Health Research [Clinician-Scientist Award, Investigator Award]; Heart and Stroke Foundation of Ontario; International Clinical Epidemiology Network; Genome Canada; Genome Quebec; Burroughs Wellcome Fund [Clinician-Scientist Award]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); International Clinical Epidemiology Network; Genome Canada(Genome Canada); Genome Quebec; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	The INTERHEART study is funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, the International Clinical Epidemiology Network and through unrestricted grants from several pharmaceutical companies. This work was supported by Genome Canada and Genome Quebec. TJH is the recipient of a Clinician-Scientist Award in Translational Research by the Burroughs Wellcome Fund and an Investigator Award from CIHR. SY holds an endowed chair from the Heart and Stroke foundation of Ontario. SA holds a clinican scientist award from the CIHR. JCE is a research scholar of the Fonds de la Recherche en Sante du Quebec (FRSQ).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cann HM, 2002, SCIENCE, V296, P261; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CHAKRABORTY R, 1990, AM J HUM GENET, V47, P87; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; HEYER E, 1995, AM J HUM GENET, V56, P970; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; KNOWLER WC, 1983, AM J PHYS ANTHROPOL, V62, P107, DOI 10.1002/ajpa.1330620114; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; NELSON MR, 2006, DEV DENSELY GENOTYPE; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weir B. S., 1996, GENETIC DATA ANAL; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	44	52	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1382	10.1371/journal.pone.0001382	http://dx.doi.org/10.1371/journal.pone.0001382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18196181	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900010
J	Singer-Lahat, D; Chikvashvili, D; Lotan, I				Singer-Lahat, Dafna; Chikvashvili, Dodo; Lotan, Ilana			Direct Interaction of Endogenous Kv Channels with Syntaxin Enhances Exocytosis by Neuroendocrine Cells	PLOS ONE			English	Article							DEPENDENT K+ CHANNELS; BOTULINUM TOXIN C1; N-TERMINUS; RAT-BRAIN; POTASSIUM CHANNELS; INSULIN-SECRETION; FUNCTIONAL IMPACT; CALCIUM-CHANNELS; SNARE COMPLEXES; MEMBRANE-FUSION	K+ efflux through voltage-gated K+ (Kv) channels can attenuate the release of neurotransmitters, neuropeptides and hormones by hyperpolarizing the membrane potential and attenuating Ca2+ influx. Notably, direct interaction between Kv2.1 channels overexpressed in PC12 cells and syntaxin has recently been shown to facilitate dense core vesicle (DCV)-mediated release. Here, we focus on endogenous Kv2.1 channels and show that disruption of their interaction with native syntaxin after ATP-dependent priming of the vesicles by Kv2.1 syntaxin-binding peptides inhibits Ca2+ - triggered exocytosis of DCVs from cracked PC12 cells in a specific and dose-dependent manner. The inhibition cannot simply be explained by the impairment of the interaction of syntaxin with its SNARE cognates. Thus, direct association between endogenous Kv2.1 and syntaxin enhances exocytosis and in combination with the Kv2.1 inhibitory effect to hyperpolarize the membrane potential, could contribute to the known activity dependence of DCV release in neuroendocrine cells and in dendrites where Kv2.1 commonly expresses and influences release.	[Singer-Lahat, Dafna; Chikvashvili, Dodo; Lotan, Ilana] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Lotan, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel.	ilotan@post.tau.ac.il			Israel Science Foundation [640/02]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation grant 640/02 (to IL).	BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BENNETT MK, 1995, CURR OPIN CELL BIOL, V7, P581, DOI 10.1016/0955-0674(95)80016-6; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; Betz A, 1997, J BIOL CHEM, V272, P2520; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; HWANG PM, 1993, J NEUROSCI, V13, P1569; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jing J, 1999, EMBO J, V18, P1245, DOI 10.1093/emboj/18.5.1245; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Leung YM, 2005, BIOCHEM J, V387, P195, DOI 10.1042/BJ20041625; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; MARTIN TFJ, 1989, J BIOL CHEM, V264, P10299; MARTIN TFJ, 1989, METHOD ENZYMOL, V168, P225; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Murakoshi H, 1999, J NEUROSCI, V19, P1728; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Roeper J, 1996, CURR OPIN NEUROBIOL, V6, P338, DOI 10.1016/S0959-4388(96)80117-6; Singer-Lahat D, 2007, J NEUROSCI, V27, P1651, DOI 10.1523/JNEUROSCI.4006-06.2007; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Stanley EF, 2003, EUR J NEUROSCI, V17, P1303, DOI 10.1046/j.1460-9568.2003.02536.x; TRIMMER JS, 1993, FEBS LETT, V324, P205, DOI 10.1016/0014-5793(93)81394-F; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597	39	26	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1381	10.1371/journal.pone.0001381	http://dx.doi.org/10.1371/journal.pone.0001381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167541	Green Submitted, Green Published, gold			2022-12-27	WOS:000260468900009
J	Le Tortorec, A; Le Grand, R; Denis, H; Satie, AP; Mannioui, K; Roques, P; Maillard, A; Daniels, S; Jegou, B; Dejucq-Rainsford, N				Le Tortorec, Anna; Le Grand, Roger; Denis, Helene; Satie, Anne-Pascale; Mannioui, Karim; Roques, Pierre; Maillard, Anne; Daniels, Sylvanne; Jegou, Bernard; Dejucq-Rainsford, Nathalie			Infection of Semen-Producing Organs by SIV during the Acute and Chronic Stages of the Disease	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; MESSENGER-RNA EXPRESSION; MALE GENITAL-TRACT; WHITE BLOOD-CELLS; MEMORY T-CELLS; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; SEMINAL PLASMA; IN-SITU	Background: Although indirect evidence suggests the male genital tract as a possible source of persistent HIV shedding in semen during antiretroviral therapy, this phenomenon is poorly understood due to the difficulty of sampling semen-producing organs in HIV+ asymptomatic individuals. Methodology/Principal Findings: Using a range of molecular and cell biological techniques, this study investigates SIV infection within reproductive organs of macaques during the acute and chronic stages of the disease. We demonstrate for the first time the presence of SIV in the testes, epididymides, prostate and seminal vesicles as early as 14 days post-inoculation. This infection persists throughout the chronic stage and positively correlates with blood viremia. The prostate and seminal vesicles appear to be the most efficiently infected reproductive organs, followed by the epididymides and testes. Within the male genital tract, mostly T lymphocytes and a small number of germ cells harbour SIV antigens and RNA. In contrast to the other organs studied, the testis does not display an immune response to the infection. Testosteronemia is transiently increased during the early phase of the infection but spermatogenesis remains unaffected. Conclusions/Significance: The present study reveals that SIV infection of the macaque male genital tract is an early event and that semen-producing organs display differential infection levels and immune responses. These results help elucidate the origin of HIV in semen and constitute an essential base to improving the design of antiretroviral therapies to eradicate virus from semen.	[Le Tortorec, Anna; Denis, Helene; Satie, Anne-Pascale; Daniels, Sylvanne; Jegou, Bernard; Dejucq-Rainsford, Nathalie] Univ Rennes 1, INSERM, U625, Grp Etud Reprod Chez Homme & Mammiferes,IFR 140, Rennes, France; [Le Grand, Roger; Mannioui, Karim; Roques, Pierre] DSV iMETI, Serv Immuno Virol, CEA, Fontenay Aux Roses, France; [Maillard, Anne] Ctr Hosp Univ Regional Pontchaillou, Unite Retrovirol, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CEA; CHU Rennes	Le Tortorec, A (corresponding author), Univ Rennes 1, INSERM, U625, Grp Etud Reprod Chez Homme & Mammiferes,IFR 140, Campus Beaulieu, Rennes, France.	nathalie.dejucq-rainsford@rennes.inserm.fr	Le Tortorec, Anna/J-5291-2015; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Roques, Pierre/M-2212-2013; Jégou, Bernard/I-4742-2015	Roques, Pierre/0000-0003-1825-1054; JEGOU, Bernard/0000-0003-0623-3609; Daniels, Sylvanne/0000-0003-4300-5672; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690	INSERM; ANRS; Sidaction; Region Bretagne; Ministere de l'Enseignement Superieur et de la Recherche; Organon stipend; European Microbicides Project	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Region Bretagne(Region Bretagne); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Organon stipend; European Microbicides Project	Sources of support: INSERM, ANRS, Sidaction, Region Bretagne, Ministere de l'Enseignement Superieur et de la Recherche. Anna Le Tortorec has been successively a recipient of an Organon and an ANRS stipend. Helene Denis is supported by ANRS and Sidaction. Karim Mannioui is financed by the European Microbicides Project.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Abel K, 2001, CYTOKINE, V16, P191, DOI 10.1006/cyto.2001.0961; Alexander RB, 1998, UROLOGY, V52, P744, DOI 10.1016/S0090-4295(98)00390-2; Anderson DJ, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1647, DOI 10.1016/B978-012491543-5/50100-5; ANDERSON DJ, 1991, LANCET, V338, P573, DOI 10.1016/0140-6736(91)91139-L; ANDERSON RM, 1988, J ACQ IMMUN DEF SYND, V1, P241; ARANEO BA, 1991, BLOOD, V78, P688, DOI 10.1182/blood.V78.3.688.688; BEHRE HM, 1997, ANDROLOGY MALE REPRO, P163; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Benveniste O, 1996, P NATL ACAD SCI USA, V93, P3658, DOI 10.1073/pnas.93.8.3658; Bladergroen BA, 2001, J IMMUNOL, V166, P3218, DOI 10.4049/jimmunol.166.5.3218; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Bourlet T, 2001, AIDS, V15, P284, DOI 10.1097/00002030-200101260-00025; BROGI A, 1995, J SUBMICR CYTOL PATH, V27, P565; Bujan L, 2004, AIDS, V18, P757, DOI 10.1097/00002030-200403260-00006; Bujan L, 2007, J ANDROL, V28, P444, DOI 10.2164/jandrol.106.001529; Byrn RA, 1997, LANCET, V350, P1141, DOI 10.1016/S0140-6736(97)24042-0; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; CHAKRABARTI L, 1991, AM J PATHOL, V139, P1273; Cheret A, 1996, AIDS RES HUM RETROV, V12, P1263, DOI 10.1089/aid.1996.12.1263; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Dai ZH, 2005, J IMMUNOL, V174, P1165, DOI 10.4049/jimmunol.174.3.1165; DASILVA M, 1990, AM J CLIN PATHOL, V93, P196, DOI 10.1093/ajcp/93.2.196; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DECESARIS P, 1992, BIOCHEM BIOPH RES CO, V186, P1639; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Dejucq-Rainsford N, 2004, CURR PHARM DESIGN, V10, P557, DOI 10.2174/1381612043453225; Delezay O, 1997, AIDS, V11, P1311, DOI 10.1097/00002030-199711000-00004; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; ELDEMIRY MIM, 1985, BRIT J UROL, V57, P769, DOI 10.1111/j.1464-410X.1985.tb07051.x; Eron JJ, 1998, AIDS, V12, pF181, DOI 10.1097/00002030-199815000-00003; Eyre R C, 2000, Urology, V55, P591, DOI 10.1016/S0090-4295(99)00592-0; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Filippini A, 2001, HUM REPROD UPDATE, V7, P444, DOI 10.1093/humupd/7.5.444; Garrido N, 2005, HUM REPROD, V20, P1028, DOI 10.1093/humrep/deh699; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Greenier JL, 2001, J VIROL, V75, P3753, DOI 10.1128/JVI.75.8.3753-3765.2001; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Haigwood NL, 2004, AIDS REV, V6, P187; Hales DB, 2002, J REPROD IMMUNOL, V57, P3, DOI 10.1016/S0165-0378(02)00020-7; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hofmann-Lehmann R, 2002, AIDS RES HUM RETROV, V18, P627, DOI 10.1089/088922202760019329; Hu LH, 2004, WORLD J GASTROENTERO, V10, P3514; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kiessling AA, 1998, AIDS RES HUM RETROV, V14, pS33; Krieger JN, 1998, J UROLOGY, V159, P820, DOI 10.1016/S0022-5347(01)63742-X; KROODSMA KL, 1994, J INFECT DIS, V170, P1292, DOI 10.1093/infdis/170.5.1292; Lafeuillade Alain, 2002, HIV Clin Trials, V3, P27; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu XA, 2003, J VIROL, V77, P3470, DOI 10.1128/JVI.77.6.3470-3476.2003; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; MILLER CJ, 1994, LAB INVEST, V70, P255; Miller LJ, 2002, J UROLOGY, V167, P753, DOI 10.1016/S0022-5347(01)69139-0; Miyake A, 2006, J GEN VIROL, V87, P1311, DOI 10.1099/vir.0.81307-0; Moniuszko M, 2005, VIROLOGY, V333, P159, DOI 10.1016/j.virol.2005.01.003; Muciaccia B, 1998, FASEB J, V12, P151, DOI 10.1096/fasebj.12.2.151; Naito M, 2008, AM J REPROD IMMUNOL, V59, P55, DOI 10.1111/j.1600-0897.2007.00556.x; Nasr IW, 2005, J IMMUNOL, V174, P6161, DOI 10.4049/jimmunol.174.10.6161; Nicopoullos JDM, 2004, HUM REPROD, V19, P2289, DOI 10.1093/humrep/deh426; Nilsson J, 2007, AIDS, V21, P565, DOI 10.1097/QAD.0b013e3280117204; NUOVO GJ, 1994, AM J PATHOL, V144, P1142; O'Bryan MK, 2005, AM J PHYSIOL-REG I, V288, pR1744, DOI 10.1152/ajpregu.00651.2004; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Paulis Gianni, 2003, Arch Ital Urol Androl, V75, P179; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Ping LH, 2000, J VIROL, V74, P8946, DOI 10.1128/JVI.74.19.8946-8952.2000; POLLANEN P, 1990, J REPROD IMMUNOL, V18, P51, DOI 10.1016/0165-0378(90)90024-Z; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puaux AL, 2004, VACCINE, V22, P3535, DOI 10.1016/j.vaccine.2004.03.044; PUDNEY J, 1991, AM J PATHOL, V139, P149; Pudney J, 1998, J REPROD IMMUNOL, V41, P105, DOI 10.1016/S0165-0378(98)00052-7; Pullium JK, 2001, J INFECT DIS, V183, P1023, DOI 10.1086/319293; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; RIVENSON A, 1981, CELL MOL BIOL, V27, P49; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; SETCHELL BP, 1988, ANATOMY VASCULATURE, P753; Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7; Shevchuk MM, 1998, J REPROD IMMUNOL, V41, P69, DOI 10.1016/S0165-0378(98)00049-7; Shiboski SC, 1998, J ACQ IMMUN DEF SYND, V19, P527, DOI 10.1097/00042560-199812150-00013; Smith DM, 2004, AIDS, V18, P1600, DOI 10.1097/01.aids.0000131364.60081.01; Solas C, 2003, ANTIMICROB AGENTS CH, V47, P238, DOI 10.1128/AAC.47.1.238-243.2003; Staprans SI, 1999, J VIROL, V73, P4829, DOI 10.1128/JVI.73.6.4829-4839.1999; STREILEIN JW, 1995, SCIENCE, V270, P1158, DOI 10.1126/science.270.5239.1158; Suarez-Pinzon W, 2000, DIABETES, V49, P1810, DOI 10.2337/diabetes.49.11.1810; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tachet A, 1999, AIDS, V13, P823, DOI 10.1097/00002030-199905070-00012; TERASAWA E, 1987, ENDOCRINOLOGY, V120, P2265, DOI 10.1210/endo-120-6-2265; Thiebot H, 2005, BLOOD, V105, P2403, DOI 10.1182/blood-2004-01-0025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERNAZZA PL, 1994, AIDS, V8, P1325, DOI 10.1097/00002030-199409000-00017; VICENZI E, 1994, CHEM-BIOL INTERACT, V91, P101, DOI 10.1016/0009-2797(94)90030-2; VIVIER E, 1993, J EXP MED, V178, P2023, DOI 10.1084/jem.178.6.2023; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Willey S, 2003, AIDS, V17, P183, DOI 10.1097/00002030-200301240-00007; WOLFF H, 1995, FERTIL STERIL, V63, P1143; WOLFF H, 1988, FERTIL STERIL, V49, P497; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	109	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1792	10.1371/journal.pone.0001792	http://dx.doi.org/10.1371/journal.pone.0001792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18347738	Green Published, gold			2022-12-27	WOS:000260723000043
J	Song, XY; Li, F; Zhang, FH; Zhong, JH; Zhou, XF				Song, Xing-Yun; Li, Fang; Zhang, Feng-He; Zhong, Jin-Hua; Zhou, Xin-Fu			Peripherally-Derived BDNF Promotes Regeneration of Ascending Sensory Neurons after Spinal Cord Injury	PLOS ONE			English	Article								Background: The blood brain barrier (BBB) and truncated trkB receptor on astrocytes prevent the penetration of brain derived neurotrophic factor (BDNF) applied into the peripheral (PNS) and central nervous system (CNS) thus restrict its application in the treatment of nervous diseases. As BDNF is anterogradely transported by axons, we propose that peripherally derived and/or applied BDNF may act on the regeneration of central axons of ascending sensory neurons. Methodology/Principal Findings: The present study aimed to test the hypothesis by using conditioning lesion of the sciatic nerve as a model to increase the expression of endogenous BDNF in sensory neurons and by injecting exogenous BDNF into the peripheral nerve or tissues. Here we showed that most of regenerating sensory neurons expressed BDNF and p-CREB but not p75NTR. Conditioning-lesion induced regeneration of ascending sensory neuron and the increase in the number of p-Erk positive and GAP-43 positive neurons was blocked by the injection of the BDNF antiserum in the periphery. Enhanced neurite outgrowth of dorsal root ganglia (DRG) neurons in vitro by conditioning lesion was also inhibited by the neutralization with the BDNF antiserum. The delivery of exogenous BDNF into the sciatic nerve or the footpad significantly increased the number of regenerating DRG neurons and regenerating sensory axons in the injured spinal cord. In a contusion injury model, an injection of BDNF into the footpad promoted recovery of motor functions. Conclusions/Significance: Our data suggest that endogenous BDNF in DRG and spinal cord is required for the enhanced regeneration of ascending sensory neurons after conditioning lesion of sciatic nerve and peripherally applied BDNF may have therapeutic effects on the spinal cord injury.	[Song, Xing-Yun; Li, Fang; Zhang, Feng-He; Zhong, Jin-Hua; Zhou, Xin-Fu] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Li, Fang] Central South Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Changsha, Peoples R China	Flinders University South Australia; Central South University	Song, XY (corresponding author), Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia.	xin-fu.zhou@flinders.edu.au	Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/G-6643-2011; zhou, xin-fu/F-4119-2013	Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175	NHMRC [375109]; Postgraduate Scholarship from Flinders University	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Postgraduate Scholarship from Flinders University	This work was supported by NHMRC grant (375109). XYS is supported by Postgraduate Scholarship from Flinders University. All authors claim no financial conflict of interest.	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Andersen LB, 1999, EXP NEUROL, V155, P157, DOI 10.1006/exnr.1998.6903; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Bradbury EJ, 1998, EUR J NEUROSCI, V10, P3058, DOI 10.1046/j.1460-9568.1998.00307.x; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Bradbury EJ, 2000, TRENDS PHARMACOL SCI, V21, P389, DOI 10.1016/S0165-6147(00)01536-4; Butowt R, 2005, MOL CELL NEUROSCI, V29, P11, DOI 10.1016/j.mcn.2005.02.004; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; CHONG MS, 1994, J NEUROSCI, V14, P4375; Curtis R, 1998, MOL CELL NEUROSCI, V12, P105, DOI 10.1006/mcne.1998.0704; Deng YS, 1999, NEUROTOX RES, V1, P311, DOI 10.1007/BF03033260; Deng YS, 2000, EXP NEUROL, V164, P344, DOI 10.1006/exnr.2000.7432; Farhadi HF, 2000, J NEUROSCI, V20, P4059; FOSTER E, 1994, BRAIN RES, V659, P267, DOI 10.1016/0006-8993(94)90891-5; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gao Y, 2003, J NEUROSCI, V23, P11770; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Hu P, 2003, J NEUROSCI, V23, P10559; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ibanez CF, 2007, NEURON, V54, P673, DOI 10.1016/j.neuron.2007.05.023; Jin Y, 2000, NEUROREHAB NEURAL RE, V14, P311, DOI 10.1177/154596830001400407; KODA M, EUROPEAN SPINE J; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lee SE, 1998, BRAIN RES, V796, P99, DOI 10.1016/S0006-8993(98)00335-7; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; Li L, 2006, NEUROTOX RES, V9, P269, DOI 10.1007/BF03033317; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Liu Y, 1999, J NEUROSCI, V19, P4370; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MCQUARRIE IG, 1978, BRAIN RES, V141, P21, DOI 10.1016/0006-8993(78)90614-5; Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Obata K, 2003, J NEUROSCI, V23, P4117, DOI 10.1523/jneurosci.23-10-04117.2003; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; Puigdellivol-Sanchez A, 2002, J NEUROSCI METH, V115, P115, DOI 10.1016/S0165-0270(01)00532-5; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer LM, 2007, J NEUROSCI, V27, P5812, DOI 10.1523/JNEUROSCI.0491-07.2007; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1987, BRAIN RES, V411, P406, DOI 10.1016/0006-8993(87)91096-1; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; SCHREYER DJ, 1991, J NEUROSCI, V11, P3738; SEBERT ME, 1993, J NEUROSCI RES, V36, P357, DOI 10.1002/jnr.490360402; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tomita K, 2007, GLIA, V55, P1199, DOI 10.1002/glia.20533; Tonra JR, 1998, J NEUROSCI, V18, P4374; von Bartheld CS, 2004, J NEUROBIOL, V58, P295, DOI 10.1002/neu.10315; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zhang SH, 1999, J NEUROSCI METH, V89, P69, DOI 10.1016/S0165-0270(99)00038-2; Zhou XF, 2005, NEUROSCIENCE, V132, P591, DOI 10.1016/j.neuroscience.2004.12.034; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x; Zhou XF, 1996, J NEUROSCI, V16, P2901; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220	78	79	84	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1707	10.1371/journal.pone.0001707	http://dx.doi.org/10.1371/journal.pone.0001707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320028	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600003
J	Van der Velden, J; Zheng, Y; Patullo, BW; Macmillan, DL				Van der Velden, Joanne; Zheng, Ying; Patullo, Blair W.; Macmillan, David L.			Crayfish Recognize the Faces of Fight Opponents	PLOS ONE			English	Article								The capacity to associate stimuli underlies many cognitive abilities, including recognition, in humans and other animals. Vertebrates process different categories of information separately and then reassemble the distilled information for unique identification, storage and recall. Invertebrates have fewer neural networks and fewer neural processing options so study of their behavior may reveal underlying mechanisms still not fully understood for any animal. Some invertebrates form complex social colonies and are capable of visual memory-bees and wasps, for example. This ability would not be predicted in species that interact in random pairs without strong social cohesion; for example, crayfish. They have chemical memory but the extent to which they remember visual features is unknown. Here we demonstrate that the crayfish Cherax destructor is capable of visual recognition of individuals. The simplicity of their interactions allowed us to examine the behavior and some characteristics of the visual features involved. We showed that facial features are learned during face-to-face fights, that highly variable cues are used, that the type of variability is important, and that the learning is context-dependent. We also tested whether it is possible to engineer false identifications and for animals to distinguish between twin opponents.	[Van der Velden, Joanne; Zheng, Ying; Patullo, Blair W.; Macmillan, David L.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia	University of Melbourne	Van der Velden, J (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	b.patullo@zoology.unimelb.edu.au			Australian Research Council	Australian Research Council(Australian Research Council)	Funding support was from the Australian Research Council discovery project scheme to D.L.M.	Atema Jelle, 1995, P313, DOI 10.1016/B978-012247570-2/50035-9; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; Basil J, 2000, ETHOLOGY, V106, P247, DOI 10.1046/j.1439-0310.2000.00524.x; BERRILL M, 1975, B MAR SCI, V25, P515; BOVBJERG RV, 1953, PHYSIOL ZOOL, V26, P173, DOI 10.1086/physzool.26.2.30154514; BREITHAUPT T, 1993, BIOL BULL, V185, P318, DOI 10.1086/BBLv185n2p318; Breithaupt T, 2002, J EXP BIOL, V205, P1221; BRUSKI CA, 1987, BEHAVIOUR, V103, P83, DOI 10.1163/156853987X00288; CALDWELL RL, 1985, ANIM BEHAV, V33, P101, DOI 10.1016/S0003-3472(85)80123-8; Chiao CC, 2000, BRAIN BEHAV EVOLUT, V56, P107, DOI 10.1159/000006681; COURCHESNE E, 1971, Z VERGL PHYSIOL, V74, P32; Crook R, 2004, MAR FRESHW BEHAV PHY, V37, P271, DOI 10.1080/10236240400016595; Daws AG, 2002, MAR FRESHW BEHAV PHY, V35, P139, DOI 10.1080/1023624021000014725; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; Diaz ER, 2004, BIOL BULL-US, V206, P134, DOI 10.2307/1543637; DUNHAM DW, 1978, MAR BEHAV PHYSIOL, V5, P137, DOI 10.1080/10236247809378529; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Fisher J., 1954, P71; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gherardi F, 2005, ETHOLOGY, V111, P271, DOI 10.1111/j.1439-0310.2004.01060.x; Gherardi F, 2004, BEHAV ECOL SOCIOBIOL, V55, P524, DOI 10.1007/s00265-003-0734-9; Gherardi F, 2003, CAN J ZOOL, V81, P1269, DOI 10.1139/Z03-107; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; HAZLETT BA, 1972, ANIM BEHAV, V20, P101, DOI 10.1016/S0003-3472(72)80178-7; HAZLETT BA, 1969, NATURE, V222, P268, DOI 10.1038/222268a0; Hazlett BA, 2007, MAR FRESHW BEHAV PHY, V40, P257, DOI 10.1080/10236240701562412; HEMSWORTH R, 2007, BIOL B IN PRESS; Herath P, 2001, HUM BRAIN MAPP, V12, P110, DOI 10.1002/1097-0193(200102)12:2<110::AID-HBM1008>3.0.CO;2-0; HERRNKIN.W, 1969, SCIENCE, V164, P1425, DOI 10.1126/science.164.3886.1425; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Horridge A, 2005, PHYSIOL ENTOMOL, V30, P2, DOI 10.1111/j.0307-6962.2005.00425.x; JOHNSON VR, 1977, ANIM BEHAV, V25, P418, DOI 10.1016/0003-3472(77)90017-3; Kaczer L, 2007, NEUROBIOL LEARN MEM, V87, P140, DOI 10.1016/j.nlm.2006.08.002; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Kelly S, 1999, MAR FRESHWATER RES, V50, P409, DOI 10.1071/MF98126; KENNEDY D, 1961, J GEN PHYSIOL, V44, P1089, DOI 10.1085/jgp.44.6.1089; Kilner R, 1998, ANIM BEHAV, V56, P705, DOI 10.1006/anbe.1998.0785; Lake P.S., 1986, 87 AUSTR WAT RES COU; Marshall NJ, 1996, J COMP PHYSIOL A, V179, P473; Muller CA, 2007, P ROY SOC B-BIOL SCI, V274, P959, DOI 10.1098/rspb.2006.0222; Pavey CR, 1996, J ZOOL, V238, P445, DOI 10.1111/j.1469-7998.1996.tb05405.x; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Rufino MM, 2001, J CRUSTACEAN BIOL, V21, P388, DOI 10.1651/0278-0372(2001)021[0388:BIRILD]2.0.CO;2; Schneider RAZ, 2001, BEHAVIOUR, V138, P137, DOI 10.1163/15685390151074348; SEIBT U, 1972, NATURWISSENSCHAFTEN, V59, P40, DOI 10.1007/BF00594633; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sokal RR, 1995, BIOMETRY; SPANIER E, 1992, J EXP MAR BIOL ECOL, V164, P103, DOI 10.1016/0022-0981(92)90139-2; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; VANNINI M, 1981, MAR BEHAV PHYSIOL, V8, P13, DOI 10.1080/10236248109386999; Ward J, 2004, MAR FRESHW BEHAV PHY, V37, P35, DOI 10.1080/1023624042000199908; WINSTON ML, 1978, ANIM BEHAV, V26, P184, DOI 10.1016/0003-3472(78)90018-0; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; ZIMMERFAUST RK, 1987, J EXP MAR BIOL ECOL, V105, P57, DOI 10.1016/S0022-0981(87)80029-1	60	54	54	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1695	10.1371/journal.pone.0001695	http://dx.doi.org/10.1371/journal.pone.0001695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18305823	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500039
J	Fujishima, K; Sugahara, J; Tomita, M; Kanai, A				Fujishima, Kosuke; Sugahara, Junichi; Tomita, Masaru; Kanai, Akio			Sequence Evidence in the Archaeal Genomes that tRNAs Emerged Through the Combination of Ancestral Genes as 5 ' and 3 ' tRNA Halves	PLOS ONE			English	Article								The discovery of separate 5' and 3' halves of transfer RNA (tRNA) molecules-so-called split tRNA-in the archaeal parasite Nanoarchaeum equitans made us wonder whether ancestral tRNA was encoded on 1 or 2 genes. We performed a comprehensive phylogenetic analysis of tRNAs in 45 archaeal species to explore the relationship between the three types of tRNAs (nonintronic, intronic and split). We classified 1953 mature tRNA sequences into 22 clusters. All split tRNAs have shown phylogenetic relationships with other tRNAs possessing the same anticodon. We also mimicked split tRNA by artificially separating the tRNA sequences of 7 primitive archaeal species at the anticodon and analyzed the sequence similarity and diversity of the 5' and 3' tRNA halves. Network analysis revealed specific characteristics of and topological differences between the 5' and 3' tRNA halves: the 5' half sequences were categorized into 6 distinct groups with asequence similarity of >80%, while the 39 half sequences were categorized into 9 groups with a higher sequence similarity of >88%, suggesting different evolutionary backgrounds of the 2 halves. Furthermore, the combinations of 5' and 3' halves corresponded with the variation of amino acids in the codon table. We found not only universally conserved combinations of 5'-3' tRNA halves in tRNA(iMet), tRNA(Thr), tRNA(Ile), tRNA(Gly), tRNA(Gln), tRNA(Glu), tRNA(Asp), tRNA(Lys), tRNA(Arg) and tRNA(Leu) but also phylum-specific combinations in tRNA(Pro), tRNA(Ala), and tRNA(Trp). Our results support the idea that tRNA emerged through the combination of separate genes and explain the sequence diversity that arose during archaeal tRNA evolution.	[Fujishima, Kosuke; Sugahara, Junichi; Tomita, Masaru; Kanai, Akio] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Fujishima, Kosuke; Sugahara, Junichi; Tomita, Masaru; Kanai, Akio] Keio Univ, Grad Sch Media & Governance, Fujisawa, Kanagawa, Japan; [Tomita, Masaru; Kanai, Akio] Keio Univ, Dept Env & Informat, Fujisawa, Kanagawa, Japan	Keio University; Keio University; Keio University	Fujishima, K (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata, Japan.	akio@sfc.keio.ac.jp	Kanai, Akio/C-4921-2014	Kanai, Akio/0000-0002-6362-2419; Fujishima, Kosuke/0000-0002-8844-812X	21st Century Center of Excellence (COE) Program, Keio University [Grant-in-Aid]; Yamagata Prefectural Government and Tsuruoka City, Japan	21st Century Center of Excellence (COE) Program, Keio University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamagata Prefectural Government and Tsuruoka City, Japan	This research was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas; a Grant-in-Aid for the 21st Century Center of Excellence (COE) Program, entitled Understanding and Control of Life's Function via Systems Biology (Keio University); research funds from the Yamagata Prefectural Government and Tsuruoka City, Japan; and a grant from Keio University.	Auchtung TA, 2006, APPL ENVIRON MICROB, V72, P5077, DOI 10.1128/AEM.00052-06; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Belfort M, 1997, CELL, V89, P1003, DOI 10.1016/S0092-8674(00)80287-1; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; Chiang CC, 1997, MOL CELL BIOL, V17, P4526, DOI 10.1128/MCB.17.8.4526; Di Giulio M, 1999, J THEOR BIOL, V197, P403, DOI 10.1006/jtbi.1998.0882; Di Giulio M, 2006, J THEOR BIOL, V240, P343, DOI 10.1016/j.jtbi.2005.09.023; Di Giulio M, 2006, J THEOR BIOL, V242, P257, DOI 10.1016/j.jtbi.2006.01.034; Diener JL, 1998, MOL CELL, V1, P883, DOI 10.1016/S1097-2765(00)80087-8; DIGIULIO M, 1992, J THEOR BIOL, V159, P199; HIPPS D, 1995, P NATL ACAD SCI USA, V92, P5550, DOI 10.1073/pnas.92.12.5550; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KACAR Y, 1995, GENE, V156, P129, DOI 10.1016/0378-1119(95)00079-L; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Marck C, 2003, RNA, V9, P1516, DOI 10.1261/rna.5132503; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Nagaswamy U, 2003, ORIGINS LIFE EVOL B, V33, P199, DOI 10.1023/A:1024658727570; OHSHIMA K, 1993, P NATL ACAD SCI USA, V90, P6260, DOI 10.1073/pnas.90.13.6260; Pavlicek A, 2006, TRENDS GENET, V22, P69, DOI 10.1016/j.tig.2005.11.005; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; Randau L, 2005, FEBS LETT, V579, P2945, DOI 10.1016/j.febslet.2005.04.051; Randau L, 2005, NATURE, V433, P537, DOI 10.1038/nature03233; Schmitz J, 2004, GENOME RES, V14, P1911, DOI 10.1101/gr.2720104; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soma A, 2007, SCIENCE, V318, P450, DOI 10.1126/science.1145718; Sugahara Junichi, 2006, In Silico Biology, V6, P411; Sugahara J, 2007, RNA, V13, P671, DOI 10.1261/rna.309507; Tang TH, 2002, NUCLEIC ACIDS RES, V30, P921, DOI 10.1093/nar/30.4.921; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P15418, DOI 10.1073/pnas.0506750102; Wang SY, 1997, GENE, V196, P105, DOI 10.1016/S0378-1119(97)00214-X; Watanabe Y, 2002, FEBS LETT, V510, P27, DOI 10.1016/S0014-5793(01)03219-7; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei FP, 2006, MOL PHYLOGENET EVOL, V38, P1, DOI 10.1016/j.ympev.2005.09.017; Weiner AM, 1999, BIOL BULL, V196, P327, DOI 10.2307/1542962; Wilm A, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-19; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011	42	33	36	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1622	10.1371/journal.pone.0001622	http://dx.doi.org/10.1371/journal.pone.0001622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286179	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400015
J	Ho, SYW; Saarma, U; Barnett, R; Haile, J; Shapiro, B				Ho, Simon Y. W.; Saarma, Urmas; Barnett, Ross; Haile, James; Shapiro, Beth			The Effect of Inappropriate Calibration: Three Case Studies in Molecular Ecology	PLOS ONE			English	Article							BEARS URSUS-ARCTOS; ANCIENT DNA; BROWN BEAR; BOWHEAD WHALES; AVIAN DIVERSIFICATION; TIME DEPENDENCY; MITOCHONDRIAL GENOME; BAYESIAN-ESTIMATION; SUBSTITUTION RATES; DIVERGENCE TIMES	Time-scales estimated from sequence data play an important role in molecular ecology. They can be used to draw correlations between evolutionary and palaeoclimatic events, to measure the tempo of speciation, and to study the demographic history of an endangered species. In all of these studies, it is paramount to have accurate estimates of time-scales and substitution rates. Molecular ecological studies typically focus on intraspecific data that have evolved on genealogical scales, but often these studies inappropriately employ deep fossil calibrations or canonical substitution rates (e. g., 1% per million years for birds and mammals) for calibrating estimates of divergence times. These approaches can yield misleading estimates of molecular time-scales, with significant impacts on subsequent evolutionary and ecological inferences. We illustrate this calibration problem using three case studies: avian speciation in the late Pleistocene, the demographic history of bowhead whales, and the Pleistocene biogeography of brown bears. For each data set, we compare the date estimates that are obtained using internal and external calibration points. In all three cases, the conclusions are significantly altered by the application of revised, internally-calibrated substitution rates. Collectively, the results emphasise the importance of judicious selection of calibrations for analyses of recent evolutionary events.	[Ho, Simon Y. W.; Haile, James; Shapiro, Beth] Univ Oxford, Dept Zool, Oxford, England; [Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia; [Saarma, Urmas] Estonian Biocentre, Tartu, Estonia; [Barnett, Ross] Univ York, Dept Biol, York, N Yorkshire, England	University of Oxford; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of York - UK	Ho, SYW (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	drsimonho@gmail.com	Saarma, Urmas/J-6448-2015; Ho, Simon YW/A-8417-2008; Saarma, Urmas/AAC-9813-2019; Barnett, Ross/G-1920-2011	Saarma, Urmas/0000-0002-3222-571X; Ho, Simon YW/0000-0002-0361-2307; Saarma, Urmas/0000-0002-3222-571X; Barnett, Ross/0000-0003-4023-0284	Leverhulme Trust; Estonian Science Foundation [7040]; Arts and Humanities Research Board; Royal Society	Leverhulme Trust(Leverhulme Trust); Estonian Science Foundation; Arts and Humanities Research Board(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Royal Society(Royal Society of London)	S.Y.W.H. was supported by the Leverhulme Trust. U.S. was supported by the Estonian Science Foundation (grant 7040). J.H. was supported by the Arts and Humanities Research Board. B.S. was supported by the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Barnes LG, 1984, GRAY WHALE ESCHRICHT, P3; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Borge T, 2007, MOL ECOL, V16, P2223, DOI 10.1111/j.1365-294X.2007.03287.x; Buckley-Beason VA, 2006, CURR BIOL, V16, P2371, DOI 10.1016/j.cub.2006.08.066; Charlesworth B, 2005, GENET RES, V86, P149, DOI 10.1017/S0016672305007743; Cicero C, 2006, EVOLUTION, V60, P413; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DRUMMOND AJ, 2007, BEAST; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heide-Jorgensen MP, 2006, MAR MAMMAL SCI, V22, P34, DOI 10.1111/j.1748-7692.2006.00004.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ho SYW, 2007, BIOL LETTERS, V3, P702, DOI 10.1098/rsbl.2007.0377; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2007, MOL BIOL EVOL, V24, P1416, DOI 10.1093/molbev/msm062; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Hofreiter M, 2004, CURR BIOL, V14, P40, DOI 10.1016/j.cub.2003.12.035; Hofreiter M, 2002, MOL BIOL EVOL, V19, P1244, DOI 10.1093/oxfordjournals.molbev.a004185; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Johnson NK, 2004, EVOLUTION, V58, P1122; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Klicka J, 1999, P ROY SOC B-BIOL SCI, V266, P695, DOI 10.1098/rspb.1999.0691; Kurten B., 1980, PLEISTOCENE MAMMALS; KURTEN B, 1976, CAVE BEAR STORY; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Mao L, 2006, EXP GERONTOL, V41, P11, DOI 10.1016/j.exger.2005.09.012; Matheus P, 2004, SCIENCE, V306, P1150, DOI 10.1126/science.1101495; Matheus PE, 1995, QUATERNARY RES, V44, P447, DOI 10.1006/qres.1995.1090; Matsuhashi T, 1999, MOL BIOL EVOL, V16, P676, DOI 10.1093/oxfordjournals.molbev.a026150; MCLEOD SA, 1993, BOWHEAD WHALE, P45; Moore Sue E., 1993, Society for Marine Mammalogy Special Publication, V2, P313; Nielsen R, 1999, GENETICS, V153, P497; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Randi E, 1996, MOL PHYLOGENET EVOL, V6, P214, DOI 10.1006/mpev.1996.0072; Ritchie PA, 2004, MOL BIOL EVOL, V21, P240, DOI 10.1093/molbev/msh012; Rooney AP, 2001, EVOLUTION, V55, P1678; Ross W. Gillies, 1993, Society for Marine Mammalogy Special Publication, V2, P511; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; SHIELDS GF, 1987, J MOL EVOL, V24, P212, DOI 10.1007/BF02111234; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; VALDIOSERA CE, 2007, MOL ECOL IN PRESS; Waits LP, 1998, CONSERV BIOL, V12, P408, DOI 10.1046/j.1523-1739.1998.96351.x; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199; Woodhams M, 2006, MOL BIOL EVOL, V23, P2271, DOI 10.1093/molbev/msl107; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Zink RM, 2006, EVOLUTION, V60, P411; Zink RM, 2004, PHILOS T ROY SOC B, V359, P215, DOI 10.1098/rstb.2003.1392	78	184	186	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1615	10.1371/journal.pone.0001615	http://dx.doi.org/10.1371/journal.pone.0001615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286172	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586400008
J	Picardeau, M; Bulach, DM; Bouchier, C; Zuerner, RL; Zidane, N; Wilson, PJ; Creno, S; Kuczek, ES; Bommezzadri, S; Davis, JC; McGrath, A; Johnson, MJ; Boursaux-Eude, C; Seemann, T; Rouy, Z; Coppel, RL; Rood, JI; Lajus, A; Davies, JK; Medigue, C; Adler, B				Picardeau, Mathieu; Bulach, Dieter M.; Bouchier, Christiane; Zuerner, Richard L.; Zidane, Nora; Wilson, Peter J.; Creno, Sophie; Kuczek, Elizabeth S.; Bommezzadri, Simona; Davis, John C.; McGrath, Annette; Johnson, Matthew J.; Boursaux-Eude, Caroline; Seemann, Torsten; Rouy, Zoe; Coppel, Ross L.; Rood, Julian I.; Lajus, Aurelie; Davies, John K.; Medigue, Claudine; Adler, Ben			Genome Sequence of the Saprophyte Leptospira biflexa Provides Insights into the Evolution of Leptospira and the Pathogenesis of Leptospirosis	PLOS ONE			English	Article								Leptospira biflexa is a free-living saprophytic spirochete present in aquatic environments. We determined the genome sequence of L. biflexa, making it the first saprophytic Leptospira to be sequenced. The L. biflexa genome has 3,590 protein-coding genes distributed across three circular replicons: the major 3,604 chromosome, a smaller 278-kb replicon that also carries essential genes, and a third 74-kb replicon. Comparative sequence analysis provides evidence that L. biflexa is an excellent model for the study of Leptospira evolution; we conclude that 2052 genes (61%) represent a progenitor genome that existed before divergence of pathogenic and saprophytic Leptospira species. Comparisons of the L. biflexa genome with two pathogenic Leptospira species reveal several major findings. Nearly one-third of the L. biflexa genes are absent in pathogenic Leptospira. We suggest that once incorporated into the L. biflexa genome, laterally transferred DNA undergoes minimal rearrangement due to physical restrictions imposed by high gene density and limited presence of transposable elements. In contrast, the genomes of pathogenic Leptospira species undergo frequent rearrangements, often involving recombination between insertion sequences. Identification of genes common to the two pathogenic species, L. borgpetersenii and L. interrogans, but absent in L. biflexa, is consistent with a role for these genes in pathogenesis. Differences in environmental sensing capacities of L. biflexa, L. borgpetersenii, and L. interrogans suggest a model which postulates that loss of signal transduction functions in L. borgpetersenii has impaired its survival outside a mammalian host, whereas L. interrogans has retained environmental sensory functions that facilitate disease transmission through water.	[Picardeau, Mathieu; Bommezzadri, Simona] Inst Pasteur, Unite Biol Spirochetes, Paris, France; [Bulach, Dieter M.; Seemann, Torsten; Coppel, Ross L.; Rood, Julian I.; Davies, John K.; Adler, Ben] Monash Univ, Victorian Bioinformat Consort, Clayton, Vic, Australia; [Bulach, Dieter M.; Coppel, Ross L.; Rood, Julian I.; Davies, John K.; Adler, Ben] Monash Univ, Dept Microbiol, Australian Res Council, Ctr Excellence Struct & Funct Microb Genom, Clayton, Vic, Australia; [Bulach, Dieter M.; Rood, Julian I.; Davies, John K.; Adler, Ben] Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic, Australia; [Bouchier, Christiane; Zidane, Nora; Creno, Sophie] Inst Pasteur, Plate forme Genom, Paris, France; [Zuerner, Richard L.] USDA, NADC, ARS, Bacter Dis Livestock Res Unit, Ames, IA USA; [Wilson, Peter J.; Kuczek, Elizabeth S.; Davis, John C.; McGrath, Annette; Johnson, Matthew J.] Univ Queensland, Gehrmann Lab, Australian Genome Res Facility, St Lucia, Qld, Australia; [Boursaux-Eude, Caroline] Inst Pasteur, Plate forme Integrat Analyse genom, Paris, France; [Rouy, Zoe; Lajus, Aurelie; Medigue, Claudine] Inst Genom, Lab Genom Comparat, Direct des Sci du Vivant, CEA, Evry, France; [Medigue, Claudine] CNRS, UMR8030, Evry, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Monash University; Monash University; Monash University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; United States Department of Agriculture (USDA); University of Queensland; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, Paris, France.	Ben.Adler@med.monash.edu.au	McGrath, Annette/T-7991-2018; Bulach, Dieter M/D-5793-2011; Seemann, Torsten/B-2318-2010; Coppel, Ross L/A-6626-2008; Zuerner, Richard/AAG-7645-2021; Rood, Julian I/A-4858-2008	McGrath, Annette/0000-0002-1765-7039; Bulach, Dieter M/0000-0001-9823-6078; Seemann, Torsten/0000-0001-6046-610X; Coppel, Ross L/0000-0002-4476-9124; Rood, Julian I/0000-0003-2126-7209; Kuczek, Elizabeth/0000-0002-5412-5509	National Health and Medical Research Council, Australia; Australian Research Council; U.S. Department of Agriculture; Institut Pasteur, Paris, France; French Ministry of Research ANR Jeunes Chercheurs [05-JCJC-0105-01]; Consortium National de Recherche en Genomique [RNG-20040057]; ACI IMPBio 2004 (MicroScope project)	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Institut Pasteur, Paris, France; French Ministry of Research ANR Jeunes Chercheurs(French National Research Agency (ANR)Ministry of Research, France); Consortium National de Recherche en Genomique(General Electric); ACI IMPBio 2004 (MicroScope project)	This work was supported by the following: National Health and Medical Research Council, Australia; Australian Research Council; U.S. Department of Agriculture; Institut Pasteur, Paris, France; French Ministry of Research ANR Jeunes Chercheurs (no. 05-JCJC-0105-01); Consortium National de Recherche en Genomique (no. RNG-20040057); ACI IMPBio 2004 (MicroScope project). Funders had no role in the planning, performance or analysis of the work.	Babudieri B., 1961, STUDIO SEROLOGICO GR, P408; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Bourhy P, 2005, J BACTERIOL, V187, P3931, DOI 10.1128/JB.187.12.3931-3940.2005; Bourhy P, 2007, INFECT IMMUN, V75, P677, DOI 10.1128/IAI.01067-06; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003; DELREAL G, 1989, INFECT IMMUN, V57, P2588, DOI 10.1128/IAI.57.8.2588-2590.1989; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fuchsman CA, 2006, APPL ENVIRON MICROB, V72, P6841, DOI 10.1128/AEM.00429-06; Glockner G, 2004, NUCLEIC ACIDS RES, V32, P6038, DOI 10.1093/nar/gkh953; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Kickstein E, 2007, MICROBIOL-SGM, V153, P2259, DOI 10.1099/mic.0.2007/005256-0; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Louvel H, 2006, J BACTERIOL, V188, P7893, DOI 10.1128/JB.00711-06; LOUVEL H, 2007, CURRENT PROTOCOLS MI; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; PASTER BJ, 1991, J BACTERIOL, V173, P6101, DOI 10.1128/JB.173.19.6101-6109.1991; RAMADASS P, 1992, INT J SYST BACTERIOL, V42, P215, DOI 10.1099/00207713-42-2-215; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000; SAINTGIRONS I, 1990, RES MICROBIOL, V141, P1131, DOI 10.1016/0923-2508(90)90086-6; SEGERS RPAM, 1992, INFECT IMMUN, V60, P1707, DOI 10.1128/IAI.60.4.1707-1710.1992; SEGERS RPAM, 1990, INFECT IMMUN, V58, P2177, DOI 10.1128/IAI.58.7.2177-2185.1990; Stamm LA, 2004, MICROBES INFECT, V6, P1418, DOI 10.1016/j.micinf.2004.10.003; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; Trueba G, 2004, INT MICROBIOL, V7, P35; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; ZUERNER RL, 1993, J BACTERIOL, V175, P5445, DOI 10.1128/JB.175.17.5445-5451.1993	38	221	639	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1607	10.1371/journal.pone.0001607	http://dx.doi.org/10.1371/journal.pone.0001607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270594	Green Submitted, Green Published, gold			2022-12-27	WOS:000260535900041
J	Warden, CD; Kim, SH; Yi, SV				Warden, Charles D.; Kim, Seong-Ho; Yi, Soojin V.			Predicted Functional RNAs within Coding Regions Constrain Evolutionary Rates of Yeast Proteins	PLOS ONE			English	Article							NONCODING RNAS; SECONDARY STRUCTURES; SEQUENCE; IDENTIFICATION; DIVERGENCE; EXPRESSION; SELECTION; ELEMENTS; PACKAGE	Functional RNAs (fRNAs) are being recognized as an important regulatory component in biological processes. Interestingly, recent computational studies suggest that the number and biological significance of functional RNAs within coding regions (coding fRNAs) may have been underestimated. We hypothesized that such coding fRNAs will impose additional constraint on sequence evolution because the DNA primary sequence has to simultaneously code for functional RNA secondary structures on the messenger RNA in addition to the amino acid codons for the protein sequence. To test this prediction, we first utilized computational methods to predict conserved fRNA secondary structures within multiple species alignments of Saccharomyces sensu strico genomes. We predict that as much as 5% of the genes in the yeast genome contain at least one functional RNA secondary structure within their protein-coding region. We then analyzed the impact of coding fRNAs on the evolutionary rate of protein-coding genes because a decrease in evolutionary rate implies constraint due to biological functionality. We found that our predicted coding fRNAs have a significant influence on evolutionary rates (especially at synonymous sites), independent of other functional measures. Thus, coding fRNA may play a role on sequence evolution. Given that coding regions of humans and flies contain many more predicted coding fRNAs than yeast, the impact of coding fRNAs on sequence evolution may be substantial in genomes of higher eukaryotes.	[Warden, Charles D.; Yi, Soojin V.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kim, Seong-Ho] Indiana Univ, Sch Med, Div Biostat, Indianapolis, IN USA	Princeton University; Indiana University System; Indiana University-Purdue University Indianapolis	Warden, CD (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	soojinyi@gatech.edu		Warden, Charles/0000-0002-1827-4486				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Griffiths-Jones S, 2007, ANNU REV GENOM HUM G, V8, P279, DOI 10.1146/annurev.genom.8.080706.092419; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; Kim SH, 2007, GENETICA, V131, P151, DOI 10.1007/s10709-006-9125-2; Kim SH, 2006, MOL BIOL EVOL, V23, P1068, DOI 10.1093/molbev/msj115; Lin YS, 2007, MOL BIOL EVOL, V24, P1005, DOI 10.1093/molbev/msm019; Marais G, 2001, J MOL EVOL, V52, P275, DOI 10.1007/s002390010155; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; McCutcheon JP, 2003, NUCLEIC ACIDS RES, V31, P4119, DOI 10.1093/nar/gkg438; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Missal K, 2005, BIOINFORMATICS, V21, P77, DOI 10.1093/bioinformatics/bti1113; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Ouellet DL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/69616; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; R Development Core Team, 2006, R LANG ENV STAT COMP; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Steigele S, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-25; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Weile C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-244; Whittaker J, 1996, GRAPHICAL MODELS APP; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang Z, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S14	49	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1559	10.1371/journal.pone.0001559	http://dx.doi.org/10.1371/journal.pone.0001559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270559	gold, Green Published, Green Submitted			2022-12-27	WOS:000260535900004
J	Goto, E; Mito-Yoshida, M; Uematsu, M; Aoki, M; Matsuki, Y; Ohmura-Hoshino, M; Hotta, H; Miyagishi, M; Ishido, S				Goto, Eiji; Mito-Yoshida, Mari; Uematsu, Mika; Aoki, Masami; Matsuki, Yohei; Ohmura-Hoshino, Mari; Hotta, Hak; Miyagishi, Makoto; Ishido, Satoshi			An Excellent Monitoring System for Surface Ubiquitination-Induced Internalization in Mammals	PLOS ONE			English	Article								Background. At present, it is difficult to visualize the internalization of surface receptors induced by ubiquitination that is taken place at the plasma membrane in mammals. This problem makes it difficult to reveal molecular basis for ubiquitination-mediated internalization in mammals. Methodology/Principle Findings. In order to overcome it, we have generated T-REx-c-MIR, a novel mammalian Tet-on B cell line using a constitutively active E3 ubiquitin ligase, c-MIR, and its artificial target molecule. By applying the surface biotinylation method to T-REx-c-MIR, we succeeded to monitor the fate of surface target molecules after initiation of ubiquitination process by doxycycline (Dox)-induced c-MIR expression. Target molecules that preexisted at the plasma membrane before induction of c-MIR expression were oligo-ubiquitinated and degraded by Dox-induced c-MIR expression. Dox-induced c-MIR expression initiated rapid internalization of surface target molecules, and blockage of the internalization induced the accumulation of the surface target molecules that were newly ubiquitinated by c-MIR. Inhibition of the surface ubiquitination by down-regulating ubiquitin conjugating enzyme E2 impaired the internalization of target molecules. Finally, a complex of c-MIR and target molecule was detected at the plasma membrane. Conclusions/Significances. These results demonstrate that in T-REx-c-MIR, surface target molecule is ubiquitinated at the plasma membrane and followed by being internalized from the plasma membrane. Thus, T-REx-c-MIR is a useful experimental tool to analyze how surface ubiquitination regulates internalization in mammals.	[Goto, Eiji; Mito-Yoshida, Mari; Uematsu, Mika; Aoki, Masami; Matsuki, Yohei; Ohmura-Hoshino, Mari; Ishido, Satoshi] RIKEN, Res Ctr Allergy & Immunol, Lab Infect Immun, Yokohama, Kanagawa, Japan; [Hotta, Hak] Kobe Univ, Grad Sch Med, Dept Pathol & Microbiol, Kobe, Hyogo, Japan; [Miyagishi, Makoto] Univ Tokyo, Sch Med, Century 21 COE Prog, Tokyo, Japan	RIKEN; Kobe University; University of Tokyo	Ishido, S (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Infect Immun, Yokohama, Kanagawa, Japan.	ishido@rcai.riken.jp	Miyagishi, Makoto/L-8174-2016	Miyagishi, Makoto/0000-0001-7654-3616	Ministry of Education, Science, Sports, and Culture (MEXT) of Japan [Grant-in-Aid for Scientific Research]; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Science, Sports, and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture (MEXT) of Japan and by the Japan Society for the Promotion of Science (JSPS).	BAKER A, 1995, LEUKEMIA RES, V19, P309, DOI 10.1016/0145-2126(94)00128-W; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Matsumoto Sahohime, 2007, Methods Mol Biol, V360, P131; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; RIDGE SA, 1990, P NATL ACAD SCI USA, V87, P1377, DOI 10.1073/pnas.87.4.1377; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	29	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1490	10.1371/journal.pone.0001490	http://dx.doi.org/10.1371/journal.pone.0001490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231577	Green Submitted, gold, Green Published			2022-12-27	WOS:000260504200003
J	Le Mee, G; Ezzeddine, N; Capri, M; Ait-Ahmed, O				Le Mee, Gwenn; Ezzeddine, Nader; Capri, Michele; Ait-Ahmed, Ounissa			Repeat Length and RNA Expression Level Are Not Primary Determinants in CUG Expansion Toxicity in Drosophila Models	PLOS ONE			English	Article								Evidence for an RNA gain-of-function toxicity has now been provided for an increasing number of human pathologies. Myotonic dystrophies (DM) belong to a class of RNA-dominant diseases that result from RNA repeat expansion toxicity. Specifically, DM of type 1 (DM1), is caused by an expansion of CUG repeats in the 39UTR of the DMPK protein kinase mRNA, while DM of type 2 (DM2) is linked to an expansion of CCUG repeats in an intron of the ZNF9 transcript (ZNF9 encodes a zinc finger protein). In both pathologies the mutant RNA forms nuclear foci. The mechanisms that underlie the RNA pathogenicity seem to be rather complex and not yet completely understood. Here, we describe Drosophila models that might help unravelling the molecular mechanisms of DM1-associated CUG expansion toxicity. We generated transgenic flies that express inducible repeats of different type (CUG or CAG) and length (16, 240, 480 repeats) and then analyzed transgene localization, RNA expression and toxicity as assessed by induced lethality and eye neurodegeneration. The only line that expressed a toxic RNA has a (CTG) 240 insertion. Moreover our analysis shows that its level of expression cannot account for its toxicity. In this line, (CTG) 240.4, the expansion inserted in the first intron of CG9650, a zinc finger protein encoding gene. Interestingly, CG9650 and (CUG) 240.4 expansion RNAs were found in the same nuclear foci. In conclusion, we suggest that the insertion context is the primary determinant for expansion toxicity in Drosophila models. This finding should contribute to the still open debate on the role of the expansions per se in Drosophila and in human pathogenesis of RNA-dominant diseases.	[Le Mee, Gwenn; Ezzeddine, Nader; Capri, Michele; Ait-Ahmed, Ounissa] CNRS, Inst Genet Humaine, Unite Propre Rech 1142, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Ait-Ahmed, O (corresponding author), CNRS, Inst Genet Humaine, Unite Propre Rech 1142, Montpellier, France.	Ounissa.Ait-ahmed@igh.cnrs.fr			CNRS; AFM; MRT;  [French national PhD programme];  [AFM fellowship]	CNRS(Centre National de la Recherche Scientifique (CNRS)); AFM(Association Francaise contre les Myopathies); MRT; ; 	This work was supported by the CNRS (Centre National de la Recherche Scientifique) and an AFM (Association Francaise contre les Myopathies) grant to OA. GLM was supported by a 3 year fellowship of the French national PhD programme (MRT) and a 1 year AFM fellowship. NE was supported by a 2 year AFM fellowship.	Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; Begemann G, 1997, DEVELOPMENT, V124, P4321; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROOK, 1992, CELL, V69, P385; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Capri M, 1997, MECH DEVELOP, V68, P91, DOI 10.1016/S0925-4773(97)00130-5; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Delaunay J, 2004, NUCLEIC ACIDS RES, V32, P3070, DOI 10.1093/nar/gkh627; Ezzeddine N, 2002, P NATL ACAD SCI USA, V99, P257, DOI 10.1073/pnas.012555499; FOUTS D, 1988, GENE, V63, P261, DOI 10.1016/0378-1119(88)90530-6; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P3866, DOI 10.1093/nar/gki698; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; McGovern VL, 2003, MECH DEVELOP, V120, P1193, DOI 10.1016/s0925-4773(03)00159-X; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; O'Kane CJ, 2003, SEMIN CELL DEV BIOL, V14, P3, DOI 10.1016/S1084-9521(02)00162-3; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum L.P., 2006, ANN REV NEUROSCI; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; SHAW DJ, 1989, BRIT MED BULL, V45, P745, DOI 10.1093/oxfordjournals.bmb.a072355; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Tseng ASK, 2002, GENETICS, V162, P229; VAESSIN H, 1994, DEVELOPMENT, V120, P935; Wansink DG, 2003, CYTOGENET GENOME RES, V100, P230, DOI 10.1159/000072859; Worth PF, 2000, NAT GENET, V24, P214, DOI 10.1038/73411; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1466	10.1371/journal.pone.0001466	http://dx.doi.org/10.1371/journal.pone.0001466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213375	Green Published, Green Submitted, gold			2022-12-27	WOS:000260503900012
J	Allhorn, M; Olin, AI; Nimmerjahn, F; Collin, M				Allhorn, Maria; Olin, Anders I.; Nimmerjahn, Falk; Collin, Mattias			Human IgG/Fc gamma R Interactions Are Modulated by Streptococcal IgG Glycan Hydrolysis	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; SERUM IGG; RHEUMATOID-ARTHRITIS; INTERACTION SITES; FC; RECEPTOR; PROTEIN; GLYCOSYLATION; PYOGENES; ENDOGLYCOSIDASE	Background. The human pathogen Streptococcus pyogenes produces an endoglycosidase, EndoS that hydrolyzes the chitobiose core of the asparagine-linked glycan on the heavy chain of human IgG. IgG-binding to Fc gamma receptors (Fc gamma R) on leukocytes triggers effector functions including phagocytosis, oxidative burst and the release of inflammatory mediators. The interactions between Fc gamma R and the Fc domain of IgG depend on the IgG glycosylation state. Methodology/Principal Findings. Here we show for the first time that EndoS hydrolyzes the heavy chain glycan of all four human IgG subclasses (IgG1-4), in purified form and in a plasma environment. An inactive form of EndoS, obtained by site-directed mutagenesis, binds IgG with high affinity, in contrast to wild type EndoS that only transiently interacts with IgG, as shown by Slot-blotting and surface plasmon resonance technology. Furthermore, EndoS hydrolysis of the IgG glycan influences the binding of IgG to immobilized soluble Fc gamma R and to an erythroleukemic cell line, K562, expressing Fc gamma RIIa. Incubation of whole blood with EndoS results in a dramatic decrease of IgG binding to activated monocytes as analyzed by flow cytometry. Moreover, the IgG bound to K562 cells dissociates when cells are treated with EndoS. Likewise, IgG bound to immobilized Fc gamma RIIa and subsequently treated with EndoS, dissociates from the receptor as analyzed by surface plasmon resonance and Western blot. Conclusions/Significance. We provide novel information about bacterial enzymatic modulation of the IgG/FccR interaction that emphasizes the importance of glycosylation for antibody effector functions. Moreover, EndoS could be used as a biochemical tool for specific IgG N-glycan hydrolysis and IgG purification/detection, or as a potential immunosuppressing agent for treatment of antibody-mediated pathological processes.	[Allhorn, Maria; Olin, Anders I.; Collin, Mattias] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Nimmerjahn, Falk] Nikolaus Fiebiger Ctr for Mol Med, Expt Immunol & Immunother, Erlangen, Germany	Lund University	Allhorn, M (corresponding author), Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden.	maria.allhorn@med.lu.se	Nimmerjahn, Falk/J-4986-2013; Collin, Mattias/C-6398-2009	Collin, Mattias/0000-0002-6166-7410; Nimmerjahn, Falk/0000-0002-5418-316X	Swedish Research Council [2005-4791, Assistant Professorship]; Foundations of Kock, Jeansson, Zoegas, Bergvall, Osterlund, Groschinsky; Swedish Society for Medical Research; Royal Physiografic Society; Medical Faculty at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Kock, Jeansson, Zoegas, Bergvall, Osterlund, Groschinsky; Swedish Society for Medical Research; Royal Physiografic Society(Royal Society of London); Medical Faculty at Lund University	This work was supported by the Swedish Research Council (projects 2005-4791), the Foundations of Kock, Jeansson, Zoegas, Bergvall, Osterlund, Groschinsky, the Swedish Society for Medical Research, the Royal Physiografic Society, and the Medical Faculty at Lund University. MC is the recipient of an Assistant Professorship from Swedish Research Council. The funders had no influence of the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Allhorn M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-3; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Collin M, 2003, INFECT IMMUN, V71, P2983, DOI 10.1128/IAI.71.6.2983-2992.2003; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DUBE R, 1990, GUT, V31, P431, DOI 10.1136/gut.31.4.431; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; FORSGREN A, 1966, J IMMUNOL, V97, P822; Holland M, 2002, CLIN EXP IMMUNOL, V129, P183, DOI 10.1046/j.1365-2249.2002.01864.x; HULETT MD, 1994, J BIOL CHEM, V269, P15287; HULETT MD, 1994, ADV IMMUNOL, V57, P1, DOI 10.1016/S0065-2776(08)60671-9; Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITTAUA R, 1990, J IMMUNOL, V144, P3183; Matsumoto A, 2000, J BIOCHEM-TOKYO, V128, P621, DOI 10.1093/oxfordjournals.jbchem.a022794; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2006, SPRINGER SEMIN IMMUN, V28, P305, DOI 10.1007/s00281-006-0052-1; PAREKH R, 1989, J AUTOIMMUN, V2, P101, DOI 10.1016/0896-8411(89)90148-0; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; SJOBRING U, 1991, J BIOL CHEM, V266, P399; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; VANZEBEN D, 1994, BRIT J RHEUMATOL, V33, P36; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266	35	81	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1413	10.1371/journal.pone.0001413	http://dx.doi.org/10.1371/journal.pone.0001413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183294	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400010
J	Lingappa, JR; Lambdin, B; Bukusi, EA; Ngure, K; Kavuma, L; Inambao, M; Kanweka, W; Allen, S; Kiarie, JN; Makhema, J; Were, E; Manongi, R; Coetzee, D; de Bruyn, G; Delany-Moretlwe, S; Magaret, A; Mugo, N; Mujugira, A; Ndase, P; Celum, C				Lingappa, Jairam R.; Lambdin, Barrot; Bukusi, Elizabeth Ann; Ngure, Kenneth; Kavuma, Linda; Inambao, Mubiana; Kanweka, William; Allen, Susan; Kiarie, James N.; Makhema, Joseph; Were, Edwin; Manongi, Rachel; Coetzee, David; de Bruyn, Guy; Delany-Moretlwe, Sinead; Magaret, Amalia; Mugo, Nelly; Mujugira, Andrew; Ndase, Patrick; Celum, Connie		Partners Prevention HSV-2 HIV	Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; UGANDA; TRANSMISSION; WOMEN; EPIDEMIOLOGY; TANZANIA; HERPES	Background. Most HIV-1 transmission in Africa occurs among HIV-1-discordant couples (one partner HIV-1 infected and one uninfected) who are unaware of their discordant HIV-1 serostatus. Given the high HIV-1 incidence among HIV-1 discordant couples and to assess efficacy of interventions for reducing HIV-1 transmission, HIV-1 discordant couples represent a critical target population for HIV-1 prevention interventions and prevention trials. Substantial regional differences exist in HIV-1 prevalence in Africa, but regional differences in HIV-1 discordance among African couples, has not previously been reported. Methodology/Principal Findings. The Partners in Prevention HSV-2/HIV-1 Transmission Trial ("Partners HSV-2 Study''), the first large HIV-1 prevention trial in Africa involving HIV-1 discordant couples, completed enrollment in May 2007. Partners HSV-2 Study recruitment data from 12 sites from East and Southern Africa were used to assess HIV-1 discordance among couples accessing couples HIV-1 counseling and testing, and to correlate with enrollment of HIV-1 discordant couples. HIV-1 discordance at Partners HSV-2 Study sites ranged from 8-31% of couples tested from the community. Across all study sites and, among all couples with one HIV-1 infected partner, almost half (49%) of couples were HIV-1 discordant. Site-specific monthly enrollment of HIV-1 discordant couples into the clinical trial was not directly associated with prevalence of HIV-1 discordance, but was modestly correlated with national HIV-1 counseling and testing rates and access to palliative care/basic health care (r = 0.74, p = 0.09). Conclusions/Significance. HIV-1 discordant couples are a critical target for HIV-1 prevention in Africa. In addition to community prevalence of HIV-1 discordance, national infrastructure for HIV-1 testing and healthcare delivery and effective community outreach strategies impact recruitment of HIV-1 discordant couples into HIV-1 prevention trials.	[Mugo, Nelly; Mujugira, Andrew; Ndase, Patrick; Celum, Connie] Univ Washington, Dept Med, Seattle, WA USA; [Lambdin, Barrot] Univ Washington, Dept Epidemiol, Seattle, WA USA; [Bukusi, Elizabeth Ann] Ctr Microbiol Res, Kenya Med Res Inst, Nairobi, Kenya; [Ngure, Kenneth; Mugo, Nelly] Kenyatta Natl Hosp, Nairobi, Kenya; [Kavuma, Linda] Makerere Univ, Med Sch, Infect Dis Inst, Kampala, Uganda; [Inambao, Mubiana] Rwanda Zambia HIV Res Grp RZHRG, Ndola, Zambia; [Kanweka, William] Rwanda Zambia HIV Res Grp (RZHRG), Kitwe, Zambia; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, RZHRG, Atlanta, GA USA; [Kiarie, James N.] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Makhema, Joseph] Botswana Harvard Partnership, Gaborone, Botswana; [Were, Edwin] Moi Univ, Dept Reproduct Hlth, Eldoret, Kenya; [Manongi, Rachel] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Coetzee, David] Univ Cape Town, Infect Dis Epidemiol Unit, Cape Town, South Africa; [de Bruyn, Guy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Delany-Moretlwe, Sinead] Univ Witwatersrand, Reproduct Hlth Res Unit, Johannesburg, South Africa; [Magaret, Amalia] Univ Washington, Dept Lab Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kenya Medical Research Institute; Kenyatta National Hospital; Makerere University; Emory University; Rollins School Public Health; University of Nairobi; Moi University; Kilimanjaro Christian Medical Centre; University of Cape Town; University of Witwatersrand; University of Witwatersrand; University of Washington; University of Washington Seattle	Lingappa, JR (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	lingappa@u.washington.edu	de Bruyn, Guy/E-5574-2010; Lingappa, Jairam/N-7760-2017	kiarie, james/0000-0003-4180-7858; Were, Edwin/0000-0002-4783-0795; Rees, Helen/0000-0003-1442-6734; Lambdin, Barrot/0000-0001-8546-0126; Mujugira, Andrew/0000-0001-6646-6733; Ronald, Allan/0000-0002-5746-3490; Kapiga, Saidi/0000-0003-1753-4060	Bill and Melinda Gates Foundation; United States National Institutes of Health (Institutes of Allergy and Infectious Diseases and Mental Health and Child Health Development) [R01 MH66767]; International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United States National Institutes of Health (Institutes of Allergy and Infectious Diseases and Mental Health and Child Health Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative (IAVI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for the Partners HSV-2/HIV-1 Transmission Study is through the Bill and Melinda Gates Foundation. Dr. Allen's research was supported by the United States National Institutes of Health, including the Institutes of Allergy and Infectious Diseases and Mental Health and Child Health Development [NIMH Grant No. R01 MH66767] and by the International AIDS Vaccine Initiative (IAVI).	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; ALLEN SEC, 2007, BIOMED CENT IN PRESS; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Baryarama F, 2004, JAIDS-J ACQ IMM DEF, V37, P1180, DOI 10.1097/01.qai.0000127063.76701.bb; Baryarama F, 2007, JAIDS-J ACQ IMM DEF, V44, P99, DOI 10.1097/01.qai.0000245879.36015.54; Bunnell RE, 2005, AIDS CARE, V17, P999, DOI 10.1080/09540120500100718; BUNNELL RE, 2008, AIDS IN PRESS; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Central Bureau of Statistics (CBS) Kenya Ministry of Health ORC Macro, 2003, KEN DEM HLTH SURV; CHOMBA E, 2007, J ACQUIR IM IN PRESS; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Dorrington R. E., 2006, DEMOGRAPHIC IMPACT H; Freeman EE, 2004, AIDS, V18, P1715, DOI 10.1097/01.aids.0000139075.13906.2f; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; HIRA SK, 1990, J ACQ IMMUN DEF SYND, V3, P83; Kapiga SH, 2006, AIDS CARE, V18, P379, DOI 10.1080/09540120500465012; McKenna SL, 1997, AIDS, V11, pS103; Ministry of Health [Uganda] ORC Macro, 2006, UG HIV AIDS SER SURV; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; *OFF US GLOB AIDS, 2007, US PRES EM PLAN AIDS; Porter L, 2004, DEMOGRAPHY, V41, P465, DOI 10.1353/dem.2004.0025; *UN AIDS WHO, 2006, UN WORLD AIDS BOTSW; *UN AIDS WHO, 2006, AIDS EP UPD, P1; Wald Anna, 2004, Herpes, V11, P70; *ZAMB CENTR STAT O, 2003, ZAMB DEM HLTH SURV 2	27	109	111	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1411	10.1371/journal.pone.0001411	http://dx.doi.org/10.1371/journal.pone.0001411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183292	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400008
J	Masquelier, T; Guyonneau, R; Thorpe, SJ				Masquelier, Timothee; Guyonneau, Rudy; Thorpe, Simon J.			Spike Timing Dependent Plasticity Finds the Start of Repeating Patterns in Continuous Spike Trains	PLOS ONE			English	Article							DEVELOPING RETINOTECTAL SYSTEM; RECURRING DISCHARGE PATTERNS; RETINAL GANGLION-CELLS; VISUAL-CORTEX; COINCIDENCE DETECTOR; NEURONAL RESPONSES; RECEPTIVE-FIELDS; CORTICAL NEURON; BARREL CORTEX; PRECISION	Experimental studies have observed Long Term synaptic Potentiation (LTP) when a presynaptic neuron fires shortly before a postsynaptic neuron, and Long Term Depression (LTD) when the presynaptic neuron fires shortly after, a phenomenon known as Spike Timing Dependant Plasticity (STDP). When a neuron is presented successively with discrete volleys of input spikes STDP has been shown to learn 'early spike patterns', that is to concentrate synaptic weights on afferents that consistently fire early, with the result that the postsynaptic spike latency decreases, until it reaches a minimal and stable value. Here, we show that these results still stand in a continuous regime where afferents fire continuously with a constant population rate. As such, STDP is able to solve a very difficult computational problem: to localize a repeating spatio-temporal spike pattern embedded in equally dense 'distractor' spike trains. STDP thus enables some form of temporal coding, even in the absence of an explicit time reference. Given that the mechanism exposed here is simple and cheap it is hard to believe that the brain did not evolve to use it.	[Masquelier, Timothee; Guyonneau, Rudy; Thorpe, Simon J.] Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, Fac Med Rangueil, F-31062 Toulouse, France; [Masquelier, Timothee; Guyonneau, Rudy; Thorpe, Simon J.] SpikeNet Technol SARL, Prologue 1 La Pyreneenne, Labege, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Masquelier, T (corresponding author), Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, Fac Med Rangueil, F-31062 Toulouse, France.	timothee.masquelier@alum.mit.edu	THORPE, Simon J/A-5661-2008; Masquelier, Timothee/F-1159-2010	THORPE, Simon J/0000-0003-4997-3367; Masquelier, Timothee/0000-0001-8629-9506; Guyonneau, Rudy/0000-0002-2013-5872	CNRS [IST-027198]; ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	This project was supported by the CNRS, STREP Decisions-in-Motion (IST-027198), ANR projects Natstats and Hearing in Time, and SpikeNet Technology SARL.	Abeles M, 2004, SCIENCE, V304, P523, DOI 10.1126/science.1097725; ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; Abeles M., 1991, CORTICONICS NEURAL C, pxiv; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Berry MJ, 1998, J NEUROSCI, V18, P2200; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boloori AR, 2006, J NEUROSCI, V26, P3767, DOI 10.1523/JNEUROSCI.4056-05.2006; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CASSENAER S, 2007, NATURE; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; FROSTIG RD, 1990, BIOL CYBERN, V62, P495, DOI 10.1007/BF00205111; FROSTIG RD, 1990, BIOL CYBERN, V62, P487, DOI 10.1007/BF00205110; GERSTNER W, 1995, PHYS REV E, V51, P738, DOI 10.1103/PhysRevE.51.738; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W, 2002, SPIKING NEURON MODEL; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Guyonneau R, 2004, J PHYSIOL-PARIS, V98, P487, DOI 10.1016/j.jphysparis.2005.09.004; Guyonneau R, 2005, NEURAL COMPUT, V17, P859, DOI 10.1162/0899766053429390; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Liu RC, 2001, J NEUROPHYSIOL, V86, P2789, DOI 10.1152/jn.2001.86.6.2789; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Movshon JA, 2000, NEURON, V27, P412, DOI 10.1016/S0896-6273(00)00049-0; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Young JM, 2007, NAT NEUROSCI, V10, P887, DOI 10.1038/nn1913; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	50	190	197	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1377	10.1371/journal.pone.0001377	http://dx.doi.org/10.1371/journal.pone.0001377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167538	Green Published, gold			2022-12-27	WOS:000260468900006
J	Rubio, D; Garcia, S; Paz, MF; De la Cueva, T; Lopez-Fernandez, LA; Lloyd, AC; Garcia-Castro, J; Bernad, A				Rubio, Daniel; Garcia, Silvia; Paz, Maria F.; De la Cueva, Teresa; Lopez-Fernandez, Luis A.; Lloyd, Alison C.; Garcia-Castro, Javier; Bernad, Antonio			Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation	PLOS ONE			English	Article							TELOMERASE; CANCER; GENE; IMMORTALIZATION; METHYLATION; P16(INK4A); MLL; P53; ASSOCIATION; INK4A/ARF	Background. We previously reported the in vitro spontaneous transformation of human mesenchymal stem cells (MSC) generating a population with tumorigenic potential, that we termed transformed mesenchymal cells (TMC). Methodology/Principal Findings. Here we have characterized the molecular changes associated with TMC generation. Using microarrays techniques we identified a set of altered pathways and a greater number of downregulated than upregulated genes during MSC transformation, in part due to the expression of many untranslated RNAs in MSC. Microarray results were validated by qRT-PCR and protein detection. Conclusions/Significance. In our model, the transformation process takes place through two sequential steps; first MSC bypass senescence by upregulating c-myc and repressing p16 levels. The cells then bypass cell crisis with acquisition of telomerase activity, Ink4a/Arf locus deletion and Rb hyperphosphorylation. Other transformation-associated changes include modulation of mitochondrial metabolism, DNA damage-repair proteins and cell cycle regulators. In this work we have characterized the molecular mechanisms implicated in TMC generation and we propose a two-stage model by which a human MSC becomes a tumor cell.	[Rubio, Daniel; Garcia, Silvia; Paz, Maria F.; De la Cueva, Teresa; Garcia-Castro, Javier; Bernad, Antonio] CNIC, Dept Regenerat Cardiol, Madrid, Spain; [Rubio, Daniel; Garcia, Silvia; Paz, Maria F.; De la Cueva, Teresa; Garcia-Castro, Javier; Bernad, Antonio] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Lopez-Fernandez, Luis A.] Hosp Gen Univ Gregorio Maranon, Serv Farm, Madrid, Spain; [Lloyd, Alison C.] UCL, Lab Mol Cell Biol, London, England; [Garcia-Castro, Javier] Andalusian Stem Cell Bank, Granada, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); General University Gregorio Maranon Hospital; University of London; University College London	Bernad, A (corresponding author), CNIC, Dept Regenerat Cardiol, Madrid, Spain.	abernad@cnic.es	Lopez-Fernandez, Luis A/I-9679-2019; Lopez-Fernandez, Luis/AAV-2580-2021; Garcia-Castro, Javier/H-5274-2011; Lopez-Fernandez, Luis A/B-7330-2011; Bernad, Antonio/P-8573-2017; Garcia-Castro, Javier/ABC-9741-2021	Lopez-Fernandez, Luis A/0000-0003-3964-5837; Lopez-Fernandez, Luis/0000-0003-3964-5837; Garcia-Castro, Javier/0000-0001-7604-1640; Lopez-Fernandez, Luis A/0000-0003-3964-5837; Garcia-Castro, Javier/0000-0001-7604-1640	Spanish Ministry of Education and Science [predoctoral fellowships]; Ministry of Science and Technology [CP03/0031]; Ministerio de Sanidad y Consumo [CP06/0267]; Spanish Ministry of Science and Technology (CICYT) [SAF2001-2262, SAF2005-0864, GEN2001-4856-C13-02]	Spanish Ministry of Education and Science(Spanish Government); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Spanish Ministry of Science and Technology (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	DR and SG received predoctoral fellowships from the Spanish Ministry of Education and Science, JG-C and L L-F received postdoctoral fellowships from the Ministry of Science and Technology and the Ministerio de Sanidad y Consumo (FIS; CP03/0031 and CP06/0267). This work was partially supported by Spanish Ministry of Science and Technology (CICYT) grants SAF2001-2262, SAF2005-0864 and GEN2001-4856-C13-02 to AB. The Department of Immunology and Oncology was founded and is supported by the Spanish National Research Council (CSIC) and by Pfizer.	BENANTI JA, 2007, MOL CANCER RES, V5, pOF1; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Daibata M, 2000, CANCER GENET CYTOGEN, V117, P28, DOI 10.1016/S0165-4608(99)00083-7; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Gorgoulis VG, 1998, AM J PATHOL, V153, P1749, DOI 10.1016/S0002-9440(10)65690-8; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Milyavsky M, 2003, CANCER RES, V63, P7147; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Mund C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni072; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pegram LD, 2000, BLOOD, V96, P4360; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Rea MA, 2006, J INVEST DERMATOL, V126, P2507, DOI 10.1038/sj.jid.5700424; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Ruiz JF, 2004, NUCLEIC ACIDS RES, V32, P5861, DOI 10.1093/nar/gkh929; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Serakinci N, 2006, REGEN MED, V1, P125, DOI 10.2217/17460751.1.1.125; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408; Tsutsui T, 2002, CARCINOGENESIS, V23, P2111, DOI 10.1093/carcin/23.12.2111; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Weinberg RA., 2002, NEW ENGL J MED, V347, P1593, DOI [DOI 10.1056/NEJMRA021902, 10.1056/NEJMra021902]; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xing EP, 1999, CARCINOGENESIS, V20, P77, DOI 10.1093/carcin/20.1.77; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	43	128	144	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1398	10.1371/journal.pone.0001398	http://dx.doi.org/10.1371/journal.pone.0001398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167557	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900026
J	Soerensen, J; Jakupoglu, C; Beck, H; Forster, H; Schmidt, J; Schmahl, W; Schweizer, U; Conrad, M; Brielmeier, M				Soerensen, Jonna; Jakupoglu, Cemile; Beck, Heike; Foerster, Heidi; Schmidt, Joerg; Schmahl, Wolfgang; Schweizer, Ulrich; Conrad, Marcus; Brielmeier, Markus			The Role of Thioredoxin Reductases in Brain Development	PLOS ONE			English	Article								The thioredoxin-dependent system is an essential regulator of cellular redox balance. Since oxidative stress has been linked with neurodegenerative disease, we studied the roles of thioredoxin reductases in brain using mice with nervous system (NS)-specific deletion of cytosolic (Txnrd1) and mitochondrial (Txnrd2) thioredoxin reductase. While NS-specific Txnrd2 null mice develop normally, mice lacking Txnrd1 in the NS were significantly smaller and displayed ataxia and tremor. A striking patterned cerebellar hypoplasia was observed. Proliferation of the external granular layer (EGL) was strongly reduced and fissure formation and laminar organisation of the cerebellar cortex was impaired in the rostral portion of the cerebellum. Purkinje cells were ectopically located and their dendrites stunted. The Bergmann glial network was disorganized and showed a pronounced reduction in fiber strength. Cerebellar hypoplasia did not result from increased apoptosis, but from decreased proliferation of granule cell precursors within the EGL. Of note, neuron-specific inactivation of Txnrd1 did not result in cerebellar hypoplasia, suggesting a vital role for Txnrd1 in Bergmann glia or neuronal precursor cells.	[Soerensen, Jonna; Jakupoglu, Cemile; Schmidt, Joerg; Brielmeier, Markus] Helmholtz Zentrum Munchen German Res Ctr Environm, Dept Comparat Med, Neuherberg, Germany; [Foerster, Heidi; Conrad, Marcus] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Clin Mol Biol & Tumour Genet, Munich, Germany; [Schweizer, Ulrich] Charite, Neurosci Res Ctr, Inst Experiment Endocrinol, AG Neurobiology of Selenium, Berlin, Germany; [Schmahl, Wolfgang] Ludwig Maximilians Univ Munchen, Inst Vet Pathol, Chair General Pathol & Neuropathol, Munich, Germany; [Beck, Heike] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr, Inst Physiol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Munich	Soerensen, J (corresponding author), Helmholtz Zentrum Munchen German Res Ctr Environm, Dept Comparat Med, Neuherberg, Germany.	Brielmeier@helmholtz-muenchen.de	Brielmeier, Markus/M-7352-2014; Schweizer, Ulrich/E-8105-2013; Conrad, Marcus/E-8792-2015	Brielmeier, Markus/0000-0002-8715-869X; Conrad, Marcus/0000-0003-1140-5612; Schweizer, Ulrich/0000-0003-1380-4780	Deutsche Forschungsgemeinschaft Priority Programme 1087	Deutsche Forschungsgemeinschaft Priority Programme 1087	This work was supported by the Deutsche Forschungsgemeinschaft Priority Programme 1087 "Selenoproteins" to MC, MB and US. The supporting foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; Altman J, 1997, DEV CEREBELLAR SYSTE; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Berggren M, 1996, ANTICANCER RES, V16, P3459; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; DETALAMONI NT, 1993, P NATL ACAD SCI USA, V90, P11949, DOI 10.1073/pnas.90.24.11949; Fernagut PO, 2003, NEUROSCIENCE, V116, P1123, DOI 10.1016/S0306-4522(02)00778-9; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gasdaska JR, 1999, J BIOL CHEM, V274, P25379, DOI 10.1074/jbc.274.36.25379; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; Hattori I, 2004, ANTIOXID REDOX SIGN, V6, P81, DOI 10.1089/152308604771978372; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Malynn BA, 2000, GENE DEV, V14, P1390; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Nalvarte I, 2004, J BIOL CHEM, V279, P54510, DOI 10.1074/jbc.M408494200; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2006, ENDOCRINOLOGY, V147, P1306, DOI 10.1210/en.2005-1089; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; SCHWEIZER U, 2006, SELENIUM ITS MOL BIO, pCH23; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; Takagi Y, 2000, J CEREBR BLOOD F MET, V20, P829, DOI 10.1097/00004647-200005000-00009; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; WAHLSTEN D, 1991, BRAIN RES, V557, P184, DOI 10.1016/0006-8993(91)90133-G; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282	55	82	87	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1813	10.1371/journal.pone.0001813	http://dx.doi.org/10.1371/journal.pone.0001813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350150	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762300016
J	Feenders, G; Liedvogel, M; Rivas, M; Zapka, M; Horita, H; Hara, E; Wada, K; Mouritsen, H; Jarvis, ED				Feenders, Gesa; Liedvogel, Miriam; Rivas, Miriam; Zapka, Manuela; Horita, Haruhito; Hara, Erina; Wada, Kazuhiro; Mouritsen, Henrik; Jarvis, Erich D.			Molecular Mapping of Movement-Associated Areas in the Avian Brain: A Motor Theory for Vocal Learning Origin	PLOS ONE			English	Article							DRIVEN GENE-EXPRESSION; IMMEDIATE-EARLY GENE; SONG SYSTEM; AUDITORY RESPONSES; NEURAL PATHWAYS; ZEBRA FINCHES; ANTERIOR FOREBRAIN; MIGRATORY BIRDS; PASSERINE BIRDS; NUCLEUS BASALIS	Vocal learning is a critical behavioral substrate for spoken human language. It is a rare trait found in three distantly related groups of birds-songbirds, hummingbirds, and parrots. These avian groups have remarkably similar systems of cerebral vocal nuclei for the control of learned vocalizations that are not found in their more closely related vocal non-learning relatives. These findings led to the hypothesis that brain pathways for vocal learning in different groups evolved independently from a common ancestor but under pre-existing constraints. Here, we suggest one constraint, a pre-existing system for movement control. Using behavioral molecular mapping, we discovered that in songbirds, parrots, and hummingbirds, all cerebral vocal learning nuclei are adjacent to discrete brain areas active during limb and body movements. Similar to the relationships between vocal nuclei activation and singing, activation in the adjacent areas correlated with the amount of movement performed and was independent of auditory and visual input. These same movement-associated brain areas were also present in female songbirds that do not learn vocalizations and have atrophied cerebral vocal nuclei, and in ring doves that are vocal non-learners and do not have cerebral vocal nuclei. A compilation of previous neural tracing experiments in songbirds suggests that the movement-associated areas are connected in a network that is in parallel with the adjacent vocal learning system. This study is the first global mapping that we are aware for movement-associated areas of the avian cerebrum and it indicates that brain systems that control vocal learning in distantly related birds are directly adjacent to brain systems involved in movement control. Based upon these findings, we propose a motor theory for the origin of vocal learning, this being that the brain areas specialized for vocal learning in vocal learners evolved as a specialization of a pre-existing motor pathway that controls movement.	[Feenders, Gesa; Liedvogel, Miriam; Zapka, Manuela; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol Umweltwissenschaften, Volkswagen Nachwuchsgruppe Animal Navigat, Oldenburg, Germany; [Rivas, Miriam; Horita, Haruhito; Hara, Erina; Wada, Kazuhiro; Jarvis, Erich D.] Duke Univ Med Ctr, Dept Neurobiol, Durham, NC USA	Carl von Ossietzky Universitat Oldenburg; Volkswagen; Duke University	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol Umweltwissenschaften, Volkswagen Nachwuchsgruppe Animal Navigat, Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de; jarvis@neuro.duke.edu	Liedvogel, Miriam/HDM-7933-2022; Liedvogel, Miriam/S-8341-2019; Wada, Kazuhiro/A-6548-2012; Mouritsen, Henrik/A-5401-2010; Liedvogel, Miriam/D-5418-2015; Jarvis, Erich D/A-2319-2008	Mouritsen, Henrik/0000-0001-7082-4839; Liedvogel, Miriam/0000-0002-8372-8560; Jarvis, Erich D/0000-0001-8931-5049; Wada, Kazuhiro/0000-0001-8137-9144	NSF Alan T. Waterman Award; NIH Director's Pioneer Award; DFG; Volkswagen Stiftung Nachwuchsgruppe and Lichtenberg Professorships; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER	NSF Alan T. Waterman Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Volkswagen Stiftung Nachwuchsgruppe and Lichtenberg Professorships; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a NSF Alan T. Waterman Award and a NIH Director's Pioneer Award to E.D.J. and by the DFG, Volkswagen Stiftung Nachwuchsgruppe and Lichtenberg Professorship grants to H.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allott R., 1992, LANGUAGE ORIGIN MULT, P105, DOI DOI 10.1007/978-94-017-2039-7_7; Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; Bailey DJ, 2006, NEUROSCI LETT, V401, P86, DOI 10.1016/j.neulet.2006.02.076; BAPTISTA LF, 1990, ETHOLOGY, V84, P15; Boiko V P, 1985, Neurosci Behav Physiol, V15, P265, DOI 10.1007/BF01182997; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 2000, J COMP NEUROL, V420, P244; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; DUBBELDAM JL, 1994, EUR J MORPHOL, V32, P127; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Edelman DB, 2005, CONSCIOUS COGN, V14, P169, DOI 10.1016/j.concog.2004.09.001; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Farabaugh SM, 1997, BRAIN RES, V747, P18, DOI 10.1016/S0006-8993(96)01143-2; Farabaugh Susan M., 1992, Bioacoustics, V4, P111; Farries MA, 2004, ANN NY ACAD SCI, V1016, P61, DOI 10.1196/annals.1298.007; Farries MA, 2001, BRAIN BEHAV EVOLUT, V58, P80, DOI 10.1159/000047263; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fitch WT, 2005, COGNITION, V97, P179, DOI 10.1016/j.cognition.2005.02.005; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; Frost BJ, 2006, CURR OPIN NEUROBIOL, V16, P481, DOI 10.1016/j.conb.2006.06.005; FUNKE K, 1989, EXP BRAIN RES, V76, P620, DOI 10.1007/BF00248918; Gahr M, 2000, J COMP NEUROL, V426, P182; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Ghysen A, 2003, INT J DEV BIOL, V47, P555; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HEIL P, 1986, J COMP NEUROL, V252, P279, DOI 10.1002/cne.902520302; Hessler NA, 1999, J NEUROSCI, V19, P10461; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Ito H, 2007, BRAIN BEHAV EVOLUT, V69, P76, DOI 10.1159/000095196; Iwaniuk AN, 2006, BRAIN BEHAV EVOLUT, V67, P53, DOI 10.1159/00089120; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iyengar S, 1999, J NEUROSCI, V19, P6037, DOI 10.1523/JNEUROSCI.19-14-06037.1999; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JARVIS ED, 1995, LEARN MEMORY, V2, P62, DOI 10.1101/lm.2.2.62; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; KONISHI MASAKAZU, 1964, CONDOR, V66, P85, DOI 10.2307/1365388; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; KRUEGER K, 1982, Comparative Biochemistry and Physiology A, V73, P679; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; LEWALD J, 1990, EXP BRAIN RES, V82, P423; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Manger PR, 2002, EUR J NEUROSCI, V16, P743, DOI 10.1046/j.1460-9568.2002.02119.x; MARGOLIASH D, 1994, BRAIN BEHAV EVOLUT, V44, P247, DOI 10.1159/000113580; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MILLER SJ, 1983, ANIM BEHAV, V31, P689, DOI 10.1016/S0003-3472(83)80224-3; Mouritsen H, 1998, ANIM BEHAV, V55, P1311, DOI 10.1006/anbe.1997.0696; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Necker R, 2001, J COMP NEUROL, V429, P403; Nelson RJ, 1996, CURR OPIN NEUROBIOL, V6, P801, DOI 10.1016/S0959-4388(96)80031-6; Nguyen AP, 2004, J NEUROSCI, V24, P4962, DOI 10.1523/JNEUROSCI.0146-04.2004; NixdorfBergweiler BE, 1996, J COMP NEUROL, V375, P445, DOI 10.1002/(SICI)1096-9861(19961118)375:3<445::AID-CNE7>3.0.CO;2-2; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Nottebohm F., 1980, PROGR PSYCHOBIOLOGY, V9, P85; Okanoya K, 2007, CURR OPIN NEUROBIOL, V17, P271, DOI 10.1016/j.conb.2007.03.011; PATON JA, 1981, J NEUROSCI, V1, P1279; Perkel DJ, 2004, ANN NY ACAD SCI, V1016, P736, DOI 10.1196/annals.1298.039; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Plummer TK, 2000, J NEUROBIOL, V42, P79, DOI 10.1002/(SICI)1097-4695(200001)42:1<79::AID-NEU8>3.0.CO;2-W; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647; Purves D, 2001, NEUROSCIENCE, V2nd edition; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Reiner A, 2004, J COMP NEUROL, V469, P239, DOI 10.1002/cne.11012; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell L, 2001, BEHAV BRAIN SCI, V24, P324, DOI DOI 10.1017/S0140525X0100396X; Sanvito S, 2007, ETHOLOGY, V113, P137, DOI 10.1111/j.1439-0310.2006.01306.x; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Shimizu Toru, 1993, P103; SHOLOMENKO GN, 1991, EXP BRAIN RES, V85, P659, DOI 10.1007/BF00231752; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; van Schie HT, 2006, CORTEX, V42, P495, DOI 10.1016/S0010-9452(08)70385-X; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VEENMAN CL, 1995, J COMP NEUROL, V354, P87, DOI 10.1002/cne.903540108; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; WEIDNER C, 1985, BRAIN RES, V340, P99, DOI 10.1016/0006-8993(85)90778-4; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wild JM, 1997, BRAIN RES, V759, P122, DOI 10.1016/S0006-8993(97)00253-9; Wild JM, 2000, NEUROSCIENCE, V96, P333, DOI 10.1016/S0306-4522(99)00546-1; Wild JM, 1999, J COMP NEUROL, V413, P520, DOI 10.1002/(SICI)1096-9861(19991101)413:4<520::AID-CNE3>3.0.CO;2-B; Wild JM, 1996, J COMP NEUROL, V365, P306, DOI 10.1002/(SICI)1096-9861(19960205)365:2<306::AID-CNE8>3.0.CO;2-9; Wild JM, 2001, BRAIN BEHAV EVOLUT, V57, P39, DOI 10.1159/000047225; Wild JM, 2000, J COMP NEUROL, V416, P429; Wild JM, 1997, BRAIN RES, V755, P137, DOI 10.1016/S0006-8993(97)00026-7; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZEIER H, 1971, BRAIN RES, V31, P313, DOI 10.1016/0006-8993(71)90185-5; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1002/AJPA.10171; [No title captured]; [No title captured]; [No title captured]; [No title captured]	131	187	190	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1768	10.1371/journal.pone.0001768	http://dx.doi.org/10.1371/journal.pone.0001768			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18335043	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000022
J	Finocchietto, P; Barreyro, F; Holod, S; Peralta, J; Franco, MC; Mendez, C; Converso, DP; Estevez, A; Carreras, MC; Poderoso, JJ				Finocchietto, Paola; Barreyro, Fernando; Holod, Silvia; Peralta, Jorge; Franco, Maria C.; Mendez, Carlos; Converso, Daniela P.; Estevez, Alvaro; Carreras, Maria C.; Poderoso, Juan J.			Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome	PLOS ONE			English	Article								Background: In the metabolic syndrome with hyperinsulinemia, mitochondrial inhibition facilitates muscle fat and glycogen accumulation and accelerates its progression. In the last decade, nitric oxide (NO) emerged as a typical mitochondrial modulator by reversibly inhibiting citochrome oxidase and oxygen utilization. We wondered whether insulin-operated signaling pathways modulate mitochondrial respiration via NO, to alternatively release complete glucose oxidation to CO(2) and H(2)O or to drive glucose storage to glycogen. Methodology/Principal Findings: We illustrate here that NO produced by translocated nNOS (mtNOS) is the insulin-signaling molecule that controls mitochondrial oxygen utilization. We evoke a hyperinsulinemic-normoglycemic non-invasive clamp by subcutaneously injecting adult male rats with long-lasting human insulin glargine that remains stable in plasma by several hours. At a precise concentration, insulin increased phospho-Akt2 that translocates to mitochondria and determines in situ phosphorylation and substantial cooperative mtNOS activation (+4-8 fold, P<.05), high NO, and a lowering of mitochondrial oxygen uptake and resting metabolic rate (-25 to -60%, P<.05). Comparing in vivo insulin metabolic effects on gastrocnemius muscles by direct electroporation of siRNA nNOS or empty vector in the two legs of the same animal, confirmed that in the silenced muscles disrupted mtNOS allows higher oxygen uptake and complete (U-(14)C)-glucose utilization respect to normal mtNOS in the vector-treated ones (respectively 37 +/- 3 vs 10 +/- 1 mu molO(2)/h. g tissue and 13 +/- 61 vs 7.2 +/- 1 mmol (3)H(2)O/h.g tissue, P<.05), which reciprocally restricted glycogen-synthesis by a half. Conclusions/Significance: These evidences show that after energy replenishment, insulin depresses mitochondrial respiration in skeletal muscle via NO which permits substrates to be deposited as macromolecules; at discrete hyperinsulinemia, persistent mtNOS activation could contribute to mitochondrial dysfunction with insulin resistance and obesity and therefore, to the progression of the metabolic syndrome.	[Finocchietto, Paola; Barreyro, Fernando; Holod, Silvia; Peralta, Jorge; Franco, Maria C.; Converso, Daniela P.; Carreras, Maria C.; Poderoso, Juan J.] Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina; [Holod, Silvia; Carreras, Maria C.] Univ Buenos Aires, Univ Hosp, Sch Pharm & Biochem, Dept Clin Biochem, Buenos Aires, DF, Argentina; [Finocchietto, Paola; Barreyro, Fernando; Peralta, Jorge; Poderoso, Juan J.] Univ Buenos Aires, Univ Hosp, Dept Med, Buenos Aires, DF, Argentina; [Mendez, Carlos] Univ Buenos Aires, Sch Med, Dept Human Biochem, Buenos Aires, DF, Argentina; [Estevez, Alvaro] Cornell Univ, Burke Med Res Inst, Ithaca, NY USA	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Cornell University	Finocchietto, P (corresponding author), Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina.	jpoderos@fmed.uba.ar	Franco, Maria/O-7862-2015	Mendez, Carlos Fernando/0000-0002-9659-1866	Agencia Nacional para la Promocion Cientifica Tecnologica [PICT 8468, PICT 14199]; University of Buenos Aires [Ubacyt M063]; CONICET [PIP 5495]; Fundacion Perez Companc; Fundacion Florencio Fiorini; Fundacion Qualitas; Asociacion Cooperadora del Hospital de Clinicas, Buenos Aires, Argentina	Agencia Nacional para la Promocion Cientifica Tecnologica; University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Perez Companc; Fundacion Florencio Fiorini; Fundacion Qualitas; Asociacion Cooperadora del Hospital de Clinicas, Buenos Aires, Argentina	This work was supported with research grants from the Agencia Nacional para la Promocion Cientifica Tecnologica (FONCYT; PICT 8468 and PICT 14199), Ubacyt M063 (University of Buenos Aires), CONICET (PIP 5495), Fundacion Perez Companc, Fundacion Florencio Fiorini, Fundacion Qualitas, and Asociacion Cooperadora del Hospital de Clinicas, Buenos Aires, Argentina.	Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Auwerx J, 2006, NAT MED, V12, P44, DOI 10.1038/nm0106-44; Barreyro FJ, 2006, HEPATOLOGY, V44, p662A; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; BOVERIS A, 2000, NITRIC OXIDE BIOL PA, P355; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; CHO H, 2001, SCIENCE, V242, P1228; CUENDET GS, 1976, J CLIN INVEST, V58, P1078, DOI 10.1172/JCI108559; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Derave W, 2000, AM J PHYSIOL-ENDOC M, V279, pE947, DOI 10.1152/ajpendo.2000.279.5.E947; Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200; Franco MC, 2006, J BIOL CHEM, V281, P4779, DOI 10.1074/jbc.M512080200; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Golzio M, 2005, GENE THER, V12, P246, DOI 10.1038/sj.gt.3302405; Hargreaves M, 2004, P NUTR SOC, V63, P217, DOI 10.1079/PNS2004344; Hofmann T, 2002, INT J TOXICOL, V21, P181, DOI 10.1080/10915810290096315; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kim YI, 2006, DIABETES, V55, P2311, DOI 10.2337/db05-1606; Korotchkina LG, 2006, J BIOL CHEM, V281, P9688, DOI 10.1074/jbc.M511481200; LELOIR LF, 1960, J BIOL CHEM, V235, P919; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; McKeage K, 2001, DRUGS, V61, P1599, DOI 10.2165/00003495-200161110-00007; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE986, DOI 10.1152/ajpendo.00399.2006; Peralta JG, 2003, AM J PHYSIOL-HEART C, V284, pH2375, DOI 10.1152/ajpheart.00785.2002; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Reinhart L, 2002, AM J HEALTH-SYST PH, V59, P643, DOI 10.1093/ajhp/59.7.643; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; Sasaoka T, 2004, J BIOL CHEM, V279, P14835, DOI 10.1074/jbc.M311534200; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zaobornyj T, 2005, J APPL PHYSIOL, V98, P2370, DOI 10.1152/japplphysiol.00986.2004	49	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1749	10.1371/journal.pone.0001749	http://dx.doi.org/10.1371/journal.pone.0001749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335029	gold, Green Submitted, Green Published			2022-12-27	WOS:000260723000003
J	Nakakuki, T; Yumoto, N; Naka, T; Shirouzu, M; Yokoyama, S; Hatakeyama, M				Nakakuki, Takashi; Yumoto, Noriko; Naka, Takashi; Shirouzu, Mikako; Yokoyama, Shigeyuki; Hatakeyama, Mariko			Topological Analysis of MAPK Cascade for Kinetic ErbB Signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR; B-RAF; PHOSPHORYLATION SITES; KINASE CASCADE; IN-VIVO; IDENTIFICATION; ACTIVATION; ERK; NETWORK	Ligand-induced homo-and hetero-dimer formation of ErbB receptors results in different biological outcomes irrespective of recruitment and activation of similar effector proteins. Earlier experimental research indicated that cells expressing both EGFR (epidermal growth factor receptor) and the ErbB4 receptor (E1/4 cells) induced E1/4 cell-specific B-Raf activation and higher extracellular signal-regulated kinase (ERK) activation, followed by cellular transformation, than cells solely expressing EGFR (E1 cells) in Chinese hamster ovary (CHO) cells. Since our experimental data revealed the presence of positive feedback by ERK on upstream pathways, it was estimated that the cross-talk/feedback pathway structure of the Raf-MEK-ERK cascade might affect ERK activation dynamics in our cell system. To uncover the regulatory mechanism concerning the ERK dynamics, we used topological models and performed parameter estimation for all candidate structures that possessed ERK-mediated positive feedback regulation of Raf. The structure that reliably reproduced a series of experimental data regarding signal amplitude and duration of the signaling molecules was selected as a solution. We found that the pathway structure is characterized by ERK-mediated positive feedback regulation of B-Raf and B-Raf-mediated negative regulation of Raf-1. Steady-state analysis of the estimated structure indicated that the amplitude of Ras activity might critically affect ERK activity through ERK-B-Raf positive feedback coordination with sustained B-Raf activation in E1/4 cells. However, Rap1 that positively regulates B-Raf activity might be less effective concerning ERK and B-Raf activity. Furthermore, we investigated how such Ras activity in E1/4 cells can be regulated by EGFR/ErbB4 heterodimer-mediated signaling. From a sensitivity analysis of the detailed upstream model for Ras activation, we concluded that Ras activation dynamics is dominated by heterodimer-mediated signaling coordination with a large initial speed of dimerization when the concentration of the ErbB4 receptor is considerably high. Such characteristics of the signaling cause the preferential binding of the Grb2-SOS complex to heterodimer-mediated signaling molecules.	[Nakakuki, Takashi; Yumoto, Noriko; Hatakeyama, Mariko] RIKEN Genom Sci Ctr, Computat & Expt Syst Biol Grp, Cellular Syst Biol Team, Tsurumi Ku, Kanagawa, Japan; [Naka, Takashi] Kyushu Sangyo Univ, Fac Informat Sci, Dept Intelligent Informat, Fukuoka, Japan; [Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Genom Sci Ctr, Protein Res Group, Kanagawa, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo, Japan	RIKEN; RIKEN; University of Tokyo	Nakakuki, T (corresponding author), RIKEN Genom Sci Ctr, Computat & Expt Syst Biol Grp, Cellular Syst Biol Team, Tsurumi Ku, Kanagawa, Japan.	marikoh@gsc.riken.jp	Yokoyama, Shigeyuki/N-6911-2015; Okada, Mariko/N-6933-2015; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; 				Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Baulida J, 1996, J BIOL CHEM, V271, P5251; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; CAMPA MJ, 1991, BIOCHEM BIOPH RES CO, V174, P1, DOI 10.1016/0006-291X(91)90475-M; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Cohen BD, 1996, J BIOL CHEM, V271, P30897, DOI 10.1074/jbc.271.48.30897; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hatakeyama M, 2004, ONCOGENE, V23, P5023, DOI 10.1038/sj.onc.1207664; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Holt KH, 1996, J BIOL CHEM, V271, P8300, DOI 10.1074/jbc.271.14.8300; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim JH, 2002, EUR J BIOCHEM, V269, P2323, DOI 10.1046/j.1432-1033.2002.02877.x; Kimura S, 2003, IEEE SYS MAN CYBERN, P335; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARUTA H, 1994, BIOESSAYS, V16, P489, DOI 10.1002/bies.950160708; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wiseman SM, 2005, CANCER-AM CANCER SOC, V103, P1770, DOI 10.1002/cncr.20970; Xia WY, 1999, CLIN CANCER RES, V5, P4164; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yumoto N, 2006, MOL CELL BIOCHEM, V285, P165, DOI 10.1007/s11010-005-9075-5; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1782	10.1371/journal.pone.0001782	http://dx.doi.org/10.1371/journal.pone.0001782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335053	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000034
J	Lopman, B; Gregson, S				Lopman, Ben; Gregson, Simon			When Did HIV Incidence Peak in Harare, Zimbabwe? Back-Calculation from Mortality Statistics	PLOS ONE			English	Article							INFECTION; AIDS; AFRICA; SPREAD; IMPACT; TIME	HIV prevalence has recently begun to decline in Zimbabwe, a result of both high levels of AIDS mortality and a reduction in incident infections. An important component in understanding the dynamics in HIV prevalence is knowledge of past trends in incidence, such as when incidence peaked and at what level. However, empirical measurements of incidence over an extended time period are not available from Zimbabwe or elsewhere in sub-Saharan Africa. Using mortality data, we use a back-calculation technique to reconstruct historic trends in incidence. From AIDS mortality data, extracted from death registration in Harare, together with an estimate of survival post-infection, HIV incidence trends were reconstructed that would give rise to the observed patterns of AIDS mortality. Models were fitted assuming three parametric forms of the incidence curve and under nine different assumptions regarding combinations of trends in non-AIDS mortality and patterns of survival post-infection with HIV. HIV prevalence was forward-projected from the fitted incidence and mortality curves. Models that constrained the incidence pattern to a cubic spline function were flexible and produced well-fitting, realistic patterns of incidence. In models assuming constant levels of non-AIDS mortality, annual incidence peaked between 4 and 5% between 1988 and 1990. Under other assumptions the peak level ranged from 3 to 8% per annum. However, scenarios assuming increasing levels of non-AIDS mortality resulted in implausibly low estimates of peak prevalence (11%), whereas models with decreasing underlying crude mortality could be consistent with the prevalence and mortality data. HIV incidence is most likely to have peaked in Harare between 1988 and 1990, which may have preceded the peak elsewhere in Zimbabwe. This finding, considered alongside the timing and location of HIV prevention activities, will give insight into the decline of HIV prevalence in Zimbabwe.	[Lopman, Ben; Gregson, Simon] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Gregson, Simon] Biomed Res & Training Inst, Harare, Zimbabwe	Imperial College London; Biomedical Research Training Institute	Lopman, B (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, London, England.	Ben.Lopman@hpa.org.uk		Gregson, Simon/0000-0003-2707-0714	Wellcome Trust; UNAIDS	Wellcome Trust(Wellcome Trust); UNAIDS	This work was supported by the Wellcome Trust and UNAIDS. The funders had no influence in the collection, analysis, and interpretation of the data, or in the preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; [Anonymous], WORLD POP PROSP 2004; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; Brookmeyer R., 1994, AIDS EPIDEMIOLOGY QU; *CASCASE COLL, LANCET, V355, P1131; Feeney G, 2001, POPUL DEV REV, V27, P771, DOI 10.1111/j.1728-4457.2001.00771.x; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2005, AIDS CARE, V17, P785, DOI 10.1080/09540120500258029; Gregson S, 1998, AIDS, V12, P2049, DOI 10.1097/00002030-199815000-00017; HOWDEN D, 2006, INDEPENDENT, P8; ISHAM V, 1989, PHILOS T ROY SOC B, V325, P113, DOI 10.1098/rstb.1989.0076; Machekano R., 1998, Central African Journal of Medicine, V44, P98; Mbizvo M. T., 1997, Central African Journal of Medicine, V43, P135; Mbizvo M T, 2001, Cent Afr J Med, V47, P115; *MEAS DHS ZIMB CEN, 2006, ZIMB DEM HLTH SURV 2; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; MOTULKSKY H, 2004, FITTING MODELS BIOL; OSULLIVAN F, STAT SCI, V1, P502; POTTS D, 1990, J S AFR STUD, V16, P677, DOI 10.1080/03057079008708256; Sonnenberg P, 2004, AIDS, V18, P657, DOI 10.1097/00002030-200403050-00010; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; *UN POP DIV, 2004, POP DAT; *UNAIDS, 2004, REP GLOB AIDS EP; *UNAIDS, 2005, EV HIV DECL ZIMB COM; *UNAIDS ZIMB MIN H, 2005, ZIMB NAT HIV AIDS ES; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201	27	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1711	10.1371/journal.pone.0001711	http://dx.doi.org/10.1371/journal.pone.0001711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320032	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600007
J	Wootton, DG; Opara, H; Biagini, GA; Kanjala, MK; Duparc, S; Kirby, PL; Woessner, M; Neate, C; Nyirenda, M; Blencowe, H; Dube-Mbeye, Q; Kanyok, T; Ward, S; Molyneux, M; Dunyo, S; Winstanley, PA				Wootton, Daniel G.; Opara, Hyginus; Biagini, Giancarlo A.; Kanjala, Maxwell K.; Duparc, Stephan; Kirby, Paula L.; Woessner, Mary; Neate, Colin; Nyirenda, Maggie; Blencowe, Hannah; Dube-Mbeye, Queen; Kanyok, Thomas; Ward, Stephen; Molyneux, Malcolm; Dunyo, Sam; Winstanley, Peter A.			Open-Label Comparative Clinical Study of Chlorproguanil-Dapsone Fixed Dose Combination (Lapdap (TM)) Alone or with Three Different Doses of Artesunate for Uncomplicated Plasmodium falciparum Malaria	PLOS ONE			English	Article								The objective of this study was to determine the appropriate dose of artesunate for use in a fixed dose combination therapy with chlorproguanil-dapsone (CPG-DDS) for the treatment of uncomplicated falciparum malaria. Methods: Open-label clinical trial comparing CPG-DDS alone or with artesunate 4, 2, or 1 mg/kg at medical centers in Blantyre, Malawi and Farafenni, The Gambia. The trial was conducted between June 2002 and February 2005, including 116 adults (median age 27 years) and 107 children (median age 38 months) with acute uncomplicated Plasmodium falciparum malaria. Subjects were randomized into 4 groups to receive CPG-DDS alone or plus 4, 2 or 1 mg/kg of artesunate once daily for 3 days. Assessments took place on Days 023 in hospital and follow-up on Days 7 and 14 as out-patients. Efficacy was evaluated in the Day 3 per-protocol (PP) population using mean time to reduce baseline parasitemia by 90% (PC90). A number of secondary outcomes were also included. Appropriate artesunate dose was determined using a pre-defined decision matrix based on primary and secondary outcomes. Treatment emergent adverse events were recorded from clinical assessments and blood parameters. Safety was evaluated in the intent to treat (ITT) population. Results: In the Day 3 PP population for the adult group (N = 85), mean time to PC90 was 19.1 h in the CPG-DDS group, significantly longer than for the + artesunate 1 mg/kg (12.5 h; treatment difference -6.6 h [95% CI -11.8, -1.5]), 2 mg/kg (10.7 h; -8.4 h [95% CI -13.6, -3.2]) and 4 mg/kg (10.3 h; -8.7 h [95% CI -14.1, -3.2]) groups. For children in the Day 3 PP population (N = 92), mean time to PC90 was 21.1 h in the CPG-DDS group, similar to the + artesunate 1 mg/kg group (17.7 h; -3.3 h [95% CI -8.6, 2.0]), though the + artesunate 2 mg/kg and 4 mg/kg groups had significantly shorter mean times to PC90 versus CPG-DDS; 14.4 h (treatment difference 26.4 h [95% CI -11.7, -1.0]) and 12.8 h (-7.4 h [ 95% CI -12.9, -1.8]), respectively. An analysis of mean time to PC90 for the Day 14 PP and ITT populations was consistent with the primary analysis. Treatment emergent, drug-related adverse events were experienced in 35.3% (41/116) of adults and 70.1% (75/107) of children; mostly hematological and gastroenterological. The nature and incidence of adverse events was similar between the groups. No dose-related changes in laboratory parameters were observed. Nine serious adverse events due to any cause occurred in five subjects including two cases of hemolysis believed to be associated with drug treatment (one adult, one child). One adult died of anaphylactic shock, not associated with investigational therapy. Conclusions: CP-DDS plus artesunate demonstrated advantages over CPG-DDS alone for the primary efficacy endpoint (mean time to PC90) except in children for the 1 mg/kg artesunate dose. Based on a pre-defined decision matrix, the primary endpoint in the child group supported an artesunate dose of 4 mg/kg. Secondary endpoints also supported a 4 mg/kg artesunate dose to take forward into the remainder of the development program.	[Wootton, Daniel G.; Winstanley, Peter A.] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; [Wootton, Daniel G.; Kanjala, Maxwell K.; Molyneux, Malcolm] Coll Med, Malawi Liverpool Wellcome Trust, Major Overseas Programme, Blantyre, Malawi; [Opara, Hyginus; Dunyo, Sam] MRC Labs, Banjul, Gambia; [Biagini, Giancarlo A.; Ward, Stephen; Molyneux, Malcolm] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Duparc, Stephan; Kirby, Paula L.; Woessner, Mary; Neate, Colin] GlaxoSmithKline Inc, Greenford, Middx, England; [Nyirenda, Maggie; Blencowe, Hannah; Dube-Mbeye, Queen] Coll Med, Dept Paediat, Blantyre, Malawi; [Kanyok, Thomas] Bill & Melinda Gates Fdn, Global Hlth Infect Dis, Seattle, WA USA	University of Liverpool; University of Malawi; MRC Laboratory Molecular Biology; Liverpool School of Tropical Medicine; GlaxoSmithKline; University of Malawi; Bill & Melinda Gates Foundation	Wootton, DG (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England.	p.a.winstanley@liverpool.ac.uk	Ward, Steve/G-6003-2015; Biagini, Giancarlo A/F-3449-2011; Duparc, Stephan/AAH-8758-2020; Blencowe, Hannah/K-7415-2012	Ward, Steve/0000-0003-2331-3192; Biagini, Giancarlo A/0000-0001-6356-6595; Duparc, Stephan/0000-0002-9649-4847; Blencowe, Hannah/0000-0003-1556-3159	UK government Department for International Development; Liverpool School of Tropical Medicine, Liverpool University; London School of Hygiene and Tropical Medicine	UK government Department for International Development; Liverpool School of Tropical Medicine, Liverpool University; London School of Hygiene and Tropical Medicine	The development of chlorproguanil-dapsone-artesunate fixed dose combination is by public-private partnership and was commissioned by the Medicines for Malaria Venture. A development agreement was made between the UNICEF-United Nations Development Programme-World Bank-World Health Organization Special Programme for Research and Training in Tropical Medicine and GlaxoSmithKline PLC. The UK government Department for International Development supplied some initial funding to the project. Liverpool School of Tropical Medicine, Liverpool University, and the London School of Hygiene and Tropical Medicine joined the joint development team as academic partners. A committee comprising representatives from all development partners developed the protocol.	ALIN MH, 1994, AM J TROP MED HYG, V50, P771, DOI 10.4269/ajtmh.1994.50.771; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Angus BJ, 2002, ANTIMICROB AGENTS CH, V46, P778, DOI 10.1128/AAC.46.3.778-782.2002; [Anonymous], 2003, ASS MON ANT DRUG EFF; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Borrmann S, 2003, ANTIMICROB AGENTS CH, V47, P901, DOI 10.1128/AAC.47.3.901-904.2003; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; DEGOWIN RL, 1966, B WORLD HEALTH ORGAN, V35, P165; DUTTA GP, 1989, CHEMOTHERAPY, V35, P200, DOI 10.1159/000238671; Hallett RL, 2004, ANTIMICROB AGENTS CH, V48, P3940, DOI 10.1128/AAC.48.10.3940-3943.2004; Hyde JE, 2005, TRENDS PARASITOL, V21, P494, DOI 10.1016/j.pt.2005.08.020; *JOINT UN PROGR HI, 2006, REP GLOB AIDS EP 200; Laufer MK, 2006, J INFECT DIS, V193, P872, DOI 10.1086/500245; MURPHY S, 1995, AM J TROP MED HYG, V53, P303, DOI 10.4269/ajtmh.1995.53.303; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Schwarz NG, 2005, AM J TROP MED HYG, V73, P705, DOI 10.4269/ajtmh.2005.73.705; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; van Vugt M, 2000, T ROY SOC TROP MED H, V94, P545, DOI 10.1016/S0035-9203(00)90082-8; *WHO, 2005, WORLD MAL REP WHO; WHO, 2002, MON ANT DRUG RES REP; WHO, 2004, POS PAP WHO ROLL BAC; *WHO, 2004, REV SAF CHLORPR DAPS; Winstanley P, 2001, TROP MED INT HEALTH, V6, P952, DOI 10.1046/j.1365-3156.2001.00751.x	27	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1779	10.1371/journal.pone.0001779	http://dx.doi.org/10.1371/journal.pone.0001779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320064	Green Published, gold, Green Accepted			2022-12-27	WOS:000260586600042
J	Ye, WB; Lv, Q; Wong, CKA; Hu, S; Fu, C; Hua, Z; Cai, GP; Li, GX; Yang, BB; Zhang, Y				Ye, Wenbin; Lv, Qing; Wong, Chung-Kwun Amy; Hu, Sean; Fu, Chao; Hua, Zhong; Cai, Guoping; Li, Guoxi; Yang, Burton B.; Zhang, Yaou			The Effect of Central Loops in miRNA:MRE Duplexes on the Efficiency of miRNA-Mediated Gene Regulation	PLOS ONE			English	Article							CELL-PROLIFERATION; MICRORNA EXPRESSION; MESSENGER-RNAS; TARGETS; PREDICTION; DIFFERENTIATION; IDENTIFICATION; SPECIFICITY; BIOGENESIS; SEQUENCE	MicroRNAs (miRNAs) guide posttranscriptional repression of mRNAs. Hundreds of miRNAs have been identified but the target identification of mammalian mRNAs is still a difficult task due to a poor understanding of the interaction between miRNAs and the miRNA recognizing element (MRE). In recent research, the importance of the 59 end of the miRNA:MRE duplex has been emphasized and the effect of the tail region addressed, but the role of the central loop has largely remained unexplored. Here we examined the effect of the loop region in miRNA: MRE duplexes and found that the location of the central loop is one of the important factors affecting the efficiency of gene regulation mediated by miRNAs. It was further determined that the addition of a loop score combining both location and size as a new criterion for predicting MREs and their cognate miRNAs significantly decreased the false positive rates and increased the specificity of MRE prediction.	[Wong, Chung-Kwun Amy; Yang, Burton B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Lab Med & Pathol, Toronto, ON, Canada; [Ye, Wenbin; Lv, Qing; Fu, Chao] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing, Peoples R China; [Ye, Wenbin; Lv, Qing; Fu, Chao; Hua, Zhong; Cai, Guoping; Zhang, Yaou] Tsinghua Univ, Grad Sch, Div Life Sci, Shenzhen, Peoples R China; [Hu, Sean; Li, Guoxi] Shenzhen Beike Biotechnol Co Ltd, Shenzhen, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Yang, BB (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Lab Med & Pathol, Toronto, ON, Canada.	byang@sri.utoronto.ca; zhangyo@sz.tsinghua.edu.cn	Hua, Zhong/J-8149-2014; Lyu, Qing/AAF-5181-2021; Lyu, Qing/AAP-8387-2020	Lyu, Qing/0000-0002-1325-6828; 	Canadian Institutes of Health Research [MOP-62729]; National Natural Science Foundation of China [30611120519]; Shenzhen Bureau of Science Technology & Information [387 2005-k2-046]; Heart and Stroke Foundation of Ontario [CI 5958]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science Technology & Information; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a China-Canada Joint Health Research Grant (from Canadian Institutes of Health Research and the National Natural Science Foundation of China to Burton B. Yang and Yaou Zhang), Grant MOP-62729 from Canadian Institutes of Health Research to Burton B. Yang, Grant 30611120519 from the National Natural Science Foundation of China to Yaou Zhang, and Grant 387 2005-k2-046 from the Shenzhen Bureau of Science Technology & Information to Yaou Zhang. Burton B. Yang is the recipient of a Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Makunin IV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001133; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; MARTIN MM, 2006, J BIOL CHEM; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sandmann T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001265; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sheng Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000946; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	65	117	121	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1719	10.1371/journal.pone.0001719	http://dx.doi.org/10.1371/journal.pone.0001719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320040	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600015
J	Jiao, JW; Nakajima, A; Janssen, WGM; Bindokas, VP; Xiong, XL; Morrison, JH; Brorson, JR; Tang, YP				Jiao, Jianwei; Nakajima, Akira; Janssen, William G. M.; Bindokas, Vytautas P.; Xiong, Xiaoli; Morrison, John H.; Brorson, James R.; Tang, Ya-Ping			Expression of NR2B in Cerebellar Granule Cells Specifically Facilitates Effect of Motor Training on Motor Learning	PLOS ONE			English	Article								It is believed that gene/environment interaction (GEI) plays a pivotal role in the development of motor skills, which are acquired via practicing or motor training. However, the underlying molecular/neuronal mechanisms are still unclear. Here, we reported that the expression of NR2B, a subunit of NMDA receptors, in cerebellar granule cells specifically enhanced the effect of voluntary motor training on motor learning in the mouse. Moreover, this effect was characterized as motor learning-specific and developmental stage-dependent, because neither emotional/spatial memory was affected nor was the enhanced motor learning observed when the motor training was conducted starting at the age of 3 months old in these transgenic mice. These results indicate that changes in the expression of gene(s) that are involved in regulating synaptic plasticity in cerebellar granule cells may constitute a molecular basis for the cerebellum to be involved in the GEI by facilitating motor skill learning.	[Jiao, Jianwei; Nakajima, Akira; Xiong, Xiaoli; Tang, Ya-Ping] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; [Janssen, William G. M.; Morrison, John H.] Mount Sinai Sch Med, Dept Neurosci, New York, NY USA; [Bindokas, Vytautas P.] Univ Chicago, Dept Neurobiol, Pharmacol, & Physiol, Chicago, IL USA; [Brorson, James R.] Univ Chicago, Dept Neurol, Chicago, IL USA	University of Chicago; Icahn School of Medicine at Mount Sinai; University of Chicago; University of Chicago	Jiao, JW (corresponding author), Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA.	yptang@bsd.uchicago.edu	Nakajima, Akira/I-7077-2014; Tang, Ya-Ping/A-1035-2011; Morrison, John/F-9229-2012	Xiong, Xiaoli/0000-0002-4623-4326; Tang, Ya-Ping/0000-0002-0445-4072	NIMH/NIH [MH066243]; Alzheimer's Association [NIRG-02-4368]; NSF [0213112]; Brain Research Foundation (Chicago); Louis Block Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066243] Funding Source: NIH RePORTER	NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Alzheimer's Association(Alzheimer's Association); NSF(National Science Foundation (NSF)); Brain Research Foundation (Chicago); Louis Block Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was partially supported by grants from NIMH/NIH (MH066243), Alzheimer's Association (NIRG-02-4368), NSF (0213112), Brain Research Foundation (Chicago), and Louis Block Foundation, all to YPT.	AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bahn S, 1997, P NATL ACAD SCI USA, V94, P9417, DOI 10.1073/pnas.94.17.9417; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; BARNES R H, 1970, Journal of Nutrition, V100, P149; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Bergersen L, 2003, EUR J NEUROSCI, V18, P931, DOI 10.1046/j.1460-9568.2003.02828.x; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; Bloedel JR, 2004, PROG BRAIN RES, V143, P319, DOI 10.1016/S0079-6123(03)43031-8; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; BRORSON JR, 1991, J NEUROSCI, V11, P4024; Brutsaert TD, 2006, RESP PHYSIOL NEUROBI, V151, P109, DOI 10.1016/j.resp.2005.12.013; Butefisch CM, 2004, J NEUROPHYSIOL, V91, P2110, DOI 10.1152/jn.01038.2003; Chen GX, 2000, BRAIN RES, V887, P144, DOI 10.1016/S0006-8993(00)03005-5; CHEN Q, 2007, NEUROBIOL DIS; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; FLEISHMAN EA, 1960, J EXP PSYCHOL, V60, P162, DOI 10.1037/h0044953; Fox PW, 1996, NATURE, V384, P356, DOI 10.1038/384356a0; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Heck AL, 2004, NUTRITION, V20, P598, DOI 10.1016/j.nut.2004.04.010; Hilber P, 2001, NEUROSCIENCE, V102, P615, DOI 10.1016/S0306-4522(00)00509-1; HOGAN B, 1994, MANIPULATION MOUSE E; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kishimoto Y, 1997, NEUROREPORT, V8, P3717, DOI 10.1097/00001756-199712010-00012; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Levin SI, 2006, J NEUROPHYSIOL, V96, P785, DOI 10.1152/jn.01193.2005; Llansola M, 2005, CEREBELLUM, V4, P154, DOI 10.1080/14734220510007996; Llinas R, 1993, Curr Opin Neurobiol, V3, P958, DOI 10.1016/0959-4388(93)90168-X; Maia JAR, 2002, AM J PREV MED, V23, P87, DOI 10.1016/S0749-3797(02)00478-6; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; McGue M, 1998, ANNU REV NEUROSCI, V21, P1, DOI 10.1146/annurev.neuro.21.1.1; MEIRI N, 1994, P NATL ACAD SCI USA, V91, P3196, DOI 10.1073/pnas.91.8.3196; Merrill KA, 1999, BEHAV GENET, V29, P95, DOI 10.1023/A:1021656405314; Montgomery H, 1999, LANCET, V353, P541, DOI 10.1016/S0140-6736(98)07131-1; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nyberg L, 2006, NEUROPSYCHOLOGIA, V44, P711, DOI 10.1016/j.neuropsychologia.2005.08.006; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rogers RG, 2006, OBSTET GYN CLIN N AM, V33, P297, DOI 10.1016/j.ogc.2006.02.004; Rondi-Reig L, 2002, BEHAV BRAIN RES, V132, P11, DOI 10.1016/S0166-4328(01)00381-3; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Takehara K, 2004, NEUROSCI LETT, V364, P43, DOI 10.1016/j.neulet.2004.04.024; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Toga AW, 2005, ANNU REV NEUROSCI, V28, P1, DOI 10.1146/annurev.neuro.28.061604.135655; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.3.CO;2-J; Wallen K, 1996, HORM BEHAV, V30, P364, DOI 10.1006/hbeh.1996.0042; WATANABE M, 1994, J COMP NEUROL, V343, P513, DOI 10.1002/cne.903430402; Wei F, 2001, NAT NEUROSCI, V4, P164, DOI 10.1038/83993; Welsh JP, 2005, P NATL ACAD SCI USA, V102, P17166, DOI 10.1073/pnas.0508191102; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Yamamoto M, 2003, J NEUROSCI, V23, P6759	74	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1684	10.1371/journal.pone.0001684	http://dx.doi.org/10.1371/journal.pone.0001684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301761	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500028
J	Leroux-Roels, I; Bernhard, R; Gerard, P; Drame, M; Hanon, E; Leroux-Roels, G				Leroux-Roels, Isabel; Bernhard, Roger; Gerard, Pascal; Drame, Mamadou; Hanon, Emmanuel; Leroux-Roels, Geert			Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine	PLOS ONE			English	Article								Background: The availability of H5N1 vaccines that can elicit a broad cross-protective immunity against different currently circulating clade 2 H5N1 viruses is a pre-requisite for the development of a successful pre-pandemic vaccination strategy. In this regard, it has recently been shown that adjuvantation of a recombinant clade 1 H5N1 inactivated split-virion vaccine with an oil-in-water emulsion-based adjuvant system also promoted cross-immunity against a recent clade 2 H5N1 isolate (A/Indonesia/5/2005, subclade 2.1). Here we further analyse the cross-protective potential of the vaccine against two other recent clade 2 isolates (A/turkey/Turkey/1/2005 and A/Anhui/1/2005 which are, as defined by WHO, representatives of subclades 2.2 and 2.3 respectively). Methods and Findings: Two doses of the recombinant A/Vietnam/1194/2004 (H5N1, clade 1) vaccine were administered 21 days apart to volunteers aged 18-60 years. We studied the cross-clade immunogenicity of the lowest antigen dose (3.8 mu g haemagglutinin) given with (N = 20) or without adjuvant (N = 20). Immune responses were assessed at 21 days following the first and second vaccine doses and at 6 months following first vaccination. Vaccination with two doses of 3.8 mg of the adjuvanted vaccine induced four-fold neutralising seroconversion rates in 85% of subjects against A/turkey/Turkey/1/2005 (subclade 2.2) and 75% of subjects against A/Anhui/1/2005 (subclade 2.3) recombinant strains. There was no response induced against these strains in the non-adjuvanted group. At 6 months following vaccination, 70% and 60% of subjects retained neutralising antibodies against the recombinant subclade 2.2 and 2.3 strains, respectively and 40% of subjects retained antibodies against the recombinant subclade 2.1 A/Indonesia/5/2005 strain. Conclusions: In addition to antigen dose-sparing, adjuvantation of inactivated split H5N1 vaccine promotes broad and persistent cross-clade immunity which is a pre-requisite for a pre-pandemic vaccine.	[Leroux-Roels, Isabel; Leroux-Roels, Geert] Ghent Univ & Hosp, Ctr Vaccinol, Ghent, Belgium; [Bernhard, Roger] GlaxoSmithKline Biologicals, Dresden, Germany; [Gerard, Pascal; Drame, Mamadou; Hanon, Emmanuel] GlaxoSmithKline Biologicals, Rixensart, Belgium	Ghent University; Ghent University Hospital; GlaxoSmithKline; GlaxoSmithKline	Leroux-Roels, I (corresponding author), Ghent Univ & Hosp, Ctr Vaccinol, Ghent, Belgium.	Geert.LerouxRoels@UGent.be			GSK Biologicals	GSK Biologicals(GlaxoSmithKline)	GSK Biologicals was the funding source and was involved in all stages of the study conduct and analysis.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Claas ECJ, 1998, LANCET, V351, P1292; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; CLAAS ECJ, 1998, LANCET          0425; *EUR COMM PROP MED, 2004, GUID DOSS STRUCT CON; *EUR COMM PROPR ME, COMM MED PROD HUM US; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; HEHME N, 2006, INT C INFL VACC WORL; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Sambhara S, 2006, LANCET, V367, P1636, DOI 10.1016/S0140-6736(06)68657-1; Shortridge KF, 2006, LANCET, V367, P1374, DOI 10.1016/S0140-6736(06)68512-7; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *US FDA, 2007, 1 BIRD FLU VACC HUM; *US FDA, GUID CLIN DAT NEED S; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; *WHO, CUM NUM CONF CAS AV; *WHO, 2007, ANT GEN CHAR H5N1 VI; *WHO, WHO GLOB PAND INFL A; World Health Organization, AV INFL ASS PAND THR; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	32	133	152	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1665	10.1371/journal.pone.0001665	http://dx.doi.org/10.1371/journal.pone.0001665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301743	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500010
J	Perel, P; Miranda, JJ; Ortiz, Z; Casas, JP				Perel, Pablo; Miranda, J. Jaime; Ortiz, Zulma; Casas, Juan Pablo			Relation between the Global Burden of Disease and Randomized Clinical Trials Conducted in Latin America Published in the Five Leading Medical Journals	PLOS ONE			English	Article							COUNTRIES; AFRICA	Background: Since 1990 non communicable diseases and injuries account for the majority of death and disability-adjusted life years in Latin America. We analyzed the relationship between the global burden of disease and Randomized Clinical Trials (RCTs) conducted in Latin America that were published in the five leading medical journals. Methodology/Principal Findings: We included all RCTs in humans, exclusively conducted in Latin American countries, and published in any of the following journals: Annals of Internal Medicine, British Medical Journal, Journal of the American Medical Association, Lancet, and New England Journal of Medicine. We described the trials and reported the number of RCTs according to the main categories of the global burden of disease. Sixty-six RCTs were identified. Communicable diseases accounted for 38 (57%) reports. Maternal, perinatal, and nutritional conditions accounted for 19 (29%) trials. Non-communicable diseases represent 48% of the global burden of disease but only 14% of reported trials. No trial addressed injuries despite its 18% contribution to the burden of disease in 2000. Conclusions/Significance: A poor correlation between the burden of disease and RCTs publications was found. Non communicable diseases and injuries account for up to two thirds of the burden of disease in Latin America but these topics are seldom addressed in published RCTs in the selected sample of journals. Funding bodies of health research and editors should be aware of the increasing burden of non communicable diseases and injuries occurring in Latin America to ensure that this growing epidemic is not neglected in the research agenda and not affected by publication bias.	[Perel, Pablo; Miranda, J. Jaime; Casas, Juan Pablo] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru; [Ortiz, Zulma] Natl Acad Med, Epidemiol Res Inst, Buenos Aires, DF, Argentina	University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; Buenos Aires National Academy of Medicine; IIE - Instituto de Investigaciones Epidemiologicas	Perel, P (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	jaime.miranda@lshtm.ac.uk	Miranda, J. Jaime/A-8482-2008	Miranda, J. Jaime/0000-0002-4738-5468; /0000-0002-2342-301X	Wellcome Trust Research Training Fellowship [GR074833MA]	Wellcome Trust Research Training Fellowship(Wellcome Trust)	JJM is supported by a Wellcome Trust Research Training Fellowship (GR074833MA). The authors have no additional support or funding to report.	[Anonymous], 2006, LANCET, V368, P619; [Anonymous], 1996, GLOBAL BURDEN DIS CO; BAKKE P, 1985, SCIENTOMETRICS, V1, P11; Bruzzi P, 2008, BMJ-BRIT MED J, V336, P1, DOI 10.1136/bmj.39416.559942.BE; Doval HC, 2005, BMJ-BRIT MED J, V331, P425, DOI 10.1136/bmj.38516.398067.E0; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; *GLOB FOR HLTH RES, 2002, 1090 GLOB FOR HLTH R; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; HIGGINS JPT, 2005, COCHRANE LIB, V1; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Keiser J, 2004, BMJ-BRIT MED J, V328, P1229, DOI 10.1136/bmj.38069.518137.F6; Kenyon S, 2002, BJOG-INT J OBSTET GY, V109, P1341; Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; OBUAYA CC, 2002, EURO SCI EDIT, V28, P72; Perel P, 2006, PLOS MED, V3, P1448, DOI 10.1371/journal.pmed.0030344; Reveiz L, 2006, REV PANAM SALUD PUBL, V19, P417, DOI 10.1590/S1020-49892006000600014; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; Sumathipala Athula, 2004, BMC Med Ethics, V5, pE5	25	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1696	10.1371/journal.pone.0001696	http://dx.doi.org/10.1371/journal.pone.0001696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301772	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000260586500040
J	Dewals, B; Boudry, C; Farnir, F; Drion, PV; Vanderplasschen, A				Dewals, Benjamin; Boudry, Christel; Farnir, Frederic; Drion, Pierre-Vincent; Vanderplasschen, Alain			Malignant Catarrhal Fever Induced by Alcelaphine herpesvirus 1 Is Associated with Proliferation of CD8(+) T Cells Supporting a Latent Infection	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; BLUE WILDEBEEST; NUCLEAR ANTIGEN; HTLV-I; VIRUS; DNA; LYMPHOCYTES; EXPRESSION; GENES; BROMODEOXYURIDINE	Alcelaphine herpesvirus 1 (AlHV-1), carried by wildebeest asymptomatically, causes malignant catarrhal fever (WD-MCF) when cross-species transmitted to a variety of susceptible species of the Artiodactyla order. Experimentally, WD-MCF can be induced in rabbits. The lesions observed are very similar to those described in natural host species. Here, we used the rabbit model and in vivo 5-Bromo-2'-Deoxyuridine (BrdU) incorporation to study WD-MCF pathogenesis. The results obtained can be summarized as follows. (i) AlHV-1 infection induces CD8(+) T cell proliferation detectable as early as 15 days post-inoculation. (ii) While the viral load in peripheral blood mononuclear cells remains below the detection level during most of the incubation period, it increases drastically few days before death. At that time, at least 10% of CD8(+) cells carry the viral genome; while CD11b(+), IgM(+) and CD4(+) cells do not. (iii) RT-PCR analyses of mononuclear cells isolated from the spleen and the popliteal lymph node of infected rabbits revealed no expression of ORF25 and ORF9, low or no expression of ORF50, and high or no expression of ORF73. Based on these data, we propose a new model for the pathogenesis of WD-MCF. This model relies on proliferation of infected CD8(+) cells supporting a predominantly latent infection.	[Dewals, Benjamin; Boudry, Christel; Vanderplasschen, Alain] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium; [Farnir, Frederic] Univ Liege, Fac Vet Med, Dept Clin Sci, Biostat B43, Liege, Belgium; [Drion, Pierre-Vincent] Univ Liege, Animal Fac B23, Liege, Belgium	University of Liege; University of Liege; University of Liege	Dewals, B (corresponding author), Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Immunol Vaccinol B43b, Liege, Belgium.	A.vdplasschen@ulg.ac.be	Dewals, Benjamin G./AAL-5754-2021	Dewals, Benjamin G./0000-0003-1497-0799	Fonds National Belge de la Recherche Scientifique (FNRS); Fonds pour la formation a la Recherche dans lIndustrie et dans lAgriculture (FRIA) [research fellow]	Fonds National Belge de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans lIndustrie et dans lAgriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	B. Dewals is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS). C. Boudry is a Research Fellow of the Fonds pour la formation a la Recherche dans lIndustrie et dans lAgriculture (FRIA). This work was supported by various grants of the FNRS.	Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Boudry C, 2007, J GEN VIROL, V88, P3224, DOI 10.1099/vir.0.83153-0; BRIDGEN A, 1992, J COMP PATHOL, V106, P351, DOI 10.1016/0021-9975(92)90021-L; BUXTON D, 1980, VET REC, V106, P243, DOI 10.1136/vr.106.11.243; Calderwood M, 2005, J GEN VIROL, V86, P2703, DOI 10.1099/vir.0.81230-0; Castro AE, 1985, BOVINE PRACT, V20, P162; Collins CM, 2002, J GEN VIROL, V83, P2269, DOI 10.1099/0022-1317-83-9-2269; Collins CM, 2002, ADV CANCER RES, V84, P155, DOI 10.1016/S0065-230X(02)84005-2; Dewals B, 2006, J GEN VIROL, V87, P509, DOI 10.1099/vir.0.81465-0; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; EDINGTON N, 1979, EUR J CANCER, V15, P1515, DOI 10.1016/0014-2964(79)90033-1; FRAME FM, 2007, VET RES COMMUN; Gillet L, 2004, J VIROL, V78, P2336, DOI 10.1128/JVI.78.5.2336-2347.2004; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Hair JR, 2007, J GEN VIROL, V88, P1689, DOI 10.1099/vir.0.82548-0; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Hanon E, 1996, J VIROL, V70, P4116, DOI 10.1128/JVI.70.6.4116-4120.1996; Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392; Holm M, 1998, CYTOMETRY, V32, P28, DOI 10.1002/(SICI)1097-0320(19980501)32:1<28::AID-CYTO4>3.0.CO;2-B; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; KRISS JP, 1962, CANCER RES, V22, P254; LI H, 1995, J GEN VIROL, V76, P123, DOI 10.1099/0022-1317-76-1-123; Li H, 2000, J CLIN MICROBIOL, V38, P1313, DOI 10.1128/JCM.38.4.1313-1318.2000; Liu SF, 2000, J VIROL, V74, P2029, DOI 10.1128/JVI.74.4.2029-2037.2000; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; NAKAJIMA Y, 1994, J VET MED SCI, V56, P1065, DOI 10.1292/jvms.56.1065; PATEL JR, 1981, ARCH VIROL, V68, P321, DOI 10.1007/BF01314589; PLOWRIGHT W, 1960, NATURE, V188, P1167, DOI 10.1038/1881167a0; Plowright W., 1990, Virus infections of ruminants., P123; PLOWRIGHT W, 1968, J AM VET MED ASSOC, V152, P795; PLOWRIGHT W, 1975, RES VET SCI, V19, P159, DOI 10.1016/S0034-5288(18)33526-4; PLOWRIGHT W, 1965, RES VET SCI, V6, P56; Raftery MJ, 1999, J EXP MED, V190, P1103, DOI 10.1084/jem.190.8.1103; Renne R, 1998, J VIROL, V72, P5182, DOI 10.1128/JVI.72.6.5182-5188.1998; ROCHA B, 1990, EUR J IMMUNOL, V20, P1697, DOI 10.1002/eji.1830200812; Rosbottom J, 2002, J GEN VIROL, V83, P2999, DOI 10.1099/0022-1317-83-12-2999; Rossiter P B, 1985, Prog Vet Microbiol Immunol, V1, P121; Schock A, 1996, VET MICROBIOL, V53, P111, DOI 10.1016/S0378-1135(96)01239-4; Simon S, 2003, J GEN VIROL, V84, P2009, DOI 10.1099/vir.0.19048-0; SIVAKUMAR R, 2007, J VIROL; Swa S, 2001, IMMUNOLOGY, V102, P44, DOI 10.1046/j.1365-2567.2001.01154.x; Thonur L, 2006, VIRUS GENES, V32, P27, DOI 10.1007/s11262-005-5842-3; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Traul DL, 2005, J VIROL METHODS, V129, P186, DOI 10.1016/j.jviromet.2005.05.021; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; Zhao TM, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-34	47	37	37	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1627	10.1371/journal.pone.0001627	http://dx.doi.org/10.1371/journal.pone.0001627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286184	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400020
J	Kolatkar, A; Kennedy, K; Halabuk, D; Kunken, J; Marrinucci, D; Bethel, K; Guzman, R; Huckaby, T; Kuhn, P				Kolatkar, Anand; Kennedy, Kevin; Halabuk, Dan; Kunken, Josh; Marrinucci, Dena; Bethel, Kelly; Guzman, Rodney; Huckaby, Tim; Kuhn, Peter			C-ME: A 3D Community-Based, Real-Time Collaboration Tool for Scientific Research and Training	PLOS ONE			English	Article								The need for effective collaboration tools is growing as multidisciplinary proteome-wide projects and distributed research teams become more common. The resulting data is often quite disparate, stored in separate locations, and not contextually related. Collaborative Molecular Modeling Environment (C-ME) is an interactive community-based collaboration system that allows researchers to organize information, visualize data on a two-dimensional (2-D) or three-dimensional (3-D) basis, and share and manage that information with collaborators in real time. C-ME stores the information in industry-standard databases that are immediately accessible by appropriate permission within the computer network directory service or anonymously across the internet through the C-ME application or through a web browser. The system addresses two important aspects of collaboration: context and information management. C-ME allows a researcher to use a 3-D atomic structure model or a 2-D image as a contextual basis on which to attach and share annotations to specific atoms or molecules or to specific regions of a 2-D image. These annotations provide additional information about the atomic structure or image data that can then be evaluated, amended or added to by other project members.	[Kolatkar, Anand; Kunken, Josh; Marrinucci, Dena; Kuhn, Peter] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Bethel, Kelly] Scripps Clin, Dept Pathol, La Jolla, CA USA; [Kennedy, Kevin; Halabuk, Dan; Guzman, Rodney; Huckaby, Tim] Interknowlogy, Carlsbad, CA USA	Scripps Research Institute; Scripps Research Institute	Kolatkar, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	pkuhn@scripps.edu		Bethel, Kelly/0000-0002-7005-8641	Microsoft Corporation; National Institutes of Health [U54GM074961, HHSN 266200400058C, R01CA11359]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	Microsoft Corporation(Microsoft); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Microsoft Corporation as well as the National Institutes of Health grants U54GM074961, HHSN 266200400058C, and R01CA11359. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 2006, TRENDS BIOCHEM SCI, V31, P76, DOI 10.1016/j.tibs.2005.12.006; Beltrao P, 2007, CURR OPIN STRUC BIOL, V17, P378, DOI 10.1016/j.sbi.2007.05.005; Bhandarkar M, 1999, SIMUL SERIES, V31, P242; BLY S, 1998, INTERACTIONS, V5, P31; Bourne P, 1998, Pac Symp Biocomput, P118; CHIN G, 2004, P 2004 ACM C COMP SU, P409; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; KHAMSI R, 2005, REFERENCE REVOLUTION; MYERS JD, 2004, 227 AM CHEM SOC ACS; PETZOLD C, 2006, APPL CODE MARKUP GUI; RICHARDSON DC, 1992, PROTEIN SCI, V1, P3; Tapscott D., 2006, WIKINOMICS MASS COLL	13	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1621	10.1371/journal.pone.0001621	http://dx.doi.org/10.1371/journal.pone.0001621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286178	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400014
J	Mathevon, N; Aubin, T; Vielliard, J; da Silva, ML; Sebe, F; Boscolo, D				Mathevon, Nicolas; Aubin, Thierry; Vielliard, Jacques; da Silva, Maria-Luisa; Sebe, Frederic; Boscolo, Danilo			Singing in the Rain Forest: How a Tropical Bird Song Transfers Information	PLOS ONE			English	Article							ACOUSTIC-SIGNAL; HABITAT; SELECTION; EVOLUTION; ECOLOGY; SOUND; CALL	How information transmission processes between individuals are shaped by natural selection is a key question for the understanding of the evolution of acoustic communication systems. Environmental acoustics predict that signal structure will differ depending on general features of the habitat. Social features, like individual spacing and mating behavior, may also be important for the design of communication. Here we present the first experimental study investigating how a tropical rainforest bird, the white-browed warbler Basileuterus leucoblepharus, extracts various information from a received song: species-specific identity, individual identity and location of the sender. Species-specific information is encoded in a resistant acoustic feature and is thus a public signal helping males to reach a wide audience. Conversely, individual identity is supported by song features susceptible to propagation: this private signal is reserved for neighbors. Finally, the receivers can locate the singers by using propagation-induced song modifications. Thus, this communication system is well matched to the acoustic constraints of the rain forest and to the ecological requirements of the species. Our results emphasize that, in a constraining acoustic environment, the efficiency of a sound communication system results from a coding/decoding process particularly well tuned to the acoustic properties of this environment.	[Mathevon, Nicolas; Aubin, Thierry; Sebe, Frederic] Univ Paris 11, CNRS, Equipe Commun Acoust NAMC, UMR8620, F-91405 Orsay, France; [Mathevon, Nicolas] Univ St Etienne, Lab Ecol & Neuro Ethol Sensorielles, EA 3988, St Etienne, France; [Vielliard, Jacques] Univ Estadual Campinas, Inst Biol, Lab Bioacust, Sao Paulo, Brazil; [da Silva, Maria-Luisa] Univ Sao Paulo, Inst Biol, Lab Ecol Paisagem Conserv, Sao Paulo, Brazil; [da Silva, Maria-Luisa] Univ Fed Para, Campus Univ Guama, Ctr Ciencias Biol, Belem, Para, Brazil	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite Jean Monnet; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal do Para	Mathevon, N (corresponding author), Univ Paris 11, CNRS, Equipe Commun Acoust NAMC, UMR8620, F-91405 Orsay, France.	mathevon@univ-st-etienne.fr; thierry.aubin@u-psud.fr	Boscolo, Danilo/I-8655-2019	Boscolo, Danilo/0000-0002-0741-501X; SEBE, Frederic/0000-0003-0264-9519; Mathevon, Nicolas/0000-0003-0219-6601	Centre National de la Recherche Scientifique (CNRS) in France; BIOTA-FAPESP program in Brazil	Centre National de la Recherche Scientifique (CNRS) in France(Centre National de la Recherche Scientifique (CNRS)); BIOTA-FAPESP program in Brazil	This study was supported by the Centre National de la Recherche Scientifique (CNRS) in France and the BIOTA-FAPESP program in Brazil.	Aubin T, 2004, AN ACAD BRAS CIENC, V76, P335, DOI 10.1590/S0001-37652004000200022; Aubin T, 2002, J EXP BIOL, V205, P3793; AUBIN T, 1994, BIOACOUSTICS, V6, P80; Becker P.H., 1982, P213; Boncoraglio G, 2007, FUNCT ECOL, V21, P134, DOI 10.1111/j.1365-2435.2006.01207.x; Boscolo D, 2006, AN ACAD BRAS CIENC, V78, P629, DOI 10.1590/S0001-37652006000400003; BOWMAN R I, 1979, Journal fuer Ornithologie, V120, P353, DOI 10.1007/BF01642911; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; CLARK CW, 1987, ETHOLOGY, V76, P101; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hauser, 1996, EVOL COMMUN; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Khanna H., 1997, Bioacoustics, V7, P209; Kroodsma Donald E., 1996, P269; Marler P., 2004, NATURES MUSIC SCI BI; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P291, DOI 10.1007/BF00299741; McGregor Peter K., 1996, P409; McGregor PK, 2005, ANIMAL COMMUNICATION; Miller E.H., 1982, P253; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Naguib M, 2001, ANIM BEHAV, V62, P825, DOI 10.1006/anbe.2001.1860; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Specht R., 2004, AVISOFT SAS LAB PRO; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Wiley R. H., 1982, ACOUSTIC COMMUNICATI, P131; WILLIAMS JM, 1993, IBIS, V135, P202, DOI 10.1111/j.1474-919X.1993.tb02833.x; [No title captured]; [No title captured]	35	43	45	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1580	10.1371/journal.pone.0001580	http://dx.doi.org/10.1371/journal.pone.0001580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270571	Green Submitted, gold, Green Published			2022-12-27	WOS:000260535900016
J	Woo, H; Okamoto, S; Guiney, D; Gunn, JS; Fierer, J				Woo, Heungjeong; Okamoto, Sharon; Guiney, Donald; Gunn, John S.; Fierer, Joshua			A Model of Salmonella Colitis with Features of Diarrhea in SLC11A1 Wild-Type Mice	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM COLITIS; EPITHELIAL-CELLS; PATHOGENICITY ISLAND-1; RESISTANCE; INFECTION; DISEASE; PROTEIN; VIRULENCE; GENES; PATHOGENESIS	Background: Mice do not get diarrhea when orally infected with S. enterica, but pre-treatment with oral aminoglycosidesmakes them susceptible to Salmonella colitis. However, genetically susceptible ItyS mice (Nramp1(G169D) allele) die from systemic infection before they develop diarrhea, so a new model is needed to study the pathogenesis of diarrhea. We pretreated ItyR mice (Nramp1(G169)) with oral kanamycin prior to infecting them with virulent S. Typhimurium strain 14028s in order to study Salmonella-induced diarrhea. We used both a visual scoring system and the measurement of fecal water content to measure diarrhea. BALB/c.D2(Nramp1) congenic started losing weight 5 days post-infection and they began to die from colitis 10-14 days after infection. A SPI-1 (invA) mutant caused cecal, but not colonic inflammation and did not cause diarrhea. A phoP-mutant did not cause manifestations of diarrhea in either normal or NADPH-deficient (gp91(phox)) mice. However, strain 14028s caused severe colitis and diarrhea in gp91(phox)-deficient mice on an ItyR background. pmr A and F mutants, which are less virulent in orally infected BALB/c mice, were fully virulent in this model of colitis. Conclusions: S. enterica must be able to invade the colonic epithelium and to persist in the colon in order to cause colitis with manifestations of diarrhea. The NADPH oxidase is not required for diarrhea in Salmonella colitis. Furthermore, a Salmonella phoP mutant can be cleared from the colon by non-oxidative host defenses.	[Woo, Heungjeong; Okamoto, Sharon; Fierer, Joshua] VA Healthcare, Dept Infect Dis, San Diego, CA USA; [Guiney, Donald; Fierer, Joshua] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, San Diego, CA USA; [Gunn, John S.] Ohio State Univ, Ctr Microb Interface Biol, Dept Mol Virol, Immunol, & Med Genet, Columbus, OH USA	University of California System; University of California San Diego; University System of Ohio; Ohio State University	Woo, H (corresponding author), VA Healthcare, Dept Infect Dis, San Diego, CA USA.	jfierer@ucsd.edu	Gunn, John/E-3167-2011; , jfierer/W-2823-2019		 [AI047884];  [AI32178];  [DK35108];  [AI043521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047884, R01AI032178, R29AI043521, R56AI032178, R01AI043521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108] Funding Source: NIH RePORTER	; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by AI047884 (JF), AI32178 and DK35108 (DG), and AI043521 (JSG).	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; Bertelsen LS, 2004, AM J PHYSIOL-CELL PH, V287, pC939, DOI 10.1152/ajpcell.00413.2003; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; Chao HC, 2000, PEDIATR INFECT DIS J, V19, P1158, DOI 10.1097/00006454-200012000-00008; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; DAY DW, 1978, HISTOPATHOLOGY, V2, P117, DOI 10.1111/j.1365-2559.1978.tb01700.x; Dinauer MC, 1997, J IMMUNOL, V158, P5581; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Elewaut D, 1999, J IMMUNOL, V163, P1457; Ernst RK, 2001, MICROBES INFECT, V3, P1327, DOI 10.1016/S1286-4579(01)01494-0; Foster N, 2006, CYTOKINE, V36, P134, DOI 10.1016/j.cyto.2006.11.005; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1992, J BACTERIOL, V174, P4338; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Garg P, 2006, J IMMUNOL, V177, P4103, DOI 10.4049/jimmunol.177.6.4103; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; HEFFERNAN EJ, 1987, J INFECT DIS, V155, P1254, DOI 10.1093/infdis/155.6.1254; Helms M, 2005, EMERG INFECT DIS, V11, P859, DOI 10.3201/eid1106.041017; JONES BD, 1993, P NATL ACAD SCI USA, V90, P10390, DOI 10.1073/pnas.90.21.10390; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; MCGOVERN VJ, 1979, AM J SURG PATHOL, V3, P483, DOI 10.1097/00000478-197912000-00001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Nakao M, 2002, NUTRITION, V18, P35, DOI 10.1016/S0899-9007(01)00715-8; Nishimuta M, 2006, J NUTR SCI VITAMINOL, V52, P121, DOI 10.3177/jnsv.52.121; POTTER M, 1983, INFECT IMMUN, V40, P1234, DOI 10.1128/IAI.40.3.1234-1235.1983; ROBERTS T, 1989, AM J AGR ECON, V71, P468, DOI 10.2307/1241614; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; RUITENBERG EJ, 1971, BRIT J EXP PATHOL, V52, P192; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Stecher B, 2006, INFECT IMMUN, V74, P5047, DOI 10.1128/IAI.00072-06; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Valle E, 2005, INFECT IMMUN, V73, P2835, DOI 10.1128/IAI.73.5.2835-2840.2005; Varma JK, 2005, EMERG INFECT DIS, V11, P943; Vassiloyanakopoulos AP, 1998, P NATL ACAD SCI USA, V95, P7676, DOI 10.1073/pnas.95.13.7676; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	54	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1603	10.1371/journal.pone.0001603	http://dx.doi.org/10.1371/journal.pone.0001603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270590	gold, Green Published, Green Submitted			2022-12-27	WOS:000260535900037
J	Michels, G; Er, F; Khan, IF; Endres-Becker, J; Brandt, MC; Gassanov, N; Johns, DC; Hoppe, UC				Michels, Guido; Er, Fikret; Khan, Ismail F.; Endres-Becker, Jeannette; Brandt, Mathias C.; Gassanov, Natig; Johns, David C.; Hoppe, Uta C.			K+ Channel Regulator KCR1 Suppresses Heart Rhythm by Modulating the Pacemaker Current I-f	PLOS ONE			English	Article								Hyperpolarization-activated, cyclic nucleotide sensitive (HCN) channels underlie the pacemaker current I-f, which plays an essential role in spontaneous cardiac activity. HCN channel subunits (HCN1-4) are believed to be modulated by additional regulatory proteins, which still have to be identified. Using biochemistry, molecularbiology and electrophysiology methods we demonstrate a protein-protein interaction between HCN2 and the K+ channel regulator protein 1, named KCR1. In coimmunoprecipitation experiments we show that KCR1 and HCN2 proteins are able to associate. Heterologously expressed HCN2 whole-cell current density was significantly decreased by KCR1. KCR1 profoundly suppressed I-HCN2 single-channel activity, indicating a functional interaction between KCR1 and the HCN2 channel subunit. Endogenous KCR1 expression could be detected in adult and neonatal rat ventriculocytes. Adenoviral-mediated overexpression of KCR1 in rat cardiomyocytes (i) reduced I-f whole-cell currents, (ii) suppressed most single-channel gating parameters, (iii) altered the activation kinetics, (iv) suppressed spontaneous action potential activity, and (v) the beating rate. More importantly, siRNA-based knock-down of endogenous KCR1 increased the native I-f current size and single-channel activity and accelerated spontaneous beating rate, supporting an inhibitory action of endogenous KCR1 on native I-f. Our observations demonstrate for the first time that KCR1 modulates I-HCN2/I-f channel gating and indicate that KCR1 serves as a regulator of cardiac automaticity.	[Michels, Guido; Er, Fikret; Khan, Ismail F.; Endres-Becker, Jeannette; Brandt, Mathias C.; Gassanov, Natig; Hoppe, Uta C.] Univ Cologne, Dept Internal Med 3, Cologne, Germany; [Johns, David C.] Johns Hopkins Univ, Gene Vector Ctr, Baltimore, MD USA; [Hoppe, Uta C.] Univ Cologne, Ctr Mol Med, Cologne, Germany	University of Cologne; Johns Hopkins University; University of Cologne	Hoppe, UC (corresponding author), Univ Cologne, Dept Internal Med 3, Cologne, Germany.	uta.hoppe@uni-koeln.de	Brandt, Mathias/ABF-6631-2021		Deutsche Forschungsgemeinschaft [Ho 2146/3-1]; Koln Fortune; Marga und Walter Boll-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune; Marga und Walter Boll-Stiftung	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (Ho 2146/3-1), by Koln Fortune, and by the Marga und Walter Boll-Stiftung. Funders were not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BUGAISKY LB, 1989, CIRC RES, V64, P493, DOI 10.1161/01.RES.64.3.493; Chu SH, 2005, LIFE SCI, V76, P2735, DOI 10.1016/j.lfs.2004.12.013; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; DiFrancesco D, 2005, CIRCULATION, V112, pE72, DOI 10.1161/CIRCULATIONAHA.105.541367; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Er F, 2004, CIRCULATION, V110, P3100, DOI 10.1161/01.CIR.0000146900.84943.E0; Fischer M, 2005, J MOL DIAGN, V7, P89, DOI 10.1016/S1525-1578(10)60013-X; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hoppe UC, 1998, CIRCULATION, V97, P55, DOI 10.1161/01.CIR.97.1.55; Hoppe UC, 2000, J CLIN INVEST, V105, P1077, DOI 10.1172/JCI8757; Hoppe UC, 1999, CIRC RES, V84, P964; Hoppe UC, 2001, P NATL ACAD SCI USA, V98, P5335, DOI 10.1073/pnas.091239098; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Hoshi N, 1998, J BIOL CHEM, V273, P23080, DOI 10.1074/jbc.273.36.23080; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Kimura K, 2004, GENES CELLS, V9, P631, DOI 10.1111/j.1356-9597.2004.00752.x; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kupershmidt S, 2003, FASEB J, V17, P2263, DOI 10.1096/fj.02-1057fje; Lam JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001009; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Michels G, 2005, CIRCULATION, V111, P399, DOI 10.1161/01.CIR.0000153799.65783.3A; Michels G, 2002, MOL PHARMACOL, V61, P682, DOI 10.1124/mol.61.3.682; Michels G, 2006, ENDOCRINOLOGY, V147, P5160, DOI 10.1210/en.2006-0186; Nakajima T, 2007, J BIOL CHEM, V282, P5506, DOI 10.1074/jbc.M605976200; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Simeone TA, 2005, J PHYSIOL-LONDON, V568, P371, DOI 10.1113/jphysiol.2005.093161; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Tu HY, 2004, J NEUROSCI RES, V76, P713, DOI 10.1002/jnr.20109; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511	47	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1511	10.1371/journal.pone.0001511	http://dx.doi.org/10.1371/journal.pone.0001511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231597	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200023
J	de Jong, D; Jansen, R; Hoefnagels, W; Jellesma-Eggenkamp, M; Verbeek, M; Borm, G; Kremer, B				de Jong, Danielle; Jansen, Rene; Hoefnagels, Willibrord; Jellesma-Eggenkamp, Marja; Verbeek, Marcel; Borm, George; Kremer, Berry			No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial	PLOS ONE			English	Article								Background. The objective of this study was to determine whether treatment with the nonselective nonsteroidal anti-inflammatory drug (NSAID) indomethacin slows cognitive decline in patients with Alzheimer's disease (AD). Methodology/Principal Findings. This double-blind, randomized, placebo-controlled trial was conducted between May 2000 and September 2005 in two hospitals in the Netherlands. 51 patients with mild to moderate AD were enrolled into the study. Patients received 100 mg indomethacin or placebo daily for 12 months. Additionally, all patients received omeprazole. The primary outcome measure was the change from baseline after one year of treatment on the cognitive subscale of the AD Assessment Scale (ADAS-cog). Secondary outcome measures included the Mini-Mental State Examination, the Clinician's Interview Based Impression of Change with caregiver input, the noncognitive subscale of the ADAS, the Neuropsychiatric Inventory, and the Interview for Deterioration in Daily life in Dementia. Considerable recruitment problems of participants were encountered, leading to an underpowered study. In the placebo group, 19 out of 25 patients completed the study, and 19 out of 26 patients in the indomethacin group. The deterioration on the ADAS-cog was less in the indomethacin group (7.8 +/- 67.6), than in the placebo group (9.3 +/- 10.0). This difference (1.5 points; CI 24.5-7.5) was not statistically significant, and neither were any of the secondary outcome measures. Conclusions/Significance. The results of this study are inconclusive with respect to the hypothesis that indomethacin slows the progression of AD. Trial Registration. ClinicalTrials.gov NCT00432081	[de Jong, Danielle; Verbeek, Marcel; Kremer, Berry] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [de Jong, Danielle; Jansen, Rene; Hoefnagels, Willibrord] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Jansen, Rene; Hoefnagels, Willibrord; Verbeek, Marcel] Radboud Univ Nijmegen Med Ctr, Alzheimer Ctr Nijmegen, Nijmegen, Netherlands; [Verbeek, Marcel] Radboud Univ Nijmegen Med Ctr, Lab Pediat & Neurol, Nijmegen, Netherlands; [Borm, George] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands; [Jellesma-Eggenkamp, Marja] Rijnstate Hosp, Dept Geriat Med, Arnhem, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Rijnstate Hospital	de Jong, D (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	d.dejong@neuro.umcn.nl	Verbeek, Marcel M/D-1971-2010	Verbeek, Marcel M/0000-0003-4635-7876	Zon-MW Innovational Research [917.46.331]; Hersenstichting Nederland; Alzheimer Nederland; American Health Assistance Foundation [A2001-15]	Zon-MW Innovational Research; Hersenstichting Nederland; Alzheimer Nederland; American Health Assistance Foundation(BrightFocus Foundation)	Supported in part by grants from Zon-MW Innovational Research (no. 917.46.331), Hersenstichting Nederland, Alzheimer Nederland, and the American Health Assistance Foundation (A2001-15). Our study sponsors were not involved in the study design; collection, analysis, and interpretation of data; writing of the paper; or the decision to submit it for publication.	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Blom MAA, 1997, BRAIN RES, V777, P210, DOI 10.1016/S0006-8993(97)01204-3; Bour AMJJ, 2000, EXP GERONTOL, V35, P1017, DOI 10.1016/S0531-5565(00)00128-5; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Du ZY, 1999, INT J IMMUNOPHARMACO, V21, P219, DOI 10.1016/S0192-0561(98)00084-8; Dzenko KA, 1997, J NEUROIMMUNOL, V80, P6, DOI 10.1016/S0165-5728(97)00128-8; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Fagarasan MO, 1996, BRAIN RES, V723, P231, DOI 10.1016/0006-8993(96)00259-4; Fagarasan MO, 1996, MOL PSYCHIATR, V1, P398; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hirohata M, 2005, NEUROPHARMACOLOGY, V49, P1088, DOI 10.1016/j.neuropharm.2005.07.004; Hoozemans JJM, 2001, EXP GERONTOL, V36, P559, DOI 10.1016/S0531-5565(00)00226-6; Kadoyama K, 2001, BIOCHEM BIOPH RES CO, V281, P483, DOI 10.1006/bbrc.2001.4357; Kat M G, 2002, Tijdschr Gerontol Geriatr, V33, P150; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; KNOPMAN DS, 1994, NEUROLOGY, V44, P2315, DOI 10.1212/WNL.44.12.2315; Ma TC, 1997, ARZNEIMITTEL-FORSCH, V47, P595; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Netland EE, 1998, NEUROBIOL AGING, V19, P201, DOI 10.1016/S0197-4580(98)00047-5; Quinn J, 2003, J NEUROIMMUNOL, V137, P32, DOI 10.1016/S0165-5728(03)00037-7; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Soininen H, 2007, DEMENT GERIATR COGN, V23, P8, DOI 10.1159/000096588; Sung S, 2004, AM J PATHOL, V165, P2197, DOI 10.1016/S0002-9440(10)63269-5; Teunisse S, 1997, Int Psychogeriatr, V9 Suppl 1, P155, DOI 10.1017/S1041610297004845; Van Gool WA, 2001, LANCET, V358, P455, DOI 10.1016/S0140-6736(01)05623-9; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Yao YM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-21	34	110	112	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1475	10.1371/journal.pone.0001475	http://dx.doi.org/10.1371/journal.pone.0001475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213383	Green Published, gold			2022-12-27	WOS:000260503900020
J	Rizzolio, F; Bione, S; Sala, C; Tribioli, C; Ciccone, R; Zuffardi, O; di Iorgi, N; Maghnie, M; Toniolo, D				Rizzolio, Flavio; Bione, Silvia; Sala, Cinzia; Tribioli, Carla; Ciccone, Roberto; Zuffardi, Orsetta; di Iorgi, Natascia; Maghnie, Mohamad; Toniolo, Daniela			Highly Conserved Non-Coding Sequences and the 18q Critical Region for Short Stature: A Common Mechanism of Disease?	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; PITUITARY-HORMONE DEFICIENCY; KEY DEVELOPMENTAL GENES; GALANIN; CHROMOSOME; EXPRESSION; CHILDREN; PATIENT; FAMILY; MEMBER	Background. Isolated growth hormone deficiency (IGHD) and multiple pituitary hormone deficiency (MPHD) are heterogeneous disorders with several different etiologies and they are responsible for most cases of short stature. Mutations in different genes have been identified but still many patients did not present mutations in any of the known genes. Chromosomal rearrangements may also be involved in short stature and, among others, deletions of 18q23 defined a critical region for the disorder. No gene was yet identified. Methodology/Principal Findings. We now report a balanced translocation X; 18 in a patient presenting a breakpoint in 18q23 that was surprisingly mapped about 500 Kb distal from the short stature critical region. It separated from the flanking SALL3 gene a region enriched in highly conserved non-coding elements (HCNE) that appeared to be regulatory sequences, active as enhancers or silencers during embryonic development. Conclusion. We propose that, during pituitary development, the 18q rearrangement may alter expression of 18q genes or of X chromosome genes that are translocated next to the HCNEs. Alteration of expression of developmentally regulated genes by translocation of HCNEs may represent a common mechanism for disorders associated to isolated chromosomal rearrangements.	[Rizzolio, Flavio; Bione, Silvia; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Dept Biotechnol Res DIBIT, I-20132 Milan, Italy; [Bione, Silvia; Tribioli, Carla; Ciccone, Roberto; Zuffardi, Orsetta; Toniolo, Daniela] CNR, Inst Mol Genet, Pavia, Italy; Univ Pavia, Med Genet, Pavia, Italy; [di Iorgi, Natascia; Maghnie, Mohamad] Univ Genoa, IRCCS, Dept Pediat, Genoa, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Pavia; University of Genoa	Toniolo, D (corresponding author), Ist Sci San Raffaele, Dept Biotechnol Res DIBIT, I-20132 Milan, Italy.	daniela.toniolo@hsr.it	Di Iorgi, Natascia/AAB-8486-2021; Sala, Cinzia Felicita/AAN-1900-2020; Rizzolio, Flavio/K-2690-2018; Toniolo, Daniela/AAE-2969-2019	Di Iorgi, Natascia/0000-0002-4492-4585; Rizzolio, Flavio/0000-0002-3400-4363; Toniolo, Daniela/0000-0001-9545-6032; zuffardi, orsetta/0000-0002-1466-4559; Venkatasubramanian, Siddharth/0000-0002-5860-0768; TRIBIOLI, CARLA/0000-0003-2544-476X; Bione, Silvia/0000-0002-3924-4606; s, hema/0000-0002-3440-9475	Telethon Italy [MIUR-FIRB RBNE0189HM_005]; MIUR-Genomica Funzional [CNR02.00157.ST97]; Fondazione Cariplo; Ministero dell'Universita e della Ricerca [cofin05-MIUR]; Mariani Foundation [R-06-55]	Telethon Italy(Fondazione Telethon); MIUR-Genomica Funzional; Fondazione Cariplo(Fondazione Cariplo); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Mariani Foundation	This work was supported by Telethon Italy, by MIUR-FIRB RBNE0189HM_005, and MIUR-Genomica Funzional CNR02.00157.ST97, by the Fondazione Cariplo (to DT and OZ), by the Ministero dell'Universita e della Ricerca (MIUR) (cofin05-MIUR to OZ) and by the Mariani Foundation (R-06-55) (to OZ).	Baroukh N, 2005, MAMM GENOME, V16, P91, DOI 10.1007/s00335-004-2442-9; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bekiesinska-Figatowska M, 2001, NEURORADIOLOGY, V43, P875, DOI 10.1007/s002340100578; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cody JD, 1997, AM J MED GENET, V71, P420, DOI 10.1002/(SICI)1096-8628(19970905)71:4<420::AID-AJMG9>3.3.CO;2-A; Coffinier C, 2001, MECH DEVELOP, V100, P119, DOI 10.1016/S0925-4773(00)00507-4; Dattani MT, 2005, CLIN ENDOCRINOL, V63, P121, DOI 10.1111/j.1365-2265.2005.02289.x; Feenstra I, 2007, AM J MED GENET A, V143A, P1858, DOI 10.1002/ajmg.a.31850; Hale DE, 2000, J CLIN ENDOCR METAB, V85, P4450, DOI 10.1210/jc.85.12.4450; Kelberman D, 2006, ANN MED, V38, P560, DOI 10.1080/07853890600994963; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kohlhase J, 1999, GENOMICS, V62, P216, DOI 10.1006/geno.1999.6005; LARIZZA D, 1993, EUR J PEDIATR, V152, P424, DOI 10.1007/BF01955903; Lin JM, 2006, MOL CELL BIOL, V26, P4577, DOI 10.1128/MCB.02127-05; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Lundstrom L, 2005, NEUROMOL MED, V7, P157, DOI 10.1385/NMM:7:1-2:157; Mazarati A, 2004, NEUROSCIENCE, V128, P431, DOI 10.1016/j.neuroscience.2004.06.052; Mullis PE, 2007, ENDOCRIN METAB CLIN, V36, P17, DOI 10.1016/j.ecl.2006.11.010; Ott T, 2001, MECH DEVELOP, V101, P203, DOI 10.1016/S0925-4773(00)00552-9; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rainbow LA, 2005, CLIN ENDOCRINOL, V62, P163, DOI 10.1111/j.1365-2265.2004.02189.x; Rizzolio F, 2007, HUM GENET, V121, P441, DOI 10.1007/s00439-007-0329-z; Rizzolio F, 2007, GENE EXPR PATTERNS, V7, P529, DOI 10.1016/j.modgep.2006.10.005; Rizzolio F, 2006, HUM REPROD, V21, P1477, DOI 10.1093/humrep/dei495; Rosen KG, 2000, PRENAT NEONAT MED, V5, P155; Rosenfeld MG, 2000, RECENT PROG HORM RES, V55, P1; Rossetti F, 2004, EUR J HUM GENET, V12, P829, DOI 10.1038/sj.ejhg.5201186; ROSSI E, 1994, GENOMICS, V24, P34, DOI 10.1006/geno.1994.1579; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Walton KM, 2006, CURR OPIN DRUG DISC, V9, P560; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	33	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1460	10.1371/journal.pone.0001460	http://dx.doi.org/10.1371/journal.pone.0001460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213369	Green Submitted, Green Published, gold			2022-12-27	WOS:000260503900006
J	Beringue, V; Le Dur, A; Tixador, P; Reine, F; Lepourry, L; Perret-Liaudet, A; Haik, S; Vilotte, JL; Fontes, M; Laude, H				Beringue, Vincent; Le Dur, Annick; Tixador, Philippe; Reine, Fabienne; Lepourry, Laurence; Perret-Liaudet, Armand; Haik, Stephane; Vilotte, Jean-Luc; Fontes, Michel; Laude, Hubert			Prominent and Persistent Extraneural Infection in Human PrP Transgenic Mice Infected with Variant CJD	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; HUMAN PRION PROTEIN; BLOOD-TRANSFUSION; INCUBATION-TIME; TISSUE SAMPLES; SCRAPIE AGENT; VCJD; UK; CELLS; SUSCEPTIBILITY	Background. The evolution of the variant Creutzfeldt-Jakob disease (vCJD) epidemic is hazardous to predict due to uncertainty in ascertaining the prevalence of infection and because the disease might remain asymptomatic or produce an alternate, sporadic-like phenotype. Methodology/Principal Findings. Transgenic mice were produced that overexpress human prion protein with methionine at codon 129, the only allele found so far in vCJD-affected patients. These mice were infected with prions derived from variant and sporadic CJD (sCJD) cases by intracerebral or intraperitoneal route, and transmission efficiency and strain phenotype were analyzed in brain and spleen. We showed that i) the main features of vCJD infection in humans, including a prominent involvement of the lymphoid tissues compared to that in sCJD infection were faithfully reproduced in such mice; ii) transmission of vCJD agent by intracerebral route could lead to the propagation of either vCJD or sCJD-like prion in the brain, whereas vCJD prion was invariably propagated in the spleen, iii) after peripheral exposure, inefficient neuroinvasion was observed, resulting in an asymptomatic infection with life-long persistence of vCJD prion in the spleen at stable and elevated levels. Conclusion/Significance. Our findings emphasize the possibility that human-to-human transmission of vCJD might produce alternative neuropathogical phenotypes and that lymphoid tissue examination of CJD cases classified as sporadic might reveal an infection by vCJD-type prions. They also provide evidence for the strong propensity of this agent to establish long-lasting, subclinical vCJD infection of lymphoreticular tissues, thus amplifying the risk for iatrogenic transmission.	[Beringue, Vincent; Le Dur, Annick; Tixador, Philippe; Reine, Fabienne; Laude, Hubert] Inst Sci Rech Agron INRA, UR892, Jouy En Josas, France; [Lepourry, Laurence; Vilotte, Jean-Luc] Genet Biochim Cytogenet, Inst Sci Rech Agronom INRA, UR339, Jouy En Josas, France; [Perret-Liaudet, Armand] Grp Hosp Est Hopitaux Lyon, Ctr Biol Pathol CBPE, Serv Neurobiol, Bron, France; [Haik, Stephane] INSERM, Equipe Avenir, Maladies Prions lHomme, Paris, France; [Haik, Stephane] Assist Publ Hopit Paris AP HP, Lab Neuropathol R Escour, Grp Hosp Pitie Salpetriere, Paris, France; [Fontes, Michel] INSERM UMR 491 IPHM, Fac Med Timone, Marseille, France	INRAE; INRAE; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Beringue, V (corresponding author), Inst Sci Rech Agron INRA, UR892, Jouy En Josas, France.	vincent.beringue@jouy.inra.fr; hubert.laude@jouy.inra.fr	Vilotte, Jean-Luc/AAF-4688-2019; Haik, Stephane/M-7247-2018		INRA; Institut de Veille Sanitaire (InVS); Ministry of Research, France	INRA; Institut de Veille Sanitaire (InVS); Ministry of Research, France(Ministry of Research, France)	This work was supported by INRA, Institut de Veille Sanitaire (InVS) and the Ministry of Research, France. The sponsors of this study had no role in study conduct, collection analysis, interpretation of the data, writing of the report or approval of the manuscript.	Aguzzi A, 2006, NAT CLIN PRACT NEURO, V2, P321, DOI 10.1038/ncpneuro0214; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Beringue V, 2000, J VIROL, V74, P5432, DOI 10.1128/JVI.74.12.5432-5440.2000; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; COLLIS SC, 1985, FEMS MICROBIOL LETT, V29, P111; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Frosh A, 2004, LANCET, V364, P1260, DOI 10.1016/S0140-6736(04)17143-2; Glatzel M, 2003, LANCET NEUROL, V2, P757, DOI 10.1016/S1474-4422(03)00588-X; Hauw JJ, 2000, NEUROLOGY, V54, P1641, DOI 10.1212/WNL.54.8.1641; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Kitamoto T, 2002, BIOCHEM BIOPH RES CO, V294, P280, DOI 10.1016/S0006-291X(02)00476-X; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Minor P, 2004, J GEN VIROL, V85, P1777, DOI 10.1099/vir.0.79959-0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; SCHMIDT ML, 1995, AM J PATHOL, V147, P503; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Szakal AK, 2002, SEMIN IMMUNOL, V14, P267, DOI 10.1016/S1044-5323(02)00059-3; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Wadsworth JDF, 2007, GUT, V56, P90, DOI 10.1136/gut.2006.091637; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; EURO SURVEILL, V12	38	83	84	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1419	10.1371/journal.pone.0001419	http://dx.doi.org/10.1371/journal.pone.0001419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183299	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400015
J	Jupiter, DC; VanBuren, V				Jupiter, Daniel C.; VanBuren, Vincent			A Visual Data Mining Tool that Facilitates Reconstruction of Transcription Regulatory Networks	PLOS ONE			English	Article							GENE; EXPRESSION; INFERENCE; INFORMATION; MODELS	Background: Although the use of microarray technology has seen exponential growth, analysis of microarray data remains a challenge to many investigators. One difficulty lies in the interpretation of a list of differentially expressed genes, or in how to plan new experiments given that knowledge. Clustering methods can be used to identify groups of genes with similar expression patterns, and genes with unknown function can be provisionally annotated based on the concept of "guilt by association'', where function is tentatively inferred from the known functions of genes with similar expression patterns. These methods frequently suffer from two limitations: ( 1) visualization usually only gives access to group membership, rather than specific information about nearest neighbors, and ( 2) the resolution or quality of the relationships are not easily inferred. Methodology/Principal Findings: We have addressed these issues by improving the precision of similarity detection over that of a single experiment and by creating a tool to visualize tractable association networks: we ( 1) performed meta-analysis computation of correlation coefficients for all gene pairs in a heterogeneous data set collected from 2,145 publicly available micorarray samples in mouse, ( 2) filtered the resulting distribution of over 130 million correlation coefficients to build new, more tractable distributions from the strongest correlations, and ( 3) designed and implemented a new Web based tool (StarNet, http://vanburenlab.medicine.tamhsc.edu/starnet.html) for visualization of sub-networks of the correlation coefficients built according to user specified parameters. Conclusions/Significance: Correlations were calculated across a heterogeneous collection of publicly available microarray data. Users can access this analysis using a new freely available Web-based application for visualizing tractable correlation networks that are flexibly specified by the user. This new resource enables rapid hypothesis development for transcription regulatory relationships.	[Jupiter, Daniel C.; VanBuren, Vincent] Texas A&M Univ, Coll Med, Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, Temple, TX 76508 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Jupiter, DC (corresponding author), Texas A&M Univ, Coll Med, Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, Temple, TX 76508 USA.	vanburen@tamu.edu			American Heart Association [0630263N]; Department of Systems Biology and Translational Medicine and the Dean of the College of Medicine, Texas A & M Health Science Center	American Heart Association(American Heart Association); Department of Systems Biology and Translational Medicine and the Dean of the College of Medicine, Texas A & M Health Science Center	This work was funded by a Scientist Development Grant from the American Heart Association (Grant ID: 0630263N), and by start-up funds from the Department of Systems Biology and Translational Medicine and the Dean of the College of Medicine, Texas A & M Health Science Center. The project funders had no role in the design and conduct of the study, no role in the collection, analysis, and interpretation of the data, and no role in the preparation, review, or approval of the manuscript.	Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Bolstad B, 2005, BIOINFORMATICS COMPU; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Duselis AR, 2007, HUM MOL GENET, V16, P808, DOI 10.1093/hmg/ddm025; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hastie T, 2001, GENOME BIOL, V2; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaufman PJ L.R., 1990, FINDING GROUPS DATA; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rogers S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Weitzman Jonathan B, 2004, J Biol, V3, P19, DOI 10.1186/jbiol18	32	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1717	10.1371/journal.pone.0001717	http://dx.doi.org/10.1371/journal.pone.0001717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320038	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600013
J	de Miranda, MP; Alenquer, M; Marques, S; Rodrigues, L; Lopes, F; Bustelo, XR; Simas, JP				de Miranda, Marta Pires; Alenquer, Marta; Marques, Sofia; Rodrigues, Lenia; Lopes, Filipa; Bustelo, Xose R.; Simas, J. Pedro			The Gammaherpesvirus m2 Protein Manipulates the Fyn/Vav Pathway through a Multidocking Mechanism of Assembly	PLOS ONE			English	Article								To establish latent infections in B-cells, gammaherpesviruses express proteins in the infected B-cells of the host that spuriously activate signalling pathways located downstream of the B-cell receptor. One such protein is M2, a murine gammaherpesvirus 68-encoded molecule that activates the Vav1/Rac1 pathway via the formation of trimolecular complexes with Scr family members. Previous reports have shown that the formation of this heteromolecular complex involves interactions between a proline rich region of M2 and the Vav1 and Fyn SH3 domains. Here, we show that the optimal association of these proteins requires a second structural motif encompassing two tyrosine residues (Tyr120 and 129). These residues are inducibly phosphorylated by Fyn in non-hematopoietic cells and constitutively phosphorylated in B-cells. We also demonstrate that the phosphorylation of Tyr120 creates specific docking sites for the SH2 domains of both Vav1 and Fyn, a condition sine qua non for the optimal association of these two signalling proteins in vivo. Interestingly, signaling experiments indicate that the expression of M2 in B-cells promotes the tyrosine phosphorylation of Vav1 and additional signaling proteins, a biological process that requires the integrity of both the M2 phosphotyrosine and proline rich region motifs. By infecting mice with viruses mutated in the m2 locus, we show that the integrity of each of these two M2 docking motifs is essential for the early steps of murine gammaherpesvirus-68 latency. Taken together, these results indicate that the M2 phosphotyrosine motif and the previously described M2 proline rich region work in a concerted manner to manipulate the signaling machinery of the host B-cell.	[de Miranda, Marta Pires; Alenquer, Marta; Marques, Sofia; Rodrigues, Lenia; Lopes, Filipa; Simas, J. Pedro] Univ Lisbon, Fac Med, Inst Microbiol, P-1699 Lisbon, Portugal; [de Miranda, Marta Pires; Alenquer, Marta; Marques, Sofia; Rodrigues, Lenia; Lopes, Filipa; Simas, J. Pedro] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Bustelo, Xose R.] Univ Salamanca, CSIC, Ctr Investigac Canc, Inst Biol Mol Cel Canc, Salamanca, Spain	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); University of Salamanca	de Miranda, MP (corresponding author), Univ Lisbon, Fac Med, Inst Microbiol, P-1699 Lisbon, Portugal.	xbustelo@usal.es; psimas@fm.ul.pt	Bustelo, Xose R./A-9526-2010; Simas, J Pedro/M-5157-2013; Bustelo, Xose R./AAD-2081-2022	Bustelo, Xose R./0000-0001-9398-6072; Simas, J Pedro/0000-0001-6982-9253; Bustelo, Xose R./0000-0001-9398-6072; Alenquer, Marta/0000-0003-3062-1222; Marques, Sofia/0000-0003-1467-1529; Rodrigues, Lenia/0000-0003-4233-6170; Pires de Miranda, Marta/0000-0003-3733-4963	Portuguese Fundacao para a Ciencia e Tecnologia [POCI/SAU-IMI/57365/2004]; US National Cancer Institute/NIH [5R01-CA73735-11]; Spanish Ministry of Education and Science [SAF2006-01789]; Castilla-Leon Autonomous Government [SA053A05]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/0001]; Fondo de Investigaciones Sanitarias; Carlos III Institute; Spanish Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); US National Cancer Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Spanish Ministry of Education and Science(Spanish Government); Castilla-Leon Autonomous Government; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Carlos III Institute(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant to J.P.S. from the Portuguese Fundacao para a Ciencia e Tecnologia (POCI/SAU-IMI/57365/2004). X.R.B.'s work is supported by grants from the US National Cancer Institute/NIH (5R01-CA73735-11), the Spanish Ministry of Education and Science (MES) (SAF2006-01789), the Castilla-Leon Autonomous Government (SA053A05), and the Red Tematica de Investigacion Cooperativa en Cancer (RTICC) (RD06/0020/0001, Fondo de Investigaciones Sanitarias (FIS), Carlos III Institute, Spanish Ministry of Health). All Spanish funding is co-sponsored by the European Union FEDER program. M.P.M., M.A., S.M., L.R. and F.L. were recipients of fellowships from the Fundacao para a Ciencia e Tecnologia.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Adler H, 2001, J VIROL, V75, P5692, DOI 10.1128/JVI.75.12.5692-5696.2001; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Billadeau DD, 2000, J EXP MED, V192, P381, DOI 10.1084/jem.192.3.381; Bowden RJ, 1997, J GEN VIROL, V78, P1675, DOI 10.1099/0022-1317-78-7-1675; Brinkmann MM, 2006, J GEN VIROL, V87, P1047, DOI 10.1099/vir.0.81598-0; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Damania B, 2004, NAT REV MICROBIOL, V2, P656, DOI 10.1038/nrmicro958; Flano E, 2003, J IMMUNOL, V170, P3828, DOI 10.4049/jimmunol.170.7.3828; Flano E, 2002, J EXP MED, V196, P1363, DOI 10.1084/jem.20020890; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Herskowitz J, 2005, J VIROL, V79, P2261, DOI 10.1128/JVI.79.4.2261-2273.2005; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; KIM KJ, 1979, J IMMUNOL, V122, P549; Lagunoff M, 1999, P NATL ACAD SCI USA, V96, P5704, DOI 10.1073/pnas.96.10.5704; Lee BS, 2005, J VIROL, V79, P12173, DOI 10.1128/JVI.79.19.12173-12184.2005; Lee H, 1998, MOL CELL BIOL, V18, P5219, DOI 10.1128/MCB.18.9.5219; Liang XZ, 2006, J VIROL, V80, P5862, DOI 10.1128/JVI.02732-05; Liang XZ, 2004, J VIROL, V78, P12416, DOI 10.1128/JVI.78.22.12416-12427.2004; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Macrae AI, 2003, J VIROL, V77, P9700, DOI 10.1128/JVI.77.17.9700-9709.2003; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Meng WX, 2004, EMBO J, V23, P760, DOI 10.1038/sj.emboj.7600095; Merchant M, 2001, Int Rev Immunol, V20, P805, DOI 10.3109/08830180109045591; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Simas JP, 2004, J GEN VIROL, V85, P2789, DOI 10.1099/vir.0.80138-0; Simas JP, 1998, J GEN VIROL, V79, P149, DOI 10.1099/0022-1317-79-1-149; Simas JP, 1998, TRENDS MICROBIOL, V6, P276; Simas JP, 1999, J GEN VIROL, V80, P75, DOI 10.1099/0022-1317-80-1-75; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003; YANG WY, 1995, J BIOL CHEM, V270, P20832, DOI 10.1074/jbc.270.35.20832; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	49	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1654	10.1371/journal.pone.0001654	http://dx.doi.org/10.1371/journal.pone.0001654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301737	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500004
J	Larouche, M; Beffert, U; Herz, J; Hawkes, R				Larouche, Matt; Beffert, Uwe; Herz, Joachim; Hawkes, Richard			The Reelin Receptors Apoer2 and Vldlr Coordinate the Patterning of Purkinje Cell Topography in the Developing Mouse Cerebellum	PLOS ONE			English	Article								The adult cerebellar cortex is comprised of reproducible arrays of transverse zones and parasagittal stripes of Purkinje cells. Adult stripes are created through the perinatal rostrocaudal dispersion of embryonic Purkinje cell clusters, triggered by signaling through the Reelin pathway. Reelin is secreted by neurons in the external granular layer and deep cerebellar nuclei and binds to two high affinity extracellular receptors on Purkinje cells-the Very low density lipoprotein receptor (Vldlr) and apolipoprotein E receptor 2 (Apoer2). In mice null for either Reelin or double null for Vldlr and Apoer2, Purkinje cell clusters fail to disperse. Here we report that animals null for either Vldlr or Apoer2 individually, exhibit specific and parasagittally-restricted Purkinje cell ectopias. For example, in mice lacking Apoer2 function immunostaining reveals ectopic Purkinje cells that are largely restricted to the zebrin II-immunonegative population of the anterior vermis. In contrast, mice null for Vldlr have a much larger population of ectopic Purkinje cells that includes members from both the zebrin II-immunonegative and -immunopositive phenotypes. HSP25 immunoreactivity reveals that in Vldlr null animals a large portion of zebrin II-immunopositive ectopic cells are probably destined to become stripes in the central zone (lobules VI-VII). A small population of ectopic zebrin II-immunonegative Purkinje cells is also observed in animals heterozygous for both receptors (Apoer2(+/-): Vldlr(+/-)), but no ectopia is present in mice heterozygous for either receptor alone. These results indicate that Apoer2 and Vldlr coordinate the dispersal of distinct, but overlapping subsets of Purkinje cells in the developing cerebellum.	[Larouche, Matt; Hawkes, Richard] Univ Calgary, Fac Med, Genes & Dev Res Grp, Calgary, AB, Canada; [Beffert, Uwe; Herz, Joachim] Univ Texas SW Med Ctr, Dept Mol Genet, Dallas, TX USA	University of Calgary; University of Texas System; University of Texas Southwestern Medical Center Dallas	Larouche, M (corresponding author), Univ Calgary, Fac Med, Genes & Dev Res Grp, Calgary, AB, Canada.	rhawkes@ucalgary.ca	Hawkes, Richard/F-7971-2011	Beffert, Uwe/0000-0001-5877-922X	Canadian Institutes of Health Research; NIH; CIHR; HFSP; American Heart Association; Humboldt Foundation [Wolfgang Paul Award]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); HFSP(Human Frontier Science Program); American Heart Association(American Heart Association); Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by grants from the Canadian Institutes of Health Research (RH). Supported by grants from the NIH (to J.H.), CIHR (to U.B.) and the HFSP (to U.B.). J.H. is an Established Investigator of the American Heart Association and the recipient of a Wolfgang Paul Award from the Humboldt Foundation.	AHN AH, 1994, DEVELOPMENT, V120, P2081; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; Armstrong C, 2001, J COMP NEUROL, V439, P151, DOI 10.1002/cne.1339; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Armstrong CL, 2005, J COMP NEUROL, V491, P69, DOI 10.1002/cne.20703; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Beierbach E, 2001, J COMP NEUROL, V436, P42; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; Chung S, 2007, BRAIN RES, V1140, P120, DOI 10.1016/j.brainres.2006.01.100; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; DECAMILLI P, 1984, NEUROSCIENCE, V11, P761, DOI 10.1016/0306-4522(84)90193-3; EDWARDS MA, 1994, ANAT EMBRYOL, V190, P417; Eisenman LM, 1998, J COMP NEUROL, V394, P106, DOI 10.1002/(SICI)1096-9861(19980427)394:1<106::AID-CNE8>3.0.CO;2-4; EISENMAN LM, 1993, J COMP NEUROL, V335, P586, DOI 10.1002/cne.903350410; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gallagher E, 1998, J COMP NEUROL, V402, P238; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Goldowitz D, 1997, J NEUROSCI, V17, P8767; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Hashimoto M, 2003, J NEUROSCI, V23, P11342; Hawkes R, 1997, PERSPECT DEV NEUROBI, V5, P95; HAWKES R, 1994, ACTA ANAT, V151, P139; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; Hawkes R, 1997, PROG BRAIN RES, V114, P39; HECKROTH JA, 1989, J COMP NEUROL, V279, P546, DOI 10.1002/cne.902790404; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; INOUYE M, 1980, J COMP NEUROL, V194, P499, DOI 10.1002/cne.901940302; Jensen P, 2002, J NEUROSCI, V22, P8110; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; LANE PW, 1992, J HERED, V83, P315, DOI 10.1093/oxfordjournals.jhered.a111221; Larouche M, 2006, J COMP NEUROL, V494, P215, DOI 10.1002/cne.20791; Larouche M, 2006, CEREBELLUM, V5, P77, DOI 10.1080/14734220600804668; Luque JM, 2007, BRAIN RES, V1140, P41, DOI 10.1016/j.brainres.2006.02.056; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Miyata T, 1997, J NEUROSCI, V17, P3599; Nakamura M, 2004, EUR J NEUROSCI, V20, P2929, DOI 10.1111/j.1460-9568.2004.03768.x; Napieralski JA, 1996, J COMP NEUROL, V364, P718, DOI 10.1002/(SICI)1096-9861(19960122)364:4<718::AID-CNE9>3.0.CO;2-6; Nunzi MG, 1999, J COMP NEUROL, V404, P97; Oberdick J, 1998, TRENDS NEUROSCI, V21, P383, DOI 10.1016/S0166-2236(98)01325-3; Ozol K, 1999, J COMP NEUROL, V412, P95; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Park C, 2002, GENESIS, V32, P32, DOI 10.1002/gene.10024; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; Perez-Garcia CG, 2004, EUR J NEUROSCI, V20, P2827, DOI 10.1111/j.1460-9568.2004.03733.x; Rice DS, 1998, DEVELOPMENT, V125, P3719; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; SEIL FJ, 1995, J COMP NEUROL, V356, P398, DOI 10.1002/cne.903560307; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4; Sillitoe RV, 2002, J HISTOCHEM CYTOCHEM, V50, P235, DOI 10.1177/002215540205000211; Singec I, 2003, J COMP NEUROL, V459, P278, DOI 10.1002/cne.10600; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; WASSEF M, 1990, J COMP NEUROL, V294, P223, DOI 10.1002/cne.902940207; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; Yang HT, 2002, J NEUROSCI, V22, P464, DOI 10.1523/JNEUROSCI.22-02-00464.2002; YUASA S, 1993, ANAT EMBRYOL, V188, P317; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	69	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1653	10.1371/journal.pone.0001653	http://dx.doi.org/10.1371/journal.pone.0001653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301736	gold, Green Submitted, Green Published			2022-12-27	WOS:000260586500003
J	Hiroyama, T; Miharada, K; Sudo, K; Danjo, I; Aoki, N; Nakamura, Y				Hiroyama, Takashi; Miharada, Kenichi; Sudo, Kazuhiro; Danjo, Inaho; Aoki, Naoko; Nakamura, Yukio			Establishment of Mouse Embryonic Stem Cell-Derived Erythroid Progenitor Cell Lines Able to Produce Functional Red Blood Cells	PLOS ONE			English	Article								Background. The supply of transfusable red blood cells (RBCs) is not sufficient in many countries. If erythroid cell lines able to produce transfusable RBCs in vitro were established, they would be valuable resources. However, such cell lines have not been established. To evaluate the feasibility of establishing useful erythroid cell lines, we attempted to establish such cell lines from mouse embryonic stem (ES) cells. Methodology/Principal Findings. We developed a robust method to obtain differentiated cell lines following the induction of hematopoietic differentiation of mouse ES cells and established five independent hematopoietic cell lines using the method. Three of these lines exhibited characteristics of erythroid cells. Although their precise characteristics varied, each of these lines could differentiate in vitro into more mature erythroid cells, including enucleated RBCs. Following transplantation of these erythroid cells into mice suffering from acute anemia, the cells proliferated transiently, subsequently differentiated into functional RBCs, and significantly ameliorated the acute anemia. In addition, we did not observe formation of any tumors following transplantation of these cells. Conclusion/Significance. To the best of our knowledge, this is the first report to show the feasibility of establishing erythroid cell lines able to produce mature RBCs. Considering the number of human ES cell lines that have been established so far, the intensive testing of a number of these lines for erythroid potential may allow the establishment of human erythroid cell lines similar to the mouse erythroid cell lines described here. In addition, our results strongly suggest the possibility of establishing useful cell lines committed to specific lineages other than hematopoietic progenitors from human ES cells.	[Hiroyama, Takashi; Miharada, Kenichi; Sudo, Kazuhiro; Danjo, Inaho; Aoki, Naoko; Nakamura, Yukio] RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan	RIKEN	Nakamura, Y (corresponding author), RIKEN, BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan.	yukionak@brc.riken.jp	Nakamura, Yukio/A-5263-2016; Miharada, Kenichi/C-1397-2014	Nakamura, Yukio/0000-0001-8056-4946; Miharada, Kenichi/0000-0001-8073-4001	Ministry of Education, Culture, Sports, Science, and Technology in Japan	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.	ALTER BP, 1982, EXP HEMATOL, V10, P754; Boyd AS, 2005, ADV DRUG DELIVER REV, V57, P1944, DOI 10.1016/j.addr.2005.08.004; Carotta S, 2004, BLOOD, V104, P1873, DOI 10.1182/blood-2004-02-0570; Cerdan C, 2004, BLOOD, V103, P2504, DOI 10.1182/blood-2003-07-2563; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Hiroyama T, 2006, EXP HEMATOL, V34, P760, DOI 10.1016/j.exphem.2006.03.004; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KODAMA H, 1994, EXP HEMATOL, V22, P979; Kurita R, 2006, STEM CELLS, V24, P2014, DOI 10.1634/stemcells.2005-0499; Lansdorp PM, 2005, ANN NY ACAD SCI, V1044, P220, DOI 10.1196/annals.1349.027; Li F, 2001, BLOOD, V98, P335, DOI 10.1182/blood.V98.2.335; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Miharada K, 2005, FASEB J, V19, P1881, DOI 10.1096/fj.05-3809fje; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olivier EN, 2006, EXP HEMATOL, V34, P1635, DOI 10.1016/j.exphem.2006.07.003; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Umeda K, 2004, DEVELOPMENT, V131, P1869, DOI 10.1242/dev.01065; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vogel G, 2005, SCIENCE, V308, P1534, DOI 10.1126/science.308.5728.1534; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944	33	64	71	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1544	10.1371/journal.pone.0001544	http://dx.doi.org/10.1371/journal.pone.0001544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253492	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700016
J	Egawa, T; Kreslavsky, T; Littman, DR; von Boehmer, H				Egawa, Takeshi; Kreslavsky, Taras; Littman, Dan R.; von Boehmer, Harald			Lineage Diversion of T Cell Receptor Transgenic Thymocytes Revealed by Lineage Fate Mapping	PLOS ONE			English	Article								Background. The binding of the T cell receptor (TCR) to major histocompatibility complex (MHC) molecules in the thymus determines fates of lymphocytes that subsequently home to secondary lymphoid tissue. TCR transgenic models have been used to study thymic selection and lineage commitment. Most TCR transgenic mice express the rearranged TCR alpha beta prematurely at the double negative stage and abnormal TCR alpha beta populations of T cells that are not easily detected in non-transgenic mice have been found in secondary lymphoid tissue of TCR transgenic mice. Methodology and Principal Findings. To determine developmental pathways of TCR-transgenic thymocytes, we used Cre-LoxP-mediated fate mapping and show here that premature expression of a transgenic TCR alpha beta diverts some developing thymocytes to a developmental pathway which resembles that of gamma delta cells. We found that most peripheral T cells with the HY-TCR in male mice have bypassed the ROR gamma t-positive CD4(+)8(+) ( double positive, DP) stage to accumulate either as CD4(-)8(-) ( double negative, DN) or as CD8 alpha(+) T cells in lymph nodes or gut epithelium. Likewise, DN TCR alpha beta cells in lymphoid tissue of female mice were not derived from DP thymocytes. Conclusion. The results further support the hypothesis that the premature expression of the TCR alpha beta can divert DN thymocytes into gamma delta lineage cells.	[Egawa, Takeshi; Littman, Dan R.] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Mol Path, New York, NY 10003 USA; [Littman, Dan R.] NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY USA; [Kreslavsky, Taras; von Boehmer, Harald] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA	New York University; New York University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med,Mol Path, New York, NY 10003 USA.	littman@saturn.med.nyu.edu; harald_von_boehmer@dfci.harvard.edu		Kreslavsky, Taras/0000-0002-6672-1914	Human Frontier Science Program [LT00278/202]; Leukemia and Lymphoma Society [3547-07]; National Institutes of Health [R01AI45846]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045846] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by postdoctoral fellowships from the Human Frontier Science Program (LT00278/202) and the Leukemia and Lymphoma Society (3547-07) to TE and by a grant from the National Institutes of Health (R01AI45846) to HvB. DRL is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2006, J EXP MED, V203, P1543, DOI 10.1084/jem.20051711; Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; CROOKS MEC, 1994, IMMUNITY, V1, P277; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Guy-Grand D, 2004, SCIENCE, V305, P185, DOI 10.1126/science.1100890; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KILLEEN N, 1992, J EXP MED, V176, P89, DOI 10.1084/jem.176.1.89; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752; Teh H S, 1990, Dev Immunol, V1, P1, DOI 10.1155/1990/18208; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; Terrence K, 2000, J EXP MED, V192, P537, DOI 10.1084/jem.192.4.537; Villey I, 1999, EUR J IMMUNOL, V29, P4072, DOI 10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; VONBOEHMER H, 1991, J EXP MED, V174, P1001, DOI 10.1084/jem.174.5.1001; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070	26	38	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1512	10.1371/journal.pone.0001512	http://dx.doi.org/10.1371/journal.pone.0001512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231598	Green Submitted, Green Published, gold			2022-12-27	WOS:000260504200024
J	Williamson, SJ; Rusch, DB; Yooseph, S; Halpern, AL; Heidelberg, KB; Glass, JI; Andrews-Pfannkoch, C; Fadrosh, D; Miller, CS; Sutton, G; Frazier, M; Venter, JC				Williamson, Shannon J.; Rusch, Douglas B.; Yooseph, Shibu; Halpern, Aaron L.; Heidelberg, Karla B.; Glass, John I.; Andrews-Pfannkoch, Cynthia; Fadrosh, Douglas; Miller, Christopher S.; Sutton, Granger; Frazier, Marvin; Venter, J. Craig			The Sorcerer II Global Ocean Sampling Expedition: Metagenomic Characterization of Viruses within Aquatic Microbial Samples	PLOS ONE			English	Article							TROPHIC STATE INDEX; PHOTOSYNTHESIS GENES; MARINE-BACTERIA; SYNECHOCOCCUS; DIVERSITY; PROCHLOROCOCCUS; COMMUNITY; PROTEIN; VIRIOPLANKTON; CYANOPHAGES	Viruses are the most abundant biological entities on our planet. Interactions between viruses and their hosts impact several important biological processes in the world's oceans such as horizontal gene transfer, microbial diversity and biogeochemical cycling. Interrogation of microbial metagenomic sequence data collected as part of the Sorcerer II Global Ocean Expedition (GOS) revealed a high abundance of viral sequences, representing approximately 3% of the total predicted proteins. Cluster analyses of the viral sequences revealed hundreds to thousands of viral genes encoding various metabolic and cellular functions. Quantitative analyses of viral genes of host origin performed on the viral fraction of aquatic samples confirmed the viral nature of these sequences and suggested that significant portions of aquatic viral communities behave as reservoirs of such genetic material. Distributional and phylogenetic analyses of these host-derived viral sequences also suggested that viral acquisition of environmentally relevant genes of host origin is a more abundant and widespread phenomenon than previously appreciated. The predominant viral sequences identified within microbial fractions originated from tailed bacteriophages and exhibited varying global distributions according to viral family. Recruitment of GOS viral sequence fragments against 27 complete aquatic viral genomes revealed that only one reference bacteriophage genome was highly abundant and was closely related, but not identical, to the cyanomyovirus P-SSM4. The co-distribution across all sampling sites of P-SSM4-like sequences with the dominant ecotype of its host, Prochlorococcus supports the classification of the viral sequences as P-SSM4-like and suggests that this virus may influence the abundance, distribution and diversity of one of the most dominant components of picophytoplankton in oligotrophic oceans. In summary, the abundance and broad geographical distribution of viral sequences within microbial fractions, the prevalence of genes among viral sequences that encode microbial physiological function and their distinct phylogenetic distribution lend strong support to the notion that viral-mediated gene acquisition is a common and ongoing mechanism for generating microbial diversity in the marine environment.	[Williamson, Shannon J.; Rusch, Douglas B.; Yooseph, Shibu; Halpern, Aaron L.; Heidelberg, Karla B.; Glass, John I.; Andrews-Pfannkoch, Cynthia; Fadrosh, Douglas; Sutton, Granger; Frazier, Marvin; Venter, J. Craig] J Craig Venter Inst, Rockville, MD USA; [Heidelberg, Karla B.] USC, Los Angeles, CA USA; [Miller, Christopher S.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA	J. Craig Venter Institute; University of Southern California; University of California System; University of California Los Angeles	Williamson, SJ (corresponding author), J Craig Venter Inst, Rockville, MD USA.	swilliamson@jcvi.org	Heidelberg, Karla B./L-2096-2017; Glass, John/A-6572-2015	Heidelberg, Karla B./0000-0002-2645-8269; Glass, John/0000-0002-3784-5301; Yooseph, Shibu/0000-0001-5581-5002; Miller, Christopher/0000-0002-9448-8144	The Department of Energy (DOE) Office of Science, and Office of Biological and Environmental Research [DE-FG02-02ER63453]; Gordon and Betty Moore Foundation; Discovery Channel; J. Craig Venter Science Foundation	The Department of Energy (DOE) Office of Science, and Office of Biological and Environmental Research(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Discovery Channel; J. Craig Venter Science Foundation	This study was funded by The Department of Energy (DOE) Office of Science, and Office of Biological and Environmental Research (DE-FG02-02ER63453), the Gordon and Betty Moore Foundation, the Discovery Channel and the J. Craig Venter Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H., 1987, VIRUSES PROKARYOTES, V1; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Auguet JC, 2006, MICROB ECOL, V51, P197, DOI 10.1007/s00248-005-0043-0; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; BORSHEIM KY, 1990, APPL ENVIRON MICROB, V56, P352; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; BRUSSOW H, 2004, MICROBIOLOGY MOL BIO, V68; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; CARLSON RE, 1983, WATER RESOUR BULL, V19, P307; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Claverie JM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-52; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; FUHRMAN JA, 1993, BARCELONA SPAIN TREN, P295; Gobler CJ, 1997, LIMNOL OCEANOGR, V42, P1492, DOI 10.4319/lo.1997.42.7.1492; HELDAL M, 1991, MAR ECOL PROG SER, V72, P205, DOI 10.3354/meps072205; Hwang DM, 1996, J MOL EVOL, V43, P536, DOI 10.1007/PL00006114; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; LI WKW, 1983, SCIENCE, V219, P292, DOI 10.1126/science.219.4582.292; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Marston MF, 2003, APPL ENVIRON MICROB, V69, P4639, DOI 10.1128/AEM.69.8.4639-4647.2003; McDaniel L, 2005, APPL ENVIRON MICROB, V71, P842, DOI 10.1128/AEM.71.2.842-850.2005; McDaniel L, 2002, NATURE, V415, P496, DOI 10.1038/415496a; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Montanie H, 2002, AQUAT MICROB ECOL, V28, P105, DOI 10.3354/ame028105; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; RUSCH DB, 2007, PLOS BIOL IN PRESS; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sambrook J., 2001, MOL CLONING LAB MANU; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; SHERMAN LA, 1976, VIROLOGY, V71, P17, DOI 10.1016/0042-6822(76)90090-8; Shibata A, 1997, MAR ECOL PROG SER, V155, P303, DOI 10.3354/meps155303; STEWART FM, 1984, THEOR POPUL BIOL, V26, P93, DOI 10.1016/0040-5809(84)90026-1; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V426, P584, DOI 10.1038/nature02147; Suttle C, 2005, ENVIRON MICROBIOL, V7, P481, DOI 10.1111/j.1462-2920.2005.803_11.x; SUTTLE CA, 1994, APPL ENVIRON MICROB, V60, P3167, DOI 10.1128/AEM.60.9.3167-3174.1994; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang K, 2004, AQUAT MICROB ECOL, V34, P105, DOI 10.3354/ame034105; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; WATERBURY JB, 1986, PHOTOSYNTHETIC PICOP, P71; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Wichels A, 1998, APPL ENVIRON MICROB, V64, P4128; Williamson SJ, 2004, AQUAT MICROB ECOL, V36, P9, DOI 10.3354/ame036009; WOMMACK KE, 1992, APPL ENVIRON MICROB, V58, P2965, DOI 10.1128/AEM.58.9.2965-2970.1992; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x	62	236	248	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1456	10.1371/journal.pone.0001456	http://dx.doi.org/10.1371/journal.pone.0001456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213365	Green Submitted, gold, Green Published			2022-12-27	WOS:000260503900002
J	Marella, M; Seo, BB; Nakamaru-Ogiso, E; Greenamyre, JT; Matsuno-Yagi, A; Yagi, T				Marella, Mathieu; Seo, Byoung Boo; Nakamaru-Ogiso, Eiko; Greenamyre, J. Timothy; Matsuno-Yagi, Akemi; Yagi, Takao			Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's Disease	PLOS ONE			English	Article								It is widely recognized that mitochondrial dysfunction, most notably defects in the NADH-quinone oxidoreductase (complex I), is closely related to the etiology of sporadic Parkinson's disease (PD). In fact, rotenone, a complex I inhibitor, has been used for establishing PD models both in vitro and in vivo. A rat model with chronic rotenone exposure seems to reproduce pathophysiological conditions of PD more closely than acute mouse models as manifested by neuronal cell death in the substantia nigra and Lewy body-like cytosolic aggregations. Using the rotenone rat model, we investigated the protective effects of alternative NADH dehydrogenase (Ndi1) which we previously demonstrated to act as a replacement for complex I both in vitro and in vivo. A single, unilateral injection of recombinant adeno-associated virus carrying the NDI1 gene into the vicinity of the substantia nigra resulted in expression of the Ndi1 protein in the entire substantia nigra of that side. It was clear that the introduction of the Ndi1 protein in the substantia nigra rendered resistance to the deleterious effects caused by rotenone exposure as assessed by the levels of tyrosine hydroxylase and dopamine. The presence of the Ndi1 protein also prevented cell death and oxidative damage to DNA in dopaminergic neurons observed in rotenone-treated rats. Unilateral protection also led to uni-directional rotation of the rotenone-exposed rats in the behavioral test. The present study shows, for the first time, the powerful neuroprotective effect offered by the Ndi1 enzyme in a rotenone rat model of PD.	[Marella, Mathieu; Seo, Byoung Boo; Nakamaru-Ogiso, Eiko; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA USA; [Greenamyre, J. Timothy] Univ Pittsburgh, Pittsburgh Inst Neurodegen Dis, Dept Neurol, Pittsburgh, PA USA	Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Matsuno-Yagi, A (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA USA.	ayagi@scripps.edu; yagi@scripps.edu	Greenamyre, J. Timothy/B-4049-2011; Waldvogel, Henry/D-6691-2012	Greenamyre, J. Timothy/0000-0003-3468-7878; Waldvogel, Henry/0000-0003-2165-8568	US Public Health Service [R01NS048441, R01DK053244, US4ES012068]; The Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048441] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); The Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US Public Health Service Grants R01NS048441 and R01DK053244 (to TY and AM-Y) and by The Picower Foundation and US Public Health Service Grant US4ES012068 (to JTG).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8; Bashkatova V, 2004, EXP NEUROL, V186, P235, DOI 10.1016/j.expneurol.2003.12.005; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Burger C, 2005, HUM GENE THER, V16, P781, DOI 10.1089/hum.2005.16.781; Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; GERLACH M, 1991, EUR J PHARM-MOLEC PH, V208, P273, DOI 10.1016/0922-4106(91)90073-Q; Huang J, 2006, BIOMATERIALS, V27, P937, DOI 10.1016/j.biomaterials.2005.07.005; Jankovic J, 2006, MT SINAI J MED, V73, P682; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lau YS, 2003, METH MOLEC MED, V79, P103; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Park JS, 2007, BBA-MOL BASIS DIS, V1772, P533, DOI 10.1016/j.bbadis.2007.01.009; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Przedborski S, 1998, MOVEMENT DISORD, V13, P35; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2002, MOL THER, V6, P336, DOI 10.1006/mthe.2002.0674; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2006, MOVEMENT DISORD, V21, P136, DOI 10.1002/mds.20861; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Waldmeier P, 2006, BIOCHEM PHARMACOL, V72, P1197, DOI 10.1016/j.bcp.2006.06.031; YAGI T, 2004, ADV PHOTOSYNTHESIS R, P15	39	82	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1433	10.1371/journal.pone.0001433	http://dx.doi.org/10.1371/journal.pone.0001433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197244	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000260503800005
J	Xu, ZF; Zhou, Y; Li, LJ; Zhou, R; Xiao, SB; Wan, Y; Zhang, SH; Wang, K; Li, W; Li, L; Jin, H; Kang, MS; Dalai, BL; Li, TT; Liu, L; Cheng, YY; Zhang, L; Xu, T; Zheng, HJ; Pu, SY; Wang, BF; Gu, WY; Zhang, XL; Zhu, GF; Wang, SY; Zhao, GP; Chen, HC				Xu, Zhuofei; Zhou, Yan; Li, Liangjun; Zhou, Rui; Xiao, Shaobo; Wan, Yun; Zhang, Sihua; Wang, Kai; Li, Wei; Li, Lu; Jin, Hui; Kang, Mingsong; Dalai, Baolige; Li, Tingting; Liu, Lei; Cheng, Yangyi; Zhang, Lei; Xu, Tao; Zheng, Huajun; Pu, Shiying; Wang, Bofei; Gu, Wenyi; Zhang, Xiang-Lin; Zhu, Geng-Feng; Wang, Shengyue; Zhao, Guo-Ping; Chen, Huanchun			Genome Biology of Actinobacillus pleuropneumoniae JL03, an Isolate of Serotype 3 Prevalent in China	PLOS ONE			English	Article							ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; GENE-CLUSTER; ANAEROBIC RESPIRATION; MOLECULAR-CLONING; APX TOXINS; SEQUENCE; VIRULENCE; POLYSACCHARIDE; EXPRESSION	Actinobacillus pleuropneumoniae is the etiologic agent of porcine contagious pleuropneumonia, a cause of considerable world wide economic losses in the swine industry. We sequenced the complete genome of A. pleuropneumoniae, JL03, an isolate of serotype 3 prevalent in China. Its genome is a single chromosome of 2,242,062 base pairs containing 2,097 predicted protein-coding sequences, six ribosomal rRNA operons, and 63 tRNA genes. Preliminary analysis of the genomic sequence and the functions of the encoded proteins not only confirmed the present physiological and pathological knowledge but also offered new insights into the metabolic and virulence characteristics of this important pathogen. We identified a full spectrum of genes related to its characteristic chemoheterotrophic catabolism of fermentation and respiration with an incomplete TCA system for anabolism. In addition to confirming the lack of ApxI toxin, identification of a nonsense mutation in apxIVA and a 5' -proximal truncation of the flp operon deleting both its promoter and the flp1flp2tadV genes have provided convincing scenarios for the low virulence property of JL03. Comparative genomic analysis using the available sequences of other serotypes, probable strain ( serotype)specific genomic islands related to capsular polysaccharides and lipopolysaccharide O-antigen biosyntheses were identified in JL03, which provides a foundation for future research into the mechanisms of serotypic diversity of A. pleuropneumoniae.	[Zhou, Yan; Wang, Kai; Cheng, Yangyi; Zhang, Lei; Xu, Tao; Zheng, Huajun; Pu, Shiying; Wang, Bofei; Gu, Wenyi; Zhang, Xiang-Lin; Zhu, Geng-Feng; Wang, Shengyue; Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genomics, Shanghai, Peoples R China; [Zhou, Yan; Wang, Shengyue; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol, State Key Lab Genet Engn, Shanghai, Peoples R China; [Zhao, Guo-Ping] Natl Engn Ctr Biochip Res Shanghai, Shanghai, Peoples R China; [Zhao, Guo-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Lab Mol Microbiol, Shanghai, Peoples R China; [Xu, Zhuofei; Li, Liangjun; Xiao, Shaobo; Wan, Yun; Zhang, Sihua; Li, Wei; Li, Lu; Jin, Hui; Kang, Mingsong; Dalai, Baolige; Li, Tingting; Liu, Lei; Chen, Huanchun] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong Agricultural University	Zhou, R (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China.	rzhou@mail.hzau.edu; gpzhao@sibs.ac.cn; chenhch@mail.hzau.edu.cn	KANG, MINGSONG/A-9211-2017; zhu, gengfeng/HGC-7575-2022	KANG, MINGSONG/0000-0002-8795-2973; Xiao, Shaobo/0000-0003-0023-9188; WANG, kai/0000-0002-6194-0480; Zhao, Guo-Ping/0000-0002-7621-6620	National Natural Science Foundation of China [30530590, 30771599]; 973 Program [2006CB504402]; 863 Program [2007AA02Z193, 2006AA02Z335]; National Scientific and Technical Supporting Programs [2006BAD06A01, 2006BAD06A04]; Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China [706042]; Shanghai Commission for Science and Technology [05DZ22201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Scientific and Technical Supporting Programs; Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China(Ministry of Education, China); Shanghai Commission for Science and Technology	This work was supported by the National Natural Science Foundation of China (30530590; 30771599), 973 Program (2006CB504402), 863 Program (2007AA02Z193; 2006AA02Z335), National Scientific and Technical Supporting Programs (2006BAD06A01; 2006BAD06A04), Cultivation Fund of the Key Scientific and Technical Innovation Project, Ministry of Education of China (706042) and Shanghai Commission for Science and Technology (05DZ22201).	Allen JWA, 2005, BIOCHEM J, V389, P587, DOI 10.1042/BJ20041894; Bandara AB, 2003, INFECT IMMUN, V71, P3320, DOI 10.1128/IAI.71.6.3320-3328.2003; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BEDDEK AJ, 2004, INFECT IMMUN, V74, P4124; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bosse JT, 1997, INFECT IMMUN, V65, P4389; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bosse JT, 2001, J BACTERIOL, V183, P1242, DOI 10.1128/JB.183.4.1242-1247.2001; Brondijk THC, 2002, MOL MICROBIOL, V44, P245, DOI 10.1046/j.1365-2958.2002.02875.x; Challacombe JF, 2007, J BACTERIOL, V189, P1890, DOI 10.1128/JB.01422-06; DEWHIRST FE, 1992, J BACTERIOL, V174, P2002, DOI 10.1128/jb.174.6.2002-2013.1992; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Dubreuil J. Daniel, 2000, Animal Health Research Reviews, V1, P73, DOI 10.1017/S1466252300000074; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; FREY J, 1993, J GEN MICROBIOL, V139, P1723, DOI 10.1099/00221287-139-8-1723; Gioia J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06; Gonzalez OG, 2004, FEMS MICROBIOL LETT, V234, P81, DOI 10.1111/j.1574-6968.2004.tb09516.x; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; [何启盖 He Qigai], 2003, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V25, P360; Hong SH, 2004, NAT BIOTECHNOL, V22, P1275, DOI 10.1038/nbt1010; Jacobsen I, 2005, INFECT IMMUN, V73, P3740, DOI 10.1128/IAI.73.6.3740-3744.2005; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Jacobsen MJ, 1996, VET MICROBIOL, V49, P159, DOI 10.1016/0378-1135(95)00184-0; Jacques M, 2004, CAN J VET RES, V68, P81; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; JANSEN R, 1994, INFECT IMMUN, V62, P4411, DOI 10.1128/IAI.62.10.4411-4418.1994; Kamp EM, 1997, INFECT IMMUN, V65, P4350, DOI 10.1128/IAI.65.10.4350-4354.1997; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; LU Z, 2002, CHIN J VET SCI TECH, V37, P33; MACKIEWICZ P, 2004, NUCLEIC ACIDS RES, V25, P955; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Mikael LG, 2002, MICROBIOL-SGM, V148, P2869, DOI 10.1099/00221287-148-9-2869; Nakano Y, 2000, BBA-GENE STRUCT EXPR, V1493, P259, DOI 10.1016/S0167-4781(00)00179-2; Nika JR, 2002, INFECT IMMUN, V70, P2965, DOI 10.1128/IAI.70.6.2965-2975.2002; [陈凡 Chen Fan], 2004, [微生物学报, Acta Microbiologica Sinica], V44, P679; Provost M, 2003, FEMS MICROBIOL LETT, V223, P7, DOI 10.1016/S0378-1097(03)00247-7; Ravcheev DA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-54; Ruckert C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-121; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Satran P, 2002, VET MED-CZECH, V47, P92, DOI 10.17221/5810-VETMED; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Sekowska A, 2000, J MOL MICROB BIOTECH, V2, P145; Sheehan BJ, 2003, INFECT IMMUN, V71, P3960, DOI 10.1128/IAI.71.7.3960-3970.2003; SIDIBE M, 1993, CAN J VET RES, V57, P204; Srikumar R, 2004, MICROBIOL-SGM, V150, P1723, DOI 10.1099/mic.0.27046-0; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tian YQ, 2005, BIOCHEM BIOPH RES CO, V333, P14, DOI 10.1016/j.bbrc.2005.05.070; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; Wilson JW, 2002, POSTGRAD MED J, V78, P216, DOI 10.1136/pmj.78.918.216; Zhao QX, 2000, FEMS MICROBIOL LETT, V184, P127, DOI 10.1111/j.1574-6968.2000.tb09002.x; ZHOU L, 2007, VET RECORD IN PRESS, V161	56	60	441	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1450	10.1371/journal.pone.0001450	http://dx.doi.org/10.1371/journal.pone.0001450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197260	Green Published, gold			2022-12-27	WOS:000260503800021
J	Nadai, Y; Eyzaguirre, LM; Constantine, NT; Sill, AM; Cleghorn, F; Blattner, WA; Carr, JK				Nadai, Yuka; Eyzaguirre, Lindsay M.; Constantine, Niel T.; Sill, Anne M.; Cleghorn, Farley; Blattner, William A.; Carr, Jean K.			Protocol for Nearly Full-Length Sequencing of HIV-1 RNA from Plasma	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; IN-VIVO; RT-PCR; VIRUS; DNA; AMPLIFICATION; RECOMBINATION; POLYMERASE; HYPERMUTATION; HYDROLYSIS	Nearly full-length genome sequencing of HIV-1 using peripheral blood mononuclear cells (PBMC) DNA as a template for PCR is now a relatively routine laboratory procedure. However, this has not been the case when using virion RNA as the template and this has made full genome analysis of circulating viruses difficult. Therefore, a well-developed procedure for sequencing of full-length HIV-1 RNA directly from plasma was needed. Plasma from U. S. donors representing a range of viral loads (VL) was used to develop the assay. RNA was extracted from plasma and reverse-transcribed. Two or three overlapping regions were PCR amplified to cover the entire viral genome and sequenced for verification. The success of the procedure was sensitive to VL but was routinely successful for VL greater than 10 5 and the rate declined in proportion to the VL. While the two-amplicon strategy had an advantage of increasing the possibility of amplifying a single species of HIV-1, the three-amplicon strategy was more successful in amplifying samples with low viral loads. This protocol provides a useful tool for molecular analysis to understand the HIV epidemic and pathogenesis, as well as diagnosis, therapy and future vaccine strategies.	[Nadai, Yuka; Eyzaguirre, Lindsay M.; Constantine, Niel T.; Sill, Anne M.; Blattner, William A.; Carr, Jean K.] Univ Maryland, Inst Human Virol, Dept Epidemiol, Baltimore, MD 21201 USA; [Cleghorn, Farley] Futures Grp Inc, Washington, DC USA	University System of Maryland; University of Maryland Baltimore	Carr, JK (corresponding author), Univ Maryland, Inst Human Virol, Dept Epidemiol, Baltimore, MD 21201 USA.	jecarr@ihv.umaryland.edu			NIH [R21-A1057084-02]; Henry M. Jackson Foundation for the Advancement of Military Medicine; U.S. Department of Defense	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine; U.S. Department of Defense(United States Department of Defense)	The present work was supported by an NIH grant R21-A1057084-02 and a cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the U.S. Department of Defense.	AbouHaidar MG, 1999, Z NATURFORSCH C, V54, P542; Arens M, 1999, CLIN MICROBIOL REV, V12, P612, DOI 10.1128/CMR.12.4.612; Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; CHESTER N, 1993, ANAL BIOCHEM, V209, P284, DOI 10.1006/abio.1993.1121; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Das M, 2001, PHYSIOL GENOMICS, V6, P57, DOI 10.1152/physiolgenomics.2001.6.2.57; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Fang GW, 1998, J VIROL METHODS, V76, P139, DOI 10.1016/S0166-0934(98)00133-5; Gerard GF, 2002, BIOTECHNIQUES, V33, P984, DOI 10.2144/02335bm03; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harrison GP, 1998, NUCLEIC ACIDS RES, V26, P3433, DOI 10.1093/nar/26.14.3433; Hawkins PR, 2003, BIOTECHNIQUES, V34, P768, DOI 10.2144/03344st06; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; *LOS AL NAT LAB TH, 2006, HIV SEQ DAT; *LOS AL NAT LAB TH, 2006, PRIM HIV SEQ DAT TOO; Malboeuf CM, 2001, BIOTECHNIQUES, V30, P1074, DOI 10.2144/01305rr06; Malet I, 2003, J VIROL METHODS, V109, P161, DOI 10.1016/S0166-0934(03)00067-3; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; MELLORS JW, 1995, ANN INTERN MED, V122, P573, DOI 10.7326/0003-4819-122-8-199504150-00003; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Piche Caroline, 2005, J Biomol Tech, V16, P239; Preston BD, 1996, TRENDS MICROBIOL, V4, P16, DOI 10.1016/0966-842X(96)81500-9; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Rozak DA, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni081; SALMINEN MO, 1995, VIROLOGY, V213, P80, DOI 10.1006/viro.1995.1548; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Swift GH, 2000, BIOTECHNIQUES, V28, P524, DOI 10.2144/00283rr01; Van Laethem K, 2006, J VIROL METHODS, V132, P181, DOI 10.1016/j.jviromet.2005.10.008; Villahermosa ML, 2000, J HUMAN VIROL, V3, P27; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	42	48	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1420	10.1371/journal.pone.0001420	http://dx.doi.org/10.1371/journal.pone.0001420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183300	Green Published, Green Submitted, gold			2022-12-27	WOS:000260469400016
J	Hill, PC; Jackson-Sillah, DJ; Fox, A; Brookes, RH; de Jong, BC; Lugos, MD; Adetifa, IM; Donkor, SA; Aiken, AM; Howie, SR; Corrah, T; McAdam, KP; Adegbola, RA				Hill, Philip C.; Jackson-Sillah, Dolly J.; Fox, Annette; Brookes, Roger H.; de Jong, Bouke C.; Lugos, Moses D.; Adetifa, Ifedayo M.; Donkor, Simon A.; Aiken, Alex M.; Howie, Stephen R.; Corrah, Tumani; McAdam, Keith P.; Adegbola, Richard A.			Incidence of Tuberculosis and the Predictive Value of ELISPOT and Mantoux Tests in Gambian Case Contacts	PLOS ONE			English	Article							LINKED IMMUNOSPOT ASSAY; INTERFERON-GAMMA ASSAY; HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; HOUSEHOLD CONTACTS; RISK-FACTORS; INFECTION; DIAGNOSIS; SURVEILLANCE	Background. Studies of Tuberculosis (TB) case contacts are increasingly being utilised for understanding the relationship between M. tuberculosis and the human host and for assessing new interventions and diagnostic tests. We aimed to identify the incidence rate of new TB cases among TB contacts and to relate this to their initial Mantoux and ELISPOT test results. Methods and Findings. After initial Mantoux and ELISPOT tests and exclusion of co-prevalent TB cases, we followed 2348 household contacts of sputum smear positive TB cases. We visited them at 3 months, 6 months, 12 months, 18 months and 24 months, and investigated those with symptoms consistent with TB. Those who were diagnosed separately at a government clinic had a chest x-ray. Twenty six contacts were diagnosed with definite TB over 4312 person years of follow-up (Incidence rate 603/100,000 person years; 95% Confidence Interval, 370-830). Nine index and secondary case pairs had cultured isolates available for genotyping. Of these, 6 pairs were concordant and 3 were discordant. 2.5% of non-progressors were HIV positive compared to 12% of progressors (HR 6.2; 95% CI 1.7-22.5; p = 0.010). 25 secondary cases had initial Mantoux results, 14 (56%) were positive; 21 had initial ELISPOT results, 11 (52%) were positive; 15 (71%) of 21 tested were positive by one or the other test. Of the 6 contacts who had concordant isolates with their respective index case, 4 (67%) were Mantoux positive at recruitment, 3 (50%) were ELISPOT positive; 5 (83%) were positive by one or other of the two tests. ELISPOT positive contacts, and those with discordant results, had a similar rate of progression to those who were Mantoux positive. Those negative on either or both tests had the lowest rate of progression. Conclusions. The incidence rate of TB disease in Gambian TB case contacts, after screening for co-prevalent cases, was 603/100,000 person years. Since initial ELISPOT test and Mantoux tests were each positive in only just over half of cases, but 71% were positive by one or other test, positivity by either might be the best indication for preventive treatment. These data do not support the replacement of the Mantoux test by an ELISPOT test in The Gambia or similar settings.	[Hill, Philip C.; Jackson-Sillah, Dolly J.; Fox, Annette; Brookes, Roger H.; de Jong, Bouke C.; Lugos, Moses D.; Adetifa, Ifedayo M.; Donkor, Simon A.; Aiken, Alex M.; Howie, Stephen R.; Corrah, Tumani; McAdam, Keith P.; Adegbola, Richard A.] MRC Labs, Bacterial Dis Programme, Banjul, Gambia	MRC Laboratory Molecular Biology	Hill, PC (corresponding author), MRC Labs, Bacterial Dis Programme, Banjul, Gambia.	pandmhill@hotmail.com	de Jong, Bouke/A-3636-2013; Lugos, Moses D/AAZ-5179-2020	de Jong, Bouke/0000-0002-1017-4675; Lugos, Moses D/0000-0002-4921-2691; Brookes, Roger/0000-0002-5361-0617; Fox, Annette/0000-0002-0565-7146	Medical Research Council (UK); European Commission; Medical Research Council [MC_U190088478, MC_U190071468, MC_U190081982] Funding Source: researchfish; MRC [MC_U190088478, MC_U190081982, MC_U190071468] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council (UK) and the European Commission. Neither funder had any role in conducting the study or preparing the manuscript.	Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390; EGSMOSE T, 1965, B WORLD HEALTH ORGAN, V33, P419; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000183; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Jeffries DJ, 2004, INT J TUBERC LUNG D, V8, P1095; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaufmann SHE, 2007, NAT MED, V13, P299, DOI 10.1038/nm0307-299; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; *NIH CLIN EXC, 2006, CLIN GUID, V33; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; PUFFER RR, 1952, AM REV TUBERC PULM, V65, P111; TAYLOR RE, 2007, ARCH DIS CH IN PRESS; van der Loeff MFS, 2003, AIDS, V17, P1841, DOI [10.1097/00002030-200308150-00014, 10.1097/01.aids.0000076303.76477.49]; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9	29	105	108	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1379	10.1371/journal.pone.0001379	http://dx.doi.org/10.1371/journal.pone.0001379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167540	gold, Green Accepted, Green Published			2022-12-27	WOS:000260468900008
J	Ridge, PG; Zhang, Y; Gladyshev, VN				Ridge, Perry G.; Zhang, Yan; Gladyshev, Vadim N.			Comparative Genomic Analyses of Copper Transporters and Cuproproteomes Reveal Evolutionary Dynamics of Copper Utilization and Its Link to Oxygen	PLOS ONE			English	Article							ESCHERICHIA-COLI; NADH DEHYDROGENASE-2; METAL HOMEOSTASIS; DISEASE; PROTEIN; GENES; RESISTANCE; CHEMISTRY; BACTERIA; LIFE	Copper is an essential trace element in many organisms and is utilized in all domains of life. It is often used as a cofactor of redox proteins, but is also a toxic metal ion. Intracellular copper must be carefully handled to prevent the formation of reactive oxygen species which pose a threat to DNA, lipids, and proteins. In this work, we examined patterns of copper utilization in prokaryotes by analyzing the occurrence of copper transporters and copper-containing proteins. Many organisms, including those that lack copper-dependent proteins, had copper exporters, likely to protect against copper ions that inadvertently enter the cell. We found that copper use is widespread among prokaryotes, but also identified several phyla that lack cuproproteins. This is in contrast to the use of other trace elements, such as selenium, which shows more scattered and reduced usage, yet larger selenoproteomes. Copper transporters had different patterns of occurrence than cuproproteins, suggesting that the pathways of copper utilization and copper detoxification are independent of each other. We present evidence that organisms living in oxygen-rich environments utilize copper, whereas the majority of anaerobic organisms do not. In addition, among copper users, cuproproteomes of aerobic organisms were larger than those of anaerobic organisms. Prokaryotic cuproproteomes were small and dominated by a single protein, cytochrome c oxidase. The data are consistent with the idea that proteins evolved to utilize copper following the oxygenation of the Earth.	[Ridge, Perry G.; Zhang, Yan; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Gladyshev, Vadim/0000-0002-0372-7016	NIH [GM061603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by NIH GM061603.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews NC, 2002, CURR OPIN CHEM BIOL, V6, P181, DOI 10.1016/S1367-5931(02)00307-1; Arciero DM, 2002, BIOCHEMISTRY-US, V41, P1703, DOI 10.1021/bi015908w; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Banci L, 2004, J BIOL CHEM, V279, P27502, DOI 10.1074/jbc.M402005200; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; Cavet JS, 2003, FEMS MICROBIOL REV, V27, P165, DOI 10.1016/S0168-6445(03)00050-0; CHA JS, 1993, APPL ENVIRON MICROB, V59, P1671, DOI 10.1128/AEM.59.5.1671-1674.1993; Chan SI, 2004, BIOCHEMISTRY-US, V43, P4421, DOI 10.1021/bi0497603; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Coombs JM, 2005, APPL ENVIRON MICROB, V71, P7083, DOI 10.1128/AEM.71.11.7083-7091.2005; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Decker H, 2000, J EXP BIOL, V203, P1777; ELLIS MJ, 2007, J BIOL INOR IN PRESS; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; GUPTA SD, 1995, J BACTERIOL, V177, P4207, DOI 10.1128/jb.177.15.4207-4215.1995; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Janulczyk R, 1999, MOL MICROBIOL, V34, P596, DOI 10.1046/j.1365-2958.1999.01626.x; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; OCHIAI EI, 1983, BIOSYSTEMS, V16, P81, DOI 10.1016/0303-2647(83)90029-1; Rapisarda VA, 2002, ARCH BIOCHEM BIOPHYS, V405, P87, DOI 10.1016/S0003-9861(02)00277-1; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rodriguez-Montelongo L, 2006, ARCH BIOCHEM BIOPHYS, V451, P1, DOI 10.1016/j.abb.2006.04.019; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Sayre LM, 2001, CURR MED CHEM, V8, P721, DOI 10.2174/0929867013372922; Shcolnick S, 2006, PLANT PHYSIOL, V141, P805, DOI 10.1104/pp.106.079251; Silver S, 2005, J IND MICROBIOL BIOT, V32, P587, DOI 10.1007/s10295-005-0019-6; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Talbot K, 2002, POSTGRAD MED J, V78, P513, DOI 10.1136/pmj.78.923.513; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Voloudakis AE, 2005, APPL ENVIRON MICROB, V71, P782, DOI 10.1128/AEM.71.2.782-789.2005; VULPE CD, 1995, ANNU REV NUTR, V15, P293, DOI 10.1146/annurev.nu.15.070195.001453; WILLIAMS RJP, 2006, CHEM EVOLUTION DEV E, P253; Wilmot CM, 2003, BIOCHEM SOC T, V31, P493, DOI 10.1042/bst0310493; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; ZHANG Y, 2007, NUCL ACIDS IN PRESS; Zhang Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r94	45	134	135	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1378	10.1371/journal.pone.0001378	http://dx.doi.org/10.1371/journal.pone.0001378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167539	Green Published, gold			2022-12-27	WOS:000260468900007
J	Cooley, M; Carychao, D; Crawford-Miksza, L; Jay, MT; Myers, C; Rose, C; Keys, C; Farrar, J; Mandrell, RE				Cooley, Michael; Carychao, Diana; Crawford-Miksza, Leta; Jay, Michele T.; Myers, Carol; Rose, Christopher; Keys, Christine; Farrar, Jeff; Mandrell, Robert E.			Incidence and Tracking of Escherichia coli O157:H7 in a Major Produce Production Region in California	PLOS ONE			English	Article								Fresh vegetables have become associated with outbreaks caused by Escherichia coli O157:H7 (EcO157). Between 1995-2006, 22 produce outbreaks were documented in the United States, with nearly half traced to lettuce or spinach grown in California. Outbreaks between 2002 and 2006 induced investigations of possible sources of pre-harvest contamination on implicated farms in the Salinas and San Juan valleys of California, and a survey of the Salinas watershed. EcO157 was isolated at least once from 15 of 22 different watershed sites over a 19 month period. The incidence of EcO157 increased significantly when heavy rain caused an increased flow rate in the rivers. Approximately 1000 EcO157 isolates obtained from cultures of >100 individual samples were typed using Multi-Locus Variable-number-tandem-repeat Analysis (MLVA) to assist in identifying potential fate and transport of EcO157 in this region. A subset of these environmental isolates were typed by Pulse Field Gel Electrophoresis (PFGE) in order to make comparisons with human clinical isolates associated with outbreak and sporadic illness. Recurrence of identical and closely related EcO157 strains from specific locations in the Salinas and San Juan valleys suggests that transport of the pathogen is usually restricted. In a preliminary study, EcO157 was detected in water at multiple locations in a low-flow creek only within 135 meters of a point source. However, possible transport up to 32 km was detected during periods of higher water flow associated with flooding. During the 2006 baby spinach outbreak investigation, transport was also detected where water was unlikely to be involved. These results indicate that contamination of the environment is a dynamic process involving multiple sources and methods of transport. Intensive studies of the sources, incidence, fate and transport of EcO157 near produce production are required to determine the mechanisms of pre-harvest contamination and potential risks for human illness.	[Cooley, Michael; Carychao, Diana; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA; [Crawford-Miksza, Leta; Jay, Michele T.] Calif Dept Hlth Serv, Food & Drug Lab Branch, Richmond, CA USA; [Rose, Christopher] Calif Environm Protect Agcy, Cent Coast Reg Water Qual Control Board, San Luis Obispo, CA USA; [Keys, Christine] US FDA, CFSAN, OPDF DMS, College Pk, MD USA	United States Department of Agriculture (USDA); California Department of Health Care Services; California Environmental Protection Agency; US Food & Drug Administration (FDA)	Cooley, M (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA.	mcooley@pw.usda.gov; mandrell@pw.usda.gov	Mandrell, Robert E/O-9814-2018; Bond, Ronald F./C-9201-2009	Bond, Ronald F./0000-0003-1823-2478	CRIS [5325-42000-045-00D, 5325-42000-044-00D]; FDA [5325-42000-045-01R]; CAL-EPA State Water Resources Control Board [05-221-130-0]; USDA-CSREES Section 32.1 [2006-01240]	CRIS; FDA(United States Department of Health & Human Services); CAL-EPA State Water Resources Control Board; USDA-CSREES Section 32.1(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	A portion of this work was funded by CRIS projects 5325-42000-045-00D and 5325-42000-044-00D, an interagency transfer of funds provided by FDA (5325-42000-045-01R), a contract with the CAL-EPA State Water Resources Control Board (05-221-130-0), and a grant from USDA-CSREES Section 32.1 (project no. 2006-01240).	Arthur TM, 2004, J FOOD PROTECT, V67, P658, DOI 10.4315/0362-028X-67.4.658; Barkocy-Gallagher GA, 2004, J FOOD PROTECT, V67, P993, DOI 10.4315/0362-028X-67.5.993; Barkocy-Gallagher GA, 2002, J FOOD PROTECT, V65, P1527, DOI 10.4315/0362-028X-65.10.1527; Barkocy-Gallagher GA, 2001, APPL ENVIRON MICROB, V67, P3810, DOI 10.1128/AEM.67.9.3810-3818.2001; BARRETT TJ, 1980, J CLIN MICROBIOL, V11, P385, DOI 10.1128/JCM.11.4.385-388.1980; Benham BL, 2006, T ASABE, V49, P987, DOI 10.13031/2013.21739; *CA EPA, 2002, 2002 CWA SECT 303 D; *CDHS, 2004, INV E COL O157 H7 OU; *CDHS, 2005, ADD REP INV PREW MIX; [CDHS-FDA] California Department of Human Services and the Food and Drug Administration, 2007, INV ESCH COL O157 H7; Chapman PA, 1997, EPIDEMIOL INFECT, V119, P245, DOI 10.1017/S0950268897007826; Cooley MB, 2003, APPL ENVIRON MICROB, V69, P4915, DOI 10.1128/AEM.69.8.4915-4926.2003; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; Crabill C, 1999, WATER RES, V33, P2163, DOI 10.1016/S0043-1354(98)00437-0; Czajkowska D, 2005, POL J ENVIRON STUD, V14, P423; Davis MA, 2005, APPL ENVIRON MICROB, V71, P6816, DOI 10.1128/AEM.71.11.6816-6822.2005; Davis MA, 2003, EPIDEMIOL INFECT, V131, P923, DOI 10.1017/S0950268803008884; Desmarchelier PM, 1998, J CLIN MICROBIOL, V36, P1801, DOI 10.1128/JCM.36.6.1801-1804.1998; Dewell GA, 2005, FOODBORNE PATHOG DIS, V2, P70, DOI 10.1089/fpd.2005.2.70; Dorner SM, 2006, ENVIRON SCI TECHNOL, V40, P4746, DOI 10.1021/es060426z; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; *FDA CFSAN, 2006, TAC BELL E COL O157; *FDA CFSAN, 2007, FDA STAT CLOS ID SOU; Ferguson C, 2003, CRIT REV ENV SCI TEC, V33, P299, DOI 10.1080/10643380390814497; Foster G, 2006, APPL ENVIRON MICROB, V72, P2265, DOI 10.1128/AEM.72.3.2265-2267.2006; Fratamico PM, 2000, J FOOD PROTECT, V63, P1032, DOI 10.4315/0362-028X-63.8.1032; Gagliardi JV, 2000, APPL ENVIRON MICROB, V66, P877, DOI 10.1128/AEM.66.3.877-883.2000; Gannon VPJ, 2005, SCI TOTAL ENVIRON, V348, P19, DOI 10.1016/j.scitotenv.2004.12.076; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; Ibekwe AM, 2004, CAN J MICROBIOL, V50, P1007, DOI 10.1139/W04-097; Ingham SC, 2005, J FOOD PROTECT, V68, P1134, DOI 10.4315/0362-028X-68.6.1134; Islam M, 2005, FOOD MICROBIOL, V22, P63, DOI 10.1016/j.fm.2004.04.007; Islam M, 2004, J FOOD PROTECT, V67, P1365, DOI 10.4315/0362-028X-67.7.1365; JACKSON SA, 2006, FORENSIC SCI INT; Johannessen GS, 2005, APPL ENVIRON MICROB, V71, P2221, DOI 10.1128/AEM.71.5.2221-2225.2005; Kaufmann M, 2006, J FOOD PROTECT, V69, P260, DOI 10.4315/0362-028X-69.2.260; Keen JE, 2006, EMERG INFECT DIS, V12, P780; Keen JE, 2002, J AM VET MED ASSOC, V220, P756, DOI 10.2460/javma.2002.220.756; Keys C, 2005, J APPL MICROBIOL, V98, P928, DOI 10.1111/j.1365-2672.2004.02532.x; LeJeune JT, 2001, APPL ENVIRON MICROB, V67, P3053, DOI 10.1128/AEM.67.7.3053-3057.2001; LeJeune JT, 2004, APPL ENVIRON MICROB, V70, P377, DOI 10.1128/AEM.70.1.377-384.2004; Lindstedt BA, 2004, J MICROBIOL METH, V58, P213, DOI 10.1016/j.mimet.2004.03.016; *MDPH, 2005, HLTH OFF INV E COLI; *MMWR, 2006, MORBITY MORTALITY WE, V55, P1045; Moriya K, 1999, MED VET ENTOMOL, V13, P214, DOI 10.1046/j.1365-2915.1999.00161.x; Muirhead RW, 2006, APPL ENVIRON MICROB, V72, P3406, DOI 10.1128/AEM.72.5.3406-3411.2006; Mukherjee A, 2006, J APPL MICROBIOL, V101, P429, DOI 10.1111/j.1365-2672.2006.02913.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; Ogden ID, 2005, J APPL MICROBIOL, V98, P646, DOI 10.1111/j.1365-2672.2004.02493.x; OKREND AJG, 1992, J FOOD PROTECT, V55, P214, DOI 10.4315/0362-028X-55.3.214; Paiba GA, 2002, VET REC, V150, P593, DOI 10.1136/vr.150.19.593; Paton AW, 1998, INFECT IMMUN, V66, P5580, DOI 10.1128/IAI.66.11.5580-5586.1998; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rasmussen MA, 2001, CRIT REV MICROBIOL, V27, P57, DOI 10.1080/20014091096701; Ren JH, 2002, J ENVIRON ENG-ASCE, V128, P624, DOI 10.1061/(ASCE)0733-9372(2002)128:7(624); Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rivera-Betancourt M, 2004, J FOOD PROTECT, V67, P295, DOI 10.4315/0362-028X-67.2.295; ROSE C, 2006, PHASE 4 PROJECT ANAL; Sargeant JM, 1999, J AM VET MED ASSOC, V215, P792; Scott L, 2006, VET MICROBIOL, V114, P331, DOI 10.1016/j.vetmic.2005.11.066; Scott L, 2006, J FOOD PROTECT, V69, P6, DOI 10.4315/0362-028X-69.1.6; SEARS SD, 1984, J INFECT DIS, V149, P640, DOI 10.1093/infdis/149.4.640; Seo KH, 1999, J FOOD PROTECT, V62, P3, DOI 10.4315/0362-028X-62.1.3; SMALL I, 2005, ADDENDUM REPORT INVE; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Sproston EL, 2006, APPL ENVIRON MICROB, V72, P144, DOI 10.1128/AEM.72.1.144-149.2006; Takeuchi K, 2000, J FOOD PROTECT, V63, P434, DOI 10.4315/0362-028X-63.4.434; Tanaka Y, 2000, J APPL MICROBIOL, V88, P228, DOI 10.1046/j.1365-2672.2000.00960.x; Tutenel AV, 2003, INT J FOOD MICROBIOL, V84, P63, DOI 10.1016/S0168-1605(02)00395-1; *USDA, 2001, LETT OUT BAG; *USGS, 2007, NAT WAT INF SYST WEB; Wachtel MR, 2002, J FOOD PROTECT, V65, P18, DOI 10.4315/0362-028X-65.1.18; Wang GD, 1998, J FOOD PROTECT, V61, P662, DOI 10.4315/0362-028X-61.6.662; Watterworth L, 2006, WATER AIR SOIL POLL, V177, P367, DOI 10.1007/s11270-006-9179-x; Westerman RB, 1997, J CLIN MICROBIOL, V35, P679, DOI 10.1128/JCM.35.3.679-684.1997; Wetzel AN, 2006, APPL ENVIRON MICROB, V72, P2621, DOI 10.1128/AEM.72.4.2621-2626.2006; Yaron S, 2002, J APPL MICROBIOL, V92, P633, DOI 10.1046/j.1365-2672.2002.01563.x; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	80	257	260	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1159	10.1371/journal.pone.0001159	http://dx.doi.org/10.1371/journal.pone.0001159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18174909	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459100002
J	Sreenivasan, R; Cai, MN; Bartfai, R; Wang, XG; Christoffels, A; Orban, L				Sreenivasan, Rajini; Cai, Minnie; Bartfai, Richard; Wang, Xingang; Christoffels, Alan; Orban, Laszlo			Transcriptomic Analyses Reveal Novel Genes with Sexually Dimorphic Expression in the Zebrafish Gonad and Brain	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; SEX-DIFFERENTIATION; MICROARRAY ANALYSIS; MAMMALIAN SEPTIN; CDNA MICROARRAY; RAINBOW-TROUT; PROTEIN; OVARY; TESTIS; AROMATASE	Background: Our knowledge on zebrafish reproduction is very limited. We generated a gonad-derived cDNA microarray from zebrafish and used it to analyze large-scale gene expression profiles in adult gonads and other organs. Methodology/Principal Findings: We have identified 116638 gonad-derived zebrafish expressed sequence tags (ESTs), 21% of which were isolated in our lab. Following in silico normalization, we constructed a gonad-derived microarray comprising 6370 unique, full-length cDNAs from differentiating and adult gonads. Labeled targets from adult gonad, brain, kidney and 'rest-of-body' from both sexes were hybridized onto the microarray. Our analyses revealed 1366, 881 and 656 differentially expressed transcripts (34.7% novel) that showed highest expression in ovary, testis and both gonads respectively. Hierarchical clustering showed correlation of the two gonadal transcriptomes and their similarities to those of the brains. In addition, we have identified 276 genes showing sexually dimorphic expression both between the brains and between the gonads. By in situ hybridization, we showed that the gonadal transcripts with the strongest array signal intensities were germline-expressed. We found that five members of the GTP-binding septin gene family, from which only one member (septin 4) has previously been implicated in reproduction in mice, were all strongly expressed in the gonads. Conclusions/Significance: We have generated a gonad-derived zebrafish cDNA microarray and demonstrated its usefulness in identifying genes with sexually dimorphic co-expression in both the gonads and the brains. We have also provided the first evidence of large-scale differential gene expression between female and male brains of a teleost. Our microarray would be useful for studying gonad development, differentiation and function not only in zebrafish but also in related teleosts via cross-species hybridizations. Since several genes have been shown to play similar roles in gonadogenesis in zebrafish and other vertebrates, our array may even provide information on genetic disorders affecting gonadal phenotypes and fertility in mammals.	[Sreenivasan, Rajini; Cai, Minnie; Bartfai, Richard; Wang, Xingang; Orban, Laszlo] Temasek Life Sci Lab, Reprod Genom Grp, Singapore, Singapore; [Wang, Xingang; Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Christoffels, Alan] Temasek Life Sci Lab, Singapore, Singapore; [Christoffels, Alan] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Orban, L (corresponding author), Temasek Life Sci Lab, Reprod Genom Grp, Singapore, Singapore.	laszlo@tll.org.sg	Bartfai, Richard/E-2083-2012; Sreenivasan, Rajini/G-6930-2019; Orbán, László/A-3030-2009; Christoffels, Alan/C-3269-2014	Bartfai, Richard/0000-0002-8460-6477; Sreenivasan, Rajini/0000-0002-6357-5392; Orbán, László/0000-0001-5435-5948; Christoffels, Alan/0000-0002-0420-2916	Temasek Life Sciences Laboratory [fellowships]; Department of Biological Sciences of the National University of Singapore [fellowships]	Temasek Life Sciences Laboratory(National University of Singapore); Department of Biological Sciences of the National University of Singapore(National University of Singapore)	This work was supported by fellowships from Temasek Life Sciences Laboratory and the Department of Biological Sciences of the National University of Singapore as well as by internal research grants from Temasek Life Sciences Laboratory.	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beier DR, 1998, GENOME RES, V8, P9, DOI 10.1101/gr.8.1.9; Blaser S, 2003, GENE, V312, P313, DOI 10.1016/S0378-1119(03)00635-8; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chiang EFL, 2001, MOL BIOL EVOL, V18, P542, DOI 10.1093/oxfordjournals.molbev.a003833; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; Dennis C, 2004, NATURE, V427, P390, DOI 10.1038/427390a; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; DICLEMENTE N, 1992, DEVELOPMENT, V114, P721; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; Dodd A, 2000, HUM MOL GENET, V9, P2443, DOI 10.1093/hmg/9.16.2443; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725; Ensslin M, 1998, BIOL REPROD, V58, P1057, DOI 10.1095/biolreprod58.4.1057; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P10673, DOI 10.1073/pnas.90.22.10673; FRANCIS RC, 1992, Q REV BIOL, V67, P1, DOI 10.1086/417445; Gahr M, 2003, P NATL ACAD SCI USA, V100, P7959, DOI 10.1073/pnas.1335934100; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Giuili G, 1997, DEVELOPMENT, V124, P1799; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Guo J, 2003, CYTOGENET GENOME RES, V103, P58, DOI 10.1159/000076290; Guo JH, 2005, CYTOGENET GENOME RES, V111, P107, DOI 10.1159/000086378; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hanai N, 2004, FEBS LETT, V568, P83, DOI 10.1016/j.febslet.2004.05.030; Herrera L, 2005, DEV BIOL, V279, P271, DOI 10.1016/j.ydbio.2004.11.029; Hsia N, 2004, BIOL REPROD, V70, P448, DOI 10.1095/biolreprod.103.021493; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Josso N, 2001, MOL CELL ENDOCRINOL, V179, P25, DOI 10.1016/S0303-7207(01)00467-1; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Li Y, 2004, COMP FUNCT GENOM, V5, P403, DOI 10.1002/cfg.418; Liao J, 1997, BIOTECHNIQUES, V23, P368, DOI 10.2144/97233bm03; Liu SJ, 2000, J STEROID BIOCHEM, V75, P291, DOI 10.1016/S0960-0760(00)00186-2; Liu XJ, 2006, BIOL REPROD, V74, P1016, DOI 10.1095/biolreprod.105.049403; Lo J, 2003, GENOME RES, V13, P455, DOI 10.1101/gr.885403; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Mold DE, 2001, MOL REPROD DEV, V58, P4, DOI 10.1002/1098-2795(200101)58:1&lt;4::AID-MRD2&gt;3.0.CO;2-P; Montagna C, 2003, CANCER RES, V63, P2179; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; ORBAN L, 2008, GENOME MAPP IN PRESS; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Petrunkina AM, 2003, REPRODUCTION, V125, P377, DOI 10.1530/reprod/125.3.377; PICARD JY, 1986, P NATL ACAD SCI USA, V83, P5464, DOI 10.1073/pnas.83.15.5464; Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90; Rey R, 2003, MOL CELL ENDOCRINOL, V211, P21, DOI 10.1016/j.mce.2003.09.007; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Santos EM, 2007, PHYSIOL GENOMICS, V30, P111, DOI 10.1152/physiolgenomics.00284.2006; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Ton C, 2002, BIOCHEM BIOPH RES CO, V296, P1134, DOI 10.1016/S0006-291X(02)02010-7; Uchida D, 2002, J EXP BIOL, V205, P711; van der Ven K, 2005, COMP BIOCHEM PHYS B, V141, P408, DOI 10.1016/j.cbpc.2005.05.004; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; von Hofsten J, 2005, DEV DYNAM, V233, P595, DOI 10.1002/dvdy.20335; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; Wang H, 1999, BBA-GENE STRUCT EXPR, V1446, P156, DOI 10.1016/S0167-4781(99)00066-4; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Wixon J, 2000, YEAST, V17, P225, DOI 10.1002/1097-0061(20000930)17:3&lt;225::AID-YEA34&gt;3.0.CO;2-5; Xu M, 2001, INT J BIOCHEM CELL B, V33, P1172, DOI 10.1016/S1357-2725(01)00089-9; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	85	88	91	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1791	10.1371/journal.pone.0001791	http://dx.doi.org/10.1371/journal.pone.0001791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335061	Green Published, Green Submitted, gold			2022-12-27	WOS:000260723000042
J	Huang, J; Gan, Q; Han, LM; Li, J; Zhang, H; Sun, Y; Zhang, ZY; Tong, TJ				Huang, Jing; Gan, Qini; Han, Limin; Li, Jian; Zhang, Hai; Sun, Ying; Zhang, Zongyu; Tong, Tanjun			SIRT1 Overexpression Antagonizes Cellular Senescence with Activated ERK/S6k1 Signaling in Human Diploid Fibroblasts	PLOS ONE			English	Article								Sir2, a NAD-dependent deacetylase, modulates lifespan in yeasts, worms and flies. The SIRT1, mammalian homologue of Sir2, regulates signaling for favoring survival in stress. But whether SIRT1 has the function to influence cell viability and senescence under non-stressed conditions in human diploid fibroblasts is far from unknown. Our data showed that enforced SIRT1 expression promoted cell proliferation and antagonized cellular senescence with the characteristic features of delayed Senescence-Associated beta-galactosidase (SA-beta-gal) staining, reduced Senescence-Associated Heterochromatic Foci (SAHF) formation and G1 phase arrest, increased cell growth rate and extended cellular lifespan in human fibroblasts, while dominant-negative SIRT1 allele (H363Y) did not significantly affect cell growth and senescence but displayed a bit decreased lifespan.. Western blot results showed that SIRT1 reduced the expression of p16(INK4A) and promoted phosphorylation of Rb. Our data also exposed that overexpression of SIRT1 was accompanied by enhanced activation of ERK and S6K1 signaling. These effects were mimicked in both WI38 cells and 2BS cells by concentration-dependent resveratrol, a SIRT1 activator. It was noted that treatment of SIRT1-.transfected cells with Rapamycin, a mTOR inhibitor, reduced the phosphorylation of S6K1 and the expression of Id1, implying that SIRT1-induced phosphorylation of S6K1 may be partly for the decreased expression of p16(INK4A) and promoted phosphorylation of Rb in 2BS. It was also observed that the expression of SIRT1 and phosphorylation of ERK and S6K1 was declined in senescent 2BS. These findings suggested that SIRT1-promoted cell proliferation and antagonized cellular senescence in human diploid fibroblasts may be, in part, via the activation of ERK/S6K1 signaling.	[Huang, Jing; Gan, Qini; Han, Limin; Li, Jian; Zhang, Hai; Sun, Ying; Zhang, Zongyu; Tong, Tanjun] Peking Univ, Res Ctr Aging, Beijing 100871, Peoples R China; [Huang, Jing; Gan, Qini; Han, Limin; Li, Jian; Zhang, Hai; Sun, Ying; Zhang, Zongyu; Tong, Tanjun] Peking Univ Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing, Peoples R China	Peking University; Peking University	Huang, J (corresponding author), Peking Univ, Res Ctr Aging, Beijing 100871, Peoples R China.	tztong@bjmu.edu.cn	Li, Jian/N-7001-2014		National Basic Research Programs of China [2007CB507400]; National Natural Science Foundation of China [3050082, 30671064]; National Post doctoral Foundation of China	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Post doctoral Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Basic Research Programs of China (No. 2007CB507400), the National Natural Science Foundation of China (No.3050082 and No.30671064), and the National Post doctoral Foundation of China.	Arvisais EW, 2006, J BIOL CHEM, V281, P26904, DOI 10.1074/jbc.M605371200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Duan JM, 2001, J BIOL CHEM, V276, P48325, DOI 10.1074/jbc.M104814200; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gerasimovskaya EV, 2005, J BIOL CHEM, V280, P1838, DOI 10.1074/jbc.M409466200; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hidayat S, 2003, BIOCHEM BIOPH RES CO, V301, P417, DOI 10.1016/S0006-291X(02)03052-8; Hutter E, 2002, EXP GERONTOL, V37, P1165, DOI 10.1016/S0531-5565(02)00136-5; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Kobayashi Y, 2006, ONCOGENE, V25, P512, DOI 10.1038/sj.onc.1209072; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lorenzini A, 2005, MECH AGEING DEV, V126, P1130, DOI 10.1016/j.mad.2005.05.004; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Munro J, 2004, EXP CELL RES, V295, P525, DOI 10.1016/j.yexcr.2004.01.017; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Raffetto Joseph D, 2006, Vasc Endovascular Surg, V40, P59, DOI 10.1177/153857440604000108; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Shay J W, 2001, Novartis Found Symp, V235, P116; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zhang H, 2000, EXP CELL RES, V259, P284, DOI 10.1006/excr.2000.4965; Zheng WJ, 2004, J BIOL CHEM, V279, P31524, DOI 10.1074/jbc.M400365200	45	147	155	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1710	10.1371/journal.pone.0001710	http://dx.doi.org/10.1371/journal.pone.0001710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320031	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586600006
J	Sawalha, AH; Webb, R; Han, SZ; Kelly, JA; Kaufman, KM; Kimberly, RP; Alarcon-Riquelme, ME; James, JA; Vyse, TJ; Gilkeson, GS; Choi, CB; Scofield, RH; Bae, SC; Nath, SK; Harley, JB				Sawalha, Amr H.; Webb, Ryan; Han, Shizhong; Kelly, Jennifer A.; Kaufman, Kenneth M.; Kimberly, Robert P.; Alarcon-Riquelme, Marta E.; James, Judith A.; Vyse, Timothy J.; Gilkeson, Gary S.; Choi, Chan-Bum; Scofield, R. Hal; Bae, Sang-Cheol; Nath, Swapan K.; Harley, John B.			Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus	PLOS ONE			English	Article								Systemic lupus erythematosus (SLE) is a predominantly female autoimmune disease that affects multiple organ systems. Herein, we report on an X-chromosome gene association with SLE. Methyl-CpG-binding protein 2 (MECP2) is located on chromosome Xq28 and encodes for a protein that plays a critical role in epigenetic transcriptional regulation of methylation-sensitive genes. Utilizing a candidate gene association approach, we genotyped 21 SNPs within and around MECP2 in SLE patients and controls. We identify and replicate association between SLE and the genomic element containing MECP2 in two independent SLE cohorts from two ethnically divergent populations. These findings are potentially related to the overexpression of methylation-sensitive genes in SLE.	[Sawalha, Amr H.; Kaufman, Kenneth M.; James, Judith A.; Scofield, R. Hal; Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Sawalha, Amr H.; Kaufman, Kenneth M.; Scofield, R. Hal; Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Sawalha, Amr H.; Webb, Ryan; Han, Shizhong; Kelly, Jennifer A.; Kaufman, Kenneth M.; James, Judith A.; Scofield, R. Hal; Nath, Swapan K.; Harley, John B.] Oklahoma Med Res Fdn, Arthrit & Immunol Program, Oklahoma City, OK USA; [Kimberly, Robert P.] Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA; [Alarcon-Riquelme, Marta E.] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Vyse, Timothy J.] Hammersmith Hosp, Imperial Coll, Rheumatology Sect, London, England; [Gilkeson, Gary S.] Med Univ South Carolina Charleston, Dept Med, Div Rheumatol, Charleston, SC USA; [Choi, Chan-Bum; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Internal Med, Div Rheumatol, Seoul, South Korea	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Alabama System; University of Alabama Birmingham; Uppsala University; Imperial College London; Medical University of South Carolina; Hanyang University	Sawalha, AH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA.	amr-sawalha@omrf.ouhsc.edu	Scofield, Robert Hal/AEJ-8314-2022; Han, Shizhong/H-5785-2011; Choi, Chan-Bum/M-4110-2017; Alarcón-Riquelme, Marta E./ABF-8163-2020; Han, Shizhong/E-4084-2010	Choi, Chan-Bum/0000-0002-4691-5455; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Han, Shizhong/0000-0002-5114-6742; Kimberly, Robert/0000-0002-5330-3086; Bae, Sang-Cheol/0000-0003-4658-1093; Kelly, Jennifer/0000-0002-3203-2467	NIH [P20-RR015577, AI63622, AR42460, AI024717, AI31584, AR62277, AR048940, AR0490084]; University of Oklahoma College of Medicine (AHS); Kirkland Scholar award; Alliance for Lupus Research; U.S. Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R01AI031584, R01AI024717, R01AI063622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042460, P50AR048940, P30AR053483] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oklahoma College of Medicine (AHS); Kirkland Scholar award; Alliance for Lupus Research; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This publication was made possible by NIH Grant Number P20-RR015577 from the National Center for Research Resources and by funding from the University of Oklahoma College of Medicine (AHS), NIH Grant Number AI63622 (SKN), and NIH Grants Number AR42460, AI024717, AI31584, AR62277, AR048940, AR0490084, Kirkland Scholar award, Alliance for Lupus Research, and the U.S. Department of Veterans Affairs (JBH).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BIRD AP, 1993, COLD SPRING HARB SYM, V58, P281, DOI 10.1101/SQB.1993.058.01.033; Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.3.CO;2-E; Francke U, 2006, NAT CLIN PRACT NEURO, V2, P212, DOI 10.1038/ncpneuro0148; Gan L, 2006, IMMUNOL RES, V35, P295, DOI 10.1385/IR:35:3:295; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaplan MJ, 2004, J IMMUNOL, V172, P3652, DOI 10.4049/jimmunol.172.6.3652; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Leonard H, 1997, EUR CHILD ADOLES PSY, V6, P8; LU Q, J IMMUNOLOG IN PRESS; Miltenberger-Miltenyi G, 2003, HUM MUTAT, V22, P107, DOI 10.1002/humu.10243; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Oelke K, 2004, ARTHRITIS RHEUM-US, V50, P1850, DOI 10.1002/art.20255; Petri M, 2002, BEST PRACT RES CL RH, V16, P847, DOI 10.1053/berh.2002.0259; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; RICHARDSON B, 1986, HUM IMMUNOL, V17, P456, DOI 10.1016/0198-8859(86)90304-6; RICHARDSON BC, 1992, ARTHRITIS RHEUM, V35, P647, DOI 10.1002/art.1780350608; Sawalha Amr H., 2005, Current Pharmacogenomics, V3, P73, DOI 10.2174/1570160053174983; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shibayama A, 2004, AM J MED GENET B, V128B, P50, DOI 10.1002/ajmg.b.30016; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; YUNG RL, 1995, J IMMUNOL, V154, P3025	27	114	120	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1727	10.1371/journal.pone.0001727	http://dx.doi.org/10.1371/journal.pone.0001727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320046	gold, Green Submitted, Green Published			2022-12-27	WOS:000260586600022
J	Gillet, L; Colaco, S; Stevenson, PG				Gillet, Laurent; Colaco, Susanna; Stevenson, Philip G.			The Murid Herpesvirus-4 gH/gL Binds to Glycosaminoglycans	PLOS ONE			English	Article								The first contact a virus makes with cells is an important determinant of its tropism. Murid Herpesvirus-4 (MuHV-4) is highly dependent on glycosaminoglycans (GAGs) for cell binding. Its first contact is therefore likely to involve a GAG-binding virion glycoprotein. We have previously identified two such proteins, gp70 and gp150. Gp70 binds strongly to GAGs. However, deleting it makes little difference to MuHV-4 cell binding or GAG-dependence. Deleting gp150, by contrast, frees MuHV-4 from GAG dependence. This implies that GAGs normally displace gp150 to allow GAG-independent cell binding. But the gp150 GAG interaction is weak, and so would seem unlikely to make an effective first contact. Since neither gp70 nor gp150 matches the expected profile of a first contact glycoprotein, our understanding of MuHV-4 GAG interactions must be incomplete. Here we relate the seemingly disconnected gp70 and gp150 GAG interactions by showing that the MuHV-4 gH/gL also binds to GAGs. gH/gL-blocking and gp70-blocking antibodies individually had little effect on cell binding, but together were strongly inhibitory. Thus, there was redundancy in GAG binding between gp70 and gH/gL. Gp150-deficient MuHV-4 largely resisted blocks to gp70 and gH/gL binding, consistent with its GAG independence. The failure of wild-type MuHV-4 to do the same argues that gp150 is normally engaged only down-stream of gp70 or gH/gL. MuHV-4 GAG dependence is consequently two-fold: gp70 or gH/gL binding provides virions with a vital first foothold, and gp150 is then engaged to reveal GAG-independent binding.	[Gillet, Laurent; Colaco, Susanna; Stevenson, Philip G.] Univ Liege, Fac Vet Med, Liege, Belgium	University of Liege	Gillet, L (corresponding author), Univ Liege, Fac Vet Med, Liege, Belgium.	pgs27@cam.ac.uk	Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Stevenson, Philip g/0000-0002-3520-5060; Gillet, Laurent/0000-0002-1047-2525	Fonds National Belge de la Recherche Scientifique (FNRS); Wellcome Trust Senior Clinical Fellow [GR076956MA]; Medical Research Council [G0400427, G9800903]; Cancer Research UK [C19612/A6189]; Medical Research Council [G9800943] Funding Source: researchfish; MRC [G0400427, G9800943] Funding Source: UKRI	Fonds National Belge de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Wellcome Trust Senior Clinical Fellow(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Laurent Gillet is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique (FNRS). Philip Stevenson is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427 and G9800903 and by Cancer Research UK grant C19612/A6189.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Blom AM, 2007, ADV EXP MED BIOL, V598, P105; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000899; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, EMBO J, V26, P5131, DOI 10.1038/sj.emboj.7601925; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; HUTCHINSON L, 1992, J VIROL, V66, P2240, DOI 10.1128/JVI.66.4.2240-2250.1992; Kapadia SB, 1999, J VIROL, V73, P7658, DOI 10.1128/JVI.73.9.7658-7670.1999; KAYE JF, 1992, J GEN VIROL, V73, P2693, DOI 10.1099/0022-1317-73-10-2693; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lopes FB, 2004, J VIROL, V78, P13370, DOI 10.1128/JVI.78.23.13370-13375.2004; Mark L, 2006, MOL IMMUNOL, V43, P1665, DOI 10.1016/j.molimm.2005.09.016; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Parry C, 2005, J GEN VIROL, V86, P7, DOI 10.1099/vir.0.80567-0; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; TRYBALA E, 1993, J VIROL, V67, P1278, DOI 10.1128/JVI.67.3.1278-1285.1993; Turk SM, 2006, J VIROL, V80, P9628, DOI 10.1128/JVI.00622-06; Wadstrom T, 1999, J MED MICROBIOL, V48, P223, DOI 10.1099/00222615-48-3-223	32	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1669	10.1371/journal.pone.0001669	http://dx.doi.org/10.1371/journal.pone.0001669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301747	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586500014
J	Kajava, AV; Anisimova, M; Peeters, N				Kajava, Andrey V.; Anisimova, Maria; Peeters, Nemo			Origin and Evolution of GALA-LRR, a New Member of the CC-LRR Subfamily: From Plants to Bacteria?	PLOS ONE			English	Article							AMINO-ACID SITES; LEUCINE-RICH REPEAT; PATHOGEN RALSTONIA-SOLANACEARUM; LIKELIHOOD-RATIO TEST; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; EFFECTOR PROTEINS; UBIQUITIN LIGASE; SECRETION SYSTEM; COMPLEX	The phytopathogenic bacterium Ralstonia solanacearum encodes type III effectors, called GALA proteins, which contain F-box and LRR domains. The GALA LRRs do not perfectly fit any of the previously described LRR subfamilies. By applying protein sequence analysis and structural prediction, we clarify this ambiguous case of LRR classification and assign GALA-LRRs to CC-LRR subfamily. We demonstrate that side-by-side packing of LRRs in the 3D structures may control the limits of repeat variability within the LRR subfamilies during evolution. The LRR packing can be used as a criterion, complementing the repeat sequences, to classify newly identified LRR domains. Our phylogenetic analysis of F-box domains proposes the lateral gene transfer of bacterial GALA proteins from host plants. We also present an evolutionary scenario which can explain the transformation of the original plant LRRs into slightly different bacterial LRRs. The examination of the selective evolutionary pressure acting on GALA proteins suggests that the convex side of their horse-shoe shaped LRR domains is more prone to positive selection than the concave side, and we therefore hypothesize that the convex surface might be the site of protein binding relevant to the adaptor function of the F-box GALA proteins. This conclusion provides a strong background for further functional studies aimed at determining the role of these type III effectors in the virulence of R. solanacearum.	[Kajava, Andrey V.] Univ Montpellier I, CNRS, Ctr Rech Biochim Macromol, Montpellier, France; [Anisimova, Maria] Swiss Fed Inst Technol, Inst Comp Sci, Zurich, Switzerland; [Anisimova, Maria] Swiss Inst Bioinformat, Lausanne, Switzerland; [Peeters, Nemo] INRA CNRS, UMR 441 2594, Lab Interactions Plantes Microorganismes, Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Kajava, AV (corresponding author), Univ Montpellier I, CNRS, Ctr Rech Biochim Macromol, Montpellier, France.	andrey.kajava@crbm.cnrs.fr	Kajava, Andrey V/E-1107-2014; Peeters, Nemo/R-5834-2019; Peeters, Nemo M/A-2488-2012	Kajava, Andrey V/0000-0002-2342-6886; Peeters, Nemo/0000-0002-1802-0769; Peeters, Nemo M/0000-0002-1802-0769; Anisimova, Maria/0000-0001-8145-7966	BBSRC (UK); ETH, Zurich;  [2007 ANR jeune-chercheur (FR) grant]	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ETH, Zurich(ETH Zurich); 	MA was supported by the BBSRC (UK) grant to Prof Ziheng Yang and, at finalizing stage of this study, by the ETH, Zurich. This work is partly supported by a 2007 ANR jeune-chercheur (FR) grant to NP.	Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Angot A, 2006, P NATL ACAD SCI USA, V103, P14620, DOI 10.1073/pnas.0509393103; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; DAYRINGER HE, 1986, J MOL GRAPHICS, V4, P82; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hirt RP, 2002, MOL BIOCHEM PARASIT, V125, P195, DOI 10.1016/S0166-6851(02)00211-6; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V26, P282; Lupas A, 1997, MOL BIOL REP, V24, P125, DOI 10.1023/A:1006803512761; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Mercier A, 2007, RES MICROBIOL, V158, P537, DOI 10.1016/j.resmic.2007.05.003; Mukaihara T, 2004, MOL MICROBIOL, V54, P863, DOI 10.1111/j.1365-2958.2004.04328.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schrammeijer B, 2001, CURR BIOL, V11, P258, DOI 10.1016/S0960-9822(01)00069-0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	46	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1694	10.1371/journal.pone.0001694	http://dx.doi.org/10.1371/journal.pone.0001694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301771	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500038
J	Kringelbach, ML; Lehtonen, A; Squire, S; Harvey, AG; Craske, MG; Holliday, IE; Green, AL; Aziz, TZ; Hansen, PC; Cornelissen, PL; Stein, A				Kringelbach, Morten L.; Lehtonen, Annukka; Squire, Sarah; Harvey, Allison G.; Craske, Michelle G.; Holliday, Ian E.; Green, Alexander L.; Aziz, Tipu Z.; Hansen, Peter C.; Cornelissen, Piers L.; Stein, Alan			A Specific and Rapid Neural Signature for Parental Instinct	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; VENTRAL TEMPORAL CORTEX; POSTNATAL DEPRESSION; INFANT INTERACTIONS; VISUAL RECOGNITION; BRAIN; FACES; REPRESENTATIONS; REGISTRATION; ORGANIZATION	Darwin originally pointed out that there is something about infants which prompts adults to respond to and care for them, in order to increase individual fitness, i.e. reproductive success, via increased survivorship of one's own offspring. Lorenz proposed that it is the specific structure of the infant face that serves to elicit these parental responses, but the biological basis for this remains elusive. Here, we investigated whether adults show specific brain responses to unfamiliar infant faces compared to adult faces, where the infant and adult faces had been carefully matched across the two groups for emotional valence and arousal, as well as size and luminosity. The faces also matched closely in terms of attractiveness. Using magnetoencephalography (MEG) in adults, we found that highly specific brain activity occurred within a seventh of a second in response to unfamiliar infant faces but not to adult faces. This activity occurred in the medial orbitofrontal cortex (mOFC), an area implicated in reward behaviour, suggesting for the first time a neural basis for this vital evolutionary process. We found a peak in activity first in mOFC and then in the right fusiform face area (FFA). In mOFC the first significant peak (p<0.001) in differences in power between infant and adult faces was found at around 130 ms in the 10-15 Hz band. These early differences were not found in the FFA. In contrast, differences in power were found later, at around 165 ms, in a different band (20-25 Hz) in the right FFA, suggesting a feedback effect from mOFC. These findings provide evidence in humans of a potential brain basis for the "innate releasing mechanisms'' described by Lorenz for affection and nurturing of young infants. This has potentially important clinical applications in relation to postnatal depression, and could provide opportunities for early identification of families at risk.	[Kringelbach, Morten L.; Lehtonen, Annukka; Squire, Sarah; Stein, Alan] Univ Oxford, Dept Psychiat, Oxford, England; [Kringelbach, Morten L.; Aziz, Tipu Z.] Univ Oxford, Dept Physiol, Anat & Genet, Oxford, England; [Harvey, Allison G.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA USA; [Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Holliday, Ian E.] Aston Univ, Sch Life & Hlth Sci, Wellcome Trust Lab MEG Stud, Birmingham, W Midlands, England; [Hansen, Peter C.] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [Cornelissen, Piers L.] York Univ, Dept Psychol, York, N Yorkshire, England; [Kringelbach, Morten L.; Green, Alexander L.; Aziz, Tipu Z.] John Radcliffe Hosp, Dept Neurosurg, Oxford, England; [Kringelbach, Morten L.] Aarhus Univ, CFIN, Aarhus, Denmark	University of Oxford; University of Oxford; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; Aston University; University of Birmingham; University of York - UK; University of Oxford; Aarhus University	Kringelbach, ML (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	Morten.Kringelbach@psych.ox.ac.uk	Hansen, Peter C/F-3163-2010; Cornelissen, Piers/F-5391-2010; Kringelbach, Morten L/AAF-5508-2020; Kringelbach, Morten/AAW-5847-2021; Cornelissen, Piers L/K-4914-2012	Hansen, Peter C/0000-0002-4948-1007; Kringelbach, Morten/0000-0002-3908-6898; Cornelissen, Piers L/0000-0002-2695-9581; Stein, Alan/0000-0001-8207-2822; Stein, John/0000-0001-5843-8986	Wellcome Trust [017571]; Dr. Hadwen Trust; Lord Dowding Fund for Humane Research; TrygFonden Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Dr. Hadwen Trust; Lord Dowding Fund for Humane Research; TrygFonden Charitable Foundation	The work was funded by the Wellcome Trust (017571), Dr. Hadwen Trust, The Lord Dowding Fund for Humane Research and TrygFonden Charitable Foundation. We are grateful to Dr Alan Kalvin for his advice.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; BOWLBY J, 1957, BRIT J MED PSYCHOL, V30, P230, DOI 10.1111/j.2044-8341.1957.tb01202.x; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Burnham D, 2002, SCIENCE, V296, P1435, DOI 10.1126/science.1069587; COHN JF, 1983, CHILD DEV, V54, P185, DOI 10.2307/1129876; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; de Araujo IET, 2003, EUR J NEUROSCI, V18, P2059, DOI 10.1046/j.1460-9568.2003.02915.x; Ekman P., 2003, UNMASKING FACE GUIDE; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Lorenz K, 1971, STUDIES ANIMAL HUMAN, VII; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Ranote S, 2004, NEUROREPORT, V15, P1825, DOI 10.1097/01.wnr.0000137078.64128.6a; Reck C, 2004, PSYCHOPATHOLOGY, V37, P272, DOI 10.1159/000081983; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TRONICK ED, 1977, J COMMUN, V27, P74, DOI 10.1111/j.1460-2466.1977.tb01829.x; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056	46	169	176	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1664	10.1371/journal.pone.0001664	http://dx.doi.org/10.1371/journal.pone.0001664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301742	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500009
J	Sandin, SA; Smith, JE; DeMartini, EE; Dinsdale, EA; Donner, SD; Friedlander, AM; Konotchick, T; Malay, M; Maragos, JE; Obura, D; Pantos, O; Paulay, G; Richie, M; Rohwer, F; Schroeder, RE; Walsh, S; Jackson, JBC; Knowlton, N; Sala, E				Sandin, Stuart A.; Smith, Jennifer E.; DeMartini, Edward E.; Dinsdale, Elizabeth A.; Donner, Simon D.; Friedlander, Alan M.; Konotchick, Talina; Malay, Machel; Maragos, James E.; Obura, David; Pantos, Olga; Paulay, Gustav; Richie, Morgan; Rohwer, Forest; Schroeder, Robert E.; Walsh, Sheila; Jackson, Jeremy B. C.; Knowlton, Nancy; Sala, Enric			Baselines and Degradation of Coral Reefs in the Northern Line Islands	PLOS ONE			English	Article							BIODIVERSITY LOSS; BIOMASS; ECOSYSTEM; COMMUNITIES; IMPACTS; DECLINE; FISHES; COVER; TRAJECTORIES; PRODUCTIVITY	Effective conservation requires rigorous baselines of pristine conditions to assess the impacts of human activities and to evaluate the efficacy of management. Most coral reefs are moderately to severely degraded by local human activities such as fishing and pollution as well as global change, hence it is difficult to separate local from global effects. To this end, we surveyed coral reefs on uninhabited atolls in the northern Line Islands to provide a baseline of reef community structure, and on increasingly populated atolls to document changes associated with human activities. We found that top predators and reef-building organisms dominated unpopulated Kingman and Palmyra, while small planktivorous fishes and fleshy algae dominated the populated atolls of Tabuaeran and Kiritimati. Sharks and other top predators overwhelmed the fish assemblages on Kingman and Palmyra so that the biomass pyramid was inverted (top-heavy). In contrast, the biomass pyramid at Tabuaeran and Kiritimati exhibited the typical bottom-heavy pattern. Reefs without people exhibited less coral disease and greater coral recruitment relative to more inhabited reefs. Thus, protection from overfishing and pollution appears to increase the resilience of reef ecosystems to the effects of global warming.	[Sandin, Stuart A.; Konotchick, Talina; Richie, Morgan; Walsh, Sheila; Jackson, Jeremy B. C.; Knowlton, Nancy; Sala, Enric] Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA USA; [Smith, Jennifer E.] Univ Calif Santa Barbara, National Ctr Ecol Anal & Synthesis, Santa Barbara, CA USA; [DeMartini, Edward E.] Pacific Islands Fisheries Sci Ctr, NOAA, Honolulu, HI USA; [Dinsdale, Elizabeth A.; Pantos, Olga; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA USA; [Donner, Simon D.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ USA; [Friedlander, Alan M.] Ocean Inst, Natl Ctr Coastal Ocean Sci Biogeography Team, NOAA, Waimanalo, HI USA; [Malay, Machel; Paulay, Gustav] Univ Florida, Florida Museum Natural History, Gainesville, FL USA; [Maragos, James E.] US Fish & Wildlife Serv, Pacific Remote Islands, Natl Wildlife Refuge Complex, Honolulu, HI USA; [Obura, David] CORDIO East Africa, Mombasa, Kenya; [Schroeder, Robert E.] NOAA, Joint Inst Marine & Atmospheric Res, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Jackson, Jeremy B. C.; Knowlton, Nancy] Smithsonian Trop Res Inst, Balboa, Panama; [Sala, Enric] CSIC, Ctr dEstudis Avancats Blanes, Blanes, Spain	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Diego State University; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of Florida; United States Department of the Interior; US Fish & Wildlife Service; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian Tropical Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Sandin, SA (corresponding author), Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA USA.	esala@ucsd.edu	Malay, Maria Celia/ABF-2001-2020; Smith, Jennifer/E-5207-2013; Rohwer, Forest/AAC-5315-2019	Malay, Maria Celia/0000-0003-0219-4788; Rohwer, Forest/0000-0003-1548-5429; Obura, David/0000-0003-2256-6649; dinsdale, elizabeth/0000-0002-2177-203X	Moore Family Foundation; Gordon and Betty Moore Foundation; Fairweather Foundation; National Geographic Society; Marine Managed Areas Science Project of Conservation International; Scripps Institution of Oceanography	Moore Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Fairweather Foundation; National Geographic Society(National Geographic Society); Marine Managed Areas Science Project of Conservation International; Scripps Institution of Oceanography(University of California System)	This research was supported by the Moore Family Foundation, the Gordon and Betty Moore Foundation, the Fairweather Foundation, National Geographic Society, the Marine Managed Areas Science Project of Conservation International, Scripps Institution of Oceanography, E. Scripps, I. Gayler, and several private donors.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1988, P 6 INT CORAL REEF S; Ballantyne F, 2004, J THEOR BIOL, V226, P349, DOI 10.1016/j.jtbi.2003.09.013; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; BRAINARD R, 2005, STATE CORAL REEF ECO, P338; Brown Barbara, 1997, P65; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Corbett DR, 1999, LIMNOL OCEANOGR, V44, P1045, DOI 10.4319/lo.1999.44.4.1045; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Evans SL, 2006, HYDROBIOLOGIA, V569, P151, DOI 10.1007/s10750-006-0129-9; FARRELL A, 1928, J CAMERONS ODYSSEY; FRIEDLANDER A, 1997, ECOLOGICAL SURVEYS C; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; FROESE R, 2007, FISHBASE; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, ENVIRON BIOL FISH, V78, P57, DOI 10.1007/s10641-006-9077-5; GRIGG RW, 1974, ECOLOGY, V55, P387, DOI 10.2307/1935226; GRIGGS R A, 1984, Current Psychological Research and Reviews, V3, P3, DOI 10.1007/BF02686552; Hoegh-Guldberg O, 2004, SYMBIOSIS, V37, P1; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kulbicki M, 2005, CYBIUM, V29, P235; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Legendre P., 2012, NUMERICAL ECOLOGY; MAC ARTHUR ROBERT H., 1967; MARAGOS JE, 1997, ECOLOGICAL SURVEYS C; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McClanahan TR, 1999, BIOL CONSERV, V89, P161, DOI 10.1016/S0006-3207(98)00123-2; Moore MM, 1999, ECOL APPL, V9, P1266, DOI 10.1890/1051-0761(1999)009[1266:RCAERA]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; ODUM E. P, 1959, FUNDAMENTALS ECOLOGY; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; POLOVINA JJ, 1984, CORAL REEFS, V3, P1, DOI 10.1007/BF00306135; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; RICKER WE, 1946, ECOL MONOGR, V16, P373, DOI 10.2307/1961642; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	79	647	661	3	347	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1548	10.1371/journal.pone.0001548	http://dx.doi.org/10.1371/journal.pone.0001548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301734	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500001
J	Kawa, S; Kitahara, K; Hamano, H; Ozaki, Y; Arakura, N; Yoshizawa, K; Umemura, T; Ota, M; Mizoguchi, S; Shimozuru, Y; Bahram, S				Kawa, Shigeyuki; Kitahara, Kei; Hamano, Hideaki; Ozaki, Yayoi; Arakura, Norikazu; Yoshizawa, Kaname; Umemura, Takeji; Ota, Masao; Mizoguchi, Sadaaki; Shimozuru, Yasunori; Bahram, Seiamak			A Novel Immunoglobulin-Immunoglobulin Interaction in Autoimmunity	PLOS ONE			English	Article								Well over six decades since its first description, the Rheumatoid Factor (RF)-autoantibodies recognizing Fc (constant) portion of IgG through their own Fab (antigen binding variable segments)-is believed to have come of age. Autoimmune pancreatitis is a unique form of pancreatitis, biologically characterized by an elevated serum IgG4 concentration. Given the fact that IgG4 myeloma proteins can act as RF, we initially hypothesized that IgG4 in autoimmune pancreatitis might do likewise, hence potentially contributing to disease pathogenesis. Indeed Western blotting clearly showed that IgG4 binds to IgG1 kappa, IgG2 kappa, IgG3 kappa myeloma proteins, as well as to IgG Fc, in line with a typical RF activity. Further experiments however unraveled the unexpected fact that unlike hitherto known RF, IgG4 does not engage IgG Fc through its Fab, but its very own Fc. These data therefore collectively describe a Novel RF (NRF) in autoimmune pancreatitis. In the future, the relevance of NRF, beyond autoimmune pancreatitis, in both diagnosis/prognosis as well as pathophysiology of autoimmune and other systemic diseases where IgG4's role seems paramount, needs to be systematically assessed.	[Kawa, Shigeyuki] Shinshu Univ, Ctr Hlth Safety & Environm Management, Matsumoto, Nagano 390, Japan; [Kitahara, Kei; Hamano, Hideaki; Ozaki, Yayoi; Arakura, Norikazu; Yoshizawa, Kaname; Umemura, Takeji] Shinshu Univ, Dept Med, Sch Med, Matsumoto, Nagano 390, Japan; [Ota, Masao] Shinshu Univ, Dept Legal Med, Sch Med, Matsumoto, Nagano 390, Japan; [Mizoguchi, Sadaaki; Shimozuru, Yasunori] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan; [Bahram, Seiamak] Hop Univ Strasbourg, Lab Cent Immunol, Strasbourg, France; [Bahram, Seiamak] Ctr Rech Immunol & Hematol, Strasbourg, France	Shinshu University; Shinshu University; Shinshu University; Eisai Co Ltd; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kawa, S (corresponding author), Shinshu Univ, Ctr Hlth Safety & Environm Management, Matsumoto, Nagano 390, Japan.	skawapc@hsp.md.shinshu-u.ac.jp; siamak@hemato-ulp.u-strasbg.fr	Bahram, Seiamak/GZA-7150-2022	Umemura, Takeji/0000-0001-7985-919X; Bahram, Seiamak/0000-0002-6928-9952	Ministry of Education, Science, Sports and Culture of Japan [12670471, 13557047, 15659167, 16390205]; Japan Health Sciences Foundation [KH21022]; Research on Specific Diseases, Health and Labour Sciences Research Grant, Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Sciences Foundation; Research on Specific Diseases, Health and Labour Sciences Research Grant, Japan	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (12670471, 13557047, 15659167 and 16390205) and from the Japan Health Sciences Foundation (KH21022), and by a Research on Specific Diseases, Health and Labour Sciences Research Grant, Japan. Seiamak Bahram's laboratory is supported by the Hopitaux Universitaires de Strasbourg, the Association Francaise du Gougerot Sjogren et des syndromes secs, the Ligue contre le Cancer, the Association pour la recherche sur le Cancer (ARC), the Agence de Biomedecine and the Agence Nationale de la Recherche (ANR).	AALBERSE RC, 1993, ALLERGY, V48, P559, DOI 10.1111/j.1398-9995.1993.tb00749.x; Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Abraham SC, 2003, AM J SURG PATHOL, V27, P110, DOI 10.1097/00000478-200301000-00012; Asada M, 2006, PANCREAS, V33, P20, DOI 10.1097/01.mpa.0000226881.48204.fd; COHEN PL, 1987, J IMMUNOL, V139, P1466; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Detrick B, 2006, MANUAL OF MOLECULAR AND CLINICAL LABORATORY IMMUNOLOGY, 7TH EDITION, pXXV; Dorner T, 2004, CURR OPIN RHEUMATOL, V16, P246; Erkelens GW, 1999, LANCET, V354, P43, DOI 10.1016/S0140-6736(99)00603-0; Finkelberg DL, 2006, NEW ENGL J MED, V355, P2670, DOI 10.1056/NEJMra061200; Fujii H, 2003, KIDNEY INT, V64, P1662, DOI 10.1046/j.1523-1755.2003.00252.x; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hennig C, 2000, LANCET, V355, P1617, DOI 10.1016/S0140-6736(00)02223-6; Horiuchi A, 1998, AM J GASTROENTEROL, V93, P260, DOI 10.1016/S0002-9270(97)00067-1; Horiuchi A, 2002, GASTROINTEST ENDOSC, V55, P494, DOI 10.1067/mge.2002.122653; Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Komatsu K, 2005, DIGEST DIS SCI, V50, P1052, DOI 10.1007/s10620-005-2703-9; Muraki T, 2006, PANCREAS, V32, P16, DOI 10.1097/01.mpa.0000188308.75043.e4; NISONOFF A, 1960, ARCH BIOCHEM BIOPHYS, V88, P241, DOI 10.1016/0003-9861(60)90229-0; Njoku DB, 2006, CLIN VACCINE IMMUNOL, V13, P258, DOI 10.1128/CVI.13.2.258-265.2006; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Oliveira DBG, 1998, LANCET, V351, P670, DOI 10.1016/S0140-6736(97)04122-6; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; OTTESEN EA, 1985, J IMMUNOL, V134, P2707; Pickartz T, 2007, NAT CLIN PRACT GASTR, V4, P314, DOI 10.1038/ncpgasthep0837; PIKE RM, 1949, J IMMUNOL, V63, P447; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; ROCK B, 1989, NEW ENGL J MED, V320, P1463, DOI 10.1056/NEJM198906013202206; ROSE HM, 1948, P SOC EXP BIOL MED, V68, P1; Saegusa H, 2003, PANCREAS, V27, P20, DOI 10.1097/00006676-200307000-00003; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Sutton B, 2000, IMMUNOL TODAY, V21, P177, DOI 10.1016/S0167-5699(00)01589-9; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; van der Vliet HJJ, 2004, ANN INTERN MED, V141, P896, DOI 10.7326/0003-4819-141-11-200412070-00033; Waaler E, 1940, ACTA PATHOL MIC SC, V17, P172, DOI DOI 10.1111/J.1699-0463.1940.TB01475.X; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Yoshimura Y, 2006, INTERNAL MED, V45, P897, DOI 10.2169/internalmedicine.45.1752; ZACK DJ, 1995, J IMMUNOL, V155, P5057	45	70	83	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1637	10.1371/journal.pone.0001637	http://dx.doi.org/10.1371/journal.pone.0001637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18297131	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400030
J	He, X; Han, B; Mura, M; Li, L; Cypel, M; Soderman, A; Picha, K; Yang, J; Liu, MY				He, Xiaolin; Han, Bing; Mura, Marco; Li, Li; Cypel, Marcelo; Soderman, Avery; Picha, Kristen; Yang, Jing; Liu, Mingyao			Anti-Human Tissue Factor Antibody Ameliorated Intestinal Ischemia Reperfusion-Induced Acute Lung Injury in Human Tissue Factor Knock-In Mice	PLOS ONE			English	Article								Interaction between the coagulation and inflammation systems plays an important role in the development of acute respiratory distress syndrome ( ARDS). Anti-coagulation is an attractive option for ARDS treatment, and this has promoted development of new antibodies. However, preclinical trials for these antibodies are often limited by the high cost and availability of non-human primates. In the present study, we developed a novel alternative method to test the role of a humanized anti-tissue factor mAb in acute lung injury with transgenic mice. Methodology/Principal Findings. Human tissue factor knock-in (hTF-KI) transgenic mice and a novel humanized anti-human tissue factor mAb (anti-hTF mAb, CNTO859) were developed. The hTF-KI mice showed a normal and functional expression of hTF. The anti-hTF mAb specifically blocked the pro-coagulation activity of brain extracts from the hTF-KI mice and human, but not from wild type mice. An extrapulmonary ARDS model was used by intestinal ischemia-reperfusion. Significant lung tissue damage in hTF-KI mice was observed after 2 h reperfusion. Administration of CNTO859 (5 mg/kg, i.v.) attenuated the severity of lung tissue injury, decreased the total cell counts and protein concentration in bronchoalveolar lavage fluid, and reduced Evans blue leakage. In addition, the treatment significantly reduced alveolar fibrin deposition, and decreased tissue factor and plasminogen activator inhibitor-1 activity in the serum. This treatment also down-regulated cytokine expression and reduced cell death in the lung. Conclusions. This novel anti-hTF antibody showed beneficial effects on intestinal ischemia-reperfusion induced acute lung injury, which merits further investigation for clinical usage. In addition, the use of knock-in transgenic mice to test the efficacy of antibodies against human-specific proteins is a novel strategy for preclinical studies.	[He, Xiaolin; Han, Bing; Mura, Marco; Cypel, Marcelo; Liu, Mingyao] Univ Toronto, Univ Hlth Network Toronto, Gen Res Inst, Dept Surg,Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Li, Li] Therakos, Exton, PA USA; [Soderman, Avery; Picha, Kristen; Yang, Jing] Centocor Inc, Malvern, PA USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Liu, MY (corresponding author), Univ Toronto, Univ Hlth Network Toronto, Gen Res Inst, Dept Surg,Latner Thorac Surg Res Labs, Toronto, ON, Canada.	mingyao.liu@utoronto.ca	Mura, Marco/G-5729-2013	Mura, Marco/0000-0002-2159-7083; Liu, Mingyao/0000-0002-9188-8417; Li, Li/0000-0001-9844-7692; Cypel, Marcelo/0000-0001-5652-1938	Canadian Institutes of Health Research [MOP-13270, MOP-42546]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research Grants MOP-13270 and MOP-42546.	Abraham E, 2000, AM J RESP CELL MOL, V22, P401, DOI 10.1165/ajrcmb.22.4.f184; Bastarache JA, 2007, THORAX, V62, P608, DOI 10.1136/thx.2006.063305; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Carraway MS, 2003, AM J RESP CRIT CARE, V167, P1200, DOI 10.1164/rccm.200204-287OC; Cho HY, 2002, AM J RESP CELL MOL, V26, P42, DOI 10.1165/ajrcmb.26.1.4536; Choi G, 2006, ANESTHESIOLOGY, V105, P689, DOI 10.1097/00000542-200610000-00013; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Fang CH, 1996, THROMB HAEMOSTASIS, V76, P361; Fischer S, 2000, ANN SURG, V231, P424, DOI 10.1097/00000658-200003000-00016; He XL, 2007, SHOCK, V28, P106, DOI 10.1097/SHK.0b013e3180310f3a; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Liu MY, 2005, AM J RESP CRIT CARE, V171, P298, DOI 10.1164/rccm.2412002; Luther T, 1996, AM J PATHOL, V149, P101; MORRISSEY JH, 1995, THROMB HAEMOSTASIS, V74, P185; Muller AM, 2002, RESPIRATION, V69, P526, DOI 10.1159/000066471; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Mura M, 2007, SHOCK, V28, P227, DOI 10.1097/SHK.0b013e318033e927; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; Ngo CV, 2007, INT J CANCER, V120, P1261, DOI 10.1002/ijc.22426; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; OLSEN EGJ, 1975, LAB INVEST, V32, P323; Oltrona L, 1997, CIRCULATION, V96, P646; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Petersen LC, 2005, THROMB RES, V116, P75, DOI 10.1016/j.thromres.2004.11.003; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Quadri SM, 2005, AM J TRANSPLANT, V5, P292, DOI 10.1111/j.1600-6143.2004.00701.x; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Rijneveld AW, 2006, CRIT CARE MED, V34, P1725, DOI 10.1097/01.CCM.0000218807.20570.C2; Schultz MJ, 2004, THORAX, V59, P130, DOI 10.1136/thorax.2003.013888; Schultz MJ, 2006, CRIT CARE MED, V34, P871, DOI 10.1097/01.CCM.0000202136.91651.34; Siegbahn A, 2005, THROMB HAEMOSTASIS, V93, P27, DOI 10.1160/TH04-07-0405; SNYDER LA, 2007, J THROMB HAEMOST; Tang PS, 2006, J CELL PHYSIOL, V209, P457, DOI 10.1002/jcp.20751; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2006, AM J PHYSIOL-LUNG C, V291, pL307, DOI 10.1152/ajplung.00157.2006; Welty-Wolf KE, 2001, AM J RESP CRIT CARE, V164, P1988, DOI 10.1164/ajrccm.164.10.2105027; Welty-Wolf KE, 2006, AM J PHYSIOL-LUNG C, V290, pL21, DOI 10.1152/ajplung.00155.2005; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200	40	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1527	10.1371/journal.pone.0001527	http://dx.doi.org/10.1371/journal.pone.0001527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231608	gold, Green Published, Green Submitted			2022-12-27	WOS:000260504200035
J	Lynnerup, N; Kjeldsen, H; Heegaard, S; Jacobsen, C; Heinemeier, J				Lynnerup, Niels; Kjeldsen, Henrik; Heegaard, Steffen; Jacobsen, Christina; Heinemeier, Jan			Radiocarbon Dating of the Human Eye Lens Crystallines Reveal Proteins without Carbon Turnover throughout Life	PLOS ONE			English	Article								Lens crystallines are special proteins in the eye lens. Because the epithelial basement membrane (lens capsule) completely encloses the lens, desquamation of aging cells is impossible, and due to the complete absence of blood vessels or transport of metabolites in this area, there is no subsequent remodelling of these fibers, nor removal of degraded lens fibers. Human tissue ultimately derives its C-14 content from the atmospheric carbon dioxide. The C-14 content of the lens proteins thus reflects the atmospheric content of C-14 when the lens crystallines were formed. Precise radiocarbon dating is made possible by comparing the C-14 content of the lens crystallines to the so-called bomb pulse, i.e. a plot of the atmospheric C-14 content since the Second World War, when there was a significant increase due to nuclear-bomb testing. Since the change in concentration is significant even on a yearly basis this allows very accurate dating. Methodology/Principal Findings. Our results allow us to conclude that the crystalline formation in the lens nucleus almost entirely takes place around the time of birth, with a very small, and decreasing, continuous formation throughout life. The close relationship may be further expressed as a mathematical model, which takes into account the timing of the crystalline formation. Conclusions/Significance. Such a lifelong permanence of human tissue has hitherto only been described for dental enamel. In confront to dental enamel it must be held in mind that the eye lens is a soft structure, subjected to almost continuous deformation, due to lens accommodation, yet its most important constituent, the lens crystalline, is never subject to turnover or remodelling once formed. The determination of the C-14 content of various tissues may be used to assess turnover rates and degree of substitution (for example for brain cell DNA). Potential targets may be nervous tissues in terms of senile or pre-senile degradation, as well as other highly specialised structures of the eyes. The precision with which the year of birth may be calculated points to forensic uses of this technique.	[Lynnerup, Niels; Jacobsen, Christina] Univ Copenhagen, Dept Forens Med, Copenhagen, Denmark; [Kjeldsen, Henrik; Heinemeier, Jan] Univ Aarhus, Dept Phys & Anat, AMS 14C Dating Ctr, Aarhus, Denmark; [Heegaard, Steffen] Univ Copenhagen, Dept Neurosci & Pharmacol, Eye Pathol Sect, Copenhagen, Denmark	University of Copenhagen; Aarhus University; University of Copenhagen	Lynnerup, N (corresponding author), Univ Copenhagen, Dept Forens Med, Copenhagen, Denmark.	n.lynnerup@antrolab.ku.dk		Jacobsen, Christina/0000-0001-7257-0772	Danish Medical Association Fund	Danish Medical Association Fund	The Danish Medical Association Fund (private non-commercial foundation)	BEBE DC, 2003, ST LOUIS ADLERS PHYS, P117; Cook GT, 2006, RADIOCARBON, V48, P305, DOI 10.1017/S0033822200038765; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; Goodsite ME, 2001, RADIOCARBON, V43, P495; Kueppers LM, 2004, OECOLOGIA, V141, P641, DOI 10.1007/s00442-004-1689-x; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Pau H, 2006, OPHTHALMOLOGICA, V220, P1, DOI 10.1159/000089267; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; SMEETS MH, 1993, BIOCHIM BIOPHYS ACTA, V1164, P236, DOI 10.1016/0167-4838(93)90254-O; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028	12	161	163	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1529	10.1371/journal.pone.0001529	http://dx.doi.org/10.1371/journal.pone.0001529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231610	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200037
J	Overduin, SA; Servos, P				Overduin, Simon A.; Servos, Philip			Symmetric Sensorimotor Somatotopy	PLOS ONE			English	Article							SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; ORGANIZATION; MOTOR; FMRI; REPRESENTATION; AREA-3B	Background. Functional imaging has recently been used to investigate detailed somatosensory organization in human cortex. Such studies frequently assume that human cortical areas are only identifiable insofar as they resemble those measured invasively in monkeys. This is true despite the electrophysiological basis of the latter recordings, which are typically extracellular recordings of action potentials from a restricted sample of cells. Methodology/Principal Findings. Using high-resolution functional magnetic resonance imaging in human subjects, we found a widely distributed cortical response in both primary somatosensory and motor cortex upon pneumatic stimulation of the hairless surface of the thumb, index and ring fingers. Though not organized in a discrete somatotopic fashion, the population activity in response to thumb and index finger stimulation indicated a disproportionate response to fingertip stimulation, and one that was modulated by stimulation direction. Furthermore, the activation was structured with a line of symmetry through the central sulcus reflecting inputs both to primary somatosensory cortex and, precentrally, to primary motor cortex. Conclusions/Significance. In considering functional activation that is not somatotopically or anatomically restricted as in monkey electrophysiology studies, our methodology reveals finger-related activation that is not organized in a simple somatotopic manner but is nevertheless as structured as it is widespread. Our findings suggest a striking functional mirroring in cortical areas conventionally ascribed either an input or an output somatotopic function.	[Servos, Philip] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada; [Overduin, Simon A.] MIT, McGovern Inst Brain Res, Dept Brain & Cogn Sci, Cambridge, MA USA	Wilfrid Laurier University; Massachusetts Institute of Technology (MIT)	Servos, P (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.	pservos@wlu.ca			Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canada Research Chairs program; Ontario Premier's Research Excellence Award program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Ontario Premier's Research Excellence Award program	Part of this work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (S.A.O. and P.S.), and from the Canadian Institutes of Health Research, the Canada Research Chairs program, and the Ontario Premier's Research Excellence Award program (P.S.).	Balasubramanian M, 2002, SCIENCE, V295; Blankenburg F, 2003, CEREB CORTEX, V13, P987, DOI 10.1093/cercor/13.9.987; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; Cox TF, 1994, MONOGRAPHS STAT APPL; Dechent P, 2003, HUM BRAIN MAPP, V18, P272, DOI 10.1002/hbm.10084; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fisher NI, 1995, STAT ANAL CIRCULAR D; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; GELDARD FA, 1972, SCIENCE, V178, P178, DOI 10.1126/science.178.4057.178; Gelnar PA, 1998, NEUROIMAGE, V7, P261, DOI 10.1006/nimg.1998.0341; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Huffman KJ, 2001, CEREB CORTEX, V11, P849, DOI 10.1093/cercor/11.9.849; JANE JA, 1967, J NEUROSURG, V26, P244, DOI 10.3171/jns.1967.26.2.0244; JONES EG, 1982, J NEUROPHYSIOL, V48, P521, DOI 10.1152/jn.1982.48.2.521; Kurth R, 1998, NEUROREPORT, V9, P207, DOI 10.1097/00001756-199801260-00006; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; McGlone F, 2002, BEHAV BRAIN RES, V135, P147, DOI 10.1016/S0166-4328(02)00144-4; Moore CI, 2000, J NEUROPHYSIOL, V84, P558, DOI 10.1152/jn.2000.84.1.558; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; Overduin SA, 2004, NEUROIMAGE, V23, P462, DOI 10.1016/j.neuroimage.2004.06.024; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057, DOI 10.1152/jn.1992.67.5.1057; RUSSELL JR, 1961, NEUROLOGY, V11, P96, DOI 10.1212/WNL.11.2.96; SCHWARTZ EL, 1989, IEEE T PATTERN ANAL, V11, P1005, DOI 10.1109/34.35506; Servos P, 1998, NEUROREPORT, V9, P605, DOI 10.1097/00001756-199803090-00008; STRICK PL, 1982, J NEUROPHYSIOL, V48, P150, DOI 10.1152/jn.1982.48.1.150; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; WOOLSEY CN, 1979, J NEUROSURG, V51, P476, DOI 10.3171/jns.1979.51.4.0476; Young JP, 2003, HUM BRAIN MAPP, V19, P183, DOI 10.1002/hbm.10114	30	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1505	10.1371/journal.pone.0001505	http://dx.doi.org/10.1371/journal.pone.0001505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231592	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200018
J	Bhasin, JM; Chakrabarti, E; Peng, DQ; Kulkarni, A; Chen, X; Smith, JD				Bhasin, Jeffrey M.; Chakrabarti, Enakshi; Peng, Dao-Quan; Kulkarni, Aneesh; Chen, Xi; Smith, Jonathan D.			Sex Specific Gene Regulation and Expression QTLs in Mouse Macrophages from a Strain Intercross	PLOS ONE			English	Article								Background. A powerful way to identify genes for complex traits it to combine genetic and genomic methods. Many trait quantitative trait loci (QTLs) for complex traits are sex specific, but the reason for this is not well understood. Methodology/Principal Findings. RNA was prepared from bone marrow derived macrophages of 93 female and 114 male F-2 mice derived from a strain intercross between apoE-deficient mice on the AKR and DBA/2 genetic backgrounds, and was subjected to transcriptome profiling using microarrays. A high density genome scan was performed using a mouse SNP chip, and expression QTLs (eQTLs) were located for expressed transcripts. Using suggestive and significant LOD score cutoffs of 3.0 and 4.3, respectively, thousands of eQTLs in the female and male cohorts were identified. At the suggestive LOD threshold the majority of the eQTLs were trans eQTLs, mapping unlinked to the position of the gene. Cis eQTLs, which mapped to the location of the gene, had much higher LOD scores than trans eQTLs, indicating their more direct effect on gene expression. The majority of cis eQTLs were common to both males and females, but only similar to 1% of the trans eQTLs were shared by both sexes. At the significant LOD threshold, the majority of eQTLs were cis eQTLs, which were mostly sex-shared, while the trans eQTLs were overwhelmingly sex-specific. Pooling the male and female data, 31% of expressed transcripts were expressed at different levels in males vs. females after correction for multiple testing. Conclusions/Significance. These studies demonstrate a large sex effect on gene expression and trans regulation, under conditions where male and female derived cells were cultured ex vivo and thus without the influence of endogenous sex steroids. These data suggest that eQTL data from male and female mice should be analyzed separately, as many effects, such as trans regulation are sex specific.	[Bhasin, Jeffrey M.; Chakrabarti, Enakshi; Peng, Dao-Quan; Kulkarni, Aneesh; Smith, Jonathan D.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA; [Chen, Xi] Cleveland Clinic, Dept Quant Health Sci, Cleveland, OH USA; [Smith, Jonathan D.] Case Western Reserve Univ, Cleveland Clinic, Lerner Coll Med, Dept Molec Med, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Smith, JD (corresponding author), Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA.	smithj4@ccf.org	; Smith, Jonathan D./H-9723-2013	Bhasin, Jeffrey/0000-0001-6134-1982; Smith, Jonathan D./0000-0002-0415-386X	National Heart Lung and Blood Institute of the National Institutes of Health [P50HL077107]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by SCCOR grant P50HL077107 from the National Heart Lung and Blood Institute of the National Institutes of Health.	Akiyama H, 2003, J BIOL CHEM, V278, P10752, DOI 10.1074/jbc.M209856200; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Charng MJ, 1998, J BIOL CHEM, V273, P9365, DOI 10.1074/jbc.273.16.9365; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2006, NAT GENET, V38, P856, DOI 10.1038/ng0806-856; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dansky HM, 2002, GENETICS, V160, P1599; Drake Thomas A, 2005, Am J Ther, V12, P503, DOI 10.1097/01.mjt.0000178775.39149.64; Drake TA, 2006, MAMM GENOME, V17, P466, DOI 10.1007/s00335-005-0175-z; Fitzgerald J, 2000, BRAIN RES, V877, P110, DOI 10.1016/S0006-8993(00)02692-5; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Petretto E, 2006, NAT GENET, V38, P858, DOI 10.1038/ng0806-858; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Smith JD, 2006, MAMM GENOME, V17, P220, DOI 10.1007/s00335-005-0099-7; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wurthner JU, 2001, J BIOL CHEM, V276, P19495, DOI 10.1074/jbc.M006473200; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	37	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1435	10.1371/journal.pone.0001435	http://dx.doi.org/10.1371/journal.pone.0001435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197246	Green Published, Green Submitted, gold			2022-12-27	WOS:000260503800007
J	van Boxtel, JJA; Alais, D; Erkelens, CJ; van Ee, R				van Boxtel, Jeroen J. A.; Alais, David; Erkelens, Casper J.; van Ee, Raymond			The Role of Temporally Coarse Form Processing during Binocular Rivalry	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; MOTION PERCEPTION; SPATIAL-FREQUENCY; CHROMATIC FLICKER; SACCADES; STIMULUS; VISION; SUPPRESSION; PERSISTENCE	Presenting the eyes with spatially mismatched images causes a phenomenon known as binocular rivalry-a fluctuation of awareness whereby each eye's image alternately determines perception. Binocular rivalry is used to study interocular conflict resolution and the formation of conscious awareness from retinal images. Although the spatial determinants of rivalry have been well-characterized, the temporal determinants are still largely unstudied. We confirm a previous observation that conflicting images do not need to be presented continuously or simultaneously to elicit binocular rivalry. This process has a temporal limit of about 350 ms, which is an order of magnitude larger than the visual system's temporal resolution. We characterize this temporal limit of binocular rivalry by showing that it is independent of low-level information such as interocular timing differences, contrast-reversals, stimulus energy, and eye-of-origin information. This suggests the temporal factors maintaining rivalry relate more to higher-level form information, than to low-level visual information. Systematically comparing the role of form and motion-the processing of which may be assigned to ventral and dorsal visual pathways, respectively-reveals that this temporal limit is determined by form conflict rather than motion conflict. Together, our findings demonstrate that binocular conflict resolution depends on temporally coarse form-based processing, possibly originating in the ventral visual pathway.	[Erkelens, Casper J.; van Ee, Raymond] Univ Utrecht, Helmholtz Inst, Dept Phys, Utrecht, Netherlands; [Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW, Australia	Utrecht University; University of Sydney	van Boxtel, JJA (corresponding author), Univ Utrecht, Helmholtz Inst, Dept Phys, Utrecht, Netherlands.	j.j.a.vanboxtel@phys.uu.nl	van Boxtel, Jeroen J.A./O-7624-2014; van Ee, Raymond/C-4881-2013; Erkelens, Casper J/C-4777-2009	van Boxtel, Jeroen J.A./0000-0003-2643-0474; Erkelens, Casper J/0000-0002-7234-1029; van Ee, Raymond/0000-0002-1134-8665	Utrecht University [High Potential grant]	Utrecht University	RvE was supported by a High Potential grant from Utrecht University. Part of this work has been conducted during a research visit of JvB and RvE at the University of Sydney, made possible partly by grants from the National Academy of Science (KNAW) to RvE.	Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Alais D, 2006, NEURON, V52, P911, DOI 10.1016/j.neuron.2006.10.027; Andrews TJ, 2002, VISION RES, V42, P301, DOI 10.1016/S0042-6989(01)00286-3; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P468; Bair W, 2005, CURR OPIN NEUROBIOL, V15, P459, DOI 10.1016/j.conb.2005.07.006; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 1998, J COGNITIVE NEUROSCI, V10, P46, DOI 10.1162/089892998563770; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Blake Randolph, 2005, Behav Cogn Neurosci Rev, V4, P21, DOI 10.1177/1534582305276839; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Brascamp JW, 2007, J VISION, V7, DOI 10.1167/7.12.12; Breitmeyer B. G., 2006, VISUAL MASKING TIME, P370; BREITMEYER BG, 1981, J EXP PSYCHOL HUMAN, V7, P972, DOI 10.1037/0096-1523.7.5.972; Carlson TA, 2000, CURR BIOL, V10, P1055, DOI 10.1016/S0960-9822(00)00672-2; Carlson TA, 2004, NEURON, V43, P907, DOI 10.1016/j.neuron.2004.08.039; COLTHEART M, 1980, PHILOS T ROY SOC B, V290, P57, DOI 10.1098/rstb.1980.0082; DODWELL PC, 1963, NATURE, V198, P39, DOI 10.1038/198039a0; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Ferber S, 2005, NEUROPSYCHOLOGIA, V43, P41, DOI 10.1016/j.neuropsychologia.2004.06.020; FOX R, 1972, J EXP PSYCHOL, V93, P283, DOI 10.1037/h0032455; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Gheorghiu E, 2005, VISION RES, V45, P1603, DOI 10.1016/j.visres.2004.12.005; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; He S., 2005, BINOCULAR RIVALRY, P81; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Irwin DE, 2004, PSYCHOL SCI, V15, P467, DOI 10.1111/j.0956-7976.2004.00703.x; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; Kanai R, 2003, J COGNITIVE NEUROSCI, V15, P664, DOI 10.1162/089892903322307384; Kourtzi Z, 2005, NEUROIMAGE, V28, P440, DOI 10.1016/j.neuroimage.2005.06.017; Large ME, 2005, J NEUROPHYSIOL, V93, P3453, DOI 10.1152/jn.00934.2004; LEHMKUHLE S, 1980, J EXP PSYCHOL HUMAN, V6, P605, DOI 10.1037/0096-1523.6.4.605; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lorenceau J, 2001, NAT NEUROSCI, V4, P745, DOI 10.1038/89543; MEYER GE, 1977, SCIENCE, V198, P524, DOI 10.1126/science.910146; MICHAELS CF, 1979, PSYCHOL RES-PSYCH FO, V41, P1, DOI 10.1007/BF00309423; Moutoussis K, 2005, VISION RES, V45, P2231, DOI 10.1016/j.visres.2005.02.007; Mukamel R, 2004, CEREB CORTEX, V14, P575, DOI 10.1093/cercor/bhh019; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; OSHEA RP, 1986, PERCEPT PSYCHOPHYS, V39, P59, DOI 10.3758/BF03207584; OSHEA RP, 1984, PERCEPT PSYCHOPHYS, V36, P266, DOI 10.3758/BF03206368; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Ramachandran VS, 1998, NATURE, V395, P852, DOI 10.1038/27573; Tadin D, 2002, NAT NEUROSCI, V5, P1010, DOI 10.1038/nn914; TOLHURST DJ, 1973, J PHYSIOL-LONDON, V231, P385, DOI 10.1113/jphysiol.1973.sp010239; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2001, BRAIN MIND, V2, P55, DOI DOI 10.1023/A:1017942718744; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; van Boxtel JJA, 2006, PERCEPTION, V35, P32; Van Boxtel JJA, 2007, J VISION, V7, DOI 10.1167/7.14.3; VANDEGRIND WA, 1973, HDB SENSORY PHYSL, P431; von Wartburg R, 2007, PERCEPTION, V36, P355, DOI 10.1068/p5552; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554	66	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1429	10.1371/journal.pone.0001429	http://dx.doi.org/10.1371/journal.pone.0001429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SN	18197242	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503800003
J	Dahlgren, A; Lundmark, P; Axelsson, T; Lind, L; Syvanen, AC				Dahlgren, Andreas; Lundmark, Per; Axelsson, Tomas; Lind, Lars; Syvanen, Ann-Christine			Association of the Estrogen Receptor 1 (ESR1) Gene with Body Height in Adult Males from Two Swedish Population Cohorts	PLOS ONE			English	Article								Human body height is a complex genetic trait with high heritability. We performed an association study of 17 candidate genes for height in the Uppsala Longitudinal Study of Adult Men (ULSAM) that consists of 1153 elderly men of age 70 born in the central region of Sweden. First we genotyped a panel of 137 single nucleotide polymorphism (SNPs) evenly distributed across the candidate genes in the ULSAM cohort. We identified 4 SNPs in the estrogen receptor gene (ESR1) on chromosome 6q25.1 with suggestive signals of association (p<0.05) with standing body height. This result was followed up by genotyping the same 25 SNPs in the ESR1 gene as in ULSAM in a second population cohort, the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) cohort that consist of 507 males and 509 females of age 70 from the same geographical region as ULSAM. One SNP, rs2179922 located in intron 4 of ESR1 showed and association signal (p = 0.0056) in the male samples from the PIVUS cohort. Homozygote carriers of the G-allele of the SNP rs2179922 were on average 0.90 cm taller than individuals with the two other genotypes at this SNP in the ULSAM cohort and 2.3 cm taller in the PIVUS cohort. No association was observed for the females in the PIVUS cohort.	[Dahlgren, Andreas; Lundmark, Per; Axelsson, Tomas; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lind, Lars] Uppsala Univ Hosp, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Dahlgren, A (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se			Swedish Research Council; Knut and Alice Wallenberg Foundation; Uppsala University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Uppsala University Hospital	The study was supported by research grants from the Swedish Research Council, the Knut and Alice Wallenberg Foundation and from Uppsala University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL PA, 2002, BIOTECHNIQUES S, V70, P7476; Deng HW, 2002, AM J MED GENET, V113, P29, DOI 10.1002/ajmg.10742; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Khosla S, 2002, CLIN ENDOCRINOL, V56, P291, DOI 10.1046/j.1365-2265.2002.01428.x; LEHRER S, 1994, HORM METAB RES, V26, P486, DOI 10.1055/s-2007-1001739; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Liu YZ, 2004, ANN HUM GENET, V68, P472, DOI 10.1046/j.1529-8817.2003.00117.x; Lorentzon M, 1999, J CLIN ENDOCR METAB, V84, P4597, DOI 10.1210/jc.84.12.4597; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; R Development Core Team, 2006, R LANG ENV STAT COMP; Sammalisto S, 2005, J MED GENET, V42, P932, DOI 10.1136/jmg.2005.031278; Schuit SCE, 2004, J CLIN ENDOCR METAB, V89, P303, DOI 10.1210/jc.2003-031095; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Willemsen G, 2004, EUR J HUM GENET, V12, P820, DOI 10.1038/sj.ejhg.5201229; Wu XD, 2003, EUR J HUM GENET, V11, P271, DOI 10.1038/sj.ejhg.5200952; Xu JF, 2002, AM J HUM GENET, V71, P646, DOI 10.1086/342216	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1807	10.1371/journal.pone.0001807	http://dx.doi.org/10.1371/journal.pone.0001807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350145	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300011
J	Gupta, S; Hopner, S; Rupp, B; Gunther, S; Dickhaut, K; Agarwal, N; Cardoso, MC; Kuhne, R; Wiesmuller, KH; Jung, G; Falk, K; Rotzschke, O				Gupta, Shashank; Hoepner, Sabine; Rupp, Bernd; Guenther, Sebastian; Dickhaut, Katharina; Agarwal, Noopur; Cardoso, M. Cristina; Kuehne, Ronald; Wiesmueller, Karl-Heinz; Jung, Guenther; Falk, Kirsten; Roetzschke, Olaf			Anchor Side Chains of Short Peptide Fragments Trigger Ligand-Exchange of Class II MHC Molecules	PLOS ONE			English	Article								Class II MHC molecules display peptides on the cell surface for the surveillance by CD4+ T cells. To ensure that these ligands accurately reflect the content of the intracellular MHC loading compartment, a complex processing pathway has evolved that delivers only stable peptide/MHC complexes to the surface. As additional safeguard, MHC molecules quickly acquire a 'non-receptive' state once they have lost their ligand. Here we show now that amino acid side chains of short peptides can bypass these safety mechanisms by triggering the reversible ligand-exchange. The catalytic activity of dipeptides such as Tyr-Arg was stereo-specific and could be enhanced by modifications addressing the conserved H-bond network near the P1 pocket of the MHC molecule. It affected both antigen-loading and ligand-release and strictly correlated with reported anchor preferences of P1, the specific target site for the catalytic side chain of the dipeptide. The effect was evident also in CD4+ T cell assays, where the allele-selective influence of the dipeptides translated into increased sensitivities of the antigen-specific immune response. Molecular dynamic calculations support the hypothesis that occupation of P1 prevents the 'closure' of the empty peptide binding site into the non-receptive state. During antigen-processing and -presentation P1 may therefore function as important "sensor'' for peptide-load. While it regulates maturation and trafficking of the complex, on the cell surface, short protein fragments present in blood or lymph could utilize this mechanism to alter the ligand composition on antigen presenting cells in a catalytic way.	[Gupta, Shashank; Hoepner, Sabine; Guenther, Sebastian; Dickhaut, Katharina; Agarwal, Noopur; Cardoso, M. Cristina; Falk, Kirsten; Roetzschke, Olaf] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Rupp, Bernd; Kuehne, Ronald] Leibniz Inst Mol Pharmacol FMP, Berlin, Germany; [Dickhaut, Katharina] Charite, Berlin, Germany; [Wiesmueller, Karl-Heinz; Jung, Guenther] Univ Tubingen, Tubingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen	Gupta, S (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	falk@mdc-berlin.de; roetzsch@mdc-berlin.de	Cardoso, M. Cristina/F-5215-2011; Guenther, Sebastian/GON-7207-2022; Roetzschke, Olaf/GXH-0012-2022	Guenther, Sebastian/0000-0002-7329-6653; Rupp, Bernd/0000-0001-9447-9638	BMBF [network grant MHCenhancer]; EC; MDC	BMBF(Federal Ministry of Education & Research (BMBF)); EC(European CommissionEuropean Commission Joint Research Centre); MDC	B. Rupp, R. Kuhne, G. Jung, O. Rotzschke and K. Falk were supported by the BMBF-sponsored network grant MHCenhancer (www.MHCenhancer.de). S. Gupta was supported by the EC-funded Marie-Curie Research Training Network (MC-RTN) Drugs for therapy. S. Hopner and S. Gunther were supported by grants awarded by MDC Ph.D. stipend programs.	Chen QY, 2004, P NATL ACAD SCI USA, V101, P9363, DOI 10.1073/pnas.0403271101; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Falk K, 2000, EUR J IMMUNOL, V30, P3012, DOI 10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q; Falk K, 2002, J BIOL CHEM, V277, P2709, DOI 10.1074/jbc.M109098200; Fleckenstein B, 1996, EUR J BIOCHEM, V240, P71, DOI 10.1111/j.1432-1033.1996.0071h.x; Fourneau JM, 2004, J IMMUNOL METHODS, V285, P253, DOI 10.1016/j.jim.2003.11.011; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; Hochweller K, 2006, CURR MOL MED, V6, P631, DOI 10.2174/156652406778194982; Hopner S, 2006, J BIOL CHEM, V281, P38535, DOI 10.1074/jbc.M606437200; HUMPHREY W, 1996, J MOL GRAPHICS, V14; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; KROPSHOFER H, 1995, SCIENCE, V270, P1357, DOI 10.1126/science.270.5240.1357; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Marin-Esteban V, 2004, J BIOL CHEM, V279, P50684, DOI 10.1074/jbc.M407598200; Marin-Esteban V, 2003, J AUTOIMMUN, V20, P63, DOI 10.1016/S0896-8411(02)00107-5; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; ONG B, 1991, P NATL ACAD SCI USA, V88, P7343, DOI 10.1073/pnas.88.16.7343; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vergelli M, 1997, EUR J IMMUNOL, V27, P941, DOI 10.1002/eji.1830270421; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Xu M, 2001, SCAND J IMMUNOL, V54, P39, DOI 10.1046/j.1365-3083.2001.00964.x	38	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1814	10.1371/journal.pone.0001814	http://dx.doi.org/10.1371/journal.pone.0001814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350151	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000260762300017
J	Aguas, R; White, LJ; Snow, RW; Gomes, MGM				Aguas, Ricardo; White, Lisa J.; Snow, Robert W.; Gomes, M. Gabriela M.			Prospects for Malaria Eradication in Sub-Saharan Africa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; TRANSMISSION DYNAMICS; ACQUIRED-IMMUNITY; INOCULATION RATE; DISEASE; MANIFESTATIONS; CONSEQUENCES; EPIDEMIOLOGY; ENDEMICITY; INTENSITY	Background: A characteristic of Plasmodium falciparum infections is the gradual acquisition of clinical immunity resulting from repeated exposures to the parasite. While the molecular basis of protection against clinical malaria remains unresolved, its effects on epidemiological patterns are well recognized. Accumulating epidemiological data constitute a valuable resource that must be intensively explored and interpreted as to effectively inform control planning. Methodology/Principal Finding: Here we apply a mathematical model to clinical data from eight endemic regions in sub-Saharan Africa. The model provides a quantitative framework within which differences in age distribution of clinical disease are assessed in terms of the parameters underlying transmission. The shorter infectious periods estimated for clinical infections induce a regime of bistability of endemic and malaria-free states in regions of mesoendemic transmission. The two epidemiological states are separated by a threshold that provides a convenient measure for intervention design. Scenarios of eradication and resurgence are simulated. Conclusions/Significance: In regions that support mesoendemic transmission, intervention success depends critically on reducing prevalence below a threshold which separates endemic and malaria-free regimes.	[Aguas, Ricardo; Gomes, M. Gabriela M.] Gulbenkian Inst Sci, Oeiras, Portugal; [White, Lisa J.] Univ Warwick, Dept Biol Sci, Ecol & Epidemiol Grp, Coventry, W Midlands, England; [Snow, Robert W.] Kenya Govt Med Res Ctr, Ctr Geographic Med, Malaria Public Hlth & Epidemiol Grp, Nairobi, Kenya; [Snow, Robert W.] Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford, England; [Gomes, M. Gabriela M.] Univ Lisbon, Ctr Matematica Aplicacoes Fundamentais, Lisbon, Portugal	University of Warwick; Kenya Medical Research Institute; University of Oxford; Universidade de Lisboa	Aguas, R (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	ggomes@igc.gulbenkian.pt	Snow, Robert William/AFR-1436-2022; White, Lisa/AAC-9396-2020; Gomes, Gabriela/H-7218-2014	Snow, Robert William/0000-0003-3725-6088; White, Lisa/0000-0002-6523-185X; Gomes, Gabriela/0000-0002-1454-4979	Portuguese Research Council-FCT [SFRH/BD/23900/2005]; European Commission [MEXT-CT-2004-14338]; Wellcome Trust [061584]	Portuguese Research Council-FCT(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by the Portuguese Research Council-FCT (grant SFRH/BD/23900/2005), the European Commission (grant MEXT-CT-2004-14338), and the Wellcome Trust (grant 061584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2006, LANCET INFECT DIS, V6, P112, DOI 10.1016/S1473-3099(06)70384-X; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Dushoff J, 1996, J THEOR BIOL, V180, P181, DOI 10.1006/jtbi.1996.0094; Freeman J, 1999, AM J TROP MED HYG, V60, P774, DOI 10.4269/ajtmh.1999.60.774; Gouagna LC, 2004, PARASITOLOGY, V128, P235, DOI 10.1017/S003118200300444X; Gramiccia G., 1988, Malaria: principles and practice of malariology. Volume 2., P1335; Gu WD, 2003, ACTA TROP, V86, P71, DOI 10.1016/S0001-706X(03)00020-2; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; HALLORAN ME, 1992, PARASITOL TODAY, V8, P77, DOI 10.1016/0169-4758(92)90240-3; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Medley GF, 2001, NAT MED, V7, P619, DOI 10.1038/87953; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Molineaux L, 1980, THE GARKI PROJECT; Mueller I, 2005, AM J TROP MED HYG, V72, P554, DOI 10.4269/ajtmh.2005.72.554; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Snow RW, 1998, BRIT MED BULL, V54, P293, DOI 10.1093/oxfordjournals.bmb.a011689; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SNOW RW, 1999, B WORLD HEALTH ORGAN, P77; *UN, 2005, POP RES ENV DEV 2005; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450	36	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1767	10.1371/journal.pone.0001767	http://dx.doi.org/10.1371/journal.pone.0001767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335042	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000021
J	Grant, SFA; Li, MY; Bradfield, JP; Kim, CE; Annaiah, K; Santa, E; Glessner, JT; Casalunovo, T; Frackelton, EC; Otieno, FG; Shaner, JL; Smith, RM; Imielinski, M; Eckert, AW; Chiavacci, RM; Berkowitz, RI; Hakonarson, H				Grant, Struan F. A.; Li, Mingyao; Bradfield, Jonathan P.; Kim, Cecilia E.; Annaiah, Kiran; Santa, Erin; Glessner, Joseph T.; Casalunovo, Tracy; Frackelton, Edward C.; Otieno, F. George; Shaner, Julie L.; Smith, Ryan M.; Imielinski, Marcin; Eckert, Andrew W.; Chiavacci, Rosetta M.; Berkowitz, Robert I.; Hakonarson, Hakon			Association Analysis of the FTO Gene with Obesity in Children of Caucasian and African Ancestry Reveals a Common Tagging SNP	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-H POLYMORPHISM; CHILDHOOD PREDICTORS; INSULIN-RESISTANCE; ADULT; OVERWEIGHT; VARIANTS; RISK; ADOLESCENTS; TWIN	Recently an association was demonstrated between the single nucleotide polymorphism (SNP), rs9939609, within the FTO locus and obesity as a consequence of a genome wide association (GWA) study of type 2 diabetes in adults. We examined the effects of two perfect surrogates for this SNP plus 11 other SNPs at this locus with respect to our childhood obesity cohort, consisting of both Caucasians and African Americans (AA). Utilizing data from our ongoing GWA study in our cohort of 418 Caucasian obese children (BMI >= 95th percentile), 2,270 Caucasian controls (BMI<95th percentile), 578 AA obese children and 1,424 AA controls, we investigated the association of the previously reported variation at the FTO locus with the childhood form of this disease in both ethnicities. The minor allele frequencies (MAF) of rs8050136 and rs3751812 (perfect surrogates for rs9939609 i.e. both r(2) = 1) in the Caucasian cases were 0.448 and 0.443 respectively while they were 0.391 and 0.386 in Caucasian controls respectively, yielding for both an odds ratio (OR) of 1.27 (95% CI 1.08-1.47; P = 0.0022). Furthermore, the MAFs of rs8050136 and rs3751812 in the AA cases were 0.449 and 0.115 respectively while they were 0.436 and 0.090 in AA controls respectively, yielding an OR of 1.05 (95% CI 0.91-1.21; P = 0.49) and of 1.31 (95% CI 1.050-1.643; P = 0.017) respectively. Investigating all 13 SNPs present on the Illumina HumanHap550 BeadChip in this region of linkage disequilibrium, rs3751812 was the only SNP conferring significant risk in AA. We have therefore replicated and refined the association in an AA cohort and distilled a tag-SNP, rs3751812, which captures the ancestral origin of the actual mutation. As such, variants in the FTO gene confer a similar magnitude of risk of obesity to children as to their adult counterparts and appear to have a global impact.	[Grant, Struan F. A.; Bradfield, Jonathan P.; Kim, Cecilia E.; Annaiah, Kiran; Santa, Erin; Glessner, Joseph T.; Casalunovo, Tracy; Frackelton, Edward C.; Otieno, F. George; Shaner, Julie L.; Smith, Ryan M.; Imielinski, Marcin; Eckert, Andrew W.; Chiavacci, Rosetta M.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Pennsylvania, Sch Med, Dept Pediat, Philadelphia, PA USA; [Li, Mingyao] Univ Pennsylvania, Dept Biostat & Epidemiol, Philadelphia, PA USA; [Berkowitz, Robert I.] Univ Pennsylvania, Sch Med, Dept Psychiat, Weight & Eating Disorders Program, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Grant, SFA (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	grants@chop.edu; hakonarson@chop.edu		Glessner, Joseph/0000-0001-5131-2811	Children's Hospital of Philadelphia	Children's Hospital of Philadelphia	This research was financially supported by the Children's Hospital of Philadelphia.	[Anonymous], 1985, Ann Intern Med, V103, P147; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BORJESON M, 1976, ACTA PAEDIATR SCAND, V65, P279, DOI 10.1111/j.1651-2227.1976.tb04887.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dietz WH, 1998, PEDIATRICS, V101, P518; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farooqi IS, 2005, INT J OBESITY, V29, P1149, DOI 10.1038/sj.ijo.0803056; Flodmark CE, 2004, INT J OBESITY, V28, P1189, DOI 10.1038/sj.ijo.0802787; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; GERKEN T, 2007, OBESITY ASS FTO GENE; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hebebrand J, 2003, Obes Rev, V4, P139; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; Koplan JP, 2005, J AM DIET ASSOC, V105, P131, DOI 10.1016/j.jada.2004.11.023; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lyon HN, 2005, AM J CLIN NUTR, V82, p215S, DOI 10.1093/ajcn/82.1.215S; Must A, 2003, NUTR REV, V61, P139, DOI 10.1301/nr.2003.apr.139-142; Nicklas TA, 2001, J AM COLL NUTR, V20, P599, DOI 10.1080/07315724.2001.10719064; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Troiano RP, 1998, PEDIATRICS, V101, P497; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; ZEGGINI E, 2006, DIABETOLOGIA; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZIMMET P, 1990, DIABETES METAB REV, V6, P91, DOI 10.1002/dmr.5610060203	48	158	166	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1746	10.1371/journal.pone.0001746	http://dx.doi.org/10.1371/journal.pone.0001746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335027	Green Submitted, Green Published, gold			2022-12-27	WOS:000260723000001
J	Sadlish, H; Rampelt, H; Shorter, J; Wegrzyn, RD; Andreasson, C; Lindquist, S; Bukau, B				Sadlish, Heather; Rampelt, Heike; Shorter, James; Wegrzyn, Renee D.; Andreasson, Claes; Lindquist, Susan; Bukau, Bernd			Hsp110 Chaperones Regulate Prion Formation and Propagation in S-cerevisiae by Two Discrete Activities	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; DE-NOVO APPEARANCE; PSI+ PRION; CYTOSOLIC HSP70; YEAST; TOXICITY; PSI(+); HSP40; SSE1; SSB	The cytosolic chaperone network of Saccharomyces cerevisiae is intimately associated with the emergence and maintenance of prion traits. Recently, the Hsp110 protein, Sse1, has been identified as a nucleotide exchange factor (NEF) for both cytosolic Hsp70 chaperone family members, Ssa1 and Ssb1. We have investigated the role of Sse1 in the de novo formation and propagation of [PSI+], the prion form of the translation termination factor, Sup35. As observed by others, we find that Sse1 is essential for efficient prion propagation. Our results suggest that the NEF activity is required for maintaining sufficient levels of substrate-free Ssa1. However, Sse1 exhibits an additional NEF-independent activity; it stimulates in vitro nucleation of Sup35NM, the prion domain of Sup35. We also observe that high levels of Sse1, but not of an unrelated NEF, very potently inhibit Hsp104-mediated curing of [PSI+]. Taken together, these results suggest a chaperone-like activity of Sse1 that assists in stabilization of early folding intermediates of the Sup35 prion conformation. This activity is not essential for prion formation under conditions of Sup35 overproduction, however, it may be relevant for spontaneous [PSI+] formation as well as for protection of the prion trait upon physiological Hsp104 induction.	[Sadlish, Heather; Rampelt, Heike; Wegrzyn, Renee D.; Andreasson, Claes; Bukau, Bernd] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Shorter, James] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA USA; [Lindquist, Susan] Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Pennsylvania; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Sadlish, H (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de	Shorter, James/E-8207-2011; Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Rampelt, Heike/0000-0002-5458-5652; Bukau, Bernd/0000-0003-0521-7199; Andreasson, Claes/0000-0001-8948-0685	Boehringer Ingelheim Fonds [scholarship]; EMBO [fellowship]; American Heart Association [Scientist Development Grant]; Fonds der Chemischen Industrie; Sonderforschungsbereich 638	Boehringer Ingelheim Fonds(Boehringer Ingelheim); EMBO(European Molecular Biology Organization (EMBO)); American Heart Association(American Heart Association); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Sonderforschungsbereich 638(German Research Foundation (DFG))	This work was supported by a scholarship of the Boehringer Ingelheim Fonds (to H.R.), an EMBO fellowship (to C.A.), an American Heart Association Scientist Development Grant (to J.S.), as well as by grants from the Fonds der Chemischen Industrie and the Sonderforschungsbereich 638 (to B.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Chacinska A, 2001, CURR GENET, V39, P62, DOI 10.1007/s002940000180; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chernoff YO, 2001, MUTAT RES-REV MUTAT, V488, P39, DOI 10.1016/S1383-5742(00)00060-0; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Jones GW, 2003, MOL GENET GENOMICS, V269, P304, DOI 10.1007/s00438-003-0838-y; Jones GW, 2003, GENETICS, V163, P495; Jung G, 2000, GENETICS, V156, P559; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200	44	58	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1763	10.1371/journal.pone.0001763	http://dx.doi.org/10.1371/journal.pone.0001763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335038	Green Published, gold			2022-12-27	WOS:000260723000017
J	Rossi, S; De Capua, A; Pasqualetti, P; Ulivelli, M; Fadiga, L; Falzarano, V; Bartalini, S; Passero, S; Nuti, D; Rossini, PM				Rossi, Simone; De Capua, Alberto; Pasqualetti, Patrizio; Ulivelli, Monica; Fadiga, Luciano; Falzarano, Vincenzo; Bartalini, Sabina; Passero, Stefano; Nuti, Daniele; Rossini, Paolo M.			Distinct Olfactory Cross-Modal Effects on the Human Motor System	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL EXCITABILITY MODULATION; HAND MUSCLES; FACILITATION; ACTIVATION; POTENTIALS; HEARING; IMAGERY; EMPATHY; OUTPUT	Background: Converging evidence indicates that action observation and action-related sounds activate cross-modally the human motor system. Since olfaction, the most ancestral sense, may have behavioural consequences on human activities, we causally investigated by transcranial magnetic stimulation (TMS) whether food odour could additionally facilitate the human motor system during the observation of grasping objects with alimentary valence, and the degree of specificity of these effects. Methodology/Principal Findings: In a repeated-measure block design, carried out on 24 healthy individuals participating to three different experiments, we show that sniffing alimentary odorants immediately increases the motor potentials evoked in hand muscles by TMS of the motor cortex. This effect was odorant-specific and was absent when subjects were presented with odorants including a potentially noxious trigeminal component. The smell-induced corticospinal facilitation of hand muscles during observation of grasping was an additive effect which superimposed to that induced by the mere observation of grasping actions for food or non-food objects. The odour-induced motor facilitation took place only in case of congruence between the sniffed odour and the observed grasped food, and specifically involved the muscle acting as prime mover for hand/fingers shaping in the observed action. Conclusions/Significance: Complex olfactory cross-modal effects on the human corticospinal system are physiologically demonstrable. They are odorant-specific and, depending on the experimental context, muscle- and action-specific as well. This finding implies potential new diagnostic and rehabilitative applications.	[Rossi, Simone; Ulivelli, Monica; Bartalini, Sabina; Passero, Stefano] Univ Siena, Dipartimento Neurosci, Sez Neurol, I-53100 Siena, Italy; [De Capua, Alberto; Falzarano, Vincenzo] Univ Siena, Dipartimento Neurosci, Siena, Italy; [Pasqualetti, Patrizio] Isola Tiberina, AFaR Fatebenefratelli Ass Res, Med Stat & Informat Technol, Rome, Italy; [Pasqualetti, Patrizio; Rossini, Paolo M.] Fatebenefratelli Isola Tiberina, AFaR Dipartimento Neurosci, Rome, Italy; [Pasqualetti, Patrizio; Nuti, Daniele; Rossini, Paolo M.] Casa di Cura San Raffaele Cassino, IRCCS San Raffaele Pisana, Rome, Italy; [Fadiga, Luciano] Univ Ferrara, Dipartimento Sci Biomed, Sezione Fisiologia Umana, Ferrara, Italy; [Rossini, Paolo M.] Univ Campus Biomed, Clin Neurol, Rome, Italy; [Fadiga, Luciano] Italian Inst Technol, Genoa, Italy	University of Siena; University of Siena; IRCCS San Raffaele Pisana; University of Ferrara; University Campus Bio-Medico - Rome Italy; Istituto Italiano di Tecnologia - IIT	Rossi, S (corresponding author), Univ Siena, Dipartimento Neurosci, Sez Neurol, Via Laterina 8, I-53100 Siena, Italy.	Rossisimo@unisi.it	Fadiga, Luciano/AAC-7404-2022; Rossini, Paolo M./D-4994-2013; Ulivelli, Monica/K-7270-2016; Pasqualetti, Patrizio/D-4496-2013; Rossi, Simone/AAC-6067-2022	Rossini, Paolo M./0000-0003-2665-534X; Ulivelli, Monica/0000-0003-3463-6341; Pasqualetti, Patrizio/0000-0001-5560-1979; Rossi, Simone/0000-0001-6697-9459; fadiga, luciano/0000-0001-5691-5080				Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Castiello U, 2006, CHEM SENSES, V31, P665, DOI 10.1093/chemse/bjl007; CHENG Y, 2006, CER CORTEX; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; Ferrari PF, 2005, BEHAV BRAIN RES, V161, P95, DOI 10.1016/j.bbr.2005.01.009; Filippi MM, 2000, BRAIN RES, V881, P159, DOI 10.1016/S0006-8993(00)02837-7; Fontanini A, 2006, TRENDS NEUROSCI, V29, P429, DOI 10.1016/j.tins.2006.06.013; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Herz RS, 1998, ANN NY ACAD SCI, V855, P670, DOI 10.1111/j.1749-6632.1998.tb10643.x; Hummel T, 2005, CHEM SENSES, V30, pI205, DOI 10.1093/chemse/bjh186; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; LEMON RN, 1995, J NEUROSCI, V15, P6145; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Rizzolatti G, 1998, NOVART FDN SYMP, V218, P81; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rossi S, 2004, TRENDS COGN SCI, V8, P273, DOI 10.1016/j.tics.2004.04.012; Rossi S, 1998, NEUROIMAGE, V8, P163, DOI 10.1006/nimg.1998.0352; Rossi S, 1998, NEUROSCI LETT, V243, P147, DOI 10.1016/S0304-3940(98)00088-3; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; ROTHMAN KJ, EPIDEMIOLOGY INTRO; Royet JP, 2000, J NEUROSCI, V20, P7752; Savic I, 2002, HUM BRAIN MAPP, V17, P17, DOI 10.1002/hbm.10045; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spence C, 2001, Q J EXP PSYCHOL-A, V54, P775, DOI 10.1080/02724980042000480; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zucco GM, 2003, EUR PSYCHOL, V8, P77, DOI 10.1027//1016-9040.8.2.77	49	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1702	10.1371/journal.pone.0001702	http://dx.doi.org/10.1371/journal.pone.0001702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301777	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586500046
J	Malawista, SE; Chevance, AD				Malawista, Stephen E.; Chevance, Anne de Boisfleury			Clocking the Lyme Spirochete	PLOS ONE			English	Article								In order to clear the body of infecting spirochetes, phagocytic cells must be able to get hold of them. In real-time phase-contrast videomicroscopy we were able to measure the speed of Borrelia burgdorferi (Bb), the Lyme spirochete, moving back and forth across a platelet to which it was tethered. Its mean crossing speed was 1,636 mu m/min (N = 28), maximum, 2800 mm/min (N = 3). This is the fastest speed recorded for a spirochete, and upward of two orders of magnitude above the speed of a human neutrophil, the fastest cell in the body. This alacrity and its interpretation, in an organism with bidirectional motor capacity, may well contribute to difficulties in spirochete clearance by the host.	[Malawista, Stephen E.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Chevance, Anne de Boisfleury] Hop La Pitie Salpetriere, Ctr Ecol Cellulaire, Paris, France	Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Malawista, SE (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	stephen.malawista@yale.edu			USPHS [AR-10493, AI-43558]; G. Harold and Leila Y. Mathers Charitable Foundation; Eshe Fund; John Simon Guggenheim Memorial Foundation [fellow]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR010493] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); G. Harold and Leila Y. Mathers Charitable Foundation; Eshe Fund; John Simon Guggenheim Memorial Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported in part by the USPHS (AR-10493, AI-43558), the G. Harold and Leila Y. Mathers Charitable Foundation, and the Eshe Fund. Dr. Malawista was a Fellow of the John Simon Guggenheim Memorial Foundation.	BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; CASSIMERIS L, 1990, J CELL BIOL, V110, P1067, DOI 10.1083/jcb.110.4.1067; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CHARON NW, 1981, P NATL ACAD SCI-BIOL, V78, P7166, DOI 10.1073/pnas.78.11.7166; COBURN J, 1994, INFECT IMMUN, V62, P5559, DOI 10.1128/IAI.62.12.5559-5567.1994; GOLDSTEIN SF, 1994, P NATL ACAD SCI USA, V91, P3433, DOI 10.1073/pnas.91.8.3433; GRULER H, 1987, Z NATURFORSCH C, V42, P1126; KIMSEY RB, 1990, J INFECT DIS, V162, P1205, DOI 10.1093/infdis/162.5.1205; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li YM, 2002, J IMMUNOL, V168, P816, DOI 10.4049/jimmunol.168.2.816; MONTGOMERY RR, 1993, J IMMUNOL, V150, P909; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826	12	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1633	10.1371/journal.pone.0001633	http://dx.doi.org/10.1371/journal.pone.0001633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286190	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400026
J	Shen, RL; Ye, Y; Chen, L; Yan, QT; Barsky, SH; Gao, JX				Shen, Rulong; Ye, Yin; Chen, Li; Yan, Qingtao; Barsky, Sanford H.; Gao, Jian-Xin			Precancerous Stem Cells Can Serve As Tumor Vasculogenic Progenitors	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; BONE-MARROW; THERAPEUTIC IMPLICATIONS; DENDRITIC CELLS; BLOOD-VESSELS; FACTOR VEGF; ANGIOGENESIS; CANCER; RECEPTOR	Tumor neo-vascularization is critical for tumor growth, invasion and metastasis, which has been considered to be mediated by a mechanism of angiogenesis. However, histopathological studies have suggested that tumor cells might be the progenitor for tumor vasculature. Recently, we have reported that the precancerous stem cells (pCSCs) representing the early stage of developing cancer stem cells (CSCs), have the potential for both benign and malignant differentiation. Therefore, we investigated whether pCSCs serve as progenitors for tumor vasculogenesis. Herein, we report that in the pCSC-derived tumors, most blood vessels were derived from pCSCs. Some pCSCs constitutively expressed vasculogenic receptor VEGFR-2, which can be up-regulated by hypoxia and angiogenesis-promoting cytokines, such as GM-CSF, Flt3 ligand, and IL-13. The pCSCs are much more potent in tumor vasculogenesis than the differentiated tumor monocytic cells (TMCs) from the same tumor, which had comparable or even higher capacity to produce some vascular growth factors, suggesting that the potent tumor vasculogenesis of pCSCs is associated with their intrinsic stem-like property. Consistently tumor vasculogenesis was also observed in human cancers such as cervical cancer and breast cancer and xenograft lymphoma. Our studies indicate that pCSCs can serve as tumor vasculogenic stem/progenitor cells (TVPCs), and may explain why anti-angiogenic cancer therapy trials are facing challenge.	[Shen, Rulong; Ye, Yin; Chen, Li; Yan, Qingtao; Barsky, Sanford H.; Gao, Jian-Xin] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Shen, RL (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	Sanford.Barsky@osumc.edu; Jian-Xin.Gao@osumc.edu	Shen, Rulong/E-4079-2011		SIG OSU; Immunology Program Award; American Cancer society [IRG-112367]; Davis/Bremer Medical Research	SIG OSU; Immunology Program Award; American Cancer society(American Cancer Society); Davis/Bremer Medical Research	The work is supported from Strategy Initiative Grant(SIG, OSU), 2006/2007 (JXG); Immunology Program Award 2007 (OSUCCC)(JXG); American Cancer society Grant #IRG-112367 (JXG); Davis/Bremer Medical Research Grant, OSU (RS); and SIG 2006(SHB).	Al-Rawi MAA, 2005, INT J ONCOL, V27, P721; Medina MA, 2007, J CELL MOL MED, V11, P374, DOI 10.1111/j.1582-4934.2007.00056.x; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Bailey AS, 2003, EXP HEMATOL, V31, P987, DOI 10.1016/j.exphem.2003.07.001; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clauss M, 2000, SEMIN THROMB HEMOST, V26, P561, DOI 10.1055/s-2000-13213; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Deininger MWN, 2001, CANCER RES, V61, P8005; Dentelli P, 1999, J IMMUNOL, V163, P2151; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Eubank TD, 2004, IMMUNITY, V21, P831, DOI 10.1016/j.immuni.2004.10.011; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FUKUMURA D, 2007, MICROVASC RES; Fukushi J, 2000, J IMMUNOL, V165, P2818, DOI 10.4049/jimmunol.165.5.2818; Gao JX, 2003, J IMMUNOL, V170, P5927, DOI 10.4049/jimmunol.170.12.5927; GAO JX, 2007, J CELL MOL MED ONLIN; GAO JX, 2007, J CELL MOL IN PRESS; Gottfried E, 2007, SCAND J IMMUNOL, V65, P329, DOI 10.1111/j.1365-3083.2007.01903.x; HAMMERSEN F, 1985, INT J MICROCIRC, V4, P31; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hilbe W, 2004, J CLIN PATHOL, V57, P965, DOI 10.1136/jcp.2004.016444; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Klug CA, 2000, BLOOD, V96, P894, DOI 10.1182/blood.V96.3.894.015k35_894_901; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; McClintock JY, 2005, J APPL PHYSIOL, V99, P861, DOI 10.1152/japplphysiol.00006.2005; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Ribatti D, 2007, LEUKEMIA, V21, P2085, DOI 10.1038/sj.leu.2404900; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Shaw JP, 2004, BLOOD CELL MOL DIS, V32, P168, DOI 10.1016/j.bcmd.2003.10.003; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Stratmann A, 2001, INT J CANCER, V91, P273, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1054>3.0.CO;2-Q; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Valdembri D, 2001, FASEB J, V15, P225, DOI 10.1096/fj.01-0633fje; Volpert OV, 1998, J EXP MED, V188, P1039, DOI 10.1084/jem.188.6.1039; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang XJ, 1996, J NEUROSCI, V16, P6089	63	78	82	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1652	10.1371/journal.pone.0001652	http://dx.doi.org/10.1371/journal.pone.0001652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286204	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400045
J	Turagabeci, AR; Nakamura, K; Takano, T				Turagabeci, Amelia R.; Nakamura, Keiko; Takano, Takehito			Healthy Lifestyle Behaviour Decreasing Risks of Being Bullied, Violence and Injury	PLOS ONE			English	Article							UNITED-STATES; ADOLESCENTS; ASSOCIATIONS; DEPRESSION; CHILDREN	Background: Bullying and violence are problems of aggression in schools among adolescents. Basic daily healthy practices including nutritious diet, hygiene and physical activity are common approaches in comprehensive health promotion programs in school settings, however thier relationship to these aggressive behaviours is vague. We attempted to show the advantages of these healthy lifestyle behaviours in 9 developing countries by examining the association with being frequently bullied, violence and injury. Methodology/Principal Findings: A cross-sectional cross-national survey of 9 countries using the WHO Global School Based Student Health Survey dataset was used. Measurements included experiences of "being frequently bullied'' in the preceding 30 days and violence/injury in the past 12 months. Association of risk behaviours (smoking, alcohol, sexual behaviour) and healthy lifestyle (nutrition, hygiene practices, physical activity) to being bullied, and violence/injury were assessed using multivariate logistic regression. Hygiene behaviour showed lower risks of being frequently bullied [male: RR = 0.7 (97.5CI: 0.5, 0.9); female: RR = 0.6 (0.5, 0.8)], and lower risk of experiences of violence/injury [RR = 0.7 (0.5, 0.9) for males], after controlling for risk behaviours, age, education, poverty, and country. Conclusion/Significance: Healthy lifestyle showed an association to decreased relative risk of being frequently bullied and violence/injury in developing countries. A comprehensive approach to risk and health promoting behaviours reducing bullying and violence is encouraged at school settings.	[Turagabeci, Amelia R.; Nakamura, Keiko] Tokyo Med & Dent Univ, Grad Sch, Div Publ Hlth, Int Hlth Sect, Tokyo, Japan; [Takano, Takehito] Tokyo Med & Dent Univ, Grad Sch, Hlth Promotion Sect, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Turagabeci, AR (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Div Publ Hlth, Int Hlth Sect, Tokyo, Japan.	nakamura.ith@tmd.ac.jp		Nakamura, Keiko/0000-0002-9119-4730; Turagabeci, Amelia/0000-0002-4923-7397	Japanese Ministry of Education, Science, Culture and Sports [Grants-in-Aid]	Japanese Ministry of Education, Science, Culture and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by Grants-in-Aid for Scientific Study by the Japanese Ministry of Education, Science, Culture and Sports.	Agudo A, 2005, MEASURING INTAKE FRU; Astrom AN, 2004, COMMUNITY DENT ORAL, V32, P354, DOI 10.1111/j.1600-0528.2004.00174.x; Beyers JM, 2004, J ADOLESCENT HEALTH, V35, P3, DOI 10.1016/j.jadohealth.2003.08.015; Craig W.M., 2004, YOUNG PEOPLES HLTH C, P133; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Eaton DK, 2006, J SCHOOL HEALTH, V76, P353, DOI 10.1111/j.1746-1561.2006.00127.x; Forero R, 1999, BRIT MED J, V319, P344, DOI 10.1136/bmj.319.7206.344; Hallfors DD, 2004, AM J PREV MED, V27, P224, DOI 10.1016/j.amepre.2004.06.001; Hart KH, 2003, J HUM NUTR DIET, V16, P89, DOI 10.1046/j.1365-277X.2003.00429.x; He K, 2004, J ADOLESCENT HEALTH, V35, P26, DOI 10.1016/j.jadohealth.2003.09.004; Hills AP, 2007, SPORTS MED, V37, P533, DOI 10.2165/00007256-200737060-00006; JESSOR R, 1987, BRIT J ADDICT, V82, P331; Juvonen J, 2003, PEDIATRICS, V112, P1231, DOI 10.1542/peds.112.6.1231; Kaltiala-Heino R, 1999, BRIT MED J, V319, P348, DOI 10.1136/bmj.319.7206.348; Liang HL, 2007, CHILD ABUSE NEGLECT, V31, P161, DOI 10.1016/j.chiabu.2006.08.007; Morris EB, 2006, J SCHOOL HEALTH, V76, P465, DOI 10.1111/j.1746-1561.2006.00143.x; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; Nicolle L, 2007, CAN MED ASSOC J, V176, P767, DOI 10.1503/cmaj.061741; Pickett W, 2006, INJURY PREV, V12, P87, DOI 10.1136/ip.2005.011106; Pickett W, 2005, INJURY PREV, V11, P213, DOI 10.1136/ip.2004.007021; Simpson K, 2005, J EPIDEMIOL COMMUN H, V59, P1072, DOI 10.1136/jech.2005.036723; St Leger L, 2001, HEALTH PROMOT INT, V16, P197, DOI 10.1093/heapro/16.2.197; Turbin MS, 2006, HEALTH PSYCHOL, V25, P445, DOI 10.1037/0278-6133.25.4.445; *WHO, 1999, VIOL PREV IMP EL HLT, P1; *WHO REG OFF W PAC, 1996, HLTH PROM SCH SER, V5; World Health Organization, 2002, WORLD REPORT VIOLENC	26	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1585	10.1371/journal.pone.0001585	http://dx.doi.org/10.1371/journal.pone.0001585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XR	18297133	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400002
J	Zhu, J; He, FH; Wang, J; Yu, J				Zhu, Jiang; He, Fuhong; Wang, Jing; Yu, Jun			Modeling Transcriptome Based on Transcript-Sampling Data	PLOS ONE			English	Article							HIGH-THROUGHPUT ANALYSIS; GENE-EXPRESSION; SERIAL ANALYSIS; HUMAN-GENOME; SAGE; DNA; IDENTIFICATION; SEQUENCES; ABUNDANCE; LONGSAGE	Background: Newly-evolved multiplex sequencing technology has been bringing transcriptome sequencing into an unprecedented depth. Millions of transcript tags now can be acquired in a single experiment through parallelization. The significant increase in throughput and reduction in cost required us to address some fundamental questions, such as how many transcript tags do we have to sequence for a given transcriptome? How could we estimate the total number of unique transcripts for different cell types (transcriptome diversity) and the distribution of their copy numbers (transcriptome dynamics)? What is the probability that a transcript with a given expression level to be detected at a certain sampling depth? Methodology/Principal Findings: We developed a statistical model to evaluate these parameters based on transcriptome-sampling data. Three mixture models were exploited for their potentials to model the sampling frequencies. We demonstrated that relative abundances of all transcripts in a transcriptome follow the generalized inverse Gaussian distribution. The widely known beta and gamma distributions failed to fulfill the singular characteristics of relative abundance distribution, i.e., highly skewed toward zero and with a long tail. An estimator of transcriptome diversity and an analytical form of sampling growth curve were proposed in a coherent framework. Experimental data fitted this model very well and Monte Carlo simulations based on this model replicated sampling experiments in a remarkable precision. Conclusions: Taking human embryonic stem cell as a prototype, we demonstrated that sequencing tens of thousands of transcript tags in an ordinary EST/SAGE experiment was far from sufficient. In order to fully characterize a human transcriptome, millions of transcript tags had to be sequenced. This model lays a statistical basis for transcriptome-sampling experiments and in essence can be used in all sampling-based data.	[Zhu, Jiang; He, Fuhong; Wang, Jing; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Gen, Beijing, Peoples R China; [Zhu, Jiang; He, Fuhong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, J (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Gen, Beijing, Peoples R China.	wangjing@big.ac.cn; junyu@big.ac.cn	郑, 征/C-8514-2011; Zhu, Jiang/E-3049-2013; He, Fuhong/HHZ-2474-2022; He, Fuhong/T-4887-2019	He, Fuhong/0000-0002-3176-8309	National Natural Science Foundation of China (NSFC) [90608003, 30221004]; National Basic Research Program of China [2006CB910404]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (NSFC) (Grant No. 90608003, 30221004) and the National Basic Research Program of China (973 Program) (Grant No. 2006CB910404).	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ATKINSON AC, 1982, J AM STAT ASSOC, V77, P153, DOI 10.2307/2287782; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; BISHOP JO, 1978, PHILOS T ROY SOC B, V283, P373, DOI 10.1098/rstb.1978.0039; Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brenner S, 2000, P NATL ACAD SCI USA, V97, P1665, DOI 10.1073/pnas.97.4.1665; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; BURRELL QL, 1993, J AM SOC INFORM SCI, V44, P61, DOI 10.1002/(SICI)1097-4571(199303)44:2<61::AID-ASI1>3.0.CO;2-J; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Colinge J, 2001, BIOINFORMATICS, V17, P840, DOI 10.1093/bioinformatics/17.9.840; Eyras E, 2004, GENOME RES, V14, P976, DOI 10.1101/gr.1862204; Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768; Hirst M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r113; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khattra J, 2007, GENOME RES, V17, P108, DOI 10.1101/gr.5488207; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kim N, 2005, GENOME RES, V15, P566, DOI 10.1101/gr.3030405; Kuznetsov VA, 2002, GENETICS, V161, P1321; Lee S, 2002, GENOMICS, V79, P598, DOI 10.1006/geno.2002.6730; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morris JS, 2003, BIOMETRICS, V59, P476, DOI 10.1111/1541-0420.00057; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; Pauws E, 2001, NUCLEIC ACIDS RES, V29, P1690, DOI 10.1093/nar/29.8.1690; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ruan YJ, 2004, TRENDS BIOTECHNOL, V22, P23, DOI 10.1016/j.tibtech.2003.11.002; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sichel H. S., 1986, MATH SCI, V11, P45; SICHEL HS, 1975, J AM STAT ASSOC, V70, P542, DOI 10.2307/2285930; SICHEL HS, 1992, INFORM PROCESS MANAG, V28, P5, DOI 10.1016/0306-4573(92)90088-H; Silva APM, 2004, NUCLEIC ACIDS RES, V32, P6104, DOI 10.1093/nar/gkh937; Sorek R, 2003, NUCLEIC ACIDS RES, V31, P1067, DOI 10.1093/nar/gkg170; STEIN GZ, 1987, J AM STAT ASSOC, V82, P938; Stern MD, 2003, BIOINFORMATICS, V19, P443, DOI 10.1093/bioinformatics/btg018; Thygesen HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-157; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	50	17	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1659	10.1371/journal.pone.0001659	http://dx.doi.org/10.1371/journal.pone.0001659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286206	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400048
J	Yu, XH; Koczan, D; Sulonen, AM; Akkad, DA; Kroner, A; Comabella, M; Costa, G; Corongiu, D; Goertsches, R; Camina-Tato, M; Thiesen, HJ; Nyland, HI; Mork, SJ; Montalban, X; Rieckmann, P; Marrosu, MG; Myhr, KM; Epplen, JT; Saarela, J; Ibrahim, SM				Yu, Xinhua; Koczan, Dirk; Sulonen, Anna-Maija; Akkad, Denis A.; Kroner, Antje; Comabella, Manuel; Costa, Gianna; Corongiu, Daniela; Goertsches, Robert; Camina-Tato, Montserrat; Thiesen, Hans-Juergen; Nyland, Harald I.; Mork, Sverre J.; Montalban, Xavier; Rieckmann, Peter; Marrosu, Maria G.; Myhr, Kjell-Morten; Epplen, Joerg T.; Saarela, Janna; Ibrahim, Saleh M.			mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis	PLOS ONE			English	Article								Background: Mitochondrial DNA (mtDNA) polymorphism is a possible factor contributing to the maternal parent-of-origin effect in multiple sclerosis (MS) susceptibility. Methods and Findings: In order to investigate the role of mtDNA variations in MS, we investigated six European MS case-control cohorts comprising > 5,000 individuals. Three well matched cohorts were genotyped with seven common, potentially functional mtDNA single nucleotide polymorphisms (SNPs). A SNP, nt13708 G/A, was significantly associated with MS susceptibility in all three cohorts. The nt 13708A allele was associated with an increased risk of MS (OR = 1.71, 95% Cl 1.28-2.26, P = 0.0002). Subsequent sequencing of the mtDNA of 50 individuals revealed that the nt13708 itself, rather than SNPs linked to it, was responsible for the association. However, the association of nt13708 G/A with MS was not significant in MS cohorts which were not well case-control matched, indicating that the significance of association was affected by the population structure of controls. Conclusions: Taken together, our finding identified the nt13708A variant as a susceptibility allele to MS, which could contribute to defining the role of the mitochondrial genome in MS pathogenesis.	[Yu, Xinhua; Ibrahim, Saleh M.] Univ Rostock, Sect Immunogenet, Rostock, Germany; [Koczan, Dirk; Goertsches, Robert; Thiesen, Hans-Juergen] Univ Rostock, Dept Immunol, Rostock, Germany; [Sulonen, Anna-Maija; Saarela, Janna] Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; [Akkad, Denis A.; Epplen, Joerg T.] Ruhr Univ, IGSN, Dept Human Genet, Bochum, Germany; [Kroner, Antje; Rieckmann, Peter] Univ Wurzburg, Dept Neurol, Clin Res Grp MS & Neuroimmunol, Wurzburg, Germany; [Comabella, Manuel; Camina-Tato, Montserrat; Montalban, Xavier] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Unit Neuroimmunol Clin, Barcelona, Spain; [Costa, Gianna; Corongiu, Daniela; Marrosu, Maria G.] Univ Cagliari, Dipart Sci Cardiovascol Neurol, Centro Sclerosi Multipla, Cagliari, Italy; [Nyland, Harald I.; Myhr, Kjell-Morten] Univ Bergen, Haukeland Univ Hosp, Dept Neurol, Bergen, Norway; [Nyland, Harald I.; Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, Bergen, Norway; [Mork, Sverre J.] Univ Bergen, Gades Inst, Haukeland Univ Hosp, Dept Pathol, Bergen, Norway	University of Rostock; University of Rostock; Finland National Institute for Health & Welfare; Ruhr University Bochum; University of Wurzburg; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Cagliari; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Yu, XH (corresponding author), Univ Rostock, Sect Immunogenet, Rostock, Germany.	saleh.ibrahim@med.uni-rostock.de	Mörk, Sverre Jarl/AAW-1330-2020; Ibrahim, Saleh/AAO-9541-2020; Saarela, Janna S/E-5369-2014; Montalban, Xavier/J-5938-2016; Myhr, Kjell-Morten/H-1528-2018; Yu, Xinhua/F-6125-2011	Montalban, Xavier/0000-0002-0098-9918; Myhr, Kjell-Morten/0000-0002-0980-510X; Comabella Lopez, Manuel/0000-0002-2373-6657; Marrosu, Maria Giovanna/0000-0003-2334-2081; Saarela, Janna/0000-0002-0853-6219; Epplen, Joerg T./0000-0002-6087-3327; Sulonen, Anna-Maija/0000-0002-5518-1975; Ibrahim, Saleh/0000-0001-7827-2290	EU FP6 (EURO-RA); Hertie Stiftung	EU FP6 (EURO-RA)(European Commission); Hertie Stiftung(Austrian Science Fund (FWF))	This work was supported by grants from EU FP6 (EURO-RA) and Hertie Stiftung.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Houshmand M, 2005, MULT SCLER J, V11, P728, DOI 10.1191/1352458505ms1228sr; Howell N, 2005, TRENDS GENET, V21, P583, DOI 10.1016/j.tig.2005.08.012; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; Kalman B, 1995, Mult Scler, V1, P32; Kalman B, 1997, Mult Scler, V2, P267; Kalman B, 1998, ACTA NEUROL SCAND, V98, P232, DOI 10.1111/j.1600-0404.1998.tb07301.x; Kalman B, 1999, ACTA NEUROL SCAND, V99, P16; KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121; LEES F, 1964, J NEUROL NEUROSUR PS, V27, P415, DOI 10.1136/jnnp.27.5.415; Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mihailova SM, 2007, EUR J NEUROL, V14, P44, DOI 10.1111/j.1468-1331.2006.01541.x; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293; SADOVNICK AD, 1991, ANN NEUROL, V29, P252, DOI 10.1002/ana.410290304; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Silander K, 2003, TWIN RES, V6, P391, DOI 10.1375/136905203770326394; Sumelahti ML, 2000, NEUROEPIDEMIOLOGY, V19, P67, DOI 10.1159/000026241; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; TORRONI A, 1994, AM J HUM GENET, V55, P760; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Vogler S, 2005, J MOL MED, V83, P806, DOI 10.1007/s00109-005-0661-5; Wallace DC, 2001, MENT RETARD DEV D R, V7, P158, DOI 10.1002/mrdd.1023	33	72	79	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1530	10.1371/journal.pone.0001530	http://dx.doi.org/10.1371/journal.pone.0001530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270557	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535900001
J	Chen, XW; Liu, M; Ward, R				Chen, Xue-wen; Liu, Mei; Ward, Robert			Protein Function Assignment through Mining Cross-Species Protein-Protein Interactions	PLOS ONE			English	Article							FUNCTION PREDICTION; SEMANTIC SIMILARITY; GENE ONTOLOGY; DATABASE; GENOMES; CYCLIN; IDENTIFICATION; LOCALIZATION; ANNOTATION; EXPRESSION	Background: As we move into the post genome-sequencing era, an immediate challenge is how to make best use of the large amount of high-throughput experimental data to assign functions to currently uncharacterized proteins. We here describe CSIDOP, a new method for protein function assignment based on shared interacting domain patterns extracted from cross-species protein-protein interaction data. Methodology/Principal Findings: The proposed method is assessed both biologically and statistically over the genome of H. sapiens. The CSIDOP method is capable of making protein function prediction with accuracy of 95.42% using 2,972 gene ontology (GO) functional categories. In addition, we are able to assign novel functional annotations for 181 previously uncharacterized proteins in H. sapiens. Furthermore, we demonstrate that for proteins that are characterized by GO, the CSIDOP may predict extra functions. This is attractive as a protein normally executes a variety of functions in different processes and its current GO annotation may be incomplete. Conclusions/Significance: It can be shown through experimental results that the CSIDOP method is reliable and practical in use. The method will continue to improve as more high quality interaction data becomes available and is readily scalable to a genome-wide application.	[Chen, Xue-wen; Liu, Mei] Univ Kansas, Bioinformat & Computat Life Sci Lab, ITTC, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA; [Ward, Robert] Univ Kansas, Dept Mol Biosci, Lawrence, KS USA	University of Kansas; University of Kansas	Chen, XW (corresponding author), Univ Kansas, Bioinformat & Computat Life Sci Lab, ITTC, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA.	xwchen@ku.edu			NSF [IIS-0644366]	NSF(National Science Foundation (NSF))	NSF award IIS-0644366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; *AMIGO, GEN ONT AMIGO; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Brun C, 2004, GENOME BIOL, V5; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Deng MH, 2004, BIOINFORMATICS, V20, P895, DOI 10.1093/bioinformatics/btg500; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; GALLANT P, 1994, EMBO J, V13, P595, DOI 10.1002/j.1460-2075.1994.tb06297.x; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lee H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-269; Lee MO, 2002, MOL CELL ENDOCRINOL, V188, P47, DOI 10.1016/S0303-7207(01)00753-5; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; McDermott J, 2005, BIOINFORMATICS, V21, P3217, DOI 10.1093/bioinformatics/bti514; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Nariai N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000337; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pereira-Leal JB, 2005, GENOME RES, V15, P552, DOI 10.1101/gr.3102105; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; POLLER W, 1989, HUM GENET, V83, P93, DOI 10.1007/BF00274157; *QUICKGO, GO BROWS; Ramirez F, 2007, PROTEOMICS, V7, P2541, DOI 10.1002/pmic.200600924; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schlicker A, 2007, BIOINFORMATICS, V23, P859, DOI 10.1093/bioinformatics/btm012; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Tschop K, 2006, FEBS J, V273, P1681, DOI 10.1111/j.1742-4658.2006.05184.x; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wojcik J, 2001, Bioinformatics, V17 Suppl 1, pS296; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	54	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1562	10.1371/journal.pone.0001562	http://dx.doi.org/10.1371/journal.pone.0001562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253506	gold, Green Published, Green Submitted			2022-12-27	WOS:000260535700030
J	Geiger, T; Sabanay, H; Kravchenko-Balasha, N; Geiger, B; Levitzki, A				Geiger, Tamar; Sabanay, Helena; Kravchenko-Balasha, Nataly; Geiger, Benjamin; Levitzki, Alexander			Anomalous Features of EMT during Keratinocyte Transformation	PLOS ONE			English	Article								During the evolution of epithelial cancers, cells often lose their characteristic features and acquire a mesenchymal phenotype, in a process known as epithelial-mesenchymal transition (EMT). In the present study we followed early stages of keratinocyte transformation by HPV16, and observed diverse cellular changes, associated with EMT. We compared primary keratinocytes with early and late passages of HF1 cells, a cell line of HPV16-transformed keratinocytes. We have previously shown that during the progression from the normal cells to early HF1 cells, immortalization is acquired, while in the progression to late HF1, cells become anchorage independent. We show here that during the transition from the normal state to late HF1 cells, there is a progressive reduction in cytokeratin expression, desmosome formation, adherens junctions and focal adhesions, ultimately leading to poorly adhesive phenotype, which is associated with anchorage-independence. Surprisingly, unlike "conventional EMT'', these changes are associated with reduced Rac1-dependent cell migration. We monitored reduced Rac1-dependent migration also in the cervical cancer cell line SiHa. Therefore we can conclude that up to the stage of tumor formation migratory activity is eliminated.	[Geiger, Tamar; Kravchenko-Balasha, Nataly; Levitzki, Alexander] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Sabanay, Helena; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science	Geiger, T (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	levitzki@vms.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016; Geiger, Tamar/C-2349-2014	Kravchenko-Balasha, Nataly/0000-0001-6943-7479; Geiger, Tamar/0000-0002-9526-197X	Hebrew University; Algen Biopharmaceuticals Ltd	Hebrew University; Algen Biopharmaceuticals Ltd	This study was supported by funds from the Hebrew University and Algen Biopharmaceuticals Ltd.	Alazawi WOF, 2003, VIRCHOWS ARCH, V443, P51, DOI 10.1007/s00428-003-0771-9; Bauer NN, 2007, EXP CELL RES, V313, P3832, DOI 10.1016/j.yexcr.2007.08.017; BenBassat H, 1997, CANCER RES, V57, P3741; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; CARICO E, 1993, GYNECOL ONCOL, V49, P61, DOI 10.1006/gyno.1993.1087; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; Faraldo MM, 2001, EMBO REP, V2, P431, DOI 10.1093/embo-reports/kve086; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000605; GIGILEITNER O, 1986, DIFFERENTIATION, V31, P191, DOI 10.1111/j.1432-0436.1986.tb00400.x; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; HODIVALA KJ, 1994, ONCOGENE, V9, P943; HUSZAR M, 1986, DIFFERENTIATION, V31, P141, DOI 10.1111/j.1432-0436.1986.tb00395.x; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Keely P, 1998, TRENDS CELL BIOL, V8, P101, DOI 10.1016/S0962-8924(97)01219-1; Kirfel G, 2004, PROTOPLASMA, V223, P67, DOI 10.1007/s00709-003-0031-5; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; MITRANIROSENBAUM S, 1992, INTERVIROLOGY, V33, P76, DOI 10.1159/000150234; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Mizrachy-Schwartz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000628; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Peluso JJ, 2001, BIOL REPROD, V64, P1183, DOI 10.1095/biolreprod64.4.1183; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van Dorst EBL, 1998, J CLIN PATHOL, V51, P679, DOI 10.1136/jcp.51.9.679; VANWAES C, 1995, CANCER RES, V55, P5434; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; WILBANKS GD, 1976, CANCER RES, V36, P2485; WOODWORTH CD, 1990, CANCER RES, V50, P3709; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	45	33	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1574	10.1371/journal.pone.0001574	http://dx.doi.org/10.1371/journal.pone.0001574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253510	Green Published, gold, Green Submitted			2022-12-27	WOS:000260535700034
J	Bright, RA; Carter, DM; Crevar, CJ; Toapanta, FR; Steckbeck, JD; Cole, KS; Kumar, NM; Pushko, P; Smith, G; Tumpey, TM; Ross, TM				Bright, Rick A.; Carter, Donald M.; Crevar, Corey J.; Toapanta, Franklin R.; Steckbeck, Jonathan D.; Cole, Kelly S.; Kumar, Niranjan M.; Pushko, Peter; Smith, Gale; Tumpey, Terrence M.; Ross, Ted M.			Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTE; A H5N1; REVERSE-GENETICS; HETEROSUBTYPIC IMMUNITY; NEUTRALIZING ANTIBODIES; ADAMANTANE RESISTANCE; HUMAN-DISEASE; PLAQUE ASSAY; VACCINE; MICE	Background. Vaccination is a cost-effective counter-measure to the threat of seasonal or pandemic outbreaks of influenza. To address the need for improved influenza vaccines and alternatives to egg-based manufacturing, we have engineered an influenza virus-like particle (VLP) as a new generation of non-egg or non-mammalian cell culture-based candidate vaccine. Methodology/Principal Findings. We generated from a baculovirus expression system using insect cells, a non-infectious recombinant VLP vaccine from both influenza A H5N1 clade 1 and clade 2 isolates with pandemic potential. VLPs were administered to mice in either a one-dose or two-dose regimen and the immune responses were compared to those induced by recombinant hemagglutinin (rHA). Both humoral and cellular responses were analyzed. Mice vaccinated with VLPs were protected against challenge with lethal reassortant viruses expressing the H5N1 HA and NA, regardless if the H5N1 clade was homologous or heterologous to the vaccine. However, rHA-vaccinated mice showed considerable weight loss and death following challenge with the heterovariant clade virus. Protection against death induced by VLPs was independent of the prechallenge HAI titer or cell-mediated responses to HA or M1 since vaccinated mice, with low to undetectable cross-clade HAI antibodies or cellular responses to influenza antigens, were still protected from a lethal viral challenge. However, an apparent association rate of antibody binding to HA correlated with protection and was enhanced using VLPs, particularly when delivered intranasally, compared to rHA vaccines. Conclusion/Significance. This is the first report describing the use of an H5N1 VLP vaccine created from a clade 2 isolate. The results show that a non-replicating virus-like particle is effective at eliciting a broadened, cross-clade protective immune response to proteins from emerging H5N1 influenza isolates giving rise to a potential pandemic influenza vaccine candidate for humans that can be stockpiled for use in the event of an outbreak of H5N1 influenza.	[Bright, Rick A.; Kumar, Niranjan M.; Pushko, Peter; Smith, Gale] Novavax Inc, Rockville, MD USA; [Carter, Donald M.; Crevar, Corey J.; Toapanta, Franklin R.; Steckbeck, Jonathan D.; Cole, Kelly S.; Ross, Ted M.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Tumpey, Terrence M.] Ctr Dis Control & Prev, Influenza Div, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Bright, RA (corresponding author), Novavax Inc, Rockville, MD USA.	rbright@novavax.com; tmr15@pitt.edu	Toapanta, Franklin/Y-1774-2019		Center for Vaccine Research, Novavax	Center for Vaccine Research, Novavax	The Center for Vaccine Research, Novavax supported this work.	Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Askonas BA, 1982, BASIC APPLIED INFLUE, P159; Booy R, 2006, MED J AUSTRALIA, V185, pS62; Bower JF, 2005, CURR HIV RES, V3, P191, DOI 10.2174/1570162053506937; Bower JF, 2004, VIROLOGY, V328, P292, DOI 10.1016/j.virol.2004.07.031; BRACIALE TJ, 1978, J EXP MED, V147, P1236, DOI 10.1084/jem.147.4.1236; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Epstein SL, 1998, J IMMUNOL, V160, P322; Evans TG, 2001, J INFECT DIS, V183, P1485, DOI 10.1086/320190; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Flynn KJ, 1999, P NATL ACAD SCI USA, V96, P8597, DOI 10.1073/pnas.96.15.8597; Focosi D, 2006, NEW ENGL J MED, V354, P2724; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; HAFFAR OK, 1991, VIROLOGY, V183, P487, DOI 10.1016/0042-6822(91)90978-K; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; HURT AC, 2006, SUSCEPTIBILITY HIGHL; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Kozak W, 1997, AM J PHYSIOL-REG I, V272, pR621, DOI 10.1152/ajpregu.1997.272.2.R621; Lalvani A, 1997, J IMMUNOL METHODS, V210, P65, DOI 10.1016/S0022-1759(97)00177-4; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lorin C, 2004, J VIROL, V78, P146, DOI 10.1128/JVI.78.1.146-157.2004; Luke CJ, 2006, EMERG INFECT DIS, V12, P66, DOI 10.3201/eid1201.051147; McBurney SP, 2006, CURR HIV RES, V4, P475, DOI 10.2174/157016206778560018; MCBURNEY SP, 2006, VIROLOGY; Mitchell JA, 2003, VACCINE, V21, P902, DOI 10.1016/S0264-410X(02)00539-X; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; ORGANIZATION WH, 2005, EMERG INFECT DIS, V11, P1515; ORGANIZATION WH, 2006, RECOMMENDATION PANDE; ORGANIZATION WH, 2006, AVIAN INFLUENZA SITU; Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098; Qiao C, 2006, DEV BIOLOGICALS, V124, P127; REED L. J., 1938, AMER JOUR HYG, V27, P493; Riberdy JM, 1999, J VIROL, V73, P1453, DOI 10.1128/JVI.73.2.1453-1459.1999; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Sambhara S, 2001, CELL IMMUNOL, V210, P1, DOI 10.1006/cimm.2001.1799; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SMINIA T, 1999, MUCOSAL IMMUNOLOGY, V2, P357; Steckbeck JD, 2006, J MED PRIMATOL, V35, P248, DOI 10.1111/j.1600-0684.2006.00173.x; Steckbeck JD, 2005, J VIROL, V79, P12311, DOI 10.1128/JVI.79.19.12311-12320.2005; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; STOHR K, 2005, NEW ENGL J MED, V352, P333; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Szucs TD, 2001, INFECT CONT HOSP EP, V22, P472, DOI 10.1086/503405; TILNEY NL, 1971, J ANAT, V109, P369; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Toapanta FR, 2004, VACCINE, V22, P1773, DOI 10.1016/j.vaccine.2003.10.050; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P23, DOI 10.1007/BF02123574; Tochikubo K, 1998, VACCINE, V16, P150, DOI 10.1016/S0264-410X(97)00194-1; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Webster RG, 2006, VIROLOGY, V351, P303, DOI 10.1016/j.virol.2006.01.044; Wiley JA, 2001, AM J PATHOL, V158, P119, DOI 10.1016/S0002-9440(10)63950-8; Wiley JA, 2001, J IMMUNOL, V167, P3293, DOI 10.4049/jimmunol.167.6.3293; WOOD J, 1997, DEV BIOL STAND, V39, P193; Wu HY, 1997, SCAND J IMMUNOL, V46, P506, DOI 10.1046/j.1365-3083.1997.d01-159.x; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; Yoshikawa T, 2004, J GEN VIROL, V85, P2339, DOI 10.1099/vir.0.79892-0; Young KR, 2006, AIDS RES HUM RETROV, V22, P99, DOI 10.1089/aid.2006.22.99; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	79	208	235	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1501	10.1371/journal.pone.0001501	http://dx.doi.org/10.1371/journal.pone.0001501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231588	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200014
J	Kerneis, S; Grais, RF; Boelle, PY; Flahault, A; Vergu, E				Kerneis, Solen; Grais, Rebecca F.; Boelle, Pierre-Yves; Flahault, Antoine; Vergu, Elisabeta			Does the Effectiveness of Control Measures Depend on the Influenza Pandemic Profile?	PLOS ONE			English	Article								Background. Although strategies to contain influenza pandemics are well studied, the characterization and the implications of different geographical and temporal diffusion patterns of the pandemic have been given less attention. Methodology/Main Findings. Using a well-documented metapopulation model incorporating air travel between 52 major world cities, we identified potential influenza pandemic diffusion profiles and examined how the impact of interventions might be affected by this heterogeneity. Clustering methods applied to a set of pandemic simulations, characterized by seven parameters related to the conditions of emergence that were varied following Latin hypercube sampling, were used to identify six pandemic profiles exhibiting different characteristics notably in terms of global burden ( from 415 to.160 million of cases) and duration ( from 26 to 360 days). A multivariate sensitivity analysis showed that the transmission rate and proportion of susceptibles have a strong impact on the pandemic diffusion. The correlation between interventions and pandemic outcomes were analyzed for two specific profiles: a fast, massive pandemic and a slow building, long-lasting one. In both cases, the date of introduction for five control measures ( masks, isolation, prophylactic or therapeutic use of antivirals, vaccination) correlated strongly with pandemic outcomes. Conversely, the coverage and efficacy of these interventions only moderately correlated with pandemic outcomes in the case of a massive pandemic. Pre-pandemic vaccination influenced pandemic outcomes in both profiles, while travel restriction was the only measure without any measurable effect in either. Conclusions. Our study highlights: (i) the great heterogeneity in possible profiles of a future influenza pandemic; (ii) the value of being well prepared in every country since a pandemic may have heavy consequences wherever and whenever it starts; (iii) the need to quickly implement control measures and even to anticipate pandemic emergence through pre-pandemic vaccination; and (iv) the value of combining all available control measures except perhaps travel restrictions.	[Vergu, Elisabeta] INRA, Math & Informat Appl UR341, Jouy En Josas, France; [Kerneis, Solen; Grais, Rebecca F.; Boelle, Pierre-Yves; Flahault, Antoine] Univ Pierre Marie Curie Paris 6, UMR S 707, Paris, France; [Kerneis, Solen; Grais, Rebecca F.; Boelle, Pierre-Yves; Flahault, Antoine] INSERM, UMR S 707, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vergu, E (corresponding author), INRA, Math & Informat Appl UR341, Jouy En Josas, France.	elisabeta.vergu@jouy.inra.fr		Freeman Grais, Rebecca/0000-0002-5037-8218; Boelle, Pierre-Yves/0000-0002-5367-8232	Fondation Recherche Medicale	Fondation Recherche Medicale	Solen Kerneis received a research grant from the Fondation Recherche Medicale. The views expressed in this article are those of the authors.	Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bush R., 2007, ENCY INFECT DIS MODE, P199; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; CARRAT F, AM J EPIDEM IN PRESS; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Kendall MG, 1942, BIOMETRIKA, V32, P277, DOI 10.1093/biomet/32.3-4.277; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MCKAY MD, 1979, TECHNOMETRICS, V21; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; *WHO, 2006, EMERG INFECT DIS; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	35	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1478	10.1371/journal.pone.0001478	http://dx.doi.org/10.1371/journal.pone.0001478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213386	Green Submitted, gold, Green Published			2022-12-27	WOS:000260503900023
J	Sandkuhler, S; Bhattacharya, J				Sandkuehler, Simone; Bhattacharya, Joydeep			Deconstructing Insight: EEG Correlates of Insightful Problem Solving	PLOS ONE			English	Article							HUMAN THETA-OSCILLATIONS; UPPER ALPHA; INDIVIDUAL-DIFFERENCES; BRAIN OSCILLATIONS; PREFRONTAL CORTEX; NEURAL ACTIVITY; EFFECTS MODELS; MEMORY; ACTIVATION; ATTENTION	Background. Cognitive insight phenomenon lies at the core of numerous discoveries. Behavioral research indicates four salient features of insightful problem solving: (i) mental impasse, followed by (ii) restructuring of the problem representation, which leads to (iii) a deeper understanding of the problem, and finally culminates in (iv) an "Aha!'' feeling of suddenness and obviousness of the solution. However, until now no efforts have been made to investigate the neural mechanisms of these constituent features of insight in a unified framework. Methodology/Principal Findings. In an electroencephalographic study using verbal remote associate problems, we identified neural correlates of these four features of insightful problem solving. Hints were provided for unsolved problems or after mental impasse. Subjective ratings of the restructuring process and the feeling of suddenness were obtained on trial-by-trial basis. A negative correlation was found between these two ratings indicating that sudden insightful solutions, where restructuring is a key feature, involve automatic, subconscious recombination of information. Electroencephalogram signals were analyzed in the space x time x frequency domain with a nonparametric cluster randomization test. First, we found strong gamma band responses at parieto-occipital regions which we interpreted as (i) an adjustment of selective attention (leading to a mental impasse or to a correct solution depending on the gamma band power level) and (ii) encoding and retrieval processes for the emergence of spontaneous new solutions. Secondly, we observed an increased upper alpha band response in right temporal regions (suggesting active suppression of weakly activated solution relevant information) for initially unsuccessful trials that after hint presentation led to a correct solution. Finally, for trials with high restructuring, decreased alpha power (suggesting greater cortical excitation) was observed in right prefrontal area. Conclusions/Significance. Our results provide a first account of cognitive insight by dissociating its constituent components and potential neural correlates.	[Sandkuehler, Simone; Bhattacharya, Joydeep] Austrian Acad Sci, Commiss Sci Visualizat, A-1010 Vienna, Austria; [Sandkuehler, Simone] Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria; [Bhattacharya, Joydeep] Univ London, Dept Psychol, London, England	Austrian Academy of Sciences; Medical University of Vienna; University of London	Bhattacharya, J (corresponding author), Austrian Acad Sci, Commiss Sci Visualizat, A-1010 Vienna, Austria.	j.bhattacharya@gold.ac.uk			JST.ERATO Shimojo Implicit Brain Function Project; OENB-Jubilaeumsfond Project [11497]	JST.ERATO Shimojo Implicit Brain Function Project(Japan Science & Technology Agency (JST)); OENB-Jubilaeumsfond Project	Supported by the JST.ERATO Shimojo Implicit Brain Function Project and OENB-Jubilaeumsfond Project (Nr. 11497) to JB.	Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Ansburg PI, 2000, CURR PSYCHOL, V19, P143, DOI 10.1007/s12144-000-1011-y; Ash IK, 2006, PSYCHON B REV, V13, P66, DOI 10.3758/BF03193814; AUBLE PM, 1979, MEM COGNITION, V7, P426, DOI 10.3758/BF03198259; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Beeman MJ, 2000, MEM COGNITION, V28, P1231, DOI 10.3758/BF03211823; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Bowden EM, 1998, PSYCHOL SCI, V9, P435, DOI 10.1111/1467-9280.00082; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; BOWERS KS, 1990, COGNITIVE PSYCHOL, V22, P72, DOI 10.1016/0010-0285(90)90004-N; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Buzsaki G., 2006, RHYTHMS BRAIN, P448; Caplan JB, 2001, J NEUROPHYSIOL, V86, P368, DOI 10.1152/jn.2001.86.1.368; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Csikszentmihalyi M., 1995, NATURE INSIGHT, P329, DOI [10.1007/978-94-017-9085-7, DOI 10.1007/978-94-017-9085-7, DOI 10.1002/J.2162-6057.1998.TB00816.X]; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Davidson J. E., 1995, NATURE INSIGHT, P157; Davidson J. E., 1995, NATURE INSIGHT, P125; Dominowski R.L., 1995, NATURE INSIGHT, P33; DUNCKER K, 1945, PROBLEM SOLVING; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Finke I. A., 1995, NATURE INSIGHT, P255; Fiore SM, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P349; Fleck JI, 2004, MEM COGNITION, V32, P990, DOI 10.3758/BF03196876; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gick M.L., 1995, NATURE INSIGHT, P197; GICK ML, 1992, J EXP PSYCHOL LEARN, V18, P623, DOI 10.1037/0278-7393.18.3.623; Goel V, 2000, COGN NEUROPSYCHOL, V17, P415, DOI 10.1080/026432900410775; Goel V, 2005, CEREB CORTEX, V15, P1170, DOI 10.1093/cercor/bhh217; Greeno J. G., 1978, HDB LEARNING COGNITI, V5, P239; Gruber H. E., 1995, NATURE INSIGHT, P397; HAYES JR, 1989, COMPLETE PROBLEM SOL, P376; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; HORVITZ LA, 2002, EUREKA SCI BREAKTHRO; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Isaak M. I., 1995, NATURE INSIGHT, P281; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; KAPLAN CA, 1990, COGNITIVE PSYCHOL, V22, P374, DOI 10.1016/0010-0285(90)90008-R; Kiebel SJ, 2005, HUM BRAIN MAPP, V26, P170, DOI 10.1002/hbm.20153; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Knoblich G, 1998, Z PSYCHOL, V206, P207; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LINDSTROM MJ, 1988, J AM STAT ASSOC, V83, P1014; LOCKHART RS, 1988, MEM COGNITION, V16, P36, DOI 10.3758/BF03197743; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; Luo J, 2003, HIPPOCAMPUS, V13, P316, DOI 10.1002/hipo.10069; Mai XQ, 2004, HUM BRAIN MAPP, V22, P261, DOI 10.1002/hbm.20030; Maier N. R. F., 1931, J COMP PSYCHOL, V12, P181, DOI 10.1037/h0071361; Mayer R. E, 1992, THINKING PROBLEM SOL; METCALFE J, 1987, MEM COGNITION, V15, P238, DOI 10.3758/BF03197722; METCALFE J, 1986, J EXP PSYCHOL LEARN, V12, P288, DOI 10.1037/0278-7393.12.2.288; Miller LA, 1996, NEUROPSYCHOLOGIA, V34, P387, DOI 10.1016/0028-3932(95)00116-6; Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001; Momjian S, 2003, ADV TECH STAND NEUR, V28, P91; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OHLSSON S, 1984, SCAND J PSYCHOL, V25, P117, DOI 10.1111/j.1467-9450.1984.tb01005.x; Ohlsson S., 1992, ADV PSYCHOL THINKING, V1, DOI DOI 10.1017/CB09780511780295; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Papp N, 1977, Biomed Sci Instrum, V13, P135; PERKINS DN, 1981, MINDS BEST WORK CAMB; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pinheiro J., 2006, NLME PACKAGE LINEAR, V314; PINHEIRO JC, 2001, MIXED EFFECTS MODELS; Qiu J, 2006, NEUROREPORT, V17, P679, DOI 10.1097/00001756-200604240-00025; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; Schack B, 2003, HUM BRAIN MAPP, V19, P18, DOI 10.1002/hbm.10104; SCHOOLER JW, 1993, J EXP PSYCHOL GEN, V122, P166, DOI 10.1037/0096-3445.122.2.166; Seifert M. C., 1995, NATURE INSIGHT, P65, DOI DOI 10.1111/1467-8721.00065; SHEER DE, 1989, BRAIN DYNAMICS; Siegler RS, 2000, CURR DIR PSYCHOL SCI, V9, P79, DOI 10.1111/1467-8721.00065; SIEGLER RS, 2006, UNCONSCIOUS CONSCIOU, P4; SMITH SM, 1991, AM J PSYCHOL, V104, P61, DOI 10.2307/1422851; Soanes C., 2005, COMPACT OXFORD ENGLI; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wertheimer M., 1959, PRODUCTIVE THINKING; WURTZ RH, 1982, SCI AM, V246, P124, DOI 10.1038/scientificamerican0682-124	102	110	126	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1459	10.1371/journal.pone.0001459	http://dx.doi.org/10.1371/journal.pone.0001459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213368	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000260503900005
J	Trenner, MU; Heekeren, HR; Bauer, M; Rossner, K; Wenzel, R; Villringer, A; Fahle, M				Trenner, Maja U.; Heekeren, Hauke R.; Bauer, Markus; Rossner, Konstanze; Wenzel, Ruediger; Villringer, Arno; Fahle, Manfred			What Happens in Between? Human Oscillatory Brain Activity Related to Crossmodal Spatial Cueing	PLOS ONE			English	Article							PERCEPTUAL DECISION-MAKING; SCALE NEURAL-NETWORK; PREFRONTAL CORTEX; ATTENTIONAL SHIFTS; VISUAL-ATTENTION; VISUOSPATIAL ATTENTION; POLYSENSORY MECHANISMS; SELECTIVE ATTENTION; EXOGENOUS ATTENTION; AUDIOVISUAL LINKS	Previous studies investigated the effects of crossmodal spatial attention by comparing the responses to validly versus invalidly cued target stimuli. Dynamics of cortical rhythms in the time interval between cue and target might contribute to cue effects on performance. Here, we studied the influence of spatial attention on ongoing oscillatory brain activity in the interval between cue and target onset. In a first experiment, subjects underwent periods of tactile stimulation (cue) followed by visual stimulation (target) in a spatial cueing task as well as tactile stimulation as a control. In a second experiment, cue validity was modified to be 50%, 75%, or else 25%, to separate effects of exogenous shifts of attention caused by tactile stimuli from that of endogenous shifts. Tactile stimuli produced: 1) a stronger lateralization of the sensorimotor beta-rhythm rebound (15-22 Hz) after tactile stimuli serving as cues versus not serving as cues; 2) a suppression of the occipital alpha-rhythm (7-13 Hz) appearing only in the cueing task (this suppression was stronger contralateral to the endogenously attended side and was predictive of behavioral success); 3) an increase of prefrontal gamma-activity (25-35 Hz) specifically in the cueing task. We measured cue-related modulations of cortical rhythms which may accompany crossmodal spatial attention, expectation or decision, and therefore contribute to cue validity effects. The clearly lateralized alpha suppression after tactile cues in our data indicates its dependence on endogenous rather than exogenous shifts of visuo-spatial attention following a cue independent of its modality.	[Trenner, Maja U.; Rossner, Konstanze; Wenzel, Ruediger; Villringer, Arno] Charite, Berlin NeuroImaging Ctr, Neurol Klin & Poliklin, D-13353 Berlin, Germany; [Heekeren, Hauke R.; Bauer, Markus] Max Planck Inst Human Dev, Berlin, Germany; [Fahle, Manfred] Univ Bremen, Ctr Cognitive Sci Human Neurobiol, Bremen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; University of Bremen	Trenner, MU (corresponding author), Charite, Berlin NeuroImaging Ctr, Neurol Klin & Poliklin, D-13353 Berlin, Germany.	maja.trenner@charite.de	Bauer, Markus/G-3808-2012; Heekeren, Hauke/B-7739-2008; Bauer, Markus/AAR-2596-2020	Bauer, Markus/0000-0001-6906-1678; Heekeren, Hauke/0000-0001-7912-6826; Villringer, Arno/0000-0003-2604-2404	BMBF; Kommission fur wissenschaftlichen Nachwuchs of Charite Universitatsmedizin Berlin	BMBF(Federal Ministry of Education & Research (BMBF)); Kommission fur wissenschaftlichen Nachwuchs of Charite Universitatsmedizin Berlin	This work was supported by grants of the BMBF (Berlin NeuroImaging Center, BNIC, BMBF-DLR, FKZ 01 GO 020), Center for Advanced Imaging (CAI), and by the Kommission fur wissenschaftlichen Nachwuchs of Charite Universitatsmedizin Berlin.	Bauer M, 2006, J NEUROSCI, V26, P490, DOI 10.1523/JNEUROSCI.5228-04.2006; BROVELLI A, 2005, NEUROIMAGE; BUCHTEL HA, 1988, NEUROPSYCHOLOGIA, V26, P499, DOI 10.1016/0028-3932(88)90107-8; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; BUTTER CM, 1989, NEUROPSYCHOLOGIA, V27, P1231, DOI 10.1016/0028-3932(89)90035-3; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; D'Esposito M, 2000, NEUROIMAGE, V11, P400, DOI 10.1006/nimg.2000.0571; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eimer M, 2002, J COGNITIVE NEUROSCI, V14, P254, DOI 10.1162/089892902317236885; Fell J, 2003, BRAIN RES REV, V42, P265, DOI 10.1016/S0165-0173(03)00178-4; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gobbele R, 2002, NEUROSCI LETT, V327, P57, DOI 10.1016/S0304-3940(02)00384-1; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green JJ, 2006, PSYCHOPHYSIOLOGY, V43, P161, DOI 10.1111/j.1469-8986.2006.00394.x; Gruber T, 1999, CLIN NEUROPHYSIOL, V110, P2074, DOI 10.1016/S1388-2457(99)00176-5; Heekeren HR, 2006, P NATL ACAD SCI USA, V103, P10023, DOI 10.1073/pnas.0603949103; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Ivry R, 2002, NAT NEUROSCI, V5, P394, DOI 10.1038/nn0502-394; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; JENSEN O, 2007, TRENDS NEUROSCI; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jongen EMM, 2006, PSYCHOPHYSIOLOGY, V43, P113, DOI 10.1111/j.1469-8986.2006.00375.x; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; KLIMESCH W, 2006, BRAIN RES BRAIN RES; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Mayer AR, 2004, NEUROIMAGE, V23, P534, DOI 10.1016/j.neuroimage.2004.06.027; McDonald JJ, 1999, PERCEPT PSYCHOPHYS, V61, P1411, DOI 10.3758/BF03206190; McDonald JJ, 2001, CAN J EXP PSYCHOL, V55, P141, DOI 10.1037/h0087361; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; Pfurtscheller G, 2002, NEUROSCI LETT, V323, P113, DOI 10.1016/S0304-3940(02)00119-2; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; RAFAL RD, 1989, J EXP PSYCHOL HUMAN, V15, P673, DOI 10.1037/0096-1523.15.4.673; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Senkowski D, 2005, EXP BRAIN RES, V166, P411, DOI 10.1007/s00221-005-2381-z; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Spence C, 1996, J EXP PSYCHOL HUMAN, V22, P1005, DOI 10.1037/0096-1523.22.4.1005; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Spence C, 2000, J EXP PSYCHOL HUMAN, V26, P1298, DOI 10.1037//0096-1523.26.4.1298; TASSINARI G, 1989, ACTA PSYCHOL, V70, P267, DOI 10.1016/0001-6918(89)90026-7; Taylor TL, 1998, PSYCHON B REV, V5, P625, DOI 10.3758/BF03208839; Thut G, 2003, NEUROIMAGE, V18, P334, DOI 10.1016/S1053-8119(02)00048-4; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Van Velzen J, 2002, PSYCHOPHYSIOLOGY, V39, P874, DOI 10.1017/S0048577202020140; WARD LM, 1994, CAN J EXP PSYCHOL, V48, P242, DOI 10.1037/1196-1961.48.2.242; Worden MS, 2000, J NEUROSCI, V20; Yamagishi N, 2005, COGNITIVE BRAIN RES, V25, P799, DOI 10.1016/j.cogbrainres.2005.09.006	71	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1467	10.1371/journal.pone.0001467	http://dx.doi.org/10.1371/journal.pone.0001467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SO	18213376	Green Published, Green Submitted, gold			2022-12-27	WOS:000260503900013
J	Anders, CK; Acharya, CR; Hsu, DS; Broadwater, G; Garman, K; Foekens, JA; Zhang, Y; Wang, YX; Marcom, K; Marks, JR; Mukherjee, S; Nevins, JR; Blackwell, KL; Potti, A				Anders, Carey K.; Acharya, Chaitanya R.; Hsu, David S.; Broadwater, Gloria; Garman, Katherine; Foekens, John A.; Zhang, Yi; Wang, Yixin; Marcom, Kelly; Marks, Jeffrey R.; Mukherjee, Sayan; Nevins, Joseph R.; Blackwell, Kimberly L.; Potti, Anil			Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2F-1; EXPRESSION; CANCER; SURVIVAL; SIGNATURES; PROGNOSIS; SUBTYPES; GROWTH; GUIDE	Purpose. To define the biology driving the aggressive nature of breast cancer arising in young women. Experimental Design. Among 784 patients with early stage breast cancer, using prospectively-defined, age-specific cohorts (young <= 45 years; older <= 65 years), 411 eligible patients (n = 200 <= 45 years; n = 211 <= 65 years) with clinically-annotated Affymetrix microarray data were identified. GSEA, signatures of oncogenic pathway deregulation and predictors of chemotherapy sensitivity were evaluated within the two age-defined cohorts. Results. In comparing deregulation of oncogenic pathways between age groups, a higher probability of PI3K (p = 0.006) and Myc (p = 0.03) pathway deregulation was observed in breast tumors arising in younger women. When evaluating unique patterns of pathway deregulation, a low probability of Src and E2F deregulation in tumors of younger women, concurrent with a higher probability of PI3K, Myc, and beta-catenin, conferred a worse prognosis (HR = 4.15). In contrast, a higher probability of Src and E2F pathway activation in tumors of older women, with concurrent low probability of PI3K, Myc and beta-catenin deregulation, was associated with poorer outcome (HR = 2.7). In multivariate analyses, genomic clusters of pathway deregulation illustrate prognostic value. Conclusion. Results demonstrate that breast cancer arising in young women represents a distinct biologic entity characterized by unique patterns of deregulated signaling pathways that are prognostic, independent of currently available clinico-pathologic variables. These results should enable refinement of targeted treatment strategies in this clinically challenging situation.	[Anders, Carey K.; Hsu, David S.; Marcom, Kelly; Blackwell, Kimberly L.; Potti, Anil] Duke Univ, Dept Med, Div Med Oncol, Durham, NC 27706 USA; [Acharya, Chaitanya R.; Hsu, David S.; Garman, Katherine; Marks, Jeffrey R.; Mukherjee, Sayan; Nevins, Joseph R.; Potti, Anil] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Broadwater, Gloria] Duke Univ, Med Ctr, Canc Ctr Biostat, Durham, NC USA; [Foekens, John A.] Erasmus MC, Rotterdam, Netherlands; [Zhang, Yi; Wang, Yixin] Johnson & Johnson, Veridex Inc, San Diego, CA USA	Duke University; Duke University; Duke University; Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Johnson & Johnson USA	Potti, A (corresponding author), Duke Univ, Dept Med, Div Med Oncol, Durham, NC 27706 USA.	anil.potti@duke.edu	Acharya, Chaitanya/T-3510-2019	Mukherjee, Sayan/0000-0002-6715-3920	NCI [CA093245-05]; NATIONAL CANCER INSTITUTE [T32CA093245] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported by T32 (CA093245-05) Duke Translational Research in Oncology Training Grant, provided by the NCI (CA).	ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Albain K S, 1994, J Natl Cancer Inst Monogr, P35; ANDERS C, 2007, YOUNG AGE DIAG UNPUB; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bramis J, 2004, ANTICANCER RES, V24, P3041; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Han S, 2003, BREAST CANCER RES TR, V82, P11, DOI 10.1023/B:BREA.0000003843.53726.63; Harrell FE, 2001, REGRESSION MODELING; Holli K, 1997, EUR J CANCER, V33, P425; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson DG, 2006, CURR MOL MED, V6, P731; Kollias J, 1997, BRIT J CANCER, V75, P1318, DOI 10.1038/bjc.1997.223; LEHRER S, 1989, MT SINAI J MED, V56, P83; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Pittman J, 2004, BIOSTATISTICS, V5, P587, DOI 10.1093/biostatistics/kxh011; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Rabbani F, 1999, J NATL CANCER I, V91, P874, DOI 10.1093/jnci/91.10.874; Rounbehler RJ, 2002, CANCER RES, V62, P3276; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	29	76	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1373	10.1371/journal.pone.0001373	http://dx.doi.org/10.1371/journal.pone.0001373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167534	Green Published, gold			2022-12-27	WOS:000260468900002
J	Pandey, M; Patel, SS; Gabriel, A				Pandey, Manjula; Patel, Smita S.; Gabriel, Abram			Kinetic Pathway of Pyrophosphorolysis by a Retrotransposon Reverse Transcriptase	PLOS ONE			English	Article							DEPENDENT DNA-POLYMERASE; T7 RNA-POLYMERASE; ACTIVE-SITE ASPARTATE; PRIMER-UNBLOCKING; CATALYTIC COMPLEX; MECHANISM; VIRUS; POLYMERIZATION; TRANSLOCATION; RESISTANCE	DNA and RNA polymerases use a common phosphoryl transfer mechanism for base addition that requires two or three acidic amino acid residues at their active sites. We previously showed, for the reverse transcriptase (RT) encoded by the yeast retrotransposon Ty1, that one of the three conserved active site aspartates (D-211) can be substituted by asparagine and still retain in vitro polymerase activity, although in vivo transposition is lost. Transposition is partially restored by second site suppressor mutations in the RNAse H domain. The novel properties of this amino acid substitution led us to express the WT and D211N mutant enzymes, and study their pre-steady state kinetic parameters. We found that the k(pol) was reduced by a factor of 223 in the mutant, although the K-d for nucleotide binding was unaltered. Further, the mutant enzyme had a marked preference for Mn2+ over Mg2+. To better understand the functions of this residue within the Ty1 RT active site, we have now examined the in vitro properties of WT and D211N mutant Ty1 RTs in carrying out pyrophosphorolysis, the reverse reaction to polymerization, where pyrophosphate is the substrate and dNTPs are the product. We find that pyrophosphorolysis is efficient only when the base-paired primer template region is > 14 bases, and that activity increases when the primer end is blunt-ended or recessed by only a few bases. Using pre-steady state kinetic analysis, we find that the rate of pyrophosphorolysis (k(pyro)) in the D211N mutant is nearly 320 fold lower than the WT enzyme, and that the mutant enzyme has an similar to 170 fold lower apparent K-d for pyrophosphate. These findings indicate that subtle substrate differences can strongly affect the enzyme's ability to properly position the primer-end to carry out pyrophosphorolysis. Further the kinetic data suggests that the D-211 residue has a role in pyrophosphate binding and release, which could affect polymerase translocation, and help explain the D211N mutant's transposition defect.	[Pandey, Manjula; Gabriel, Abram] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Pandey, Manjula; Patel, Smita S.] Univ Med & Dent NJ, Dept Biochem, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gabriel, A (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.	gabriel@cabm.rutgers.edu			PHS [GM60534, GM55310, GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310, R01GM051966, R01GM060534, R37GM051966] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in part, from PHS grants GM60534 (to AG) and GM55310 and GM51966 (to SP). The sponsors or funders had no role in the design or conduct of the study, nor in the collection, analysis, or interpretation of the data, nor in the preparation, review or approval on the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bibillo A, 2005, NUCLEIC ACIDS RES, V33, P171, DOI 10.1093/nar/gki150; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; D'Abramo CM, 2004, J MOL BIOL, V337, P1, DOI 10.1016/j.jmb.2004.01.030; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JIANG MY, 1994, BIOESSAYS, V16, P531, DOI 10.1002/bies.950160803; Johnson K. A., 1992, ENZYMES, P1; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P11536, DOI 10.1021/bi960364x; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; Lin P, 2006, P NATL ACAD SCI USA, V103, P13294, DOI 10.1073/pnas.0606006103; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Pandey M, 2004, J BIOL CHEM, V279, P47840, DOI 10.1074/jbc.M406019200; Patel PH, 2000, P NATL ACAD SCI USA, V97, P5095, DOI 10.1073/pnas.97.10.5095; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; REARDON JE, 1993, J BIOL CHEM, V268, P8743; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SKALKA A, 1993, REVERSE TRANSCRIPTAS; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Urban S, 2001, P NATL ACAD SCI USA, V98, P4984, DOI 10.1073/pnas.091324398; Uzun O, 2001, J VIROL, V75, P6337, DOI 10.1128/JVI.75.14.6337-6347.2001; Wilhelm FX, 2005, CYTOGENET GENOME RES, V110, P269, DOI 10.1159/000084960; Wilhelm M, 2000, BIOCHEM J, V348, P337, DOI 10.1042/0264-6021:3480337; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1389	10.1371/journal.pone.0001389	http://dx.doi.org/10.1371/journal.pone.0001389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167548	Green Submitted, gold, Green Published			2022-12-27	WOS:000260468900017
J	Ryan, PL; Young, JAT				Ryan, Patricia L.; Young, John A. T.			Evidence against a Human Cell-Specific Role for LRP6 in Anthrax Toxin Entry	PLOS ONE			English	Article								The role of the cellular protein LRP6 in anthrax toxin entry is controversial. Previous studies showed that LRP6 was important for efficient intoxication of human M2182 prostate carcinoma cells but other studies performed with cells from gene-knockout mice demonstrated no role for either LRP6 or the related LRP5 protein in anthrax toxin entry. One possible explanation for this discrepancy is that LRP6 may be important for anthrax toxin entry into human, but not mouse, cells. To test this idea we have investigated the effect of knocking down LRP6 or LRP5 expression with siRNAs in human HeLa cells. We show here that efficient knockdown of either LRP6, LRP5, or both proteins has no influence on the kinetics of anthrax lethal toxin entry or MEK1 substrate cleavage in these cells. These data argue against a human-specific role for LRP6 in anthrax toxin entry and suggest instead that involvement of this protein may be restricted to certain cell types independently of their species of origin.	[Ryan, Patricia L.; Young, John A. T.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; [Ryan, Patricia L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA USA	Salk Institute; University of California System; University of California San Diego	Ryan, PL (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyoung@salk.edu		Young, John/0000-0003-1824-2561	NIH [AI48489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI48489.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Boll W, 2004, EUR J CELL BIOL, V83, P281, DOI 10.1078/0171-9335-00373; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027	24	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1817	10.1371/journal.pone.0001817	http://dx.doi.org/10.1371/journal.pone.0001817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350154	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762300020
J	Morris, GAJ; Ikumapayi, UN; Antonio, M; Howie, SRC; Adegbola, RA				Morris, Gerard A. J.; Ikumapayi, Usman N.; Antonio, Martin; Howie, Stephen R. C.; Adegbola, Richard A.			A Novel Campylobacter jejuni Sequence Type from a Culture-Negative Patient in The Gambia	PLOS ONE			English	Article							PNEUMONIA; CLONES; BLOOD	The introduction of molecular diagnostic methods is crucial for improved understanding of the aetiology and epidemiology of bacterial infections in communities in resource poor settings. A blood sample from a 7 month old patient diagnosed with malaria in 2001 in a Gambian outpatient clinic was reported as culture negative after it was subjected to traditional bacterial culture protocols. We re-addressed the analysis of the blood sample from this case more recently (after 6.5 years in archival storage) in pilot work establishing 16S rRNA PCR in our molecular laboratory. Initial 16S rRNA PCR results confirmed the presence of bacterial DNA in the sample. 16S rRNA sequence analysis identified the organism as Campylobacter spp. In light of the molecular evidence we successfully grew the organism using appropriate culture conditions and subsequently biochemically confirmed that the isolate was Campylobacter jejuni. PCR and DNA sequencing of a set of seven C. jejuni housekeeping genes and in silico Multilocus Sequence Typing (MLST) analysis revealed that the isolate exhibits a novel sequence type (ST) of C. jejuni (ST 2928) and belongs to ST-443 clonal complex. This study demonstrates the potential for molecular tools to enhance the diagnosis of bacterial infections, which remain a major killer globally, not least in children in the developing world. Improvements in diagnostics are needed, and will be important not only for sick individuals but also for populations, where better measures of disease burden will contribute significantly to the improvement of public health policy.	[Morris, Gerard A. J.; Ikumapayi, Usman N.; Antonio, Martin; Howie, Stephen R. C.; Adegbola, Richard A.] MRC Labs, Bacterial Dis Programme, Fajara, Gambia	MRC Laboratory Molecular Biology	Morris, GAJ (corresponding author), MRC Labs, Bacterial Dis Programme, Fajara, Gambia.	gmorris@mrc.gm			Medical Research Council United Kingdom; MRC [MC_U190088478, MC_U190081991, MC_U190074190] Funding Source: UKRI; Medical Research Council [MC_U190081991, MC_U190088478, MC_U190074190] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was mainly supported by funding from Medical Research Council United Kingdom. The MRC UK was not directly involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	BLASER MJ, 1995, MANDELL DOUGLAS BENN; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; McLaughlin RW, 2002, J CLIN MICROBIOL, V40, P4771, DOI 10.1128/JCM.40.12.4771-4775.2002; Miller RL, 2007, AM J EVAL, V28, P7, DOI 10.1177/1098214006298057; Mulholland EK, 2005, NEW ENGL J MED, V352, P75, DOI 10.1056/NEJMe048306; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Rao MR, 2001, AM J EPIDEMIOL, V154, P166, DOI 10.1093/aje/154.2.166; Scott JAG, 1999, CHEST, V116, P1716, DOI 10.1378/chest.116.6.1716; Wassenaar TM, 2000, APPL ENVIRON MICROB, V66, P1, DOI 10.1128/AEM.66.1.1-9.2000; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1773	10.1371/journal.pone.0001773	http://dx.doi.org/10.1371/journal.pone.0001773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335047	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000026
J	Uzochukwu, BSC; Onwujekwe, EO; Onoka, CA; Ughasoro, MD				Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel O.; Onoka, Chima A.; Ughasoro, Maduka D.			Rural-Urban Differences in Maternal Responses to Childhood Fever in South East Nigeria	PLOS ONE			English	Article							MALARIA MORBIDITY; SEEKING BEHAVIOR; HOME TREATMENT; BURKINA-FASO; CHILDREN; DISTRICT; KNOWLEDGE; MANAGEMENT; COMMUNITY; DIAGNOSIS	Background: Childhood fevers due to malaria remain a major cause of morbidity and mortality among under-five children in Nigeria. The degree of vulnerability perceived by mothers will affect their perception of the severity and threat of their child's fever and the patterns of health care use. This study was undertaken to compare maternal responses to childhood fever in urban and rural areas of Enugu, south east Nigeria. Methodology/Principal Findings: Data was collected with pre-tested interviewer-administered questionnaires from 276 and 124 urban and rural households respectively. In each household, only one woman aged 15-49 years who had lived in each of the urban and rural communities for at least one year and had at least one child less than 5 years old was interviewed. Malaria was mentioned as the commonest cause of childhood fevers. Rural mothers were more likely to recognize danger signs and symptoms than urban mothers. Rural mothers use more of informal than formal health services, and there is more home management of the fever with urban than rural mothers. Chloroquine, ACT, SP and Paracetamol are the main drugs given at home for childhood fevers, but the rural mothers were more likely to use leftover drugs from previous treatment to treat the fevers than urban mothers. The urban respondents were also more likely to use a preventive measure. Urban mothers sought actions faster than rural mothers and the total cost of treatment was also higher in urban areas. Conclusions/Significance: Both urban and rural mothers are aware that malaria is the major cause of childhood fevers. Although rural mothers recognize childhood fever and danger signs better than urban mothers, the urban mothers' responses to fever seem to be better than that for rural mothers. These responses and differences may be important for geographical targeting by policy makers for malaria interventions.	[Uzochukwu, Benjamin S. C.] Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria; [Onwujekwe, Emmanuel O.] Univ Nigeria, Coll Med, Dept Hlth Administrat & Management, Enugu, Nigeria; [Onoka, Chima A.] Univ Nigeria Teach Hosp, Dept Community Med, Enugu, Nigeria; [Ughasoro, Maduka D.] Univ Nigeria Teach Hosp, Dept Paediat, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria; University of Nigeria	Uzochukwu, BSC (corresponding author), Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria.	bscuzochukwu@yahoo.com	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285; Onoka, Chima/0000-0002-3328-1887				ADETUNJI JA, 1991, SOC SCI MED, V32, P1379, DOI 10.1016/0277-9536(91)90198-L; Adikwu MU, 1996, HEALTH POLICY PLANN, V11, P202, DOI 10.1093/heapol/11.2.202; AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6; Akogun OB, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-13; BAUDON D, 1985, T ROY SOC TROP MED H, V79, P283, DOI 10.1016/0035-9203(85)90361-X; Baume C, 2000, SOC SCI MED, V51, P1491, DOI 10.1016/S0277-9536(00)00049-6; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; BRIEGER WR, 2002, AFRICAN J MED MED SC, V30, P7; BRODY JE, 1993, NY TIMES, P20; Brugha R, 2002, HLTH POLICY PLAN, V13, P103; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; CHANDRASHEKHAR T, 2006, BMC INT HEALTH HUM R, V6, P7, DOI DOI 10.1186/1472-698X-6-7; DEMING MS, 1989, B WORLD HEALTH ORGAN, V67, P695; DNELLI M, 2005, URBAN MALARIA AFRICA; ERHUN OO, 2001, J HLTH POPULATION DE, V4, P23; ERHUN WO, 1992, NIGERIAN J PHARM, V23, P13; Fawole O I, 2001, West Afr J Med, V20, P152; *FED MIN HLTH, 2001, STRAT PLAN ROLL BACK; *FED REP NIG, 2003, NIG DEM HLTH SURV; Federal Ministry of Health, 2005, ANN REP FED MIN HLTH; Feyisetan B J, 1997, Health Transit Rev, V7, P221; Fotso J, 2006, INT J EQUITY HEALTH, V5; GENTON B, 1994, T ROY SOC TROP MED H, V88, P537, DOI 10.1016/0035-9203(94)90152-X; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; GLIK DC, 1989, J HLTH SOCIAL BEHAV, V30, P426; Hamel MJ, 2001, B WORLD HEALTH ORGAN, V79, P1014; HANSON K, 2004, EC MALARIA CONTROL I; HASIBEDER G, 1988, THEOR POPUL BIOL, V33, P31, DOI 10.1016/0040-5809(88)90003-2; IWEZE EA, 1987, URBAN POOR NIGERIA, P317; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Kelly L, 1996, J Pediatr Health Care, V10, P167, DOI 10.1016/S0891-5245(96)90040-1; KLINKENBERG E, 2004, AM J TROP MED HYG; Krantz C, 2001, Pediatr Nurs, V27, P567; LEVY J, 2001, PEDIAT NURSING, V27, P567; LISA C, 2004, 176 INT FOOD POL RES; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; *MVCU, 2000, PREV MAL MORB MORT E; Njama D, 2003, TROP MED INT HEALTH, V8, P685, DOI 10.1046/j.1365-3156.2003.01060.x; Nyamongo IK, 2002, SOC SCI MED, V54, P377, DOI 10.1016/S0277-9536(01)00036-3; Oguonu T, 2005, PUBLIC HEALTH, V119, P409, DOI 10.1016/j.puhe.2004.05.008; OKEKE TA, 2006, NIGERIAN COMMUNITY M, V5, P97; Onwujekwe O, 2004, ACTA TROP, V91, P101, DOI 10.1016/j.actatropica.2004.03.005; Onwujekwe Obinna, 2005, Health Policy, V71, P383, DOI 10.1016/j.healthpol.2004.06.006; ONWUJEKWE OE, 2003, J COLL MED, V8, P20; Ruel Marie, 1998, 51 INT FOOD POL RES; Ruel MT, 2001, NESTLE NUTR WORKS SE, V47, P123; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; *STAT MIN HLTH EN, 2000, DEM PROF EN STAT; STEIN CM, 1988, TROP GEOGR MED, V40, P264; TABIBZADEH I, 1989, SPOTLIGHT CITIES IMP; TANNER M, 1995, ACTION RES URBAN HEA; Tarimo DS, 2000, TROP MED INT HEALTH, V5, P179, DOI 10.1046/j.1365-3156.2000.00537.x; Thera MA, 2000, TROP MED INT HEALTH, V5, P876, DOI 10.1046/j.1365-3156.2000.00652.x; Uzochukwu Benjamin Sc, 2004, Int J Equity Health, V3, P6, DOI 10.1186/1475-9276-3-6; VanderStuyft P, 1996, TROP MED INT HEALTH, V1, P161	56	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1788	10.1371/journal.pone.0001788	http://dx.doi.org/10.1371/journal.pone.0001788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18335058	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000039
J	Paruchuri, V; Prasad, A; McHugh, K; Bhat, HK; Polyak, K; Ganju, RK				Paruchuri, Vikram; Prasad, Anil; McHugh, Kevin; Bhat, Hari K.; Polyak, Kornelia; Ganju, Ramesh K.			S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation	PLOS ONE			English	Article							PSORIASIN S100A7 EXPRESSION; CARCINOMA IN-SITU; FACTOR RECEPTOR; C-SRC; BONE METASTASES; EGF RECEPTOR; PROTEIN; ACTIVATION; IDENTIFICATION; HER2	S100A7 is a small calcium binding protein, which has been shown to be differentially expressed in psoriatic skin lesions, as well as in squamous cell tumors of the skin, lung and breast. Although its expression has been correlated to HER+ high-grade tumors and to a high risk of progression, the molecular mechanisms of these S100A7-mediated tumorigenic effects are not well known. Here, we showed for the first time that epidermal growth factor (EGF) induces S100A7 expression in both MCF-7 and MDA-MB-468 cell lines. We also observed a decrease in EGF-directed migration in shRNA-downregulated MDA-MB-468 cell lines. Furthermore, our signaling studies revealed that EGF induced simultaneous EGF receptor phosphorylation at Tyr1173 and HER2 phosphorylation at Tyr1248 in S100A7-downregulated cell lines as compared to the vector-transfected controls. In addition, reduced phosphorylation of Src at tyrosine 416 and p-SHP2 at tyrosine 542 was observed in these downregulated cell lines. Further studies revealed that S100A7-downregulated cells had reduced angiogenesis in vivo based on matrigel plug assays. Our results also showed decreased tumor-induced osteoclastic resorption in an intra-tibial bone injection model involving SCID mice. S100A7-downregulated cells had decreased osteoclast number and size as compared to the vector controls, and this decrease was associated with variations in IL-8 expression in in vitro cell cultures. This is a novel report on the role of S100A7 in EGF-induced signaling in breast cancer cells and in osteoclast formation.	[Paruchuri, Vikram; Prasad, Anil; Ganju, Ramesh K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA; [McHugh, Kevin] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Rheumatol, Boston, MA USA; [Bhat, Hari K.] Columbia Univ, Mailman Sch Public Hlth, Dept Environmental Hlth Sci, New York, NY USA; [Polyak, Kornelia] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ganju, RK (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA.	ramesh.ganju@osumc.edu			National Institutes of Health [CA109527]; Susan G. Komen Breast Cancer Foundation; Department of Defense Award [W81XWH-05-1-0465]; NATIONAL CANCER INSTITUTE [R01CA109527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research is supported in part by a grant from the National Institutes of Health CA109527, Susan G. Komen Breast Cancer Foundation, and the Department of Defense Award # W81XWH-05-1-0465 to RKG.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Bendre M, 2003, CLIN ORTHOP RELAT R, pS39, DOI 10.1097/01.blo.0000093844.72468.f4; Bendre MS, 2002, CANCER RES, V62, P5571; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Bryborn M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-118; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chelouche-Lev D, 2004, EUR J CANCER, V40, P2509, DOI 10.1016/j.ejca.2004.05.024; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Emberley ED, 2003, CANCER RES, V63, P1954; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Harvey HA, 1997, CANCER-AM CANCER SOC, V80, P1646, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1646::AID-CNCR14>3.0.CO;2-#; HENNIPMAN A, 1989, CANCER RES, V49, P516; Hudelist G, 2006, INT J CANCER, V118, P1126, DOI 10.1002/ijc.21492; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; LIU E, 1992, ONCOGENE, V7, P1027; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; Lotz M, 2003, J SURG RES, V109, P123, DOI 10.1016/S0022-4804(02)00100-2; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Ostergaard M, 1997, CANCER RES, V57, P4111; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Pederson L, 1999, CANCER RES, V59, P5849; Porter D, 2003, MOL CANCER RES, V1, P362; RADINSKY R, 1995, CLIN CANCER RES, V1, P19; Silva AR, 2006, INT J SURG PATHOL, V14, P268, DOI 10.1177/1066896906290820; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Vogl G, 2006, APPL IMMUNOHISTO M M, V14, P138, DOI 10.1097/01.pai.0000168591.58721.a6; Webb M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-17; Weber KL, 2003, CANCER RES, V63, P2940; Wilson GR, 2006, BRIT J CANCER, V95, P1410, DOI 10.1038/sj.bjc.6603444; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208	46	34	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1741	10.1371/journal.pone.0001741	http://dx.doi.org/10.1371/journal.pone.0001741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320059	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600036
J	Yu, Y; Zhang, HM; Tian, F; Bacon, L; Zhang, Y; Zhang, WS; Song, JZ				Yu, Ying; Zhang, Huanmin; Tian, Fei; Bacon, Larry; Zhang, Yuan; Zhang, Wensheng; Song, Jiuzhou			Quantitative Evaluation of DNA Methylation Patterns for ALVE and TVB Genes in a Neoplastic Disease Susceptible and Resistant Chicken Model	PLOS ONE			English	Article							AVIAN-LEUKOSIS VIRUSES; TRANSPOSABLE ELEMENTS; SUBGROUP-A; EXPRESSION; EPIGENETICS; MUTATIONS; RECEPTORS; INFECTION; LINKAGE; PRIMER	Chicken endogenous viruses, ALVE (Avian Leukosis Virus subgroup E), are inherited as LTR (long terminal repeat) retrotransposons, which are negatively correlated with disease resistance, and any changes in DNA methylation may contribute to the susceptibility to neoplastic disease. The relationship between ALVE methylation status and neoplastic disease in the chicken is undefined. White Leghorn inbred lines 7(2) and 6(3) at the ADOL have been respectively selected for resistance and susceptibility to tumors that are induced by avian viruses. In this study, the DNA methylation patterns of 3 similar to 6 CpG sites of four conserved regions in ALVE, including one unique region in ALVE1, the promoter region in the TVB (tumor virus receptor of ALV subgroup B, D and E) locus, were analyzed in the two lines using pyrosequencing methods in four tissues, i.e., liver, spleen, blood and hypothalamus. A significant CpG hypermethylation level was seen in line 7(2) in all four tissues, e.g., 91.86 +/- 1.63% for ALVE region2 in blood, whereas the same region was hemimethylated (46.16 +/- 2.56%) in line 6(3). CpG methylation contents of the ALVE regions were significantly lower in line 6(3) than in line 7(2) in all tissues (P < 0.01) except the ALVE region 3/4 in liver. RNA expressions of ALVE regions 2 and 3 (PPT-U3) were significantly higher in line 6(3) than in line 7(2) (P < 0.01). The methylation levels of six recombinant congenic strains (RCSs) closely resembled to the background line 6(3) in ALVE-region 2, which imply the methylation pattern of ALVE-region 2 may be a biomarker in resistant disease breeding. The methylation level of the promoter region in the TVB was significantly different in blood (P < 0.05) and hypothalamus (P < 0.0001), respectively. Our data disclosed a hypermethylation pattern of ALVE that may be relevant for resistance against ALV induced tumors in chickens.	[Yu, Ying; Tian, Fei; Zhang, Wensheng; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Zhang, Huanmin; Bacon, Larry] USDA, Avian Dis & Oncol Lab, Agr Res Serv, E Lansing, MI USA; [Zhang, Yuan] China Agr Univ, Coll Animal Sci, Beijing, Peoples R China	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); China Agricultural University	Yu, Y (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020; Zhang, Huanmin/M-9792-2019	Zhang, Huanmin/0000-0003-4896-2391	Maryland State Fund	Maryland State Fund	Maryland State Fund	Atwood-Moore A, 2005, J VIROL, V79, P14863, DOI 10.1128/JVI.79.23.14863-14875.2005; Bacon LD, 2004, AVIAN PATHOL, V33, P233, DOI 10.1080/0307943042000195731; BACON LD, 1986, IMMUNOGENETICS, V23, P213, DOI 10.1007/BF00373015; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; BAKER B, 1981, VIROLOGY, V114, P8, DOI 10.1016/0042-6822(81)90248-8; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Borisenko L, 2003, FOLIA BIOL-PRAGUE, V49, P177; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; CONKLIN KF, 1982, MOL CELL BIOL, V2, P638, DOI 10.1128/MCB.2.6.638; CONKLIN KF, 1991, J VIROL, V65, P2525, DOI 10.1128/JVI.65.5.2525-2532.1991; COOPER GM, 1978, CELL, V15, P573, DOI 10.1016/0092-8674(78)90025-9; Crittenden L. B., 1991, Critical Reviews in Poultry Biology, V3, P73; CRITTENDEN LB, 1983, VIROLOGY, V129, P514, DOI 10.1016/0042-6822(83)90192-7; CRITTENDEN LB, 1985, POULTRY SCI, V64, P454, DOI 10.3382/ps.0640454; CRITTENDEN LB, 1974, VIROLOGY, V57, P128, DOI 10.1016/0042-6822(74)90114-7; CRITTENDEN LB, 1980, J VIROL, V33, P915, DOI 10.1128/JVI.33.2.915-919.1980; CRITTENDEN LB, 1984, AVIAN DIS, V28, P1037, DOI 10.2307/1590280; CULLEN BR, 1983, P NATL ACAD SCI-BIOL, V80, P2946, DOI 10.1073/pnas.80.10.2946; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; DAVIS T, 1985, BIOCHEM BIOPH RES CO, V126, P678, DOI 10.1016/0006-291X(85)90238-4; Davis TL, 1998, DEV GENET, V23, P111, DOI 10.1002/(SICI)1520-6408(1998)23:2&lt;111::AID-DVG3&gt;3.0.CO;2-9; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Elleder D, 2004, ANIM GENET, V35, P176, DOI 10.1111/j.1365-2052.2004.01118.x; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fadly A, 2003, DIS POULTRY, V11, P465; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2001, P NATL ACAD SCI USA, V98, P392, DOI 10.1073/pnas.98.2.392; JELINIC P, 2006, J PATHOL; Jeltsch A, 1998, J MOL BIOL, V275, P747, DOI 10.1006/jmbi.1997.1492; Johnson JA, 2001, J VIROL, V75, P3605, DOI 10.1128/JVI.75.8.3605-3612.2001; LUBBERT M, 1992, BLOOD, V80, P2066; McWilliams MJ, 2006, VIROLOGY, V348, P378, DOI 10.1016/j.virol.2005.12.042; Miles LR, 2005, J VIROL, V79, P6859, DOI 10.1128/JVI.79.11.6859-6867.2005; Nair V, 2005, VET J, V170, P175, DOI 10.1016/j.tvjl.2004.05.009; Rausch JW, 2007, NUCLEIC ACIDS RES, V35, P256, DOI 10.1093/nar/gkl909; Scholzova E, 2007, CANCER LETT, V246, P12, DOI 10.1016/j.canlet.2006.03.021; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; Shi HD, 2007, CARCINOGENESIS, V28, P60, DOI 10.1093/carcin/bgl092; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith E J, 1998, Microb Comp Genomics, V3, P13, DOI 10.1089/omi.1.1998.3.13; Tost Jorg, 2007, V373, P89; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; WEBER AP, 2007, PLANT PHYSIOLNAT GEN, P42466; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Zhang HM, 2005, AVIAN PATHOL, V34, P324, DOI 10.1080/03079450500179491	47	23	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1731	10.1371/journal.pone.0001731	http://dx.doi.org/10.1371/journal.pone.0001731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320050	Green Published, gold			2022-12-27	WOS:000260586600026
J	Delhey, K; Peters, A				Delhey, Kaspar; Peters, Anne			Quantifying Variability of Avian Colours: Are Signalling Traits More Variable?	PLOS ONE			English	Article								Background: Increased variability in sexually selected ornaments, a key assumption of evolutionary theory, is thought to be maintained through condition-dependence. Condition-dependent handicap models of sexual selection predict that (a) sexually selected traits show amplified variability compared to equivalent non-sexually selected traits, and since males are usually the sexually selected sex, that (b) males are more variable than females, and (c) sexually dimorphic traits more variable than monomorphic ones. So far these predictions have only been tested for metric traits. Surprisingly, they have not been examined for bright coloration, one of the most prominent sexual traits. This omission stems from computational difficulties: different types of colours are quantified on different scales precluding the use of coefficients of variation. Methodology/Principal Findings: Based on physiological models of avian colour vision we develop an index to quantify the degree of discriminable colour variation as it can be perceived by conspecifics. A comparison of variability in ornamental and non-ornamental colours in six bird species confirmed (a) that those coloured patches that are sexually selected or act as indicators of quality show increased chromatic variability. However, we found no support for (b) that males generally show higher levels of variability than females, or (c) that sexual dichromatism per se is associated with increased variability. Conclusions/Significance: We show that it is currently possible to realistically estimate variability of animal colours as perceived by them, something difficult to achieve with other traits. Increased variability of known sexually-selected/quality-indicating colours in the studied species, provides support to the predictions borne from sexual selection theory but the lack of increased overall variability in males or dimorphic colours in general indicates that sexual differences might not always be shaped by similar selective forces.	[Delhey, Kaspar; Peters, Anne] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany	Max Planck Society	Delhey, K (corresponding author), Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany.	delhey@orn.mpg.de	Delhey, Kaspar/AAZ-5362-2020; Delhey, Kaspar/F-6515-2010; Peters, Anne/A-1821-2010	Delhey, Kaspar/0000-0001-5190-5406; Peters, Anne/0000-0001-8071-0560	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1988, BIOL J LINN SOC, V34, P363, DOI 10.1111/j.1095-8312.1988.tb01969.x; Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Arden R, 2006, PERS INDIV DIFFER, V41, P39, DOI 10.1016/j.paid.2005.11.027; Blanco G, 2002, ANIM BEHAV, V63, P217, DOI 10.1006/anbe.2001.1909; Campenhausen MV, 1998, J COMP PHYSIOL A, V183, P1; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Cotton S, 2004, EVOLUTION, V58, P1038, DOI 10.1111/j.0014-3820.2004.tb00437.x; Cotton S, 2007, CURR BIOL, V17, pR335, DOI 10.1016/j.cub.2007.03.004; Cuervo JJ, 1999, BIOL J LINN SOC, V68, P505, DOI 10.1111/j.1095-8312.1999.tb01186.x; Cuthill IC, 2006, BIRD COLORATION, V1, P3; Dale J., 2006, BIRD COLORATION, V2, P36; Darwin C., 1871, P423; Doucet SM, 2007, AM NAT, V169, pS62, DOI 10.1086/510162; Dunn PO, 2001, EVOLUTION, V55, P161; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; EVANS MR, 1995, BIOL J LINN SOC, V54, P371, DOI 10.1111/j.1095-8312.1995.tb01043.x; Fitzpatrick S, 1997, BIOL J LINN SOC, V62, P145; Gonzalez-Solis J, 2004, OIKOS, V105, P247, DOI 10.1111/j.0030-1299.2004.12997.x; Grafen A., 2002, MODERN STAT LIFE SCI; Gray DA, 1996, AM NAT, V148, P453, DOI 10.1086/285935; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; GRIFFITH SC, 2006, BIRD COLORATION, V2, P233; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hastad O, 2005, P NATL ACAD SCI USA, V102, P6391, DOI 10.1073/pnas.0409228102; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Hill GE., 2006, BIRD COLOURATION, P507, DOI [10.4159/9780674273788, DOI 10.4159/9780674273788]; HILL GE, 2006, BIRD COLORATION, P589; HUNT GR, 1993, EMU, V93, P71, DOI 10.1071/MU9930071; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Kahn NW, 1998, AUK, V115, P1074; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kemp DJ, 2006, EVOL ECOL RES, V8, P515; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; MAIER EJ, 1993, J COMP PHYSIOL A, V172, P295, DOI 10.1007/BF00216611; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Merilaita S, 2003, EVOLUTION, V57, P1248; MOLLER AP, 1991, EVOLUTION, V45, P1823, DOI 10.1111/j.1558-5646.1991.tb02690.x; Montgomerie R., 2006, BIRD COLORATION, P90; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Quintana F, 2003, J FIELD ORNITHOL, V74, P370, DOI 10.1648/0273-8570-74.4.370; RICE WR, 1994, P NATL ACAD SCI USA, V91, P225, DOI 10.1073/pnas.91.1.225; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Schaefer HM, 2006, BEHAV ECOL, V17, P784, DOI 10.1093/beheco/arl011; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Sokal R. R, 1981, BIOMETRY; TAYLOR PD, 1982, THEOR POPUL BIOL, V22, P392, DOI 10.1016/0040-5809(82)90052-1; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	61	45	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1689	10.1371/journal.pone.0001689	http://dx.doi.org/10.1371/journal.pone.0001689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301766	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500033
J	Chao, YC; Huang, CS; Lee, CN; Chang, SY; King, CC; Kao, CL				Chao, Yuan-Chang; Huang, Ching-Shan; Lee, Chun-Nan; Chang, Sui-Yuan; King, Chwan-Chuen; Kao, Chuan-Liang			Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; NEUTROPHIL DYSFUNCTION; REPLICATION; ANEMIA; FEVER	The prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency is high in Asia. An ex vivo study was conducted to elucidate the association of G6PD deficiency and dengue virus (DENV) infection when many Asian countries are hyperendemic. Human monocytes from peripheral mononuclear cells collected from 12 G6PD-deficient patients and 24 age-matched controls were infected with one of two DENV serotype 2 (DENV-2) strains-the New Guinea C strain (from a case of dengue fever) or the 16681 strain (from a case of dengue hemorrhagic fever) with a multiplicity of infection of 0.1. The infectivity of DENV-2 in human monocytes was analyzed by flow cytometry. Experimental results indicated that the monocytes of G6PD-deficient patients exhibited a greater levels of infection with DENV-2 New Guinea C strain than did those in healthy controls [mean +/- SD: 33.6%+/- 3.5 (27.2%similar to 39.2%) vs 20.3%+/- 6.2 (8.0%similar to 30.4%), P < 0.01]. Similar observations were made of infection with the DENV-2 16681 strain [40.9%+/- 3.9 (35.1%similar to 48.9%) vs 27.4%+/- 7.1 (12.3%similar to 37.1%), P < 0.01]. To our knowledge, this study demonstrates for the first time higher infection of human monocytes in G6PD patients with the dengue virus, which may be important in increasing epidemiological transmission and perhaps with the potential to develop more severe cases pathogenically.	[Chao, Yuan-Chang; Lee, Chun-Nan; Chang, Sui-Yuan; Kao, Chuan-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chao, Yuan-Chang; Lee, Chun-Nan; Chang, Sui-Yuan; Kao, Chuan-Liang] NTU Hosp, Dept Lab Med, Taipei, Taiwan; [Huang, Ching-Shan] Fooyin Univ, Dept Med Technol, Kaohsiung, Taiwan; [King, Chwan-Chuen; Kao, Chuan-Liang] NTU, Coll Publ Hlth, Grad Inst Epidemiol, Taipei, Taiwan	National Taiwan University; National Taiwan University; Fooyin University; National Taiwan University	Chao, YC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	chuanliang@ntu.edu.tw	Huang, Ching-Shan/AAJ-3698-2021	KAO, CHUAN-LIANG/0000-0002-1020-2605; King, Chwan-Chuen/0000-0002-6078-2601; CHANG, SUI-YUAN/0000-0002-6009-6724	NHRI [NHRI-CN-CL9302P]	NHRI(National Health Research Institutes - Taiwan)	The authors would like to thank NHRI for their financial support (NHRI-CN-CL9302P) of this study.	ABUOSBA YK, 1989, J PEDIATR-US, V114, P748, DOI 10.1016/S0022-3476(89)80131-3; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; CHEN TP, 1993, PEDIATR RES, V34, P544, DOI 10.1203/00006450-199310000-00032; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Chiang Szu-Hui, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P72; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; CORRONS JLV, 1982, BLOOD, V59, P428; Costa E, 2002, J PEDIAT HEMATOL ONC, V24, P164, DOI 10.1097/00043426-200202000-00023; Gotsman I, 2001, J GASTROEN HEPATOL, V16, P1239, DOI 10.1046/j.1440-1746.2001.02611.x; GRAY GR, 1973, LANCET, V2, P530; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Hayes JM, 2006, T ROY SOC TROP MED H, V100, P559, DOI 10.1016/j.trstmh.2005.08.013; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Huang CS, 2002, GASTROENTEROLOGY, V123, P127, DOI 10.1053/gast.2002.34173; Iwai K, 2001, HUM GENET, V108, P445, DOI 10.1007/s004390100527; Kao CL, 2001, J CLIN MICROBIOL, V39, P3672, DOI 10.1128/JCM.39.10.3672-3677.2001; King Chwan-Chuen, 2000, Dengue Bulletin, V24, P1; Kung CM, 2007, J MED VIROL, V79, P60, DOI 10.1002/jmv.20761; Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005; LaFleur C, 2002, HUM IMMUNOL, V63, P1039, DOI 10.1016/S0198-8859(02)00682-1; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; MAMLOK RJ, 1987, J PEDIATR-US, V111, P852, DOI 10.1016/S0022-3476(87)80203-2; Mehta A, 2000, BEST PRACT RES CL HA, V13, P21, DOI 10.1053/beha.1999.0055; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; SCOTT RM, 1980, J INFECT DIS, V141, P1, DOI 10.1093/infdis/141.1.1; Tanphaichitr Voravarn S., 2002, Journal of the Medical Association of Thailand, V85, pS522; van Bruggen R, 2002, BLOOD, V100, P1026, DOI 10.1182/blood.V100.3.1026; Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704	32	27	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1557	10.1371/journal.pone.0001557	http://dx.doi.org/10.1371/journal.pone.0001557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270558	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900002
J	Trimarchi, JM; Stadler, MB; Cepko, CL				Trimarchi, Jeffrey M.; Stadler, Michael B.; Cepko, Constance L.			Individual Retinal Progenitor Cells Display Extensive Heterogeneity of Gene Expression	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ANAPHASE-PROMOTING COMPLEX; HOMEOBOX GENE; SINGLE-CELL; RAT RETINA; PHOTORECEPTOR DIFFERENTIATION; FATE DETERMINATION; DNA-REPLICATION; NEURAL RETINA; IN-VIVO	The development of complex tissues requires that mitotic progenitor cells integrate information from the environment. The highly varied outcomes of such integration processes undoubtedly depend at least in part upon variations among the gene expression programs of individual progenitor cells. To date, there has not been a comprehensive examination of these differences among progenitor cells of a particular tissue. Here, we used comprehensive gene expression profiling to define these differences among individual progenitor cells of the vertebrate retina. Retinal progenitor cells (RPCs) have been shown by lineage analysis to be multipotent throughout development and to produce distinct types of daughter cells in a temporal, conserved order. A total of 42 single RPCs were profiled on Affymetrix arrays. In situ hybridizations performed on both retinal sections and dissociated retinal cells were used to validate the results of the microarrays. An extensive amount of heterogeneity in gene expression among RPCs, even among cells isolated from the same developmental time point, was observed. While many classes of genes displayed heterogeneity of gene expression, the expression of transcription factors constituted a significant amount of the observed heterogeneity. In contrast to previous findings, individual RPCs were found to express multiple bHLH transcription factors, suggesting alternative models to those previously developed concerning how these factors may be coordinated. Additionally, the expression of cell cycle related transcripts showed differences among those associated with G2 and M, versus G1 and S phase, suggesting different levels of regulation for these genes. These data provide insights into the types of processes and genes that are fundamental to cell fate choices, proliferation decisions, and, for cells of the central nervous system, the underpinnings of the formation of complex circuitry.	[Trimarchi, Jeffrey M.; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Stadler, Michael B.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Cepko, Constance L.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA USA	Harvard University; Harvard Medical School; Friedrich Miescher Institute for Biomedical Research; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Trimarchi, JM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cepko@genetics.med.harvard.edu		Trimarchi, Jeffrey/0000-0001-7923-1538	National Eye Institute [EY08064]; Ruth L. Kirchenstein National Research Service Award [F32 EY014495]; NATIONAL EYE INSTITUTE [R01EY008064, F32EY014495] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ruth L. Kirchenstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a National Eye Institute grant EY08064 and a Ruth L. Kirchenstein National Research Service Award F32 EY014495 (JMT).	Al-Bader MD, 2005, DEV BRAIN RES, V156, P38, DOI 10.1016/j.devbrainres.2005.01.010; Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; ALTSHULER DM, 1991, P RET RES F, V3, P37; Bae SK, 2000, DEVELOPMENT, V127, P2933; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Bastians H, 1999, MOL BIOL CELL, V10, P3927, DOI 10.1091/mbc.10.11.3927; Belliveau M. J., 1999, DEVELOPMENT IN PRESS; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; BRADY G, 1993, METHOD ENZYMOL, V225, P611; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cayouette M, 2003, NEURON, V40, P897, DOI 10.1016/S0896-6273(03)00756-6; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chiang MK, 2003, DEV CELL, V4, P383, DOI 10.1016/S1534-5807(03)00035-2; Chowers I, 2003, INVEST OPHTH VIS SCI, V44, P3732, DOI 10.1167/iovs.02-1080; Decembrini S, 2006, PLOS BIOL, V4, P1562, DOI 10.1371/journal.pbio.0040272; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Ginsberg SD, 2005, J COMP NEUROL, V487, P107, DOI 10.1002/cne.20535; Gouge A, 2001, MECH DEVELOP, V107, P203, DOI 10.1016/S0925-4773(01)00465-8; HANNAN AJ, 1995, MOL CELL NEUROSCI, V6, P397, DOI 10.1006/mcne.1995.1030; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Humbert PO, 2000, GENE DEV, V14, P690; Hyatt GA, 1996, P NATL ACAD SCI USA, V93, P13298, DOI 10.1073/pnas.93.23.13298; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Irniger S, 2002, FEBS LETT, V532, P7, DOI 10.1016/S0014-5793(02)03657-8; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; Jaszai J, 2002, MECH DEVELOP, V113, P73, DOI 10.1016/S0925-4773(01)00655-4; Kalma Y, 2001, ONCOGENE, V20, P1379, DOI 10.1038/sj.onc.1204230; Kamme F, 2003, J NEUROSCI, V23, P3607; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; Kelley MW, 1999, NEUROREPORT, V10, P2389, DOI 10.1097/00001756-199908020-00031; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Levine EM, 2004, SEMIN CELL DEV BIOL, V15, P63, DOI 10.1016/j.semcdb.2003.09.001; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Martins RAP, 2006, EUR J NEUROSCI, V24, P969, DOI 10.1111/j.1460-9568.2006.04966.x; Masland RH, 2000, ANNU REV NEUROSCI, V23, P249, DOI 10.1146/annurev.neuro.23.1.249; Mathers PH, 2000, CELL MOL LIFE SCI, V57, P186, DOI 10.1007/PL00000683; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matter-Sadzinski L, 2005, DEVELOPMENT, V132, P3907, DOI 10.1242/dev.01960; Moore KB, 2002, NEURON, V34, P183, DOI 10.1016/S0896-6273(02)00666-9; Morrow EM, 1999, DEVELOPMENT, V126, P23; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nagaraj R, 2007, DEVELOPMENT, V134, P825, DOI 10.1242/dev.02788; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; OHSAWA R, 2007, BRAIN RES; Oshima A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034397; Otteson DC, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-15; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Porter FD, 1997, DEVELOPMENT, V124, P2935; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Rapaport DH, 2001, J NEUROBIOL, V49, P129, DOI 10.1002/neu.1070; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rodieck R.W., 1998, 1 STEPS SEEING; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Sano M, 2006, ONCOL REP, V16, P1093; Sen J, 2005, DEVELOPMENT, V132, P5147, DOI 10.1242/dev.02100; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sidman RL, 1961, STRUCTURE EYE, P487; Steele BK, 2002, ANAL BIOCHEM, V307, P341, DOI 10.1016/S0003-2697(02)00045-3; Stolt CC, 2005, DEV BIOL, V281, P309, DOI 10.1016/j.ydbio.2005.03.010; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Teng SC, 2006, J MOL HISTOL, V37, P293, DOI 10.1007/s10735-006-9032-y; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tseng SF, 2005, J BIOL CHEM, V280, P39594, DOI 10.1074/jbc.M508425200; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Valente T, 2001, MECH DEVELOP, V108, P207, DOI 10.1016/S0925-4773(01)00492-0; VANDERWEYDEN L, 2007, BIOCH BIOPHYS ACTA; VARDIMON L, 1986, P NATL ACAD SCI USA, V83, P9060, DOI 10.1073/pnas.83.23.9060; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; WALTHER C, 1991, DEVELOPMENT, V113, P1435; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Yu JD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r65; Zaki PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-46	129	132	132	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1588	10.1371/journal.pone.0001588	http://dx.doi.org/10.1371/journal.pone.0001588			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270576	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900022
J	Jones, RB; Garrison, KE; Wong, JC; Duan, EH; Nixon, DF; Ostrowski, MA				Jones, R. Brad; Garrison, Keith E.; Wong, Jessica C.; Duan, Erick H.; Nixon, Douglas F.; Ostrowski, Mario A.			Nucleoside Analogue Reverse Transcriptase Inhibitors Differentially Inhibit Human LINE-1 Retrotransposition	PLOS ONE			English	Article							MATERNAL-FETAL TRANSFER; AMNIOTIC-FLUID ACCUMULATION; L1 RETROTRANSPOSITION; ORF1 PROTEIN; CHAPERONE ACTIVITY; DYSTROPHIN GENE; INSERTION; SEQUENCE; ELEMENT; LAMIVUDINE	Background: Intact LINE-1 elements are the only retrotransposons encoded by the human genome known to be capable of autonomous replication. Numerous cases of genetic disease have been traced to gene disruptions caused by LINE-1 retrotransposition events in germ-line cells. In addition, genomic instability resulting from LINE-1 retrotransposition in somatic cells has been proposed as a contributing factor to oncogenesis and to cancer progression. LINE-1 element activity may also play a role in normal physiology. Methods and Principal Findings: Using an in vitro LINE-1 retrotransposition reporter assay, we evaluated the abilities of several antiretroviral compounds to inhibit LINE-1 retrotransposition. The nucleoside analogue reverse transcriptase inhibitors (nRTIs): stavudine, zidovudine, tenofovir disoproxil fumarate, and lamivudine all inhibited LINE-1 retrotransposition with varying degrees of potencies, while the non-nucleoside HIV-1 reverse transcriptase inhibitor nevirapine showed no effect. Conclusions/Significance: Our data demonstrates the ability for nRTIs to suppress LINE-1 retrotransposition. This is immediately applicable to studies aimed at examining potential roles for LINE-1 retrotransposition in physiological processes. In addition, our data raises novel safety considerations for nRTIs based on their potential to disrupt physiological processes involving LINE-1 retrotransposition.	[Jones, R. Brad; Wong, Jessica C.; Duan, Erick H.; Ostrowski, Mario A.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Garrison, Keith E.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA; [Ostrowski, Mario A.] St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Jones, RB (corresponding author), Univ Toronto, Dept Immunol, Med Sci Bldg, Toronto, ON, Canada.	brad.jones@utoronto.ca	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786	Canadian Institutes for Health Research (CIHR); UCSF AIDS Research Institute (ARI); Pfizer; Ontario HIV Treatment Network (OHTN) [studentship]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); UCSF AIDS Research Institute (ARI); Pfizer(Pfizer); Ontario HIV Treatment Network (OHTN)	This work was supported by funds from the Canadian Institutes for Health Research (CIHR), and funds from the UCSF AIDS Research Institute (ARI). M.A.O and D.F.N receive funding from Pfizer under a sponsored research agreement. M.A.O receives salary support from the Ontario HIV Treatment Network (OHTN) and the CIHR. R.B.J receives a studentship from the OHTN. Biosafety level 3 laboratory space and equipment was provided by the Canadian Foundation for HIV Research (CANFAR) in partnership with the Canadian Foundation for Innovation and the Ontario Innovation Trust. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: Stavudine, Nevirapine, Lamivudine, Tenofovir Disoproxil Fumarate, Integrase Inhibitor II8-D-24.	Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006; Basame S, 2006, J MOL BIOL, V357, P351, DOI 10.1016/j.jmb.2005.12.063; BAWDON RE, 1994, GYNECOL OBSTET INVES, V38, P1, DOI 10.1159/000292432; Bloom SL, 1997, AM J OBSTET GYNECOL, V176, P291, DOI 10.1016/S0002-9378(97)70487-3; *BRISTOLMYERSSQUIB, 2006, ZER STAV; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chappuy H, 2004, ANTIMICROB AGENTS CH, V48, P4332, DOI 10.1128/AAC.48.11.4332-4336.2004; Cherry CL, 2006, JAIDS-J ACQ IMM DEF, V42, P435, DOI 10.1097/01.qai.0000224974.67962.ce; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; DREW RH, 1989, ANTIMICROB AGENTS CH, V33, P1801, DOI 10.1128/AAC.33.10.1801; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; *GILEADSCIENCES, 2007, VIR; *GLAXOSMITHKLINE, 2001, RETR PRESCR INF; *GLAXOSMITHKLINE, 2001, EP PRESCR INF; HEIDMANN T, 1988, P NATL ACAD SCI USA, V85, P2219, DOI 10.1073/pnas.85.7.2219; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mandelbrot L, 2001, AM J OBSTET GYNECOL, V184, P153, DOI 10.1067/mob.2001.108344; Mangiacasale R, 2003, ONCOGENE, V22, P2750, DOI 10.1038/sj.onc.1206354; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Martin SL, 2000, J MOL BIOL, V304, P11, DOI 10.1006/jmbi.2000.4182; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Martin SL, 2003, P NATL ACAD SCI USA, V100, P13815, DOI 10.1073/pnas.2336221100; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; MIKI Y, 1992, CANCER RES, V52, P643; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Musova Z, 2006, BIOCHEM BIOPH RES CO, V347, P145, DOI 10.1016/j.bbrc.2006.06.071; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Patterson TA, 2000, TERATOLOGY, V62, P93, DOI 10.1002/1096-9926(200008)62:2<93::AID-TERA5>3.3.CO;2-D; PRESCOTT LM, 1995, J INT ASS PHYS AIDS, V1, P34; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; SMERDON SJ, 1994, P NATL ACAD SCI USA, V91, P3911, DOI 10.1073/pnas.91.9.3911; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Szak ST, 2002, GENOME BIOL, V3; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; XIE H, 1995, ANTIVIR RES, V28, P113, DOI 10.1016/0166-3542(95)00042-K	45	61	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1547	10.1371/journal.pone.0001547	http://dx.doi.org/10.1371/journal.pone.0001547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253495	gold, Green Published, Green Submitted			2022-12-27	WOS:000260535700019
J	Wang, HY; Frankfurt, M; Burns, LH				Wang, Hoau-Yan; Frankfurt, Maya; Burns, Lindsay H.			RETRACTED: High-Affinity Naloxone Binding to Filamin A Prevents Mu Opioid Receptor-Gs Coupling Underlying Opioid Tolerance and Dependence (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							LOW-DOSE NALTREXONE; G-BETA-GAMMA; SENSORY NEURONS; GM1 GANGLIOSIDE; MORPHINE; POTENCY; DELTA; ANALGESIA; ALPHA; MICE	Ultra-low-dose opioid antagonists enhance opioid analgesia and reduce analgesic tolerance and dependence by preventing a G protein coupling switch (Gi/o to Gs) by the mu opioid receptor (MOR), although the binding site of such ultra-low-dose opioid antagonists was previously unknown. Here we show that with approximately 200-fold higher affinity than for the mu opioid receptor, naloxone binds a pentapeptide segment of the scaffolding protein filamin A, known to interact with the mu opioid receptor, to disrupt its chronic opioid-induced Gs coupling. Naloxone binding to filamin A is demonstrated by the absence of [H-3]-and FITC-naloxone binding in the melanoma M2 cell line that does not contain filamin or MOR, contrasting with strong [H-3] naloxone binding to its filamin A-transfected subclone A7 or to immunopurified filamin A. Naloxone binding to A7 cells was displaced by naltrexone but not by morphine, indicating a target distinct from opioid receptors and perhaps unique to naloxone and its analogs. The intracellular location of this binding site was confirmed by FITC-NLX binding in intact A7 cells. Overlapping peptide fragments from c-terminal filamin A revealed filamin A(2561-2565) as the binding site, and an alanine scan of this pentapeptide revealed an essential mid-point lysine. Finally, in organotypic striatal slice cultures, peptide fragments containing filamin A(2561-2565) abolished the prevention by 10 pM naloxone of both the chronic morphine-induced mu opioid receptor-Gs coupling and the downstream cAMP excitatory signal. These results establish filamin A as the target for ultra-low-dose opioid antagonists previously shown to enhance opioid analgesia and to prevent opioid tolerance and dependence.	[Wang, Hoau-Yan; Frankfurt, Maya] CUNY, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA; [Burns, Lindsay H.] Pain Therapeutics, Inc, San Mateo, CA USA	City University of New York (CUNY) System	Wang, HY (corresponding author), CUNY, Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA.	hywang@sci.ccny.cuny.edu	Frankfurt, Maya/I-5812-2019	Frankfurt, Maya/0000-0003-3737-0497	Pain Therapeutics, Inc	Pain Therapeutics, Inc	This study was supported by Pain Therapeutics, Inc.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Chakrabarti S, 2005, MOL BRAIN RES, V135, P217, DOI 10.1016/j.molbrainres.2004.12.016; Crain SM, 2001, BRAIN RES, V888, P75, DOI 10.1016/S0006-8993(00)03010-9; CRAIN SM, 1992, J PHARMACOL EXP THER, V260, P182; Crain SM, 2000, PAIN, V84, P121, DOI 10.1016/S0304-3959(99)00223-7; CRAIN SM, 1995, P NATL ACAD SCI USA, V92, P10540, DOI 10.1073/pnas.92.23.10540; EMMERSON PJ, 1994, J PHARMACOL EXP THER, V271, P1630; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GHARAGOZLOU P, 2003, BMC PHARM, V3, P1471; Gintzler AR, 2000, MOL NEUROBIOL, V21, P21, DOI 10.1385/MN:21:1-2:021; Jin LQ, 2001, J NEUROCHEM, V78, P981, DOI 10.1046/j.1471-4159.2001.00470.x; LAUGWITZ KL, 1993, NEURON, V10, P233, DOI 10.1016/0896-6273(93)90314-H; Leri F, 2005, PHARMACOL BIOCHEM BE, V82, P252, DOI 10.1016/j.pbb.2005.08.008; Lewanowitsch T, 2003, BRAIN RES, V964, P302, DOI 10.1016/S0006-8993(02)04117-3; Olmstead MC, 2005, PSYCHOPHARMACOLOGY, V181, P576, DOI 10.1007/s00213-005-0022-7; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Powell KJ, 2002, J PHARMACOL EXP THER, V300, P588, DOI 10.1124/jpet.300.2.588; SHEN KF, 1990, BRAIN RES, V531, P1, DOI 10.1016/0006-8993(90)90751-V; Shen KF, 2001, BRAIN RES, V919, P20, DOI 10.1016/S0006-8993(01)02990-0; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2007, BRIT J PHARMACOL, V151, P1324, DOI 10.1038/sj.bjp.0707328; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Wang HY, 2006, J NEUROBIOL, V66, P1302, DOI 10.1002/neu.20286; Wang HY, 2005, NEUROSCIENCE, V135, P247, DOI 10.1016/j.neuroscience.2005.06.003; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914	27	48	53	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1554	10.1371/journal.pone.0001554	http://dx.doi.org/10.1371/journal.pone.0001554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253501	Green Published, gold			2022-12-27	WOS:000260535700025
J	Della Bella, S; Taddeo, A; Calabro, ML; Brambilla, L; Bellinvia, M; Bergamo, E; Clerici, M; Villa, ML				Della Bella, Silvia; Taddeo, Adriano; Calabro, Maria L.; Brambilla, Lucia; Bellinvia, Monica; Bergamo, Elisa; Clerici, Mario; Villa, Maria L.			Peripheral Blood Endothelial Progenitors as Potential Reservoirs of Kaposi's Sarcoma-Associated Herpesvirus	PLOS ONE			English	Article								The cellular reservoirs of Kaposi's sarcoma-associated herpesvirus (KSHV) and the exact nature of the putative KSHV-infected circulating precursor of spindle cells of Kaposi's sarcoma (KS) still remain poorly defined. Because KS spindle cells are thought to be of endothelial origin, and because mature endothelial cells do not sustain persistent KSHV-infection, our attention was focalized on circulating hematopoietic precursors able to differentiate into endothelial lineage. Methods and Findings. Late endothelial progenitor cells (late-EPCs) were cultured from the peripheral blood mononuclear cells of 16 patients with classic KS. The presence and load of KSHV genomes were analyzed by real-time polymerase chain reaction in DNA extracted from cells and supernatants of late-EPC cultures obtained from 7 patients. Endothelial colonies cultured from the peripheral blood of KS patients were found to satisfy all requisites to be defined late-EPCs: they appeared from the CD14-negative fraction of adherent cells after 11-26 days of culture, could be serially expanded in vitro, expressed high levels of endothelial antigens but lacked leukocyte markers. Late-EPC cultures were found to harbor KSHV-DNA at variable levels and to retain the virus after multiple passages in cells as well as in supernatants, suggesting that a quote of KSHV lytic infection may spontaneously occur. Lytic phase induction or hypoxia could amplify virus release in supernatants. Conclusion. Our results suggest that circulating endothelial progenitors from KS patients are KSHV-infected and support viral productive replication and may therefore represent potential virus reservoirs and putative precursors of KS spindle cells.	[Della Bella, Silvia; Taddeo, Adriano; Clerici, Mario; Villa, Maria L.] Univ Milan, Dipartimento Sci & Tecnol Biomed, Immunol Lab, Milan, Italy; [Calabro, Maria L.; Bergamo, Elisa] IRCCS, Ist Oncol Veneto, UOC Immunol & Diagnostic Mol Oncol, Padua, Italy; [Brambilla, Lucia; Bellinvia, Monica] IRCCS Ospedale Maggiore, Dept Dermatol, Milan, Italy; [Clerici, Mario] IRCCS Fdn Don Gnocchi, Ctr Santa Maria Nascente, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; IRCCS Istituto Oncologico Veneto (IOV); IRCCS Fondazione Don Carlo Gnocchi Onlus	Della Bella, S (corresponding author), Univ Milan, Dipartimento Sci & Tecnol Biomed, Immunol Lab, Milan, Italy.	silvia.dellabella@unimi.it	Taddeo, Adriano/AAW-3861-2021; Bella, Silvia Della/AAB-7904-2019; Calabrò, Maria Luisa/H-6015-2016	Taddeo, Adriano/0000-0003-3281-1548; Calabrò, Maria Luisa/0000-0001-9401-6182; Della Bella, Silvia/0000-0003-0818-5049; Clerici, Mario/0000-0001-5920-6191	Ministero dell Istruzione, dell Universita e della Ricerca [2003069391-001, 2006065944-002]; Fondazione Cariplo (Milan, Italy) [1055/104878-2005]; Istituto Superiore di Sanita [50G.3]; AIRC	Ministero dell Istruzione, dell Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo (Milan, Italy)(Fondazione Cariplo); Istituto Superiore di Sanita; AIRC(Fondazione AIRC per la ricerca sul cancro)	Supported by grants 2003069391-001 and 2006065944-002 from Ministero dell Istruzione, dell Universita e della Ricerca (MLV and SDB); by grant 1055/104878-2005 from Fondazione Cariplo (Milan, Italy) (MLV); by grant 50G.3 from Istituto Superiore di Sanita (MLC) and by funds from AIRC (MLC).	Aluigi MG, 1996, RES VIROLOGY, V147, P267, DOI 10.1016/0923-2516(96)82285-0; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Brambilla L, 2003, EUR J DERMATOL, V13, P83; Brambilla L, 2006, J DERMATOL, V33, P451, DOI 10.1111/j.1346-8138.2006.00108.x; Calabro ML, 2001, J NATL CANCER I, V93, P154, DOI 10.1093/jnci/93.2.154; Davis DA, 2001, BLOOD, V97, P3244, DOI 10.1182/blood.V97.10.3244; Della Bella S, 2004, BLOOD, V104, P4020, DOI 10.1182/blood-2004-03-0885; Della Bella S, 2001, CLIN EXP RHEUMATOL, V19, P647; Della Bella S, 2006, CLIN IMMUNOL, V119, P317, DOI 10.1016/j.clim.2006.01.011; Duprez R, 2007, JNCI-J NATL CANCER I, V99, P1086, DOI 10.1093/jnci/djm045; Flamand L, 1996, J ACQ IMMUN DEF SYND, V13, P194, DOI 10.1097/00042560-199610010-00011; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; Gasperini P, 2005, J CLIN MICROBIOL, V43, P2866, DOI 10.1128/JCM.43.6.2866-2875.2005; Gill PS, 2007, J NATL CANCER I, V99, P1063, DOI 10.1093/jnci/djm063; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21; Henry M, 1999, J INVEST DERMATOL, V113, P613, DOI 10.1046/j.1523-1747.1999.00733.x; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Lebbe C, 1997, ARCH DERMATOL RES, V289, P421, DOI 10.1007/s004030050215; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; Monini P, 1999, BLOOD, V93, P4044; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Pellet C, 2006, J INVEST DERMATOL, V126, P621, DOI 10.1038/sj.jid.5700083; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; TADDEO A, 2008, J INVEST DE IN PRESS; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Webster-Cyriaque J, 2002, NEW ENGL J MED, V346, P1207, DOI 10.1056/NEJMoa012125; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	35	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1520	10.1371/journal.pone.0001520	http://dx.doi.org/10.1371/journal.pone.0001520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231605	Green Submitted, Green Published, gold			2022-12-27	WOS:000260504200032
J	Stewart, L; Overath, T; Warren, JD; Foxton, JM; Griffiths, TD				Stewart, Lauren; Overath, Tobias; Warren, Jason D.; Foxton, Jessica M.; Griffiths, Timothy D.			fMRI Evidence for a Cortical Hierarchy of Pitch Pattern Processing	PLOS ONE			English	Article								Pitch patterns, such as melodies, consist of two levels of structure: a global level, comprising the pattern of ups and downs, or contour; and a local level, comprising the precise intervals that make up this contour. An influential neuropsychological model suggests that these two levels of processing are hierarchically linked, with processing of the global structure occurring within the right hemisphere in advance of local processing within the left. However, the predictions of this model and its anatomical basis have not been tested in neurologically normal individuals. The present study used fMRI and required participants to listen to consecutive pitch sequences while performing a same/different one-back task. Sequences, when different, either preserved (local) or violated (global) the contour of the sequence preceding them. When the activations for the local and global conditions were contrasted directly, additional activation was seen for local processing in right planum temporale and posterior superior temporal sulcus (pSTS). The presence of additional activation for local over global processing supports the hierarchical view that the global structure of a pitch sequence acts as a "framework'' on which the local detail is subsequently hung. However, the lateralisation of activation seen in the present study, with global processing occurring in left pSTS and local processing occurring bilaterally, differed from that predicted by the neuroanatomical model. A re-examination of the individual lesion data on which the neuroanatomical model is based revealed that the lesion data equally well support the laterality scheme suggested by our data. While the present study supports the hierarchical view of local and global processing, there is an evident need for further research, both in patients and neurologically normal individuals, before an understanding of the functional lateralisation of local and global processing can be considered established.	[Stewart, Lauren] Univ London, Dept Psychol, London, England; [Overath, Tobias; Griffiths, Timothy D.] Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Overath, Tobias; Griffiths, Timothy D.] Newcastle Univ, Med Sch, Auditory Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Warren, Jason D.] Inst Neurol, Dementia Res Ctr, London, England; [Foxton, Jessica M.] Ctr Hosp Le Vinatier, INSERM, Unit 280, Lyon, France	University of London; University of London; University College London; Newcastle University - UK; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm)	Stewart, L (corresponding author), Univ London, Dept Psychol, London, England.	l.stewart@gold.ac.uk; t.overath@fil.ion.ucl.ac.uk	Stewart, Lauren/HHC-2911-2022	stewart, lauren/0000-0002-6221-6064; Warren, Jason/0000-0002-5405-0826; Griffiths, Timothy/0000-0001-8066-4381	Wellcome Trust (UK) [Intermediate Clinical Fellowship]; Research Councils UK (RCUK) [academic fellowship]; German Academic Exchange Service; Engineering and Physical Sciences Research Council [EP/E500161/1] Funding Source: researchfish	Wellcome Trust (UK)(Wellcome Trust); Research Councils UK (RCUK)(UK Research & Innovation (UKRI)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is supported by the Wellcome Trust (UK). LS is supported by an academic fellowship awarded by Research Councils UK (RCUK). TO is supported by the German Academic Exchange Service. JDW is supported by a Wellcome Trust Intermediate Clinical Fellowship.	BARTLETT JC, 1980, J EXP PSYCHOL HUMAN, V6, P501, DOI 10.1037/0096-1523.6.3.501; CUDDY LL, 1976, Q J EXP PSYCHOL, V28, P255, DOI 10.1080/14640747608400555; DOWLING WJ, 1987, PERCEPT PSYCHOPHYS, V41, P642, DOI 10.3758/BF03210496; DOWLING WJ, 1978, PSYCHOL REV, V85, P341, DOI 10.1037/0033-295X.85.4.341; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Foxton JM, 2003, NAT NEUROSCI, V6, P343, DOI 10.1038/nn1035; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Justus T, 2005, COGNITION, V98, P31, DOI 10.1016/j.cognition.2004.11.001; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; List A, 2007, BRAIN RES, V1153, P122, DOI 10.1016/j.brainres.2007.03.040; PATEL AD, TRENDS COGN IN PRESS; PERETZ I, 1990, BRAIN, V113, P1185, DOI 10.1093/brain/113.4.1185; Sanders LD, 2007, NEUROPSYCHOLOGIA, V45, P1172, DOI 10.1016/j.neuropsychologia.2006.10.010; Schiavetto A, 1999, NEUROREPORT, V10, P2467, DOI 10.1097/00001756-199908200-00006; Schuppert M, 2000, BRAIN, V123, P546, DOI 10.1093/brain/123.3.546; Trainor LJ, 2002, J COGNITIVE NEUROSCI, V14, P430, DOI 10.1162/089892902317361949; Trainor LJ, 1999, AUST J PSYCHOL, V51, P147, DOI 10.1080/00049539908255352; TREHUB SE, 1993, INFANT BEHAV DEV, V16, P193, DOI 10.1016/0163-6383(93)80017-3	21	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1470	10.1371/journal.pone.0001470	http://dx.doi.org/10.1371/journal.pone.0001470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231575	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000260504200001
J	Allen, DJ; Gray, JJ; Gallimore, CI; Xerry, J; Iturriza-Gomara, M				Allen, David J.; Gray, Jim J.; Gallimore, Chris I.; Xerry, Jacqueline; Iturriza-Gomara, Miren			Analysis of Amino Acid Variation in the P2 Domain of the GII-4 Norovirus VP1 Protein Reveals Putative Variant-Specific Epitopes	PLOS ONE			English	Article							EPOCHAL EVOLUTION; HUMAN CALICIVIRUS; CAPSID PROTEIN; GASTROENTERITIS; OUTBREAKS; ENGLAND; RECOMBINATION; SURVEILLANCE; MUTATIONS; DIVERSITY	Background. Human noroviruses are a highly diverse group of viruses classified into three of the five currently recognised Norovirus genogroups, and contain numerous genotypes or genetic clusters. Noroviruses are the major aetiological agent of endemic gastroenteritis in all age groups, as well as the cause of periodic epidemic gastroenteritis. The noroviruses most commonly associated with outbreaks of gastroenteritis are genogroup II genotype 4 (GII-4) strains. The relationship between genotypes of noroviruses with their phenotypes and antigenic profile remains poorly understood through an inability to culture these viruses and the lack of a suitable animal model. Methodology/ Principal Findings. Here we describe a study of the diversity of amino acid sequences of the highly variable P2 region in the major capsid protein, VP1, of the GII-4 human noroviruses strains using sequence analysis and homology modelling techniques. Conclusions/Significance. Our data identifies two sites in this region, which show significant amino acid substitutions associated with the appearance of variant strains responsible for epidemics with major public health impact. Homology modelling studies revealed the exposed nature of these sites on the capsid surface, providing supportive structural data that these two sites are likely to be associated with putative variant-specific epitopes. Furthermore, the patterns in the evolution of these viruses at these sites suggests that noroviruses follow a neutral network pattern of evolution.	[Allen, David J.; Gray, Jim J.; Gallimore, Chris I.; Xerry, Jacqueline; Iturriza-Gomara, Miren] Hlth Protect Agcy, Ctr Infect, Virus Reference Dept, Enter Virus Unit, London, England; [Allen, David J.] London Sch Hyg & Tropical Med, Dept Infect & Tropical Dis, London, England	Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine	Allen, DJ (corresponding author), Hlth Protect Agcy, Ctr Infect, Virus Reference Dept, Enter Virus Unit, London, England.	david.james.allen@hpa.org.uk	Gomara, Miren Iturriza/B-4351-2013	Gomara, Miren Iturriza/0000-0001-5816-6423; Allen, David/0000-0002-1194-0415	European Commission, DG Research Quality of Life Program [SP22-CT-2004-502571]	European Commission, DG Research Quality of Life Program(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission, DG Research Quality of Life Program, under the 6th Framework (EVENT; SP22-CT-2004-502571).	Ambert-Balay K, 2005, J CLIN MICROBIOL, V43, P5179, DOI 10.1128/JCM.43.10.5179-5186.2005; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Green K, 2007, FIELDS VIROLOGY, P949; GUNSON RN, 2007, J CLIN MICROBIOL; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardy ME, 1997, ARCH VIROL, V142, P1469, DOI 10.1007/s007050050173; Jiang X, 1999, ARCH VIROL, V144, P2377, DOI 10.1007/s007050050651; Katayama K, 2002, VIROLOGY, V299, P225, DOI 10.1006/viro.2002.1568; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; LAU KF, 1990, P NATL ACAD SCI USA, V87, P638, DOI 10.1073/pnas.87.2.638; Lochridge VP, 2005, J GEN VIROL, V86, P2799, DOI 10.1099/vir.0.81134-0; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Lopman BA, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-13; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Noel JS, 1997, J MED VIROL, V53, P372, DOI 10.1002/(SICI)1096-9071(199712)53:4&lt;372::AID-JMV10&gt;3.0.CO;2-H; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Rohayem J, 2005, J VIROL, V79, P4977, DOI 10.1128/JVI.79.8.4977-4990.2005; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Tan M, 2005, J VIROL, V79, P14017, DOI 10.1128/JVI.79.22.14017-14030.2005; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Vinje J, 2000, ARCH VIROL, V145, P223, DOI 10.1007/s007050050020	29	108	114	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1485	10.1371/journal.pone.0001485	http://dx.doi.org/10.1371/journal.pone.0001485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213393	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000260503900030
J	Jovanic, T; Roche, B; Attal-Bonnefoy, G; Leclercq, O; Rougeon, F				Jovanic, Tihana; Roche, Benjamin; Attal-Bonnefoy, Geraldine; Leclercq, Olivier; Rougeon, Francois			Ectopic Expression of AID in a Non-B Cell Line Triggers A:T and G:C Point Mutations in Non-Replicating Episomal Vectors	PLOS ONE			English	Article								Somatic hypermutation (SHM) of immunoglobulin genes is currently viewed as a two step process initiated by the deamination of deoxycytidine (C) to deoxyuridine (U), catalysed by the activation induced deaminase (AID). Phase 1 mutations arise from DNA replication across the uracil residue or the abasic site, generated by the uracil-DNA glycosylase, yielding transitions or transversions at G:C pairs. Phase 2 mutations result from the recognition of the U:G mismatch by the Msh2/Msh6 complex (MutS Homologue), followed by the excision of the mismatched nucleotide and the repair, by the low fidelity DNA polymerase g, of the gap generated by the exonuclease I. These mutations are mainly focused at A:T pairs. Whereas in activated B cells both G:C and A:T pairs are equally targeted, ectopic expression of AID was shown to trigger only G:C mutations on a stably integrated reporter gene. Here we show that when using non-replicative episomal vectors containing a GFP gene, inactivated by the introduction of stop codons at various positions, a high level of EGFP positive cells was obtained after transient expression in Jurkat cells constitutively expressing AID. We show that mutations at G:C and A:T pairs are produced. EGFP positive cells are obtained in the absence of vector replication demonstrating that the mutations are dependent only on the mismatch repair (MMR) pathway. This implies that the generation of phase 1 mutations is not a prerequisite for the expression of phase 2 mutations.	[Jovanic, Tihana; Roche, Benjamin; Attal-Bonnefoy, Geraldine; Leclercq, Olivier; Rougeon, Francois] Inst Pasteur, CNRS, Dept Immunol, Unite Genet & Biochim Dev,URA 2581, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rougeon, F (corresponding author), Inst Pasteur, CNRS, Dept Immunol, Unite Genet & Biochim Dev,URA 2581, Paris, France.	frougeon@pasteur.fr		Roche, Benjamin/0000-0003-3912-6340; Leclercq, Olivier/0000-0003-1333-0044	Fondation de France; ARC (Association pour la Recherche sur le Cancer)	Fondation de France(Fondation de France); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from Fondation de France and ARC (Association pour la Recherche sur le Cancer).	Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Bachl J, 1999, EUR J IMMUNOL, V29, P1383, DOI 10.1002/(SICI)1521-4141(199904)29:04<1383::AID-IMMU1383>3.3.CO;2-O; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Casali P, 2006, TRENDS IMMUNOL, V27, P313, DOI 10.1016/j.it.2006.05.001; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; MacPhee DG, 1996, GENETICA, V97, P183, DOI 10.1007/BF00054625; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Martomo SA, 2006, CURR OPIN IMMUNOL, V18, P243, DOI 10.1016/j.coi.2006.03.007; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2007, J EXP MED, V204, P7, DOI 10.1084/jem.20062409; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Wright BE, 2004, GENES IMMUN, V5, P176, DOI 10.1038/sj.gene.6364053; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x; Wright BE, 2002, CANCER RES, V62, P5641; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1480	10.1371/journal.pone.0001480	http://dx.doi.org/10.1371/journal.pone.0001480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213388	gold, Green Submitted, Green Published			2022-12-27	WOS:000260503900025
J	Yang, J; Wang, ZL; Zhao, XQ; Wang, DP; Qi, DL; Xu, BH; Ren, YH; Tian, HF				Yang, Jie; Wang, Zhen Long; Zhao, Xin Quan; Wang, De Peng; Qi, De Lin; Xu, Bao Hong; Ren, Yong Hong; Tian, Hui Fang			Natural Selection and Adaptive Evolution of Leptin in the Ochotona Family Driven by the Cold Environmental Stress	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; AMINO-ACID SITES; TISSUE IN-VITRO; BODY-WEIGHT; GENE-EXPRESSION; PLASMA LEPTIN; FOOD-INTAKE; GLUCOSE-METABOLISM; OBESE GENE; OB/OB MICE	Background. Environmental stress can accelerate the evolutionary rate of specific stress-response proteins and create new functions specialized for different environments, enhancing an organism's fitness to stressful environments. Pikas (order Lagomorpha), endemic, non-hibernating mammals in the modern Holarctic Region, live in cold regions at either high altitudes or high latitudes and have a maximum distribution of species diversification confined to the Qinghai-Tibet Plateau. Variations in energy metabolism are remarkable for them living in cold environments. Leptin, an adipocyte-derived hormone, plays important roles in energy homeostasis. Methodology/Principal Findings. To examine the extent of leptin variations within the Ochotona family, we cloned the entire coding sequence of pika leptin from 6 species in two regions (Qinghai-Tibet Plateau and Inner Mongolia steppe in China) and the leptin sequences of plateau pikas (O. curzonia) from different altitudes on Qinghai-Tibet Plateau. We carried out both DNA and amino acid sequence analyses in molecular evolution and compared modeled spatial structures. Our results show that positive selection (PS) acts on pika leptin, while nine PS sites located within the functionally significant segment 85-119 of leptin and one unique motif appeared only in pika lineages-the ATP synthase a and b subunit signature site. To reveal the environmental factors affecting sequence evolution of pika leptin, relative rate test was performed in pikas from different altitudes. Stepwise multiple regression shows that temperature is significantly and negatively correlated with the rates of non-synonymous substitution (Ka) and amino acid substitution (Aa), whereas altitude does not significantly affect synonymous substitution (Ks), Ka and Aa. Conclusions/Significance. Our findings support the viewpoint that adaptive evolution may occur in pika leptin, which may play important roles in pikas' ecological adaptation to extreme environmental stress. We speculate that cold, and probably not hypoxia, may be the primary environmental factor for driving adaptive evolution of pika leptin.	[Yang, Jie; Wang, Zhen Long; Zhao, Xin Quan; Wang, De Peng; Qi, De Lin] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Qinghai Tibetan Plateau Biol Evolut & Ada, Xining, Qinghai, Peoples R China; [Yang, Jie; Wang, Zhen Long; Wang, De Peng; Qi, De Lin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; Qufu Normal Univ, Coll Life Sci, Shandong, Peoples R China; [Xu, Bao Hong; Ren, Yong Hong; Tian, Hui Fang] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qufu Normal University	Zhao, XQ (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Qinghai Tibetan Plateau Biol Evolut & Ada, Xining, Qinghai, Peoples R China.	xqzhao@nwipb.ac.cn			National Natural Science Foundation of China [30700073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30700073).	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Baldi P, 2004, J MACH LEARN RES, V4, P575, DOI 10.1162/153244304773936054; BRADFORD BL, 2000, NATURE, V404, P652; Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Casabiell X, 1998, J CLIN ENDOCR METAB, V83, P2149, DOI 10.1210/jc.83.6.2149; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; CORBET GB, 1978, MAMMALS PALAEARCTIC, P67; Cusin I, 1998, DIABETES, V47, P1014, DOI 10.2337/diabetes.47.7.1014; Dawson M.R., 1967, ESSAYS PALEONTOLOGY, V2, P287; DEVOS P, 1995, J BIOL CHEM, V270, P15958, DOI 10.1074/jbc.270.27.15958; DONG G, 1995, CHINA SOC QINGHAI TI, P13; DU J, 1984, Acta Zoologica Fennica, V171, P201; Du J., 1982, Acta Theriologica Sinica, V2, P35; FANG X, 1995, CHINA SOC QINGHAI TI, P41; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; FENG ZJ, 1985, ACTA THERIO SINICA, V20, P269; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grasso P, 1997, ENDOCRINOLOGY, V138, P1413, DOI 10.1210/en.138.4.1413; Grasso P, 1999, REGUL PEPTIDES, V85, P93, DOI 10.1016/S0167-0115(99)00082-8; Grasso P, 1999, DIABETES, V48, P2204, DOI 10.2337/diabetes.48.11.2204; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; Grosfeld A, 2002, J BIOL CHEM, V277, P42953, DOI 10.1074/jbc.M206775200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall E. R., 1981, MAMMALS N AM; Havel PJ, 1996, J CLIN ENDOCR METAB, V81, P4406, DOI 10.1210/jc.81.12.4406; Hoffman Robert S., 1993, P807; HUNTLEY B, 1989, J BIOGEOGR, V16, P5, DOI 10.2307/2845307; Imagawa K, 1998, J BIOL CHEM, V273, P35245, DOI 10.1074/jbc.273.52.35245; Iserentant H, 2005, J CELL SCI, V118, P2519, DOI 10.1242/jcs.02386; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kimura M., 1983, NEUTRAL THEORY MOL E, P367, DOI [10.1017/CBO9780511623486, DOI 10.1139/cjz-2013-0127]; Li QF, 2001, COMP BIOCHEM PHYS A, V129, P949, DOI 10.1016/S1095-6433(01)00357-9; Li XS, 2005, HORM BEHAV, V48, P321, DOI 10.1016/j.yhbeh.2005.04.004; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mantzoros CS, 1996, DIABETES, V45, P909, DOI 10.2337/diabetes.45.7.909; Masuzaki H, 1997, J CLIN ENDOCR METAB, V82, P2542, DOI 10.1210/jc.82.8.2542; MEAD JI, 1987, BOREAS, V16, P165; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Peacock AJ, 1998, BRIT MED J, V317, P1063; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Peino R, 2000, EUR J ENDOCRINOL, V142, P195, DOI 10.1530/eje.0.1420195; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pineiro V, 1999, J ENDOCRINOL, V160, P425, DOI 10.1677/joe.0.1600425; Pineiro V, 1998, BIOCHEM BIOPH RES CO, V252, P345, DOI 10.1006/bbrc.1998.9649; POLLASTRI G, 2002, BIOINFORMATICS S1, V18, P62; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PUGH LGCE, 1957, J PHYSIOL-LONDON, V135, P590, DOI 10.1113/jphysiol.1957.sp005733; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; SMITH A E, 1990, P14; Smith AT, 1999, ANIM CONSERV, V2, P235, DOI 10.1111/j.1469-1795.1999.tb00069.x; STOREY KB, 1999, ENV STRESS GENE REGU, P1; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; TRAYHUM P, 1986, BROWN ADIPOSE TISSUE, P214; TRAYHURN P, 1995, BIOCHEM J, V311, P729, DOI 10.1042/bj3110729; Wang JM, 2006, OECOLOGIA, V149, P373, DOI 10.1007/s00442-006-0469-1; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Wright BE, 1997, FEBS LETT, V402, P4, DOI 10.1016/S0014-5793(96)01479-2; Yang J, 2006, BIOCHEM BIOPH RES CO, V345, P1405, DOI 10.1016/j.bbrc.2006.05.052; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu N, 2000, MOL PHYLOGENET EVOL, V16, P85, DOI 10.1006/mpev.2000.0776; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	83	54	67	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1472	10.1371/journal.pone.0001472	http://dx.doi.org/10.1371/journal.pone.0001472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213380	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503900017
J	Banda, AC; Makombe, SD; Jahn, A; Tweya, H; Chuka, S; Yu, JKL; Hedt, B; Weigel, R; Nkhata, A; Schouten, EJ; Kamoto, K; Harries, AD				Banda, Alfred C.; Makombe, Simon D.; Jahn, Andreas; Tweya, Hannock; Chuka, Stuart; Yu, Joseph Kwong-Leung; Hedt, Bethany; Weigel, Ralf; Nkhata, Amon; Schouten, Erik J.; Kamoto, Kelita; Harries, Anthony D.			Antiretroviral Therapy in the Malawi Defence Force: Access, Treatment Outcomes and Impact on Mortality	PLOS ONE			English	Article								Background. HIV/AIDS affects all sectors of the population and the defence forces are not exempt. A national survey was conducted in all public and private sectors in Malawi that provide antiretroviral therapy (ART) to determine the uptake of ART by army personnel, their outcomes while on treatment, and the impact of ART on mortality in the Malawi Defence Force. Methodology/Principal Findings. A retrospective cohort analysis was carried out, collecting data on access and retention on treatment from all 103 public and 38 private sector ART clinics in Malawi, using standardised patient master cards and clinic registers. Observations were censored on December 31(st) 2006. Independent data on mortality trends in army personnel from all causes between 2002 and 2006 were available from army records. By December 31st 2006, there were 85,168 patients ever started on ART in both public and private sectors, of whom 547 (0.7%) were army personnel. Of these, 22% started ART in WHO clinical stage 1 or 2 with a CD4-lymphocyte count of <= 250/mm(3) and 78% started in stage 3 or 4. Treatment outcomes of army personnel by December 31st 2006 were: 2365 (67%) alive and on ART at their registration facility, 98 (18%) transferred out to another facility, 71 (13%) dead, 9 (2%) lost to follow-up, and 4 (< 1%) stopped treatment. The probability of being alive on ART at 6-, 12- and 18-months was 89.8%, 83.4% and 78.8% respectively. All-cause mortality in army personnel declined dramatically over the five year period from 2002-2006. Conclusion/Significance. There has been a good access of army personnel to ART during the last five years with excellent outcomes, and this should serve as an example for other defence forces and large companies in the region.	[Banda, Alfred C.] Malawi Def Force, Med Dept, Lilongwe, Malawi; [Jahn, Andreas; Tweya, Hannock; Weigel, Ralf] Lighthouse Trust, Lilongwe, Malawi; [Jahn, Andreas] Int Train & Educ Ctr HIV, Seattle, WA USA; [Chuka, Stuart] Malawi Bus Coal Against AIDS, Blantyre, Malawi; [Yu, Joseph Kwong-Leung] Mzuzu Ctr Hosp, Taiwan Med Mission, Mzuzu, Malawi; [Hedt, Bethany] Harvard Sch Pub Hlth, Boston, MA USA; [Schouten, Erik J.] Manage Sci Hlth, Lilongwe, Malawi; Fam Hlth Int, Malawi Country Off, Lilongwe, Malawi; London Sch Hyg & Trop Med, London, England; [Makombe, Simon D.; Nkhata, Amon; Schouten, Erik J.; Kamoto, Kelita] Minist Hlth, HIV Unit, Lilongwe, Malawi	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Harries, AD (corresponding author), Minist Hlth, HIV Unit, Lilongwe, Malawi.	adharries@malawi.net	Jahn, Andreas/ABB-7796-2020; Weigel, Ralf/ABD-2310-2020	Jahn, Andreas/0000-0003-4645-1600; Weigel, Ralf/0000-0001-9034-2634				Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Libamba E, 2006, B WORLD HEALTH ORGAN, V84, P320; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Makombe SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000620; *MIN HLTH MAL, 2006, TREATM AIDS GUID US; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; World Health Organization, 2006, ANT THER HIV INF AD	7	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1445	10.1371/journal.pone.0001445	http://dx.doi.org/10.1371/journal.pone.0001445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197255	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503800016
J	Bennett, CB; Westmoreland, TJ; Verrier, CS; Blanchette, CAB; Sabin, TL; Phatnani, HP; Mishina, YV; Huper, G; Selim, AL; Madison, ER; Bailey, DD; Falae, AI; Galli, A; Olson, JA; Greenleaf, AL; Marks, JR				Bennett, Craig B.; Westmoreland, Tammy J.; Verrier, Carmel S.; Blanchette, Carrie A. B.; Sabin, Tiffany L.; Phatnani, Hemali P.; Mishina, Yuliya V.; Huper, Gudrun; Selim, Alice L.; Madison, Ernest R.; Bailey, Dominique D.; Falae, Adebola I.; Galli, Alvaro; Olson, John A., Jr.; Greenleaf, Arno L.; Marks, Jeffrey R.			Yeast Screens Identify the RNA Polymerase II CTD and SPT5 as Relevant Targets of BRCA1 Interaction	PLOS ONE			English	Article								BRCA1 has been implicated in numerous DNA repair pathways that maintain genome integrity, however the function responsible for its tumor suppressor activity in breast cancer remains obscure. To identify the most highly conserved of the many BRCA1 functions, we screened the evolutionarily distant eukaryote Saccharomyces cerevisiae for mutants that suppressed the G1 checkpoint arrest and lethality induced following heterologous BRCA1 expression. A genome-wide screen in the diploid deletion collection combined with a screen of ionizing radiation sensitive gene deletions identified mutants that permit growth in the presence of BRCA1. These genes delineate a metabolic mRNA pathway that temporally links transcription elongation (SPT4, SPT5, CTK1, DEF1) to nucleopore-mediated mRNA export (ASM4, MLP1, MLP2, NUP2, NUP53, NUP120, NUP133, NUP170, NUP188, POM34) and cytoplasmic mRNA decay at P-bodies (CCR4, DHH1). Strikingly, BRCA1 interacted with the p hosphorylated RNA polymerase II (RNAPII) c arboxy terminal domain (P-CTD), phosphorylated in the pattern specified by the CTDK-I kinase, to induce DEF1-dependent cleavage and accumulation of a RNAPII fragment containing the P-CTD. Significantly, breast cancer associated BRCT domain defects in BRCA1 that suppressed P-CTD cleavage and lethality in yeast also suppressed the physical interaction of BRCA1 with human SPT5 in breast epithelial cells, thus confirming SPT5 as a relevant target of BRCA1 interaction. Furthermore, enhanced P-CTD cleavage was observed in both yeast and human breast cells following UV-irradiation indicating a conserved eukaryotic damage response. Moreover, P-CTD cleavage in breast epithelial cells was BRCA1-dependent since damage-induced P-CTD cleavage was only observed in the mutant BRCA1 cell line HCC1937 following ectopic expression of wild type BRCA1. Finally, BRCA1, SPT5 and hyperphosphorylated RPB1 form a complex that was rapidly degraded following MMS treatment in wild type but not BRCA1 mutant breast cells. These results extend the mechanistic links between BRCA1 and transcriptional consequences in response to DNA damage and suggest an important role for RNAPII P-CTD cleavage in BRCA1-mediated cancer suppression.	[Verrier, Carmel S.] Duke Univ, Med Ctr, Dept Med, Durham, NC USA; [Sabin, Tiffany L.; Phatnani, Hemali P.; Mishina, Yuliya V.; Greenleaf, Arno L.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC USA; [Galli, Alvaro] CNR, Inst Clin Physiol, Gene & Mol Therapy Lab, CNR Res Area Moruzzi, Pisa, Italy; [Westmoreland, Tammy J.; Blanchette, Carrie A. B.; Huper, Gudrun; Selim, Alice L.; Madison, Ernest R.; Bailey, Dominique D.; Falae, Adebola I.; Olson, John A., Jr.; Marks, Jeffrey R.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Duke University	Bennett, CB (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	benne048@mc.duke.edu	Galli, Alvaro/AAL-7247-2020; Galli, Alvaro/K-3146-2018	Galli, Alvaro/0000-0002-9091-5639	CDMRP DOD Breast Cancer Initiative [DAMD17-03-1-0232]; Italian Association for Research on Cancer; NIH [CA84955]; NATIONAL CANCER INSTITUTE [U01CA084955] Funding Source: NIH RePORTER	CDMRP DOD Breast Cancer Initiative; Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a CDMRP DOD Breast Cancer Initiative grant DAMD17-03-1-0232 to CBB, a regional grant of the Italian Association for Research on Cancer to AG and a NIH grant CA84955 to JRM.	Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Aiyar S, 2005, J CELL BIOCHEM, V94, P1103, DOI 10.1002/jcb.20386; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Basrai MA, 1996, MOL CELL BIOL, V16, P2838; Bau DT, 2006, CANCER LETT, V240, P1, DOI 10.1016/j.canlet.2005.08.003; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bennett CB, 1996, MOL CELL BIOL, V16, P4414; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Chiba N, 2001, J BIOL CHEM, V276, P38549, DOI 10.1074/jbc.M105227200; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Coyne RS, 2004, CANCER BIOL THER, V3, P453, DOI 10.4161/cbt.3.5.809; Deng CX, 2000, BIOESSAYS, V22, P728; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Guo SC, 2005, CANCER RES, V65, P3011, DOI 10.1158/0008-5472.CAN-04-3624; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Humphrey JS, 1997, P NATL ACAD SCI USA, V94, P5820, DOI 10.1073/pnas.94.11.5820; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jeong SJ, 2005, J MICROBIOL, V43, P516; Jona G, 2001, GENE, V267, P31, DOI 10.1016/S0378-1119(01)00389-4; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Krum SA, 2003, J BIOL CHEM, V278, P52012, DOI 10.1074/jbc.M308418200; Le Page F, 2000, CANCER RES, V60, P5548; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; LEE JM, 1991, GENE EXPRESSION, V1, P149; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Moisan A, 2004, MOL CELL BIOL, V24, P6947, DOI 10.1128/MCB.24.16.6947-6956.2004; Mulder KW, 2005, NUCLEIC ACIDS RES, V33, P6384, DOI 10.1093/nar/gki938; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Starita LM, 2005, J BIOL CHEM, V280, P24498, DOI 10.1074/jbc.M414020200; Traven A, 2005, GENETICS, V169, P65, DOI 10.1534/genetics.104.030940; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang Y, 2000, GENE DEV, V14, P927; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woolstencroft RN, 2006, J CELL SCI, V119, P5178, DOI 10.1242/jcs.03221; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200	57	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1448	10.1371/journal.pone.0001448	http://dx.doi.org/10.1371/journal.pone.0001448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197258	gold, Green Published			2022-12-27	WOS:000260503800019
J	Fleming, JN; Nash, RA; McLeod, DO; Fiorentino, DF; Shulman, HM; Connolly, MK; Molitor, JA; Henstorf, G; Lafyatis, R; Pritchard, DK; Adams, LD; Furst, DE; Schwartz, SM				Fleming, Jo N.; Nash, Richard A.; McLeod, D. O.; Fiorentino, David F.; Shulman, Howard M.; Connolly, M. Kari; Molitor, Jerry A.; Henstorf, Gretchen; Lafyatis, Robert; Pritchard, David K.; Adams, Lawrence D.; Furst, Daniel E.; Schwartz, Stephen M.			Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?	PLOS ONE			English	Article								Background. Scleroderma is an autoimmune disease with a characteristic vascular pathology. The vasculopathy associated with scleroderma is one of the major contributors to the clinical manifestations of the disease. Methodology/Principal Findings. We used immunohistochemical and mRNA in situ hybridization techniques to characterize this vasculopathy and showed with morphometry that scleroderma has true capillary rarefaction. We compared skin biopsies from 23 scleroderma patients and 24 normal controls and 7 scleroderma patients who had undergone high dose immunosuppressive therapy followed by autologous hematopoietic cell transplant. Along with the loss of capillaries there was a dramatic change in endothelial phenotype in the residual vessels. The molecules defining this phenotype are: vascular endothelial cadherin, a supposedly universal endothelial marker required for tube formation (lost in the scleroderma tissue), antiangiogenic interferon a (overexpressed in the scleroderma dermis) and RGS5, a signaling molecule whose expression coincides with the end of branching morphogenesis during development and tumor angiogenesis (also overexpressed in scleroderma skin. Following high dose immunosuppressive therapy, patients experienced clinical improvement and 5 of the 7 patients with scleroderma had increased capillary counts. It was also observed in the same 5 patients, that the interferon a and vascular endothelial cadherin had returned to normal as other clinical signs in the skin regressed, and in all 7 patients, RGS5 had returned to normal. Conclusion/Significance. These data provide the first objective evidence for loss of vessels in scleroderma and show that this phenomenon is reversible. Coordinate changes in expression of three molecules already implicated in angiogenesis or anti-angiogenesis suggest that control of expression of these three molecules may be the underlying mechanism for at least the vascular component of this disease. Since rarefaction has been little studied, these data may have implications for other diseases characterized by loss of capillaries including hypertension, congestive heart failure and scar formation.	[Nash, Richard A.] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA USA; [Fiorentino, David F.] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA USA; [Shulman, Howard M.] Fred Hutchinson Canc Ctr, Seattle Canc Alliance, Clin Res Div, Seattle, WA USA; [Connolly, M. Kari] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Molitor, Jerry A.] Virginia Mason Med Ctr, Dept Rheumatol, Seattle, WA USA; [Henstorf, Gretchen] Fred Hutchinson Canc Res Ctr, Clin Res Div, Progr Transplant Biol, Seattle, WA USA; [Lafyatis, Robert] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA USA; [Furst, Daniel E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Rheumatol, Los Angeles, CA USA; [McLeod, D. O.; Pritchard, David K.; Adams, Lawrence D.; Schwartz, Stephen M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Stanford University; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco; Virginia Mason Medical Center; Fred Hutchinson Cancer Center; Boston University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle	Fleming, JN (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	flemij@u.washington.edu		Lafyatis, Robert/0000-0002-9398-5034	Scleroderma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005419] Funding Source: NIH RePORTER	Scleroderma Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Scleroderma Research Foundation that had no role in the design and conduct of the study, in the collection, analysis, and interpretation of data, or in the preparation, review and approval of the manuscript.	Adams LD, 2000, CIRC RES, V87, P623, DOI 10.1161/01.RES.87.7.623; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Antonios TFT, 1999, HYPERTENSION, V34, P655, DOI 10.1161/01.HYP.34.4.655; Antonios TFT, 2003, HEART, V89, P175, DOI 10.1136/heart.89.2.175; Asahara T, 2002, J HEMATOTH STEM CELL, V11, P171, DOI 10.1089/152581602753658385; Bachmeyer C, 1996, BRIT J DERMATOL, V135, P481, DOI 10.1046/j.1365-2133.1996.d01-1028.x; Beretta L, 2002, BRIT J DERMATOL, V147, P385, DOI 10.1046/j.1365-2133.2002.48901.x; Bielenberg DR, 1999, J INVEST DERMATOL, V112, P802, DOI 10.1046/j.1523-1747.1999.00566.x; Black CM, 1999, ARTHRITIS RHEUM, V42, P299, DOI 10.1002/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R; BLANN AD, 1993, J RHEUMATOL, V20, P1325; Braverman IM, 2000, J INVEST DERM SYMP P, V5, P3, DOI 10.1046/j.1087-0024.2000.00010.x; CARPENTIER PH, 1990, RHEUM DIS CLIN N AM, V16, P75; Cederqvist K, 2005, PEDIATR RES, V57, P831, DOI 10.1203/01.PDR.0000161416.63314.70; Cho H, 2003, FASEB J, V17, P440, DOI 10.1096/fj.02-0340fje; Choi JJ, 2003, J RHEUMATOL, V30, P1529; Clements PJ, 2003, SYSTEMIC SCLEROSIS, P129; CLOUGH G, 2005, MICROVASCULAR RES BI, P565; D'Andrea MR, 2000, BIOTECH HISTOCHEM, V75, P85, DOI 10.3109/10520290009064152; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; DENTON CP, 2003, SYSTEMIC SCLEROSIS, P184; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Distler O, 2004, CIRC RES, V95, P109, DOI 10.1161/01.RES.0000134644.89917.96; DUIJVESTIJN AM, 1988, AM J PATHOL, V130, P147; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Facchetti F, 2003, VIRCHOWS ARCH, V443, P703, DOI 10.1007/s00428-003-0918-8; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; GERRITSEN M, 2005, MICROVASCULAR RES BI, P51; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; GRUSCHWITZ M, 1992, J AM ACAD DERMATOL, V27, P169, DOI 10.1016/0190-9622(92)70165-C; HANDA R, 2002, J INDIAN ACAD CLIN M, V3, P35; HERRICK AL, 2003, SYSTEMIC SCLEROSIS, P309; HIGGINS JC, 1981, BRIT J DERMATOL, V104, P521, DOI 10.1111/j.1365-2133.1981.tb08166.x; Houben AJH, 2003, MICROCIRCULATION, V10, P471, DOI 10.1038/sj.mn.7800211; Isner JM, 2001, ANN NY ACAD SCI, V953, P75, DOI 10.1111/j.1749-6632.2001.tb02075.x; Isner JM, 2000, J CLIN INVEST, V106, P615, DOI 10.1172/JCI10961; Jimenez SA, 1996, RHEUM DIS CLIN N AM, V22, P647, DOI 10.1016/S0889-857X(05)70294-5; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; JONES NF, 2003, SYSTEMIC SCLEROSIS, P269; Kahaleh MB, 2004, CLIN EXP RHEUMATOL, V22, pS19; Komminoth P., 1996, NONRADIOACTIVE IN SI, P126; Kuwana M, 2004, LANCET, V364, P603, DOI 10.1016/S0140-6736(04)16853-0; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; McSweeney PA, 2002, BLOOD, V100, P1602, DOI 10.1182/blood.V100.5.1602.h81702001602_1602_1610; MEDSGER TA, 2003, SYSTEMIC SCLEROSIS, P17; MINASIAN LM, 1993, J CLIN ONCOL, V11, P1368, DOI 10.1200/JCO.1993.11.7.1368; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; Murayama T, 2002, CURR OPIN MOL THER, V4, P395; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Nash RA, 2006, ARTHRITIS RHEUM-US, V54, P1982, DOI 10.1002/art.21908; NEWMAN PJ, 1992, J CELL BIOL, V119, P239, DOI 10.1083/jcb.119.1.239; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; Renaudineau Y, 2001, AUTOIMMUNITY, V33, P171, DOI 10.3109/08916930109008045; Rivera-Nieves J, 2006, J EXP MED, V203, P907, DOI 10.1084/jem.20052530; Romero LI, 1997, J CELL PHYSIOL, V173, P84, DOI 10.1002/(SICI)1097-4652(199710)173:1<84::AID-JCP10>3.0.CO;2-N; SALOMON RN, 1991, AM J PATHOL, V138, P791; Sapadin AN, 2001, MT SINAI J MED, V68, P233; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Shore AC, 2000, BRIT J CLIN PHARMACO, V50, P501, DOI 10.1046/j.1365-2125.2000.00278.x; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; SINGH RK, 1995, P NATL ACAD SCI USA, V92, P4562, DOI 10.1073/pnas.92.10.4562; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Steinberg SF, 2005, MOL PHARMACOL, V67, P2, DOI 10.1124/mol.104.003103; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Storek J, 2004, CLIN IMMUNOL, V113, P285, DOI 10.1016/j.clim.2004.07.006; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; TROTTA F, 1984, CLIN EXP RHEUMATOL, V2, P209; Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008; WHITE B, 2003, SYSTEMIC SCLEROSIS, P163; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Wollenberg A, 2002, J INVEST DERMATOL, V119, P1096, DOI 10.1046/j.1523-1747.2002.19515.x; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382	76	152	152	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1452	10.1371/journal.pone.0001452	http://dx.doi.org/10.1371/journal.pone.0001452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197262	Green Published, gold			2022-12-27	WOS:000260503800022
J	Ueno, A; Hirata, S; Fuwa, K; Sugama, K; Kusunoki, K; Matsuda, G; Fukushima, H; Hiraki, K; Tomonaga, M; Hasegawa, T				Ueno, Ari; Hirata, Satoshi; Fuwa, Kohki; Sugama, Keiko; Kusunoki, Kiyo; Matsuda, Goh; Fukushima, Hirokata; Hiraki, Kazuo; Tomonaga, Masaki; Hasegawa, Toshikazu			Auditory ERPs to Stimulus Deviance in an Awake Chimpanzee (Pan troglodytes): Towards Hominid Cognitive Neurosciences	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; STAGE-2 SLEEP; RECOGNITION; PERCEPTION; TOOL	Background. For decades, the chimpanzee, phylogenetically closest to humans, has been analyzed intensively in comparative cognitive studies. Other than the accumulation of behavioral data, the neural basis for cognitive processing in the chimpanzee remains to be clarified. To increase our knowledge on the evolutionary and neural basis of human cognition, comparative neurophysiological studies exploring endogenous neural activities in the awake state are needed. However, to date, such studies have rarely been reported in non-human hominid species, due to the practical difficulties in conducting non-invasive measurements on awake individuals. Methodology/Principal Findings. We measured auditory event-related potentials (ERPs) of a fully awake chimpanzee, with reference to a well-documented component of human studies, namely mismatch negativity (MMN). In response to infrequent, deviant tones that were delivered in a uniform sound stream, a comparable ERP component could be detected as negative deflections in early latencies. Conclusions/Significance. The present study reports the MMN-like component in a chimpanzee for the first time. In human studies, various ERP components, including MMN, are well-documented indicators of cognitive and neural processing. The results of the present study validate the use of noninvasive ERP measurements for studies on cognitive and neural processing in chimpanzees, and open the way for future studies comparing endogenous neural activities between humans and chimpanzees. This signifies an essential step in hominid cognitive neurosciences.	[Hirata, Satoshi; Fuwa, Kohki; Sugama, Keiko; Kusunoki, Kiyo] Great Ape Res Inst, Hayashibara Biochem Lab, Okayama, Japan; [Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Aichi, Japan; [Matsuda, Goh; Fukushima, Hirokata; Hiraki, Kazuo; Hasegawa, Toshikazu] Univ Tokyo, Tokyo, Japan	Hayashibara Biochemical Laboratories, Inc.; Kyoto University; University of Tokyo	Ueno, A (corresponding author), Univ Tokyo, Tokyo, Japan.	aueno@ecs.c.u-tokyo.ac.jp			21st century COE program, University of Tokyo), Japan	21st century COE program, University of Tokyo), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was funded by the 21st century COE program (the center for evolutionary cognitive sciences at the University of Tokyo), Japan.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; BERNTSON GG, 1993, DEV PSYCHOBIOL, V26, P305, DOI 10.1002/dev.420260602; BERNTSON GG, 1989, BEHAV NEUROSCI, V103, P235, DOI 10.1037/0735-7044.103.2.235; BERNTSON GG, 1989, DEV PSYCHOBIOL, V22, P771, DOI 10.1002/dev.420220803; BERNTSON GG, 1990, ADV INFANCY RES, V6, P187; BOYSEN ST, 1986, J COMP PSYCHOL, V100, P321, DOI 10.1037/0735-7036.100.3.321; BOYSEN ST, 1985, ELECTROEN CLIN NEURO, V62, P150, DOI 10.1016/0168-5597(85)90027-9; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P215, DOI 10.1037/0735-7036.103.3.215; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Idani G., 2006, PRIMATE PERSPECTIVES, P29; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; KOJIMA S, 1990, FOLIA PRIMATOL, V55, P62, DOI 10.1159/000156501; NAATANEN R, 1995, EAR HEARING, V16, P6; NAATANEN R, 1993, PSYCHOPHYSIOLOGY, V30, P436, DOI 10.1111/j.1469-8986.1993.tb02067.x; Paavilainen P, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P246; Parr L A, 2001, Anim Cogn, V4, P223, DOI 10.1007/s100710100085; Parr LA, 2000, PHYSIOL BEHAV, V71, P363, DOI 10.1016/S0031-9384(00)00349-8; SALLINEN M, 1994, ELECTROEN CLIN NEURO, V91, P140, DOI 10.1016/0013-4694(94)90035-3; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; WINTER O, 1995, EVOKED POTENTIAL, V96, P398, DOI 10.1016/0168-5597(95)00030-V	23	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1442	10.1371/journal.pone.0001442	http://dx.doi.org/10.1371/journal.pone.0001442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SN	18197252	Green Published, Green Submitted, gold			2022-12-27	WOS:000260503800013
J	Wu, LJ; Ren, M; Wang, HS; Kim, SS; Cao, XY; Zhuo, M				Wu, Long-Jun; Ren, Ming; Wang, Hansen; Kim, Susan S.; Cao, Xiaoyan; Zhuo, Min			Neurabin Contributes to Hippocampal Long-Term Potentiation and Contextual Fear Memory	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; PRIMATE PREFRONTAL CORTEX; FILAMENT-BINDING PROTEIN; SYNAPTIC PLASTICITY; DENDRITIC SPINES; SUBCELLULAR-DISTRIBUTION; SILENT SYNAPSES; SPINOPHILIN; PHOSPHATASE-1; LTP	Neurabin is a scaffolding protein that interacts with actin and protein phosphatase-1. Highly enriched in the dendritic spine, neurabin is important for spine morphogenesis and synaptic formation. However, less is known about the role of neurabin in hippocampal plasticity and its possible effect on behavioral functions. Using neurabin knockout (KO) mice, here we studied the function of neurabin in hippocampal synaptic transmission, plasticity and behavioral memory. We demonstrated that neurabin KO mice showed a deficit in contextual fear memory but not auditory fear memory. Whole-cell patch clamp recordings in the hippocampal CA1 neurons showed that long-term potentiation (LTP) was significantly reduced, whereas long-term depression (LTD) was unaltered in neurabin KO mice. Moreover, increased AMPA receptor but not NMDA receptor-mediated synaptic transmission was found in neurabin KO mice, and is accompanied by decreased phosphorylation of GluR1 at the PKA site (Ser845) but no change at the CaMKII/PKC site (Ser831). Pre-conditioning with LTD induction rescued the following LTP in neurabin KO mice, suggesting the loss of LTP may be due to the saturated synaptic transmission. Our results indicate that neurabin regulates contextual fear memory and LTP in hippocampal CA1 pyramidal neurons.	[Wu, Long-Jun; Ren, Ming; Wang, Hansen; Kim, Susan S.; Cao, Xiaoyan] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto	Zhuo, M (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	min.zhuo@utoronto.ca	Wu, Long-Jun/E-2684-2012; Wu, Long-Jun/AAK-7113-2020; wang, hansen/I-2510-2019; Zhuo, Min/A-2072-2008	Wu, Long-Jun/0000-0001-8019-3380; wang, hansen/0000-0003-4414-3372; Zhuo, Min/0000-0001-9062-3241	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health; Canada Research Chair; CIHR [postdoctoral fellowships]; Fragile X Research Foundation of Canada [postdoctoral fellowships]	EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); Fragile X Research Foundation of Canada	Supported by the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, and the Canada Research Chair to MZ. L-JW is supported by postdoctoral fellowships from the CIHR and Fragile X Research Foundation of Canada.	Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Hu XD, 2006, J NEUROCHEM, V98, P1841, DOI 10.1111/j.1471-4159.2006.04070.x; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kavalali ET, 2006, NEUROSCIENTIST, V12, P57, DOI 10.1177/1073858405281852; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Muly EC, 2004, CEREB CORTEX, V14, P1398, DOI 10.1093/cercor/bhh101; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Radley JJ, 2006, EUR J NEUROSCI, V24, P876, DOI 10.1111/j.1460-9568.2006.04962.x; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Silva AJ, 2003, J NEUROBIOL, V54, P224, DOI 10.1002/neu.10169; Strack S, 1997, J NEUROCHEM, V68, P2119; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wu LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000167; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	42	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1407	10.1371/journal.pone.0001407	http://dx.doi.org/10.1371/journal.pone.0001407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183288	Green Published, Green Submitted, gold			2022-12-27	WOS:000260469400004
J	Bento, M; Pereira, HS; Rocheta, M; Gustafson, P; Viegas, W; Silva, M				Bento, Miguel; Pereira, H. Sofia; Rocheta, Margarida; Gustafson, Perry; Viegas, Wanda; Silva, Manuela			Polyploidization as a Retraction Force in Plant Genome Evolution: Sequence Rearrangements in Triticale	PLOS ONE			English	Article							NUCLEOLAR DOMINANCE; GENE-EXPRESSION; HUBBARD POACEAE; WHEAT; RETROTRANSPOSONS; ALLOPOLYPLOIDY; ARABIDOPSIS; ACTIVATION; AEGILOPS; METHYLATION	Background. Polyploidization is a major evolutionary process in plants where hybridization and chromosome doubling induce enormous genomic stress and can generate genetic and epigenetic modifications. However, proper evaluation of DNA sequence restructuring events and the precise characterization of sequences involved are still sparse. Methodology/Principal Findings. Inter Retrotransposons Amplified Polymorphism ( IRAP), Retrotransposons Microsatellite Amplified Polymorphism (REMAP) and Inter Simple Sequence Repeat (ISSR) largely confirmed the absence of any intraspecific variation in wheat, rye and triticale. The comparative analysis of banding profiles between wheat and rye inbred lines revealed 34% of monomorphic ( common to both parental species) bands for the ten different primer combinations used. The analysis of triticale plants uncovered nearly 51% of rearranged bands in the polyploid, being the majority of these modifications, due to the loss of rye bands (83%). Sequence analysis of rye fragments absent in triticale revealed for instance homology with hydroxyproline-rich glycoproteins ( HRGP), a protein that belongs to a major family of inducible defence response proteins. Conversely, a wheat-specific band absent in triticale comprises a nested structure of copia-like retrotransposons elements, namely Claudia and Barbara. Sequencing of a polyploid-specific band ( absent in both parents) revealed a microsatellite related sequence. Cytological studies using Fluorescent In Situ Hybridization ( FISH) with REMAP products revealed a widespread distribution of retrotransposon and/or microsatellite flanking sequences on rye chromosomes, with a preferential accumulation in heterochromatic sub-telomeric domains. Conclusions/Significance.. Here, we used PCR-based molecular marker techniques involving retrotransposons and microsatellites to uncover polyploidization induced genetic restructuring in triticale. Sequence analysis of rearranged genomic fragments either from rye or wheat origin showed these to be retrotransposon-related as well as coding sequences. Further FISH analysis revealed possible chromosome hotspots for sequence rearrangements. The role of chromatin condensation on the origin of genomic rearrangements mediated by polyploidization in triticale is also discussed.	[Bento, Miguel; Pereira, H. Sofia; Rocheta, Margarida; Viegas, Wanda; Silva, Manuela] Univ Tecn Lisbon, Ctr Bot Aplicada Agr, Seccao Genet, Inst Super Agron, Lisbon, Portugal; [Gustafson, Perry] Univ Missouri, Curits Hall, Columbia, MO USA	Universidade de Lisboa; University of Missouri System; University of Missouri Columbia	Silva, M (corresponding author), Univ Tecn Lisbon, Ctr Bot Aplicada Agr, Seccao Genet, Inst Super Agron, Lisbon, Portugal.	manuelasilva@isa.utl.pt	Rocheta, Margarida/E-9156-2015; Silva, Manuela/ABF-7085-2020; Silva, Manuela/GSN-4031-2022	Rocheta, Margarida/0000-0003-3939-4564; Silva, Manuela/0000-0003-4677-870X; Bento, Miguel/0000-0002-7545-8943; Pereira, H. Sofia/0000-0002-7933-6097; Viegas, Wanda/0000-0003-4660-1226	Fundacao de Ciencias e Tecnologia, Portugal [POCI/BIA-BDE/57575/2004];  [SFRH/BD/28657/2006];  [SFRH/BPD/20320/2004];  [SFRH/BPD/14549/2003]	Fundacao de Ciencias e Tecnologia, Portugal; ; ; 	Miguel Bento is funded by a doctoral scholarship (SFRH/BD/28657/2006). Manuela Silva and H. Sofia Pereira are funded by postdoctoral fellowships (SFRH/BPD/20320/2004 and SFRH/BPD/14549/2003, respectively). This research was financed by Fundacao de Ciencias e Tecnologia, Portugal, (Project POCI/BIA-BDE/57575/2004).	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Baumel A, 2001, MOL ECOL, V10, P1689, DOI 10.1046/j.1365-294X.2001.01299.x; Baumel A, 2002, MOL BIOL EVOL, V19, P1218, DOI 10.1093/oxfordjournals.molbev.a004182; Belyayev A, 2001, CHROMOSOME RES, V9, P129, DOI 10.1023/A:1009231019833; BENNETT MD, 1976, THEOR APPL GENET, V65, P353; BENNETT MD, 1974, MEIOTIC GAMETOPHITIC, P137; Berenyi M, 2002, THEOR APPL GENET, V105, P862, DOI 10.1007/s00122-002-1015-0; BOYKO EV, 1984, CEREAL RES COMMUN, V12, P99; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; CORBIN DR, 1987, MOL CELL BIOL, V7, P4337, DOI 10.1128/MCB.7.12.4337; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GUSTAFSON JP, 1976, CROP SCI, V16, P688, DOI 10.2135/cropsci1976.0011183X001600050022x; Kalendar R, 1999, THEOR APPL GENET, V98, P704, DOI 10.1007/s001220051124; Kashkush K, 2002, GENETICS, V160, P1651; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Ma XF, 2004, GENOME, V47, P839, DOI [10.1139/g04-051, 10.1139/G04-051]; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; MERKER A, 1976, HEREDITAS, V83, P215; Neves N, 1997, CHROMOSOME RES, V5, P125, DOI 10.1023/A:1018470208730; Ozkan H, 2003, J HERED, V94, P260, DOI 10.1093/jhered/esg053; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pereira HS, 2005, THEOR APPL GENET, V111, P871, DOI 10.1007/s00122-005-0009-0; Perlman PS, 2004, SCIENCE, V303, P182, DOI 10.1126/science.1093514; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; Schwarzacher T., 2000, PRACTICAL SITU HYBRI; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Smykal P, 2006, J APPL GENET, V47, P221, DOI 10.1007/BF03194627; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; SUONIEMI A, 1997, GENETICA, V100; VARMUS H, 1989, MOBILE DNA, P53; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237; Vitte C, 2005, CYTOGENET GENOME RES, V110, P91, DOI 10.1159/000084941; WYCOFF KL, 1995, PLANT PHYSIOL, V109, P41, DOI 10.1104/pp.109.1.41	46	64	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1402	10.1371/journal.pone.0001402	http://dx.doi.org/10.1371/journal.pone.0001402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167561	gold, Green Published, Green Submitted			2022-12-27	WOS:000260468900030
J	Shinkareva, SV; Mason, RA; Malave, VL; Wang, W; Mitchell, TM; Just, MA				Shinkareva, Svetlana V.; Mason, Robert A.; Malave, Vicente L.; Wang, Wei; Mitchell, Tom M.; Just, Marcel Adam			Using fMRI Brain Activation to Identify Cognitive States Associated with Perception of Tools and Dwellings	PLOS ONE			English	Article							VENTRAL TEMPORAL CORTEX; CORTICAL ACTIVITY; OBJECTS; REPRESENTATIONS; PATTERNS; CLASSIFICATION; PARCELLATION; RECOGNITION; RETRIEVAL; DORSAL	Previous studies have succeeded in identifying the cognitive state corresponding to the perception of a set of depicted categories, such as tools, by analyzing the accompanying pattern of brain activity, measured with fMRI. The current research focused on identifying the cognitive state associated with a 4s viewing of an individual line drawing (1 of 10 familiar objects, 5 tools and 5 dwellings, such as a hammer or a castle). Here we demonstrate the ability to reliably (1) identify which of the 10 drawings a participant was viewing, based on that participant's characteristic whole-brain neural activation patterns, excluding visual areas; (2) identify the category of the object with even higher accuracy, based on that participant's activation; and (3) identify, for the first time, both individual objects and the category of the object the participant was viewing, based only on other participants' activation patterns. The voxels important for category identification were located similarly across participants, and distributed throughout the cortex, focused in ventral temporal perceptual areas but also including more frontal association areas (and somewhat left-lateralized). These findings indicate the presence of stable, distributed, communal, and identifiable neural states corresponding to object concepts.	[Shinkareva, Svetlana V.; Mason, Robert A.; Malave, Vicente L.; Just, Marcel Adam] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Shinkareva, Svetlana V.; Wang, Wei; Mitchell, Tom M.] Carnegie Mellon Univ, Sch Comp Sci, Machine Learn Dept, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University	Shinkareva, SV (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	shinkareva@sc.edu		Just, Marcel/0000-0003-1245-3050; Shinkareva, Svetlana/0000-0001-5112-4829	W. M. Keck Foundation; NSF [IIS-0423070]	W. M. Keck Foundation(W.M. Keck Foundation); NSF(National Science Foundation (NSF))	This research was supported by the W. M. Keck Foundation and by the National Science Foundation-Collaborative Research in Computational Neuroscience Grant IIS-0423070.	Abdi H., 2007, ENCY MEASUREMENT STA, P955; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kherif F, 2003, NEUROIMAGE, V20, P2197, DOI 10.1016/j.neuroimage.2003.08.018; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; LAVIT C, 1994, COMPUT STAT DATA AN, V18, P97, DOI 10.1016/0167-9473(94)90134-1; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; O'Toole AJ, 2005, J COGNITIVE NEUROSCI, V17, P580, DOI 10.1162/0898929053467550; Phillips JA, 2002, BRAIN, V125, P2067, DOI 10.1093/brain/awf215; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; Robert P., 1976, APPL STAT, P257, DOI DOI 10.2307/2347233; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Shinkareva SV, 2006, NEUROIMAGE, V33, P63, DOI 10.1016/j.neuroimage.2006.06.032; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839	32	132	134	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1394	10.1371/journal.pone.0001394	http://dx.doi.org/10.1371/journal.pone.0001394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167553	Green Published, gold			2022-12-27	WOS:000260468900022
J	Russell, JH; Keiler, KC				Russell, Jay H.; Keiler, Kenneth C.			Screen for Localized Proteins in Caulobacter crescentus	PLOS ONE			English	Article								Precise localization of individual proteins is required for processes such as motility, chemotaxis, cell-cycle progression, and cell division in bacteria, but the number of proteins that are localized in bacterial species is not known. A screen based on transposon mutagenesis and fluorescence activated cell sorting was devised to identify large numbers of localized proteins, and employed in Caulobacter crescentus. From a sample of the clones isolated in the screen, eleven proteins with no previously characterized localization in C. crescentus were identified, including six hypothetical proteins. The localized hypothetical proteins included one protein that was localized in a helix-like structure, and two proteins for which the localization changed as a function of the cell cycle, suggesting that complex three-dimensional patterns and cell cycle-dependent localization are likely to be common in bacteria. Other mutants produced localized fusion proteins even though the transposon has inserted near the 59 end of a gene, demonstrating that short peptides can contain sufficient information to localize bacterial proteins. The screen described here could be used in most bacterial species.	[Russell, Jay H.; Keiler, Kenneth C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Russell, JH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kkeiler@psu.edu		Keiler, Kenneth/0000-0001-8753-335X	NIGMS [GM068720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068720] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS grant GM068720. The funders played no role in any aspect of the research or manuscript.	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Ausmees N, 2003, ANNU REV MICROBIOL, V57, P225, DOI 10.1146/annurev.micro.57.030502.091006; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Bingle WH, 2000, J BACTERIOL, V182, P3298, DOI 10.1128/JB.182.11.3298-3301.2000; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; EDWARDS P, 1991, J BACTERIOL, V173, P5568, DOI 10.1128/jb.173.17.5568-5572.1991; ELY B, 1991, METHOD ENZYMOL, V204, P372; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Jacobs-Wagner C, 2004, MOL MICROBIOL, V51, P7, DOI 10.1046/j.1365-2958.2003.03828.x; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; MADDOCK JR, 1993, SCIENCE, V259, P1717; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; OCHMAN H, 1988, GENETICS, V120, P621; Russell JH, 2007, J BACTERIOL, V189, P7581, DOI 10.1128/JB.00981-07; Ryan KR, 2003, ANNU REV BIOCHEM, V72, P367, DOI 10.1146/annurev.biochem.72.121801.161824; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Shiomi D, 2005, J BACTERIOL, V187, P7647, DOI 10.1128/JB.187.22.7647-7654.2005; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1756	10.1371/journal.pone.0001756	http://dx.doi.org/10.1371/journal.pone.0001756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335033	Green Published, Green Submitted, gold			2022-12-27	WOS:000260723000010
J	Sockman, KW				Sockman, Keith W.			Ovulation Order Mediates a Trade-Off between Pre-Hatching and Post-Hatching Viability in an Altricial Bird	PLOS ONE			English	Article							BROOD REDUCTION; EGG-VIABILITY; CLUTCH SIZE; ADAPTIVE SIGNIFICANCE; SIBLING COMPETITION; SEX-RATIOS; ASYNCHRONY; CONSTRAINT; ANDROGENS; FAILURE	Simultaneously dependent siblings often compete for parentally provided resources. This competition may lead to mortality, the probability of which may be a function, in part, of the individual offspring's production order. In birds, serial ovulation followed by hatching asynchrony of simultaneous dependents leads to differences in post-hatching survival that largely depend on ovulation (laying) order. This has led to the widespread assumption that early-laid eggs are of greater value and therefore should possess different maternally manipulated characteristics than later-laid eggs. However, this perspective ignores the potential effect of laying order on pre-hatching viability, an effect which some studies suggest should offset the effect of laying order on post-hatching viability. I examined the relationship between laying order and hatching and fledging probability in wild, free-living Lincoln's sparrows (Melospiza lincolnii). In broods with complete hatching success, first-laid and therefore first-hatched offspring had the highest probability of fledging, and fledging probability declined with increasing laying order. However, first-laid eggs were less likely than later-laid eggs to hatch. This effect of laying order on pre-hatching viability seemed to offset that on post-hatching viability, and, consistently, maternal investment in egg size varied little if at all with respect to laying order. These results suggest that ovulation order mediates a trade-off between pre-hatching and post-hatching viability and should encourage a re-evaluation of the solitary role postembryonic survival often plays when researchers make assumptions about the value of propagules based on the order in which they are produced.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Sockman, KW (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	kws@unc.edu			R.J. Reynolds fund [U.N.C. Award]	R.J. Reynolds fund	A U.N.C. Award from the R.J. Reynolds fund to K.W.S. provided financial support. The funder of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 2001, IBIS, V143, P17, DOI 10.1111/j.1474-919X.2001.tb04165.x; Ammon E. M., 1995, BIRDS N AM; AMUNDSEN T, 1988, J ANIM ECOL, V57, P329, DOI 10.2307/4909; ARNOLD TW, 1987, AM NAT, V130, P643, DOI 10.1086/284736; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; BORTOLOTTI GR, 1986, AM NAT, V127, P495, DOI 10.1086/284498; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Cabezas-Diaz S, 2007, ARDEA, V95, P55, DOI 10.5253/078.095.0106; Cicero C, 1997, GREAT BASIN NAT, V57, P104; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; CODERO PJ, 1999, J AVIAN BIOL, V30, P103; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cooper CB, 2005, ECOLOGY, V86, P2018, DOI 10.1890/03-8028; Cordero PJ, 1999, J AVIAN BIOL, V30, P103, DOI 10.2307/3677249; EVANS RM, 1990, WILSON BULL, V102, P684; Godard RD, 2007, J AVIAN BIOL, V38, P709, DOI 10.1111/j.0908-8857.2007.04052.x; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; HOYT DF, 1979, AUK, V96, P73; Krackow S, 2001, BEHAV ECOL SOCIOBIOL, V50, P293, DOI 10.1007/s002650100366; Lack D., 1954, P343; MAGRATH RD, 1990, BIOL REV, V65, P587, DOI 10.1111/j.1469-185X.1990.tb01239.x; Mock D. W., 1997, EVOLUTION SIBLING RI, P464; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Monaghan P, 1998, P ROY SOC B-BIOL SCI, V265, P1731, DOI 10.1098/rspb.1998.0495; Morton Martin L., 2002, Studies in Avian Biology, V24, P1; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; PIJANOWSKI BC, 1992, AM NAT, V139, P1270, DOI 10.1086/285386; Potti J, 1996, CONDOR, V98, P328, DOI 10.2307/1369151; POUGH FH, 2005, VERTEBRATE LIFE, P684; PULLIAINEN E, 1994, ORNIS FENNICA, V71, P109; RABEHESKETH S, 2005, MULTILEVEL LONGITUDI, P317; Romanoff A. L., 1949, AVIAN EGG; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Smiseth PT, 2007, ECOLOGY, V88, P3174, DOI 10.1890/06-1992.1; Sockman KW, 2006, BIOL REV, V81, P629, DOI 10.1017/S1464793106007147; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; SOCKMAN KW, 2007, BEHAV ECOLOGY SOCIOB; Stenning MJ, 1996, TRENDS ECOL EVOL, V11, P243, DOI 10.1016/0169-5347(96)10030-6; Stoleson Scott H., 1995, Current Ornithology, V12, P191; Stoleson SH, 1999, J ANIM ECOL, V68, P951, DOI 10.1046/j.1365-2656.1999.00342.x; VEIGA JP, 1992, AM NAT, V139, P669, DOI 10.1086/285351	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1785	10.1371/journal.pone.0001785	http://dx.doi.org/10.1371/journal.pone.0001785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335056	Green Submitted, gold, Green Published			2022-12-27	WOS:000260723000037
J	Akesson, M; Bensch, S; Hasselquist, D; Tarka, M; Hansson, B				Akesson, Mikael; Bensch, Staffan; Hasselquist, Dennis; Tarka, Maja; Hansson, Bengt			Estimating Heritabilities and Genetic Correlations: Comparing the 'Animal Model' with Parent-Offspring Regression Using Data from a Natural Population	PLOS ONE			English	Article								Quantitative genetic parameters are nowadays more frequently estimated with restricted maximum likelihood using the 'animal model' than with traditional methods such as parent-offspring regressions. These methods have however rarely been evaluated using equivalent data sets. We compare heritabilities and genetic correlations from animal model and parent-offspring analyses, respectively, using data on eight morphological traits in the great reed warbler (Acrocephalus arundinaceus). Animal models were run using either mean trait values or individual repeated measurements to be able to separate between effects of including more extended pedigree information and effects of replicated sampling from the same individuals. We show that the inclusion of more pedigree information by the use of mean traits animal models had limited effect on the standard error and magnitude of heritabilities. In contrast, the use of repeated measures animal model generally had a positive effect on the sampling accuracy and resulted in lower heritabilities; the latter due to lower additive variance and higher phenotypic variance. For most trait combinations, both animal model methods gave genetic correlations that were lower than the parent-offspring estimates, whereas the standard errors were lower only for the mean traits animal model. We conclude that differences in heritabilities between the animal model and parent-offspring regressions were mostly due to the inclusion of individual replicates to the animal model rather than the inclusion of more extended pedigree information. Genetic correlations were, on the other hand, primarily affected by the inclusion of more pedigree information. This study is to our knowledge the most comprehensive empirical evaluation of the performance of the animal model in relation to parent-offspring regressions in a wild population. Our conclusions should be valuable for reconciliation of data obtained in earlier studies as well as for future meta-analyses utilizing estimates from both traditional methods and the animal model.	[Akesson, Mikael; Bensch, Staffan; Hasselquist, Dennis; Tarka, Maja; Hansson, Bengt] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden	Lund University	Akesson, M (corresponding author), Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden.	mikael.akesson@zooekol.lu.se	Hasselquist, Dennis/M-5223-2014; Hansson, Bengt/L-8874-2013; Åkesson, Mikael/K-5370-2014; Tarka, Maja/L-8065-2013	Hasselquist, Dennis/0000-0002-0056-6616; Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101	Swedish Research Council; Swedish Council for Environment; Agricultural Sciences and Spatial Planning (FORMAS); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Ahlstrand and Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society; Crafoordska Stiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Environment; Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Ahlstrand and Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society(National Geographic Society); Crafoordska Stiftelsen	The work was supported by grants from the Swedish Research Council (VR), the Swedish Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the National Swedish Environment Protection Board, the Carl Tryggers stiftelse, the Royal Swedish Academy of Science (J.A. Ahlstrand and Hierta-Retzius Foundations), the Lunds Djurskyddsfond, the Magn Bergvalls Stiftelse, the National Geographic Society and the Crafoordska Stiftelsen	Akesson M, 2007, J AVIAN BIOL, V38, P58, DOI 10.1111/j.2006.0908-8857.03669.x; Arlt D, 2004, BEHAVIOUR, V141, P863, DOI 10.1163/1568539042265699; Becker W. A, 1984, MANUAL QUANTITATIVE; BENSCH S, 1991, J ANIM ECOL, V60, P857, DOI 10.2307/5418; Bensch S, 1998, EVOLUTION, V52, P877, DOI 10.1111/j.1558-5646.1998.tb03712.x; BROWN GH, 1969, BIOMETRICS, V25, P63, DOI 10.2307/2528678; Coltman DW, 2005, EVOLUTION, V59, P1372; Cramp S., 1992, HDB BIRDS EUROPE MID; Falconer D. S., 1996, INTRO QUANTITATIVE G; Galton F, 1889, NATURAL INHERITANCE, P1; Gilmour A., 2006, ASREML USER GUIDE RE; GRANT PR, 1983, PROC R SOC SER B-BIO, V220, P219, DOI 10.1098/rspb.1983.0096; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; HANSSON B, 2004, BIOL LETT, V271, P290; HASSELQUIST D, 1995, OIKOS, V72, P173, DOI 10.2307/3546219; HASSELQUIST D, 1995, BEHAV ECOL, V6, P27, DOI 10.1093/beheco/6.1.27; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Helbig AJ, 1999, MOL PHYLOGENET EVOL, V11, P246, DOI 10.1006/mpev.1998.0571; HOULE D, 1992, GENETICS, V130, P195; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; KNOTT SA, 1995, FUNCT ECOL, V9, P122, DOI 10.2307/2390099; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LANDE R, 1989, GENETICS, V122, P915; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lynch M., 1998, GENETICS ANAL QUANTI; MacColl ADC, 2003, EVOLUTION, V57, P2191; Merila J, 2001, CURR ORNITHOL, V16, P179; MERILA J, 1993, J EVOLUTION BIOL, V6, P375, DOI 10.1046/j.1420-9101.1993.6030375.x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; PRICE T, 1992, TRENDS ECOL EVOL, V7, P307, DOI 10.1016/0169-5347(92)90229-5; Provine WB., 2001, ORIGINS THEORETICAL; Reale D, 1999, HEREDITY, V83, P526, DOI 10.1038/sj.hdy.6885430; REEVE ECR, 1955, BIOMETRICS, V11, P357, DOI 10.2307/3001774; ROBERTSON A, 1959, BIOMETRICS, V15, P469, DOI 10.2307/2527750; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Sheldon BC, 2003, EVOLUTION, V57, P406; Sokal R.R., 2012, BIOMETRY; SPSS Inc, 2005, SPSS 14 0 WIND; Svensson L., 1992, IDENTIFICATION GUIDE; VANVLECK LD, 1961, BIOMETRICS, V17, P359, DOI 10.2307/2527831; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Windig JJ, 1997, J EVOLUTION BIOL, V10, P853, DOI 10.1007/s000360050058	46	64	67	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1739	10.1371/journal.pone.0001739	http://dx.doi.org/10.1371/journal.pone.0001739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320057	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586600034
J	Kurt, S; Deutscher, A; Crook, JM; Ohl, FW; Budinger, E; Moeller, CK; Scheich, H; Schulze, H				Kurt, Simone; Deutscher, Anke; Crook, John M.; Ohl, Frank W.; Budinger, Eike; Moeller, Christoph K.; Scheich, Henning; Schulze, Holger			Auditory Cortical Contrast Enhancing by Global Winner-Take-All Inhibitory Interactions	PLOS ONE			English	Article								Brains decompose the world into discrete objects of perception, thereby facing the problem of how to segregate and selectively address similar objects that are concurrently present in a scene. Theoretical models propose that this could be achieved by neuronal implementations of so-called winner-take-all algorithms where neuronal representations of objects or object features interact in a competitive manner. Here we present evidence for the existence of such a mechanism in an animal species. We present electrophysiological, neuropharmacological and neuroanatomical data which suggest a novel view of the role of GABA(A)-mediated inhibition in primary auditory cortex (AI), where intracortical GABA(A)-mediated inhibition operates on a global scale within a circular map of sound periodicity representation in AI, with functionally inhibitory projections of similar effect from any location throughout the whole map. These interactions could underlie the proposed competitive ''winner-take-all'' algorithm to support object segregation, e.g., segregation of different speakers in cocktail-party situations.	[Kurt, Simone; Deutscher, Anke; Ohl, Frank W.; Budinger, Eike; Moeller, Christoph K.; Scheich, Henning; Schulze, Holger] Leibniz Inst Neurobiol, Magdeburg, Germany; [Kurt, Simone] Univ Ulm, Inst Neurobiol, Ulm, Germany; [Crook, John M.] Newcastle Univ, Sch Biol, Div Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [Budinger, Eike] Otto von Guericke Univ, Clin Neurol II, Magdeburg, Germany; [Schulze, Holger] Univ Erlangen Nurnberg, Expt Otorhinolaryngol, Erlangen, Germany	Leibniz Institut fur Neurobiologie (LIN); Ulm University; Newcastle University - UK; Otto von Guericke University; University of Erlangen Nuremberg	Kurt, S (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	Holger.Schulze@uk-erlangen.de	Kurt, Simone/I-2927-2012	Kurt, Simone/0000-0002-1820-2597; Budinger, Eike/0000-0003-2420-8159	DFG [SFB-TR 31]; German Ministry of Education and Research [0311891]	DFG(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study presents data that were collected in our laboratory over a period of several years. It cumulates results of a number of experiments that were supported by different institutions: The interaction experiment was supported by the VolkswagenStiftung (I/77 356). The microiontophoretic experiments were supported by the Deutsche Forschungsgemeinschaft (DFG; SCHU 1272/2-1,2). The anatomical studies were supported by the DFG (SFB-TR 31, cooperation between projects A2 and A3). Dr. Ohl was supported by the BMBF (German Ministry of Education and Research; grant BioFuture 0311891).	Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2000, EUR J NEUROSCI, V12, P2425, DOI 10.1046/j.1460-9568.2000.00142.x; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Chen QC, 2000, HEARING RES, V150, P161, DOI 10.1016/S0378-5955(00)00197-0; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Deutscher A, 2006, NEUROREPORT, V17, P853, DOI 10.1097/01.wnr.0000221837.20255.62; Fabri M, 2004, NEUROSCIENCE, V123, P557, DOI 10.1016/j.neuroscience.2003.09.011; Fay RR, 1998, HEARING RES, V120, P69, DOI 10.1016/S0378-5955(98)00058-6; Foeller E, 2001, JARO, V2, P279; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Kurt S, 2006, HEARING RES, V212, P224, DOI 10.1016/j.heares.2005.12.002; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; MOLLER C, 2007, ASS RES OT 30 MIDW R; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Porrill J, 1999, NATURE, V397, P63, DOI 10.1038/16244; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; SCHEICH H, 2005, 23 PROBLEMS SYSTEM N, P343; Scheich H, 2007, HEARING RES, V229, P213, DOI 10.1016/j.heares.2007.01.025; Schul J, 2006, NEUROSCIENCE, V138, P1, DOI 10.1016/j.neuroscience.2005.11.023; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Standage DI, 2005, NEURAL NETWORKS, V18, P620, DOI 10.1016/j.neunet.2005.06.015; SUTTER ML, 1991, J NEUROPHYSIOL, V65, P1207, DOI 10.1152/jn.1991.65.5.1207; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Wang J, 2000, NEUROREPORT, V11, P1137, DOI 10.1097/00001756-200004070-00045; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	33	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1735	10.1371/journal.pone.0001735	http://dx.doi.org/10.1371/journal.pone.0001735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320054	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586600030
J	Barney, JN; Whitlow, TH; Lembo, AJ				Barney, Jacob N.; Whitlow, Thomas H.; Lembo, Arthur J., Jr.			Revealing Historic Invasion Patterns and Potential Invasion Sites for Two Non-Native Plant Species	PLOS ONE			English	Article							ALIEN PLANTS; SPREAD; CONSEQUENCES; DISPERSAL; BIOLOGY	The historical spatio-temporal distribution of invasive species is rarely documented, hampering efforts to understand invasion dynamics, especially at regional scales. Reconstructing historical invasions through use of herbarium records combined with spatial trend analysis and modeling can elucidate spreading patterns and identify susceptible habitats before invasion occurs. Two perennial species were chosen to contrast historic and potential phytogeographies: Japanese knotweed (Polygonum cuspidatum), introduced intentionally across the US; and mugwort (Artemisia vulgaris), introduced largely accidentally to coastal areas. Spatial analysis revealed that early in the invasion, both species have a stochastic distribution across the contiguous US, but east of the 90(th) meridian, which approximates the Mississippi River, quickly spread to adjacent counties in subsequent decades. In contrast, in locations west of the 90(th) meridian, many populations never spread outside the founding county, probably a result of encountering unfavorable environmental conditions. Regression analysis using variables categorized as environmental or anthropogenic accounted for 24% (Japanese knotweed) and 30% (mugwort) of the variation in the current distribution of each species. Results show very few counties with high habitat suitability (>= 80%) remain un-invaded (5 for Japanese knotweed and 6 for mugwort), suggesting these perennials are reaching the limits of large-scale expansion. Despite differences in initial introduction loci and pathways, Japanese knotweed and mugwort demonstrate similar historic patterns of spread and show declining rates of regional expansion. Invasion mitigation efforts should be concentrated on areas identified as highly susceptible that border invaded regions, as both species demonstrate secondary expansion from introduction loci.	[Barney, Jacob N.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Whitlow, Thomas H.] Cornell Univ, Dept Hort, Ithaca, NY USA; [Lembo, Arthur J., Jr.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA	University of California System; University of California Davis; Cornell University; Cornell University	Barney, JN (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jbarney@ucdavis.edu	Barney, Jacob/C-2412-2008	Barney, Jacob/0000-0003-2949-5003				Baker H., 1986, ECOLOGY BIOL INVASIO, P44; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Barney JN, 2006, CAN J PLANT SCI, V86, P887, DOI 10.4141/P05-170; Barney JN, 2006, BIOL INVASIONS, V8, P703, DOI 10.1007/s10530-005-3174-9; Barney JN, 2003, CAN J PLANT SCI, V83, P205, DOI 10.4141/P01-098; Bollmann J., 2004, Feddes Repertorium, V115, P178; Chauvel B, 2006, J BIOGEOGR, V33, P665, DOI 10.1111/j.1365-2699.2005.01401.x; Colautti RI, 2006, BIOL INVASIONS, V8, P45, DOI 10.1007/s10530-005-0236-y; Dark SJ, 2004, DIVERS DISTRIB, V10, P1, DOI 10.1111/j.1472-4642.2004.00054.x; Delisle F, 2003, J BIOGEOGR, V30, P1033, DOI 10.1046/j.1365-2699.2003.00897.x; Drake JM, 2004, BIOSCIENCE, V54, P931, DOI 10.1641/0006-3568(2004)054[0931:TPDOZM]2.0.CO;2; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Holt JS, 2000, WEED SCI, V48, P43, DOI 10.1614/0043-1745(2000)048[0043:PFSOAT]2.0.CO;2; Mack R.N., 2000, BIOL INVASIONS, V2, P111, DOI DOI 10.1023/A:1010088422771; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; Mihulka S, 2001, J BIOGEOGR, V28, P597, DOI 10.1046/j.1365-2699.2001.00574.x; Morisette JT, 2006, FRONT ECOL ENVIRON, V4, P11, DOI 10.1890/1540-9295(2006)004[0012:ATHSMF]2.0.CO;2; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Novak SJ, 2001, BIOSCIENCE, V51, P114, DOI 10.1641/0006-3568(2001)051[0114:TPIASG]2.0.CO;2; O'sullivan D., 2003, GEOGRAPHIC INFORM AN; Pauchard A, 2006, BIOL INVASIONS, V8, P399, DOI 10.1007/s10530-005-6419-8; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ricciardi A, 2003, FRESHWATER BIOL, V48, P972, DOI 10.1046/j.1365-2427.2003.01071.x; RICH T C G, 1992, Watsonia, V19, P73; Sheeley SE, 1996, B TORREY BOT CLUB, V123, P148, DOI 10.2307/2996072	30	17	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1635	10.1371/journal.pone.0001635	http://dx.doi.org/10.1371/journal.pone.0001635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286192	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400028
J	Leroy, V; Ekouevi, DK; Becquet, R; Viho, I; Dequae-Merchadou, L; Tonwe-Gold, B; Rouet, F; Sakarovitch, C; Horo, A; Timite-Konan, M; Rouzioux, C; Dabis, F				Leroy, Valeriane; Ekouevi, Didier K.; Becquet, Renaud; Viho, Ida; Dequae-Merchadou, Laurence; Tonwe-Gold, Besigin; Rouet, Francois; Sakarovitch, Charlotte; Horo, Appolinaire; Timite-Konan, Marguerite; Rouzioux, Christine; Dabis, Francois		ANRS 1201 1202 DITRAME PLUS Study	18-Month Effectiveness of Short-Course Antiretroviral Regimens Combined with Alternatives to Breastfeeding to Prevent HIV Mother-to-Child Transmission	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-DOSE NEVIRAPINE; COTE-DIVOIRE; POSTNATAL TRANSMISSION; RANDOMIZED-TRIAL; ORAL ZIDOVUDINE; DOUBLE-BLIND; EFFICACY; ABIDJAN; ACCEPTABILITY	Objective: We assessed the 18-month effectiveness of short-course (sc) antiretroviral peripartum regimens combined with alternatives to prolonged breastfeeding to prevent mother-to-child transmission (MTCT) of HIV-1 in Abidjan, Cote d'Ivoire. Methodology: HIV-1 infected pregnant women received from >= 32-36 weeks of gestation scZidovudine (ZDV)+/-Lamivudine (3TC)+single-dose Nevirapine (sdNVP) at delivery within the ANRS 1201/1202 DITRAME-Plus cohort (2001-2003). Neonates received a sdNVP+7-day ZDV prophylaxis. Two infant-feeding interventions were systematically offered free of charge: formula-feeding or exclusive shortened breastfeeding with early cessation from four months. The reference group was the ANRS 049a DITRAME cohort (1994-2000) exposed to scZDV from 36 weeks, then to prolonged breastfeeding. Pediatric HIV infection was defined by a positive plasma HIV-1 RNA at any age, or if aged >= 18 months, a positive HIV-1 serology. Turnbull estimates of cumulative transmission risks (CTR) and effectiveness (HIV-free survival) were compared by exposure group using a Cox model. Findings: Among 926 live-born children enrolled, 107 (11.6%) were HIV-infected at 18 months. CTRs were 22.3% (95% confidence interval[CI]: 16-30%) in the 238 ZDV long-term breastfed reference group, 15.9% (CI: 10-27%) in the 169 ZDV+sdNVP shortened breastfed group; 9.4% (CI: 6-14%) in the 195 ZDV+sdNVP formula-fed group; 6.8% (CI: 4-11%) in the 198 ZDV+3TC+sdNVP shortened breastfed group, and 5.6% (CI: 2-10%) in the 126 ZDV+3TC+sdNVP formula-fed group. Each combination had a significantly higher effectiveness than the ZDV long-term breastfed group except for ZDV+sdNVP shortened breastfed children, ranging from 51% (CI: 20-70%) for ZDV+sdNVP formula fed children to 63% (CI: 40-80%) for ZDV+3TC+NVPsd shortened breastfed children, after adjustment for maternal eligibility for antiretroviral therapy (ART), home delivery and low birth-weight. Substantial MTCT risk reductions are reachable in Africa, even in short-term breastfed children. The two sc antiretroviral combinations associated to any of the two infant feeding interventions, formula-feeding and shortened breastfeeding, reduce significantly MTCT with long-term benefit until age 18 months and without increasing mortality.	[Leroy, Valeriane; Becquet, Renaud; Dequae-Merchadou, Laurence; Sakarovitch, Charlotte; Dabis, Francois] French Natl Inst Hlth & Med Res INSERM, U897, Ctr Rech Epidemiol & Biostat, Bordeaux, France; [Leroy, Valeriane; Becquet, Renaud; Dequae-Merchadou, Laurence; Tonwe-Gold, Besigin; Sakarovitch, Charlotte; Dabis, Francois] Univ Victor Segalen Bordeaux 2, ISPED, Bordeaux, France; [Ekouevi, Didier K.; Viho, Ida; Tonwe-Gold, Besigin] Univ Treichville, Ctr Hosp, ANRS, Programme PACCI, Abidjan, Cote Ivoire; [Rouet, Francois] Univ Treichville, Ctr Hosp, CeDReS, Abidjan, Cote Ivoire; [Horo, Appolinaire] Univ Yopougon, Ctr Hosp, Serv Gyn Obstet, Abidjan, Cote Ivoire; [Timite-Konan, Marguerite] Univ Yopougon, Ctr Hosp, Serv Pediat, Abidjan, Cote Ivoire; [Rouzioux, Christine] Univ Necker Enfants Malades, Ctr Hosp, Lab Virol Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Leroy, V (corresponding author), French Natl Inst Hlth & Med Res INSERM, U897, Ctr Rech Epidemiol & Biostat, Bordeaux, France.	valeriane.leroy@isped.u-bordeaux2.fr	Mandelbrot, Laurent/AAD-3554-2019; Leroy, Valeriane/GQB-1102-2022; Leroy, Valeriane/AAO-5175-2020; Tonwe-Gold, Besigin/AAL-8438-2020; Becquet, Renaud/F-4837-2013; Leroy, Valeriane/F-8129-2013; EKOUEVI, Didier K/E-7960-2014; DABIS, FRANCOIS/S-9298-2019	Mandelbrot, Laurent/0000-0002-5883-7597; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Becquet, Renaud/0000-0003-3277-0985; Leroy, Valeriane/0000-0003-3542-8616; DABIS, FRANCOIS/0000-0002-1614-8857	French Ministry of Foreign Affairs; French Ministry of Education, Research and Technology [fellow]; SIDACTION [fellow]	French Ministry of Foreign Affairs; French Ministry of Education, Research and Technology; SIDACTION	The primary sponsor of the ANRS 1201/1202 Ditrame-Plus Cohort was the Agence Nationale de Recherches sur le Sida (ANRS), from 2000 to 2005. Laurence Bequet and Francois Rouet were supported by the French Ministry of Foreign Affairs. Renaud Becquet was a fellow of the French Ministry of Education, Research and Technology and is now a post-doctoral fellow of the French charity SIDACTION. Didier K. Ekouevi was a fellow of the French charity SIDACTION. Zidovudine and lamivudine were provided by Glaxo Smith Kline International.	Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Becquet R, 2005, JAIDS-J ACQ IMM DEF, V40, P600, DOI 10.1097/01.qai.0000171726.17436.82; BECQUET R, 12011202 ANRS; Chaix ML, 2006, J INFECT DIS, V193, P482, DOI 10.1086/499966; COFFIE P, 2008, SHORT COURSE ZIDOVUD; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Dabis F, 2005, AIDS, V19, P309; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/00002030-200403050-00018; Farquhar C, 2001, AIDS, V15, P815, DOI 10.1097/00002030-200104130-00027; Fawzi WW, 1998, LANCET, V351, P1477, DOI 10.1016/S0140-6736(98)04197-X; Gaillard P, 2001, STAT MED, V20, P3525, DOI 10.1002/sim.1092; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Leroy V, 2007, JAIDS-J ACQ IMM DEF, V44, P77, DOI 10.1097/01.qai.0000243115.37035.97; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; Meda N, 2002, AIDS, V16, P2323, DOI 10.1097/00002030-200211220-00013; Msellati P, 2006, INT J STD AIDS, V17, P57, DOI 10.1258/095646206775220559; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rouet F, 2004, J CLIN MICROBIOL, V42, P4147, DOI 10.1128/JCM.42.9.4147-4153.2004; Rouet F, 2001, AIDS, V15, P1849, DOI 10.1097/00002030-200109280-00015; Saba J, 2002, LANCET, V359, P1178; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; Shapiro RL, 2005, J INFECT DIS, V192, P720, DOI 10.1086/432483; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; *UNICEF UNAIDS WHO, 1998, 9892 WHOFRHNUTCHD UN; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; *WHO, 2006, WHO HIV INF FEED TEC; *WHO UNAIDS UNICEF, 1998, 982 WHOFRHNUTCHD UNA; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; World Health Organization & Unicef, 1993, BREASTF COUNS TRAIN; World Health Organization (WHO), 2004, EM SCAL UP ANT THER	38	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1645	10.1371/journal.pone.0001645	http://dx.doi.org/10.1371/journal.pone.0001645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286200	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400038
J	Lipson, KL; Ghosh, R; Urano, F				Lipson, Kathryn L.; Ghosh, Rajarshi; Urano, Fumihiko			The Role of IRE1 alpha in the Degradation of Insulin mRNA in Pancreatic beta-Cells	PLOS ONE			English	Article								Background: The endoplasmic reticulum (ER) is a cellular compartment for the biosynthesis and folding of newly synthesized secretory proteins such as insulin. Perturbations to ER homeostasis cause ER stress and subsequently activate cell signaling pathways, collectively known as the Unfolded Protein Response (UPR). IRE1 alpha is a central component of the UPR. In pancreatic beta-cells, IRE1 alpha also functions in the regulation of insulin biosynthesis. Principal Findings: Here we report that hyperactivation of IRE1 alpha caused by chronic high glucose treatment or IRE1 alpha overexpression leads to insulin mRNA degradation in pancreatic beta-cells. Inhibition of IRE1 alpha signaling using its dominant negative form prevents insulin mRNA degradation. Islets from mice heterozygous for IRE1 alpha retain expression of more insulin mRNA after chronic high glucose treatment than do their wild-type littermates. Conclusions/Significance: These results reveal a role of IRE1 alpha in insulin mRNA expression under ER stress conditions caused by chronic high glucose. The rapid degradation of insulin mRNA could provide immediate relief for the ER and free up the translocation machinery. Thus, this mechanism would preserve ER homeostasis and help ensure that the insulin already inside the ER can be properly folded and secreted. This adaptation may be crucial for the maintenance of beta-cell homeostasis and may explain why the beta-cells of type 2 diabetic patients with chronic hyperglycemia stop producing insulin in the absence of apoptosis. This mechanism may also be involved in suppression of the autoimmune type 1 diabetes by reducing the amount of misfolded insulin, which could be a source of "neo-autoantigens.''	[Lipson, Kathryn L.; Ghosh, Rajarshi; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Urano, Fumihiko] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lipson, KL (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	urano@erstress.com	Urano, Fumihiko/AAF-4492-2020	Ghosh, Rajarshi/0000-0002-5780-8241	NIH [R01DK067493]; NIH-NIDDK Diabetes and Endocrinology Research Center at the UMass Medical School [DK032520]; Juvenile Diabetes Research Foundation Innovative Award; Iacocca Foundation/JDRF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK067493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIDDK Diabetes and Endocrinology Research Center at the UMass Medical School; Juvenile Diabetes Research Foundation Innovative Award(Juvenile Diabetes Research Foundation); Iacocca Foundation/JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research in the laboratory of F. Urano is supported by an NIH R01DK067493 grant, NIH-NIDDK Diabetes and Endocrinology Research Center at the UMass Medical School (DK032520), a Juvenile Diabetes Research Foundation Innovative Award, and an Iacocca Foundation/JDRF joint Grant.	Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; LEAHY JL, 2004, DIABETES MELLITUS FU, P115; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; MATSUOKA TA, 2007, MOL ENDOCRINOL; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; OLSON LK, 1995, P NATL ACAD SCI USA, V92, P9127, DOI 10.1073/pnas.92.20.9127; OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pirot P, 2007, DIABETOLOGIA, V50, P1006, DOI 10.1007/s00125-007-0609-0; Poitout V, 1996, J CLIN INVEST, V97, P1041, DOI 10.1172/JCI118496; RHODES CJ, 2005, JOSLINS DIABETES MEL, P65; Robertson RP, 2004, DIABETES MELLITUS, P129; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, TRENDS BIOCH SCI; SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	26	137	144	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1648	10.1371/journal.pone.0001648	http://dx.doi.org/10.1371/journal.pone.0001648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286202	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400041
J	Desset, S; Buchon, N; Meignin, C; Coiffet, M; Vaury, C				Desset, Sophie; Buchon, Nicolas; Meignin, Carine; Coiffet, Michael; Vaury, Chantal			In Drosophila melanogaster the COM Locus Directs the Somatic Silencing of Two Retrotransposons through both Piwi-Dependent and -Independent Pathways	PLOS ONE			English	Article							RNA-INTERFERENCE; ENDOGENOUS RETROVIRUS; ZAM; MOBILIZATION; ELEMENTS; PROTEIN; LINE	Background. In the Drosophila germ line, repeat-associated small interfering RNAs (rasiRNAs) ensure genomic stability by silencing endogenous transposable elements. This RNA silencing involves small RNAs of 26-30 nucleotides that are mainly produced from the antisense strand and function through the Piwi protein. Piwi belongs to the subclass of the Argonaute family of RNA interference effector proteins, which are expressed in the germline and in surrounding somatic tissues of the reproductive apparatus. In addition to this germ-line expression, Piwi has also been implicated in diverse functions in somatic cells. Principal Findings. Here, we show that two LTR retrotransposons from Drosophila melanogaster, ZAM and Idefix, are silenced by an RNA silencing pathway that has characteristics of the rasiRNA pathway and that specifically recognizes and destroys the sense-strand RNAs of the retrotransposons. This silencing depends on Piwi in the follicle cells surrounding the oocyte. Interestingly, this silencing is active in all the somatic tissues examined from embryos to adult flies. In these somatic cells, while the silencing still involves the strict recognition of sense-strand transcripts, it displays the marked difference of being independent of the Piwi protein. Finally, we present evidence that in all the tissues examined, the repression is controlled by the heterochromatic COM locus. Conclusion. Our data shed further light on the silencing mechanism that acts to target Drosophila LTR retrotransposons in somatic cells throughout fly development. They demonstrate that different RNA silencing pathways are involved in ovarian versus other somatic tissues, since Piwi is necessary for silencing in the former tissues but is dispensable in the latter. They further demonstrate that these pathways are controlled by the heterochromatic COM locus which ensures the overall protection of Drosophila against the detrimental effects of random retrotransposon mobilization.	[Desset, Sophie; Coiffet, Michael; Vaury, Chantal] Clermont Univ, CNRS, UMR6247, GReD, Clermont Ferrand, France; [Buchon, Nicolas] Ecole Polytech Fed de Lausanne, Lausanne, Switzerland; [Meignin, Carine] Univ Oxford, Dept Biochem, Oxford, England	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Oxford	Vaury, C (corresponding author), Clermont Univ, CNRS, UMR6247, GReD, BP38, Clermont Ferrand, France.	Chantal.VAURY@inserm.u-clermont1.fr	Vaury, Chantal/I-4658-2015; Buchon, Nicolas/AAE-9323-2019; desset, sophie/G-5756-2013; Desset, Sophie/AAM-8212-2021	Vaury, Chantal/0000-0002-7725-5760; Buchon, Nicolas/0000-0003-3636-8387; desset, sophie/0000-0002-4897-4977; Desset, Sophie/0000-0002-4897-4977; Meignin, Carine/0000-0002-6588-9045	CNRS [GDR2157]; Association pour la Recherche contre le Cancer [ARC 3441]; Action Concertee Incitative [ACI BCMS408]; Canceropole Lyon Auvergne Rhone-Alpes; Region Auvergne; Ministere de lEnseignement Superieur et de la Recherche (MESR)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Action Concertee Incitative; Canceropole Lyon Auvergne Rhone-Alpes; Region Auvergne(Region Auvergne-Rhone-Alpes); Ministere de lEnseignement Superieur et de la Recherche (MESR)(Ministry of Research, France)	CV is supported by CNRS (GDR2157), Association pour la Recherche contre le Cancer (ARC 3441), Action Concertee Incitative (ACI BCMS408), Canceropole Lyon Auvergne Rhone-Alpes (CLARA, Projet EpiPro), and Region Auvergne. NB received a grant from the Ministere de lEnseignement Superieur et de la Recherche (MESR).	Ahmad K, 1996, GENETICS, V144, P657; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bernstein E, 2001, RNA, V7, P1509; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Desset S, 1999, MOL BIOL EVOL, V16, P54, DOI 10.1093/oxfordjournals.molbev.a026038; Desset S, 2003, GENETICS, V164, P501; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Leblanc P, 2000, J VIROL, V74, P10658, DOI 10.1128/JVI.74.22.10658-10669.2000; Leblanc P, 1997, EMBO J, V16, P7521, DOI 10.1093/emboj/16.24.7521; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Meignin C, 2004, NUCLEIC ACIDS RES, V32, P3799, DOI 10.1093/nar/gkh708; Pal-Bhadpa M, 2004, COLD SPRING HARB SYM, V69, P433, DOI 10.1101/sqb.2004.69.433; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Robert V, 2001, GENETICS, V158, P701; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	32	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1526	10.1371/journal.pone.0001526	http://dx.doi.org/10.1371/journal.pone.0001526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253480	gold, Green Published, Green Submitted			2022-12-27	WOS:000260535700004
J	Dos Vultos, T; Mestre, O; Rauzier, J; Golec, M; Rastogi, N; Rasolofo, V; Tonjum, T; Sola, C; Matic, I; Gicquel, B				Dos Vultos, Tiago; Mestre, Olga; Rauzier, Jean; Golec, Marcin; Rastogi, Nalin; Rasolofo, Voahangy; Tonjum, Tone; Sola, Christophe; Matic, Ivan; Gicquel, Brigitte			Evolution and Diversity of Clonal Bacteria: The Paradigm of Mycobacterium tuberculosis	PLOS ONE			English	Article								Background. Mycobacterium tuberculosis complex species display relatively static genomes and 99.9% nucleotide sequence identity. Studying the evolutionary history of such monomorphic bacteria is a difficult and challenging task. Principal Findings. We found that single-nucleotide polymorphism (SNP) analysis of DNA repair, recombination and replication (3R) genes in a comprehensive selection of M. tuberculosis complex strains from across the world, yielded surprisingly high levels of polymorphisms as compared to house-keeping genes, making it possible to distinguish between 80% of clinical isolates analyzed in this study. Bioinformatics analysis suggests that a large number of these polymorphisms are potentially deleterious. Site frequency spectrum comparison of synonymous and non-synonymous variants and Ka/Ks ratio analysis suggest a general negative/purifying selection acting on these sets of genes that may lead to suboptimal 3R system activity. In turn, the relaxed fidelity of 3R genes may allow the occurrence of adaptive variants, some of which will survive. Furthermore, 3R-based phylogenetic trees are a new tool for distinguishing between M. tuberculosis complex strains. Conclusions/Significance. This situation, and the consequent lack of fidelity in genome maintenance, may serve as a starting point for the evolution of antibiotic resistance, fitness for survival and pathogenicity, possibly conferring a selective advantage in certain stressful situations. These findings suggest that 3R genes may play an important role in the evolution of highly clonal bacteria, such as M. tuberculosis. They also facilitate further epidemiological studies of these bacteria, through the development of high-resolution tools. With many more microbial genomes being sequenced, our results open the door to 3R gene-based studies of adaptation and evolution of other, highly clonal bacteria.	[Dos Vultos, Tiago; Mestre, Olga; Rauzier, Jean; Golec, Marcin; Sola, Christophe; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Rastogi, Nalin; Rasolofo, Voahangy] Inst Pasteur Guadeloupe, Unite TB Mycobacter, Abymes, Guadeloupe, France; Inst Pasteur Madagascar, Unite TB Mycobacter, Antananarivo, Madagascar; [Tonjum, Tone] Univ Oslo, Inst Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway; [Tonjum, Tone] Inst Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway; [Matic, Ivan] Univ Paris 05, Fac Med, Inst Natl Sante Rech Med U571, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Gicquel, B (corresponding author), Inst Pasteur, Unite Genet Mycobacterienne, Paris, France.	bgicquel@pasteur.fr	RASTOGI, NALIN/AAP-1958-2020; Sola, Christophe/A-7992-2016; Tønjum, Tone/J-4581-2014; Mestre, Olga/D-7418-2013	RASTOGI, NALIN/0000-0002-7199-7747; Sola, Christophe/0000-0003-4672-2140; Mestre, Olga/0000-0002-0993-2248; Tonjum, Tone/0000-0002-1709-6921	European Commission [LSHP-CT-2006-037919, ICA4-CT-2002-10052]; European Commission [LSHP-CT-2006-037919, ICA4-CT-2002-10052]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work received support from the European Commission (TB Adapt project LSHP-CT-2006-037919 and VACSIS project ICA4-CT-2002-10052).	Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Dos Vultos T, 2006, J BACTERIOL, V188, P3159, DOI 10.1128/JB.188.8.3159-3161.2006; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Gutacker MM, 2002, GENETICS, V162, P1533; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liu XM, 2006, J BACTERIOL, V188, P8169, DOI 10.1128/JB.01062-06; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rosas-Magallanes V, 2006, MOL BIOL EVOL, V23, P1129, DOI 10.1093/molbev/msj120; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Tonjum Tone, 2001, Trends in Microbiology, V9, P356, DOI 10.1016/S0966-842X(01)02099-6; TYE BK, 1978, P NATL ACAD SCI USA, V75, P233, DOI 10.1073/pnas.75.1.233	25	101	103	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1538	10.1371/journal.pone.0001538	http://dx.doi.org/10.1371/journal.pone.0001538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253486	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700010
J	Kotera, M; McDonald, AG; Boyce, S; Tipton, KF				Kotera, Masaaki; McDonald, Andrew G.; Boyce, Sinead; Tipton, Keith F.			Functional Group and Substructure Searching as a Tool in Metabolomics	PLOS ONE			English	Article								Background. A direct link between the names and structures of compounds and the functional groups contained within them is important, not only because biochemists frequently rely on literature that uses a free-text format to describe functional groups, but also because metabolic models depend upon the connections between enzymes and substrates being known and appropriately stored in databases. Methodology. We have developed a database named "Biochemical Substructure Search Catalogue'' (BiSSCat), which contains 489 functional groups, >200,000 compounds and >1,000,000 different computationally constructed substructures, to allow identification of chemical compounds of biological interest. Conclusions. This database and its associated web-based search program (http://bisscat.org/) can be used to find compounds containing selected combinations of substructures and functional groups. It can be used to determine possible additional substrates for known enzymes and for putative enzymes found in genome projects. Its applications to enzyme inhibitor design are also discussed.	[Kotera, Masaaki; McDonald, Andrew G.; Boyce, Sinead; Tipton, Keith F.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	Kotera, M (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	koteram@tcd.ie	Kotera, Masaaki/AAJ-9938-2020	McDonald, Andrew/0000-0003-2727-176X	Science Foundation Ireland [SFI 02/IN.1/B043- Tipton]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We are grateful to Science Foundation Ireland (grant No. SFI 02/IN.1/B043- Tipton) for support.	Allen F.H., 1993, CHEM DESIGN AUTOMATI, V8, P1; Allen F.H., 1993, CHEM DESIGN AUTOMATI, V8, P31; Antal J, 2001, ANAL BIOCHEM, V288, P156, DOI 10.1006/abio.2000.4886; Arimoto R, 2006, CURR TOP MED CHEM, V6, P1609, DOI 10.2174/156802606778108951; Ash S, 1997, J CHEM INF COMP SCI, V37, P71, DOI 10.1021/ci960109j; BARNARD JM, 1989, ACS SYM SER, V400, P76; Bayada DM, 1999, J CHEM INF COMP SCI, V39, P1, DOI 10.1021/ci980109e; Brown RD, 1997, J CHEM INF COMP SCI, V37, P1, DOI 10.1021/ci960373c; Brown RD, 1996, J CHEM INF COMP SCI, V36, P572, DOI 10.1021/ci9501047; BUSH BL, 1993, J CHEM INF COMP SCI, V33, P756, DOI 10.1021/ci00015a015; Chang C, 2006, ADV DRUG DELIVER REV, V58, P1431, DOI 10.1016/j.addr.2006.09.006; Chen B, 2007, J COMPUT AID MOL DES, V21, P53, DOI 10.1007/s10822-006-9096-5; Coles SJ, 2005, ORG BIOMOL CHEM, V3, P1832, DOI 10.1039/b502828k; DALBY A, 1992, J CHEM INF COMP SCI, V32, P244, DOI 10.1021/ci00007a012; Ellis LBM, 2006, NUCLEIC ACIDS RES, V34, pD517, DOI 10.1093/nar/gkj076; Flower DR, 1998, J CHEM INF COMP SCI, V38, P379, DOI 10.1021/ci970437z; FOX RB, NOMENCLATURE ORGANIC; GREENE N, 1999, KNOWLEDGE BASED EXPE, P289; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Hofmann O, 2005, BIOINFORMATICS, V21, P2059, DOI 10.1093/bioinformatics/bti284; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; IHLENFELDT WD, 1994, J COMPUT CHEM, V15, P793, DOI 10.1002/jcc.540150802; Ihlenfeldt WD, 2002, J CHEM INF COMP SCI, V42, P46, DOI 10.1021/ci010056s; International Union of Pure and Applied Chemistry, 1979, NOM ORG CHEM; James C.A., 2000, DAYLIGHT THEORY MANU, DOI 10.1002/mus.23684; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Khedkar SA, 2007, MED CHEM, V3, P187, DOI 10.2174/157340607780059521; Klopman Gilles, 1997, Environmental Toxicology and Chemistry, V16, P1829, DOI 10.1897/1551-5028(1997)016<1829:SBSACA>2.3.CO;2; Kotera M, 2004, J AM CHEM SOC, V126, P16487, DOI 10.1021/ja0466457; Kotera M, 2004, GENOME INFORM, V15, pP062; Leigh G.J., 1998, PRINCIPLES CHEM NOME; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McDonald Andrew G, 2007, BMC Biochem, V8, P14, DOI 10.1186/1471-2091-8-14; Muegge I, 2002, CHEM-EUR J, V8, P1976, DOI 10.1002/1521-3765(20020503)8:9<1976::AID-CHEM1976>3.0.CO;2-K; NICOLAOU CA, 2007, CURR OPIN DRUG DISC, P10; Oellien F, 2005, J CHEM INF MODEL, V45, P1456, DOI 10.1021/ci050202k; Polanski J, 2003, ADV DRUG DELIVER REV, V55, P1149, DOI 10.1016/S0169-409X(03)00116-9; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Poroikov VV, 2003, J CHEM INF COMP SCI, V43, P228, DOI 10.1021/ci020048r; Raymond JW, 2002, J COMPUT AID MOL DES, V16, P521, DOI 10.1023/A:1021271615909; Raymond JW, 2002, J CHEM INF COMP SCI, V42, P305, DOI 10.1021/ci010381f; Raymond JW, 2002, COMPUT J, V45, P631, DOI 10.1093/comjnl/45.6.631; Richmond NJ, 2006, J COMPUT AID MOL DES, V20, P567, DOI 10.1007/s10822-006-9082-y; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; WEININGER D, 1990, J CHEM INF COMP SCI, V30, P237, DOI 10.1021/ci00067a005; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wild DJ, 2000, J CHEM INF COMP SCI, V40, P155, DOI 10.1021/ci990086j; WISNIEWSKI JL, 1998, ENCY COMPUTATIONAL C, P1881; Wiswesser W.J., 1954, LINE FORMULA CHEM NO; WISWESSER WJ, 1982, J CHEM INF COMP SCI, V22, P88, DOI 10.1021/ci00034a005; WISWESSER WJ, 1985, J CHEM INF COMP SCI, V25, P258, DOI 10.1021/ci00047a023	51	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1537	10.1371/journal.pone.0001537	http://dx.doi.org/10.1371/journal.pone.0001537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253485	gold, Green Published			2022-12-27	WOS:000260535700009
J	Brascamp, JW; Knapen, THJ; Kanai, R; Noest, AJ; van Ee, R; van den Berg, AV				Brascamp, Jan W.; Knapen, Tomas H. J.; Kanai, Ryota; Noest, Andre J.; van Ee, Raymond; van den Berg, Albert V.			Multi-Timescale Perceptual History Resolves Visual Ambiguity	PLOS ONE			English	Article							NEURAL PLASTICITY; BINOCULAR-RIVALRY; CONTRAST GAIN; ADAPTATION; ATTENTION; DYNAMICS; DOMINANCE; CORTEX	When visual input is inconclusive, does previous experience aid the visual system in attaining an accurate perceptual interpretation? Prolonged viewing of a visually ambiguous stimulus causes perception to alternate between conflicting interpretations. When viewed intermittently, however, ambiguous stimuli tend to evoke the same percept on many consecutive presentations. This perceptual stabilization has been suggested to reflect persistence of the most recent percept throughout the blank that separates two presentations. Here we show that the memory trace that causes stabilization reflects not just the latest percept, but perception during a much longer period. That is, the choice between competing percepts at stimulus reappearance is determined by an elaborate history of prior perception. Specifically, we demonstrate a seconds-long influence of the latest percept, as well as a more persistent influence based on the relative proportion of dominance during a preceding period of at least one minute. In case short-term perceptual history and long-term perceptual history are opposed (because perception has recently switched after prolonged stabilization), the long-term influence recovers after the effect of the latest percept has worn off, indicating independence between time scales. We accommodate these results by adding two positive adaptation terms, one with a short time constant and one with a long time constant, to a standard model of perceptual switching.	[Brascamp, Jan W.; Noest, Andre J.; van den Berg, Albert V.] Univ Utrecht, Helmholtz Inst, Funct Neurobiol, Utrecht, Netherlands; [Knapen, Tomas H. J.; van Ee, Raymond] Univ Utrecht, Helmholtz Inst, Dept Phys, Utrecht, Netherlands; [Kanai, Ryota] CALTECH, Biol Div, Pasadena, CA USA	Utrecht University; Utrecht University; California Institute of Technology	Brascamp, JW (corresponding author), Univ Utrecht, Helmholtz Inst, Funct Neurobiol, Utrecht, Netherlands.	j.w.brascamp@uu.nl; r.vanee@phys.uu.nl	Kanai, Ryota/A-1191-2007; Knapen, Tomas/H-4431-2019; van den Berg, Albert/G-3108-2012; van Ee, Raymond/C-4881-2013; Brascamp, Jan/W-5294-2018	Knapen, Tomas/0000-0001-5863-8689; Kanai, Ryota/0000-0002-0186-2687; van den Berg, Albert Victor/0000-0002-1543-5408; van Ee, Raymond/0000-0002-1134-8665				ALBRECHT DG, 1984, J PHYSIOL-LONDON, V347, P713, DOI 10.1113/jphysiol.1984.sp015092; BONDS AB, 1991, VISUAL NEUROSCI, V6, P239, DOI 10.1017/S0952523800006258; Brascamp JW, 2007, J VISION, V7, DOI 10.1167/7.12.12; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Dorris MC, 2000, J NEUROSCI, V20; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Jiang Y, 1998, PERCEPT PSYCHOPHYS, V60, P275, DOI 10.3758/BF03206036; Kanai R, 2005, VISION RES, V45, P3109, DOI 10.1016/j.visres.2005.05.014; Kristjansson A, 2006, VIS COGN, V13, P324, DOI 10.1080/13506280544000039; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Maier A, 2003, CURR BIOL, V13, P1076, DOI 10.1016/S0960-9822(03)00414-7; Maljkovic V, 2000, VIS COGN, V7, P571, DOI 10.1080/135062800407202; Maloney LT, 2005, P NATL ACAD SCI USA, V102, P3164, DOI 10.1073/pnas.0407157102; McPeek RM, 1999, VISION RES, V39, P1555, DOI 10.1016/S0042-6989(98)00228-4; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; ORBACH J, 1963, Percept Mot Skills, V17, P439; PASTUKHOV A, 2007, J VIS, V7, P367, DOI DOI 10.1167/7.9.367; Pearson J, 2005, VISION RES, V45, P707, DOI 10.1016/j.visres.2004.09.040; ROSE D, 1982, PERCEPTION, V11, P505, DOI 10.1068/p110505; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wilson HR, 2007, VISION RES, V47, P2741, DOI 10.1016/j.visres.2007.07.007; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	30	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1497	10.1371/journal.pone.0001497	http://dx.doi.org/10.1371/journal.pone.0001497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SR	18231584	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000260504200010
J	Brosnan, SF; Grady, MF; Lambeth, SP; Schapiro, SJ; Beran, MJ				Brosnan, Sarah F.; Grady, Mark F.; Lambeth, Susan P.; Schapiro, Steven J.; Beran, Michael J.			Chimpanzee Autarky	PLOS ONE			English	Article							PAN-TROGLODYTES; EXCHANGE; RECIPROCITY; MONKEYS; OBJECTS	Economists believe that barter is the ultimate cause of social wealth-and even much of our human culture-yet little is known about the evolution and development of such behavior. It is useful to examine the circumstances under which other species will or will not barter to more fully understand the phenomenon. Chimpanzees (Pan troglodytes) are an interesting test case as they are an intelligent species, closely related to humans, and known to participate in reciprocal interactions and token economies with humans, yet they have not spontaneously developed costly barter. Methodology/Principle Findings. Although chimpanzees do engage in noncostly barter, in which otherwise value-less tokens are exchanged for food, this lack of risk is not typical of human barter. Thus, we systematically examined barter in chimpanzees to ascertain under what circumstances chimpanzees will engage in costly barter of commodities, that is, trading food items for other food items with a human experimenter. We found that chimpanzees do barter, relinquishing lower value items to obtain higher value items (and not the reverse). However, they do not trade in all beneficial situations, maintaining possession of less preferred items when the relative gains they stand to make are small. Conclusions/Significance. Two potential explanations for this puzzling behavior are that chimpanzees lack ownership norms, and thus have limited opportunity to benefit from the gains of trade, and that chimpanzees' risk of defection is sufficiently high that large gains must be imminent to justify the risk. Understanding the conditions that support barter in chimpanzees may increase understanding of situations in which humans, too, do not maximize their gains.	[Brosnan, Sarah F.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Brosnan, Sarah F.; Lambeth, Susan P.; Schapiro, Steven J.] Univ Texas, MD Anderson Canc Ctr, Michale E Keeling Ctr Compar Med & Res, Houston, TX USA; [Brosnan, Sarah F.; Beran, Michael J.] Georgia State Univ, Language Res Ctr, Atlanta, GA USA; [Grady, Mark F.] Univ Calif Los Angeles, Ctr Law & Econ, Los Angeles, CA USA	Emory University; University of Texas System; UTMD Anderson Cancer Center; University System of Georgia; Georgia State University; University of California System; University of California Los Angeles	Brosnan, SF (corresponding author), Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA.	sbrosnan@gsu.edu	Beran, Michael J./M-8743-2016; Beran, Michael J./ABY-1786-2022	Beran, Michael J./0000-0002-2504-0338; Beran, Michael J./0000-0002-2504-0338; Schapiro, Steven J./0000-0001-5406-1739	NSF [SES 0729244, BCS-0634662]; NIH/NIGMS [IRACDA]; NICHD [HD-38051]; NIH/NCRR; College of Arts and Sciences, Georgia State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038051] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); College of Arts and Sciences, Georgia State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	SFB was supported by NSF grant SES 0729244 and an NIH/NIGMS IRACDA grant awarded to Emory University. MJB was supported by NICHD grant HD-38051, and NSF grants BCS-0634662 and SES 0729244. The Bastrop colony was supported by NIH/NCRR. The LRC colony was supported by NICHD HD-38051 and the College of Arts and Sciences, Georgia State University.	ADDESSI E, 2007, P ROY SOC LOND B BIO, V274, P2709; Beran MJ, 2006, BEHAV PROCESS, V73, P315, DOI 10.1016/j.beproc.2006.07.005; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brosnan SF, 2007, CURR BIOL, V17, P1704, DOI 10.1016/j.cub.2007.08.059; Brosnan SF, 2005, PRIMATES, V46, P173, DOI 10.1007/s10329-005-0125-0; Brosnan SF, 2004, FOLIA PRIMATOL, V75, P317, DOI 10.1159/000080209; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Chalmeau R, 1998, PRIMATES, V39, P389, DOI 10.1007/BF02557563; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; DEWAAL FBM, 1988, ETHOL SOCIOBIOL, V9, P101, DOI 10.1016/0162-3095(88)90016-7; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; Dufour V, 2007, J COMP PSYCHOL, V121, P145, DOI 10.1037/0735-7036.121.2.145; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; HYATT CW, 1988, BEHAV PROCESS, V42, P177; LEFEBVRE L, 1982, J HUM EVOL, V11, P195, DOI 10.1016/S0047-2484(82)80036-5; Mitani JC, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P107, DOI 10.1007/3-540-28277-7_6; Paquette D., 1992, Human Evolution, V7, P11, DOI 10.1007/BF02436256; Rumbaugh D. M., 2003, INTELLIGENCE APES OT; SAVAGERUMBAUGH ES, 1978, BEHAV BRAIN SCI, V1, P539, DOI 10.1017/S0140525X00076536; Smith A, 2004, WEALTH NATIONS; Sousa C, 2001, Anim Cogn, V4, P213, DOI 10.1007/s100710100104; THEIRRY B, 1989, BEHAVIOUR, V110, P294; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; WESTERGAARD GC, 2007, TOKEN MEDIATED TOOL	27	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1518	10.1371/journal.pone.0001518	http://dx.doi.org/10.1371/journal.pone.0001518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SR	18231604	Green Published, gold			2022-12-27	WOS:000260504200030
J	Chesler, AT; Le Pichon, CE; Brann, JH; Araneda, RC; Zou, DJ; Firestein, S				Chesler, Alexander T.; Le Pichon, Claire E.; Brann, Jessica H.; Araneda, Ricardo C.; Zou, Dong-Jing; Firestein, Stuart			Selective Gene Expression by Postnatal Electroporation during Olfactory Interneuron Neurogenesis	PLOS ONE			English	Article								Neurogenesis persists in the olfactory system throughout life. The mechanisms of how new neurons are generated, how they integrate into circuits, and their role in coding remain mysteries. Here we report a technique that will greatly facilitate research into these questions. We found that electroporation can be used to robustly and selectively label progenitors in the Subventicular Zone. The approach was performed postnatally, without surgery, and with near 100% success rates. Labeling was found in all classes of intemeurons in the olfactory bulb, persisted to adulthood and had no adverse effects. The broad utility of electroporation was demonstrated by encoding a calcium sensor and markers of intracellular organelles. The approach was found to be effective in wildtype and transgenic mice as well as rats. Given its versatility, robustness, and both time and cost effectiveness, this method offers a powerful new way to use genetic manipulation to understand adult neurogenesis.	[Chesler, Alexander T.; Le Pichon, Claire E.; Brann, Jessica H.; Zou, Dong-Jing; Firestein, Stuart] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Araneda, Ricardo C.] Univ Maryland, Dept Biol, College Pk, MD USA	Columbia University; University System of Maryland; University of Maryland College Park	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	sjf24@columbia.edu	Araneda, Ricardo/AAN-1051-2020; Brann, Jessica/B-4031-2010; Le Pichon, Claire/ABB-9829-2020; Chesler, Alexander/V-2748-2019	Araneda, Ricardo/0000-0001-8728-3063; Le Pichon, Claire/0000-0002-9274-3615; Chesler, Alexander/0000-0002-3131-0728	NIH; NIDCD	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH, NIDCD	Belluzzi O, 2003, J NEUROSCI, V23, P10411; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Diez-Garcia J, 2007, NEUROIMAGE, V34, P859, DOI 10.1016/j.neuroimage.2006.10.021; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Ehlers MD, 2007, NEURON, V55, P686, DOI 10.1016/j.neuron.2007.08.009; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lee MY, 2006, P NATL ACAD SCI USA, V103, P13232, DOI 10.1073/pnas.0605757103; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Miyasaka N, 1999, NEUROREPORT, V10, P2319, DOI 10.1097/00001756-199908020-00018; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Puopolo M, 1998, EUR J NEUROSCI, V10, P1073, DOI 10.1046/j.1460-9568.1998.00115.x; Qiu DL, 2007, J NEUROSCI, V27, P3408, DOI 10.1523/JNEUROSCI.4831-06.2007; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	21	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1517	10.1371/journal.pone.0001517	http://dx.doi.org/10.1371/journal.pone.0001517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231603	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200029
J	Khalil, AM; Faghihi, MA; Modarresi, F; Brothers, SP; Wahlestedt, C				Khalil, Ahmad M.; Faghihi, Mohammad Ali; Modarresi, Farzaneh; Brothers, Shaun P.; Wahlestedt, Claes			A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome	PLOS ONE			English	Article								Several genome-wide transcriptomics efforts have shown that a large percentage of the mammalian genome is transcribed into RNAs, however, only a small percentage (1-2%) of these RNAs is translated into proteins. Currently there is an intense interest in characterizing the function of the different classes of noncoding RNAs and their relevance to human disease. Using genomic approaches we discovered FMR4, a primate-specific noncoding RNA transcript (2.4 kb) that resides upstream and likely shares a bidirectional promoter with FMR1. FMR4 is a product of RNA polymerase II and has a similar half-life to FMR1. The CGG expansion in the 5' UTR of FMR1 appears to affect transcription in both directions as we found FMR4, similar to FMR1, to be silenced in fragile X patients and up-regulated in premutation carriers. Knockdown of FMR4 by several siRNAs did not affect FMR1 expression, nor vice versa, suggesting that FMR4 is not a direct regulatory transcript for FMR1. However, FMR4 markedly affected human cell proliferation in vitro; siRNAs knockdown of FMR4 resulted in alterations in the cell cycle and increased apoptosis, while the overexpression of FMR4 caused an increase in cell proliferation. Collectively, our results demonstrate an antiapoptotic function of FMR4 and provide evidence that a well-studied genomic locus can show unexpected functional complexity. It cannot be excluded that altered FMR4 expression might contribute to aspects of the clinical presentation of fragile X syndrome and/or related disorders.	[Khalil, Ahmad M.; Faghihi, Mohammad Ali; Modarresi, Farzaneh; Brothers, Shaun P.; Wahlestedt, Claes] Scripps Res Inst, MIND, Jupiter, FL USA	Scripps Research Institute	Wahlestedt, C (corresponding author), Scripps Res Inst, MIND, Jupiter, FL USA.	clawah@scripps.edu	Faghihi, Mohammad Ali/AAD-7159-2020; Faghihi, Mohammad Ali/AAH-3139-2019; Brothers, Shaun/G-8690-2012	Faghihi, Mohammad Ali/0000-0002-8330-9067; Brothers, Shaun/0000-0003-2184-4037	Conquer Fragile X Foundation; Scripps Research Institute	Conquer Fragile X Foundation; Scripps Research Institute	Conquer Fragile X Foundation and the Scripps Research Institute have provided funding.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; IKEDA S, 2007, PHYSL GENOMICS; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; LADD PD, 2007, HUM MOL GENET; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Oostra BA, 2003, HUM MOL GENET, V12, pR249, DOI 10.1093/hmg/ddg298; Oostra BA, 2001, CLIN GENET, V60, P399, DOI 10.1034/j.1399-0004.2001.600601.x; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; SREERAM N, 1989, BRIT HEART J, V61, P289; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2001, J MED GENET, V38, P453, DOI 10.1136/jmg.38.7.453; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wahlestedt C, 2006, DRUG DISCOV TODAY, V11, P503, DOI 10.1016/j.drudis.2006.04.013; WALDSTEIN G, 1988, AM J MED GENET, V30, P83, DOI 10.1002/ajmg.1320300107	34	144	150	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1486	10.1371/journal.pone.0001486	http://dx.doi.org/10.1371/journal.pone.0001486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213394	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503900031
J	Sokhna, C; Cisse, B; Ba, EH; Milligan, P; Hallett, R; Sutherland, C; Gaye, O; Boulanger, D; Simondon, K; Simondon, F; Targett, G; Lines, J; Greenwood, B; Trape, JF				Sokhna, Cheikh; Cisse, Badara; Ba, El Hadj; Milligan, Paul; Hallett, Rachel; Sutherland, Colin; Gaye, Oumar; Boulanger, Denis; Simondon, Kirsten; Simondon, Francois; Targett, Geoffrey; Lines, Jo; Greenwood, Brian; Trape, Jean-Francois			A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children	PLOS ONE			English	Article								In the Sahel, most malaria deaths occur among children 1-4 years old during a short transmission season. A trial of seasonal intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine (SP) and a single dose of artesunate (AS) showed an 86% reduction in the incidence of malaria in Senegal but this may not be the optimum regimen. We compared this regimen with three alternatives. Methods. 2102 children aged 6-59 months received either one dose of SP plus one dose of AS (SP+1AS) ( the previous regimen), one dose of SP plus 3 daily doses of AS (SP+3AS), one dose of SP plus three daily doses of amodiaquine (AQ) (SP+3AQ) or 3 daily doses of AQ and AS (3AQ+3AS). Treatments were given once a month on three occasions during the malaria transmission season. The primary end point was incidence of clinical malaria. Secondary end-points were incidence of adverse events, mean haemoglobin concentration and prevalence of parasites carrying markers of resistance to SP. Findings. The incidence of malaria, and the prevalence of parasitaemia at the end of the transmission season, were lowest in the group that received SP+3AQ: 10% of children in the group that received SP+1AS had malaria, compared to 9% in the SP+3AS group (hazard ratio HR 0.90, 95% CI 0.60, 1.36); 11% in the 3AQ+3AS group, HR 1.1 (0.76-1.7); and 5% in the SP+3AQ group, HR 0.50 (0.30-0.81). Mutations associated with resistance to SP were present in almost all parasites detected at the end of the transmission season, but the prevalence of Plasmodium falciparum was very low in the SP+3AQ group. Conclusions. Monthly treatment with SP+3AQ is a highly effective regimen for seasonal IPT. Choice of this regimen would minimise the spread of drug resistance and allow artemisinins to be reserved for the treatment of acute clinical malaria. Trial Registration. Clinicaltrials.gov NCT00132548	[Sokhna, Cheikh; Ba, El Hadj; Boulanger, Denis; Simondon, Kirsten; Simondon, Francois; Trape, Jean-Francois] Inst Rech Dev, Dakar, Senegal; [Cisse, Badara; Gaye, Oumar] Univ Cheikh Anta Diop Dakar, Dakar, Senegal; [Milligan, Paul; Hallett, Rachel; Sutherland, Colin; Targett, Geoffrey; Lines, Jo; Greenwood, Brian] London Sch Hyg & Tropical Med, London, England	Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of London; London School of Hygiene & Tropical Medicine	Sokhna, C (corresponding author), Inst Rech Dev, Dakar, Senegal.	sokhna@ird.sn; paul.milligan@lshtm.ac.uk	Sutherland, Colin/AAN-3939-2020; BOULANGER, Denis/G-9644-2016; Milligan, Paul/D-8985-2017	Sutherland, Colin/0000-0003-1592-6407; BOULANGER, Denis/0000-0002-8757-0350; Milligan, Paul/0000-0003-3430-3395; Lines, Jo/0000-0001-5380-4916; Bork, Kirsten/0000-0002-5909-7332; Simondon, Francois/0000-0003-0395-1314	Bill and Melinda Gates Foundation; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The trial was funded by the Bill and Melinda Gates Foundation. The sponsor played no role in the design and conduct of the study or preparation of the paper.	Breman JG, 2001, AM J TROP MED HYG, V64, P1; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; DICKO A, 2004, AM J TROP MED HY SS6, V71; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Greenwood B, 2004, AM J TROP MED HYG, V70, P1; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; LENGELER C, 2001, COCHRANE LIB; MACETE E, 2005, ACTA TROPICA SS5, V95; Marks F, 2005, J INFECT DIS, V192, P1962, DOI 10.1086/497698; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; MAYOR A, 2005, ACTA TROPICA SS68, V95; MENON A, 1988, J TROP MED HYG, V91, P49; NDIAYE F, 1998, ENDEMIE PALUSTRE SIT, P118; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Sokhna CS, 1997, B SOC PATHOL EXOT, V90, P83; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7	24	66	67	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1471	10.1371/journal.pone.0001471	http://dx.doi.org/10.1371/journal.pone.0001471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213379	Green Published, Green Accepted, gold			2022-12-27	WOS:000260503900016
J	Pezeron, G; Lambert, G; Dickmeis, T; Strahle, U; Rosa, FM; Mourrain, P				Pezeron, Guillaume; Lambert, Guillaume; Dickmeis, Thomas; Straehle, Uwe; Rosa, Frederic M.; Mourrain, Philippe			Rasl11b Knock Down in Zebrafish Suppresses One-Eyed-Pinhead Mutant Phenotype	PLOS ONE			English	Article							ENDODERM FORMATION; ACTIVIN RECEPTOR; AXIS FORMATION; NODAL SIGNALS; RAS PROTEINS; TARAM-A; GENE; PATHWAY; CRIPTO; IDENTIFICATION	The EGF-CFC factor Oep/Cripto1/Frl1 has been implicated in embryogenesis and several human cancers. During vertebrate development, Oep/Cripto1/Frl1 has been shown to act as an essential coreceptor in the TGF beta/Nodal pathway, which is crucial for germ layer formation. Although studies in cell cultures suggest that Oep/Cripto1/Frl1 is also implicated in other pathways, in vivo it is solely regarded as a Nodal coreceptor. We have found that Rasl11b, a small GTPase belonging to a Ras subfamily of putative tumor suppressor genes, modulates Oep function in zebrafish independently of the Nodal pathway. rasl11b down regulation partially rescues endodermal and prechordal plate defects of zygotic oep(-/-) mutants (Zoep). Rasl11b inhibitory action was only observed in oep-deficient backgrounds, suggesting that normal oep expression prevents Rasl11b function. Surprisingly, rasl11b down regulation does not rescue mesendodermal defects in other Nodal pathway mutants, nor does it influence the phosphorylation state of the downstream effector Smad2. Thus, Rasl11b modifies the effect of Oep on mesendoderm development independently of the main known Oep output: the Nodal signaling pathway. This data suggests a new branch of Oep signaling that has implications for germ layer development, as well as for studies of Oep/Frl1/Cripto1 dysfunction, such as that found in tumors.	[Pezeron, Guillaume; Lambert, Guillaume; Rosa, Frederic M.] INSERM, U784, Paris, France; [Pezeron, Guillaume; Lambert, Guillaume; Rosa, Frederic M.; Mourrain, Philippe] Ecole Normale Superieure, Paris, France; [Dickmeis, Thomas] Max Planck Inst Dev Biol, Tubingen, Germany; [Straehle, Uwe] Inst Toxicol & Genetics, Forschungszentrum Karlsruhe, Karlsruhe, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology	Mourrain, P (corresponding author), INSERM, U784, Paris, France.	mourrain@wotan.ens.fr	Straehle, Uwe/K-7054-2013; Mourrain, Philippe/N-4671-2017; Rosa, Frederic/L-5990-2017; PEZERON, Guillaume/A-6291-2009; Dickmeis, Thomas/H-1355-2013; PEZERON, Guillaume/ABB-8395-2021	Pezeron, Guillaume/0000-0003-1395-6397	Ministere de l'Enseignement Superieur et de la Recherche fellowship; La ligue Nationale Contre le Cancer; EU FP6 program [ZF-MODELS]; Association pour le Recherche contre le Cancer	Ministere de l'Enseignement Superieur et de la Recherche fellowship; La ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); EU FP6 program(European Commission); Association pour le Recherche contre le Cancer	GP was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche and La ligue Nationale Contre le Cancer. FR was supported by grants ZF-MODELS (EU FP6 program) and Association pour le Recherche contre le Cancer.	Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Aoki TO, 2002, DEV BIOL, V241, P273, DOI 10.1006/dbio.2001.0510; Aoki TO, 2002, DEVELOPMENT, V129, P275; Barradas M, 2002, EXP CELL RES, V273, P127, DOI 10.1006/excr.2001.5434; Bianco C, 2003, CANCER RES, V63, P1192; Bianco C, 2002, MOL CELL BIOL, V22, P2586, DOI 10.1128/MCB.22.8.2586-2597.2002; BRANDT R, 1994, J BIOL CHEM, V269, P17320; Cheng AMS, 2000, DEVELOPMENT, V127, P1049; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; CONLON FL, 1994, DEVELOPMENT, V120, P1919; David NB, 2001, DEVELOPMENT, V128, P3937; De Santis ML, 1997, CELL GROWTH DIFFER, V8, P1257; Dickmeis T, 2001, DEV DYNAM, V222, P571, DOI 10.1002/dvdy.1220; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Etard C, 2005, DEV DYNAM, V234, P1016, DOI 10.1002/dvdy.20592; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Halpern ME, 1997, DEV BIOL, V187, P154, DOI 10.1006/dbio.1997.8605; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Key MD, 2006, METHOD ENZYMOL, V407, P513, DOI 10.1016/S0076-6879(05)07041-2; Kiecker C, 2000, MECH DEVELOP, V94, P37, DOI 10.1016/S0925-4773(00)00329-4; Kikuchi Y, 2000, GENE DEV, V14, P1279; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Louro R, 2004, BIOCHEM BIOPH RES CO, V316, P618, DOI 10.1016/j.bbrc.2004.02.091; Maroon H, 2002, DEVELOPMENT, V129, P2099; Melby AE, 1996, DEVELOPMENT, V122, P2225; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Minchiotti G, 2000, MECH DEVELOP, V90, P133, DOI 10.1016/S0925-4773(99)00235-X; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nieto M, 2007, ONCOGENE, V26, P1673, DOI 10.1038/sj.onc.1209978; Normanno N, 2004, J CELL PHYSIOL, V198, P31, DOI 10.1002/jcp.10375; Norton WH, 2005, DEVELOPMENT, V132, P645, DOI 10.1242/dev.01611; Osada SI, 1999, DEVELOPMENT, V126, P3229; Peyrieras N, 1998, CURR BIOL, V8, P783, DOI 10.1016/S0960-9822(98)70303-3; Poulain M, 2002, DEVELOPMENT, V129, P4901; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Renucci A, 1996, DEVELOPMENT, V122, P3735; ROSA FM, 2002, SCI STKE, pPE47; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 1997, DEVELOPMENT, V124, P327; SEKIYA T, 1984, P NATL ACAD SCI-BIOL, V81, P4771, DOI 10.1073/pnas.81.15.4771; Shen MM, 1997, DEVELOPMENT, V124, P429; Silva J, 2006, MUTAT RES-FUND MOL M, V594, P78, DOI 10.1016/j.mrfmmm.2005.07.017; Strahle U, 1997, Genes Funct, V1, P131; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Thisse C, 1999, DEVELOPMENT, V126, P229; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Warga RA, 2003, DEV BIOL, V261, P391, DOI 10.1016/S0012-1606(03)00328-2; Warga RM, 1999, DEVELOPMENT, V126, P827; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; Xu CH, 1999, DEVELOPMENT, V126, P483; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	70	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1434	10.1371/journal.pone.0001434	http://dx.doi.org/10.1371/journal.pone.0001434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197245	gold, Green Submitted, Green Published			2022-12-27	WOS:000260503800006
J	Watt, S; Mata, J; Lopez-Maury, L; Marguerat, S; Burns, G; Bahler, J				Watt, Stephen; Mata, Juan; Lopez-Maury, Luis; Marguerat, Samuel; Burns, Gavin; Bahler, Jurg			urg1: A Uracil-Regulatable Promoter System for Fission Yeast with Short Induction and Repression Times	PLOS ONE			English	Article								Background. The fission yeast Schizosaccharomyces pombe is a popular genetic model organism with powerful experimental tools. The thiamine-regulatable nmt1 promoter and derivatives, which take > 15 hours for full induction, are most commonly used for controlled expression of ectopic genes. Given the short cell cycle of fission yeast, however, a promoter system that can be rapidly regulated, similar to the GAL system for budding yeast, would provide a key advantage for many experiments. Methodology/Principal Findings. We used S. pombe microarrays to identify three neighbouring genes (urg1, urg2, and urg3) whose transcript levels rapidly and strongly increased in response to uracil, a condition which otherwise had little effect on global gene expression. We cloned the promoter of urg1(uracil-regulatable gene) to create several PCR-based gene targeting modules for replacing native promoters with the urg1 promoter (P urg1) in the normal chromosomal locations of genes of interest. The kanMX6 and natMX6 markers allow selection under urg1 induced and repressed conditions, respectively. Some modules also allow N-terminal tagging of gene products placed under urg1 control. Using pom1 as a proof-of-principle, we observed a maximal increase of P urg1-pom1 transcripts after uracil addition within less than 30 minutes, and a similarly rapid decrease after uracil removal. The induced and repressed transcriptional states remained stable over 24-hour periods. RT-PCR comparisons showed that both induced and repressed P urg1- pom1 transcript levels were lower than corresponding P3 nmt1-pom1 levels (wild-type nmt1 promoter) but higher than P81 nmt1-pom1 levels (weak nmt1 derivative). Conclusions/Significance. We exploited the urg1 promoter system to rapidly induce pom1 expression at defined cell-cycle stages, showing that ectopic pom1 expression leads to cell branching in G2-phase but much less so in G1-phase. The high temporal resolution provided by the urg1 promoter should facilitate experimental design and improve the genetic toolbox for the fission yeast community.	[Watt, Stephen; Mata, Juan; Lopez-Maury, Luis; Marguerat, Samuel; Burns, Gavin] Wellcome Trust Sanger Inst, Canc Res United Kingdom Fiss Yeast Funct Genom Gr, Cambridge, England	Wellcome Trust Sanger Institute	Bahler, J (corresponding author), Wellcome Trust Sanger Inst, Canc Res United Kingdom Fiss Yeast Funct Genom Gr, Cambridge, England.	jurg@sanger.ac.uk	Marguerat, Samuel/AAY-3792-2020; Bahler, Jurg/B-4572-2009; Lopez-Maury, Luis/B-3715-2015	Marguerat, Samuel/0000-0002-2402-3165; Bahler, Jurg/0000-0003-4036-1532; Lopez-Maury, Luis/0000-0002-3510-0621; Mata, Juan/0000-0002-5514-3653	Cancer Research UK [C9546/A6517]	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK [CUK] Grant No. C9546/A6517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bellemare DR, 2001, GENE, V273, P191, DOI 10.1016/S0378-1119(01)00591-1; CHEN D, 2008, MOL BIOL CE IN PRESS; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Erler A, 2006, YEAST, V23, P813, DOI 10.1002/yea.1396; FARYAR K, 1992, CURR GENET, V21, P345, DOI 10.1007/BF00351693; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Fujita Y, 2006, FEMS YEAST RES, V6, P883, DOI 10.1111/j.1567-1364.2006.00093.x; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; HOFFMAN CS, 1989, GENE, V84, P473, DOI 10.1016/0378-1119(89)90523-4; Iacovoni JS, 1999, GENE, V232, P53, DOI 10.1016/S0378-1119(99)00116-X; Jenkins CCL, 2005, EUKARYOT CELL, V4, P1840, DOI 10.1128/EC.4.11.1840-1850.2005; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KERN L, 1990, GENE, V88, P149, DOI 10.1016/0378-1119(90)90026-N; Kumar R, 2006, YEAST, V23, P55, DOI 10.1002/yea.1343; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Marguerat S, 2006, YEAST, V23, P261, DOI 10.1002/yea.1351; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Mata J, 2003, GENOME RES, V13, P2686, DOI 10.1101/gr.1420903; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Penkett CJ, 2006, YEAST, V23, P921, DOI 10.1002/yea.1422; Ren J, 2005, J BIOL CHEM, V280, P36912, DOI 10.1074/jbc.M507725200; Rozen S, 2000, Methods Mol Biol, V132, P365; Rustici G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r73; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013	39	45	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1428	10.1371/journal.pone.0001428	http://dx.doi.org/10.1371/journal.pone.0001428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197241	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503800002
J	Dietemann, V; Zheng, HQ; Hepburn, C; Hepburn, HR; Jin, SH; Crewe, RM; Radloff, SE; Hu, FL; Pirk, CWW				Dietemann, Vincent; Zheng, Huo-Qing; Hepburn, Colleen; Hepburn, H. Randall; Jin, Shui-Hua; Crewe, Robin M.; Radloff, Sarah E.; Hu, Fu-Liang; Pirk, Christian W. W.			Self Assessment in Insects: Honeybee Queens Know Their Own Strength	PLOS ONE			English	Article							APIS-MELLIFERA; SHELL WARS; EVOLUTION; BEHAVIOR; EXPERIENCE; DECISIONS; DISPLAYS; COMMUNICATION; ELIMINATION; CONFLICT	Contests mediate access to reproductive opportunities in almost all species of animals. An important aspect of the evolution of contests is the reduction of the costs incurred during intra-specific encounters to a minimum. However, escalated fights are commonly lethal in some species like the honeybee, Apis mellifera. By experimentally reducing honeybee queens' fighting abilities, we demonstrate that they refrain from engaging in lethal contests that typically characterize their reproductive dominance behavior and coexist peacefully within a colony. This suggests that weak queens exploit an alternative reproductive strategy and provides an explanation for rare occurrences of queen cohabitation in nature. Our results further indicate that self-assessment, but not mutual assessment of fighting ability occurs prior to and during the agonistic encounters.	[Zheng, Huo-Qing; Hu, Fu-Liang] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Dietemann, Vincent; Crewe, Robin M.; Pirk, Christian W. W.] Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa; [Hepburn, Colleen; Hepburn, H. Randall] Rhodes Univ, Dept Zool & Entomol, Grahamstown, South Africa; [Jin, Shui-Hua] Pinghu Breeding Apiary, Zhejiang, Peoples R China; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, Grahamstown, South Africa	Zhejiang University; University of Pretoria; Rhodes University; Rhodes University	Hu, FL (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	flhu@zju.edu.cn	Zheng, Huoqing/AAQ-3307-2021; Crewe, Robin M/B-3069-2009; Crewe, Robin/N-1973-2019; Pirk, Christian/E-4180-2010	Crewe, Robin M/0000-0003-4398-8250; Crewe, Robin/0000-0003-4398-8250; Pirk, Christian/0000-0001-6821-7044	University of Pretoria [postdoctoral fellowship]; South African National Research Foundation; National Natural Science Foundation of China [30371089]	University of Pretoria; South African National Research Foundation(National Research Foundation - South Africa); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	CWWP and VD were funded by a postdoctoral fellowship of the University of Pretoria, and the work was supported by a grant from the South African National Research Foundation, FH was funded by the National Natural Science Foundation of China (NSFC, No. 30371089). Funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; Archer J., 1988, BEHAV BIOL AGGRESSIO, DOI DOI 10.1046/J.1420-9101.1991.4030515.X; Burmeister SS, 2002, ANIM BEHAV, V64, P715, DOI 10.1006/anbe.2002.4012; BUTZ VM, 1994, J APICULT RES, V33, P87, DOI 10.1080/00218839.1994.11100855; Crowley PH, 2000, J THEOR BIOL, V204, P543, DOI 10.1006/jtbi.2000.2037; Dodson GN, 2001, J INSECT BEHAV, V14, P841, DOI 10.1023/A:1013045602493; DOWDS BM, 1983, BEHAVIOUR, V85, P1, DOI 10.1163/156853983X00011; DOWDS BM, 1985, ANIM BEHAV, V33, P649, DOI 10.1016/S0003-3472(85)80088-9; Eggert AK, 2000, ECOL ENTOMOL, V25, P262, DOI 10.1046/j.1365-2311.2000.00262.x; Elwood RW, 2006, ANIM BEHAV, V72, P853, DOI 10.1016/j.anbehav.2006.01.025; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; Gilley DC, 2001, ETHOLOGY, V107, P601, DOI 10.1046/j.1439-0310.2001.00692.x; Gilley DC, 2005, APIDOLOGIE, V36, P461, DOI 10.1051/apido:2005033; Hughes M, 2000, BEHAV ECOL, V11, P614, DOI 10.1093/beheco/11.6.614; Huntingford F.A., 1987, ANIMAL CONFLICT; Jennings DJ, 2004, ANIM BEHAV, V68, P213, DOI 10.1016/j.anbehav.2003.11.005; Labra A, 2006, ETHOLOGY, V112, P993, DOI 10.1111/j.1439-0310.2006.01256.x; LINCOLN GA, 1972, J EXP ZOOL, V182, P233, DOI 10.1002/jez.1401820208; Maan ME, 2001, ANIM BEHAV, V62, P623, DOI 10.1006/anbe.2001.1819; Maynard Smith J., 1982, pi; MAYNARDSMITH J, 1976, ANIM BEHAV, V24, P159, DOI DOI 10.1016/S0003-3472(76)80110-8); MestertonGibbons M, 1996, J THEOR BIOL, V181, P65, DOI 10.1006/jtbi.1996.0115; Neat FC, 1998, ANIM BEHAV, V55, P875, DOI 10.1006/anbe.1997.0668; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Payne RJH, 1996, J THEOR BIOL, V183, P185, DOI 10.1006/jtbi.1996.0212; Payne RJH, 1998, ANIM BEHAV, V56, P651, DOI 10.1006/anbe.1998.0835; Pflugfelder J, 2003, APIDOLOGIE, V34, P249, DOI 10.1051/apido:2003016; Prenter J, 2006, ANIM BEHAV, V72, P861, DOI 10.1016/j.anbehav.2006.01.023; RIECHERT SE, 1978, BEHAV ECOL SOCIOBIOL, V3, P135, DOI 10.1007/BF00294986; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Schneider SS, 2001, ANIM BEHAV, V61, P1173, DOI 10.1006/anbe.2000.1689; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Taylor PW, 2003, ANIM BEHAV, V65, P1195, DOI 10.1006/anbe.2003.2169; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; VISSCHER PK, 1993, J THEOR BIOL, V165, P191, DOI 10.1006/jtbi.1993.1185; Whitehouse MEA, 1997, ANIM BEHAV, V53, P913, DOI 10.1006/anbe.1996.0313; Winston, 1987, BIOL HONEYBEE; Wise SE, 1998, ANIM BEHAV, V55, P1707, DOI 10.1006/anbe.1997.0720	41	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1412	10.1371/journal.pone.0001412	http://dx.doi.org/10.1371/journal.pone.0001412			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183293	Green Submitted, gold, Green Published			2022-12-27	WOS:000260469400009
J	Palermo, C; Hope, JC; Freyer, GA; Rao, H; Walworth, NC				Palermo, Carmela; Hope, Justin C.; Freyer, Greg A.; Rao, Hui; Walworth, Nancy C.			Importance of a C-Terminal Conserved Region of Chk1 for Checkpoint Function	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; XENOPUS EGG EXTRACTS; CELL-CYCLE ARREST; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; REPLICATION CHECKPOINT; KINASE CHK1; TOPOISOMERASE-I; PROTEIN-KINASE; S-PHASE	Background. The protein kinase Chk1 is an essential component of the DNA damage checkpoint pathway. Chk1 is phosphorylated and activated in the fission yeast Schizosaccharomyces pombe when cells are exposed to agents that damage DNA. Phosphorylation, kinase activation, and nuclear accumulation are events critical to the ability of Chk1 to induce a transient delay in cell cycle progression. The catalytic domain of Chk1 is well-conserved amongst all species, while there are only a few regions of homology within the C-terminus. A potential pseudosubstrate domain exists in the C-terminus of S. pombe Chk1, raising the possibility that the C-terminus acts to inhibit the catalytic domain through interaction of this domain with the substrate binding site. Methodology/Principal Findings. To evaluate this hypothesis, we characterized mutations in the pseudosubstrate region. Mutation of a conserved aspartic acid at position 469 to alanine or glycine compromises Chk1 function when the mutants are integrated as single copies, demonstrating that this domain of Chk1 is critical for function. Our data does not support, however, the hypothesis that the domain acts to inhibit Chk1 function as other mutations in the amino acids predicted to comprise the pseudosubstrate do not result in constitutive activation of the protein. When expressed in multi-copy, Chk1D469A remains non-functional. In contrast, multi-copy Chk1D469G confers cell survival and imposes a checkpoint delay in response to some, though not all forms of DNA damage. Conclusions/Significance. Thus, we conclude that this C-terminal region of Chk1 is important for checkpoint function and predict that a limiting factor capable of associating with Chk1D469G, but not Chk1D469A, interacts with Chk1 to elicit checkpoint activation in response to a subset of DNA lesions.	[Palermo, Carmela; Walworth, Nancy C.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Palermo, Carmela; Rao, Hui; Walworth, Nancy C.] State Univ NJ, Rutgers, Grad Sch Biomed, UMDNJ, Joint Grad Prog Cell & Mol Pharmacol, Piscataway, NJ USA; [Hope, Justin C.; Freyer, Greg A.] Columbia Univ, Grad Prog Env Hlth Sci & Anat & Cell Biol, New York, NY USA; [Walworth, Nancy C.] Canc Inst NJ, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Walworth, NC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	walworna@umdnj.edu		Walworth, Nancy/0000-0001-5940-8236	NIH [GM53194]; National Institute of General Medical Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053194] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Public Health Service Grant NIH GM53194 from the National Institute of General Medical Science.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Chen L, 1999, GENE DEV, V13, P675, DOI 10.1101/gad.13.6.675; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; COTTAREL G, 1993, CURR GENET, V23, P547, DOI 10.1007/BF00312650; Dunaway S, 2004, METHODS, V33, P260, DOI 10.1016/j.ymeth.2003.11.022; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; Francesconi S, 2002, GENES CELLS, V7, P663, DOI 10.1046/j.1365-2443.2002.00552.x; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Hutchins JRA, 2000, FEBS LETT, V466, P91, DOI 10.1016/S0014-5793(99)01763-9; Jackson JR, 2000, CANCER RES, V60, P566; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Martinho RG, 1998, EMBO J, V17, P7239, DOI 10.1093/emboj/17.24.7239; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; NASMYTH KA, 1977, CELL, V12, P1109, DOI 10.1016/0092-8674(77)90173-8; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Onishi H, 1997, BIOCHEMISTRY-US, V36, P3767, DOI 10.1021/bi9630772; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shann YJ, 2001, J BIOL CHEM, V276, P48863, DOI 10.1074/jbc.M108253200; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan S, 2001, CURR GENET, V38, P299, DOI 10.1007/s002940000172; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Willson J, 1997, NUCLEIC ACIDS RES, V25, P2138, DOI 10.1093/nar/25.11.2138; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	49	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1427	10.1371/journal.pone.0001427	http://dx.doi.org/10.1371/journal.pone.0001427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183307	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400023
J	Rolland, M; Heckerman, D; Deng, WJ; Rousseau, CM; Coovadia, H; Bishop, K; Goulder, PJR; Walker, BD; Brander, C; Mullins, JI				Rolland, Morgane; Heckerman, David; Deng, Wenjie; Rousseau, Christine M.; Coovadia, Hoosen; Bishop, Karen; Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian; Mullins, James I.			Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; LONG-TERM NONPROGRESSORS; DISEASE PROGRESSION; TYPE-1 INFECTION; HLA SUPERTYPE; CD8(+); AIDS; LYMPHOCYTES; PROTEINS	Background. HLA class-I alleles differ in their ability to control HIV replication through cell-mediated immune responses. No consistent associations have been found between the breadth of Cytotoxic T Lymphocytes (CTL) responses and the control of HIV-1, and it is unknown whether the size or distribution of the viral proteome-wide epitope repertoire, i.e., the intrinsic ability to present fewer, more or specific viral epitopes, could affect clinical markers of disease progression. Methodology/Principal Findings. We used an epitope prediction model to identify all epitope motifs in a set of 302 HIV-1 full-length proteomes according to each individual's HLA (Human Leukocyte Antigen) genotype. The epitope repertoire, i.e., the number of predicted epitopes per HIV-1 proteome, varied considerably between HLA alleles and thus among individual proteomes. In a subgroup of 270 chronically infected individuals, we found that lower viral loads and higher CD4 counts were associated with a larger predicted epitope repertoire. Additionally, in Gag and Rev only, more epitopes were restricted by alleles associated with low viral loads than by alleles associated with higher viral loads. Conclusions/Significance. This comprehensive analysis puts forth the epitope repertoire as a mechanistic component of the multi-faceted HIV-specific CTL response. The favorable impact on markers of disease status of the propensity to present more HLA binding peptides and specific proteins gives impetus to vaccine design strategies that seek to elicit responses to a broad array of HIV-1 epitopes, and suggest a particular focus on Gag.	[Rolland, Morgane; Deng, Wenjie; Rousseau, Christine M.; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Heckerman, David] Microsoft Res, Machine Learn & Appl Stat Grp, Washington, DC USA; [Coovadia, Hoosen; Bishop, Karen; Goulder, Philip J. R.; Walker, Bruce D.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Path Prog, Durban, South Africa; [Goulder, Philip J. R.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Goulder, Philip J. R.; Walker, Bruce D.; Brander, Christian] Harvard Med Sch, Mass Gen Hosp, Partners AIDS Res Ctr, Charlestown, MA USA	University of Washington; University of Washington Seattle; Microsoft; University of Kwazulu Natal; University of Oxford	Mullins, JI (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@u.washington.edu	Bishop, Karen/G-7073-2015	Bishop, Karen/0000-0003-4935-7708; Brander, Christian/0000-0002-0548-5778	Boeing Corporation; US Public Health Service [AI57005, AI058894]; University of Washington Center for AIDS Research [AI27757]; Microsoft Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, P30AI027757, R01AI058894] Funding Source: NIH RePORTER	Boeing Corporation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Washington Center for AIDS Research; Microsoft Research(Microsoft); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an unrestricted gift from the Boeing Corporation and US Public Health Service grants to JIM (AI57005, AI058894) and the University of Washington Center for AIDS Research (AI27757), and by Microsoft Research. These sponsors had no role in any aspect of the design preparation or submission of this work.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Borghans JAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000920; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; CRAWFORD H, 2007, J VIROL; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2005, J VIROL, V79, P10218, DOI 10.1128/JVI.79.16.10218-10225.2005; Frahm N, 2004, J VIROL, V78, P2187, DOI 10.1128/JVI.78.5.2187-2200.2004; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; HECKERMAN D, 2006, 10 ANN INT C RES COM; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber BTM, 2005, 060036 LAUR LOS AL N; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Liu SL, 1997, J VIROL, V71, P4284, DOI 10.1128/JVI.71.6.4284-4295.1997; LIU Y, 2007, EVOLUTION HIV 1 CTL; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Louzoun Y, 2006, MOL IMMUNOL, V43, P559, DOI 10.1016/j.molimm.2005.04.017; Lundegaard C, 2006, TRENDS BIOTECHNOL, V24, P537, DOI 10.1016/j.tibtech.2006.10.001; MacDonald KS, 2001, J INFECT DIS, V183, P503, DOI 10.1086/318092; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Ramduth D, 2005, J INFECT DIS, V192, P1588, DOI 10.1086/496894; RIVIERE Y, 1995, AIDS RES HUM RETROV, V11, P903, DOI 10.1089/aid.1995.11.903; ROLLAND M, 2007, PLOS PATHOG IN PRESS; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Rousseau CM, 2006, J VIROL METHODS, V136, P118, DOI 10.1016/j.jviromet.2006.04.009; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Streeck H, 2007, AIDS, V21, P889, DOI 10.1097/QAD.0b013e3280f77439; SUHRBIER A, 1993, IMMUNOLOGY, V79, P171; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Truong HHM, 2002, J ACQ IMMUN DEF SYND, V29, P232, DOI 10.1097/00042560-200203010-00003; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	51	127	133	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1424	10.1371/journal.pone.0001424	http://dx.doi.org/10.1371/journal.pone.0001424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GT	18183304	gold, Green Published, Green Submitted			2022-12-27	WOS:000260469400020
J	Mlotshwa, S; Pruss, GJ; Peragine, A; Endres, MW; Li, JJ; Chen, XM; Poethig, RS; Bowman, LH; Vance, V				Mlotshwa, Sizolwenkosi; Pruss, Gail J.; Peragine, Angela; Endres, Matthew W.; Li, Junjie; Chen, Xuemei; Poethig, R. Scott; Bowman, Lewis H.; Vance, Vicki			DICER-LIKE2 Plays a Primary Role in Transitive Silencing of Transgenes in Arabidopsis	PLOS ONE			English	Article								Dicer-like (DCL) enzymes play a pivotal role in RNA silencing in plants, processing the long double-stranded RNA (dsRNA) that triggers silencing into the primary short interfering RNAs (siRNAs) that mediate it. The siRNA population can be augmented and silencing amplified via transitivity, an RNA-dependent RNA polymerase (RDR)-dependent pathway that uses the target RNA as substrate to generate secondary siRNAs. Here we report that Arabidopsis DCL2-but not DCL4-is required for transitivity in cell-autonomous, post-transcriptional silencing of transgenes. An insertion mutation in DCL2 blocked sense transgene-induced silencing and eliminated accumulation of the associated RDR-dependent siRNAs. In hairpin transgene-induced silencing, the dcl2 mutation likewise eliminated accumulation of secondary siRNAs and blocked transitive silencing, but did not block silencing mediated by primary siRNAs. Strikingly, in all cases, the dcl2 mutation eliminated accumulation of all secondary siRNAs, including those generated by other DCL enzymes. In contrast, mutations in DCL4 promoted a dramatic shift to transitive silencing in the case of the hairpin transgene and enhanced silencing induced by the sense transgene. Suppression of hairpin and sense transgene silencing by the P1/HC-Pro and P38 viral suppressors was associated with elimination of secondary siRNA accumulation, but the suppressors did not block processing of the stem of the hairpin transcript into primary siRNAs. Thus, these viral suppressors resemble the dcl2 mutation in their effects on siRNA biogenesis. We conclude that DCL2 plays an essential, as opposed to redundant, role in transitive silencing of transgenes and may play a more important role in silencing of viruses than currently thought.	[Mlotshwa, Sizolwenkosi; Pruss, Gail J.; Endres, Matthew W.; Bowman, Lewis H.; Vance, Vicki] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Peragine, Angela; Poethig, R. Scott] Univ Pennsylvania, Dept Biol, Philadelphia, PA USA; [Li, Junjie; Chen, Xuemei] Univ Calif Riverside, Inst Integrat Genome Biol, Dept Bot & Plant Sci, Riverside, CA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Pennsylvania; University of California System; University of California Riverside	Mlotshwa, S (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	vance@biol.sc.edu	Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862; Chen, Xuemei/0000-0002-5209-1157	NIH [GM6101401, R01 GM051893, GM61146, MCB-0718029]; NSF [0501760, 0646540, GM61146, MCB-0718029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051893, R01GM061014, R01GM061146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant GM6101401 and NSF Grants 0501760 and 0646540 to V.V. and L.H.B., NIH Grant R01 GM051893 to R.S.P., and NIH and NSF Grants GM61146 and MCB-0718029 to X.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Finnegan EJ, 2003, CURR BIOL, V13, P236, DOI 10.1016/S0960-9822(03)00010-1; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mlotshwa S, 2005, PLANT CELL, V17, P2873, DOI 10.1105/tpc.105.036608; Mlotshwa S, 2006, PLANT MOL BIOL, V61, P781, DOI 10.1007/s11103-006-0049-0; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; VANCE VB, 1988, J BIOL CHEM, V263, P1476; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	56	120	126	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1755	10.1371/journal.pone.0001755	http://dx.doi.org/10.1371/journal.pone.0001755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335032	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000009
J	Guinet, F; Ave, P; Jones, L; Huerre, M; Carniel, E				Guinet, Francoise; Ave, Patrick; Jones, Louis; Huerre, Michel; Carniel, Elisabeth			Defective Innate Cell Response and Lymph Node Infiltration Specify Yersinia pestis Infection	PLOS ONE			English	Article								Since its recent emergence from the enteropathogen Yersinia pseudotuberculosis, Y. pestis, the plague agent, has acquired an intradermal (id) route of entry and an extreme virulence. To identify pathophysiological events associated with the Y. pestis high degree of pathogenicity, we compared disease progression and evolution in mice after id inoculation of the two Yersinia species. Mortality studies showed that the id portal was not in itself sufficient to provide Y. pseudotuberculosis with the high virulence power of its descendant. Surprisingly, Y. pseudotuberculosis multiplied even more efficiently than Y. pestis in the dermis, and generated comparable histological lesions. Likewise, Y. pseudotuberculosis translocated to the draining lymph node (DLN) and similar numbers of the two bacterial species were found at 24 h post infection (pi) in this organ. However, on day 2 pi, bacterial loads were higher in Y. pestis-infected than in Y. pseudotuberculosis-infected DLNs. Clustering and multiple correspondence analyses showed that the DLN pathologies induced by the two species were statistically significantly different and identified the most discriminating elementary lesions. Y. pseudotuberculosis infection was accompanied by abscess-type polymorphonuclear cell infiltrates containing the infection, while Y. pestis-infected DLNs exhibited an altered tissue density and a vascular congestion, and were typified by an invasion of the tissue by free floating bacteria. Therefore, Y. pestis exceptional virulence is not due to its recently acquired portal of entry into the host, but is associated with a distinct ability to massively infiltrate the DLN, without inducing in this organ an organized polymorphonuclear cell reaction. These results shed light on pathophysiological processes that draw the line between a virulent and a hypervirulent pathogen.	[Guinet, Francoise; Carniel, Elisabeth] Inst Pasteur, Unite Yersinia, Paris, France; [Ave, Patrick; Huerre, Michel] Inst Pasteur, Unite Rech Expertise Histotechnol Pathol, Paris, France; [Jones, Louis] Inst Pasteur, Grp Logiciels Banques Donnees, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Guinet, F (corresponding author), Inst Pasteur, Unite Yersinia, Paris, France.	fguinet@pasteur.fr		Jones, Louis/0000-0002-3080-9770	Pasteur Institute	Pasteur Institute	Funding was from the Pasteur Institute, which had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; *ARM FORC I PATH, 1992, LAB METH HIST; Benzecri J.P., 1992, CORRES ANAL HDB; BENZECRI JP, 1982, ANAL CORRES; BERCOVIER H, 1980, CURR MICROBIOL, V4, P225, DOI 10.1007/BF02605861; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chessel D., 2004, R NEWS, V4, P5; Clausen S.E., 1998, APPL CORRES ANAL INT, V121; Cobb BA, 2005, CELL MICROBIOL, V7, P1398, DOI 10.1111/j.1462-5822.2005.00591.x; Cover TL, 1989, NEW ENGL J MED, V321, P17; CROOK LD, 1992, ARCH INTERN MED, V152, P1253, DOI 10.1001/archinte.152.6.1253; CROWELL B. C., 1915, Philippine Journal of Science, Sect. B. Trop. Med., V10, P249; Dennis David T., 1997, P21; Eastwood A, 1914, J HYG-CAMBRIDGE, V14, P285, DOI 10.1017/S0022172400005866; Ferrero RL, 2000, J PATHOL, V191, P333; Flexner S, 1901, AM J MED SCI, V122, P396; Greenacre Michael, 1984, THEORY APPL CORRES A; Guinet F, 2003, ADV EXP MED BIOL, V529, P73; HERZOG M, 1904, PLAGUE BACTERIOLOGY, P1; Jawetz E, 1944, J INFECT DIS, V74, P1, DOI 10.1093/infdis/74.1.1; Judicial Commission, 1985, INT J SYST BACTERIOL, V35, P540; Lang T, 2000, CELL MICROBIOL, V2, P415, DOI 10.1046/j.1462-5822.2000.00070.x; Majno G., 2004, CELLS TISSUES DIS PR; MORINEAU A, 1998, ANAL COMPOSANTES PRI; Naish S.J., 1989, HDB IMMUNOCHEMICAL S; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PETRIE GF, 1992, SYSTEM BACTERIOLOGY; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Pollitzer R., 1954, PLAGUE; Pouillot F, 2005, MICROBIOL-SGM, V151, P3759, DOI 10.1099/mic.0.28274-0; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219; SMITH CW, 1993, SEMIN HEMATOL, V30, P45; SMITH CW, 1993, SEMIN HEMATOL     S4, V30, P54; Smith J. H., 1997, PATHOLOGY INFECT DIS, P729; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Tzianabos AO, 2002, CURR OPIN MICROBIOL, V5, P92, DOI 10.1016/S1369-5274(02)00292-8; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; 2006, WKLY EPIDEMIOL REC, V81, P278	46	44	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1688	10.1371/journal.pone.0001688	http://dx.doi.org/10.1371/journal.pone.0001688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301765	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586500032
J	Holland, RA; Kirschvink, JL; Doak, TG; Wikelski, M				Holland, Richard A.; Kirschvink, Joseph L.; Doak, Thomas G.; Wikelski, Martin			Bats Use Magnetite to Detect the Earth's Magnetic Field	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; ORIENTATION; COMPASS; MAGNETORECEPTION; BIRDS; MAP; NAVIGATION; INTENSITY; PIGEONS; PULSE	While the role of magnetic cues for compass orientation has been confirmed in numerous animals, the mechanism of detection is still debated. Two hypotheses have been proposed, one based on a light dependent mechanism, apparently used by birds and another based on a "compass organelle'' containing the iron oxide particles magnetite (Fe3O4). Bats have recently been shown to use magnetic cues for compass orientation but the method by which they detect the Earth's magnetic field remains unknown. Here we use the classic "Kalmijn-Blakemore'' pulse re-magnetization experiment, whereby the polarity of cellular magnetite is reversed. The results demonstrate that the big brown bat Eptesicus fuscus uses single domain magnetite to detect the Earths magnetic field and the response indicates a polarity based receptor. Polarity detection is a prerequisite for the use of magnetite as a compass and suggests that big brown bats use magnetite to detect the magnetic field as a compass. Our results indicate the possibility that sensory cells in bats contain freely rotating magnetite particles, which appears not to be the case in birds. It is crucial that the ultrastructure of the magnetite containing magnetoreceptors is described for our understanding of magnetoreception in animals.	[Holland, Richard A.; Doak, Thomas G.; Wikelski, Martin] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Holland, Richard A.] Univ Leeds, Inst Integrative & Comparative Biol, Leeds, W Yorkshire, England; [Kirschvink, Joseph L.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA USA	Princeton University; University of Leeds; California Institute of Technology	Holland, RA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	rahollan@Princeton.edu	Holland, Richard A/A-6107-2010; Kirschvink, Joseph L/U-5844-2017	Holland, Richard A/0000-0003-4495-8061; Kirschvink, Joseph/0000-0001-9486-6689; Doak, Thomas/0000-0001-5487-553X	Marie Curie Outgoing international fellowship; Bat Conservation; National Geographic society; NSF	Marie Curie Outgoing international fellowship(European Commission); Bat Conservation; National Geographic society(National Geographic Society); NSF(National Science Foundation (NSF))	Richard Holland was funded by a Marie Curie Outgoing international fellowship and a Bat Conservation international grant. Martin Wikelski was funded by the National Geographic society and NSF. None of these funding bodies had any influence on the manuscript	Batschelet E, 1981, CIRCULAR STAT BIOL; Bazylinski DA, 2000, CHEM GEOL, V169, P319, DOI 10.1016/S0009-2541(00)00211-4; BEASON RC, 1995, J EXP BIOL, V198, P141; Beason RC, 1996, J EXP BIOL, V199, P1241; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245; BLAKEMORE RP, 1980, NATURE, V286, P384, DOI 10.1038/286384a0; Buchler E. R., 1985, MAGNETITE BIOMINERAL, P483; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; DIAZRICCI JC, 1991, APPL ENVIRON MICROB, V57, P3248; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Fleming TH, 2003, BAT ECOLOGY, P156; GOULD JL, 1980, J EXP BIOL, V86, P1; Holland RA, 2003, J EXP BIOL, V206, P1773, DOI 10.1242/jeb.00365; Holland RA, 2007, BEHAV ECOL SOCIOBIOL, V61, P653, DOI 10.1007/s00265-006-0297-7; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; Irwin WP, 2005, J COMP PHYSIOL A, V191, P475, DOI 10.1007/s00359-005-0609-9; Kalmijn A., 1978, ANIMAL MIGRATION NAV; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1979, EARTH PLANET SC LETT, V44, P193, DOI 10.1016/0012-821X(79)90168-7; KIRSCHVINK JL, 1982, TRENDS NEUROSCI, V5, P160, DOI 10.1016/0166-2236(82)90090-X; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; KIRSCHVINK JL, 1991, AM ZOOL, V31, P169; KIRSCHVINK JL, 1985, MAGNETITE BIOMINERAL, P243; Kramer G., 1953, Journal fuer Ornithologie, V94, P201, DOI 10.1007/BF01922508; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; LIGHT P, 1993, J EXP BIOL, V182, P1; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; MARHOLD S, 1997, 5 ROYAL I NAV; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Nemec P, 2001, SCIENCE, V294, P366, DOI 10.1126/science.1063351; PHILLIPS JB, 1986, SCIENCE, V233, P765, DOI 10.1126/science.3738508; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; Thalau P, 2006, J R SOC INTERFACE, V3, P583, DOI 10.1098/rsif.2006.0130; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALLRAFF HG, 1979, BEHAV ECOL SOCIOBIOL, V5, P201, DOI 10.1007/BF00293306; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wang YN, 2007, P R SOC B, V274, P2901, DOI 10.1098/rspb.2007.0904; Wegner RE, 2006, J EXP BIOL, V209, P4747, DOI 10.1242/jeb.02573; WILLIAMS TC, 1967, SCIENCE, V155, P1435, DOI 10.1126/science.155.3768.1435; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2006, BIOESSAYS, V28, P157, DOI 10.1002/bies.20363; WILTSCHKO R, 1994, BEHAV ECOL SOCIOBIOL, V35, P63, DOI 10.1007/s002650050071; Wiltschko W, 1998, J EXP BIOL, V201, P3257; Wiltschko W, 2002, J EXP BIOL, V205, P3031; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wiltschko W, 2006, P R SOC B, V273, P2815, DOI 10.1098/rspb.2006.3651	52	89	93	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1676	10.1371/journal.pone.0001676	http://dx.doi.org/10.1371/journal.pone.0001676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301753	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000260586500020
J	Hughes, DA; Tang, K; Strotmann, R; Schoneberg, T; Prenen, J; Nilius, B; Stoneking, M				Hughes, David A.; Tang, Kun; Strotmann, Rainer; Schoneberg, Torsten; Prenen, Jean; Nilius, Bernd; Stoneking, Mark			Parallel Selection on TRPV6 in Human Populations	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; EPITHELIAL CALCIUM-CHANNEL; LINKAGE-DISEQUILIBRIUM; NATURAL-SELECTION; HUMAN GENOME; CA2+ ENTRY; ECAC1; CELL; ADAPTATION; EVOLUTION	We identified and examined a candidate gene for local directional selection in Europeans, TRPV6, and conclude that selection has acted on standing genetic variation at this locus, creating parallel soft sweep events in humans. A novel modification of the extended haplotype homozygosity (EHH) test was utilized, which compares EHH for a single allele across populations, to investigate the signature of selection at TRPV6 and neighboring linked loci in published data sets for Europeans, Asians and African-Americans, as well as in newly-obtained sequence data for additional populations. We find that all non-African populations carry a signature of selection on the same haplotype at the TRPV6 locus. The selective footprints, however, are significantly differentiated between non-African populations and estimated to be younger than an ancestral population of non-Africans. The possibility of a single selection event occurring in an ancestral population of non-Africans was tested by simulations and rejected. The putatively-selected TRPV6 haplotype contains three candidate sites for functional differences, namely derived non-synonymous substitutions C157R, M378V and M681T. Potential functional differences between the ancestral and derived TRPV6 proteins were investigated by cloning the ancestral and derived forms, transfecting cell lines, and carrying out electrophysiology experiments via patch clamp analysis. No statistically-significant differences in biophysical channel function were found, although one property of the protein, namely Ca2+ dependent inactivation, may show functionally relevant differences between the ancestral and derived forms. Although the reason for selection on this locus remains elusive, this is the first demonstration of a widespread parallel selection event acting on standing genetic variation in humans, and highlights the utility of between population EHH statistics.	[Hughes, David A.; Tang, Kun; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Strotmann, Rainer; Schoneberg, Torsten] Univ Leipzig, Inst Biochem, Mol Biochem, Med Fac, Leipzig, Germany; [Prenen, Jean; Nilius, Bernd] Katholieke Univ Leuven, Dept Physiol, Leuven, Belgium	Max Planck Society; Leipzig University; KU Leuven	Hughes, DA (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	hughes@eva.mpg.de	Tang, Kun/GSD-3218-2022; Hughes, David/E-7190-2015	Hughes, David/0000-0002-9644-8998	Max Planck Society; Bundesministerium fur Bildung und Forschung; Human Frontiers Science Programme [RGP 32/2004]; Belgian Federal Government; Flemish Government; Onderzoeksraad KU Leuven [GOA 2004/07, G.0214.99, G. 0136.00, G.0172.03]; Poles of Attraction Program, Prime Ministers Office IUAP [3P4/23]; Excellentiefinanciering [EF/95/010]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Human Frontiers Science Programme(Human Frontier Science Program); Belgian Federal Government; Flemish Government(European Commission); Onderzoeksraad KU Leuven(KU Leuven); Poles of Attraction Program, Prime Ministers Office IUAP; Excellentiefinanciering(KU Leuven)	The work by DAH, KT and MS was funded by the Max Planck Society. The work of RS and TS is funded by the Bundesministerium fur Bildung und Forschung and the work of JP and BN was supported by the Human Frontiers Science Programme (RGP 32/2004), the Belgian Federal Government, the Flemish Government and the Onderzoeksraad KU Leuven (GOA 2004/07, F.W.O. G.0214.99, F.W.O. G. 0136.00; F.W.O. G.0172.03, Poles of Attraction Program, Prime Ministers Office IUAP Nr.3P4/23, Excellentiefinanciering EF/95/010).	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2006, HUM MOL GENET, V15, P2106, DOI 10.1093/hmg/ddl134; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bessou-Touya S, 1998, J INVEST DERMATOL, V111, P1103, DOI 10.1046/j.1523-1747.1998.00405.x; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry AE, 2006, AM J HUM GENET, V78, P1053, DOI 10.1086/504160; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Haynes G., 2002, EARLY SETTLEMENT N A; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hope G.S., 2005, PAPUAN PASTS CULTURA, P541; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Kayser M, 2003, MOL BIOL EVOL, V20, P893, DOI 10.1093/molbev/msg092; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Lehen'kyi V, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611398200; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Minwalla L, 2001, J INVEST DERMATOL, V117, P341, DOI 10.1046/j.0022-202x.2001.01411.x; Muller D, 2002, NEPHROL DIAL TRANSPL, V17, P1614, DOI 10.1093/ndt/17.9.1614; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nijenhuis T, 2003, PFLUG ARCH EUR J PHY, V446, P401, DOI 10.1007/s00424-003-1038-7; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2003, PFLUG ARCH EUR J PHY, V445, P584, DOI 10.1007/s00424-002-0923-9; Nilius B, 2002, J BIOL CHEM, V277, P30852, DOI 10.1074/jbc.M202418200; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Oota H, 2005, PLOS BIOL, V3, P536, DOI 10.1371/journal.pbio.0030071; Orr HA, 2001, GENETICS, V157, P875; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Ptak SE, 2004, GENETICS, V167, P387, DOI 10.1534/genetics.167.1.387; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schwarz EC, 2006, CELL CALCIUM, V39, P163, DOI 10.1016/j.ceca.2005.10.006; Stajich JE, 2005, MOL BIOL EVOL, V22, P63, DOI 10.1093/molbev/msh252; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STONEKING M, 1990, GENETICS, V124, P717; Storz JF, 2004, MOL BIOL EVOL, V21, P1800, DOI 10.1093/molbev/msh192; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; THOMSON G, 1977, GENETICS, V85, P753; van de Graaf SFJ, 2004, J STEROID BIOCHEM, V89-90, P303, DOI 10.1016/j.jsbmb.2004.03.029; Vennekens R, 2001, J PHYSIOL-LONDON, V530, P183, DOI 10.1111/j.1469-7793.2001.0183l.x; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; VOETS T, 2003, BIOPHYS J; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Wang Y, 2006, AM J HUM GENET, V78, P615, DOI 10.1086/502632; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354	72	32	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1686	10.1371/journal.pone.0001686	http://dx.doi.org/10.1371/journal.pone.0001686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301763	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500030
J	Wright, GA; Kottcamp, SM; Thomson, MGA				Wright, Geraldine A.; Kottcamp, Sonya M.; Thomson, Mitchell G. A.			Generalization Mediates Sensitivity to Complex Odor Features in the Honeybee	PLOS ONE			English	Article							APIS-MELLIFERA; STIMULUS GENERALIZATION; OLFACTORY SYSTEM; SIGNAL EVOLUTION; ANTENNAL LOBE; INTENSITY; DISCRIMINATION; FLOWERS; REPRESENTATION; THRESHOLDS	Animals use odors as signals for mate, kin, and food recognition, a strategy which appears ubiquitous and successful despite the high intrinsic variability of naturally-occurring odor quantities. Stimulus generalization, or the ability to decide that two objects, though readily distinguishable, are similar enough to afford the same consequence [1], could help animals adjust to variation in odor signals without losing sensitivity to key inter-stimulus differences. The present study was designed to investigate whether an animal's ability to generalize learned associations to novel odors can be influenced by the nature of the associated outcome. We use a classical conditioning paradigm for studying olfactory learning in honeybees [2] to show that honeybees conditioned on either a fixed- or variable-proportion binary odor mixture generalize learned responses to novel proportions of the same mixture even when inter-odor differences are substantial. We also show that the resulting olfactory generalization gradients depend critically on both the nature of the stimulus-reward paradigm and the intrinsic variability of the conditioned stimulus. The reward dependency we observe must be cognitive rather than perceptual in nature, and we argue that outcome-dependent generalization is necessary for maintaining sensitivity to inter-odor differences in complex olfactory scenes.	[Wright, Geraldine A.; Thomson, Mitchell G. A.] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; [Kottcamp, Sonya M.] Ohio State Univ, Rothenbuhler Honeybee Lab, Columbus, OH USA	Newcastle University - UK; University System of Ohio; Ohio State University	Wright, GA (corresponding author), Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England.	jeri.wright@ncl.ac.uk			NSF [0112050]; NIH NCRR [9 R01 RR1466]	NSF(National Science Foundation (NSF)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by an NSF grant awarded to the Mathematical Biosciences Institute (agreement no. 0112050) and by an NIH NCRR (9 R01 RR1466) award held by Brian H. Smith.	Ayasse M, 2000, EVOLUTION, V54, P1995, DOI 10.1111/j.0014-3820.2000.tb01243.x; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BLOUGH DS, 1967, SCIENCE, V158, P940, DOI 10.1126/science.158.3803.940; Blough DS, 2001, BEHAV PROCESS, V54, P127, DOI 10.1016/S0376-6357(01)00154-1; Chittka L., 2001, ANIMAL BEHAV FLORAL; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; FOSTER DH, 1991, PSYCHOL BULL, V109, P152, DOI 10.1037/0033-2909.109.1.152; Green DM, 1966, SIGNAL DETECTION THE; HEINEMAN.EG, 1969, J EXP PSYCHOL, V80, P215, DOI 10.1037/h0027309; Helsper JPFG, 1998, PLANTA, V207, P88, DOI 10.1007/s004250050459; Kim HJ, 2000, J CHROMATOGR A, V902, P389, DOI 10.1016/S0021-9673(00)00863-3; Lynn SK, 2005, EVOLUTION, V59, P1300, DOI 10.1111/j.0014-3820.2005.tb01780.x; Mant J, 2005, EVOLUTION, V59, P1449, DOI 10.1111/j.0014-3820.2005.tb01795.x; Martin J, 2007, BIOL LETTERS, V3, P125, DOI 10.1098/rsbl.2006.0589; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Miklas N, 2000, J CHEM ECOL, V26, P2473, DOI 10.1023/A:1005517410299; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; ten Cate C, 2007, TRENDS ECOL EVOL, V22, P380, DOI 10.1016/j.tree.2007.03.006; Wright GA, 2005, P ROY SOC B-BIOL SCI, V272, P2417, DOI 10.1098/rspb.2005.3252; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; Wright GA, 2004, CHEM SENSES, V29, P127, DOI 10.1093/chemse/bjh016; WRIGHT GA, 2005, RECENT ADV PHYTOCHEM, P191	32	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1704	10.1371/journal.pone.0001704	http://dx.doi.org/10.1371/journal.pone.0001704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301779	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500048
J	Xiong, MM; Arnett, FC; Guo, XJ; Xiong, H; Zhou, XD				Xiong, Momiao; Arnett, Frank C.; Guo, Xinjian; Xiong, Hao; Zhou, Xiaodong			Differential Dynamic Properties of Scleroderma Fibroblasts in Response to Perturbation of Environmental Stimuli	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; SYSTEMS BIOLOGY; MAXIMUM-LIKELIHOOD; BAYESIAN NETWORKS; EXPRESSION DATA; ROBUSTNESS; ACTIVATION; STABILITY; SCLEROSIS; SILICA	Diseases are believed to arise from dysregulation of biological systems (pathways) perturbed by environmental triggers. Biological systems as a whole are not just the sum of their components, rather ever-changing, complex and dynamic systems over time in response to internal and external perturbation. In the past, biologists have mainly focused on studying either functions of isolated genes or steady-states of small biological pathways. However, it is systems dynamics that play an essential role in giving rise to cellular function/dysfunction which cause diseases, such as growth, differentiation, division and apoptosis. Biological phenomena of the entire organism are not only determined by steady-state characteristics of the biological systems, but also by intrinsic dynamic properties of biological systems, including stability, transient-response, and controllability, which determine how the systems maintain their functions and performance under a broad range of random internal and external perturbations. As a proof of principle, we examine signal transduction pathways and genetic regulatory pathways as biological systems. We employ widely used state-space equations in systems science to model biological systems, and use expectation-maximization (EM) algorithms and Kalman filter to estimate the parameters in the models. We apply the developed state-space models to human fibroblasts obtained from the autoimmune fibrosing disease, scleroderma, and then perform dynamic analysis of partial TGF-beta pathway in both normal and scleroderma fibroblasts stimulated by silica. We find that TGF-beta pathway under perturbation of silica shows significant differences in dynamic properties between normal and scleroderma fibroblasts. Our findings may open a new avenue in exploring the functions of cells and mechanism operative in disease development.	[Xiong, Momiao] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Arnett, Frank C.; Guo, Xinjian; Zhou, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Med Sch, Div Rheumatol & Clin Immunogenet, Houston, TX USA; [Xiong, Hao] Texas A&M Univ, Dept Comp Sci, College Stn, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station	Xiong, MM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA.	xiaodong.zhou@uth.tmc.edu			NIH/NIAMS Center of Research Translation (CORT) in Scleroderma [1 P50 AR054144, 5RO3AR050517-02]; NIH/NCRR Center for Clinical and Translational Sciences [1UL1 RR 024148, M01RR002558]; University of Texas Health Science Center at Houston CreFF; Department of the Army, Medical Research Acquisition Activity [PR064803]; Scleroderma Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002558, UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054144, R03AR050517] Funding Source: NIH RePORTER	NIH/NIAMS Center of Research Translation (CORT) in Scleroderma(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NCRR Center for Clinical and Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center at Houston CreFF; Department of the Army, Medical Research Acquisition Activity; Scleroderma Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by UTHSC-H grants from NIH/NIAMS Center of Research Translation (CORT) in Scleroderma (1 P50 AR054144) (F.C.A) and 5RO3AR050517-02 (X.Z.), NIH/NCRR Center for Clinical and Translational Sciences (Houston CTSA Program) (1UL1 RR 024148), NIH PHS NCRR GCRC grant M01RR002558, University of Texas Health Science Center at Houston CreFF (X.Z.), Department of the Army, Medical Research Acquisition Activity: PR064803 (X.Z) and the Scleroderma Foundation (X.Z.).	Akutsu T, 1999, Pac Symp Biocomput, P17; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arcangeli G, 2001, SCI TOTAL ENVIRON, V270, P135, DOI 10.1016/S0048-9697(00)00781-6; Assmus HE, 2006, EXPERT REV MOL DIAGN, V6, P891, DOI 10.1586/14737159.6.6.891; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Binder B, 2002, MOL BIOL REP, V29, P51, DOI 10.1023/A:1020302318189; CABRAL AR, 1994, REV INVEST CLIN, V46, P257; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P602, DOI 10.1109/TCSI.2002.1001949; CLAMAN HN, 1991, ARTHRITIS RHEUM, V34, P1495; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dojer N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-249; Gerriets JE, 1996, BBA-MOL BASIS DIS, V1316, P121, DOI 10.1016/0925-4439(96)00019-1; Gibson S, 2005, AUTOMATICA, V41, P1667, DOI 10.1016/j.automatica.2005.05.008; Herrero J, 2004, NUCLEIC ACIDS RES, V32, pW485, DOI 10.1093/nar/gkh421; JIMENEZ SA, 1986, BIOCHEM J, V237, P837, DOI 10.1042/bj2370837; Jinnin M, 2006, BIOCHEM BIOPH RES CO, V343, P904, DOI 10.1016/j.bbrc.2006.03.037; Kailath T., 1999, LINEAR ESTIMATION; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kim KA, 2002, TOXICOL LETT, V135, P185, DOI 10.1016/S0378-4274(02)00237-0; Kremling A, 2007, J BIOTECHNOL, V129, P329, DOI 10.1016/j.jbiotec.2007.02.009; LEROY EC, 1988, J RHEUMATOL, V15, P202; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Martins NC, 2006, IEEE T AUTOMAT CONTR, V51, P438, DOI 10.1109/TAC.2006.871940; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Ogata K., 1998, SYSTEM DYNAMICS, VVol. 3; Pan Y, 2007, BIOINFORMATICS, V23, pI367, DOI 10.1093/bioinformatics/btm228; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; RANGEL C, 2001, P 2 INT C SYST BIOL, P248; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Vinson DR, 2000, J PROCESS CONTR, V10, P185, DOI 10.1016/S0959-1524(99)00045-1; VOIT EO, 2007, UNDERSTANDING MODELI; Wei YM, 2003, APPL MATH COMPUT, V145, P45, DOI 10.1016/S0096-3003(02)00437-X; Werhli AV, 2007, STAT APPL GENET MOL, V6; Wolkenhauer O, 2005, MOL BIOSYST, V1, P14, DOI 10.1039/b502088n; Wolkenhauer O, 2005, FEBS LETT, V579, P1846, DOI 10.1016/j.febslet.2005.02.008; Xiong MA, 2005, FEBS LETT, V579, P5325, DOI 10.1016/j.febslet.2005.08.058; Zhou XD, 2006, ARTHRITIS RHEUM, V54, P3885, DOI 10.1002/art.22249	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1693	10.1371/journal.pone.0001693	http://dx.doi.org/10.1371/journal.pone.0001693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301770	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586500037
J	Li, W; Bengtson, MH; Ulbrich, A; Matsuda, A; Reddy, VA; Orth, A; Chanda, SK; Batalov, S; Joazeiro, CAP				Li, Wei; Bengtson, Mario H.; Ulbrich, Axel; Matsuda, Akio; Reddy, Venkateshwar A.; Orth, Anthony; Chanda, Sumit K.; Batalov, Serge; Joazeiro, Claudio A. P.			Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle's Dynamics and Signaling	PLOS ONE			English	Article								Specificity of protein ubiquitylation is conferred by E3 ubiquitin (Ub) ligases. We have annotated similar to 617 putative E3s and substrate-recognition subunits of E3 complexes encoded in the human genome. The limited knowledge of the function of members of the large E3 superfamily prompted us to generate genome-wide E3 cDNA and RNAi expression libraries designed for functional screening. An imaging-based screen using these libraries to identify E3s that regulate mitochondrial dynamics uncovered MULAN/FLJ12875, a RING finger protein whose ectopic expression and knockdown both interfered with mitochondrial trafficking and morphology. We found that MULAN is a mitochondrial protein - two transmembrane domains mediate its localization to the organelle's outer membrane. MULAN is oriented such that its E3-active, C-terminal RING finger is exposed to the cytosol, where it has access to other components of the Ub system. Both an intact RING finger and the correct subcellular localization were required for regulation of mitochondrial dynamics, suggesting that MULAN's downstream effectors are proteins that are either integral to, or associated with, mitochondria and that become modified with Ub. Interestingly, MULAN had previously been identified as an activator of NF-kappa B, thus providing a link between mitochondrial dynamics and mitochondria-to-nucleus signaling. These findings suggest the existence of a new, Ub-mediated mechanism responsible for integration of mitochondria into the cellular environment.	[Li, Wei; Bengtson, Mario H.; Ulbrich, Axel; Joazeiro, Claudio A. P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Matsuda, Akio] ASAHI KASEI Corp, Inst Life Sci Res, Shizuoka, Japan; [Reddy, Venkateshwar A.; Orth, Anthony; Chanda, Sumit K.; Batalov, Serge] Novartis Res Fdn, Gen Inst, San Diego, CA USA	Scripps Research Institute; Asahi Kasei Corporation; Novartis	Joazeiro, CAP (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	joazeiro@scripps.edu		Batalov, Sergey/0000-0002-0925-0554	The Genomics Institute of the Novartis Research Foundation (GNF)	The Genomics Institute of the Novartis Research Foundation (GNF)	TSRI start-up funds and funds from The Genomics Institute of the Novartis Research Foundation (GNF)	Beckmann JS, 2005, HUM MUTAT, V25, P507, DOI 10.1002/humu.20175; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Fritz S, 2003, MOL BIOL CELL, V14, P2303, DOI 10.1091/mbc.E02-12-0831; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Li W, 2005, METHOD ENZYMOL, V398, P280, DOI 10.1016/S0076-6879(05)98023-3; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Neutzner A, 2005, J BIOL CHEM, V280, P18598, DOI 10.1074/jbc.M500807200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	39	499	519	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1487	10.1371/journal.pone.0001487	http://dx.doi.org/10.1371/journal.pone.0001487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213395	Green Submitted, gold, Green Published			2022-12-27	WOS:000260503900032
J	Poderoso, C; Converso, DP; Maloberti, P; Duarte, A; Neuman, I; Galli, S; Maciel, FC; Paz, C; Carreras, MC; Poderoso, JJ; Podesta, EJ				Poderoso, Cecilia; Converso, Daniela P.; Maloberti, Paula; Duarte, Alejandra; Neuman, Isabel; Galli, Soledad; Maciel, Fabiana Cornejo; Paz, Cristina; Carreras, Maria C.; Poderoso, Juan J.; Podesta, Ernesto J.			A Mitochondrial Kinase Complex Is Essential to Mediate an ERK1/2-Dependent Phosphorylation of a Key Regulatory Protein in Steroid Biosynthesis	PLOS ONE			English	Article								ERK1/2 is known to be involved in hormone-stimulated steroid synthesis, but its exact roles and the underlying mechanisms remain elusive. Both ERK1/2 phosphorylation and steroidogenesis may be triggered by cAMP/cAMP-dependent protein kinase (PKA)-dependent and-independent mechanisms; however, ERK1/2 activation by cAMP results in a maximal steroidogenic rate, whereas canonical activation by epidermal growth factor (EGF) does not. We demonstrate herein by Western blot analysis and confocal studies that temporal mitochondrial ERK1/2 activation is obligatory for PKA-mediated steroidogenesis in the Leydig-transformed MA-10 cell line. PKA activity leads to the phosphorylation of a constitutive mitochondrial MEK1/2 pool with a lower effect in cytosolic MEKs, while EGF allows predominant cytosolic MEK activation and nuclear pERK1/2 localization. These results would explain why PKA favors a more durable ERK1/2 activation in mitochondria than does EGF. By means of ex vivo experiments, we showed that mitochondrial maximal steroidogenesis occurred as a result of the mutual action of steroidogenic acute regulatory (StAR) protein -a key regulatory component in steroid biosynthesis-, active ERK1/2 and PKA. Our results indicate that there is an interaction between mitochondrial StAR and ERK1/2, involving a D domain with sequential basic-hydrophobic motifs similar to ERK substrates. As a result of this binding and only in the presence of cholesterol, ERK1/2 phosphorylates StAR at Ser(232). Directed mutagenesis of Ser(232) to a non-phosphorylable amino acid such as Ala ( StAR S232A) inhibited in vitro StAR phosphorylation by active ERK1/2. Transient transfection of MA-10 cells with StAR S232A markedly reduced the yield of progesterone production. In summary, here we show that StAR is a novel substrate of ERK1/2, and that mitochondrial ERK1/2 is part of a multimeric protein kinase complex that regulates cholesterol transport. The role of MAPKs in mitochondrial function is underlined.	[Converso, Daniela P.; Galli, Soledad; Carreras, Maria C.; Poderoso, Juan J.] Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina; [Carreras, Maria C.] Univ Buenos Aires, Univ Hosp, Dept Clin Biochem, Buenos Aires, DF, Argentina; [Poderoso, Cecilia; Maloberti, Paula; Duarte, Alejandra; Neuman, Isabel; Maciel, Fabiana Cornejo; Paz, Cristina; Podesta, Ernesto J.] Univ Buenos Aires, Sch Med, Dept Human Biochem, IIMHNO, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Podesta, EJ (corresponding author), Univ Buenos Aires, Sch Med, Dept Human Biochem, IIMHNO, Buenos Aires, DF, Argentina.	biohrdc@fmed.uba.ar	Maloberti, Paula/AAU-5216-2020	CORNEJO MACIEL, MARIA FABIANA/0000-0003-0685-9038	National Research Council (CONICET); University of Buenos Aires (UBA); National Agency for Promotion of Science and Technology (ANPCyT); Sigma Xi; Scientific Research Society	National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBA)(University of Buenos Aires); National Agency for Promotion of Science and Technology (ANPCyT)(ANPCyT); Sigma Xi; Scientific Research Society	National Research Council (CONICET) University of Buenos Aires (UBA) National Agency for Promotion of Science and Technology (ANPCyT) Sigma Xi, the Scientific Research Society.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; ASCOLI M, 1987, J BIOL CHEM, V262, P9196; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bardwell AJ, 2003, BIOCHEM J, V370, P1077, DOI 10.1042/BJ20021806; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Castillo AF, 2006, FEBS J, V273, P5011, DOI 10.1111/j.1742-4658.2006.05496.x; CHAREST DL, 1993, MOL CELL BIOL, V13, P4679, DOI 10.1128/MCB.13.8.4679; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Colonna C, 2005, EXP CELL RES, V304, P432, DOI 10.1016/j.yexcr.2004.11.019; COOKE BA, 1976, BIOCHEM J, V160, P439, DOI 10.1042/bj1600439; CRIVELLO JF, 1980, J BIOL CHEM, V255, P8144; Duarte A, 2007, FEBS LETT, V581, P4023, DOI 10.1016/j.febslet.2007.07.040; EPSTEIN LF, 1991, J BIOL CHEM, V266, P19739; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Fleury A, 2004, J STEROID BIOCHEM, V91, P259, DOI 10.1016/j.jsbmb.2004.04.010; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Granot Z, 2007, MOL CELL ENDOCRINOL, V265, P51, DOI 10.1016/j.mce.2006.12.003; Gyles SL, 2001, J BIOL CHEM, V276, P34888, DOI 10.1074/jbc.M102063200; Gyles SL, 2000, ENDOCR RES, V26, P579, DOI 10.3109/07435800009048574; Hengen PN, 1996, TRENDS BIOCHEM SCI, V21, P400, DOI 10.1016/S0968-0004(96)30035-2; Hirakawa T, 2003, MOL ENDOCRINOL, V17, P2189, DOI 10.1210/me.2003-0205; KRUEGER RJ, 1983, J BIOL CHEM, V258, P159; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Maciel FC, 2001, J ENDOCRINOL, V170, P403, DOI 10.1677/joe.0.1700403; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Manna PR, 2007, J ENDOCRINOL, V193, P53, DOI 10.1677/JOE-06-0201; Martinelle N, 2004, ENDOCRINOLOGY, V145, P4629, DOI 10.1210/en.2004-0496; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Miller WL, 2007, MOL CELL ENDOCRINOL, V265, P46, DOI 10.1016/j.mce.2006.12.002; Miller WL, 2007, MOL ENDOCRINOL, V21, P589, DOI 10.1210/me.2006-0303; NEHER R, 1982, P NATL ACAD SCI-BIOL, V79, P1727, DOI 10.1073/pnas.79.6.1727; Otis M, 2007, MOL CELL ENDOCRINOL, V265, P126, DOI 10.1016/j.mce.2006.12.008; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Paz C, 2002, J ENDOCRINOL, V175, P793, DOI 10.1677/joe.0.1750793; Petrescu AD, 2001, J BIOL CHEM, V276, P36970, DOI 10.1074/jbc.M101939200; PODESTA EJ, 1979, P NATL ACAD SCI USA, V76, P5187, DOI 10.1073/pnas.76.10.5187; PODESTA EJ, 1976, FEBS LETT, V70, P212, DOI 10.1016/0014-5793(76)80760-0; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; RAE PA, 1979, P NATL ACAD SCI USA, V76, P1896, DOI 10.1073/pnas.76.4.1896; Renlund N, 2006, J MOL ENDOCRINOL, V36, P327, DOI 10.1677/jme.1.01963; Robinson FL, 2002, J BIOL CHEM, V277, P14844, DOI 10.1074/jbc.M107776200; SALA GB, 1979, J BIOL CHEM, V254, P3861; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seger R, 2001, J BIOL CHEM, V276, P13957, DOI 10.1074/jbc.M006852200; Shiraishi K, 2006, ENDOCRINOLOGY, V147, P3419, DOI 10.1210/en.2005-1478; Soltys BJ, 1999, TRENDS BIOCHEM SCI, V24, P174, DOI 10.1016/S0968-0004(99)01390-0; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; STOCCO DM, 1983, ANAL BIOCHEM, V131, P453, DOI 10.1016/0003-2697(83)90198-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang XJ, 1998, ENDOCRINOLOGY, V139, P3903, DOI 10.1210/en.139.9.3903; Xu BE, 2001, J BIOL CHEM, V276, P26509, DOI 10.1074/jbc.M102769200; Yamazaki T, 2006, BBA-PROTEINS PROTEOM, V1764, P1561, DOI 10.1016/j.bbapap.2006.08.016; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	62	89	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1443	10.1371/journal.pone.0001443	http://dx.doi.org/10.1371/journal.pone.0001443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197253	gold, Green Published, Green Submitted			2022-12-27	WOS:000260503800014
J	Bassichetto, KC; Bergamaschi, DP; Oliveira, SM; Deienno, MCV; Bortolato, R; de Rezende, HV; Arthur, T; Tomiyama, H; Watkins, C; Mesquita, F; Abbate, MC; Kallas, EG				Bassichetto, Katia Cristina; Bergamaschi, Denise Pimentel; Oliveira, Solange Maria; Verri Deienno, Marylei Casteldelli; Bortolato, Reginaldo; de Rezende, Heloiza Vilma; Arthur, Thais; Tomiyama, Helena; Watkins, Colyn; Mesquita, Fabio; Abbate, Maria Cristina; Kallas, Esper Georges			Elevated Risk for HIV-1 Infection in Adolescents and Young Adults in Sao Paulo, Brazil	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SENSITIVE ENZYME-IMMUNOASSAY; TESTING STRATEGY; MEN; PREVENTION; BEHAVIORS; HIV/AIDS; SANTOS; SEX	Background. Recent studies have sought to describe HIV infection and transmission characteristics around the world. Identification of early HIV-1 infection is essential to proper surveillance and description of regional transmission trends. In this study we compare people recently infected (RI) with HIV-1, as defined by Serologic Testing Algorithm for Recent HIV Seroconversion (STARHS), to those with chronic infection. Methodology/Principal Findings. Subjects were identified from 2002-2004 at four testing sites in Sao Paulo. Of 485 HIV-1-positive subjects, 57 (12%) were defined as RI. Of the participants, 165 (34.0%) were aware of their serostatus at the time of HIV-1 testing. This proportion was statistically larger (p<0.001) among the individuals without recent infection (n = 158, 95.8%) compared to 7 individuals (4.2%) with recently acquired HIV-1 infection. In the univariate analysis, RI was more frequent in,25 and >59 years-old age strata (p < 0.001). The majority of study participants were male (78.4%), 25 to 45 years-old (65.8%), white (63.2%), single (61.7%), with family income of four or more times the minimum wage (41.0%), but with an equally distributed educational level. Of those individuals infected with HIV-1, the predominant route of infection was sexual contact (89.4%), with both hetero (47.5%) and homosexual (34.5%) exposure. Regarding sexual activity in these individuals, 43.9% reported possible HIV-1 exposure through a seropositive partner, and 49.4% reported multiple partners, with 47% having 2 to 10 partners and 37.4% 11 or more; 53.4% of infected individuals reported condom use sometimes; 34.2% reported non-injecting, recreational drug use and 23.6% were reactive for syphilis by VDRL. Subjects younger than 25 years of age were most vulnerable according to the multivariate analysis. Conclusions/Significance. In this study, we evaluated RI individuals and discovered that HIV-1 has been spreading among younger individuals in Sao Paulo and preventive approaches should, therefore, target this age stratum.	[Bassichetto, Katia Cristina; Mesquita, Fabio; Abbate, Maria Cristina] Publ Hlth Dept Sao Paulo, Sao Paulo, Brazil; [Bergamaschi, Denise Pimentel; Arthur, Thais; Kallas, Esper Georges] Univ Sao Paulo, Dept Allergy & Immunol, Sao Paulo, Brazil; [Oliveira, Solange Maria] Henfil Counseling & Testing Ctr, Sao Paulo, Brazil; [Verri Deienno, Marylei Casteldelli] Spec Attend Serv STD Aids Camp Eliseos, Sao Paulo, Brazil; [Bortolato, Reginaldo] Spec Attend Serv STD Aids Lapa, Sao Paulo, Brazil; [de Rezende, Heloiza Vilma] Pirituba Counsel & Test Ctr, Sao Paulo, Brazil; [Tomiyama, Helena; Watkins, Colyn; Kallas, Esper Georges] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Bassichetto, KC (corresponding author), Publ Hlth Dept Sao Paulo, Sao Paulo, Brazil.	kbassichetto@prefeitura.sp.gov.br	Kallas, Esper G/C-9539-2012; Bergamaschi, Denise Pimentel/I-7383-2017; Mesquita, Fabio/AAZ-7021-2020	Bergamaschi, Denise Pimentel/0000-0002-6889-8588; Kallas, Esper/0000-0003-2026-6925; Mesquita, Fabio/0000-0002-8297-0224	Brazilian Program for STD and AIDS; Ministry of Health [TC282/05, 914/BRA/3014]; Sao Paulo City Health Department [2004-0.168.922-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9]	Brazilian Program for STD and AIDS; Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported with funding from the Brazilian Program for STD and AIDS, Ministry of Health (TC282/05, UNESCO/Bassichetto and 914/BRA/3014, UNESCO/Kallas), the Sao Paulo City Health Department (2004-0.168.922-7/Kallas), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Kallas).	Alves K, 2003, JAIDS-J ACQ IMM DEF, V32, P551, DOI 10.1097/00126334-200304150-00014; Sucupira MCA, 2007, AIDS PATIENT CARE ST, V21, P116, DOI 10.1089/apc.2006.0079; *BRAS MIN SAUD, 2002, B EP AIDS, V15; *BRAS MIN SAUD SEC, 2002, VIG HIV BRAS NOV DIR; *BRAS MIN SAUD SEC, 2002, SIST INF CENTR TEST; *CDCP, 2001, MMWR, V50; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; Cochran W.G., 1967, STAT METHODS; Cooperman NA, 2007, AIDS EDUC PREV, V19, P321, DOI 10.1521/aeap.2007.19.4.321; da Silva CGM, 2005, AIDS, V19, pS31, DOI 10.1097/01.aids.0000191488.77038.bb; DEAN AG, 2002, EPI INFO DATABASE ST; Diaz RS, 1999, AIDS, V13, P1417, DOI 10.1097/00002030-199907300-00024; Hosmer DW, 2001, APPL LOGISTIC REGRES; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jarlais DC, 2005, AM J PUBLIC HEALTH, V95, P1439, DOI 10.2105/AJPH.2003.036517; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Oliveira CAD, 2005, J CLIN MICROBIOL, V43, P1439, DOI 10.1128/JCM.43.3.1439-1442.2005; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Puchhammer-Stokl E, 2005, J CLIN MICROBIOL, V43, P497, DOI 10.1128/JCM.43.1.497-498.2005; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Rosa H, 2006, REV SAUDE PUBL, V40, P220, DOI 10.1590/S0034-89102006000200006; Schwarcz SK, 2002, J INFECT DIS, V186, P1019, DOI 10.1086/342954; *SECR MUN SAUD SAO, 2007, B EP AIDS DST HEP B; STALL R, 1994, ARCH INTERN MED, V154, P57, DOI 10.1001/archinte.154.1.57; STATA, 2001, STAT STAT SOFTW REL; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Szwarcwald CL, 2005, AIDS, V19, pS51, DOI 10.1097/01.aids.0000191491.66736.16	28	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2008	3	1							e1423	10.1371/journal.pone.0001423	http://dx.doi.org/10.1371/journal.pone.0001423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366GT	18183303	Green Published, gold, Green Submitted			2022-12-27	WOS:000260469400019
J	Erixon, P; Oxelman, B				Erixon, Per; Oxelman, Bengt			Whole-Gene Positive Selection, Elevated Synonymous Substitution Rates, Duplication, and Indel Evolution of the Chloroplast clpP1 Gene	PLOS ONE			English	Article							MOLECULAR ADAPTATION; GENOME SEQUENCE; MITOCHONDRIAL; NUCLEAR; FAMILY; CARYOPHYLLACEAE; PHYLOGENY; PROTEASES; PATTERNS; SEARCH	Background. Synonymous DNA substitution rates in the plant chloroplast genome are generally relatively slow and lineage dependent. Non-synonymous rates are usually even slower due to purifying selection acting on the genes. Positive selection is expected to speed up non-synonymous substitution rates, whereas synonymous rates are expected to be unaffected. Until recently, positive selection has seldom been observed in chloroplast genes, and large-scale structural rearrangements leading to gene duplications are hitherto supposed to be rare. Methodology/Principle Findings. We found high substitution rates in the exons of the plastid clpP1 gene in Oenothera(the Evening Primrose family) and three separate lineages in the tribe Sileneae (Caryophyllaceae, the Carnation family). Introns have been lost in some of the lineages, but where present, the intron sequences have substitution rates similar to those found in other introns of their genomes. The elevated substitution rates of clpP1 are associated with statistically significant whole-gene positive selection in three branches of the phylogeny. In two of the lineages we found multiple copies of the gene. Neighboring genes present in the duplicated fragments do not show signs of elevated substitution rates or positive selection. Although non-synonymous substitutions account for most of the increase in substitution rates, synonymous rates are also markedly elevated in some lineages. Whereas plant clpP1 genes experiencing negative (purifying) selection are characterized by having very conserved lengths, genes under positive selection often have large insertions of more or less repetitive amino acid sequence motifs. Conclusions/Significance. We found positive selection of the clpP1 gene in various plant lineages to correlated with repeated duplication of the clpP1 gene and surrounding regions, repetitive amino acid sequences, and increase in synonymous substitution rates. The present study sheds light on the controversial issue of whether negative or positive selection is to be expected after gene duplications by providing evidence for the latter alternative. The observed increase in synonymous substitution rates in some of the lineages indicates that the detection of positive selection may be obscured under such circumstances. Future studies are required to explore the functional significance of the large inserted repeated amino acid motifs, as well as the possibility that synonymous substitution rates may be affected by positive selection.	[Erixon, Per; Oxelman, Bengt] Uppsala Univ, Dept Systemat Bot, Evolutionary Biol Ctr, Uppsala, Sweden; [Erixon, Per; Oxelman, Bengt] Gothenburg Univ, Dept Plant & Env Sci, Gothenburg, Sweden	Uppsala University; University of Gothenburg	Erixon, P (corresponding author), Uppsala Univ, Dept Systemat Bot, Evolutionary Biol Ctr, Uppsala, Sweden.	per.erixon@ebc.uu.se	Oxelman, Bengt/F-2944-2010	Oxelman, Bengt/0000-0002-6104-4264	Linnaeus Centre for Bioinformatics; Uppsala University; Helge Ax:son Johnson foundation, the Nilsson-Ehle foundation, and the Royal Swedish Academy of Sciences; Swedish Research Council	Linnaeus Centre for Bioinformatics; Uppsala University; Helge Ax:son Johnson foundation, the Nilsson-Ehle foundation, and the Royal Swedish Academy of Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Linnaeus Centre for Bioinformatics, Uppsala University, and by grants from the Helge Ax:son Johnson foundation, the Nilsson-Ehle foundation, and the Royal Swedish Academy of Sciences to PE and partly by a grant from the Swedish Research Council to BO	Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Clarke AK, 1999, ANN BOT-LONDON, V83, P593, DOI 10.1006/anbo.1999.0878; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; ERIXON P, 2006, THESIS UPPSALA U; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Levin RA, 2004, SYST BOT, V29, P147, DOI 10.1600/036364404772974293; MacCallum C, 2006, PLOS BIOL, V4, P293, DOI 10.1371/journal.pbio.0040087; Muse SV, 1997, GENETICS, V146, P393; OHTA T, 1993, GENETICS, V134, P1271; OLMSTEAD RG, 1999, SOLANACEAE, V4, P111; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; OXELMAN B, 1995, TAXON, V44, P525, DOI 10.2307/1223498; Oxelman B, 2000, NORD J BOT, V20, P743, DOI 10.1111/j.1756-1051.2000.tb00760.x; Popp M, 2004, SYST BIOL, V53, P914, DOI 10.1080/10635150490888840; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Roth C, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-12; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhang JZ, 2004, MOL BIOL EVOL, V21, P1332, DOI 10.1093/molbev/msh117; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	40	102	107	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1386	10.1371/journal.pone.0001386	http://dx.doi.org/10.1371/journal.pone.0001386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167545	Green Submitted, Green Published, gold			2022-12-27	WOS:000260468900014
J	Torok, ME; Chau, TTH; Mai, PP; Phong, ND; Dung, NT; Van Chuong, L; Lee, SJ; Caws, M; de Jong, MD; Hien, TT; Farrar, JJ				Torok, M. Estee; Chau, Tran Thi Hong; Mai, Pham Phuong; Phong, Nguyen Duy; Dung, Nguyen Thi; Van Chuong, Ly; Lee, Sue J.; Caws, M.; de Jong, Menno D.; Hien, Tran Tinh; Farrar, Jeremy J.			Clinical and Microbiological Features of HIV-Associated Tuberculous Meningitis in Vietnamese Adults	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; INFECTION; OUTCOMES; THERAPY; ERA	Methods: The aim of this prospective, observational cohort study was to determine the clinical and microbiological features, outcome, and baseline variables predictive of death, in Vietnamese adults with HIV-associated tuberculous meningitis (TBM). 58 patients were admitted to the Hospital for Tropical Diseases in Ho Chi Minh City and underwent routine clinical and laboratory assessments. Treatment was with standard antituberculous therapy and adjunctive dexamethasone; antiretroviral therapy was not routinely available. Patients were followed up until the end of TB treatment or death. Results: The median symptom duration was 11 days (range 2-90 days), 21.8% had a past history of TB, and 41.4% had severe (grade 3) TBM. The median CD4 count was 32 cells/mm(3). CSF findings were as follows: median leucocyte count 438610 9 cells/l (63% neutrophils), 69% smear positive and 87.9% culture positive. TB drug resistance rates were high (13% mono-resistance 32.6% poly-resistance 8.7% multidrug resistance). 17% patients developed further AIDS-defining illnesses. 67.2% died (median time to death 20 days). Three baseline variables were predictive of death by multivariate analysis: increased TBM grade [adjusted hazard ratio (AHR) 1.73, 95% CI 1.08-2.76, p = 0.02], lower serum sodium (AHR 0.93, 95% CI 0.89 to 0.98, p = 0.002) and decreased CSF lymphocyte percentage (AHR 0.98, 95% CI 0.97 to 0.99, p = 0.003). Conclusions: HIV-associated TBM is devastating disease with a dismal prognosis. CSF findings included CSF neutrophil predominance, high rates of smear and culture positivity, and high rates of antituberculous drug resistance. Three baseline variables were independently associated with death: increased TBM grade; low serum sodium and decreased CSF lymphocyte percentage.	[Torok, M. Estee; Caws, M.; de Jong, Menno D.; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Chau, Tran Thi Hong; Mai, Pham Phuong; Phong, Nguyen Duy; Dung, Nguyen Thi; Van Chuong, Ly; Hien, Tran Tinh] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Lee, Sue J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Torok, M. Estee; Caws, M.; de Jong, Menno D.; Farrar, Jeremy J.] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England	University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Torok, ME (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	etorok@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X; Torok, Mili Estee/0000-0001-9098-8590; Caws, Maxine/0000-0002-9109-350X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	This study was funded by the Wellcome Trust, UK. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Azuaje C, 2006, ENFERM INFEC MICR CL, V24, P245, DOI 10.1016/S0213-005X(06)73770-3; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; DUBE MP, 1992, AM J MED, V93, P520, DOI 10.1016/0002-9343(92)90579-Z; Enberg G Margarita, 2006, Rev. chil. infectol., V23, P134; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Garg RK, 1999, POSTGRAD MED J, V75, P133, DOI 10.1136/pgmj.75.881.133; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; KARANDE S, 2005, HIV INDIAN J PEDIAT, V72, P755; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; MARSHALL G, 1948, LANCET, V254, P582; Martinez M, 2006, J CLIN MICROBIOL, V44, P2967, DOI 10.1128/JCM.00754-06; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Ormerod P, 1998, THORAX, V53, P536; Schutte CM, 2001, INFECTION, V29, P213, DOI 10.1007/s15010-001-1198-3; Shelburne Samuel A. III, 2003, AIDS Reviews, V5, P67; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Simmons CP, 2006, J IMMUNOL, V176, P2007, DOI 10.4049/jimmunol.176.3.2007; Stoll Matthias, 2003, Curr Infect Dis Rep, V5, P266, DOI 10.1007/s11908-003-0083-x; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2005, J INFECT DIS, V192, P79, DOI 10.1086/430616; Thwaites GE, 2002, INT J TUBERC LUNG D, V6, P865; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; TOROK ME, 2005, PRACTICAL NEUROLOGY, V5, P334; UNAIDS, 2006, AIDS EP UPD, P1; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; *WHO, 2003, WHOGDSTB2003313; World Health Organization, 2006, WHOHTMTB2006362; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710	42	66	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1772	10.1371/journal.pone.0001772	http://dx.doi.org/10.1371/journal.pone.0001772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350135	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300001
J	Garvin, P; Nilsson, L; Carstensen, J; Jonasson, L; Kristenson, M				Garvin, Peter; Nilsson, Lennart; Carstensen, John; Jonasson, Lena; Kristenson, Margareta			Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; MATRIX METALLOPROTEINASES; TNF-ALPHA; ATHEROSCLEROTIC LESIONS; MYOCARDIAL-INFARCTION; MONONUCLEAR-CELLS; OXIDATIVE STRESS; 92-KD GELATINASE; PLASMA	Background: Elevated levels of circulating matrix metalloproteinase-9 (MMP-9) have been demonstrated in patients with established coronary artery disease (CAD). The aim of this study was to analyse levels of MMP-9 in a population free from symptomatic CAD and investigate their associations with cardiovascular (CV) risk factors, including C-reactive protein (CRP). Methods: A cross-sectional study was performed in a population based random sample aged 45-69 (n = 345, 50% women). MMP-9 levels were measured in EDTA-plasma using an ELISA-method. CV risk factors were measured using questionnaires and standard laboratory methods. Results: Plasma MMP-9 was detectable in all participants, mean 38.9 ng/mL (SD 22.1 ng/mL). Among individuals without reported symptomatic CAD a positive association (p<0.001) was seen, for both men and women, of MMP-9 levels regarding total risk load of eight CV risk factors i.e. blood pressure, dyslipidemia, diabetes, obesity, smoking, alcohol intake, physical activity and fruit and vegetable intake. The association was significant also after adjustment for CRP, and was not driven by a single risk factor alone. In regression models adjusted for age, sex, smoking, alcohol intake and CRP, elevated MMP-9 levels were independently positively associated with systolic blood pressure (p = 0.037), smoking (p<0.001), alcohol intake (p = 0.003) and CRP (p<0.001). The correlation coefficient between MMP-9 and CRP was r = 0.24 (p<0.001). Conclusions: In a population without reported symptomatic CAD, MMP-9 levels were associated with total CV risk load as well as with single risk factors. This was found also after adjustment for CRP.	[Garvin, Peter; Kristenson, Margareta] Linkoping Univ, Dept Med & Hlth Sci, Div Community Med, Linkoping, Sweden; [Nilsson, Lennart; Jonasson, Lena] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiol, Linkoping, Sweden; [Carstensen, John] Linkoping Univ, Dept Med & Hlth Sci, Div Hlth & Soc, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Garvin, P (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Community Med, Linkoping, Sweden.	peter.garvin@ihs.liu.se		Carstensen, John/0000-0003-2256-8089; Garvin, Peter/0000-0001-7429-0889	Swedish Research Council [2004-1881]; Swedish Heart and Lung Foundation [20040530]; Linkoping University; County of Ostergotland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Linkoping University; County of Ostergotland	Grants from the Swedish Research Council (2004-1881), the Swedish Heart and Lung Foundation (20040530), from Linkoping University and the County of Ostergotland via the two joint strategic programmes CIRC, Cardiovascular Inflammation Research Centre and Health and Society, respectively. All grants received after application, where specifying the design of the study. Apart from the scientific review, none of the funders have had any role in the design, implementation, interpretation of the data or writing of the manuscript.	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P5988, DOI 10.1210/jc.86.12.5988; BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; BROWN DL, 1995, CIRCULATION, V91, P2125, DOI 10.1161/01.CIR.91.8.2125; Derosa G, 2007, HEART VESSELS, V22, P361, DOI 10.1007/s00380-007-0989-6; Eriksson JS, 2020, SCAND J MED SCI SPOR, V30, P370, DOI 10.1111/sms.13581; Evans J, 2007, EUR J VASC ENDOVASC, V34, P302, DOI 10.1016/j.ejvs.2007.04.011; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gerlach RF, 2007, CLIN BIOCHEM, V40, P119, DOI 10.1016/j.clinbiochem.2006.10.007; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HAVERKATE F, 1995, THROMB HAEMOSTASIS, V73, P561; Hollman G, 2007, EUR J CARDIOVASC NUR; Holven KB, 2006, STROKE, V37, P1731, DOI 10.1161/01.STR.0000226465.84561.cb; Kalela A, 2000, EUR J CLIN INVEST, V30, P99; Kameda K, 2003, EUR HEART J, V24, P2180, DOI 10.1016/j.ehj.2003.09.022; Kameda K, 2006, CIRC J, V70, P673, DOI 10.1253/circj.70.673; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Loftus IM, 2000, STROKE, V31, P40, DOI 10.1161/01.STR.31.1.40; Newby AC, 2006, CURR OPIN LIPIDOL, V17, P556, DOI 10.1097/01.mol.0000245262.48258.b4; Nikkari ST, 1996, AM J PATHOL, V149, P1427; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Orbe J, 2003, ATHEROSCLEROSIS, V170, P269, DOI 10.1016/S0021-9150(03)00251-X; Potier M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1237, DOI 10.1152/ajpendo.00451.2002; Potier M, 2001, J AM SOC NEPHROL, V12, P241, DOI 10.1681/ASN.V122241; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rouy D, 2005, ANAL BIOCHEM, V338, P294, DOI 10.1016/j.ab.2004.10.052; Saren P, 1996, J IMMUNOL, V157, P4159; Sillanaukee P, 2002, EUR J CLIN INVEST, V32, P225, DOI 10.1046/j.1365-2362.2002.00975.x; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Tayebjee MH, 2005, CURR MED CHEM, V12, P917, DOI 10.2174/0929867053507270; Tayebjee MH, 2004, AM J HYPERTENS, V17, P764, DOI 10.1016/j.amjhyper.2004.05.019; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Wagner DR, 2006, J CARD FAIL, V12, P66, DOI 10.1016/j.cardfail.2005.08.002; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41	40	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1774	10.1371/journal.pone.0001774	http://dx.doi.org/10.1371/journal.pone.0001774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335048	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000027
J	Crevel, G; Bennett, D; Cotterill, S				Crevel, Gilles; Bennett, Dorothy; Cotterill, Sue			The Human TPR Protein TTC4 Is a Putative Hsp90 Co-Chaperone Which Interacts with CDC6 and Shows Alterations in Transformed Cells	PLOS ONE			English	Article								Background: The human TTC4 protein is a TPR (tetratricopeptide repeat) motif-containing protein. The gene was originally identified as being localized in a genomic region linked to breast cancer and subsequent studies on melanoma cell lines revealed point mutations in the TTC4 protein that may be associated with the progression of malignant melanoma. Methodology/Principle Findings: Here we show that TTC4 is a nucleoplasmic protein which interacts with HSP90 and HSP70, and also with the replication protein CDC6. It has significant structural and functional similarities with a previously characterised Drosophila protein Dpit47. We show that TTC4 protein levels are raised in malignant melanoma cell lines compared to melanocytes. We also see increased TTC4 expression in a variety of tumour lines derived from other tissues. In addition we show that TTC4 proteins bearing some of the mutations previously identified from patient samples lose their interaction with the CDC6 protein. Conclusions/Significance: Based on these results and our previous work with the Drosophila Dpit47 protein we suggest that TTC4 is an HSP90 co-chaperone protein which forms a link between HSP90 chaperone activity and DNA replication. We further suggest that the loss of the interaction with CDC6 or with additional client proteins could provide one route through which TTC4 could influence malignant development of cells.	[Crevel, Gilles; Bennett, Dorothy; Cotterill, Sue] St George Hosp, Sch Med, Dept Basic Med Sci, London, England	St Georges University London	Crevel, G (corresponding author), St George Hosp, Sch Med, Dept Basic Med Sci, Cranmer Terrace, London, England.	s.cotterill@sghms.ac.uk	Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527	AICR	AICR	AICR	Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; BENNETT DC, 1985, J CELL SCI, V77, P167; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Crevel G, 2005, J CELL SCI, V118, P2451, DOI 10.1242/jcs.02361; Crevel G, 2001, J CELL SCI, V114, P2015; Crevel G, 2001, NUCLEIC ACIDS RES, V29, P4834, DOI 10.1093/nar/29.23.4834; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dmitriev RI, 2007, BIOCHEM BIOPH RES CO, V355, P1051, DOI 10.1016/j.bbrc.2007.02.073; Dolinski KJ, 1998, MOL CELL BIOL, V18, P7344, DOI 10.1128/MCB.18.12.7344; Franzen B, 1996, BRIT J CANCER, V74, P1632, DOI 10.1038/bjc.1996.600; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Hey Y, 2000, CYTOGENET CELL GENET, V88, P272, DOI 10.1159/000015536; Irwin N, 2002, J INVEST DERMATOL, V119, P186, DOI 10.1046/j.1523-1747.2002.18181.x; Konieczny I, 1999, GENET ENG P, V21, P95; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24; Marsh JA, 1998, MOL CELL BIOL, V18, P7353, DOI 10.1128/MCB.18.12.7353; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Moir RD, 2004, ADV PROTEIN CHEM, V67, P93; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Poetsch M, 2000, ONCOGENE, V19, P5817, DOI 10.1038/sj.onc.1203961; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SMITH RL, 1995, GENE DEV, V9, P2903, DOI 10.1101/gad.9.23.2903; Su GF, 1999, GENOMICS, V55, P157, DOI 10.1006/geno.1998.5633; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	33	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e0001737	10.1371/journal.pone.0001737	http://dx.doi.org/10.1371/journal.pone.0001737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320024	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600032
J	Day, JJ; Cotton, JA; Barraclough, TG				Day, Julia J.; Cotton, James A.; Barraclough, Timothy G.			Tempo and Mode of Diversification of Lake Tanganyika Cichlid Fishes	PLOS ONE			English	Article								Background: Understanding the causes of disparities in species diversity across taxonomic groups and regions is a fundamental aim in evolutionary biology. Addressing these questions is difficult because of the need for densely sampled phylogenies and suitable empirical systems. Methodology/Principal Findings: Here we investigate the cichlid fish radiation of Lake Tanganyika and show that per lineage diversification rates have been more than six times slower than in the species flocks of Lakes Victoria and Malawi. The result holds even at peak periods of diversification in Lake Tanganyika, ruling out the age of the lake as an explanation for slow average rates, and is robust to uncertainties over the calibration of cichlid radiations in geological time. Moreover, Lake Tanganyika lineages, irrespective of different biological characteristics ( e. g. sexually dichromatic versus sexually monochromatic clades), have diversified at similar rates, falling within typical estimates across a range of plant and animal clades. For example, the mostly sexually dichromatic haplochromines, which have speciated explosively in Lakes Victoria and Malawi, have displayed modest rates in Lake Tanganyika ( where they are called Tropheini). Conclusion/Significance: Our results show that either the Lake Tanganyika environment is less conducive for cichlid speciation or the remarkable diversifying abilities of the haplochromines were inhibited by the prior occupancy of older radiations. Although the results indicate a dominant role for the environment in shaping cichlid diversification, differences in the timing of diversification among the Tanganyikan tribes indicate that biological differences were still important for the dynamics of species build-up in the lake. While we cannot resolve the timing of the radiation relative to the origin of the lake, because of the lack of robust geological date calibrations for cichlids, our results are consistent with a scenario that the different clades reflect independent adaptive radiations into different broad niches in the lake.	[Day, Julia J.; Cotton, James A.] Nat Hist Museum, Dept Zool, London, England; [Cotton, James A.] Univ London, Sch Biol & Chem Sci, London, England; [Barraclough, Timothy G.] Imperial Coll London, NERC Ctr Populat Biol, Div Biol, Ascot, Berks, England	Natural History Museum London; University of London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Day, JJ (corresponding author), UCL, Dept Biol, London, England.	j.day@ucl.ac.uk	Cotton, James A/B-8806-2008	Cotton, James A/0000-0001-5475-3583; Day, Julia/0000-0002-6765-7782; Barraclough, Timothy/0000-0002-8084-2640	Dorothy Hodgkin Royal Society fellowship	Dorothy Hodgkin Royal Society fellowship	JJD is supported by a Dorothy Hodgkin Royal Society fellowship.	Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Barraclough TG, 1998, PHILOS T R SOC B, V353, P241, DOI 10.1098/rstb.1998.0206; Barraclough TG, 2002, MOL BIOL EVOL, V19, P1706, DOI 10.1093/oxfordjournals.molbev.a003993; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; BINDAEMONDS ORP, 2007, NATURE, V446, P507; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Clabaut C, 2005, J MOL EVOL, V61, P666, DOI 10.1007/s00239-004-0217-2; COHEN AS, 1993, GEOLOGY, V21, P511, DOI 10.1130/0091-7613(1993)021<0511:ETAOFO>2.3.CO;2; Cohen AS, 1997, BASIN RES, V9, P107, DOI 10.1046/j.1365-2117.1997.00038.x; Coyne J.A., 2004, SPECIATION; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; Davies TJ, 2005, AM NAT, V166, P418, DOI 10.1086/432022; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Day JJ, 2006, BIOL LETT-UK, V2, P548, DOI 10.1098/rsbl.2006.0532; DELVAUX D, 1996, AGE LAKE MALAWI NYAS, P99; DOMINEY WJ, 1984, EVOLUTION FISH SPECI, P231; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Genner MJ, 2004, J BIOGEOGR, V31, P93, DOI 10.1046/j.0305-0270.2003.00986.x; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Konings A, 2015, TANGANYIKA CICHLIDS; Langenberg V. T., 2002, Aquatic Ecosystem Health & Management, V5, P255, DOI 10.1080/14634980290031956; Marijnissen SAE, 2006, MOL PHYLOGENET EVOL, V40, P628, DOI 10.1016/j.ympev.2006.03.025; McCune Amy R., 1997, P585; McCune AR, 1998, ENDLESS FORMS, P172; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Nagl S, 2000, P ROY SOC B-BIOL SCI, V267, P1049, DOI 10.1098/rspb.2000.1109; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nee S, 2001, EVOLUTION, V55, P661, DOI 10.1554/0014-3820(2001)055[0661:ISRFP]2.0.CO;2; NISHIDA M, 1997, FISH COMMUNITIES LAK, P3; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; PURVIS A, 1995, P ROY SOC B-BIOL SCI, V260, P329, DOI 10.1098/rspb.1995.0100; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Development Core Team, 2006, R LANG ENV STAT COMP; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Ricklefs RE, 2003, P ROY SOC B-BIOL SCI, V270, P2285, DOI 10.1098/rspb.2003.2489; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; SALZBURGER W, 2002, SYST BIOL, V1, P1; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Swofford D.L., 2002, PAUP 4 0B 10; Takahashi T, 2003, ICHTHYOL RES, V50, P367, DOI 10.1007/s10228-003-0181-7; Terai Y, 2003, MOL BIOL EVOL, V20, P924, DOI 10.1093/molbev/msg104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiercelin J.J., 1991, LAKE TANGANYIKA ITS, P7; Turner GT, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P113; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yanagisawa Y, 1997, FISH COMMUNITIES LAK, P151; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339; Zwickl DJ., 2006, THESIS	65	73	73	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1730	10.1371/journal.pone.0001730	http://dx.doi.org/10.1371/journal.pone.0001730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320049	Green Submitted, gold, Green Published			2022-12-27	WOS:000260586600025
J	Gadi, VK; Malone, KE; Guthrie, KA; Porter, PL; Nelson, JL				Gadi, Vijayakrishna K.; Malone, Kathleen E.; Guthrie, Katherine A.; Porter, Peggy L.; Nelson, J. Lee			Case-Control Study of Fetal Microchimerism and Breast Cancer	PLOS ONE			English	Article							HEALTHY WOMEN; BRCA2 MUTATIONS; HOST-DISEASE; CELLS; PREGNANCY; PARITY; GRAFT; BLOOD; RISK; LONG	Background: Prior pregnancy is known to protect against development of breast cancer. Recent studies have demonstrated that pregnancy has the capacity to establish small numbers of immunologically active fetal-derived cells in the mother, a phenomenon known as fetal microchimerism (FMc). We asked whether presence of FMc, routinely acquired during pregnancy, is a protective factor for breast cancer. Methodology/Principal Findings: DNA extracts from peripheral blood specimens were obtained from a population-based case-control study of risk factors for breast cancer in women 21 to 45 years old. Specimens were tested with quantitative PCR for presence and concentrations of male DNA presumed to derive from prior pregnancies with a male fetus. Odds ratios (OR) and 95% confidence intervals (CI) were estimated with consideration of multiple established reproductive and environmental risk factors for breast cancer. FMc results were generated on 99 parous women, 54 with primary invasive breast cancer and 45 general population controls. FMc prevalence was 56% (25/45) and 26% (14/54) in controls and cases, respectively. Women harboring FMc were less likely to have had breast cancer (OR = 0.29, 95% CI 0.11-0.83; p = 0.02, adjusting for age, number of children, birth of a son, history of miscarriage, and total DNA tested). In addition, FMc concentrations were higher in controls versus cases (p = 0.01). Median concentrations were 2 (0 - 78) and 0 (0 - 374) fetal genomes/10(6) maternal genomes in controls and cases, respectively. Conclusions: Results suggest that the enigma of why some parous women are not afforded protection from breast cancer by pregnancy might in part be explained by differences in FMc. Mechanistic studies of FMc-derived protection against breast cancer are warranted.	[Gadi, Vijayakrishna K.; Guthrie, Katherine A.; Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Malone, Kathleen E.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA USA; [Porter, Peggy L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA USA; [Gadi, Vijayakrishna K.; Porter, Peggy L.; Nelson, J. Lee] Univ Washington, Dept Med, Seattle, WA USA; [Malone, Kathleen E.] Univ Washington, Dept Epidemiol, Seattle, WA USA; [Guthrie, Katherine A.] Univ Washington, Dept Biostat, Seattle, WA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gadi, VK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	vkgadi@u.washington.edu			National Institutes of Health [AI41721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by a research grant AI41721 from the National Institutes of Health (JLN). The funding source had no role in the design of the studies presented, in the collection or presentation of data, in the writing of the manuscript, or in the decision to submit this manuscript.	BERAL V, 1983, CIBA F SYMP, V96, P182; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; BRINTON LA, 1995, J NATL CANCER I, V87, P827, DOI 10.1093/jnci/87.11.827; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Ganz PA, 2005, AM J MED, V118, P1410, DOI 10.1016/j.amjmed.2005.10.024; Klintschar M, 2001, J CLIN ENDOCR METAB, V86, P2494, DOI 10.1210/jc.86.6.2494; Lambert NC, 2004, ARTHRITIS RHEUM-US, V50, P906, DOI 10.1002/art.20200; Lambert NC, 2002, BLOOD, V100, P2845, DOI 10.1182/blood-2002-01-0295; LAYDE PM, 1989, J CLIN EPIDEMIOL, V42, P963, DOI 10.1016/0895-4356(89)90161-3; Lo YMD, 2000, CLIN CHEM, V46, P1301; McClain MR, 2005, GENET MED, V7, P28, DOI 10.1097/01.GIM.0000151155.36470.FF; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Scaletti C, 2002, ARTHRITIS RHEUM, V46, P445, DOI 10.1002/art.10049; Tykodi SS, 2004, CLIN CANCER RES, V10, P7799, DOI 10.1158/1078-0432.CCR-04-0072; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; WEIDEN PL, 1981, NEW ENGL J MED, V304, P1529, DOI 10.1056/NEJM198106183042507	19	51	54	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1706	10.1371/journal.pone.0001706	http://dx.doi.org/10.1371/journal.pone.0001706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320027	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586600002
J	Mappes, T; Koivula, M; Koskela, E; Oksanen, TA; Savolainen, T; Sinervo, B				Mappes, Tapio; Koivula, Minna; Koskela, Esa; Oksanen, Tuula A.; Savolainen, Tiina; Sinervo, Barry			Frequency and Density-Dependent Selection on Life-History Strategies - A Field Experiment	PLOS ONE			English	Article								Negative frequency-dependence, which favors rare genotypes, promotes the maintenance of genetic variability and is of interest as a potential explanation for genetic differentiation. Density-dependent selection may also promote cyclic changes in frequencies of genotypes. Here we show evidence for both density-dependent and negative frequency-dependent selection on opposite life-history tactics (low or high reproductive effort, RE) in the bank vole (Myodes glareolus). Density-dependent selection was evident among the females with low RE, which were especially favored in low densities. Instead, both negative frequency-dependent and density-dependent selection were shown in females with high RE, which were most successful when they were rare in high densities. Furthermore, selection at the individual level affected the frequencies of tactics at the population level, so that the frequency of the rare high RE tactic increased significantly at high densities. We hypothesize that these two selection mechanisms (density- and negative frequency-dependent selection) may promote genetic variability in cyclic mammal populations. Nevertheless, it remains to be determined whether the origin of genetic variance in life-history traits is causally related to density variation (e.g. population cycles).	[Mappes, Tapio; Koskela, Esa; Oksanen, Tuula A.; Savolainen, Tiina] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Koivula, Minna] MTT Biotechnol & Food Res, Jokioinen, Finland; [Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA USA	University of Jyvaskyla; Natural Resources Institute Finland (Luke); University of California System; University of California Santa Cruz	Mappes, T (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	tmappes@bytl.jyu.fi	Mappes, Tapio/B-9780-2013	Koskela, Esa/0000-0002-9418-5733; Oksanen, Tuula/0000-0003-3481-6158; Mappes, Tapio/0000-0002-5936-7355	Academy of Finland [206091, 118603, 109165, 100143, 78777, 103148, 115961]; Centre of Excellence of Evolutionary Research of the Academy of Finland	Academy of Finland(Academy of Finland); Centre of Excellence of Evolutionary Research of the Academy of Finland(Academy of Finland)	Financial supported by the Academy of Finland (grant no. 206091, 118603, 109165 to T.M; 100143, 78777, 103148, 115961 to E.K.) and Centre of Excellence of Evolutionary Research of the Academy of Finland.	ANTONOVICS J, 1984, EVOLUTION, V38, P103, DOI 10.1111/j.1558-5646.1984.tb00263.x; BUJALSKA G, 1970, Acta Theriologica, V15, P381; Bulmer MG, 1985, MATH THEORY QUANTITA; Burger R, 2004, GENETICS, V167, P1425, DOI 10.1534/genetics.103.018986; Chitty D., 1967, Proceedings of the Ecological Society of Australia, V2, P51; Falconer D. S., 1996, INTRO QUANTITATIVE G; GUSTAFSSON L, 1986, AM NAT, V128, P761, DOI 10.1086/284601; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; HANSSON L, 1979, OIKOS, V33, P55, DOI 10.2307/3544511; Hopfner R, 2006, J MATH BIOL, V52, P439, DOI 10.1007/s00285-005-0361-3; HUITU O, 2006, OIKOS IN PRESS; Jonsson P, 2002, EVOL ECOL, V16, P455, DOI 10.1023/A:1020854525220; Kleiber M, 1961, FIRE LIFE; Koivula M, 2003, ECOLOGY, V84, P398, DOI 10.1890/0012-9658(2003)084[0398:CORITW]2.0.CO;2; Kopp M, 2006, EVOLUTION, V60, P1537; Korpimaki E, 2005, P ROY SOC B-BIOL SCI, V272, P193, DOI 10.1098/rspb.2004.2860; Koskela E, 1999, J ANIM ECOL, V68, P513, DOI 10.1046/j.1365-2656.1999.00308.x; Koskela E, 1997, J ANIM ECOL, V66, P341, DOI 10.2307/5980; KRUCZEK M, 1986, BIOL REPROD, V35, P537, DOI 10.1095/biolreprod35.3.537; Lidicker WZ, 2000, ECOSCIENCE, V7, P247, DOI 10.1080/11956860.2000.11682594; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P15, DOI 10.1098/rspb.1990.0024; MAPPES T, 1995, P ROY SOC B-BIOL SCI, V261, P19, DOI 10.1098/rspb.1995.0111; Mappes T, 2004, EVOLUTION, V58, P645, DOI 10.1111/j.0014-3820.2004.tb01686.x; Maynard Smith J., 1982, EVOLUTION THEORY GAM; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Merila J, 2000, AM NAT, V155, P301, DOI 10.1086/303330; MILLAR JS, 1977, EVOLUTION, V31, P370, DOI 10.2307/2407759; Mills SC, 2007, P ROY SOC B-BIOL SCI, V274, P143, DOI 10.1098/rspb.2006.3639; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Oksanen TA, 2002, EVOLUTION, V56, P1530; Oksanen TA, 2003, J ANIM ECOL, V72, P321, DOI 10.1046/j.1365-2656.2003.00703.x; Oksanen TA, 2007, EVOLUTION, V61, P2822, DOI 10.1111/j.1558-5646.2007.00245.x; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Paterson S, 2003, TRENDS PARASITOL, V19, P370, DOI 10.1016/S1471-4922(03)00149-1; POIKONEN T, 2008, EVOLUTION IN PRESS; PRICE T, 1991, EVOLUTION, V45, P853, DOI 10.1111/j.1558-5646.1991.tb04354.x; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Roff Derek, 2002, pi; Roff Derek A., 1992; RUEFFLER C, 2003, THEORETICAL POPULATI, V65, P165; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2001, GENETICA, V112, P417, DOI 10.1023/A:1013360426789; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Sinervo B, 2007, AM NAT, V170, P663, DOI 10.1086/522092; STENSETH NC, 1985, ANN ZOOL FENN, V22, P215; Trotter MV, 2007, GENETICS, V176, P1729, DOI 10.1534/genetics.107.073072; Turchin P, 2001, ECOLOGY, V82, P1521, DOI 10.2307/2679797; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wojcik AM, 2006, EVOLUTION, V60, P1925; WOLFF JO, 1993, OIKOS, V68, P364, DOI 10.2307/3544853	53	31	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1687	10.1371/journal.pone.0001687	http://dx.doi.org/10.1371/journal.pone.0001687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301764	Green Published, gold			2022-12-27	WOS:000260586500031
J	Stringer, MJ; Sales-Pardo, M; Amaral, LAN				Stringer, Michael J.; Sales-Pardo, Marta; Amaral, Luis A. Nunes			Effectiveness of Journal Ranking Schemes as a Tool for Locating Information	PLOS ONE			English	Article							IMPACT; PAPER; JUDGE; AREA	Background: The rise of electronic publishing [1], preprint archives, blogs, and wikis is raising concerns among publishers, editors, and scientists about the present day relevance of academic journals and traditional peer review [2]. These concerns are especially fuelled by the ability of search engines to automatically identify and sort information [1]. It appears that academic journals can only remain relevant if acceptance of research for publication within a journal allows readers to infer immediate, reliable information on the value of that research. Methodology/Principal Findings: Here, we systematically evaluate the effectiveness of journals, through the work of editors and reviewers, at evaluating unpublished research. We find that the distribution of the number of citations to a paper published in a given journal in a specific year converges to a steady state after a journal-specific transient time, and demonstrate that in the steady state the logarithm of the number of citations has a journal-specific typical value. We then develop a model for the asymptotic number of citations accrued by papers published in a journal that closely matches the data. Conclusions/Significance: Our model enables us to quantify both the typical impact and the range of impacts of papers published in a journal. Finally, we propose a journal-ranking scheme that maximizes the efficiency of locating high impact research.	[Sales-Pardo, Marta; Amaral, Luis A. Nunes] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Stringer, Michael J.] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA; [Stringer, Michael J.; Sales-Pardo, Marta; Amaral, Luis A. Nunes] Northwestern Univ, Northwestern Inst Complex Syst (NICO), Evanston, IL USA	Northwestern University; Northwestern University; Northwestern University	Amaral, LAN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.	amaral@northwestern.edu	Sales-Pardo, Marta/O-9797-2019; Amaral, Luis N./C-5485-2009; Amaral, LAN/A-4980-2008; Sales-Pardo, Marta/C-1725-2008	Sales-Pardo, Marta/0000-0002-8140-6525; Amaral, LAN/0000-0002-3762-789X; Sales-Pardo, Marta/0000-0002-8140-6525				Borgman CL, 2002, ANNU REV INFORM SCI, V36, P3; Cronin B., 2000, WEB KNOWLEDGE FESTSC; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fuyuno I, 2006, NATURE, V441, P792, DOI 10.1038/441792b; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Giles J, 2007, NATURE, V445, P9, DOI 10.1038/445009a; HAMILTON DP, 1991, SCIENCE, V251, P25, DOI 10.1126/science.1986409; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; Menczer F, 2004, EUR PHYS J B, V38, P211, DOI 10.1140/epjb/e2004-00114-1; Moed HF, 1996, NATURE, V381, P186, DOI 10.1038/381186a0; Narin F, 1996, SCIENTOMETRICS, V36, P293, DOI 10.1007/BF02129596; Nicolaisen J, 2007, ANNU REV INFORM SCI, V41, P609, DOI 10.1002/aris.2007.1440410120; Pennock DM, 2002, P NATL ACAD SCI USA, V99, P5207, DOI 10.1073/pnas.032085699; Press WH., 2002, NUMERICAL RECIPES C, V2; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Seglen PO, 1997, BRIT MED J, V314, P498; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; Tomlin S, 2005, NATURE, V438, P547, DOI 10.1038/438547a; Vinkler P, 2004, J AM SOC INF SCI TEC, V55, P431, DOI 10.1002/asi.10391; Weingart P, 2005, SCIENTOMETRICS, V62, P117, DOI 10.1007/s11192-005-0007-7; Zhang SD, 2006, NATURE, V442, P26, DOI 10.1038/442026b	29	106	108	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1683	10.1371/journal.pone.0001683	http://dx.doi.org/10.1371/journal.pone.0001683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301760	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586500027
J	Macedo-Ribeiro, S; Almeida, C; Calisto, BM; Friedrich, T; Mentele, R; Sturzebecher, J; Fuentes-Prior, P; Pereira, PJB				Macedo-Ribeiro, Sandra; Almeida, Carla; Calisto, Barbara M.; Friedrich, Thomas; Mentele, Reinhard; Stuerzebecher, Jorg; Fuentes-Prior, Pablo; Barbosa Pereira, Pedro Jose			Isolation, Cloning and Structural Characterisation of Boophilin, a Multifunctional Kunitz-Type Proteinase Inhibitor from the Cattle Tick	PLOS ONE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; FACTOR PATHWAY INHIBITOR; RAY CRYSTAL-STRUCTURE; HUMAN ALPHA-THROMBIN; PROTEOLYTIC-ENZYME INHIBITOR; BOVINE BETA-TRYPSIN; SALIVARY-GLANDS; PROTEASE INHIBITOR; COMPLEX; MICROPLUS	Inhibitors of coagulation factors from blood-feeding animals display a wide variety of structural motifs and inhibition mechanisms. We have isolated a novel inhibitor from the cattle tick Boophilus microplus, one of the most widespread parasites of farm animals. The inhibitor, which we have termed boophilin, has been cloned and overexpressed in Escherichia coli. Mature boophilin is composed of two canonical Kunitz-type domains, and inhibits not only the major procoagulant enzyme, thrombin, but in addition, and by contrast to all other previously characterised natural thrombin inhibitors, significantly interferes with the proteolytic activity of other serine proteinases such as trypsin and plasmin. The crystal structure of the bovine alpha-thrombin.bophilin complex, refined at 2.35 angstrom resolution reveals a non-canonical binding mode to the proteinase. The N-terminal region of the mature inhibitor, Q16-R17-N18, binds in a parallel manner across the active site of the proteinase, with the guanidinium group of R17 anchored in the S-1 pocket, while the C-terminal Kunitz domain is negatively charged and docks into the basic exosite I of thrombin. This binding mode resembles the previously characterised thrombin inhibitor, ornithodorin which, unlike boophilin, is composed of two distorted Kunitz modules. Unexpectedly, both boophilin domains adopt markedly different orientations when compared to those of ornithodorin, in its complex with thrombin. The N-terminal boophilin domain rotates 9 degrees and is displaced by 6 angstrom, while the C-terminal domain rotates almost 6 degrees accompanied by a 3 angstrom displacement. The reactive-site loop of the N-terminal Kunitz domain of boophilin with its P-1 residue, K31, is fully solvent exposed and could thus bind a second trypsin-like proteinase without sterical restraints. This finding explains the formation of a ternary thrombin.boophilin. trypsin complex, and suggests a mechanism for prothrombinase inhibition in vivo.	[Macedo-Ribeiro, Sandra; Almeida, Carla] Ctr Neurociencias & Biol Celular CNC, Coimbra, Portugal; [Macedo-Ribeiro, Sandra; Calisto, Barbara M.; Barbosa Pereira, Pedro Jose] Univ Porto, IBMC, Porto, Portugal; [Friedrich, Thomas] BASF AG, Ludwigshafen, Germany; [Mentele, Reinhard] Univ Munich, Munich, Germany; [Stuerzebecher, Jorg] Zentrum Vask Biol & Med, Erfurt, Germany; [Fuentes-Prior, Pablo] ICCC, CSIC, Barcelona, Spain	Universidade de Coimbra; Universidade do Porto; BASF; University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Macedo-Ribeiro, S (corresponding author), Ctr Neurociencias & Biol Celular CNC, Coimbra, Portugal.	PFuentes@csic-iccc.org; ppereira@ibmc.up.pt	Pereira, Pedro/F-8972-2011; Macedo-Ribeiro, Sandra/D-9258-2011	Pereira, Pedro/0000-0003-0969-5438; Macedo-Ribeiro, Sandra/0000-0002-7698-1170; Calisto, Barbara/0000-0003-1732-571X; Fuentes-Prior, Pablo/0000-0002-6618-3204	Fundacao para a Ciencia e a Tecnologia (Portugal) [POCTI/MGI/38108/2001, POCTI/BME/45559/2002]; Ministerio de Educacion y Ciencia [SAF2004-00543]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Ministerio de Educacion y Ciencia(Spanish Government)	This work had the financial support of grants POCTI/MGI/38108/2001 (S.M.-R.) and POCTI/BME/45559/2002 (P.J.B.P.) from Fundacao para a Ciencia e a Tecnologia (Portugal), and of Plan Nacional SAF2004-00543 from Ministerio de Educacion y Ciencia (P.F.-P.). The funding bodies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler M, 2000, BIOCHEMISTRY-US, V39, P12534, DOI 10.1021/bi001477q; ANTONINI E, 1983, BIOPOLYMERS, V22, P363, DOI 10.1002/bip.360220147; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; ASCENZI P, 1988, BIOCHIM BIOPHYS ACTA, V956, P156, DOI 10.1016/0167-4838(88)90262-2; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; BRANDSTETTER H, 1992, J MOL BIOL, V226, P1085, DOI 10.1016/0022-2836(92)91054-S; BROZE GJ, 1995, ANNU REV MED, V46, P103, DOI 10.1146/annurev.med.46.1.103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgering MJM, 1997, J MOL BIOL, V269, P395, DOI 10.1006/jmbi.1997.1029; Ciprandi A, 2006, EXP PARASITOL, V114, P40, DOI 10.1016/j.exppara.2006.02.010; Czapinska H, 1999, EUR J BIOCHEM, V260, P571, DOI 10.1046/j.1432-1327.1999.00160.x; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; EVANS R, 1990, VIA, V11, P134; Fogaca AC, 2006, PEPTIDES, V27, P667, DOI 10.1016/j.peptides.2005.07.013; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; Francischetti NMB, 2004, THROMB HAEMOSTASIS, V91, P886, DOI 10.1160/TH03-11-0715; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Grzesiak A, 2000, J BIOL CHEM, V275, P33346, DOI 10.1074/jbc.M006085200; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; Guerrero FD, 2005, INSECT BIOCHEM MOLEC, V35, P585, DOI 10.1016/j.ibmb.2005.01.020; GUINTO ER, 1994, J BIOL CHEM, V269, P18395; Helland R, 1999, J MOL BIOL, V287, P923, DOI 10.1006/jmbi.1999.2654; Horn F, 2000, ARCH BIOCHEM BIOPHYS, V384, P68, DOI 10.1006/abbi.2000.2076; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002; Jittapalapong S, 2004, ANN NY ACAD SCI, V1026, P312, DOI 10.1196/annals.1307.048; Lai R, 2004, GENE, V342, P243, DOI 10.1016/j.gene.2004.07.012; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LEBONNIEC BF, 1993, J BIOL CHEM, V268, P19055; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Malkowski MG, 1997, PROTEIN SCI, V6, P1438, DOI 10.1002/pro.5560060708; Mans BJ, 2002, INSECT BIOCHEM MOLEC, V32, P821, DOI 10.1016/S0965-1748(01)00169-2; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; Maskos K, 2003, J MOL BIOL, V325, P495, DOI 10.1016/S0022-2836(02)01248-2; Merigeau K, 1998, ACTA CRYSTALLOGR D, V54, P306, DOI 10.1107/S0907444997010846; Mine S, 2002, BIOCHEMISTRY-US, V41, P78, DOI 10.1021/bi011299g; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nienaber J, 1999, EXP PARASITOL, V93, P82, DOI 10.1006/expr.1999.4448; Parkin S, 1996, ACTA CRYSTALLOGR D, V52, P18, DOI 10.1107/S0907444995008675; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; PINTIGNY D, 1992, EUR J BIOCHEM, V207, P89, DOI 10.1111/j.1432-1033.1992.tb17024.x; Richardson JL, 2000, EMBO J, V19, P5650, DOI 10.1093/emboj/19.21.5650; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; Santos IKFD, 2004, ANN NY ACAD SCI, V1026, P242, DOI 10.1196/annals.1307.037; Sasaki SD, 2004, BIOCHIMIE, V86, P643, DOI 10.1016/j.biochi.2004.09.010; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; Schmidt AE, 2005, J BIOL CHEM, V280, P27832, DOI 10.1074/jbc.M504105200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sichler K, 2002, FEBS LETT, V530, P220, DOI 10.1016/S0014-5793(02)03495-6; SIEKMANN J, 1987, BIOL CHEM H-S, V368, P1589, DOI 10.1515/bchm3.1987.368.2.1589; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Tanaka AS, 1999, IMMUNOPHARMACOLOGY, V45, P171, DOI 10.1016/S0162-3109(99)00074-0; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; vandeLocht A, 1996, EMBO J, V15, P6011, DOI 10.1002/j.1460-2075.1996.tb00989.x; vandeLocht A, 1997, EMBO J, V16, P2977, DOI 10.1093/emboj/16.11.2977; Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530; VERMEULEN NMJ, 1988, INT J BIOCHEM, V20, P621, DOI 10.1016/0020-711X(88)90102-4; VILJOEN GJ, 1985, INSECT BIOCHEM, V15, P475, DOI 10.1016/0020-1790(85)90060-5; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; WILLADSEN P, 1979, BIOCHEM J, V177, P41, DOI 10.1042/bj1770041; WILLADSEN P, 1980, BIOCHEM J, V189, P295, DOI 10.1042/bj1890295; WILLADSEN P, 1983, AUST J EXP BIOL MED, V61, P231, DOI 10.1038/icb.1983.21; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452	76	87	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1624	10.1371/journal.pone.0001624	http://dx.doi.org/10.1371/journal.pone.0001624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286181	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586400017
J	Marstrand, TT; Frellsen, J; Moltke, I; Thiim, M; Valen, E; Retelska, D; Krogh, A				Marstrand, Troels T.; Frellsen, Jes; Moltke, Ida; Thiim, Martin; Valen, Eivind; Retelska, Dorota; Krogh, Anders			Asap: A Framework for Over-Representation Statistics for Transcription Factor Binding Sites	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; REGULATORY ELEMENTS; DISCOVERY; DATABASE; TOOLS; MODEL	Background: In studies of gene regulation the efficient computational detection of over-represented transcription factor binding sites is an increasingly important aspect. Several published methods can be used for testing whether a set of hypothesised co-regulated genes share a common regulatory regime based on the occurrence of the modelled transcription factor binding sites. However there is little or no information available for guiding the end users choice of method. Furthermore it would be necessary to obtain several different software programs from various sources to make a well-founded choice. Methodology: We introduce a software package, Asap, for fast searching with position weight matrices that include several standard methods for assessing over-representation. We have compared the ability of these methods to detect over-epresented transcription factor binding sites in artificial promoter sequences. Controlling all aspects of our input data we are able to identify the optimal statistics across multiple threshold values and for sequence sets containing different distributions of transcription factor binding sites. Conclusions: We show that our implementation is significantly faster than more naive scanning algorithms when searching with many weight matrices in large sequence sets. When comparing the various statistics, we show that those based on binomial over-representation and Fisher's exact test performs almost equally good and better than the others. An online server is available at http://servers.binf.ku.dk/asap/.	[Marstrand, Troels T.; Frellsen, Jes; Moltke, Ida; Thiim, Martin; Valen, Eivind; Krogh, Anders] Univ Copenhagen, Dept Mol Biol, Bioinformat Ctr, Copenhagen, Denmark; [Retelska, Dorota] ISREC, Swiss Inst Bioinformat, Epalinges, Switzerland	University of Copenhagen; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics	Marstrand, TT (corresponding author), Univ Copenhagen, Dept Mol Biol, Bioinformat Ctr, Copenhagen, Denmark.	dolle@binf.ku.dk	Sandelin, Albin/G-2881-2011; Marstrand, Troels/C-7039-2011; Valen, Eivind/A-8617-2011; Moltke, Ida/C-6158-2011; Frellsen, Jes/K-4337-2014; Krogh, Anders/M-1541-2014	Sandelin, Albin/0000-0002-7109-7378; Moltke, Ida/0000-0001-7052-8554; Frellsen, Jes/0000-0001-9224-1271; Krogh, Anders/0000-0002-5147-6282; Valen, Eivind/0000-0003-1840-6108; Marstrand, Troels/0000-0002-8290-223X	Novo Nordisk Foundation; SNSF [PBLAA-109445]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); SNSF(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the Novo Nordisk Foundation. DR was supported by the SNSF grant PBLAA-109445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2003, NUCLEIC ACIDS RES, V31, P1753, DOI 10.1093/nar/gkg268; Beckstette M, 2004, P GERM C BIOINF, P53; BRYNE JC, 2007, NUCL ACIDS RES; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Clarke ND, 2003, BIOINFORMATICS, V19, P212, DOI 10.1093/bioinformatics/19.2.212; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Kasai T., 2001, Combinatorial Pattern Matching. 12th Annual Symposium, CPM 2001. Proceedings (Lecture Notes in Computer Science Vol. 2089), P181; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; TEAM RDC, 2006, R LANGUAGE ENVIROMEN; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	26	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1623	10.1371/journal.pone.0001623	http://dx.doi.org/10.1371/journal.pone.0001623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286180	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400016
J	Bandhakavi, S; Xie, HW; O'Callaghan, B; Sakurai, H; Kim, DH; Griffin, TJ				Bandhakavi, Sricharan; Xie, Hongwei; O'Callaghan, Brennon; Sakurai, Hiroshi; Kim, Do-Hyung; Griffin, Timothy J.			Hsf1 Activation Inhibits Rapamycin Resistance and TOR Signaling in Yeast Revealed by Combined Proteomic and Genetic Analysis	PLOS ONE			English	Article							SHOCK TRANSCRIPTION FACTOR; CEREVISIAE HEAT-SHOCK; GENOME-WIDE ANALYSIS; DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; MAMMALIAN TOR; AMINO-ACID; TARGET; EXPRESSION	TOR kinases integrate environmental and nutritional signals to regulate cell growth in eukaryotic organisms. Here, we describe results from a study combining quantitative proteomics and comparative expression analysis in the budding yeast, S. cerevisiae, to gain insights into TOR function and regulation. We profiled protein abundance changes under conditions of TOR inhibition by rapamycin treatment, and compared this data to existing expression information for corresponding gene products measured under a variety of conditions in yeast. Among proteins showing abundance changes upon rapamycin treatment, almost 90% of them demonstrated homodirectional (i. e., in similar direction) transcriptomic changes under conditions of heat/oxidative stress. Because the known downstream responses regulated by Tor1/2 did not fully explain the extent of overlap between these two conditions, we tested for novel connections between the major regulators of heat/oxidative stress response and the TOR pathway. Specifically, we hypothesized that activation of regulator(s) of heat/oxidative stress responses phenocopied TOR inhibition and sought to identify these putative TOR inhibitor(s). Among the stress regulators tested, we found that cells (hsf1-R206S, F256S and ssa1-3 ssa2-2) constitutively activated for heat shock transcription factor 1, Hsf1, inhibited rapamycin resistance. Further analysis of the hsf1-R206S, F256S allele revealed that these cells also displayed multiple phenotypes consistent with reduced TOR signaling. Among the multiple Hsf1 targets elevated in hsf1-R206S, F256S cells, deletion of PIR3 and YRO2 suppressed the TOR-regulated phenotypes. In contrast to our observations in cells activated for Hsf1, constitutive activation of other regulators of heat/oxidative stress responses, such as Msn2/4 and Hyr1, did not inhibit TOR signaling. Thus, we propose that activated Hsf1 inhibits rapamycin resistance and TOR signaling via elevated expression of specific target genes in S. cerevisiae. Additionally, these results highlight the value of comparative expression analyses between large-scale proteomic and transcriptomic datasets to reveal new regulatory connections.	[Bandhakavi, Sricharan; Xie, Hongwei; O'Callaghan, Brennon; Kim, Do-Hyung; Griffin, Timothy J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sakurai, Hiroshi] Kanazawa Univ, Fac Med, Sch Hlth Sci, Kanazawa, Ishikawa, Japan	University of Minnesota System; University of Minnesota Twin Cities; Kanazawa University	Bandhakavi, S (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	tgriffin@umn.edu	SAKURAI, Hiroshi/L-3693-2015	Griffin, Timothy/0000-0001-6801-2559; Sakurai, Hiroshi/0000-0002-0336-2301; O'Callaghan, Brennon L/0000-0002-0800-5856; Kim, Do-Hyung/0000-0002-2924-4370	Biomedical Genomics Center at the University of Minnesota [0755679Z]; American Heart Association [0755679Z]; NIH [DK073731]; Eli Lili & Company	Biomedical Genomics Center at the University of Minnesota; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lili & Company	This work was funded in part by a proteomics seed grant from the Biomedical Genomics Center at the University of Minnesota, American Heart Association grant 0755679Z, NIH grant DK073731, and a grant to TJG from Eli Lili & Company.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Avery AM, 2004, J BIOL CHEM, V279, P46652, DOI 10.1074/jbc.M408340200; Bandhakavi S, 2003, FEBS LETT, V554, P295, DOI 10.1016/S0014-5793(03)01165-7; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; BOORSTEIN WR, 1990, J BIOL CHEM, V265, P18912; Boy-Marcotte E, 1999, MOL MICROBIOL, V33, P274, DOI 10.1046/j.1365-2958.1999.01467.x; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Butcher RA, 2006, NAT CHEM BIOL, V2, P103, DOI 10.1038/nchembio762; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; DAMBERGER FF, 1994, PROTEIN SCI, V3, P1806, DOI 10.1002/pro.5560031020; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; HALLADAY JT, 1995, MOL CELL BIOL, V15, P4890; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hashikawa N, 2006, J BIOL CHEM, V281, P3936, DOI 10.1074/jbc.M510827200; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huang J, 2004, P NATL ACAD SCI USA, V101, P16594, DOI 10.1073/pnas.0407117101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Imazu H, 2005, EUKARYOT CELL, V4, P1050, DOI 10.1128/EC.4.6.1050-1056.2005; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Iser WB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001240; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller G, 2001, J BIOL CHEM, V276, P38697, DOI 10.1074/jbc.M107131200; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Mason DE, 2003, J PROTEOME RES, V2, P265, DOI 10.1021/pr0255856; Morano KA, 1999, MOL CELL BIOL, V19, P402; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; NELSON RJ, 1992, GENETICS, V131, P277; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rimoldi M, 2001, BRAIN RES BULL, V56, P353, DOI 10.1016/S0361-9230(01)00602-5; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; SEWELL AK, 1995, J BIOL CHEM, V270, P25079, DOI 10.1074/jbc.270.42.25079; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; TOHE A, 1993, YEAST, V9, P481, DOI 10.1002/yea.320090504; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie HW, 2005, ANAL CHEM, V77, P3198, DOI 10.1021/ac0482256; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yamamoto A, 2006, BIOCHEM BIOPH RES CO, V346, P1324, DOI 10.1016/j.bbrc.2006.06.057; Yun DJ, 1997, P NATL ACAD SCI USA, V94, P7082, DOI 10.1073/pnas.94.13.7082; Zarzov P, 1997, J CELL SCI, V110, P1879; Zohlnhofer D, 2004, MOL PHARMACOL, V65, P880, DOI 10.1124/mol.65.4.880	90	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1598	10.1371/journal.pone.0001598	http://dx.doi.org/10.1371/journal.pone.0001598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270585	Green Submitted, gold, Green Published			2022-12-27	WOS:000260535900032
J	Gregson, AL; Oliveira, G; Othoro, C; Calvo-Calle, JM; Thorton, GB; Nardin, E; Edelman, R				Gregson, Aric L.; Oliveira, Giane; Othoro, Caroline; Calvo-Calle, J. Mauricio; Thorton, George B.; Nardin, Elizabeth; Edelman, Robert			Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein	PLOS ONE			English	Article							T-CELL EPITOPES; MALARIA VACCINE; GAMMA-INTERFERON; IMMUNE-RESPONSES; PROTECTIVE ROLE; CUTTING EDGE; IMMUNOGENICITY; ANTIBODIES; EFFICACY; SAFETY	The objectives of this non-randomized, non-blinded, dose-escalating Phase I clinical trial were to assess the safety, reactogenicity and immunogenicity of ICC-1132 formulated with Alhydrogel (aluminum hydroxide) in 51 healthy, malaria-naive adults aged 18 to 45 years. ICC-1132 (Malariavax) is a recombinant, virus-like particle malaria vaccine comprised of hepatitis core antigen engineered to express the central repeat regions from Plasmodium falciparum circumsporozoite protein containing an immunodominant B [(NANP)(3)] epitope, an HLA-restricted CD4 (NANPNVDPNANP) epitope and a universal T cell epitope (T*) ( amino acids 326-345, NF54 isolate). We assessed an Alhydrogel (aluminum hydroxide)-adjuvanted vaccine formulation at three ICC-1132 dose levels, each injected intramuscularly (1.0 mL) on study days 0, 56 and 168. A saline vaccine formulation was found to be unstable after prolonged storage and this formulation was subsequently removed from the study. Thirty-two volunteers were followed for one year. Local and systemic adverse clinical events were measured and immune responses to P. falciparum and hepatitis B virus core antigens were determined utilizing the following assays: IgG and IgM ELISA, indirect immunofluorescence against P. falciparum sporozoites, circumsporozoite precipitin (CSP) and transgenic sporozoite neutralization assays. Cellular responses were measured by proliferation and IL-2 assays. Local and systemic reactions were similarly mild and well tolerated between dose cohorts. Depending on the ICC-1132 vaccine concentration, 95 to 100% of volunteers developed antibody responses to the ICC-1132 immunogen and HBc after two injections; however, only 29-75% and 29-63% of volunteers, respectively, developed malaria-specific responses measured by the malaria repeat synthetic peptide ELISA and IFA; 2 of 8 volunteers had positive reactions in the CSP assay. Maximal transgenic sporozoite neutralization assay inhibition was 54%. Forty-seven to seventy-five percent demonstrated T cell proliferation in response to ICC-1132 or to recombinant circumsporozoite protein (rCS) NF-54 isolate. This candidate malaria vaccine was well tolerated, but the vaccine formulation was poorly immunogenic. The vaccine may benefit from a more powerful adjuvant to improve immunogenicity.	[Gregson, Aric L.; Edelman, Robert] Univ Calif Los Angeles, Div Infect Dis, Dept Med, Los Angeles, CA 90024 USA; [Oliveira, Giane; Othoro, Caroline; Calvo-Calle, J. Mauricio; Nardin, Elizabeth] NYU, Dept Med & Mol Parasitol, New York, NY USA; [Thorton, George B.] Apovia, Inc, San Diego, CA USA	University of California System; University of California Los Angeles; New York University	Gregson, AL (corresponding author), Univ Calif Los Angeles, Div Infect Dis, Dept Med, Los Angeles, CA 90024 USA.	redelman@medicine.umaryland.edu		Gregson, Aric/0000-0001-6806-0868	NIH [N01-AI-85342]; University of Maryland General Clinical Research Center [M01 RR 16500]; General Clinical Research Centers Program, NCRR, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); General Clinical Research Centers Program, NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by NIH contract #N01-AI-85342. Partial support was provided by the University of Maryland General Clinical Research Center Grant M01 RR 16500, General Clinical Research Centers Program, NCRR, NIH. Sponsors had no role in the collection, analysis and interpretation of the data. Nor did they review or give approval of the manuscript.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bellier B, 2006, VACCINE, V24, P2643, DOI 10.1016/j.vaccine.2005.11.034; Birkett A, 2002, INFECT IMMUN, V70, P6860, DOI 10.1128/IAI.70.12.6860-6870.2002; BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; BOMFORD R, 1984, INT ARCH ALLER A IMM, V75, P280, DOI 10.1159/000233630; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Breman JG, 2001, AM J TROP MED HYG, V64, P1; CalvoCalle JM, 1997, J IMMUNOL, V159, P1362; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; EDELMAN R, 1993, J INFECT DIS, V168, P1066, DOI 10.1093/infdis/168.4.1066; FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218; Galarza JM, 2005, VIRAL IMMUNOL, V18, P365, DOI 10.1089/vim.2005.18.365; Goldberg SM, 2005, CLIN CANCER RES, V11, P8114, DOI 10.1158/1078-0432.CCR-05-1410; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; HOFFMAN SL, 1986, NEW ENGL J MED, V315, P601, DOI 10.1056/NEJM198609043151001; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; HOLLINGDALE MR, 1989, T ROY SOC TROP MED H, V83, P322, DOI 10.1016/0035-9203(89)90488-4; HOLLINGDALE MR, 1990, T ROY SOC TROP MED H, V84, P325, DOI 10.1016/0035-9203(90)90303-V; Huang YH, 2005, VIRAL IMMUNOL, V18, P668, DOI 10.1089/vim.2005.18.668; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kotloff KL, 2001, INFECT IMMUN, V69, P988, DOI 10.1128/IAI.69.2.988-995.2001; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; MAHESHWARI RK, 1986, INFECT IMMUN, V53, P628, DOI 10.1128/IAI.53.3.628-630.1986; Molano A, 2000, J IMMUNOL, V164, P5005, DOI 10.4049/jimmunol.164.10.5005; MORENO A, 1993, J IMMUNOL, V151, P489; Nardin EH, 2004, INFECT IMMUN, V72, P6519, DOI 10.1128/IAI.72.11.6519-6527.2004; NARDIN EH, 1982, J EXP MED, V156, P20, DOI 10.1084/jem.156.1.20; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; NARDIN EH, 1989, SCIENCE, V246, P1603, DOI 10.1126/science.2480642; Nardin EH, 2000, J INFECT DIS, V182, P1486, DOI 10.1086/315871; Oliveira GA, 2005, INFECT IMMUN, V73, P3587, DOI 10.1128/IAI.73.6.3587-3597.2005; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; R Development Core Team, 2007, R LANG ENV STAT COMP; Schodel F, 1997, Behring Inst Mitt, P114; SCHODEL F, 1994, J EXP MED, V180, P1037, DOI 10.1084/jem.180.3.1037; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwenk R, 2003, PARASITE IMMUNOL, V25, P17, DOI 10.1046/j.1365-3024.2003.00495.x; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; VANDERBERG J, 1969, MIL MED, V134, P1183; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Walther M, 2005, VACCINE, V23, P857, DOI 10.1016/j.vaccine.2004.08.020; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; WIRTZ RA, 1987, EXP PARASITOL, V63, P166, DOI 10.1016/0014-4894(87)90158-5; WONG VK, 1991, AM J DIS CHILD, V145, P742; YIN JZ, 1989, J BIOL RESP MODIF, V8, P190; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947; Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556	57	42	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1556	10.1371/journal.pone.0001556	http://dx.doi.org/10.1371/journal.pone.0001556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253503	Green Submitted, Green Published, gold			2022-12-27	WOS:000260535700027
J	Childress, AR; Ehrman, RN; Wang, Z; Li, Y; Sciortino, N; Hakun, J; Jens, W; Suh, J; Listerud, J; Marquez, K; Franklin, T; Langleben, D; Detre, J; O'Brien, CP				Childress, Anna Rose; Ehrman, Ronald N.; Wang, Ze; Li, Yin; Sciortino, Nathan; Hakun, Jonathan; Jens, William; Suh, Jesse; Listerud, John; Marquez, Kathleen; Franklin, Teresa; Langleben, Daniel; Detre, John; O'Brien, Charles P.			Prelude to Passion: Limbic Activation by "Unseen" Drug and Sexual Cues	PLOS ONE			English	Article							AMYGDALA RESPONSE; PERCEPTION; SENSITIVITY; AWARENESS; STIMULI; FACES; FEAR	Background. The human brain responds to recognizable signals for sex and for rewarding drugs of abuse by activation of limbic reward circuitry. Does the brain respond in similar way to such reward signals even when they are "unseen'', i.e., presented in a way that prevents their conscious recognition? Can the brain response to "unseen'' reward cues predict the future affective response to recognizable versions of such cues, revealing a link between affective/motivational processes inside and outside awareness? Methodology/Principal Findings. We exploited the fast temporal resolution of event-related functional magnetic resonance imaging (fMRI) to test the brain response to "unseen'' (backward-masked) cocaine, sexual, aversive and neutral cues of 33 milliseconds duration in male cocaine patients (n = 22). Two days after scanning, the affective valence for visible versions of each cue type was determined using an affective bias (priming) task. We demonstrate, for the first time, limbic brain activation by "unseen'' drug and sexual cues of only 33 msec duration. Importantly, increased activity in an large interconnected ventral pallidum/amygdala cluster to the "unseen'' cocaine cues strongly predicted future positive affect to visible versions of the same cues in subsequent off-magnet testing, pointing both to the functional significance of the rapid brain response, and to shared brain substrates for appetitive motivation within and outside awareness. Conclusions/Significance. These findings represent the first evidence that brain reward circuitry responds to drug and sexual cues presented outside awareness. The results underscore the sensitivity of the brain to "unseen'' reward signals and may represent the brain's primordial signature for desire. The limbic brain response to reward cues outside awareness may represent a potential vulnerability in disorders (e. g., the addictions) for whom poorly-controlled appetitive motivation is a central feature.	[Childress, Anna Rose; Ehrman, Ronald N.; Wang, Ze; Li, Yin; Sciortino, Nathan; Hakun, Jonathan; Jens, William; Suh, Jesse; Listerud, John; Marquez, Kathleen; Franklin, Teresa; Langleben, Daniel; O'Brien, Charles P.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John] Univ Penn, Med Sch, Dept Neurol, Philadelphia, PA USA; [Childress, Anna Rose; Ehrman, Ronald N.; Wang, Ze; Li, Yin; Suh, Jesse; Listerud, John; Marquez, Kathleen; Langleben, Daniel; O'Brien, Charles P.] Phila Dept VA Med Ctr, MIRECC, VISN 4, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania	Childress, AR (corresponding author), Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	childress_a@mail.trc.upenn.edu	Wang, Ze/A-1043-2007; Langleben, Daniel D/K-7407-2014	Jens, William/0000-0001-5201-1412	NIH/NIDA [RO1-10241, RO1-15149, P-60-DA-05186, P-50-DA-12756]; VA VISN 4 MIRECC; Alexander Foundation; DANA Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA012756, R01DA015149, R01DA010241, P60DA005186] Funding Source: NIH RePORTER	NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); VA VISN 4 MIRECC; Alexander Foundation; DANA Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH/NIDA (RO1-10241, RO1-15149, P-60-DA-05186, P-50-DA-12756) VA VISN 4 MIRECC, the Alexander Foundation and the DANA Foundation. The sponsors had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; CHILDRESS AR, 2002, NEUROPSYCHOPHARMACOL, P1575; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Darwin C., 1876, NATURE, V15, P18, DOI [10.1038/015018a0, DOI 10.1038/015018A0]; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FREUD, 1900, INTERPRETATION DREAM; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; GREVE D, 2002, OPTSEQ; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Holender D, 2004, PERCEPT PSYCHOPHYS, V66, P872, DOI 10.3758/BF03194980; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Lang P.J., 1988, INT AFFECTIVE PICTUR; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Overgaard M, 2006, CONSCIOUS COGN, V15, P700, DOI 10.1016/j.concog.2006.04.002; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; *WELLC DEP IM NEUR, 2002, SPM 2; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wright P, 2006, NEUROIMAGE, V29, P628, DOI 10.1016/j.neuroimage.2005.07.047	36	195	198	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1506	10.1371/journal.pone.0001506	http://dx.doi.org/10.1371/journal.pone.0001506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SR	18231593	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200019
J	Laxmi, A; Pan, JW; Morsy, M; Chen, RJ				Laxmi, Ashverya; Pan, Jianwei; Morsy, Mustafa; Chen, Rujin			Light Plays an Essential Role in Intracellular Distribution of Auxin Efflux Carrier PIN2 in Arabidopsis thaliana	PLOS ONE			English	Article							ROOT GRAVITROPISM; GENE-EXPRESSION; CELL POLARITY; TRANSPORT; PROTEINS; COP1; PHOTOMORPHOGENESIS; PHOTOTROPISM; DEGRADATION; ENDOCYTOSIS	Background. Light plays a key role in multiple plant developmental processes. It has been shown that root development is modulated by shoot-localized light signaling and requires shoot-derived transport of the plant hormone, auxin. However, the mechanism by which light regulates root development is not largely understood. In plants, the endogenous auxin, indole-3-acetic acid, is directionally transported by plasma-membrane (PM)-localized auxin influx and efflux carriers in transporting cells. Remarkably, the auxin efflux carrier PIN proteins exhibit asymmetric PM localization, determining the polarity of auxin transport. Similar to PM-resident receptors and transporters in animal and yeast cells, PIN proteins undergo constitutive cycling between the PM and endosomal compartments. Auxin plays multiple roles in PIN protein intracellular trafficking, inhibiting PIN2 endocytosis at some concentrations and promoting PIN2 degradation at others. However, how PIN proteins are turned over in plant cells is yet to be addressed. Methodology and Principle Findings. Using laser confocal scanning microscopy, and physiological and molecular genetic approaches, here, we show that in dark-grown seedlings, the PM localization of auxin efflux carrier PIN2 was largely reduced, and, in addition, PIN2 signal was detected in vacuolar compartments. This is in contrast to light-grown seedlings where PIN2 was predominantly PM-localized. In light-grown plants after shift to dark or to continuous red or far-red light, PIN2 also accumulated in vacuolar compartments. We show that PIN2 vacuolar targeting was derived from the PM via endocytic trafficking and inhibited by HY5-dependent light signaling. In addition, the ubiquitin 26S proteasome is involved in the process, since its inhibition by mutations in COP9 and a proteasome inhibitor MG132 impaired the process. Conclusions and Significance. Collectively, our data indicate that light plays an essential role in PIN2 intracellular trafficking, promoting PM-localization in the presence of light and, on the other hand, vacuolar targeting for protein degradation in the absence of light. Based on these results, we postulate that light regulation of root development is mediated at least in part by changes in the intracellular distribution of auxin efflux carriers, PIN proteins, in response to the light environment.	[Laxmi, Ashverya; Pan, Jianwei; Morsy, Mustafa; Chen, Rujin] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA	Noble Research Institute	Chen, RJ (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	rchen@noble.org	Chen, Rujin/AAT-8254-2020; Morsy, Mustafa R/E-6245-2013	Morsy, Mustafa R/0000-0003-1803-4893	National Science Foundation [DBI-00400580]; Samuel Roberts Noble Foundation	National Science Foundation(National Science Foundation (NSF)); Samuel Roberts Noble Foundation	Funds were provided by the National Science Foundation (DBI-00400580) for purchasing the Laser Confocal Scanning Microscope used in this study. Financial support for the work done in the corresponding author's laboratory was from the Samuel Roberts Noble Foundation.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Benfey PN, 2002, CURR BIOL, V12, pR389, DOI 10.1016/S0960-9822(02)00881-3; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Boutte Y, 2006, J CELL SCI, V119, P1255, DOI 10.1242/jcs.02847; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen RJ, 2006, PLANT CELL MONOGR, V1, P139, DOI 10.1007/7089_009; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Chory J, 1996, P NATL ACAD SCI USA, V93, P12066, DOI 10.1073/pnas.93.22.12066; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; Correll MJ, 2003, ADV SPACE RES, V31, P2203, DOI 10.1016/S0273-1177(03)00245-X; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; DHONUKSHE P, 2007, CURR BIOL; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Estelle M, 2001, NATURE, V413, P374, DOI 10.1038/35096672; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Golan A, 1996, PLANT PHYSIOL, V112, P901, DOI 10.1104/pp.112.3.901; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Jaillais Y, 2007, CELL, V130, P1057, DOI 10.1016/j.cell.2007.08.040; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; Jones AM, 1998, SCIENCE, V282, P2201, DOI 10.1126/science.282.5397.2201; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp.105.061572; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Muday GK, 2002, PLANT CELL, V14, P293, DOI 10.1105/tpc.140230; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nakamoto D, 2006, PLANT PHYSIOL, V141, P456, DOI 10.1104/pp.105.076273; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Paciorek T, 2006, J CELL SCI, V119, P1199, DOI 10.1242/jcs.02910; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Ruppel NJ, 2001, PLANTA, V212, P424, DOI 10.1007/s004250000410; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Salisbury FJ, 2007, PLANT J, V50, P429, DOI 10.1111/j.1365-313X.2007.03059.x; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shin H, 2005, PLANT J, V42, P188, DOI 10.1111/j.1365-313X.2005.02369.x; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Tamura K, 2003, PLANT J, V35, P545, DOI 10.1046/j.1365-313X.2003.01822.x; TANAKA H, 2006, CELL MOL LIFE SCI; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tian Q, 2001, J PLANT GROWTH REGUL, V20, P274, DOI 10.1007/s003440010022; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; Vitha S, 2000, PLANT PHYSIOL, V122, P453, DOI 10.1104/pp.122.2.453; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Yamada K, 2005, PLANT J, V41, P888, DOI 10.1111/j.1365-313X.2005.02349.x; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	73	176	187	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1510	10.1371/journal.pone.0001510	http://dx.doi.org/10.1371/journal.pone.0001510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231596	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200022
J	Li, L; Johnson, LA; Dai-Ju, JQ; Sandri-Goldin, RM				Li, Ling; Johnson, Lisa A.; Dai-Ju, Jenny Q.; Sandri-Goldin, Rozanne M.			Hsc70 Focus Formation at the Periphery of HSV-1 Transcription Sites Requires ICP27	PLOS ONE			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; REGULATORY PROTEIN ICP27; REPLICATION COMPARTMENTS; MESSENGER-RNAS; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; INTERACTS; CHAPERONE	Background. The cellular chaperone protein Hsc70, along with components of the 26S proteasome and ubiquitin-conjugated proteins have been shown to be sequestered in discrete foci in the nuclei of herpes simplex virus 1 (HSV-1) infected cells. We recently reported that cellular RNA polymerase II (RNAP II) undergoes proteasomal degradation during robust HSV-1 transcription, and that the immediate early protein ICP27 interacts with the C-terminal domain and is involved in the recruitment of RNAP II to viral transcription/replication compartments. Methodology/Principle Findings. Here we show that ICP27 also interacts with Hsc70, and is required for the formation of Hsc70 nuclear foci. During infection with ICP27 mutants that are unable to recruit RNAP II to viral replication sites, viral transcript levels were greatly reduced, viral replication compartments were poorly formed and Hsc70 focus formation was curtailed. Further, a dominant negative Hsc70 mutant that cannot hydrolyze ATP, interfered with RNAP II degradation during HSV-1 infection, and an increase in ubiquitinated forms of RNAP II was observed. There was also a decrease in virus yields, indicating that proteasomal degradation of stalled RNAP II complexes during robust HSV-1 transcription and replication benefits viral gene expression. Conclusions/Significance. We propose that one function of the Hsc70 nuclear foci may be to serve to facilitate the process of clearing stalled RNAP II complexes from viral genomes during times of highly active transcription.	[Li, Ling; Johnson, Lisa A.; Dai-Ju, Jenny Q.; Sandri-Goldin, Rozanne M.] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine	Sandri-Goldin, RM (corresponding author), Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	rmsandri@uci.edu			National Institute of Allergy and Infectious Diseases (NIAID) [RO1 61397, R37 21215]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021515] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID grants RO1 61397 and R37 21215).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; Burch AD, 2004, J VIROL, V78, P7175, DOI 10.1128/JVI.78.13.7175-7185.2004; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Chen IHB, 2002, J VIROL, V76, P12877, DOI 10.1128/JVI.76.24.12877-12889.2002; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; Doyle O, 2002, J STRUCT BIOL, V140, P154, DOI 10.1016/S1047-8477(02)00547-6; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; Fraser KA, 2005, J VIROL, V79, P11323, DOI 10.1128/JVI.79.17.11323-11334.2005; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; HARDWICKE MA, 1989, J VIROL, V63, P4590, DOI 10.1128/JVI.63.11.4590-4602.1989; HIBBARD MK, 1995, J VIROL, V69, P4656, DOI 10.1128/JVI.69.8.4656-4667.1995; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Jean S, 2001, VIROLOGY, V283, P273, DOI 10.1006/viro.2001.0902; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kauppinen KP, 2005, J BIOL CHEM, V280, P21638, DOI 10.1074/jbc.M413984200; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Koffa MD, 2001, EMBO J, V20, P5769, DOI 10.1093/emboj/20.20.5769; KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9; Lee KB, 2004, BIOCHEMISTRY-US, V43, P15223, DOI 10.1021/bi048719x; Lengyel J, 2002, J VIROL, V76, P11866, DOI 10.1128/JVI.76.23.11866-11879.2002; Long MC, 1999, J VIROL, V73, P5593, DOI 10.1128/JVI.73.7.5593-5604.1999; Lukonis CJ, 1997, J VIROL, V71, P2390, DOI 10.1128/JVI.71.3.2390-2399.1997; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Pearson A, 2004, J VIROL, V78, P23, DOI 10.1128/JVI.78.1.23-32.2004; RICE SA, 1994, J VIROL, V68, P988, DOI 10.1128/JVI.68.2.988-1001.1994; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; RICE SA, 1994, J VIROL, V68, P823, DOI 10.1128/JVI.68.2.823-833.1994; RICE SA, 1993, J VIROL, V67, P1778, DOI 10.1128/JVI.67.4.1778-1787.1993; SandriGoldin RM, 1996, J VIROL, V70, P108, DOI 10.1128/JVI.70.1.108-118.1996; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Stingley SW, 2000, J VIROL, V74, P9916, DOI 10.1128/JVI.74.21.9916-9927.2000; Sun AX, 2004, J VIROL, V78, P10470, DOI 10.1128/JVI.78.19.10470-10478.2004; Ungewickell E, 1997, J BIOL CHEM, V272, P19594, DOI 10.1074/jbc.272.31.19594; ZHANG J, 1991, J BIOL CHEM, V266, P2290; ZHANG J, 1991, J BIOL CHEM, V266, P2297; Zhi Y, 1999, VIROLOGY, V257, P341, DOI 10.1006/viro.1999.9698; Zhou CH, 2002, J VIROL, V76, P5893, DOI 10.1128/JVI.76.12.5893-5904.2002	48	45	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1491	10.1371/journal.pone.0001491	http://dx.doi.org/10.1371/journal.pone.0001491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231578	Green Published, gold			2022-12-27	WOS:000260504200004
J	Rolfs, A; Hu, Y; Ebert, L; Hoffmann, D; Zuo, D; Ramachandran, N; Raphael, J; Kelley, F; McCarron, S; Jepson, DA; Shen, B; Baqui, MMA; Pearlberg, J; Taycher, E; DeLoughery, C; Hoerlein, A; Korn, B; LaBaer, J				Rolfs, Andreas; Hu, Yanhui; Ebert, Lars; Hoffmann, Dietmar; Zuo, Dongmei; Ramachandran, Niro; Raphael, Jacob; Kelley, Fontina; McCarron, Seamus; Jepson, Daniel A.; Shen, Binghua; Baqui, Munira M. A.; Pearlberg, Joseph; Taycher, Elena; DeLoughery, Craig; Hoerlein, Andreas; Korn, Bernhard; LaBaer, Joshua			A Biomedically Enriched Collection of 7000 Human ORF Clones	PLOS ONE			English	Article							NONREDUNDANT SEQUENCE DATABASE; HUMAN ORFEOME; REFSEQ; TRANSCRIPTS; REPOSITORY; CLONING; GENOMES	We report the production and availability of over 7000 fully sequence verified plasmid ORF clones representing over 3400 unique human genes. These ORF clones were derived using the human MGC collection as template and were produced in two formats: with and without stop codons. Thus, this collection supports the production of either native protein or proteins with fusion tags added to either or both ends. The template clones used to generate this collection were enriched in three ways. First, gene redundancy was removed. Second, clones were selected to represent the best available GenBank reference sequence. Finally, a literature-based software tool was used to evaluate the list of target genes to ensure that it broadly reflected biomedical research interests. The target gene list was compared with 4000 human diseases and over 8500 biological and chemical MeSH classes in,15 Million publications recorded in PubMed at the time of analysis. The outcome of this analysis revealed that relative to the genome and the MGC collection, this collection is enriched for the presence of genes with published associations with a wide range of diseases and biomedical terms without displaying a particular bias towards any single disease or concept. Thus, this collection is likely to be a powerful resource for researchers who wish to study protein function in a set of genes with documented biomedical significance.	[Rolfs, Andreas; Hu, Yanhui; Zuo, Dongmei; Ramachandran, Niro; Raphael, Jacob; Kelley, Fontina; McCarron, Seamus; Jepson, Daniel A.; Shen, Binghua; Baqui, Munira M. A.; Pearlberg, Joseph; Taycher, Elena; LaBaer, Joshua] Harvard Univ, Sch Med, Harvard Inst Prote, Cambridge, MA 02138 USA; [Ebert, Lars; Hoerlein, Andreas; Korn, Bernhard] RZPD, Heidelberg, Germany; [Hoffmann, Dietmar; DeLoughery, Craig] Sanofi Aventis, Cambridge, MA USA	Harvard University; Harvard Medical School; Sanofi-Aventis	LaBaer, J (corresponding author), Harvard Univ, Sch Med, Harvard Inst Prote, Cambridge, MA 02138 USA.	Joshua_labaer@hms.harvard.edu	Baqui, Munira M. A/H-5243-2013	Baqui, Munira M. A/0000-0002-7945-2899; Hu, Yanhui/0000-0003-1494-1402	Sanofi-Aventis; Breast Cancer Research Foundation; German Ministry of Science, NGFN2 [01GR0413, 01GR0420]	Sanofi-Aventis(Sanofi-Aventis); Breast Cancer Research Foundation; German Ministry of Science, NGFN2	We would like to thank Sanofi-Aventis and the Breast Cancer Research Foundation for generous support of this project. The project has partly been funded by the German Ministry of Science, NGFN2 (grants 01GR0413 and 01GR0420).	Baross A, 2004, GENOME RES, V14, P2083, DOI 10.1101/gr.2473704; Collins JE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r84; De Los Rios P, 2005, BIOPHYS J, V89, P14, DOI 10.1529/biophysj.104.055004; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Haas S, 1998, NUCLEIC ACIDS RES, V26, P3006, DOI 10.1093/nar/26.12.3006; Harrison OJ, 2005, J CELL SCI, V118, P4123, DOI 10.1242/jcs.02539; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Hu YH, 2003, J PROTEOME RES, V2, P405, DOI 10.1021/pr0340227; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Murthy T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000577; Park J, 2005, P NATL ACAD SCI USA, V102, P8114, DOI 10.1073/pnas.0503141102; Pennisi E, 2007, SCIENCE, V316, P1113; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Staden R, 2001, Methods Biochem Anal, V43, P303; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Taycher E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-198; Temple G, 2006, HUM MOL GENET, V15, pR31, DOI 10.1093/hmg/ddl048; Witt AE, 2006, J PROTEOME RES, V5, P599, DOI 10.1021/pr050395r	24	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1528	10.1371/journal.pone.0001528	http://dx.doi.org/10.1371/journal.pone.0001528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231609	Green Published, gold, Green Submitted			2022-12-27	WOS:000260504200036
J	Thompson, FM; Porter, DW; Okitsu, SL; Westerfeld, N; Vogel, D; Todryk, S; Poulton, I; Correa, S; Hutchings, C; Berthoud, T; Dunachie, S; Andrews, L; Williams, JL; Sinden, R; Gilbert, SC; Pluschke, G; Zurbriggen, R; Hill, AVS				Thompson, Fiona M.; Porter, David W.; Okitsu, Shinji L.; Westerfeld, Nicole; Vogel, Denise; Todryk, Stephen; Poulton, Ian; Correa, Simon; Hutchings, Claire; Berthoud, Tamara; Dunachie, Susanna; Andrews, Laura; Williams, Jack L.; Sinden, Robert; Gilbert, Sarah C.; Pluschke, Gerd; Zurbriggen, Rinaldo; Hill, Adrian V. S.			Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; POLYMERASE-CHAIN-REACTION; PRIME-BOOST IMMUNIZATION; PLASMODIUM-FALCIPARUM; VIRUS ANKARA; INHIBITORY ANTIBODIES; IMMUNOGENICITY; SPOROZOITE; REGIMENS; FP9	Background. Previous research indicates that a combination vaccine targeting different stages of the malaria life cycle is likely to provide the most effective malaria vaccine. This trial was the first to combine two existing vaccination strategies to produce a vaccine that induces immune responses to both the pre-erythrocytic and blood stages of the P. falciparum life cycle. Methods. This was a Phase I/IIa study of a new combination malaria vaccine FFM ME-TRAP+PEV3A. PEV3A includes peptides from both the pre-erythrocytic circumsporozoite protein and the blood-stage antigen AMA-1. This study was conducted at the Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, UK. The participants were healthy, malaria naive volunteers, from Oxford. The interventions were vaccination with PEV3A alone, or PEV3A+FFM ME-TRAP. The main outcome measure was protection from malaria in a sporozoite challenge model. Other outcomes included measures of parasite specific immune responses induced by either vaccine; and safety, assessed by collection of adverse event data. Results. We observed evidence of blood stage immunity in PEV3A vaccinated volunteers, but no volunteers were completely protected from malaria. PEV3A induced high antibody titres, and antibodies bound parasites in immunofluorescence assays. Moreover, we observed boosting of the vaccine-induced immune response by sporozoite challenge. Immune responses induced by FFM ME-TRAP were unexpectedly low. The vaccines were safe, with comparable side effect profiles to previous trials. Although there was no sterile protection two major observations support an effect of the vaccine-induced response on blood stage parasites: (i) Lower rates of parasite growth were observed in volunteers vaccinated with PEV3A compared to unvaccinated controls (p = 0.012), and this was reflected in the PCR results from PEV3A vaccinated volunteers. These showed early control of parasitaemia by some volunteers in this group. One volunteer, who received PEV3A alone, was diagnosed very late, on day 20 compared to an average of 11.8 days in unvaccinated controls. (ii). Morphologically abnormal parasites were present in the blood of all (n = 24) PEV3A vaccinated volunteers, and in only 2/6 controls (p = 0.001). We describe evidence of vaccine-induced blood stage efficacy for the first time in a sporozoite challenge study. Trial Registration. ClinicalTrials.Gov NCT00408668	[Thompson, Fiona M.; Porter, David W.; Todryk, Stephen; Poulton, Ian; Hutchings, Claire; Berthoud, Tamara; Dunachie, Susanna; Andrews, Laura; Gilbert, Sarah C.; Hill, Adrian V. S.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Okitsu, Shinji L.; Vogel, Denise; Pluschke, Gerd] Swiss Trop Inst, Basel, Switzerland; [Westerfeld, Nicole; Zurbriggen, Rinaldo] Pevion Biotech Ltd, Bern, Switzerland; [Correa, Simon] Medical Research Council MRC, Res Lab, Fajara, Gambia; [Williams, Jack L.] Walter Reed Army Inst Res, Div Commun Dis & Immunol, Silver Spring, MD USA; [Sinden, Robert] Imperial Coll London, Biol Dept, Infect & Immun Sect, London, England	University of Oxford; University of Basel; Swiss Tropical & Public Health Institute; University of London; London School of Hygiene & Tropical Medicine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Imperial College London	Thompson, FM (corresponding author), Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England.	fiona.thompson@ndm.ox.ac.uk	Gilbert, Sarah C./H-2857-2019; Todryk, Stephen/AAA-3950-2019	Gilbert, Sarah C./0000-0002-6823-9750; Todryk, Stephen/0000-0003-4566-0793; Dunachie, Susanna/0000-0001-5665-6293	UK Medical Research Council; MRC [G0500634, G84/6323] Funding Source: UKRI; Medical Research Council [G0500634, G84/6323] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This trial was funded by a grant from the UK Medical Research Council.	Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; CLARK IA, 1981, INFECT IMMUN, V32, P1058, DOI 10.1128/IAI.32.3.1058-1066.1981; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; FERREIRA MU, 1995, J IMMUNOL METHODS, V187, P297, DOI 10.1016/0022-1759(95)00186-4; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Genton B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001018; GLUCK R, 1992, J CLIN INVEST, V90, P2491, DOI 10.1172/JCI116141; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Hutchings CL, 2007, INFECT IMMUN, V75, P5819, DOI 10.1128/IAI.00828-07; JENSEN JB, 1982, SCIENCE, V216, P1230, DOI 10.1126/science.7043736; KARUNAWEERA ND, 1992, CLIN EXP IMMUNOL, V88, P499, DOI 10.1111/j.1365-2249.1992.tb06478.x; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; KLOTZ FW, 1987, J EXP MED, V165, P359, DOI 10.1084/jem.165.2.359; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; MILLER LH, 1986, SCIENCE, V234, P1349, DOI 10.1126/science.2431481; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Okitsu SL, 2007, CHEM BIOL, V14, P577, DOI 10.1016/j.chembiol.2007.04.008; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Taliaferro WH, 1944, J INFECT DIS, V75, P1, DOI 10.1093/infdis/75.1.1; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Wang RB, 1996, IMMUNOL LETT, V53, P83, DOI 10.1016/S0165-2478(96)02610-7; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102	33	93	94	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1493	10.1371/journal.pone.0001493	http://dx.doi.org/10.1371/journal.pone.0001493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231580	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000260504200006
J	Kemmer, D; Podowski, RM; Yusuf, D; Brumm, J; Cheung, W; Wahlestedt, C; Lenhard, B; Wasserman, WW				Kemmer, Danielle; Podowski, Raf M.; Yusuf, Dimas; Brumm, Jochen; Cheung, Warren; Wahlestedt, Claes; Lenhard, Boris; Wasserman, Wyeth W.			Gene Characterization Index: Assessing the Depth of Gene Annotation	PLOS ONE			English	Article							HUMAN GENOME; SEQUENCE DATABASE; ION CHANNELS; INFORMATION; KNOWLEDGE; RESOURCE; ONTOLOGY; UNIPROT; GPCRDB	Background. We introduce the Gene Characterization Index, a bioinformatics method for scoring the extent to which a protein-encoding gene is functionally described. Inherently a reflection of human perception, the Gene Characterization Index is applied for assessing the characterization status of individual genes, thus serving the advancement of both genome annotation and applied genomics research by rapid and unbiased identification of groups of uncharacterized genes for diverse applications such as directed functional studies and delineation of novel drug targets. Methodology/Principal Findings. The scoring procedure is based on a global survey of researchers, who assigned characterization scores from 1 (poor) to 10 (extensive) for a sample of genes based on major online resources. By evaluating the survey as training data, we developed a bioinformatics procedure to assign gene characterization scores to all genes in the human genome. We analyzed snapshots of functional genome annotation over a period of 6 years to assess temporal changes reflected by the increase of the average Gene Characterization Index. Applying the Gene Characterization Index to genes within pharmaceutically relevant classes, we confirmed known drug targets as high-scoring genes and revealed potentially interesting novel targets with low characterization indexes. Removing known drug targets and genes linked to sequence-related patent filings from the entirety of indexed genes, we identified sets of low-scoring genes particularly suited for further experimental investigation. Conclusions/Significance. The Gene Characterization Index is intended to serve as a tool to the scientific community and granting agencies for focusing resources and efforts on unexplored areas of the genome. The Gene Characterization Index is available from	[Yusuf, Dimas; Brumm, Jochen; Cheung, Warren; Wasserman, Wyeth W.] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; [Kemmer, Danielle; Podowski, Raf M.; Wahlestedt, Claes; Lenhard, Boris] Karolinska Inst, Ctr Genom & Bioinform, Stockholm, Sweden; [Kemmer, Danielle] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Brumm, Jochen] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Wahlestedt, Claes; Lenhard, Boris] Scripps Res Inst, Mol & Integrative Neurosci Dept, Jupiter, FL USA; Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen Ctr Comp Sci, Comp Biol Unit, Unifob AS, Bergen, Norway	Child & Family Research Institute; University of British Columbia; Karolinska Institutet; University of British Columbia; University of British Columbia; Scripps Research Institute; University of Bergen	Wasserman, WW (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada.	wyeth@cmmt.ubc.ca	Wasserman, Wyeth/I-4866-2015; Kemmer, Danielle/AAO-6478-2021	Podowski, Raf/0000-0001-5500-8913; Lenhard, Boris/0000-0002-1114-1509; Cheung, Warren/0000-0003-0267-7464; Brumm, Jochen/0000-0001-9518-038X; Wasserman, Wyeth/0000-0001-6098-6412	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Funding from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER RG, 1992, SCIENCE, V257, P908, DOI 10.1126/science.1502557; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Connolly CN, 2004, BIOCHEM SOC T, V32, P529, DOI 10.1042/BST0320529; Curran ME, 1998, CURR OPIN BIOTECH, V9, P565, DOI 10.1016/S0958-1669(98)80133-X; Donizelli M, 2006, NUCLEIC ACIDS RES, V34, pD267, DOI 10.1093/nar/gkj104; Eisenthal Y, 2006, NEURAL COMPUT, V18, P119, DOI 10.1162/089976606774841602; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Gewin V, 2005, PLOS BIOL, V3, P13, DOI 10.1371/journal.pbio.0030024; GUNES H, 2004, P SOC PHOTO-OPT INS, P968; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Horn F, 2003, NUCLEIC ACIDS RES, V31, P294, DOI 10.1093/nar/gkg103; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lenhard B, 2001, GENOME RES, V11, P2151, DOI 10.1101/gr.199801; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; Mizielinska S, 2006, BIOCHEM SOC T, V34, P863, DOI 10.1042/BST0340863; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Oh JH, 2005, MAMM GENOME, V16, P942, DOI 10.1007/s00335-005-0075-2; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pennisi E, 2003, SCIENCE, V300, P1484, DOI 10.1126/science.300.5625.1484b; Pennisi E, 2003, SCIENCE, V300, P409, DOI 10.1126/science.300.5618.409; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Resnik DB, 2003, HEALTH POLICY, V65, P181, DOI 10.1016/S0168-8510(02)00206-3; RESNIK P, 1995, USING INFORM CONTENT, P448; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schulman IG, 2004, CHEM BIOL, V11, P639, DOI 10.1016/j.chembiol.2003.12.021; Vapnik V., 2013, NATURE STAT LAERNING; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161	40	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1440	10.1371/journal.pone.0001440	http://dx.doi.org/10.1371/journal.pone.0001440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213364	Green Submitted, gold, Green Published			2022-12-27	WOS:000260503900001
J	Wang, ZP; Zhang, SC; Wang, GF; An, Y				Wang, Zhiping; Zhang, Shicui; Wang, Guangfeng; An, Yan			Complement Activity in the Egg Cytosol of Zebrafish Danio rerio: Evidence for the Defense Role of Maternal Complement Components	PLOS ONE			English	Article								Most fish embryos that develop externally are exposed to an environment full of microbes. How they survive microbial attacks are not understood to date. Here we demonstrated that the egg cytosol prepared from the newly fertilized eggs of zebrafish Danio rerio is capable of killing the Gram-negative bacterium Escherichia coli, via in vitro assay system of the complement activity established. All findings indicate that it is the complement system operating via the alternative pathway that is attributable to the bacteriolytic activity. This is the first report providing the evidence for the functional role of the maternal complement components in fish eggs, paving the way for study of maternal immunity in other organisms whose eggs are fertilized in vitro.	[Wang, Zhiping; Zhang, Shicui; Wang, Guangfeng; An, Yan] Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China	Ocean University of China	Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China.	sczhang@ouc.edu.cn			Ministry of Science and Technology (MOST) [2006CB101805, 30730072]; Natural Science Foundation of China (NSFC) [2006CB101805, 30730072]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants (2006CB101805; 30730072) of Ministry of Science and Technology (MOST) and Natural Science Foundation of China (NSFC).	BLY JE, 1986, COMP BIOCHEM PHYS A, V84, P309, DOI 10.1016/0300-9629(86)90620-1; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breuil G, 1997, FISH SHELLFISH IMMUN, V7, P29, DOI 10.1006/fsim.1996.0061; CASTILLO A, 1993, DEV COMP IMMUNOL, V17, P419, DOI 10.1016/0145-305X(93)90033-M; Ellingsen T, 2005, FISH SHELLFISH IMMUN, V18, P351, DOI 10.1016/j.fsi.2004.09.002; Ellis A. E., 1988, Fish vaccination., P20; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Huttenhuis HBT, 2006, FISH SHELLFISH IMMUN, V20, P586, DOI 10.1016/j.fsi.2005.07.008; KANLIS G, 1995, FISHERIES SCI, V61, P787, DOI 10.2331/fishsci.61.787; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Koppenheffer TL, 1998, DEV COMP IMMUNOL, V22, P231, DOI 10.1016/S0145-305X(98)00015-9; Kuo MM, 2000, J PARASITOL, V86, P1223, DOI 10.1645/0022-3395(2000)086[1223:ACSOMA]2.0.CO;2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lovoll M, 2007, FISH SHELLFISH IMMUN, V23, P542, DOI 10.1016/j.fsi.2007.01.002; Lvoll M, 2006, IMMUNOGENETICS, V58, P168, DOI 10.1007/s00251-006-0096-3; Magnadottir B, 2004, COMP BIOCHEM PHYS B, V139, P217, DOI 10.1016/j.cbpc.2004.07.009; MOR A, 1990, J FISH BIOL, V37, P249, DOI 10.1111/j.1095-8649.1990.tb05856.x; MORGAN BP, 1995, CRIT REV CL LAB SCI, V32, P265, DOI 10.3109/10408369509084686; Nonaka M, 1999, J IMMUNOL, V162, P387; Olsen YA, 1997, FISH SHELLFISH IMMUN, V7, P81, DOI 10.1006/fsim.1996.0064; Picchietti S, 2004, CELL TISSUE RES, V315, P259, DOI 10.1007/s00441-003-0819-9; Picchietti S, 2001, J FISH BIOL, V59, P1503, DOI 10.1111/j.1095-8649.2001.tb00215.x; Robertson M, 1998, CURR BIOL, V8, pR595, DOI 10.1016/S0960-9822(98)70384-7; Rubio-Godoy M, 2004, FISH SHELLFISH IMMUN, V17, P95, DOI 10.1016/j.fsi.2003.11.005; RUDDY S, 1974, TRANSPLANT P, V6, P1; SUNYER JO, 1995, VET IMMUNOL IMMUNOP, V45, P333, DOI 10.1016/0165-2427(94)05430-Z; Swain P, 2006, FISH SHELLFISH IMMUN, V20, P519, DOI 10.1016/j.fsi.2005.06.011; Takemura A, 1997, FISH SHELLFISH IMMUN, V7, P355, DOI 10.1006/fsim.1997.0090; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turner MW, 1996, IMMUNOL TODAY, V17, P532, DOI 10.1016/0167-5699(96)10062-1; van Loon J. J. A, 1981, ASPECTS DEV COMP IMM, P469; VANDIJK H, 1985, J IMMUNOL METHODS, V85, P233, DOI 10.1016/0022-1759(85)90134-6; Yano Tomoki, 1996, Fish Physiology, V15, P105; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zarkadis IK, 2001, DEV COMP IMMUNOL, V25, P745, DOI 10.1016/S0145-305X(01)00034-9; Zhang SC, 2003, ZOOL SCI, V20, P1207, DOI 10.2108/zsj.20.1207	39	56	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1463	10.1371/journal.pone.0001463	http://dx.doi.org/10.1371/journal.pone.0001463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SO	18213372	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503900009
J	Ilyinskii, PO; Gambaryan, AS; Meriin, AB; Gabai, V; Kartashov, A; Thoidis, G; Shneider, AM				Ilyinskii, Petr O.; Gambaryan, Alexandra S.; Meriin, Anatoli B.; Gabai, Vladimir; Kartashov, Alex; Thoidis, Galini; Shneider, Alexander M.			Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency	PLOS ONE			English	Article								The effectiveness of recombinant vaccines encoding full-length M2 protein of influenza virus or its ectodomain (M2e) have previously been tested in a number of models with varying degrees of success. Recently, we reported a strong cytotoxic effect exhibited by M2 on mammalian cells in vitro. Here we demonstrated a decrease in protection when M2 was added to a DNA vaccination regimen that included influenza NP. Furthermore, we have constructed several fusion proteins of conserved genes of influenza virus and tested their expression in vitro and protective potential in vivo. The four-partite NP-M1-M2-NS1 fusion antigen that has M2 sequence engineered in the middle part of the composite protein was shown to not be cytotoxic in vitro. A three-partite fusion protein (consisting of NP, M1 and NS1) was expressed much more efficiently than the four-partite protein. Both of these constructs provided statistically significant protection upon DNA vaccination, with construct NP-M1-M2-NS1 being the most effective. We conclude that incorporation of M2 into a vaccination regimen may be beneficial only when its apparent cytotoxicity-linked negative effects are neutralized. The possible significance of this data for influenza vaccination regimens and preparations is discussed.	[Ilyinskii, Petr O.; Thoidis, Galini; Shneider, Alexander M.] Cure Lab, Canton, MA USA; [Gambaryan, Alexandra S.] Chumakov Inst Poliomyelitis & Viral Encephalitis, Moscow, Russia; [Meriin, Anatoli B.; Gabai, Vladimir] Boston Univ, Sch Med, Boston, MA USA; [Kartashov, Alex] Policy Anal, Brookline, MA USA	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Boston University; Policy Analysis Inc	Shneider, AM (corresponding author), Cure Lab, Canton, MA USA.	ashneider@curelab.com	Gabai, Vladimir L/I-1650-2013; Gambaryan, Alexandra S/E-2667-2014	Gabai, Vladimir L/0000-0003-4505-4718; Meriin, Anatoli/0000-0003-0087-814X	Cure Lab, Inc	Cure Lab, Inc	This work was entirely funded by Cure Lab, Inc	Altstein AD, 2006, ARCH VIROL, V151, P921, DOI 10.1007/s00705-005-0676-9; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; GITELMAN AK, 1984, VIROLOGY, V134, P230, DOI 10.1016/0042-6822(84)90288-5; Heinen PP, 2002, J GEN VIROL, V83, P1851, DOI 10.1099/0022-1317-83-8-1851; ILYINSKII P, 2007, CELL CYCLE IN PRESS, V6; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Schroeder C, 2005, EUR BIOPHYS J BIOPHY, V34, P52, DOI 10.1007/s00249-004-0424-1; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhirnov OP, 2007, INFLUENZA OTHER RESP, V1, P71, DOI 10.1111/j.1750-2659.2007.00010.x	15	8	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1417	10.1371/journal.pone.0001417	http://dx.doi.org/10.1371/journal.pone.0001417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197240	Green Published, gold			2022-12-27	WOS:000260503800001
J	Couvreur, B; Beaufays, J; Charon, C; Lahaye, K; Gensale, F; Denis, V; Charloteaux, B; Decrem, Y; Prevot, PP; Brossard, M; Vanhamme, L; Godfroid, E				Couvreur, Bernard; Beaufays, Jerome; Charon, Cedric; Lahaye, Kathia; Gensale, Francois; Denis, Valerie; Charloteaux, Benoit; Decrem, Yves; Prevot, Pierre-Paul; Brossard, Michel; Vanhamme, Luc; Godfroid, Edmond			Variability and Action Mechanism of a Family of Anticomplement Proteins in Ixodes ricinus	PLOS ONE			English	Article							AMERICAN VISCERAL LEISHMANIASIS; HYDROPHOBIC CLUSTER-ANALYSIS; ANTI-COMPLEMENT ACTIVITY; COBRA VENOM FACTOR; X-RAY-SCATTERING; SAND FLY VECTOR; ALTERNATIVE PATHWAY; TICK SALIVA; ORNITHODOROS-MOUBATA; ACQUIRED-RESISTANCE	Background. Ticks are blood feeding arachnids that characteristically take a long blood meal. They must therefore counteract host defence mechanisms such as hemostasis, inflammation and the immune response. This is achieved by expressing batteries of salivary proteins coded by multigene families. Methodology/Principal Findings. We report the in-depth analysis of a tick multigene family and describe five new anticomplement proteins in Ixodes ricinus. Compared to previously described Ixodes anticomplement proteins, these segregated into a new phylogenetic group or subfamily. These proteins have a novel action mechanism as they specifically bind to properdin, leading to the inhibition of C3 convertase and the alternative complement pathway. An excess of non-synonymous over synonymous changes indicated that coding sequences had undergone diversifying selection. Diversification was not associated with structural, biochemical or functional diversity, adaptation to host species or stage specificity but rather to differences in antigenicity. Conclusions/Significance. Anticomplement proteins from I. ricinus are the first inhibitors that specifically target a positive regulator of complement, properdin. They may provide new tools for the investigation of role of properdin in physiological and pathophysiological mechanisms. They may also be useful in disorders affecting the alternative complement pathway. Looking for and detecting the different selection pressures involved will help in understanding the evolution of multigene families and hematophagy in arthropods.	[Couvreur, Bernard; Beaufays, Jerome; Charon, Cedric; Lahaye, Kathia; Gensale, Francois; Denis, Valerie; Decrem, Yves; Prevot, Pierre-Paul; Vanhamme, Luc; Godfroid, Edmond] Free Univ Brussels, Lab Mol Biol Ectoparasites, IBMM, Gosselies, Belgium; [Charloteaux, Benoit] Gembloux Agr Univ, Ctr Biophys Mol Numerique, Gembloux, Belgium; [Brossard, Michel] Univ Neuchatel, Inst Zool, Neuchatel, Switzerland; [Vanhamme, Luc] Free Univ Brussels, Inst Biol Med Mol IBMM, Lab Mol Parasitol, Brussels, Belgium	Universite Libre de Bruxelles; University of Liege; University of Neuchatel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Godfroid, E (corresponding author), Free Univ Brussels, Lab Mol Biol Ectoparasites, IBMM, Gosselies, Belgium.	edmond.godfroid@ulb.ac.be			Belgian National Fund for Scientific Research; Fonds pour la Formation a la Recherche dans lIndustrie et dans lAgriculture of the Belgian Federal Governement [PhD studentship]; Ministere de la Region Wallonne in Belgium [215107, 415702]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche dans lIndustrie et dans lAgriculture of the Belgian Federal Governement(Fonds de la Recherche Scientifique - FNRS); Ministere de la Region Wallonne in Belgium	LVH is a Senior Research Associate at the Belgian National Fund for Scientific Research. CC is supported by a PhD studentship from the Fonds pour la Formation a la Recherche dans lIndustrie et dans lAgriculture of the Belgian Federal Governement. This work was supported by contracts 215107 and 415702 from the Ministere de la Region Wallonne in Belgium.	Astigarraga A, 1997, PARASITE IMMUNOL, V19, P401, DOI 10.1046/j.1365-3024.1997.d01-236.x; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; COLLIGAN JE, 1994, CURRENT PROTOCOLS IM; CURMAN B, 1977, BIOCHEMISTRY-US, V16, P5368, DOI 10.1021/bi00643a031; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; DISCIPIO RG, 1981, BIOCHEM J, V199, P485, DOI 10.1042/bj1990485; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Giclas PC, 1997, MANUAL CLIN LAB IMMU, V5, P181; GOUNDIS D, 1988, NATURE, V335, P82, DOI 10.1038/335082a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta-Bansal R, 2000, MOL IMMUNOL, V37, P191, DOI 10.1016/S0161-5890(00)00047-X; Holers VM, 2004, MOL IMMUNOL, V41, P147, DOI 10.1016/j.molimm.2004.03.012; HOOGSTRAAL H, 1982, B SOC ENTOMOL SUISSE, V55, P5; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Janeway CA, 2001, IMMUNOBIOLOGY; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Kock MA, 2004, J BIOL CHEM, V279, P30836, DOI 10.1074/jbc.M403196200; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kostavasil I, 1997, J IMMUNOL, V158, P1763; Kovar L, 2004, FOLIA MICROBIOL, V49, P327, DOI 10.1007/BF02931051; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lanzaro GC, 1999, INSECT MOL BIOL, V8, P267, DOI 10.1046/j.1365-2583.1999.820267.x; Lawrie CH, 1999, EXP PARASITOL, V93, P207, DOI 10.1006/expr.1999.4456; Lawrie CH, 2005, MOL IMMUNOL, V42, P31, DOI 10.1016/j.molimm.2004.07.001; Mans BJ, 2002, MOL BIOL EVOL, V19, P1695, DOI 10.1093/oxfordjournals.molbev.a003992; Mans J, 2004, PARASITOLOGY, V129, pS95, DOI 10.1017/S0031182003004670; Mejri N, 2002, PARASITOL RES, V88, P192, DOI 10.1007/s00436-001-0515-1; Milleron RS, 2004, AM J TROP MED HYG, V70, P286, DOI 10.4269/ajtmh.2004.70.286; Milleron RS, 2004, AM J TROP MED HYG, V70, P278, DOI 10.4269/ajtmh.2004.70.278; MILNE A, 1949, PARASITOLOGY, V39, P173, DOI 10.1017/S0031182000083736; Mizuno M., 2004, Current Drug Targets - Inflammation and Allergy, V3, P87, DOI 10.2174/1568010043483890; Mollnes TE, 2006, MOL IMMUNOL, V43, P107, DOI 10.1016/j.molimm.2005.06.014; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; NOLAN KF, 1991, EUR J IMMUNOL, V21, P771, DOI 10.1002/eji.1830210333; NOLAN KF, 1993, METHOD ENZYMOL, V223, P35; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Ohno S., 1970, EVOLUTION GENE DUPLI; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmer M. J., 1994, Insect Molecular Biology, V3, P57, DOI 10.1111/j.1365-2583.1994.tb00151.x; PANGBURN MK, 1989, J IMMUNOL, V142, P202; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Prevot PP, 2006, J BIOL CHEM, V281, P26361, DOI 10.1074/jbc.M604197200; Price PW, 1980, MONOGRAPHS POPULATIO; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RIBEIRO JMC, 1987, EXP PARASITOL, V64, P347, DOI 10.1016/0014-4894(87)90046-4; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; SCHREIBER RD, 1978, J EXP MED, V148, P1722, DOI 10.1084/jem.148.6.1722; Schroeder H, 2007, MICROBES INFECT, V9, P247, DOI 10.1016/j.micinf.2006.10.020; SMITH CA, 1984, J BIOL CHEM, V259, P4582; SMITH KF, 1991, BIOCHEMISTRY-US, V30, P8000, DOI 10.1021/bi00246a018; Soares CAG, 2005, INSECT MOL BIOL, V14, P443, DOI 10.1111/j.1365-2583.2005.00575.x; SONENSHINE B, 1991, BIOL TICKS, V1; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Sun Z, 2004, J MOL BIOL, V343, P1327, DOI 10.1016/j.jmb.2004.09.001; TACK BF, 1981, METHODS ENZYMOLOGY, V80; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Ullmann AJ, 2005, INSECT MOL BIOL, V14, P217, DOI 10.1111/j.1365-2583.2005.00551.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Vullo A, 2004, BIOINFORMATICS, V20, P653, DOI 10.1093/bioinformatics/btg463; WEISMAN HF, 1990, T ASSOC AM PHYSICIAN, V103, P64; WIKEL SK, 1979, AM J TROP MED HYG, V28, P586, DOI 10.4269/ajtmh.1979.28.586; WIKEL SK, 1977, IMMUNOLOGY, V32, P457; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	90	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1400	10.1371/journal.pone.0001400	http://dx.doi.org/10.1371/journal.pone.0001400			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167559	Green Published, gold, Green Submitted			2022-12-27	WOS:000260468900028
J	Lee, S; Sayin, A; Grice, S; Burdett, H; Baban, D; van den Heuvel, M				Lee, Sheena; Sayin, Arzu; Grice, Stuart; Burdett, Howard; Baban, Dilair; van den Heuvel, Marcel			Genome-Wide Expression Analysis of a Spinal Muscular Atrophy Model: Towards Discovery of New Drug Targets	PLOS ONE			English	Article							SURVIVAL MOTOR-NEURON; DETERMINING GENE; PROTEIN; RECEPTOR; DISEASE; SMN; IDENTIFICATION; NEUROPATHY; DROSOPHILA; MUTANT	Spinal Muscular Atrophy is a recessive genetic disease and affects lower motor neurones and muscle tissue. A single gene is disrupted in SMA: SMN1 activity is abolished but a second copy of the gene (SMN2) provides limited activity. While the SMN protein has been shown to function in the assembly of RNA-protein complexes, it is unclear how the overall reduction in SMN activity specifically results in the neuromuscular phenotypes. Similar to humans, reduced smn activity in the fly causes earliest phenotypes in neuromuscular tissues. To uncover the effects of reduced SMN activity, we have studied gene expression in control and diseased fly tissues using whole genome micro-arrays. A number of gene expression changes are recovered and independently validated. Identified genes show trends in their predicted function: several are consistent with the function of SMN, in addition some uncover novel pathways. This and subsequent genetic analysis in the fly indicates some of the identified genes could be taken for further studies as potential drug targets for SMA and other neuromuscular disorders.	[Lee, Sheena] Univ Oxford, Dept Human Anat & Genet, Oxford Ctr Gene Funct, OXION Initiat, Oxford, England; [Sayin, Arzu; Grice, Stuart; Burdett, Howard; Baban, Dilair; van den Heuvel, Marcel] Univ Oxford, Dept Physiol Human Anat & Genet, Med Res Council, Funct Genet Unit, Oxford, England	University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford	Lee, S (corresponding author), Univ Oxford, Dept Human Anat & Genet, Oxford Ctr Gene Funct, OXION Initiat, Oxford, England.	sheena.lee@dpag.ox.ac.uk			Motor Neurone Disease Association; Jennifer Trust and Medical Research Council; Wellcome Trust Integrative Physiology Initiative on Ion Channels (OXION)	Motor Neurone Disease Association; Jennifer Trust and Medical Research Council; Wellcome Trust Integrative Physiology Initiative on Ion Channels (OXION)(Wellcome Trust)	We gratefully acknowledge funding by the Motor Neurone Disease Association, Jennifer Trust and Medical Research Council for the Drosophila SMA model and array validation. We thank the Wellcome Trust Integrative Physiology Initiative on Ion Channels (OXION) for funding the microarray work.	ARNOLD AS, 2004, REDUCED EXPRESSION N, P1; Bergin A, 1997, GENE, V204, P47, DOI 10.1016/S0378-1119(97)00510-6; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Verstreken P, 2002, TRENDS NEUROSCI, V25, P383, DOI 10.1016/S0166-2236(02)02197-5; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Zhang HLL, 2003, J NEUROSCI, V23, P6627	18	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1404	10.1371/journal.pone.0001404	http://dx.doi.org/10.1371/journal.pone.0001404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167563	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900001
J	Welle, S; Tawil, R; Thornton, CA				Welle, Stephen; Tawil, Rabi; Thornton, Charles A.			Sex-Related Differences in Gene Expression in Human Skeletal Muscle	PLOS ONE			English	Article							OLD HUMAN-SUBJECTS; PROTEIN-SYNTHESIS; BODY-COMPOSITION; TESTOSTERONE REPLACEMENT; POSTMENOPAUSAL WOMEN; HYPOGONADAL MEN; NEGATIVE REGULATION; GENDER-DIFFERENCES; ANDROGEN RECEPTOR; ELDERLY-MEN	There is sexual dimorphism of skeletal muscle, the most obvious feature being the larger muscle mass of men. The molecular basis for this difference has not been clearly defined. To identify genes that might contribute to the relatively greater muscularity of men, we compared skeletal muscle gene expression profiles of 15 normal men and 15 normal women by using comprehensive oligonucleotide microarrays. Although there were sex-related differences in expression of several hundred genes, very few of the differentially expressed genes have functions that are obvious candidates for explaining the larger muscle mass of men. The men tended to have higher expression of genes encoding mitochondrial proteins, ribosomal proteins, and a few translation initiation factors. The women had >2-fold greater expression than the men (P < 0.0001) of two genes that encode proteins in growth factor pathways known to be important in regulating muscle mass: growth factor receptor-bound 10 (GRB10) and activin A receptor IIB (ACVR2B). GRB10 encodes a protein that inhibits insulin-like growth factor-1 (IGF-1) signaling. ACVR2B encodes a myostatin receptor. Quantitative RT-PCR confirmed higher expression of GRB10 and ACVR2B genes in these women. In an independent microarray study of 10 men and 9 women with facioscapulohumeral dystrophy, women had higher expression of GRB10 (2.7-fold, P < 0.001) and ACVR2B (1.7-fold, P < 0.03). If these sex-related differences in mRNA expression lead to reduced IGF-1 activity and increased myostatin activity, they could contribute to the sex difference in muscle size.	Univ Rochester, Dept Med, Rochester, NY 14627 USA; [Tawil, Rabi; Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY USA	University of Rochester; University of Rochester	Welle, S (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14627 USA.	stephen_welle@urmc.rochester.edu			National Institutes of Health [AG17891, AG18254, AR/NS48143, RR00044]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG018254, R01AG017891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by grants from the National Institutes of Health (AG17891, AG18254, AR/NS48143, RR00044). The funding agency had no other role in the conduct of this study or preparation of this paper.	Bamman MM, 2003, J GERONTOL A-BIOL, V58, P108; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; Brodsky IG, 1996, J CLIN ENDOCR METAB, V81, P3469, DOI 10.1210/jc.81.10.3469; Brown CJ, 2003, TRENDS GENET, V19, P432, DOI 10.1016/S0168-9525(03)00177-X; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; FORSBERG AM, 1991, CLIN SCI, V81, P249, DOI 10.1042/cs0810249; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; HASSAGER C, 1989, METABOLISM, V38, P662, DOI 10.1016/0026-0495(89)90104-2; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hunter SK, 2001, J APPL PHYSIOL, V91, P2686, DOI 10.1152/jappl.2001.91.6.2686; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jahn LA, 1999, J CLIN ENDOCR METAB, V84, P1007, DOI 10.1210/jc.84.3.1007; JENSEN J, 1986, MATURITAS, V8, P209, DOI 10.1016/0378-5122(86)90028-9; Kent-Braun JA, 2002, J APPL PHYSIOL, V93, P1813, DOI 10.1152/japplphysiol.00091.2002; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Langlais P, 2004, MOL ENDOCRINOL, V18, P350, DOI 10.1210/me.2003-0117; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V284, pE377, DOI 10.1152/ajpendo.00282.2002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Reid KJ, 2001, J BIOL CHEM, V276, P2943, DOI 10.1074/jbc.M009170200; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435, DOI 10.1152/ajpendo.00266.2001; Roth SM, 2003, EXP BIOL MED, V228, P706, DOI 10.1177/153537020322800609; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Sipila S, 2001, CLIN SCI, V101, P147, DOI 10.1042/CS20000271; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Steffensen CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE634, DOI 10.1152/ajpendo.00078.2001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taaffe DR, 2005, MED SCI SPORT EXER, V37, P1741, DOI 10.1249/01.mss.0000181678.28092.31; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; URBAN RJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE820, DOI 10.1152/ajpendo.1995.269.5.E820; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Walsh S, 2007, J APPL PHYSIOL, V102, P2142, DOI 10.1152/japplphysiol.01322.2006; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; Welle S, 1999, J APPL PHYSIOL, V86, P1220, DOI 10.1152/jappl.1999.86.4.1220; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Welle S, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-23; WELLE S, 1994, AM J PHYSIOL-ENDOC M, V267, pE599, DOI 10.1152/ajpendo.1994.267.4.E599; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yoshioka M, 2007, J MOL ENDOCRINOL, V39, P119, DOI 10.1677/JME-07-0027	56	113	115	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1385	10.1371/journal.pone.0001385	http://dx.doi.org/10.1371/journal.pone.0001385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167544	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900013
J	Yang, L; Wong, CM; Lau, EHY; Chan, KP; Ou, CQ; Peiris, JSM				Yang, Lin; Wong, Chit Ming; Lau, Eric H. Y.; Chan, King Pan; Ou, Chun Quan; Peiris, Joseph S. M.			Synchrony of Clinical and Laboratory Surveillance for Influenza in Hong Kong	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SPATIAL HIERARCHIES; WAVELET TRANSFORM; UNITED-STATES; TIME-SERIES; EPIDEMIOLOGY; MORTALITY; EVOLUTION; ILLNESS; ECOLOGY	Background. Consultation rates of influenza-like illness (ILI) in an outpatient setting have been regarded as a good indicator of influenza virus activity in the community. As ILI-like symptoms may be caused by etiologies other than influenza, and influenza virus activity in the tropics and subtropics is less predictable than in temperate regions, the correlation between of ILI and influenza virus activity in tropical and subtropical regions is less well defined. Methodology and Principal Findings. In this study, we used wavelet analysis to investigate the relationship between seasonality of influenza virus activity and consultation rates of ILI reported separately by General Out-patient Clinics (GOPC) and General Practitioners (GP). During the periods 1998-2000 and 2002-2003, influenza virus activity exhibited both annual and semiannual cycles, with one peak in the winter and another in late spring or early summer. But during 2001 and 2004-2006, only annual cycles could be clearly identified. ILI consultation rates in both GOPC and GP settings share a similar non-stationary seasonal pattern. We found high coherence between ILI in GOPC and influenza virus activity for the annual cycle, but this was only significant (p < 0.05) during the periods 1998-1999 and 2002-2006. For the semiannual cycle high coherence (p < 0.05) was also found significant during the period 1998-1999 and year 2003 when two peaks of influenza were evident. Similarly, ILI in GP setting is also associated with influenza virus activity for both the annual and semiannual cycles. On average, oscillation of ILI in GP and of ILI in GOPC preceded influenza virus isolation by approximately four and two weeks, respectively. Conclusions. Our findings suggest that consultation rates of ILI precede the oscillations of laboratory surveillance by at least two weeks and can be used as a predictor for influenza epidemics in Hong Kong. The validity of our model for other tropical regions needs to be explored.	[Yang, Lin; Wong, Chit Ming; Lau, Eric H. Y.; Chan, King Pan; Ou, Chun Quan] Univ Hong Kong, Dept Community Med, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Peiris, Joseph S. M.] Univ Hong Kong, Hong Kong Spec Admin Reg, Dept Microbiol, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CM (corresponding author), Univ Hong Kong, Dept Community Med, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China.	hrmrwcm@hkucc.hku.hk	Lau, Eric/AAJ-6588-2021; Yang, Lin/E-5183-2011; YANG, Lin/F-9601-2014	Lau, Eric/0000-0002-6688-9637; YANG, Lin/0000-0002-5964-3233; Ou, Chun-Quan/0000-0001-6866-7213	Research Fund for the Control of Infectious Disease of the Health, Welfare and Food Bureau of the Hong Kong Special Administrative Region Government [0405021]	Research Fund for the Control of Infectious Disease of the Health, Welfare and Food Bureau of the Hong Kong Special Administrative Region Government	This work was supported by the Research Fund for the Control of Infectious Disease of the Health, Welfare and Food Bureau of the Hong Kong Special Administrative Region Government (RFCID No. 0405021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Broutin H, 2005, AM J EPIDEMIOL, V161, P1159, DOI 10.1093/aje/kwi141; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; *CENS STAT DEP, 2003, 12 CENS STAT DEP; Centers for Disease Control and Prevention (CDC), 2006, INFL FLU CLIN DESCR; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; *CTR HLTH PROT, 2006, SENT SURV; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Lau KM, 1995, B AM METEOROL SOC, V76, P2391, DOI 10.1175/1520-0477(1995)076<2391:CSDUWT>2.0.CO;2; Leung GM, 2005, SOC SCI MED, V61, P577, DOI 10.1016/j.socscimed.2004.12.029; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; MARAUN D, 2006, WAVELET SPECTRAL ANA; Meerhoff TJ, 2004, VIRUS RES, V103, P31, DOI 10.1016/j.virusres.2004.02.009; Monto AS, 2006, J INFECT DIS, V194, pS92, DOI 10.1086/507559; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; SHORTRIDGE KF, 1982, LANCET, V2, P812; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P191; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	35	62	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1399	10.1371/journal.pone.0001399	http://dx.doi.org/10.1371/journal.pone.0001399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167558	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900027
J	Fonteneau, E; van der Lely, HKJ				Fonteneau, Elisabeth; van der Lely, Heather K. J.			Electrical Brain Responses in Language-Impaired Children Reveal Grammar-Specific Deficits	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ELECTROPHYSIOLOGICAL EVIDENCE; SYNTACTIC ANALYSIS; VIOLATIONS; COMPLEXITY; FACULTY; REPAIR	Background: Scientific and public fascination with human language have included intensive scrutiny of language disorders as a new window onto the biological foundations of language and its evolutionary origins. Specific language impairment (SLI), which affects over 7% of children, is one such disorder. SLI has received robust scientific attention, in part because of its recent linkage to a specific gene and loci on chromosomes and in part because of the prevailing question regarding the scope of its language impairment: Does the disorder impact the general ability to segment and process language or a specific ability to compute grammar? Here we provide novel electrophysiological data showing a domain-specific deficit within the grammar of language that has been hitherto undetectable through behavioural data alone. Methods and Findings: We presented participants with Grammatical(G)-SLI, age-matched controls, and younger child and adult controls, with questions containing syntactic violations and sentences containing semantic violations. Electrophysiological brain responses revealed a selective impairment to only neural circuitry that is specific to grammatical processing in G-SLI. Furthermore, the participants with G-SLI appeared to be partially compensating for their syntactic deficit by using neural circuitry associated with semantic processing and all non-grammar-specific and low-level auditory neural responses were normal. Conclusions: The findings indicate that grammatical neural circuitry underlying language is a developmentally unique system in the functional architecture of the brain, and this complex higher cognitive system can be selectively impaired. The findings advance fundamental understanding about how cognitive systems develop and all human language is represented and processed in the brain.	[Fonteneau, Elisabeth; van der Lely, Heather K. J.] UCL, UCL Ctr Dev Language Disorders & Cognit Neurosci, London, England	University of London; University College London	Fonteneau, E (corresponding author), UCL, UCL Ctr Dev Language Disorders & Cognit Neurosci, London, England.	h.vanderlely@ucl.ac.uk			Wellcome Trust University Award [063713]	Wellcome Trust University Award(Wellcome Trust)	This research and both authors were supported by a Wellcome Trust University Award (Grant No: 063713) to Heather van der Lely.	Ainsworth-Darnell K, 1998, J MEM LANG, V38, P112, DOI 10.1006/jmla.1997.2537; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Hagoort P, 2003, P NATL ACAD SCI USA, V100, P4340, DOI 10.1073/pnas.0230613100; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Hahne A, 2004, J COGNITIVE NEUROSCI, V16, P1302, DOI 10.1162/0898929041920504; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Joanisse MF, 1998, TRENDS COGN SCI, V2, P240, DOI 10.1016/S1364-6613(98)01186-3; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Leonard L.B., 1998, CHILDREN SPECIFIC LA; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Montgomery JW, 2002, APPL PSYCHOLINGUIST, V23, P447, DOI 10.1017/S0142716402003077; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/S0028-3932(97)00119-X; Oberecker R, 2005, J COGNITIVE NEUROSCI, V17, P1667, DOI 10.1162/089892905774597236; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Raven J. C., 1986, MANUAL RAVENS PROGRE; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; THOMAS M, 2002, BEHAV BRAIN SCI, V25, P750; van der Lely HKJ, 1998, CURR BIOL, V8, P1253, DOI 10.1016/S0960-9822(07)00534-9; van der Lely HKJ, 2004, COGNITION, V94, P167, DOI 10.1016/j.cognition.2004.01.003; van der Lely HKJ, 2005, TRENDS COGN SCI, V9, P53, DOI 10.1016/j.tics.2004.12.002; VanderLely HKJ, 1996, BRAIN LANG, V52, P484, DOI 10.1006/brln.1996.0026	27	52	52	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1832	10.1371/journal.pone.0001832	http://dx.doi.org/10.1371/journal.pone.0001832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18347740	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000048
J	Hennige, AM; Staiger, H; Wicke, C; Machicao, F; Fritsche, A; Haring, HU; Stefan, N				Hennige, Anita M.; Staiger, Harald; Wicke, Corinna; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Stefan, Norbert			Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ALPHA(2)-HEREMANS-SCHMID GLYCOPROTEIN/FETUIN-A; CORONARY-HEART-DISEASE; BETA-CELL FUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPOSE-TISSUE; HUMAN PREADIPOCYTES; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION	Background: The secreted liver protein fetuin-A (AHSG) is up-regulated in hepatic steatosis and the metabolic syndrome. These states are strongly associated with low-grade inflammation and hypoadiponectinemia. We, therefore, hypothesized that fetuin-A may play a role in the regulation of cytokine expression, the modulation of adipose tissue expression and plasma concentration of the insulin-sensitizing and atheroprotective adipokine adiponectin. Methodology and Principal Findings: Human monocytic THP1 cells and human in vitro differenttiated adipocytes as well as C57BL/6 mice were treated with fetuin-A. mRNA expression of the genes encoding inflammatory cytokines and the adipokine adiponectin (ADIPOQ) was assessed by real-time RT-PCR. In 122 subjects, plasma levels of fetuin-A, adiponectin and, in a subgroup, the multimeric forms of adiponectin were determined. Fetuin-A treatment induced TNF and IL1B mRNA expression in THP1 cells (p<0.05). Treatment of mice with fetuin-A, analogously, resulted in a marked increase in adipose tissue Tnf mRNA as well as Il6 expression (27- and 174-fold, respectively). These effects were accompanied by a decrease in adipose tissue Adipoq mRNA expression and lower circulating adiponectin levels (p< 0.05, both). Furthermore, fetuin-A repressed ADIPOQ mRNA expression of human in vitro differentiated adipocytes (p<0.02) and induced inflammatory cytokine expression. In humans in plasma, fetuin-A correlated positively with high-sensitivity C-reactive protein, a marker of subclinical inflammation (r = 0.26, p = 0.01), and negatively with total- (r = -0.28, p = 0.02) and, particularly, high molecular weight adiponectin (r = -0.36, p = 0.01). Conclusions and Significance: We provide novel evidence that the secreted liver protein fetuin-A induces low-grade inflammation and represses adiponectin production in animals and in humans. These data suggest an important role of fatty liver in the pathophysiology of insulin resistance and atherosclerosis.	[Hennige, Anita M.; Staiger, Harald; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Stefan, Norbert] Univ Tubingen, Dept Internal Med, Div Endocrinol Nephrol Vasc Dis & Clin Chem, D-7400 Tubingen, Germany; [Wicke, Corinna] Univ Tubingen, Dept Gen, Visceral & Transplant Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hennige, AM (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Nephrol Vasc Dis & Clin Chem, D-7400 Tubingen, Germany.	norbert.stefan@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595	Deutsche Forschungsgemeinschaft [KFO 114, HE 3653/3-1]; FP6 EUGENE2 [LSHM-CT-2004-512013]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FP6 EUGENE2	The study was partially supported grants from the Deutsche Forschungsgemeinschaft(KFO 114 and HE 3653/3-1) and the European Community's frame program FP6 EUGENE2 (LSHM-CT-2004-512013). The funders had a limited influence on the design of the study but no influence on the conduct of the study, on the collection, analysis, and interpretation of the data, and on the preparation, review, or approval of the manuscript.	AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; BACHA F, DIABETES CARE, V27, P547; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Dahlman I, 2004, DIABETOLOGIA, V47, P1974, DOI 10.1007/s00125-004-1556-7; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; DZIEGIELEWSKA KM, 1990, J BIOL CHEM, V265, P4354; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Iglseder B, 2005, STROKE, V36, P2577, DOI 10.1161/01.STR.0000190834.00284.fd; Ix JH, 2006, CIRCULATION, V113, P1760, DOI 10.1161/CIRCULATIONAHA.105.588723; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kappes A, 2000, HORM METAB RES, V32, P548, DOI 10.1055/s-2007-978684; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Lam Karen S L, 2005, Curr Diab Rep, V5, P254, DOI 10.1007/s11892-005-0019-y; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lihn AS, 2003, AM J PHYSIOL-ENDOC M, V285, pE1072, DOI 10.1152/ajpendo.00206.2003; Lin X, 1998, LIFE SCI, V63, P145, DOI 10.1016/S0024-3205(98)00250-1; LYLES JM, 1993, J NEUROSCI RES, V34, P273, DOI 10.1002/jnr.490340304; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; Mathews ST, 2000, MOL CELL ENDOCRINOL, V164, P87, DOI 10.1016/S0303-7207(00)00237-9; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Mori K, 2007, CLIN ENDOCRINOL, V66, P246, DOI 10.1111/j.1365-2265.2006.02716.x; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Pollin TI, 2005, DIABETES, V54, P268, DOI 10.2337/diabetes.54.1.268; RAUTH G, 1992, EUR J BIOCHEM, V204, P523, DOI 10.1111/j.1432-1033.1992.tb16663.x; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Rothenbacher D, 2005, EUR HEART J, V26, P1640, DOI 10.1093/eurheartj/ehi340; Ruminy P, 2001, INFLAMM RES, V50, P383, DOI 10.1007/PL00000260; Santoliquido A, 2005, Eur Rev Med Pharmacol Sci, V9, P269; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; SCHMIDT W, 1990, J BIOL CHEM, V265, P15489; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Siddiq A, 2005, DIABETES, V54, P2477, DOI 10.2337/diabetes.54.8.2477; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; VIONNET N, AM J HUM GENET, V67, P1470; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	54	219	225	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1765	10.1371/journal.pone.0001765	http://dx.doi.org/10.1371/journal.pone.0001765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335040	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000019
J	Markman, S; Leitner, S; Catchpole, C; Barnsley, S; Muller, CT; Pascoe, D; Buchanan, KL				Markman, Shai; Leitner, Stefan; Catchpole, Clive; Barnsley, Sara; Mueller, Carsten T.; Pascoe, David; Buchanan, Katherine L.			Pollutants Increase Song Complexity and the Volume of the Brain Area HVC in a Songbird	PLOS ONE			English	Article							SEASONAL PLASTICITY; CHEMICALS; FEMINIZATION; DDT	Environmental pollutants which alter endocrine function are now known to decrease vertebrate reproductive success. There is considerable evidence for endocrine disruption from aquatic ecosystems, but knowledge is lacking with regard to the interface between terrestrial and aquatic ecosystems. Here, we show for the first time that birds foraging on invertebrates contaminated with environmental pollutants, show marked changes in both brain and behaviour. We found that male European starlings (Sturnus vulgaris) exposed to environmentally relevant levels of synthetic and natural estrogen mimics developed longer and more complex songs compared to control males, a sexually selected trait important in attracting females for reproduction. Moreover, females preferred the song of males which had higher pollutant exposure, despite the fact that experimentally dosed males showed reduced immune function. We also show that the key brain area controlling male song complexity (HVC) is significantly enlarged in the contaminated birds. This is the first evidence that environmental pollutants not only affect, but paradoxically enhance a signal of male quality such as song. Our data suggest that female starlings would bias their choice towards exposed males, with possible consequences at the population level. As the starling is a migratory species, our results suggest that transglobal effects of pollutants on terrestrial vertebrate physiology and reproduction could occur in birds.	[Markman, Shai; Barnsley, Sara; Mueller, Carsten T.; Pascoe, David; Buchanan, Katherine L.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Leitner, Stefan; Catchpole, Clive] Univ London, Sch Biol Sci, Egham, Surrey, England; [Leitner, Stefan] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany	Cardiff University; University of London; Royal Holloway University London; Max Planck Society	Markman, S (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	buchanankl1@Cardiff.ac.uk	Müller, Carsten T/A-7114-2010; Buchanan, Kate/A-8178-2012; Leitner, Stefan/D-2129-2012	Müller, Carsten T/0000-0003-0455-7132; Buchanan, Kate/0000-0002-6648-5819; Leitner, Stefan/0000-0002-9482-0362	BBSRC [S18938, C500260]; Biotechnology and Biological Sciences Research Council [S18938] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by BBSRC research grants S18938 and C500260.	Airey DC, 2000, J NEUROBIOL, V44, P1; Andersson Malte, 1994; ARNOLD AP, 1993, BRAIN BEHAV EVOLUT, V42, P231, DOI 10.1159/000114157; Birkett J.W., 2003, ENDOCRINE DISRUPTERS, DOI DOI 10.1016/0015-1882(91)80016-X; Casto JM, 1996, HORM BEHAV, V30, P387, DOI 10.1006/hbeh.1996.0044; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Darwin Charles, 1871, DESCENT MAN; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1850; Desbrow C, 1998, ENVIRON SCI TECHNOL, V32, P1549, DOI 10.1021/es9707973; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Feare C.J., 1984, STARLING; Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025; FRY DM, 1981, SCIENCE, V213, P922, DOI 10.1126/science.7256288; Fusani L, 2006, NEUROSCIENCE, V138, P939, DOI 10.1016/j.neuroscience.2005.08.041; Granbom M, 2005, BEHAV ECOL, V16, P497, DOI 10.1093/beheco/arh137; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Iwaniuk AN, 2006, BEHAV BRAIN RES, V173, P1, DOI 10.1016/j.bbr.2006.05.026; Jarvis Erich D., 2004, P226, DOI 10.1016/B978-012473070-0/50011-6; Jiang JQ, 2005, CHEMOSPHERE, V61, P544, DOI 10.1016/j.chemosphere.2005.02.029; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Learner MA, 1998, J APPL ECOL, V35, P720, DOI 10.1046/j.1365-2664.1998.355342.x; LOCHMILLER RL, 1993, AUK, V110, P503, DOI 10.2307/4088414; Markman S, 2007, CHEMOSPHERE, V70, P119, DOI 10.1016/j.chemosphere.2007.06.045; PARKINSON TJ, 1995, P ROY SOC B-BIOL SCI, V259, P1, DOI 10.1098/rspb.1995.0001; Robinson RA, 2005, BIRD STUDY, V52, P252, DOI 10.1080/00063650509461398; SCHLINGER BA, 1991, P NATL ACAD SCI USA, V88, P4191, DOI 10.1073/pnas.88.10.4191; Schlinger BA, 1997, J NEUROBIOL, V33, P619, DOI 10.1002/(SICI)1097-4695(19971105)33:5<619::AID-NEU9>3.0.CO;2-7; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Soma KK, 2004, J NEUROBIOL, V58, P413, DOI 10.1002/neu.10288; Sower SA, 2000, ENVIRON HEALTH PERSP, V108, P1085; Sumpter J.P., 1996, TOXICOLOGY AQUATIC P, P205, DOI [10.1017/CBO9780511735516.011, DOI 10.1017/CBO9780511735516.011]; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Wikelski M, 2002, NATURE, V417, P607, DOI 10.1038/417607a	34	73	73	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1674	10.1371/journal.pone.0001674	http://dx.doi.org/10.1371/journal.pone.0001674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301751	Green Published, Green Accepted, gold			2022-12-27	WOS:000260586500018
J	Yamahara, K; Sone, M; Itoh, H; Yamashita, JK; Yurugi-Kobayashi, T; Homma, K; Chao, TH; Miyashita, K; Park, K; Oyamada, N; Sawada, N; Taura, D; Fukunaga, Y; Tamura, N; Nakao, K				Yamahara, Kenichi; Sone, Masakatsu; Itoh, Hiroshi; Yamashita, Jun K.; Yurugi-Kobayashi, Takami; Homma, Koichiro; Chao, Ting-Hsing; Miyashita, Kazutoshi; Park, Kwijun; Oyamada, Naofumi; Sawada, Naoya; Taura, Daisuke; Fukunaga, Yasutomo; Tamura, Naohisa; Nakao, Kazuwa			Augmentation of Neovascularizaiton in Hindlimb Ischemia by Combined Transplantation of Human Embryonic Stem Cells-Derived Endothelial and Mural Cells	PLOS ONE			English	Article								Background: We demonstrated that mouse embryonic stem (ES) cells-derived vascular endothelial growth factor receptor-2 (VEGF-R2) positive cells could differentiate into both endothelial cells (EC) and mural cells (MC), and termed them as vascular progenitor cells (VPC). Recently, we have established a method to expand monkey and human ES cells-derived VPC with the proper differentiation stage in a large quantity. Here we investigated the therapeutic potential of human VPC-derived EC and MC for vascular regeneration. Methods and Results: After the expansion of human VPC-derived vascular cells, we transplanted these cells to nude mice with hindlimb ischemia. The blood flow recovery and capillary density in ischemic hindlimbs were significantly improved in human VPC-derived EC-transplanted mice, compared to human peripheral and umbilical cord blood-derived endothelial progenitor cells (pEPC and uEPC) transplanted mice. The combined transplantation of human VPC-derived EC and MC synergistically improved blood flow of ischemic hindlimbs remarkably, compared to the single cell transplantations. Transplanted VPC-derived vascular cells were effectively incorporated into host circulating vessels as EC and MC to maintain long-term vascular integrity. Conclusions: Our findings suggest that the combined transplantation of human ES cells-derived EC and MC can be used as a new promising strategy for therapeutic vascular regeneration in patients with tissue ischemia.	[Yamahara, Kenichi; Sone, Masakatsu; Itoh, Hiroshi; Miyashita, Kazutoshi; Park, Kwijun; Oyamada, Naofumi; Sawada, Naoya; Taura, Daisuke; Fukunaga, Yasutomo; Tamura, Naohisa; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Itoh, Hiroshi; Homma, Koichiro; Miyashita, Kazutoshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Yamashita, Jun K.; Yurugi-Kobayashi, Takami] Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr, Lab Stem Cell Differentiation, Kyoto, Japan; [Chao, Ting-Hsing] Natl Cheng Kung Univ, Med Ctr, Dept Internal Med, Div Cardiol, Tainan, Taiwan	Kyoto University; Keio University; Kyoto University; National Cheng Kung University	Yamahara, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan.	hrith@sc.itc.keio.ac.jp	Homma, Koichiro/J-3146-2015	Miyashita, Kazutoshi/0000-0003-3757-4334	Japanese Ministry of Education, Culture, Sports, Science and Technology [grant-in-aid]; 21st COE Program for Integration of Transplantation Therapy and Regenerative Medicine, Japan Society for the Promotion of Science; Japan Foundation for Aging and Health	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st COE Program for Integration of Transplantation Therapy and Regenerative Medicine, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Aging and Health	This work is supported by a grant-in-aid for scientific research (the Japanese Ministry of Education, Culture, Sports, Science and Technology), a research grant from them 21st COE Program for Integration of Transplantation Therapy and Regenerative Medicine (Japan Society for the Promotion of Science), a research grant from the Project for Development of Regenerative Medicine (the Japanese Ministry of Education, Culture, Sports, Science and Technology), and a research grant from the Japan Foundation for Aging and Health (the Japanese Ministry of Health, Labor and Welfare).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; FINA L, 1990, BLOOD, V75, P2417; FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O; Fukino K, 2003, BIOCHEM BIOPH RES CO, V310, P143, DOI 10.1016/j.bbrc.2003.08.134; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kato H, 2003, CANCER SCI, V94, P1059, DOI 10.1111/j.1349-7006.2003.tb01401.x; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Miwa Y, 2000, MOL PHARMACOL, V58, P837, DOI 10.1124/mol.58.4.837; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; SAKATA N, 1990, EXP MOL PATHOL, V52, P179, DOI 10.1016/0014-4800(90)90003-V; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Sone M, 2003, CIRCULATION, V107, P2085, DOI 10.1161/01.CIR.0000070022.78747.1B; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yurugi-Kobayashi T, 2003, BLOOD, V101, P2675, DOI 10.1182/blood-2002-06-1877	24	81	92	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1666	10.1371/journal.pone.0001666	http://dx.doi.org/10.1371/journal.pone.0001666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301744	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586500011
J	Cottingham, MG; Andersen, RF; Spencer, AJ; Saurya, S; Furze, J; Hill, AVS; Gilbert, SC				Cottingham, Matthew G.; Andersen, Rikke F.; Spencer, Alexandra J.; Saurya, Saroj; Furze, Julie; Hill, Adrian V. S.; Gilbert, Sarah C.			Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; STEROID-HORMONE SYNTHESIS; CELL IMMUNE-RESPONSES; HOST-RANGE SELECTION; MEMORY T-CELLS; SMALLPOX VACCINATION; ESCHERICHIA-COLI; GENOMIC SEQUENCE; MALARIA VACCINES; FOWLPOX VIRUS	The production, manipulation and rescue of a bacterial artificial chromosome clone of Vaccinia virus (VAC-BAC) in order to expedite construction of expression vectors and mutagenesis of the genome has been described (Domi & Moss, 2002, PNAS 99 12415-20). The genomic BAC clone was 'rescued' back to infectious virus using a Fowlpox virus helper to supply transcriptional machinery. We apply here a similar approach to the attenuated strain Modified Vaccinia virus Ankara (MVA), now widely used as a safe non-replicating recombinant vaccine vector in mammals, including humans. Four apparently full-length, rescuable clones were obtained, which had indistinguishable immunogenicity in mice. One clone was shotgun sequenced and found to be identical to the parent. We employed GalK recombination-mediated genetic engineering (recombineering) of MVA-BAC to delete five selected viral genes. Deletion of C12L, A44L, A46R or B7R did not significantly affect CD8(+) T cell immunogenicity in BALB/c mice, but deletion of B15R enhanced specific CD8(+) T cell responses to one of two endogenous viral epitopes (from the E2 and F2 proteins), in accordance with published work (Staib et al., 2005, J. Gen. Virol. 86, 1997-2006). In addition, we found a higher frequency of triple-positive IFN-gamma, TNF-alpha and IL-2 secreting E3-specific CD8(+) T-cells 8 weeks after vaccination with MVA lacking B15R. Furthermore, a recombinant vaccine capable of inducing CD8(+) T cells against an epitope from Plasmodium berghei was created using GalK counterselection to insert an antigen expression cassette lacking a tandem marker gene into the traditional thymidine kinase locus of MVA-BAC. MVA continues to feature prominently in clinical trials of recombinant vaccines against diseases such as HIV-AIDS, malaria and tuberculosis. Here we demonstrate in proof-of-concept experiments that MVA-BAC recombineering is a viable route to more rapid and efficient generation of new candidate mutant and recombinant vaccines based on a clinically deployable viral vector.	[Cottingham, Matthew G.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Jenner Institute	Cottingham, MG (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	matt.cottingham@well.ox.ac.uk	Andersen, Rikke/GRS-3064-2022; Gilbert, Sarah C./H-2857-2019; Balasubramanian, Madhan/E-7255-2010; Cottingham, Matthew/F-1218-2011; Spencer, Alexandra/AAE-6494-2019	Gilbert, Sarah C./0000-0002-6823-9750; Spencer, Alexandra/0000-0001-7958-6961; Andersen, Rikke Fredslund/0000-0002-5894-7745; Cottingham, Matthew/0000-0003-0766-6465	Wellcome Trust; Foundation for the National Institutes of Health [Grand Challenges in Global Health]	Wellcome Trust(Wellcome TrustEuropean Commission); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by the Wellcome Trust and a Grand Challenges in Global Health grant from the Foundation for the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaitua F, 2006, VIRUS RES, V116, P11, DOI 10.1016/j.virusres.2005.08.008; Alcami A, 1999, J GEN VIROL, V80, P949, DOI 10.1099/0022-1317-80-4-949; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Anderson RJ, 2004, J IMMUNOL, V172, P3094, DOI 10.4049/jimmunol.172.5.3094; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Chavan R, 2006, J VIROL, V80, P7676, DOI 10.1128/JVI.02748-05; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Cosma A, 2007, AIDS RES HUM RETROV, V23, P782, DOI 10.1089/aid.2006.0226; Cottingham MG, 2006, CLIN VACCINE IMMUNOL, V13, P747, DOI 10.1128/CVI.00088-06; Coupar BEH, 2000, J GEN VIROL, V81, P431, DOI 10.1099/0022-1317-81-2-431; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Domi A, 2005, NAT METHODS, V2, P95, DOI 10.1038/NMETH734; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Froggatt GC, 2007, J GEN VIROL, V88, P1917, DOI 10.1099/vir.0.82815-0; Garnett CT, 2006, CURR PHARM DESIGN, V12, P351, DOI 10.2174/138161206775201929; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Gomez CE, 2001, VACCINE, V20, P961, DOI 10.1016/S0264-410X(01)00389-9; Haga IR, 2005, PARASITOLOGY, V130, pS11, DOI 10.1017/S0031182005008127; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hirsch VM, 1996, J VIROL, V70, P3741, DOI 10.1128/JVI.70.6.3741-3752.1996; Jarmin SA, 2006, J GEN VIROL, V87, P3545, DOI 10.1099/vir.0.82373-0; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kent S, 2007, CURR OPIN INVEST DR, V8, P159; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kong YP, 1999, J VIROL METHODS, V80, P129, DOI 10.1016/S0166-0934(99)00033-6; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Kudo-Saito C, 2006, VACCINE, V24, P4975, DOI 10.1016/j.vaccine.2006.03.042; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Mayr A, 2003, COMP IMMUNOL MICROB, V26, P423, DOI 10.1016/S0147-9571(03)00025-0; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; MERCHLINSKY M, 1989, J VIROL, V63, P1595, DOI 10.1128/JVI.63.4.1595-1603.1989; MOORE JB, 1992, EMBO J, V11, P1973, DOI 10.1002/j.1460-2075.1992.tb05251.x; Okeke MI, 2006, J GEN VIROL, V87, P21, DOI 10.1099/vir.0.81479-0; Perera LP, 2007, J VIROL, V81, P8774, DOI 10.1128/JVI.00538-07; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J EXP MED, V197, P1269, DOI 10.1084/jem.20022201; Reyes-Sandoval A, 2004, J VIROL, V78, P7392, DOI 10.1128/JVI.78.14.7392-7399.2004; Reyes-Sandoval A, 2007, IMMUNOLOGY, V121, P158, DOI 10.1111/j.1365-2567.2006.02552.x; ROMERO P, 1990, IMMUNOL LETT, V25, P27, DOI 10.1016/0165-2478(90)90086-6; Roper RL, 2006, J VIROL, V80, P306, DOI 10.1128/JVI.80.1.306-313.2006; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Semprini S, 2007, NUCLEIC ACIDS RES, V35, P1402, DOI 10.1093/nar/gkl1108; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SMITH GL, 1983, P NATL ACAD SCI-BIOL, V80, P7155, DOI 10.1073/pnas.80.23.7155; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Staib C, 2000, BIOTECHNIQUES, V28, P1137, DOI 10.2144/00286st04; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; Staib C, 2003, BIOTECHNIQUES, V34, P694, DOI 10.2144/03344bm02; SUTTER G, 1994, VACCINE, V12, P1032, DOI 10.1016/0264-410X(94)90341-7; Symons JA, 2002, J GEN VIROL, V83, P1953, DOI 10.1099/0022-1317-83-8-1953; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Webb LMC, 2005, MINI-REV MED CHEM, V5, P833, DOI 10.2174/1389557054867110; Wyatt LS, 1998, VIROLOGY, V251, P334, DOI 10.1006/viro.1998.9397; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	74	74	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1638	10.1371/journal.pone.0001638	http://dx.doi.org/10.1371/journal.pone.0001638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286194	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400031
J	Gerstner, JR; Bremer, QZ; Vander Heyden, WM; LaVaute, TM; Yin, JC; Landry, CF				Gerstner, Jason R.; Bremer, Quentin Z.; Vander Heyden, William M.; LaVaute, Timothy M.; Yin, Jerry C.; Landry, Charles F.			Brain Fatty Acid Binding Protein (Fabp7) Is Diurnally Regulated in Astrocytes and Hippocampal Granule Cell Precursors in Adult Rodent Brain	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GENE-EXPRESSION; MESSENGER-RNA; COCAINE SENSITIZATION; NEURONAL-ACTIVITY; LIPID-METABOLISM; CIRCADIAN GENES; AMIDE HYDROLASE; CLOCK GENE; SLEEP	Brain fatty acid binding protein (Fabp7), which is important in early nervous system development, is expressed in astrocytes and neuronal cell precursors in mature brain. We report here that levels of Fabp7 mRNA in adult murine brain change over a 24 hour period. Unlike Fabp5, a fatty acid binding protein that is expressed widely in various cell types within brain, RNA analysis revealed that Fabp7 mRNA levels were elevated during the light period and lower during dark in brain regions involved in sleep and activity mechanisms. This pattern of Fabp7 mRNA expression was confirmed using in situ hybridization and found to occur throughout the entire brain. Changes in the intracellular distribution of Fabp7 mRNA were also evident over a 24 hour period. Diurnal changes in Fabp7, however, were not found in postnatal day 6 brain, when astrocytes are not yet mature. In contrast, granule cell precursors of the subgranular zone of adult hippocampus did undergo diurnal changes in Fabp7 expression. These changes paralleled oscillations in Fabp7 mRNA throughout the brain suggesting that cell-coordinated signals likely control brain-wide Fabp7 mRNA expression. Immunoblots revealed that Fabp7 protein levels also underwent diurnal changes in abundance, with peak levels occurring in the dark period. Of clock or clock-regulated genes, the synchronized, global cycling pattern of Fabp7 expression is unique and implicates glial cells in the response or modulation of activity and/or circadian rhythms.	[Gerstner, Jason R.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Gerstner, Jason R.; Yin, Jerry C.] Univ Wisconsin, Dept Genet, Madison, WI USA; [Gerstner, Jason R.; Bremer, Quentin Z.; Vander Heyden, William M.; LaVaute, Timothy M.; Landry, Charles F.] Univ Wisconsin, Dept Psychiat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gerstner, JR (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	clandry@wisc.edu	Gerstner, Jason/J-3778-2013	Gerstner, Jason/0000-0003-3113-6974	National Institutes of Health [5 P50 CA084724-04, DA19153]; NATIONAL CANCER INSTITUTE [P50CA084724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grant 5 P50 CA084724-04 (JRG) and DA19153 (CFL).	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Adida A, 2006, BBA-MOL CELL BIOL L, V1761, P172, DOI 10.1016/j.bbalip.2006.02.006; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BENNETT E, 1994, J NEUROCHEM, V63, P1616; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Bisogno T, 2002, CURR PHARM DESIGN, V8, P533, DOI 10.2174/1381612023395655; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Chen C, 2005, PROSTAG OTH LIPID M, V77, P65, DOI 10.1016/j.prostaglandins.2005.07.001; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; de Mendonca A, 2002, BRAIN RES, V932, P56, DOI 10.1016/S0006-8993(02)02281-3; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gerstner JR, 2006, NEUROSCIENCE, V139, P1435, DOI 10.1016/j.neuroscience.2006.01.020; Gerstner JR, 2007, DEV NEUROSCI-BASEL, V29, P203, DOI 10.1159/000096389; Gerstner JR, 2007, NEUROCHEM RES, V32, P241, DOI 10.1007/s11064-006-9271-z; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; GLATZ JFC, 1984, J BIOL CHEM, V259, P4295; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Huang ZL, 2007, CURR OPIN PHARMACOL, V7, P33, DOI 10.1016/j.coph.2006.09.004; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; HUYNH HT, 1995, CANCER RES, V55, P2225; Inoue I, 2005, J ATHEROSCLER THROMB, V12, P169, DOI 10.5551/jat.12.169; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; KHAN SH, 1994, P NATL ACAD SCI USA, V91, P848, DOI 10.1073/pnas.91.3.848; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; Liu Y, 2000, BRAIN RES, V852, P16, DOI 10.1016/S0006-8993(99)02158-7; Liu Y, 1997, J NEUROSCI RES, V48, P551, DOI 10.1002/(SICI)1097-4547(19970615)48:6<551::AID-JNR8>3.0.CO;2-9; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Murillo-Rodriguez E, 2007, EUR J PHARMACOL, V562, P82, DOI 10.1016/j.ejphar.2007.01.076; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Prinsen CFM, 1998, BIOCHEM J, V329, P265; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Qi KM, 2002, CURR OPIN CLIN NUTR, V5, P133, DOI 10.1097/00075197-200203000-00003; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schiltz CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-16; Shieh KR, 2005, J BIOMED SCI, V12, P209, DOI 10.1007/s11373-004-8176-6; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Straub SV, 2007, TRENDS CARDIOVAS MED, V17, P183, DOI 10.1016/j.tcm.2007.05.001; Suri V, 2000, J NEUROSCI, V20, P7547; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tang MK, 2004, CELL TISSUE RES, V316, P339, DOI 10.1007/s00441-004-0881-y; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; Veerkamp JH, 2001, J MOL NEUROSCI, V16, P133, DOI 10.1385/JMN:16:2-3:133; Wenger T, 2002, PROSTAG LEUKOTR ESS, V66, P301, DOI 10.1054/plef.2001.0353; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yan LL, 2000, J NEUROSCI RES, V59, P291, DOI 10.1002/(SICI)1097-4547(20000115)59:2<291::AID-JNR16>3.0.CO;2-O	72	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1631	10.1371/journal.pone.0001631	http://dx.doi.org/10.1371/journal.pone.0001631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286188	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400024
J	Landi, MT; Dracheva, T; Rotunno, M; Figueroa, JD; Liu, H; Dasgupta, A; Mann, FE; Fukuoka, J; Hames, M; Bergen, AW; Murphy, SE; Yang, P; Pesatori, AC; Consonni, D; Bertazzi, PA; Wacholder, S; Shih, JH; Caporaso, NE; Jen, J				Landi, Maria Teresa; Dracheva, Tatiana; Rotunno, Melissa; Figueroa, Jonine D.; Liu, Huaitian; Dasgupta, Abhijit; Mann, Felecia E.; Fukuoka, Junya; Hames, Megan; Bergen, Andrew W.; Murphy, Sharon E.; Yang, Ping; Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto; Wacholder, Sholom; Shih, Joanna H.; Caporaso, Neil E.; Jen, Jin			Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival	PLOS ONE			English	Article								Background: Tobacco smoking is responsible for over 90% of lung cancer cases, and yet the precise molecular alterations induced by smoking in lung that develop into cancer and impact survival have remained obscure. Methodology/Principal Findings: We performed gene expression analysis using HG-U133A Affymetrix chips on 135 fresh frozen tissue samples of adenocarcinoma and paired noninvolved lung tissue from current, former and never smokers, with biochemically validated smoking information. ANOVA analysis adjusted for potential confounders, multiple testing procedure, Gene Set Enrichment Analysis, and GO-functional classification were conducted for gene selection. Results were confirmed in independent adenocarcinoma and non-tumor tissues from two studies. We identified a gene expression signature characteristic of smoking that includes cell cycle genes, particularly those involved in the mitotic spindle formation (e. g., NEK2, TTK, PRC1). Expression of these genes strongly differentiated both smokers from non-smokers in lung tumors and early stage tumor tissue from non-tumor tissue (p<0.001 and fold-change >1.5, for each comparison), consistent with an important role for this pathway in lung carcinogenesis induced by smoking. These changes persisted many years after smoking cessation. NEK2 (p<0.001) and TTK (p = 0.002) expression in the noninvolved lung tissue was also associated with a 3-fold increased risk of mortality from lung adenocarcinoma in smokers. Conclusions/Significance: Our work provides insight into the smoking-related mechanisms of lung neoplasia, and shows that the very mitotic genes known to be involved in cancer development are induced by smoking and affect survival. These genes are candidate targets for chemoprevention and treatment of lung cancer in smokers.	[Landi, Maria Teresa; Rotunno, Melissa; Figueroa, Jonine D.; Dasgupta, Abhijit; Bergen, Andrew W.; Wacholder, Sholom; Caporaso, Neil E.] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Dracheva, Tatiana; Mann, Felecia E.; Fukuoka, Junya; Hames, Megan; Jen, Jin] NCI, Ctr Canc Res, NIH, DHHS, Bethesda, MD USA; [Figueroa, Jonine D.] NIH, NCI, Canc Prevent Fellowship, DHHS, Bethesda, MD USA; [Liu, Huaitian; Shih, Joanna H.] NCI, Div Canc Treatment & Diagnosis, NIH, DHHS, Bethesda, MD USA; [Murphy, Sharon E.] Univ Minnesota, Canc Ctr, Minneapolis, MN USA; [Yang, Ping] Mayo Clin, Dept Hlth Sci, Rochester, MN USA; [Pesatori, Angela C.; Consonni, Dario; Bertazzi, Pier Alberto] Univ Milan, Fdn OM Policlin, Milan, Italy	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Milan	Landi, MT (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA.	landim@mail.nih.gov	Fukuoka, Junya/AAT-2924-2021; Dasgupta, Abhijit/W-7750-2019; Figueroa, Jonine/GWD-1322-2022; Consonni, Dario/AAM-2947-2020; Figueroa, Jonine/AAG-1065-2022; bertazzi, pietro alberto/D-5039-2017; Figueroa, Jonine/AFK-2752-2022; Dasgupta, Abhijit/J-6400-2014; pesatori, angela/K-5742-2016	Dasgupta, Abhijit/0000-0001-6062-9896; Figueroa, Jonine/0000-0002-5100-623X; Consonni, Dario/0000-0002-8935-3843; Figueroa, Jonine/0000-0002-5100-623X; bertazzi, pietro alberto/0000-0003-3475-2449; Figueroa, Jonine/0000-0002-5100-623X; Dasgupta, Abhijit/0000-0002-1388-4779; Fukuoka, Junya/0000-0002-2496-3050; Bergen, Andrew/0000-0002-1237-7644; pesatori, angela/0000-0002-0261-3252	Intramural Research Program, NIH; National Cancer Institute, Division of Cancer Epidemiology and Genetics [NIH-R01-84354, Cancer Prevention Fellowship]; Center for Cancer Research; NATIONAL CANCER INSTITUTE [Z01CP010163] Funding Source: NIH RePORTER	Intramural Research Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of NIH, National Cancer Institute, Division of Cancer Epidemiology and Genetics and the Center for Cancer Research, and from the NIH-R01-84354 grant to P.Y. J.F. was supported by the Cancer Prevention Fellowship Program, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baonza A, 2002, NAT CELL BIOL, V4, P976, DOI 10.1038/ncb887; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borczuk Alain C, 2007, Proc Am Thorac Soc, V4, P127, DOI 10.1513/pats.200607-143JG; Bryant A, 2007, CHEST, V132, P185, DOI 10.1378/chest.07-0442; COX DR, 1972, J R STAT SOC B, V34, P187; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hecht SS, 1999, CANCER RES, V59, P590; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lampe JW, 2004, CANCER EPIDEM BIOMAR, V13, P445; Lerman MI, 2000, CANCER RES, V60, P6116; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Miura K, 2002, CANCER RES, V62, P3244; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Petersen S, 2000, BRIT J CANCER, V82, P65; Powell CA, 2003, AM J RESP CELL MOL, V29, P157, DOI 10.1165/rcmb.2002-0183RC; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wistuba II, 2000, CANCER RES, V60, P1949; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	30	487	505	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1651	10.1371/journal.pone.0001651	http://dx.doi.org/10.1371/journal.pone.0001651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18297132	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400044
J	Uttl, B				Uttl, Bob			Transparent Meta-Analysis of Prospective Memory and Aging	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; RETROSPECTIVE MEMORY; TASK COMPLEXITY; REMEMBERING INTENTIONS; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; OLDER-ADULTS; PERFORMANCE; YOUNGER; RETRIEVAL	Prospective memory (ProM) refers to our ability to become aware of a previously formed plan at the right time and place. After two decades of research on prospective memory and aging, narrative reviews and summaries have arrived at widely different conclusions. One view is that prospective memory shows large age declines, larger than age declines on retrospective memory (RetM). Another view is that prospective memory is an exception to age declines and remains invariant across the adult lifespan. The present meta-analysis of over twenty years of research settles this controversy. It shows that prospective memory declines with aging and that the magnitude of age decline varies by prospective memory subdomain (vigilance, prospective memory proper, habitual prospective memory) as well as test setting (laboratory, natural). Moreover, this meta-analysis demonstrates that previous claims of no age declines in prospective memory are artifacts of methodological and conceptual issues afflicting prior research including widespread ceiling effects, low statistical power, age confounds, and failure to distinguish between various subdomains of prospective memory (e. g., vigilance and prospective memory proper).			Uttl, B (corresponding author), Red Deer Coll, Red Deer, AB, Canada.	uttlbob@gmail.com	Sools, Anneke/B-1392-2012		Center of Excellence, Tamagawa University, Tokyo, Japan	Center of Excellence, Tamagawa University, Tokyo, Japan	The research was supported in part by Center of Excellence, Tamagawa University, Tokyo, Japan, where Bob Uttl was Center of Excellence Professor. There was no role of any sponsors in the design, data collection, analysis, interpretation, etc. of the study.	Bastin C., 2002, CURRENT PSYCHOL LETT, V7, P105; BIRT AR, 2003, PROQUEST INFORM LEAR; CECI SJ, 1985, CHILD DEV, V56, P152, DOI 10.2307/1130182; Cherry KE, 1999, PSYCHOL AGING, V14, P60, DOI 10.1037/0882-7974.14.1.60; Cherry KE, 2003, ADV PSY RES, V25, P49; Cherry KE, 2004, ADV PSY RES, V31, P63; Cherry KE, 2001, MEMORY, V9, P177, DOI 10.1080/09658210143000092; COCKBURN J, 1994, BRIT J PSYCHOL, V85, P273, DOI 10.1111/j.2044-8295.1994.tb02523.x; Cohen AL, 2003, CAN J EXP PSYCHOL, V57, P274, DOI 10.1037/h0087431; Cohen AL, 2001, AGING NEUROPSYCHOL C, V8, P1, DOI 10.1076/anec.8.1.1.845; Costermans J, 1999, CAH PSYCHOL COGN, V18, P289; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; Craik FIM, 2006, MEM COGNITION, V34, P1236, DOI 10.3758/BF03193268; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; Crowder RG., 1996, PROSPECTIVE MEMORY T, P143; Cuttler C, 2007, SCAND J PSYCHOL, V48, P215, DOI 10.1111/j.1467-9450.2007.00570.x; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; d'Ydewalle G, 1999, EUR J COGN PSYCHOL, V11, P219, DOI 10.1080/713752309; Davidson A.C., 1997, BOOTSTRAP METHODS TH; Deeks JJ, 2002, STAT MED, V21, P1575, DOI 10.1002/sim.1188; Delbello R., 2001, PSICOLOGICA, V22, P97, DOI DOI 10.5334/pb-52-2-3-205; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; DiCiccio TJ, 1996, STAT SCI, V11, P189; DOBBS AR, 1987, CAN J PSYCHOL, V41, P209, DOI 10.1037/h0084152; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; dYdewalle G, 1995, PSYCHOL BELG, V35, P189; dYdewalle G, 1996, CONTEMPORARY PSYCHOLOGY IN EUROPE, P161; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Einstein G. O., 1996, PROSPECTIVE MEMORY T, P115; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Einstein GO, 1998, PSYCHOL SCI, V9, P284, DOI 10.1111/1467-9280.00056; Einstein GO, 2000, PSYCHOL AGING, V15, P671, DOI 10.1037//0882-7974.15.4.671; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; GRAF P, 2002, PRO RETROSPECTIVE ME, P257; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Hedges LV, 2014, STAT METHODS META AN; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hunter J.E., 2004, METHODS META ANAL CO; Huppert FA, 2000, APPL COGNITIVE PSYCH, V14, pS63, DOI 10.1002/acp.771; Kelemen WL, 2006, PSYCHON B REV, V13, P1028, DOI 10.3758/BF03213920; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2003, INT J PSYCHOL, V38, P207, DOI 10.1080/00207590344000132; Kvavilashvili L, 1998, APPL COGNITIVE PSYCH, V12, P533, DOI 10.1002/(SICI)1099-0720(1998120)12:6<533::AID-ACP538>3.0.CO;2-1; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; LAVOIE D, 1994, PSYCHOL AGING, V9, P539, DOI 10.1037/0882-7974.9.4.539; LEVY RL, 1980, J BEHAV THER EXP PSY, V11, P105, DOI 10.1016/0005-7916(80)90005-1; Logie R, 2004, EUR J COGN PSYCHOL, V16, P441, DOI 10.1080/09541440340000114; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MANTYLA T, 1994, J GERONTOL, V49, pP276, DOI 10.1093/geronj/49.6.P276; Mantyla T, 1993, Memory, V1, P203, DOI 10.1080/09658219308258233; Mantyla T, 1997, AGING NEUROPSYCHOL C, V4, P81, DOI 10.1080/13825589708256638; Marsh RL, 2002, MEM COGNITION, V30, P302, DOI 10.3758/BF03195291; MARTIN M, 1986, HUM LEARN, V5, P63; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Martin M, 2001, INT J BEHAV DEV, V25, P386, DOI 10.1080/01650250042000302; Maylor EA, 1998, AGING NEUROPSYCHOL C, V5, P107, DOI 10.1076/anec.5.2.107.599; MAYLOR EA, 1993, PSYCHOL AGING, V8, P420, DOI 10.1037/0882-7974.8.3.420; Maylor EA, 1996, PSYCHOL AGING, V11, P74, DOI 10.1037/0882-7974.11.1.74; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; MCDANIEL M, 2007, PROSPECTIVE MEMORY C, P141; McDaniel M. A., 2007, PROSPECTIVE MEMORY; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2003, PSYCHOL AGING, V18, P823, DOI 10.1037/0882-7974.18.4.823; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDermott K, 2004, APPL COGNITIVE PSYCH, V18, P349, DOI 10.1002/acp.977; Meacham J. A., 1982, MEMORY OBSERVED REME, P327; Moscovitch M., 1982, AGING COGNITIVE PROC, P55; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; PATTON GW, 1993, EXP AGING RES, V19, P165, DOI 10.1080/03610739308253929; Reese CM, 2002, AGING NEUROPSYCHOL C, V9, P98, DOI 10.1076/anec.9.2.98.9546; Rendell P. G., 1993, AUSTRALAS J AGEING, V12, P11, DOI [DOI 10.1111/J.1741-6612.1993.TB00578.X, 10.1111/J.1741-6612.1993.TB00578.X]; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Roediger H. L., 1996, PROSPECTIVE MEMORY T, P149; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Shapiro S, 1999, J EXP PSYCHOL-APPL, V5, P169, DOI 10.1037/1076-898X.5.2.169; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; Taylor RS, 2004, MEMORY, V12, P203, DOI 10.1080/09658210244000559; TOMBAUGH TN, 1995, CLIN NEUROPSYCHOL, V9, P135, DOI 10.1080/13854049508401595; Uttl B, 2006, AGING NEUROPSYCHOL C, V13, P141, DOI 10.1080/138255890969618; Uttl B, 2005, PSYCHOL SCI, V16, P460; Uttl B, 2003, PSYCHOL AGING, V18, P616, DOI 10.1037/0882-7974.18.3.616; Uttl B, 2002, J CLIN EXP NEUROPSYC, V24, P1123, DOI 10.1076/jcen.24.8.1123.8375; Uttl B, 2001, CONSCIOUS COGN, V10, P451, DOI 10.1006/ccog.2001.0505; Vogels WWA, 2002, BRAIN COGNITION, V49, P341, DOI 10.1006/brcg.2001.1504; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; West R, 1999, PSYCHOL AGING, V14, P264, DOI 10.1037/0882-7974.14.2.264; West R, 2003, PSYCHOL AGING, V18, P461, DOI 10.1037/0882-7974.18.3.461; West R, 2001, NEUROREPORT, V12, P2855, DOI 10.1097/00001756-200109170-00020; West R, 2001, PSYCHOL AGING, V16, P682, DOI 10.1037//0882-7974.16.4.682; West R., 1988, PRACTICAL ASPECTS ME, V2, P119; WEST RL, 1988, J GERONTOL B-PSYCHOL, P119; Zimmermann TD, 2006, Q J EXP PSYCHOL, V59, P2040, DOI 10.1080/17470210600917835	106	83	85	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1568	10.1371/journal.pone.0001568	http://dx.doi.org/10.1371/journal.pone.0001568			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XR	18286167	Green Published, gold, Green Submitted			2022-12-27	WOS:000260586400001
J	Spor, A; Wang, S; Dillmann, C; de Vienne, D; Sicard, D				Spor, Ayme; Wang, Shaoxiao; Dillmann, Christine; de Vienne, Dominique; Sicard, Delphine			"Ant'' and "Grasshopper'' Life-History Strategies in Saccharomyces cerevisiae	PLOS ONE			English	Article							TRADE-OFF; CELL-SIZE; EXPERIMENTAL POPULATIONS; PHENOTYPIC PLASTICITY; NATURAL-SELECTION; K-SELECTION; R-SELECTION; GROWTH-RATE; GLUCOSE; ACCUMULATION	From the evolutionary and ecological points of view, it is essential to distinguish between the genetic and environmental components of the variability of life-history traits and of their trade-offs. Among the factors affecting this variability, the resource uptake rate deserves particular attention, because it depends on both the environment and the genetic background of the individuals. In order to unravel the bases of the life-history strategies in yeast, we grew a collection of twelve strains of Saccharomyces cerevisiae from different industrial and geographical origins in three culture media differing for their glucose content. Using a population dynamics model to fit the change of population size over time, we estimated the intrinsic growth rate (r), the carrying capacity (K), the mean cell size and the glucose consumption rate per cell. The life-history traits, as well as the glucose consumption rate, displayed large genetic and plastic variability and genetic-by-environment interactions. Within each medium, growth rate and carrying capacity were not correlated, but a marked trade-off between these traits was observed over the media, with high K and low r in the glucose rich medium and low K and high r in the other media. The cell size was tightly negatively correlated to carrying capacity in all conditions. The resource consumption rate appeared to be a clear-cut determinant of both the carrying capacity and the cell size in all media, since it accounted for 37% to 84% of the variation of those traits. In a given medium, the strains that consume glucose at high rate have large cell size and low carrying capacity, while the strains that consume glucose at low rate have small cell size but high carrying capacity. These two contrasted behaviors may be metaphorically defined as "ant'' and "grasshopper'' strategies of resource utilization. Interestingly, a strain may be "ant'' in one medium and "grasshopper'' in another. These life-history strategies are discussed with regards to yeast physiology, and in an evolutionary perspective.	[Spor, Ayme; Wang, Shaoxiao; Dillmann, Christine; de Vienne, Dominique; Sicard, Delphine] Univ Paris 11, INRA, CNRS, UMR Genet Vegetale,AgroParisTech, Gif Sur Yvette, France; [Wang, Shaoxiao] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA USA	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Spor, A (corresponding author), Univ Paris 11, INRA, CNRS, UMR Genet Vegetale,AgroParisTech, Gif Sur Yvette, France.	spor@moulon.inra.fr	wang, shaoxiao/N-7126-2013; Spor, Aymé/A-6271-2012	wang, shaoxiao/0000-0002-0195-6210; Spor, Aymé/0000-0002-4707-9559; Dillmann, Christine/0000-0002-9025-341X	French Agence Nationale de la Recherche [NT05-4_45721]; Ministere de lEnseignement Superieur et de la Recherche [PhD fellowship]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de lEnseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by the French Agence Nationale de la Recherche (ANR Project ADAPTALEVURE n NT05-4_45721) and a PhD fellowship of the Ministere de lEnseignement Superieur et de la Recherche to AS.	Azumi M, 2001, YEAST, V18, P1145, DOI 10.1002/yea.767; Ben-Ari G, 2005, HEREDITY, V95, P493, DOI 10.1038/sj.hdy.6800759; Blionis GJ, 2005, PLANT ECOL, V178, P77, DOI 10.1007/s11258-004-2495-6; Borderia AV, 2002, INFECT GENET EVOL, V2, P137, DOI 10.1016/S1567-1348(02)00094-1; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; CVRCKOVA F, 1993, EMBO J, V12, P5277, DOI 10.1002/j.1460-2075.1993.tb06223.x; DAMORE T, 1988, APPL ENVIRON MICROB, V54, P110, DOI 10.1128/AEM.54.1.110-114.1988; de Jong G, 2005, NEW PHYTOL, V166, P101, DOI 10.1111/j.1469-8137.2005.01322.x; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; del Monte-Luna P, 2004, GLOBAL ECOL BIOGEOGR, V13, P485, DOI 10.1111/j.1466-822X.2004.00131.x; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Dihazi H, 2003, BIOCHEMISTRY-US, V42, P6275, DOI 10.1021/bi034167r; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fisher RA, 1930, GENETICAL THEORY NAT; Flick K, 1998, MOL CELL BIOL, V18, P2492, DOI 10.1128/MCB.18.5.2492; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Goncalves P, 1998, TRENDS MICROBIOL, V6, P314, DOI 10.1016/S0966-842X(98)01305-5; James J., 1974, AUST J BIOL SCI, V27, P99; Koots KR, 1996, GENETICS, V143, P1409; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; LUCKINBILL LS, 1984, ECOLOGY, V65, P1170, DOI 10.2307/1938325; LUCKINBILL LS, 1978, ECOLOGY, V59, P1271, DOI 10.2307/1938241; MAC ARTHUR ROBERT H., 1967; MacLean RC, 2008, HEREDITY, V100, P233, DOI 10.1038/sj.hdy.6801073; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Mueller LD, 1997, ANNU REV ECOL SYST, V28, P269, DOI 10.1146/annurev.ecolsys.28.1.269; MUELLER LD, 1991, SCIENCE, V253, P433, DOI 10.1126/science.1907401; MUELLER LD, 1981, P NATL ACAD SCI-BIOL, V78, P1303, DOI 10.1073/pnas.78.2.1303; MUELLER LD, 1981, GENETICS, V97, P667; Myers DK, 1997, APPL ENVIRON MICROB, V63, P145, DOI 10.1128/AEM.63.1.145-150.1997; Newcomb LL, 2003, EUKARYOT CELL, V2, P143, DOI 10.1128/EC.2.1.143-149.2003; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Roff Derek, 2002, pi; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Schneider BL, 2004, MOL CELL BIOL, V24, P10802, DOI 10.1128/MCB.24.24.10802-10813.2004; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; SOLBRIG OT, 1974, J ECOL, V62, P473, DOI 10.2307/2258993; Stearns S.C., 1992, pi; STUCKI JW, 1980, EUR J BIOCHEM, V109, P257, DOI 10.1111/j.1432-1033.1980.tb04791.x; Waddell TG, 1999, BIOCHEM EDUC, V27, P12, DOI 10.1016/S0307-4412(98)00266-0; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1952, NATURE, V169, P278, DOI 10.1038/169278a0; Wegmann D, 2006, GENETICS, V174, P2009, DOI 10.1534/genetics.106.062851; White EP, 2007, TRENDS ECOL EVOL, V22, P323, DOI 10.1016/j.tree.2007.03.007; Zeyl C, 2006, FEMS YEAST RES, V6, P685, DOI 10.1111/j.1567-1364.2006.00061.x	53	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1579	10.1371/journal.pone.0001579	http://dx.doi.org/10.1371/journal.pone.0001579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270570	Green Submitted, gold, Green Published			2022-12-27	WOS:000260535900015
J	Schwachtje, J; Kutschbach, S; Baldwin, IT				Schwachtje, Jens; Kutschbach, Susan; Baldwin, Ian T.			Reverse Genetics in Ecological Research	PLOS ONE			English	Article							MANDUCA-SEXTA LEPIDOPTERA; HOST NICOTIANA-ATTENUATA; AGROBACTERIUM-MEDIATED TRANSFORMATION; LARGE-SCALE CHANGES; MOLECULAR-INTERACTIONS; MICROARRAY ANALYSIS; TRANSCRIPTIONAL RESPONSES; PLANT TRANSFORMATION; SOMACLONAL VARIATION; FITNESS COSTS	By precisely manipulating the expression of individual genetic elements thought to be important for ecological performance, reverse genetics has the potential to revolutionize plant ecology. However, untested concerns about possible side-effects of the transformation technique, caused by Agrobacterium infection and tissue culture, on plant performance have stymied research by requiring onerous sample sizes. We compare 5 independently transformed Nicotiana attenuata lines harboring empty vector control (EVC) T-DNA lacking silencing information with isogenic wild types (WT), and measured a battery of ecologically relevant traits, known to be important in plant-herbivore interactions: phytohormones, secondary metabolites, growth and fitness parameters under stringent competitive conditions, and transcriptional regulation with microarrays. As a positive control, we included a line silenced in trypsin proteinase inhibitor gene (TPI) expression, a potent anti-herbivore defense known to exact fitness costs in its expression, in the analysis. The experiment was conducted twice, with 10 and 20 biological replicates per genotype. For all parameters, we detected no difference between any EVC and WT lines, but could readily detect a fitness benefit of silencing TPI production. A statistical power analyses revealed that the minimum sample sizes required for detecting significant fitness differences between EVC and WT was 2-3 orders of magnitude larger than the 10 replicates required to detect a fitness effect of TPI silencing. We conclude that possible side-effects of transformation are far too low to obfuscate the study of ecologically relevant phenotypes.	[Schwachtje, Jens; Kutschbach, Susan; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013	Baldwin, Ian/0000-0001-5371-2974	Max-Planck-Society	Max-Planck-Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max-Planck-Society.	BALDWIN IT, 1994, J CHEM ECOL, V20, P2139, DOI 10.1007/BF02066250; Bhat SR, 2002, PLANT SCI, V163, P673, DOI 10.1016/S0168-9452(02)00152-8; Bubner B, 2006, PLANT CELL REP, V25, P668, DOI 10.1007/s00299-005-0111-4; Butaye KMJ, 2005, MOL BREEDING, V16, P79, DOI 10.1007/s11032-005-4929-9; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Filipecki M, 2006, J APPL GENET, V47, P277, DOI 10.1007/BF03194637; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Heidel AJ, 2004, PLANT CELL ENVIRON, V27, P1362, DOI 10.1111/j.1365-3040.2004.01228.x; Hermsmeier D, 2001, PLANT PHYSIOL, V125, P683, DOI 10.1104/pp.125.2.683; Hui DQ, 2003, PLANT PHYSIOL, V131, P1877, DOI 10.1104/pp.102.018176; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Kirik A, 2000, EMBO J, V19, P5562, DOI 10.1093/emboj/19.20.5562; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Latham JR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/25376; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; Pandey SP, 2007, PLANT J, V50, P40, DOI 10.1111/j.1365-313X.2007.03030.x; Preston CA, 1999, ECOLOGY, V80, P481, DOI 10.1890/0012-9658(1999)080[0481:PANSRG]2.0.CO;2; Purrington CB, 1997, GENETICS, V145, P807; RAMULU KS, 1985, PLANT SCI, V41, P69, DOI 10.1016/0168-9452(85)90067-6; Roda AL, 2003, BASIC APPL ECOL, V4, P15, DOI 10.1078/1439-1791-00130; Rogan GJ, 2000, J AGR FOOD CHEM, V48, P5936, DOI 10.1021/jf000742b; Ruebelt MC, 2006, J AGR FOOD CHEM, V54, P2169, DOI 10.1021/jf052358q; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SANDOVAL J, 1995, PLANT GROWTH REGUL, V17, P219, DOI 10.1007/BF00024729; Schittko U, 2001, PLANT PHYSIOL, V125, P701, DOI 10.1104/pp.125.2.701; Schmidt DD, 2005, PLANT PHYSIOL, V138, P1763, DOI 10.1104/pp.105.061192; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Shepherd LVT, 2006, TRANSGENIC RES, V15, P409, DOI 10.1007/s11248-006-0012-5; SIME KR, 2003, BMC ECOLOGY, V3; STEPPUHN A, 2007, COSTS BENEFITS 2 DIR; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Voelckel C, 2004, PLANT J, V38, P650, DOI 10.1111/j.1365-313X.2004.02077.x; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zavala Jorge A., 2004, BMC Ecology, V4, P11, DOI 10.1186/1472-6785-4-11	46	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1543	10.1371/journal.pone.0001543	http://dx.doi.org/10.1371/journal.pone.0001543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253491	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700015
J	De Langhe, SP; Carraro, G; Tefft, D; Li, CG; Xu, X; Chai, Y; Minoo, P; Hajihosseini, MK; Drouin, J; Kaartinen, V; Bellusci, S				De Langhe, Stijn P.; Carraro, Gianni; Tefft, Denise; Li, Changgong; Xu, Xin; Chai, Yang; Minoo, Parviz; Hajihosseini, Mohammad K.; Drouin, Jacques; Kaartinen, Vesa; Bellusci, Saverio			Formation and Differentiation of Multiple Mesenchymal Lineages during Lung Development Is Regulated by beta-catenin Signaling	PLOS ONE			English	Article								The role of beta-catenin signaling in mesodermal lineage formation and differentiation has been elusive. Methodology. To define the role of beta-catenin signaling in these processes, we used a Dermo1(Twist2)(Cre/+) line to target a floxed beta-catenin allele, throughout the embryonic mesenchyme. Strikingly, the Dermo1(Cre/+); beta-catenin(f/-) conditional Knock Out embryos largely phenocopy Pitx1(-/-)/Pitx2(-/-) double knockout embryos, suggesting that beta-catenin signaling in the mesenchyme depends mostly on the PITX family of transcription factors. We have dissected this relationship further in the developing lungs and find that mesenchymal deletion of beta-catenin differentially affects two major mesenchymal lineages. The amplification but not differentiation of Fgf10-expressing parabronchial smooth muscle progenitor cells is drastically reduced. In the angioblast-endothelial lineage, however, only differentiation into mature endothelial cells is impaired. Conclusion. Taken together these findings reveal a hierarchy of gene activity involving beta-catenin and PITX, as important regulators of mesenchymal cell proliferation and differentiation.	[De Langhe, Stijn P.; Carraro, Gianni; Tefft, Denise; Kaartinen, Vesa; Bellusci, Saverio] Childrens Hosp Los Angeles, Saban Res Inst, Dept Surg, Dev Biol Program, Los Angeles, CA 90027 USA; [Li, Changgong; Minoo, Parviz] USC, Keck Sch Med, Womens & Child Hosp, Dept Pediat, Los Angeles, CA USA; [Xu, Xin; Chai, Yang] USC, Sch Dentistry, Ctr Craniofacial Mol Biol, Los Angeles, CA USA; [Hajihosseini, Mohammad K.] UEA, Sch Biol Sci, Norwich, Norfolk, England; [Drouin, Jacques] IRCM, Lab Genet, Montreal, PQ, Canada	Children's Hospital Los Angeles; University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of East Anglia; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Bellusci, S (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dept Surg, Dev Biol Program, Los Angeles, CA 90027 USA.	SBellusci@chla.usc.edu	Kaartinen, Vesa/AAU-5396-2021; De Langhe, Stijn/ABH-6876-2020	De Langhe, Stijn/0000-0003-3867-4572; Carraro, Gianni/0000-0003-0824-7692; Kaartinen, Vesa/0000-0002-9432-510X; Drouin, Jacques/0000-0001-8226-5691	ALA [Senior Research Training Fellowship]; CHLA [Career Development Fellowship]; AHA; NIH [RO1 HL074832, HL056590, 073471, HL074862]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056590, R01HL074832, R01HL073471, R01HL074862] Funding Source: NIH RePORTER	ALA; CHLA; AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SDL acknowledges the support of ALA Senior Research Training Fellowship and CHLA Career Development Fellowship. This work was funded by AHA and an NIH RO1 HL074832 (to SB), HL056590 and 073471 (to PM) and HL074862 (VK).	Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Colvin JS, 2001, DEVELOPMENT, V128, P2095; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; De Langhe SP, 2006, DEV BIOL, V299, P52, DOI 10.1016/j.ydbio.2006.07.001; del Moral PM, 2006, DEV BIOL, V293, P77, DOI 10.1016/j.ydbio.2006.01.020; Driskell RR, 2004, AM J PHYSIOL-LUNG C, V287, pL752, DOI 10.1152/ajplung.00026.2004; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Harada H, 2002, DEVELOPMENT, V129, P1533; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Jakkaraju S, 2005, DEV CELL, V9, P39, DOI 10.1016/j.devcel.2005.04.015; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu CY, 2001, DEVELOPMENT, V128, P2039; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; PERSSON H, 1984, SCIENCE, V225, P687, DOI 10.1126/science.6431612; SATO TN, 1993, ADV EXP MED BIOL, V331, P183; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tebar M, 2001, MECH DEVELOP, V109, P437, DOI 10.1016/S0925-4773(01)00556-1; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Yang Y, 1998, DEVELOPMENT, V125, P2621; Yang Y, 2000, J CLIN INVEST, V106, P1321, DOI 10.1172/JCI8893; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	48	83	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1516	10.1371/journal.pone.0001516	http://dx.doi.org/10.1371/journal.pone.0001516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231602	Green Submitted, Green Published, gold			2022-12-27	WOS:000260504200028
J	Baras, B; Stittelaar, KJ; Simon, JH; Thoolen, RJMM; Mossman, SP; Pistoor, FHM; van Amerongen, G; Wettendorff, MA; Hanon, E; Osterhaus, ADME				Baras, Benoit; Stittelaar, Koert J.; Simon, James H.; Thoolen, Robert J. M. M.; Mossman, Sally P.; Pistoor, Frank H. M.; van Amerongen, Geert; Wettendorff, Martine A.; Hanon, Emmanuel; Osterhaus, Albert D. M. E.			Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; VIRUS-INFECTION; IMMUNOGENICITY; HUMANS; ADULTS	Background. Unprecedented spread between birds and mammals of highly pathogenic avian influenza viruses ( HPAI) of the H5N1 subtype has resulted in hundreds of human infections with a high fatality rate. This has highlighted the urgent need for the development of H5N1 vaccines that can be produced rapidly and in sufficient quantities. Potential pandemic inactivated vaccines will ideally induce substantial intra-subtypic cross-protection in humans to warrant the option of use, either prior to or just after the start of a pandemic outbreak. In the present study, we evaluated a split H5N1 A/H5N1/Vietnam/1194/04, clade 1 candidate vaccine, adjuvanted with a proprietary oil-in-water emulsion based Adjuvant System proven to be well- tolerated and highly immunogenic in the human (Leroux-Roels et al. ( 2007) The Lancet 370: 580-589), for its ability to induce intra-subtypic cross-protection against clade 2 H5N1/A/Indonesia/5/05 challenge in ferrets. Methodology and Principal Findings. All ferrets in control groups receiving non-adjuvanted vaccine or adjuvant alone failed to develop specific or cross-reactive neutralizing antibodies and all died or had to be euthanized within four days of virus challenge. Two doses of adjuvanted split H5N1 vaccine containing >= 1.7 mu g HA induced neutralizing antibodies in the majority of ferrets to both clade 1 (17/23 (74%) responders) and clade 2 viruses (14/23 (61%) responders), and 96% (22/23) of vaccinees survived the lethal challenge. Furthermore lung virus loads and viral shedding in the upper respiratory tract were reduced in vaccinated animals relative to controls suggesting that vaccination might also confer a reduced risk of viral transmission. Conclusion. These protection data in a stringent challenge model in association with an excellent clinical profile highlight the potential of this adjuvanted H5N1 candidate vaccine as an effective tool in pandemic preparedness.	[Stittelaar, Koert J.; Simon, James H.; Pistoor, Frank H. M.; van Amerongen, Geert; Osterhaus, Albert D. M. E.] ViroClin BV, Rotterdam, Netherlands; [Baras, Benoit; Mossman, Sally P.; Wettendorff, Martine A.; Hanon, Emmanuel] GlaxoSmithKline Biologicals, Preclin Virol, Rixensart, Belgium; [Thoolen, Robert J. M. M.] Glob Pathol Sup Toxicol Pathol, The Hague, Netherlands; [Osterhaus, Albert D. M. E.] Erasmus Med Ctr MC, Dept Virol, Rotterdam, Netherlands	GlaxoSmithKline; Erasmus University Rotterdam; Erasmus MC	Osterhaus, ADME (corresponding author), ViroClin BV, Rotterdam, Netherlands.	a.osterhaus@erasmusmc.nl		Osterhaus, Albert/0000-0002-6074-1172	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This work was supported by GlaxoSmithKline (GSK) Biologicals (Rixensart, Belgium).	Allison AC, 1999, METHODS, V19, P87, DOI 10.1006/meth.1999.0832; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Hampson AW, 2006, J INFECT DIS, V194, P143, DOI 10.1086/505229; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Ott G, 1995, Pharm Biotechnol, V6, P277; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2000, VACCINE, V19, P1180, DOI 10.1016/S0264-410X(00)00310-8; Sambhara S, 2007, LANCET, V370, P544, DOI 10.1016/S0140-6736(07)61269-0; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Vandepapeliere P, 2005, VACCINE, V23, P2591, DOI 10.1016/j.vaccine.2004.11.034; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wood JM, 2002, MED MICROBIOL IMMUN, V191, P197, DOI 10.1007/s00430-002-0146-x; World Health Organization, 2005, WHO GLOB INFL PREP P	30	136	144	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1401	10.1371/journal.pone.0001401	http://dx.doi.org/10.1371/journal.pone.0001401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167560	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900029
J	Hao, YH; Wang, Y; Burdette, D; Mukherjee, S; Keitany, G; Goldsmith, E; Orth, K				Hao, Yi-Heng; Wang, Yong; Burdette, Dara; Mukherjee, Sohini; Keitany, Gladys; Goldsmith, Elizabeth; Orth, Kim			Structural Requirements for Yersinia YopJ Inhibition of MAP Kinase Pathways	PLOS ONE			English	Article							NF-KAPPA-B; EFFECTOR YOPJ; ACTIVATION; PROTEINS; PHOSPHORYLATION; RESPONSES	MAPK signaling cascades are evolutionally conserved. The bacterial effector, YopJ, uses the unique activity of Ser/Thr acetylation to inhibit the activation of the MAPK kinase (MKK) and prevent activation by phosphorylation. YopJ is also able to block yeast MAPK signaling pathways using this mechanism. Based on these observations, we performed a genetic screen to isolate mutants in the yeast MKK, Pbs2, that suppress YopJ inhibition. One suppressor contains a mutation in a conserved tyrosine residue and bypasses YopJ inhibition by increasing the basal activity of Pbs2. Mutations on the hydrophobic face of the conserved G alpha-helix in the kinase domain prevent both binding and acetylation by YopJ. Corresponding mutants in human MKKs showed that they are conserved not only structurally, but also functionally. These studies reveal a conserved binding site found on the superfamily of MAPK kinases while providing insight into the molecular interactions required for YopJ inhibition.	[Hao, Yi-Heng; Burdette, Dara; Mukherjee, Sohini; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Goldsmith, Elizabeth] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX USA; [Wang, Yong] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Keitany, Gladys] Univ Washington, Sch Pub Hlth, Seattle, WA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	NIH AID [AI056404]; NIH/NIDDK [1R21DK072134-01]; Welch Research Foundation [I-1561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072134] Funding Source: NIH RePORTER	NIH AID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Welch Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by NIH AID grant AI056404 (to KO), NIH/NIDDK grant 1R21DK072134-01 (to KO) and Welch Research Foundation grant I-1561 (to KO).	Carter RS, 2003, J BIOL CHEM, V278, P48903, DOI 10.1074/jbc.M310686200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MITTAL R, 2006, P NATL ACAD SCI US; MUKHERJEE S, 2007, TRENDS BIOCH SCI; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	21	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1375	10.1371/journal.pone.0001375	http://dx.doi.org/10.1371/journal.pone.0001375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167536	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900004
J	Pan, A; Ye, XW; Franco, OH; Li, HX; Yu, ZJ; Wang, J; Qi, QB; Gu, WJ; Pang, XH; Liu, H; Lin, X				Pan, An; Ye, Xingwang; Franco, Oscar H.; Li, Huaixing; Yu, Zhijie; Wang, Jing; Qi, Qibin; Gu, Wenjia; Pang, Xinghuo; Liu, Hong; Lin, Xu			The Association of Depressive Symptoms with Inflammatory Factors and Adipokines in Middle-Aged and Older Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; OBESITY; MARKERS; HEALTH; MOOD	Background. Studies in Western populations find that depression is associated with inflammation and obesity. The present study aimed to evaluate the relation of depressive symptoms with inflammatory factors and adipose-derived adipokines in middle-aged and older Chinese. Methodology/Principal Findings. Data were from 3289 community residents aged 50-70 from Beijing and Shanghai who participated in the Nutrition and Health of Aging Population in China project. Depressive symptoms were defined as a Center for Epidemiological Studies of Depression Scale (CES-D) score of 16 or higher. Plasma concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), adiponectin, resistin, plasminogen activator inhibitor-1 (PAI-1) and retinol binding protein 4 (RBP4) were measured. Of the 3289 participants, 312 (9.5%) suffered from current depressive symptoms. IL-6 level was higher in participants with depressive symptoms compared to their counterparts in the crude analyses (1.17 vs. 1.05 pg/mL, p = 0.023) and this association lost statistical significance after multiple adjustments (1.13 vs. 1.10 pg/mL, p = 0.520). Depressive symptoms were not associated with increased mean levels of any other inflammatory factors or adipokines in the unadjusted or adjusted analyses. Conclusions/Significance. We found no evidence that depressive symptoms were associated with inflammatory factors and adipokines in the middle-aged and older Chinese populations. Prospective studies and studies in clinically diagnosed patients are needed to confirm our results and clarify the relation of depression with inflammatory factors and adipokines.	[Pan, An; Ye, Xingwang; Li, Huaixing; Yu, Zhijie; Wang, Jing; Qi, Qibin; Gu, Wenjia; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Franco, Oscar H.] Unilever Corp Res, Colworth House, Sharnbrook, Beds, England; [Pang, Xinghuo] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Liu, Hong] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Unilever; Shanghai Center for Disease Control & Prevention	Lin, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xlin@sibs.ac.cn	Ye, Xingwang/D-5193-2011; Qi, Qibin/H-9055-2012; Franco, Óscar H/ABE-2305-2020; Pan, An/C-5572-2011	Franco, Óscar H/0000-0002-4606-4929; Pan, An/0000-0002-1089-7945	Chinese Academy of Sciences; Shanghai-Unilever Research Development Fund; Science and Technology Commission of Shanghai Municipality; Ministry of Science and Technology of China;  [KSCX2-2-25];  [200306];  [04DZ14007];  [2006CB503900]	Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai-Unilever Research Development Fund(Unilever); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); ; ; ; 	This study was funded by Grants KSCX2-2-25, 200306, 04DZ14007 and 973 Program 2006CB503900 from the Chinese Academy of Sciences, the Shanghai-Unilever Research Development Fund, the Science and Technology Commission of Shanghai Municipality, and the Ministry of Science and Technology of China, respectively. None of the funding sources had any role in the collection of data, interpretation of results, or preparation of this manuscript.	Almeida OP, 2007, PSYCHOL MED, V37, P1775, DOI 10.1017/S0033291707000827; [Anonymous], GUIDELINES DATA PROC; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Dentino AN, 1999, J AM GERIATR SOC, V47, P6, DOI 10.1111/j.1532-5415.1999.tb01894.x; Douglas KM, 2004, PSYCHOSOM MED, V66, P679, DOI 10.1097/01.psy.0000138132.66332.85; Elovainio M, 2006, PSYCHOL MED, V36, P797, DOI 10.1017/S0033291706007574; Eskandari F, 2005, METABOLISM, V54, P918, DOI 10.1016/j.metabol.2005.02.006; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0; Lahlou-Laforet K, 2006, AM J CARDIOL, V97, P1287, DOI 10.1016/j.amjcard.2005.11.062; Leo R, 2006, NEUROSCI LETT, V407, P211, DOI 10.1016/j.neulet.2006.08.043; Li JJ, 2004, MED HYPOTHESES, V62, P499, DOI 10.1016/j.mehy.2003.12.014; Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIN N, 1989, J NERV MENT DIS, V177, P121, DOI 10.1097/00005053-198903000-00001; Liukkonen T, 2006, BIOL PSYCHIAT, V60, P825, DOI 10.1016/j.biopsych.2006.02.016; Mamalakis G, 2006, PHARMACOL BIOCHEM BE, V85, P474, DOI 10.1016/j.pbb.2006.10.008; Matthews KA, 2007, PSYCHOSOM MED, V69, P124, DOI 10.1097/01.psy.0000256574.30389.1b; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Musselman DL, 2000, ARCH GEN PSYCHIAT, V57, P875, DOI 10.1001/archpsyc.57.9.875; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Otte C, 2005, AM J PSYCHIAT, V162, P2139, DOI 10.1176/appi.ajp.162.11.2139; Otte C, 2004, BIOL PSYCHIAT, V56, P241, DOI 10.1016/j.biopsych.2004.06.003; Pan A, 2008, J AFFECT DISORDERS, V105, P167, DOI 10.1016/j.jad.2007.05.003; Panagiotakos DB, 2004, EUR HEART J, V25, P492, DOI 10.1016/j.ehj.2004.01.018; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Prins JB, 2002, BEST PRACT RES CL EN, V16, P639, DOI 10.1053/beem.2002.0222; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosmond R, 2004, MED HYPOTHESES, V62, P976, DOI 10.1016/j.mehy.2003.12.030; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Steptoe A, 2003, PSYCHOL MED, V33, P667, DOI 10.1017/S0033291702007250; Suarez EC, 2004, PSYCHOSOM MED, V66, P684, DOI 10.1097/01.psy.0000138281.73634.67; Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025; Whooley MA, 2007, BIOL PSYCHIAT, V62, P314, DOI 10.1016/j.biopsych.2006.10.016; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zhang J, 2002, J PERS ASSESS, V79, P492, DOI 10.1207/S15327752JPA7903_06; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	51	53	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1392	10.1371/journal.pone.0001392	http://dx.doi.org/10.1371/journal.pone.0001392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366GP	18167551	Green Published, Green Submitted, gold			2022-12-27	WOS:000260468900020
J	Salemi, M; de Oliveira, T; Ciccozzi, M; Rezza, G; Goodenow, MM				Salemi, Marco; de Oliveira, Tulio; Ciccozzi, Massimo; Rezza, Giovanni; Goodenow, Maureen M.			High-Resolution Molecular Epidemiology and Evolutionary History of HIV-1 Subtypes in Albania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POPULATION HISTORY; TYPE-1 EPIDEMIC; ORIGIN; GENE; CIRCULATION; RESISTANCE; DIVERSITY; SELECTION; ANCESTOR	Background. HIV-1 epidemic in Western Europe is largely due to subtype B. Little is known about the HIV-1 in Eastern Europe, but a few studies have shown that non-B subtypes are quite common. In Albania, where a recent study estimated a ten-fold increase of AIDS incidence during the last six years, subtype A and B account for 90% of the know infections. Methodology/Principal Findings. We investigated the demographic history of HIV-1 subtype A and B in Albania by using a statistical framework based on coalescent theory and phylogeography. High-resolution phylogenetic and molecular clock analysis showed a limited introduction to the Balkan country of subtype A during the late 1980s followed by an epidemic outburst in the early 1990s. In contrast, subtype B was apparently introduced multiple times between the mid-1970s and mid-1980s. Both subtypes are growing exponentially, although the HIV-1A epidemic displays a faster growth rate, and a significantly higher basic reproductive number R-0. HIV-1A gene flow occurs primarily from the capital Tirane, in the center of the country, to the periphery, while HIV-1B flow is characterized by a balanced exchange between center and periphery. Finally, we calculated that the actual number of infections in Albania is at least two orders of magnitude higher than previously thought. Conclusions/Significance. Our analysis demonstrates the power of recently developed computational tools to investigate molecular epidemiology of pathogens, and emphasize the complex factors involved in the establishment of HIV-1 epidemics. We suggest that a significant correlation exists between HIV-1 exponential spread and the socio-political changes occurred during the Balkan wars. The fast growth of a relatively new non-B epidemic in the Balkans may have significant consequences for the evolution of HIV-1 epidemiology in neighboring countries in Eastern and Western Europe.	[Salemi, Marco; Goodenow, Maureen M.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [de Oliveira, Tulio] Med Res Council MRC, Bioinform Unit, Cape Town, South Africa; [Ciccozzi, Massimo; Rezza, Giovanni] Inst Sup Sanita, Rome, Italy	State University System of Florida; University of Florida; Istituto Superiore di Sanita (ISS)	Salemi, M (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	salemi@pathology.ufl.edu	CICCOZZI, MASSIMO/C-6484-2016; Ciccozzi, Massimo/AAC-3271-2022; rezza, giovanni/D-4393-2016	CICCOZZI, MASSIMO/0000-0003-3866-9239; Ciccozzi, Massimo/0000-0003-3866-9239; rezza, giovanni/0000-0003-0268-6790	PHS [HD032259, AI047723, AI065265]; Center for Research in Pediatric Immune Deficiency; Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047723, R01AI065265] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Center for Research in Pediatric Immune Deficiency; Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by PHS R01 awards HD032259, AI047723, and AI065265; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research (MMG).	Ciccozzi M, 2005, J INFECT DIS, V192, P475, DOI 10.1086/431599; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esparza J, 2000, LANCET, V355, P2061, DOI 10.1016/S0140-6736(00)02360-6; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HAHN BH, 1984, NATURE, V312, P166, DOI 10.1038/312166a0; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Lazouskaya NV, 2005, AIDS RES HUM RETROV, V21, P830, DOI 10.1089/aid.2005.21.830; Leal ED, 2004, VIROLOGY, V325, P181, DOI 10.1016/j.virol.2004.04.004; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lukashov VV, 1999, AIDS RES HUM RETROV, V15, P1577, DOI 10.1089/088922299309874; McCutchan FE, 2000, AIDS, V14, pS31; Peeters M, 2000, AIDS, V14, pS129; Pybus OG, 2000, GENETICS, V155, P1429; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rouzine IM, 1999, J VIROL, V73, P8167, DOI 10.1128/JVI.73.10.8167-8178.1999; Saad MD, 2006, AIDS RES HUM RETROV, V22, P709, DOI 10.1089/aid.2006.22.709; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SEILLIERMOISEIWITSCH F, 1994, ANNU REV GENET, V28, P559; SLATKIN M, 1989, GENETICS, V123, P603; Stanojevic M, 2002, AIDS RES HUM RETROV, V18, P519, DOI 10.1089/088922202317406673; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; SWOFFORD D, 2003, PHYLOGENETIC HDB PRA, P160; Thompson JD, 1994, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876	41	56	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1390	10.1371/journal.pone.0001390	http://dx.doi.org/10.1371/journal.pone.0001390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167549	Green Published, gold			2022-12-27	WOS:000260468900018
J	Letcher, BH; Nislow, KH; Coombs, JA; O'Donnell, MJ; Dubreuil, TL				Letcher, Benjamin H.; Nislow, Keith H.; Coombs, Jason A.; O'Donnell, Matthew J.; Dubreuil, Todd L.			Population Response to Habitat Fragmentation in a Stream-Dwelling Brook Trout Population	PLOS ONE			English	Article							CUTTHROAT TROUT; RECAPTURE; EVOLUTION; DYNAMICS; GROWTH; SIZE; DISPERSAL; SURVIVAL; TRENDS; FISH	Fragmentation can strongly influence population persistence and expression of life-history strategies in spatially-structured populations. In this study, we directly estimated size-specific dispersal, growth, and survival of stream-dwelling brook trout in a stream network with connected and naturally-isolated tributaries. We used multiple-generation, individual-based data to develop and parameterize a size-class and location-based population projection model, allowing us to test effects of fragmentation on population dynamics at local (i.e., subpopulation) and system-wide (i.e., metapopulation) scales, and to identify demographic rates which influence the persistence of isolated and fragmented populations. In the naturally-isolated tributary, persistence was associated with higher early juvenile survival (similar to 45% greater), shorter generation time (one-half) and strong selection against large body size compared to the open system, resulting in a stage-distribution skewed towards younger, smaller fish. Simulating barriers to upstream migration into two currently-connected tributary populations caused rapid (2-6 generations) local extinction. These local extinctions in turn increased the likelihood of system-wide extinction, as tributaries could no longer function as population sources. Extinction could be prevented in the open system if sufficient immigrants from downstream areas were available, but the influx of individuals necessary to counteract fragmentation effects was high (7-46% of the total population annually). In the absence of sufficient immigration, a demographic change (higher early survival characteristic of the isolated tributary) was also sufficient to rescue the population from fragmentation, suggesting that the observed differences in size distributions between the naturally-isolated and open system may reflect an evolutionary response to isolation. Combined with strong genetic divergence between the isolated tributary and open system, these results suggest that local adaptation can 'rescue' isolated populations, particularly in one-dimensional stream networks where both natural and anthropogenically-mediated isolation is common. However, whether rescue will occur before extinction depends critically on the race between adaptation and reduced survival in response to fragmentation.	[Letcher, Benjamin H.; Coombs, Jason A.; O'Donnell, Matthew J.; Dubreuil, Todd L.] US Geol Survey, Leetown Sci Ctr, SO Conte Anadromous Fish Res Ctr, Turners Falls, MA USA; [Coombs, Jason A.] Univ Massachusetts, Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Nislow, Keith H.] Univ Massachusetts, No Res Stn, USDA, US Forest Serv, Amherst, MA 01003 USA	United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Agriculture (USDA); United States Forest Service; University of Massachusetts System; University of Massachusetts Amherst	Letcher, BH (corresponding author), US Geol Survey, Leetown Sci Ctr, SO Conte Anadromous Fish Res Ctr, Turners Falls, MA USA.	ben_letcher@usgs.gov	O'Donnell, Matt/O-5850-2019	O'Donnell, Matt/0000-0002-9089-2377; Coombs, Jason/0000-0001-6099-3954	USGS Conte Anadromous Fish Research Center; US Forest Service; Northeastern Research Station; USGS Eastern Region; Nature Conservancy, Connecticut River Program	USGS Conte Anadromous Fish Research Center(United States Geological Survey); US Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Northeastern Research Station; USGS Eastern Region(United States Geological Survey); Nature Conservancy, Connecticut River Program	This work was funded by USGS Conte Anadromous Fish Research Center, the US Forest Service, Northeastern Research Station, USGS Eastern Region, and The Nature Conservancy, Connecticut River Program. Funders were not involved in any details of the study. The manuscript was approved by USGS.	BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K. P., 1998, MODEL SELECTION INFE, P353; CASE TJ, 1978, ECOLOGY, V59, P1, DOI 10.2307/1936628; CASWELL H, 2001, MATRIX POPULATION MO, P723; Choquet R., 2004, Animal Biodiversity and Conservation, V27, P207; Choquet R., 2005, U CARE 2 2 USERS MAN; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; DRISCOLL CT, 2001, BIOSCIENCE WASHINGTO, P180; Dunham Jason B., 1997, North American Journal of Fisheries Management, V17, P1126, DOI 10.1577/1548-8675(1997)017<1126:HFAERO>2.3.CO;2; Einum S, 2006, OIKOS, V113, P489, DOI 10.1111/j.2006.0030-1299.14806.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAUSCH KD, 2006, RMRSGTR174 U GEN; Felsenstein J, PHYLIP PHYLOGENY INF; Fishback AG, 2002, AQUACULTURE, V206, P137, DOI 10.1016/S0044-8486(01)00707-4; Fujiwara M, 2002, ECOLOGY, V83, P3257, DOI 10.2307/3072076; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Gries G, 2002, N AM J FISH MANAGE, V22, P219, DOI 10.1577/1548-8675(2002)022<0219:TRASOA>2.0.CO;2; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; Harig AL, 2002, ECOL APPL, V12, P535, DOI 10.1890/1051-0761(2002)012[0535:MHRFET]2.0.CO;2; Hilderbrand RH, 2000, T AM FISH SOC, V129, P1160, DOI 10.1577/1548-8659(2000)129<1160:MPOSRC>2.0.CO;2; King TL, 2005, MOL ECOL NOTES, V5, P130, DOI 10.1111/j.1471-8286.2005.00860.x; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Kinnison MT, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P208; Koskinen MT, 2002, NATURE, V419, P826, DOI 10.1038/nature01029; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; Lowe WH, 2002, CONSERV BIOL, V16, P183, DOI 10.1046/j.1523-1739.2002.00360.x; Lowe WH, 2003, ECOLOGY, V84, P2145, DOI 10.1890/0012-9658(2003)084[2145:LDTLPD]2.0.CO;2; MAC ARTHUR ROBERT H., 1967; Morita K, 2002, ECOL MODEL, V155, P85, DOI 10.1016/S0304-3800(02)00128-X; Morita K, 2002, CONSERV BIOL, V16, P1318, DOI 10.1046/j.1523-1739.2002.01476.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NILSSON J, 1994, T AM FISH SOC, V123, P430, DOI 10.1577/1548-8659(1994)123&lt;0430:GOGOJA&gt;2.3.CO;2; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; RIEMAN BE, 1995, T AM FISH SOC, V124, P285, DOI 10.1577/1548-8659(1995)124<0285:OOBTIN>2.3.CO;2; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; Wang SZ, 2002, REV FISH BIOL FISHER, V11, P301; Warren ML, 1998, T AM FISH SOC, V127, P637, DOI 10.1577/1548-8659(1998)127<0637:RCABTS>2.0.CO;2; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; Zydlewski GB, 2006, FISHERIES, V31, P492, DOI 10.1577/1548-8446(2006)31[492:RMOFIS]2.0.CO;2	45	138	141	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1139	10.1371/journal.pone.0001139	http://dx.doi.org/10.1371/journal.pone.0001139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	18188404	Green Published, gold, Green Submitted			2022-12-27	WOS:000207459000023
J	Bisson, GP; Gaolathe, T; Gross, R; Rollins, C; Bellamy, S; Mogorosi, M; Avalos, A; Friedman, H; Dickinson, D; Frank, I; Ndwapi, N				Bisson, Gregory P.; Gaolathe, Tendani; Gross, Robert; Rollins, Caitlin; Bellamy, Scarlett; Mogorosi, Mpho; Avalos, Ava; Friedman, Harvey; Dickinson, Diana; Frank, Ian; Ndwapi, Ndwapi			Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; MORTALITY; OUTCOMES; EXPERIENCE; PROGRAM; AFRICA	Background: Monitoring the effectiveness of global antiretroviral therapy scale-up efforts in resource-limited settings is a global health priority, but is complicated by high rates of losses to follow-up after treatment initiation. Determining definitive outcomes of these lost patients, and the effects of losses to follow-up on estimates of survival and risk factors for death after HAART, are key to monitoring the effectiveness of global HAART scale-up efforts. Methodology/Principal Findings: A cohort study comparing clinical outcomes and risk factors for death after HAART initiation as reported before and after tracing of patients lost to follow-up was conducted in Botswana's National Antiretroviral Therapy Program. 410 HIV-infected adults consecutively presenting for HAART were evaluated. The main outcome measures were death or loss to follow-up within the first year after HAART initiation. Of 68 patients initially categorized as lost, over half (58.8%) were confirmed dead after tracing. Patient tracing resulted in reporting of significantly lower survival rates when death was used as the outcome and losses to follow-up were censored [1-year Kaplan Meier survival estimate 0.92 (95% confidence interval, 0.88-0.94 before tracing and 0.83 (95% confidence interval, 0.79-0.86) after tracing, log rank P<0.001]. In addition, a significantly increased risk of death after HAART among men [adjusted hazard ratio 1.74 (95% confidence interval, 1.05-2.87)] would have been missed had patients not been traced [adjusted hazard ratio 1.41 (95% confidence interval, 0.65-3.05)]. Conclusions/Significance: Due to high rates of death among patients lost to follow-up after HAART, survival rates may be inaccurate and important risk factors for death may be missed if patients are not actively traced. Patient tracing and uniform reporting of outcomes after HAART are needed to enable accurate monitoring of global HAART scale-up efforts.	[Bisson, Gregory P.; Gross, Robert; Rollins, Caitlin; Bellamy, Scarlett; Friedman, Harvey; Frank, Ian] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Gaolathe, Tendani; Ndwapi, Ndwapi] Botswana Harvard Sch Public Hlth AIDS Initiative, Partnership HIV Res & Ed, Gaborone, Botswana; [Mogorosi, Mpho; Avalos, Ava] Princess Marina Hosp, Infect Dis Care Clin, Gaborone, Botswana; [Dickinson, Diana] Independence Surg, Gaborone, Botswana	University of Pennsylvania	Bisson, GP (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	gregbisson@mac.com		Bellamy, Scarlett/0000-0002-2906-4046	National Institutes of Health [P30-AI45008]; PENN AIDS Clinical Trials Unit [U01-AI32783]; Career Development Awards [K23AI058881, K08MH01584]; Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics [HS10399]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, K23AI058881, U01AI032783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PENN AIDS Clinical Trials Unit; Career Development Awards; Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful for the support of the National Institutes of Health which supported this research through the University of Pennsylvania Center for AIDS Research International, Developmental and Clinical Cores (P30-AI45008) the PENN AIDS Clinical Trials Unit (U01-AI32783), Career Development Awards K23AI058881 (GB) and K08MH01584 (RG), and an Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics cooperative agreement (HS10399).	Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; GAMMINO VBG, 2007, NATL TUBERCULOSIS PR; GUIARD S, 2004, TRICAM MEDICOECONOMI; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosseinipour Mina C, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P103, DOI 10.1177/1545109706288722; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Macharia DK, 2003, AIDS, V17, P938, DOI 10.1097/00002030-200304110-00028; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2006, REP GLOB AIDS EP; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; *WHO, 2006, SCAL ANT THER RES LT; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	28	96	97	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1725	10.1371/journal.pone.0001725	http://dx.doi.org/10.1371/journal.pone.0001725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320045	Green Submitted, Green Published, gold			2022-12-27	WOS:000260586600021
J	Plyusnin, I; Evans, AR; Karme, A; Gionis, A; Jernvall, J				Plyusnin, Ilya; Evans, Alistair R.; Karme, Aleksis; Gionis, Aristides; Jernvall, Jukka			Automated 3D Phenotype Analysis Using Data Mining	PLOS ONE			English	Article							TOPOGRAPHY; MORPHOLOGY; EVOLUTION	The ability to analyze and classify three-dimensional (3D) biological morphology has lagged behind the analysis of other biological data types such as gene sequences. Here, we introduce the techniques of data mining to the study of 3D biological shapes to bring the analyses of phenomes closer to the efficiency of studying genomes. We compiled five training sets of highly variable morphologies of mammalian teeth from the MorphoBrowser database. Samples were labeled either by dietary class or by conventional dental types (e.g. carnassial, selenodont). We automatically extracted a multitude of topological attributes using Geographic Information Systems (GIS)-like procedures that were then used in several combinations of feature selection schemes and probabilistic classification models to build and optimize classifiers for predicting the labels of the training sets. In terms of classification accuracy, computational time and size of the feature sets used, non-repeated best-first search combined with 1-nearest neighbor classifier was the best approach. However, several other classification models combined with the same searching scheme proved practical. The current study represents a first step in the automatic analysis of 3D phenotypes, which will be increasingly valuable with the future increase in 3D morphology and phenomics databases.	[Plyusnin, Ilya; Evans, Alistair R.; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Karme, Aleksis] Univ Helsinki, Dept Geol, Helsinki, Finland; [Gionis, Aristides] Yahoo Res Barcelona, Barcelona, Spain	University of Helsinki; University of Helsinki	Plyusnin, I (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	ipljusni@cc.hut.fi	Gionis, Aristides/G-2225-2013; Evans, Alistair R/D-4239-2011	Gionis, Aristides/0000-0002-5211-112X; Evans, Alistair R/0000-0002-4078-4693	Academy of Finland	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BUTLER PM, 1983, J BIOL BUCCALE, V11, P285; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 2001, J MICROSC-OXFORD, V204, P108, DOI 10.1046/j.1365-2818.2001.00939.x; Evans G, 2005, INTEGR COMP BIOL, V45, P1129; Evans G, 2006, J VERTEBR PALEONTOL, V26, p59A; Funkhouser T, 2005, COMMUN ACM, V48, P58, DOI 10.1145/1064830.1064859; Hand D., 2001, ADAP COMP MACH LEARN; Hillson S., 2005, TEETH; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; JERNVALL J, 1999, PALAEONTOLOGIA ELECT, V2; JOHN HG, 1995, 11 C UNC ART INT SAN, P338; KAY RF, 1985, ANNU REV ANTHROPOL, V14, P315, DOI 10.1146/annurev.an.14.100185.001531; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Levoy M, 2000, COMP GRAPH, P131, DOI 10.1145/344779.344849; Lucas P., 2004, DENT FUNCTIONAL MORP; NOWAK MR, 1999, WALKERS MAMMALS WORL; Osada R, 2002, ACM T GRAPHIC, V21, P807, DOI 10.1145/571647.571648; Osborn, 1907, EVOLUTION MAMMALIAN, P48; Quinlan JR., 1993, C45 PROGRAMS MACHINE; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; REED DNO, 1997, AM J PHYS ANTHR S, V24, P113; Regli WC, 2000, COMPUT AIDED DESIGN, V32, P119, DOI 10.1016/S0010-4485(99)00095-0; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; Strait S, 2006, J VERTEBR PALEONTOL, V26, p129A; Tangelder JWH, 2004, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, P145, DOI 10.1109/SMI.2004.1314502; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Witten I. H., 2005, DATA MINING PRACTICA; Zuccotti LF, 1998, AM J PHYS ANTHROPOL, V107, P137, DOI 10.1002/(SICI)1096-8644(199809)107:1<137::AID-AJPA11>3.0.CO;2-1	32	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1742	10.1371/journal.pone.0001742	http://dx.doi.org/10.1371/journal.pone.0001742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XT	18320060	Green Published, gold			2022-12-27	WOS:000260586600037
J	Smith, DO; Rosenheimer, JL; Kalil, RE				Smith, Dean O.; Rosenheimer, Julie L.; Kalil, Ronald E.			Delayed Rectifier and A-Type Potassium Channels Associated with Kv 2.1 and Kv 4.3 Expression in Embryonic Rat Neural Progenitor Cells	PLOS ONE			English	Article							KV2.1 K+ CHANNEL; SUBVENTRICULAR ZONE; STEM-CELLS; VOLTAGE; CURRENTS; DIFFERENTIATION; PRECURSOR; BRAIN; IDENTIFICATION; POPULATION	Background: Because of the importance of voltage-activated K+ channels during embryonic development and in cell proliferation, we present here the first description of these channels in E15 rat embryonic neural progenitor cells derived from the subventricular zone (SVZ). Activation, inactivation, and single-channel conductance properties of recorded progenitor cells were compared with those obtained by others when these Kv gene products were expressed in oocytes. Methodology/Principal Findings: Neural progenitor cells derived from the subventricular zone of E15 embryonic rats were cultured under conditions that did not promote differentiation. Immunocytochemical and Western blot assays for nestin expression indicated that almost all of the cells available for recording expressed this intermediate filament protein, which is generally accepted as a marker for uncommitted embryonic neural progenitor cells. However, a very small numbers of the cells expressed GFAP, a marker for astrocytes, O4, a marker for immature oligodendrocytes, and beta III-tubulin, a marker for neurons. Using immunocytochemistry and Western blots, we detected consistently the expression of Kv2.1, and 4.3. In whole-cell mode, we recorded two outward currents, a delayed rectifier and an A-type current. Conclusions/Significance: We conclude that Kv2.1, and 4.3 are expressed in E15 SVZ neural progenitor cells, and we propose that they may be associated with the delayed-rectifier and the A-type currents, respectively, that we recorded. These results demonstrate the early expression of delayed rectifier and A-type K+ currents and channels in embryonic neural progenitor cells prior to the differentiation of these cells.	[Smith, Dean O.] Univ Hawaii Manoa, Stem Cell Res Lab, Manoa, HI USA; [Rosenheimer, Julie L.] Univ Hawaii Manoa, Dept Anat, Manoa, HI USA; [Kalil, Ronald E.] Univ Wisconsin Madison, Dept Ophthalmol & Visual Sci, Madison, WI USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Wisconsin System; University of Wisconsin Madison	Smith, DO (corresponding author), Univ Hawaii Manoa, Stem Cell Res Lab, Manoa, HI USA.	dean.smith@ttu.edu			University of Hawaiis Chancellors Office; Retina Research Foundation	University of Hawaiis Chancellors Office; Retina Research Foundation	Funding was provided by the University of Hawaiis Chancellors Office and the Retina Research Foundation. Neither had any role in any aspect of this study.	BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Feldman DH, 1996, EXP NEUROL, V140, P206, DOI 10.1006/exnr.1996.0130; FICKER E, 1992, J PHYSIOL-LONDON, V445, P431, DOI 10.1113/jphysiol.1992.sp018932; Franqueza L, 1999, CARDIOVASC RES, V41, P212, DOI 10.1016/S0008-6363(98)00220-X; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Ghiani CA, 1999, J NEUROSCI, V19, P5380; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; HWANG PM, 1993, J NEUROSCI, V13, P1569; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Koopmann R, 2001, J MEMBRANE BIOL, V182, P49, DOI 10.1007/s00232-001-0029-X; KUES WA, 1992, EUR J NEUROSCI, V4, P1296, DOI 10.1111/j.1460-9568.1992.tb00155.x; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Lowe DL, 1997, MOL BRAIN RES, V48, P37, DOI 10.1016/S0169-328X(97)00072-7; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; Piper DR, 2000, J NEUROPHYSIOL, V84, P534, DOI 10.1152/jn.2000.84.1.534; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; SHI GY, 1994, J BIOL CHEM, V269, P23204; Spitzer NC, 2002, CURR OPIN NEUROBIOL, V12, P315, DOI 10.1016/S0959-4388(02)00330-6; SPITZER NC, 1981, STUDIES DEV NEUROBIO, P261; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stewart RR, 1999, J NEUROPHYSIOL, V81, P95, DOI 10.1152/jn.1999.81.1.95; SURMEIER DJ, 1994, METH NEUROSCI, V19, P39; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wang DD, 2003, J NEUROPHYSIOL, V90, P2291, DOI 10.1152/jn.01116.2002; Wang K, 2005, STEM CELLS, V23, P1526, DOI 10.1634/stemcells.2004-0299; Wang SM, 2004, J PHYSIOL-LONDON, V557, P705, DOI 10.1113/jphysiol.2003.058578; Whittemore SR, 1999, EXP CELL RES, V252, P75, DOI 10.1006/excr.1999.4621; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; YOOL AJ, 1988, J NEUROSCI, V8, P1971	42	29	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1604	10.1371/journal.pone.0001604	http://dx.doi.org/10.1371/journal.pone.0001604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18270591	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900038
J	Wesolowski, LG; MacKellar, DA; Ethridge, SF; Zhu, JH; Owen, SM; Sullivan, PS				Wesolowski, Laura G.; MacKellar, Duncan A.; Ethridge, Steven F.; Zhu, Julia H.; Owen, S. Michele; Sullivan, Patrick S.		Post Mkt Surveillance Team	Repeat Confirmatory Testing for Persons with Discordant Whole Blood and Oral Fluid Rapid HIV Test Results: Findings from Post Marketing Surveillance	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TRANSUDATE; ANTIBODIES	Background. Reactive oral fluid and whole blood rapid HIV tests must be followed with a confirmatory test (Western blot (WB), immunofluorescent assay (IFA) or approved nucleic acid amplification test (NAAT)). When the confirmatory result is negative or indeterminate (i.e. discordant with rapid result), repeat confirmatory testing should be conducted using a follow-up specimen. Previous reports have not described whether repeat testing adequately resolves the HIV-infection status of persons with discordant results. Methodology. Post-marketing surveillance was conducted in 368 testing sites affiliated with 14 state and 2 city health departments from August 11, 2004 to June 30, 2005 and one health department through December 31, 2005. For persons with discordant results, data were collected on demographics, risk behaviors, HIV test results and specimen types. Persons with repeat confirmatory results were classified as HIV-infected or uninfected. Regression models were created to assess risk factors for not having repeat testing. Principal Findings. Of 167,371 rapid tests conducted, 2589 (1.6%) were reactive: of these, 2417 (93%) had positive WB/IFA, 172 (7%) had negative or indeterminate WB/IFA. Of 89/172 (52%) persons with a repeat confirmatory test: 17 (19%) were HIV-infected, including 3 with indeterminate WB and positive NAAT; 72 (81%) were uninfected, including 12 with repeat indeterminate WB. Factors associated with HIV-infection included having an initial indeterminate WB/IFA (vs. negative) (p < 0.001) and having an initial oral fluid WB (vs. serum) (p, 0.001). Persons who had male-female sex (vs. male-male sex) were at increased risk for not having a repeat test [adjusted OR 2.6, 95% CI (1.3, 4.9)]. Conclusions. Though only half of persons with discordant results had repeat confirmatory testing, of those who did, nearly one in five were HIV-infected. These findings underscore the need for rapid HIV testing programs to increase repeat confirmatory testing for persons with discordant results. Because of the lower sensitivity of oral fluid WBs, confirmatory testing following a reactive rapid test should be conducted using serum or plasma, when possible.	[Wesolowski, Laura G.; MacKellar, Duncan A.; Ethridge, Steven F.; Zhu, Julia H.; Owen, S. Michele; Sullivan, Patrick S.] Ctr Dis Control & Prevent, STD & TB Prevent, Natl Ctr HIV, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Wesolowski, LG (corresponding author), Ctr Dis Control & Prevent, STD & TB Prevent, Natl Ctr HIV, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	lig7@cdc.gov		Sullivan, Patrick Sean/0000-0002-7728-0587	Centers for Disease Control and Prevention.	Centers for Disease Control and Prevention.(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this project was provided by the Centers for Disease Control and Prevention.	[Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; *CDC, CLIA CERT WAIV FACT; CDC, 2007, QUAL ASS GUID TEST U; CDC, 2004, MMWR-MORBID MORTAL W, V53, P221; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P1287; CELUM CL, 1991, J INFECT DIS, V164, P656, DOI 10.1093/infdis/164.4.656; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Gallo D, 1997, JAMA-J AM MED ASSOC, V277, P254, DOI 10.1001/jama.277.3.254; *GENPROBE INC, 2006, APT HIV 1 RNA QUAL A; Granade TC, 1998, CLIN DIAGN LAB IMMUN, V5, P171, DOI 10.1128/CDLI.5.2.171-175.1998; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; MacKellar D. A., 2006, Morbidity and Mortality Weekly Report, V55, P673; *OR TECHN INC, 2004, ORAQUICK ADV RAP HIV; SOTORAMIREZ LE, 1992, J CLIN MICROBIOL, V30, P2780; Stekler J, 2007, ANN INTERN MED, V147, P147, DOI 10.7326/0003-4819-147-2-200707170-00022; WESOLOWSKI LG, 2006, POSTMARKETING SURVEI, P1661; ORASURE HIV 1 W BLOT	19	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1524	10.1371/journal.pone.0001524	http://dx.doi.org/10.1371/journal.pone.0001524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253478	Green Submitted, Green Published, gold			2022-12-27	WOS:000260535700002
J	Huntley, B; Collingham, YC; Willis, SG; Green, RE				Huntley, Brian; Collingham, Yvonne C.; Willis, Stephen G.; Green, Rhys E.			Potential Impacts of Climatic Change on European Breeding Birds	PLOS ONE			English	Article								Background. Climatic change is expected to lead to changes in species' geographical ranges. Adaptation strategies for biodiversity conservation require quantitative estimates of the magnitude, direction and rates of these potential changes. Such estimates are of greatest value when they are made for large ensembles of species and for extensive (sub-continental or continental) regions. Methodology/Principal Findings. For six climate scenarios for 2070-99 changes have been estimated for 431 European breeding bird species using models relating species' distributions in Europe to climate. Mean range centroid potentially shifted 258-882 km in a direction between 341 degrees (NNW) and 45 degrees (NE), depending upon the climate scenario considered. Potential future range extent averaged 72-89% of the present range, and overlapped the present range by an average of 31-53% of the extent of the present range. Even if potential range changes were realised, the average number of species breeding per 50x50 km grid square would decrease by 6.8-23.2%. Many species endemic or near-endemic to Europe have little or no overlap between their present and potential future ranges; such species face an enhanced extinction risk as a consequence of climatic change. Conclusions/Significance. Although many human activities exert pressures upon wildlife, the magnitude of the potential impacts estimated for European breeding birds emphasises the importance of climatic change. The development of adaptation strategies for biodiversity conservation in the face of climatic change is an urgent need; such strategies must take into account quantitative evidence of potential climatic change impacts such as is presented here.	[Collingham, Yvonne C.; Willis, Stephen G.] Univ Durham, Sch Biol & Biomed Sci, Inst Ecosyst Sci, Durham, England; [Green, Rhys E.] Roy Soc Protect Birds, Conserv Sci Dept, Sandy, Beds, England; [Green, Rhys E.] Univ Cambridge, Dept Zool, Conservation Sci Grp, Cambridge, England	Durham University; Royal Society for Protection of Birds; University of Cambridge	Huntley, B (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Inst Ecosyst Sci, Durham, England.	brian.huntley@durham.ac.uk; reg29@hermes.cam.ac.uk	Willis, Stephen G/F-8503-2015	Willis, Stephen G/0000-0002-8656-5808	UK Natural Environment Research Council; Royal Society for the Protection of Birds (RSPB); Royal Society - Wolfson Foundation Research Merit Award	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society for the Protection of Birds (RSPB); Royal Society - Wolfson Foundation Research Merit Award	The research work reported was supported in part by a grant from the UK Natural Environment Research Council and in part by a contract from the Royal Society for the Protection of Birds (RSPB). During the preparation of the manuscript Prof. Brian Huntley was in receipt of financial support from a Royal Society - Wolfson Foundation Research Merit Award. The post of Prof. Rhys E. Green at Cambridge University also is funded by the RSPB. Nonetheless, the sponsors have played no direct role in the design or conduct of the study, nor in the interpretation of the data or the preparation, review or approval of the manuscript. Data relating to the European breeding distributions of birds were collected by the European Bird Census Council (EBCC), who made those data available to us to use in our work. The EBCC played no role in the research work nor in the preparation of this paper.	[Anonymous], 2000, SPECIAL REPORT EMISS; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cramer W., 1988, NORSK GEOGR TIDSSKR, V42, P149, DOI DOI 10.1080/00291958808552193; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Davis M., 1976, GEOSCIENCE MAN, V13, P13; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; Huntley B, 1995, J BIOGEOGR, V22, P967, DOI 10.2307/2845830; HUNTLEY B, 1989, J BIOGEOGR, V16, P5, DOI 10.2307/2845307; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Huppop O, 2006, J ORNITHOL, V147, P344, DOI 10.1007/s10336-005-0049-x; JACOBSON GL, 1987, N AM ADJACENT OCEANS, P277; Knutson TR, 1999, J GEOPHYS RES-ATMOS, V104, P30981, DOI 10.1029/1999JD900965; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Mila B, 2006, EVOLUTION, V60, P2403; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; PIGOTT CD, 1981, ANN BOT FENN, V18, P255; PIGOTT CD, 1993, J ECOL, V81, P557, DOI 10.2307/2261534; PIGOTT CD, 1981, NEW PHYTOL, V87, P817, DOI 10.1111/j.1469-8137.1981.tb01716.x; PIGOTT CD, 1975, WEATHER, V30, P82; Roeckner E, 1996, CLIM DYNAM, V12, P737, DOI 10.1007/s003820050140; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; SHIPLEY JW, 2000, CAUSE CORRELATION BI; SODANO EM, 1963, DIRECT INVERSE SOLUT; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; VANDENBOSCH F, 1992, J BIOGEOGR, V19, P135, DOI 10.2307/2845500; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x	47	193	201	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1439	10.1371/journal.pone.0001439	http://dx.doi.org/10.1371/journal.pone.0001439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197250	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000260503800011
J	Lee, HG; Kim, YC; Dunning, JS; Han, KA				Lee, Hyun-Gwan; Kim, Young-Cho; Dunning, Jennifer S.; Han, Kyung-An			Recurring Ethanol Exposure Induces Disinhibited Courtship in Drosophila	PLOS ONE			English	Article							MALE SEXUAL-BEHAVIOR; TARGETED GENE-EXPRESSION; WHITE GENE; MALE-RAT; TYROSINE-HYDROXYLASE; HUMAN HOMOLOG; DOPAMINE; ALCOHOL; MELANOGASTER; FRUITLESS	Alcohol has a strong causal relationship with sexual arousal and disinhibited sexual behavior in humans; however, the physiological support for this notion is largely lacking and thus a suitable animal model to address this issue is instrumental. We investigated the effect of ethanol on sexual behavior in Drosophila. Wild-type males typically court females but not males; however, upon daily administration of ethanol, they exhibited active intermale courtship, which represents a novel type of behavioral disinhibition. The ethanol-treated males also developed behavioral sensitization, a form of plasticity associated with addiction, since their intermale courtship activity was progressively increased with additional ethanol experience. We identified three components crucial for the ethanol-induced courtship disinhibition: the transcription factor regulating male sex behavior Fruitless, the ABC guanine/tryptophan transporter White and the neuromodulator dopamine. fruitless mutant males normally display conspicuous intermale courtship; however, their courtship activity was not enhanced under ethanol. Likewise, white males showed negligible ethanol-induced intermale courtship, which was not only reinstated but also augmented by transgenic White expression. Moreover, inhibition of dopamine neurotransmission during ethanol exposure dramatically decreased ethanol-induced intermale courtship. Chronic ethanol exposure also affected a male's sexual behavior toward females: it enhanced sexual arousal but reduced sexual performance. These findings provide novel insights into the physiological effects of ethanol on sexual behavior and behavioral plasticity.	[Lee, Hyun-Gwan; Han, Kyung-An] Penn State Univ, Dept Biol, Grad Program Genet, Huck Inst, University Pk, PA 16802 USA; [Kim, Young-Cho] Penn State Univ, Huck Inst Neurosci Grad Program, Dept Biol, University Pk, PA USA; [Dunning, Jennifer S.] Penn State Univ, Dept Biol, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Han, KA (corresponding author), Penn State Univ, Dept Biol, Grad Program Genet, Huck Inst, University Pk, PA 16802 USA.	kxh29@psu.edu	Kim, Youngcho/C-5676-2014	Kim, Youngcho/0000-0003-4810-2738	NIH [HD048766, GM07838]; NSF [IOB-0620056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH HD048766 and NSF IOB-0620056 grants to K-AH and NIH GM07838, in which K-AH is Co-PI.	Anand A, 2001, GENETICS, V158, P1569; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Berger KH, 2004, ALCOHOL CLIN EXP RES, V28, P1469, DOI 10.1097/01.ALC.0000141817.15993.98; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; CURCILLO PG, 1987, BEHAV GENET, V17, P81, DOI 10.1007/BF01066012; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196; El-Ghundi M, 2007, REV NEUROSCIENCE, V18, P37; Ferraro FA, 2004, PHARMACOL BIOCHEM BE, V78, P427, DOI 10.1016/j.pbb.2004.03.020; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; George W H, 2000, Annu Rev Sex Res, V11, P92; Godenschwege TA, 2004, EUR J NEUROSCI, V20, P611, DOI 10.1111/j.1460-9568.2004.03527.x; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hingson R, 2005, ANNU REV PUBL HEALTH, V26, P259, DOI 10.1146/annurev.publhealth.26.021304.144652; Horn C, 2003, GENETICS, V163, P647; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kirov G, 2001, MOL PSYCHIATR, V6, P671, DOI 10.1038/sj.mp.4000899; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koob GF, 2004, BIOCHEM PHARMACOL, V68, P1515, DOI 10.1016/j.bcp.2004.07.031; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Markos AR, 2005, INT J STD AIDS, V16, P123, DOI 10.1258/0956462053057639; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Nakamura M, 1999, MOL PSYCHIATR, V4, P155, DOI 10.1038/sj.mp.4000515; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Pfaus JG, 1999, CURR OPIN NEUROBIOL, V9, P751, DOI 10.1016/S0959-4388(99)00034-3; PFAUS JG, 1989, PSYCHOBIOLOGY, V17, P195; PINEL JPJ, 1992, PHARMACOL BIOCHEM BE, V41, P133, DOI 10.1016/0091-3057(92)90072-N; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sari Y, 2006, ALCOHOL CLIN EXP RES, V30, P46, DOI 10.1111/j.1530-0277.2006.00010.x; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; SCOTT MP, 1994, PHARMACOL BIOCHEM BE, V48, P929, DOI 10.1016/0091-3057(94)90202-X; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Weiss F, 2002, J NEUROSCI, V22, P3332; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	56	47	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1391	10.1371/journal.pone.0001391	http://dx.doi.org/10.1371/journal.pone.0001391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167550	gold, Green Published, Green Submitted			2022-12-27	WOS:000260468900019
J	Rodgers, CI; Armstrong, GAB; Shoemaker, KL; LaBrie, JD; Moyes, CD; Robertson, RM				Rodgers, Corinne I.; Armstrong, Gary A. B.; Shoemaker, Kelly L.; LaBrie, John D.; Moyes, Christopher D.; Robertson, R. Meldrum			Stress Preconditioning of Spreading Depression in the Locust CNS	PLOS ONE			English	Article								Cortical spreading depression (CSD) is closely associated with important pathologies including stroke, seizures and migraine. The mechanisms underlying SD in its various forms are still incompletely understood. Here we describe SD-like events in an invertebrate model, the ventilatory central pattern generator (CPG) of locusts. Using K+-sensitive microelectrodes, we measured extracellular K+ concentration ([K+](o)) in the metathoracic neuropile of the CPG while monitoring CPG output electromyographically from muscle 161 in the second abdominal segment to investigate the role K+ in failure of neural circuit operation induced by various stressors. Failure of ventilation in response to different stressors (hyperthermia, anoxia, ATP depletion, Na+/K+ ATPase impairment, K+ injection) was associated with a disturbance of CNS ion homeostasis that shares the characteristics of CSD and SD-like events in vertebrates. Hyperthermic failure was preconditioned by prior heat shock (3 h, 45 degrees C) and induced-thermotolerance was associated with an increase in the rate of clearance of extracellular K+ that was not linked to changes in ATP levels or total Na+/K+ ATPase activity. Our findings suggest that SD-like events in locusts are adaptive to terminate neural network operation and conserve energy during stress and that they can be preconditioned by experience. We propose that they share mechanisms with CSD in mammals suggesting a common evolutionary origin.	[Rodgers, Corinne I.; Armstrong, Gary A. B.; Shoemaker, Kelly L.; LaBrie, John D.; Moyes, Christopher D.; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Rodgers, CI (corresponding author), Queens Univ, Dept Biol, Biosci Complex, Kingston, ON K7L 3N6, Canada.	9cir@queensu.ca	Robertson, Robert M/B-2482-2009	Robertson, Robert M/0000-0002-2666-7861; Armstrong, Gary/0000-0003-4613-8817	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding: Funded by the Natural Sciences and Engineering Research Council of Canada.	Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Armstrong GAB, 2006, J NEUROSCI, V26, P12118, DOI 10.1523/JNEUROSCI.3347-06.2006; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; BANKS WM, 1975, COMP BIOCHEM PHYS A, V52, P223, DOI 10.1016/S0300-9629(75)80157-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustami HP, 2000, J INSECT PHYSIOL, V46, P1285, DOI 10.1016/S0022-1910(00)00050-0; DAVENPORT AP, 1984, INSECT BIOCHEM, V14, P135, DOI 10.1016/0020-1790(84)90021-0; Dawson-Scully K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000773; Evans AM, 2006, J PHYSIOL-LONDON, V574, P113, DOI 10.1113/jphysiol.2006.108381; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Gulinson SL, 1996, J EXP BIOL, V199, P379; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Henderson DR, 1998, RESP PHYSIOL, V114, P297, DOI 10.1016/S0034-5687(98)00096-6; HUSTERT R, 1975, J COMP PHYSIOL, V97, P159, DOI 10.1007/BF00645359; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kretzschmar D, 2002, BRAIN RES BULL, V57, P121, DOI 10.1016/S0361-9230(01)00643-8; Largo C, 1997, J NEUROPHYSIOL, V77, P9, DOI 10.1152/jn.1997.77.1.9; Lauritzen M, 2001, CEPHALALGIA, V21, P757, DOI 10.1046/j.1468-2982.2001.00244.x; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LIGHTON JRB, 1990, J EXP BIOL, V154, P509; Loder E, 2002, CEPHALALGIA, V22, P624, DOI 10.1046/j.1468-2982.2002.00437.x; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; Newman AEM, 2003, J INSECT PHYSIOL, V49, P1039, DOI 10.1016/j.jinsphys.2003.08.001; Qin WS, 2003, CELL STRESS CHAPERON, V8, P144, DOI 10.1379/1466-1268(2003)008<0144:CACOAM>2.0.CO;2; Ramirez JM, 1999, J NEUROPHYSIOL, V81, P795, DOI 10.1152/jn.1999.81.2.795; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Robertson RM, 2004, INTEGR COMP BIOL, V44, P21, DOI 10.1093/icb/44.1.21; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; SNYDER GK, 1980, J INSECT PHYSIOL, V26, P699, DOI 10.1016/0022-1910(80)90043-8; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tupling AR, 2004, J BIOL CHEM, V279, P52382, DOI 10.1074/jbc.M409336200; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; VANHARREVELD A, 1978, J NEUROBIOL, V9, P419, DOI 10.1002/neu.480090602; Walther C, 1998, J NEUROPHYSIOL, V80, P785, DOI 10.1152/jn.1998.80.2.785; WHYARD S, 1986, J COMP PHYSIOL B, V156, P813, DOI 10.1007/BF00694255; Wu J, 2000, J NEUROPHYSIOL, V84, P1355, DOI 10.1152/jn.2000.84.3.1355	39	62	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1366	10.1371/journal.pone.0001366	http://dx.doi.org/10.1371/journal.pone.0001366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159249	gold, Green Submitted, Green Published			2022-12-27	WOS:000207459700023
J	Yang, K; Zhao, ZD; Gross, RW; Han, XL				Yang, Kui; Zhao, Zhongdan; Gross, Richard W.; Han, Xianlin			Shotgun Lipidomics Identifies a Paired Rule for the Presence of Isomeric Ether Phospholipid Molecular Species	PLOS ONE			English	Article								Background. Ether phospholipids are abundant membrane constituents present in electrically active tissues (e.g., heart and the brain) that play important roles in cellular function. Alterations of ether phospholipid molecular species contents are associated with a number of genetic disorders and human diseases. Methodology/Principal Findings. Herein, the power of shotgun lipidomics, in combination with high mass accuracy/high resolution mass spectrometry, was explored to identify a paired rule for the presence of isomeric ether phospholipid molecular species in cellular lipidomes. The rule predicts that if an ether phospholipid A'-B is present in a lipidome, its isomeric counterpart B'-A is also present (where the 9 represents an ether linkage). The biochemical basis of this rule results from the fact that the enzymes which participate in either the sequential oxidation of aliphatic alcohols to fatty acids, or the reduction of long chain fatty acids to aliphatic alcohols (metabolic precursors of ether lipid synthesis), are not entirely selective with respect to acyl chain length or degree of unsaturation. Moreover, the enzymatic selectivity for the incorporation of different aliphatic chains into the obligatory precursor of ether lipids (i.e., 1-O-alkyl-glycero-3-phosphate) is also limited. Conclusions/Significance. This intrinsic amplification of the number of lipid molecular species present in biological membranes predicted by this rule and demonstrated in this study greatly expands the number of ether lipid molecular species present in cellular lipidomes. Application of this rule to mass spectrometric analyses provides predictive clues to the presence of specific molecular species and greatly expands the number of identifiable and quantifiable ether lipid species present in biological samples. Through appropriate alterations in the database, use of the paired rule increases the number of identifiable metabolites in metabolic networks, thereby facilitating identification of biomarkers presaging disease states.	[Yang, Kui; Zhao, Zhongdan; Gross, Richard W.; Han, Xianlin] Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Han, XL (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA.	xianlin@wustl.edu			National Institutes of Health [P01 HL57278]; National Institute on Aging [R01 AG23168, R01 AG31675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031675, R01AG023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was supported by National Institutes of Health Grant P01 HL57278 as well as National Institute on Aging Grants R01 AG23168 and R01 AG31675.	Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cheng H, 2007, J NEUROCHEM, V101, P57, DOI 10.1111/j.1471-4159.2006.04342.x; Cheng H, 2006, J NEUROCHEM, V97, P1288, DOI 10.1111/j.1471-4159.2006.03794.x; DeMar JC, 1997, J BIOL CHEM, V272, P31362, DOI 10.1074/jbc.272.50.31362; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; GLASER PE, 1994, BIOCHEMISTRY-US, V33, P5805, DOI 10.1021/bi00185a019; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GROSS RW, 1980, J CHROMATOGR, V197, P79, DOI 10.1016/S0021-9673(00)80538-5; GROSS RW, 1985, BIOCHEMISTRY-US, V24, P1662, DOI 10.1021/bi00328a014; GROSS RW, 1984, BIOCHEMISTRY-US, V23, P158, DOI 10.1021/bi00296a026; Hajra AK, 1995, PROG LIPID RES, V34, P343, DOI 10.1016/0163-7827(95)00013-5; Han XL, 1996, BIOCHEMISTRY-US, V35, P5822, DOI 10.1021/bi952927v; HAN XL, 1990, BIOCHEMISTRY-US, V29, P4992, DOI 10.1021/bi00472a032; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2005, J LIPID RES, V46, P1548, DOI 10.1194/jlr.D500007-JLR200; Han XL, 1995, J AM SOC MASS SPECTR, V6, P1202, DOI 10.1016/1044-0305(95)00568-4; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Han XL, 1998, BBA-BIOMEMBRANES, V1414, P95, DOI 10.1016/S0005-2736(98)00154-0; Horrocks L. A., 1982, PHOSPHOLIPIDS, P51; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Jiang XT, 2007, ANAL BIOCHEM, V371, P135, DOI 10.1016/j.ab.2007.08.019; Pettegrew JW, 2001, BIOL PSYCHIAT, V49, P444, DOI 10.1016/S0006-3223(00)00953-7; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; SNYDER F, 1996, BIOCH LIPIDS LIPOPRO, P183	28	42	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1368	10.1371/journal.pone.0001368	http://dx.doi.org/10.1371/journal.pone.0001368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159251	Green Published, Green Submitted, gold			2022-12-27	WOS:000207459700025
J	Morgan, OW; Rodrigues, B; Elston, T; Verlander, NQ; Brown, DFJ; Brazier, J; Reacher, M				Morgan, Oliver W.; Rodrigues, Boaventura; Elston, Tony; Verlander, Neville Q.; Brown, Derek F. J.; Brazier, Jonathan; Reacher, Mark			Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study	PLOS ONE			English	Article							NORTH-AMERICA; DISEASE; EPIDEMIC; STRAIN; DIARRHEA; OUTBREAKS	Background: Clostridium difficile is a leading infectious cause of health care associated diarrhoea. Several industrialised countries have reported increased C. difficile infections and outbreaks, which have been attributed to the emergent PCR ribotype 027 strain. Methods and Findings: We conducted a case-case study to compare severity of C. difficile disease for patients with 027 versus non-027 ribotypes. We retrospectively collected clinical information about 123/136 patients with C. difficile infections admitted to hospitals in the East of England region in 2006 and from whom stool isolates were cultured and ribotyped as part of an earlier national survey. We defined severe C. difficile disease as having one or more of shock, paralytic ileus, pseudo membranous colitis or toxic megacolon. Patient median age was 83 years old (range 3 to 98, interquartile range 75 to 89), 86% were prescribed antibiotics in the eight weeks before illness onset, 41% had ribotype 027 and 30-day all cause mortality during hospital admission was 21%. Severe disease occurred in 24% (95% CI 13% to 37%) and 17% (95% CI 9% to 27%) of patients with PCR ribotype 027 and non-027 ribotypes respectively. In a multivariable model, ribotype 027 was not associated with severe disease after adjusting for sex, discharge from hospital prior to 60 days of current admission, gastroenteritis on admission, number of initiator antibiotics for C. difficile disease, and hospital where the patient was admitted. Conclusions: Our study found no evidence to support previous assertions that ribotype 027 is more virulent than other PCR ribotypes. This finding raises questions about the contribution of this strain to the recent increase in C. difficile disease throughout North America and Europe.	[Morgan, Oliver W.; Reacher, Mark] E England Reg Epidemiol Unit, Hlth Protect Agcy, Cambridge, England; [Rodrigues, Boaventura] Eastern Deanery Public Hlth Train Scheme, Cambridge, England; [Elston, Tony] Essex Rivers NHS Trust, Colchester, Essex, England; [Verlander, Neville Q.] Ctr Infect, Statist, Model & Bioinformat Dept, Hlth Protect Agcy, London, England; [Brown, Derek F. J.] Addenbrookes Hosp, Clin Microbiol & Public Hlth Lab, Hlth Protect Agcy, Cambridge, England; [Brazier, Jonathan] Univ Hosp Wales, Natl Public Hlth Serv, Anaerobe Reference Lab, Cardiff, S Glam, Wales	Health Protection Agency; Health Protection Agency; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; Cardiff University	Morgan, OW (corresponding author), E England Reg Epidemiol Unit, Hlth Protect Agcy, Cambridge, England.	omorgan@bigfoot.com	Reacher, Mark/Y-6979-2018	Reacher, Mark/0000-0001-6871-7903				[Anonymous], 2007, Health Stat Q, P71; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Barbut F, 2007, INFECT CONT HOSP EP, V28, P131, DOI 10.1086/511794; Bartlett JG, 2005, NEW ENGL J MED, V353, P2503, DOI 10.1056/NEJMe058221; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Beaulieu M, 2006, CLIN INFECT DIS, V42, P725, DOI 10.1086/500264; BRAZIER J, 2007, EUROSURVEILLANCE, V12; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Kazakova SV, 2006, ARCH INTERN MED, V166, P2518, DOI 10.1001/archinte.166.22.2518; KUIJPER E, 2007, EURO SURVEILL, V12; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lauritsen J, EPIDATA DATA ENTRY D; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McCarthy N, 1999, INT J EPIDEMIOL, V28, P764, DOI 10.1093/ije/28.4.764; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Musher DM, 2006, NEW ENGL J MED, V354, P1199; REDELINGS M, 2007, EMERG INFECT DIS; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; *STATACORP, 2006, STAT STAT SOFTW REL; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	26	88	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1812	10.1371/journal.pone.0001812	http://dx.doi.org/10.1371/journal.pone.0001812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350149	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300015
J	Kim, J; Lee, JH; Iyer, VR				Kim, Jonghwan; Lee, Ji-hoon; Iyer, Vishwanath R.			Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo	PLOS ONE			English	Article								The Myc oncoprotein is a transcription factor involved in a variety of human cancers. Overexpression of Myc is associated with malignant transformation. In normal cells, Myc is induced by mitotic signals, and in turn, it regulates the expression of downstream target genes. Although diverse roles of Myc have been predicted from many previous studies, detailed functions of Myc targets are still unclear. By combining chromatin immunoprecipitation (ChIP) and promoter microarrays, we identified a total of 1469 Myc direct target genes, the majority of which are novel, in HeLa cells and human primary fibroblasts. We observed dramatic changes of Myc occupancy at its target promoters in foreskin fibroblasts in response to serum stimulation. Among the targets of Myc, 107 were nuclear encoded genes involved in mitochondrial biogenesis. Genes with important roles in mitochondrial replication and biogenesis, such as POLG, POLG2, and NRF1 were identified as direct targets of Myc, confirming a direct role for Myc in regulating mitochondrial biogenesis. Analysis of target promoter sequences revealed a strong preference for Myc occupancy at promoters containing one of several described consensus sequences, CACGTG, in vivo. This study thus sheds light on the transcriptional regulatory networks mediated by Myc in vivo.	[Kim, Jonghwan; Lee, Ji-hoon; Iyer, Vishwanath R.] Univ Texas Austin, Inst Cell & Mol Biol, Ctr Systems & Synthet Biol, Sect Mol Genet & Microbiol, Austin, TX USA	University of Texas System; University of Texas Austin	Kim, J (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Ctr Systems & Synthet Biol, Sect Mol Genet & Microbiol, Austin, TX USA.	vishy@mail.utexas.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843	NIH; NSF; US Army	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); US Army(United States Department of DefenseUnited States Army)	This work was supported in part by grants from the NIH, NSF, and the US Army.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r42; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Izumi H, 2001, J CELL SCI, V114, P1533; James L, 2002, P NATL ACAD SCI USA, V99, P10429, DOI 10.1073/pnas.162369299; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Morrish F, 2003, GENE DEV, V17, P240, DOI 10.1101/gad.1032503; Morrish F, 2003, CELL CYCLE, V2, P11, DOI 10.4161/cc.2.1.275; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; WICK M, 1994, J CELL SCI, V107, P227; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	45	157	163	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1798	10.1371/journal.pone.0001798	http://dx.doi.org/10.1371/journal.pone.0001798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335064	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000046
J	Tamaki, T; Akatsuka, A; Okada, Y; Uchiyama, Y; Tono, K; Wada, M; Hoshi, A; Iwaguro, H; Iwasaki, H; Oyamada, A; Asahara, T				Tamaki, Tetsuro; Akatsuka, Akira; Okada, Yoshinori; Uchiyama, Yoshiyasu; Tono, Kayoko; Wada, Mika; Hoshi, Akio; Iwaguro, Hideki; Iwasaki, Hiroto; Oyamada, Akira; Asahara, Takayuki			Cardiomyocyte Formation by Skeletal Muscle-Derived Multi-Myogenic Stem Cells after Transplantation into Infarcted Myocardium	PLOS ONE			English	Article							CELLULAR CARDIOMYOPLASTY; INTERSTITIAL SPACES; CARDIAC-MUSCLE; PAX7; DIFFERENTIATION; PERFORMANCE; MYOBLASTS; RENEWAL; REPAIR; HEART	Background: Cellular cardiomyoplasty for myocardial infarction has been developed using various cell types. However, complete differentiation and/or trans-differentiation into cardiomyocytes have never occurred in these transplant studies, whereas functional contributions were reported. Methods and Results: Skeletal muscle interstitium-derived CD34(+)/CD45(-) (Sk-34) cells were purified from green fluorescent protein transgenic mice by flowcytometory. Cardiac differentiation of Sk-34 cells was examined by in vitro clonal culture and co-culture with embryonic cardiomyocytes, and in vivo transplantation into a nude rat myocardial infarction (MI) model (left ventricle). Lower relative expression of cardiomyogenic transcription factors, such as GATA-4, Nkx2-5, Isl-1, Mef2 and Hand2, was seen in clonal cell culture. However, vigorous expression of these factors was seen on co-culture with embryonic cardiomyocytes, together with formation of gap-junctions and synchronous contraction following sphere-like colony formation. At 4 weeks after transplantation of freshly isolated Sk-34 cells, donor cells exhibited typical cardiomyocyte structure with formation of gap-junctions, as well as intercalated discs and desmosomes, between donor and recipient and/or donor and donor cells. Fluorescence in situ hybridization (FISH) analysis detecting the rat and mouse genomic DNA and immunoelectron microscopy using anti-GFP revealed donor-derived cells. Transplanted Sk-34 cells were incorporated into infarcted portions of recipient muscles and contributed to cardiac reconstitution. Significant improvement in left ventricular function, as evaluated by transthoracic echocardiography and micro-tip conductance catheter, was also observed. Conclusions and Significance: Skeletal muscle-derived multipotent Sk-34 cells that can give rise to skeletal and smooth muscle cells as reported previously, also give rise to cardiac muscle cells as multi-myogenic stem cells, and thus are a potential source for practical cellular cardiomyoplasty.	[Tamaki, Tetsuro; Akatsuka, Akira; Okada, Yoshinori; Uchiyama, Yoshiyasu; Tono, Kayoko; Hoshi, Akio] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Kanagawa 2591100, Japan; [Tamaki, Tetsuro; Tono, Kayoko; Wada, Mika; Iwaguro, Hideki; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med, Div Basic Clin Sci, Isehara, Kanagawa, Japan; [Akatsuka, Akira; Okada, Yoshinori] Tokai Univ, Sch Med, Teach & Res Support Ctr, Isehara, Kanagawa, Japan; [Uchiyama, Yoshiyasu] Tokai Univ, Sch Med, Dept Orthoped, Div Surg, Isehara, Kanagawa, Japan; [Hoshi, Akio] Tokai Univ, Sch Med, Dept Urol, Div Surg, Isehara, Kanagawa, Japan; [Iwasaki, Hiroto; Oyamada, Akira; Asahara, Takayuki] Stem Cell Translat Res, RIKEN Ctr Dev Biol, Kobe Inst Biomed Res & Innovat, Kobe, Hyogo, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Institute for Biomedical Research & Innovation (IBRI); RIKEN	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Kanagawa 2591100, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X	New Energy and Industrial Technology Development Organization of Japan; Tokai University Research aid	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Tokai University Research aid	This work was supported by a Grant from the New Energy and Industrial Technology Development Organization of Japan (T.T.), and Tokai University Research aid (T.T.).	Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Chiu RCJ, 2004, INT J CARDIOL, V95, pS3, DOI 10.1016/S0167-5273(04)90001-0; CHIU RCJ, 1995, ANN THORAC SURG, V60, P12; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Edelman GM, 1993, TOPOBIOLOGY INTRO MO; Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Horackova M, 2004, AM J PHYSIOL-HEART C, V287, pH1599, DOI 10.1152/ajpheart.00965.2003; Hutcheson KA, 2000, CELL TRANSPLANT, V9, P359, DOI 10.1177/096368970000900307; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Kao RL, 1989, PHYSIOLOGIST, V32, P220; Marelli D, 1992, Cell Transplant, V1, P383; Murry CE, 2002, J CARD FAIL, V8, pS532, DOI 10.1054/jcaf.2002.129268; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pouzet B, 2000, CIRCULATION, V102, P210; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Scorsin M, 1997, CIRCULATION, V96, P188; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2003, EXP CELL RES, V291, P83, DOI 10.1016/S0014-4827(03)00376-8; Tamaki T, 2002, J HISTOCHEM CYTOCHEM, V50, P1097, DOI 10.1177/002215540205000812; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Winitsky SO, 2005, PLOS BIOL, V3, P662, DOI 10.1371/journal.pbio.0030087	35	35	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1789	10.1371/journal.pone.0001789	http://dx.doi.org/10.1371/journal.pone.0001789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335059	Green Published, gold, Green Submitted			2022-12-27	WOS:000260723000040
J	Diniz, JAP; dos Santos, ZA; Braga, MAG; Dias, ALB; da Silva, DEA; Medeiros, DBD; Barros, VLRD; Chiang, JO; Zoghbi, KED; Quaresma, JAS; Takiya, CM; Neto, VM; de Souza, W; Vasconcelos, PFD; Diniz, CWP				Picanco Diniz, Jose Antonio; dos Santos, Zaire Alves; Galvao Braga, Marcio Augusto; Barros Dias, Adila Liliane; Andrade da Silva, Daisy Elaine; de Almeida Medeiros, Daniele Barbosa; Reis de Souza Barros, Vera Lucia; Chiang, Jannifer Oliveira; de Freitas Zoghbi, Kendra Eyllen; Simoes Quaresma, Juarez Antonio; Takiya, Christina Maeda; Neto, Vivaldo Moura; de Souza, Wanderley; da Costa Vasconcelos, Pedro Fernando; Picanco Diniz, Cristovam Wanderley			Early and Late Pathogenic Events of Newborn Mice Encephalitis Experimentally Induced by Itacaiunas and Curionopolis Bracorhabdoviruses Infection	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; MOUSE HEPATITIS-VIRUS; INTRANASAL INOCULATION; JAPANESE-ENCEPHALITIS; NERVOUS-SYSTEM; CELL-CULTURES; RABIES VIRUS; T-CELLS; BRAIN; RHABDOVIRUSES	In previous reports we proposed a new genus for Rhabdoviridae and described neurotropic preference and gross neuropathology in newborn albino Swiss mice after Curionopolis and Itacaiunas infections. In the present report a time-course study of experimental encephalitis induced by Itacaiunas and Curionopolis virus was conducted both in vivo and in vitro to investigate cellular targets and the sequence of neuroinvasion. We also investigate, after intranasal inoculation, clinical signs, histopathology and apoptosis in correlation with viral immunolabeling at different time points. Curionopolis and Itacaiunas viral antigens were first detected in the parenchyma of olfactory pathways at 2 and 3 days post-inoculation (dpi) and the first clinical signs were observed at 4 and 8 dpi, respectively. After Curionopolis infection, the mortality rate was 100% between 5 and 6 dpi, and 35% between 8 and 15 dpi after Itacaiunas infection. We identified CNS mice cell types both in vivo and in vitro and the temporal sequence of neuroanatomical olfactory areas infected by Itacaiunas and Curionopolis virus. Distinct virulences were reflected in the neuropathological changes including TUNEL immunolabeling and cytopathic effects, more intense and precocious after intracerebral or in vitro inoculations of Curionopolis than after Itacaiunas virus. In vitro studies revealed neuronal but not astrocyte or microglial cytopathic effects at 2 dpi, with monolayer destruction occurring at 5 and 7 dpi with Curionopolis and Itacaiunas virus, respectively. Ultrastructural changes included virus budding associated with interstitial and perivascular edema, endothelial hypertrophy, a reduced and/or collapsed small vessel luminal area, thickening of the capillary basement membrane, and presence of phagocytosed apoptotic bodies. Glial cells with viral budding similar to oligodendrocytes were infected with Itacaiunas virus but not with Curionopolis virus. Thus, Curionopolis and Itacaiunas viruses share many pathological and clinical features present in other rhabdoviruses but distinct virulence and glial targets in newborn albino Swiss mice brain.	[Picanco Diniz, Jose Antonio; Barros Dias, Adila Liliane; Andrade da Silva, Daisy Elaine; de Almeida Medeiros, Daniele Barbosa; Reis de Souza Barros, Vera Lucia; Chiang, Jannifer Oliveira; de Freitas Zoghbi, Kendra Eyllen; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Belem, Para, Brazil; [dos Santos, Zaire Alves; Galvao Braga, Marcio Augusto; Simoes Quaresma, Juarez Antonio; Picanco Diniz, Cristovam Wanderley] Univ Fed Para, Belem, Para, Brazil; [Takiya, Christina Maeda; Neto, Vivaldo Moura; de Souza, Wanderley] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil	Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Rio de Janeiro	Diniz, JAP (corresponding author), Inst Evandro Chagas, Belem, Para, Brazil.	pedrovasconcelos@iec.pa.gov.br	Neurociencia, Inct/I-1011-2013; Vasconcelos, Pedro/AAH-3142-2019; Takiya, Christina/AAU-5959-2021; Quaresma, Juarez AS/M-4190-2014; Moura-Neto, VIVALDO/V-9913-2019; QUARESMA, JUAREZ ANTONIO SIMOES/F-8390-2012; Diniz, Cristovam W.P./G-1474-2010	Takiya, Christina/0000-0002-8019-628X; Quaresma, Juarez AS/0000-0002-6267-9966; Moura-Neto, VIVALDO/0000-0002-6266-043X; QUARESMA, JUAREZ ANTONIO SIMOES/0000-0002-6267-9966; Diniz, Cristovam W.P./0000-0001-6611-6880	CNPq [300460/2005-8, 484511/2007-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was partially supported by CNPq (processes 300460/2005-8 and 484511/2007-6).	Anlar B, 2001, J CHILD NEUROL, V16, P895, DOI 10.1177/088307380101601206; BABIC N, 1994, VIROLOGY, V204, P616, DOI 10.1006/viro.1994.1576; Barber GN, 2005, ONCOGENE, V24, P7710, DOI 10.1038/sj.onc.1209042; BARNETT EM, 1993, VIROLOGY, V194, P185, DOI 10.1006/viro.1993.1248; BARTHOLD SW, 1987, VIRUS RES, V7, P225, DOI 10.1016/0168-1702(87)90030-X; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Buki A, 2000, J NEUROSCI, V20, P2825; CHAN WL, 1989, J NEUROIMMUNOL, V23, P195, DOI 10.1016/0165-5728(89)90051-9; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Crotty S, 2002, J GEN VIROL, V83, P1707, DOI 10.1099/0022-1317-83-7-1707; da Rosa APAT, 2002, EMERG INFECT DIS, V8, P614, DOI 10.3201/eid0806.010384; DALCANTO MC, 1976, LAB INVEST, V35, P515; Diniz JAP, 2006, ARCH VIROL, V151, P2519, DOI 10.1007/s00705-006-0812-1; Dobler G, 1996, ARCH VIROL, P33; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; ESIRI MM, 1984, J NEUROL SCI, V64, P213, DOI 10.1016/0022-510X(84)90039-X; Fazakerley JK, 2006, NEUROPATH APPL NEURO, V32, P397, DOI 10.1111/j.1365-2990.2006.00739.x; Fazakerley JK, 2004, ARCH VIROL, P179; FORGER JM, 1991, J VIROL, V65, P4950, DOI 10.1128/JVI.65.9.4950-4958.1991; Fu ZF, 2005, CURR TOP MICROBIOL, V292, P1; Fu ZF, 2005, J NEUROVIROL, V11, P101, DOI 10.1080/13550280590900445; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Gomes-Leal W, 2006, ACTA TROP, V97, P126, DOI 10.1016/j.actatropica.2005.09.006; GRIFFIN DE, 1995, SPRINGER SEMIN IMMUN, V17, P121; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; HEPLER PK, 1980, J CELL BIOL, V86, P490, DOI 10.1083/jcb.86.2.490; HUNEYCUTT BS, 1994, BRAIN RES, V635, P81, DOI 10.1016/0006-8993(94)91426-5; Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341; Iwasaki T, 2004, ARCH VIROL, V149, P1139, DOI 10.1007/s00705-003-0271-x; Jackson AC, 2001, J MED VIROL, V65, P614, DOI 10.1002/jmv.2080; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Khuth ST, 2005, J NEUROCHEM, V94, P1580, DOI 10.1111/j.1471-4159.2005.03309.x; Khuth ST, 2001, J VIROL, V75, P8268, DOI 10.1128/JVI.75.17.8268-8282.2001; Komatsu T, 1999, NITRIC OXIDE-BIOL CH, V3, P327, DOI 10.1006/niox.1999.0237; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001; LUNDH B, 1987, NEUROPATH APPL NEURO, V13, P111, DOI 10.1111/j.1365-2990.1987.tb00175.x; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Maslin CLV, 2005, CURR HIV RES, V3, P303, DOI 10.2174/157016205774370401; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MURPHY FA, 1973, LAB INVEST, V28, P361; PLAKHOV IV, 1995, VIROLOGY, V209, P257, DOI 10.1006/viro.1995.1252; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Rempel JD, 2004, VIROLOGY, V318, P381, DOI 10.1016/j.virol.2003.09.023; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; SOILUHANNINEN M, 1994, J VIROL, V68, P6291; SoiluHanninen M, 1997, J NEUROVIROL, V3, P350, DOI 10.3109/13550289709030749; Travassos da Rosa Amelia P.A., 2001, American Journal of Tropical Medicine and Hygiene, V64, P93; Van der Poel WHM, 2000, ARCH VIROL, V145, P1919, DOI 10.1007/s007050070066; Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1733	10.1371/journal.pone.0001733	http://dx.doi.org/10.1371/journal.pone.0001733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320052	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586600028
J	Sligte, IG; Scholte, HS; Lamme, VAF				Sligte, Ilja G.; Scholte, H. Steven; Lamme, Victor A. F.			Are There Multiple Visual Short-Term Memory Stores?	PLOS ONE			English	Article							WORKING-MEMORY; DISTINCT MODES; ICONIC MEMORY; INFORMATION; STORAGE; ATTENTION; FIGURE; CAPACITY; REPRESENTATIONS; FEATURES	Background: Classic work on visual short-term memory (VSTM) suggests that people store a limited amount of items for subsequent report. However, when human observers are cued to shift attention to one item in VSTM during retention, it seems as if there is a much larger representation, which keeps additional items in a more fragile VSTM store. Thus far, it is not clear whether the capacity of this fragile VSTM store indeed exceeds the traditional capacity limits of VSTM. The current experiments address this issue and explore the capacity, stability, and duration of fragile VSTM representations. Methodology/Principal Findings: We presented cues in a change-detection task either just after off-set of the memory array (iconic-cue), 1,000 ms after off-set of the memory array (retro-cue) or after on-set of the probe array (post-cue). We observed three stages in visual information processing 1) iconic memory with unlimited capacity, 2) a four seconds lasting fragile VSTM store with a capacity that is at least a factor of two higher than 3) the robust and capacity-limited form of VSTM. Iconic memory seemed to depend on the strength of the positive after-image resulting from the memory display and was virtually absent under conditions of isoluminance or when intervening light masks were presented. This suggests that iconic memory is driven by prolonged retinal activation beyond stimulus duration. Fragile VSTM representations were not affected by light masks, but were completely overwritten by irrelevant pattern masks that spatially overlapped the memory array. Conclusions/Significance: We find that immediately after a stimulus has disappeared from view, subjects can still access information from iconic memory because they can see an after-image of the display. After that period, human observers can still access a substantial, but somewhat more limited amount of information from a high-capacity, but fragile VSTM that is overwritten when new items are presented to the eyes. What is left after that is the traditional VSTM store, with a limit of about four objects. We conclude that human observers store more sustained representations than is evident from standard change detection tasks and that these representations can be accessed at will.	[Sligte, Ilja G.; Scholte, H. Steven; Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands; [Lamme, Victor A. F.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Sligte, IG (corresponding author), Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands.	I.G.Sligte@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788				ADELSON EH, 1978, SCIENCE, V201, P544, DOI 10.1126/science.663675; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Block N, 2005, TRENDS COGN SCI, V9, P46, DOI 10.1016/j.tics.2004.12.006; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; DICK AO, 1969, J EXP PSYCHOL, V82, P279, DOI 10.1037/h0028147; Eng HY, 2005, PSYCHON B REV, V12, P1127, DOI 10.3758/BF03206454; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; Irwin DE, 1996, CURR DIR PSYCHOL SCI, V5, P94, DOI 10.1111/1467-8721.ep10772833; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P446, DOI 10.3758/BF03194892; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Landman R, 2004, PSYCHON B REV, V11, P254, DOI 10.3758/BF03196567; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Lepsien J, 2007, CEREB CORTEX, V17, P2072, DOI 10.1093/cercor/bhl116; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MAKOVSKI T, J EXPT PSYC IN PRESS; Makovski T, 2007, PSYCHON B REV, V14, P1072, DOI 10.3758/BF03193093; Matsukura M, 2007, PERCEPT PSYCHOPHYS, V69, P1422, DOI 10.3758/BF03192957; MCRAE K, 1987, PSYCHOL RES-PSYCH FO, V49, P221, DOI 10.1007/BF00309030; MEWHORT DJK, 1981, MEM COGNITION, V9, P50, DOI 10.3758/BF03196951; Olsson H, 2005, P NATL ACAD SCI USA, V102, P8776, DOI 10.1073/pnas.0500810102; PARR WV, 1992, B PSYCHONOMIC SOC, V30, P369; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; TOWNSEND VM, 1973, J EXP PSYCHOL, V98, P113, DOI 10.1037/h0034309; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92	39	301	304	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1699	10.1371/journal.pone.0001699	http://dx.doi.org/10.1371/journal.pone.0001699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301775	gold, Green Submitted, Green Published			2022-12-27	WOS:000260586500043
J	Sahin, A; Espiau, B; Tetaud, E; Cuvillier, A; Lartigue, L; Ambit, A; Robinson, DR; Merlin, G				Sahin, Annelise; Espiau, Benoit; Tetaud, Emmanuel; Cuvillier, Armelle; Lartigue, Lydia; Ambit, Audrey; Robinson, Derrick R.; Merlin, Gilles			The Leishmania ARL-1 and Golgi Traffic	PLOS ONE			English	Article								We present here the characterisation of the Leishmania small G protein ADP-Ribosylation Factor-Like protein 1 (ARL-1). The ARL-1 gene is present in one copy per haploid genome and conserved among trypanosomatids. It encodes a protein of 20 kDa, which is equally expressed in the insect promastigote and mammalian amastigote forms of the parasite. ARL-1 localises to the Trans-Golgi Network (TGN); N-terminal myristoylation is essential for TGN localisation. In vivo expression of the LdARL-1/Q74L and LdARL-1/T51N mutants (GTP- and GDP-bound blocked forms respectively) shows that GDP/GTP cycling occurs entirely within the TGN. This is contrary to previous reports in yeast and mammals, where the mutant empty form devoid of nucleotide has been considered as the GDP-blocked form. The dominant-negative empty form mutant LdARL-1/T34N inhibits endocytosis and intracellular trafficking from the TGN to the Lysosome/Multivesicular Tubule and to the acidocalcisomes; these defects are probably related to a mislocalisation of the GRIP domain-containing vesicle tethering factors which cannot be recruited to the TGN by the cytoplasmic LdARL-1/T34N. Thus, besides the functional characterization of a new mutant and a better understanding of ARL-1 GDP/GTP cycling, this work shows that Leishmania ARL-1 is a key component of an essential pathway worth future study.	[Sahin, Annelise; Espiau, Benoit; Tetaud, Emmanuel; Cuvillier, Armelle; Lartigue, Lydia; Ambit, Audrey; Robinson, Derrick R.; Merlin, Gilles] Univ Bordeaux 2, UMR CNRS 5234, Lab Microbiol Cell Mol Pathogen, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Sahin, A (corresponding author), Univ Bordeaux 2, UMR CNRS 5234, Lab Microbiol Cell Mol Pathogen, Bordeaux, France.	merlin@u-bordeaux2.fr	lartigue, lydia/I-9548-2014		CNRS; Universite Bordeaux2; Region Aquitaine; Ministere de lEducation Nationale, de la Recherche et de la Technologie [fellowship]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux2; Region Aquitaine(Region Nouvelle-Aquitaine); Ministere de lEducation Nationale, de la Recherche et de la Technologie	The work was funded by CNRS, Universite Bordeaux2 and Region Aquitaine. A. Cuvillier and A. Sahin were recipients of fellowships of the Ministere de lEducation Nationale, de la Recherche et de la Technologie.	Abudugupur A, 2002, CELL DEATH DIFFER, V9, P158, DOI 10.1038/sj.cdd.4400942; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Amor JC, 2001, J BIOL CHEM, V276, P42477, DOI 10.1074/jbc.M106660200; Bakalara N, 1995, EXP PARASITOL, V81, P302, DOI 10.1006/expr.1995.1121; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Briones MRS, 1999, MOL BIOCHEM PARASIT, V104, P219, DOI 10.1016/S0166-6851(99)00155-3; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cuvillier A, 2000, J CELL SCI, V113, P2065; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DELAFAILLE MAC, 1992, P NATL ACAD SCI USA, V89, P2703, DOI 10.1073/pnas.89.7.2703; Ding M, 1996, J BIOL CHEM, V271, P24005, DOI 10.1074/jbc.271.39.24005; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Espiau B, 2006, J BIOL CHEM, V281, P1516, DOI 10.1074/jbc.M506947200; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Graham TR, 2004, CURR BIOL, V14, pR483, DOI 10.1016/j.cub.2004.06.017; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Hong JX, 1998, J BIOL CHEM, V273, P15872, DOI 10.1074/jbc.273.25.15872; Howell GJ, 2006, INT REV CYTOL, V252, P1, DOI 10.1016/S0074-7696(06)52005-4; Ilgoutz SC, 1999, EMBO J, V18, P2746, DOI 10.1093/emboj/18.10.2746; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Jochum A, 2002, MOL CELL BIOL, V22, P4914, DOI 10.1128/MCB.22.13.4914-4928.2002; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; Kjer-Nielsen L, 1999, J CELL SCI, V112, P1645; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; LAKE JA, 1988, P NATL ACAD SCI USA, V85, P4779, DOI 10.1073/pnas.85.13.4779; Lee FJS, 1997, J BIOL CHEM, V272, P30998, DOI 10.1074/jbc.272.49.30998; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; LODES MJ, 1995, MOL CELL BIOL, V15, P6845; Lowe SL, 1996, J CELL SCI, V109, P209; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2001, J CELL SCI, V114, P4543; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; McConville MJ, 2002, EUR J CELL BIOL, V81, P485, DOI 10.1078/0171-9335-00268; Morgan GW, 2001, J CELL SCI, V114, P2605; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Mullin KA, 2001, MOL BIOL CELL, V12, P2364, DOI 10.1091/mbc.12.8.2364; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Porter-Kelley JM, 2004, TRAFFIC, V5, P868, DOI 10.1111/j.1600-0854.2004.00229.x; Price HP, 2007, MOL BIOCHEM PARASIT, V155, P123, DOI 10.1016/j.molbiopara.2007.06.009; Price HP, 2007, MOL BIOL CELL, V18, P864, DOI 10.1091/mbc.E06-08-0736; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Price HP, 2003, J BIOL CHEM, V278, P7206, DOI 10.1074/jbc.M211391200; Prina E, 1996, J IMMUNOL, V156, P4318; ROBINSON DR, 1994, J CELL BIOL, V126, P641, DOI 10.1083/jcb.126.3.641; Rosenwald AG, 2002, YEAST, V19, P1039, DOI 10.1002/yea.897; Sahin A, 2005, J CHROMATOGR B, V818, P19, DOI 10.1016/j.jchromb.2004.10.022; Sahin A, 2008, MOL BIOCHEM PARASIT, V157, P83, DOI 10.1016/j.molbiopara.2007.08.003; SCHURMANN A, 1994, J BIOL CHEM, V269, P15683; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; Tetaud E, 2002, MOL BIOCHEM PARASIT, V120, P195, DOI 10.1016/S0166-6851(02)00002-6; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Vaughan M, 1997, ADV EXP MED BIOL, V419, P315; Vichi A, 2005, P NATL ACAD SCI USA, V102, P1945, DOI 10.1073/pnas.0409800102; Waller RF, 2002, INT J PARASITOL, V32, P1435, DOI 10.1016/S0020-7519(02)00140-6; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714	75	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1620	10.1371/journal.pone.0001620	http://dx.doi.org/10.1371/journal.pone.0001620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286177	gold, Green Published, Green Submitted			2022-12-27	WOS:000260586400013
J	Sekeres, M; Gold, JL; Chan, AW; Lexchin, J; Moher, D; Van Laethem, MLP; Maskalyk, J; Ferris, L; Taback, N; Rochon, PA				Sekeres, Melanie; Gold, Jennifer L.; Chan, An-Wen; Lexchin, Joel; Moher, David; Van Laethem, Marleen L. P.; Maskalyk, James; Ferris, Lorraine; Taback, Nathan; Rochon, Paula A.			Poor Reporting of Scientific Leadership Information in Clinical Trial Registers	PLOS ONE			English	Article							INTERNATIONAL-COMMITTEE; REGISTRATION; STATEMENT	Background: In September 2004, the International Committee of Medical Journal Editors (ICMJE) issued a Statement requiring that all clinical trials be registered at inception in a public register in order to be considered for publication. The World Health Organization (WHO) and ICMJE have identified 20 items that should be provided before a trial is considered registered, including contact information. Identifying those scientifically responsible for trial conduct increases accountability. The objective is to examine the proportion of registered clinical trials providing valid scientific leadership information. Methodology/Principal Findings: We reviewed clinical trial entries listing Canadian investigators in the two largest international and public trial registers, the International Standard Randomized Controlled Trial Number (ISRCTN) register, and ClinicalTrials.gov. The main outcome measures were the proportion of clinical trials reporting valid contact information for the trials' Principal Investigator (PI)/Co-ordinating Investigator/Study Chair/Site PI, and trial e-mail contact address, stratified by funding source, recruiting status, and register. A total of 1388 entries (142 from ISRCTN and 1246 from ClinicalTrials.gov) comprised our sample. We found non-compliance with mandatory registration requirements regarding scientific leadership and trial contact information. Non-industry and partial industry funded trials were significantly more likely to identify the individual responsible for scientific leadership (OR = 259, 95% CI: 95-701) and to provide a contact e-mail address (OR = 9.6,95% CI: 6.6-14) than were solely industry funded trials. Conclusions/Significance: Despite the requirements set by WHO and ICMJE, data on scientific leadership and contact e-mail addresses are frequently omitted from clinical trials registered in the two leading public clinical trial registers. To promote accountability and transparency in clinical trials research, public clinical trials registers should ensure adequate monitoring of trial registration to ensure completion of mandatory contact information fields identifying scientific leadership	[Sekeres, Melanie; Rochon, Paula A.] Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada; [Gold, Jennifer L.] Ontario Med Ass, Toronto, ON, Canada; [Chan, An-Wen; Maskalyk, James; Rochon, Paula A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lexchin, Joel] York Univ, Sch Hlth Policy & Managem, Toronto, ON, Canada; [Moher, David] Childrens Hosp, Eastern Ontario Res Inst, Chalmers Res Grp, Ottawa, ON, Canada; [Van Laethem, Marleen L. P.] Toronto Rehab Inst, Toronto, ON, Canada; [Maskalyk, James] St Michaels Hosp, Toronto, ON, Canada; [Ferris, Lorraine] Sunnybrook Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON, Canada; [Taback, Nathan] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON, Canada; [Rochon, Paula A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Sekeres, Melanie] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lexchin, Joel; Maskalyk, James] Univ Hlth Network, Toronto, ON, Canada; [Lexchin, Joel] Univ Toronto, Dept Family & Commun Med, Toronto, ON, Canada; [Moher, David] Univ Ottawa, Dept Epidemiol & Commun Med, Ottawa, ON, Canada; [Ferris, Lorraine; Taback, Nathan] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; York University - Canada; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Ottawa; University of Toronto	Sekeres, M (corresponding author), Baycrest, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada.	melanie.sekeres@utoronto.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151; Sekeres, Melanie/0000-0002-7952-3175; Taback, Nathan/0000-0001-9497-3951; Moher, David/0000-0003-2434-4206	Canadian Institutes for Health Research (CIHR) [EIC-77338]; CIHR Investigator Award; Premier's Research Excellence Award	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Investigator Award(Canadian Institutes of Health Research (CIHR)); Premier's Research Excellence Award	This project was supported by a Canadian Institutes for Health Research (CIHR) Grant entitled the Evaluation of the Integrity of Clinical Research in Canada (EIC-77338). Dr. Rochon is also supported by a CIHR Investigator Award and a Premier's Research Excellence Award.	Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; *CLINICALTRIALS GO, 2005, CLINICALTRIALS GOV R; De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109; De Angelis CD, 2005, NEW ENGL J MED, V352, P2436, DOI 10.1056/NEJMe058127; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; *ISRCTN, 2005, REQ DAT IT; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; McCray AT, 2000, ANN INTERN MED, V133, P609, DOI 10.7326/0003-4819-133-8-200010170-00013; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; MOJA LP, 2005, 5 INT C PEER REV BIO; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; 2006, ISRCTN SCHEME	14	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1610	10.1371/journal.pone.0001610	http://dx.doi.org/10.1371/journal.pone.0001610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18286168	Green Published, Green Submitted, gold			2022-12-27	WOS:000260586400003
J	Ibrahim, B; Diekmann, S; Schmitt, E; Dittrich, P				Ibrahim, Bashar; Diekmann, Stephan; Schmitt, Eberhard; Dittrich, Peter			In-Silico Modeling of the Mitotic Spindle Assembly Checkpoint	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; HUMAN MPS1 KINASE; KINETOCHORE LOCALIZATION; PROTEIN BUBR1; AURORA-B; CHROMOSOME MISSEGREGATION; MAD2 ACTIVATION; MOTOR PROTEINS; CDC20; INHIBITION	Background: The Mitotic Spindle Assembly Checkpoint ( M SAC) is an evolutionary conserved mechanism that ensures the correct segregation of chromosomes by restraining cell cycle progression from entering anaphase until all chromosomes have made proper bipolar attachments to the mitotic spindle. Its malfunction can lead to cancer. Principle Findings: We have constructed and validated for the human M SAC mechanism an in silico dynamical model, integrating 11 proteins and complexes. The model incorporates the perspectives of three central control pathways, namely Mad1/Mad2 induced Cdc20 sequestering based on the Template Model, MCC formation, and APC inhibition. Originating from the biochemical reactions for the underlying molecular processes, non-linear ordinary differential equations for the concentrations of 11 proteins and complexes of the M SAC are derived. Most of the kinetic constants are taken from literature, the remaining four unknown parameters are derived by an evolutionary optimization procedure for an objective function describing the dynamics of the APC: Cdc20 complex. MCC: APC dissociation is described by two alternatives, namely the "Dissociation'' and the "Convey'' model variants. The attachment of the kinetochore to microtubuli is simulated by a switching parameter silencing those reactions which are stopped by the attachment. For both, the Dissociation and the Convey variants, we compare two different scenarios concerning the microtubule attachment dependent control of the dissociation reaction. Our model is validated by simulation of ten perturbation experiments. Conclusion: Only in the controlled case, our models show M SAC behaviour at meta-to anaphase transition in agreement with experimental observations. Our simulations revealed that for M SAC activation, Cdc20 is not fully sequestered; instead APC is inhibited by MCC binding.	[Ibrahim, Bashar; Dittrich, Peter] Univ Jena, Bio Syst Anal Grp, Inst Comp Sci, Jena, Germany; [Ibrahim, Bashar; Dittrich, Peter] JCB, Jena, Germany; [Diekmann, Stephan; Schmitt, Eberhard] FLI, Leibniz Inst Age Res, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Ibrahim, B (corresponding author), Univ Jena, Bio Syst Anal Grp, Inst Comp Sci, Jena, Germany.	dittrich@minet.uni-jena.de	Ibrahim, Bashar/A-6926-2011; Ibrahim, Bashar/R-7112-2016	Ibrahim, Bashar/0000-0001-7773-0122	DAAD, German Academic Exchange Service [A/04/31166]; DFG, German Research Foundation [Di 852/4-x]; BMBF, Federal Ministry of Education and Research of Germany [0312704A]; EU, ESIGNET [12789]	DAAD, German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); DFG, German Research Foundation(German Research Foundation (DFG)); BMBF, Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); EU, ESIGNET	We acknowledge funding by the DAAD (German Academic Exchange Service, grant A/04/31166) the DFG (German Research Foundation, grant Di 852/4-x), the BMBF (Federal Ministry of Education and Research of Germany, grant 0312704A), and the EU (ESIGNET, grant 12789).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Acquaviva C, 2004, NAT CELL BIOL, V6, P892, DOI 10.1038/ncb1167; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Bolanos-Garcia VM, 2005, BIOPHYS J, V89, P2640, DOI 10.1529/biophysj.105.063511; Boronat S, 2007, MOL CELL BIOL, V27, P1158, DOI 10.1128/MCB.01745-05; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chang L, 2001, MOL CELL BIOL, V21, P6681, DOI 10.1128/MCB.21.19.6681-6694.2001; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chung EN, 2003, NAT CELL BIOL, V5, P748, DOI 10.1038/ncb1022; Ciliberto A, 2005, CELL CYCLE, V4, P1107; Compton DA, 2006, NAT CELL BIOL, V8, P308, DOI 10.1038/ncb0406-308; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; DeAntoni A, 2005, PHILOS T R SOC B, V360, P637, DOI 10.1098/rstb.2004.1618; DEANTONI A, 2005, PHILOS T R SOC LON B, V360, P447; Diaz-Martinez LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-23; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Doncic A, 2005, P NATL ACAD SCI USA, V102, P6332, DOI 10.1073/pnas.0409142102; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fisk HA, 2004, CURR BIOL, V14, pR1058, DOI 10.1016/j.cub.2004.11.047; Fisk HA, 2004, CELL CYCLE, V3, P439; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hagan RS, 2005, NATURE, V434, P575, DOI 10.1038/434575a; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hansen N, 2004, LECT NOTES COMPUT SC, V3242, P282; Hansen N, 2003, EVOL COMPUT, V11, P1, DOI 10.1162/106365603321828970; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Heald R, 2006, SCIENCE, V311, P343, DOI 10.1126/science.1123525; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; IBRAHIM B, 2007, BIOPHYS CHEM UNPUB; IBRAHIM B, 2007, MCC ASSEMBLY I UNPUB; Ibrahim B, 2007, J INTEGR BIOINFORMAT, V4; Iwanaga Y, 2002, J BIOL CHEM, V277, P31005, DOI 10.1074/jbc.M110666200; Iwanaga Y, 2007, CANCER RES, V67, P160, DOI 10.1158/0008-5472.CAN-06-3326; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kienitz A, 2005, ONCOGENE, V24, P4301, DOI 10.1038/sj.onc.1208589; Kim M, 2005, CANCER BIOL THER, V4, P164; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Lee MS, 2004, P NATL ACAD SCI USA, V101, P10655, DOI 10.1073/pnas.0404102101; Lenart P, 2006, CURR BIOL, V16, pR412, DOI 10.1016/j.cub.2006.05.008; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Mondal G, 2007, CARCINOGENESIS, V28, P81, DOI 10.1093/carcin/bgl100; Mondal Gourish, 2003, International Journal of Human Genetics, V3, P89; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nezi L, 2006, J CELL BIOL, V174, P39, DOI 10.1083/jcb.200602109; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Passmore LA, 2004, BIOCHEM SOC T, V32, P724, DOI 10.1042/BST0320724; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Schmidt M, 2006, CELL CYCLE, V5, P159, DOI 10.4161/cc.5.2.2309; Sear RP, 2006, P NATL ACAD SCI USA, V103, P16758, DOI 10.1073/pnas.0603174103; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shannon KB, 2002, MOL BIOL CELL, V13, P3706, DOI 10.1091/mbc.E02-03-0137; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Steuerwald N, 2005, CYTOGENET GENOME RES, V111, P256, DOI 10.1159/000086897; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhang YK, 2001, MOL CELL BIOL, V21, P5190, DOI 10.1128/MCB.21.15.5190-5199.2001; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	113	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2008	3	2							e1555	10.1371/journal.pone.0001555	http://dx.doi.org/10.1371/journal.pone.0001555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367EQ	18253502	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535700026
J	Manderson, EN; Malleshaiah, M; Michnick, SW				Manderson, Emily N.; Malleshaiah, Mohan; Michnick, Stephen W.			A Novel Genetic Screen Implicates Elm1 in the Inactivation of the Yeast Transcription Factor SBF	PLOS ONE			English	Article								Background. Despite extensive large scale analyses of expression and protein-protein interactions (PPI) in the model organism Saccharomyces cerevisiae, over a thousand yeast genes remain uncharacterized. We have developed a novel strategy in yeast that directly combines genetics with proteomics in the same screen to assign function to proteins based on the observation of genetic perturbations of sentinel protein interactions (GePPI). As proof of principle of the GePPI screen, we applied it to identify proteins involved in the regulation of an important yeast cell cycle transcription factor, SBF that activates gene expression during G1 and S phase. Methodology/Principle Findings. The principle of GePPI is that if a protein is involved in a pathway of interest, deletion of the corresponding gene will result in perturbation of sentinel PPIs that report on the activity of the pathway. We created a fluorescent protein-fragment complementation assay (PCA) to detect the interaction between Cdc28 and Swi4, which leads to the inactivation of SBF. The PCA signal was quantified by microscopy and image analysis in deletion strains corresponding to 25 candidate genes that are periodically expressed during the cell cycle and are substrates of Cdc28. We showed that the serine-threonine kinase Elm1 plays a role in the inactivation of SBF and that phosphorylation of Elm1 by Cdc28 may be a mechanism to inactivate Elm1 upon completion of mitosis. Conclusions/Significance. Our findings demonstrate that GePPI is an effective strategy to directly link proteins of known or unknown function to a specific biological pathway of interest. The ease in generating PCA assays for any protein interaction and the availability of the yeast deletion strain collection allows GePPI to be applied to any cellular network. In addition, the high degree of conservation between yeast and mammalian proteins and pathways suggest GePPI could be used to generate insight into human disease.	[Manderson, Emily N.; Malleshaiah, Mohan; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca		Malleshaiah, Mohan/0000-0003-2896-8585	Genome Canada; Genome Quebec; Canadian Institutes of Health Research (CIHR) [MOP -152556]; Fonds de la recherche en sante Quebec [post-doctoral fellowship]	Genome Canada(Genome Canada); Genome Quebec; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante Quebec(Fonds de la Recherche en Sante du Quebec)	This research was supported by grants from Genome Canada, Genome Quebec and the Canadian Institutes of Health Research (CIHR) (MOP -152556) to S.W. Michnick. E.N. Manderson is the recipient of a post-doctoral fellowship from the Fonds de la recherche en sante Quebec.	AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bailly E, 2003, J CELL SCI, V116, P4119, DOI 10.1242/jcs.00706; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; BLACKETER MJ, 1995, GENETICS, V140, P1259; BLACKETER MJ, 1993, MOL CELL BIOL, V13, P5567, DOI 10.1128/MCB.13.9.5567; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Bouquin N, 2000, J CELL SCI, V113, P1435; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Edgington NP, 1999, MOL CELL BIOL, V19, P1369; Geymonat M, 2004, MOL CELL BIOL, V24, P2277, DOI 10.1128/MCB.24.6.2277-2285.2004; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Koehler CM, 1997, FEBS LETT, V408, P109, DOI 10.1016/S0014-5793(97)00401-8; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Michnick SW, 2006, METHODS, V40, P287, DOI 10.1016/j.ymeth.2006.07.016; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Remy I, 2004, MOL CELL BIOL, V24, P1493, DOI 10.1128/MCB.24.4.1493-1504.2004; Remy I, 2001, P NATL ACAD SCI USA, V98, P7678, DOI 10.1073/pnas.131216098; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sherman F., 1974, METHODS YEAST GENETI; Siegmund RF, 1996, MOL CELL BIOL, V16, P2647; SIKORSKI RS, 1989, GENETICS, V122, P19; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	40	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2008	3	1							e1500	10.1371/journal.pone.0001500	http://dx.doi.org/10.1371/journal.pone.0001500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SR	18231587	Green Published, Green Submitted, gold			2022-12-27	WOS:000260504200013
J	Schweitzer, F; Mach, R				Schweitzer, Frank; Mach, Robert			The Epidemics of Donations: Logistic Growth and Power-Laws	PLOS ONE			English	Article							THRESHOLD MODELS	This paper demonstrates that collective social dynamics resulting from individual donations can be well described by an epidemic model. It captures the herding behavior in donations as a non-local interaction between individual via a time-dependent mean field representing the mass media. Our study is based on the statistical analysis of a unique dataset obtained before and after the tsunami disaster of 2004. We find a power-law behavior for the distributions of donations with similar exponents for different countries. Even more remarkably, we show that these exponents are the same before and after the tsunami, which accounts for some kind of universal behavior in donations independent of the actual event. We further show that the time-dependent change of both the number and the total amount of donations after the tsunami follows a logistic growth equation. As a new element, a time-dependent scaling factor appears in this equation which accounts for the growing lack of public interest after the disaster. The results of the model are underpinned by the data analysis and thus also allow for a quantification of the media influence.	[Schweitzer, Frank; Mach, Robert] ETH, Chair Syst Design, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schweitzer, F (corresponding author), ETH, Chair Syst Design, Zurich, Switzerland.	fschweitzer@ethz.ch	Schweitzer, Frank/B-2127-2012	Schweitzer, Frank/0000-0003-1551-6491				BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; COUZIN ID, 2001, ADV ETHOLOGY, V36; FRANK S, 2007, B MATH BIOL, V69, P539; Grabowski A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.031908; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; GRANOVETTER M, 1983, J MATH SOCIOL, V9, P165, DOI 10.1080/0022250X.1983.9989941; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Malcolm Gladwell, 2000, TIPPING POINT LITTLE; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; Murray JD, 1993, MATH BIOL; ROMUALDO PS, 2001, PHYS REV LETT, V86; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Schwammle V, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066108; Schweitzer F, 2002, PHYSICA A, V303, P189, DOI 10.1016/S0378-4371(01)00486-1; SHERIDAN D, 2004, PHYS REV LETT, V92; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; VERHULST PF, 1838, MEMOIRS ACAD ROYAL B, V18, P1; VICTOR EM, 2002, PHYS REV LETT, V89; VICTOR EM, 2000, PHYS REV LETT, V85; ZHENG B, 2004, PHYS REV E, V69	20	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2008	3	1							e1458	10.1371/journal.pone.0001458	http://dx.doi.org/10.1371/journal.pone.0001458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366SO	18213367	Green Published, gold			2022-12-27	WOS:000260503900004
J	Nomura, T; Takahashi, M; Hara, Y; Osumi, N				Nomura, Tadashi; Takahashi, Masanori; Hara, Yoshinobu; Osumi, Noriko			Patterns of Neurogenesis and Amplitude of Reelin Expression Are Essential for Making a Mammalian-Type Cortex	PLOS ONE			English	Article								The mammalian neocortex is characterized as a six-layered laminar structure, in which distinct types of pyramidal neurons are distributed coordinately during embryogenesis. In contrast, no other vertebrate class possesses a brain region that is strictly analogous to the neocortical structure. Although it is widely accepted that the pallium, a dorsal forebrain region, is specified in all vertebrate species, little is known of the differential mechanisms underlying laminated or non-laminated structures in the pallium. Here we show that differences in patterns of neuronal specification and migration provide the pallial architectonic diversity. We compared the neurogenesis in mammalian and avian pallium, focusing on subtype-specific gene expression, and found that the avian pallium generates distinct types of neurons in a spatially restricted manner. Furthermore, expression of Reelin gene is hardly detected in the developing avian pallium, and an experimental increase in Reelin-positive cells in the avian pallium modified radial fiber organization, which resulted in dramatic changes in the morphology of migrating neurons. Our results demonstrate that distinct mechanisms govern the patterns of neuronal specification in mammalian and avian pallial development, and that Reelin-dependent neuronal migration plays a critical role in mammalian type corticogenesis. These lines of evidence shed light on the developmental programs underlying the evolution of the mammalian specific laminated cortex.	[Nomura, Tadashi; Takahashi, Masanori; Hara, Yoshinobu] Tohoku Univ, Sch Med, CTTAR, Div Dev Neurosci, Sendai, Miyagi 980, Japan; [Hara, Yoshinobu; Osumi, Noriko] Japan Sci & Technol Agency, Core Res Evol Sci & Technol, Kawaguchi, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Osumi, N (corresponding author), Tohoku Univ, Sch Med, CTTAR, Div Dev Neurosci, Sendai, Miyagi 980, Japan.	osumi@mail.tains.tohoku.ac.jp	Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; hara, Yoshinobu/0000-0001-6339-5116	Japanese Ministry of Education, Culture, Sports and Technology [18053003]; Uehara Memorial Foundation; Core Research for Evolutional Science and Technology from Japanese Science and Technology Agency	Japanese Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Core Research for Evolutional Science and Technology from Japanese Science and Technology Agency	This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports and Technology (18053003 to TN), Uehara Memorial Foundation (to TN), and by the Core Research for Evolutional Science and Technology from Japanese Science and Technology Agency (to NO).	Aboitiz F, 2002, BRAZ J MED BIOL RES, V35, P1455, DOI 10.1590/S0100-879X2002001200006; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bernier B, 2000, J COMP NEUROL, V422, P448; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; BRUCE LL, 1995, BRAIN BEHAV EVOLUT, V46, P224, DOI 10.1159/000113276; Cabrera-Socorro A, 2007, BRAIN RES, V1132, P59, DOI 10.1016/j.brainres.2006.11.015; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; GOFFINET AM, 1986, J COMP NEUROL, V243, P106, DOI 10.1002/cne.902430109; GRAY GE, 1992, DEVELOPMENT, V114, P271; Guillemot F, 2006, EUR J NEUROSCI, V23, P857, DOI 10.1111/j.1460-9568.2006.04626.x; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hartfuss E, 2003, DEVELOPMENT, V130, P4597, DOI 10.1242/dev.00654; Henion PD, 2000, DEV DYNAM, V218, P150, DOI 10.1002/(SICI)1097-0177(200005)218:1<150::AID-DVDY13>3.0.CO;2-6; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jossin Y, 2003, CEREB CORTEX, V13, P627, DOI 10.1093/cercor/13.6.627; KARTEN HJ, 1991, BRAIN BEHAV EVOLUT, V38, P264, DOI 10.1159/000114393; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; LAVAIL JH, 1971, BRAIN RES, V28, P421; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; Meyer G, 1999, EUR J NEUROSCI, V11, P3937, DOI 10.1046/j.1460-9568.1999.00818.x; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; NIEUWENHUYS R, 1994, ANAT EMBRYOL, V190, P307; Nomura T, 2006, DEVELOPMENT, V133, P1335, DOI 10.1242/dev.02290; Nomura T, 2000, DEVELOPMENT, V127, P1899; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Striedter GF, 2000, J NEUROSCI, V20, P8021; Striedter GF, 1997, BRAIN BEHAV EVOLUT, V49, P179, DOI 10.1159/000112991; STRIEDTER GF, 2005, PRINCIPLES BRAIN EVO, P255; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Sugiyama S, 2003, DEVELOPMENT, V130, P451, DOI 10.1242/dev.00232; Tabata H, 2003, J NEUROSCI, V23, P9996; Takahashi M, 2002, DEVELOPMENT, V129, P1327; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tissir F, 2002, BRAZ J MED BIOL RES, V35, P1473, DOI 10.1590/S0100-879X2002001200007; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; TSAI HM, 1981, J COMP NEUROL, V198, P293, DOI 10.1002/cne.901980208; TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207; Weiss KH, 2003, J COMP NEUROL, V460, P56, DOI 10.1002/cne.10644; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Yun K, 2001, DEVELOPMENT, V128, P193; Zhao ST, 2004, DEVELOPMENT, V131, P5117, DOI 10.1242/dev.01387	66	68	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2008	3	1							e1454	10.1371/journal.pone.0001454	http://dx.doi.org/10.1371/journal.pone.0001454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366SN	18197264	Green Published, gold, Green Submitted			2022-12-27	WOS:000260503800025
J	Vannberg, FO; Chapman, SJ; Khor, CC; Tosh, K; Floyd, S; Jackson-Sillah, D; Crampin, A; Sichali, L; Bah, B; Gustafson, P; Aaby, P; McAdam, KPWJ; Bah-Sow, O; Lienhardt, C; Sirugo, G; Fine, P; Hill, AVS				Vannberg, Fredrik O.; Chapman, Stephen J.; Khor, Chiea C.; Tosh, Kerrie; Floyd, Sian; Jackson-Sillah, Dolly; Crampin, Amelia; Sichali, Lifted; Bah, Boubacar; Gustafson, Per; Aaby, Peter; McAdam, Keith P. W. J.; Bah-Sow, Oumou; Lienhardt, Christian; Sirugo, Giorgio; Fine, Paul; Hill, Adrian V. S.			CD209 Genetic Polymorphism and Tuberculosis Disease	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; HUMAN DENDRITIC CELLS; LECTINS DC-SIGN; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; TRANS-INFECTION; CUTTING EDGE; RISK-FACTORS; T-CELLS; VIRUS	Background. Tuberculosis causes significant morbidity and mortality worldwide, especially in sub-Saharan Africa. DC-SIGN, encoded by CD209, is a receptor capable of binding and internalizing Mycobacterium tuberculosis. Previous studies have reported that the CD209 promoter single nucleotide polymorphism (SNP)-336A/G exerts an effect on CD209 expression and is associated with human susceptibility to dengue, HIV-1 and tuberculosis in humans. The present study investigates the role of the CD209-336A/G variant in susceptibility to tuberculosis in a large sample of individuals from sub-Saharan Africa. Methods and Findings. A total of 2,176 individuals enrolled in tuberculosis case-control studies from four sub-Saharan Africa countries were genotyped for the CD209-336A/G SNP (rs4804803). Significant overall protection against pulmonary tuberculosis was observed with the -336G allele when the study groups were combined (n = 914 controls vs. 1262 cases, Mantel-Haenszel 2x2 chi(2) = 7.47, P = 0.006, odds ratio = 0.86, 95% CI 0.77-0.96). In addition, the patients with -336GG were associated with a decreased risk of cavitory tuberculosis, a severe form of tuberculosis disease (n = 557, Pearson's 262 chi(2) = 17.34, P = 0.00003, odds ratio = 0.42, 95% CI 0.27-0.65). This direction of association is opposite to a previously observed result in a smaller study of susceptibility to tuberculosis in a South African Coloured population, but entirely in keeping with the previously observed protective effect of the -336G allele. Conclusion. This study finds that the CD209-336G variant allele is associated with significant protection against tuberculosis in individuals from sub-Saharan Africa and, furthermore, cases with -336GG were significantly less likely to develop tuberculosis-induced lung cavitation. Previous in vitro work demonstrated that the promoter variant -336G allele causes down-regulation of CD209 mRNA expression. Our present work suggests that decreased levels of the DC-SIGN receptor may therefore be protective against both clinical tuberculosis in general and cavitory tuberculosis disease in particular. This is consistent with evidence that Mycobacteria can utilize DC-SIGN binding to suppress the protective pro-inflammatory immune response.	[Vannberg, Fredrik O.; Chapman, Stephen J.; Khor, Chiea C.; Tosh, Kerrie; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Floyd, Sian; Crampin, Amelia; Fine, Paul] London Sch Hyg & Trop Med, London, England; [Jackson-Sillah, Dolly; McAdam, Keith P. W. J.; Lienhardt, Christian; Sirugo, Giorgio] MRC Labs, Fajara, Gambia; [Crampin, Amelia; Sichali, Lifted] Karonga Prevent Study, Chilumba, Malawi; [Bah, Boubacar; Bah-Sow, Oumou] Univ Ignace Deen, Conakry, Guinea; [Gustafson, Per; Aaby, Peter] Bandim Hlth Project, Bissau, Guinea Bissau; [Lienhardt, Christian] Inst Rech Dev IRD, UMR 145, Dakar, Senegal	University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; Malawi Epidemiology and Intervention Research Unit	Vannberg, FO (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	fredrik.vannberg@well.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Sirugo, Giorgio/N-9056-2019; Sirugo, Giorgio/L-1628-2016	Lienhardt, Christian/0000-0003-0233-893X; Crampin, Amelia/0000-0002-1513-4330; Aaby, Peter/0000-0001-8331-1389; Khor, Chiea Chuen/0000-0002-1128-4729	EU GenoSept; UK Overseas Research Student Scheme; Wellcome Trust [Clinical Research Fellow, Principal Fellow, IC18CT980375]; Agency for Science, Technology and Research (A-STAR), Singapore; EU	EU GenoSept; UK Overseas Research Student Scheme; Wellcome Trust(Wellcome Trust); Agency for Science, Technology and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR)); EU(European Commission)	FOV is supported by the EU GenoSept Grant and the UK Overseas Research Student Scheme. SJC is a Wellcome Trust Clinical Research Fellow; AVSH is a Wellcome Trust Principal Fellow. CCK is a scholar of the Agency for Science, Technology and Research (A-STAR), Singapore and member of the MBBS-PhD programme, Faculty of Medicine, National University of Singapore. The tuberculosis samples were collected as part of an EU-funded project (contract number IC18CT980375). This work was funded by the Wellcome Trust.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Barreiro LB, 2006, HUM IMMUNOL, V67, P102, DOI 10.1016/j.humimm.2006.02.028; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bennett S, 2002, AM J EPIDEMIOL, V155, P1074, DOI 10.1093/aje/155.11.1074; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Doffinger R, 2002, MOL IMMUNOL, V38, P903, DOI 10.1016/S0161-5890(02)00017-2; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Koppel EA, 2004, IMMUNOBIOLOGY, V209, P117, DOI 10.1016/j.imbio.2004.03.003; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Soilleux EJ, 2006, J PATHOL, V209, P182, DOI 10.1002/path.1972; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Storm Niels, 2003, Methods Mol Biol, V212, P241; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Tailleux L, 2003, TRENDS MICROBIOL, V11, P259, DOI 10.1016/S0966-842X(03)00102-1; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; van Kooyk Y, 2004, CURR OPIN IMMUNOL, V16, P488, DOI 10.1016/j.coi.2004.05.010; van Kooyk Y, 2003, TRENDS MOL MED, V9, P153, DOI 10.1016/S1471-4914(03)00027-3; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; 2003, WKLY EPIDEMIOL REC, V78, P122	44	84	90	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1388	10.1371/journal.pone.0001388	http://dx.doi.org/10.1371/journal.pone.0001388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167547	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000260468900016
J	Coussens, M; Maresh, JG; Yanagimachi, R; Maeda, G; Allsopp, R				Coussens, Matthew; Maresh, John G.; Yanagimachi, Ryuzo; Maeda, Gregg; Allsopp, Richard			Sirt1 Deficiency Attenuates Spermatogenesis and Germ Cell Function	PLOS ONE			English	Article								In mammals, Sirt1, a member of the sirtuin family of proteins, functions as a nicotinamide adenine dinucleotide-dependent protein deactylase, and has important physiological roles, including the regulation of glucose metabolism, cell survival, and mitochondrial respiration. The initial investigations of Sirt1 deficient mice have revealed a phenotype that includes a reduced lifespan, small size, and an increased frequency of abnormal sperm. We have now performed a detailed analysis of the molecular and functional effects of Sirt1 deficiency in the germ line of Sirt1 knock-out (-/-) mice. We find that Sirt1 deficiency markedly attenuates spermatogenesis, but not oogenesis. Numbers of mature sperm and spermatogenic precursors, as early as d15.5 of development, are significantly reduced (similar to 2-10-fold less; P <= 0.004) in numbers in Sirt1-/- mice, whereas Sirt1 deficiency did not effect the efficiency oocyte production following superovulation of female mice. Furthermore, the proportion of mature sperm with elevated DNA damage (similar to 7.5% of total epididymal sperm; P = 0.02) was significantly increased in adult Sirt1-/- males. Analysis of global gene expression by microarray analysis in Sirt1 deficient testis revealed dysregulated expression of 85 genes, which were enriched (P < 0.05) for genes involved in spermatogenesis and protein sumoylation. To assess the function of Sirt1 deficient germ cells, we compared the efficiency of generating embryos and viable offspring in in vitro fertilization (IVF) experiments using gametes from Sirt1-/- and sibling Sirt1+/- mice. While viable animals were derived in both Sirt1-/- X wild type and Sirt1-/- X Sirt1-/- crosses, the efficiency of producing both 2-cell zygotes and viable offspring was diminished when IVF was performed with Sirt1-/- sperm and/or oocytes. Together, these data support an important role for Sirt1 in spermatogenesis, including spermatogenic stem cells, as well as germ cell function.	[Coussens, Matthew; Maresh, John G.; Yanagimachi, Ryuzo; Maeda, Gregg; Allsopp, Richard] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Coussens, Matthew; Allsopp, Richard] Univ Hawaii, Inst Biogen Res, Honolulu, HI USA	University of Hawaii System; University of Hawaii System	Coussens, M (corresponding author), Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA.	allsopp@hawaii.edu		Whitman, Mary/0000-0001-6297-7499	NIH [P20 RR16467-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grant P20 RR16467-05 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; ASHBURNER M, NAT GENET, V25, P25; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Coussens M, 2006, BIOL REPROD, V75, P785, DOI 10.1095/biolreprod.106.052167; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; HOPPE PC, 1973, BIOL REPROD, V8, P420, DOI 10.1093/biolreprod/8.4.420; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kennedy BK, 2005, CELL, V123, P548, DOI 10.1016/j.cell.2005.11.002; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nagy A., 2002, MANIPULATING MOUSE E; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; WELCH JE, 1990, BIOL REPROD, V43, P569, DOI 10.1095/biolreprod43.4.569; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	34	129	136	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1571	10.1371/journal.pone.0001571	http://dx.doi.org/10.1371/journal.pone.0001571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18612420	Green Published, Green Submitted, gold			2022-12-27	WOS:000260535900010
